PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Angrilli, A; Spironelli, C; Elbert, T; Crow, TJ; Marano, G; Stegagno, L				Angrilli, Alessandro; Spironelli, Chiara; Elbert, Thomas; Crow, Timothy J.; Marano, Gianfranco; Stegagno, Luciano			Schizophrenia as Failure of Left Hemispheric Dominance for the Phonological Component of Language	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; CEREBRAL ASYMMETRY; PLANUM TEMPORALE; WORKING-MEMORY; HOMO-SAPIENS; EEG ACTIVITY; BROCAS AREA; LATERALIZATION; BRAIN; CORTEX	Background: T. J. Crow suggested that the genetic variance associated with the evolution in Homo sapiens of hemispheric dominance for language carries with it the hazard of the symptoms of schizophrenia. Individuals lacking the typical left hemisphere advantage for language, in particular for phonological components, would be at increased risk of the typical symptoms such as auditory hallucinations and delusions. Methodology/Principal Findings: Twelve schizophrenic patients treated with low levels of neuroleptics and twelve matched healthy controls participated in an event-related potential experiment. Subjects matched word-pairs in three tasks: rhyming/phonological, semantic judgment and word recognition. Slow evoked potentials were recorded from 26 scalp electrodes, and a laterality index was computed for anterior and posterior regions during the inter stimulus interval. During phonological processing individuals with schizophrenia failed to achieve the left hemispheric dominance consistently observed in healthy controls. The effect involved anterior (fronto-temporal) brain regions and was specific for the Phonological task; group differences were small or absent when subjects processed the same stimulus material in a Semantic task or during Word Recognition, i.e. during tasks that typically activate more widespread areas in both hemispheres. Conclusions/Significance: We show for the first time how the deficit of lateralization in the schizophrenic brain is specific for the phonological component of language. This loss of hemispheric dominance would explain typical symptoms, e. g. when an individual's own thoughts are perceived as an external intruding voice. The change can be interpreted as a consequence of "hemispheric indecision'', a failure to segregate phonological engrams in one hemisphere.	[Angrilli, Alessandro; Spironelli, Chiara; Stegagno, Luciano] Univ Padua, Dept Gen Psychol, Padua, Italy; [Angrilli, Alessandro] CNR, Inst Neurosci, Padua, Italy; [Elbert, Thomas] Univ Konstanz, Ctr Psychiat, D-7750 Constance, Germany; [Elbert, Thomas] Univ Konstanz, Dept Psychol, D-7750 Constance, Germany; [Crow, Timothy J.] Warneford Hosp, Dept Psychiat, SANE POWIC, Oxford, England; [Marano, Gianfranco] Ctr Eating Disorders, Rovigo, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Konstanz; University of Konstanz	Angrilli, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	alessandro.angrilli@unipd.it	Angrilli, Alessandro/I-5519-2012; Spironelli, Chiara/AAC-1701-2021; Elbert, Thomas/C-8556-2009; Spironelli, Chiara/D-1548-2014	Spironelli, Chiara/0000-0002-8547-2431; Elbert, Thomas/0000-0003-1332-4939; Spironelli, Chiara/0000-0002-8547-2431; Angrilli, Alessandro/0000-0002-5571-7637	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); University of Padova [CPDA047438]; DFG (Deutsche Forschungsgemeinschaft)	MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); University of Padova; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by a grant (PRIN 2006110284_001) from the MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) and University of Padova project n. CPDA047438 to A.A. and from DFG (Deutsche Forschungsgemeinschaft) funds to T.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Angrilli A, 2003, NEUROIMAGE, V20, P657, DOI 10.1016/S1053-8119(03)00395-1; Angrilli A, 2000, CLIN NEUROPHYSIOL, V111, P706, DOI 10.1016/S1388-2457(99)00308-9; BAUER H, 1989, ELECTROEN CLIN NEURO, V72, P545, DOI 10.1016/0013-4694(89)90232-0; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BORTOLINI V, 1972, LESSICO FREQUENZA LI; Broca P, 1877, B ACADEMIE MED, V6, P508; Buxhoeveden DR, 2001, BRAIN BEHAV EVOLUT, V57, P349, DOI 10.1159/000047253; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Crow T. J., 2007, EVOLUTION NERVOUS SY, V4, P549; Crow TJ, 2007, NEUROL PSYCHIAT BR, V14, P87; Crow TJ, 2004, CURR OPIN PSYCHIATR, V17, P97, DOI 10.1097/00001504-200403000-00006; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; CROW TJ, 1995, EUR ARCH PSY CLIN N, V245, P61, DOI 10.1007/BF02190732; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; CROW TJ, 1989, ARCH GEN PSYCHIAT, V46, P1145; Cullen TJ, 2006, BRIT J PSYCHIAT, V188, P26, DOI 10.1192/bjp.bp.104.008169; DELISI LE, 1994, SCHIZOPHR RES, V12, P19, DOI 10.1016/0920-9964(94)90080-9; ESIRI MM, 2008, GREENFIELDS NEUROPAT; FLORHENRY P, 1983, CEREBRAL BASIS PSYCH; Gilissen E, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P187; GOLD JM, 1995, CURR OPIN NEUROBIOL, V5, P225, DOI 10.1016/0959-4388(95)80030-1; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heim S, 2004, EUR CHILD ADOLES PSY, V13, P125, DOI 10.1007/s00787-004-0361-7; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Kayser J, 1999, INT J PSYCHOPHYSIOL, V34, P249, DOI 10.1016/S0167-8760(99)00082-3; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; McCarley RW, 2002, ARCH GEN PSYCHIAT, V59, P321, DOI 10.1001/archpsyc.59.4.321; McDonald B, 2000, AM J PSYCHIAT, V157, P40, DOI 10.1176/ajp.157.1.40; Miller R, 2008, NEURODYNAMIC THEORY; Ngan ETC, 2003, NEUROIMAGE, V20, P889, DOI 10.1016/S1053-8119(03)00385-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Penolazzi B, 2006, NEUROREPORT, V17, P429, DOI 10.1097/01.wnr.0000203350.99256.7d; Penolazzi B, 2008, PSYCHOPHYSIOLOGY, V45, P1025, DOI 10.1111/j.1469-8986.2008.00709.x; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Petty RG, 1999, SCHIZOPHRENIA BULL, V25, P121, DOI 10.1093/oxfordjournals.schbul.a033360; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rockstroh B, 1998, NEUROREPORT, V9, P3819, DOI 10.1097/00001756-199812010-00010; Rockstroh B, 2001, BIOL PSYCHIAT, V49, P694, DOI 10.1016/S0006-3223(00)01023-4; Rockstroh B., 1989, SLOW CORTICAL POTENT; Ruchkin DS, 1997, NEUROPSYCHOLOGIA, V35, P195, DOI 10.1016/S0028-3932(96)00068-1; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sommer IEC, 2003, SCHIZOPHR RES, V60, P183, DOI 10.1016/S0920-9964(02)00300-6; Spironelli C, 2008, J PSYCHIATR NEUROSCI, V33, P235; Spironelli C, 2008, NEUROIMAGE, V40, P912, DOI 10.1016/j.neuroimage.2007.12.012; Spironelli C, 2008, BIOL PSYCHOL, V77, P123, DOI 10.1016/j.biopsycho.2007.09.009; Spironelli C, 2006, BEHAV BRAIN RES, V175, P296, DOI 10.1016/j.bbr.2006.08.038; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Williams NA, 2006, AM J MED GENET B, V141B, P623, DOI 10.1002/ajmg.b.30357	60	71	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4507	10.1371/journal.pone.0004507	http://dx.doi.org/10.1371/journal.pone.0004507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KG	19223971	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485800011
J	de la Puerta, ML; Trinidad, AG; Rodriguez, MD; Bogetz, J; Crespo, MS; Mustelin, T; Alonso, A; Bayon, Y				Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Bogetz, Jori; Sanchez Crespo, Mariano; Mustelin, Tomas; Alonso, Andres; Bayon, Yolanda			Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH	PLOS ONE			English	Article								YopH is an exceptionally active tyrosine phosphatase that is essential for virulence of Yersinia pestis, the bacterium causing plague. YopH breaks down signal transduction mechanisms in immune cells and inhibits the immune response. Only a few substrates for YopH have been characterized so far, for instance p130Cas and Fyb, but in view of YopH potency and the great number of proteins involved in signalling pathways it is quite likely that more proteins are substrates of this phosphatase. In this respect, we show here YopH interaction with several proteins not shown before, such as Gab1, Gab2, p85, and Vav and analyse the domains of YopH involved in these interactions. Furthermore, we show that Gab1, Gab2 and Vav are not dephosphorylated by YopH, in contrast to Fyb, Lck, or p85, which are readily dephosphorylated by the phosphatase. These data suggests that YopH might exert its actions by interacting with adaptors involved in signal transduction pathways, what allows the phosphatase to reach and dephosphorylate its susbstrates.	[Luisa de la Puerta, Maria; Trinidad, Antonio G.; del Carmen Rodriguez, Maria; Sanchez Crespo, Mariano; Alonso, Andres; Bayon, Yolanda] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain; [Bogetz, Jori; Mustelin, Tomas] Burnham Inst Med Res, Inflammatory & Infect Dis Ctr, Program Inflammat, La Jolla, CA USA; [Bogetz, Jori; Mustelin, Tomas] Burnham Inst Med Res, Program Signal Transduct, La Jolla, CA USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	de la Puerta, ML (corresponding author), Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid, Spain.	ybayon@ibgm.uva.es	BAyón, Yolanda/L-7635-2014; Bogetz, Jori F./U-2258-2019; Alonso, Andrés/L-7523-2014	BAyón, Yolanda/0000-0003-3089-5485; Alonso, Andrés/0000-0001-8674-9378; Mustelin, Tomas/0000-0001-5912-8840; Sanchez Crespo, Mariano/0000-0002-6149-154X	Junta de Castilla y Leon [VA002B05]; Plan Nacional de Biologia Fundamental [BFU2006-01203/BMC]; Red Tematica de Investigacion Cardiovascular; Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo	Junta de Castilla y Leon(Junta de Castilla y Leon); Plan Nacional de Biologia Fundamental; Red Tematica de Investigacion Cardiovascular; Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo(Spanish Government)	This work was supported by Junta de Castilla y Leon (VA002B05), Plan Nacional de Biologia Fundamental (Grant BFU2006-01203/BMC), and Red Tematica de Investigacion Cardiovascular. Y. B. is under contract within the Ramon y Cajal Program (Ministerio de Educacion and Fondo Social Europeo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 1999, BIOL CHEM, V380, P795, DOI 10.1515/BC.1999.099; Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; CHRISTIE A B, 1982, Ecology of Disease, V1, P111; Cleri D J, 1997, Semin Respir Infect, V12, P12; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; GREEN SP, 1995, J LEUKOCYTE BIOL, V57, P972, DOI 10.1002/jlb.57.6.972; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Hinnebusch BJ, 1997, J MOL MED, V75, P645, DOI 10.1007/s001090050148; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Ivanov MI, 2005, MOL MICROBIOL, V55, P1346, DOI 10.1111/j.1365-2958.2005.04477.x; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Titball RW, 1998, BRIT MED BULL, V54, P625, DOI 10.1093/oxfordjournals.bmb.a011715; Titball RW, 2001, VACCINE, V19, P4175, DOI 10.1016/S0264-410X(01)00163-3; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343	37	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4431	10.1371/journal.pone.0004431	http://dx.doi.org/10.1371/journal.pone.0004431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221593	Green Submitted, Green Published, gold			2022-12-27	WOS:000265485700003
J	Gadkari, RA; Varughese, D; Srinivasan, N				Gadkari, Rupali A.; Varughese, Deepthi; Srinivasan, N.			Recognition of Interaction Interface Residues in Low-Resolution Structures of Protein Assemblies Solely from the Positions of C alpha Atoms	PLOS ONE			English	Article								Background: The number of available structures of large multi-protein assemblies is quite small. Such structures provide phenomenal insights on the organization, mechanism of formation and functional properties of the assembly. Hence detailed analysis of such structures is highly rewarding. However, the common problem in such analyses is the low resolution of these structures. In the recent times a number of attempts that combine low resolution cryo-EM data with higher resolution structures determined using X-ray analysis or NMR or generated using comparative modeling have been reported. Even in such attempts the best result one arrives at is the very course idea about the assembly structure in terms of trace of the C alpha atoms which are modeled with modest accuracy. Methodology/Principal Findings: In this paper first we present an objective approach to identify potentially solvent exposed and buried residues solely from the position of C alpha atoms and amino acid sequence using residue type-dependent thresholds for accessible surface areas of C alpha. We extend the method further to recognize potential protein-protein interface residues. Conclusion/Significance: Our approach to identify buried and exposed residues solely from the positions of C alpha atoms resulted in an accuracy of 84%, sensitivity of 83-89% and specificity of 67-94% while recognition of interfacial residues corresponded to an accuracy of 94%, sensitivity of 70-96% and specificity of 58-94%. Interestingly, detailed analysis of cases of mismatch between recognition of interface residues from C alpha positions and all-atom models suggested that, recognition of interfacial residues using C alpha atoms only correspond better with intuitive notion of what is an interfacial residue. Our method should be useful in the objective analysis of structures of protein assemblies when positions of only C alpha positions are available as, for example, in the cases of integration of cryo-EM data and high resolution structures of the components of the assembly.	[Gadkari, Rupali A.; Varughese, Deepthi; Srinivasan, N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gadkari, RA (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	rupali@mbu.iisc.ernet.in; ns@mbu.iisc.ernet.in		VARUGHESE, DEEPTHI/0000-0001-8784-2427	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India under the Mathematical Biology programme	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India under the Mathematical Biology programme(Department of Science & Technology (India))	This research is supported by Department of Biotechnology, Government of India and also by Department of Science and Technology, Government of India under the Mathematical Biology programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carugo O, 2000, PROTEIN ENG, V13, P607, DOI 10.1093/protein/13.9.607; CHAN HS, 1990, P NATL ACAD SCI USA, V87, P6388, DOI 10.1073/pnas.87.16.6388; DeLano W.L., PYMOL MOL GRAPHICS S; Dror O, 2007, ACTA CRYSTALLOGR D, V63, P42, DOI 10.1107/S0907444906041059; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Fischer TB, 2006, J STRUCT BIOL, V153, P103, DOI 10.1016/j.jsb.2005.11.005; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Hubbard S. J., 1993, NACCESS; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kazmierkiewicz R, 2003, BIOPHYS CHEM, V100, P261, DOI 10.1016/S0301-4622(02)00285-5; Kitmitto Ashraf, 2006, V129, P315; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEVITT M, 1977, J MOL BIOL, V114, P181, DOI 10.1016/0022-2836(77)90207-8; Marrone TJ, 1997, ANNU REV PHARMACOL, V37, P71, DOI 10.1146/annurev.pharmtox.37.1.71; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Poupon A, 2004, CURR OPIN STRUC BIOL, V14, P233, DOI 10.1016/j.sbi.2004.03.010; RAMAKRISHNAN C, 1982, INT J PEPT PROT RES, V20, P218; Rekha N, 2005, PROTEINS, V58, P339, DOI 10.1002/prot.20319; ROSE GD, 1977, J MOL BIOL, V113, P153, DOI 10.1016/0022-2836(77)90046-8; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salwinski L, 2003, CURR OPIN STRUC BIOL, V13, P377, DOI 10.1016/S0959-440X(03)00070-8; Singh YH, 2006, BIOPHYS CHEM, V124, P145, DOI 10.1016/j.bpc.2006.06.013; SOMAN K, 1984, IDENTIFICATION SECON; Thompson MJ, 1996, PROTEINS, V25, P38, DOI 10.1002/(SICI)1097-0134(199605)25:1<38::AID-PROT4>3.3.CO;2-H; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang JY, 2005, PROTEINS, V61, P481, DOI 10.1002/prot.20620; Xu ZG, 2006, PROTEINS, V63, P961, DOI 10.1002/prot.20934; Yuan Z, 2006, J PROTEOME RES, V5, P1063, DOI 10.1021/pr050397b; Yuan Z, 2004, PROTEINS, V57, P558, DOI 10.1002/prot.20234; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4476	10.1371/journal.pone.0004476	http://dx.doi.org/10.1371/journal.pone.0004476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214247	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484300012
J	Lessler, J; Kaufman, JH; Ford, DA; Douglas, JV				Lessler, Justin; Kaufman, James H.; Ford, Daniel A.; Douglas, Judith V.			The Cost of Simplifying Air Travel When Modeling Disease Spread	PLOS ONE			English	Article							INFLUENZA	Background: Air travel plays a key role in the spread of many pathogens. Modeling the long distance spread of infectious disease in these cases requires an air travel model. Highly detailed air transportation models can be over determined and computationally problematic. We compared the predictions of a simplified air transport model with those of a model of all routes and assessed the impact of differences on models of infectious disease. Methodology/Principal Findings: Using U. S. ticket data from 2007, we compared a simplified "pipe'' model, in which individuals flow in and out of the air transport system based on the number of arrivals and departures from a given airport, to a fully saturated model where all routes are modeled individually. We also compared the pipe model to a "gravity'' model where the probability of travel is scaled by physical distance; the gravity model did not differ significantly from the pipe model. The pipe model roughly approximated actual air travel, but tended to overestimate the number of trips between small airports and underestimate travel between major east and west coast airports. For most routes, the maximum number of false (or missed) introductions of disease is small (<1 per day) but for a few routes this rate is greatly underestimated by the pipe model. Conclusions/Significance: If our interest is in large scale regional and national effects of disease, the simplified pipe model may be adequate. If we are interested in specific effects of interventions on particular air routes or the time for the disease to reach a particular location, a more complex point-to-point model will be more accurate. For many problems a hybrid model that independently models some frequently traveled routes may be the best choice. Regardless of the model used, the effect of simplifications and sensitivity to errors in parameter estimation should be analyzed.	[Lessler, Justin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Kaufman, James H.; Ford, Daniel A.; Douglas, Judith V.] IBM Corp, Almaden Res Ctr, San Jose, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Business Machines (IBM)	Lessler, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	judydouglas@comcast.net		Lessler, Justin/0000-0002-9741-8109; Kaufman, James/0000-0002-7049-7134	U.S. Air Force Surgeon General's Office (AF/SG); Air Force District of Washington (AFDW) [FA7014-07-C-0044]	U.S. Air Force Surgeon General's Office (AF/SG); Air Force District of Washington (AFDW)	This project is being developed under Contract Number FA7014-07-C-0044, with the U.S. Air Force Surgeon General's Office (AF/SG) and administered by the Air Force District of Washington (AFDW). The Air Force has not accepted the products depicted and issuance of a contract does not constitute Federal endorsement of the IBM Almaden Research Center. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Brownstein JS, 2006, PLOS MED, V3, P2160, DOI 10.1371/journal.pmed.0030502; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; *ECL FDN, 2008, OP HLTH FRAM SPAT TE; Ford Daniel Alexander, 2006, Int J Health Geogr, V5, P4, DOI 10.1186/1476-072X-5-4; Kaufman JH, 2008, LECT N BIOINFORMAT, V5354, P143, DOI 10.1007/978-3-540-89746-0_14; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERGING INFECT DIS, V1; Paul Rodrigue, 2006, GEOGRAPHY TRANSPORT; R Core Team, 2018, R LANG ENV STAT COMP; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503	13	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4403	10.1371/journal.pone.0004403	http://dx.doi.org/10.1371/journal.pone.0004403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197382	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483700011
J	Wang, ZX; Chen, F; Zhai, RH; Zhang, LS; Su, L; Lin, XH; Thompson, T; Christiani, DC				Wang, Zhaoxi; Chen, Feng; Zhai, Rihong; Zhang, Lingsong; Su, Li; Lin, Xihong; Thompson, Taylor; Christiani, David C.			Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development	PLOS ONE			English	Article								Background: We conducted an exploratory study of genome-wide gene expression in whole blood and found that the expression of neutrophil elastase inhibitor (PI3, elafin) was down-regulated during the early phase of ARDS. Further analyses of plasma PI3 levels revealed a rapid decrease during early ARDS development. PI3 and secretory leukocyte proteinase inhibitor (SLPI) are important low-molecular-weight proteinase inhibitors produced locally at neutrophil infiltration site in the lung. In this study, we tested the hypothesis that an imbalance between neutrophil elastase (HNE) and its inhibitors in blood is related to the development of ARDS. Methodology/Principal Findings: PI3, SLPI, and HNE were measured in plasma samples collected from 148 ARDS patients and 63 critical ill patients at risk for ARDS (controls). Compared with the controls, the ARDS patients had higher HNE, but lower PI3, at the onset of ARDS, resulting in increased HNE/PI3 ratio (mean = 14.5; 95% CI, 10.9-19.4, P<0.0001), whereas plasma SLPI was not associated with the risk of ARDS development. Although the controls had elevated plasma PI3 and HNE, their HNE/PI3 ratio (mean = 6.5; 95% CI, 4.9-8.8) was not significantly different from the healthy individuals (mean = 3.9; 95% CI, 2.7-5.9). Before the onset (7-days period prior to ARDS diagnosis), we only observed significantly elevated HNE, but the HNE-PI3 balance remained normal. With the progress from prior to the onset of ARDS, the plasma level of PI3 declined, whereas HNE was maintained at a higher level, tilting the balance toward more HNE in the circulation as characterized by an increased HNE/PI3 ratio. In contrast, three days after ICU admission, there was a significant drop of HNE/PI3 ratio in the at-risk controls. Conclusions/Significance: Plasma profiles of PI3, HNE, and HNE/PI3 may be useful clinical biomarkers in monitoring the development of ARDS.	[Wang, Zhaoxi; Chen, Feng; Zhai, Rihong; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Lingsong; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Thompson, Taylor; Christiani, David C.] Massachusetts Gen Hosp, Pulmon & Critical Care Unit, Boston, MA 02114 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wang, ZX (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	mikewang@hsph.harvard.edu			National Institute of Health [HL60710, ES00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from National Institute of Health (HL60710, ES00002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; DONNELLY SC, 1995, AM J RESP CRIT CARE, V151, P1428, DOI 10.1164/ajrccm.151.5.7735596; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; Frutos-Vivar Fernando, 2004, Curr Opin Crit Care, V10, P1, DOI 10.1097/00075198-200402000-00001; FUJISHIMA S, 2007, BIOMED PHARMACOTHER; Gando S, 2004, INFLAMMATION, V28, P237, DOI 10.1023/B:IFLA.0000049049.81688.fe; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Gong MN, 2005, EUR RESPIR J, V26, P382, DOI 10.1183/09031936.05.00000505; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Hashimoto S, 2008, RESPIROLOGY, V13, P581, DOI 10.1111/j.1440-1843.2008.01283.x; Hoshi K, 2005, TOHOKU J EXP MED, V207, P143, DOI 10.1620/tjem.207.143; IDELL S, 1985, AM REV RESPIR DIS, V132, P1098; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kodama T, 2007, INTERNAL MED, V46, P699, DOI 10.2169/internalmedicine.46.6182; LEE CT, 1981, NEW ENGL J MED, V304, P192, DOI 10.1056/NEJM198101223040402; McClintock DE, 2007, AM J RESP CRIT CARE, V175, P256, DOI 10.1164/rccm.200607-947OC; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; Mortelliti MP, 2002, AM FAM PHYSICIAN, V65, P1823; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; Parsons PE, 2005, AM J PHYSIOL-LUNG C, V288, pL426, DOI 10.1152/ajplung.00302.2004; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Reid PT, 1999, FEBS LETT, V457, P33, DOI 10.1016/S0014-5793(99)01004-2; RICE WG, 1990, SCIENCE, V249, P178, DOI 10.1126/science.2371565; ROCKER GM, 1989, LANCET, V1, P120; Sallenave JM, 1999, EUR RESPIR J, V13, P1029, DOI 10.1183/09031936.99.13510299; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; TAKAHASHI H, 1988, J BIOL CHEM, V263, P2543; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218; Zeiher BG, 2002, CRIT CARE MED, V30, pS281, DOI 10.1097/00003246-200205001-00018; Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85; Zhai RH, 2007, CRIT CARE MED, V35, P893, DOI 10.1097/01.CCM.0000256845.92640.38	37	39	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4380	10.1371/journal.pone.0004380	http://dx.doi.org/10.1371/journal.pone.0004380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197381	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483700005
J	Major, L; La Linn, M; Slade, RW; Schroder, WA; Hyatt, AD; Gardner, J; Cowley, J; Suhrbier, A				Major, Lee; La Linn, May; Slade, Robert W.; Schroder, Wayne A.; Hyatt, Alex D.; Gardner, Joy; Cowley, Jeff; Suhrbier, Andreas			Ticks Associated with Macquarie Island Penguins Carry Arboviruses from Four Genera	PLOS ONE			English	Article								Macquarie Island, a small subantarctic island, is home to rockhopper, royal and king penguins, which are often infested with the globally distributed seabird tick, Ixodes uriae. A flavivirus, an orbivirus, a phlebovirus, and a nairovirus were isolated from these ticks and partial sequences obtained. The flavivirus was nearly identical to Gadgets Gully virus, isolated some 30 year previously, illustrating the remarkable genetic stability of this virus. The nearest relative to the orbivirus (for which we propose the name Sandy Bay virus) was the Scottish Broadhaven virus, and provided only the second available sequences from the Great Island orbivirus serogroup. The phlebovirus (for which we propose the name Catch-me-cave virus) and the previously isolated Precarious Point virus were distinct but related, with both showing homology with the Finnish Uukuniemi virus. These penguin viruses provided the second and third available sequences for the Uukuniemi group of phleboviruses. The nairovirus (for which we propose the name Finch Creek virus) was shown to be related to the North American Tillamook virus, the Asian Hazara virus and Nairobi sheep disease virus. Macquarie Island penguins thus harbour arboviruses from at least four of the seven arbovirus-containing genera, with related viruses often found in the northern hemisphere.	[Major, Lee; La Linn, May; Schroder, Wayne A.; Gardner, Joy; Suhrbier, Andreas] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Slade, Robert W.] So Cross Univ, Lismore, NSW, Australia; [Hyatt, Alex D.] CSIRO, Australian Animal Hlth Lab, Geelong, Vic, Australia; [Cowley, Jeff] CSIRO, Livestock Indust, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Southern Cross University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Major, L (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	andreasS@qimr.edu.au	Cowley, Jeff A/H-7553-2013	Cowley, Jeff/0000-0003-0454-4825; Suhrbier, Andreas/0000-0001-8986-9025	Australian Antarctic Science Advisory Committee (Project 1334); Australian Centre for International and Tropical Health; Australian Antarctic Division, NH&MRC Australia	Australian Antarctic Science Advisory Committee (Project 1334); Australian Centre for International and Tropical Health; Australian Antarctic Division, NH&MRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Australian Antarctic Science Advisory Committee (Project 1334) and the Australian Centre for International and Tropical Health. Australian Antarctic Division, NH&MRC Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Briese T, 2005, J NEUROVIROL, V11, P469, DOI 10.1080/13550280500187617; CHASTEL C, 1983, REV EPIDEMIOL SANTE, V31, P445; Chastel C, 1995, B SOC PATHOL EXOT, V88, P81; CHASTEL C, 1986, PRESSE MED, V15, P441; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DOHERTY RL, 1975, AM J TROP MED HYG, V24, P521, DOI 10.4269/ajtmh.1975.24.521; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; ERASMUS BJ, 1975, AUST VET J, V51, P196, DOI 10.1111/j.1751-0813.1975.tb00054.x; FOULKE RS, 1981, J GEN VIROL, V53, P169, DOI 10.1099/0022-1317-53-1-169; Gauthier-Clerc M, 1998, COLON WATERBIRD, V21, P229, DOI 10.2307/1521910; GORMAN BM, 1984, AUST J EXP BIOL MED, V62, P101, DOI 10.1038/icb.1984.10; Gould EA, 2006, EMERG INFECT DIS, V12, P549, DOI 10.3201/eid1204.051010; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; HAWKES RA, 1985, MED J AUSTRALIA, V143, P555, DOI 10.5694/j.1326-5377.1985.tb119949.x; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; HUMPHERYSMITH I, 1991, EPIDEMIOL INFECT, V107, P435, DOI 10.1017/S0950268800049086; HYATT AD, 1994, MICRON, V25, P597, DOI 10.1016/0968-4328(94)90022-1; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001; LVOV DK, 1974, J HYG EPID MICROB IM, V18, P87; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; MARIN MS, 1995, VIROLOGY, V206, P1133, DOI 10.1006/viro.1995.1038; MORGAN IR, 1981, AUST VET J, V57, P333, DOI 10.1111/j.1751-0813.1981.tb05839.x; MORGAN IR, 1985, J WILDLIFE DIS, V21, P193, DOI 10.7589/0090-3558-21.3.193; MOSS SR, 1988, J GEN VIROL, V69, P2721, DOI 10.1099/0022-1317-69-11-2721; Nunn MA, 2006, PARASITOLOGY, V132, P233, DOI 10.1017/S0031182005008930; NUTTALL PA, 1984, ARCH VIROL, V79, P35, DOI 10.1007/BF01314301; Pearce DA, 2003, ANTARCT SCI, V15, P319, DOI 10.1017/S0954102003001330; Pijlman GP, 2006, EXPERT OPIN BIOL TH, V6, P135, DOI 10.1517/14712598.6.2.135; Potgieter AC, 2002, J GEN VIROL, V83, P2215, DOI 10.1099/0022-1317-83-9-2215; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Reed Kurt D, 2003, Clin Med Res, V1, P5; SAIKKU P, 1975, MED BIOL, V53, P317; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496; STGEORGE TD, 1985, AM J TROP MED HYG, V34, P406; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAAVIK T, 1975, MED BIOL, V53, P321; Tuttle AD, 2005, JAVMA-J AM VET MED A, V226, P2059, DOI 10.2460/javma.2005.226.2059; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; YUNKER CE, 1975, MED BIOL, V53, P302	44	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4375	10.1371/journal.pone.0004375	http://dx.doi.org/10.1371/journal.pone.0004375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194498	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483600008
J	Gottig, N; Garavaglia, BS; Garofalo, CG; Orellano, EG; Ottado, J				Gottig, Natalia; Garavaglia, Betiana S.; Garofalo, Cecilia G.; Orellano, Elena G.; Ottado, Jorgelina			A Filamentous Hemagglutinin-Like Protein of Xanthomonas axonopodis pv. citri, the Phytopathogen Responsible for Citrus Canker, Is Involved in Bacterial Virulence	PLOS ONE			English	Article								Xanthomonas axonopodis pv. citri, the phytopathogen responsible for citrus canker has a number of protein secretion systems and among them, at least one type V protein secretion system belonging to the two-partner secretion pathway. This system is mainly associated to the translocation of large proteins such as adhesins to the outer membrane of several pathogens. Xanthomonas axonopodis pv. citri possess a filamentous hemagglutinin-like protein in close vicinity to its putative transporter protein, XacFhaB and XacFhaC, respectively. Expression analysis indicated that XacFhaB was induced in planta during plant-pathogen interaction. By mutation analysis of XacFhaB and XacFhaC genes we determined that XacFhaB is involved in virulence both in epiphytic and wound inoculations, displaying more dispersed and fewer canker lesions. Unexpectedly, the XacFhaC mutant in the transporter protein produced an intermediate virulence phenotype resembling wild type infection, suggesting that XacFhaB could be secreted by another partner different from XacFhaC. Moreover, XacFhaB mutants showed a general lack of adhesion and were affected in leaf surface attachment and biofilm formation. In agreement with the in planta phenotype, adhesin lacking cells moved faster in swarming plates. Since no hyperflagellation phenotype was observed in this bacteria, the faster movement may be attributed to the lack of cell-to-cell aggregation. Moreover, XacFhaB mutants secreted more exopolysaccharide that in turn may facilitate its motility. Our results suggest that this hemagglutinin-like protein is required for tissue colonization being mainly involved in surface attachment and biofilm formation, and that plant tissue attachment and cell-to-cell aggregation are dependent on the coordinated action of adhesin molecules and exopolysaccharides.	[Gottig, Natalia; Garavaglia, Betiana S.; Garofalo, Cecilia G.; Orellano, Elena G.; Ottado, Jorgelina] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario,CONICET, RA-2000 Rosario, Argentina	National University of Rosario	Gottig, N (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Div Mol Biol, Inst Biol Mol & Celular Rosario,CONICET, RA-2000 Rosario, Argentina.	ottado@ibr.gov.ar		Gottig, Natalia/0000-0002-8730-8248	ANPCyT [PICT2006-00678]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) [Fellows]	ANPCyT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by ANPCyT PICT2006-00678 to Jorgelina Ottado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NG, EGO and JO are staff members and BSG and CGG are Fellows of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina).	Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Castelli ME, 2008, J BACTERIOL, V190, P213, DOI 10.1128/JB.01348-07; Chatterjee S, 2008, MOL PLANT MICROBE IN, V21, P1309, DOI 10.1094/MPMI-21-10-1309; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Fall R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-31; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hinsa SM, 2006, MICROBIOL-SGM, V152, P1375, DOI 10.1099/mic.0.28696-0; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; JacobDubuisson F, 1997, J BACTERIOL, V179, P775, DOI 10.1128/jb.179.3.775-783.1997; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; KAMOUN S, 1990, APPL ENVIRON MICROB, V56, P3855, DOI 10.1128/AEM.56.12.3855-3860.1990; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Mehta A, 2003, CURR MICROBIOL, V47, P400, DOI 10.1007/s00284-003-4051-3; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Moreira LM, 2004, ANNU REV PHYTOPATHOL, V42, P163, DOI 10.1146/annurev.phyto.42.040803.140310; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murray TS, 2008, J BACTERIOL, V190, P2700, DOI 10.1128/JB.01620-07; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Sambrook J., 2002, MOL CLONING LAB MANU; Shen YW, 2001, MOL PLANT MICROBE IN, V14, P204, DOI 10.1094/MPMI.2001.14.2.204; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668	50	122	123	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4358	10.1371/journal.pone.0004358	http://dx.doi.org/10.1371/journal.pone.0004358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194503	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483500008
J	Gazzolo, D; Frigiola, A; Bashir, M; Iskander, I; Mufeed, H; Aboulgar, H; Venturini, P; Marras, M; Serra, G; Frulio, R; Michetti, F; Petraglia, F; Abella, R; Florio, P				Gazzolo, Diego; Frigiola, Alessandro; Bashir, Moataza; Iskander, Iman; Mufeed, Hala; Aboulgar, Hanna; Venturini, Pierluigi; Marras, Mauro; Serra, Giovanni; Frulio, Rosanna; Michetti, Fabrizio; Petraglia, Felice; Abella, Raul; Florio, Pasquale			Diagnostic Accuracy of S100B Urinary Testing at Birth in Full-Term Asphyxiated Newborns to Predict Neonatal Death	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; EARLY INDICATOR; INTRAVENTRICULAR HEMORRHAGE; EARLY IDENTIFICATION; PRETERM INFANTS; S-100 PROTEIN; BRAIN-DAMAGE; TOOL; ENCEPHALOPATHY; SERUM	Background: Neonatal death in full-term infants who suffer from perinatal asphyxia (PA) is a major subject of investigation, since few tools exist to predict patients at risk of ominous outcome. We studied the possibility that urine S100B measurement may identify which PA-affected infants are at risk of early postnatal death. Methodology/Principal Findings: In a cross-sectional study between January 1, 2001 and December 1, 2006 we measured S100B protein in urine collected from term infants (n = 132), 60 of whom suffered PA. According to their outcome at 7 days, infants with PA were subsequently classified either as asphyxiated infants complicated by hypoxic ischemic encephalopathy with no ominous outcome (HIE Group; n = 48), or as newborns who died within the first post-natal week (Ominous Outcome Group; n = 12). Routine laboratory variables, cerebral ultrasound, neurological patterns and urine concentrations of S100B protein were determined at first urination and after 24, 48 and 96 hours. The severity of illness in the first 24 hours after birth was measured using the Score for Neonatal Acute Physiology-Perinatal Extension (SNAP-PE). Urine S100B levels were higher from the first urination in the ominous outcome group than in healthy or HIE Groups (p < 0.001 for all), and progressively increased. Multiple logistic regression analysis showed a significant correlation between S100B concentrations and the occurrence of neonatal death. At a cut-off.1.0 mg/L S100B had a sensitivity/specificity of 100% for predicting neonatal death. Conclusions/Significance: Increased S100B protein urine levels in term newborns suffering PA seem to suggest a higher risk of neonatal death for these infants.	[Gazzolo, Diego; Venturini, Pierluigi; Marras, Mauro; Serra, Giovanni; Frulio, Rosanna] Univ Genoa, G Gaslini Childrens Hosp, Dept Obstet Pediat & Neurosci, Genoa, Italy; [Gazzolo, Diego] G Garibaldi Hosp, Dept Maternal Fetal & Neonatal Hlth, Catania, Italy; [Frigiola, Alessandro; Abella, Raul] S Donato Milanese Univ Hosp, Dept Cardiac Surg, Perinatal Res Lab, Milan, Italy; [Bashir, Moataza; Iskander, Iman; Mufeed, Hala; Aboulgar, Hanna] Cairo Univ, Dept Neonatol, Cairo, Egypt; [Michetti, Fabrizio] Catholic Univ, Inst Anat, Rome, Italy; [Petraglia, Felice; Florio, Pasquale] Univ Siena, Dept Pediat Obstet & Reproduct Med, I-53100 Siena, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Egyptian Knowledge Bank (EKB); Cairo University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena	Gazzolo, D (corresponding author), Univ Genoa, G Gaslini Childrens Hosp, Dept Obstet Pediat & Neurosci, Genoa, Italy.	dgazzolo@hotmail.com	Petraglia, Felice/D-4373-2019; Frigiola, Alessandro/ABG-7502-2020	Petraglia, Felice/0000-0002-8851-625X; Frigiola, Alessandro/0000-0003-2762-9258	Italian Ministry of University and Scientific Research; Let's improve prenatal life Foundation; Stella Cometa Foundations	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Let's improve prenatal life Foundation; Stella Cometa Foundations	This work was partially supported by grants (COFIN 2005) provided by the Italian Ministry of University and Scientific Research, and from the "Let's improve prenatal life" and Stella Cometa" Foundations. The funding sources had no role in the design or conduct of the study, in the collection, management, analysis, or interpretation of the data, or in the preparation, review and approval of the manuscript.	BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; Florio P, 2004, LANCET, V364, P270, DOI 10.1016/S0140-6736(04)16677-4; Florio P, 2006, PEDIATRICS, V118, pE747, DOI 10.1542/peds.2005-2875; FREEMAN JM, 1988, PEDIATRICS, V82, P240; Gazzolo D, 1998, CLIN CHEM, V44, P1058; Gazzolo D, 2005, PEDIATR RES, V58, P1170, DOI 10.1203/01.pdr.0000185131.22985.30; Gazzolo D, 2004, CLIN CHEM, V50, P941, DOI 10.1373/clinchem.2003.021048; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2002, CRIT CARE MED, V30, P1356, DOI 10.1097/00003246-200206000-00037; Gazzolo D, 2002, PEDIATR RES, V51, P215, DOI 10.1203/00006450-200202000-00015; Gazzolo D, 2002, ACTA PAEDIATR, V91, P218, DOI 10.1080/080352502317285243; Gazzolo D, 2001, CLIN CHEM, V47, P1836; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Heizmann CW, 1999, NEUROCHEM RES, V24, P1097, DOI 10.1023/A:1020700117665; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Marinoni E, 2002, OBSTET GYNECOL, V99, P1093, DOI 10.1016/S0029-7844(02)01996-8; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; Michetti F, 2002, CLIN CHEM, V48, P2097; MICHETTI F, 1979, NEUROSCI LETT, V11, P171, DOI 10.1016/0304-3940(79)90122-8; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Prechtl HFR., 1982, PSYCHOBIOLOGY HUMAN, P21; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Stephan C, 2003, CLIN CHEM, V49, P433, DOI 10.1373/49.3.433; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZWEIG MH, 1993, CLIN CHEM, V39, P561; INT J GYNECOL OBSTET, V61, P309	34	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4298	10.1371/journal.pone.0004298	http://dx.doi.org/10.1371/journal.pone.0004298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183802	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483200001
J	Oomen, CA; Girardi, CEN; Cahyadi, R; Verbeek, EC; Krugers, H; Joels, M; Lucassen, PJ				Oomen, Charlotte A.; Girardi, Carlos E. N.; Cahyadi, Rudy; Verbeek, Eva C.; Krugers, Harm; Joels, Marian; Lucassen, Paul J.			Opposite Effects of Early Maternal Deprivation on Neurogenesis in Male versus Female Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ADULT HIPPOCAMPAL NEUROGENESIS; CORTICOTROPIN-RELEASING-FACTOR; CHRONIC PSYCHOSOCIAL STRESS; GONADAL HORMONE MODULATION; FIBRILLARY ACIDIC PROTEIN; PRENATAL RESTRAINT STRESS; GENERATED GRANULE CELLS; CA3 PYRAMIDAL NEURONS; LONG-LASTING CHANGES	Background: Major depression is more prevalent in women than in men. The underlying neurobiological mechanisms are not well understood, but recent data shows that hippocampal volume reductions in depressed women occur only when depression is preceded by an early life stressor. This underlines the potential importance of early life stress, at least in women, for the vulnerability to develop depression. Perinatal stress exposure in rodents affects critical periods of brain development that persistently alter structural, emotional and neuroendocrine parameters in adult offspring. Moreover, stress inhibits adult hippocampal neurogenesis, a form of structural plasticity that has been implicated a.o. in antidepressant action and is highly abundant early postnatally. We here tested the hypothesis that early life stress differentially affects hippocampal structural plasticity in female versus male offspring. Principal Findings: We show that 24 h of maternal deprivation (MD) at PND3 affects hippocampal structural plasticity at PND21 in a sex-dependent manner. Neurogenesis was significantly increased in male but decreased in female offspring after MD. Since no other structural changes were found in granule cell layer volume, newborn cell survival or proliferation rate, astrocyte number or gliogenesis, this indicates that MD elicits specific changes in subsets of differentiating cells and differentially affects immature neurons. The MD induced sex-specific effects on neurogenesis cannot be explained by differences in maternal care. Conclusions: Our data shows that early environment has a critical influence on establishing sex differences in neural plasticity and supports the concept that the setpoint for neurogenesis may be determined during perinatal life. It is tempting to speculate that a reduced level of neurogenesis, secondary to early stress exposure, may contribute to maladaptation of the HPA axis and possibly to the increased vulnerability of women to stress-related disorders.	[Oomen, Charlotte A.; Girardi, Carlos E. N.; Cahyadi, Rudy; Verbeek, Eva C.; Krugers, Harm; Joels, Marian; Lucassen, Paul J.] Univ Amsterdam, SILS Ctr Neurosci, Amsterdam, Netherlands	University of Amsterdam	Oomen, CA (corresponding author), Univ Amsterdam, SILS Ctr Neurosci, Amsterdam, Netherlands.	Lucassen@science.uva.nl	Girardi, Carlos E N/H-4567-2014; Lucassen, Paul/ABA-3113-2020; Oomen, Charlotte/K-5259-2014; Joëls, Marian/P-6415-2016; Girardi, Carlos Eduardo Neves/B-4254-2015	Girardi, Carlos E N/0000-0002-1739-6924; Lucassen, Paul/0000-0001-9708-9133; Girardi, Carlos Eduardo Neves/0000-0002-1739-6924; Joels, Marian/0000-0002-4826-6209	Netherlands Brain Foundation	Netherlands Brain Foundation	PJL is supported by the Netherlands Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Belanoff JK, 2002, BIOL PSYCHIAT, V52, P386, DOI 10.1016/S0006-3223(02)01432-4; Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Bland RC, 1997, CAN J PSYCHIAT, V42, P367, DOI 10.1177/070674379704200403; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Conejo NM, 2005, J NEUROSCI RES, V79, P488, DOI 10.1002/jnr.20372; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Dallman MF, 2003, PHYSIOL BEHAV, V79, P3, DOI 10.1016/S0031-9384(03)00100-8; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Desbonnet L, 2008, INT J DEV NEUROSCI, V26, P259, DOI 10.1016/j.ijdevneu.2008.02.004; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; Falconer EM, 2003, BRAIN RES, V975, P22, DOI 10.1016/S0006-8993(03)02542-3; Fenoglio KA, 2006, FRONT NEUROENDOCRIN, V27, P180, DOI 10.1016/j.yfrne.2006.02.001; Frye C A, 2000, Stress, V3, P185, DOI 10.3109/10253890009001122; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; GARCIASEGURA LM, 1988, BRAIN RES, V456, P357, DOI 10.1016/0006-8993(88)90239-9; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gould E, 1997, J NEUROSCI, V17, P2492; Greisen MH, 2005, J NEUROSCI RES, V79, P772, DOI 10.1002/jnr.20418; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HENRY C, 1994, J NEUROENDOCRINOL, V6, P341, DOI 10.1111/j.1365-2826.1994.tb00591.x; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; HOFER MA, 1994, DEV PSYCHOBIOL, V27, P503, DOI 10.1002/dev.420270804; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; JOELS M, 2007, FRONTIERS NEUROENDOC; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Koehl M, 2001, NEUROTOX RES, V3, P65, DOI 10.1007/BF03033231; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Kole MHP, 2004, HIPPOCAMPUS, V14, P742, DOI 10.1002/hipo.10212; Ladd CO, 1996, ENDOCRINOLOGY, V137, P1212, DOI 10.1210/en.137.4.1212; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LEVINE S, 1956, J PERS, V24, P475, DOI 10.1111/j.1467-6494.1956.tb01283.x; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Levine S., 1994, ANN NY ACAD SCI, V746, P282, DOI DOI 10.1111/J.1749-6632.1994.TB39245.X; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Llorente R, 2008, DEV NEUROBIOL, V68, P1334, DOI 10.1002/dneu.20666; LUCASSEN PJ, 2008, EUR J NEURO IN PRESS; LUCASSEN PJ, 2008, REGULATION HIPPOCAMP, P363; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Mandyam CD, 2008, DEV NEUROBIOL, V68, P575, DOI 10.1002/dneu.20600; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; Miranda P, 1999, J NEUROSCI, V19, P3316; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Nacher J, 2004, NEUROSCI LETT, V370, P40, DOI 10.1016/j.neulet.2004.07.062; OOMEN CA, 2007, BRIEF TREATMEN UNPUB; Penke Z, 2001, EUR J NEUROSCI, V14, P747, DOI 10.1046/j.0953-816x.2001.01691.x; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Pryce CR, 2001, DEV PSYCHOBIOL, V38, P239, DOI 10.1002/dev.1018; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Reus VI, 2001, EXPERT OPIN INV DRUG, V10, P1789, DOI 10.1517/13543784.10.10.1789; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmitz C, 2002, MOL PSYCHIATR, V7, P810, DOI 10.1038/sj.mp.4001118; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Spritzer MD, 2007, DEV NEUROBIOL, V67, P1321, DOI 10.1002/dneu.20457; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Sutanto W, 1996, DEV BRAIN RES, V92, P156, DOI 10.1016/0165-3806(95)00213-8; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tauber SC, 2008, BRAIN PATHOL, V18, P497, DOI 10.1111/j.1750-3639.2008.00149.x; Thomas RM, 2008, GENE EXPRESSION, V14, P183; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Ustun T B, 2000, J Gend Specif Med, V3, P54; Vallee M, 1997, J NEUROSCI, V17, P2626; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Weiss EL, 1999, AM J PSYCHIAT, V156, P816, DOI 10.1176/ajp.156.6.816; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Workel JO, 1997, DEV BRAIN RES, V103, P199, DOI 10.1016/S0165-3806(97)81796-8; Workel JO, 2001, J NEUROENDOCRINOL, V13, P569, DOI 10.1046/j.1365-2826.2001.00668.x; Young E A, 1998, J Gend Specif Med, V1, P21	124	145	147	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e3675	10.1371/journal.pone.0003675	http://dx.doi.org/10.1371/journal.pone.0003675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19180242	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483100002
J	Gross, HJ; Pahl, M; Si, A; Zhu, H; Tautz, J; Zhang, SW				Gross, Hans J.; Pahl, Mario; Si, Aung; Zhu, Hong; Tautz, Juergen; Zhang, Shaowu			Number-Based Visual Generalisation in the Honeybee	PLOS ONE			English	Article							NUMERICAL COMPETENCE; MEMORY; SENSE; BEES; REPRESENTATION; RECOGNITION; PERCEPTION; SYMMETRY	Although the numerical abilities of many vertebrate species have been investigated in the scientific literature, there are few convincing accounts of invertebrate numerical competence. Honeybees, Apis mellifera, by virtue of their other impressive cognitive feats, are a prime candidate for investigations of this nature. We therefore used the well-established delayed match-to-sample paradigm, to test the limits of honeybees' ability to match two visual patterns solely on the basis of the shared number of elements in the two patterns. Using a y-maze, we found that bees can not only differentiate between patterns containing two and three elements, but can also use this prior knowledge to differentiate three from four, without any additional training. However, bees trained on the two versus three task could not distinguish between higher numbers, such as four versus five, four versus six, or five versus six. Control experiments confirmed that the bees were not using cues such as the colour of the exact configuration of the visual elements, the combined area or edge length of the elements, or illusory contours formed by the elements. To our knowledge, this is the first report of number-based visual generalisation by an invertebrate.	[Gross, Hans J.] Univ Wurzburg, Bioctr, Chair Biochem, Wurzburg, Germany; [Pahl, Mario; Tautz, Juergen] Univ Wurzburg, Bioctr, BEEgrp, D-97070 Wurzburg, Germany; [Pahl, Mario; Si, Aung; Zhu, Hong; Zhang, Shaowu] Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Excellence Vision Sci, Canberra, ACT, Australia	University of Wurzburg; University of Wurzburg; Australian National University	Gross, HJ (corresponding author), Univ Wurzburg, Bioctr, Chair Biochem, Wurzburg, Germany.	tautz@biozentrum.uni-wuerzburg.de; swzhang@rsbs.anu.edu.au		Zhang, Shaowu/0000-0002-3551-5587; Si, Aung/0000-0001-8115-9176	ARC COE in Vision Sciences [CE0561903, DP-0450535]; Alexander von Humboldt Foundation; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; DAAD [doctoral student's scholarship]	ARC COE in Vision Sciences(Australian Research Council); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the ARC COE in Vision Sciences (CE0561903), ARC DP-0450535 to SWZ, MP, AS and HZ. The Alexander von Humboldt Foundation supported the research of SWZ in Germany. MP was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg, and a DAAD (German Academic Exchange Service) doctoral student's scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; DAVIS H, 1984, ANIM LEARN BEHAV, V12, P409, DOI 10.3758/BF03199987; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; FRANKS N, 2006, P ROY SOC LOND B BIO, P165; GALLISTEL CR, 2005, MATH COGNITION, P559; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HORRIDGE GA, 1992, PHILOS T R SOC B, V337, P59, DOI 10.1098/rstb.1992.0083; Horridge GA, 1996, J INSECT PHYSIOL, V42, P755, DOI 10.1016/0022-1910(96)00026-1; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; Kilian A, 2003, LEARN BEHAV, V31, P133; Koehler O., 1941, Naturwissenschaften Berlin, V29, P201; LEPPIK EE, 1953, AM NAT, V87, P229, DOI 10.1086/281778; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Pahl M, 2007, J EXP BIOL, V210, P3559, DOI 10.1242/jeb.005488; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Zhang SW, 1999, NEUROBIOL LEARN MEM, V72, P180, DOI 10.1006/nlme.1998.3901; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102; Zhang SW, 2004, J EXP BIOL, V207, P3289, DOI 10.1242/jeb.01155; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	37	130	131	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4263	10.1371/journal.pone.0004263	http://dx.doi.org/10.1371/journal.pone.0004263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JG	19173008	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483000002
J	Wolfenson, H; Lubelski, A; Regev, T; Klafter, J; Henis, YI; Geiger, B				Wolfenson, Haguy; Lubelski, Ariel; Regev, Tamar; Klafter, Joseph; Henis, Yoav I.; Geiger, Benjamin			A Role for the Juxtamembrane Cytoplasm in the Molecular Dynamics of Focal Adhesions	PLOS ONE			English	Article							MATRIX ADHESIONS; ALPHA-ACTININ; INTEGRIN; CONTACTS; PHOSPHORYLATION; MECHANOSENSORS; ASSOCIATION; DIFFUSION; BINDING; KINASE	Focal adhesions (FAs) are specialized membrane-associated multi-protein complexes that link the cell to the extracellular matrix and play crucial roles in cell-matrix sensing. Considerable information is available on the complex molecular composition of these sites, yet the regulation of FA dynamics is largely unknown. Based on a combination of FRAP studies in live cells, with in silico simulations and mathematical modeling, we show that the FA plaque proteins paxillin and vinculin exist in four dynamic states: an immobile FA-bound fraction, an FA-associated fraction undergoing exchange, a juxtamembrane fraction experiencing attenuated diffusion, and a fast-diffusing cytoplasmic pool. The juxtamembrane region surrounding FAs displays a gradient of FA plaque proteins with respect to both concentration and dynamics. Based on these findings, we propose a new model for the regulation of FA dynamics in which this juxtamembrane domain acts as an intermediary layer, enabling an efficient regulation of FA formation and reorganization.	[Wolfenson, Haguy; Regev, Tamar; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Lubelski, Ariel; Klafter, Joseph] Tel Aviv Univ, Sackler Fac Exact Sci, Sch Chem, IL-69978 Tel Aviv, Israel; [Klafter, Joseph] Univ Freiburg, FRIAS, D-7800 Freiburg, Germany; [Geiger, Benjamin] Weizmann Inst Sci, Dept Molecular Cell Biol, Rehovot, Israel	Tel Aviv University; Tel Aviv University; University of Freiburg; Weizmann Institute of Science	Wolfenson, H (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	YoavHe@tauex.tau.ac.il; benny.geiger@weizmann.ac.il	Wolfenson, Haguy/AAC-7601-2020	Henis, Yoav/0000-0002-1408-3877; Regev, Tamar/0000-0003-0639-0890	National Institutes of Health [PN2 EY016586]; VW Foundation; German Israeli collaboration; Juvenile Diabetes Research Foundation; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VW Foundation(Volkswagen); German Israeli collaboration(German-Israeli Foundation for Scientific Research and Development); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Nanotechnology Center for Mechanics in Regenerative Medicine (PN2 EY016586); the VW Foundation; the German Israeli collaboration; the Juvenile Diabetes Research Foundation. None of these organizations have any impact in the study design.	Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; DUBAND JL, 1988, J CELL BIOL, V107, P1385, DOI 10.1083/jcb.107.4.1385; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; ELSON EL, 1979, J SUPRAMOL STR CELL, V12, P481, DOI 10.1002/jss.400120408; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; PETERSEN NO, 1986, HDB EXPT IMMUNOLOGY; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Webb Donna J., 2004, V294, P3; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WEISS GH, 1994, ASPECTS APPL RANDOM, pR14; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WOJCIESZYN JW, 1981, P NATL ACAD SCI-BIOL, V78, P4407, DOI 10.1073/pnas.78.7.4407; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	45	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4304	10.1371/journal.pone.0004304	http://dx.doi.org/10.1371/journal.pone.0004304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172999	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483000013
J	Taylor-Cousar, JL; Zariwala, MA; Burch, LH; Pace, RG; Drumm, ML; Calloway, H; Fan, HY; Weston, BW; Wright, FA; Knowles, MR				Taylor-Cousar, Jennifer L.; Zariwala, Maimoona A.; Burch, Lauranell H.; Pace, Rhonda G.; Drumm, Mitchell L.; Calloway, Hollin; Fan, Haiying; Weston, Brent W.; Wright, Fred A.; Knowles, Michael R.		Gene Modifier Study Grp	Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity	PLOS ONE			English	Article								Background: The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microbial binding by airway mucus, and thus predispose to early lung infection and more severe lung disease in a subset of patients with CF. Methods and Principal Findings: Clinical information and DNA was collected on > 800 patients with the Delta F508/Delta F508 genotype. Patients in the most severe and mildest quartiles for lung phenotype were enrolled. Blood samples underwent lymphocyte transformation and DNA extraction using standard methods. PCR and sequencing were performed using standard techniques to identify the 9 SNPs required to determine ABO blood type, and to identify the four SNPs that account for 90-95% of Lewis status in Caucasians. Allele identification of the one nonsynonymous SNP in FUT2 that accounts for > 95% of the incidence of nonsecretor phenotype in Caucasians was completed using an ABI Taqman assay. The overall prevalence of ABO types, and of FUT2 (secretor) and FUT 3 (Lewis) alleles was consistent with that found in the Caucasian population. There was no difference in distribution of ABH type in the severe versus mild patients, or the age of onset of Pseudomonas aeruginosa infection in the severe or mild groups. Multivariate analyses of other clinical phenotypes, including gender, asthma, and meconium ileus demonstrated no differences between groups based on ABH type. Conclusions and Significance: Polymorphisms in the genes encoding ABO blood type, secretor or Lewis genotypes were not shown to associate with severity of CF lung disease, or age of onset of P. aeruginosa infection, nor was there any association with other clinical phenotypes in a group of 808 patients homozygous for the Delta F508 mutation.	Univ New Mexico, Hlth Sci Ctr, Div Pulm, Albuquerque, NM 87131 USA; [Zariwala, Maimoona A.; Pace, Rhonda G.; Calloway, Hollin; Knowles, Michael R.] Univ N Carolina, Cystic Fibrosis Pulmonary Res & Treatment Ctr, Chapel Hill, NC USA; [Burch, Lauranell H.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Fan, Haiying; Weston, Brent W.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonary, Cleveland, OH 44106 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University	Taylor-Cousar, JL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Div Pulm, Albuquerque, NM 87131 USA.	JTCousar@salud.unm.edu	/L-2667-2019	Pace, Rhonda/0000-0001-8606-0327	NIH [HL068890, 1F32HL082207-01]; GlaxoSmithKline Pulmonary Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068890, F32HL082207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline Pulmonary Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH HL068890, NIH 1F32HL082207-01, and the GlaxoSmithKline Pulmonary Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYSTIC FIBROSIS MUTA; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Boyle Michael P, 2007, Proc Am Thorac Soc, V4, P52, DOI 10.1513/pats.200605-129JG; Bremer LA, 2008, HUM MOL GENET, V17, P2228, DOI 10.1093/hmg/ddn123; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; CARNOY C, 1993, AM J RESP CELL MOL, V9, P323, DOI 10.1165/ajrcmb/9.3.323; CLAMP JR, 1979, CLIN SCI, V57, P445, DOI 10.1042/cs0570445; COHEN BH, 1980, AM J EPIDEMIOL, V111, P285, DOI 10.1093/oxfordjournals.aje.a112898; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; DEVARAJ N, 1994, GLYCOBIOLOGY, V4, P307, DOI 10.1093/glycob/4.3.307; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; ELMGREN A, 2002, PEDIAT PULMONOLOGY, V34, P226; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; HAPONIK EF, 1985, EUR J RESPIR DIS, V67, P381; Harmening D.., 2008, MODERN BLOOD BANKING, V5; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; Kauffmann F, 1996, AM J RESP CRIT CARE, V153, P76, DOI 10.1164/ajrccm.153.1.8542166; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KOMIYAMA K, 1987, INFECT IMMUN, V55, P2364, DOI 10.1128/IAI.55.10.2364-2369.1987; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Orntoft TF, 1996, J BIOL CHEM, V271, P32260, DOI 10.1074/jbc.271.50.32260; Pang H, 1998, HUM GENET, V102, P675, DOI 10.1007/s004390050760; PITTMAN JCH, 2008, PEDIAT PULMONOLOGY, V43, pA332; Rhim AD, 2001, GLYCOCONJUGATE J, V18, P649, DOI 10.1023/A:1020815205022; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Ronchetti F, 2001, EUR RESPIR J, V17, P1236, DOI 10.1183/09031936.01.99109101; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; SAADI AT, 1994, FEMS IMMUNOL MED MIC, V8, P315, DOI 10.1111/j.1574-695X.1994.tb00458.x; Salomaa V, 2000, J INTERN MED, V247, P689, DOI 10.1046/j.1365-2796.2000.00682.x; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Shori DK, 2001, PFLUG ARCH EUR J PHY, V443, pS55; Svensson L, 2000, TRANSFUSION, V40, P856, DOI 10.1046/j.1537-2995.2000.40070856.x; THIRU S, 1990, J CLIN PATHOL, V43, P1014, DOI 10.1136/jcp.43.12.1014; Thomsson KA, 2002, BIOCHEM J, V367, P609, DOI 10.1042/BJ20020371; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; WANG EEL, 1984, NEW ENGL J MED, V311, P1653, DOI 10.1056/NEJM198412273112602; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wu AM, 2006, BIOCHIMIE, V88, P1479, DOI 10.1016/j.biochi.2006.05.004; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Zemel BS, 2000, J PEDIATR-US, V137, P374, DOI 10.1067/mpd.2000.107891	45	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1					CP5	U11	e4270	10.1371/journal.pone.0004270	http://dx.doi.org/10.1371/journal.pone.0004270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169360	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482800001
J	Paupe, V; Dassa, EP; Goncalves, S; Auchere, F; Lonn, M; Holmgren, A; Rustin, P				Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Auchere, Francoise; Loenn, Maria; Holmgren, Arne; Rustin, Pierre			Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia	PLOS ONE			English	Article							IRON-SULFUR PROTEIN; ANTIOXIDANT DEFENSES; SUPEROXIDE-DISMUTASE; HUMAN GLUTAREDOXIN-2; DROSOPHILA MODEL; PHASE-2 ENZYMES; REACTIVE OXYGEN; TRANSGENIC MICE; NARP MUTATION; FRATAXIN	Background: Friedreich ataxia originates from a decrease in mitochondrial frataxin, which causes the death of a subset of neurons. The biochemical hallmarks of the disease include low activity of the iron sulfur cluster-containing proteins (ISP) and impairment of antioxidant defense mechanisms that may play a major role in disease progression. Methodology/Principal Findings: We thus investigated signaling pathways involved in antioxidant defense mechanisms. We showed that cultured fibroblasts from patients with Friedreich ataxia exhibited hypersensitivity to oxidative insults because of an impairment in the Nrf2 signaling pathway, which led to faulty induction of antioxidant enzymes. This impairment originated from previously reported actin remodeling by hydrogen peroxide. Conclusions/Significance: Thus, the defective machinery for ISP synthesis by causing mitochondrial iron dysmetabolism increases hydrogen peroxide production that accounts for the increased susceptibility to oxidative stress.	[Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Paupe, Vincent; Dassa, Emmanuel P.; Goncalves, Sergio; Rustin, Pierre] Univ Paris 07, Fac Med, Lab Ingenierie Proteines Controle Metabol, IFR02, F-75221 Paris, France; [Auchere, Francoise] CNRS, Inst Jacques Monod, Dept Biol Genomes, UMR 7592, Paris, France; [Loenn, Maria; Holmgren, Arne] Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, Stockholm, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Paupe, V (corresponding author), Hop Robert Debre, INSERM, U676, Bat Ecran, F-75019 Paris, France.	pierre.rustin@inserm.fr			AFAF; REVAmoto; ACHAF; FARA; European Community sixth Framework Program for Research [LSHM-CT-2004-503116]; Leducq foundation; ANR MRAR Friedreich project; AFM (Association Francaise contre les Myopathies); AMMi (Association contre les Maladies Mitochondriales)	AFAF; REVAmoto; ACHAF; FARA; European Community sixth Framework Program for Research; Leducq foundation(Leducq Foundation); ANR MRAR Friedreich project(French National Research Agency (ANR)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); AMMi (Association contre les Maladies Mitochondriales)	This work was supported by Friedreich ataxia patient organizations in France (AFAF and REVAmoto), Switzerland (ACHAF), and the US (FARA). EPD and PR were supported by the European Community sixth Framework Program for Research, contract number LSHM-CT-2004-503116; EPD and PR by the Leducq foundation; SG, V, and PR by the ANR MRAR Friedreich project; and PR by the AFM (Association Francaise contre les Myopathies) and AMMi (Association contre les Maladies Mitochondriales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; AUCHERE F, 2008, HUM MOL GENET; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Dassa EP, 2008, BIOCHEM BIOPH RES CO, V368, P620, DOI 10.1016/j.bbrc.2008.01.125; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; DROBINSKAYA IE, 1978, FEBS LETT, V96, P111, DOI 10.1016/0014-5793(78)81073-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Gianello P, 1996, TRANSPLANTATION, V62, P1664, DOI 10.1097/00007890-199612150-00022; Goncalves S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-20; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Isaya G, 2004, ACTA PAEDIATR, V93, P68, DOI 10.0180/08035320310021318; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Jiralerspong S, 2001, FEBS LETT, V509, P101, DOI 10.1016/S0014-5793(01)03140-4; KAHL R, 1989, TOXICOLOGY, V59, P179, DOI 10.1016/0300-483X(89)90056-5; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Rustin P, 2003, EXPERT OPIN INV DRUG, V12, P569, DOI 10.1517/eoid.12.4.569.23756; Rustin P, 2002, NAT GENET, V30, P352, DOI 10.1038/ng0402-352; Rustin P, 1999, BIOFACTORS, V9, P247, DOI 10.1002/biof.5520090220; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tzagoloff A, 1982, MITOCHONDRIA; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wallace DC, 1998, NAT GENET, V19, P105, DOI 10.1038/448; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304	53	147	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4253	10.1371/journal.pone.0004253	http://dx.doi.org/10.1371/journal.pone.0004253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158945	gold, Green Submitted, Green Published			2022-12-27	WOS:000265482200009
J	Fujimoto, T; Miyasaka, K; Koyanagi, M; Tsunoda, T; Baba, I; Doi, K; Ohta, M; Kato, N; Sasazuki, T; Shirasawa, S				Fujimoto, Takahiro; Miyasaka, Kyoko; Koyanagi, Midori; Tsunoda, Toshiyuki; Baba, Iwai; Doi, Keiko; Ohta, Minoru; Kato, Norihiro; Sasazuki, Takehiko; Shirasawa, Senji			Altered Energy Homeostasis and Resistance to Diet-Induced Obesity in KRAP-Deficient Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID OXIDATION; GROWTH-HORMONE; EXPRESSION; PROTEIN; LEPTIN; GENE; ADIPOCYTES; LOCALIZATION; TRANSLATION	Obesity and related metabolic disorders have become leading causes of adult morbidity and mortality. KRAP (Ki-ras-induced actin-interacting protein) is a cytoskeleton-associated protein and a ubiquitous protein among tissues, originally identified as a cancer-related molecule, however, its physiological roles remain unknown. Here we demonstrate that KRAP-deficient (KRAP(-/-)) mice show enhanced metabolic rate, decreased adiposity, improved glucose tolerance, hypoinsulinemia and hypoleptinemia. KRAP(-/-) mice are also protected against high-fat diet-induced obesity and insulin resistance despite of hyperphagia. Notably, glucose uptake in the brown adipose tissue (BAT) in KRAP(-/-) mice is enhanced in an insulin-independent manner, suggesting that BAT is involved in altered energy homeostasis in KRAP(-/-) mice, although UCP (Uncoupling protein) expressions are not altered. Of interest is the down-regulation of fatty acid metabolism-related molecules, including acetyl-CoA carboxylase (ACC)-1, ACC-2 and fatty acid synthase in the liver of KRAP(-/-) mice, which could in part account for the metabolic phenotype in KRAP(-/-) mice. Thus, KRAP is a novel regulator in whole-body energy homeostasis and may be a therapeutic target in obesity and related diseases.	[Fujimoto, Takahiro; Koyanagi, Midori; Tsunoda, Toshiyuki; Baba, Iwai; Doi, Keiko; Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Jonan Ku, Fukuoka 81401, Japan; [Fujimoto, Takahiro; Koyanagi, Midori; Tsunoda, Toshiyuki; Doi, Keiko; Shirasawa, Senji] Fukuoka Univ, Ctr Advanced Mol Med, Fukuoka, Japan; [Miyasaka, Kyoko; Ohta, Minoru] Tokyo Metropolitan Inst Gerontol, Dept Clin Physiol, Tokyo, Japan; [Kato, Norihiro; Sasazuki, Takehiko] Int Med Ctr Japan, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan	Fukuoka University; Fukuoka University; Tokyo Metropolitan Institute of Gerontology; National Center for Global Health & Medicine - Japan	Fujimoto, T (corresponding author), Fukuoka Univ, Fac Med, Dept Cell Biol, Jonan Ku, Fukuoka 81401, Japan.	sshirasa@fukuoka-u.ac.jp		Fujimoto, Takahiro/0000-0002-9975-7008	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Ayuk J, 2006, POSTGRAD MED J, V82, P24, DOI 10.1136/pgmj.2005.036087; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Chakrabarti P, 2008, MOL ENDOCRINOL, V22, P2260, DOI 10.1210/me.2008-0148; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chevillard Gregory, 2004, BMC Biochemistry, V5, P3, DOI 10.1186/1471-2091-5-3; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujimoto T, 2007, J HUM GENET, V52, P978, DOI 10.1007/s10038-007-0204-8; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Ichikawa M, 2000, J NUTR, V130, P2562, DOI 10.1093/jn/130.10.2562; Inokuchi J, 2004, J HUM GENET, V49, P46, DOI 10.1007/s10038-003-0106-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Maeda N, 2006, BIOL PHARM BULL, V29, P1936, DOI 10.1248/bpb.29.1936; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Shimizu Y, 1998, BIOCHEM J, V330, P397, DOI 10.1042/bj3300397; Shirasawa S, 2004, P NATL ACAD SCI USA, V101, P13921, DOI 10.1073/pnas.0404217101; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4240	10.1371/journal.pone.0004240	http://dx.doi.org/10.1371/journal.pone.0004240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156225	gold, Green Submitted, Green Published			2022-12-27	WOS:000265482100012
J	Nakamura, S; Yang, CS; Sakon, N; Ueda, M; Tougan, T; Yamashita, A; Goto, N; Takahashi, K; Yasunaga, T; Ikuta, K; Mizutani, T; Okamoto, Y; Tagami, M; Morita, R; Maeda, N; Kawai, J; Hayashizaki, Y; Nagai, Y; Horii, T; Iida, T; Nakaya, T				Nakamura, Shota; Yang, Cheng-Song; Sakon, Naomi; Ueda, Mayo; Tougan, Takahiro; Yamashita, Akifumi; Goto, Naohisa; Takahashi, Kazuo; Yasunaga, Teruo; Ikuta, Kazuyoshi; Mizutani, Tetsuya; Okamoto, Yoshiko; Tagami, Michihira; Morita, Ryoji; Maeda, Norihiro; Kawai, Jun; Hayashizaki, Yoshihide; Nagai, Yoshiyuki; Horii, Toshihiro; Iida, Tetsuya; Nakaya, Takaaki			Direct Metagenomic Detection of Viral Pathogens in Nasal and Fecal Specimens Using an Unbiased High-Throughput Sequencing Approach	PLOS ONE			English	Article								With the severe acute respiratory syndrome epidemic of 2003 and renewed attention on avian influenza viral pandemics, new surveillance systems are needed for the earlier detection of emerging infectious diseases. We applied a "nextgeneration'' parallel sequencing platform for viral detection in nasopharyngeal and fecal samples collected during seasonal influenza virus (Flu) infections and norovirus outbreaks from 2005 to 2007 in Osaka, Japan. Random RT-PCR was performed to amplify RNA extracted from 0.1-0.25 ml of nasopharyngeal aspirates (N = 3) and fecal specimens (N = 5), and more than 10 mu g of cDNA was synthesized. Unbiased high-throughput sequencing of these 8 samples yielded 15,298-32,335 (average 24,738) reads in a single 7.5 h run. In nasopharyngeal samples, although whole genome analysis was not available because the majority (>90%) of reads were host genome-derived, 20-460 Flu-reads were detected, which was sufficient for subtype identification. In fecal samples, bacteria and host cells were removed by centrifugation, resulting in gain of 484-15,260 reads of norovirus sequence (78-98% of the whole genome was covered), except for one specimen that was under-detectable by RT-PCR. These results suggest that our unbiased high-throughput sequencing approach is useful for directly detecting pathogenic viruses without advance genetic information. Although its cost and technological availability make it unlikely that this system will very soon be the diagnostic standard worldwide, this system could be useful for the earlier discovery of novel emerging viruses and bioterrorism, which are difficult to detect with conventional procedures.	[Yamashita, Akifumi; Goto, Naohisa; Yasunaga, Teruo] Osaka Univ, RIMD, Dept Genome Informat, Osaka, Japan; [Yang, Cheng-Song; Ueda, Mayo; Horii, Toshihiro; Iida, Tetsuya; Nakaya, Takaaki] Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka 565, Japan; [Yang, Cheng-Song; Ueda, Mayo; Ikuta, Kazuyoshi] Osaka Univ, RIMD, Dept Virol, Suita, Osaka 565, Japan; [Sakon, Naomi; Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka, Japan; [Tougan, Takahiro; Horii, Toshihiro] Osaka Univ, RIMD, Dept Mol Protozool, Suita, Osaka 565, Japan; [Mizutani, Tetsuya] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Okamoto, Yoshiko; Nagai, Yoshiyuki] RIKEN, Ctr Res Network Infect Dis, Tokyo, Japan; [Tagami, Michihira; Morita, Ryoji; Maeda, Norihiro; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN, OSC, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Osaka Prefectural Institute of Public Health; Osaka University; National Institute of Infectious Diseases (NIID); RIKEN; RIKEN	Nakamura, S (corresponding author), Osaka Univ, RIMD, Dept Genome Informat, Osaka, Japan.	tnakaya@biken.osaka-u.ac.jp	Tougan, Takahiro/AAP-5129-2020; Hayashizaki, Yoshihide/N-6590-2015; Kawai, Jun/A-6451-2016; Nakamura, Shota/E-3033-2010; MIZUTANI, Tetsuya/G-1086-2013	Nakamura, Shota/0000-0003-2058-5942; MIZUTANI, Tetsuya/0000-0003-2570-0452; Horii, Toshihiro/0000-0002-3000-2045	Ministry of Education, Science, Sports Culture and Technology (MEXT) [Grant-in-Aid for Scientific Research]	Ministry of Education, Science, Sports Culture and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports Culture and Technology (MEXT), The Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases by the MEXT (S. N., T. H., T. I. and T. N.), a Research Grant for RIKEN OSC from MEXT (J. K., and Y.H.) and the project for the International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University from the MEXT (T. H., T. I. and T. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Bainbridge MN, 2007, BIOINFORMATICS, V23, P2622, DOI 10.1093/bioinformatics/btl513; Bialasiewicza S, 2007, J CLIN VIROL, V40, P15, DOI 10.1016/j.jcv.2007.07.001; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; GOTO N, 2003, GENOME INFORM, V14, P629; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lodes MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000924; Lopman B, 2008, PLOS MED, V5, P187, DOI 10.1371/journal.pmed.0050042; MacConaill L, 2008, NAT GENET, V40, P380, DOI 10.1038/ng0408-380; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Norja P, 2007, J CLIN VIROL, V40, P307, DOI 10.1016/j.jcv.2007.09.008; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Sakon N, 2007, JPN J INFECT DIS, V60, P409; Spatz SJ, 2008, VIRUS GENES, V36, P479, DOI 10.1007/s11262-008-0213-5; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Vabret A, 2006, CLIN INFECT DIS, V42, P634, DOI 10.1086/500136; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Watanabe S, 2008, J CLIN VIROL, V43, P56, DOI 10.1016/j.jcv.2008.05.004; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; Yang J, 2000, RNA, V6, P1551, DOI 10.1017/S135583820000100X; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	41	176	189	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4219	10.1371/journal.pone.0004219	http://dx.doi.org/10.1371/journal.pone.0004219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156205	gold, Green Published, Green Submitted			2022-12-27	WOS:000265481900002
J	Hayakawa, J; Washington, K; Uchida, N; Phang, O; Kang, EM; Hsieh, MM; Tisdale, JF				Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.			Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection	PLOS ONE			English	Article							BLOOD PROGENITOR CELLS; THERAPY; SCID-X1; CLONES; MDS1-EVI1; REGIONS; LUNG	We previously reported the efficacy of nonmyeloablative allogeneic transplantation in 2 HIV positive recipients, one of whom received retrovirus transduced hematopoietic stem cells to confer resistance to HIV. Here we report an assessment of retroviral integration sites (RISs) recovered out to 3 years post-transplantation. We identified 213 unique RISs from the patient's peripheral blood samples by linear amplification-mediated PCR (LAM-PCR). While vector integration patterns were similar to that previously reported, only 3.76% of RISs were common among early (up to 3 months) and late samples (beyond 1 year). Additionally, common integration sites were enriched among late samples (14.9% vs. 36.8%, respectively). Three RISs were found near or within known oncogenes, but 2 were limited to early timepoints. Interestingly, an integration site near the MDS1 gene was detected in long-term follow-up samples; however, the overall contribution of MDS1 integrated clone remained stably low during follow-up.	[Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.] NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; [Hayakawa, Jun; Washington, Kareem; Uchida, Naoya; Phang, Oswald; Kang, Elizabeth M.; Hsieh, Matthew M.; Tisdale, John F.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hayakawa, J (corresponding author), NIDDK, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases; National Heart, Lung, and Blood Institute of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000991, ZIAAI000991] Funding Source: NIH RePORTER	intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the National Institute of Diabetes, Digestive, and Kidney Diseases and the National Heart, Lung, and Blood Institute of the National Institutes of Health. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Horn PA, 2003, BLOOD, V102, P4329, DOI 10.1182/blood-2003-01-0082; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kang EM, 2002, J HEMATOTH STEM CELL, V11, P809, DOI 10.1089/152581602760404612; Kang EM, 2002, BLOOD, V99, P698, DOI 10.1182/blood.V99.2.698; Kim HJ, 2000, BLOOD, V96, P1; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mautino MR, 2001, J VIROL, V75, P3590, DOI 10.1128/JVI.75.8.3590-3599.2001; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; MEZQUITA P, 2008, GENE THER; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morgan RA, 1996, HUM GENE THER, V7, P1281, DOI 10.1089/hum.1996.7.10-1281; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tisdale JF, 1998, BLOOD, V92, P1131, DOI 10.1182/blood.V92.4.1131.416k41_1131_1141; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4211	10.1371/journal.pone.0004211	http://dx.doi.org/10.1371/journal.pone.0004211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148292	gold, Green Submitted, Green Published			2022-12-27	WOS:000265479900005
J	Joshi, T; Ganesan, LP; Cheney, C; Ostrowski, MC; Muthusamy, N; Byrd, JC; Tridandapani, S				Joshi, Trupti; Ganesan, Latha P.; Cheney, Carolyn; Ostrowski, Michael C.; Muthusamy, Natarajan; Byrd, John C.; Tridandapani, Susheela			The PtdIns 3-Kinase/Akt Pathway Regulates Macrophage-Mediated ADCC against B Cell Lymphoma	PLOS ONE			English	Article								Macrophages are important effectors in the clearance of antibody-coated tumor cells. However, the signaling pathways that regulate macrophage-induced ADCC are poorly defined. To understand the regulation of macrophage-mediated ADCC, we used human B cell lymphoma coated with Rituximab as the tumor target and murine macrophages primed with IFN gamma as the effectors. Our data demonstrate that the PtdIns 3-kinase/Akt pathway is activated during macrophage-induced ADCC and that the inhibition of PtdIns 3-kinase results in the inhibition of macrophage-mediated cytotoxicity. Interestingly, downstream of PtdIns 3-kinase, expression of constitutively active Akt (Myr-Akt) in macrophages significantly enhanced their ability to mediate ADCC. Further analysis revealed that in this model, macrophage-mediated ADCC is dependent upon the release of nitric oxide (NO). However, the PtdIns 3-kinase/Akt pathway does not appear to regulate NO production. An examination of the role of the PtdIns 3-kinase/Akt pathway in regulating conjugate formation indicated that macrophages treated with an inhibitor of PtdIns 3-kinase fail to polarize the cytoskeleton at the synapse and show a significant reduction in the number of conjugates formed with tumor targets. Further, inhibition of PtdIns 3-kinase also reduced macrophage spreading on Rituximab-coated surfaces. On the other hand, Myr-Akt expressing macrophages displayed a significantly greater ability to form conjugates with tumor cells. Taken together, these findings illustrate that the PtdIns 3-kinase/Akt pathway plays a critical role in macrophage ADCC through its influence on conjugate formation between macrophages and antibody-coated tumor cells.	[Tridandapani, Susheela] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Ganesan, Latha P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Div Pulmonary & Critical Care, Columbus, OH 43210 USA; [Ganesan, Latha P.; Tridandapani, Susheela] Ohio State Univ, Comprehensive Canc Ctr, Columbus, OH 43210 USA; [Cheney, Carolyn; Muthusamy, Natarajan; Byrd, John C.] Ohio State Univ, Coll Med, Div Hematol Oncol, Columbus, OH 43210 USA; [Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Joshi, T (corresponding author), Ohio State Univ, Biochem Program, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Tridandapani, Susheela/E-4209-2011; Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297	NIH/NCI [R01 AI059406, P01 CA095426]; Leukemia and Lymphoma Society; D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA053271, P01CA097189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059406] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); D. Warren Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH/NCI grants R01 AI059406 (ST), and P01 CA095426 (ST,NM, JCB) and Leukemia and Lymphoma Society and D. Warren Brown Foundation grants (JCB). The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1980, J IMMUNOL, V124, P286; Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; AZZONI L, 1992, J EXP MED, V176, P1745, DOI 10.1084/jem.176.6.1745; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Billadeau DD, 1998, J EXP MED, V188, P549, DOI 10.1084/jem.188.3.549; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; CARPEN O, 1983, J IMMUNOL, V131, P2695; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; DUERKSENHUGHES PJ, 1992, J IMMUNOL, V149, P2114; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Galandrini R, 2005, BLOOD, V106, P577, DOI 10.1182/blood-2004-10-4100; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Gismondi A, 2004, BLOOD, V104, P436, DOI 10.1182/blood-2003-07-2621; HIBBS JB, 1987, J IMMUNOL, V138, P550; HIGUCHI M, 1990, J IMMUNOL, V144, P1425; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Joshi T, 2006, INT J HEMATOL, V84, P210, DOI 10.1532/IJH97.06140; KATZ P, 1982, J IMMUNOL, V129, P2816; KELLER R, 1990, INT J CANCER, V46, P682, DOI 10.1002/ijc.2910460422; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; LE JM, 1983, J IMMUNOL, V131, P2821; Lefebvre ML, 2006, J IMMUNOTHER, V29, P388, DOI 10.1097/01.cji.0000203081.43235.d7; MACE KF, 1988, CANCER RES, V48, P5427; May RC, 2001, J CELL SCI, V114, P1061; Miura TA, 2003, J IMMUNOL, V170, P4119, DOI 10.4049/jimmunol.170.8.4119; Nascimento FRF, 1998, BRAZ J MED BIOL RES, V31, P1593; NATHAN CF, 1979, J EXP MED, V149, P100, DOI 10.1084/jem.149.1.100; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; PACE JL, 1983, J IMMUNOL, V130, P2011; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; POWELL CB, 1990, CANCER IMMUNOL IMMUN, V32, P131, DOI 10.1007/BF01754210; Ptak W, 1998, SCAND J IMMUNOL, V47, P136; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Romieu-Mourez R, 2006, CANCER RES, V66, P10576, DOI 10.1158/0008-5472.CAN-06-1279; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SHEPARD HM, 1988, J CLIN IMMUNOL, V8, P333, DOI 10.1007/BF00917148; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vyas YM, 2002, IMMUNOL REV, V189, P161, DOI 10.1034/j.1600-065X.2002.18914.x; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	57	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4208	10.1371/journal.pone.0004208	http://dx.doi.org/10.1371/journal.pone.0004208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148288	gold, Green Submitted, Green Published			2022-12-27	WOS:000265479900002
J	Wieten, L; Berlo, SE; ten Brink, CB; van Kooten, PJ; Singh, M; van der Zee, R; Glant, TT; Broere, F; van Eden, W				Wieten, Lotte; Berlo, Suzanne E.; ten Brink, Corlinda B.; van Kooten, Peter J.; Singh, Mahavir; van der Zee, Ruurd; Glant, Tibor T.; Broere, Femke; van Eden, Willem			IL-10 Is Critically Involved in Mycobacterial HSP70 Induced Suppression of Proteoglycan-Induced Arthritis	PLOS ONE			English	Article								Background: The anti-inflammatory capacity of heat shock proteins (HSP) has been demonstrated in various animal models of inflammatory diseases and in patients. However, the mechanisms underlying this anti-inflammatory capacity are poorly understood. Therefore, the possible protective potential of HSP70 and its mechanisms were studied in proteoglycan (PG) induced arthritis (PGIA), a chronic and relapsing, T cell mediated murine model of arthritis. Methodology/Principal Findings: HSP70 immunization, 10 days prior to disease induction with PG, inhibited arthritis both clinically and histologically. In addition, it significantly reduced PG-specific IgG2a but not IgG1 antibody production. Furthermore, IFN-gamma and IL-10 production upon in vitro restimulation with HSP70 was indicative of the induction of an HSP70-specific T cell response in HSP70 immunized mice. Remarkably, HSP70 treatment also modulated the PG-specific T cell response, as shown by the increased production of IL-10 and IFN-gamma upon in vitro PG restimulation. Moreover, it increased IL-10 mRNA expression in CD4(+)CD25(+) cells. HSP70 vaccination did not suppress arthritis in IL-10(-/-) mice, indicating the crucial role of IL-10 in the protective effect. Conclusions/Significance: In conclusion, a single mycobacterial HSP70 immunization can suppress inflammation and tissue damage in PGIA and results in an enhanced regulatory response as shown by the antigen-specific IL-10 production. Moreover, HSP70 induced protection is critically IL-10 dependent.	[Wieten, Lotte; Berlo, Suzanne E.; ten Brink, Corlinda B.; van Kooten, Peter J.; van der Zee, Ruurd; Broere, Femke; van Eden, Willem] Univ Utrecht, Div Immunol, Inst Infect Dis & Immunol, Utrecht, Netherlands; [Singh, Mahavir] LIONEX Diagnost & Therapeut GmbH, Braunschweig, Germany; [Glant, Tibor T.] Rush Univ, Med Ctr, Dept Orthoped Surg, Sect Mol Med, Chicago, IL USA	Utrecht University; Lionex Diagnostics & Therapeutics GmbH; Rush University	Wieten, L (corresponding author), Univ Utrecht, Div Immunol, Inst Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	van der Zee, Ruurd/O-5256-2015; Broere, femke/C-2675-2012	van der Zee, Ruurd/0000-0002-4331-2755; van Eden, Willem/0000-0003-1272-704X; Broere, Femke/0000-0001-9343-0111	Dutch Arthritis Association; SenterNovem; IOP Genomics project [IGE03018]; European Union FP7 TOLERAGE [HEALTH-F4-2008-202156]	Dutch Arthritis Association; SenterNovem; IOP Genomics project; European Union FP7 TOLERAGE	This work was supported by grants of the Dutch Arthritis Association, "Reumafonds" and SenterNovem, IOP Genomics project nr IGE03018, the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156. Funders were not involved in design and conduct of the study, collection analysis and interpretation of the data or in the preperation, review or approval of the manuscript.	ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Berlo SE, 2006, ARTHRITIS RHEUM-US, V54, P2423, DOI 10.1002/art.22013; Bockova J, 1997, J AUTOIMMUN, V10, P323, DOI 10.1006/jaut.1997.0150; BOOG CJP, 1992, J EXP MED, V175, P1805, DOI 10.1084/jem.175.6.1805; Corrigall VM, 2001, J IMMUNOL, V166, P1492, DOI 10.4049/jimmunol.166.3.1492; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Giant TT, 2004, METH MOLEC MED, V102, P313; Glant TT, 2003, CRIT REV IMMUNOL, V23, P199, DOI 10.1615/CritRevImmunol.v23.i3.20; Guichelaar T, 2008, J IMMUNOL, V180, P1373, DOI 10.4049/jimmunol.180.3.1373; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Haug M, 2005, EUR J IMMUNOL, V35, P3163, DOI 10.1002/eji.200535050; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kaplan C, 2002, ARTHRITIS RES, V4, P54, DOI 10.1186/ar383; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; Kim HR, 2006, J IMMUNOL, V177, P6634, DOI 10.4049/jimmunol.177.10.6634; Kingston AE, 1996, CLIN EXP IMMUNOL, V103, P77, DOI 10.1046/j.1365-2249.1996.929628.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Mekala DJ, 2005, P NATL ACAD SCI USA, V102, P11817, DOI 10.1073/pnas.0505445102; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prakken BJ, 2001, J IMMUNOL, V167, P4147, DOI 10.4049/jimmunol.167.8.4147; Quintana FJ, 2004, ARTHRITIS RHEUM-US, V50, P3712, DOI 10.1002/art.20635; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Tanaka S, 1999, J IMMUNOL, V163, P5560; TANG Q, 2005, NAT IMMUNOL, V9, P239; Ulmansky R, 2002, J IMMUNOL, V168, P6463, DOI 10.4049/jimmunol.168.12.6463; van der Zee R, 1998, SEMIN IMMUNOL, V10, P35, DOI 10.1006/smim.1997.0103; van Eden W, 2003, ARTHRITIS RHEUM-US, V48, P1788, DOI 10.1002/art.11077; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Van Eden W, 2007, ANN NY ACAD SCI, V1113, P217, DOI 10.1196/annals.1391.020; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; vanRoon JAG, 1996, ARTHRITIS RHEUM, V39, P829, DOI 10.1002/art.1780390516; Verhoef CM, 2001, J RHEUMATOL, V28, P1960; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711	40	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4186	10.1371/journal.pone.0004186	http://dx.doi.org/10.1371/journal.pone.0004186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142233	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700007
J	Bhak, G; Lee, JH; Hahn, JS; Paik, SR				Bhak, Ghibom; Lee, Jung-Ho; Hahn, Ji-Sook; Paik, Seung R.			Granular Assembly of alpha-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress	PLOS ONE			English	Article								alpha-Synuclein participates in the Lewy body formation of Parkinson's disease. Elucidation of the underlying molecular mechanism of the amyloid fibril formation is crucial not only to develop a controlling strategy toward the disease, but also to apply the protein fibrils for future biotechnology. Discernable homogeneous granules of alpha-synuclein composed of approximately 11 monomers in average were isolated in the middle of a lag phase during the in vitro fibrillation process. They were demonstrated to experience almost instantaneous fibrillation during a single 12-min centrifugal membrane-filtration at 14,000xg. The granular assembly leading to the drastically accelerated fibril formation was demonstrated to be a result of the physical influence of shear force imposed on the preformed granular structures by either centrifugal filtration or rheometer. Structural rearrangement of the preformed oligomomeric structures is attributable for the suprastructure formation in which the granules act as a growing unit for the fibril formation. To parallel the prevailing notion of nucleation-dependent amyloidosis, we propose a double-concerted fibrillation model as one of the mechanisms to explain the in vitro fibrillation of alpha-synuclein, in which two consecutive concerted associations of monomers and subsequent oligomeric granular species are responsible for the eventual amyloid fibril formation.	[Bhak, Ghibom; Lee, Jung-Ho; Hahn, Ji-Sook; Paik, Seung R.] Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul, South Korea	Seoul National University (SNU)	Bhak, G (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Coll Engn, Seoul, South Korea.	srpaik@snu.ac.kr	Rho, Hyunji/R-6242-2016	Rho, Hyunji/0000-0001-7650-8933	Korea Science and Engineering Foundation [R01-2007-000-20089-0]; Institute of Bioengineering at SNU [10538]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Institute of Bioengineering at SNU	This study was supported in part by a basic research program grant (R01-2007-000-20089-0) from Korea Science and Engineering Foundation and by another grant from the Seoul R&BD Program (10538) through Institute of Bioengineering at SNU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrer K, 2006, J MEMBRANE SCI, V274, P108, DOI 10.1016/j.memsci.2005.08.018; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; ASAKURA T, 1973, NATURE, V244, P437, DOI 10.1038/244437a0; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bajaj H, 2004, BIOPHYS J, V87, P4048, DOI 10.1529/biophysj.104.048686; Barg A, 2007, THROMB HAEMOSTASIS, V97, P514, DOI 10.1160/TH06-05-0274; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARM SE, 1971, BIOTECHNOL BIOENG, V13, P185, DOI 10.1002/bit.260130203; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elias C B, 1998, Adv Biochem Eng Biotechnol, V59, P47; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; KIM KJ, 1993, BIOTECHNOL BIOENG, V42, P260, DOI 10.1002/bit.260420216; Kurnaz ML, 1997, PHYS REV E, V55, P572, DOI 10.1103/PhysRevE.55.572; LEE JH, 2008, BIOPHYS J IN PRESS; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Maa YF, 1996, BIOTECHNOL BIOENG, V51, P458, DOI 10.1002/(SICI)1097-0290(19960820)51:4<458::AID-BIT9>3.0.CO;2-H; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; MAR CD, 2005, P NATL ACAD SCI USA, V102, P15477; Maruyama T, 2001, BIOTECHNOL BIOENG, V75, P233, DOI 10.1002/bit.10001; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Murphy R. M., 2006, MISBEHAVING PROTEINS; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; REESE ET, 1980, BIOTECHNOL BIOENG, V22, P323, DOI 10.1002/bit.260220207; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tappel A, 2004, MED HYPOTHESES, V63, P98, DOI 10.1016/j.mehy.2004.01.022; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	59	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4177	10.1371/journal.pone.0004177	http://dx.doi.org/10.1371/journal.pone.0004177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137068	Green Submitted, gold, Green Published			2022-12-27	WOS:000265479500008
J	Kumar, S; Farhana, A; Hasnain, SE				Kumar, Sandeep; Farhana, Aisha; Hasnain, Seyed E.			In-Vitro Helix Opening of M. tuberculosis oriC by DnaA Occurs at Precise Location and Is Inhibited by IciA Like Protein	PLOS ONE			English	Article								Background: Mycobacterium tuberculosis (M.tb), the pathogen that causes tuberculosis, is capable of staying asymptomatically in a latent form, persisting for years in very low replicating state, before getting reactivated to cause active infection. It is therefore important to study M.tb chromosome replication, specifically its initiation and regulation. While the region between dnaA and dnaN gene is capable of autonomous replication, little is known about the interaction between DnaA initiator protein, oriC origin of replication sequences and their negative effectors of replication. Methodology/Principal Findings: By KMnO4 mapping assays the sequences involved in open complex formation within oriC, mediated by M.tb DnaA protein, were mapped to position 2500 to 2518 with respect to the dnaN gene. Contrary to E. coli, the M.tb DnaA in the presence of non-hydrolysable analogue of ATP (ATP gamma S) was unable to participate in helix opening thereby pointing to the importance of ATP hydrolysis. Interestingly, ATPase activity in the presence of supercoiled template was higher than that observed for DnaA box alone. M.tb rRv1985c, a homologue of E. coli IciA (Inhibitor of chromosomal initiation) protein, could inhibit DnaA-mediated in-vitro helix opening by specifically binding to A+T rich region of oriC, provided the open complex formation had not initiated. rIciA could also inhibit in-vitro replication of plasmid carrying the M.tb origin of replication. Conclusions/Significance: These results have a bearing on the functional role of the important regulator of M.tb chromosomal replication belonging to the LysR family of bacterial regulatory proteins in the context of latency.	[Farhana, Aisha] CDFD, Lab Mol & Cellular Biol, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Kumar, S (corresponding author), CDFD, Lab Mol & Cellular Biol, Hyderabad, Andhra Pradesh, India.	seh@uohyd.ernet.in	Farhana, Aisha/AAR-7356-2020; KUMAR, SANDEEP/GZA-7182-2022	Farhana, Aisha/0000-0002-4631-2769; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; Government of India [J. C. Bose National Fellow, Senior Research Fellowships]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Government of India; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by research grant to SEH from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. SEH is a J. C. Bose National Fellow, Government of India. SK and AF thank the Council of Scientific and Industrial Research (CSIR), Government of India for Senior Research Fellowships.	Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; Ghosh S, 2004, BIOTECHNIQUES, V37, P418, DOI 10.2144/04373ST07; GILLE H, 1991, METHOD ENZYMOL, V208, P146; Han JS, 1998, MOL GEN GENET, V259, P610, DOI 10.1007/s004380050854; HWANG DS, 1992, J BIOL CHEM, V267, P23087; HWANG DS, 1990, CELL, V63, P325, DOI 10.1016/0092-8674(90)90165-B; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Lee YS, 1996, MOL MICROBIOL, V19, P389, DOI 10.1046/j.1365-2958.1996.485902.x; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; MORIYA S, 1992, MOL MICROBIOL, V6, P309, DOI 10.1111/j.1365-2958.1992.tb01473.x; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Prakash P, 2005, J BIOL CHEM, V280, P19641, DOI 10.1074/jbc.M413026200; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; RAJAGOPALAN M, 1995, J BACTERIOL, V177, P6527, DOI 10.1128/jb.177.22.6527-6535.1995; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Seitz H, 2001, EMBO REP, V2, P1003, DOI 10.1093/embo-reports/kve225; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; THONY B, 1991, P NATL ACAD SCI USA, V88, P4066, DOI 10.1073/pnas.88.10.4066; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Wei T, 1996, NUCLEIC ACIDS RES, V24, P1865, DOI 10.1093/nar/24.10.1865; Zawilak A, 2004, BIOCHEM J, V382, P247, DOI 10.1042/BJ20040338; Zawilak-Pawlik A, 2005, BIOCHEM J, V389, P471, DOI 10.1042/BJ20050143	37	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4139	10.1371/journal.pone.0004139	http://dx.doi.org/10.1371/journal.pone.0004139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127296	Green Published, gold			2022-12-27	WOS:000265473300007
J	Peters, M; Simmons, LW; Rhodes, G				Peters, Marianne; Simmons, Leigh W.; Rhodes, Gillian			Preferences across the Menstrual Cycle for Masculinity and Symmetry in Photographs of Male Faces and Bodies	PLOS ONE			English	Article							HUMAN FEMALE PREFERENCES; WOMENS PREFERENCES; SEXUAL-DIMORPHISM; FACIAL ATTRACTIVENESS; EVOLUTIONARY PSYCHOLOGY; APPARENT HEALTH; MATING SUCCESS; TESTOSTERONE; OVULATION; SCENT	Background: Previous studies have shown that women increase their preference for masculinity during the fertile phase of the menstrual cycle. Evidence for a similar preference shift for symmetry is equivocal. These studies have required participants to choose between subtle variations in computer-generated stimuli, and preferences for more natural stimuli have not been investigated. Methodology/Principal Findings: Our study employed photographs of individual males to investigate women's preferences for face and body masculinity and symmetry across the menstrual cycle. We collected attractiveness ratings from 25 normally cycling women at high- and low-fertility days of the menstrual cycle. Attractiveness ratings made by these women were correlated with independent ratings of masculinity and symmetry provided by different sets of raters. We found no evidence for any cyclic shift in female preferences. Correlations between attractiveness and masculinity, and attractiveness and symmetry did not differ significantly between high- and low-fertility test sessions. Furthermore, there was no significant difference between high- and low-fertility ratings of attractiveness. Conclusions: These results suggest that a menstrual cycle shift in visual preferences for masculinity and symmetry may be too subtle to influence responses to real faces and bodies, and subsequent mate-choice decisions.	[Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Peters, Marianne; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Peters, M (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia.	mpeters@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518	University of Western Australia [scholarship]; Australian Research Council (ARC)	University of Western Australia; Australian Research Council (ARC)(Australian Research Council)	MP was supported with a scholarship from the University of Western Australia. GR & LWS were supported with Australian Research Council (ARC) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bullivant SB, 2004, J SEX RES, V41, P82, DOI 10.1080/00224490409552216; Cardenas RA, 2007, EVOL HUM BEHAV, V28, P96, DOI 10.1016/j.evolhumbehav.2006.08.003; Cohen J., 1983, APPL MULTIPLE REGRES; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; FROST P, 1994, PERCEPT MOTOR SKILL, V79, P507, DOI 10.2466/pms.1994.79.1.507; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2002, P ROY SOC B-BIOL SCI, V269, P975, DOI 10.1098/rspb.2001.1952; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Gangestad SW., 1997, EVOLUTIONARY SOCIAL, P169; Gilbert S.F., 2000, DEV BIOL; Guermandi E, 2001, OBSTET GYNECOL, V97, P92, DOI 10.1016/S0029-7844(00)01083-8; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Jones BC, 2005, P ROY SOC B-BIOL SCI, V272, P347, DOI 10.1098/rspb.2004.2962; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Koehler N, 2002, ANIM BEHAV, V64, P233, DOI 10.1006/anbe.2002.3063; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2007, BIOL PSYCHOL, V76, P209, DOI 10.1016/j.biopsycho.2007.08.003; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Moller AP, 1997, ASYMMETRY DEV STABIL; Oinonen KA, 2007, BIOL PSYCHOL, V75, P136, DOI 10.1016/j.biopsycho.2007.01.003; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Peters M, 2008, ANIM BEHAV, V76, P297, DOI 10.1016/j.anbehav.2008.02.008; Polak M., 2003, CAUSES CONSEQUENCES; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Simmons LW, 2004, BEHAV ECOL, V15, P864, DOI 10.1093/beheco/arh099; Sinha-Hikim I, 1998, J CLIN ENDOCR METAB, V83, P1312, DOI 10.1210/jc.83.4.1312; Small CM, 2007, ANN EPIDEMIOL, V17, P163, DOI 10.1016/j.annepidem.2006.05.005; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301	49	68	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4138	10.1371/journal.pone.0004138	http://dx.doi.org/10.1371/journal.pone.0004138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127295	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473300006
J	Bates, KT; Manning, PL; Hodgetts, D; Sellers, WI				Bates, Karl T.; Manning, Phillip L.; Hodgetts, David; Sellers, William I.			Estimating Mass Properties of Dinosaurs Using Laser Imaging and 3D Computer Modelling	PLOS ONE			English	Article							BODY-SIZE; INERTIAL PROPERTIES; FUNCTIONAL-ANATOMY; LIMB POSTURE; RANGE SIZE; TYRANNOSAURUS; MAMMALS; LOCOMOTION; RECONSTRUCTION; CONSERVATION	Body mass reconstructions of extinct vertebrates are most robust when complete to near-complete skeletons allow the reconstruction of either physical or digital models. Digital models are most efficient in terms of time and cost, and provide the facility to infinitely modify model properties non-destructively, such that sensitivity analyses can be conducted to quantify the effect of the many unknown parameters involved in reconstructions of extinct animals. In this study we use laser scanning (LiDAR) and computer modelling methods to create a range of 3D mass models of five specimens of non-avian dinosaur; two near-complete specimens of Tyrannosaurus rex, the most complete specimens of Acrocanthosaurus atokensis and Strutiomimum sedens, and a near-complete skeleton of a sub-adult Edmontosaurus annectens. LiDAR scanning allows a full mounted skeleton to be imaged resulting in a detailed 3D model in which each bone retains its spatial position and articulation. This provides a high resolution skeletal framework around which the body cavity and internal organs such as lungs and air sacs can be reconstructed. This has allowed calculation of body segment masses, centres of mass and moments or inertia for each animal. However, any soft tissue reconstruction of an extinct taxon inevitably represents a best estimate model with an unknown level of accuracy. We have therefore conducted an extensive sensitivity analysis in which the volumes of body segments and respiratory organs were varied in an attempt to constrain the likely maximum plausible range of mass parameters for each animal. Our results provide wide ranges in actual mass and inertial values, emphasizing the high level of uncertainty inevitable in such reconstructions. However, our sensitivity analysis consistently places the centre of mass well below and in front of hip joint in each animal, regardless of the chosen combination of body and respiratory structure volumes. These results emphasize that future biomechanical assessments of extinct taxa should be preceded by a detailed investigation of the plausible range of mass properties, in which sensitivity analyses are used to identify a suite of possible values to be tested as inputs in analytical models.	[Sellers, William I.] Univ Manchester, Adapt Organismal Biol Res Grp, Fac Life Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Manchester, Manchester Museum, Manchester M13 9PL, Lancs, England; [Manning, Phillip L.; Hodgetts, David] Univ Manchester, Sch Earth, Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Bates, KT (corresponding author), Univ Manchester, Adapt Organismal Biol Res Grp, Fac Life Sci, Jacksons Mill, Manchester, Lancs, England.	karl.bates@postgrad.manchester.ac.uk	Manning, Phillip/F-9966-2011; Hodgetts, David/A-5216-2011; Sellers, William Irvin/Q-3843-2019	Manning, Phillip/0000-0002-7161-6246; Sellers, William Irvin/0000-0002-2913-5406; Hodgetts, David/0000-0002-7437-7930	National Environmental Research Council [NER/S/A/2006/14101]	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Environmental Research Council doctoral grant to KTB (NER/S/A/2006/14101). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ARITA HT, 1990, CONSERV BIOL, V4, P181, DOI 10.1111/j.1523-1739.1990.tb00107.x; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; BATES KT, 2007, J VERTEBRATE PALEO S, V27, P45; Bellian JA, 2005, J SEDIMENT RES, V75, P166, DOI 10.2110/jsr.2005.013; BENTON MJ, 1989, PALAEOBIOLOGY SYNTHE, P147; BERGMANN C, 1847, VERHALTNISSE WARME 1; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Breithaupt Brent H., 2004, Ichnos, V11, P11, DOI 10.1080/10420940490442296; BROCHU CA, 2003, MEMOIR SOC VERTEBRAT, V7, P1, DOI DOI 10.2307/3889334; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; CLAESSENS LPA, 2004, J VERTEBR PALEONTOL, V24, P90; COLBERT EH, 1962, AM MUS NOVIT, P1; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Cope E.D., 1896, PRIMARY FACTORS ORGA, DOI DOI 10.5962/BHL.TITLE.2068; Crompton RH, 1996, AM J PHYS ANTHROPOL, V99, P547, DOI 10.1002/(SICI)1096-8644(199604)99:4<547::AID-AJPA3>3.0.CO;2-R; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Damuth J., 1990, BODY SIZE MAMMALIAN; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; GALTON PM, 1969, PELVIC MUSCULATURE D; Gaston KJ, 1996, CONSERV BIOL, V10, P638, DOI 10.1046/j.1523-1739.1996.10020638.x; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gaudin Timothy J., 2006, P1; GIERLINSKI G, 2005, P TRACK DIN OR DIXIE; GRAVES GR, 1991, P NATL ACAD SCI USA, V88, P2322, DOI 10.1073/pnas.88.6.2322; GREGORY WK, 1905, WEIGHT BRONTOSAURUS, V22, P572; Gunga HC, 2007, NATURWISSENSCHAFTEN, V94, P623, DOI 10.1007/s00114-007-0234-2; HALLAM A, 1975, NATURE, V258, P493, DOI 10.1038/258493a0; Hallam A., 1990, P249; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; HENDERSON DM, 2004, P ROYAL SOC LONDON S, V271, P57; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Isler K, 2006, J ANAT, V209, P201, DOI 10.1111/j.1469-7580.2006.00588.x; JABLONSKI DM, 1996, EVOLUTIONARY PALAEOB, P211; Kingsolver JG, 2004, EVOLUTION, V58, P1608; LABARBERA M, 1986, PATTERNS PROCESSES H, P69; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Perry SF, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P429; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; Romer A, 1956, OSTEOLOGY REPTILES; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; STANLEY SM, 1986, PALEOBIOLOGY, V12, P89, DOI 10.1017/S0094837300003006; STANLEY SM, 1990, DELAYED RECOVERY SPA, P410; STANLEY SM, EXTINCTION; Stevens JW, 2002, HEAT TRANSFER ENG, V23, P34, DOI 10.1080/01457630290090482; STEVENS KA, 2008, TYRANNOSAURUS REX TY, P435; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	71	91	92	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4532	10.1371/journal.pone.0004532	http://dx.doi.org/10.1371/journal.pone.0004532			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225569	Green Submitted, Green Published, gold			2022-12-27	WOS:000265486000009
J	Schwartz, M; Oren, YS; Bester, AC; Rahat, A; Sfez, R; Yitzchaik, S; de Villartay, JP; Kerem, B				Schwartz, Michal; Oren, Yifat S.; Bester, Assaf C.; Rahat, Ayelet; Sfez, Ruthy; Yitzchaik, Shlomo; de Villartay, Jean-Pierre; Kerem, Batsheva			Impaired Replication Stress Response in Cells from Immunodeficiency Patients Carrying Cernunnos/XLF Mutations	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-LIGASE-IV; COMMON FRAGILE SITES; END-JOINING GENES; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; GENOMIC INSTABILITY; HISTONE H2AX; CANCER RISK; REPAIR	Non-Homologous End Joining (NHEJ) is one of the two major pathways of DNA Double Strand Breaks (DSBs) repair. Mutations in human NHEJ genes can lead to immunodeficiency due to its role in V(D)J recombination in the immune system. In addition, most patients carrying mutations in NHEJ genes display developmental anomalies which are likely the result of a general defect in repair of endogenously induced DSBs such as those arising during normal DNA replication. Cernunnos/XLF is a recently identified NHEJ gene which is mutated in immunodeficiency with microcephaly patients. Here we aimed to investigate whether Cernunnos/XLF mutations disrupt the ability of patient cells to respond to replication stress conditions. Our results demonstrate that Cernunnos/XLF mutated cells and cells downregulated for Cernunnos/XLF have increased sensitivity to conditions which perturb DNA replication. In addition, under replication stress, these cells exhibit impaired DSB repair and increased accumulation of cells in G2/M. Moreover Cernunnos/XLF mutated and down regulated cells display greater chromosomal instability, particularly at fragile sites, under replication stress conditions. These results provide evidence for the role of Cernunnos/XLF in repair of DSBs and maintenance of genomic stability under replication stress conditions. This is the first study of a NHEJ syndrome showing association with impaired cellular response to replication stress conditions. These findings may be related to the clinical features in these patients which are not due to the V(D) J recombination defect. Additionally, in light of the emerging important role of replication stress in the early stages of cancer development, our findings may provide a mechanism for the role of NHEJ in preventing tumorigenesis.	[Schwartz, Michal; Oren, Yifat S.; Bester, Assaf C.; Rahat, Ayelet; Kerem, Batsheva] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Sfez, Ruthy; Yitzchaik, Shlomo] Hebrew Univ Jerusalem, Dept Inorgan & Analytical Chem, IL-91905 Jerusalem, Israel; [de Villartay, Jean-Pierre] Inst Natl Sante & Rech Med, U768, Paris, France; [de Villartay, Jean-Pierre] Univ Paris 05, Fac Med Rene Descartes, Site Necker, IFR 94, Paris, France; [de Villartay, Jean-Pierre] Assistance Publ Hop Paris, Hop Necker Enfants Malades, Serv Immunol Hematol Pediat, Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Schwartz, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel.	kerem@cc.huji.ac.il	Bester, Assaf/ABG-1707-2021; de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463; Schwartz, Michal/0000-0001-5442-0201	Ministry of Science and Technology Israel; Deutsches Krebsforschungszetrum (DKFZ); Clore Israel Foundation [fellowship]	Ministry of Science and Technology Israel(Ministry of Science, Technology and Space (MOST), Israel); Deutsches Krebsforschungszetrum (DKFZ); Clore Israel Foundation	This research was supported by grants from the Ministry of Science and Technology Israel and the Deutsches Krebsforschungszetrum (DKFZ) to B.K.. M.S. is supported by a fellowship from the Clore Israel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bau DT, 2004, CANCER RES, V64, P5013, DOI 10.1158/0008-5472.CAN-04-0403; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Casper AM, 2004, AM J HUM GENET, V75, P654, DOI 10.1086/422701; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Daboussi F, 2008, J CELL SCI, V121, P162, DOI 10.1242/jcs.010330; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fu YP, 2003, CANCER RES, V63, P2440; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; HOWLETT NG, 2005, HUM MOL GENET; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Knuutila S, 1998, AM J PATHOL, V152, P1107; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Liu YH, 2008, HUM MUTAT, V29, P381, DOI 10.1002/humu.20645; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Ozeri-Galai E, 2008, ONCOGENE, V27, P2109, DOI 10.1038/sj.onc.1210849; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4516	10.1371/journal.pone.0004516	http://dx.doi.org/10.1371/journal.pone.0004516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223975	gold, Green Submitted, Green Published			2022-12-27	WOS:000265485800016
J	Danielyan, L; Zellmer, S; Sickinger, S; Tolstonog, GV; Salvetter, J; Lourhmati, A; Reissig, DD; Gleiter, CH; Gebhardt, R; Buniatian, GH				Danielyan, Lusine; Zellmer, Sebastian; Sickinger, Stefan; Tolstonog, Genrich V.; Salvetter, Juergen; Lourhmati, Ali; Reissig, Dieter D.; Gleiter, Cristoph H.; Gebhardt, Rolf; Buniatian, Gayane Hrachia			Keratinocytes as Depository of Ammonium-Inducible Glutamine Synthetase: Age- and Anatomy-Dependent Distribution in Human and Rat Skin	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; HEPATIC STELLATE CELLS; SKELETAL-MUSCLE; TIGHT JUNCTIONS; PORTACAVAL ANASTOMOSIS; GENE-EXPRESSION; BRAIN-BARRIER; IN-VIVO; LIVER; METALLOTHIONEIN	In inner organs, glutamine contributes to proliferation, detoxification and establishment of a mechanical barrier, i.e., functions essential for skin, as well. However, the age-dependent and regional peculiarities of distribution of glutamine synthetase (GS), an enzyme responsible for generation of glutamine, and factors regulating its enzymatic activity in mammalian skin remain undisclosed. To explore this, GS localization was investigated using immunohistochemistry and double-labeling of young and adult human and rat skin sections as well as skin cells in culture. In human and rat skin GS was almost completely co-localized with astrocyte-specific proteins (e.g. GFAP). While GS staining was pronounced in all layers of the epidermis of young human skin, staining was reduced and more differentiated among different layers with age. In stratum basale and in stratum spinosum GS was co-localized with the adherens junction component beta-catenin. Inhibition of, glycogen synthase kinase 3 beta in cultured keratinocytes and HaCaT cells, however, did not support a direct role of beta-catenin in regulation of GS. Enzymatic and reverse transcriptase polymerase chain reaction studies revealed an unusual mode of regulation of this enzyme in keratinocytes, i.e., GS activity, but not expression, was enhanced about 8-10 fold when the cells were exposed to ammonium ions. Prominent posttranscriptional up-regulation of GS activity in keratinocytes by ammonium ions in conjunction with widespread distribution of GS immunoreactivity throughout the epidermis allows considering the skin as a large reservoir of latent GS. Such a depository of glutamine-generating enzyme seems essential for continuous	[Danielyan, Lusine; Lourhmati, Ali; Gleiter, Cristoph H.] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Zellmer, Sebastian; Sickinger, Stefan; Gebhardt, Rolf; Buniatian, Gayane Hrachia] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Tolstonog, Genrich V.] Heinrich Pette Inst Expt Virol & Immunol, Hamburg, Germany; [Salvetter, Juergen; Reissig, Dieter D.] Univ Leipzig, Inst Anat, Leipzig, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leipzig University; Heinrich Pette Institute; Leipzig University	Danielyan, L (corresponding author), Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany.	rgebhardt@medizin.uni-leipzig.de; buniatian@web.de		Danielyan, Lusine/0000-0003-4130-8477	Medical Faculties of the University of Tuebingen and Leipzig	Medical Faculties of the University of Tuebingen and Leipzig	This study was supported by the Medical Faculties of the University of Tuebingen and Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 1997, J TRAUMA, V42, P421, DOI 10.1097/00005373-199703000-00009; ABCOUWER SF, 1995, J SURG RES, V59, P59, DOI 10.1006/jsre.1995.1132; ARDAWI MSM, 1988, CLIN SCI, V74, P165, DOI 10.1042/cs0740165; AROLA L, 1981, ARCH INT PHYSIOL BIO, V89, P189, DOI 10.3109/13813458109069465; BAYREUTHER K, 1992, ANN NY ACAD SCI, V663, P167, DOI 10.1111/j.1749-6632.1992.tb38660.x; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bode JG, 1998, BIOCHEM J, V335, P697, DOI 10.1042/bj3350697; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGA VMM, 1995, CELL ADHES COMMUN, V3, P201, DOI 10.3109/15419069509081287; Buniatian G, 1996, EUR J CELL BIOL, V70, P23; Buniatian GH, 2003, CELL PROLIFERAT, V36, P307, DOI 10.1046/j.1365-2184.2003.00287.x; Buniatian GH, 2002, ANAT RECORD, V267, P296, DOI 10.1002/ar.10115; Buniatian GH, 2001, NEUROCHEM INT, V38, P373, DOI 10.1016/S0197-0186(00)00116-9; Burbaeva GS, 2005, NEUROCHEM RES, V30, P1443, DOI 10.1007/s11064-005-8654-x; BURCH HB, 1978, BIOCHEM BIOPH RES CO, V82, P498, DOI 10.1016/0006-291X(78)90902-6; Chakraborty T, 2007, LIFE SCI, V81, P489, DOI 10.1016/j.lfs.2007.06.023; Chatauret N, 2006, J HEPATOL, V44, P1083, DOI 10.1016/j.jhep.2005.11.048; Chwals WJ, 2004, MINI-REV MED CHEM, V4, P833, DOI 10.2174/1389557043403396; Conjard A, 2003, J BIOL CHEM, V278, P38159, DOI 10.1074/jbc.M302885200; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; Danielyan L, 2007, J INVEST DERMATOL, V127, P555, DOI 10.1038/sj.jid.5700575; DEJONG CHC, 1994, J HEPATOL, V21, P299, DOI 10.1016/S0168-8278(05)80305-8; Denes Z, 1985, Z Alternsforsch, V40, P159; Desjardins P, 1999, METAB BRAIN DIS, V14, P273, DOI 10.1023/A:1020741226752; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; Eizayaga F, 2006, WORLD J GASTROENTERO, V12, P1367, DOI 10.3748/wjg.v12.i9.1367; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Filipe J. A. C., 2002, Autonomic & Autacoid Pharmacology, V22, P155, DOI 10.1046/j.1474-8673.2002.00255.x; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Gebhardt R, 1998, CELL BIOL TOXICOL, V14, P55, DOI 10.1023/A:1007468521927; GEBHARDT R, 1994, ADV ENZYME REGUL, V34, P27, DOI 10.1016/0065-2571(94)90007-8; GEBHARDT R, 1986, CELL BIOL TOXICOL, V2, P9, DOI 10.1007/BF00117703; GEBHARDT R, 1994, HEPATOLOGY, V20, P684, DOI 10.1016/0270-9139(94)90105-8; GEBHARDT R, 1984, GLUTAMINE METABOLISM, P98; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GIRARD G, 1992, DIGEST DIS SCI, V37, P1121, DOI 10.1007/BF01300297; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Haberle J, 2006, J INHERIT METAB DIS, V29, P352, DOI 10.1007/s10545-006-0256-5; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; HAN EKH, 1993, J CELL BIOL, V122, P461, DOI 10.1083/jcb.122.2.461; HANSSON E, 1989, NEUROCHEM RES, V14, P585, DOI 10.1007/BF00964922; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hasan W, 2000, CELL TISSUE RES, V300, P97, DOI 10.1007/s004410050051; HOLASH JA, 1993, P NATL ACAD SCI USA, V90, P11069, DOI 10.1073/pnas.90.23.11069; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; JACKSON MJ, 1995, NEUROCHEM RES, V20, P201, DOI 10.1007/BF00970545; JAENICKE L, 1977, H-S Z PHYSIOL CHEM, V358, P883, DOI 10.1515/bchm2.1977.358.2.883; Jensen JM, 2005, EXP DERMATOL, V14, P609, DOI 10.1111/j.0906-6705.2005.00342.x; Keiding S, 2006, HEPATOLOGY, V43, P42, DOI 10.1002/hep.21001; Kruithof-de Julio M, 2005, J HEPATOL, V43, P126, DOI 10.1016/j.jhep.2005.01.036; KUBLER MD, 1993, J INVEST DERMATOL, V100, P785, DOI 10.1111/1523-1747.ep12476492; Labow BI, 1999, AM J PHYSIOL-ENDOC M, V276, pE1136, DOI 10.1152/ajpendo.1999.276.6.E1136; LEPRINCE G, 1995, NEUROCHEM RES, V20, P859, DOI 10.1007/BF00969698; LEVINTOW L, 1954, J NATL CANCER I, V15, P347; LEYDEN JJ, 1977, ARCH DERMATOL, V113, P1678, DOI 10.1001/archderm.113.12.1678; Li N, 2004, AM J PHYSIOL-GASTR L, V287, pG726, DOI 10.1152/ajpgi.00012.2004; LieVenema H, 1997, BIOCHEM J, V323, P611, DOI 10.1042/bj3230611; Malminen M, 2003, BRIT J DERMATOL, V149, P255, DOI 10.1046/j.1365-2133.2003.05438.x; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Michel M, 1996, J CELL SCI, V109, P1017; Mirlean N, 2006, ENVIRON POLLUT, V143, P335, DOI 10.1016/j.envpol.2005.11.022; NAGEL W, 1990, IMMUNOL LETT, V26, P291, DOI 10.1016/0165-2478(90)90162-J; Niemann C, 2006, BIOESSAYS, V28, P1, DOI 10.1002/bies.20352; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; Nose K, 2005, ANAL SCI, V21, P1471, DOI 10.2116/analsci.21.1471; OBANION MK, 1994, MOL BRAIN RES, V22, P57, DOI 10.1016/0169-328X(94)90032-9; Padden M, 2007, ACTA NEUROPATHOL, V113, P177, DOI 10.1007/s00401-006-0145-x; PATEL AJ, 1985, DEV BRAIN RES, V18, P175, DOI 10.1016/0165-3806(85)90262-7; Penkowa M, 2000, GLIA, V32, P247, DOI 10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T; Pinel C, 2006, NUTRITION, V22, P778, DOI 10.1016/j.nut.2006.05.005; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; PROZIALECK WC, 1993, LIFE SCI, V53, pPL337, DOI 10.1016/0024-3205(93)90567-M; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; REMESAR X, 1982, HORM METAB RES, V14, P419, DOI 10.1055/s-2007-1019033; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; SONI T, 1991, MOL CELL BIOCHEM, V102, P149; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Sullivan DM, 1997, GENE THER, V4, P1036, DOI 10.1038/sj.gt.3300505; Troy TC, 2007, MOL BIOTECHNOL, V36, P166, DOI 10.1007/s12033-007-0027-z; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Vastag M, 2005, PFLUG ARCH EUR J PHY, V449, P384, DOI 10.1007/s00424-004-1341-y; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Yoneda Kozo, 1992, Journal of Dermatology (Tokyo), V19, P761; ZELLMER S, 2001, EPITHELIAL CELL CULT, P179; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhen YX, 1999, ARCH DERMATOL RES, V291, P555, DOI 10.1007/s004030050453; Zhu QL, 2004, CELL TISSUE RES, V316, P243, DOI 10.1007/s00441-004-0864-z; ZIYLAN YZ, 1993, MOL CHEM NEUROPATHOL, V20, P203	94	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4416	10.1371/journal.pone.0004416	http://dx.doi.org/10.1371/journal.pone.0004416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204801	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000007
J	Ratner, L; Harrington, W; Feng, X; Grant, C; Jacobson, S; Noy, A; Sparano, J; Lee, J; Ambinder, R; Campbell, N; Lairmore, M				Ratner, Lee; Harrington, William; Feng, Xuan; Grant, Christian; Jacobson, Steve; Noy, Ariela; Sparano, Joseph; Lee, Jeannette; Ambinder, Richard; Campbell, Nancy; Lairmore, Michael		AIDS Malignancy Consortium	Human T Cell Leukemia Virus Reactivation with Progression of Adult T-Cell Leukemia-Lymphoma	PLOS ONE			English	Article								Background: Human T-cell leukemia virus-associated adult T-cell leukemia-lymphoma (ATLL) has a very poor prognosis, despite trials of a variety of different treatment regimens. Virus expression has been reported to be limited or absent when ATLL is diagnosed, and this has suggested that secondary genetic or epigenetic changes are important in disease pathogenesis. Methods and Findings: We prospectively investigated combination chemotherapy followed by antiretroviral therapy for this disorder. Nineteen patients were prospectively enrolled between 2002 and 2006 at five medical centers in a phase II clinical trial of infusional chemotherapy with etoposide, doxorubicin, and vincristine, daily prednisone, and bolus cyclophosphamide (EPOCH) given for two to six cycles until maximal clinical response, and followed by antiviral therapy with daily zidovudine, lamivudine, and alpha interferon-2a for up to one year. Seven patients were on study for less than one month due to progressive disease or chemotherapy toxicity. Eleven patients achieved an objective response with median duration of response of thirteen months, and two complete remissions. During chemotherapy induction, viral RNA expression increased (median 190-fold), and virus replication occurred, coincident with development of disease progression. Conclusions: EPOCH chemotherapy followed by antiretroviral therapy is an active therapeutic regimen for adult T-cell leukemia-lymphoma, but viral reactivation during induction chemotherapy may contribute to treatment failure. Alternative therapies are sorely needed in this disease that simultaneously prevent virus expression, and are cytocidal for malignant cells.	[Ratner, Lee; Feng, Xuan; Campbell, Nancy] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA; [Harrington, William] Univ Miami, Sch Med, Miami, FL USA; [Grant, Christian; Jacobson, Steve] NINDS, NIH, Neuroimmunol Branch, Bethesda, MD USA; [Noy, Ariela] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, New York, NY USA; [Sparano, Joseph] Albert Einstein Coll Med, Dept Oncol, Bronx, NY USA; [Lee, Jeannette] Univ Alabama, Sch Med, Div Hematol Oncol, Birmingham, AL USA; [Ambinder, Richard] Johns Hopkins Univ, Inst Med, Dept Oncol, Baltimore, MD 21218 USA; [Lairmore, Michael] Ohio State Univ, Coll Vet Med, Ctr Retrovirus Res, Columbus, OH 43210 USA	Washington University (WUSTL); University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; University System of Ohio; Ohio State University	Ratner, L (corresponding author), Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA.	lratner@im.wustl.edu	Ambinder, Richard/G-1607-2011	Sparano, Joseph/0000-0002-9031-2010; Ratner, Lee/0000-0003-2744-7294; Noy, Ariela/0000-0002-3001-4898	Glaxo-Smith-Kline; PHS [U01CA070058, U01CA070054, U01CA071375, U01CA083038, U01CA070062, U01CA070019, CA10521]; NATIONAL CANCER INSTITUTE [U01CA071375, U01CA070054, U01CA083038, U01CA070058, U01CA070062, P01CA100730, U01CA070019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003040, ZIANS002817] Funding Source: NIH RePORTER	Glaxo-Smith-Kline(GlaxoSmithKline); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Combivir was provided by Glaxo-Smith-Kline. This study was supported by PHS grants U01CA070058, U01CA070054, U01CA071375, U01CA083038, U01CA070062, U01CA070019, and CA10521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, EUR J HAEMATOL, V81, P209, DOI 10.1111/j.1600-0609.2008.01105.x; Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016/S1470-2045(04)01608-0; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Furukawa Y, 2006, INT J CANCER, V118, P381, DOI 10.1002/ijc.21328; Furukawa Y, 2001, BLOOD, V97, P987, DOI 10.1182/blood.V97.4.987; FURUKAWA Y, 1995, BLOOD, V85, P1865, DOI 10.1182/blood.V85.7.1865.bloodjournal8571865; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; HERMINE O, 1995, NEW ENGL J MED, V332, P1749, DOI 10.1056/NEJM199506293322604; Horie R, 2006, DRUG NEWS PERSPECT, V19, P201, DOI 10.1358/dnp.2006.19.4.985934; Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; KAMIHIRA S, 1992, LEUKEMIA RES, V16, P435, DOI 10.1016/0145-2126(92)90168-7; Kato K, 2007, BIOL BLOOD MARROW TR, V13, P90, DOI 10.1016/j.bbmt.2006.09.002; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Lin HC, 2005, VIROLOGY, V339, P1, DOI 10.1016/j.virol.2005.05.015; Little RF, 2003, BLOOD, V101, P4653, DOI 10.1182/blood-2002-11-3589; MAJOR ME, 1993, J GEN VIROL, V74, P2531, DOI 10.1099/0022-1317-74-11-2531; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Miller V, 2001, ANTIVIR THER, V6, P25; Mitsiades CS, 2006, CURR DRUG TARGETS, V7, P1341, DOI 10.2174/138945006778559247; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; Nagai M, 2001, J INFECT DIS, V183, P197, DOI 10.1086/317932; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ratner L, 2004, FRONT BIOSCI-LANDMRK, V9, P2852, DOI 10.2741/1442; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Shimauchi T, 2008, CANCER SCI, V99, P98, DOI 10.1111/j.1349-7006.2007.00646.x; Shimoyama M., 1991, BRIT J HAEMATOL, V79, P426; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Taylor GP, 1999, J VIROL, V73, P10289, DOI 10.1128/JVI.73.12.10289-10295.1999; Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Waldmann TA, 2006, ADV IMMUNOL, V90, P83, DOI 10.1016/S0065-2776(06)90003-0; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Yamada Y, 2005, LEUKEMIA LYMPHOMA, V46, P1553, DOI 10.1080/10428190500244217; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88; Yano H, 2007, INT J CANCER, V120, P2052, DOI 10.1002/ijc.22536	39	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4420	10.1371/journal.pone.0004420	http://dx.doi.org/10.1371/journal.pone.0004420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204798	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000009
J	Muller, IB; Wu, F; Bergmann, B; Knockel, J; Walter, RD; Gehring, H; Wrenger, C				Mueller, Ingrid B.; Wu, Fang; Bergmann, Baerbel; Knoeckel, Julia; Walter, Rolf D.; Gehring, Heinz; Wrenger, Carsten			Poisoning Pyridoxal 5-Phosphate-Dependent Enzymes: A New Strategy to Target the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article								The human malaria parasite Plasmodium falciparum is able to synthesize de novo pyridoxal 5-phosphate (PLP), a crucial cofactor, during erythrocytic schizogony. However, the parasite possesses additionally a pyridoxine/pyridoxal kinase (PdxK) to activate B6 vitamers salvaged from the host. We describe a strategy whereby synthetic pyridoxyl-amino acid adducts are channelled into the parasite. Trapped upon phosphorylation by the plasmodial PdxK, these compounds block PLP-dependent enzymes and thus impair the growth of P. falciparum. The novel compound PT3, a cyclic pyridoxyl-tryptophan methyl ester, inhibited the proliferation of Plasmodium very efficiently (IC50-value of 14 mu M) without harming human cells. The non-cyclic pyridoxyl-tryptophan methyl ester PT5 and the pyridoxyl-histidine methyl ester PHME were at least one order of magnitude less effective or completely ineffective in the case of the latter. Modeling in silico indicates that the phosphorylated forms of PT3 and PT5 fit well into the PLP-binding site of plasmodial ornithine decarboxylase (PfODC), the key enzyme of polyamine synthesis, consistent with the ability to abolish ODC activity in vitro. Furthermore, the antiplasmodial effect of PT3 is directly linked to the capability of Plasmodium to trap this pyridoxyl analog, as shown by an increased sensitivity of parasites overexpressing PfPdxK in their cytosol, as visualized by GFP fluorescence.	[Mueller, Ingrid B.; Bergmann, Baerbel; Knoeckel, Julia; Walter, Rolf D.; Wrenger, Carsten] Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany; [Wu, Fang; Gehring, Heinz] Univ Zurich, Dept Biochem, CH-8006 Zurich, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; University of Zurich	Muller, IB (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany.	ibmueller@bni-hamburg.de	Wu, Fang/B-1945-2008; Wrenger, Carsten/E-4110-2013	Wu, Fang/0000-0002-4194-2243; Wrenger, Carsten/0000-0001-5987-1749; Vivian, Julia/0000-0001-6688-7714	Deutsche Forschungsgemeinschaft [WA 395/15, WR 124/2]; COST Switzerland [C02.0017]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST Switzerland	This work was supported by Deutsche Forschungsgemeinschaft Grants WA 395/15 and WR 124/2 and by COST Switzerland (Action 922, Grant C02.0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Birkholtz L, 2003, PROTEINS, V50, P464, DOI 10.1002/prot.10274; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Crabb BS, 2004, METH MOL B, V270, P263; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Eschbach ML, 2006, BIOL CHEM, V387, P1583, DOI 10.1515/BC.2006.197; FONDA ML, 1982, AM J CLIN NUTR, V35, P1391, DOI 10.1093/ajcn/35.6.1391; FRIEDRICH W, 1988, VITAMINS, P1060; GAO GJ, 1994, J BIOL CHEM, V269, P7163; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; HELLER JS, 1975, BIOCHIM BIOPHYS ACTA, V403, P197, DOI 10.1016/0005-2744(75)90022-4; KHOMUTOV RM, 1971, BIOCHEM J, V124, P99, DOI 10.1042/bj1240099; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Muller IB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001815; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; Noda M, 2004, J BIOL CHEM, V279, P46143, DOI 10.1074/jbc.M404603200; PEGG AE, 1995, J CELL BIOCHEM, P132; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PLATZER EG, 1978, J PROTOZOOL, V25, P556, DOI 10.1111/j.1550-7408.1978.tb04186.x; POULIN R, 1992, J BIOL CHEM, V267, P150; Scott TC, 1997, MOL BIOCHEM PARASIT, V88, P1, DOI 10.1016/S0166-6851(97)00077-7; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Storici P, 2004, J BIOL CHEM, V279, P363, DOI 10.1074/jbc.M305884200; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; WANG CC, 1995, ANNU REV PHARMACOL, V35, P93, DOI 10.1146/annurev.pa.35.040195.000521; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Wrenger C, 2001, J BIOL CHEM, V276, P29651, DOI 10.1074/jbc.M100578200; Wu F, 2008, FASEB J, V22, P890, DOI 10.1096/fj.07-9566com; Wu F, 2007, MOL CANCER THER, V6, P1831, DOI 10.1158/1535-7163.MCT-07-0045	38	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4406	10.1371/journal.pone.0004406	http://dx.doi.org/10.1371/journal.pone.0004406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197387	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483700013
J	Elahi, E; Suraweera, N; Volikos, E; Haines, J; Brown, N; Davidson, G; Churchman, M; Ilyas, M; Tomlinson, I; Silver, A				Elahi, Eiram; Suraweera, Nirosha; Volikos, Emmanouil; Haines, Jackie; Brown, Natalie; Davidson, Gerovie; Churchman, Mike; Ilyas, Mohammed; Tomlinson, Ian; Silver, Andrew			Five Quantitative Trait Loci Control Radiation-Induced Adenoma Multiplicity in Mom1R ApcMin/+ Mice	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; NADPH OXIDASES; SUSCEPTIBILITY; MOUSE; MODIFIER; CANCER; GENE; IDENTIFICATION; APC(MIN/+)	Ionising radiation is a carcinogen capable of inducing tumours, including colorectal cancer, in both humans and animals. By backcrossing a recombinant line of Apc(Min/+) mice to the inbred BALB/c mouse strain, which is unusually sensitive to radiation-induced tumour development, we obtained panels of 2Gy-irradiated and sham-irradiated N2 Apc(Min/+) mice for genotyping with a genome-wide panel of microsatellites at similar to 15 cM density and phenotyping by counting adenomas in the small intestine. Interval and composite interval mapping along with permutation testing identified five significant susceptibility quantitative trait loci (QTLs) responsible for radiation induced tumour multiplicity in the small intestine. These were defined as Mom (Modifier of Min) radiation-induced polyposis (Mrip1-5) on chromosome 2 (log of odds, LOD 2.8, p = 0.0003), two regions within chromosome 5 (LOD 5.2, p<0.00001, 6.2, p<0.00001) and two regions within chromosome 16 respectively (LOD 4.1, p = 4x10(-5), 4.8, p<0.00001). Suggestive QTLs were found for sham-irradiated mice on chromosomes 3, 6 and 13 (LOD 1.7, 1.5 and 2.0 respectively; p<0.005). Genes containing BALB/c specific non-synonymous polymorphisms were identified within Mrip regions and prediction programming used to locate potentially functional polymorphisms. Our study locates the QTL regions responsible for increased radiation-induced intestinal tumorigenesis in Apc(Min/+) mice and identifies candidate genes with predicted functional polymorphisms that are involved in spindle checkpoint and chromosomal stability (Bub1b, Casc5, and Bub1), DNA repair (Recc1 and Prkdc) or inflammation (Duox2, Itgb2l and Cxcl5). Our study demonstrates use of in silico analysis in candidate gene identification as a way of reducing large-scale backcross breeding programmes.	[Elahi, Eiram; Suraweera, Nirosha; Volikos, Emmanouil; Silver, Andrew] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Haines, Jackie; Brown, Natalie] HPA, Radiat Protect Div, Didcot, Oxon, England; [Davidson, Gerovie; Churchman, Mike] Univ Oxford, Radcliffe Infirmary, Canc Res UK, Genotyping Facil, Oxford OX1 2JD, England; [Ilyas, Mohammed] Queens Med Ctr, Sch Mol Med Sci, Div Pathol, Nottingham, England; [Tomlinson, Ian] Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London, England	University of London; Queen Mary University London; Health Protection Agency; Cancer Research UK; Radcliffe Infirmary; University of Oxford; University of Nottingham; Cancer Research UK	Elahi, E (corresponding author), Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England.	a.r.silver@qmul.ac.uk	Suraweera, Nirosha/E-5912-2012		Cancer Research UK	Cancer Research UK(Cancer Research UK)	Cancer Research UK funded this research. The Funder (Cancer Research UK) had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2007, GASTROENTEROLOGY, V132, P2448, DOI 10.1053/j.gastro.2007.03.027; Baier PK, 2005, ANTICANCER RES, V25, P3581; Basten C.J., 1994, P 5 WORLD C GEN APPL, P65; BASTEN CJ, 2004, QTL CARTOGRAPHER VER; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belknap JK, 2001, BEHAV GENET, V31, P5, DOI 10.1023/A:1010249607128; Bogue MA, 2007, NUCLEIC ACIDS RES, V35, pD643, DOI 10.1093/nar/gkl1049; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Degg NL, 2003, CANCER RES, V63, P2361; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Dimberg J, 2007, INT J ONCOL, V31, P97; Dragani TA, 2003, CANCER RES, V63, P3011; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Haines J, 2005, P NATL ACAD SCI USA, V102, P2868, DOI 10.1073/pnas.0500039102; Hashiguchi K, 2007, NUCLEIC ACIDS RES, V35, P2913, DOI 10.1093/nar/gkm115; Hojgaard A, 2006, IMMUNOLOGY, V119, P212, DOI 10.1111/j.1365-2567.2006.02426.x; JANSEN RC, 1994, GENETICS, V136, P1447; Katoh M, 2007, INT J ONCOL, V30, P247; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kwong LN, 2007, GENETICS, V176, P1237, DOI 10.1534/genetics.107.071217; LUONGO C, 1994, CANCER RES, V54, P5947; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; MacLaren Erik J, 2005, Alcohol Clin Exp Res, V29, P1568, DOI 10.1097/01.alc.0000179376.27331.ac; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Marshall KE, 2002, GENOME BIOL, V3; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; Mori N, 2000, J RADIAT RES, V41, P367, DOI 10.1269/jrr.41.367; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Silverman KA, 2002, GENOME RES, V12, P88, DOI 10.1101/gr.206002; SIPLEY JD, 1995, P NATL ACAD SCI USA, V92, P7515, DOI 10.1073/pnas.92.16.7515; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Turina M, 2008, ARCH SURG-CHICAGO, V143, P46, DOI 10.1001/archsurg.2007.7; *UNSCEAR, 2000, 55 SESS NEW YORK U S, V46; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; YU K, 2001, CANCER RES, V61, P1820; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4388	10.1371/journal.pone.0004388	http://dx.doi.org/10.1371/journal.pone.0004388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194513	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483600013
J	Popp, A; Urbach, A; Witte, OW; Frahm, C				Popp, Anke; Urbach, Anja; Witte, Otto W.; Frahm, Christiane			Adult and Embryonic GAD Transcripts Are Spatiotemporally Regulated during Postnatal Development in the Rat Brain	PLOS ONE			English	Article								Background: GABA (gamma-aminobutyric acid), the main inhibitory neurotransmitter in the brain, is synthesized by glutamic acid decarboxylase (GAD). GAD exists in two adult isoforms, GAD65 and GAD67. During embryonic brain development at least two additional transcripts exist, I-80 and I-86, which are distinguished by insertions of 80 or 86 bp into GAD67 mRNA, respectively. Though it was described that embryonic GAD67 transcripts are not detectable during adulthood there are evidences suggesting re-expression under certain pathological conditions in the adult brain. In the present study we systematically analyzed for the first time the spatiotemporal distribution of different GADs with emphasis on embryonic GAD67 mRNAs in the postnatal brain using highly sensitive methods. Methodology/Principal Findings: QPCR was used to precisely investigate the postnatal expression level of GAD related mRNAs in cortex, hippocampus, cerebellum, and olfactory bulb of rats from P1 throughout adulthood. Within the first three postnatal weeks the expression of both GAD65 and GAD67 mRNAs reached adult levels in hippocampus, cortex, and cerebellum. The olfactory bulb showed by far the highest expression of GAD65 as well as GAD67 transcripts. Embryonic GAD67 splice variants were still detectable at birth. They continuously declined to barely detectable levels during postnatal development in all investigated regions with exception of a comparatively high expression in the olfactory bulb. Radioactive in situ hybridizations confirmed the occurrence of embryonic GAD67 transcripts in the olfactory bulb and furthermore detected their localization mainly in the subventricular zone and the rostral migratory stream. Conclusions/Significance: Embryonic GAD67 transcripts can hardly be detected in the adult brain, except for specific regions associated with neurogenesis and high synaptic plasticity. Therefore a functional role in processes like proliferation, migration or synaptogenesis is suggested.	[Popp, Anke; Urbach, Anja; Witte, Otto W.; Frahm, Christiane] Univ Jena, Dept Neurol, Jena, Germany	Friedrich Schiller University of Jena	Popp, A (corresponding author), Univ Jena, Dept Neurol, Jena, Germany.	christiane.frahm@med.uni-jena.de	Urbach, Anja/CAG-0282-2022; Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	BMBF [01GZ0306, 0311578]; Kompetenznetzwerk Schlaganfall, BMBF [01GI9905]	BMBF(Federal Ministry of Education & Research (BMBF)); Kompetenznetzwerk Schlaganfall, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (nos. 01GZ0306 and 0311578) and Kompetenznetzwerk Schlaganfall, BMBF (no. 01GI9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggensteiner M, 2003, DEV BRAIN RES, V142, P77, DOI 10.1016/S0165-3806(03)00033-6; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; BEHAR T, 1994, DEV BRAIN RES, V77, P77, DOI 10.1016/0165-3806(94)90215-1; BEHAR T, 1993, DEV BRAIN RES, V72, P203, DOI 10.1016/0165-3806(93)90185-D; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BOND RW, 1990, P NATL ACAD SCI USA, V87, P8771, DOI 10.1073/pnas.87.22.8771; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Dupuy ST, 1996, J NEUROSCI, V16, P6919; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Frahm C, 2001, DEV BRAIN RES, V132, P1, DOI 10.1016/S0165-3806(01)00288-7; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; GREIF KF, 1992, DEV BIOL, V153, P158, DOI 10.1016/0012-1606(92)90100-U; Guo YH, 1997, DEV BRAIN RES, V103, P127, DOI 10.1016/S0165-3806(97)81789-0; Gutierrez R, 2000, J NEUROPHYSIOL, V84, P3088, DOI 10.1152/jn.2000.84.6.3088; Gutierrez R, 2001, EUR J NEUROSCI, V13, P1371, DOI 10.1046/j.0953-816x.2001.01508.x; HOUSER CR, 1994, HIPPOCAMPUS, V4, P530, DOI 10.1002/hipo.450040503; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kobori H, 2001, HYPERTENSION, V37, P1329, DOI 10.1161/01.HYP.37.5.1329; Krizbai IA, 2000, NEUROREPORT, V11, P791, DOI 10.1097/00001756-200003200-00027; Kuppers E, 2000, MOL BRAIN RES, V81, P19, DOI 10.1016/S0169-328X(00)00156-X; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Liu YWJ, 2007, CURR PHARM BIOTECHNO, V8, P187; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Sloviter RS, 1996, J COMP NEUROL, V373, P593; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Szabo G, 2000, NEUROSCIENCE, V100, P287, DOI 10.1016/S0306-4522(00)00275-X; Varja P, 2002, J NEUROCHEM, V80, P605, DOI 10.1046/j.0022-3042.2001.00733.x; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	45	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4371	10.1371/journal.pone.0004371	http://dx.doi.org/10.1371/journal.pone.0004371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190758	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483300010
J	Hohn, C; Lee, SR; Pinchuk, LM; Petrie-Hanson, L				Hohn, Claudia; Lee, Sang-Ryul; Pinchuk, Lesya M.; Petrie-Hanson, Lora			Zebrafish Kidney Phagocytes Utilize Macropinocytosis and Ca2+-Dependent Endocytic Mechanisms	PLOS ONE			English	Article								Background: The innate immune response constitutes the first line of defense against invading pathogens and consists of a variety of immune defense mechanisms including active endocytosis by macrophages and granulocytes. Endocytosis can be used as a reliable measure of selective and non-selective mechanisms of antigen uptake in the early phase of an immune response. Numerous assays have been developed to measure this response in a variety of mammalian and fish species. The small size of the zebrafish has prevented the large-scale collection of monocytes/macrophages and granulocytes for these endocytic assays. Methodology/Principal Findings: Pooled zebrafish kidney hematopoietic tissues were used as a source of phagocytic cells for flow-cytometry based endocytic assays. FITC-Dextran, Lucifer Yellow and FITC-Edwardsiella ictaluri were used to evaluate selective and non-selective mechanisms of uptake in zebrafish phagocytes. Conclusions/Significance: Zebrafish kidney phagocytes characterized as monocytes/macrophages, neutrophils and lymphocytes utilize macropinocytosis and Ca2+-dependant endocytosis mechanisms of antigen uptake. These cells do not appear to utilize a mannose receptor. Heat-killed Edwardsiella ictaluri induces cytoskeletal interactions for internalization in zebrafish kidney monocytes/macrophages and granulocytes. The proposed method is easy to implement and should prove especially useful in immunological, toxicological and epidemiological research.	[Hohn, Claudia; Lee, Sang-Ryul; Pinchuk, Lesya M.; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Mississippi State University	Hohn, C (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu						AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; BARAKAT KK, 2005, RES J AGR BIOL SCI, V1, P195; BLAZER V S, 1991, Journal of Aquatic Animal Health, V3, P77, DOI 10.1577/1548-8667(1991)003&lt;0077:PMFANI&gt;2.3.CO;2; Boyd BL, 2004, VET IMMUNOL IMMUNOP, V102, P53, DOI 10.1016/j.vetimm.2004.06.009; Chaves-Pozo Elena, 2004, Biological Procedures Online, V6, P129, DOI 10.1251/bpo81; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DUNN PA, 1983, J IMMUNOL METHODS, V64, P71, DOI 10.1016/0022-1759(83)90385-X; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Esteban MA, 1998, CELL TISSUE RES, V293, P133, DOI 10.1007/s004410051105; Esteban MA, 2004, FISH SHELLFISH IMMUN, V16, P447, DOI 10.1016/j.fsi.2003.07.004; EWANOWICH CA, 1990, INFECT IMMUN, V58, P3187, DOI 10.1128/IAI.58.10.3187-3193.1990; GIVAN AL, 2001, FLOW CYTOMETRY 1 PRI, P154; HARDIE LJ, 1994, DEV COMP IMMUNOL, V18, P57, DOI 10.1016/0145-305X(94)90252-6; Harford AJ, 2006, FISH SHELLFISH IMMUN, V20, P562, DOI 10.1016/j.fsi.2005.07.005; Harford AJ, 2005, AQUAT TOXICOL, V75, P330, DOI 10.1016/j.aquatox.2005.09.005; HASUI M, 1989, J IMMUNOL METHODS, V117, P53, DOI 10.1016/0022-1759(89)90118-X; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hermann AC, 2004, J IMMUNOL METHODS, V292, P119, DOI 10.1016/j.jim.2004.06.016; Hohn C, 2007, ZEBRAFISH, V4, P117, DOI 10.1089/zeb.2006.0501; HOHN CM, 2008, THESIS MISSISSIPPI S; Inoue T, 2002, FISH SHELLFISH IMMUN, V13, P379, DOI 10.1006/fsim.2002.0413; Jensch BE, 2006, AQUACULTURE, V251, P509, DOI 10.1016/j.aquaculture.2005.05.042; KAHN S, 1995, J EXP MED, P182; Kamilya D, 2006, AQUACULTURE, V253, P130, DOI 10.1016/j.aquaculture.2005.07.038; Koduru S, 2006, DEV GENES EVOL, V216, P133, DOI 10.1007/s00427-005-0043-6; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Mendez E, 2001, ENDOCRINOLOGY, V142, P1090, DOI 10.1210/en.142.3.1090; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Neumann NF, 2001, DEV COMP IMMUNOL, V25, P807, DOI 10.1016/S0145-305X(01)00037-4; Nolan CM, 2006, DEV GENES EVOL, V216, P144, DOI 10.1007/s00427-005-0046-3; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Palic D, 2007, J IMMUNOL METHODS, V319, P87, DOI 10.1016/j.jim.2006.11.003; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; PETRIEHANSON L, BMC IMMUNOL IN PRESS; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Rodriguez A, 2003, FISH SHELLFISH IMMUN, V14, P375, DOI 10.1006/fsim.2002.0446; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SANTOS JL, 1995, IMMUNOL LETT, V45, P1, DOI 10.1016/0165-2478(94)00180-Y; Sarder MRI, 2001, DEV COMP IMMUNOL, V25, P37, DOI 10.1016/S0145-305X(00)00040-9; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; SCHREIBER S, 1991, P NATL ACAD SCI USA, V88, P1616, DOI 10.1073/pnas.88.5.1616; Secombes C. J., 1992, Annual Review of Fish Diseases, V2, P53, DOI 10.1016/0959-8030(92)90056-4; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Skirpstunas RT, 2002, DIS AQUAT ORGAN, V51, P161, DOI 10.3354/dao051161; Steinkamp JA, 2000, CYTOMETRY, V39, P45, DOI 10.1002/(SICI)1097-0320(20000101)39:1<45::AID-CYTO7>3.0.CO;2-1; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; WATTS C, 1992, J CELL SCI, V103, P1; WEEKS BA, 1986, VET IMMUNOL IMMUNOP, V12, P313, DOI 10.1016/0165-2427(86)90135-2; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WHITEOWEN C, 1992, J CLIN MICROBIOL, V30, P2071, DOI 10.1128/JCM.30.8.2071-2076.1992; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1; YOSHIDA T, 1993, AQUACULTURE, V109, P207, DOI 10.1016/0044-8486(93)90163-S	70	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4314	10.1371/journal.pone.0004314	http://dx.doi.org/10.1371/journal.pone.0004314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183805	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483200004
J	Zangenehpour, S; Ghazanfar, AA; Lewkowicz, DJ; Zatorre, RJ				Zangenehpour, Shahin; Ghazanfar, Asif A.; Lewkowicz, David J.; Zatorre, Robert J.			Heterochrony and Cross-Species Intersensory Matching by Infant Vervet Monkeys	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; RHESUS-MONKEY; 1ST YEAR; MULTISENSORY INTEGRATION; BRAIN EVOLUTION; AUDITORY-CORTEX; ALARM CALLS; PERCEPTION; SPEECH; CUES	Background: Understanding the evolutionary origins of a phenotype requires understanding the relationship between ontogenetic and phylogenetic processes. Human infants have been shown to undergo a process of perceptual narrowing during their first year of life, whereby their intersensory ability to match the faces and voices of another species declines as they get older. We investigated the evolutionary origins of this behavioral phenotype by examining whether or not this developmental process occurs in non-human primates as well. Methodology/Principal Findings: We tested the ability of infant vervet monkeys (Cercopithecus aethiops), ranging in age from 23 to 65 weeks, to match the faces and voices of another non-human primate species (the rhesus monkey, Macaca mulatta). Even though the vervets had no prior exposure to rhesus monkey faces and vocalizations, our findings show that infant vervets can, in fact, recognize the correspondence between rhesus monkey faces and voices (but indicate that they do so by looking at the non-matching face for a greater proportion of overall looking time), and can do so well beyond the age of perceptual narrowing in human infants. Our results further suggest that the pattern of matching by vervet monkeys is influenced by the emotional saliency of the Face+Voice combination. That is, although they looked at the non-matching screen for Face+Voice combinations, they switched to looking at the matching screen when the Voice was replaced with a complex tone of equal duration. Furthermore, an analysis of pupillary responses revealed that their pupils showed greater dilation when looking at the matching natural face/voice combination versus the face/tone combination. Conclusions/Significance: Because the infant vervets in the current study exhibited cross-species intersensory matching far later in development than do human infants, our findings suggest either that intersensory perceptual narrowing does not occur in Old World monkeys or that it occurs later in development. We argue that these findings reflect the faster rate of neural development in monkeys relative to humans and the resulting differential interaction of this factor with the effects of early experience.	[Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada; [Ghazanfar, Asif A.] Princeton Univ, Neurosci Inst, Dept Psychol, Princeton, NJ 08544 USA; [Lewkowicz, David J.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA	McGill University; Princeton University; State University System of Florida; Florida Atlantic University	Zangenehpour, S (corresponding author), McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ, Canada.	shahin.zangenehpour@mcgill.ca		Lewkowicz, David/0000-0001-6685-3178	Canadian Institutes of Health Research (CIHR) [Fellowship]; W.G. Stairs Foundation; NICHD [R01 HD35849]; NSF [BCS-0751888, BCS-0547760]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035849] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); W.G. Stairs Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Canadian Institutes of Health Research (CIHR) Fellowship (to SZ), an operating grant from CIHR (to RJZ), a joint seed grant from W.G. Stairs Foundation (to SZ and RJZ), NICHD grant R01 HD35849 and NSF grant BCS-0751888 (to DJL), and an NSF BCS-0547760 CAREER award (to AAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2006, PRIMATES, V47, P350, DOI 10.1007/s10329-006-0182-z; Antinucci F., 1989, P67; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Bernstein LE, 2004, SPEECH COMMUN, V44, P5, DOI 10.1016/j.specom.2004.10.011; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; DEACON TW, 1990, AM ZOOL, V30, P629; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; GIBSON EJ, 1984, CHILD DEV, V55, P453, DOI 10.2307/1129956; Gibson K.R., 1991, BRAIN MATURATION COG, P29; Gottlieb G., 1992, INDIVIDUAL DEV EVOLU; Gould S. J., 1977, ONTOGENY PHYLOGENY; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; HAUSER MD, 1994, BRAIN LANG, V46, P232, DOI 10.1006/brln.1994.1014; HAUSER MD, 1993, ANIM BEHAV, V45, P423, DOI 10.1006/anbe.1993.1054; HAUSER MD, 1988, BEHAVIOUR, V105, P187, DOI 10.1163/156853988X00016; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Jordan KE, 2006, P NATL ACAD SCI USA, V103, P3486, DOI 10.1073/pnas.0508107103; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewkowicz DJ, 2008, BRAIN RES, V1242, P291, DOI 10.1016/j.brainres.2008.03.084; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Malkova L, 2006, EUR J NEUROSCI, V24, P3204, DOI 10.1111/j.1460-9568.2006.05175.x; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Petersen A. C., 1991, BRAIN MATURATION COG, P181; PETRINOVICH L, 1987, ANIM BEHAV, V35, P961, DOI 10.1016/S0003-3472(87)80153-7; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Schneirla T. C., 1949, PHILOS FUTURE, P243; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; TURKEWITZ G, 1982, DEV PSYCHOBIOL, V15, P357, DOI 10.1002/dev.420150408; Vatakis A, 2008, J VISION, V8, DOI 10.1167/8.9.14; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4302	10.1371/journal.pone.0004302	http://dx.doi.org/10.1371/journal.pone.0004302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JG	19172998	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483000011
J	Roussel, E; Carcaud, J; Sandoz, JC; Giurfa, M				Roussel, Edith; Carcaud, Julie; Sandoz, Jean-Christophe; Giurfa, Martin			Reappraising Social Insect Behavior through Aversive Responsiveness and Learning	PLOS ONE			English	Article							DIVISION-OF-LABOR; SUCROSE RESPONSE THRESHOLDS; HONEY-BEES; STINGING RESPONSE; FORAGING BEHAVIOR; GENOTYPE; TACTILE; PHEROMONE; REWARD; AGE	Background: The success of social insects can be in part attributed to their division of labor, which has been explained by a response threshold model. This model posits that individuals differ in their response thresholds to task-associated stimuli, so that individuals with lower thresholds specialize in this task. This model is at odds with findings on honeybee behavior as nectar and pollen foragers exhibit different responsiveness to sucrose, with nectar foragers having higher response thresholds to sucrose concentration. Moreover, it has been suggested that sucrose responsiveness correlates with responsiveness to most if not all other stimuli. If this is the case, explaining task specialization and the origins of division of labor on the basis of differences in response thresholds is difficult. Methodology: To compare responsiveness to stimuli presenting clear-cut differences in hedonic value and behavioral contexts, we measured appetitive and aversive responsiveness in the same bees in the laboratory. We quantified proboscis extension responses to increasing sucrose concentrations and sting extension responses to electric shocks of increasing voltage. We analyzed the relationship between aversive responsiveness and aversive olfactory conditioning of the sting extension reflex, and determined how this relationship relates to division of labor. Principal Findings: Sucrose and shock responsiveness measured in the same bees did not correlate, thus suggesting that they correspond to independent behavioral syndromes, a foraging and a defensive one. Bees which were more responsive to shock learned and memorized better aversive associations. Finally, guards were less responsive than nectar foragers to electric shocks, exhibiting higher tolerance to low voltage shocks. Consequently, foragers, which are more sensitive, were the ones learning and memorizing better in aversive conditioning. Conclusions: Our results constitute the first integrative study on how aversive responsiveness affects learning, memory and social organization in honeybees. We suggest that parallel behavioral modules (e. g. appetitive, aversive) coexist within each individual bee and determine its tendency to adopt a given task. This conclusion, which is at odds with a simple threshold model, should open new opportunities for exploring the division of labor in social insects.	[Roussel, Edith; Carcaud, Julie; Sandoz, Jean-Christophe; Giurfa, Martin] Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, UMR5169, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Roussel, E (corresponding author), Univ Toulouse 3, CNRS, Res Ctr Anim Cognit, UMR5169, F-31062 Toulouse, France.	giurfa@cict.fr	Giurfa, Martin/H-5140-2016; Giurfa, Martin/AAS-4945-2020; Sandoz, Jean-Christophe/A-6085-2012; Carcaud, Julie/AAF-3453-2019; Giurfa, Martin MG/A-7322-2008	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; Sandoz, Jean-Christophe/0000-0002-5423-9645; Carcaud, Julie/0000-0003-3672-9963	BEESHOP; The French National Research Agency; French Research Council (CNRS); University Paul-Sabatier	BEESHOP; The French National Research Agency(French National Research Agency (ANR)); French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul-Sabatier	This work was supported by BEESHOP (European research grant Bees in Europe and Sustainable Honey Production), The French National Research Agency (Project INSAVEL), the French Research Council (CNRS) and the University Paul-Sabatier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; Balderrama N, 2002, J COMP PHYSIOL A, V188, P485, DOI 10.1007/s00359-002-0321-y; Balderrama N., 1987, P121; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BOCH R, 1962, NATURE, V195, P1018, DOI 10.1038/1951018b0; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BURRELL BD, 1994, J COMP PHYSIOL A, V174, P581, DOI 10.1007/BF00217379; Erber J, 2006, BEHAV BRAIN RES, V174, P174, DOI 10.1016/j.bbr.2006.07.023; Farooqui T, 2003, J NEUROSCI, V23, P5370; FREE JB, 1977, SOCIAL ORG HONEYBEES; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Hammer M, 1998, LEARN MEMORY, V5, P146; Humphries MA, 2005, J COMP PHYSIOL A, V191, P669, DOI 10.1007/s00359-005-0624-x; Lenoir JC, 2006, INSECT SOC, V53, P80, DOI 10.1007/s00040-005-0838-5; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maynard-Smith J., 1999, ORIGINS LIFE BIRTH L; Millor J, 1999, P NATL ACAD SCI USA, V96, P12611, DOI 10.1073/pnas.96.22.12611; NUNEZ J, 1983, PHARMACOL BIOCHEM BE, V19, P921, DOI 10.1016/0091-3057(83)90391-X; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Oster G.F., 1978, Monographs in Population Biology, pi; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P1; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; PAXTON RJ, 1994, J APICULT RES, V33, P75, DOI 10.1080/00218839.1994.11100853; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; ROBINSON GE, 1989, WESTV STUD, P61; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Scheiner R., 2001, ANIM COGN, V3, P227, DOI [10.1007/s100710100080, DOI 10.1007/S100710100080]; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Uribe-Rubio JL, 2008, BEHAV GENET, V38, P93, DOI 10.1007/s10519-007-9177-9; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288	52	48	49	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4197	10.1371/journal.pone.0004197	http://dx.doi.org/10.1371/journal.pone.0004197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IF	19142222	Green Published, gold			2022-12-27	WOS:000265479700016
J	Urbach, A; Benvenisty, N				Urbach, Achia; Benvenisty, Nissim			Studying Early Lethality of 45,XO (Turner's Syndrome) Embryos Using Human Embryonic Stem Cells	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; CANDIDATE GENE; SHORT STATURE; DIFFERENTIATION; DELETIONS; CULTURE; ESCAPE; GENOME; MODEL	Turner's syndrome (caused by monosomy of chromosome X) is one of the most common chromosomal abnormalities in females. Although 3% of all pregnancies start with XO embryos, 99% of these pregnancies terminate spontaneously during the first trimester. The common genetic explanation for the early lethality of monosomy X embryos, as well as the phenotype of surviving individuals is haploinsufficiency of pseudoautosomal genes on the X chromosome. Another possible mechanism is null expression of imprinted genes on the X chromosome due to the loss of the expressed allele. In contrast to humans, XO mice are viable, and fertile. Thus, neither cells from patients nor mouse models can be used in order to study the cause of early lethality in XO embryos. Human embryonic stem cells (HESCs) can differentiate in culture into cells from the three embryonic germ layers as well as into extraembryonic cells. These cells have been shown to have great value in modeling human developmental genetic disorders. In order to study the reasons for the early lethality of 45, XO embryos we have isolated HESCs that have spontaneously lost one of their sex chromosomes. To examine the possibility that imprinted genes on the X chromosome play a role in the phenotype of XO embryos, we have identified genes that were no longer expressed in the mutant cells. None of these genes showed a monoallelic expression in XX cells, implying that imprinting is not playing a major role in the phenotype of XO embryos. To suggest an explanation for the embryonic lethality caused by monosomy X, we have differentiated the XO HESCs in vitro an in vivo. DNA microarray analysis of the differentiated cells enabled us to compare the expression of tissue specific genes in XO and XX cells. The tissue that showed the most significant differences between the clones was the placenta. Many placental genes are expressed at much higher levels in XX cells in compare to XO cells. Thus, we suggest that abnormal placental differentiation as a result of haploinsufficiency of X-linked pseudoautosomal genes causes the early lethality in XO human embryos.	[Urbach, Achia; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Urbach, A (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	/GLR-9975-2022	Urbach, Achia/0000-0001-9393-4504	Bereshit Consortium; Israeli Ministry of Trade and Industry; European Community [018739]; Israel Science Foundation [227/06]	Bereshit Consortium; Israeli Ministry of Trade and Industry; European Community(European Commission); Israel Science Foundation(Israel Science Foundation)	This research was partially supported by funds from the Bereshit Consortium, the Israeli Ministry of Trade and Industry, the European Community (ESTOOLS, Grant number 018739), and by a grant from the Israel Science Foundation grant #227/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; CANKI N, 1988, ANN GENET-PARIS, V31, P4; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Davies W, 2007, BIOL PSYCHIAT, V61, P1351, DOI 10.1016/j.biopsych.2006.08.011; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Geerkens C, 1996, HUM GENET, V97, P39; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kopper O, 2005, STEM CELL REV, V1, P145, DOI 10.1385/SCR:1:2:145; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Saenger P, 1996, NEW ENGL J MED, V335, P1749, DOI 10.1056/NEJM199612053352307; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Staessen C, 2003, HUM REPROD UPDATE, V9, P319, DOI 10.1093/humupd/dmg029; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0	40	67	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4175	10.1371/journal.pone.0004175	http://dx.doi.org/10.1371/journal.pone.0004175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137066	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479500006
J	Drexler, HCA				Drexler, Hannes C. A.			Synergistic Apoptosis Induction in Leukemic Cells by the Phosphatase Inhibitor Salubrinal and Proteasome Inhibitors	PLOS ONE			English	Article								Background: Cells adapt to endoplasmic reticulum (ER)-stress by arresting global protein synthesis while simultaneously activating specific transcription factors and their downstream targets. These processes are mediated in part by the phosphorylation-dependent inactivation of the translation initiation factor eIF2 alpha. Following restoration of homeostasis protein synthesis is resumed when the serine/threonine-protein phosphatase PP1 dephosphorylates and reactivates eIF2 alpha. Proteasome inhibitors, used to treat multiple myeloma patients evoke ER-stress and apoptosis by blocking the ER-associated degradation of misfolded proteins (ERAD), however, the role of eIF2 alpha phosphorylation in leukemic cells under conditions of proteasome inhibitor-mediated ER stress is currently unclear. Methodology and Principal Findings: Bcr-Abl-positive and negative leukemic cell lines were used to investigate the functional implications of PP1-related phosphatase activities on eIF2 alpha phosphorylation in proteasome inhibitor-mediated ER stress and apoptosis. Rather unexpectedly, salubrinal, a recently identified PP1 inhibitor capable to protect against ER stress in various model systems, strongly synergized with proteasome inhibitors to augment apoptotic death of different leukemic cell lines. Salubrinal treatment did not affect the phosphorlyation status of eIF2 alpha. Furthermore, the proapoptotic effect of salubrinal occurred independently from the chemical nature of the proteasome inhibitor, was recapitulated by a second unrelated phosphatase inhibitor and was unaffected by overexpression of a dominant negative eIF2 alpha S51A variant that can not be phosphorylated. Salubrinal further aggravated ER-stress and proteotoxicity inflicted by the proteasome inhibitors on the leukemic cells since characteristic ER stress responses, such as ATF4 and CHOP synthesis, XBP1 splicing, activation of MAP kinases and eventually apoptosis were efficiently abrogated by the translational inhibitor cycloheximide. Conclusions: Although PP1 activity does not play a major role in regulating the ER stress response in leukemic cells, phosphatase signaling nevertheless significantly limits proteasome inhibitor-mediated ER-stress and apoptosis. Inclusion of specific phosphatase inhibitors might therefore represent an option to improve current proteasome inhibitor-based treatment modalities for hematological cancers.	Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany	Max Planck Society	Drexler, HCA (corresponding author), Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Munster, Germany.	hannes.drexler@mpi-muenster.mpg.de	Drexler, Hannes/AAI-3449-2020		Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Bali P, 2005, CLIN CANCER RES, V11, P6382, DOI 10.1158/1078-0432.CCR-05-0344; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dai Y, 2003, ONCOGENE, V22, P7108, DOI 10.1038/sj.onc.1206863; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; David E, 2005, BLOOD, V106, P4322, DOI 10.1182/blood-2005-06-2584; Drexler HCA, 2005, APOPTOSIS, V10, P743, DOI 10.1007/s10495-005-2942-4; Emanuele S, 2007, APOPTOSIS, V12, P1327, DOI 10.1007/s10495-007-0063-y; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Ghribi O, 2004, NEUROBIOL DIS, V16, P417, DOI 10.1016/j.nbd.2004.04.002; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Long K, 2005, BIOORG MED CHEM LETT, V15, P3849, DOI 10.1016/j.bmcl.2005.05.120; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Saito J, 2007, BIOCHEM J, V405, P591, DOI 10.1042/BJ20070231; Sakoff JA, 2002, INVEST NEW DRUG, V20, P1, DOI 10.1023/A:1014460818734; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sutheesophon K, 2006, ACTA HAEMATOL-BASEL, V115, P78, DOI 10.1159/000089471; Swingle Mark, 2007, V365, P23; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yew EHJ, 2005, J NEUROCHEM, V94, P943, DOI 10.1111/j.1471-4159.2005.03220.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737	57	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4161	10.1371/journal.pone.0004161	http://dx.doi.org/10.1371/journal.pone.0004161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129918	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473500008
J	Guwatudde, D; Wabwire-Mangen, F; Eller, LA; Eller, M; McCutchan, F; Kibuuka, H; Millard, M; Sewankambo, N; Serwadda, D; Michael, N; Robb, M				Guwatudde, David; Wabwire-Mangen, Fred; Eller, Leigh Anne; Eller, Michael; McCutchan, Francine; Kibuuka, Hannah; Millard, Monica; Sewankambo, Nelson; Serwadda, David; Michael, Nelson; Robb, Merlin		Kayunga Cohort Res Team	Relatively Low HIV Infection Rates in Rural Uganda, but with High Potential for a Rise: A Cohort Study in Kayunga District, Uganda	PLOS ONE			English	Article								Background: Few studies have been conducted in Uganda to identify and quantify the determinants of HIV-1 infection. We report results from a community-based cohort study, whose primary objectives were to determine HIV-1 prevalence, incidence, and determinants of these infections, among other objectives. Methodology: Consenting volunteers from the rural district of Kayunga in Uganda aged 15-49 years were enrolled between March and July 2006. Participants were evaluated every six months. A questionnaire that collected information on behavioral and other HIV-1 risk factors was administered, and a blood sample obtained for laboratory analysis at each study visit. Principal Findings: HIV-1 prevalence among the 2025 participants was 9.9% (95% CI = 8.6%-11.2%). By the end of 12 months of follow-up, 1689.7 person-years had been accumulated, with a median follow-up time of 11.97 months. Thirteen HIV-1 incident cases were detected giving an annual HIV-1 incidence of 0.77% (95% CI = 0.35-1.19). Prevalence of HSV-2 infection was 57% and was strongly associated with prevalent HIV-1 infection (adjusted Odds Ratio = 3.9, 95% CI = 2.50-6.17); as well as incident HIV-1 infection (adjusted Rate Ratio (RR) = 8.7, 95% CI = 1.11-67.2). The single most important behavioral characteristic associated with incident HIV infection was the number of times in the past 6 months, a participant had sex with person(s) they suspected/knew were having sex with others; attaining statistical significance at 10 times and higher (adjusted RR = 6.3, 95% CI = 1.73-23.1). By the end of 12 months of follow-up, 259 participants (13%) were lost to follow-up, 13 (0.6%) had died, and 2 (0.1%) had withdrawn consent. Conclusions: Despite relatively low HIV-1 incidence observed in this community, prevalence remains relatively high. In the presence of high prevalence of HSV-2 infection and the behavioral characteristic of having sex with more than one partner, there is potential for increase in HIV-1 incidence.	[Guwatudde, David; Eller, Leigh Anne; Eller, Michael; Kibuuka, Hannah; Millard, Monica] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Guwatudde, David; Wabwire-Mangen, Fred; Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Eller, Leigh Anne; Eller, Michael; McCutchan, Francine; Robb, Merlin] Henry M Jackson Fdn, Rockville, MD USA; [Sewankambo, Nelson] Makerere Univ, Sch Med, Kampala, Uganda; [Michael, Nelson] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA	Makerere University; Makerere University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Guwatudde, D (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	dguwatudde@muwrp.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Sewankambo, Nelson/0000-0001-9362-053X	U.S. Army Medical Research and Material Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine [1Y-A1-26-42-07]; DAIDS [1Y-A1-26-42-07]	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine; DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the U.S. Army Medical Research and Material Command and its cooperative agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine and by an interagency agreement (1Y-A1-26-42-07) with DAIDS. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Eller LA, 2007, J CLIN MICROBIOL, V45, P3281, DOI 10.1128/JCM.00894-07; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; KengeyaKayondo JF, 1996, INT J EPIDEMIOL, V25, P1077, DOI 10.1093/ije/25.5.1077; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Lihana RW, 2006, AIDS RES HUM RETROV, V22, P1172, DOI 10.1089/aid.2006.22.1172; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Murphy EM, 2006, PLOS MED, V3, P1443, DOI 10.1371/journal.pmed.0030379; Okware S, 2001, B WORLD HEALTH ORGAN, V79, P1113; Parikh SA, 2007, AM J PUBLIC HEALTH, V97, P1198, DOI 10.2105/AJPH.2006.088682; Quigley MA, 2004, AIDS, V18, P2055, DOI 10.1097/00002030-200410210-00010; Rodriguez MDM, 2002, AIDS, V16, P451; *SAS I INC, 2001, STAT AN SOFTW SAS VE; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; *UBOS, 2001, UG BUR STAT UBOS POP; Uganda-MOH, 2006, UG MIN HLTH UG HIV A; *UNAIDS, 2002, EP FACT SHEETS HIV S; *UNAIDS, 2006, OV GLOB AIDS EP REP; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; WAWER MJ, 1991, BRIT MED J, V303, P1303, DOI 10.1136/bmj.303.6813.1303; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Whitworth JAG, 2002, TROP MED INT HEALTH, V7, P1047, DOI 10.1046/j.1365-3156.2002.00973.x; WHO, 2001, WHO CONRAD TECHNICAL, P11; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72	37	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4145	10.1371/journal.pone.0004145	http://dx.doi.org/10.1371/journal.pone.0004145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127290	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473300010
J	Klok, CJ; Harrison, JF				Klok, C. Jaco; Harrison, Jon F.			Atmospheric Hypoxia Limits Selection for Large Body Size in Insects	PLOS ONE			English	Article							PAS PROTEIN; OXYGEN; DROSOPHILA; RESPONSES; EVOLUTION; TEMPERATURE; MODEL	Background: The correlations between Phanerozoic atmospheric oxygen fluctuations and insect body size suggest that higher oxygen levels facilitate the evolution of larger size in insects. Methods and Principal Findings: Testing this hypothesis we selected Drosophila melanogaster for large size in three oxygen atmospheric partial pressures (aPO(2)). Fly body sizes increased by 15% during 11 generations of size selection in 21 and 40 kPa aPO(2). However, in 10 kPa aPO(2), sizes were strongly reduced. Beginning at the 12(th) generation, flies were returned to normoxia. All flies had similar, enlarged sizes relative to the starting populations, demonstrating that selection for large size had functionally equivalent genetic effects on size that were independent of aPO(2). Significance: Hypoxia provided a physical constraint on body size even in a tiny insect strongly selected for larger mass, supporting the hypothesis that Triassic hypoxia may have contributed to a reduction in insect size.	[Klok, C. Jaco; Harrison, Jon F.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Klok, CJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	cjklok@asu.edu			National Science Foundation [IBN 0419704]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation, IBN 0419704, to JFH.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Bonner J.T., 2006, WHY SIZE MATTERS; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; de Crespigny FEC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1229, DOI 10.1007/s00265-007-0353-y; Dudley R, 1998, J EXP BIOL, V201, P1043; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Jaenike J, 2007, TRENDS ECOL EVOL, V22, P167, DOI 10.1016/j.tree.2007.01.008; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; KLOEK GP, 1979, AVIAT SPACE ENVIR MD, V50, P1126; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Partridge L, 1999, GENET RES, V74, P43, DOI 10.1017/S0016672399003778; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wenger RH, 2000, J EXP BIOL, V203, P1253; Wootton RJ, 2000, BIOL REV, V75, P129, DOI 10.1017/S0006323199005459; WOOTTON RJ, 1981, ANNU REV ENTOMOL, V26, P319, DOI 10.1146/annurev.en.26.010181.001535	31	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e3876	10.1371/journal.pone.0003876	http://dx.doi.org/10.1371/journal.pone.0003876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127286	Green Submitted, gold, Green Published			2022-12-27	WOS:000265473300001
J	Hanif, M; Rosengardten, Y; Sagelius, H; Rozell, B; Eriksson, M				Hanif, Mubashir; Rosengardten, Ylva; Sagelius, Hanna; Rozell, Bjorn; Eriksson, Maria			Differential Expression of A-Type and B-Type Lamins during Hair Cycling	PLOS ONE			English	Article								Multiple genetic disorders caused by mutations that affect the proteins lamin A and C show strong skin phenotypes. These disorders include the premature aging disorders Hutchinson-Gilford progeria syndrome and mandibuloacral dysplasia, as well as restrictive dermopathy. Prior studies have shown that the lamin A/C and B proteins are expressed in skin, but little is known about their normal expression in the different skin cell-types and during the hair cycle. Our immunohistochemical staining for lamins A/C and B in wild-type mice revealed strong expression in the basal cell layer of the epidermis, the outer root sheath, and the dermal papilla during all stages of the hair cycle. Lower expression of both lamins A/C and B was seen in suprabasal cells of the epidermis, in the hypodermis, and in the bulb of catagen follicles. In addition, we have utilized a previously described mouse model of Hutchinson-Gilford progeria syndrome and show here that the expression of progerin does not result in pronounced effects on hair cycling or the expression of lamin B.	Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Rosengardten, Ylva; Sagelius, Hanna; Eriksson, Maria] Karolinska Univ Hosp, Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Rozell, Bjorn] Karolinska Univ Hosp, Karolinska Inst, Clin Res Ctr, Dept Lab Med, Huddinge, Sweden	University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hanif, M (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	Maria.Eriksson.2@ki.se			Loo and Hans Osterman Foundation; Torsten and Ragnar Soderberg Foundations; Jeansson Foundation; Swedish Medical Research Council; Swedish Foundation for Strategic Research; Wennergrenska samfundet [postdoctoral fellowship]	Loo and Hans Osterman Foundation(Instituto de Salud Carlos III); Torsten and Ragnar Soderberg Foundations; Jeansson Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wennergrenska samfundet	This work was supported by grants from the Loo and Hans Osterman Foundation, the Torsten and Ragnar Soderberg Foundations, the Jeansson Foundation, the Swedish Medical Research Council, and the Swedish Foundation for Strategic Research. M.H. is supported by a postdoctoral fellowship from the Wennergrenska samfundet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Bailey DM, 1998, BRIT J UROL, V81, P745; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hoffman RM, 2006, EXPERT OPIN DRUG DEL, V3, P437, DOI 10.1517/17425247.3.3.437; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Oguchi M, 2002, BRIT J DERMATOL, V147, P853, DOI 10.1046/j.1365-2133.2002.04948.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; ROBER RA, 1989, DEVELOPMENT, V105, P365; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; SLOMINSKI A, 1991, J INVEST DERMATOL, V96, P172, DOI 10.1111/1523-1747.ep12460956; So PL, 2004, TRENDS BIOTECHNOL, V22, P493, DOI 10.1016/j.tibtech.2004.08.007; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Tilli CMLJ, 2003, BRIT J DERMATOL, V148, P102, DOI 10.1046/j.1365-2133.2003.05026.x; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4114	10.1371/journal.pone.0004114	http://dx.doi.org/10.1371/journal.pone.0004114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122810	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472900001
J	Wang, H; Vavylonis, D				Wang, Hui; Vavylonis, Dimitrios			Model of For3p-Mediated Actin Cable Assembly in Fission Yeast	PLOS ONE			English	Article							FORMIN FOR3P; CELL POLARITY; F-ACTIN; CONTRACTILE RING; ARP2/3 COMPLEX; DYNAMICS; GROWTH; LOCALIZATION; CYTOKINESIS; LATRUNCULIN	Formin For3p nucleates actin cables at the tips of fission yeast cells for polarized cell growth. The results of prior experiments have suggested a possible mechanism for actin cable assembly that involves association of For3p near cell tips, For3p-mediated actin polymerization, retrograde flow of actin cables toward the cell center, For3p dissociation from cell tips, and cable disassembly. We used analytical and computational modeling to test the validity and implications of the proposed coupled For3p/actin mechanism. We compared the model to prior experiments quantitatively and generated predictions for the expected behavior of the actin cable system upon changes of parameter values. We found that the model generates stable steady states with realistic values of rate constants and actin and For3p concentrations. Comparison of our results to previous experiments monitoring the FRAP of For3p-3GFP and the response of actin cables to treatments with actin depolymerizing drugs provided further support for the model. We identified the set of parameter values that produces results in agreement with experimental observations. We discuss future experiments that will help test the model's predictions and eliminate other possible mechanisms. The results of the model suggest that flow of actin cables may establish actin and For3p concentration gradients in the cytoplasm that could be important in global cell patterning.	[Wang, Hui; Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA	Lehigh University	Wang, H (corresponding author), Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA.	vavylonis@lehigh.edu			Lehigh University	Lehigh University	This work was supported by Lehigh University	Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Carlsson AE, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/418; Chang Fred, 2005, Novartis Found Symp, V269, P59; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Csikasz-Nagy A, 2008, YEAST, V25, P59, DOI 10.1002/yea.1571; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Gao LN, 2008, MOL BIOL CELL, V19, P1474, DOI 10.1091/mbc.E07-05-0520; Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kamasaki T, 2005, NAT CELL BIOL, V7, P916, DOI 10.1038/ncb1295; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; MITCHISON JM, 1985, J CELL SCI, V75, P357; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; O'Shaughnessy B, 2000, EUR PHYS J E, V1, P159, DOI 10.1007/PL00014596; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yarmola EG, 2000, J BIOL CHEM, V275, P28120	40	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4078	10.1371/journal.pone.0004078	http://dx.doi.org/10.1371/journal.pone.0004078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116660	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600005
J	Luo, L; Luo, JZQ; Xiong, F; Abedi, M; Greer, D				Luo, LuGuang; Luo, John Z. Q.; Xiong, Fang; Abedi, Mehrdad; Greer, Deborah			Cytokines Inducing Bone Marrow SCA(+) Cells Migration into Pancreatic Islet and Conversion into Insulin-Positive Cells In Vivo	PLOS ONE			English	Article								We hypothesize that specific bone marrow lineages and cytokine treatment may facilitate bone marrow migration into islets, leading to a conversion into insulin producing cells in vivo. In this study we focused on identifying which bone marrow subpopulations and cytokine treatments play a role in bone marrow supporting islet function in vivo by evaluating whether bone marrow is capable of migrating into islets as well as converting into insulin positive cells. We approached this aim by utilizing several bone marrow lineages and cytokine-treated bone marrow from green fluorescent protein (GFP) positive bone marrow donors. Sorted lineages of Mac-1(+), Mac-1(-), Sca(+), Sca(-), Sca(-)/Mac-1(+) and Sca(+)/Mac-1(-) from GFP positive mice were transplanted to irradiated C57BL6 GFP negative mice. Bone marrow from transgenic human ubiquitin C promoter GFP (uGFP, with strong signal) C57BL6 mice was transplanted into GFP negative C57BL6 recipients. After eight weeks, migration of GFP positive donor' bone marrow to the recipient's pancreatic islets was evaluated as the percentage of positive GFP islets/total islets. The results show that the most effective migration comes from the Sca(+)/Mac(-) lineage and these cells, treated with cytokines for 48 hours, were found to have converted into insulin positive cells in pancreatic islets in vivo. This study suggests that bone marrow lineage positive cells and cytokine treatments are critical factors in determining whether bone marrow is able to migrate and form insulin producing cells in vivo. The mechanisms causing this facilitation as well as bone marrow converting to pancreatic beta cells still need to be investigated.			Luo, L (corresponding author), Roger Williams Gen Hosp, Ctr Stem Cell Biol, Providence, RI 02908 USA.	Lluo@rwmc.org	Abedi, Mehrdad/ABC-3565-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER; NCRR NIH HHS [2P20RR018757-06, P20 RR018757] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ai CW, 2007, STEM CELLS DEV, V16, P757, DOI 10.1089/scd.2007.0038; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Banerjee M, 2005, BIOCHEM BIOPH RES CO, V328, P318, DOI 10.1016/j.bbrc.2004.12.176; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Kang EM, 2005, EXP HEMATOL, V33, P699, DOI 10.1016/j.exphem.2005.03.008; Lavazais E, 2007, DIABETES METAB, V33, P68, DOI 10.1016/j.diabet.2006.11.002; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Naselli G, 2001, Int J Exp Diabetes Res, V1, P239; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Zanone MM, 2007, FASEB J, V21, P3308, DOI 10.1096/fj.06-7905com; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955	21	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4504	10.1371/journal.pone.0004504	http://dx.doi.org/10.1371/journal.pone.0004504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225560	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486000002
J	Lee, DY; Shatseva, T; Jeyapalan, Z; Du, WW; Deng, ZQ; Yang, BB				Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Deng, Zhaoqun; Yang, Burton B.			A 3 '-Untranslated Region (3 ' UTR) Induces Organ Adhesion by Regulating miR-199a*Functions	PLOS ONE			English	Article								Mature microRNAs ( miRNAs) are single-stranded RNAs of 18-24 nucleotides that repress post-transcriptional gene expression. However, it is unknown whether the functions of mature miRNAs can be regulated. Here we report that expression of versican 3'UTR induces organ adhesion in transgenic mice by modulating miR-199a* activities. The study was initiated by the hypothesis that the non-coding 3'UTR plays a role in the regulation of miRNA function. Transgenic mice expressing a construct harboring the 3'UTR of versican exhibits the adhesion of organs. Computational analysis indicated that a large number of microRNAs could bind to this fragment potentially including miR-199a*. Expression of versican and fibronectin, two targets of miR-199a*, are up-regulated in transgenic mice, suggesting that the 3'UTR binds and modulates miR-199a* activities, freeing mRNAs of versican and fibronectin from being repressed by miR-199a*. Confirmation of the binding was performed by PCR using mature miR-199a* as a primer and the targeting was performed by luciferase assays. Enhanced adhesion by expression of the 3'UTR was confirmed by in vitro assays. Our results demonstrated that upon arrival in cytoplasm, miRNA activities can be modulated locally by the 3'UTR. Our assay may be developed as sophisticated approaches for studying the mutual regulation of miRNAs and mRNAs in vitro and in vivo. We anticipate that expression of the 3'UTR may be an approach in the development of gene therapy.	[Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Du, William W.; Deng, Zhaoqun; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Lee, Daniel Y.; Shatseva, Tatiana; Jeyapalan, Zina; Deng, Zhaoqun; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Lee, DY (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			Heart and Stroke Foundation of Ontario [NA 6282, CI 5958]; National Sciences and Engineering Research Council of Canada [227937-01];  [Canada Graduate Scholarship]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); 	This work was supported by grants from Heart and Stroke Foundation of Ontario (NA 6282) and National Sciences and Engineering Research Council of Canada (227937-01) to BBY who is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario. DYL is the recipient of a Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ruvkun G, 2006, SCIENCE, V311, P36; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2007, J CELL PHYSIOL, V211, P213, DOI 10.1002/jcp.20921; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Xiang YY, 2006, J BIOL CHEM, V281, P19358, DOI 10.1074/jbc.M512980200; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zheng PS, 2006, J BIOL CHEM, V281, P8175, DOI 10.1074/jbc.M509182200; Zheng PS, 2004, J CELL SCI, V117, P5887, DOI 10.1242/jcs.01516; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	66	92	93	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4527	10.1371/journal.pone.0004527	http://dx.doi.org/10.1371/journal.pone.0004527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223980	gold, Green Submitted, Green Published			2022-12-27	WOS:000265485800018
J	Yang, SZ; Wang, K; Gregory, B; Berrettini, W; Wang, LS; Hakonarson, H; Bucan, M				Yang, Shuzhang; Wang, Kai; Gregory, Brittany; Berrettini, Wade; Wang, Li-San; Hakonarson, Hakon; Bucan, Maja			Genomic Landscape of a Three-Generation Pedigree Segregating Affective Disorder	PLOS ONE			English	Article							COPY-NUMBER VARIATION; BIPOLAR AFFECTIVE-DISORDER; STRUCTURAL VARIATION; WIDE ASSOCIATION; GENE; AMISH; LOCI; RESOLUTION; MUTATIONS; VARIANTS	Bipolar disorder (BPD) is a common psychiatric illness with a complex mode of inheritance. Besides traditional linkage and association studies, which require large sample sizes, analysis of common and rare chromosomal copy number variants (CNVs) in extended families may provide novel insights into the genetic susceptibility of complex disorders. Using the Illumina HumanHap550 BeadChip with over 550,000 SNP markers, we genotyped 46 individuals in a three-generation Old Order Amish pedigree with 19 affected (16 BPD and three major depression) and 27 unaffected subjects. Using the PennCNV algorithm, we identified 50 CNV regions that ranged in size from 12 to 885 kb and encompassed at least 10 single nucleotide polymorphisms (SNPs). Of 19 well characterized CNV regions that were available for combined genotype-expression analysis 11 (58%) were associated with expression changes of genes within, partially within or near these CNV regions in fibroblasts or lymphoblastoid cell lines at a nominal P value <0.05. To further investigate the mode of inheritance of CNVs in the large pedigree, we analyzed a set of four CNVs, located at 6q27, 9q21.11, 12p13.31 and 15q11, all of which were enriched in subjects with affective disorders. We additionally show that these variants affect the expression of neuronal genes within or near the rearrangement. Our analysis suggests that family based studies of the combined effect of common and rare CNVs at many loci may represent a useful approach in the genetic analysis of disease susceptibility of mental disorders.	[Yang, Shuzhang; Wang, Kai; Gregory, Brittany; Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Berrettini, Wade] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Bucan, Maja] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Yang, SZ (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; bucan@pobox.upenn.edu			NIH [R01MH604687, R21 MH078179]; NARSAD Distinguished Investigator Award; Penn Genomics Frontiers Institute; Cotswold Foundation [Research Development Award]; Center for Applied Genomics from the Children's Hospital of Philadelphia [Institutional Development Award]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH078179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Distinguished Investigator Award(NARSAD); Penn Genomics Frontiers Institute; Cotswold Foundation; Center for Applied Genomics from the Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by NIH grants R01MH604687, R21 MH078179 and NARSAD Distinguished Investigator Award (M.B.), by Penn Genomics Frontiers Institute (LSW); by Research Development Award from the Cotswold Foundation (H.H.). The genotyping was funded by an Institutional Development Award to the Center for Applied Genomics from the Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; BUCAN M, 2008, GENOMIC LANDSC UNPUB; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DISKIN S, 2008, NUCL ACIDS IN PRESS; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EGELAND JA, 1983, AM J PSYCHIAT, V140, P56; FERREIRA MA, 2008, NAT GENET; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Francomano CA, 2003, AM J MED GENET C, V121C, P1, DOI 10.1002/ajmg.c.20001; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; HOSTETTER AM, 1983, AM J PSYCHIAT, V140, P62; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; IONITALAZA I, 2008, GENOMICS; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SERRETTI A, 2008, MOL PSYCHIAT; Shaw JA, 2005, J AM ACAD CHILD PSY, V44, P1104, DOI 10.1097/01.chi.0000177052.26476.e5; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; STEFANSSON H, 2008, NATURE; STONE JL, 2008, NATURE; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang S, 2007, GENES BRAIN BEHAV, V6, P77, DOI 10.1111/j.1601-183X.2006.00235.x; YANG S, 2008, MOL PSYCHIAT	47	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4474	10.1371/journal.pone.0004474	http://dx.doi.org/10.1371/journal.pone.0004474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214233	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484300011
J	Ciarrocchi, A; D'Angelo, R; Cordiglieri, C; Rispoli, A; Santi, S; Riccio, M; Carone, S; Mancia, AL; Paci, S; Cipollini, E; Ambrosetti, D; Melli, M				Ciarrocchi, Alessia; D'Angelo, Romina; Cordiglieri, Chiara; Rispoli, Ada; Santi, Spartaco; Riccio, Massimo; Carone, Simona; Mancia, Anna Laura; Paci, Simone; Cipollini, Elena; Ambrosetti, Davide; Melli, Marialuisa			Tollip Is a Mediator of Protein Sumoylation	PLOS ONE			English	Article								Tollip is an interactor of the interleukin-1 receptor involved in its activation. The endosomal turnover of ubiquitylated IL-1RI is also controlled by Tollip. Furthermore, together with Tom1, Tollip has a general role in endosomal protein traffic. This work shows that Tollip is involved in the sumoylation process. Using the yeast two-hybrid technique, we have isolated new Tollip partners including two sumoylation enzymes, SUMO-1 and the transcriptional repressor Daxx. The interactions were confirmed by GST-pull down experiments and immunoprecipitation of the co-expressed recombinants. More specifically, we show that the TIR domain of the cytoplasmic region of IL-1RI is a sumoylation target of Tollip. The sumoylated and unsumoylated RanGAP-1 protein also interacts with Tollip, suggesting a possible role in RanGAP-1 modification and nuclear-cytoplasmic protein translocation. In fact, Tollip is found in the nuclear bodies of SAOS-2/IL-1RI cells where it colocalizes with SUMO-1 and the Daxx repressor. We conclude that Tollip is involved in the control of both nuclear and cytoplasmic protein traffic, through two different and often contrasting processes: ubiquitylation and sumoylation.	[Ciarrocchi, Alessia; D'Angelo, Romina; Cordiglieri, Chiara; Rispoli, Ada; Carone, Simona; Mancia, Anna Laura; Paci, Simone; Cipollini, Elena; Ambrosetti, Davide; Melli, Marialuisa] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Santi, Spartaco; Riccio, Massimo] CNR, ITOI, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR)	Ciarrocchi, A (corresponding author), Arcispedale Santa Maria Nuova, Mol Biol Lab, Reggio Emilia, Italy.	marialuisa.melli@unibo.it	Ciarrocchi, Alessia/AAA-1130-2019; Cordiglieri, Chiara/AAX-1638-2021; Cordiglieri, Chiara/K-2041-2016; mancia, annalaura/F-9706-2013; Santi, Spartaco/Q-7587-2016	Ciarrocchi, Alessia/0000-0002-5541-2075; Cordiglieri, Chiara/0000-0002-2013-0043; Cordiglieri, Chiara/0000-0002-2013-0043; mancia, annalaura/0000-0001-8680-3530; Santi, Spartaco/0000-0001-9856-7053	Telethon [GGP030248]; Italian Ministry of Technology and Scientific Research; FIRB Neuroscienze [RBNE01WY7P]	Telethon(Fondazione Telethon); Italian Ministry of Technology and Scientific Research; FIRB Neuroscienze	This work was supported by Telethon grant GGP030248, partly by a grant from the Italian Ministry of Technology and Scientific Research and by a grant from FIRB Neuroscienze RBNE01WY7P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; DEDHAR S, 1989, EXP CELL RES, V183, P207, DOI 10.1016/0014-4827(89)90430-8; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; EDMONDS M, 1971, P NATL ACAD SCI USA, V6, P1336; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; RODAN SB, 1990, J IMMUNOL, V145, P1231; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; van den Akker E, 2005, J BIOL CHEM, V280, P38035, DOI 10.1074/jbc.M502938200; Yamakami M, 2004, BIOL PHARM BULL, V27, P564, DOI 10.1248/bpb.27.564; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	28	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4404	10.1371/journal.pone.0004404	http://dx.doi.org/10.1371/journal.pone.0004404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198660	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483900009
J	Esue, O; Tseng, Y; Wirtz, D				Esue, Osigwe; Tseng, Yiider; Wirtz, Denis			alpha-Actinin and Filamin Cooperatively Enhance the Stiffness of Actin Filament Networks	PLOS ONE			English	Article								Background: The close subcellular proximity of different actin filament crosslinking proteins suggests that these proteins may cooperate to organize F-actin structures to drive complex cellular functions during cell adhesion, motility and division. Here we hypothesize that alpha-actinin and filamin, two major F-actin crosslinking proteins that are both present in the lamella of adherent cells, display synergistic mechanical functions. Methodology/Principal Findings: Using quantitative rheology, we find that combining alpha-actinin and filamin is much more effective at producing elastic, solid-like actin filament networks than alpha-actinin and filamin separately. Moreover, F-actin networks assembled in the presence of alpha-actinin and filamin strain-harden more readily than networks in the presence of either a-actinin or filamin. Significance: These results suggest that cells combine auxiliary proteins with similar ability to crosslink filaments to generate stiff cytoskeletal structures, which are required for the production of internal propulsive forces for cell migration, and that these proteins do not have redundant mechanical functions.	[Esue, Osigwe; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Esue, Osigwe] Genentech Inc, Dept Early Stage Pharm Dev, San Francisco, CA USA; [Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	Johns Hopkins University; Roche Holding; Genentech; State University System of Florida; University of Florida	Esue, O (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Wirtz, Denis/A-3257-2010		NIH [GM084204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the NIH grant GM084204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCH RJ, 1983, J CELL BIOL, V97, P217, DOI 10.1083/jcb.97.1.217; Critchley David R., 1993, P22; Doi M., 1989, THEORY POLYM DYNAMIC; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; GOLDMANN WH, 1993, FEBS LETT, V336, P408, DOI 10.1016/0014-5793(93)80847-N; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; LANGANGER G, 1984, J CELL BIOL, V99, P1324, DOI 10.1083/jcb.99.4.1324; LEBART MC, 1993, J BIOL CHEM, V268, P5642; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095; SHADIACK AM, 1991, J NEUROBIOL, V22, P617, DOI 10.1002/neu.480220607; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tilney LG, 2000, J CELL BIOL, V148, P87, DOI 10.1083/jcb.148.1.87; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2002, J BIOL CHEM, V277, P25609, DOI 10.1074/jbc.M202609200; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; ZEECE MG, 1979, BIOCHIM BIOPHYS ACTA, V581, P365, DOI 10.1016/0005-2795(79)90258-7	29	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4411	10.1371/journal.pone.0004411	http://dx.doi.org/10.1371/journal.pone.0004411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198659	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900012
J	De Lisle, RC; Meldi, L; Roach, E; Flynn, M; Sewell, R				De Lisle, Robert C.; Meldi, Lauren; Roach, Eileen; Flynn, Maureen; Sewell, Racquel			Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse	PLOS ONE			English	Article								Background: Cystic fibrosis (CF) has many effects on the gastrointestinal tract and a common problem in this disease is poor nutrition. In the CF mouse there is an innate immune response with a large influx of mast cells into the muscularis externa of the small intestine and gastrointestinal dysmotility. The aim of this study was to evaluate the potential role of mast cells in gastrointestinal dysmotility using the CF mouse (Cftr(tm1UNC), Cftr knockout). Methodology: Wild type (WT) and CF mice were treated for 3 weeks with mast cell stabilizing drugs (ketotifen, cromolyn, doxantrazole) or were treated acutely with a mast cell activator (compound 48/80). Gastrointestinal transit was measured using gavage of a fluorescent tracer. Results: In CF mice gastric emptying at 20 min post-gavage did not differ from WT, but was significantly less than in WT at 90 min post-gavage. Gastric emptying was significantly increased in WT mice by doxantrazole, but none of the mast cell stabilizers had any significant effect on gastric emptying in CF mice. Mast cell activation significantly enhanced gastric emptying in WT mice but not in CF mice. Small intestinal transit was significantly less in CF mice as compared to WT. Of the mast cell stabilizers, only doxantrazole significantly affected small intestinal transit in WT mice and none had any effect in CF mice. Mast cell activation resulted in a small but significant increase in small intestinal transit in CF mice but not WT mice. Conclusions: The results indicate that mast cells are not involved in gastrointestinal dysmotility but their activation can stimulate small intestinal transit in cystic fibrosis.	[De Lisle, Robert C.; Meldi, Lauren; Roach, Eileen; Flynn, Maureen; Sewell, Racquel] Univ Kansas, Sch Med, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center	De Lisle, RC (corresponding author), Univ Kansas, Sch Med, Kansas City, KS USA.	rdelisle@kumc.edu			Cystic Fibrosis Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation to RCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALI A, 1983, BRIT MED J, V287, P1011, DOI 10.1136/bmj.287.6398.1011; Barbara G, 2006, NEUROGASTROENT MOTIL, V18, P6, DOI 10.1111/j.1365-2982.2005.00685.x; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Brown JF, 1998, BRIT J PHARMACOL, V123, P31, DOI 10.1038/sj.bjp.0701576; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Dalzell A M, 1990, Acta Univ Carol Med (Praha), V36, P159; DALZELL AM, 1990, ARCH DIS CHILD, V65, P585, DOI 10.1136/adc.65.6.585; De Lisle RC, 2001, AM J PHYSIOL-GASTR L, V281, pG899, DOI 10.1152/ajpgi.2001.281.4.G899; De Lisle RC, 2007, AM J PHYSIOL-GASTR L, V293, pG577, DOI 10.1152/ajpgi.00195.2007; De Lisle RC, 2007, AM J PHYSIOL-GASTR L, V293, pG104, DOI 10.1152/ajpgi.00548.2006; De Schepper HU, 2008, ALIMENT PHARM THER, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; ESCOBAR H, 1992, J PEDIATR GASTR NUTR, V14, P204, DOI 10.1097/00005176-199202000-00015; FARGEAS MJ, 1992, GASTROENTEROLOGY, V102, P157, DOI 10.1016/0016-5085(92)91795-6; Fridge JL, 2007, J PEDIATR GASTR NUTR, V44, P212, DOI 10.1097/MPG.0b013e31802c0ceb; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; GOLDHILL JM, 1995, J PHARMACOL EXP THER, V274, P72; Gregory PC, 1996, J PEDIATR GASTR NUTR, V23, P513, DOI 10.1097/00005176-199612000-00001; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Kalia N, 2000, J GASTROEN HEPATOL, V15, P133, DOI 10.1046/j.1440-1746.2000.02064.x; Knight PA, 2007, AM J PATHOL, V171, P1237, DOI 10.2353/ajpath.2007.061245; Lewindon PJ, 1998, J PAEDIATR CHILD H, V34, P79, DOI 10.1046/j.1440-1754.1998.00159.x; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MURPHY MS, 1992, DIGEST DIS SCI, V37, P187, DOI 10.1007/BF01308170; Norkina O, 2004, INFECT IMMUN, V72, P6040, DOI 10.1128/IAI.72.10.6040-6049.2004; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Raia V, 2000, PEDIATR RES, V47, P344, DOI 10.1203/00006450-200003000-00010; SAND E, 2008, NEUROPHARMACOLOGY; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; SCOTT RB, 1993, DIGEST DIS SCI, V38, P396, DOI 10.1007/BF01316490; Scudamore CL, 1997, AM J PATHOL, V150, P1661; Serna H, 2006, J PHARMACOL EXP THER, V319, P1104, DOI 10.1124/jpet.106.104620; Smyth RL, 2000, ARCH DIS CHILD, V82, P394, DOI 10.1136/adc.82.5.394; Steiner DRS, 2003, J APPL PHYSIOL, V94, P325, DOI 10.1152/japplphysiol.00637.2002; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Van Nassauw L, 2007, AUTON NEUROSCI-BASIC, V133, P91, DOI 10.1016/j.autneu.2006.10.003; Wang XY, 2007, NEUROGASTROENT MOTIL, V19, P349, DOI 10.1111/j.1365-2982.2006.00894.x; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Wood JD, 2007, J CLIN GASTROENTEROL, V41, pS7, DOI 10.1097/MCG.0b013e31802f1331	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4283	10.1371/journal.pone.0004283	http://dx.doi.org/10.1371/journal.pone.0004283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172182	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482900004
J	Yarkoni, T; Barch, DM; Gray, JR; Conturo, TE; Braver, TS				Yarkoni, Tal; Barch, Deanna M.; Gray, Jeremy R.; Conturo, Thomas E.; Braver, Todd S.			BOLD Correlates of Trial-by-Trial Reaction Time Variability in Gray and White Matter: A Multi-Study fMRI Analysis	PLOS ONE			English	Article								Background: Reaction time (RT) is one of the most widely used measures of performance in experimental psychology, yet relatively few fMRI studies have included trial-by-trial differences in RT as a predictor variable in their analyses. Using a multi-study approach, we investigated whether there are brain regions that show a general relationship between trial-by-trial RT variability and activation across a range of cognitive tasks. Methodology/Principal Findings: The relation between trial-by-trial differences in RT and brain activation was modeled in five different fMRI datasets spanning a range of experimental tasks and stimulus modalities. Three main findings were identified. First, in a widely distributed set of gray and white matter regions, activation was delayed on trials with long RTs relative to short RTs, suggesting delayed initiation of underlying physiological processes. Second, in lateral and medial frontal regions, activation showed a "time-on-task'' effect, increasing linearly as a function of RT. Finally, RT variability reliably modulated the BOLD signal not only in gray matter but also in diffuse regions of white matter. Conclusions/Significance: The results highlight the importance of modeling trial-by-trial RT in fMRI analyses and raise the possibility that RT variability may provide a powerful probe for investigating the previously elusive white matter BOLD signal.	[Yarkoni, Tal; Barch, Deanna M.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Barch, Deanna M.; Conturo, Thomas E.; Braver, Todd S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA; [Gray, Jeremy R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Washington University (WUSTL); Washington University (WUSTL); Yale University	Yarkoni, T (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	tyarkoni@wustl.edu	Warfield, Simon/B-3352-2009; Barch, Deanna M/G-8638-2013	Warfield, Simon/0000-0002-7659-3880; Braver, Todd/0000-0002-2631-3393	NIH [MH066088, MH066031, MH71616, NS39538]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066088, R01MH066078, P50MH071616, R01MH066031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grants MH066088, MH066031, MH71616, and NS39538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Bellgowan PSF, 2003, P NATL ACAD SCI USA, V100, P1415, DOI 10.1073/pnas.0337747100; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bonner-Jackson A, 2005, BIOL PSYCHIAT, V58, P47, DOI 10.1016/j.biopsych.2005.05.011; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; CARPENTER DA, 1990, NEUROLOGY, V40, P1587, DOI 10.1212/WNL.40.10.1587; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Desai R, 2006, J COGNITIVE NEUROSCI, V18, P278, DOI 10.1162/089892906775783633; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Dobbins IG, 2006, J COGNITIVE NEUROSCI, V18, P1439, DOI 10.1162/jocn.2006.18.9.1439; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; GRINBAND J, 2008, NEUROIMAGE; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Karadottir R, 2008, NAT NEUROSCI; KERNS JG, 2004, ANTERIOR CINGULATE C, P1023; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kerr DL, 2004, NEUROREPORT, V15, P607, DOI 10.1097/00001756-200403220-00007; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; MENON RS, 1998, MENTAL CHRONOMETRY U, P10902; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Ostergaard L, 1998, J CEREBR BLOOD F MET, V18, P935, DOI 10.1097/00004647-199809000-00002; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; ROSENTHAL R, 1978, PSYCHOL BULL, V85, P185, DOI 10.1037/0033-2909.85.1.185; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Stern ER, 2007, BRAIN RES, V1176, P92, DOI 10.1016/j.brainres.2007.07.060; Sternberg S, 1966, HIGH SPEED SCANNING, P652; TETTAMANTI M, 2002, INTERHEMISPHERIC TRA, P1051; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yarkoni T, 2005, J EXP ANAL BEHAV, V84, P537, DOI 10.1901/jeab.2005.121-04; Yarkoni T, 2005, COGNITIVE BRAIN RES, V23, P71, DOI 10.1016/j.cogbrainres.2005.01.013; YARKONI T, MEDIAL POSTERI UNPUB; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	69	229	229	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4257	10.1371/journal.pone.0004257	http://dx.doi.org/10.1371/journal.pone.0004257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165335	Green Published, gold			2022-12-27	WOS:000265482400005
J	Yang, JW; Zhang, YX; Xu, J; Geng, Y; Chen, XY; Yang, HL; Wang, SN; Wang, HA; Jiang, XC; Guo, XK; Zhao, GP				Yang, Junwei; Zhang, Yixuan; Xu, Jing; Geng, Yan; Chen, Xiaoying; Yang, Hongliang; Wang, Shengnian; Wang, Hengan; Jiang, Xucheng; Guo, Xiaokui; Zhao, Guoping			Serum Activity of Platelet-Activating Factor Acetylhydrolase Is a Potential Clinical Marker for Leptospirosis Pulmonary Hemorrhage	PLOS ONE			English	Article							GUINEA-PIG; ICTEROHAEMORRHAGIAE; SUSCEPTIBILITY; IMMUNOGLOBULIN; NICARAGUA; HEMOLYSIN; PROTEOME; ANTIGEN; LIVER; TRIAL	Pulmonary hemorrhage has been recognized as a major, often lethal, manifestation of severe leptospirosis albeit the pathogenesis remains unclear. The Leptospira interrogans virulent serogroup Icterohaemorrhagiae serovar Lai encodes a protein (LA2144), which exhibited the platelet-activating factor acetylhydrolase (PAF-AH) activity in vitro similar to that of human serum with respect to its substrate affinity and specificity and thus designated L-PAF-AH. On the other hand, the primary amino acid sequence of L-PAF-AH is homologous to the alpha 1-subunit of the bovine brain PAF-AH isoform I. The L-PAFAH was proven to be an intracellular protein, which was encoded unanimously and expressed similarly in either pathogenic or saprophytic leptospires. Mongolian gerbil is an appropriate experimental model to study the PAF-AH level in serum with its basal activity level comparable to that of human while elevated directly associated with the course of pulmonary hemorrhage during severe leptospirosis. Mortality occurred around the peak of pulmonary hemorrhage, along with the transition of the PAF-AH activity level in serum, from the increasing phase to the final decreasing phase. Limited clinical data indicated that the serum activity of PAF-AH was likely to be elevated in the patients infected by L. interrogans serogroup Icterohaemorrhagiae, but not in those infected by other less severe serogroups. Although L-PAF-AH might be released into the micro-environment via cell lysis, its PAF-AH activity apparently contributed little to this elevation. Therefore, the change of PAF-AH in serum not only may be influential for pulmonary hemorrhage, but also seems suitable for disease monitoring to ensure prompt clinical treatment, which is critical for reducing the mortality of severe leptospirosis.	[Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China; [Zhang, Yixuan; Geng, Yan; Chen, Xiaoying] Shenyang Pharm Univ, Sch Life Sci & Biopharm, Shenyang, Peoples R China; [Xu, Jing; Yang, Hongliang; Wang, Hengan; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Dept Med Microbiol & Parasitol, Dept Pathol, Dept Animal Biotechnol, Shanghai, Peoples R China; [Xu, Jing] Shanghai Inst Hlth Sci, Shanghai, Peoples R China; [Wang, Shengnian; Zhao, Guoping] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shenyang Pharmaceutical University; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Yang, JW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China.	gpzhao@sibs.ac.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30830002, 30370071, 30670102, 30770820]; National High Technology Research and Development Program of China; Shanghai Leading Academic Discipline Project [T0206]; Shanghai Natural Science Foundation of China [062R14056]; Shanghai Educational Development Foundation [2007CGB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Educational Development Foundation	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30830002, 30370071, 30670102 and 30770820), the National High Technology Research and Development Program of China and Shanghai Leading Academic Discipline Project (T0206), Shanghai Natural Science Foundation of China (No. 062R14056), and Shanghai Educational Development Foundation (2007CGB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES VAF, 1992, EXP TOXICOL PATHOL, V44, P425, DOI 10.1016/S0940-2993(11)80185-5; BERNHEIMER AW, 1986, INFECT IMMUN, V54, P262, DOI 10.1128/IAI.54.1.262-264.1986; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; DEBRITO T, 1992, INT J EXP PATHOL, V73, P633; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Galfre G, 1981, Methods Enzymol, V73, P3; Garofalo P, 1967, Minerva Pediatr, V19, P1464; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Guidugli F., 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14657858; HATTORI M, 1994, J BIOL CHEM, V269, P23150; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Howard KM, 1997, J BIOL CHEM, V272, P27543, DOI 10.1074/jbc.272.44.27543; IM JG, 1989, AM J ROENTGENOL, V152, P955, DOI 10.2214/ajr.152.5.955; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V262, P438; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P53, DOI 10.1016/S0176-6724(86)80062-1; Lee C, 1999, ARTERIOSCL THROM VAS, V19, P1437, DOI 10.1161/01.ATV.19.6.1437; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Liu GC, 2004, J BIOL CHEM, V279, P17738, DOI 10.1074/jbc.M400143200; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Memon RA, 1999, AM J PHYSIOL-REG I, V277, pR94, DOI 10.1152/ajpregu.1999.277.1.R94; Merien F, 1998, FEMS MICROBIOL LETT, V169, P95, DOI 10.1111/j.1574-6968.1998.tb13304.x; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; Moon TC, 2003, ARCH PHARM RES, V26, P554, DOI 10.1007/BF02976880; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; RANDALL WBD, 2002, ECKERT ANIMAL PHYSL; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheffield PJ, 2001, PROTEIN ENG, V14, P513, DOI 10.1093/protein/14.7.513; SORENSEN J, 1994, INTENS CARE MED, V20, P555, DOI 10.1007/BF01705721; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; WATT G, 1988, LANCET, V1, P433; YASUDA PH, 1986, EXP PATHOL-JENA, V29, P35, DOI 10.1016/S0232-1513(86)80004-4; YUKAWA M, 1990, VET MICROBIOL, V24, P63, DOI 10.1016/0378-1135(90)90051-V; YUKAWA M, 1994, VET MICROBIOL, V41, P99, DOI 10.1016/0378-1135(94)90139-2; Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8	47	15	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4181	10.1371/journal.pone.0004181	http://dx.doi.org/10.1371/journal.pone.0004181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145243	Green Submitted, Green Published, gold			2022-12-27	WOS:000265479800001
J	Polouliakh, N; Nock, R; Nielsen, F; Kitano, H				Polouliakh, Natalia; Nock, Richard; Nielsen, Frank; Kitano, Hiroaki			G-Protein Coupled Receptor Signaling Architecture of Mammalian Immune Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NETWORKS; RECONSTRUCTION	A series of recent studies on large-scale networks of signaling and metabolic systems revealed that a certain network structure often called "bow-tie network" are observed. In signaling systems, bow-tie network takes a form with diverse and redundant inputs and outputs connected via a small numbers of core molecules. While arguments have been made that such network architecture enhances robustness and evolvability of biological systems, its functional role at a cellular level remains obscure. A hypothesis was proposed that such a network function as a stimuli-reaction classifier where dynamics of core molecules dictate downstream transcriptional activities, hence physiological responses against stimuli. In this study, we examined whether such hypothesis can be verified using experimental data from Alliance for Cellular Signaling (AfCS) that comprehensively measured GPCR related ligands response for B-cell and macrophage. In a GPCR signaling system, cAMP and Ca2+ act as core molecules. Stimuli-response for 32 ligands to B-Cells and 23 ligands to macrophages has been measured. We found that ligands with correlated changes of cAMP and Ca2+ tend to cluster closely together within the hyperspaces of both cell types and they induced genes involved in the same cellular processes. It was found that ligands inducing cAMP synthesis activate genes involved in cell growth and proliferation; cAMP and Ca2+ molecules that increased together form a feedback loop and induce immune cells to migrate and adhere together. In contrast, ligands without a core molecules response are scattered throughout the hyperspace and do not share clusters. G-protein coupling receptors together with immune response specific receptors were found in cAMP and Ca2+ activated clusters. Analyses have been done on the original software applicable for discovering 'bow-tie' network architectures within the complex network of intracellular signaling where ab initio clustering has been implemented as well. Groups of potential transcription factors for each specific group of genes were found to be partly conserved across B-Cell and macrophage. A series of findings support the hypothesis.	[Polouliakh, Natalia; Nielsen, Frank; Kitano, Hiroaki] Sony Comp Sci Labs Inc, Tokyo, Japan; [Polouliakh, Natalia; Kitano, Hiroaki] Syst Biol Inst, Tokyo, Japan; [Nock, Richard] Univ Antilles Guyane, CEREGMIA, Schoelcher, France	Sony Corporation	Polouliakh, N (corresponding author), Sony Comp Sci Labs Inc, Tokyo, Japan.	h.kitano@csl.sony.co.jp		Polouliakh, Natalia/0000-0001-8266-2697; Nielsen, Frank/0000-0001-5728-0726	ERATO/SORST program (Japan Science and Technology Agency: JST); Sweden-Japan Strategic Collaboration Program (JST); Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology)	ERATO/SORST program (Japan Science and Technology Agency: JST)(Japan Science & Technology Agency (JST)); Sweden-Japan Strategic Collaboration Program (JST)(Japan Science & Technology Agency (JST)); Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported, in part, by the ERATO/SORST program (Japan Science and Technology Agency: JST), the Sweden-Japan Strategic Collaboration Program (JST), and the Genome Network Project (Ministry of Education, Sports, Culture, Science, and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liu XH, 2006, AM J PHYSIOL-CELL PH, V290, pC873, DOI 10.1152/ajpcell.00229.2005; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nock R, 2003, INT J PATTERN RECOGN, V17, P1369, DOI 10.1142/S0218001403002952; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Polouliakh Natalia, 2006, Journal of Bioinformatics and Computational Biology, V4, P469, DOI 10.1142/S0219720006001849; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zass R., 2006, ADV NEURAL INFORM PR; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141; [No title captured]	27	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4189	10.1371/journal.pone.0004189	http://dx.doi.org/10.1371/journal.pone.0004189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142232	Green Submitted, Green Published, gold			2022-12-27	WOS:000265479700010
J	Sawka, AM; Goldstein, DP; Brierley, JD; Tsang, RW; Rotstein, L; Ezzat, S; Straus, S; George, SR; Abbey, S; Rodin, G; O'Brien, MA; Gafni, A; Thabane, L; Goguen, J; Naeem, A; Magalhaes, L				Sawka, Anna M.; Goldstein, David P.; Brierley, James D.; Tsang, Richard W.; Rotstein, Lorne; Ezzat, Shereen; Straus, Sharon; George, Susan R.; Abbey, Susan; Rodin, Gary; O'Brien, Mary Ann; Gafni, Amiram; Thabane, Lehana; Goguen, Jeannette; Naeem, Asima; Magalhaes, Lilian			The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; BREAST-CANCER; OF-LIFE; ADJUVANT CHEMOTHERAPY; REMNANT ABLATION; COMPUTER-PROGRAM; CARCINOMA; THERAPY; ASSIST; WOMEN	Background: Adjuvant treatment with radioactive iodine (RAI) is often considered in the treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of thyroid cancer survivors on the diagnosis of WDTC, adjuvant radioactive iodine (RAI) treatment, and decision-making related to RAI treatment. Participants provided recommendations for healthcare providers on counseling future patients on adjuvant RAI treatment. Methods: We conducted three focus group sessions, including WDTC survivors recruited from two Canadian academic hospitals. Participants had a prior history of WDTC that was completely resected at primary surgery and had been offered adjuvant RAI treatment. Open-ended questions were used to generate discussion in the groups. Saturation of major themes was achieved among the groups. Findings: There were 16 participants in the study, twelve of whom were women (75%). All but one participant had received RAI treatment (94%). Participants reported that a thyroid cancer diagnosis was life-changing, resulting in feelings of fear and uncertainty. Some participants felt dismissed as not having a serious disease. Some participants reported receiving conflicting messages from healthcare providers on the appropriateness of adjuvant RAI treatment or insufficient information. If RAI-related side effects occurred, their presence was not legitimized by some healthcare providers. Conclusions: The diagnosis and treatment of thyroid cancer significantly impacts the lives of survivors. Fear and uncertainty related to a cancer diagnosis, feelings of the diagnosis being dismissed as not serious, conflicting messages about adjuvant RAI treatment, and treatment-related side effects, have been raised as important concerns by thyroid cancer survivors.	[Ezzat, Shereen; George, Susan R.; Goguen, Jeannette] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Sawka, Anna M.; George, Susan R.; Naeem, Asima] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Goldstein, David P.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Goldstein, David P.] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Brierley, James D.; Tsang, Richard W.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Brierley, James D.; Tsang, Richard W.] Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; [Rotstein, Lorne] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Rotstein, Lorne] Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Ezzat, Shereen] Mt Sinai Hosp, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Ezzat, Shereen] Freeman Ctr Endocrine Oncol, Toronto, ON, Canada; [Ezzat, Shereen; Rodin, Gary] Ontario Canc Inst, Toronto, ON, Canada; [Straus, Sharon] Univ Toronto, Dept Knowledge Translat, Toronto, ON, Canada; [Abbey, Susan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Abbey, Susan] Univ Hlth Network, Dept Psychiat, Toronto, ON, Canada; [Rodin, Gary] Univ Hlth Network, Princess Margaret Hosp, Dept Psychosocial Oncol & Palliative Care, Toronto, ON, Canada; [O'Brien, Mary Ann] McMaster Univ, Juravinski Canc Ctr, Supportive Canc Care Res Unit, Hamilton, ON, Canada; [Gafni, Amiram; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Gafni, Amiram] McMaster Univ, Ctr Hlth Econ & Policy Evaluat, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON, Canada; [Goguen, Jeannette] St Michaels Hosp, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Magalhaes, Lilian] Univ Western Ontario, Sch Occupat Therapy, London, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario)	Sawka, AM (corresponding author), Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada.	sawkaam@yahoo.com	Sawka, Anna/AAA-4336-2020; George, Susan/W-7494-2019; Magalhães, Lilian V/B-2458-2008; goldstein, David/AAT-6302-2020	Magalhães, Lilian V/0000-0003-3666-3685; Rodin, Gary/0000-0002-6626-6974; Tsang, Richard/0000-0002-7487-8487	Canadian Institutes of Health Research New Investigator Program [CNI-80701]; University Health Network Thyroid Research Centre Endowment Fund; Connaught New Staff Matching Grant of the University of Toronto	Canadian Institutes of Health Research New Investigator Program(Canadian Institutes of Health Research (CIHR)); University Health Network Thyroid Research Centre Endowment Fund; Connaught New Staff Matching Grant of the University of Toronto	A. Sawka and this project are supported by the Canadian Institutes of Health Research New Investigator Program (CNI-80701). This study is also supported in part by the University Health Network Thyroid Research Centre Endowment Fund and the Connaught New Staff Matching Grant of the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Air M, 2007, THYROID, V17, P259, DOI 10.1089/thy.2006.0300; Allen JD, 2009, PSYCHO-ONCOLOGY, V18, P71, DOI 10.1002/pon.1380; *AM ASS CLIN END, 2001, ENDOCR PRACT, V7, P202; *AM CANC SOC, 2007, EST NEW CANC CAS DEA; [Anonymous], NATURALISTIC INQUIRY; Ashbury J., 1999, QUAL HEALTH RES, V5, P414; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; British Thyroid Association Royal College of Physicians., 2007, GUID MAN THYR CANC; *CANC RES UK, 2008, THYR CANC; Charles C, 2005, HEALTH EXPECT, V8, P114, DOI 10.1111/j.1369-7625.2005.00325.x; Crevenna R, 2003, SUPPORT CARE CANCER, V11, P597, DOI 10.1007/s00520-003-0474-4; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Denzin L. K., 2005, SAGE HDB QUALITATIVE; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Elit L, 2003, GYNECOL ONCOL, V88, P89, DOI 10.1016/S0090-8258(02)00090-2; Finlay L, 2002, QUAL HEALTH RES, V12, P531, DOI 10.1177/104973202129120052; GIACOMINI MK, 2000, JAMA-J AM MED ASSOC, V284, P505; Giusti M, 2005, J ENDOCRINOL INVEST, V28, P599, DOI 10.1007/BF03347258; Hay Ian D, 2007, Endocr Pract, V13, P521; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hewitt M., 2005, CANC PATIENT CANC SU; Hoftijzer HC, 2008, J CLIN ENDOCR METAB, V93, P200, DOI 10.1210/jc.2007-1203; Holmes-Rovner M, 2000, J EVAL CLIN PRACT, V6, P263, DOI 10.1046/j.1365-2753.2000.00258.x; Irwin E, 1999, PATIENT EDUC COUNS, V37, P283, DOI 10.1016/S0738-3991(98)00117-7; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Kennelly C., 2001, QUAL HLTH CARE S1, V10, P23, DOI [10.1136/qhc.0100023, DOI 10.1136/QHC.0100023]; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kreling B, 2006, PSYCHO-ONCOLOGY, V15, P1065, DOI 10.1002/pon.1042; LEVINE MN, 1992, ANN INTERN MED, V117, P53, DOI 10.7326/0003-4819-117-1-53; Liamputtong P., 2005, QUALITATIVE RES METH; *NAT CANC I, 2006, THYR CANC PDQ TREATM; National Comprehensive Cancer Network, 2008, NCCN CLIN PRACT GUID; O'Connor A, 2001, ACP J Club, V135, pA11; O'Connor A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001431; Pacini F, 2008, ANN ONCOL, V19, P99, DOI 10.1093/annonc/mdn115; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; PARK SH, 1988, JPN J CLIN ONCOL, V18, P297; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peele PB, 2005, MED DECIS MAKING, V25, P301, DOI 10.1177/0272989X05276851; Pieterse AH, 2008, BRIT J CANCER, V99, P875, DOI 10.1038/sj.bjc.6604611; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Ravdin PM, 1995, B CANCER, V82, pS561; Ravdin PM, 1996, SEMIN ONCOL, V23, P43; SAWKA A, 2005, I 131 REMNANT ABLATI; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Sawka Anna M, 2008, Endocr Pract, V14, P175; Sawka AM, 2008, ENDOCRIN METAB CLIN, V37, P457, DOI 10.1016/j.ecl.2008.02.007; Sawka AM, 2007, THYROID, V17, P1235, DOI 10.1089/thy.2007.0077; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Tan LGL, 2007, LARYNGOSCOPE, V117, P507, DOI 10.1097/MLG.0b013e31802e3739; Trevena L, 2003, PATIENT EDUC COUNS, V50, P265, DOI 10.1016/S0738-3991(03)00047-8; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Weinfurt KP, 2003, CLIN THER, V25, P671, DOI 10.1016/S0149-2918(03)80104-2; Whelan T, 2003, J NATL CANCER I, V95, P581, DOI 10.1093/jnci/95.8.581; Whelan TJ, 2005, J CLIN ONCOL, V23, P1627, DOI 10.1200/JCO.2005.10.072	61	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4191	10.1371/journal.pone.0004191	http://dx.doi.org/10.1371/journal.pone.0004191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IF	19142227	Green Published, gold			2022-12-27	WOS:000265479700012
J	Claessens, LPAM; O'Connor, PM; Unwin, DM				Claessens, Leon P. A. M.; O'Connor, Patrick M.; Unwin, David M.			Respiratory Evolution Facilitated the Origin of Pterosaur Flight and Aerial Gigantism	PLOS ONE			English	Article							POSTCRANIAL SKELETON; UNCINATE PROCESSES; PELVIC ASPIRATION; REPTILIAN LUNGS; PNEUMATICITY; DINOSAUR; VENTILATION; ANATOMY; FLOW	Pterosaurs, enigmatic extinct Mesozoic reptiles, were the first vertebrates to achieve true flapping flight. Various lines of evidence provide strong support for highly efficient wing design, control, and flight capabilities. However, little is known of the pulmonary system that powered flight in pterosaurs. We investigated the structure and function of the pterosaurian breathing apparatus through a broad scale comparative study of respiratory structure and function in living and extinct archosaurs, using computer-assisted tomographic (CT) scanning of pterosaur and bird skeletal remains, cineradiographic (X-ray film) studies of the skeletal breathing pump in extant birds and alligators, and study of skeletal structure in historic fossil specimens. In this report we present various lines of skeletal evidence that indicate that pterosaurs had a highly effective flow-through respiratory system, capable of sustaining powered flight, predating the appearance of an analogous breathing system in birds by approximately seventy million years. Convergent evolution of gigantism in several Cretaceous pterosaur lineages was made possible through body density reduction by expansion of the pulmonary air sac system throughout the trunk and the distal limb girdle skeleton, highlighting the importance of respiratory adaptations in pterosaur evolution, and the dramatic effect of the release of physical constraints on morphological diversification and evolutionary radiation.	Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [O'Connor, Patrick M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Unwin, David M.] Univ Leicester, Dept Museum Studies, Leicester LE1 7RH, Leics, England	College of the Holy Cross; University System of Ohio; Ohio University; University of Leicester	Claessens, LPAM (corresponding author), Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA.	lclaesse@holycross.edu	OConnor, Patrick M/I-9383-2012; Claessens, Leon P.A.M./F-5036-2012	OConnor, Patrick M/0000-0002-6762-3806; Claessens, Leon P.A.M./0000-0002-1873-6070	National Science Foundation [IBN 0206169]; Harvard University; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Deutsche Forschungsgemeinschaft; University of Leicester; Humboldt University, Berlin	National Science Foundation(National Science Foundation (NSF)); Harvard University; Ohio University College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Leicester; Humboldt University, Berlin	LC acknowledges funding from the National Science Foundation (IBN 0206169) and Harvard University for cineradiographic experiments. PO would like to thank the Ohio University College of Osteopathic Medicine and the Ohio University Office of Research and Sponsored Programs for support. DU thanks the Deutsche Forschungsgemeinschaft, the University of Leicester and the Humboldt University, Berlin for support.	AKESTER AR, 1973, J ZOOL, V170, P493; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bignon F, 1889, MEM SOC ZOOL FRANCE, V2, P260; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; BROILI F, 1927, SITZUNGSBER BAYER MN, P49; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; CLAESSENS LPA, J EXPT ZO A IN PRESS; CLAESSENS LPA, 2005, THESIS HARVARD U CAM; Claessens LPAM, 2004, P ROY SOC B-BIOL SCI, V271, P1461, DOI 10.1098/rspb.2004.2743; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Farmer CG, 2000, J EXP BIOL, V203, P1679; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hicks JW, 1999, RESP PHYSIOL, V117, P73, DOI 10.1016/S0034-5687(99)00060-2; Jones TD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P443; KUETHE DO, 1988, J EXP BIOL, V136, P1; LIEM KF, 1989, AM ZOOL, V29, P333; MARTILL DM, 1989, NATURE, V340, P138, DOI 10.1038/340138a0; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; OWEN R, 1859, MONOGRAPH FOSSIL REP, V1, P1; Owerkowicz T, 1999, SCIENCE, V284, P1661, DOI 10.1126/science.284.5420.1661; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; PADIAN K, 1983, PALEOBIOLOGY, V9, P218, DOI 10.1017/S009483730000765X; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; SHAROV AG, 1971, AKAD NAUK SSSR PALEO, V130, P104; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; WELLNHOFER P, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V215, P43; Wellnhofer P., 1975, PALAONTOGRAPHICA A, V148, P1; Wellnhofer P., 1978, PTEROSAURIA; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Wilkinson MT, 2008, ZOOL J LINN SOC-LOND, V154, P27, DOI 10.1111/j.1096-3642.2008.00409.x; Wilkinson MT, 2006, P ROY SOC B-BIOL SCI, V273, P119, DOI 10.1098/rspb.2005.3278; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Zimmer K., 1935, Zoologica Stuttgart, V33, P1; [No title captured]	49	104	105	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4497	10.1371/journal.pone.0004497	http://dx.doi.org/10.1371/journal.pone.0004497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223979	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485800006
J	Diaz, JA; Murillo, MF; Jaramillo, NA				Diaz, Jairo A.; Murillo, Mauricio F.; Jaramillo, Natalia A.			Framework of Collagen Type I - Vasoactive Vessels Structuring Invariant Geometric Attractor in Cancer Tissues: Insight into Biological Magnetic Field	PLOS ONE			English	Article								In a previous research, we have described and documented self-assembly of geometric triangular chiral hexagon crystal-like complex organizations (GTCHC) in human pathological tissues. This article documents and gathers insights into the magnetic field in cancer tissues and also how it generates an invariant functional geometric attractor constituted for collider partners in their entangled environment. The need to identify this hierarquic attractor was born out of the concern to understand how the vascular net of these complexes are organized, and to determine if the spiral vascular subpatterns observed adjacent to GTCHC complexes and their assembly are interrelational. The study focuses on cancer tissues and all the macroscopic and microscopic material in which GTCHC complexes are identified, which have been overlooked so far, and are rigorously revised. This revision follows the same parameters that were established in the initial phase of the investigation, but with a new item: the visualization and documentation of external dorsal serous vascular bed areas in spatial correlation with the localization of GTCHC complexes inside the tumors. Following the standard of the electro-optical collision model, we were able to reproduce and replicate collider patterns, that is, pairs of left and right hand spin-spiraled subpatterns, associated with the orientation of the spinning process that can be an expansion or contraction disposition of light particles. Agreement between this model and tumor data is surprisingly close; electromagnetic spiral patterns generated were identical at the spiral vascular arrangement in connection with GTCHC complexes in malignant tumors. These findings suggest that the framework of collagen type 1 - vasoactive vessels that structure geometric attractors in cancer tissues with invariant morphology sets generate collider partners in their magnetic domain with opposite biological behavior. If these principles are incorporated into nanomaterial, biomedical devices, and engineered tissues, new therapeutic strategies could be developed for cancer treatment.	[Diaz, Jairo A.; Murillo, Mauricio F.; Jaramillo, Natalia A.] Univ Cooperat Colombia, Dept Pathol, Sch Med, Pathol Lab,Clin Corp, Villavicencio, Meta, Colombia	Universidad Cooperativa de Colombia	Diaz, JA (corresponding author), Univ Cooperat Colombia, Dept Pathol, Sch Med, Pathol Lab,Clin Corp, Villavicencio, Meta, Colombia.	jaditod@hotmail.com		Jaramillo Gomez, Natalia/0000-0002-0939-171X	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Corporation University Cooperative of Colombia, Villavicencio, Meta, Colombia	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Corporation University Cooperative of Colombia, Villavicencio, Meta, Colombia	This investigation was possible thanks to the logistical and economic support of the Medicine School, Pathology Department, Cooperative University of Colombia and the Clinical Corporation University Cooperative of Colombia. Villavicencio, Meta. Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kilani A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051912; Ambjorn J, 2006, CONTEMP PHYS, V47, P103, DOI 10.1080/00107510600603344; Bou-Gharios G, 2004, CELL PROLIFERAT, V37, P207, DOI 10.1111/j.1365-2184.2004.00306.x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; DEKEERSMAECKER K, 2008, NOT PROTEIN ITS LOCA; DIAZ JA, 2007, GEOMETRIC TRIANGULAR; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; FRASER G, 2007, NEW PHYS 21 CENTURY; GIRTON TS, 1998, TISSUE ENG METHODS P, P67; Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010; Higashi T, 1996, BIOELECTROMAGNETICS, V17, P335, DOI 10.1002/(SICI)1521-186X(1996)17:4<335::AID-BEM10>3.0.CO;2-N; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Ingber DE, 1998, SCI AM, V278, P48, DOI 10.1038/scientificamerican0198-48; KARDILOV N, 2008, 3 DIMENSIONAL IMAGIN; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MUKAI K, 1980, AM J SURG PATHOL, V4, P273, DOI 10.1097/00000478-198006000-00008; NG LG, 2008, MIGRATORY DERMAL DEN; OKAZAKI M, 1988, PHYSIOL CHEM PHYS ME, V20, P3; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4506	10.1371/journal.pone.0004506	http://dx.doi.org/10.1371/journal.pone.0004506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223987	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485800010
J	Faucherre, A; Pujol-Marti, J; Kawakami, K; Lopez-Schier, H				Faucherre, Adele; Pujol-Marti, Jesus; Kawakami, Koichi; Lopez-Schier, Hernan			Afferent Neurons of the Zebrafish Lateral Line Are Strict Selectors of Hair-Cell Orientation	PLOS ONE			English	Article							MEDIATED ENHANCER TRAP; DIRECTIONAL SENSITIVITY; XENOPUS-LAEVIS; FISH; ORGAN; INNERVATION; NEUROMASTS; MUTATIONS; EFFERENT; SYSTEM	Hair cells in the inner ear display a characteristic polarization of their apical stereocilia across the plane of the sensory epithelium. This planar orientation allows coherent transduction of mechanical stimuli because the axis of morphological polarity of the stereocilia corresponds to the direction of excitability of the hair cells. Neuromasts of the lateral line in fishes and amphibians form two intermingled populations of hair cells oriented at 180 degrees relative to each other, however, creating a stimulus-polarity ambiguity. Therefore, it is unknown how these animals resolve the vectorial component of amechanical stimulus. Using genetic mosaics and live imaging in transgenic zebrafish to visualize hair cells and neurons at single-cell resolution, we show that lateral-line afferents can recognize the planar polarization of hair cells. Each neuron forms synapses with hair cells of identical orientation to divide the neuromast into functional planar-polarity compartments. We also show that afferent neurons are strict selectors of polarity that can re-establish synapses with identically oriented targets during hair-cell regeneration. Our results provide the anatomical bases for the physiological models of signal-polarity resolution by the lateral line.	[Faucherre, Adele; Pujol-Marti, Jesus; Lopez-Schier, Hernan] Ctr Regulacio Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain; [Kawakami, Koichi] Grad Univ Advanced Studies, Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Advanced Studies, Dept Genet, Mishima, Shizuoka, Japan	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Faucherre, A (corresponding author), Ctr Regulacio Genom, Lab Sensory Cell Biol & Organogenesis, Barcelona, Spain.	hernan.lopez@crg.es	Kawakami, Koichi/AAF-1380-2019	Faucherre, Adele/0000-0002-6099-3898; Pujol-Marti, Jesus/0000-0001-9500-7106	CRG; Ministerio de Ciencia e Innovacion of Spain [SAF2006-04684]; Ramon y Cajal Investigator; National BioResource Project; Ministry of Education, Culture, Sports, Science and Technology of Japan; Obra Social Fundacio La Caixa [fellowship]	CRG; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal Investigator(Spanish Government); National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Obra Social Fundacio La Caixa(La Caixa Foundation)	This research was supported by start-up funds from the CRG and by a grant (SAF2006-04684) from the Ministerio de Ciencia e Innovacion of Spain, of which H.L. S. is a Ramon y Cajal Investigator. K.K. was funded by the National BioResource Project and by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. J.P.-M. was supported by a fellowship from Obra Social Fundacio La Caixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleckmann H, 2007, FISH PHYSIOL, V25, P411, DOI 10.1016/S1546-5098(06)25010-6; Bricaud O, 2001, J COMP NEUROL, V434, P253, DOI 10.1002/cne.1175; Chagnaud BP, 2008, ZOOLOGY, V111, P204, DOI 10.1016/j.zool.2007.07.009; Chagnaud BP, 2007, J COMP PHYSIOL A, V193, P753, DOI 10.1007/s00359-007-0230-1; Coombs S, 1997, J COMP PHYSIOL A, V180, P401, DOI 10.1007/s003590050058; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; ECHTELER SM, 1992, P NATL ACAD SCI USA, V89, P6324, DOI 10.1073/pnas.89.14.6324; Fain G, 2003, SENSORY TRANSDUCTION; Fame RM, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-4; FLOCK A, 1962, J CELL BIOL, V15, P19, DOI 10.1083/jcb.15.1.19; FLOCK A, 1971, FISH PHYSIOL, V5, P241; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Gompel N, 2001, DEVELOPMENT, V128, P387; GORNER P, 1963, Z VERGL PHYSIOL, V47, P316, DOI 10.1007/BF00298039; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KROESE ABA, 1992, J NEUROPHYSIOL, V68, P2212, DOI 10.1152/jn.1992.68.6.2212; KROESE ABA, 1980, J EXP BIOL, V86, P63; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Ledent V, 2002, DEVELOPMENT, V129, P597; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; McHenry MJ, 2008, J COMP PHYSIOL A, V194, P795, DOI 10.1007/s00359-008-0350-2; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Mohr C, 1996, BRAIN BEHAV EVOLUT, V48, P55, DOI 10.1159/000113186; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; MUNZ H, 1985, J COMP PHYSIOL A, V157, P555, DOI 10.1007/BF01351350; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; ROUSE GW, 1991, P ROY SOC B-BIOL SCI, V246, P123, DOI 10.1098/rspb.1991.0133; Sapede D, 2005, P NATL ACAD SCI USA, V102, P1714, DOI 10.1073/pnas.0406382102; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; Sidi S, 2004, J NEUROSCI, V24, P4213, DOI 10.1523/JNEUROSCI.0223-04.2004; WERSALL J, 1965, COLD SPRING HARB SYM, V30, P115, DOI 10.1101/SQB.1965.030.01.015; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	46	96	96	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4477	10.1371/journal.pone.0004477	http://dx.doi.org/10.1371/journal.pone.0004477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223970	Green Submitted, gold, Green Published			2022-12-27	WOS:000265485800004
J	Essafi-Benkhadir, K; Grosso, S; Puissant, A; Robert, G; Essafi, M; Deckert, M; Chamorey, E; Dassonville, O; Milano, G; Auberger, P; Pages, G				Essafi-Benkhadir, Khadija; Grosso, Sebastien; Puissant, Alexandre; Robert, Guillaume; Essafi, Makram; Deckert, Marcel; Chamorey, Emmanuel; Dassonville, Olivier; Milano, Gerard; Auberger, Patrick; Pages, Gilles			Dual Role of Sp3 Transcription Factor as an Inducer of Apoptosis and a Marker of Tumour Aggressiveness	PLOS ONE			English	Article								Background: The ambiguous role of transcription factor Sp3 for tumour progression is still debated since it was described as a transcriptional repressor or activator. Here we tried to decipher the molecular mechanisms implicated in Sp3 accumulation observed in aggressive tumours. Methodology: We generated normal and tumour cell lines conditionally expressing Sp3. Cell growth was analyzed in vitro and after inoculation in nude mice. Apoptosis was assessed by pan- caspase activity assays, by counting fragmented nuclei and by determination of caspase 9 cleavage. Gene expression was determined by quantitative PCR. Cleavage by different caspases was performed after in vitro translation of the Sp3 cDNA in the presence of [S(35)] labelled methionine. Different tumour cell lines and head and neck tumour samples were tested for the presence of Sp3 by western blots. Correlation between Sp3 expression and overall survival has been statistically determined. Principal Findings: Conditional over-expression of Sp3 induces apoptosis and modifies expression of genes implicated in the regulation of cell cycle and pro and anti apoptotic genes. Sp3 over-expression strongly reduces the development of tumours in nude mice confirming its pro-apoptotic potential in vivo. However, cells can survive to apoptosis through selective Sp3 cleavage by caspase. Sp3 induction in established tumours resulted in transient regression then progression. Progression coincides with re-accumulation of the full length form of Sp3. Sp3 is over-expressed in tumour cell lines of different origins. The presence of high levels of the full-length form of Sp3 indicates a poor prognosis for overall survival of patients with head and neck tumours. Conclusions: Full length Sp3 accumulation highlights bypass of tumour cell apoptotic capacities and is indicative of head and neck tumours aggressiveness.	[Essafi-Benkhadir, Khadija; Pages, Gilles] Inst Pastuer Tunis, Unite Biochim Pathol Expt, Tunis, Tunisia; [Grosso, Sebastien; Puissant, Alexandre; Robert, Guillaume; Auberger, Patrick] Univ Nice Sophia Antipolis, Inst Dev Biol & Canc Res, Ctr Antoine Lacassagne, UMR CNRS 6543, F-06108 Nice, France; [Essafi, Makram; Deckert, Marcel] Univ Nice Sophia Antipolis, Fac Med, Equipe labellisee Ligue Natl contre Canc, Cell Death Different & Canc Team, F-06108 Nice, France; [Chamorey, Emmanuel] Univ Nice Sophia Antipolis, INSERM, U576, F-06108 Nice, France; [Dassonville, Olivier] Ctr Antoine Lacassagne, Stat Serv, Nice, France; [Milano, Gerard] Ctr Antoine Lacassagne, Oncopharmacol Unit, EA 3836, Nice, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Antoine Lacassagne	Essafi-Benkhadir, K (corresponding author), Inst Pastuer Tunis, Unite Biochim Pathol Expt, Tunis, Tunisia.	gpages@unice.fr	robert, guillaume/O-1935-2017; Deckert, Marcel/M-4998-2016; Puissant, Alexandre/AAF-3875-2021; AUBERGER, Patrick/G-1491-2013; Chamorey, Emmanuel/AGO-9982-2022; Essafi, Makram/V-8411-2019; Essafi-Benkhadir, Khadija/N-3727-2015; Pages, Gilles/N-7135-2017; Deckert, Marcel/T-3566-2019; PUISSANT, ALEXANDRE/O-9575-2016	robert, guillaume/0000-0002-6350-2222; Puissant, Alexandre/0000-0002-3997-9282; AUBERGER, Patrick/0000-0002-2481-8275; Deckert, Marcel/0000-0003-2094-559X; PUISSANT, ALEXANDRE/0000-0002-3997-9282; Milano, Gerard/0000-0003-2478-0040; Benkhadir-Essafi, Khadija/0000-0003-1371-1963	Centre National pour la Recherche Scientifique; University of Nice Sophia Antipolis; Ligue Nationale Contre le Cancer" Equipe Labellise; Association for International Cancer Research (AICR); National Institute of Cancer (INCA); French association for cancer research (ARC); Canceropale PACA	Centre National pour la Recherche Scientifique; University of Nice Sophia Antipolis; Ligue Nationale Contre le Cancer" Equipe Labellise; Association for International Cancer Research (AICR); National Institute of Cancer (INCA)(Institut National du Cancer (INCA) France); French association for cancer research (ARC); Canceropale PACA	This work was supported by the "Centre National pour la Recherche Scientifique", the University of Nice Sophia Antipolis, the "Ligue Nationale Contre le Cancer" Equipe Labellise, the Association for International Cancer Research (AICR), the National Institute of Cancer (INCA), the French association for cancer research (ARC) and the Canceropale PACA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Bertolotto C, 2000, J BIOL CHEM, V275, P12941, DOI 10.1074/jbc.275.17.12941; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chirakkal H, 2006, ONCOGENE, V25, P7192, DOI 10.1038/sj.onc.1209702; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Fujita E, 2001, CELL DEATH DIFFER, V8, P335, DOI 10.1038/sj.cdd.4400824; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; GEISER AG, 1993, GENE, V129, P223, DOI 10.1016/0378-1119(93)90272-5; HARROCH S, 1995, NUCLEIC ACIDS RES, V23, P3539, DOI 10.1093/nar/23.17.3539; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lou Z, 2005, CANCER RES, V65, P1007; Luciano F, 2002, LEUKEMIA, V16, P700, DOI 10.1038/sj.leu.2402401; Marchetti S, 2004, J CELL PHYSIOL, V199, P441, DOI 10.1002/jcp.10465; Maurer GD, 2007, CLIN CANCER RES, V13, P1123, DOI 10.1158/1078-0432.CCR-06-1668; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Nishiyama J, 2001, BIOCHEM J, V360, P49, DOI 10.1042/0264-6021:3600049; Onesto C, 2006, BRIT J CANCER, V94, P1516, DOI 10.1038/sj.bjc.6603108; Pages G, 2007, J CELL PHYSIOL, V213, P454, DOI 10.1002/jcp.21104; Pang HL, 1998, BIOCHEM J, V333, P209, DOI 10.1042/bj3330209; Ryu H, 2003, J NEUROSCI, V23, P3597; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Shi Q, 2001, CANCER RES, V61, P4143; Shi W, 1996, INT IMMUNOL, V8, P1205, DOI 10.1093/intimm/8.8.1205; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Xu R, 2007, BIOCHEM BIOPH RES CO, V356, P286, DOI 10.1016/j.bbrc.2007.02.140; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002	34	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4478	10.1371/journal.pone.0004478	http://dx.doi.org/10.1371/journal.pone.0004478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212434	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200017
J	Gupta, P; Ho, PC; Ha, SG; Lin, YW; Wei, LN				Gupta, Pawan; Ho, Ping-Chih; Ha, Sung Gil; Lin, Yi-Wei; Wei, Li-Na			HDAC3 as a Molecular Chaperone for Shuttling Phosphorylated TR2 to PML: A Novel Deacetylase Activity-Independent Function of HDAC3	PLOS ONE			English	Article								TR2 is an orphan nuclear receptor specifically expressed in early embryos (Wei and Hsu, 1994), and a transcription factor for transcriptional regulation of important genes in stem cells including the gate keeper Oct4 (Park et al. 2007). TR2 is known to function as an activator (Wei et al. 2000), or a repressor (Chinpaisal et al., 1998, Gupta et al. 2007). Due to the lack of specific ligands, mechanisms triggering its activator or repressor function have remained puzzling for decades. Recently, we found that all-trans retinoic acid (atRA) triggers the activation of extracellular-signal-regulated kinase 2 (ERK2), which phosphorylates TR2 and stimulates its partitioning to promyelocytic leukemia (PML) nuclear bodies, thereby converting the activator function of TR2 into repression (Gupta et al. 2008; Park et al. 2007). Recruitment of TR2 to PML is a crucial step in the conversion of TR2 from an activator to a repressor. However, it is unclear how phosphorylated TR2 is recruited to PML, an essential step in converting TR2 from an activator to a repressor. In the present study, we use both in vitro and in vivo systems to address the problem of recruiting TR2 to PML nuclear bodies. First, we identify histone deacetylase 3 (HDAC3) as an effector molecule. HDAC3 is known to interact with TR2 (Franco et al. 2001) and this interaction is enhanced by the atRA-stimulated phosphorylation of TR2 at Thr-210 (Gupta et al. 2008). Secondly, in this study, we also find that the carrier function of HDAC3 is independent of its deacetylase activity. Thirdly, we find another novel activity of atRA that stimulates nuclear enrichment of HDAC3 to form nuclear complex with PML, which is ERK2 independent. This is the first report identifying a deacetylase-independent function for HDAC3, which serves as a specific carrier molecule that targets a specifically phosphorylated protein to PML NBs. This is also the first study delineating how protein recruitment to PML nuclear bodies occurs, which can be stimulated by atRA in an ERK2-independent manner. These findings could provide new insights into the development of potential therapeutics and in understanding how orphan nuclear receptor activities can be regulated without ligands.	[Gupta, Pawan] Inst Microb Technol, Chandigarh, India; [Ho, Ping-Chih; Ha, Sung Gil; Lin, Yi-Wei; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Minnesota System; University of Minnesota Twin Cities	Gupta, P (corresponding author), Inst Microb Technol, Chandigarh, India.	weixx009@umn.edu		Gupta, Pawan/0000-0001-6692-7237	NIH [DK54733, DK60521, DA11190, DA 11806, K02-DA13926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060521, R01DK054733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, K02DA013926, P50DA011806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DK54733, DK60521, DA11190, DA 11806 and K02-DA13926 to LNW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Atsumi A, 2006, BIOCHEM BIOPH RES CO, V345, P1471, DOI 10.1016/j.bbrc.2006.05.047; Chinpaisal C, 1998, J BIOL CHEM, V273, P18077, DOI 10.1074/jbc.273.29.18077; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Glass CK, 2000, GENE DEV, V14, P121; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200; Gupta P, 2008, P NATL ACAD SCI USA, V105, P11424, DOI 10.1073/pnas.0710561105; Gupta P, 2007, NUCLEIC ACIDS RES, V35, P2269, DOI 10.1093/nar/gkl1147; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hildmann C, 2006, J BIOTECHNOL, V124, P258, DOI 10.1016/j.jbiotec.2006.01.030; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krusche CA, 2007, HUM REPROD, V22, P2956, DOI 10.1093/humrep/dem241; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li GJ, 2003, BIOCHEM BIOPH RES CO, V310, P384, DOI 10.1016/j.bbrc.2003.08.145; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Nakagawa M, 2007, ONCOL REP, V18, P769; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nicolas E, 2001, NUCLEIC ACIDS RES, V29, P3131, DOI 10.1093/nar/29.15.3131; Park SW, 2007, NAT STRUCT MOL BIOL, V14, P68, DOI 10.1038/nsmb1185; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WEI LN, 1994, DEV GROWTH DIFFER, V36, P187; Wei LN, 2000, J BIOL CHEM, V275, P11907, DOI 10.1074/jbc.275.16.11907; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Weichert W, 2008, NEOPLASIA, V10, P1021, DOI 10.1593/neo.08474; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	46	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4363	10.1371/journal.pone.0004363	http://dx.doi.org/10.1371/journal.pone.0004363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204783	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000002
J	Kwon, HJ; Koo, JH; Zufall, F; Leinders-Zufall, T; Margolis, FL				Kwon, Hyun J.; Koo, Jae Hyung; Zufall, Frank; Leinders-Zufall, Trese; Margolis, Frank L.			Ca2+ Extrusion by NCX Is Compromised in Olfactory Sensory Neurons of OMP-/- Mice	PLOS ONE			English	Article							NUCLEOTIDE-ACTIVATED CHANNELS; VECTOR-MEDIATED RESCUE; GENE DELETION CAUSES; MARKER PROTEIN; RECEPTOR NEURONS; SODIUM/CALCIUM EXCHANGER; GATED CHANNELS; CYTOCHEMICAL-LOCALIZATION; NA+/CA2+ EXCHANGER; CALCIUM-ENTRY	Background: The role of olfactory marker protein (OMP), a hallmark of mature olfactory sensory neurons (OSNs), has been poorly understood since its discovery. The electrophysiological and behavioral phenotypes of OMP knockout mice indicated that OMP influences olfactory signal transduction. However, the mechanism by which this occurs remained unknown. Principal Findings: We used intact olfactory epithelium obtained from WT and OMP-/- mice to monitor the Ca2+ dynamics induced by the activation of cyclic nucleotide-gated channels, voltage-operated Ca2+ channels, or Ca2+ stores in single dendritic knobs of OSNs. Our data suggested that OMP could act to modulate the Ca2+-homeostasis in these neurons by influencing the activity of the plasma membrane Na+/Ca2+-exchanger (NCX). Immunohistochemistry verifies colocalization of NCX1 and OMP in the cilia and knobs of OSNs. To test the role of NCX activity, we compared the kinetics of Ca2+ elevation by stimulating the reverse mode of NCX in both WT and OMP-/- mice. The resulting Ca2+ responses indicate that OMP facilitates NCX activity and allows rapid Ca2+ extrusion from OSN knobs. To address the mechanism by which OMP influences NCX activity in OSNs we studied protein-peptide interactions in real-time using surface plasmon resonance technology. We demonstrate the direct interaction of the XIP regulatory-peptide of NCX with calmodulin (CaM). Conclusions: Since CaM also binds to the Bex protein, an interacting protein partner of OMP, these observations strongly suggest that OMP can influence CaM efficacy and thus alters NCX activity by a series of protein-protein interactions.	[Kwon, Hyun J.; Koo, Jae Hyung; Margolis, Frank L.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Kwon, Hyun J.] Andrews Univ, Dept Engn & Comp Sci, Berrien Springs, MI 49104 USA; [Zufall, Frank; Leinders-Zufall, Trese] Univ Saarland, Dept Physiol, Homburg, Germany	University System of Maryland; University of Maryland Baltimore; Andrews University; Saarland University	Kwon, HJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	trese.leinders@uks.eu; flmomp@gmail.com	Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Koo, JaeHyung/R-3036-2019; Leinders-Zufall, Trese/S-3664-2019	Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Koo, JaeHyung/0000-0002-5538-8001; Leinders-Zufall, Trese/0000-0002-0678-362X	NIH/NIDCD [R01-DC-003112, R01-DC-02227, R01-DC-005249, T32 DC-00054]; Andrews University; Lichtenberg Professor of the Volkswagen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054, R01DC003112, R01DC005249, R01DC002227] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Andrews University; Lichtenberg Professor of the Volkswagen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by research grants from NIH/NIDCD R01-DC-003112 (FLM), R01-DC-02227 (TLZ), R01-DC-005249 (FZ) and T32 DC-00054 (FLM) and Andrews University (HJK). TLZ is a Lichtenberg Professor of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA N, 1993, HISTOCHEM J, V25, P348, DOI 10.1007/BF00159499; ASANUMA N, 1991, HISTOCHEM J, V23, P83, DOI 10.1007/BF01047112; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1993, CIBA F SYMP, V179, P97; BREER H, 1993, CIBA F SYMP, V179, P147; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; Carr VM, 1998, J NEUROBIOL, V34, P377, DOI 10.1002/(SICI)1097-4695(199803)34:4<377::AID-NEU7>3.0.CO;2-3; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; Dzeja C, 1999, EMBO J, V18, P131, DOI 10.1093/emboj/18.1.131; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Frings S, 2001, CELL MOL LIFE SCI, V58, P510, DOI 10.1007/PL00000876; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; Hallani M, 1998, J MEMBRANE BIOL, V161, P163, DOI 10.1007/s002329900323; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; Kaneko H, 2006, J GEN PHYSIOL, V127, P737, DOI 10.1085/jgp.200609497; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KLEENE SJ, 2008, CHEM SENSES; KOLESNIKOV SS, 1993, BIOCHIM BIOPHYS ACTA, V1150, P63, DOI 10.1016/0005-2736(93)90122-G; KOLESNIKOV SS, 1990, FEBS LETT, V266, P96, DOI 10.1016/0014-5793(90)81515-P; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Koo JH, 2004, J NEUROCHEM, V90, P102, DOI 10.1111/j.1471-4159.2004.02463.x; Krasznai Z, 2006, CELL MOTIL CYTOSKEL, V63, P66, DOI 10.1002/cm.20108; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; LI ZP, 1991, J BIOL CHEM, V266, P1014; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Lucero MT, 2000, PHILOS T ROY SOC B, V355, P1215, DOI 10.1098/rstb.2000.0670; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Menini A, 1999, CURR OPIN NEUROBIOL, V9, P419, DOI 10.1016/S0959-4388(99)80063-4; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; RASGADOFLORES H, 1989, J GEN PHYSIOL, V93, P1219, DOI 10.1085/jgp.93.6.1219; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; Rogister F, 2001, EUR J MED CHEM, V36, P597, DOI 10.1016/S0223-5234(01)01247-8; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Saba RI, 1999, BIOCHEM J, V338, P139, DOI 10.1042/0264-6021:3380139; SCHILD D, 1994, CELL CALCIUM, V15, P341, DOI 10.1016/0143-4160(94)90009-4; Schulze DH, 2002, ANN NY ACAD SCI, V976, P67; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Schwarzenbacher K, 2005, HISTOCHEM CELL BIOL, V123, P419, DOI 10.1007/s00418-005-0790-5; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; SIEGL PKS, 1984, P NATL ACAD SCI-BIOL, V81, P3238, DOI 10.1073/pnas.81.10.3238; THOMPSON MP, 1988, CALCIUM BINDING PROT, P89; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Youngentob SL, 2004, BEHAV NEUROSCI, V118, P636, DOI 10.1037/0735-7044.118.3.636; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 1999, NEUROREPORT, V10, P15, DOI 10.1097/00001756-199901180-00003; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	88	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4260	10.1371/journal.pone.0004260	http://dx.doi.org/10.1371/journal.pone.0004260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165324	gold, Green Submitted, Green Published			2022-12-27	WOS:000265482400008
J	Mangano, VD; Clark, TG; Auburn, S; Campino, S; Diakite, M; Fry, AE; Green, A; Richardson, A; Jallow, M; Sisay-Joof, F; Pinder, M; Griffiths, MJ; Newton, C; Peshu, N; Williams, TN; Marsh, K; Molyneux, ME; Taylor, TE; Modiano, D; Kwiatkowski, DP; Rockett, KA				Mangano, Valentina D.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Diakite, Mahamadou; Fry, Andrew E.; Green, Angela; Richardson, Anna; Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret; Griffiths, Michael J.; Newton, Charles; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin; Molyneux, Malcolm E.; Taylor, Terrie E.; Modiano, David; Kwiatkowski, Dominic P.; Rockett, Kirk A.			Lack of Association of Interferon Regulatory Factor 1 with Severe Malaria in Affected Child-Parental Trio Studies across Three African Populations	PLOS ONE			English	Article								Interferon Regulatory Factor 1 (IRF-1) is a member of the IRF family of transcription factors, which have key and diverse roles in the gene-regulatory networks of the immune system. IRF-1 has been described as a critical mediator of IFN-gamma signalling and as the major player in driving TH1 type responses. It is therefore likely to be crucial in both innate and adaptive responses against intracellular pathogens such as Plasmodium falciparum. Polymorphisms at the human IRF1 locus have been previously found to be associated with the ability to control P. falciparum infection in populations naturally exposed to malaria. In order to test whether genetic variation at the IRF1 locus also affects the risk of developing severe malaria, we performed a family-based test of association for 18 Single Nucleotide Polymorphisms (SNPs) across the gene in three African populations, using genotype data from 961 trios consisting of one affected child and his/her two parents (555 from The Gambia, 204 from Kenya and 202 from Malawi). No significant association with severe malaria or severe malaria subphenotypes (cerebral malaria and severe malaria anaemia) was observed for any of the SNPs/haplotypes tested in any of the study populations. Our results offer no evidence that the molecular pathways regulated by the transcription factor IRF-1 are involved in the immune-based pathogenesis of severe malaria.	[Mangano, Valentina D.; Clark, Taane G.; Auburn, Sarah; Campino, Susana; Diakite, Mahamadou; Fry, Andrew E.; Green, Angela; Richardson, Anna; Kwiatkowski, Dominic P.; Rockett, Kirk A.] Wellcome Trust Ctr Human Genet, Childhood Infect Grp, Oxford, England; [Mangano, Valentina D.; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Clark, Taane G.; Auburn, Sarah; Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Jallow, Muminatou; Sisay-Joof, Fatou; Pinder, Margaret] MRC, Fajara, Gambia; [Griffiths, Michael J.; Newton, Charles; Peshu, Norbert; Williams, Thomas N.; Marsh, Kevin] Ctr Geograph Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Williams, Thomas N.; Marsh, Kevin] John Radcliffe Hosp, Nuffield Dept Med, Oxford, England; [Molyneux, Malcolm E.; Taylor, Terrie E.] Malawi Liverpool Wellcome Trust Progr Clin Trop, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA	University of Oxford; Wellcome Centre for Human Genetics; Sapienza University Rome; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Oxford; University of Malawi; Liverpool School of Tropical Medicine; Michigan State University; Michigan State University College of Osteopathic Medicine	Mangano, VD (corresponding author), Wellcome Trust Ctr Human Genet, Childhood Infect Grp, Oxford, England.	vmangano@well.ox.ac.uk	mangano, valentina/I-2456-2012; Newton, Charles/V-7872-2019; Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Fry, Andrew/AFK-7448-2022; Newton, Charles RJC/B-7578-2014; Fry, Andrew/AAN-2730-2020; Auburn, Sarah/N-2266-2013	Newton, Charles/0000-0002-6999-5507; Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Fry, Andrew/0000-0001-9778-6924; Newton, Charles RJC/0000-0002-6999-5507; Fry, Andrew/0000-0001-9778-6924; Kwiatkowski, Dominic/0000-0002-5023-0176; Mangano, Valentina D/0000-0002-2021-6162; Auburn, Sarah/0000-0002-4638-536X	Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme [LSHP-CT-2004-503578]; BioMalPar PhD Fellowship; UK Medical Research Council; Wellcome Trust; Bill and Melinda Gates Foundation; National Institutes of Health; Medical Research Council [G19/9, G0600230] Funding Source: researchfish; MRC [G19/9, G0600230] Funding Source: UKRI	Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme; BioMalPar PhD Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme, and Mangano VD was funded by a BioMalPar PhD Fellowship. The sample collections and resources used in this study received funding from the UK Medical Research Council, the Wellcome Trust, the Bill and Melinda Gates Foundation, and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CLARK T, 2008, J INFECT DI IN PRESS; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Evans DM, 2006, BEHAV GENET, V36, P947, DOI 10.1007/s10519-006-9087-2; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Modiano D, 2008, HUM MOL GENET, V17, P789, DOI 10.1093/hmg/ddm350; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Plebanski M, 2000, CURR OPIN IMMUNOL, V12, P437, DOI 10.1016/S0952-7915(00)00117-5; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Teo YY, 2007, ANN HUM GENET, V71, P701, DOI 10.1111/j.1469-1809.2007.00356.x; TEO YY, 2008, HUM HEREDIT IN PRESS; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4206	10.1371/journal.pone.0004206	http://dx.doi.org/10.1371/journal.pone.0004206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145247	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000265479800012
J	Religa, P; Grudzinska, MK; Bojakowski, K; Soin, J; Nozynski, J; Zakliczynski, M; Gaciong, Z; Zembala, M; Soderberg-Naucler, C				Religa, Piotr; Grudzinska, Monika K.; Bojakowski, Krzysztof; Soin, Joanna; Nozynski, Jerzy; Zakliczynski, Michal; Gaciong, Zbigniew; Zembala, Marian; Soderberg-Naucler, Cecilia			Host-Derived Smooth Muscle Cells Accumulate in Cardiac Allografts: Role of Inflammation and Monocyte Chemoattractant Protein 1	PLOS ONE			English	Article								Transplant arteriosclerosis is characterized by inflammation and intimal thickening caused by accumulation of smooth muscle cells (SMCs) both from donor and recipient. We assessed the relationship between clinical factors and the presence of host-derived SMCs in 124 myocardial biopsies from 26 consecutive patients who received hearts from opposite-sex donors. Clinical and demographic information was obtained from the patients' medical records. Host-derived SMCs accounted for 3.35 +/- 2.3% of cells in arterioles (range, 0.08-12.51%). As shown by linear regression analysis, an increased number of SMCs was associated with rejection grade (mean, 1.41 +/- 1.03, p = 0.034) and the number of leukocytes (19.1 +/- 12.7 per 20 high-power fields, p = 0.01). The accumulation of host-derived SMCs was associated with an increased number of leukocytes in the allografts. In vitro, monocyte chemoattractant protein 1 (MCP-1) released from leukocytes was crucial for SMC migration. After heart allotransplantion, mice treated with MCP-1-specific antibodies had significantly fewer host-derived SMCs in the grafts than mice treated with isotypic antibody controls. We conclude that the number of host-derived SMCs in human cardiac allografts is associated with the rejection grade and that MCP-1 may play pivotal role in recruiting host-derived SMCs into cardiac allografts.	[Religa, Piotr; Grudzinska, Monika K.; Soderberg-Naucler, Cecilia] Karolinska Inst, Stockholm, Sweden; [Religa, Piotr; Bojakowski, Krzysztof; Soin, Joanna; Gaciong, Zbigniew] Warsaw Univ Med, Dept Internal Med & Hypertens, Warsaw, Poland; [Bojakowski, Krzysztof] Warsaw Univ Med, Dept Gen Vasc & Oncol Surg, Warsaw, Poland; [Soin, Joanna] Warsaw Univ Med, Dept Gen Biochem & Nutr, Warsaw, Poland; [Nozynski, Jerzy; Zakliczynski, Michal; Zembala, Marian] Silesian Ctr Heart Dis, Zabrze, Poland	Karolinska Institutet; Silesian Center for Heart Diseases	Religa, P (corresponding author), Karolinska Inst, Stockholm, Sweden.	piotr.religa@ki.se		Religa, Piotr/0000-0002-3884-2954; Bojakowski, Krzysztof/0000-0001-6899-8741; Zakliczynski, Michal/0000-0002-5730-019X; Grudzinska Pechhacker, Monika/0000-0001-7007-461X	Science Research Committee MNiSW [3B138]; Swedish Research Council [K2004-16X-12615-07A, K2007-56X-12615-10-3]; Swedish Society of Medicine [2003-633]; Tobias Foundation [28/03, 29/04]; Heart and Lung Foundation [199941305, 200241138, 20030055, 20050266]; King Gustaf V's 80-Year Anniversary Foundation; Swedish Cancer Foundation [060253]; Children's Cancer Foundation [05/100]; Royal Swedish Academy of Science [Research Fellow]; Knut and Alice Wallenberg Foundation	Science Research Committee MNiSW; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Tobias Foundation; Heart and Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V's 80-Year Anniversary Foundation; Swedish Cancer Foundation; Children's Cancer Foundation; Royal Swedish Academy of Science; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Science Research Committee MNiSW 3B138, Swedish Research Council (K2004-16X-12615-07A, K2007-56X-12615-10-3), the Swedish Society of Medicine (2003-633), the Tobias Foundation (28/03 and 29/04), and the Heart and Lung Foundation (199941305, 200241138, 20030055, and 20050266). King Gustaf V's 80-Year Anniversary Foundation, Swedish Cancer Foundation (060253), and Children's Cancer Foundation (05/100). C.S.-N. is a Royal Swedish Academy of Science Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojakowski K, 2000, TRANSPLANTATION, V70, P65; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Davies WR, 2005, J HEART LUNG TRANSPL, V24, P1868, DOI 10.1016/j.healun.2005.04.004; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Huang BJ, 2006, TRANSPL IMMUNOL, V16, P88, DOI 10.1016/j.trim.2006.03.010; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Lietz Katherine, 2004, Semin Thorac Cardiovasc Surg, V16, P386, DOI 10.1053/j.semtcvs.2004.09.004; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Mitchell RN, 2007, CIRC RES, V100, P967, DOI 10.1161/01.RES.0000261982.76892.09; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Orloff SL, 2002, TRANSPLANTATION, V73, P679, DOI 10.1097/00007890-200203150-00005; Religa P, 2005, CARDIOVASC RES, V65, P535, DOI 10.1016/j.cardiores.2004.10.011; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Soler MJ, 2005, AM J TRANSPLANT, V5, P2154, DOI 10.1111/j.1600-6143.2005.01010.x; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stoica SC, 2006, J HEART LUNG TRANSPL, V25, P420, DOI 10.1016/j.healun.2005.11.449; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	29	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4187	10.1371/journal.pone.0004187	http://dx.doi.org/10.1371/journal.pone.0004187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142231	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700008
J	Lohler, J; Hirner, H; Schmidt, B; Kramer, K; Fischer, D; Thal, DR; Leithauser, F; Knippschild, U				Loehler, Juergen; Hirner, Heidrun; Schmidt, Bernhard; Kramer, Klaus; Fischer, Dietmar; Thal, Dietmar R.; Leithaeuser, Frank; Knippschild, Uwe			Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1 delta in Various Tissues of Young Adult BALB/c Mice	PLOS ONE			English	Article							CASEIN-KINASE-I; PROTEIN-KINASE; BETA-CATENIN; 1 DELTA; POSSIBLE INVOLVEMENT; NEGATIVE REGULATION; MOLECULAR-CLONING; ALZHEIMER BRAIN; CKI-DELTA; PHOSPHORYLATION	Background: Casein kinase 1 delta (CK1d) phosphorylates many key proteins playing important roles in such biological processes as cell growth, differentiation, apoptosis, circadian rhythm and vesicle transport. Furthermore, deregulation of CK1d has been linked to neurodegenerative diseases and cancer. In this study, the cell specific distribution of CK1d in various tissues and organs of young adult BALB/c mice was analysed by immunohistochemistry. Methodology/Principal Findings: Immunohistochemical staining of CK1d was performed using three different antibodies against CK1d. A high expression of CK1d was found in a variety of tissues and organ systems and in several cell types of endodermal, mesodermal and ectodermal origin. Conclusions: These results give an overview of the cell-type specific expression of CK1d in different organs under normal conditions. Thus, they provide evidence for possible cell-type specific functions of CK1d, where CK1d can interact with and modulate the activity of key regulator proteins by site directed phosphorylation. Furthermore, they provide the basis for future analyses of CK1d in these tissues.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Mol Pathol Grp, D-2000 Hamburg, Germany; [Hirner, Heidrun; Schmidt, Bernhard; Kramer, Klaus; Knippschild, Uwe] Univ Ulm, Dept Gen Visceral & Transplant Surg, D-89069 Ulm, Germany; [Fischer, Dietmar] Univ Ulm, Dept Expt Neurol, D-89069 Ulm, Germany; [Thal, Dietmar R.] Univ Ulm, Inst Pathol, Lab Neuropathol, D-89069 Ulm, Germany; [Leithaeuser, Frank] Univ Ulm, Dept Pathol, D-89069 Ulm, Germany	Heinrich Pette Institute; University of Hamburg; Ulm University; Ulm University; Ulm University; Ulm University	Lohler, J (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Mol Pathol Grp, Martinistr 52, D-2000 Hamburg, Germany.	uwe.knippschild@uniklinik-ulm.de	Thal, Dietmar R/O-7483-2018	Thal, Dietmar R/0000-0002-1036-1075; Fischer, Dietmar/0000-0002-1816-3014	Deutsche Krebshilfe [10-2237-KN3, 108489]	Deutsche Krebshilfe(Deutsche Krebshilfe)	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung, 10-2237-KN3 and 108489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; BECKSTEAD JH, 1994, J HISTOCHEM CYTOCHEM, V42, P1127, DOI 10.1177/42.8.8027531; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; BROCKSCHMIDT C, 2008, GUT; Bustos VH, 2005, BIOCHEM J, V391, P417, DOI 10.1042/BJ20050717; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Chergui K, 2005, J NEUROSCI, V25, P6601, DOI 10.1523/JNEUROSCI.1082-05.2005; Chergui M, 2006, SCIENCE, V313, P1246, DOI 10.1126/science.1132749; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; ELIAS L, 1981, CANCER RES, V41, P2182; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Ghoshal N, 1999, AM J PATHOL, V155, P1163, DOI 10.1016/S0002-9440(10)65219-4; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; Gross SD, 1997, J CELL SCI, V110, P3083; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Horiguchi R, 2005, BBA-GENE STRUCT EXPR, V1727, P75, DOI 10.1016/j.bbaexp.2004.11.002; Izeradjene K, 2004, CLIN CANCER RES, V10, P6650, DOI 10.1158/1078-0432.CCR-04-0576; Kannanayakal TJ, 2006, ACTA NEUROPATHOL, V111, P413, DOI 10.1007/s00401-006-0049-9; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knippschild U, 1996, ONCOGENE, V13, P1387; Krueger SK, 1999, BIOTECH HISTOCHEM, V74, P105, DOI 10.3109/10520299909066485; Kuret J, 1997, J NEUROCHEM, V69, P2506; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Maritzen T, 2003, EUR J CELL BIOL, V82, P369, DOI 10.1078/0171-9335-00323; McKenzie JAG, 2006, FEBS LETT, V580, P2388, DOI 10.1016/j.febslet.2006.03.048; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; Okamura A, 2004, BLOOD, V103, P2997, DOI 10.1182/blood-2003-08-2768; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Price RD, 2006, J BIOMOL SCREEN, V11, P155, DOI 10.1177/1087057105283344; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; Pyle RA, 2000, J BIOL CHEM, V275, P17195, DOI 10.1074/jbc.M000674200; Reisinger EC, 1999, WIEN KLIN WOCHENSCHR, V111, P537; Schwab C, 2000, NEUROBIOL AGING, V21, P503, DOI 10.1016/S0197-4580(00)00110-X; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Takano A, 2004, NEUROREPORT, V15, P1461, DOI 10.1097/01.wnr.0000133297.77278.81; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Yasojima K, 2000, BRAIN RES, V865, P116, DOI 10.1016/S0006-8993(00)02200-9; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200	70	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4174	10.1371/journal.pone.0004174	http://dx.doi.org/10.1371/journal.pone.0004174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137063	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479500005
J	Gioiosa, L; Chiarotti, F; Alleva, E; Laviola, G				Gioiosa, Laura; Chiarotti, Flavia; Alleva, Enrico; Laviola, Giovanni			A Trouble Shared Is a Trouble Halved: Social Context and Status Affect Pain in Mouse Dyads	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; MALE-MICE; NONSELECTIVE ATTENTION; AGONISTIC ENCOUNTERS; ALLOSTATIC LOAD; FORMALIN TEST; NITRIC-OXIDE; BEHAVIOR; STRESS; EXPOSURE	In mice behavioral response to pain is modulated by social status. Recently, social context also has been shown to affect pain sensitivity. In our study, we aimed to investigate the effects of interaction between status and social context in dyads of outbred CD-1 male mice in which the dominance/submission relationship was stable. Mice were assessed for pain response in a formalin (1% concentration) test either alone (individually tested-IT), or in pairs of dominant and subordinate mice. In the latter condition, they could be either both injected (BI) or only one injected (OI) with formalin. We observed a remarkable influence of social context on behavioral response to painful stimuli regardless of the social status of the mice. In the absence of differences between OI and IT conditions, BI mice exhibited half as much Paw-licking behavior than OI group. As expected, subordinates were hypoalgesic in response to the early phase of the formalin effects compared to dominants. Clear cut-differences in coping strategies of dominants and subordinates appeared. The former were more active, whereas the latter were more passive. Finally, analysis of behavior of the non-injected subjects (the observers) in the OI dyads revealed that dominant observers were more often involved in Self-grooming behavior upon observation of their subordinate partner in pain. This was not the case for subordinate mice observing the pain response of their dominant partner. In contrast, subordinate observers Stared at the dominant significantly more frequently compared to observer dominants in other dyads. The observation of a cagemate in pain significantly affected the observer's behavior. Additionally, the quality of observer's response was also modulated by the dominance/submission relationship.	[Gioiosa, Laura; Chiarotti, Flavia; Alleva, Enrico; Laviola, Giovanni] Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Gioiosa, Laura] Consiglio Nazl Ricerche, Inst Neurobiol & Mol Med, Rome, Italy	Istituto Superiore di Sanita (ISS)	Gioiosa, L (corresponding author), Ist Super Sanita, Sect Behav Neurosci, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanni.laviola@iss.it	Alleva, Enrico/B-1630-2013; Chiarotti, Flavia/K-7970-2016; Laviola, Giovanni/AAA-2391-2022; Laviola, Giovanni/K-4392-2016	Chiarotti, Flavia/0000-0003-0084-6914; Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Alleva, Enrico/0000-0002-9633-7657	Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes"; ERARE-EuroRETT Network; Consiglio Nanzionale delle Ricerche (Roma, Italy) [fellowship]	Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes"; ERARE-EuroRETT Network; Consiglio Nanzionale delle Ricerche (Roma, Italy)	This work was supported by Italy-USA Program on Rare Disease "X-linked or autosomal rare mental retardation syndromes" and by ERARE-EuroRETT Network to Dr G. Laviola. Dr L. Gioiosa was a recipient of a fellowship from Consiglio Nanzionale delle Ricerche (Roma, Italy).	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALLEVA E, 1993, PARADIGMS STUDY BEHA, P111; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; Archer J., 1988, BEHAV BIOL AGGRESSIO, DOI DOI 10.1046/J.1420-9101.1991.4030515.X; Aspide R, 1998, BEHAV BRAIN RES, V95, P123, DOI 10.1016/S0166-4328(97)00217-9; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; BENTON D, 1980, COMP MEASURES DOMINA, P1274; BENUS RF, 1989, BEHAV PROCESS, V20, P1, DOI 10.1016/0376-6357(89)90008-9; BRAIN P, 1981, MULTIDISCIPLINARY AP, P209; Branchi I, 2006, BEHAV BRAIN RES, V172, P299, DOI 10.1016/j.bbr.2006.05.019; DELLASETA D, 1994, PHARMACOL BIOCHEM BE, V49, P701, DOI 10.1016/0091-3057(94)90090-6; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; ELY DL, 1978, HORM BEHAV, V10, P156, DOI 10.1016/0018-506X(78)90005-3; Fiore M, 1998, NEUROTOXICOL TERATOL, V20, P543, DOI 10.1016/S0892-0362(98)00003-8; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Grammatikopoulos G, 2002, BEHAV BRAIN RES, V130, P127, DOI 10.1016/S0166-4328(01)00424-7; *HENR STEPH, 1977, STRESS HLTH SOC ENV; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Levine S, 1989, PSYCHOENDOCRINOLOGY, V1989, P341, DOI DOI 10.1016/B978-0-12-137952-0.50012-4; Lindberg A. Cecilia, 2001, P37, DOI 10.1079/9780851993973.0037; MAESTRIPIERI D, 1990, PHYSIOL BEHAV, V47, P161, DOI 10.1016/0031-9384(90)90056-A; MICZEK KA, 1982, SCIENCE, V215, P1520, DOI 10.1126/science.7199758; Niederberger E, 2007, EUR J PHARMACOL, V559, P55, DOI 10.1016/j.ejphar.2006.11.074; RODGERS RJ, 1986, PHYSIOL BEHAV, V38, P427, DOI 10.1016/0031-9384(86)90116-2; RODGERS RJ, 1983, PHYSIOL BEHAV, V30, P775, DOI 10.1016/0031-9384(83)90177-4; RODGERS RJ, 1986, PHYSIOL BEHAV, V36, P947, DOI 10.1016/0031-9384(86)90458-0; Rutter M, 2002, ANNU REV PSYCHOL, V53, P463, DOI 10.1146/annurev.psych.53.100901.135223; Scattoni ML, 2004, BEHAV BRAIN RES, V152, P375, DOI 10.1016/j.bbr.2003.10.021; Sherwin CM, 1996, APPL ANIM BEHAV SCI, V48, P203, DOI 10.1016/0168-1591(96)01027-1; SIEGFRIED B, 1987, BEHAV NEUROSCI, V101, P797, DOI 10.1037/0735-7044.101.6.797; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Terranova ML, 1999, PSYCHONEUROENDOCRINO, V24, P639; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vekovishcheva O Y, 2000, Neurosci Behav Physiol, V30, P195, DOI 10.1007/BF02463158	41	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4143	10.1371/journal.pone.0004143	http://dx.doi.org/10.1371/journal.pone.0004143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FZ	19129917	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473500003
J	Bhattacharya, J				Bhattacharya, Joydeep			Increase of Universality in Human Brain during Mental Imagery from Visual Perception	PLOS ONE			English	Article							RANGE TEMPORAL CORRELATIONS; SCALING BEHAVIOR; TIME-SERIES; SURROGATE DATA; DYNAMICS; OSCILLATIONS; TASK; BAND; EEG; METASTABILITY	Background: Different complex systems behave in a similar way near their critical points of phase transitions which leads to an emergence of a universal scaling behaviour. Universality indirectly implies a long-range correlation between constituent subsystems. As the distributed correlated processing is a hallmark of higher complex cognition, I investigated a measure of universality in human brain during perception and mental imagery of complex real-life visual object like visual art. Methodology/Principal Findings: A new method was presented to estimate the strength of hidden universal structure in a multivariate data set. In this study, I investigated this method in the electrical activities (electroencephalogram signals) of human brain during complex cognition. Two broad groups - artists and non-artists - were studied during the encoding (perception) and retrieval (mental imagery) phases of actual paintings. Universal structure was found to be stronger in visual imagery than in visual perception, and this difference was stronger in artists than in non-artists. Further, this effect was found to be largest in the theta band oscillations and over the prefrontal regions bilaterally. Conclusions/Significance: Phase transition like dynamics was observed in the electrical activities of human brain during complex cognitive processing, and closeness to phase transition was higher in mental imagery than in real perception. Further, the effect of long-term training on the universal scaling was also demonstrated.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; [Bhattacharya, Joydeep] Austrian Acad Sci, Commission Scient Visualizat, Vienna, Austria	University of London; Goldsmiths University London; Austrian Academy of Sciences	Bhattacharya, J (corresponding author), Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England.	pss01jb@gold.ac.uk			JST.ERATO Shimojo Implicit Brain Functions project	JST.ERATO Shimojo Implicit Brain Functions project	The study was supported by JST.ERATO Shimojo Implicit Brain Functions project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak P, 1996, NATURE WORKS SCI SEL, Vxiii; Banavar JR, 2002, NATURE, V420, P626, DOI 10.1038/420626a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bhattacharya J, 2001, P ROY SOC B-BIOL SCI, V268, P2423, DOI 10.1098/rspb.2001.1802; Bhattacharya J, 2002, COGNITIVE BRAIN RES, V13, P179, DOI 10.1016/S0926-6410(01)00110-0; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; BINNEY J, 1996, THEORY CRITICAL PHEN; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Buiatti M, 2007, NEUROSCIENCE, V146, P1400, DOI 10.1016/j.neuroscience.2007.02.048; Cohen L., 1995, TIME FREQUENCY ANAL; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Doppelmayr M, 2000, NEUROSCI LETT, V278, P141, DOI 10.1016/S0304-3940(99)00925-8; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Espinel CH, 1998, LANCET, V352, P2007, DOI 10.1016/S0140-6736(98)10102-2; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Gelfand I. M., 1964, GEN FUNCTIONS; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; HAYKIN SS, 2001, COMMUNICATION SYSTEM, pR18; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Ivanov PC, 1998, PHYSICA A, V249, P587, DOI 10.1016/S0378-4371(97)00522-0; Kadanoff L. P., 1966, PHYSICS, V2, P263, DOI DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.2.263; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; Kiyono K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178103; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kosslyn S. M., 1980, IMAGE MIND; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; KULLBOCK S, 1959, INFORM THEORY STAT; Li WL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206807; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; MACKAY DJG, 2004, INFORM THEORY INFERE, pR12; MALLAT SG, 1999, WAVELET TOUR SIGNAL, pR24; Murphy D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.025301; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; PANTER PF, 1965, MODULATION NOISE SPE, pR8; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Popivanov D, 2006, BIOL CYBERN, V94, P149, DOI 10.1007/s00422-005-0037-5; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Stanley H.E., 1971, INTRO PHASE TRANSITI; TallonBaudry C, 1997, J NEUROSCI, V17, P722; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001	51	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4121	10.1371/journal.pone.0004121	http://dx.doi.org/10.1371/journal.pone.0004121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FT	19122817	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265472900004
J	Shen, H; Tesar, BM; Du, W; Goldstein, DR				Shen, Hua; Tesar, Bethany M.; Du, Wei; Goldstein, Daniel R.			Aging Impairs Recipient T Cell Intrinsic and Extrinsic Factors in Response to Transplantation	PLOS ONE			English	Article								Background: As increasing numbers of older people are listed for solid organ transplantation, there is an urgent need to better understand how aging modifies alloimmune responses. Here, we investigated whether aging impairs the ability of donor dendritic cells or recipient immunity to prime alloimmune responses to organ transplantation. Principal Findings: Using murine experimental models, we found that aging impaired the host environment to expand and activate antigen specific CD8(+) T cells. Additionally, aging impaired the ability of polyclonal T cells to induce acute allograft rejection. However, the alloimmune priming capability of donor dendritic cells was preserved with aging. Conclusion: Aging impairs recipient responses, both T cell intrinsic and extrinsic, in response to organ transplantation.	[Shen, Hua; Tesar, Bethany M.; Du, Wei; Goldstein, Daniel R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Shen, H (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	daniel.goldstein@yale.edu	Shen, Hua/F-5678-2010	Goldstein, Daniel/0000-0001-6695-979X	NIH [AI064660, AG028082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064660, R56AI064660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AI064660 and AG028082 to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron O, 1999, TRANSPLANT P, V31, P75, DOI 10.1016/S0041-1345(98)01444-4; Crespo-Leiro MG, 1999, TRANSPLANT P, V31, P2537, DOI 10.1016/S0041-1345(99)00453-4; Curtis JJ, 2006, AM J TRANSPLANT, V6, P1264, DOI 10.1111/j.1600-6143.2006.01318.x; Danovitch GM, 2006, AM J TRANSPLANT, V6, P1267, DOI 10.1111/j.1600-6143.2006.01311.x; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Krieger NR, 1996, J EXP MED, V184, P2013, DOI 10.1084/jem.184.5.2013; Lechler R, 2001, IMMUNITY, V14, P357, DOI 10.1016/S1074-7613(01)00116-9; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Martins PNA, 2005, TRANSPLANTATION, V79, P127, DOI 10.1097/01.TP.0000146258.79425.04; Meier-Kriesche HU, 2002, J AM GERIATR SOC, V50, P14, DOI 10.1046/j.1532-5415.2002.50002.x; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Ordemann R, 2002, J CLIN INVEST, V109, P1249, DOI 10.1172/JCI200214793; PIRSCH JD, 1989, TRANSPLANTATION, V47, P259, DOI 10.1097/00007890-198902000-00012; ROSENBERG AS, 1994, EUR J IMMUNOL, V24, P1312, DOI 10.1002/eji.1830240611; Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Tesar BM, 2004, AM J TRANSPLANT, V4, P1429, DOI 10.1111/j.1600-6143.2004.00544.x; THOMAN ML, 1982, J IMMUNOL, V128, P2358; TIELEN FJ, 1993, TRANSPL P, V25, P2872; Tullius SG, 2000, J AM SOC NEPHROL, V11, P1317, DOI 10.1681/ASN.V1171317; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Wang ZL, 2004, J IMMUNOL, V172, P5924, DOI 10.4049/jimmunol.172.10.5924; Yung RL, 2000, RHEUM DIS CLIN N AM, V26, P455, DOI 10.1016/S0889-857X(05)70151-4; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267; 2000, ANN REPORT US SCI RE	27	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4097	10.1371/journal.pone.0004097	http://dx.doi.org/10.1371/journal.pone.0004097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119314	gold, Green Published, Green Submitted			2022-12-27	WOS:000265472600005
J	Fischer, T; Nagel, F; Jacobs, S; Stumm, R; Schulz, S				Fischer, Thomas; Nagel, Falko; Jacobs, Stefan; Stumm, Ralf; Schulz, Stefan			Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2	PLOS ONE			English	Article								Background: The CXCR4 chemokine receptor regulates migration and homing of cancer cells to specific metastatic sites. Determination of the CXCR4 receptor status will provide predictive information for disease prognosis and possible therapeutic intervention. However, previous attempts to localize CXCR4 using poorly characterized mouse monoclonal or rabbit polyclonal antibodies have produced predominant nuclear and occasional cytoplasmic staining but did not result in the identification of bona fide cell surface receptors. Methodology/Principal Findings: In the present study, we extensively characterized the novel rabbit monoclonal anti-CXCR4 antibody (clone UMB-2) using transfected cells and tissues from CXCR4-deficient mice. Specificity of UMB-2 was demonstrated by cell surface staining of CXCR4-transfected cells; translocation of CXCR4 immunostaining after agonist exposure; detection of a broad band migrating at M(r) 38,000-43,000 in Western blots of homogenates from CXCR4-expressing cells; selective detection of the receptor in tissues from CXCR4+/+ but not from CXCR4-/- mice; and abolition of tissue immunostaining by preadsorption of UMB-2 with its immunizing peptide. In formalin-fixed, paraffin-embedded human tumor tissues, UMB-2 yielded highly effective plasma membrane staining of a subpopulation of tumor cells, which were often heterogeneously distributed throughout the tumor. A comparative analysis of the mouse monoclonal antibody 12G5 and other frequently used commercially available antibodies revealed that none of these was able to detect CXCR4 under otherwise identical conditions. Conclusions/Significance: Thus, the rabbit monoclonal antibody UMB-2 may prove of great value in the assessment of the CXCR4 receptor status in a variety of human tumors during routine histopathological examination.	[Fischer, Thomas; Nagel, Falko; Jacobs, Stefan; Schulz, Stefan] Univ Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Nagel, Falko; Schulz, Stefan] Univ Jena, Dept Pharmacol & Toxicol, Jena, Germany; [Stumm, Ralf] Otto von Guericke Univ, Dept Pharmacol & Toxicol, Magdeburg, Germany	University of Wurzburg; Friedrich Schiller University of Jena; Otto von Guericke University	Fischer, T (corresponding author), Univ Wurzburg, Dept Pharmacol, Wurzburg, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885; Fischer, Thomas/0000-0003-4711-645X				Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Bertolini F, 2002, CANCER RES, V62, P3106; Blot E, 2008, BREAST J, V14, P268, DOI 10.1111/j.1524-4741.2008.00573.x; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fischer T, 2008, J CLIN ENDOCRINOL ME; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lee BC, 2004, MOL CANCER RES, V2, P327; Liang ZX, 2005, CANCER RES, V65, P967; Mori T, 2004, MOL CANCER THER, V3, P29; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Stumm RK, 2002, J NEUROSCI, V22, P5865; Vaday GG, 2004, CLIN CANCER RES, V10, P5630, DOI 10.1158/1078-0432.CCR-03-0633; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Xu FY, 2007, CLIN CANCER RES, V13, P5082, DOI 10.1158/1078-0432.CCR-07-0597; Yang YC, 2007, INT J GYNECOL CANCER, V17, P676, DOI 10.1111/j.1525-1438.2007.00841.x; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197	30	58	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4069	10.1371/journal.pone.0004069	http://dx.doi.org/10.1371/journal.pone.0004069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116653	Green Submitted, Green Published, gold			2022-12-27	WOS:000265466600003
J	Lucas, JE; Carvalho, CM; Chen, JLY; Chi, JT; West, M				Lucas, Joseph E.; Carvalho, Carlos M.; Chen, Julia Ling-Yu; Chi, Jen-Tsan; West, Mike			Cross-Study Projections of Genomic Biomarkers: An Evaluation in Cancer Genomics	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EXPRESSION; METASTASIS; MOLECULES; PREDICT; GENES; RNA; MAP	Human disease studies using DNA microarrays in both clinical/observational and experimental/controlled studies are having increasing impact on our understanding of the complexity of human diseases. A fundamental concept is the use of gene expression as a "common currency'' that links the results of in vitro controlled experiments to in vivo observational human studies. Many studies - in cancer and other diseases - have shown promise in using in vitro cell manipulations to improve understanding of in vivo biology, but experiments often simply fail to reflect the enormous phenotypic variation seen in human diseases. We address this with a framework and methods to dissect, enhance and extend the in vivo utility of in vitro derived gene expression signatures. From an experimentally defined gene expression signature we use statistical factor analysis to generate multiple quantitative factors in human cancer gene expression data. These factors retain their relationship to the original, one-dimensional in vitro signature but better describe the diversity of in vivo biology. In a breast cancer analysis, we show that factors can reflect fundamentally different biological processes linked to molecular and clinical features of human cancers, and that in combination they can improve prediction of clinical outcomes.	[Lucas, Joseph E.; Chen, Julia Ling-Yu; Chi, Jen-Tsan] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Carvalho, Carlos M.] Univ Chicago, Grad Sch Business, Chicago, IL 60637 USA; [West, Mike] Duke Univ, Dept Stat Sci, Durham, NC 27706 USA	Duke University; University of Chicago; Duke University	Lucas, JE (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	joe@stat.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X	National Science Foundation [DMS-0342172]; National Institutes of Health [NCI U54-CA-112952]; NATIONAL CANCER INSTITUTE [U54CA112952] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research partially supported by National Science Foundation (DMS-0342172) and National Institutes of Health (NCI U54-CA-112952). Any opinions, findings and conclusions or recommendations expressed in this work are those of the authors and do not necessarily reflect the views of the NSF or NIH.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; CARVALHO C, 2008, J AM STAT A IN PRESS; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Erman M, 2004, ANN ONCOL, V15, P1622, DOI 10.1093/annonc/mdh437; Han HJ, 2002, EXP NEPHROL, V10, P355, DOI 10.1159/000065300; HANS C, 2007, B INT SOC BAYESIAN A, V24, P8; Hans C, 2007, J AM STAT ASSOC, V102, P507, DOI 10.1198/016214507000000121; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; HUANG E, 2002, HORM RES, V58, P55; Huang ES, 2003, CELL CYCLE, V2, P415, DOI 10.4161/cc.2.5.492; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LUCAS JE, 2008, IN VITRO IN IN PRESS; Lucas J, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P155; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nevins JR, 2003, HUM MOL GENET, V12, pR153, DOI 10.1093/hmg/ddg287; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; SCHLAG P, 1980, J CANCER RES CLIN, V97, P63, DOI 10.1007/BF00411279; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Seo DM, 2007, ANN APPL STAT, V1, P152, DOI 10.1214/07-AOAS110; Simoncini T, 1999, J CLIN ENDOCR METAB, V84, P815, DOI 10.1210/jc.84.2.815; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SPANG R, 2001, SILICO BIOL, V2; STOCK JL, 1992, J CELL PHYSIOL, V150, P517, DOI 10.1002/jcp.1041500312; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4523	10.1371/journal.pone.0004523	http://dx.doi.org/10.1371/journal.pone.0004523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225561	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000005
J	Collins, CA; Gnocchi, VF; White, RB; Boldrin, L; Perez-Ruiz, A; Relaix, F; Morgan, JE; Zammit, PS				Collins, Charlotte A.; Gnocchi, Viola F.; White, Robert B.; Boldrin, Luisa; Perez-Ruiz, Ana; Relaix, Frederic; Morgan, Jennifer E.; Zammit, Peter S.			Integrated Functions of Pax3 and Pax7 in the Regulation of Proliferation, Cell Size and Myogenic Differentiation	PLOS ONE			English	Article							MUSCLE SATELLITE CELL; STEM-CELL; CYCLE PROGRESSION; PROGENITOR CELLS; NEURAL-TUBE; PAX3-FKHR; ACTIVATION; EXPRESSION; HETEROGENEITY; DISTINCT	Pax3 and Pax7 are paired-box transcription factors with roles in developmental and adult regenerative myogenesis. Pax3 and Pax7 are expressed by postnatal satellite cells or their progeny but are down regulated during myogenic differentiation. We now show that constitutive expression of Pax3 or Pax7 in either satellite cells or C2C12 myoblasts results in an increased proliferative rate and decreased cell size. Conversely, expression of dominant-negative constructs leads to slowing of cell division, a dramatic increase in cell size and altered morphology. Similarly to the effects of Pax7, retroviral expression of Pax3 increases levels of Myf5 mRNA and MyoD protein, but does not result in sustained inhibition of myogenic differentiation. However, expression of Pax3 or Pax7 dominant-negative constructs inhibits expression of Myf5, MyoD and myogenin, and prevents differentiation from proceeding. In fibroblasts, expression of Pax3 or Pax7, or dominant-negative inhibition of these factors, reproduce the effects on cell size, morphology and proliferation seen in myoblasts. Our results show that in muscle progenitor cells, Pax3 and Pax7 function to maintain expression of myogenic regulatory factors, and promote population expansion, but are also required for myogenic differentiation to proceed.	[Collins, Charlotte A.; Boldrin, Luisa; Morgan, Jennifer E.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Gnocchi, Viola F.; White, Robert B.; Perez-Ruiz, Ana; Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Relaix, Frederic] Univ Paris 06, UPMC, Grp Myol, INSERM, UMR S 787, Fac Med Pitie Salpetriere, Mouse Mol Genet Grp, F-75252 Paris, France	University of London; University College London; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Collins, CA (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	peter.zammit@kcl.ac.uk	Zammit, peter/GXV-7746-2022; Pérez-Ruiz, Ana/I-2910-2015; White, Robert/H-6080-2014	Pérez-Ruiz, Ana/0000-0002-9901-057X; Relaix, Frederic/0000-0003-1270-1472; White, Robert/0000-0002-2854-0936; zammit, peter/0000-0001-9562-3072; Collins, Charlotte/0000-0002-8715-9035	Muscular Dystrophy Campaign [RA3/711, RA3/762]; Medical Research Council [G0700307, Joint Collaborative Career Development Award in Stem Cell Research]; The Wellcome Trust [085137, university award]; Fundacion Ramon Areces [post-doctoral fellowship]; INSERM Avenir program, UPMC, Institut de Myologie, AFM; EU 6th framework programme MYORES network of excellence [511978]; Association of International Cancer Research; MRC [G0700307, G0601943] Funding Source: UKRI; Medical Research Council [G0601943, G0601943B] Funding Source: researchfish	Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Wellcome Trust(Wellcome Trust); Fundacion Ramon Areces; INSERM Avenir program, UPMC, Institut de Myologie, AFM; EU 6th framework programme MYORES network of excellence; Association of International Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C.A.C. and L.B. were funded by the Muscular Dystrophy Campaign (RA3/711). V.F.G. received support from the Medical Research Council (grant number G0700307). R.B.W. was funded by the Muscular Dystrophy Campaign (RA3/762), and currently, by The Wellcome Trust (085137), while A.P.R. was funded by a Fundacion Ramon Areces post-doctoral fellowship. F.R. is funded by the INSERM Avenir program, UPMC, Institut de Myologie, AFM and is a member of the EU 6th framework programme MYORES network of excellence. J.E.M. was funded by an MRC Joint Collaborative Career Development Award in Stem Cell Research and is currently funded by a Wellcome Trust university award. The laboratory of P.S.Z. is also supported by the Association of International Cancer Research and the MYORES Network of Excellence contract 511978 from the European Commission 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Du SY, 2005, INT J CANCER, V115, P85, DOI 10.1002/ijc.20844; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Gang EJ, 2008, EXP CELL RES, V314, P1721, DOI 10.1016/j.yexcr.2008.02.016; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jun S, 1996, DEVELOPMENT, V122, P2639; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Mansouri A, 2001, DEVELOPMENT, V128, P1995; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; SCHAFER BW, 1994, NUCLEIC ACIDS RES, V22, P4574, DOI 10.1093/nar/22.22.4574; Scuoppo C, 2007, EXP CELL RES, V313, P2308, DOI 10.1016/j.yexcr.2007.02.037; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wiggan O, 2002, J CELL SCI, V115, P517; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	45	90	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4475	10.1371/journal.pone.0004475	http://dx.doi.org/10.1371/journal.pone.0004475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221588	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485700007
J	Scott, CP; VanWye, J; McDonald, MD; Crawford, DL				Scott, Cinda P.; VanWye, Jeff; McDonald, M. Danielle; Crawford, Douglas L.			Technical Analysis of cDNA Microarrays	PLOS ONE			English	Article							GENE-EXPRESSION	Background: There is extensive variation in gene expression among individuals within and between populations. Accurate measures of the variation in mRNA expression using microarrays can be confounded by technical variation, which includes variation in RNA isolation procedures, day of hybridization and methods used to amplify and dye label RNA for hybridization. Methodology/Principal Findings: In this manuscript we analyze the relationship between the amount of mRNA and the fluorescent signal from the microarray hybridizations demonstrating that for a wide-range of mRNA concentrations the fluorescent signal is a linear function of the amount of mRNA. Additionally, the separate isolation, labeling or hybridization of RNA does not add significant amounts of variation in microarray measures of gene expression. However, single or double rounds of amplification for labeling do have small but significant affects on 10% of genes, but this source of technical variation is easy to avoid. To examine both technical and stochastic biological variation, mRNA expression was measured from the same five individuals over a six-week time course. Conclusion: There were few, if any, meaningful differences in gene expression among time points. Thus, microarray measures using standard laboratory procedures can be precise and quantitative and are not subject to significant random biological noise.	[Scott, Cinda P.; VanWye, Jeff; McDonald, M. Danielle; Crawford, Douglas L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Fisheries, Miami, FL 33149 USA	University of Miami	Scott, CP (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Fisheries, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dcrawford@rsmas.miami.edu		McDonald, M. Danielle/0000-0003-2074-1140; Crawford, Douglas/0000-0002-6239-4012	NSF/OCE [0221879, 0432368]; NIH/NHLBI [HL65470-01A2]; NSF-NIEHS [P50ES12736]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012736] Funding Source: NIH RePORTER	NSF/OCE(National Science Foundation (NSF)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NSF/OCE 0221879; NIH/NHLBI HL65470-01A2, and NSF-NIEHS P50ES12736 and NSF OCE-0432368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Beissbarth T, 2000, BIOINFORMATICS, V16, P1014; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Crawford DL, 2007, J EXP BIOL, V210, P1613, DOI 10.1242/jeb.005454; Currie S, 1997, J EXP BIOL, V200, P607; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Dudoit S, 2003, BIOTECHNIQUES, P45; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Eberwine J, 1996, BIOTECHNIQUES, V20, P584; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gold D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-2; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2001, GENET RES, V77, P123; Koldkjaer P, 2004, J EXP BIOL, V207, P357, DOI 10.1242/jeb.00747; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Paschall JE, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-96; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; van Haaften RIM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-200; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yauk CL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh123; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4486	10.1371/journal.pone.0004486	http://dx.doi.org/10.1371/journal.pone.0004486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221589	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485700011
J	Oesterholt, MJAM; Alifrangis, M; Sutherland, CJ; Omar, SA; Sawa, P; Howitt, C; Gouagna, LC; Sauerwein, RW; Bousema, T				Oesterholt, Mayke J. A. M.; Alifrangis, Michael; Sutherland, Colin J.; Omar, Sabah A.; Sawa, Patrick; Howitt, Christina; Gouagna, Louis C.; Sauerwein, Robert W.; Bousema, Teun			Submicroscopic Gametocytes and the Transmission of Antifolate-Resistant Plasmodium falciparum in Western Kenya	PLOS ONE			English	Article								Background: Single nucleotide polymorphisms (SNPs) in the dhfr and dhps genes are associated with sulphadoxine-pyrimethamine (SP) treatment failure and gametocyte carriage. This may result in enhanced transmission of mutant malaria parasites, as previously shown for chloroquine resistant parasites. In the present study, we determine the association between parasite mutations, submicroscopic P. falciparum gametocytemia and malaria transmission to mosquitoes. Methodology/Principal Findings: Samples from children treated with SP alone or in combination with artesunate (AS) or amodiaquine were genotyped for SNPs in the dhfr and dhps genes. Gametocytemia was determined by microscopy and Pfs25 RNA-based quantitative nucleic acid sequence-based amplification (Pfs25 QT-NASBA). Transmission was determined by membrane-feeding assays. We observed no wild type infections, 66.5% (127/191) of the infections expressed mutations at all three dhfr codons prior to treatment. The presence of all three mutations was not related to higher Pfs25 QT-NASBA gametocyte prevalence or density during follow-up, compared to double mutant infections. The proportion of infected mosquitoes or oocyst burden was also not related to the number of mutations. Addition of AS to SP reduced gametocytemia and malaria transmission during follow-up. Conclusions/Significance: In our study population where all infections had at least a double mutation in the dhfr gene, additional mutations were not related to increased submicroscopic gametocytemia or enhanced malaria transmission. The absence of wild-type infections is likely to have reduced our power to detect differences. Our data further support the use of ACT to reduce the transmission of drug-resistant malaria parasites.	[Sauerwein, Robert W.; Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Alifrangis, Michael] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth, Immunol & Microbiol, DK-1168 Copenhagen, Denmark; [Alifrangis, Michael] Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Sutherland, Colin J.; Howitt, Christina] London Sch Hygiene & Trop Med, Dept Infect & Trop Dis, London, England; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi, Kenya; [Sawa, Patrick; Gouagna, Louis C.] Int Ctr Insect Physiol & Ecol, Human Hlth Div, Mbita, Kenya; [Gouagna, Louis C.] Inst Rech Dev, Bobo Dioulasso, Burkina Faso	Radboud University Nijmegen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; International Centre of Insect Physiology & Ecology (ICIPE); Institut de Recherche pour le Developpement (IRD)	Oesterholt, MJAM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	teun.bousema@lshtm.ac.uk	Bousema, Teun/N-3574-2014; Sauerwein, Robert/C-8519-2013; Sutherland, Colin/AAN-3939-2020	Bousema, Teun/0000-0003-2666-094X; Sutherland, Colin/0000-0003-1592-6407; Gouagna, Louis Clement/0000-0003-0957-4484; Alifrangis, Michael/0000-0002-3835-3333	NWO-WOTRO [2003/00702, W07.05.203.00]; UK Health Protection Agency	NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); UK Health Protection Agency	Financial support was provided by NWO-WOTRO (grant 2003/00702). T. Bousema is supported by NWO-WOTRO (W07.05.203.00 through APRIORI); C. Sutherland is supported by the UK Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifrangis M, 2005, AM J TROP MED HYG, V72, P155, DOI 10.4269/ajtmh.2005.72.155; Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Berens N, 2003, TROP MED INT HEALTH, V8, P775, DOI 10.1046/j.1365-3156.2003.01099.x; Biswas S, 2000, TROP MED INT HEALTH, V5, P737, DOI 10.1046/j.1365-3156.2000.00632.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Farnert A, 2002, AM J TROP MED HYG, V66, P487; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hallett RL, 2004, ANTIMICROB AGENTS CH, V48, P3940, DOI 10.1128/AAC.48.10.3940-3943.2004; Hamel MJ, 2008, T ROY SOC TROP MED H, V102, P338, DOI 10.1016/j.trstmh.2008.01.018; Hastings MD, 2002, T ROY SOC TROP MED H, V96, P674, DOI 10.1016/S0035-9203(02)90349-4; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Marks F, 2005, J INFECT DIS, V192, P1962, DOI 10.1086/497698; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Mendez F, 2002, AM J EPIDEMIOL, V156, P230, DOI 10.1093/aje/kwf030; Mendez F, 2007, AM J TROP MED HYG, V77, P438, DOI 10.4269/ajtmh.2007.77.438; Mendez F, 2006, AM J TROP MED HYG, V75, P640, DOI 10.4269/ajtmh.2006.75.640; Meremikwu M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-55; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P901, DOI 10.1111/j.1365-3156.2005.01471.x; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Omar S. A., 2007, Journal of Infection in Developing Countries, V1, P195; Omar SA, 2001, ANN TROP MED PARASIT, V95, P661, DOI 10.1080/00034980120103234; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Schonfeld M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-2; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Staedke SG, 2004, TROP MED INT HEALTH, V9, P624, DOI 10.1111/j.1365-3156.2004.01239.x; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Wernsdorfer WH, 2003, CURR OPIN INFECT DIS, V16, P553, DOI 10.1097/00001432-200312000-00007; ZOLG JW, 1989, MOL BIOCHEM PARASIT, V36, P253, DOI 10.1016/0166-6851(89)90173-4; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	49	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4364	10.1371/journal.pone.0004364	http://dx.doi.org/10.1371/journal.pone.0004364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194499	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000265483600007
J	Marcet-Houben, M; Gabaldon, T				Marcet-Houben, Marina; Gabaldon, Toni			The Tree versus the Forest: The Fungal Tree of Life and the Topological Diversity within the Yeast Phylome	PLOS ONE			English	Article								A recurrent topic in phylogenomics is the combination of various sequence alignments to reconstruct a tree that describes the evolutionary relationships within a group of species. However, such approach has been criticized for not being able to properly represent the topological diversity found among gene trees. To evaluate the representativeness of species trees based on concatenated alignments, we reconstruct several fungal species trees and compare them with the complete collection of phylogenies of genes encoded in the Saccharomyces cerevisiae genome. We found that, despite high levels of among-gene topological variation, the species trees do represent widely supported phylogenetic relationships. Most topological discrepancies between gene and species trees are concentrated in certain conflicting nodes. We propose to map such information on the species tree so that it accounts for the levels of congruence across the genome. We identified the lack of sufficient accuracy of current alignment and phylogenetic methods as an important source for the topological diversity encountered among gene trees. Finally, we discuss the implications of the high levels of topological variation for phylogeny-based orthology prediction strategies.	[Marcet-Houben, Marina; Gabaldon, Toni] Ctr Investigac Principe Felipe, Dept Bioinformat, Valencia, Spain	Prince Felipe Research Center	Marcet-Houben, M (corresponding author), Ctr Regulacio Genom, Bioinformat & Genom Programme, Barcelona, Spain.	tgabaldon@crg.es	Marcet-Houben, Marina/AHA-6758-2022; Marcet-Houben, Marina/H-2170-2015; Gabaldón, Toni/A-7336-2008	Marcet-Houben, Marina/0000-0003-4838-187X; Marcet-Houben, Marina/0000-0003-4838-187X; Gabaldón, Toni/0000-0003-0019-1735	Spanish Ministry of Science [GEN06-27784]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MMH and TG are supported by grant from the ERA-NET pathogenomics network funded by the Spanish Ministry of Science (GEN06-27784). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Ane C, 2007, MOL BIOL EVOL, V24, P412; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gabaldon T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-235; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Huerta-Cepas J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r109; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Pisani D, 2007, MOL BIOL EVOL, V24, P1752, DOI 10.1093/molbev/msm095; Rasmussen MD, 2007, GENOME RES, V17, P1932, DOI 10.1101/gr.7105007; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Heijden RTJM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-83; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	34	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4357	10.1371/journal.pone.0004357	http://dx.doi.org/10.1371/journal.pone.0004357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190756	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483300006
J	Lin, YW; Cheng, CM; Leduc, PR; Chen, CC				Lin, Yi-Wen; Cheng, Chao-Min; Leduc, Philip R.; Chen, Chih-Cheng			Understanding Sensory Nerve Mechanotransduction through Localized Elastomeric Matrix Control	PLOS ONE			English	Article								Background: While neural systems are known to respond to chemical and electrical stimulation, the effect of mechanics on these highly sensitive cells is still not well understood. The ability to examine the effects of mechanics on these cells is limited by existing approaches, although their overall response is intimately tied to cell-matrix interactions. Here, we offer a novel method, which we used to investigate stretch-activated mechanotransduction on nerve terminals of sensory neurons through an elastomeric interface. Methodology/Principal Findings: To apply mechanical force on neurites, we cultured dorsal root ganglion neurons on an elastic substrate, polydimethylsiloxane (PDMS), coated with extracellular matrices (ECM). We then implemented a controlled indentation scheme using a glass pipette to mechanically stimulate individual neurites that were adjacent to the pipette. We used whole-cell patch clamping to record the stretch-activated action potentials on the soma of the single neurites to determine the mechanotransduction-based response. When we imposed specific mechanical force through the ECM, we noted a significant neuronal action potential response. Furthermore, because the mechanotransduction cascade is known to be directly affected by the cytoskeleton, we investigated the cell structure and its effects. When we disrupted microtubules and actin filaments with nocodozale or cytochalasin-D, respectively, the mechanically induced action potential was abrogated. In contrast, when using blockers of channels such as TRP, ASIC, and stretch-activated channels while mechanically stimulating the cells, we observed almost no change in action potential signalling when compared with mechanical activation of unmodified cells. Conclusions/Significance: These results suggest that sensory nerve terminals have a specific mechanosensitive response that is related to cell architecture.	[Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Cheng, Chao-Min; Leduc, Philip R.] Carnegie Mellon Univ, Dept Mech & Biomed Engn & Biol Sci, Pittsburgh, PA 15213 USA	Academia Sinica - Taiwan; Carnegie Mellon University	Lin, YW (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	prl@andrew.cmu.edu; chih@ibms.sinica.edu.tw	Lin, Yi-Wen/O-3541-2015; Chen, Chih-Cheng/AAT-1062-2021; Chen, Chih-Cheng/S-7015-2018; LeDuc, Philip/M-1103-2014	Lin, Yi-Wen/0000-0001-7204-8837; Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660; LeDuc, Philip/0000-0001-6397-2905	Institute of Biomedical Sciences, Academia Sinica [postdoctoral fellowship]; National Science Foundation-CAREER; National Academies Keck Foundation Futures Initiative; Pennsylvania Infrastructure Technology Alliance; Department of Energy-Genome to Life; Beckman Young Investigators Program; Taiwan [PhD Research Scholarship]; Carnegie Mellon University, USA [Dowd-ICES Scholarship]	Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); National Science Foundation-CAREER(National Science Foundation (NSF)); National Academies Keck Foundation Futures Initiative; Pennsylvania Infrastructure Technology Alliance; Department of Energy-Genome to Life(United States Department of Energy (DOE)); Beckman Young Investigators Program; Taiwan; Carnegie Mellon University, USA	This study was supported by a start-up fund from the Institute of Biomedical Sciences, Academia Sinica (to C.-C.C.) and postdoctoral fellowship from Academia Sinica (to Y.- W.L.). P.R.L. wishes to additionally thank National Science Foundation-CAREER, National Academies Keck Foundation Futures Initiative, Pennsylvania Infrastructure Technology Alliance, the Department of Energy-Genome to Life, and the Beckman Young Investigators Program for partial support. C.-M C. was supported in part by a PhD Research Scholarship from Taiwan and the Dowd-ICES Scholarship from Carnegie Mellon University, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Choi KM, 2003, J AM CHEM SOC, V125, P4060, DOI 10.1021/ja029973k; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Di Castro A, 2006, P NATL ACAD SCI USA, V103, P4699, DOI 10.1073/pnas.0508005103; Ditting T, 2003, BASIC RES CARDIOL, V98, P388, DOI 10.1007/s00395-003-0426-7; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Greve F, 2007, BIOMATERIALS, V28, P5246, DOI 10.1016/j.biomaterials.2007.08.010; HAJDUCZOK G, 1994, J CLIN INVEST, V94, P2392, DOI 10.1172/JCI117605; Hamill OP, 1996, PHARMACOL REV, V48, P231; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Heppelmann B, 2005, EXP BRAIN RES, V167, P114, DOI 10.1007/s00221-005-0040-z; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Lin YW, 2008, NEUROSCIENCE, V151, P544, DOI 10.1016/j.neuroscience.2007.10.020; Lin YW, 2003, J NEUROSCI, V23, P4173; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Piao L, 2006, J NEUROSCI RES, V83, P1373, DOI 10.1002/jnr.20810; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sanchez D, 2007, J NEUROSCI METH, V159, P26, DOI 10.1016/j.jneumeth.2006.06.018; Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Tseng TJ, 2007, EXP NEUROL, V204, P574, DOI 10.1016/j.expneurol.2006.12.018; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zagorodnyuk VP, 2003, J PHYSIOL-LONDON, V553, P575, DOI 10.1113/jphysiol.2003.051862	40	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4293	10.1371/journal.pone.0004293	http://dx.doi.org/10.1371/journal.pone.0004293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173000	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483000006
J	Mellata, M; Touchman, JW; Curtiss, R				Mellata, Melha; Touchman, Jeffrey W.; Curtiss, Roy, III			Full Sequence and Comparative Analysis of the Plasmid pAPEC-1 of Avian Pathogenic E-coli chi 7122 (O78:K80:H9)	PLOS ONE			English	Article								Background: Extra-intestinal pathogenic E. coli (ExPEC), including Avian Pathogenic E. coli (APEC), are very diverse. They cause a complex of diseases in Human, animals, and birds. Even though large plasmids are often associated with the virulence of ExPEC, their characterization is still in its infancy. Methodology/Principal Findings: We fully sequenced and analyzed the large plasmid pAPEC-1 (103,275-bp) associated with the APEC strain chi 7122, from worldwide serogroup O78:K80:H9. A putative virulence region spanning an 80-kb region of pAPEC-1 possesses four iron acquisition systems (iutA iucABCD, sitABCD, iroBCDN, and temperature-sensitive hemagglutinin tsh), a colicin V operon, increasing serum sensitivity iss, ompT, hlyF, and etsABC. Thirty three ORFs in pAPEC-1 are identified as insertion sequences (ISs) that belong to nine families with diverse origins. The full length of the transfer region in pAPEC-1 (11 kb) is shorter compared to the tra region of other sequenced F plasmids; the absence of some tra genes in pAPEC-1 affects its self-transferability, and the conjugative function of the plasmid was effective only in the presence of other plasmids. Two-replicon systems, repFIIA-repFIC and repFIB, and two post-segregational systems, srnB and hok/sok, are also present in the sequence of pAPEC-1. The comparison of the pAPEC-1 sequence with the two available plasmid sequences reveals more gene loss and reorganization than previously appreciated. The presence of pAPEC-1-associated genes is assessed in human ExPEC by PCR. Many patterns of association between genes are found. Conclusions/Significance: The pathotype typical of pAPEC-1 was present in some human strains, which indicates a horizontal transfer between strains and the zoonotic risk of APEC strains. ColV plasmids could have common virulence genes that could be acquired by transposition, without sharing genes of plasmid function.	[Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Touchman, Jeffrey W.; Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mellata, M (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Mellata, Melha/AAP-5491-2020	Mellata, Melha/0000-0002-4967-7173	National Institutes of Health [U01060557]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for research was provided by National Institutes of Health grant U01060557. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Barnes H. J., 2003, DIS POULTRY, V11th, P631; Baumler AJ, 1998, J BACTERIOL, V180, P1446; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CAVARD D, 1990, J BACTERIOL, V172, P648, DOI 10.1128/jb.172.2.648-652.1990; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; Crosa JH., 2004, IRON TRANSPORT BACTE; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dho-Moulin M, 1999, VET RES, V30, P299; Dobrindt U, 2001, INFECT IMMUN, V69, P4248, DOI 10.1128/IAI.69.7.4248-4256.2001; Doetkott DM, 1996, AVIAN DIS, V40, P927, DOI 10.2307/1592319; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; FREDERICQ P, 1964, ANN I PASTEUR PARIS, VS, P7; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GERDES K, 1992, J MOL BIOL, V226, P637, DOI 10.1016/0022-2836(92)90621-P; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; Gratia A, 1925, CR SOC BIOL, V93, P1040; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Heimer SR, 2004, INFECT IMMUN, V72, P593, DOI 10.1128/IAI.72.1.593-597.2004; HIRAGA S, 1992, ANNU REV BIOCHEM, V61, P283; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2004, AVIAN DIS, V48, P351, DOI 10.1637/7121; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Johnson TJ, 2002, AVIAN DIS, V46, P342, DOI 10.1637/0005-2086(2002)046[0342:LOISSG]2.0.CO;2; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Kostakioti M, 2004, INFECT IMMUN, V72, P5548, DOI 10.1128/IAI.72.10.5548-5554.2004; LANE D, 1979, J BACTERIOL, V139, P141, DOI 10.1128/JB.139.1.141-151.1979; Lawley TD, 2003, J BACTERIOL, V185, P3060, DOI 10.1128/JB.185.10.3060-3067.2003; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; LUNDRIGAN MD, 1992, FEMS MICROBIOL LETT, V97, P51; MAINIL JG, 1992, INFECT IMMUN, V60, P3376, DOI 10.1128/IAI.60.8.3376-3380.1992; Maurer JJ, 1998, AVIAN DIS, V42, P106, DOI 10.2307/1592582; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Morales Cesar, 2004, Foodborne Pathog Dis, V1, P160; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Otto BR, 2002, INFECT IMMUN, V70, P5, DOI 10.1128/IAI.70.1.5-10.2002; OZANNE G, 1977, INFECT IMMUN, V17, P497, DOI 10.1128/IAI.17.3.497-503.1977; PROVENCE DL, 1994, INFECT IMMUN, V62, P1369, DOI 10.1128/IAI.62.4.1369-1380.1994; QUACKENBUSH RL, 1979, INFECT IMMUN, V24, P562, DOI 10.1128/IAI.24.2.562-564.1979; Restieri C, 2007, APPL ENVIRON MICROB, V73, P1553, DOI 10.1128/AEM.01542-06; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; SAADI S, 1984, PLASMID, V12, P61, DOI 10.1016/0147-619X(84)90067-2; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; SEIDMAN CE, 2001, CURR PROTOC MOL BIOL, V1, P1; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; SMITH HW, 1980, J GEN MICROBIOL, V121, P387; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Stathopoulos C, 1998, Membr Cell Biol, V12, P1; Stehling EG, 2003, VET MICROBIOL, V95, P111, DOI 10.1016/S0378-1135(03)00125-1; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; SUGIMURA K, 1988, J BACTERIOL, V170, P5625, DOI 10.1128/jb.170.12.5625-5632.1988; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; WILLIAMS PH, 1980, INFECT IMMUN, V29, P411; Wooley RE, 1998, AVIAN DIS, V42, P194, DOI 10.2307/1592596; WOOLEY RE, 1994, AVIAN DIS, V38, P141, DOI 10.2307/1591847; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06; ZHANG LH, 1995, GENETICS, V141, P25; Ziebuhr W, 1999, CELL MOL LIFE SCI, V56, P719, DOI 10.1007/s000180050018; Zienkiewicz M, 2007, ANTIMICROB AGENTS CH, V51, P1164, DOI 10.1128/AAC.00772-06	84	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4232	10.1371/journal.pone.0004232	http://dx.doi.org/10.1371/journal.pone.0004232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156210	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482100004
J	Wolf, LV; Yang, Y; Wang, JH; Xie, Q; Braunger, B; Tamm, ER; Zavadil, J; Cvekl, A				Wolf, Louise V.; Yang, Ying; Wang, Jinhua; Xie, Qing; Braunger, Barbara; Tamm, Ernst R.; Zavadil, Jiri; Cvekl, Ales			Identification of Pax6-Dependent Gene Regulatory Networks in the Mouse Lens	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION SITES; RETINAL PROGENITOR CELLS; ALPHA-A-CRYSTALLIN; PAIRED-DOMAIN; TARGET GENES; SEGMENT ABNORMALITIES; EMBRYONIC-DEVELOPMENT; MICROARRAY ANALYSIS; PLACODE DEVELOPMENT; DOWNSTREAM TARGET	Lineage-specific DNA-binding transcription factors regulate development by activating and repressing particular set of genes required for the acquisition of a specific cell type. Pax6 is a paired domain and homeodomain-containing transcription factor essential for development of central nervous, olfactory and visual systems, as well as endocrine pancreas. Haploinsufficiency of Pax6 results in perturbed lens development and homeostasis. Loss-of-function of Pax6 is incompatible with lens lineage formation and results in abnormal telencephalic development. Using DNA microarrays, we have identified 559 genes expressed differentially between 1-day old mouse Pax6 heterozygous and wild type lenses. Of these, 178 (31.8%) were similarly increased and decreased in Pax6 homozygous embryonic telencephalon [Holm PC, Mader MT, Haubst N, Wizenmann A, Sigvardsson M, Gotz M (2007) Loss- and gain-of-function analyses reveals targets of Pax6 in the developing mouse telencephalon. Mol Cell Neurosci 34: 99 - 119]. In contrast, 381 (68.2%) genes were differently regulated between the lens and embryonic telencephalon. Differential expression of nine genes implicated in lens development and homeostasis: Cspg2, Igfbp5, Mab21l2, Nrf2f, Olfm3, Spag5, Spock1, Spon1 and Tgfb2, was confirmed by quantitative RT-PCR, with five of these genes: Cspg2, Mab21l2, Olfm3, Spag5 and Tgfb2, identified as candidate direct Pax6 target genes by quantitative chromatin immunoprecipitation (qChIP). In Mab21l2 and Tgfb2 promoter regions, twelve putative individual Pax6-binding sites were tested by electrophoretic mobility shift assays (EMSAs) with recombinant Pax6 proteins. This led to the identification of two and three sites in the respective Mab21l2 and Tgfb2 promoter regions identified by qChIPs. Collectively, the present studies represent an integrative genome-wide approach to identify downstream networks controlled by Pax6 that control mouse lens and forebrain development.	[Wolf, Louise V.; Yang, Ying; Xie, Qing; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci & Genet, Bronx, NY 10467 USA; [Wang, Jinhua; Zavadil, Jiri] NYU, Langone Med Ctr, Canc Inst, New York, NY USA; [Braunger, Barbara; Tamm, Ernst R.] Univ Regensburg, Inst Human Anat & Embryol, D-8400 Regensburg, Germany; [Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center; University of Regensburg; New York University; NYU Langone Medical Center	Wolf, LV (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci & Genet, Bronx, NY 10467 USA.	cvekl@aecom.yu.edu	Cvekl, Ales/B-2427-2013; Braunger, Barbara Maria/K-4272-2015; Zavadil, Jiri/ABG-1780-2020; Tamm, Ernst/AAB-9772-2019	Braunger, Barbara Maria/0000-0002-3926-6725; Zavadil, Jiri/0000-0003-0640-5562; Tamm, Ernst/0000-0002-6679-8743	NIH [EY012200, EY017296]; DFG [FOR1075]; Irma T. Hirschl Career Scientist Award; NATIONAL EYE INSTITUTE [R01EY012200, R21EY017296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Irma T. Hirschl Career Scientist Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY012200 (AC), EY017296 (AC), and DFG grant FOR1075 (ERT). AC is a recipient of the Irma T. Hirschl Career Scientist Award.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Baldessari D, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-48; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Baulmann DC, 2002, MECH DEVELOP, V118, P3, DOI 10.1016/S0925-4773(02)00260-5; Bernier G, 2001, DEVELOPMENT, V128, P3987; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cancla L, 2007, MOL CELL NEUROSCI, V36, P1, DOI 10.1016/j.mcn.2007.05.007; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Donner AL, 2007, GENE EXPR PATTERNS, V7, P606, DOI 10.1016/j.modgep.2007.01.001; Duncan MK, 2000, J CELL SCI, V113, P3173; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Dunker N, 2003, CELL TISSUE RES, V313, P1, DOI 10.1007/s00441-003-0761-x; Enwright JF, 2000, DEV BIOL, V221, P10, DOI 10.1006/dbio.2000.9652; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gotoh N, 2004, P NATL ACAD SCI USA, V101, P17144, DOI 10.1073/pnas.0407577101; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grinchuk O, 2005, J BIOL CHEM, V280, P35228, DOI 10.1074/jbc.M506195200; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jun S, 1996, DEVELOPMENT, V122, P2639; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Kudo C, 2005, J COMP NEUROL, V487, P255, DOI 10.1002/cne.20551; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Ovodenko B, 2007, INVEST OPHTH VIS SCI, V48, P1447, DOI 10.1167/iovs.06-0411; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; PLAZA S, 1995, ONCOGENE, V10, P329; Pontoriero GF, 2008, DEV DYNAM, V237, P602, DOI 10.1002/dvdy.21445; Purcell P, 2005, GENE EXPR PATTERNS, V6, P110, DOI 10.1016/j.modgep.2005.04.010; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Stoykova A, 1996, DEVELOPMENT, V122, P3453; SUTER DM, 2008, STEM CELLS; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Underhill DA, 1997, J BIOL CHEM, V272, P14175, DOI 10.1074/jbc.272.22.14175; Vaes BLT, 2006, BONE, V39, P724, DOI 10.1016/j.bone.2006.04.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; Xu PX, 1997, DEVELOPMENT, V124, P219; Yamada R, 2004, DEV BIOL, V274, P295, DOI 10.1016/j.ydbio.2004.07.016; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Zaccarini R, 2007, INVEST OPHTH VIS SCI, V48, P5408, DOI 10.1167/iovs.07-0413	91	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4159	10.1371/journal.pone.0004159	http://dx.doi.org/10.1371/journal.pone.0004159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132093	Green Published, gold			2022-12-27	WOS:000265473700002
J	Beltrame, L; Rizzetto, L; Paola, R; Rocca-Serra, P; Gambineri, L; Battaglia, C; Cavalieri, D				Beltrame, Luca; Rizzetto, Lisa; Paola, Raffaele; Rocca-Serra, Philippe; Gambineri, Luca; Battaglia, Cristina; Cavalieri, Duccio			Using Pathway Signatures as Means of Identifying Similarities among Microarray Experiments	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; BREAST-CANCER; DISCOVERY; STANDARDS; MODULES; SYSTEM; TUMOR	Widespread use of microarrays has generated large amounts of data, the interrogation of the public microarray repositories, identifying similarities between microarray experiments is now one of the major challenges. Approaches using defined group of genes, such as pathways and cellular networks (pathway analysis), have been proposed to improve the interpretation of microarray experiments. We propose a novel method to compare microarray experiments at the pathway level, this method consists of two steps: first, generate pathway signatures, a set of descriptors recapitulating the biologically meaningful pathways related to some clinical/biological variable of interest, second, use these signatures to interrogate microarray databases. We demonstrate that our approach provides more reliable results than with gene-based approaches. While gene-based approaches tend to suffer from bias generated by the analytical procedures employed, our pathway based method successfully groups together similar samples, independently of the experimental design. The results presented are potentially of great interest to improve the ability to query and compare experiments in public repositories of microarray data. As a matter of fact, this method can be used to retrieve data from public microarray databases and perform comparisons at the pathway level.	[Rizzetto, Lisa; Paola, Raffaele; Cavalieri, Duccio] Univ Florence, Dept Pharmacol, Florence, Italy; [Beltrame, Luca] CNR, Inst Biomed Technol, Milan, Italy; [Rocca-Serra, Philippe] European Bioinformat Inst, Cambridge, England; [Gambineri, Luca] Inspect it, Arezzo, Italy; [Battaglia, Cristina] Univ Milan, Dept Sci & Biomed Technol, Milan, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); European Molecular Biology Laboratory (EMBL); University of Milan	Beltrame, L (corresponding author), Univ Florence, Dept Pharmacol, Florence, Italy.	duccio.cavalieri@unifi.it	Battaglia, Cristina/E-5166-2017; Beltrame, Luca/AAB-1998-2020; CAVALIERI, DUCCIO/T-3097-2017; Rizzetto, Lisa/C-7304-2016	Battaglia, Cristina/0000-0003-3025-9657; Beltrame, Luca/0000-0003-3631-6544; CAVALIERI, DUCCIO/0000-0001-6426-5719; Rizzetto, Lisa/0000-0002-2170-9276; Rocca-Serra, Philippe/0000-0001-9853-5668	UE [LSHB-CT-2004-512074]; NUGO FOOD [CT-2004-506360]; MIUR PRIN [519MIUR060]; MIUR FIRB [RBIP064CRT]	UE; NUGO FOOD; MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants UE LSHB-CT-2004-512074, NUGO FOOD- CT-2004-506360 and MIUR PRIN 519MIUR060. LB was also supported by grant MIUR FIRB RBIP064CRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ball CA, 2002, SCIENCE, V298, P539; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Buentke E, 2003, APMIS, V111, P789, DOI 10.1034/j.1600-0463.2003.11107810.x; Bussemaker HJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S6; Cavalieri D, 2007, BIOINFORMATICS, V23, P2631, DOI 10.1093/bioinformatics/btm333; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRAUR D, 2000, FUNDAMENTALS MOL EVO, P209; Grosu P, 2002, GENOME RES, V12, P1121, DOI 10.1101/gr.226602; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Hoehe MR, 2000, HUM MOL GENET, V9, P2895, DOI 10.1093/hmg/9.19.2895; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Roeder A, 2004, MED MYCOL, V42, P485, DOI 10.1080/13693780400011112; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segota I, 2008, NUCLEIC ACIDS RES, V36, pW332, DOI 10.1093/nar/gkn289; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	54	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4128	10.1371/journal.pone.0004128	http://dx.doi.org/10.1371/journal.pone.0004128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125200	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473100004
J	Zhang, H; Lin, SJ				Zhang, Huan; Lin, Senjie			Retrieval of Missing Spliced Leader in Dinoflagellates	PLOS ONE			English	Article								Spliced leader (SL) trans-splicing has recently been shown to be a common mRNA processing mechanism in dinoflagellates, in which a short (22-nt) sequence, DCCGUAGCCAUUUUGGCUCAAG (D = U, A, or G), is transplanted from the 5'-end of a small non-coding RNA (SL RNA) to the 59 end of mRNA molecules. The widespread existence of the mechanism in dinoflagellates has been demonstrated by detection of this SL (DinoSL) in a wide phylogenetic range of dinoflagellates. Furthermore, the presence of DinoSL in the transcripts of highly diverse groups of nuclear-encoded genes has led us to postulate that SL trans-splicing is universal in dinoflagellate nuclear genome. However, some observations inconsistent to this postulation have been reported, exemplified by a recent article reporting apparent absence of DinoSL in the transcripts of some nuclear-encoded genes in Amphidinium carterae. Absence of SL in these gene transcripts would have important implication on gene regulation in dinoflagellates and utility of DinoSL as a universal dinoflagellate- specific primer to study dinoflagellate transcriptomics. In this study, we re-examined transcripts of these genes and found that all of them actually contained DinoSL. Therefore, results to date are consistent to our initial postulation that DinoSL occurs in all dinoflagellate nuclear-encoded mRNAs.	[Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011		NSF [EF-0626678]	NSF(National Science Foundation (NSF))	This study is supported by the NSF grants EF-0626678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; BLUML M, 1995, CUR I ELECTR MODEL, V1, P1; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; Mayer MG, 2005, MEM I OSWALDO CRUZ, V100, P501, DOI 10.1590/S0074-02762005000500010; Pouchkina-Stantcheva NN, 2005, MOL BIOL EVOL, V22, P1482, DOI 10.1093/molbev/msi139; Thompson JD, 1994, NUCLEIC ACIDS RES, V22, P4678; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	10	39	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4129	10.1371/journal.pone.0004129	http://dx.doi.org/10.1371/journal.pone.0004129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122814	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472900008
J	Dyer, AG; Vuong, QC				Dyer, Adrian G.; Vuong, Quoc C.			Insect Brains Use Image Interpolation Mechanisms to Recognise Rotated Objects	PLOS ONE			English	Article							FACE RECOGNITION; HONEYBEES; REPRESENTATION; VIEWPOINT; MONKEYS; VISION; WASP	Recognising complex three-dimensional objects presents significant challenges to visual systems when these objects are rotated in depth. The image processing requirements for reliable individual recognition under these circumstances are computationally intensive since local features and their spatial relationships may significantly change as an object is rotated in the horizontal plane. Visual experience is known to be important in primate brains learning to recognise rotated objects, but currently it is unknown how animals with comparatively simple brains deal with the problem of reliably recognising objects when seen from different viewpoints. We show that the miniature brain of honeybees initially demonstrate a low tolerance for novel views of complex shapes (e. g. human faces), but can learn to recognise novel views of stimuli by interpolating between or 'averaging' views they have experienced. The finding that visual experience is also important for bees has important implications for understanding how three dimensional biologically relevant objects like flowers are recognised in complex environments, and for how machine vision might be taught to solve related visual problems.	Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Dyer, Adrian G.] Johannes Gutenberg Univ Mainz, Inst Zool III, D-6500 Mainz, Germany; [Vuong, Quoc C.] Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Monash University; Johannes Gutenberg University of Mainz; Newcastle University - UK	Dyer, AG (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	adrian.dyer@med.monash.edu.au		Vuong, Quoc/0000-0002-5983-964X	Alexander von Humboldt Foundation; USAF AOARD [064038, 074080]; Monash-Newcastle University Neuroscience Initiative	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); USAF AOARD; Monash-Newcastle University Neuroscience Initiative	The study was completed with the financial assistance of Alexander von Humboldt Foundation (for experiments in Germany), the USAF AOARD (064038 and 074080; provided salary support and equipment for AGD), and the Monash-Newcastle University Neuroscience Initiative (facilitated meetings and data sharing between AGD and QCV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD J, 2007, ANIM COGN, V9, P257; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; COLLETT TS, 1995, J COMP PHYSIOL A, V177, P287, DOI 10.1007/BF00192418; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; DYER AG, 2007, WORLD C NEUR; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; Liu CH, 2002, COGNITION, V83, P31, DOI 10.1016/S0010-0277(01)00164-0; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; RIND FC, 2004, METHODS INSECT SENSO, P213; SLATER A, 1985, PERCEPTION, V14, P337, DOI 10.1068/p140337; Spetch ML, 2003, PSYCHON B REV, V10, P135, DOI 10.3758/BF03196477; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stach S, 2005, BEHAV BRAIN RES, V161, P8, DOI 10.1016/j.bbr.2005.02.008; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vuong QC, 2004, VISION RES, V44, P1717, DOI 10.1016/j.visres.2004.02.002; Zhang Shaowu, 2004, P41	31	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4086	10.1371/journal.pone.0004086	http://dx.doi.org/10.1371/journal.pone.0004086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437DO	19116650	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600007
J	Varani, AD; Souza, RC; Nakaya, HI; de Lima, WC; de Almeida, LGP; Kitajima, EW; Chen, J; Civerolo, E; Vasconcelos, ATR; Van Sluys, MA				Varani, Alessandro de Mello; Souza, Rangel Celso; Nakaya, Helder I.; de Lima, Wanessa Cristina; Paula de Almeida, Luiz Gonzaga; Kitajima, Elliot Watanabe; Chen, Jianchi; Civerolo, Edwin; Ribeiro Vasconcelos, Ana Tereza; Van Sluys, Marie-Anne			Origins of the Xylella fastidiosa Prophage-Like Regions and Their Impact in Genome Differentiation	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; GENE-EXPRESSION; PROTEIN; PHAGE; EVOLUTION; SEQUENCE; BACTERIOPHAGES; VIRULENCE; DATABASE; BIOLOGY	Xylella fastidiosa is a Gram negative plant pathogen causing many economically important diseases, and analyses of completely sequenced X. fastidiosa genome strains allowed the identification of many prophage-like elements and possibly phage remnants, accounting for up to 15% of the genome composition. To better evaluate the recent evolution of the X. fastidiosa chromosome backbone among distinct pathovars, the number and location of prophage-like regions on two finished genomes (9a5c and Temecula1), and in two candidate molecules (Ann1 and Dixon) were assessed. Based on comparative best bidirectional hit analyses, the majority (51%) of the predicted genes in the X. fastidiosa prophage-like regions are related to structural phage genes belonging to the Siphoviridae family. Electron micrograph reveals the existence of putative viral particles with similar morphology to lambda phages in the bacterial cell in planta. Moreover, analysis of microarray data indicates that 9a5c strain cultivated under stress conditions presents enhanced expression of phage anti-repressor genes, suggesting switches from lysogenic to lytic cycle of phages under stress-induced situations. Furthermore, virulence-associated proteins and toxins are found within these prophage-like elements, thus suggesting an important role in host adaptation. Finally, clustering analyses of phage integrase genes based on multiple alignment patterns reveal they group in five lineages, all possessing a tyrosine recombinase catalytic domain, and phylogenetically close to other integrases found in phages that are genetic mosaics and able to perform generalized and specialized transduction. Integration sites and tRNA association is also evidenced. In summary, we present comparative and experimental evidence supporting the association and contribution of phage activity on the differentiation of Xylella genomes.	[Varani, Alessandro de Mello; de Lima, Wanessa Cristina; Van Sluys, Marie-Anne] Univ Sao Paulo, Inst Biociencias, Dept Bot, Genome & Transposable Elements Lab GaTE Lab, Sao Paulo, Brazil; [Souza, Rangel Celso; Paula de Almeida, Luiz Gonzaga; Ribeiro Vasconcelos, Ana Tereza] Lab Nacl Comput Cient, LABINFO, Rio De Janeiro, Brazil; [Nakaya, Helder I.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA; [Kitajima, Elliot Watanabe] Univ Sao Paulo, ESALQ, Sao Paulo, Brazil; [Chen, Jianchi; Civerolo, Edwin] San Joaquin Valley Agr Sci Ctr, Agr Res Serv, USDA, Parlier, CA USA	Universidade de Sao Paulo; Laboratorio Nacional de Computacao Cientifica (LNCC); Emory University; Universidade de Sao Paulo; United States Department of Agriculture (USDA)	Varani, AD (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Genome & Transposable Elements Lab GaTE Lab, Sao Paulo, Brazil.	mavsluys@gmail.com	Vasconcelos, Ana Tereza R/I-1011-2012; Almeida, Luiz GP/G-5829-2012; Nakaya, Helder I/A-1397-2010; Van Sluys, Marie-Anne/A-8483-2012; Varani, Alessandro M/F-6887-2011; Kitajima, Elliot W/C-2764-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Nakaya, Helder/AAF-1738-2020	Vasconcelos, Ana Tereza R/0000-0002-4632-2086; Almeida, Luiz GP/0000-0002-7124-2715; Nakaya, Helder I/0000-0001-5297-9108; Van Sluys, Marie-Anne/0000-0002-6506-2734; Varani, Alessandro M/0000-0002-8876-3269; Kitajima, Elliot W/0000-0002-9138-2918; Nakaya, Helder/0000-0001-5297-9108	CAPES [PhD fellowship]; FAPESP [fellowship]; USDA-ARS; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AMV was recipient of a CAPES PhD fellowship. WCL was recipient of a TT-5 FAPESP fellowship. The present work was supported by grants from USDA-ARS, FAPESP and CNPq to MAVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Almeida LGP, 2004, BIOINFORMATICS, V20, P2832, DOI 10.1093/bioinformatics/bth273; Almeida Luiz G P, 2004, Genet Mol Res, V3, P26; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Asakura M, 2007, P NATL ACAD SCI USA, V104, P14483, DOI 10.1073/pnas.0706695104; Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252; Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; Berg G, 1996, MICROBIOL RES, V151, P19, DOI 10.1016/S0944-5013(96)80051-6; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Chang KH, 1998, BIOCHEM BIOPH RES CO, V245, P313, DOI 10.1006/bbrc.1998.8432; Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-75; da Silva JF, 2007, J BACTERIOL, V189, P551, DOI 10.1128/JB.00986-06; da Silva VS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-474; Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hagemann M, 2006, ARCH MICROBIOL, V185, P449, DOI 10.1007/s00203-006-0115-7; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Holden BJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-289; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Koide T, 2006, GENET MOL RES, V5, P93; Koide T, 2006, J BACTERIOL, V188, P5821, DOI 10.1128/JB.00182-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Manson JM, 2006, MOL MICROBIOL, V61, P555, DOI 10.1111/j.1365-2958.2006.05262.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Vencio RZN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-86; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	57	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4059	10.1371/journal.pone.0004059	http://dx.doi.org/10.1371/journal.pone.0004059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116666	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600002
J	Moralli, D; Monaco, ZL				Moralli, Daniela; Monaco, Zoia L.			Simultaneous Detection of FISH Signals and Bromo-Deoxyuridine Incorporation in Fixed Tissue Cultured Cells	PLOS ONE			English	Article								FISH (Fluorescence in situ hybridization) is a powerful technique that detects and localises specific DNA sequences on metaphase chromosomes, interphase nuclei or chromatin fibres. When coupled to BrdU (5-Bromo 2-deoxy-uridine) labeling of newly replicated DNA, the replication properties of different DNA sequences can be analysed. However, the technique for the detection of BrdU incorporation is time consuming, and relies on acidic pH buffer treatments, that prevent use of pH sensitive fluorochromes such as FITC (Fluoro-isothiocianate) during FISH. In this work, we describe a simplified protocol that allows the simultaneous detection of FISH signals and BrdU incorporation. Since the technique does not involve paraformaldehyde for cell fixation, or formamide for denaturation of the target DNA and in post-hybridisation washes, it represents a safer alternative to classical FISH techniques.			Moralli, D (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	zoia@well.ox.ac.uk	Monaco, Zoia L/C-5762-2011; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alazami AM, 2004, GENOMICS, V83, P844, DOI 10.1016/j.ygeno.2003.11.011; Barbosa ACC, 2000, CHROMOSOME RES, V8, P645; Boggs BA, 1997, METHODS, V13, P259, DOI 10.1006/meth.1997.0525; Chow JC, 2003, CELL MOL LIFE SCI, V60, P2586, DOI 10.1007/s00018-003-3121-9; D'Antoni S, 2004, GENE, V333, P111, DOI 10.1016/j.gene.2004.02.029; DESARIO A, 1991, CYTOTECHNOLOGY, V7, P55, DOI 10.1007/BF00135639; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634; Mejia JE, 2001, AM J HUM GENET, V69, P315, DOI 10.1086/321977; SHIRAISHI Y, 1990, CANCER GENET CYTOGEN, V50, P175, DOI 10.1016/0165-4608(90)90178-D; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002	11	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4483	10.1371/journal.pone.0004483	http://dx.doi.org/10.1371/journal.pone.0004483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221585	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485700010
J	Yang, CZ; Glover, JR				Yang, Chunzhong; Glover, John R.			The SmpB-tmRNA Tagging System Plays Important Roles in Streptomyces coelicolor Growth and Development	PLOS ONE			English	Article							TRANSFER-MESSENGER RNA; RARE LEUCINE CODON; TRANS-TRANSLATION; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; QUALITY-CONTROL; TTA CODONS; EXPRESSION; GENES; BLDA	The ssrA gene encodes tmRNA that, together with a specialized tmRNA-binding protein, SmpB, forms part of a ribonucleoprotein complex, provides a template for the resumption of translation elongation, subsequent termination and recycling of stalled ribosomes. In addition, the mRNA-like domain of tmRNA encodes a peptide that tags polypeptides derived from stalled ribosomes for degradation. Streptomyces are unique bacteria that undergo a developmental cycle culminating at sporulation that is at least partly controlled at the level of translation elongation by the abundance of a rare tRNA that decodes UUA codons found in a relatively small number of open reading frames prompting us to examine the role of tmRNA in S. coelicolor. Using a temperature sensitive replicon, we found that the ssrA gene could be disrupted only in cells with an extra-copy wild type gene but not in wild type cells or cells with an extra-copy mutant tmRNA (tmRNA(DD)) encoding a degradation-resistant tag. A cosmid-based gene replacement method that does not include a high temperature step enabled us to disrupt both the ssrA and smpB genes separately and at the same time suggesting that the tmRNA tagging system may be required for cell survival under high temperature. Indeed, mutant cells show growth and sporulation defects at high temperature and under optimal culture conditions. Interestingly, even though these defects can be completely restored by wild type genes, the Delta ssrA strain was only partially corrected by tmRNA(DD). In addition, wildtype tmRNA can restore the hygromycin-resistance to Delta ssrA cells while tmRNA(DD) failed to do so suggesting that degradation of aberrant peptides is important for antibiotic resistance. Overall, these results suggest that the tmRNA tagging system plays important roles during Streptomyces growth and sporulation under both normal and stress conditions.	[Yang, Chunzhong; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto	Yang, CZ (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	john.glover@utoronto.ca			Natural Science and Engineering Research Council of Canada [237865-00]; Cangene Corporation [237865-00]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cangene Corporation	The research was supported by a collaborative research and development grant (CRDPJ 237865-00) co-funded by the Natural Science and Engineering Research Council of Canada and Cangene Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, MOL MICROBIOL, V69, P1491, DOI 10.1111/j.1365-2958.2008.06381.x; Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; ANNE J, 1993, FEMS MICROBIOL LETT, V114, P121, DOI 10.1016/0378-1097(93)90507-X; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Binni C, 1997, TRENDS BIOTECHNOL, V15, P315, DOI 10.1016/S0167-7799(97)01062-7; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Braud S, 2006, ARCH MICROBIOL, V184, P343, DOI 10.1007/s00203-005-0051-y; Brawner M, 1991, Curr Opin Biotechnol, V2, P674, DOI 10.1016/0958-1669(91)90033-2; Chandra G, 2008, ANTON LEEUW INT J G, V94, P111, DOI 10.1007/s10482-008-9231-5; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x; de la Cruz J, 2001, RNA, V7, P1708; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Guthrie EP, 1998, MICROBIOL-SGM, V144, P727, DOI 10.1099/00221287-144-3-727; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Harlow E., 1999, USING ANTIBODIES LAB; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hesketh A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-261; Hopwood D A, 1985, Basic Life Sci, V30, P615; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kataoka M, 1999, FEBS LETT, V462, P425, DOI 10.1016/S0014-5793(99)01569-0; Keiler KC, 2003, J BACTERIOL, V185, P1825, DOI 10.1128/JB.185.6.1825-1830.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; LESKIW BK, 1991, P NATL ACAD SCI USA, V88, P2461, DOI 10.1073/pnas.88.6.2461; LESKIW BK, 1991, MOL MICROBIOL, V5, P2861, DOI 10.1111/j.1365-2958.1991.tb01845.x; LESKIW BK, 1993, J BACTERIOL, V175, P1995, DOI 10.1128/JB.175.7.1995-2005.1993; Li WC, 2007, FEMS MICROBIOL LETT, V266, P20, DOI 10.1111/j.1574-6968.2006.00494.x; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Luidalepp Hannes, 2005, RNA Biol, V2, P70, DOI 10.4161/rna.2.2.2020; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Nguyen KT, 2003, J BACTERIOL, V185, P7291, DOI 10.1128/JB.185.24.7291-7296.2003; Ni SXY, 2003, PROTEIN EXPRES PURIF, V30, P62, DOI 10.1016/S1046-5928(03)00070-6; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Sambrook J., 2001, MOL CLONING LAB MANU; Spiers A, 2002, J BIOL CHEM, V277, P39443, DOI 10.1074/jbc.M202790200; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Takano E, 2003, MOL MICROBIOL, V50, P475, DOI 10.1046/j.1365-2958.2003.03728.x; Viala J, 2000, MOL MICROBIOL, V38, P602, DOI 10.1046/j.1365-2958.2000.02155.x; Viala J, 2003, MOL GENET GENOMICS, V268, P563, DOI 10.1007/s00438-002-0783-1; Wiegert T, 2001, J BACTERIOL, V183, P3885, DOI 10.1128/JB.183.13.3885-3889.2001; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Wower J, 2001, J NUTR, V131, p2978S, DOI 10.1093/jn/131.11.2978S; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	60	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4459	10.1371/journal.pone.0004459	http://dx.doi.org/10.1371/journal.pone.0004459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212432	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484200014
J	Grenier, J; Teillet, MA; Grifone, R; Kelly, RG; Duprez, D				Grenier, Julien; Teillet, Marie-Aimee; Grifone, Raphaelle; Kelly, Robert G.; Duprez, Delphine			Relationship between Neural Crest Cells and Cranial Mesoderm during Head Muscle Development	PLOS ONE			English	Article								Background: In vertebrates, the skeletal elements of the jaw, together with the connective tissues and tendons, originate from neural crest cells, while the associated muscles derive mainly from cranial mesoderm. Previous studies have shown that neural crest cells migrate in close association with cranial mesoderm and then circumscribe but do not penetrate the core of muscle precursor cells of the branchial arches at early stages of development, thus defining a sharp boundary between neural crest cells and mesodermal muscle progenitor cells. Tendons constitute one of the neural crest derivatives likely to interact with muscle formation. However, head tendon formation has not been studied, nor have tendon and muscle interactions in the head. Methodology/Principal Findings: Reinvestigation of the relationship between cranial neural crest cells and muscle precursor cells during development of the first branchial arch, using quail/chick chimeras and molecular markers revealed several novel features concerning the interface between neural crest cells and mesoderm. We observed that neural crest cells migrate into the cephalic mesoderm containing myogenic precursor cells, leading to the presence of neural crest cells inside the mesodermal core of the first branchial arch. We have also established that all the forming tendons associated with branchiomeric and eye muscles are of neural crest origin and express the Scleraxis marker in chick and mouse embryos. Moreover, analysis of Scleraxis expression in the absence of branchiomeric muscles in Tbx1(-/-) mutant mice, showed that muscles are not necessary for the initiation of tendon formation but are required for further tendon development. Conclusions/Significance: This results show that neural crest cells and muscle progenitor cells are more extensively mixed than previously believed during arch development. In addition, our results show that interactions between muscles and tendons during craniofacial development are similar to those observed in the limb, despite the distinct embryological origin of these cell types in the head.	[Grenier, Julien; Teillet, Marie-Aimee; Duprez, Delphine] Univ Paris 06, CNRS, UMR Biol Mol & Cellulaire Dev 7622, Paris, France; [Grifone, Raphaelle; Kelly, Robert G.] Univ Mediteranee, Dev Biol Inst Marseilles Luminy, CNRS, UMR 6216, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Grenier, J (corresponding author), Univ Paris 06, CNRS, UMR Biol Mol & Cellulaire Dev 7622, Paris, France.	delphine.duprez@upmc.fr	Duprez, Delphine/K-1856-2017; Kelly, Robert G/F-2523-2013	Duprez, Delphine/0000-0003-0248-7417; Kelly, Robert G/0000-0003-4357-0073; GRENIER, Julien/0000-0002-1897-1329	ANR; CNRS; University Paris 6; AFM; ARC; EU 6th PCRDT through the MYORES Network of excellence; Inserm Avenir Program	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 6; AFM(Association Francaise contre les Myopathies); ARC(Australian Research Council); EU 6th PCRDT through the MYORES Network of excellence; Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the ANR, CNRS, University Paris 6, AFM, ARC and the EU 6th PCRDT through the MYORES Network of excellence (D.D) and the Inserm Avenir Program and AFM (R.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bonnin MA, 2005, MECH DEVELOP, V122, P573, DOI 10.1016/j.mod.2004.11.005; Bothe I, 2007, DEV DYNAM, V236, P2397, DOI 10.1002/dvdy.21241; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brito JM, 2008, DEVELOPMENT, V135, P2311, DOI 10.1242/dev.019125; Brito JM, 2006, P NATL ACAD SCI USA, V103, P11607, DOI 10.1073/pnas.0604751103; Calloni GW, 2007, P NATL ACAD SCI USA, V104, P19879, DOI 10.1073/pnas.0708806104; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; COULY GF, 1992, DEVELOPMENT, V114, P1; COULY GF, 1993, DEVELOPMENT, V117, P409; Creuzet S, 2004, P NATL ACAD SCI USA, V101, P4843, DOI 10.1073/pnas.0400869101; Creuzet S, 2002, DEVELOPMENT, V129, P4301; Dastjerdi A, 2007, DEV DYNAM, V236, P353, DOI 10.1002/dvdy.21010; Dong FY, 2006, DEVELOPMENT, V133, P4891, DOI 10.1242/dev.02693; Duprez D, 1999, MECH DEVELOP, V89, P179, DOI 10.1016/S0925-4773(99)00206-3; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Grifone R, 2007, TRENDS GENET, V23, P365, DOI 10.1016/j.tig.2007.05.002; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Hacker A, 1998, DEVELOPMENT, V125, P3461; Hadchouel J, 2000, DEVELOPMENT, V127, P4455; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Haworth KE, 2007, DEV BIOL, V303, P244, DOI 10.1016/j.ydbio.2006.11.009; Hu D, 1999, DEVELOPMENT, V126, P4873; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kardon G, 1998, DEVELOPMENT, V125, P4019; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kulesa PM, 2008, DEV BIOL, V316, P275, DOI 10.1016/j.ydbio.2008.01.029; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; Lee SH, 2004, DEV BIOL, V276, P207, DOI 10.1016/j.ydbio.2004.08.045; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MCCLEARN D, 1988, AM J ANAT, V183, P277, DOI 10.1002/aja.1001830402; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mootoosamy RC, 2002, DEVELOPMENT, V129, P573; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Noden DM, 1999, DEV DYNAM, V216, P96, DOI 10.1002/(SICI)1097-0177(199910)216:2<96::AID-DVDY2>3.3.CO;2-Y; NODEN DM, 1986, DEV BIOL, V116, P347, DOI 10.1016/0012-1606(86)90138-7; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Olsson L, 2001, DEV BIOL, V237, P354, DOI 10.1006/dbio.2001.0377; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Schilling TF, 1997, DEVELOPMENT, V124, P2945; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Tozer S, 2007, DEVELOPMENT, V134, P2579, DOI 10.1242/DEV.02867; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Volohonsky G, 2007, DEVELOPMENT, V134, P347, DOI 10.1242/dev.02735; von Scheven G, 2006, GENE EXPR PATTERNS, V6, P383, DOI 10.1016/j.modgep.2005.09.008; von Scheven G, 2006, DEVELOPMENT, V133, P2731, DOI 10.1242/dev.02426; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	75	104	105	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4381	10.1371/journal.pone.0004381	http://dx.doi.org/10.1371/journal.pone.0004381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198652	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900003
J	Reber, L; Vermeulen, L; Haegeman, G; Frossard, N				Reber, Laurent; Vermeulen, Linda; Haegeman, Guy; Frossard, Nelly			Ser276 Phosphorylation of NF-kappa B p65 by MSK1 Controls SCF Expression in Inflammation	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; PROTEIN KINASE-1 MSK1; STEM-CELL FACTOR; TRANSCRIPTIONAL ACTIVITY; CATALYTIC SUBUNIT; P50 ACETYLATION; DNA-BINDING; HISTONE H3; ACTIVATION; GLUCOCORTICOIDS	Transcription of the mast cell growth factor SCF (stem cell factor) is upregulated in inflammatory conditions, and this is dependent upon NF-kappa B, as well as the MAP kinases p38 and ERK activation. We show here that the MAPK downstream nuclear kinase MSK1 induces NF-kappa B p65 Ser276 phosphorylation upon IL-1 beta treatment, which was inhibited in cells transfected with a MSK1 kinase-dead (KD) mutant compared to the WT control. In addition, we show by ChIP experiments that MSK1 as well as MAPK inhibition abolishes binding of p65, of its coactivator CBP, and of MSK1 itself to the kB intronic enhancer site of the SCF gene. We show that interaction between NF-kappa B and CBP is prevented in cells transfected by a p65 S276C mutant. Finally, we demonstrate that both transfections of MSK1-KD and MSK1 siRNA - but not the WT MSK1 or control siRNA - downregulate the expression of SCF induced by IL-1 beta. Our study provides therefore a direct link between MSK1-mediated phosphorylation of Ser276 p65 of NF-kappa B, allowing its binding to the SCF intronic enhancer, and pathophysiological SCF expression in inflammation.	[Frossard, Nelly] Univ Strasbourg 1, Fac Pharm, EA3771, Illkirch Graffenstaden, France; [Vermeulen, Linda; Haegeman, Guy] Univ Ghent, Dept Mol Biol, LEGEST, Ghent, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University	Reber, L (corresponding author), Univ Strasbourg 1, Fac Pharm, EA3771, Illkirch Graffenstaden, France.	nelly.frossard@pharma.u-strasbg.fr	Reber, Laurent L/K-4148-2014; Frossard, Nelly/F-8301-2013	Reber, Laurent L/0000-0003-3384-6769; 	French Research Ministry (MENRT)	French Research Ministry (MENRT)(Ministry of Research, France)	LR is supported by a grant from the French Research Ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Da Silva CA, 2003, FASEB J, V17, P2334, DOI 10.1096/fj.03-0136fje; Da Silva CA, 2002, BRIT J PHARMACOL, V135, P1634, DOI 10.1038/sj.bjp.0704617; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guan HC, 2005, J BIOL CHEM, V280, P9957, DOI 10.1074/jbc.M412180200; Hou SH, 2003, J BIOL CHEM, V278, P45994, DOI 10.1074/jbc.M307971200; Kassel O, 1998, MOL PHARMACOL, V54, P1073, DOI 10.1124/mol.54.6.1073; MOSIALOS G, 1991, MOL CELL BIOL, V11, P5867, DOI 10.1128/MCB.11.12.5867; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	28	113	125	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4393	10.1371/journal.pone.0004393	http://dx.doi.org/10.1371/journal.pone.0004393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197368	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483700008
J	Pang, YP; Singh, SK; Gao, Y; Lassiter, TL; Mishra, RK; Zhu, KY; Brimijoin, S				Pang, Yuan-Ping; Singh, Sanjay K.; Gao, Yang; Lassiter, T. Leon; Mishra, Rajesh K.; Zhu, Kun Yan; Brimijoin, Stephen			Selective and Irreversible Inhibitors of Aphid Acetylcholinesterases: Steps Toward Human-Safe Insecticides	PLOS ONE			English	Article								Aphids, among the most destructive insects to world agriculture, are mainly controlled by organophosphate insecticides that disable the catalytic serine residue of acetylcholinesterase (AChE). Because these agents also affect vertebrate AChEs, they are toxic to non-target species including humans and birds. We previously reported that a cysteine residue (Cys), found at the AChE active site in aphids and other insects but not mammals, might serve as a target for insect-selective pesticides. However, aphids have two different AChEs (termed AP and AO), and only AP-AChE carries the unique Cys. The absence of the active-site Cys in AO-AChE might raise concerns about the utility of targeting that residue. Herein we report the development of a methanethiosulfonate-containing small molecule that, at 6.0 mu M, irreversibly inhibits 99% of all AChE activity extracted from the greenbug aphid (Schizaphis graminum) without any measurable inhibition of the human AChE. Reactivation studies using beta-mercaptoethanol confirm that the irreversible inhibition resulted from the conjugation of the inhibitor to the unique Cys. These results suggest that AO-AChE does not contribute significantly to the overall AChE activity in aphids, thus offering new insight into the relative functional importance of the two insect AChEs. More importantly, by demonstrating that the Cystargeting inhibitor can abolish AChE activity in aphids, we can conclude that the unique Cys may be a viable target for species-selective agents to control aphids without causing human toxicity and resistance problems.	[Pang, Yuan-Ping; Singh, Sanjay K.; Gao, Yang; Lassiter, T. Leon; Mishra, Rajesh K.; Brimijoin, Stephen] Mayo Clin, Rochester, MN 55905 USA; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Mayo Clinic; Kansas State University	Pang, YP (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	pang@mayo.edu; brimijoi@mayo.edu		Zhu, Kun Yan/0000-0001-9372-8030	U.S. Army [W81XWH-04-2-0001, W81XWH-08-1-0154]; Minnesota Partnership for Medical Genomics and Biotechnology; University of Minnesota/Mayo/IBM Collaboration [Seed Grant]; Mayo Foundation for Medical Education and Research	U.S. Army(United States Department of DefenseUnited States Army); Minnesota Partnership for Medical Genomics and Biotechnology; University of Minnesota/Mayo/IBM Collaboration(University of Minnesota System); Mayo Foundation for Medical Education and Research	This work was supported by the U.S. Army Medical Research Acquisition Activity (W81XWH-04-2-0001 and W81XWH-08-1-0154), the Minnesota Partnership for Medical Genomics and Biotechnology, the University of Minnesota/Mayo/IBM Collaboration Seed Grant Program, and the Mayo Foundation for Medical Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boyd AE, 2000, J BIOL CHEM, V275, P22401, DOI 10.1074/jbc.M000606200; BRESTKIN AP, 1985, INSECT BIOCHEM, V15, P309, DOI 10.1016/0020-1790(85)90019-8; BRIMIJOIN S, 1979, MOL PHARMACOL, V15, P641; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davey TW, 1998, AUST J CHEM, V51, P581, DOI 10.1071/C98001; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Fialka J. J., 2006, WALL STREET J, pA4; Frisch M J, 1999, GAUSSIAN 98 REVISION; Gao JR, 2002, PESTIC BIOCHEM PHYS, V73, P164, DOI 10.1016/S0048-3575(02)00105-0; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; Grayson EJ, 2005, J ORG CHEM, V70, P9740, DOI 10.1021/jo051374j; Hammond PI, 2003, J PHARMACOL EXP THER, V307, P190, DOI 10.1124/jpet.103.053405; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; KRONMAN C, 1992, GENE, V121, P295, DOI 10.1016/0378-1119(92)90134-B; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; LAZAR MD, 1999, ESA SECT S F3 GREENB, P39; Lewis G, 2007, PEST MANAG SCI, V63, P1047, DOI 10.1002/ps.1487; Malcolm CA, 1998, INSECT MOL BIOL, V7, P107, DOI 10.1046/j.1365-2583.1998.72055.x; Mamiya A, 1997, APPL ENTOMOL ZOOL, V32, P37, DOI 10.1303/aez.32.37; MANULIS S, 1981, PESTIC BIOCHEM PHYS, V15, P267, DOI 10.1016/0048-3575(81)90010-9; Mary A, 1998, BIOORGAN MED CHEM, V6, P1835, DOI 10.1016/S0968-0896(98)00133-3; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mohr W, 2003, SYNTHESIS-STUTTGART, P1279; MOORE TL, 1966, J ORG CHEM, V31, P3587, DOI 10.1021/jo01349a027; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; NOVOZHILOV KV, 1989, INSECT BIOCHEM, V19, P15, DOI 10.1016/0020-1790(89)90004-8; Pang YP, 2001, FEBS LETT, V502, P93, DOI 10.1016/S0014-5793(01)02672-2; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pezzementi Leo, 2006, Invertebrate Neuroscience, V6, P47, DOI 10.1007/s10158-006-0017-z; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; RANDALL WR, 1994, BBA-GENE STRUCT EXPR, V1218, P453, DOI 10.1016/0167-4781(94)90204-6; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; ROSENBERRY TL, 1984, J BIOL CHEM, V259, P5643; SMISSAERT HR, 1976, PESTIC BIOCHEM PHYS, V6, P215, DOI 10.1016/0048-3575(76)90063-8; SMITH DJ, 1974, J BIOL CHEM, V249, P3317; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tomita T, 2000, INSECT BIOCHEM MOLEC, V30, P325, DOI 10.1016/S0965-1748(00)00006-0; Weber ME, 2005, J AM CHEM SOC, V127, P636, DOI 10.1021/ja044936+; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; ZAHAVI M, 1972, BIOCHIM BIOPHYS ACTA, V276, P577, DOI 10.1016/0005-2744(72)91024-8; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	56	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4349	10.1371/journal.pone.0004349	http://dx.doi.org/10.1371/journal.pone.0004349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194505	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483500005
J	Jose, MV; Govezensky, T; Garcia, JA; Bobadilla, JR				Jose, Marco V.; Govezensky, Tzipe; Garcia, Jose A.; Bobadilla, Juan R.			On the Evolution of the Standard Genetic Code: Vestiges of Critical Scale Invariance from the RNA World in Current Prokaryote Genomes	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DNA-SEQUENCES; CIRCULAR CODES; SYNTHETASES; PROTEIN; ORIGIN; PERIODICITIES; PRINCIPLE	Herein two genetic codes from which the primeval RNA code could have originated the standard genetic code (SGC) are derived. One of them, called extended RNA code type I, consists of all codons of the type RNY (purine-any base- pyrimidine) plus codons obtained by considering the RNA code but in the second (NYR type) and third (YRN type) reading frames. The extended RNA code type II, comprises all codons of the type RNY plus codons that arise from transversions of the RNA code in the first (YNY type) and third (RNR) nucleotide bases. In order to test if putative nucleotide sequences in the RNA World and in both extended RNA codes, share the same scaling and statistical properties to those encountered in current prokaryotes, we used the genomes of four Eubacteria and three Archaeas. For each prokaryote, we obtained their respective genomes obeying the RNA code or the extended RNA codes types I and II. In each case, we estimated the scaling properties of triplet sequences via a renormalization group approach, and we calculated the frequency distributions of distances for each codon. Remarkably, the scaling properties of the distance series of some codons from the RNA code and most codons from both extended RNA codes turned out to be identical or very close to the scaling properties of codons of the SGC. To test for the robustness of these results, we show, via computer simulation experiments, that random mutations of current genomes, at the rates of 10(-10) per site per year during three billions of years, were not enough for destroying the observed patterns. Therefore, we conclude that most current prokaryotes may still contain relics of the primeval RNA World and that both extended RNA codes may well represent two plausible evolutionary paths between the RNA code and the current SGC.	[Jose, Marco V.; Govezensky, Tzipe; Garcia, Jose A.; Bobadilla, Juan R.] Univ Nacl Autonoma Mexico, Theoret Biol Grp, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Garcia, Jose A.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	Universidad Nacional Autonoma de Mexico; University of Otago	Jose, MV (corresponding author), Univ Nacl Autonoma Mexico, Theoret Biol Grp, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	marcojose@biomedicas.unam.mx	José, Marco V./A-1075-2008; José, Marco/AFU-1547-2022; Athens, Josie/Q-7172-2018	José, Marco/0000-0001-8497-6681; Athens, Josie/0000-0002-9897-0683	PAPIIT [IN205307]; Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico(Universidad Nacional Autonoma de Mexico)	M.V.J. was financially supported by PAPIIT IN205307, and by the Multiproject: Tecnologias para la Universidad de la Informacion y la Computacion, UNAM, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank helpful technical computer assistance by Jose M. Pascual.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; ARQUES DG, 1990, J THEOR BIOL, V143, P307, DOI 10.1016/S0022-5193(05)80032-3; Arques DG, 1996, J THEOR BIOL, V182, P45, DOI 10.1006/jtbi.1996.0142; Balter M, 2000, SCIENCE, V289, P1866, DOI 10.1126/science.289.5486.1866; Bassingthwaighte J. B., 1994, FRACTAL PHYSL; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; CRICK FHC, 1957, P NATL ACAD SCI USA, V43, P416, DOI 10.1073/pnas.43.5.416; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Delarue M, 2007, RNA, V13, P161, DOI 10.1261/rna.257607; EIGEN M, 1985, P NATL ACAD SCI USA, V82, P2437, DOI 10.1073/pnas.82.8.2437; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P282, DOI 10.1007/BF01047470; EIGEN M, 1981, NATURWISSENSCHAFTEN, V68, P217, DOI 10.1007/BF01047323; EIGEN M, 1989, SCIENCE, V244, P673, DOI 10.1126/science.2497522; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Frey G, 2003, J THEOR BIOL, V223, P413, DOI 10.1016/S0022-5193(03)00119-X; Garcia JA, 2005, REV MEX FIS, V51, P122; Garcia JA, 2004, PHYSICA A, V342, P288, DOI 10.1016/j.physa.2004.04.090; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Herzel H, 1997, PHYS REV E, V55, P800, DOI 10.1103/PhysRevE.55.800; HORNOS JEM, 1993, PHYS REV LETT, V71, P4401, DOI 10.1103/PhysRevLett.71.4401; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; JOLIVET R, 2001, 1 EUR WORKSH EX, P173; Jose MV, 2007, B MATH BIOL, V69, P215, DOI 10.1007/s11538-006-9119-3; Jose MV, 2005, PHYSICA A, V351, P477, DOI 10.1016/j.physa.2004.11.060; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Jukes TH, 1996, J MOL EVOL, V42, P377; KENNETH DJ, 1995, ORIGINS LIFE EVOL B, V25, P515; Knight RD, 2000, CELL, V101, P569, DOI 10.1016/S0092-8674(00)80866-1; KONECNY J, 1995, J THEOR BIOL, V173, P263, DOI 10.1006/jtbi.1995.0061; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lopez-Villasenor I, 2004, BIOCHEM BIOPH RES CO, V325, P467, DOI 10.1016/j.bbrc.2004.10.053; Mandelbrot B.B, 1977, FRACTALS FORM CHANCE; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MAYNARDSMITH J, 1998, EVOLUTION GENETICS; Michel CJ, 2008, THEOR COMPUT SCI, V401, P17, DOI 10.1016/j.tcs.2008.02.049; Michel CJ, 2008, COMPUT MATH APPL, V55, P984, DOI 10.1016/j.camwa.2006.12.090; NAGEL GM, 1995, J MOL EVOL, V40, P487; NICHOLAS HB, 1995, J MOL EVOL, V40, P482; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Sanchez R, 2005, B MATH BIOL, V67, P1, DOI 10.1016/j.bulm.2004.05.005; SHEPHERD JCW, 1981, J MOL EVOL, V17, P94, DOI 10.1007/BF01732679; SHEPHERD JCW, 1981, P NATL ACAD SCI-BIOL, V78, P1596, DOI 10.1073/pnas.78.3.1596; SHEPHERD JCW, 1982, COLD SPRING HARB SYM, V47, P1099; SHEPHERD JCW, 1981, P NATL ACAD SCI USA, V47, P1588; Somette D, 2000, SPRINGER SERIES SYNE, P178; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Trevors JT, 1997, ANTON LEEUW INT J G, V71, P265, DOI 10.1023/A:1000123216769; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Trifonov EN, 1998, PHYSICA A, V249, P511, DOI 10.1016/S0378-4371(97)00510-4; West BJ, 1999, CHAOS SOLITON FRACT, V10, P1519, DOI 10.1016/S0960-0779(98)00149-0; WEST BJ, 1986, J APPL PHYSIOL, V60, P1089, DOI 10.1152/jappl.1986.60.3.1089; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE C, 1967, GENETIC CODE, pCH7; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WONG JTF, 1986, EUR J BIOCHEM, V159, P175, DOI 10.1111/j.1432-1033.1986.tb09849.x	68	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4340	10.1371/journal.pone.0004340	http://dx.doi.org/10.1371/journal.pone.0004340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183813	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483200012
J	Park, EC; Glodowski, DR; Rongo, C				Park, Eun Chan; Glodowski, Doreen R.; Rongo, Christopher			The Ubiquitin Ligase RPM-1 and the p38 MAPK PMK-3 Regulate AMPA Receptor Trafficking	PLOS ONE			English	Article								Ubiquitination occurs at synapses, yet its role remains unclear. Previous studies demonstrated that the RPM-1 ubiquitin ligase organizes presynaptic boutons at neuromuscular junctions in C. elegans motorneurons. Here we find that RPM-1 has a novel postsynaptic role in interneurons, where it regulates the trafficking of the AMPA-type glutamate receptor GLR-1 from synapses into endosomes. Mutations in rpm-1 cause the aberrant accumulation of GLR-1 in neurites. Moreover, rpm-1 mutations enhance the endosomal accumulation of GLR-1 observed in mutants for lin-10, a Mint2 ortholog that promotes GLR-1 recycling from Syntaxin-13 containing endosomes. As in motorneurons, RPM-1 negatively regulates the pmk-3/p38 MAPK pathway in interneurons by repressing the protein levels of the MAPKKK DLK-1. This regulation of PMK-3 signaling is critical for RPM-1 function with respect to GLR-1 trafficking, as pmk-3 mutations suppress both lin-10 and rpm-1 mutations. Positive or negative changes in endocytosis mimic the effects of rpm-1 or pmk-3 mutations, respectively, on GLR-1 trafficking. Specifically, RAB-5(GDP), an inactive mutant of RAB-5 that reduces endocytosis, mimics the effect of pmk-3 mutations when introduced into wild-type animals, and occludes the effect of pmk-3 mutations when introduced into pmk-3 mutants. By contrast, RAB-5(GTP), which increases endocytosis, suppresses the effect of pmk-3 mutations, mimics the effect of rpm-1 mutations, and occludes the effect of rpm-1 mutations. Our findings indicate a novel specialized role for RPM-1 and PMK-3/p38 MAPK in regulating the endosomal trafficking of AMPARs at central synapses.	[Park, Eun Chan; Glodowski, Doreen R.; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Park, EC (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08855 USA.	rongo@waksman.rutgers.edu		Park, Eunchan/0000-0002-6147-4088	National Institutes of Health [R01 NS42023]; New Jersey Commission on Spinal Cord Research [07-2924-SCR-E-0]; American Heart Association [0755979T]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord Research; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The manuscript was funded by a grant from the National Institutes of Health (R01 NS42023), the New Jersey Commission on Spinal Cord Research (07-2924-SCR-E-0), and the American Heart Association (0755979T); these agencies had no other role in the research or the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Berman Kevin, 2001, Molecular Cell Biology Research Communications, V4, P337, DOI 10.1006/mcbr.2001.0300; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jorgensen Erik M., 1995, Seminars in Developmental Biology, V6, P207, DOI 10.1016/S1044-5781(06)80030-7; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Le Guyader S, 2005, DEV BIOL, V277, P378, DOI 10.1016/j.ydbio.2004.09.029; LI GP, 1994, J BIOL CHEM, V269, P14631; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	60	42	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4284	10.1371/journal.pone.0004284	http://dx.doi.org/10.1371/journal.pone.0004284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172179	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482900005
J	Lam, MHY; Urban-Grimal, D; Bugnicourt, A; Greenblatt, JF; Haguenauer-Tsapis, R; Emili, A				Lam, Mandy H. Y.; Urban-Grimal, Daniele; Bugnicourt, Amandine; Greenblatt, Jack F.; Haguenauer-Tsapis, Rosine; Emili, Andrew			Interaction of the Deubiquitinating Enzyme Ubp2 and the E3 Ligase Rsp5 Is Required for Transporter/Receptor Sorting in the Multivesicular Body Pathway	PLOS ONE			English	Article								Protein ubiquitination is essential for many events linked to intracellular protein trafficking. We sought to elucidate the possible involvement of the S. cerevisiae deubiquitinating enzyme Ubp2 in transporter and receptor trafficking after we (this study) and others established that affinity purified Ubp2 interacts stably with the E3 ubiquitin ligase Rsp5 and the (ubiquitin associated) UBA domain containing protein Rup1. UBP2 interacts genetically with RSP5, while Rup1 facilitates the tethering of Ubp2 to Rsp5 via a PPPSY motif. Using the uracil permease Fur4 as a model reporter system, we establish a role for Ubp2 in membrane protein turnover. Similar to hypomorphic rsp5 alleles, cells deleted for UBP2 exhibited a temporal stabilization of Fur4 at the plasma membrane, indicative of perturbed protein trafficking. This defect was ubiquitin dependent, as a Fur4 N-terminal ubiquitin fusion construct bypassed the block and restored sorting in the mutant. Moreover, the defect was absent in conditions where recycling was absent, implicating Ubp2 in sorting at the multivesicular body. Taken together, our data suggest a previously overlooked role for Ubp2 as a positive regulator of Rsp5-mediated membrane protein trafficking subsequent to endocytosis.	[Lam, Mandy H. Y.; Greenblatt, Jack F.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada; [Urban-Grimal, Daniele; Bugnicourt, Amandine; Haguenauer-Tsapis, Rosine] Univ Paris 06, Inst Jacques Monod, CNRS, F-75252 Paris, France; [Urban-Grimal, Daniele; Bugnicourt, Amandine; Haguenauer-Tsapis, Rosine] Univ Paris 07, F-75221 Paris, France	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lam, MHY (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada.	andrew.emili@utoronto.ca	Haguenauer-Tsapis, Rosine/C-5446-2012		Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships; University of Toronto [Open Fellowships]; Centre National de la Recherche Scientifique; Universities Paris 6; Universities Paris 7; Association pour la Recherche sur le Cancer (ARC) [3298]; European Program 6 (FP6) [018683]	Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Toronto(University of Toronto); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universities Paris 6; Universities Paris 7; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); European Program 6 (FP6)(European Commission)	This work was supported by funds from the Protein Engineering Network Centre of Excellence of Canada (PENCE) to A.E.. Ontario Graduate Scholarships and University of Toronto Open Fellowships to M.H.Y.L. Work in R.H.T.'s lab was supported by the Centre National de la Recherche Scientifique and the Universities Paris 6 and Paris 7, by a grant from the Association pour la Recherche sur le Cancer (ARC) (grant no. 3298), by a special grant from the CNRS (ACI BCMS), and by a grant from the European Program 6 (FP6) (RUBICON, contrat no. 018683). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Baxter BK, 2005, J BIOL CHEM, V280, P39067, DOI 10.1074/jbc.M508064200; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Brachmann CB, 1998, YEAST, V14, P115; BUCKINGTHROM E, 1973, EXP CELL RES, V76, P99, DOI 10.1016/0014-4827(73)90424-2; Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; JUND R, 1970, J BACTERIOL, V102, P607, DOI 10.1128/JB.102.3.607-615.1970; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 2002, J CELL SCI, V115, P217; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Seron K, 1999, J BACTERIOL, V181, P1793; SONI R, 1993, CURR GENET, V24, P455, DOI 10.1007/BF00351857; Springael JY, 1999, J CELL SCI, V112, P1375; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu XY, 2001, CURR GENET, V40, P234, DOI 10.1007/s00294-001-0257-8	71	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4259	10.1371/journal.pone.0004259	http://dx.doi.org/10.1371/journal.pone.0004259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165343	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482400007
J	Diaz, SL; Padler-Karavani, V; Ghaderi, D; Hurtado-Ziola, N; Yu, H; Chen, X; Brinkman-Van der Linden, ECM; Varki, A; Varki, NM				Diaz, Sandra L.; Padler-Karavani, Vered; Ghaderi, Darius; Hurtado-Ziola, Nancy; Yu, Hai; Chen, Xi; Brinkman-Van der Linden, Els C. M.; Varki, Ajit; Varki, Nissi M.			Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid In Human Tissues and Biotherapeutic Products	PLOS ONE			English	Article								Background: Humans are genetically defective in synthesizing the common mammalian sialic acid N-glycolylneuraminic acid (Neu5Gc), but can metabolically incorporate it from dietary sources (particularly red meat and milk) into glycoproteins and glycolipids of human tumors, fetuses and some normal tissues. Metabolic incorporation of Neu5Gc from animal-derived cells and medium components also results in variable contamination of molecules and cells intended for human therapies. These Neu5Gc-incorporation phenomena are practically significant, because normal humans can have high levels of circulating anti-Neu5Gc antibodies. Thus, there is need for the sensitive and specific detection of Neu5Gc in human tissues and biotherapeutic products. Unlike monoclonal antibodies that recognize Neu5Gc only in the context of underlying structures, chicken immunoglobulin Y (IgY) polyclonal antibodies can recognize Neu5Gc in broader contexts. However, prior preparations of such antibodies (including our own) suffered from some non-specificity, as well as some cross-reactivity with the human sialic acid N-acetylneuraminic acid (Neu5Ac). Methodology/Principal Findings: We have developed a novel affinity method utilizing sequential columns of immobilized human and chimpanzee serum sialoglycoproteins, followed by specific elution from the latter column by free Neu5Gc. The resulting mono-specific antibody shows no staining in tissues or cells from mice with a human-like defect in Neu5Gc production. It allows sensitive and specific detection of Neu5Gc in all underlying glycan structural contexts studied, and is applicable to immunohistochemical, enzyme-linked immunosorbent assay (ELISA), Western blot and flow cytometry analyses. Non-immune chicken IgY is used as a reliable negative control. We show that these approaches allow sensitive detection of Neu5Gc in human tissue samples and in some biotherapeutic products, and finally show an example of how Neu5Gc might be eliminated from such products, by using a human cell line grown under defined conditions. Conclusions: We report a reliable antibody-based method for highly sensitive and specific detection of the non-human sialic acid Neu5Gc in human tissues and biotherapeutic products that has not been previously described.	[Diaz, Sandra L.; Padler-Karavani, Vered; Ghaderi, Darius; Varki, Ajit; Varki, Nissi M.] Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; [Hurtado-Ziola, Nancy] Gc Free Inc, La Jolla, CA USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA USA; [Brinkman-Van der Linden, Els C. M.] Crucell Holland BV, Leiden, Netherlands	University of California System; University of California San Diego; University of California System; University of California Davis; Johnson & Johnson	Diaz, SL (corresponding author), Univ Calif San Diego, Sch Med, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Chen, Xi/H-1811-2018; PADLER-KARAVANI, VERED/AAC-6055-2022	Chen, Xi/0000-0002-3160-614X; PADLER-KARAVANI, VERED/0000-0002-4761-3571	National institute of Health [R01GM32373, R41GM080959]; ISEF Foundation [postdoctoral fellowship]; NATIONAL CANCER INSTITUTE [U01CA128442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373, R41GM080959] Funding Source: NIH RePORTER	National institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISEF Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National institute of Health grants R01GM32373 (to A.V.), R41GM080959 (to N.H.), and an ISEF Foundation postdoctoral fellowship to V. P-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909; FUKUI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1149, DOI 10.1016/S0006-291X(89)80123-8; GATHURU JK, 1989, JPN J VET RES, V37, P71; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Hashii N, 2007, J CHROMATOGR A, V1160, P263, DOI 10.1016/j.chroma.2007.05.062; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; HERMENTIN P, 1992, ANAL BIOCHEM, V203, P281, DOI 10.1016/0003-2697(92)90314-W; HIGASHI H, 1985, CANCER RES, V45, P3796; HIGASHI H, 1984, GANN, V75, P1025; HIGASHI H, 1988, JPN J CANCER RES, V79, P952, DOI 10.1111/j.1349-7006.1988.tb00060.x; HIGASHI H, 1977, BIOCHEM BIOPH RES CO, V79, P388, DOI 10.1016/0006-291X(77)90169-3; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P36, DOI 10.1021/bi062001v; Jones D, 2003, BIOTECHNOL PROGR, V19, P163, DOI 10.1021/bp025574h; Kawachi Shigeo, 1992, Journal of Dermatology (Tokyo), V19, P827; Kim YG, 2008, PROTEOMICS, V8, P2596, DOI 10.1002/pmic.200700972; Lee M, 2006, J ORG CHEM, V71, P5082, DOI 10.1021/jo052659z; Lewis J.A., 2006, DEV BIOL BASEL, V123, P183; Lewis JA, 2006, DEV BIOLOGICALS, V123, P165; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MIYAKE M, 1988, CANCER RES, V48, P6154; Montesino R, 2008, ARCH BIOCHEM BIOPHYS, V470, P163, DOI 10.1016/j.abb.2007.11.019; MUKURIA CJ, 1994, JPN J MED SCI BIOL, V47, P253, DOI 10.7883/yoken1952.47.253; Nasonkin IO, 2006, EXP NEUROL, V201, P525, DOI 10.1016/j.expneurol.2006.05.002; Nichols W. W., 2002, ADENOVIRAL VECTORS G, P129; NOGUCHI A, 1995, J BIOCHEM-TOKYO, V117, P59, DOI 10.1093/oxfordjournals.jbchem.a124721; OHASHI Y, 1983, AM J OPHTHALMOL, V96, P321, DOI 10.1016/S0002-9394(14)77822-5; PADLAN EA, 1988, P NATL ACAD SCI USA, V85, P6885, DOI 10.1073/pnas.85.18.6885; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rohrer JS, 1998, GLYCOBIOLOGY, V8, P35, DOI 10.1093/glycob/8.1.35; SAIDA T, 1990, ARCH DERMATOL RES, V282, P179, DOI 10.1007/BF00372619; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; TAI T, 1988, ARCH BIOCHEM BIOPHYS, V260, P51, DOI 10.1016/0003-9861(88)90423-7; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; VARKI A, 2008, GLYCOCONJ J IN PRESS; YALLOP CA, MODERN BIOPHARMACEUT, V3, P779; Yu H, 2007, ORG BIOMOL CHEM, V5, P2458, DOI 10.1039/b706507h; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x	45	108	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4241	10.1371/journal.pone.0004241	http://dx.doi.org/10.1371/journal.pone.0004241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156207	Green Published, gold			2022-12-27	WOS:000265482100013
J	Zhu, LY; Sun, GX; Zhang, HJ; Zhang, Y; Chen, X; Jiang, XH; Jiang, XY; Krauss, S; Zhang, JF; Xiang, Y; Zhang, CY				Zhu, Lingyun; Sun, Guoxun; Zhang, Hongjie; Zhang, Yan; Chen, Xi; Jiang, Xiaohong; Jiang, Xueyuan; Krauss, Stefan; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu			PGC-1 alpha Is a Key Regulator of Glucose-Induced Proliferation and Migration in Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background: Atherosclerosis is a complex pathological condition caused by a number of mechanisms including the accelerated proliferation of vascular smooth muscle cells (VSMCs). Diabetes is likely to be an important risk factor for atherosclerosis, as hyperglycemia induces vascular smooth muscle cell (VSMC) proliferation and migration and may thus contribute to the formation of atherosclerotic lesions. This study was performed to investigate whether PGC-1 alpha, a PPAR gamma coactivator and metabolic master regulator, plays a role in regulating VSMC proliferation and migration induced by high glucose. Methodology/Principal Findings: PGC-1 alpha mRNA levels are decreased in blood vessel media of STZ-treated diabetic rats. In cultured rat VSMCs, high glucose dose-dependently inhibits PGC-1 alpha mRNA expression. Overexpression of PGC-1 alpha either by infection with adenovirus, or by stimulation with palmitic acid, significantly reduces high glucose-induced VSMC proliferation and migration. In contrast, suppression of PGC-1 alpha by siRNA mimics the effects of glucose on VSMCs. Finally, mechanistic studies suggest that PGC-1 alpha-mediated inhibition of VSMC proliferation and migration is regulated through preventing ERK1/2 phosphorylation. Conclusions/Significance: These results indicate that PGC-1 alpha is a key regulator of high glucose-induced proliferation and migration in VSMCs, and suggest that elevation of PGC-1 alpha in VSMC could be a useful strategy in preventing the development of diabetic atherosclerosis.	[Zhu, Lingyun; Sun, Guoxun; Zhang, Hongjie; Zhang, Yan; Chen, Xi; Jiang, Xiaohong; Jiang, Xueyuan; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China; [Zhang, Hongjie] Nanjing Med Univ, First Affiliated Hosp, Dept Gastroenterol, Nanjing, Peoples R China; [Krauss, Stefan] Merck Res Lab, Dept Canc Biol & Therapeut, Boston, MA USA	Nanjing University; Nanjing Medical University; Merck & Company	Zhu, LY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China.	jfzhang@nju.edu.cn; xiangy@nju.edu.cn; cyzhang@nju.edu.cn		/0000-0002-0420-4508	National Natural Science Foundation of China [30570731, 90813035, 30890044, 30471991]; 973 Program of China [2006CB503909, 2004CB518603]; "111" Project; Natural Science Foundation of Jiangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); "111" Project(Ministry of Education, China - 111 Project); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (30570731, 90813035, 30890044), the 973 Program of China (no. 2006CB503909, 2004CB518603), the "111" Project, and the Natural Science Foundation of Jiangsu Province (no. BK2004082, BK2006714) to C.Y.Z., and National Natural Science Foundation of China (30471991) to Y.X.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; DUBEY RK, 1993, AM J PHYSIOL, V265, pR726, DOI 10.1152/ajpregu.1993.265.4.R726; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FUJIWARA R, 1994, CARDIOVASC DRUG THER, V8, P861, DOI 10.1007/BF00877405; Goetze S, 1999, J CARDIOVASC PHARM, V33, P798, DOI 10.1097/00005344-199905000-00018; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hsueh W. A., 1998, AM J MED, V105, P4, DOI DOI 10.1016/S0002-9343(98)00205-8; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; KROLEWSKI AS, 1991, AM J MED S2A, V90, P56; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; MAJACK RA, 1984, J CELL PHYSIOL, V118, P253, DOI 10.1002/jcp.1041180306; Natarajan R, 1999, HYPERTENSION, V33, P378, DOI 10.1161/01.HYP.33.1.378; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Suzuki M, 2002, LIFE SCI, V72, P59, DOI 10.1016/S0024-3205(02)02182-3; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137; Zhao W, 2000, DIABETES OBES METAB, V2, P165, DOI 10.1046/j.1463-1326.2000.00079.x	32	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4182	10.1371/journal.pone.0004182	http://dx.doi.org/10.1371/journal.pone.0004182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142226	Green Submitted, gold, Green Published			2022-12-27	WOS:000265479700005
J	Leong, WF; Zhou, TL; Lim, GL; Li, BJ				Leong, Wai Fook; Zhou, Tielin; Lim, Gek Liang; Li, Baojie			Protein Palmitoylation Regulates Osteoblast Differentiation through BMP-Induced Osterix Expression	PLOS ONE			English	Article								Osteoporosis is one of the most common diseases and can be treated by either anti-resorption drugs, anabolic drugs, or both. To search for anabolic drug targets for osteoporosis therapy, it is crucial to understand the biology of bone forming cells, osteoblasts, in terms of their proliferation, differentiation, and function. Here we found that protein palmitoylation participates in signaling pathways that control osterix expression and osteoblast differentiation. Mouse calvarial osteoblasts express most of the 24 palmitoyl transferases, with some being up-regulated during differentiation. Inhibition of protein palmitoylation, with a substrate-analog inhibitor, diminished osteoblast differentiation and mineralization, but not proliferation or survival. The decrease in differentiation capacity is associated with a reduction in osterix, but not Runx2 or Atf4. Inhibition of palmitoyl transferases had little effect in p53(-/-) osteoblasts that show accelerated differentiation due to overexpression of osterix, suggesting that osterix, at least partially, mediated the effect of inhibition of palmitoyl transferases on osteoblast differentiation. BMPs are the major driving force of osteoblast differentiation in the differentiation assays. We found that inhibition of palmitoyl transferases also compromised BMP2-induced osteoblast differentiation through down-regulating osterix induction. However, palmitoyl transferases inhibitor did not inhibit Smad1/5/8 activation. Instead, it compromised the activation of p38 MAPK, which are known positive regulators of osterix expression and differentiation. These results indicate that protein palmitoylation plays an important role in BMP-induced MAPK activation, osterix expression, and osteoblast differentiation.	[Leong, Wai Fook; Zhou, Tielin; Lim, Gek Liang; Li, Baojie] ASTAR, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Leong, WF (corresponding author), ASTAR, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore, Singapore.	libj@imcb.a-star.edu.sg	Leong, Wai Fook Peter/GXG-9911-2022	Leong, Wai Fook Peter/0000-0002-2438-2715	Agency of Science, Technology, and Research of the Republic of Singapore	Agency of Science, Technology, and Research of the Republic of Singapore(Agency for Science Technology & Research (A*STAR))	The work was supported by the Agency of Science, Technology, and Research of the Republic of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hasselbaink DM, 2002, MOL CELL BIOCHEM, V239, P101, DOI 10.1023/A:1020584808730; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mishina Y, 2003, FRONT BIOSCI-LANDMRK, V8, pD855, DOI 10.2741/1097; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Rasheed N, 2006, HUM MOL GENET, V15, P1938, DOI 10.1093/hmg/ddl116; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Zaidi M, 2003, J BONE MINER RES, V18, P599, DOI 10.1359/jbmr.2003.18.4.599; Zambetti GP, 2006, J CELL BIOL, V172, P795, DOI 10.1083/jcb.200601114; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	39	33	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4135	10.1371/journal.pone.0004135	http://dx.doi.org/10.1371/journal.pone.0004135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125191	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473100009
J	Seeger, FH; Chen, L; Spyridopoulos, I; Altschmied, J; Aicher, A; Haendeler, J				Seeger, Florian Hartmut; Chen, Linping; Spyridopoulos, Ioakim; Altschmied, Joachim; Aicher, Alexandra; Haendeler, Judith			Downregulation of ETS Rescues Diabetes-Induced Reduction of Endothelial Progenitor Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; VASCULAR COMPLICATIONS; ANGIOGENESIS; DIFFERENTIATION; NUMBER; INHIBITION; INCREASE; THERAPY	Background: Transplantation of vasculogenic progenitor cells (VPC) improves neovascularization after ischemia. However, patients with type 2 diabetes mellitus show a reduced VPC number and impaired functional activity. Previously, we demonstrated that p38 kinase inhibition prevents the negative effects of glucose on VPC number by increasing proliferation and differentiation towards the endothelial lineage in vitro. Moreover, the functional capacity of progenitor cells is reduced in a mouse model of metabolic syndrome including type 2 diabetes (Lepr(db)) in vivo. Findings: The aim of this study was to elucidate the underlying signalling mechanisms in vitro and in vivo. Therefore, we performed DNA-protein binding arrays in the bone marrow of mice with metabolic syndrome, in blood-derived progenitor cells of diabetic patients as well as in VPC ex vivo treated with high levels of glucose. The transcriptional activation of ETS transcription factors was increased in all samples analyzed. Downregulation of ETS1 expression by siRNA abrogated the reduction of VPC number induced by high-glucose treatment. In addition, we observed a concomitant suppression of the non-endothelial ETS-target genes matrix metalloproteinase 9 (MMP9) and CD115 upon short term lentiviral delivery of ETS-specific shRNAs. Long term inhibition of ETS expression by lentiviral infection increased the number of cells with the endothelial markers CD144 and CD105. Conclusion: These data demonstrate that diabetes leads to dysregulated activation of ETS, which blocks the functional activity of progenitor cells and their commitment towards the endothelial cell lineage.	[Seeger, Florian Hartmut; Chen, Linping; Spyridopoulos, Ioakim; Altschmied, Joachim; Aicher, Alexandra; Haendeler, Judith] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Haendeler, Judith] Univ Dusseldorf, IUF, D-4000 Dusseldorf, Germany	Goethe University Frankfurt; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Seeger, FH (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany.	juhae001@uni-duesseldorf.de	Aicher, Alexandra/GZK-8031-2022	Haendeler, Judith/0000-0001-8507-4540; Spyridopoulos, Ioakim/0000-0002-2750-2444; Aicher, Alexandra/0000-0002-8920-9577	University of Frankfurt; Deutsche Forschungsgemeinschaft [HA-2868/3-3, SFB728 B5]	University of Frankfurt; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a start-up grant of the University of Frankfurt to FHS and by grants from the Deutsche Forschungsgemeinschaft to JH (HA-2868/3-3 and SFB728 B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gadau S, 2006, DIABETOLOGIA, V49, P405, DOI 10.1007/s00125-005-0103-5; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Howard BV, 2002, CIRCULATION, V105, pE128; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lulli V, 2006, CELL DEATH DIFFER, V13, P1064, DOI 10.1038/sj.cdd.4401811; Marchetti V, 2006, DIABETES, V55, P2231, DOI 10.2337/db06-0369; Marziali G, 2002, BLOOD CELL MOL DIS, V29, P553, DOI 10.1006/bcmd.2002.0595; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; McLaughlin F, 1999, J CELL SCI, V112, P4695; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nakano T, 2000, J CELL PHYSIOL, V184, P255, DOI 10.1002/1097-4652(200008)184:2<255::AID-JCP14>3.0.CO;2-J; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shantsila E, 2008, J AM COLL CARDIOL, V51, P669, DOI 10.1016/j.jacc.2007.09.057; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030	37	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4529	10.1371/journal.pone.0004529	http://dx.doi.org/10.1371/journal.pone.0004529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225563	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000007
J	Vassella, E; Oberle, M; Urwyler, S; Renggli, CK; Studer, E; Hemphill, A; Fragoso, C; Butikofer, P; Brun, R; Roditi, I				Vassella, Erik; Oberle, Michael; Urwyler, Simon; Renggli, Christina Kunz; Studer, Erwin; Hemphill, Andrew; Fragoso, Cristina; Butikofer, Peter; Brun, Reto; Roditi, Isabel			Major Surface Glycoproteins of Insect Forms of Trypanosoma brucei Are Not Essential for Cyclical Transmission by Tsetse	PLOS ONE			English	Article								Procyclic forms of Trypanosoma brucei reside in the midgut of tsetse flies where they are covered by several million copies of glycosylphosphatidylinositol-anchored proteins known as procyclins. It has been proposed that procyclins protect parasites against proteases and/or participate in tropism, directing them from the midgut to the salivary glands. There are four different procyclin genes, each subject to elaborate levels of regulation. To determine if procyclins are essential for survival and transmission of T. brucei, all four genes were deleted and parasite fitness was compared in vitro and in vivo. When co-cultured in vitro, the null mutant and wild type trypanosomes (tagged with cyan fluorescent protein) maintained a near-constant equilibrium. In contrast, when flies were infected with the same mixture, the null mutant was rapidly overgrown in the midgut, reflecting a reduction in fitness in vivo. Although the null mutant is patently defective in competition with procyclin-positive parasites, on its own it can complete the life cycle and generate infectious metacyclic forms. The procyclic form of T. brucei thus differs strikingly from the bloodstream form, which does not tolerate any perturbation of its variant surface glycoprotein coat, and from other parasites such as Plasmodium berghei, which requires the circumsporozoite protein for successful transmission to a new host.	[Vassella, Erik; Urwyler, Simon; Studer, Erwin; Fragoso, Cristina; Roditi, Isabel] Univ Bern, Inst Zellbiol, CH-3012 Bern, Switzerland; [Oberle, Michael; Renggli, Christina Kunz; Brun, Reto] Swiss Trop Inst, Basel, Switzerland; [Hemphill, Andrew] Univ Bern, Inst Parasitol, CH-3012 Bern, Switzerland; [Butikofer, Peter] Univ Bern, Inst Biochem Mol Med, CH-3012 Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Bern; University of Bern	Vassella, E (corresponding author), Univ Bern, Inst Pathol, Bern, Switzerland.	isabel.roditi@izb.unibe.ch		Hemphill, Andrew/0000-0002-0622-2128; Roditi, Isabel/0000-0003-2812-6513	Swiss National Science Foundation; Howard Hughes Medical Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Swiss National Science Foundation; Howard Hughes Medical Institute	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; BRUCE D, 1896, FURTHER REPORT TSETS; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 2003, MOL BIOCHEM PARASIT, V126, P287, DOI 10.1016/S0166-6851(02)00286-4; Chandra M, 2004, INSECT BIOCHEM MOLEC, V34, P1163, DOI 10.1016/j.ibmb.2004.07.004; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Furger A, 2001, FEBS LETT, V508, P90, DOI 10.1016/S0014-5793(01)03031-9; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; Gruszynski AE, 2006, MOL BIOCHEM PARASIT, V147, P211, DOI 10.1016/j.molbiopara.2006.02.013; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Haenni S, 2006, MOL BIOCHEM PARASIT, V150, P144, DOI 10.1016/j.molbiopara.2006.07.005; HAJDUK SL, 1984, J PROTOZOOL, V31, P41, DOI 10.1111/j.1550-7408.1984.tb04287.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Liniger M, 2004, MOL BIOCHEM PARASIT, V137, P247, DOI 10.1016/j.molbiopara.2004.06.006; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; RICHARDSON JP, 1988, MOL BIOCHEM PARASIT, V31, P203, DOI 10.1016/0166-6851(88)90150-8; Roditi I, 2002, TRENDS MICROBIOL, V10, P128, DOI 10.1016/S0966-842X(02)02309-0; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Schlaeppi AC, 2003, J BIOL CHEM, V278, P49980, DOI 10.1074/jbc.M309548200; SHARMA R, 2007, ASYMMETRIC CELL DIVI; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; TETLEY L, 1987, J CELL SCI, V87, P363; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2004, MOL BIOL CELL, V15, P3986, DOI 10.1091/mbc.E04-04-0341; Vassella E, 2001, J MOL BIOL, V312, P597, DOI 10.1006/jmbi.2001.5004; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2001, MOL MICROBIOL, V41, P33, DOI 10.1046/j.1365-2958.2001.02471.x; Welburn SC, 1997, MED VET ENTOMOL, V11, P286, DOI 10.1111/j.1365-2915.1997.tb00408.x; ZIEGELBAUER K, 1990, EUR J BIOCHEM, V192, P373, DOI 10.1111/j.1432-1033.1990.tb19237.x	40	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4493	10.1371/journal.pone.0004493	http://dx.doi.org/10.1371/journal.pone.0004493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223969	Green Published, gold			2022-12-27	WOS:000265485800005
J	Brenneis, M; Soppa, J				Brenneis, Mariam; Soppa, Joerg			Regulation of Translation in Haloarchaea: 5 '- and 3 '-UTRs Are Essential and Have to Functionally Interact In Vivo	PLOS ONE			English	Article								Recently a first genome-wide analysis of translational regulation using prokaryotic species had been performed which revealed that regulation of translational efficiency plays an important role in haloarchaea. In fact, the fractions of genes under differential growth phase-dependent translational control in the two species Halobacterium salinarum and Haloferax volcanii were as high as in eukaryotes. However, nothing is known about the mechanisms of translational regulation in archaea. Therefore, two genes exhibiting opposing directions of regulation were selected to unravel the importance of untranslated regions (UTRs) for differential translational control in vivo. Differential translational regulation in exponentially growing versus stationary phase cells was studied by comparing translational efficiencies using a reporter gene system. Translational regulation was not observed when 5'-UTRs or 3'-UTRs alone were fused to the reporter gene. However, their simultaneous presence was sufficient to transfer differential translational control from the native transcript to the reporter transcript. This was true for both directions of translational control. Translational regulation was completely abolished when stem loops in the 5'-UTR were changed by mutagenesis. An "UTR-swap'' experiment demonstrated that the direction of translational regulation is encoded in the 3'-UTR, not in the 5'-UTR. While much is known about 5'-UTR-dependent translational control in bacteria, the reported findings provide the first examples that both 5'- and 3'-UTRs are essential and sufficient to drive differential translational regulation in a prokaryote and therefore have to functionally interact in vivo. The current results indicate that 3'-UTR-dependent translational control had already evolved before capping and polyadenylation of transcripts were invented, which are essential for circularization of transcripts in eukaryotes.	[Brenneis, Mariam; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt	Brenneis, M (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany.	soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (DFG) [SFB579]	German Research Council (DFG)(German Research Foundation (DFG))	The described work was supported by the German Research Council (DFG) throuth grant B6 in the framework of the special research program SFB579 "RNA ligand interactions". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Danner S, 1996, MOL MICROBIOL, V19, P1265, DOI 10.1111/j.1365-2958.1996.tb02471.x; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mikulits W, 2000, FASEB J, V14, P1641, DOI 10.1096/fj.14.11.1641; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nicolai M, 2006, PLANT PHYSIOL, V141, P663, DOI 10.1104/pp.106.079418; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Patenge N, 1999, FEMS MICROBIOL LETT, V171, P27, DOI 10.1016/S0378-1097(98)00583-7; Pesole G, 2000, Brief Bioinform, V1, P236, DOI 10.1093/bib/1.3.236; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; Rother M, 2001, BIOFACTORS, V14, P75, DOI 10.1002/biof.5520140111; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4484	10.1371/journal.pone.0004484	http://dx.doi.org/10.1371/journal.pone.0004484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214227	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484300014
J	Schmitt, I; Lumbsch, HT				Schmitt, Imke; Lumbsch, H. Thorsten			Ancient Horizontal Gene Transfer from Bacteria Enhances Biosynthetic Capabilities of Fungi	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; EVOLUTION; CLUSTER; CLONING; SYMBIONT; KETOSYNTHASE; PROBES; PKS	Background: Polyketides are natural products with a wide range of biological functions and pharmaceutical applications. Discovery and utilization of polyketides can be facilitated by understanding the evolutionary processes that gave rise to the biosynthetic machinery and the natural product potential of extant organisms. Gene duplication and subfunctionalization, as well as horizontal gene transfer are proposed mechanisms in the evolution of biosynthetic gene clusters. To explain the amount of homology in some polyketide synthases in unrelated organisms such as bacteria and fungi, interkingdom horizontal gene transfer has been evoked as the most likely evolutionary scenario. However, the origin of the genes and the direction of the transfer remained elusive. Methodology/Principal Findings: We used comparative phylogenetics to infer the ancestor of a group of polyketide synthase genes involved in antibiotic and mycotoxin production. We aligned keto synthase domain sequences of all available fungal 6-methylsalicylic acid (6-MSA)-type PKSs and their closest bacterial relatives. To assess the role of symbiotic fungi in the evolution of this gene we generated 24 6-MSA synthase sequence tags from lichen-forming fungi. Our results support an ancient horizontal gene transfer event from an actinobacterial source into ascomycete fungi, followed by gene duplication. Conclusions/Significance: Given that actinobacteria are unrivaled producers of biologically active compounds, such as antibiotics, it appears particularly promising to study biosynthetic genes of actinobacterial origin in fungi. The large number of 6-MSA-type PKS sequences found in lichen-forming fungi leads us hypothesize that the evolution of typical lichen compounds, such as orsellinic acid derivatives, was facilitated by the gain of this bacterial polyketide synthase.	[Schmitt, Imke] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Schmitt, Imke] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA; [Schmitt, Imke; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago)	Schmitt, I (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	schm2109@umn.edu			Deutsche Forschungsgemeinschaft (DFG) [Emmy Noether Fellowship]; Field Museum; Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Field Museum; Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago	This study was supported by an Emmy Noether Fellowship by the Deutsche Forschungsgemeinschaft (DFG) to IS, and a start up fund by the Field Museum to HTL. Sequences were generated in the Pritzker Laboratory for Molecular Systematics at the Field Museum, Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; ARNOLD AE, 2008, SYSTEMATIC IN PRESS; BECK J, 1990, EUR J BIOCHEM, V192, P487, DOI 10.1111/j.1432-1033.1990.tb19252.x; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Buades C, 1996, J MOL EVOL, V42, P537, DOI 10.1007/BF02352283; CARDINALE M, 2008, FEMS MICROB IN PRESS; Cardinale M, 2006, FEMS MICROBIOL ECOL, V57, P484, DOI 10.1111/j.1574-6941.2006.00133.x; Castoe TA, 2007, GENE, V392, P47, DOI 10.1016/j.gene.2006.11.005; Chen J, 2000, CATENA, V39, P121, DOI 10.1016/S0341-8162(99)00085-5; DEMAIN AL, 2000, NATURAL FUNCTIONS SE, P1; Elix J. A., 1996, P154; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Gaisser S, 1997, J BACTERIOL, V179, P6271, DOI 10.1128/jb.179.20.6271-6278.1997; Gauslaa Y, 2001, OECOLOGIA, V126, P462, DOI 10.1007/s004420000541; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Grube M, 2003, MYCOL RES, V107, P1419, DOI 10.1017/S0953756203008724; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; Hawksworth DL, 1976, LICHENOLOGY PROGR PR, P139; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huneck S, 1996, IDENTIFICATION LICHE; HUNECK S, 2003, BIBL LICH, V85, P9; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Karolewiez A, 2005, SYST APPL MICROBIOL, V28, P588, DOI 10.1016/j.syapm.2005.03.008; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; KINRAIDE W T B, 1970, Lichenologist (London), V4, P234, DOI 10.1017/S0024282970000270; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kudo F, 2007, J ANTIBIOT, V60, P492, DOI 10.1038/ja.2007.63; LANGE OL, 1992, PFLANZENLEBEN UNTER; Lawrey JD, 2003, BRYOLOGIST, V106, P80, DOI 10.1639/0007-2745(2003)106[0080:LFIEAB]2.0.CO;2; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 1998, LICHENOLOGIST, V30, P357, DOI 10.1006/lich.1998.0147; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Miao V, 2001, TRENDS BIOTECHNOL, V19, P349, DOI 10.1016/S0167-7799(01)01700-0; Milinkovitch MC, 1998, MOL PHYLOGENET EVOL, V9, P348, DOI 10.1006/mpev.1998.0503; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Muggia L, 2008, MYCOL RES, V112, P277, DOI 10.1016/j.mycres.2007.08.020; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; PENALVA MA, 1990, P ROY SOC B-BIOL SCI, V241, P164, DOI 10.1098/rspb.1990.0081; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2004, J BACTERIOL, V186, P1280, DOI 10.1128/JB.186.5.1280-1286.2004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Sauer M, 2002, MYCOL RES, V106, P460, DOI 10.1017/S095375620200566X; Schmidt EW, 2008, NAT CHEM BIOL, V4, P466, DOI 10.1038/nchembio.101; Schmitt I, 2005, PHYTOCHEMISTRY, V66, P1241, DOI 10.1016/j.phytochem.2005.04.014; Schmitt I, 2008, ISME J, V2, P632, DOI 10.1038/ismej.2008.19; Schmitt I, 2008, MYCOL RES, V112, P289, DOI 10.1016/j.mycres.2007.08.023; Shao L, 2006, BIOCHEM BIOPH RES CO, V345, P133, DOI 10.1016/j.bbrc.2006.04.069; Shen B, 2000, TOP CURR CHEM, V209, P1; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347; Zhang YQ, 2005, MYCOLOGY S, V22, P355	71	93	95	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4437	10.1371/journal.pone.0004437	http://dx.doi.org/10.1371/journal.pone.0004437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212443	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200004
J	Davies, EC; Green, CF; Taylor, S; Williamson, PR; Mottram, DR; Pirmohamed, M				Davies, Emma C.; Green, Christopher F.; Taylor, Stephen; Williamson, Paula R.; Mottram, David R.; Pirmohamed, Munir			Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes	PLOS ONE			English	Article							RISK-FACTORS; EVENTS; DEFINITIONS; ADMISSIONS; COSTS	Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. Patients admitted to twelve wards over a six-month period in 2005 were assessed for ADRs throughout their admission. Suspected ADRs were recorded and analysed for causality, severity and avoidability and whether they increased the length of stay. Multivariable analysis was undertaken to identify the risk factors for ADRs. The 5% significance level was used when assessing factors for inclusion in multivariable models. Out of the 3695 patient episodes assessed for ADRs, 545 (14.7%, 95% CI 13.6-15.9%) experienced one or more ADRs. Half of ADRs were definitely or possibly avoidable. The patients experiencing ADRs were more likely to be older, female, taking a larger number of medicines, and had a longer length of stay than those without ADRs. However, the only significant predictor of ADRs, from the multivariable analysis of a representative sample of patients, was the number of medicines taken by the patient with each additional medication multiplying the hazard of an ADR episode by 1.14 (95% CI 1.09, 1.20). ADRs directly increased length of stay in 147 (26.8%) patients. The drugs most frequently associated with ADRs were diuretics, opioid analgesics, and anticoagulants. In conclusion, approximately one in seven hospital in-patients experience an ADR, which is a significant cause of morbidity, increasing the length of stay of patients by an average of 0.25 days/patient admission episode. The overall burden of ADRs on hospitals is high, and effective intervention strategies are urgently needed to reduce this burden.	[Davies, Emma C.] Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England; [Davies, Emma C.; Mottram, David R.] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England; [Green, Christopher F.] Countess Chester NHS Fdn Trust, Countess Chester Hlth Pk, Pharm Martindale House, Chester, Cheshire, England; [Taylor, Stephen; Williamson, Paula R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; [Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool; Liverpool John Moores University; University of Liverpool; University of Liverpool	Davies, EC (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England.	munirp@liv.ac.uk	Pirmohamed, Munir/H-6004-2011; Williamson, Paula R/B-6425-2016	Pirmohamed, Munir/0000-0002-7534-7266; Williamson, Paula R/0000-0001-9802-6636	Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund; Liverpool John Moores University; Medical Research Council [G0800792] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund(Australian Research Council); Liverpool John Moores University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the study was provided by the Royal Liverpool and Broadgreen University Hospitals Trust Research and Development Fund and Liverpool John Moores University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; *ASS BRIT PHARM IN, 2005, ABPI DAT SHEET COMP; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2005, BRIT NAT FORM; Brown H., 1999, APPL MIXED MODELS ME; Camargo AL, 2006, EUR J CLIN PHARMACOL, V62, P143, DOI 10.1007/s00228-005-0086-7; CARBONIN P, 1991, J AM GERIATR SOC, V39, P1093, DOI 10.1111/j.1532-5415.1991.tb02875.x; *CIPFA, 2002, HLTH SERV FIN DAT CO; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Davies EC, 2006, J CLIN PHARM THER, V31, P335, DOI 10.1111/j.1365-2710.2006.00744.x; Davies EC, 2007, CURR DRUG SAF, V2, P79, DOI 10.2174/157488607779315507; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; *DEP HLTH ENGL, 2008, DEP HLTH HEADL STAT; *DEP HLTH ENGL, 2008, AV DAIL NUMB AV OCC; Dormann H, 2004, ALIMENT PHARM THERAP, V19, P303, DOI 10.1111/j.1365-2036.2004.01854.x; Ducharme MM, 2007, INT J CLIN PRACT, V61, P157, DOI 10.1111/j.1742-1241.2006.01130.x; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; EVANS RS, 1994, ANN PHARMACOTHER, V28, P523, DOI 10.1177/106002809402800417; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; HOIGNE R, 1990, EUR J CLIN PHARMACOL, V39, P321, DOI 10.1007/BF00315403; Howard RL, 2003, QUAL SAF HEALTH CARE, V12, P280, DOI 10.1136/qhc.12.4.280; HURWITZ N, 1969, BMJ-BRIT MED J, V1, P531, DOI 10.1136/bmj.1.5643.531; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; Kvasz M, 2000, MedGenMed, V2, pE3; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEACH S, 1986, AGE AGEING, V15, P241, DOI 10.1093/ageing/15.4.241; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *MED HEALTHC PROD, WHAT REP; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; OGILVIE RI, 1967, CAN MED ASSOC J, V97, P1450; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pirmohamed M, 2003, BRIT MED J, V327, P1179, DOI 10.1136/bmj.327.7425.1179; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Rawlins MDTJ, 1977, TXB ADVERSE DRUG REA; SEIDL LG, 1965, AM J PUBLIC HEALTH N, V55, P1170, DOI 10.2105/AJPH.55.8.1170; Simmons C, 1998, HOSP PHARM, V33, P1568; SMITH JW, 1966, ANN INTERN MED, V65, P629, DOI 10.7326/0003-4819-65-4-629; Suh DC, 2000, ANN PHARMACOTHER, V34, P1373, DOI 10.1345/aph.10094; van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016; VANKRAAIJ DJW, 1994, NETH J MED, V44, P166; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x; Wiffen P, 2002, BANDOLIER EXTRA, P1; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225	47	439	454	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4439	10.1371/journal.pone.0004439	http://dx.doi.org/10.1371/journal.pone.0004439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209224	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484100009
J	Schlessinger, A; Punta, M; Yachdav, G; Kajan, L; Rost, B				Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard			Improved Disorder Prediction by Combination of Orthogonal Approaches	PLOS ONE			English	Article								Disordered proteins are highly abundant in regulatory processes such as transcription and cell-signaling. Different methods have been developed to predict protein disorder often focusing on different types of disordered regions. Here, we present MD, a novel META-Disorder prediction method that molds various sources of information predominantly obtained from orthogonal prediction methods, to significantly improve in performance over its constituents. In sustained cross-validation, MD not only outperforms its origins, but it also compares favorably to other state-of-the-art prediction methods in a variety of tests that we applied. Availability: http://www.rostlab.org/services/md/	[Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, CUBIC, New York, NY 10027 USA; [Schlessinger, Avner; Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Ctr Comput Biol & Bioinformat C2B2, New York, NY 10027 USA; [Schlessinger, Avner] Univ Calif San Francisco, Calif Inst Quant Biomed Res, Dept Biopharm Sci, San Francisco, CA 94143 USA; [Punta, Marco; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, NESG, New York, NY 10027 USA; [Punta, Marco; Yachdav, Guy; Kajan, Laszlo; Rost, Burkhard] Columbia Univ, Dept Biochem & Mol Biophys, NYCOMPS, New York, NY 10027 USA	Columbia University; Columbia University; University of California System; University of California San Francisco; Columbia University; Columbia University	Schlessinger, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, CUBIC, New York, NY 10027 USA.	as2067@columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676	National Library of Medicine (NLM) at the NIH [R01-LM07329]; NATIONAL LIBRARY OF MEDICINE [R01LM007329] Funding Source: NIH RePORTER	National Library of Medicine (NLM) at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the grant R01-LM07329 from the National Library of Medicine (NLM) at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boden M, 2006, BIOINFORMATICS, V22, P1809, DOI 10.1093/bioinformatics/btl198; BORDOLI L, 2006, ASSESSMENT DISORDER; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; Bracken C, 2004, CURR OPIN STRUC BIOL, V14, P570, DOI 10.1016/j.sbi.2004.08.003; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; CHENG J, 2005, ACCURATE PREDICTION, P213; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer David, 2007, V350, P49; Esnouf RM, 2006, ACTA CRYSTALLOGR D, V62, P1260, DOI 10.1107/S0907444906033580; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Gu J, 2006, PLOS COMPUT BIOL, V2, P769, DOI 10.1371/journal.pcbi.0020090; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Melamud E, 2003, PROTEINS, V53, P561, DOI 10.1002/prot.10533; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Moran O, 2007, BIOPHYS J, p274A; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Radivojac P, 2004, PROTEIN SCI, V13, P71, DOI 10.1110/ps.03128904; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero P, 1998, Pac Symp Biocomput, P437; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1995, PROTEIN SCI, V4, P521; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rost B., 2005, PROTEOMICS PROTOCOLS, P875, DOI DOI 10.1385/1-59259-890-0:875; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Snyder DA, 2005, J AM CHEM SOC, V127, P16505, DOI 10.1021/ja053564h; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; TSVETKOV P, 2007, PROTEINS; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yee AA, 2005, J AM CHEM SOC, V127, P16512, DOI 10.1021/ja053565+	78	142	142	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4433	10.1371/journal.pone.0004433	http://dx.doi.org/10.1371/journal.pone.0004433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209228	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484100005
J	Gingerich, PD; ul-Haq, M; von Koenigswald, W; Sanders, WJ; Smith, BH; Zalmout, IS				Gingerich, Philip D.; ul-Haq, Munir; von Koenigswald, Wighart; Sanders, William J.; Smith, B. Holly; Zalmout, Iyad S.			New Protocetid Whale from the Middle Eocene of Pakistan: Birth on Land, Precocial Development, and Sexual Dimorphism	PLOS ONE			English	Article							ARCHAEOCETE MAMMALIA; TOOTH DEVELOPMENT; LIFE-HISTORY; CETACEA; ORIGIN; DENTITION; EVOLUTION; TEETH; LOCOMOTION; FEET	Background: Protocetidae are middle Eocene (49-37 Ma) archaeocete predators ancestral to later whales. They are found in marine sedimentary rocks, but retain four legs and were not yet fully aquatic. Protocetids have been interpreted as amphibious, feeding in the sea but returning to land to rest. Methodology/Principal Findings: Two adult skeletons of a new 2.6 meter long protocetid, Maiacetus inuus, are described from the early middle Eocene Habib Rahi Formation of Pakistan. M. inuus differs from contemporary archaic whales in having a fused mandibular symphysis, distinctive astragalus bones in the ankle, and a less hind-limb dominated postcranial skeleton. One adult skeleton is female and bears the skull and partial skeleton of a single large near-term fetus. The fetal skeleton is positioned for head-first delivery, which typifies land mammals but not extant whales, evidence that birth took place on land. The fetal skeleton has permanent first molars well mineralized, which indicates precocial development at birth. Precocial development, with attendant size and mobility, were as critical for survival of a neonate at the land-sea interface in the Eocene as they are today. The second adult skeleton is the most complete known for a protocetid. The vertebral column, preserved in articulation, has 7 cervicals, 13 thoracics, 6 lumbars, 4 sacrals, and 21 caudals. All four limbs are preserved with hands and feet. This adult is 12% larger in linear dimensions than the female skeleton, on average, has canine teeth that are 20% larger, and is interpreted as male. Moderate sexual dimorphism indicates limited male-male competition during breeding, which in turn suggests little aggregation of food or shelter in the environment inhabited by protocetids. Conclusions/Significance: Discovery of a near-term fetus positioned for head-first delivery provides important evidence that early protocetid whales gave birth on land. This is consistent with skeletal morphology enabling Maiacetus to support its weight on land and corroborates previous ideas that protocetids were amphibious. Specimens this complete are virtual 'Rosetta stones' providing insight into functional capabilities and life history of extinct animals that cannot be gained any other way.	[Gingerich, Philip D.; Sanders, William J.; Zalmout, Iyad S.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Gingerich, Philip D.; Zalmout, Iyad S.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [ul-Haq, Munir] Geol Survey Pakistan, Quetta, Pakistan; [von Koenigswald, Wighart] Univ Bonn, Steinmann Inst Geol Mineral Palaontol, D-5300 Bonn, Germany; [Smith, B. Holly] Univ Michigan, Museum Anthropol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bonn; University of Michigan System; University of Michigan	Gingerich, PD (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	gingeric@umich.edu	Gingerich, Philip D/A-6903-2008; Smith, B. Holly/C-4984-2008	Gingerich, Philip D/0000-0002-1550-2674; Smith, B. Holly/0000-0001-5126-5445	Geological Survey of Pakistan, National Geographic Society [5537-95]; U. S. National Science Foundation [9714923, 0517773]; German Alexander von Humboldt Stiftung; University of Michigan	Geological Survey of Pakistan, National Geographic Society(National Geographic Society); U. S. National Science Foundation(National Science Foundation (NSF)); German Alexander von Humboldt Stiftung; University of Michigan(University of Michigan System)	Research was supported by the Geological Survey of Pakistan, National Geographic Society (5537-95), U. S. National Science Foundation (9714923, 0517773), German Alexander von Humboldt Stiftung, and University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf, 1988, GEOLOGISCHES JB B, V71, P1; BAIER W, 1958, TIERARZTLICHE GEBURS; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; BERKOVITZ BK, 1973, ARCH ORAL BIOL, V18, P465, DOI 10.1016/0003-9969(73)90066-6; Boisserie JR, 2005, P NATL ACAD SCI USA, V102, P1537, DOI 10.1073/pnas.0409518102; Boness DJ, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P278; BROWN WAB, 1991, J ZOOL, V224, P367, DOI 10.1111/j.1469-7998.1991.tb06031.x; Caldwell DK, 1985, HDB MARINE MAMMALS, V3, P33; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; DERRICKSON EM, 1992, FUNCT ECOL, V6, P57, DOI 10.2307/2389771; Dittrich L., 1960, Gegenbaurs Jahrbuch, V101, P1; Eltringham S. K., 1999, HIPPOS NATURAL HIST; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; FRANZEN J L, 1981, Senckenbergiana Lethaea, V61, P299; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip D., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P269; Gingerich Philp D., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P197; HALLMARTIN AJ, 1976, J ZOOL, V180, P263, DOI 10.1111/j.1469-7998.1976.tb04678.x; HAQ MU, 1999, GEOLOGICAL SURVEY PA, V705, P1; Harman MT, 1936, ANAT REC, V66, P97, DOI 10.1002/ar.1090660110; HELLGREN E C, 1984, Journal of Wildlife Diseases, V20, P354; Kellogg AR., 1936, CARNEGIE I WASHINGTO, V482, P1; KRAUS BS, 1969, TERATOLOGY, V2, P163, DOI 10.1002/tera.1420020212; KUBOTA K, 1961, FOLIA ANATOMICA JAPO, V37, P389; LANG EM, 1975, ZWERGFLUSSPFERD CHOE; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; LEMPPENAU U, 1964, THESIS L MAXIMILIANS; LUCKETT WP, 1982, FOLIA PRIMATOL, V37, P1; Madar SI, 2007, J PALEONTOL, V81, P176, DOI 10.1666/0022-3360(2007)81[176:TPSOEE]2.0.CO;2; Madar SI, 2002, J VERTEBR PALEONTOL, V22, P405, DOI 10.1671/0272-4634(2002)022[0405:AHROAN]2.0.CO;2; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; MCKEAN CF, 1971, ARCH ORAL BIOL, V16, P639, DOI 10.1016/0003-9969(71)90067-7; MELLANBY M, 1929, MEDICAL RES COUNCIL, V140, P15; Nievelt A.F.H., 2005, PALEOBIOLOGY, V31, P324, DOI DOI 10.1666/0094-8373(2005)031[0324:TRONTR]2.0.CO;2; OKA SW, 1969, ARCH ORAL BIOL, V14, P639, DOI 10.1016/0003-9969(69)90187-3; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; SHIN HR, 1937, VIERTELJAHRSSCHRIFT, V82, P21; Slijper E. J., 1956, Hvalradets Skrifter, VNo. 41, P1; STOSS AO, 1944, TIERARZTLICHE GEBURS; TOMICH PQ, 1970, ANAT REC, V167, P107, DOI 10.1002/ar.1091670110; TONGE CH, 1973, J ANAT, V115, P1; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Weckerly FW, 1998, J MAMMAL, V79, P33, DOI 10.2307/1382840; WEINREB MM, 1964, AM J VET RES, V25, P891; Zalmout Iyad S., 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P79	52	78	81	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4366	10.1371/journal.pone.0004366	http://dx.doi.org/10.1371/journal.pone.0004366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194487	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483500010
J	Rodahl, LM; Haglund, K; Sem-Jacobsen, C; Wendler, F; Vincent, JP; Lindmo, K; Rusten, TE; Stenmark, H				Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Wendler, Franz; Vincent, Jean-Paul; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald			Disruption of Vps4 and JNK Function in Drosophila Causes Tumour Growth	PLOS ONE			English	Article							EPITHELIAL POLARITY; TRANSPORT; RECEPTOR; ATPASE; PROLIFERATION; TRANSDUCTION; TRAFFICKING; EXPRESSION; PHENOTYPE; COMPLEX	Several regulators of endocytic trafficking have recently been identified as tumour suppressors in Drosophila. These include components of the endosomal sorting complex required for transport (ESCRT) machinery. Disruption of subunits of ESCRT-I and -II leads to cell-autonomous endosomal accumulation of ubiquitinated receptors, loss of apicobasal polarity and epithelial integrity, and increased cell death. Here we report that disruption of the ATPase dVps4, the most downstream component of the ESCRT machinery, causes the same array of cellular phenotypes. We find that loss of epithelial integrity and increased apoptosis, but not loss of cell polarity, require the activation of JNK signalling. Abrogation of JNK signalling prevents apoptosis in dVps4 deficient cells. Indeed double deficiency in dVps4 and JNK signalling leads to the formation of neoplastic tumours. We conclude that dvps4 is a tumour suppressor in Drosophila and that JNK is central to the cell-autonomous phenotypes of ESCRT-deficient cells.	[Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Rodahl, Lina M.; Haglund, Kaisa; Sem-Jacobsen, Catherine; Lindmo, Karine; Rusten, Tor Erik; Stenmark, Harald] Rikshosp Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway; [Wendler, Franz; Vincent, Jean-Paul] MRC, Natl Inst Med Res, London, England	University of Oslo; University of Oslo; National Hospital Norway; MRC National Institute for Medical Research	Rodahl, LM (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	stenmark@ulrik.uio.no	Haglund, Kaisa/B-3927-2017; Stenmark, Harald/B-8868-2008	Haglund, Kaisa/0000-0002-7946-3299; Rusten, Tor Erik/0000-0002-9150-2676	International Human Frontier Science Program Organization [postdoctoral fellow]; Norwegian Cancer Society; Novo Nordisk Foundation; Hartmann Family Foundation; Research Council of Norway; MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: researchfish	International Human Frontier Science Program Organization(Human Frontier Science Program); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Hartmann Family Foundation; Research Council of Norway(Research Council of Norway); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	KH is a postdoctoral fellow of the The International Human Frontier Science Program Organization. This work was also supported by the Norwegian Cancer Society, The Novo Nordisk Foundation, the Hartmann Family Foundation and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kwei KA, 2006, CANCER LETT, V231, P326, DOI 10.1016/j.canlet.2005.02.031; LE RC, 2005, DEV CELL, V9, P167; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Noselli S, 1999, CURR OPIN GENET DEV, V9, P466, DOI 10.1016/S0959-437X(99)80071-9; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; Sevrioukov EA, 2005, MOL BIOL CELL, V16, P2301, DOI 10.1091/mbc.E04-11-1013; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Weber U, 2000, DEVELOPMENT, V127, P3619; Yoshida S, 2001, J HUM GENET, V46, P182, DOI 10.1007/s100380170086; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	36	45	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4354	10.1371/journal.pone.0004354	http://dx.doi.org/10.1371/journal.pone.0004354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194501	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483500007
J	Bartolomucci, A; Leopardi, R				Bartolomucci, Alessandro; Leopardi, Rosario			Stress and Depression: Preclinical Research and Clinical Implications	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT TREATMENT; PSYCHOSOCIAL STRESS; CELL-PROLIFERATION; TREATMENT RESPONSE; GENE-EXPRESSION; SOCIAL STRESS; RECEPTOR; MODELS; SICKNESS		[Bartolomucci, Alessandro] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Leopardi, Rosario] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of Parma; Karolinska Institutet	Bartolomucci, A (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy.	alessandro.bartolomucci@unipr.it; Rosario.Leopardi@ki.se						Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2004, EUR J NEUROSCI, V19, P659, DOI 10.1111/j.1460-9568.2004.03178.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Asberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003590; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Bartolomucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004331; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Binder EB, 2006, ANN MED, V38, P82, DOI 10.1080/07853890600551045; Bosker FJ, 2004, CNS DRUGS, V18, P705, DOI 10.2165/00023210-200418110-00002; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CHARNEY DS, 2004, SCI STKE, V205, pRE5; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; Cooper B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003659; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Gizatullin R, 2006, BIOL PSYCHIAT, V59, P295, DOI 10.1016/j.biopsych.2005.07.034; Greden JF, 2002, J CLIN PSYCHIAT, V63, P3; Holsboer F, 2008, NAT REV NEUROSCI, V9, P638, DOI 10.1038/nrn2453; Holsboer F, 2008, EUR J PHARMACOL, V583, P350, DOI 10.1016/j.ejphar.2007.12.032; Hunter RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004328; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Ilin Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004329; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kloiber S, 2007, BIOL PSYCHIAT, V62, P321, DOI 10.1016/j.biopsych.2006.10.001; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; KOOLHAAS JM, 1995, ACTA NEUROPSYCHIATR, V7, P27, DOI 10.1017/S0924270800037479; Kornstein SG, 1997, J CLIN PSYCHIAT, V58, P12; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Laifenfeld D, 2005, BIOL PSYCHIAT, V57, P716, DOI 10.1016/j.biopsych.2004.12.016; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lucas DL, 2007, FORUM-J APPL RES CON, V5; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Malhi G S, 2000, Curr Psychiatry Rep, V2, P165, DOI 10.1007/s11920-000-0062-y; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Parker G, 2005, PSYCHOL MED, V35, P467, DOI 10.1017/S0033291704004210; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Schule C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004324; Schweizer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004326; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; SULLIVAN P, 2009, MOL PSYCH IN PRESS; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Urani A, 2005, NEUROSCI BIOBEHAV R, V29, P805, DOI 10.1016/j.neubiorev.2005.03.020; Vaez M, 2007, SOC PSYCH PSYCH EPID, V42, P381, DOI 10.1007/s00127-007-0189-9; van der Laan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004327; Van Praag HM, 2005, WORLD J BIOL PSYCHIA, V6, P5, DOI [10.1080/15622970510030018, 10.1016/j.pnpbp.2004.05.031]; Warner-Schmidt JL, 2008, CURR OPIN PHARMACOL, V8, P14, DOI 10.1016/j.coph.2007.10.013; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; World Health Organization, 2005, WHO GLOB REP PREV CH	75	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4265	10.1371/journal.pone.0004265	http://dx.doi.org/10.1371/journal.pone.0004265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549YF	19180237	gold, Green Published			2022-12-27	WOS:000274089700002
J	White, VA; Lewallen, S; Beare, NAV; Molyneux, ME; Taylor, TE				White, Valerie A.; Lewallen, Susan; Beare, Nicholas A. V.; Molyneux, Malcolm E.; Taylor, Terrie E.			Retinal Pathology of Pediatric Cerebral Malaria in Malawi	PLOS ONE			English	Article								Introduction: The causes of coma and death in cerebral malaria remain unknown. Malarial retinopathy has been identified as an important clinical sign in the diagnosis and prognosis of cerebral malaria. As part of a larger autopsy study to determine causes of death in children with coma presenting to hospital in Blantyre, Malawi, who were fully evaluated clinically prior to death, we examined the histopathology of eyes of patients who died and underwent autopsy. Methodology/Principal Findings: Children with coma were admitted to the pediatric research ward, classified according to clinical definitions as having cerebral malaria or another cause of coma, evaluated and treated. The eyes were examined by direct and indirect ophthalmoscopy. If a child died and permission was given, a standardized autopsy was carried out. The patient was then assigned an actual cause of death according to the autopsy findings. The eyes were examined pathologically for hemorrhages, cystoid macular edema, parasite sequestration and thrombi. They were stained immunohistochemically for fibrin and CD61 to identify the components of thrombi, beta-amyloid precursor protein to detect axonal damage, for fibrinogen to identify vascular leakage and for glial fibrillary acidic protein to detect gliosis. Sixty-four eyes from 64 patients were examined: 35 with cerebral malaria and 29 with comas of other causes. Cerebral malaria was distinguished by sequestration of parasitized erythrocytes, the presence and severity of retinal hemorrhages, the presence of cystoid macular edema, the occurrence and number of fibrin-platelet thrombi, the presence and amount of axonal damage and vascular leakage. Conclusions/Significance: We found significant differences in retinal histopathology between patients who died of cerebral malaria and those with other diagnoses. These histopathological findings offer insights into the etiology of malarial retinopathy and provide a pathological basis for recently described retinal capillary non-perfusion in children with malarial retinopathy. Because of the similarities between the retina and the brain it also suggests mechanisms that may contribute to coma and death in cerebral malaria.	Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [White, Valerie A.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Lewallen, Susan] British Columbia Ctr Epidemiol & Int Ophthalmol, Vancouver, BC, Canada; [Lewallen, Susan] Tumaini Univ, Kilimanjaro Christian Med Ctr, Kilimanjaro Ctr Community Ophthalmol, Moshi, Tanzania; [Beare, Nicholas A. V.] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England; [Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programme, Coll Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Taylor, Terrie E.] Queen Elizabeth Cent Hosp, Blantyre Malaria Project, Blantyre, Malawi; [Taylor, Terrie E.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA	University of British Columbia; University of British Columbia; Kilimanjaro Christian Medical Centre; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	White, VA (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	val.white@vch.ca	Beare, Nicholas/AAG-4946-2019	Beare, Nicholas/0000-0001-8086-990X	Wellcome Trust [074125]; NIH [5R01AI034969-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The autopsy study is supported by Wellcome Trust grant #074125 to Dr M. Molyneux and by NIH grant #5R01AI034969-11 to Dr. T. Taylor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, SURV OPHTHALMOL, V51, P129, DOI 10.1016/j.survophthal.2005.12.003; Beare NA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1141, DOI 10.1001/archopht.122.8.1141; BEARE NA, JID IN PRESS; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; BOONPUCKNAVIG V, 1990, ARCH PATHOL LAB MED, V114, P1028; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Browning DJ, 2002, OPHTHALMOLOGY, V109, P2154, DOI 10.1016/S0161-6420(02)01217-4; Devonport H, 2006, EYE, V20, P255, DOI 10.1038/sj.eye.6701833; DUANE TD, 1980, OPHTHALMOLOGY, V87, P66; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Harding SP, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506776315781; KINCAID MC, 1982, BRIT J OPHTHALMOL, V66, P219, DOI 10.1136/bjo.66.4.219; KWON EE, 1994, J NEUROPATH EXP NEUR, V53, P625, DOI 10.1097/00005072-199411000-00010; Laure AK, 1998, ARCH OPHTHALMOL-CHIC, V116, P1119; Lewallen S, 1996, T ROY SOC TROP MED H, V90, P144, DOI 10.1016/S0035-9203(96)90116-9; Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8; LEWALLEN S, 1993, OPHTHALMOLOGY, V100, P857, DOI 10.1016/S0161-6420(93)31563-0; Lewallen S, 2000, ARCH OPHTHALMOL-CHIC, V118, P924; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; LOOAREESUWAN S, 1983, AM J TROP MED HYG, V32, P911, DOI 10.4269/ajtmh.1983.32.911; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Ong T, 2005, EYE, V19, P359, DOI 10.1038/sj.eye.6701491; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Reichard RR, 2004, OPHTHALMOLOGY, V111, P822, DOI 10.1016/j.ophtha.2003.07.016; Schemann JF, 2002, AM J TROP MED HYG, V67, P61, DOI 10.4269/ajtmh.2002.67.61; SPITZ S, 1946, Mil Surg, V99, P555; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tranos PG, 2004, SURV OPHTHALMOL, V49, P470, DOI 10.1016/j.survophthal.2004.06.002; White VA, 2001, T ROY SOC TROP MED H, V95, P618, DOI 10.1016/S0035-9203(01)90097-5	35	71	72	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4317	10.1371/journal.pone.0004317	http://dx.doi.org/10.1371/journal.pone.0004317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177166	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000265483100006
J	Colombo, G; Meli, M; Morra, G; Gabizon, R; Gasset, M				Colombo, Giorgio; Meli, Massimiliano; Morra, Giulia; Gabizon, Ruth; Gasset, Maria			Methionine Sulfoxides on Prion Protein Helix-3 Switch on the alpha-Fold Destabilization Required for Conversion	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ENERGY-DISTRIBUTION; OXIDATIVE STRESS; AMYLOID FIBRILS; STABILITY; DETERMINANTS; MODULATION; INSIGHTS; WATER	Background: The conversion of the cellular prion protein (PrPC) into the infectious form (PrPSc) is the key event in prion induced neurodegenerations. This process is believed to involve a multi-step conformational transition from an alpha-helical (PrPC) form to a beta-sheet-rich (PrPSc) state. In addition to the conformational difference, PrPSc exhibits as covalent signature the sulfoxidation of M213. To investigate whether such modification may play a role in the misfolding process we have studied the impact of methionine oxidation on the dynamics and energetics of the HuPrP(125-229) alpha-fold. Methodology/Principal Findings: Using molecular dynamics simulation, essential dynamics, correlated motions and signal propagation analysis, we have found that substitution of the sulfur atom of M213 by a sulfoxide group impacts on the stability of the native state increasing the flexibility of regions preceding the site of the modification and perturbing the network of stabilizing interactions. Together, these changes favor the population of alternative states which maybe essential in the productive pathway of the pathogenic conversion. These changes are also observed when the sulfoxidation is placed at M206 and at both, M206 and M213. Conclusions/Significance: Our results suggest that the sulfoxidation of Helix-3 methionines might be the switch for triggering the initial alpha-fold destabilization required for the productive pathogenic conversion.	[Colombo, Giorgio; Meli, Massimiliano; Morra, Giulia] CNR, Isto Chim Riconoscimento Mol, I-20133 Milan, Italy; [Gabizon, Ruth] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, Jerusalem, Israel; [Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Colombo, G (corresponding author), CNR, Isto Chim Riconoscimento Mol, I-20133 Milan, Italy.	g.colombo@icrm.cnr.it; mgasset@iqfr.csic.es	Colombo, Giorgio/A-2730-2012; Gasset, Maria/I-2050-2014; Gasset, Maria/K-4339-2012; Morra, Giulia/O-2311-2015; Meli, Massimiliano/AAY-8570-2020	Colombo, Giorgio/0000-0002-1318-668X; Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; Morra, Giulia/0000-0002-9681-7845; Meli, Massimiliano/0000-0003-3304-6104	EU [LSHB-CT-2006-037325, FOOD-CT-2004-506579]; Spanish MICINN [SAF2006-0418]; FIRB program [RNBE03PX33]	EU(European Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FIRB program(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants LSHB-CT-2006-037325 (GC) and FOOD-CT-2004-506579 (MG, RG) from the EU, SAF2006-0418 from the Spanish MICINN (MG), and RNBE03PX33 (GC) from the FIRB program. The authors have no financial interest in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Colacino S, 2006, PROTEINS, V62, P698, DOI 10.1002/prot.20804; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; DADO GP, 1993, J AM CHEM SOC, V115, P12609, DOI 10.1021/ja00079a060; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Geerke DP, 2004, J PHYS CHEM B, V108, P1436, DOI 10.1021/jp035034i; Griffiths SW, 2002, BIOCHEMISTRY-US, V41, P6245, DOI 10.1021/bi025599p; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuper J, 2007, J AM CHEM SOC, V129, P5786, DOI 10.1021/ja067036x; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LIU HY, 1995, J AM CHEM SOC, V117, P4363, DOI 10.1021/ja00120a018; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; LUO S, 2008, FASEB J IN PRESS; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MORRA G, 2008, MODELING SIGNA UNPUB; Morra G, 2008, PROTEINS, V72, P660, DOI 10.1002/prot.21963; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Oien DB, 2008, CURR TOP DEV BIOL, V80, P93, DOI 10.1016/S0070-2153(07)80003-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144; Requena JR, 2004, ARCH BIOCHEM BIOPHYS, V432, P188, DOI 10.1016/j.abb.2004.09.012; Roccatano D, 2005, BIOPOLYMERS, V78, P259, DOI 10.1002/bip.20290; Shiraishi N, 2005, BIOCHEM J, V387, P247, DOI 10.1042/BJ20041561; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Supattapone S, 2001, MOL CELL BIOL, V21, P2608, DOI 10.1128/MCB.21.7.2608-2616.2001; Tiana G, 2004, PROTEIN SCI, V13, P113, DOI 10.1110/ps.03223804; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; VANGUSTEREN WF, 2006, ENCY COMPUTATIONAL C, V2, P1211; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	54	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4296	10.1371/journal.pone.0004296	http://dx.doi.org/10.1371/journal.pone.0004296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172188	Green Submitted, gold, Green Published			2022-12-27	WOS:000265482900011
J	Nagarajan, P; Parikh, N; Garrett-Sinha, LA; Sinha, S				Nagarajan, Priyadharsini; Parikh, Neha; Garrett-Sinha, Lee Ann; Sinha, Satrajit			Ets1 Induces Dysplastic Changes When Expressed in Terminally-Differentiating Squamous Epidermal Cells	PLOS ONE			English	Article								Background: Ets1 is an oncogene that functions as a transcription factor and regulates the activity of many genes potentially important for tumor initiation and progression. Interestingly, the Ets1 oncogene is over-expressed in many human squamous cell cancers and over-expression is highly correlated with invasion and metastasis. Thus, Ets1 is believed to mainly play a role in later stages of the oncogenic process, but not early events. Methodology/Principal Findings: To better define the role of Ets1 in squamous cell carcinogenesis, we generated a transgenic mouse model in which expression of the Ets1 oncogene could be temporally and spatially regulated. Upon Ets1 induction in differentiating cells of stratified squamous epithelium, these mice exhibited dramatic changes in epithelial organization including increased proliferation and blocked terminal differentiation. The phenotype was completely reversed when Ets1 expression was suppressed. In mice where Ets1 expression was re-induced at a later age, the phenotype was more localized and the lesions that developed were more invasive. Many potential Ets1 targets were upregulated in the skin of these mice with the most dramatic being the metalloprotease MMP13, which we demonstrate to be a direct transcriptional target of Ets1. Conclusions/Significance: Collectively, our data reveal that upregulation of Ets1 can be an early event that promotes pre-neoplastic changes in epidermal tissues via its regulation of key genes driving growth and invasion. Thus, the Ets1 oncogene may be important for oncogenic processes in both early and late stages of tumor development.	[Nagarajan, Priyadharsini; Parikh, Neha; Garrett-Sinha, Lee Ann; Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Nagarajan, P (corresponding author), SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA.	leesinha@buffalo.edu; ssinha2@buffalo.edu	Nagarajan, Priyadharsini/C-4786-2014; Garrett-Sinha, Lee Ann/K-5911-2019	Nagarajan, Priyadharsini/0000-0002-5346-2669; Garrett-Sinha, Lee Ann/0000-0001-7806-4352	American Cancer Society; National Institutes of Dental and Craniofacial Research	American Cancer Society(American Cancer Society); National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	These studies were supported by grants from the American Cancer Society and the National Institutes of Dental and Craniofacial Research. Neither funder was involved in design or conduct of the study nor in data collection and analysis or manuscript preparation/review/approval.	Akgul B, 2006, EXP DERMATOL, V15, P35, DOI 10.1111/j.0906-6705.2005.00387.x; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Cirillo N, 2007, ORAL DIS, V13, P341, DOI 10.1111/j.1601-0825.2006.01287.x; COFFER P, 1994, ONCOGENE, V9, P911; DARMIENTO J, 1995, MOL CELL BIOL, V15, P5732; Davies G, 2001, CLIN CANCER RES, V7, P3289; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dunne AA, 2003, ANTICANCER RES, V23, P2233; Endo K, 2006, HUM PATHOL, V37, P1111, DOI 10.1016/j.humpath.2006.03.020; Gu LB, 2004, J BIOL CHEM, V279, P52141, DOI 10.1074/jbc.M407915200; Ha HY, 2001, CANCER RES, V61, P984; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; HORVATH B, 2005, HEAD NECK; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Impola U, 2005, BRIT J DERMATOL, V152, P720, DOI 10.1111/j.1365-2133.2005.06447.x; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Johansson N, 1997, AM J PATHOL, V151, P499; JOHN SA, 2007, J BIOL CHEM; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kahle A, 2005, GENE, V344, P53, DOI 10.1016/j.gene.2004.10.020; KAVURMA MM, 2002, J BIOL CHEM; Keehn CA, 2004, J CUTAN PATHOL, V31, P8, DOI 10.1046/j.0303-6987.2004.0158.x; Kim E, 2003, ONCOGENE, V22, P7716, DOI 10.1038/sj.onc.1207155; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lai HC, 2005, GYNECOL ONCOL, V96, P314, DOI 10.1016/j.ygyno.2004.09.065; Lee KH, 2007, EUR SURG RES, V39, P208, DOI 10.1159/000101452; Lee S, 2008, BRAIN RES, V1207, P19, DOI 10.1016/j.brainres.2008.02.016; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Luukkaa M, 2006, HEAD NECK-J SCI SPEC, V28, P225, DOI 10.1002/hed.20322; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mukherjee T, 2003, J CANCER RES CLIN, V129, P430, DOI 10.1007/s00432-003-0457-3; NAKAZAWA Y, 2007, ONCOGENE; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pande P, 1999, J PATHOL, V189, P40, DOI 10.1002/(SICI)1096-9896(199909)189:1<40::AID-PATH405>3.0.CO;2-#; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Pons M, 2006, Clin Transl Oncol, V8, P466, DOI 10.1007/s12094-006-0046-4; Quinn CO, 2000, J MOL ENDOCRINOL, V25, P73, DOI 10.1677/jme.0.0250073; Reis JS, 2002, J CUTAN PATHOL, V29, P517, DOI 10.1034/j.1600-0560.2002.290902.x; Reisdorff J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015617.39974.FB; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Saeki H, 2000, CANCER, V89, P1670, DOI 10.1002/1097-0142(20001015)89:8<1670::AID-CNCR4>3.0.CO;2-J; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SALNIKOW K, 2008, CARCINOGENESIS; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seth A, 1999, CELL DEATH DIFFER, V6, P902, DOI 10.1038/sj.cdd.4400567; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vairaktaris E, 2007, IN VIVO, V21, P615; Vairaktaris E, 2007, J CANCER RES CLIN, V133, P227, DOI 10.1007/s00432-006-0161-1; Venanzoni MC, 1996, ONCOGENE, V12, P1199; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Wu NJ, 2002, MATRIX BIOL, V21, P149, DOI 10.1016/S0945-053X(01)00192-5; Xu DK, 2002, EMBO J, V21, P4081, DOI 10.1093/emboj/cdf413; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zhang CL, 2003, J BIOL CHEM, V278, P27903, DOI 10.1074/jbc.M304328200	75	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4179	10.1371/journal.pone.0004179	http://dx.doi.org/10.1371/journal.pone.0004179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142229	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479700004
J	Courtney, HS; Ofek, I; Penfound, T; Nizet, V; Pence, MA; Kreikemeyer, B; Podbielbski, A; Hasty, DL; Dale, JB				Courtney, Harry S.; Ofek, Itzhak; Penfound, Thomas; Nizet, Victor; Pence, Morgan A.; Kreikemeyer, Bernd; Podbielbski, Andreas; Hasty, David L.; Dale, James B.			Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes	PLOS ONE			English	Article								Background: Hydrophobicity is an important attribute of bacteria that contributes to adhesion and biofilm formation. Hydrophobicity of Streptococcus pyogenes is primarily due to lipoteichoic acid (LTA) on the streptococcal surface but the mechanism(s) whereby LTA is retained on the surface is poorly understood. In this study, we sought to determine whether members of the M protein family consisting of Emm (M protein), Mrp (M-related protein), Enn (an M-like protein), and the streptococcal protective antigen (Spa) are involved in anchoring LTA in a manner that contributes to hydrophobicity of the streptococci and its ability to form biofilms. Methodology/Principal Findings: Isogenic mutants defective in expression of emm, mrp, enn, and/or spa genes of eight different serotypes and their parental strains were tested for differences in LTA bound to surface proteins, LTA released into the culture media, and membrane-bound LTA. The effect of these mutations on the ability of streptococci to form a hydrophobic surface and to generate biofilms was also investigated. A recombinant strain overexpressing Emm1 was also engineered and similarly tested. The serotypes tested ranged from those that express only a single M protein gene to those that express two or three members of the M protein family. Overexpression of Emm1 led to enhanced hydrophobicity and biofilm formation. Inactivation of emm in those serotypes expressing only a single emm gene reduced biofilm formation, and protein-bound LTA on the surface, but did not alter the levels of membrane-bound LTA. The results were more varied in those serotypes that express two to three members of the M protein family. Conclusions/Significance: Our findings suggest that the formation of complexes with members of the M protein family is a common mechanism for anchoring LTA on the surface in a manner that contributes to hydrophobicity and to biofilm formation in S. pyogenes, but these activities in some serotypes are dependent on a trypsin-sensitive protein(s) that remains to be identified. The need for interactions between LTA and M proteins may impose functional constraints that limit variations in the sequence of the M proteins, major virulence factors of S. pyogenes.	[Ofek, Itzhak; Penfound, Thomas; Dale, James B.] Univ Tennessee, Dept Med, Memphis, TN 38104 USA; [Hasty, David L.] Univ Tennessee, Dept Anat & Neurobiol, Knoxville, TN 37996 USA; [Courtney, Harry S.; Hasty, David L.; Dale, James B.] Univ Tennessee, Dept Mol Sci, Knoxville, TN 37996 USA; [Dale, James B.] Univ Tennessee, Dept Vet Affairs Med Ctr, Knoxville, TN 37996 USA; [Ofek, Itzhak] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Nizet, Victor; Pence, Morgan A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kreikemeyer, Bernd; Podbielbski, Andreas] Univ Rostock Hosp, Dept Med Microbiol & Hosp Hyg, D-2500 Rostock, Germany	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California San Diego; University of Rostock	Courtney, HS (corresponding author), Univ Tennessee, Dept Med, Memphis, TN 38104 USA.	hcourtney@utmem.edu	Pence, Morgan A./N-1620-2019; Nizet, Victor/AAF-3190-2019; Ofek, Itzhak/L-4616-2019	Pence, Morgan A./0000-0003-0239-0228; Kreikemeyer, Bernd/0000-0001-9527-5098; Nizet, Victor/0000-0003-3847-0422; Dale, James/0000-0001-9860-9233	US Department of Veterans Affairs; US Public Health Service [AI-10085]; BMBF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI010085, R01AI077780, R37AI010085, R55AI010085] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by research funds from the US Department of Veterans Affairs (HSC, DLH) and from the US Public Health Service Grant AI-10085 (JBD). The work in the labs of Bernd Kreikemeyer and Andreas Podbielski was funded by the BMBF "ERANet Pathogenomics" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 1997, GENE, V196, P75, DOI 10.1016/S0378-1119(97)00201-1; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Courtney H. S., 1990, MICROBIAL CELL SURFA, P361; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; COURTNEY HS, 1983, J BACTERIOL, V153, P763, DOI 10.1128/JB.153.2.763-770.1983; COURTNEY HS, 1994, INFECT IMMUN, V62, P4868, DOI 10.1128/IAI.62.11.4868-4873.1994; COURTNEY HS, 2004, BACTERIAL INVASION H, P239; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 1999, J CLIN INVEST, V103, P1261, DOI 10.1172/JCI5118; Doyle R. J., 1990, MICROBIAL CELL SURFA; Eran Y, 2007, MOL MICROBIOL, V63, P1209, DOI 10.1111/j.1365-2958.2007.05581.x; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hasty DL, 2006, J IMMUNOL, V176, P5567, DOI 10.4049/jimmunol.176.9.5567; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HOGG SD, 1993, ANTON LEEUW INT J G, V63, P29, DOI 10.1007/BF00871728; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; KRAUS W, 1987, J IMMUNOL, V139, P3084; LANCEFIELD RC, 1928, J EXP MED, V47, P9; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; McLellan DGJ, 2001, INFECT IMMUN, V69, P2943, DOI 10.1128/IAI.69.5.2943-2949.2001; MIORNER H, 1983, INFECT IMMUN, V39, P336; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; NORGREN M, 1989, INFECT IMMUN, V57, P3846, DOI 10.1128/IAI.57.12.3846-3850.1989; OFEK I, 1982, J BACTERIOL, V149, P426, DOI 10.1128/JB.149.2.426-433.1982; OFEK I, 1975, J EXP MED, V141, P990, DOI 10.1084/jem.141.5.990; OFEK I, 1983, J BACTERIOL, V154, P139, DOI 10.1128/JB.154.1.139-145.1983; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; PODBIELSKI A, 1995, INFECT IMMUN, V63, P9, DOI 10.1128/IAI.63.1.9-20.1995; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; SLADE HD, 1957, J GEN PHYSIOL, V41, P63, DOI 10.1085/jgp.41.1.63	46	89	90	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4166	10.1371/journal.pone.0004166	http://dx.doi.org/10.1371/journal.pone.0004166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132104	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473700005
J	Schuz, J; Waldemar, G; Olsen, JH; Johansen, C				Schuez, Joachim; Waldemar, Gunhild; Olsen, Jorgen H.; Johansen, Christoffer			Risks for Central Nervous System Diseases among Mobile Phone Subscribers: A Danish Retrospective Cohort Study	PLOS ONE			English	Article								The aim of this study was to investigate a possible link between cellular telephone use and risks for various diseases of the central nervous system (CNS). We conducted a large nationwide cohort study of 420 095 persons whose first cellular telephone subscription was between 1982 and 1995, who were followed through 2003 for hospital contacts for a diagnosis of a CNS disorder. Standardized hospitalization ratios (SHRs) were derived by dividing the number of hospital contacts in the cohort by the number expected in the Danish population. The SHRs were increased by 10-20% for migraine and vertigo. No associations were seen for amyotrophic lateral sclerosis, multiple sclerosis or epilepsy in women. SHRs decreased by 30-40% were observed for dementia (Alzheimer disease, vascular and other dementia), Parkinson disease and epilepsy among men. In analyses restricted to subscribers of 10 years or more, the SHRs remained similarly increased for migraine and vertigo and similarly decreased for Alzheimer disease and other dementia and epilepsy (in men); the other SHRs were close to unity. In conclusion, the excesses of migraine and vertigo observed in this first study on cellular telephones and CNS disease deserve further attention. An interplay of a healthy cohort effect and reversed causation bias due to prodromal symptoms impedes detection of a possible association with dementia and Parkinson disease. Identification of the factors that result in a healthy cohort might be of interest for elucidation of the etiology of these diseases.	[Schuez, Joachim; Olsen, Jorgen H.; Johansen, Christoffer] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Waldemar, Gunhild] Univ Copenhagen Hosp, Dept Neurol, Memory Disorder Res Grp, Copenhagen, Denmark	Danish Cancer Society; University of Copenhagen	Schuz, J (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.	joachim@cancer.dk	Johansen, Christoffer/AAG-7916-2020	Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662	The Danish Strategic Research Council [2064-04-0010]	The Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	The study received funding entirely from The Danish Strategic Research Council (2064-04-0010). The study sponsor had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Ahlbom A, 2008, TOXICOLOGY, V246, P248, DOI 10.1016/j.tox.2008.02.004; BRESLOW NE, 1987, IARC SCI PUBL, V82; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Christensen HC, 2005, NEUROLOGY, V64, P1189, DOI 10.1212/01.WNL.0000156351.72313.D3; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Garcia AM, 2008, INT J EPIDEMIOL, V37, P329, DOI 10.1093/ije/dym295; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Hardell Lennart, 2006, World J Surg Oncol, V4, P74, DOI 10.1186/1477-7819-4-74; Hillert L, 2008, BIOELECTROMAGNETICS, V29, P185, DOI 10.1002/bem.20379; Hug K, 2006, SOZ PRAVENTIV MED, V51, P210, DOI 10.1007/s00038-006-5096-4; Johansen C, 2004, SCAND J WORK ENV HEA, V30, P1; Korczyn AD, 2007, J NEUROL SCI, V257, P2, DOI 10.1016/j.jns.2007.01.081; LAHKOLA A, 2008, INT J EPIDEMIOL 0802; Lahkola A, 2007, INT J CANCER, V120, P1769, DOI 10.1002/ijc.22503; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Lyngberg AC, 2005, AM J EPIDEMIOL, V161, P1066, DOI 10.1093/aje/kwi139; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; Rothman KJ, 2000, LANCET, V356, P1837, DOI 10.1016/S0140-6736(00)03244-X; *SCENIHR, 2008, POSS EFF EL FIELDS E; Schoemaker MJ, 2005, BRIT J CANCER, V93, P842, DOI 10.1038/sj.bjc.6602764; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Schuz J, 2006, BIOELECTROMAGNETICS, V27, P280, DOI 10.1002/bem.20212; Schuz J, 2005, BIOELECTROMAGNETICS, pS45, DOI 10.1002/bem.20129; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; Vrijheid M, 2006, OCCUP ENVIRON MED, V63, P237, DOI 10.1136/oem.2004.019281; Wilen J, 2003, BIOELECTROMAGNETICS, V24, P152, DOI 10.1002/bem.10101	32	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4389	10.1371/journal.pone.0004389	http://dx.doi.org/10.1371/journal.pone.0004389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194493	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483600014
J	van der Laan, S; de Kloet, ER; Meijer, OC				van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.			Timing Is Critical for Effective Glucocorticoid Receptor Mediated Repression of the cAMP-Induced CRH Gene	PLOS ONE			English	Article								Glucocorticoid negative feedback of the hypothalamus-pituitary-adrenal axis is mediated in part by direct repression of gene transcription in glucocorticoid receptor (GR) expressing cells. We have investigated the cross talk between the two main signaling pathways involved in activation and repression of corticotrophin releasing hormone (CRH) mRNA expression: cyclic AMP (cAMP) and GR. We report that in the At-T20 cell-line the glucocorticoid-mediated repression of the cAMP-induced human CRH proximal promoter activity depends on the relative timing of activation of both signaling pathways. Activation of the GR prior to or in conjunction with cAMP signaling results in an effective repression of the cAMP-induced transcription of the CRH gene. In contrast, activation of the GR 10 minutes after onset of cAMP treatment, results in a significant loss of GR-mediated repression. In addition, translocation of ligand-activated GR to the nucleus was found as early as 10 minutes after glucocorticoid treatment. Interestingly, while both signaling cascades counteract each other on the CRH proximal promoter, they synergize on a synthetic promoter containing 'positive' response elements. Since the order of activation of both signaling pathways may vary considerably in vivo, we conclude that a critical time-window exists for effective repression of the CRH gene by glucocorticoids.	[van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.] Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands; [van der Laan, Siem; de Kloet, E. Ronald; Meijer, Onno C.] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Laan, S (corresponding author), Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands.	o.meijer@lacdr.leidenuniv.nl	meijer, onno c/D-8070-2018; de Kloet, Edo Ronald/H-3278-2011	meijer, onno c/0000-0002-8394-6859; de Kloet, Ron/0000-0001-9176-1830; VAN DER LAAN, Siem/0000-0001-8169-1963	ZON-MW Vidi [016.036.381]; Royal Dutch Academy of Arts and Sciences	ZON-MW Vidi(Netherlands Organization for Health Research and Development); Royal Dutch Academy of Arts and Sciences	The research described was funded by a ZON-MW Vidi grant (016.036.381) to OCM, and the Royal Dutch Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XN, 2008, BRAIN RES, V1223, P1, DOI 10.1016/j.brainres.2008.05.043; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; Ginsberg AB, 2003, J NEUROENDOCRINOL, V15, P1075, DOI 10.1046/j.1365-2826.2003.01100.x; GuardiolaDiaz HM, 1996, MOL ENDOCRINOL, V10, P317, DOI 10.1210/me.10.3.317; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; King BR, 2007, FRONT BIOSCI, V12, P581, DOI 10.2741/2084; Kovacs KJ, 1996, J NEUROSCI, V16, P262; KRAUS J, 1995, DNA CELL BIOL, V14, P103, DOI 10.1089/dna.1995.14.103; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; Malkoski SP, 1999, MOL ENDOCRINOL, V13, P1629, DOI 10.1210/me.13.10.1629; Malkoski SP, 1997, MOL CELL ENDOCRINOL, V127, P189, DOI 10.1016/S0303-7207(96)04004-X; Pearce D, 1998, J BIOL CHEM, V273, P30081, DOI 10.1074/jbc.273.46.30081; SHIPSTON MJ, 1992, ENDOCRINOLOGY, V130, P2213, DOI 10.1210/en.130.4.2213; SPENGLER D, 1992, MOL ENDOCRINOL, V6, P1931, DOI 10.1210/me.6.11.1931; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; van der Laan S, 2008, ENDOCRINOLOGY, V149, P725, DOI 10.1210/en.2007-1234; VAN LP, 1990, ENDOCRINOLOGY, V127, P1412, DOI 10.1210/endo-127-3-1412; Watts AG, 2005, FRONT NEUROENDOCRIN, V26, P109, DOI 10.1016/j.yfrne.2005.09.001; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Winnay JN, 2006, ENDOCRINOLOGY, V147, P1322, DOI 10.1210/en.2005-0751; Wolfl S, 1999, MOL ENDOCRINOL, V13, P659, DOI 10.1210/me.13.5.659; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4327	10.1371/journal.pone.0004327	http://dx.doi.org/10.1371/journal.pone.0004327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177170	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483100010
J	Liraz, O; Rosenblum, K; Barkai, E				Liraz, Ori; Rosenblum, Kobi; Barkai, Edi			CAMKII Activation Is Not Required for Maintenance of Learning-Induced Enhancement of Neuronal Excitability	PLOS ONE			English	Article								Pyramidal neurons in the piriform cortex from olfactory-discrimination trained rats show enhanced intrinsic neuronal excitability that lasts for several days after learning. Such enhanced intrinsic excitability is mediated by long-term reduction in the post-burst after-hyperpolarization (AHP) which is generated by repetitive spike firing. AHP reduction is due to decreased conductance of a calcium-dependent potassium current, the sl(AHP). We have previously shown that learning-induced AHP reduction is maintained by persistent protein kinase C (PKC) and extracellular regulated kinase (ERK) activation. However, the molecular machinery underlying this long-lasting modulation of intrinsic excitability is yet to be fully described. Here we examine whether the CaMKII, which is known to be crucial in learning, memory and synaptic plasticity processes, is instrumental for the maintenance of learning-induced AHP reduction. KN93, that selectively blocks CaMKII autophosphorylation at Thr286, reduced the AHP in neurons from trained and control rat to the same extent. Consequently, the differences in AHP amplitude and neuronal adaptation between neurons from trained rats and controls remained. Accordingly, the level of activated CaMKII was similar in pirifrom cortex samples taken form trained and control rats. Our data show that although CaMKII modulates the amplitude of AHP of pyramidal neurons in the piriform cortex, its activation is not required for maintaining learning-induced enhancement of neuronal excitability.	[Liraz, Ori; Rosenblum, Kobi; Barkai, Edi] Univ Haifa, Fac Sci, Dept Neurobiol, IL-31999 Haifa, Israel; [Liraz, Ori; Rosenblum, Kobi; Barkai, Edi] Univ Haifa, Fac Sci, Dept Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Liraz, O (corresponding author), Univ Haifa, Fac Sci, Dept Neurobiol, IL-31999 Haifa, Israel.	ebarkai@research.haifa.ac.il			Israel Science Foundation; US-Israel Binational Foundation	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Foundation(US-Israel Binational Science Foundation)	Supported by grants from the Israel Science Foundation and the US-Israel Binational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brosh I, 2006, J NEUROPHYSIOL, V96, P1728, DOI 10.1152/jn.00376.2006; Cammarota M, 2002, CELL MOL NEUROBIOL, V22, P259, DOI 10.1023/A:1020763716886; Cohen-Matsliah SI, 2007, J NEUROSCI, V27, P12584, DOI 10.1523/JNEUROSCI.3728-07.2007; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Disterhoft JF, 2004, AGEING RES REV, V3, P383, DOI 10.1016/j.arr.2004.07.001; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Moyer JR, 1996, J NEUROSCI, V16, P5536; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Ohno M, 2006, EUR J NEUROSCI, V23, P2235, DOI 10.1111/j.1460-9568.2006.04746.x; Power JM, 2002, J NEUROSCI, V22, P7234; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 2001, J NEUROSCI, V21, P1385; Saar D, 1999, J NEUROSCI, V19, P8616; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; SANCHEZANDRES JV, 1991, J NEUROPHYSIOL, V65, P796, DOI 10.1152/jn.1991.65.4.796; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P450, DOI 10.1152/jn.1988.59.2.450; Seroussi Y, 2002, EUR J NEUROSCI, V16, P965, DOI 10.1046/j.1460-9568.2002.02155.x; Smolen P, 2008, AM J PHYSIOL-CELL PH, V294, pC503, DOI 10.1152/ajpcell.00447.2007; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Wang HM, 2008, CURR BIOL, V18, P1546, DOI 10.1016/j.cub.2008.08.064; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Zelcer I, 2006, CEREB CORTEX, V16, P460, DOI 10.1093/cercor/bhi125; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4289	10.1371/journal.pone.0004289	http://dx.doi.org/10.1371/journal.pone.0004289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172997	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483000004
J	Mercer, RE; Wevrick, R				Mercer, Rebecca E.; Wevrick, Rachel			Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice	PLOS ONE			English	Article							ESTROUS-CYCLE; MOUSE; DEFICIENCY; HYPOGONADISM; TESTOSTERONE; PUBERTY; ABSENCE; NECDIN	Background: MAGEL2 is one of several genes typically inactivated in the developmental obesity disorder Prader-Willi syndrome (PWS). The physiological consequences of loss of MAGEL2, but without the concurrent loss of other PWS genes, are not well understood. Gene-targeted mutation of Magel2 in mice disrupts circadian rhythm and metabolism causing reduced total activity, reduced weight gain before weaning, and increased adiposity after weaning. Principal Findings: We now show that loss of Magel2 in mice causes reduced fertility in both males and females through extended breeding intervals and early reproductive decline and termination. Female Magel2-null mice display extended and irregular estrous cycles, while males show decreased testosterone levels, and reduced olfactory preference for female odors. Conclusions: Our results suggest that loss of MAGEL2 contributes to the reproductive deficits seen in people with PWS, and further highlights the role of normal circadian rhythm in the maintenance of fertility.	[Mercer, Rebecca E.; Wevrick, Rachel] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta	Mercer, RE (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	rachel.wevrick@ualberta.ca		Mercer, Rebecca/0000-0002-9264-7797; Wevrick, Rachel/0000-0002-3343-5794	Natural Sciences and Engineering Research Council of Canada; Canadian Diabetes Association [Doctoral Student Research Award]; CIHR	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Diabetes Association; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Diabetes Association. REM is funded by a Canadian Diabetes Association Doctoral Student Research Award, and a CIHR Strategic Training Grant in Maternal-Fetal Newborn Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Asnicar MA, 2002, ENDOCRINOLOGY, V143, P3994, DOI 10.1210/en.2002-220354; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Boden MJ., 2005, REPROD FERT DEVELOP, V17, P126, DOI [10.1071/SRB05Abs297, DOI 10.1071/SRB05ABS297]; Brandau DT, 2008, AM J MED GENET A, V146A, P665, DOI 10.1002/ajmg.a.32194; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Crino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Eiholzer U, 2006, J CLIN ENDOCR METAB, V91, P892, DOI 10.1210/jc.2005-0902; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Guzman C, 2006, J PHYSIOL-LONDON, V572, P97, DOI 10.1113/jphysiol.2005.103903; HAMILTON CR, 1972, AM J MED, V52, P322, DOI 10.1016/0002-9343(72)90019-8; KATCHER ML, 1977, EUR J PEDIATR, V124, P257, DOI 10.1007/BF00441933; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; MILLER NL, 2008, HUM MOL GENET; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; Ren J, 2003, J NEUROSCI, V23, P1569; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; TAKANO H, 1987, ARCH HISTOL CYTOL, V50, P533, DOI 10.1679/aohc.50.533; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	33	62	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4291	10.1371/journal.pone.0004291	http://dx.doi.org/10.1371/journal.pone.0004291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172181	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482900008
J	Fink, BD; O'Malley, Y; Dake, BL; Ross, NC; Prisinzano, TE; Sivitz, WI				Fink, Brian D.; O'Malley, Yunxia; Dake, Brian L.; Ross, Nicolette C.; Prisinzano, Thomas E.; Sivitz, William I.			Mitochondrial Targeted Coenzyme Q, Superoxide, and Fuel Selectivity in Endothelial Cells	PLOS ONE			English	Article							FATTY-ACID OXIDATION; REACTIVE OXYGEN; COMPLEX-I; UNCOUPLING PROTEIN-2; DAMAGE; ANTIOXIDANT; EXPRESSION; RESPIRATION; UBIQUINONE; GENERATION	Background: Previously, we reported that the "antioxidant'' compound "mitoQ'' (mitochondrial-targeted ubiquinol/ubiquinone) actually increased superoxide production by bovine aortic endothelial (BAE) cell mitochondria incubated with complex I but not complex II substrates. Methods and Results: To further define the site of action of the targeted coenzyme Q compound, we extended these studies to include different substrate and inhibitor conditions. In addition, we assessed the effects of mitoquinone on mitochondrial respiration, measured respiration and mitochondrial membrane potential in intact cells, and tested the intriguing hypothesis that mitoquinone might impart fuel selectivity in intact BAE cells. In mitochondria respiring on differing concentrations of complex I substrates, mitoquinone and rotenone had interactive effects on ROS consistent with redox cycling at multiple sites within complex I. Mitoquinone increased respiration in isolated mitochondria respiring on complex I but not complex II substrates. Mitoquinone also increased oxygen consumption by intact BAE cells. Moreover, when added to intact cells at 50 to 1000 nM, mitoquinone increased glucose oxidation and reduced fat oxidation, at doses that did not alter membrane potential or induce cell toxicity. Although high dose mitoquinone reduced mitochondrial membrane potential, the positively charged mitochondrial-targeted cation, decyltriphenylphosphonium (mitoquinone without the coenzyme Q moiety), decreased membrane potential more than mitoquinone, but did not alter fuel selectivity. Therefore, non-specific effects of the positive charge were not responsible and the quinone moiety is required for altered nutrient selectivity. Conclusions: In summary, the interactive effects of mitoquinone and rotenone are consistent with redox cycling at more than one site within complex I. In addition, mitoquinone has substrate dependent effects on mitochondrial respiration, increases repiration by intact cells, and alters fuel selectivity favoring glucose over fatty acid oxidation at the intact cell level.	[Fink, Brian D.; O'Malley, Yunxia; Dake, Brian L.; Sivitz, William I.] Iowa City VA Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA; [Ross, Nicolette C.; Prisinzano, Thomas E.] Univ Iowa, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Fink, BD (corresponding author), Iowa City VA Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA USA.	william-sivitz@uiowa.edu	Prisinzano, Thomas E/B-7877-2010	Prisinzano, Thomas/0000-0002-0649-8052; Prisinzano, Loredana/0000-0002-8893-2210; Sivitz, William/0000-0002-7829-0189; Fink, Brian/0000-0002-1149-7935	Veterans Affairs Medical Research Funds; National Institutes of Health [DK25295]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	Veterans Affairs Medical Research Funds(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Veterans Affairs Medical Research Funds and grant DK25295 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Coppey LJ, 2003, FREE RADICAL RES, V37, P33, DOI 10.1080/1071576021000028442; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fink BD, 2007, AM J PHYSIOL-REG I, V293, pR1773, DOI 10.1152/ajpregu.00478.2007; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; James AM, 2004, ARCH BIOCHEM BIOPHYS, V423, P47, DOI 10.1016/j.abb.2003.12.025; James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1007/BF02254975; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MOSER DR, 1992, MOL ENDOCRINOL, V6, P1805, DOI 10.1210/me.6.11.1805; Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Murphy MP, 2004, BIOCHEM SOC T, V32, P1011, DOI 10.1042/BST0321011; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NOBES CD, 1990, J BIOL CHEM, V265, P12903; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schafer M, 2003, CIRC RES, V92, P1010, DOI 10.1161/01.RES.0000070882.81508.FC; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Shadid S, 2006, DIABETOLOGIA, V49, P149, DOI 10.1007/s00125-005-0051-0; Tauskela JS, 2007, IDRUGS, V10, P399; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587	48	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4250	10.1371/journal.pone.0004250	http://dx.doi.org/10.1371/journal.pone.0004250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158951	Green Submitted, gold, Green Published			2022-12-27	WOS:000265482200007
J	Carbone, MA; Ayroles, JF; Yamamoto, A; Morozova, TV; West, SA; Magwire, MM; Mackay, TFC; Anholt, RRH				Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.			Overexpression of Myocilin in the Drosophila Eye Activates the Unfolded Protein Response: Implications for Glaucoma	PLOS ONE			English	Article								Background: Glaucoma is the world's second leading cause of bilateral blindness with progressive loss of vision due to retinal ganglion cell death. Myocilin has been associated with congenital glaucoma and 2-4% of primary open angle glaucoma (POAG) cases, but the pathogenic mechanisms remain largely unknown. Among several hypotheses, activation of the unfolded protein response (UPR) has emerged as a possible disease mechanism. Methodology/Principal Findings: We used a transgenic Drosophila model to analyze whole-genome transcriptional profiles in flies that express human wild- type or mutant MYOC in their eyes. The transgenic flies display ocular fluid discharge, reflecting ocular hypertension, and a progressive decline in their behavioral responses to light. Transcriptional analysis shows that genes associated with the UPR, ubiquitination, and proteolysis, as well as metabolism of reactive oxygen species and photoreceptor activity undergo altered transcriptional regulation. Following up on the results from these transcriptional analyses, we used immunoblots to demonstrate the formation of MYOC aggregates and showed that the formation of such aggregates leads to induction of the UPR, as evident from activation of the fluorescent UPR marker, xbp1-EGFP. Conclusions/Significance: Our results show that aggregation of MYOC in the endoplasmic reticulum activates the UPR, an evolutionarily conserved stress pathway that culminates in apoptosis. We infer from the Drosophila model that MYOC-associated ocular hypertension in the human eye may result from aggregation of MYOC and induction of the UPR in trabecular meshwork cells. This process could occur at a late age with wild- type MYOC, but might be accelerated by MYOC mutants to account for juvenile onset glaucoma.	[Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Magwire, Michael M.; Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Anholt, Robert R. H.] N Carolina State Univ, Dept Zool, Raleigh, NC USA; [Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H.] North Carolina State University, WM Keck Ctr Behavioral Biol, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Carbone, MA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@unity.ncsu.edu	Anholt, Robert/S-5977-2019; West, Steven/AAG-4009-2019		National Institutes of Health [EY015873]; NATIONAL EYE INSTITUTE [R01EY015873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a grant from the National Institutes of Health grant EY015873 to RRHA and TFCM. The federal funding institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Acharya M, 2006, MOL VIS, V12, P399; Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Affymetrix, 2001, MICR SUIT US GUID VE; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Ashburner M., 1989, DROSOPHILA LAB HDB; Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borras T, 2003, GENETICS, V163, P637; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruttini M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1034, DOI 10.1001/archopht.121.7.1034; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hart H, 2007, VET OPHTHALMOL, V10, P28, DOI 10.1111/j.1463-5224.2007.00517.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; LEE JA, 2007, MECH DEV; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; MacKay EO, 2008, VET OPHTHALMOL, V11, P177, DOI 10.1111/j.1463-5224.2008.00617.x; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Moreno TA, 2005, DEV BIOL, V288, P434, DOI 10.1016/j.ydbio.2005.09.050; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Mukhopadhyay A, 2002, MOL VIS, V8, P271; Naskar R, 2006, MOL VIS, V12, P1199; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Reddy ABM, 2004, MOL VIS, V10, P696; Richards JE, 1998, OPHTHALMOLOGY, V105, P1698, DOI 10.1016/S0161-6420(98)99041-8; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; SHEPARD AR, 2007, HUM MOL GENET; Stoilova D, 1997, OPHTHALMIC GENET, V18, P109, DOI 10.3109/13816819709057124; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yagi Yoshimasa, 2000, Molecular Cell Biology Research Communications, V4, P43, DOI 10.1006/mcbr.2000.0248; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806	64	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4216	10.1371/journal.pone.0004216	http://dx.doi.org/10.1371/journal.pone.0004216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148291	gold, Green Submitted, Green Published			2022-12-27	WOS:000265479900009
J	Bonadonna, F; Caro, SP; Brooke, MD				Bonadonna, Francesco; Caro, Samuel P.; Brooke, M. de L.			Olfactory Sex Recognition Investigated in Antarctic Prions	PLOS ONE			English	Article							ODOR RECOGNITION; BLUE PETRELS; SENSORY ECOLOGY; DISCRIMINATION; MECHANISM; NEST; COMMUNICATION; PACHYPTILA; NAVIGATION; SIGNATURE	Chemical signals can yield information about an animal such as its identity, social status or sex. Such signals have rarely been considered in birds, but recent results have shown that chemical signals are actually used by different bird species to find food and to recognize their home and nest. This is particularly true in petrels whose olfactory anatomy is among the most developed in birds. Recently, we have demonstrated that Antarctic prions, Pachyptila desolata, are also able to recognize and follow the odour of their partner in a Y-maze. However, the experimental protocol left unclear whether this choice reflected an olfactory recognition of a particular individual (i.e. partner) or a more general sex recognition mechanism. To test this second hypothesis, male and female birds' odours were presented simultaneously to 54 Antarctic prions in a Y-maze. Results showed random behaviour by the tested bird, independent of its sex or reproductive status. Present results do not support the possibility that Antarctic prions can distinguish the sex of a conspecific through its odour but indirectly support the hypothesis that they can distinguish individual odours.	[Caro, Samuel P.] CNRS, CEFE, Behav Ecol Grp, Montpellier, France; [Caro, Samuel P.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Brooke, M. de L.] Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge	Bonadonna, F (corresponding author), CNRS, CEFE, Behav Ecol Grp, Montpellier, France.	francesco.bonadonna@cefe.cnrs.fr	P, Samuel/A-5750-2008; Bonadonna, Francesco/A-7456-2008	P, Samuel/0000-0002-5405-7753; Bonadonna, Francesco/0000-0002-2702-5801	Institut Polaire Francais Paul Emile Victor; FRIA	Institut Polaire Francais Paul Emile Victor; FRIA(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Institut Polaire Francais Paul Emile Victor (IPEV, Program no 354 to Francesco Bonadonna). S.P.Caro was a FRIA grant recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; BANG BG, 1968, AUK, V85, P55; BANG BG, 1971, ACTA ANAT          S, V58, P1; Bonadonna F, 2004, ANIM BEHAV, V67, P893, DOI 10.1016/j.anbehav.2003.08.013; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bonadonna F, 2001, J EXP BIOL, V204, P1485; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; BONADONNA F, 2008, ANN NEW YOR IN PRESS; Bonadonna F, 2007, J CHEM ECOL, V33, P1819, DOI 10.1007/s10886-007-9345-7; Bouchard S, 2001, J ZOOL, V254, P109, DOI 10.1017/S0952836901000607; BRETAGNOLLE V, 1990, AUK, V107, P305, DOI 10.2307/4087614; Brooke M, 2004, ALBATROSSES PETRELS; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GENEVOIS F, 1994, ETHOL ECOL EVOL, V6, P377, DOI 10.1080/08927014.1994.9522988; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Hagelin JC., 2007, REPROD BEHAV PHYLOGE, V6B, P76; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; JACOB J, 1979, BIOCHEM SYST ECOL, V7, P149, DOI 10.1016/0305-1978(79)90024-3; Minguez E, 1997, ANIM BEHAV, V53, P701, DOI 10.1006/anbe.1996.0308; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nevitt GA, 2005, MAR ECOL PROG SER, V287, P292; Nevitt GA, 2005, BIOL LETT-UK, V1, P303, DOI 10.1098/rsbl.2005.0350; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Soini HA, 2007, J CHEM ECOL, V33, P183, DOI 10.1007/s10886-006-9210-0; Vicario DS, 2001, ANIM BEHAV, V61, P805, DOI 10.1006/anbe.2000.1651; Warham J., 1996, BEHAV POPULATION BIO; Zelano B, 2002, AM NAT, V160, pS225, DOI 10.1086/342897	32	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4148	10.1371/journal.pone.0004148	http://dx.doi.org/10.1371/journal.pone.0004148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127294	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473300013
J	Hong, JJ; Reynolds, MR; Mattila, TL; Hage, A; Watkins, DI; Miller, CJ; Skinner, PJ				Hong, Jung Joo; Reynolds, Matthew R.; Mattila, Teresa L.; Hage, Aaron; Watkins, David I.; Miller, Christopher J.; Skinner, Pamela J.			Localized Populations of CD8(low/-) MHC Class I Tetramer(+) SIV-Specific T Cells in Lymphoid Follicles and Genital Epithelium	PLOS ONE			English	Article								CD8 T cells play an important role in controlling viral infections. We investigated the in situ localization of simian immunodeficiency virus (SIV)-specific T cells in lymph and genital tissues from SIV-infected macaques using MHC-class I tetramers. The majority of tetramer-binding cells localized in T cell zones and were CD8(+). Curiously, small subpopulations of tetramer-binding cells that had little to no surface CD8 were detected in situ both early and late post-infection, and in both vaginally and rectally inoculated macaques. These tetramer(+)CD8(low/-) cells were more often localized in apparent B cell follicles relative to T cell zones and more often found near or within the genital epithelium than the submucosa. Cells analyzed by flow cytometry showed similar populations of cells. Further immunohistological characterization revealed small populations of tetramer(+)CD20(-) cells inside B cell follicles and that tetramer(+) cells did not stain with gamma delta-TCR nor CD4 antibodies. Negative control tetramer staining indicated that tetramer(+)CD8(low/-) cells were not likely NK cells non-specifically binding to MHC tetramers. These findings have important implications for SIV-specific and other antigen-specific T cell function in these specific tissue locations, and suggest a model in which antigen-specific CD8+ T cells down modulate CD8 upon entering B cell follicles or the epithelial layer of tissues, or alternatively a model in which only antigen-specific CD8 T cells that down-modulate CD8 can enter B cell follicles or the epithelium.	[Hong, Jung Joo; Mattila, Teresa L.; Hage, Aaron; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Reynolds, Matthew R.; Watkins, David I.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Miller, Christopher J.] Univ Calif Davis, Davis, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Hong, JJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	skinn002@umn.edu		Skinner, Pamela/0000-0003-3388-1687	NIH [P51 RR00167-42, PAR-03-094]; National Center for Research Resources (NCRR) [P51 RR000167]; Wisconsin National Primate Research Center, University of Wisconsin-Madison; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141, P51RR000167] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wisconsin National Primate Research Center, University of Wisconsin-Madison; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants P51 RR00167-42 and PAR-03-094. Additionally, this publication was made possible in part by Grant Number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Altman JD, 1998, SCIENCE, V280, P1821; Brenner M, 2006, J VIROL, V80, P4469, DOI 10.1128/JVI.80.9.4469-4481.2006; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; GAN YH, 1995, CLIN EXP IMMUNOL, V102, P251; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Haigwood NL, 2004, AIDS REV, V6, P187; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Komatsu H, 2003, CLIN EXP IMMUNOL, V134, P9, DOI 10.1046/j.1365-2249.2003.02266.x; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; SKINNER PJ, 2005, CURR PROTOC IMMUNOL, pCH17; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Veazey RS, 2003, J MED PRIMATOL, V32, P194, DOI 10.1034/j.1600-0684.2003.00025.x; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4131	10.1371/journal.pone.0004131	http://dx.doi.org/10.1371/journal.pone.0004131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122815	Green Submitted, Green Published, gold			2022-12-27	WOS:000265472900009
J	Takahashi, K; Yoshina, S; Masashi, M; Ito, W; Inoue, T; Shiwaku, H; Arai, H; Mitani, S; Okazawa, H				Takahashi, Keiko; Yoshina, Sawako; Masashi, Maekawa; Ito, Wakana; Inoue, Takao; Shiwaku, Hiroki; Arai, Hiroyuki; Mitani, Shohei; Okazawa, Hitoshi			Nematode Homologue of PQBP1, a Mental Retardation Causative Gene, Is Involved in Lipid Metabolism	PLOS ONE			English	Article							POLYGLUTAMINE TRACT-BINDING; RENPENNING SYNDROME; MUTATIONS; ELEGANS; PROTEIN; TRANSCRIPTION; PGC-1-ALPHA; HUNTINGTIN; FAMILIES; SYSTEM	Background: PQBP1 is a causative gene for X-linked mental retardation (MR) whose patients frequently show lean body. C. elegans has a strictly conserved homologue gene of PQBP1, T21D12.3. Methodology and Principal Findings: We generated Venus-transgenic and T21D12.3-mutant nematodes to analyze developmental expression patterns and in vivo functions of the nematode PQBP1 homologue protein (pqbp-1.1). During development, pqbp-1.1 is expressed from cell proliferation stage to larva stage. In larva, intestinal cells show the highest expression of pqbp-1.1, while it decreases in adult worms. The mutants of pqbp-1.1 show a decrease of the lipid content in intestinal cells. Especially, incorporation of fatty acid into triglyceride is impaired. ShRNA-mediated repression of PQBP1 also leads to reduction of lipid content in mammalian primary white adipocytes. Conclusion/Significance: These results suggest that pqbp-1.1 is involved in lipid metabolism of intestinal cells. Dysfunction of lipid metabolism might underlie lean body, one of the most frequent symptoms associating with PQBP1-linked MR patients.	[Ito, Wakana; Shiwaku, Hiroki; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Takahashi, Keiko; Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Masashi, Maekawa; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Women's Medical University; University of Tokyo	Takahashi, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp		Shiwaku, Hiroki/0000-0001-7503-8044	Japan Science Technology Agency (PRESTO, JST, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]	Japan Science Technology Agency (PRESTO, JST, Japan)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to H.O. from Japan Science Technology Agency (PRESTO, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi Kaveh, 2007, WormBook, P1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Brouwer APM, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9482; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kleefstra T, 2004, CLIN GENET, V66, P318, DOI 10.1111/j.1399-0004.2004.00308.x; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NISHINO N, 2008, J CLIN INVEST; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	29	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4104	10.1371/journal.pone.0004104	http://dx.doi.org/10.1371/journal.pone.0004104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119319	Green Submitted, gold, Green Published			2022-12-27	WOS:000265472600006
J	Galvez, BG; San Martin, N; Rodriguez, C				Galvez, Beatriz G.; San Martin, Nuria; Rodriguez, Carlos			TNF-alpha Is Required for the Attraction of Mesenchymal Precursors to White Adipose Tissue in Ob/ob Mice	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; INFLAMMATION; DELIVERY; OBESITY; LUNG	Most adult tissues harbour a stem cell subpopulation (Mesenchymal Precursors or MPs) that represent a small proportion of the total cell number and have the potential to differentiate into several cell types within the mesenchymal lineage. In adipose tissue, adipocytes account for two-thirds of the total cell number. The remaining cells include blood and endothelial cells, along with adipocyte precursors (adipose MPs). Obesity is defined as an excess of body fat that frequently results in a significant impairment of health. The ob/ob mice bear a mutation in the ob gene that causes a deficiency in the hormone leptin and hence obesity. Here, we present evidence that ob/ob mice have a dramatic decrease in the resident MP pool of several tissues, including squeletal muscle, heart, lung and adipose tissue. Moreover, we show that that there is a migration of MP cells from distant organs, as well as homing of these cells to the adipose tissue mass of the ob/ob mice. We call this process adipotaxis. Once in the adipose tissue, migrant MPs undergoe adipose differentiation, giving rise to new differentiated adipocytes within the adipose mass. Finally, we provide evidence that adipotaxis is largely explained by the production of high levels of Tumor Necrosis Factor-alpha (TNF-alpha) within the ob/ob adipose tissue. The therapeutic implications for human obesity as well as for regenerative medicine are further discussed in this paper.	[Galvez, Beatriz G.; San Martin, Nuria; Rodriguez, Carlos] Projech Sci Technol, Madrid, Spain		Galvez, BG (corresponding author), Projech Sci Technol, Madrid, Spain.	carlosr@projech.com	Gálvez, Beatriz G./H-1644-2015	Gálvez, Beatriz G./0000-0002-8082-9323; rodriguez, carlos/0000-0001-9593-8680	Spanish Ministry of Education [CIT-090100-2007-05, CEI-010000-2007-11]	Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Education (Profit: CIT-090100-2007-05 and CEIPAR: CEI-010000-2007-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Dundas SR, 2001, J HISTOCHEM CYTOCHEM, V49, P1321, DOI 10.1177/002215540104901015; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Kathryn E., 2003, J CLIN INVEST, V112, P1785; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KIMBER I, 1992, J INVEST DERMATOL, V99, pS48, DOI 10.1111/1523-1747.ep12668986; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu XF, 2008, MOL REPROD DEV, V75, P1426, DOI 10.1002/mrd.20867; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	21	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4444	10.1371/journal.pone.0004444	http://dx.doi.org/10.1371/journal.pone.0004444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214223	Green Submitted, gold, Green Published			2022-12-27	WOS:000265484300003
J	Ducros, M; Moreaux, L; Bradley, J; Tiret, P; Griesbeck, O; Charpak, S				Ducros, Mathieu; Moreaux, Laurent; Bradley, Jonathan; Tiret, Pascale; Griesbeck, Oliver; Charpak, Serge			Spectral Unmixing: Analysis of Performance in the Olfactory Bulb In Vivo	PLOS ONE			English	Article							EXCITATION CROSS-SECTIONS; FLUORESCENT PROTEINS; MICROSCOPY; ABSORPTION; EXPRESSION; VARIANTS; CFP; PH	Background: The generation of transgenic mice expressing combinations of fluorescent proteins has greatly aided the reporting of activity and identification of specific neuronal populations. Methods capable of separating multiple overlapping fluorescence emission spectra, deep in the living brain, with high sensitivity and temporal resolution are therefore required. Here, we investigate to what extent spectral unmixing addresses these issues. Methodology/Principal Findings: Using fluorescence resonance energy transfer (FRET)-based reporters, and two-photon laser scanning microscopy with synchronous multichannel detection, we report that spectral unmixing consistently improved FRET signal amplitude, both in vitro and in vivo. Our approach allows us to detect odor-evoked FRET transients 180-250 mm deep in the brain, the first demonstration of in vivo spectral imaging and unmixing of FRET signals at depths greater than a few tens of micrometer. Furthermore, we determine the reporter efficiency threshold for which FRET detection is improved by spectral unmixing. Conclusions/Significance: Our method allows the detection of small spectral variations in depth in the living brain, which is essential for imaging efficiently transgenic animals expressing combination of multiple fluorescent proteins.	[Ducros, Mathieu; Moreaux, Laurent; Tiret, Pascale; Charpak, Serge] INSERM, U603, Paris, France; [Ducros, Mathieu; Moreaux, Laurent; Tiret, Pascale; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Ducros, Mathieu; Moreaux, Laurent; Bradley, Jonathan; Tiret, Pascale; Charpak, Serge] Univ Paris 05, Paris, France; [Bradley, Jonathan] CNRS, UMR 8118, Paris, France; [Griesbeck, Oliver] Max Planck Inst Neurobiol, Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society	Ducros, M (corresponding author), INSERM, U603, Paris, France.	serge.charpak@univ-paris5.fr	Charpak, Serge/M-9412-2017; Ducros, Mathieu/Q-6663-2017	Ducros, Mathieu/0000-0002-7625-036X; Bradley, Jonathan/0000-0002-6933-1153; Griesbeck, Oliver/0000-0001-5883-5594	Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT) [ACI NIC0025, ACI IBPC:DRAB 042492]; Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM) [ICP20001222128, ACE20071110945]; Region Ile de France (Sesame program); Fondation Bettancourt Schueller; Human frontier science program organisation (HSFPO); Ecole des Neurosciences Paris Ile-de-France (ENP); Association Francaise contre les Myopathies [12411]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Ile de France (Sesame program)(Region Ile-de-France); Fondation Bettancourt Schueller; Human frontier science program organisation (HSFPO)(Human Frontier Science Program); Ecole des Neurosciences Paris Ile-de-France (ENP); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	Financial support was provided by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT, ACI NIC0025 and ACI IBPC:DRAB 042492), the Centre National de la Recherche Scientifique (CNRS), the Fondation pour la Recherche Medicale (FRM; ICP20001222128, ACE20071110945), the Region Ile de France (Sesame program), the Fondation Bettancourt Schueller, the Human frontier science program organisation (HSFPO), Ecole des Neurosciences Paris Ile-de-France (ENP). Pascale Tiret was supported by a fellowship from the Association Francaise contre les Myopathies (12411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Buehler C, 2005, J FLUORESC, V15, P41, DOI 10.1007/s10895-005-0212-z; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; CHEONG WF, 1995, OPTICAL THERMAL RESP, P8; DAVIES LM, 2007, P SPIE, V6443; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Ecker RC, 2004, CYTOM PART A, V59A, P172, DOI 10.1002/cyto.a.20053; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Green RO, 1998, REMOTE SENS ENVIRON, V65, P227, DOI 10.1016/S0034-4257(98)00064-9; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Haraguchi T, 2002, GENES CELLS, V7, P881, DOI 10.1046/j.1365-2443.2002.00575.x; Harris AT, 2006, CYTOM PART A, V69A, P872, DOI 10.1002/cyto.a.20309; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Hiraoka Y, 1991, Semin Cell Biol, V2, P153; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Kasparov S, 2002, EXP PHYSIOL, V87, P715, DOI 10.1113/eph8702480; Lansford R, 2001, J BIOMED OPT, V6, P311, DOI 10.1117/1.1383780; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; MANK M, 2008, NAT METHODS; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nadrigny F, 2006, EUR BIOPHYS J BIOPHY, V35, P533, DOI 10.1007/s00249-005-0040-8; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shimozono S, 2008, METHOD CELL BIOL, V85, P381, DOI 10.1016/S0091-679X(08)85016-9; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Tay LH, 2007, BIOPHYS J, V93, P4031, DOI 10.1529/biophysj.107.109629; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2006, CYTOM PART A, V69A, P904, DOI 10.1002/cyto.a.20267; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wachman ES, 1997, BIOPHYS J, V73, P1215, DOI 10.1016/S0006-3495(97)78154-2; WALLACE DJ, 2008, NAT METHODS; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zimmermann A, 2002, PHOTOCHEM PHOTOBIOL, V75, P335, DOI 10.1562/0031-8655(2002)075<0335:IVIOTP>2.0.CO;2; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zucker RM, 2007, CYTOM PART A, V71A, P174, DOI 10.1002/cyto.a.20371	48	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4418	10.1371/journal.pone.0004418	http://dx.doi.org/10.1371/journal.pone.0004418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198655	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483900015
J	Olmstead, MC; Ouagazzal, AM; Kieffer, BL				Olmstead, Mary C.; Ouagazzal, Abdel-Mouttalib; Kieffer, Brigitte L.			Mu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; COCAINE; HEROIN; ETHANOL; MICE; PERFORMANCE; WITHDRAWAL; DEPENDENCE; ALCOHOL; NEURONS	Impulsivity is a primary feature of many psychiatric disorders, most notably attention deficit hyperactivity disorder and drug addiction. Impulsivity includes a number of processes such as the inability to delay gratification, the inability to withhold a motor response, or acting before all of the relevant information is available. These processes are mediated by neural systems that include dopamine, serotonin, norepinephrine, glutamate and cannabinoids. We examine, for the first time, the role of opioid systems in impulsivity by testing whether inactivation of the mu- (Oprm1) or delta- (Oprd1) opioid receptor gene alters motor impulsivity in mice. Wild-type and knockout mice were examined on either a pure C57BL6/J (BL6) or a hybrid 50% C57Bl/6J-50% 129Sv/pas (HYB) background. Mice were trained to respond for sucrose in a signaled nose poke task that provides independent measures of associative learning ( responses to the reward-paired cue) and motor impulsivity (premature responses). Oprm1 knockout mice displayed a remarkable decrease in motor impulsivity. This was observed on the two genetic backgrounds and did not result from impaired associative learning, as responses to the cue signaling reward did not differ across genotypes. Furthermore, mutant mice were insensitive to the effects of ethanol, which increased disinhibition and decreased conditioned responding in wild-type mice. In sharp contrast, mice lacking the Oprd1 gene were more impulsive than controls. Again, mutant animals showed no deficit in associative learning. Ethanol completely disrupted performance in these animals. Together, our results suggest that mu- opioid receptors enhance, whereas delta- opioid receptors inhibit, motor impulsivity. This reveals an unanticipated contribution of endogenous opioid receptor activity to disinhibition. In a broader context, these data suggest that alterations in mu- or delta- opioid receptor function may contribute to impulse control disorders.	Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Ouagazzal, Abdel-Mouttalib; Kieffer, Brigitte L.] Inst Genet Biol Mol Cellulaire, Dept Neurobiol, Illkirch Graffenstaden, France	Queens University - Canada; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Olmstead, MC (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	olmstead@queensu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); the Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Louis Pasteur (ULP); National Institute of Drug Abuse (NIH-NIDA) [DA 05010]; European Consortium GENADDICT [LSHM-CT-2004-005166]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Louis Pasteur (ULP); National Institute of Drug Abuse (NIH-NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); European Consortium GENADDICT	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Louis Pasteur (ULP), the National Institute of Drug Abuse (NIH-NIDA #DA 05010) and the European Consortium GENADDICT # LSHM-CT-2004-005166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Bowers BJ, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-21-j0004.2001; Chefer VI, 2003, EUR J NEUROSCI, V18, P1915, DOI 10.1046/j.1460-9568.2003.02912.x; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Contet C, 2004, CURR OPIN NEUROBIOL, V14, P370, DOI 10.1016/j.conb.2004.05.005; CRITCHLOW B, 1986, AM PSYCHOL, V41, P751, DOI 10.1037/0003-066X.41.7.751; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Garavan H, 2007, NEUROPSYCHOL REV, V17, P337, DOI 10.1007/s11065-007-9034-x; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Ghozland S, 2002, J NEUROSCI, V22, P1146, DOI 10.1523/JNEUROSCI.22-03-01146.2002; Isles AR, 2004, J NEUROSCI, V24, P6733, DOI 10.1523/JNEUROSCI.1650-04.2004; JOB MO, 2007, BIOL PSYCHI IN PRESS; Keller JJ, 2005, BEHAV BRAIN RES, V162, P143, DOI 10.1016/j.bbr.2005.03.004; Kim SW, 1998, J CLIN PSYCHIAT, V59, P159; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Lee TM, 2002, BRAIN INJURY, V16, P885, DOI 10.1080/02699050210128915; LINNOILA M, 1993, INT CLIN PSYCHOPHARM, V8, P53, DOI 10.1097/00004850-199309001-00008; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mitchell JM, 2007, NEUROPSYCHOPHARMACOL, V32, P439, DOI 10.1038/sj.npp.1301226; Moeller FG, 2002, DRUG ALCOHOL DEPEN, V68, P105; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Papaleo F, 2007, EUR J NEUROSCI, V25, P3398, DOI 10.1111/j.1460-9568.2007.05595.x; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; PATTIJ T, 2008, TRENDS PHAR IN PRESS; Pau CWH, 2002, ARCH CLIN NEUROPSYCH, V17, P663, DOI 10.1016/S0887-6177(01)00169-X; PLIAKAS AM, 2005, BIOL PSYCHIAT, V57, P1385; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; Roberts AJ, 2000, J PHARMACOL EXP THER, V293, P1002; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SANCHISSEGURA C, 2006, ADDICT BIOL, V11, P38; Schmidt P, 2001, FORENSIC SCI INT, V115, P219, DOI 10.1016/S0379-0738(00)00333-9; Sharpe LG, 2000, SYNAPSE, V37, P292, DOI 10.1002/1098-2396(20000915)37:4<292::AID-SYN6>3.0.CO;2-V; Shen KZ, 2002, J PHYSIOL-LONDON, V541, P219, DOI 10.1113/jphysiol.2001.013404; Tien LT, 2003, BRAIN RES BULL, V61, P109, DOI 10.1016/S0361-9230(03)00077-7; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Witkowski G, 2006, BRAIN RES, V1094, P92, DOI 10.1016/j.brainres.2006.03.119	43	74	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4410	10.1371/journal.pone.0004410	http://dx.doi.org/10.1371/journal.pone.0004410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JN	19198656	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900011
J	Redman, LM; Heilbronn, LK; Martin, CK; de Jonge, L; Williamson, DA; Delany, JP; Ravussin, E				Redman, Leanne M.; Heilbronn, Leonie K.; Martin, Corby K.; de Jonge, Lilian; Williamson, Donald A.; Delany, James P.; Ravussin, Eric		Pennington CALERIE Team	Metabolic and Behavioral Compensations in Response to Caloric Restriction: Implications for the Maintenance of Weight Loss	PLOS ONE			English	Article							ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; INDIVIDUALS; ADAPTATION; REQUIREMENTS; CHAMBER; HUMANS; WOMEN; GAIN	Background: Metabolic and behavioral adaptations to caloric restriction (CR) in free-living conditions have not yet been objectively measured. Methodology and Principal Findings: Forty-eight (36.8 +/- 61.0 y), overweight (BMI 27.8 +/- 60.7 kg/m(2)) participants were randomized to four groups for 6-months; Control: energy intake at 100% of energy requirements; CR: 25% calorie restriction; CR+EX: 12.5% CR plus 12.5% increase in energy expenditure by structured exercise; LCD: low calorie diet (890 kcal/d) until 15% weight reduction followed by weight maintenance. Body composition (DXA) and total daily energy expenditure (TDEE) over 14-days by doubly labeled water (DLW) and activity related energy activity (AREE) were measured after 3 (M3) and 6 (M6) months of intervention. Weight changes at M6 were -1.0 +/- 1.1% (Control), -10.4 +/- 0.9% (CR), -10.0 +/- 0.8% (CR+EX) and -13.9 +/- 0.8% (LCD). At M3, absolute TDEE was significantly reduced in CR (-454 +/- 76 kcal/d) and LCD (-633 +/- 66 kcal/d) but not in CR+EX or controls. At M6 the reduction in TDEE remained lower than baseline in CR (-316 +/- 118 kcal/d) and LCD (-389 +/- 124 kcal/d) but reached significance only when CR and LCD were combined (-351 +/- 83 kcal/d). In response to caloric restriction (CR/LCD combined), TDEE adjusted for body composition, was significantly lower by 2431651 and -240 +/- 83 kcal/d at M3 and M6, respectively, indicating a metabolic adaptation. Likewise, physical activity (TDEE adjusted for sleeping metabolic rate) was significantly reduced from baseline at both time points. For control and CR+EX, adjusted TDEE (body composition or sleeping metabolic rate) was not changed at either M3 or M6. Conclusions: For the first time we show that in free-living conditions, CR results in a metabolic adaptation and a behavioral adaptation with decreased physical activity levels. These data also suggest potential mechanisms by which CR causes large inter-individual variability in the rates of weight loss and how exercise may influence weight loss and weight loss maintenance.	[Redman, Leanne M.; Heilbronn, Leonie K.; Martin, Corby K.; de Jonge, Lilian; Williamson, Donald A.; Delany, James P.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Redman, LM (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	ravusse@pbrc.edu	Redman, Leanne M/N-1986-2017; Martin, Corby K./N-1976-2017; Heilbronn, Leonie K/H-1874-2013; Ravussin, Eric/N-1985-2017; Biguzzi, Felipe A/E-4724-2015	Martin, Corby K./0000-0002-8125-4015; Heilbronn, Leonie K/0000-0003-2106-7303; Ravussin, Eric/0000-0003-2129-547X; de Jonge, Lilian/0000-0001-5900-0695; DeLany, James/0000-0003-0366-3849	CALERIE [U01 AG20478, NCT00099151]; National Health and Medical Research Council of Australia; Neil Hamilton-Fairley Training Fellowship [ID 349553]; NIH [K23 DK068052-01A2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068052, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG020478] Funding Source: NIH RePORTER	CALERIE; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Neil Hamilton-Fairley Training Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CALERIE (U01 AG20478), NCT00099151 (clinicaltrials.gov). This work was supported by U01 AG20478 (ER); National Health and Medical Research Council of Australia, Neil Hamilton-Fairley Training Fellowship (ID 349553) to LMR and NIH grant K23 DK068052-01A2 to CKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1995, INT J OBESITY, V19, P644; DEGROOT LCPGM, 1989, AM J CLIN NUTR, V50, P1314, DOI 10.1093/ajcn/50.6.1314; DELANY JP, 1989, J APPL PHYSIOL, V67, P1922, DOI 10.1152/jappl.1989.67.5.1922; FRICKER J, 1991, AM J CLIN NUTR, V53, P826, DOI 10.1093/ajcn/53.4.826; Frisard MI, 2007, J GERONTOL A-BIOL, V62, P783, DOI 10.1093/gerona/62.7.783; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; HEYMAN MB, 1992, AM J PHYSIOL, V263, pR250, DOI 10.1152/ajpregu.1992.263.2.R250; JAMES WPT, 1982, HUM NUTR-CLIN NUTR, V36, P331; KEESEY RE, 1989, MED CLIN N AM, V73, P15, DOI 10.1016/S0025-7125(16)30689-7; KEMNITZ JW, 1993, J GERONTOL, V48, pB17, DOI 10.1093/geronj/48.1.B17; Keys A, 1950, BIOL HUMAN STARVATIO; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEIBEL RL, 1984, METABOLISM, V33, P164, DOI 10.1016/0026-0495(84)90130-6; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354; Nguyen T, 2003, MED BIOL ENG COMPUT, V41, P572, DOI 10.1007/BF02345320; PAVLOU KN, 1989, AM J CLIN NUTR, V49, P1115, DOI 10.1093/ajcn/49.5.1115; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; RAVUSSIN E, 1985, AM J CLIN NUTR, V41, P753, DOI 10.1093/ajcn/41.4.753; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 1996, AM J PHYSIOL-REG I, V270, pR496, DOI 10.1152/ajpregu.1996.270.3.R496; ROSENBAUM M, 2008, AM J CLIN N IN PRESS; SACHER GA, 1977, HDB BIOL AGING, P582; Schoeller DA, 1997, AM J CLIN NUTR, V66, P551, DOI 10.1093/ajcn/66.3.551; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; SCHULZ LO, 1992, J APPL PHYSIOL, V72, P23, DOI 10.1152/jappl.1992.72.1.23; SOHAL RS, 1996, OXIDATIVE STRESS CAL, P59; TATARANNI PA, 1995, AM J CLIN NUTR, V61, P1013; VANSANT G, 1989, INT J OBESITY, V13, P87; VELTHUISTEWIERIK EJM, 1995, INT J OBESITY, V19, P318; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J. E., 2002, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Weinsier RL, 2000, AM J CLIN NUTR, V72, P1088; ZURLO F, 1992, AM J PHYSIOL, V263, pE296, DOI 10.1152/ajpendo.1992.263.2.E296	38	230	232	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4377	10.1371/journal.pone.0004377	http://dx.doi.org/10.1371/journal.pone.0004377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198647	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900002
J	Thompson, D; Batterham, AM; Markovitch, D; Dixon, NC; Lund, AJS; Walhin, JP				Thompson, Dylan; Batterham, Alan M.; Markovitch, Daniella; Dixon, Natalie C.; Lund, Adam J. S.; Walhin, Jean-Philippe			Confusion and Conflict in Assessing the Physical Activity Status of Middle-Aged	PLOS ONE			English	Article							OF-SPORTS-MEDICINE; POSTPRANDIAL LIPEMIA; SEDENTARY ADULTS; PUBLIC-HEALTH; UNITED-STATES; HEART-RATE; ENERGY-EXPENDITURE; ACTIVITY PATTERNS; EXERCISE; RECOMMENDATION	Background: Physical activity (including exercise) is prescribed for health and there are various recommendations that can be used to gauge physical activity status. The objective of the current study was to determine whether twelve commonly-used physical activity recommendations similarly classified middle-aged men as sufficiently active for general health. Methods and Findings: We examined the commonality in the classification of physical activity status between twelve variations of physical activity recommendations for general health in ninety men aged 45-64 years. Physical activity was assessed using synchronised accelerometry and heart rate. Using different guidelines but the same raw data, the proportion of men defined as active ranged from to 11% to 98% for individual recommendations (median 73%, IQR 30% to 87%). There was very poor absolute agreement between the recommendations, with an intraclass correlation coefficient (A, 1) of 0.24 (95% CI, 0.15 to 0.34). Only 8% of men met all 12 recommendations and would therefore be unanimously classified as active and only one man failed to meet every recommendation and would therefore be unanimously classified as not sufficiently active. The wide variability in physical activity classification was explained by ostensibly subtle differences between the 12 recommendations for thresholds related to activity volume (time or energy), distribution (e. g., number of days of the week), moderate intensity cut-point (e. g., 3 vs. 4 metabolic equivalents or METs), and duration (including bout length). Conclusions: Physical activity status varies enormously depending on the physical activity recommendation that is applied and even ostensibly small differences have a major impact. Approximately nine out of every ten men in the present study could be variably described as either active or not sufficiently active. Either the effective dose or prescription that underlies each physical activity recommendation is different or each recommendation is seeking the same prescriptive outcome but with variable success.	[Thompson, Dylan; Markovitch, Daniella; Dixon, Natalie C.; Lund, Adam J. S.; Walhin, Jean-Philippe] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Batterham, Alan M.] Univ Teesside, Hlth & Social Care Inst, Middlesbrough TS1 3BA, Cleveland, England	University of Bath; University of Teesside	Thompson, D (corresponding author), Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England.	d.thompson@bath.ac.uk	thompson, dylan/C-2478-2009	BATTERHAM, ALAN/0000-0002-7865-7227; Thompson, Dylan/0000-0002-6312-1518	ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		*AM COLL SPORTS ME, 2008, EX MED CALL EV PHYS; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; *BRIT HEART FDN, 2007, BEAT HEART DIS TOG G; Brooks GA, 2004, AM J CLIN NUTR, V79, P921; Centers for Disease Control and Prevention, 2008, PHYS ACT EV REC; Coleman KJ, 1999, PREV MED, V28, P510, DOI 10.1006/pmed.1998.0471; COOKSEY D, 2006, HM TREASURY; CROUTER SE, 2007, EUROPEAN J CLIN NUTR; DALEY AJ, 2008, DOCT MUCH PHYS ACT S; Department of Health, 2004, LEAST 5 WEEK EV IMP; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2006, DIABETES CARE, V29, P2598, DOI 10.2337/dc06-0313; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Institute of Medicine, 2005, DIET REF INT EN CARB; KING DS, 1995, J APPL PHYSIOL, V78, P17, DOI 10.1152/jappl.1995.78.1.17; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P1209; Kruger J, 2008, JAMA-J AM MED ASSOC, V299, P30; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; Lynch BM, 2007, ANN BEHAV MED, V34, P135, DOI 10.1007/BF02872668; Macfarlane DJ, 2006, PREV MED, V43, P332, DOI 10.1016/j.ypmed.2006.06.002; MAYOR S, 2008, BRIT MED J, V336, P576; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Miyashita M, 2006, AM J CLIN NUTR, V83, P24; National Centre for Social Research, 2004, HLTH SURV ENGL 2003; National Health Service, 2006, GEN PRACT PHYS ACT Q; National Institute for Health and Clinical Excellence, 2006, NICE PUBL HLTH INT G; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Phongsavan P, 2007, PSYCHOL SPORT EXERC, V8, P939, DOI 10.1016/j.psychsport.2006.11.004; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Ramirez-Zea M, 2005, PUBLIC HEALTH NUTR, V8, P1213, DOI 10.1079/PHN2005807; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Talbot LA, 2007, PREV MED, V45, P169, DOI 10.1016/j.ypmed.2007.05.014; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tully MA, 2007, J EPIDEMIOL COMMUN H, V61, P778, DOI 10.1136/jech.2006.053058; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; *WHO, 2007, GLOB STRAT DIET PHYS	47	40	41	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4337	10.1371/journal.pone.0004337	http://dx.doi.org/10.1371/journal.pone.0004337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JI	19183812	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483200011
J	Bartolomucci, A; Cabassi, A; Govoni, P; Ceresini, G; Cero, C; Berra, D; Dadomo, H; Franceschini, P; Dell'Omo, G; Parmigiani, S; Palanza, P				Bartolomucci, Alessandro; Cabassi, Aderville; Govoni, Paolo; Ceresini, Graziano; Cero, Cheryl; Berra, Daniela; Dadomo, Harold; Franceschini, Paolo; Dell'Omo, Giacomo; Parmigiani, Stefano; Palanza, Paola			Metabolic Consequences and Vulnerability to Diet-Induced Obesity in Male Mice under Chronic Social Stress	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BODY-MASS; PSYCHOSOCIAL STRESS; FOOD-INTAKE; TYROSINE-HYDROXYLASE; CORTISOL SECRETION; ABDOMINAL OBESITY; GENE-EXPRESSION; NEUROPEPTIDE-Y; ANIMAL-MODELS	Social and psychological factors interact with genetic predisposition and dietary habit in determining obesity. However, relatively few pre-clinical studies address the role of psychosocial factors in metabolic disorders. Previous studies from our laboratory demonstrated in male mice: 1) opposite status-dependent effect on body weight gain under chronic psychosocial stress; 2) a reduction in body weight in individually housed (Ind) male mice. In the present study these observations were extended to provide a comprehensive characterization of the metabolic consequences of chronic psychosocial stress and individual housing in adult CD-1 male mice. Results confirmed that in mice fed standard diet, dominant (Dom) and Ind had a negative energy balance while subordinate (Sub) had a positive energy balance. Locomotor activity was depressed in Sub and enhanced in Dom. Hyperphagia emerged for Dom and Sub and hypophagia for Ind. Dom also showed a consistent decrease of visceral fat pads weight as well as increased norepinephrine concentration and smaller adipocytes diameter in the perigonadal fat pad. On the contrary, under high fat diet Sub and, surprisingly, Ind showed higher while Dom showed lower vulnerability to obesity associated with hyperphagia. In conclusion, we demonstrated that social status under chronic stress and individual housing deeply affect mice metabolic functions in different, sometime opposite, directions. Food intake, the hedonic response to palatable food as well as the locomotor activity and the sympathetic activation within the adipose fat pads all represent causal factors explaining the different metabolic alterations observed. Overall this study demonstrates that pre-clinical animal models offer a suitable tool for the investigation of the metabolic consequences of chronic stress exposure and associated psychopathologies.	[Bartolomucci, Alessandro; Cero, Cheryl; Berra, Daniela; Dadomo, Harold; Franceschini, Paolo; Parmigiani, Stefano; Palanza, Paola] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Cabassi, Aderville] Univ Parma, Dept Internal Med Nephrol & Hlth Sci, I-43100 Parma, Italy; [Govoni, Paolo] Univ Parma, Dept Expt Med, I-43100 Parma, Italy; [Ceresini, Graziano] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy	University of Parma; University of Parma; University of Parma; University of Parma	Bartolomucci, A (corresponding author), Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy.	alessandro.bartolomucci@unipr.it	dadomo, harold/GQP-4815-2022	Cero, Cheryl/0000-0003-0513-8669; Dell'Omo, Giacomo/0000-0002-9601-9675; PARMIGIANI, STEFANO/0000-0002-6658-2029	University of Parma	University of Parma	Supported by The University of Parma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Baran SE, 2005, NEUROREPORT, V16, P39, DOI 10.1097/00001756-200501190-00010; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; BARTNESS TJ, 1989, AM J PHYSIOL, V257, pR1533, DOI 10.1152/ajpregu.1989.257.6.R1533; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; Bartolomucci A, 2005, MED SCI MONITOR, V11, pRA147; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bartolomucci A, 2003, PHYSIOL BEHAV, V80, P57, DOI 10.1016/S0031-9384(03)00209-9; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bartolomucci A, 2002, ETHOL ECOL EVOL, V14, P341; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Cabassi A, 2005, J CLIN ENDOCR METAB, V90, P2888, DOI 10.1210/jc.2004-1995; Cabassi A, 1998, LIFE SCI, V62, P1111, DOI 10.1016/S0024-3205(98)00034-4; Cabassi A, 2002, HYPERTENSION, V39, P656, DOI 10.1161/hy0202.103471; Camm AJ, 1996, CIRCULATION, V93, P1043; Cichon M, 2002, P ROY SOC B-BIOL SCI, V269, P1493, DOI 10.1098/rspb.2002.2054; Cinti S, 1999, ADIPOSE ORGAN; COCCURELLO R, 2008, NEUROSCI BI IN PRESS; Cross-Mellor SK, 1999, AM J PHYSIOL-REG I, V277, pR705, DOI 10.1152/ajpregu.1999.277.3.R705; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Epel ES, 2000, PSYCHOSOM MED, V62, P623, DOI 10.1097/00006842-200009000-00005; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Ferrari PF, 2003, EUR J NEUROSCI, V17, P371, DOI 10.1046/j.1460-9568.2003.02447.x; Flatmark T, 2000, ACTA PHYSIOL SCAND, V168, P1; Foster MT, 2006, AM J PHYSIOL-REG I, V290, pR1284, DOI 10.1152/ajpregu.00437.2005; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; GREENO CG, 1994, PSYCHOL BULL, V115, P444, DOI 10.1037/0033-2909.115.3.444; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kaplan JR, 1999, ANN NY ACAD SCI, V896, P145, DOI 10.1111/j.1749-6632.1999.tb08112.x; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P231, DOI 10.1016/0149-7634(81)90004-X; Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Marniemi J, 2002, J INTERN MED, V251, P35, DOI 10.1046/j.1365-2796.2002.00921.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Meerlo, 1996, Stress, V1, P21; MEISEL RL, 1990, PHYSIOL BEHAV, V47, P815, DOI 10.1016/0031-9384(90)90002-L; MELHORN SJ, 2007, APPETITE, V49, P313; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Monteiro R, 2006, OBES SURG, V16, P804, DOI 10.1381/096089206777346600; NAOI M, 1988, J CHROMATOGR-BIOMED, V427, P229, DOI 10.1016/0378-4347(88)80125-7; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nonogaki K, 2007, ENDOCRINOLOGY, V148, P4658, DOI 10.1210/en.2007-0296; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; SAHAKIAN BJ, 1982, PHYSIOL BEHAV, V28, P117, DOI 10.1016/0031-9384(82)90112-3; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shi HF, 2005, AM J PHYSIOL-REG I, V288, pR1028, DOI 10.1152/ajpregu.00648.2004; Smith AW, 2005, INT J OBESITY, V29, P244, DOI 10.1038/sj.ijo.0802835; Solomon MB, 2007, AM J PHYSIOL-REG I, V292, pR283, DOI 10.1152/ajpregu.00330.2006; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Tamashiro KLK, 2007, PHYSIOL BEHAV, V91, P440, DOI 10.1016/j.physbeh.2007.04.004; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; Tamashiro KLK, 2006, PHYSIOL BEHAV, V89, P536, DOI 10.1016/j.physbeh.2006.05.026; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; van Dijk G, 2008, EUR J PHARMACOL, V585, P137, DOI 10.1016/j.ejphar.2007.11.079; van Kampen Marja, 2002, Stress, V5, P37; vanLeeuwen SD, 1997, PHYSIOL BEHAV, V62, P77, DOI 10.1016/S0031-9384(97)00144-3; VANSTRIEN T, 1986, INT J OBESITY, V10, P29; Veenema AH, 2003, J NEUROENDOCRINOL, V15, P256, DOI 10.1046/j.1365-2826.2003.00986.x; Wardle J, 2007, OBES REV, V8, P73, DOI 10.1111/j.1467-789X.2007.00322.x; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; Wilson ME, 2008, PHYSIOL BEHAV, V94, P586, DOI 10.1016/j.physbeh.2008.03.019; Yamada K, 2000, PHYSIOL BEHAV, V68, P555, DOI 10.1016/S0031-9384(99)00214-0	83	114	114	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4331	10.1371/journal.pone.0004331	http://dx.doi.org/10.1371/journal.pone.0004331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180229	gold, Green Published, Green Submitted			2022-12-27	WOS:000274089700014
J	Watanabe, T; Suzuki, T; Ishikawa, A; Yokota, Y; Ueda, HR; Yamada, RG; Tei, H; Imai, S; Tomida, S; Kobayashi, J; Naito, E; Yasuo, S; Nakao, N; Namikawa, T; Yoshimura, T; Ebihara, S				Watanabe, Tsuyoshi; Suzuki, Tohru; Ishikawa, Akira; Yokota, Yuki; Ueda, Hiroki R.; Yamada, Rikuhiro G.; Tei, Hajime; Imai, Saki; Tomida, Shigeru; Kobayashi, Junya; Naito, Emiko; Yasuo, Shinobu; Nakao, Nobuhiro; Namikawa, Takao; Yoshimura, Takashi; Ebihara, Shizufumi			Genetic and Molecular Analysis of Wild-Derived Arrhythmic Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LOCOMOTOR-ACTIVITY; CIRCADIAN PERIOD; BEHAVIORAL RHYTHMS; NEUROPEPTIDE-Y; MOUSE; CLOCK; EXPRESSION; QTL; TRANSCRIPTION	A new circadian variant was isolated by screening the intercross offspring of wild-caught mice (Mus musculus castaneus). This variant was characterized by an initial maintenance of damped oscillations and subsequent loss of rhythmicity after being transferred from light-dark (LD) cycles to constant darkness (DD). To map the genes responsible for the persistence of rhythmicity (circadian ratio) and the length of free-running period (tau), quantitative trait locus (QTL) analysis was performed using F-2 mice obtained from an F-1 cross between the circadian variant and C57BL/6J mice. As a result, a significant QTL with a main effect for circadian ratio (Arrhythmicity; Arrh-1) was mapped on Chromosome (Chr) 8. For tau, four significant QTLs, Short free-running period (Sfp-1) (Chr 1), Sfp-2 (Chr 6), Sfp-3 (Chr 8), Sfp-4 (Chr 11) were determined. An epistatic interaction was detected between Chr 3 (Arrh-2) and Chr 5 (Arrh-3). An in situ hybridization study of clock genes and mouse Period1::luciferase (mPer1::luc) real-time monitoring analysis in the suprachiasmatic nucleus (SCN) suggested that arrhythmicity in this variant might not be attributed to core circadian mechanisms in the SCN neurons. Our strategy using wild-derived variant mice may provide a novel opportunity to evaluate circadian and its related disorders in human that arise from the interaction between multiple variant genes.	[Watanabe, Tsuyoshi; Suzuki, Tohru; Yokota, Yuki; Imai, Saki; Tomida, Shigeru; Kobayashi, Junya; Naito, Emiko; Yasuo, Shinobu; Nakao, Nobuhiro; Yoshimura, Takashi; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan; [Suzuki, Tohru] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka, Japan; [Ishikawa, Akira; Namikawa, Takao] Nagoya Univ, Grad Sch Bioagricult Sci, Div Applied Genet & Physiol, Nagoya, Aichi, Japan; [Ueda, Hiroki R.; Yamada, Rikuhiro G.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Hyogo, Japan; [Ueda, Hiroki R.] RIKEN, Ctr Developmental Biol, Funct Genom Subunit, Hyogo, Japan; [Tei, Hajime] Mitsubishi Kagaku Inst Life Sci, Res Grp Chronogenom, Tokyo, Japan	Nagoya University; Hamamatsu University School of Medicine; Nagoya University; RIKEN; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Watanabe, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp	Ishikawa, Akira/I-6856-2014; Yoshimura, Takashi/C-8306-2012; Ueda, Hiroki R/C-5037-2014	Ishikawa, Akira/0000-0002-8275-4230; Yoshimura, Takashi/0000-0001-7018-9652; Ueda, Hiroki R/0000-0001-8342-9176	Grant-in-Aid for Scientific Research	Grant-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid for Scientific Research to S.E.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CHURCHILL GA, 1994, GENETICS, V138, P963; DIETRICH W, 1992, GENETICS, V131, P423; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; HOFSTETTER JR, 1995, BEHAV GENET, V25, P545, DOI 10.1007/BF02327578; Hofstetter JR, 2003, J BIOL RHYTHM, V18, P450, DOI 10.1177/0748730403259468; Hofstetter JR, 1999, CHRONOBIOL INT, V16, P269, DOI 10.3109/07420529909116857; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Knott SA, 1998, GENETICS, V149, P1069; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Lall GS, 2003, NEUROSCIENCE, V119, P611, DOI 10.1016/S0306-4522(02)00811-4; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Soscia SJ, 2004, BRAIN RES, V1023, P148, DOI 10.1016/j.brainres.2004.07.037; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Suzuki T, 2000, BEHAV GENET, V30, P447, DOI 10.1023/A:1010298701251; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vadasz C, 2000, NAT GENET, V26, P395, DOI 10.1038/82506; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Watanabe T, 2007, J BIOL RHYTHM, V22, P58, DOI 10.1177/0748730406295435; Wei WH, 2007, ANIM GENET, V38, P222, DOI 10.1111/j.1365-2052.2007.01591.x; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2002, J BIOL RHYTHM, V17, P512, DOI 10.1177/0748730402238233; Zhao WD, 2002, MAMM GENOME, V13, P345, DOI 10.1007/s00335-001-2154-3; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4301	10.1371/journal.pone.0004301	http://dx.doi.org/10.1371/journal.pone.0004301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173005	Green Published, gold			2022-12-27	WOS:000265483000010
J	Garnier-Lhomme, M; Byrne, RD; Hobday, TMC; Gschmeissner, S; Woscholski, R; Poccia, DL; Dufourc, EJ; Larijani, B				Garnier-Lhomme, Marie; Byrne, Richard D.; Hobday, Tina M. C.; Gschmeissner, Stephen; Woscholski, Rudiger; Poccia, Dominic L.; Dufourc, Erick J.; Larijani, Banafshe			Nuclear Envelope Remnants: Fluid Membranes Enriched in STEROLS and Polyphosphoinositides	PLOS ONE			English	Article								Background: The cytoplasm of eukaryotic cells is a highly dynamic compartment where membranes readily undergo fission and fusion to reorganize the cytoplasmic architecture, and to import, export and transport various cargos within the cell. The double membrane of the nuclear envelope that surrounds the nucleus, segregates the chromosomes from cytoplasm and regulates nucleocytoplasmic transport through pores. Many details of its formation are still unclear. At fertilization the sperm devoid of nuclear envelope pores enters the egg. Although most of the sperm nuclear envelope disassembles, remnants of the envelope at the acrosomal and centriolar fossae do not and are subsequently incorporated into the newly forming male pronuclear envelope. Remnants are conserved from annelid to mammalian sperm. Methodology/Principal Findings: Using lipid mass spectrometry and a new application of deuterium solid-state NMR spectroscopy we have characterized the lipid composition and membrane dynamics of the sperm nuclear envelope remnants in isolated sperm nuclei. Conclusions/Significance: We report nuclear envelope remnants are relatively fluid membranes rich in sterols, devoid of sphingomyelin, and highly enriched in polyphosphoinositides and polyunsaturated phospholipids. The localization of the polybasic effector domain of MARCKS illustrates the non-nuclear aspect of the polyphosphoinositides. Based on their atypical biophysical characteristics and phospholipid composition, we suggest a possible role for nuclear envelope remnants in membrane fusion leading to nuclear envelope assembly.	[Garnier-Lhomme, Marie; Byrne, Richard D.; Hobday, Tina M. C.; Larijani, Banafshe] Canc Res UK, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England; [Gschmeissner, Stephen] Canc Res UK, Lincolns Inn Fields Lab, Electron Microscopy Unit, London, England; [Garnier-Lhomme, Marie; Woscholski, Rudiger] Imperial Coll London, Div Cell & Molecular Biol, London, England; [Byrne, Richard D.; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Garnier-Lhomme, Marie; Dufourc, Erick J.] Univ Bordeaux 1, CNRS, UMR 5248, ENITAB, IECB, Pessac, France	Cancer Research UK; Cancer Research UK; Imperial College London; Amherst College; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Garnier-Lhomme, M (corresponding author), Canc Res UK, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015; DUFOURC, Erick Joel/AAA-4992-2020	Larijani, Banafshe/0000-0003-4735-1169; DUFOURC, Erick Joel/0000-0002-8221-9326; LHOMME, MARIE/0000-0002-6335-4506	Cancer Research UK; Amherst College Copeland Fellowship; H. Axel Schupf '57 Fund for Intellectual Life [Amherst College Faculty Research Award]; Medical Research Council [G0000138] Funding Source: researchfish; MRC [G0000138] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Amherst College Copeland Fellowship; H. Axel Schupf '57 Fund for Intellectual Life; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK core funding, an Amherst College Copeland Fellowship for RDB and an Amherst College Faculty Research Award from the H. Axel Schupf '57 Fund for Intellectual Life to DLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Aussenac F, 2003, BIOCHEMISTRY-US, V42, P1383, DOI 10.1021/bi026717b; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brzustowicz MR, 1999, FEBS LETT, V451, P197, DOI 10.1016/S0014-5793(99)00567-0; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; CHANA RS, 1985, CHEM PHYS LIPIDS, V37, P345, DOI 10.1016/0009-3084(85)90088-X; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1996, J CELL SCI, V109, P1275; COLLAS P, 1995, MOL REPROD DEV, V42, P106, DOI 10.1002/mrd.1080420114; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; Collas P, 1996, EUR J CELL BIOL, V71, P22; COLWIN AL, 1961, J BIOPHYS BIOCHEM CY, V10, P255, DOI 10.1083/jcb.10.2.255; COORSSEN JR, 1990, BIOCHEM CELL BIOL, V68, P65, DOI 10.1139/o90-008; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DECKER SJ, 1983, DEV BIOL, V96, P37, DOI 10.1016/0012-1606(83)90309-3; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FRANKE WW, 1974, INT REV CYTOL, P71; FRANKLIN LE, 1965, J CELL BIOL, V25, P81, DOI 10.1083/jcb.25.2.81; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GARNIERLHOMME M, 2007, LIPID QUANT IN PRESS; GARNIERLHOMME M, 2007, BIOCHIM BIOPHYS ACTA, V1786, P2516; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HOCHMUTH RM, 1983, SCIENCE, V220, P101, DOI 10.1126/science.6828875; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Irvine RF, 2006, BBA-MOL CELL BIOL L, V1761, P505, DOI 10.1016/j.bbalip.2006.02.008; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; KALINA M, 1977, J CELL BIOL, V74, P726, DOI 10.1083/jcb.74.3.726; KINSEY WH, 1980, J CELL BIOL, V87, P248, DOI 10.1083/jcb.87.1.248; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Larijani B., 2007, SIGNAL TRANSDUCT, V7, P142, DOI [10.1002/sita.200600128, DOI 10.1002/SITA.200600128]; Larijani B, 2006, LIPIDS, V41, P925, DOI 10.1007/s11745-006-5045-2; LEONARD A, 1991, BIOCHIMIE, V73, P1295, DOI 10.1016/0300-9084(91)90092-F; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LONGO FJ, 1968, J CELL BIOL, V39, P339, DOI 10.1083/jcb.39.2.339; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; MCCAUGHAN L, 1980, SCIENCE, V207, P1481, DOI 10.1126/science.7361101; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; RAND RP, 1968, BIOPHYS J, V8, P125, DOI 10.1016/S0006-3495(68)86479-3; Ribes E, 2004, MOL REPROD DEV, V68, P223, DOI 10.1002/mrd.20069; ROCHE Y, 2008, FASEB J; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; WANG W, 2007, BIOPHYS J	63	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4255	10.1371/journal.pone.0004255	http://dx.doi.org/10.1371/journal.pone.0004255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165341	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482400003
J	Icard, V; Diaz, O; Scholtes, C; Perrin-Cocon, L; Ramiere, C; Bartenschlager, R; Penin, F; Lotteau, V; Andre, P				Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Bartenschlager, Ralf; Penin, Francois; Lotteau, Vincent; Andre, Patrice			Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY; LIPID DROPLET; CORE PROTEIN; HUMAN SERA; PARTICLES; ASSOCIATION; RESISTANCE; CULTURE; BINDING	The density of circulating hepatitis C virus (HCV) particles in the blood of chronically infected patients is very heterogeneous. The very low density of some particles has been attributed to an association of the virus with apolipoprotein B (apoB) positive and triglyceride rich lipoproteins (TRL) likely resulting in hybrid lipoproteins known as lipoviro-particles (LVP) containing the viral envelope glycoproteins E1 and E2, capsid and viral RNA. The specific infectivity of these particles has been shown to be higher than the infectivity of particles of higher density. The nature of the association of HCV particles with lipoproteins remains elusive and the role of apolipoproteins in the synthesis and assembly of the viral particles is unknown. The human intestinal Caco-2 cell line differentiates in vitro into polarized and apoB secreting cells during asymmetric culture on porous filters. By using this cell culture system, cells stably expressing E1 and E2 secreted the glycoproteins into the basal culture medium after one week of differentiation concomitantly with TRL secretion. Secreted glycoproteins were only detected in apoB containing density fractions. The E1-E2 and apoB containing particles were unique complexes bearing the envelope glycoproteins at their surface since apoB could be co-immunoprecipitated with E2-specific antibodies. Envelope protein secretion was reduced by inhibiting the lipidation of apoB with an inhibitor of the microsomal triglyceride transfer protein. HCV glycoproteins were similarly secreted in association with TRL from the human liver cell line HepG2 but not by Huh-7 and Huh-7.5 hepatoma cells that proved deficient for lipoprotein assembly. These data indicate that HCV envelope glycoproteins have the intrinsic capacity to utilize apoB synthesis and lipoprotein assembly machinery even in the absence of the other HCV proteins. A model for LVP assembly is proposed.	[Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Univ Lyon, Lyon, France; [Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Inserm, U851, Lyon, France; [Icard, Vinca; Diaz, Olivier; Scholtes, Caroline; Perrin-Cocon, Laure; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Univ Lyon 1, IFR128, Lyon, France; [Icard, Vinca; Scholtes, Caroline; Ramiere, Christophe; Lotteau, Vincent; Andre, Patrice] Hosp Civils Lyon, Lab Virol Nord, Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-6900 Heidelberg, Germany; [Penin, Francois] Inst Biol Chim Proteines, CNRS, UMR 5086, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Icard, V (corresponding author), Univ Lyon, Lyon, France.	patrice.andre@inserm.fr	Ramière, Christophe/M-8083-2014; lotteau, vincent/M-8143-2014; diaz, olivier/M-8112-2014; Perrin-Cocon, Laure A/M-8099-2014; André, Patrice/M-8139-2014; Scholtès, Caroline/B-9039-2011; Bartenschlager, Ralf/L-2582-2015	Ramière, Christophe/0000-0002-1981-7155; diaz, olivier/0000-0002-3451-9914; Perrin-Cocon, Laure A/0000-0003-0501-6733; André, Patrice/0000-0002-5834-7395; Scholtès, Caroline/0000-0003-0691-8480; Lotteau, Vincent/0000-0003-0997-3282; Bartenschlager, Ralf/0000-0001-5601-9307	ANRS Agence nationale de recherches sur le sida et les hepatites virales	ANRS Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR))	The work was supported by a grant from the ANRS Agence nationale de recherches sur le sida et les hepatites virales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; BARTOSCH B, 2007, 14 INT S HCV REL VIR; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Domitrovich AM, 2005, J BIOL CHEM, V280, P39802, DOI 10.1074/jbc.M510391200; Dubuisson J, 2002, TRENDS CELL BIOL, V12, P517, DOI 10.1016/S0962-8924(02)02383-8; Dupuy FP, 2005, J GENE MED, V7, P1158, DOI 10.1002/jgm.769; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; LINDENBACH BD, 2005, SCIENCE; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mensenkamp AR, 2001, ARTERIOSCL THROM VAS, V21, P1366, DOI 10.1161/hq0801.093864; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nielsen SU, 2008, J GEN VIROL, V89, P2507, DOI 10.1099/vir.0.2008/000083-0; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pumeechockchai W, 2002, J MED VIROL, V68, P335, DOI 10.1002/jmv.10208; Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; THOMSSEN R, 1993, MED MICROBIOL IMMUN, V182, P329; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	97	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4233	10.1371/journal.pone.0004233	http://dx.doi.org/10.1371/journal.pone.0004233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156195	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482100005
J	Mavromatis, K; Ivanova, N; Anderson, I; Lykidis, A; Hooper, SD; Sun, H; Kunin, V; Lapidus, A; Hugenholtz, P; Patel, B; Kyrpides, NC				Mavromatis, Konstantinos; Ivanova, Natalia; Anderson, Iain; Lykidis, Athanasios; Hooper, Sean D.; Sun, Hui; Kunin, Victor; Lapidus, Alla; Hugenholtz, Philip; Patel, Bharat; Kyrpides, Nikos C.			Genome Analysis of the Anaerobic Thermohalophilic Bacterium Halothermothrix orenii	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; SEQUENCE; EXPRESSION; PURIFICATION; HALOPHILE; OXIDATION; PATHWAY; CLONING; GENE; AMYA	Halothermothirx orenii is a strictly anaerobic thermohalophilic bacterium isolated from sediment of a Tunisian salt lake. It belongs to the order Halanaerobiales in the phylum Firmicutes. The complete sequence revealed that the genome consists of one circular chromosome of 2578146 bps encoding 2451 predicted genes. This is the first genome sequence of an organism belonging to the Haloanaerobiales. Features of both Gram positive and Gram negative bacteria were identified with the presence of both a sporulating mechanism typical of Firmicutes and a characteristic Gram negative lipopolysaccharide being the most prominent. Protein sequence analyses and metabolic reconstruction reveal a unique combination of strategies for thermophilic and halophilic adaptation. H. orenii can serve as a model organism for the study of the evolution of the Gram negative phenotype as well as the adaptation under thermohalophilic conditions and the development of biotechnological applications under conditions that require high temperatures and high salt concentrations.	[Mavromatis, Konstantinos; Ivanova, Natalia; Anderson, Iain; Lykidis, Athanasios; Hooper, Sean D.; Sun, Hui; Kunin, Victor; Lapidus, Alla; Hugenholtz, Philip; Kyrpides, Nikos C.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Patel, Bharat] Griffith Univ, Sch Biomol & Phys Sci, Microbial Gene Res & Resources Facil, Nathan, Qld 4111, Australia	United States Department of Energy (DOE); Griffith University	Mavromatis, K (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Hugenholtz, Philip/AAD-9138-2019; Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Patel, Bharat/H-8050-2015	Hugenholtz, Philip/0000-0001-5386-7925; Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Kunin, Victor/0000-0002-8741-7866; Patel, Bharat/0000-0002-5332-1858; Ivanova, Natalia/0000-0002-5802-9485	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Livermore National Laboratory under Contract [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory under Contract(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	The work presented in this article was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOCH J, 1994, J BACTERIOL, V176, P5364; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; CAYOL JL, 1994, INT J SYST BACTERIOL, V44, P534, DOI 10.1099/00207713-44-3-534; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V352, P202, DOI 10.1016/0005-2736(74)90212-0; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cumino A, 2002, FEBS LETT, V517, P19, DOI 10.1016/S0014-5793(02)02516-4; de Champdore M, 2007, J R SOC INTERFACE, V4, P183, DOI 10.1098/rsif.2006.0174; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Huynh F, 2005, ACTA CRYSTALLOGR F, V61, P116, DOI 10.1107/S174430910403091X; Kikuchi Y, 2006, APPL ENVIRON MICROB, V72, P7183, DOI 10.1128/AEM.01528-06; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; LIOLIOS K, 2007, NUCL ACIDS RES DATAB, pD475; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; Lunn JE, 1999, PLANT MOL BIOL, V40, P297, DOI 10.1023/A:1006130802706; MARKOWITZ VM, 2007, NUCL ACIDS RES DATAB, pD528; Mijts BN, 2002, MICROBIOL-SGM, V148, P2343, DOI 10.1099/00221287-148-8-2343; Mijts BN, 2001, EXTREMOPHILES, V5, P61, DOI 10.1007/s007920000174; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PATEL BKC, 1995, FEMS MICROBIOL LETT, V134, P115, DOI 10.1016/0378-1097(95)00395-L; Podar M, 2006, CURR OPIN BIOTECH, V17, P250, DOI 10.1016/j.copbio.2006.05.002; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sivakumar N, 2006, FEBS LETT, V580, P2646, DOI 10.1016/j.febslet.2006.04.017; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041	35	51	229	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4192	10.1371/journal.pone.0004192	http://dx.doi.org/10.1371/journal.pone.0004192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145256	Green Published, gold			2022-12-27	WOS:000265479800003
J	Marshall, DC; Hill, KBR				Marshall, David C.; Hill, Kathy B. R.			Versatile Aggressive Mimicry of Cicadas by an Australian Predatory Katydid	PLOS ONE			English	Article								Background: In aggressive mimicry, a predator or parasite imitates a signal of another species in order to exploit the recipient of the signal. Some of the most remarkable examples of aggressive mimicry involve exploitation of a complex signal-response system by an unrelated predator species. Methodology/Principal Findings: We have found that predatory Chlorobalius leucoviridis katydids (Orthoptera: Tettigoniidae) can attract male cicadas (Hemiptera: Cicadidae) by imitating the species-specific wing-flick replies of sexually receptive female cicadas. This aggressive mimicry is accomplished both acoustically, with tegminal clicks, and visually, with synchronized body jerks. Remarkably, the katydids respond effectively to a variety of complex, species-specific Cicadettini songs, including songs of many cicada species that the predator has never encountered. Conclusions/Significance: We propose that the versatility of aggressive mimicry in C. leucoviridis is accomplished by exploiting general design elements common to the songs of many acoustically signaling insects that use duets in pair-formation. Consideration of the mechanism of versatile mimicry in C. leucoviridis may illuminate processes driving the evolution of insect acoustic signals, which play a central role in reproductive isolation of populations and the formation of species.	[Marshall, David C.; Hill, Kathy B. R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Marshall, DC (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	david.marshall@uconn.edu		Marshall, David/0000-0003-3581-8884	National Science Foundation [DEB 04-22386, DEB 05-29679, DEB 07 20664]	National Science Foundation(National Science Foundation (NSF))	This study arose during research partially supported by the National Science Foundation under Grant Numbers NSF DEB 04-22386, DEB 05-29679 and DEB 07 20664 to Dr. Chris Simon (University of Connecticut). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, SYST ZOOL, V11, P53, DOI 10.2307/2411453; Alexander RD., 1967, MISCELLANEOUS PUBLIC, V133, P1; Bailey WJ, 2003, PHYSIOL ENTOMOL, V28, P157, DOI 10.1046/j.1365-3032.2003.00337.x; BELWOOD JJ, 1987, BAT PREDATION ITS IN, P64; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; CARLSON AD, 1985, Q REV BIOL, V60, P415, DOI 10.1086/414564; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; Gorochov A.V., 1988, CRETACEOUS BIOCOENOT, P145; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; HARTLEY JC, 1993, ZOOL J LINN SOC-LOND, V107, P155, DOI 10.1006/zjls.1993.1010; Heller K.-G., 1990, P130; HELVERSEN D, 1983, NEUROETHOLOGY BEHAV; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Lakes-Harlan R, 2000, ZOOL-ANAL COMPLEX SY, V103, P31; LANE DH, 1995, SPECIATION RECOGNITI; LLOYD JE, 1990, FLA ENTOMOL, V73, P51, DOI 10.2307/3495329; LLOYD JE, 1984, FLA ENTOMOL, V67, P368, DOI 10.2307/3494715; LLOYD JE, 1975, SCIENCE, V187, P452, DOI 10.1126/science.187.4175.452; Marshall DC, 2008, MOL PHYLOGENET EVOL, V48, P1054, DOI 10.1016/j.ympev.2008.05.007; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; Moulds MS., 1990, AUSTR CICADAS; Myers JG., 1929, INSECT SINGERS NATUR; Naskrecki P, 2000, THESIS U CONNECTICUT; Otte, 1983, ACADEMY NATURAL SCI, V22, P1; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Ragge D.R, 1998, SONGS GRASSHOPPERS C; Rentz D.C.F., 1995, Journal of Orthoptera Research, V4, P199; Rentz D.C.F., 2001, TETTIGONIIDAE AUSTR, V3; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; Robinson D., 1990, P112; SAULGERSHENZ LS, 1993, AM ZOOL, V33, P139; SIMMONS LW, 1993, BEHAV ECOL, V4, P364, DOI 10.1093/beheco/4.4.364; Spooner John D., 1995, Journal of Orthoptera Research, V4, P127; STOWE MK, 1987, SCIENCE, V236, P964, DOI 10.1126/science.236.4804.964; VENCL FV, 1994, J INSECT BEHAV, V7, P843, DOI 10.1007/BF01997130; VERRELL PA, 1991, ETHOL ECOL EVOL, V3, P273, DOI 10.1080/08927014.1991.9525356; Walker T. J., 1964, Florida Entomologist, V47, P163, DOI 10.2307/3493290; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	41	35	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4185	10.1371/journal.pone.0004185	http://dx.doi.org/10.1371/journal.pone.0004185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142230	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700006
J	Aliabadian, M; Kaboli, M; Nijman, V; Vences, M				Aliabadian, Mansour; Kaboli, Mohammad; Nijman, Vincent; Vences, Miguel			Molecular Identification of Birds: Performance of Distance-Based DNA Barcoding in Three Genes to Delimit Parapatric Species	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY GENETICS; PHYLOGENY; HYBRIDIZATION; BUTTERFLIES; SPECIATION	Background: DNA barcoding based on the mitochondrial cytochrome oxidase subunit I gene (cox1 or COI) has been successful in species identification across a wide array of taxa but in some cases failed to delimit the species boundaries of closely allied allopatric species or of hybridising sister species. Methodology/Principal Findings: In this study we extend the sample size of prior studies in birds for cox1 (2776 sequences, 756 species) and target especially species that are known to occur parapatrically, and/or are known to hybridise, on a Holarctic scale. In order to obtain a larger set of taxa (altogether 2719 species), we include also DNA sequences of two other mitochondrial genes: cytochrome b (cob) ( 4614 sequences, 2087 species) and 16S (708 sequences, 498 species). Our results confirm the existence of a wide gap between intra- and interspecies divergences for both cox1 and cob, and indicate that distance-based DNA barcoding provides sufficient information to identify and delineate bird species in 98% of all possible pairwise comparisons. This DNA barcoding gap was not statistically influenced by the number of individuals sequenced per species. However, most of the hybridising parapatric species pairs have average divergences intermediate between intraspecific and interspecific distances for both cox1 and cob. Conclusions/Significance: DNA barcoding, if used as a tool for species discovery, would thus fail to identify hybridising parapatric species pairs. However, most of them can probably still assigned to known species by character-based approaches, although development of complementary nuclear markers will be necessary to account for mitochondrial introgression in hybridising species.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Aliabadian, Mansour] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [Aliabadian, Mansour] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Iran; [Kaboli, Mohammad] Univ Tehran, Fac Nat Resources, Dept Fishery & Environm, Tehran 14174, Iran; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany	University of Amsterdam; University of Amsterdam; Ferdowsi University Mashhad; University of Tehran; Oxford Brookes University; Braunschweig University of Technology	Aliabadian, M (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	M.aliabadian@uva.nl	Vences, Miguel/E-5573-2010; Aliabadian, Mansour/P-8373-2019; Nijman, Vincent/AHD-8685-2022; 赵, 鹏/B-8401-2009	Aliabadian, Mansour/0000-0002-3200-4853; Vences, Miguel/0000-0003-0747-0817; Nijman, Vincent/0000-0002-5600-4276	Ministry of Science, Research and Technology of the Islamic Republic of Iran	Ministry of Science, Research and Technology of the Islamic Republic of Iran	This work was partially funded by the Ministry of Science, Research and Technology of the Islamic Republic of Iran to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadian M, 2007, CONTRIB ZOOL, V76, P197, DOI 10.1163/18759866-07603005; Aliabadian M, 2005, BIOL LETTERS, V1, P21, DOI 10.1098/rsbl.2004.0258; Aliabadian M, 2007, MOL PHYLOGENET EVOL, V42, P665, DOI 10.1016/j.ympev.2006.08.018; ALSTROM P, 2006, ACTA ZOOLOGICA SIN S, V52, P429; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Crochet PA, 2000, J EVOLUTION BIOL, V13, P47; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dickinson EC., 2003, HOWARD MOORE COMPLET; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Haffer Juergen, 1992, Bulletin of the British Ornithologists' Club, V112, P250; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Johnson NK, 2004, EVOLUTION, V58, P1122; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lemer S, 2007, CR BIOL, V330, P86, DOI 10.1016/j.crvi.2006.09.002; Liebers D, 2004, P ROY SOC B-BIOL SCI, V271, P893, DOI 10.1098/rspb.2004.2679; Mallet J, 2003, TRENDS ECOL EVOL, V18, P57, DOI 10.1016/S0169-5347(02)00061-7; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	41	79	98	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4119	10.1371/journal.pone.0004119	http://dx.doi.org/10.1371/journal.pone.0004119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127298	gold, Green Published, Green Submitted			2022-12-27	WOS:000265473300004
J	Zhou, XP; Miller, MR; Motaleb, M; Charon, NW; He, PNA				Zhou, Xueping; Miller, Michael R.; Motaleb, Md; Charon, Nyles W.; He, Pingnian			Spent Culture Medium from Virulent Borrelia burgdorferi Increases Permeability of Individually Perfused Microvessels of Rat Mesentery	PLOS ONE			English	Article								Background: Lyme disease is a common vector-borne disease caused by the spirochete Borrelia burgdorferi (Bb), which manifests as systemic and targeted tissue inflammation. Both in vitro and in vivo studies have shown that Bb-induced inflammation is primarily host-mediated, via cytokine or chemokine production that promotes leukocyte adhesion/migration. Whether Bb produces mediators that can directly alter the vascular permeability in vivo has not been investigated. The objective of the present study was to investigate if Bb produces a mediator(s) that can directly activate endothelial cells resulting in increases in permeability in intact microvessels in the absence of blood cells. Methodology/Principal Findings: The effects of cell-free, spent culture medium from virulent (B31-A3) and avirulent (B31-A) B. burgdorferi on microvessel permeability and endothelial calcium concentration, [Ca2+](i), were examined in individually perfused rat mesenteric venules. Microvessel permeability was determined by measuring hydraulic conductivity (Lp). Endothelial [Ca2+](i), a necessary signal initiating hyperpermeability, was measured in Fura-2 loaded microvessels. B31-A3 spent medium caused a rapid and transient increase in Lp and endothelial [Ca2+](i). Within 2-5 min, the mean peak Lp increased to 5.6 +/- 0.9 times the control, and endothelial [Ca2+](i) increased from 113 +/- 11 nM to a mean peak value of 324 +/- 35 nM. In contrast, neither endothelial [Ca2+](i) nor Lp was altered by B31-A spent medium. Conclusions/Significance: A mediator(s) produced by virulent Bb under culture conditions directly activates endothelial cells, resulting in increases in microvessel permeability. Most importantly, the production of this mediator is associated with Bb virulence and is likely produced by one or more of the 8 plasmid(s) missing from strain B31-A.	[He, Pingnian] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Miller, Michael R.] W Virginia Univ, Dept Biochem, Morgantown, WV USA; [Motaleb, Md; Charon, Nyles W.] W Virginia Univ, Dept Microbiol, Immunol & Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University; West Virginia University	Zhou, XP (corresponding author), W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA.	phe@hsc.wvu.edu		HE, Pingnian/0000-0001-7346-7419; MOTALEB, MD/0000-0003-2761-5104	National Heart, Lung and Blood Institute [HL56237, HL084338]; Allergy and Infectious Diseases Institute [AI29743]; American Heart Association [0755614B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084338, R01HL056237, R29HL056237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029743] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Allergy and Infectious Diseases Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Heart, Lung and Blood Institute grants HL56237 and HL084338 (P. He), Allergy and Infectious Diseases Institute grant AI29743 (N. W. Charon) and American Heart Association grant 0755614B (M. R. Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Burns MJ, 1997, INFECT IMMUN, V65, P1217, DOI 10.1128/IAI.65.4.1217-1222.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Dame TM, 2007, J IMMUNOL, V178, P1172, DOI 10.4049/jimmunol.178.2.1172; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gergel EI, 2001, INFECT IMMUN, V69, P2190, DOI 10.1128/IAI.69.4.2190-2197.2001; Grab DJ, 2007, CLIN VACCINE IMMUNOL, V14, P1420, DOI 10.1128/CVI.00308-07; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Guerau-De-Arellano M, 2005, TRENDS MOL MED, V11, P114, DOI 10.1016/j.molmed.2005.01.003; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; HE P, 1990, AM J PHYSIOL, V258, pH1366; HE P, 1994, J APPL PHYSIOL, V76, P2288, DOI 10.1152/jappl.1994.76.6.2288; He P, 1996, AM J PHYSIOL-HEART C, V271, pH2377, DOI 10.1152/ajpheart.1996.271.6.H2377; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Jewett MW, 2007, MOL MICROBIOL, V66, P975, DOI 10.1111/j.1365-2958.2007.05969.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Jiang YY, 2008, AM J PHYSIOL-HEART C, V295, pH898, DOI 10.1152/ajpheart.00309.2008; KENDALL S, 1995, EXP PHYSIOL, V80, P359, DOI 10.1113/expphysiol.1995.sp003853; Kisand KE, 2007, APMIS, V115, P134, DOI 10.1111/j.1600-0463.2007.apm_538.x; KORTHUIS RJ, 1984, MICROVASC RES, V28, P322, DOI 10.1016/0026-2862(84)90004-9; Lawrenz MB, 2002, INFECT IMMUN, V70, P4798, DOI 10.1128/IAI.70.9.4798-4804.2002; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; MCDONALD DM, 1994, AM J PHYSIOL, V266, pL61, DOI 10.1152/ajplung.1994.266.1.L61; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Pinto DS, 2002, MED CLIN N AM, V86, P285, DOI 10.1016/S0025-7125(03)00087-7; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; SELLATI TJ, 1995, INFECT IMMUN, V63, P4439, DOI 10.1128/IAI.63.11.4439-4447.1995; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; WHITMIRE WM, 1993, INFECT IMMUN, V61, P1460, DOI 10.1128/IAI.61.4.1460-1467.1993; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wormser GP, 2006, NEW ENGL J MED, V354, P2794, DOI 10.1056/NEJMcp061181; Zeng M, 2002, AM J PHYSIOL-HEART C, V283, pH2420, DOI 10.1152/ajpheart.00787.2001; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4101	10.1371/journal.pone.0004101	http://dx.doi.org/10.1371/journal.pone.0004101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116656	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600019
J	Kuhnen, CM; Chiao, JY				Kuhnen, Camelia M.; Chiao, Joan Y.			Genetic Determinants of Financial Risk Taking	PLOS ONE			English	Article							PERSONALITY-TRAIT; POLYMORPHISM; ASSOCIATION; SEROTONIN; DOPAMINE; REWARD	Individuals vary in their willingness to take financial risks. Here we show that variants of two genes that regulate dopamine and serotonin neurotransmission and have been previously linked to emotional behavior, anxiety and addiction (5-HTTLPR and DRD4) are significant determinants of risk taking in investment decisions. We find that the 5-HTTLPR s/s allele carriers take 28% less risk than those carrying the s/l or l/l alleles of the gene. DRD4 7-repeat allele carriers take 25% more risk than individuals without the 7-repeat allele. These findings contribute to the emerging literature on the genetic determinants of economic behavior.	Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Chiao, Joan Y.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Chiao, Joan Y.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Kuhnen, CM (corresponding author), Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA.	c-kuhnen@kellogg.northwestern.edu; jchiao@northwestern.edu			Zell Center for Risk Research at the Kellogg School of Management; NSF [BCS-0720312, BCS-0722326]	Zell Center for Risk Research at the Kellogg School of Management; NSF(National Science Foundation (NSF))	Kuhnen acknowledges generous financial support for this work from the Zell Center for Risk Research at the Kellogg School of Management. This work is also supported by NSF BCS-0720312 and NSF BCS-0722326 grants to J.Y.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldu X, 2007, ANN NY ACAD SCI, V1118, P43, DOI 10.1196/annals.1412.007; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CESARINI D, 2009, Q J EC, V124; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DREBER A, EVOLUTION H IN PRESS; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Eisen SA, 1998, ADDICTION, V93, P1375; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Eisenberg DTA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-173; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; KIM SJ, 2006, J NEURAL TRANSMISSIO; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; MARKOWITZ H, 1952, J FINANCE, V0007; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; SCHULTZ W, 2007, TRENDS NEUROSCIENCE, V30; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	25	163	167	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4362	10.1371/journal.pone.0004362	http://dx.doi.org/10.1371/journal.pone.0004362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JP	19209222	Green Submitted, gold, Green Published			2022-12-27	WOS:000265484100001
J	Warter, L; Cohen, L; Benureau, Y; Chavez, D; Yang, Y; Bodola, F; Lemon, SM; Traboni, C; Lanford, RE; Martin, A				Warter, Lucile; Cohen, Lisette; Benureau, Yann; Chavez, Deborah; Yang, Yan; Bodola, Francis; Lemon, Stanley M.; Traboni, Cinzia; Lanford, Robert E.; Martin, Annette			A Cooperative Interaction between Nontranslated RNA Sequences and NS5A Protein Promotes In Vivo Fitness of a Chimeric Hepatitis C/GB Virus B	PLOS ONE			English	Article								GB virus B (GBV-B) is closely related to hepatitis C virus (HCV), infects small non-human primates, and is thus a valuable surrogate for studying HCV. Despite significant differences, the 59 nontranslated RNAs (NTRs) of these viruses fold into four similar structured domains (I-IV), with domains II-III-IV comprising the viral internal ribosomal entry site (IRES). We previously reported the in vivo rescue of a chimeric GBV-B (vGB/III(HC)) containing HCV sequence in domain III, an essential segment of the IRES. We show here that three mutations identified within the vGB/III(HC) genome (within the 3'NTR, upstream of the poly(U) tract, and NS5A coding sequence) are necessary and sufficient for production of this chimeric virus following intrahepatic inoculation of synthetic RNA in tamarins, and thus apparently compensate for the presence of HCV sequence in domain III. To assess the mechanism(s) underlying these compensatory mutations, and to determine whether 5'NTR subdomains participating in genome replication do so in a virus-specific fashion, we constructed and evaluated a series of chimeric subgenomic GBV-B replicons in which various 5'NTR subdomains were substituted with their HCV homologs. Domains I and II of the GBV-B 5'NTR could not be replaced with HCV sequence, indicating that they contain essential, virus-specific RNA replication elements. In contrast, domain III could be swapped with minimal loss of genome replication capacity in cell culture. The 3'NTR and NS5A mutations required for rescue of the related chimeric virus in vivo had no effect on replication of the subgenomic GBneoD/III(HC) RNA in vitro. The data suggest that in vivo fitness of the domain III chimeric virus is dependent on a cooperative interaction between the 5'NTR, 3'NTR and NS5A at a step in the viral life cycle subsequent to genome replication, most likely during particle assembly. Such a mechanism may be common to all hepaciviruses.	[Warter, Lucile; Cohen, Lisette; Benureau, Yann; Martin, Annette] Univ Paris 07, Inst Pasteur, CNRS, Unite Genet Mol Virus ARN, URA 3015, F-75221 Paris, France; [Chavez, Deborah; Lanford, Robert E.] SW Natl Primate Res Ctr, SW Fdn Biomed Res, San Antonio, TX USA; [Yang, Yan; Bodola, Francis; Lemon, Stanley M.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Hepatitis Res, Galveston, TX USA; [Traboni, Cinzia] Ist Ricerche Biol Molecolare P Angeletti, Pomezia, Italy	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Texas Biomedical Research Institute; University of Texas System; University of Texas Medical Branch Galveston	Warter, L (corresponding author), Singapore Immunol Network, Singapore, Singapore.	annette.martin@pasteur.fr	Martin, Annette/A-2425-2016	Martin, Annette/0000-0002-3054-3925	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [R24-RR015081, U19-AI40035, RO1 AI49574, P51 RR13986]; National Institutes of Health; French National Center for Scientific Research (CNRS) [BDI fellowship]; French National Research Agency (ANR) [fellowship]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015081, P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI040035, R01AI049574] Funding Source: NIH RePORTER	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency (ANR)(French National Research Agency (ANR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), and grants R24-RR015081, U19-AI40035, RO1 AI49574, and P51 RR13986 from the National Institutes of Health. L.W. was supported by a BDI fellowship from the French National Center for Scientific Research (CNRS) and Y.B. by a fellowship from the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Becher P, 2000, J VIROL, V74, P7884, DOI 10.1128/JVI.74.17.7884-7894.2000; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bukh J, 2001, J MED VIROL, V65, P694, DOI 10.1002/jmv.2092; Butkiewicz N, 2000, J VIROL, V74, P4291, DOI 10.1128/JVI.74.9.4291-4301.2000; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Chevalier C, 2007, MOL THER, V15, P1452, DOI 10.1038/sj.mt.6300186; Cristofari G, 2004, NUCLEIC ACIDS RES, V32, P2623, DOI 10.1093/nar/gkh579; De Tomassi A, 2002, J VIROL, V76, P7736, DOI 10.1128/JVI.76.15.7736-7746.2002; Fang JWS, 2000, J HEPATOL, V33, P632, DOI 10.1034/j.1600-0641.2000.033004632.x; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Frolov I, 1998, RNA, V4, P1418, DOI 10.1017/S1355838298981031; Ghibaudo D, 2004, J BIOL CHEM, V279, P24965, DOI 10.1074/jbc.M401148200; Grace K, 1999, J GEN VIROL, V80, P2337, DOI 10.1099/0022-1317-80-9-2337; Honda M, 1996, RNA, V2, P955; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051; Ivanyi-Nagy R, 2006, NUCLEIC ACIDS RES, V34, P2618, DOI 10.1093/nar/gkl240; Kim YK, 2002, BIOCHEM BIOPH RES CO, V290, P105, DOI 10.1006/bbrc.2001.6167; Kong LK, 2002, J VIROL, V76, P12457, DOI 10.1128/JVI.76.24.12457-12462.2002; Lanford RE, 2003, VIROLOGY, V311, P72, DOI 10.1016/S0042-6822(03)00193-4; Lemon SM, 1997, SEMIN VIROL, V8, P274, DOI 10.1006/smvy.1997.0129; Luo GX, 2003, J VIROL, V77, P3312, DOI 10.1128/JVI.77.5.3312-3318.2003; Mankouri J, 2008, J GEN VIROL, V89, P1911, DOI 10.1099/vir.0.2008/001131-0; Martin A, 2003, P NATL ACAD SCI USA, V100, P9962, DOI 10.1073/pnas.1731505100; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murakami K, 2001, ARCH VIROL, V146, P729, DOI 10.1007/s007050170142; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nam JH, 2004, J VIROL, V78, P9389, DOI 10.1128/JVI.78.17.9389-9399.2004; Ohba K, 1996, FEBS LETT, V378, P232, DOI 10.1016/0014-5793(95)01441-1; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pizzuti M, 2003, J VIROL, V77, P7502, DOI 10.1128/JVI.77.13.7502-7509.2003; Reusken CBEM, 2003, J GEN VIROL, V84, P1761, DOI 10.1099/vir.0.19063-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Rijnbrand R, 2005, HEPATOLOGY, V41, P986, DOI 10.1002/hep.20656; RIJNBRAND R, 1995, FEBS LETT, V365, P115, DOI 10.1016/0014-5793(95)00458-L; Rijnbrand R, 2000, J VIROL, V74, P773, DOI 10.1128/JVI.74.2.773-783.2000; Rijnbrand R, 2001, RNA, V7, P585, DOI 10.1017/S1355838201000589; Sbardellati A, 2001, J GEN VIROL, V82, P2437, DOI 10.1099/0022-1317-82-10-2437; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Svitkin YV, 2005, J VIROL, V79, P6868, DOI 10.1128/JVI.79.11.6868-6881.2005; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Thiel H.J., 2005, VIRUS TAXONOMY, P993; Woollard DJ, 2008, J VIROL, V82, P3054, DOI 10.1128/JVI.01153-07; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003; Yu HY, 2000, J VIROL, V74, P5825, DOI 10.1128/JVI.74.13.5825-5835.2000	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4419	10.1371/journal.pone.0004419	http://dx.doi.org/10.1371/journal.pone.0004419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204793	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000008
J	Hagan, JP; O'Neill, BL; Stewart, CL; Kozlov, SV; Croce, CM				Hagan, John P.; O'Neill, Brittany L.; Stewart, Colin L.; Kozlov, Serguei V.; Croce, Carlo M.			At Least Ten Genes Define the Imprinted Dlk1-Dio3 Cluster on Mouse Chromosome 12qF1	PLOS ONE			English	Article								Background: Genomic imprinting is an exception to Mendelian genetics in that imprinted genes are expressed monoallelically, dependent on parental origin. In mammals, imprinted genes are critical in numerous developmental and physiological processes. Aberrant imprinted gene expression is implicated in several diseases including Prader-Willi/Angelman syndromes and cancer. Methodology/Principal Findings: To identify novel imprinted genes, transcription profiling was performed on two uniparentally derived cell lines, androgenetic and parthenogenetic primary mouse embryonic fibroblasts. A maternally expressed transcript termed Imprinted (R) under bar NA near (M) under bar eg3/ Gtl2 (Irm) was identified and its expression studied by Northern blotting and whole mounts in situ hybridization. The imprinted region that contains Irm has a parent of origin effect in three mammalian species, including the sheep callipyge locus. In mice and humans, both maternal and paternal uniparental disomies (UPD) cause embryonic growth and musculoskeletal abnormalities, indicating that both alleles likely express essential genes. To catalog all imprinted genes in this chromosomal region, twenty-five mouse mRNAs in a 1.96Mb span were investigated for allele specific expression. Conclusions/Significance: Ten imprinted genes were elucidated. The imprinting of three paternally expressed protein coding genes (Dlk1, Peg11, and Dio3) was confirmed. Seven noncoding RNAs (Meg3/Gtl2, Anti-Peg11, Meg8, Irm/"Rian", AK050713, AK053394, and Meg9/Mirg) are characterized by exclusive maternal expression. Intriguingly, the majority of these noncoding RNA genes contain microRNAs and/or snoRNAs within their introns, as do their human orthologs. Of the 52 identified microRNAs that map to this region, six are predicted to regulate negatively Dlk1, suggesting an additional mechanism for interactions between allelic gene products. Since several previous studies relied heavily on in silico analysis and RT-PCR, our findings from Northerns and cDNA cloning clarify the genomic organization of this region. Our results expand the number of maternally expressed noncoding RNAs whose loss may be responsible for the phenotypes associated with mouse pUPD12 and human pUPD14 syndromes.	[Hagan, John P.; O'Neill, Brittany L.; Croce, Carlo M.] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Stewart, Colin L.] NCI, NIH, Ctr Canc Res, Canc & Dev Biol Lab, Frederick, MD USA; [Kozlov, Serguei V.] NCI, NIH, SAIC Frederick Inc, Ctr Advanced Preclin Res Mouse Canc Genet Program, Frederick, MD USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hagan, JP (corresponding author), Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	microrna@gmail.com	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Hagan, John/0000-0003-0295-4898	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; and with Federal funds from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BEECHEY C, 2003, MOUSE IMPRINTING DAT; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cotter PD, 1997, AM J MED GENET, V70, P74, DOI 10.1002/(SICI)1096-8628(19970502)70:1<74::AID-AJMG14>3.0.CO;2-U; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fan T, 2005, DEVELOPMENT, V132, P635, DOI 10.1242/dev.01612; Fokstuen S, 1999, J PEDIATR-US, V134, P689, DOI 10.1016/S0022-3476(99)70282-9; Genter MB, 2003, PHYSIOL GENOMICS, V16, P67, DOI 10.1152/physiolgenomics.00117.2003; Georgiades P, 2000, DEVELOPMENT, V127, P4719; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Hagan JP, 2004, GENOMICS, V84, P836, DOI 10.1016/j.ygeno.2004.07.007; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NUCLEIC ACIDS RES, V23, P36, DOI 10.1093/nar/23.1.36; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Hiura H, 2007, FEBS LETT, V581, P1255, DOI 10.1016/j.febslet.2007.02.034; Hogan B, 1994, MANIPULATING MOUSE E; Joyce JA, 1998, J CLIN PATHOL-MOL PA, V51, P185, DOI 10.1136/mp.51.4.185; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kato MV, 1998, GENOMICS, V47, P146, DOI 10.1006/geno.1997.5089; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; LABIALLE S, 2008, EPIGENETICS, V3; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; LINSLEY PS, 2007, MOL CELL BIOL; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morison IM, 1998, HUM MOL GENET, V7, P1599, DOI 10.1093/hmg/7.10.1599; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Palferman S, 2001, HUM MOL GENET, V10, P973; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; PENTAO L, 1992, AM J HUM GENET, V50, P690; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Schmidt JV, 2000, GENE DEV, V14, P1997; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; SchusterGossler K, 1996, MAMM GENOME, V7, P20, DOI 10.1007/s003359900006; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shimoda M, 2002, GENOMICS, V79, P483, DOI 10.1006/geno.2002.6727; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutton VR, 2000, AM J MED GENET, V93, P381, DOI 10.1002/1096-8628(20000828)93:5<381::AID-AJMG7>3.0.CO;2-9; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wassink T H, 2000, Curr Psychiatry Rep, V2, P170, DOI 10.1007/s11920-000-0063-x; Weidman JR, 2006, MAMM GENOME, V17, P157, DOI 10.1007/s00335-005-0116-x; Williamson CM, 1998, CYTOGENET CELL GENET, V81, P73, DOI 10.1159/000014992; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xiao Y, 2006, BIOCHEM BIOPH RES CO, V340, P1217, DOI 10.1016/j.bbrc.2005.12.128; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	86	108	122	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4352	10.1371/journal.pone.0004352	http://dx.doi.org/10.1371/journal.pone.0004352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194500	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483600004
J	Beduneau, A; Ma, ZY; Grotepas, CB; Kabanov, A; Rabinow, BE; Gong, N; Mosley, RL; Dou, HY; Boska, MD; Gendelman, HE				Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Kabanov, Alexander; Rabinow, Barrett E.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.			Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles	PLOS ONE			English	Article								Background: We posit that the same mononuclear phagocytes (MP) that serve as target cells and vehicles for a host of microbial infections can be used to improve diagnostics and drug delivery. We also theorize that physical and biological processes such as particle shape, size, coating and opsonization that affect MP clearance of debris and microbes can be harnessed to facilitate uptake of nanoparticles (NP) and tissue delivery. Methods: Monocytes and monocyte-derived macrophages (MDM) were used as vehicles of superparamagnetic iron oxide (SPIO) NP and immunoglobulin (IgG) or albumin coated SPIO for studies of uptake and distribution. IgG coated SPIO was synthesized by covalent linkage and uptake into monocytes and MDM investigated related to size, time, temperature, concentration, and coatings. SPIO and IgG SPIO were infused intravenously into naive mice. T-2 measures using magnetic resonance imaging (MRI) were used to monitor tissue distribution in animals. Results: Oxidation of dextran on the SPIO surface generated reactive aldehyde groups and permitted covalent linkage to amino groups of murine and human IgG and F(ab')(2) fragments and for Alexa Fluor (R) 488 hydroxylamine to form a Schiff base. This labile intermediate was immediately reduced with sodium cyanoborohydride in order to stabilize the NP conjugate. Optical density measurements of the oxidized IgG, F(ab')(2), and/or Alexa Fluor (R) 488 SPIO demonstrated similar to 50% coupling yield. IgG-SPIO was found stable at 4 degrees C for a period of 1 month during which size and polydispersity index varied little from 175 nm and 200 nm, respectively. In vitro, NP accumulated readily within monocyte and MDM cytoplasm after IgG-SPIO exposure; whereas, the uptake of native SPIO in monocytes and MDM was 10-fold less. No changes in cell viability were noted for the SPIO-containing monocytes and MDM. Cell morphology was not changed as observed by transmission electron microscopy. Compared to unconjugated SPIO, intravenous injection of IgG-SPIO afforded enhanced and sustained lymphoid tissue distribution over 24 hours as demonstrated by MRI. Conclusions: Facilitated uptake of coated SPIO in monocytes and MDM was achieved. Uptake was linked to particle size and was time and concentration dependent. The ability of SPIO to be rapidly taken up and distributed into lymphoid tissues also demonstrates feasibility of macrophage-targeted nanoformulations for diagnostic and drug therapy.	[Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Kabanov, Alexander] Univ Nebraska, Med Ctr, Dept Pharm Sci, Lincoln, NE 68583 USA; [Boska, Michael D.] Univ Nebraska, Med Ctr, Dept Radiol, Lincoln, NE 68583 USA; [Beduneau, Arnaud; Ma, Zhiya; Grotepas, Cassi B.; Gong, Nan; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Lincoln, NE 68583 USA; [Kabanov, Alexander; Mosley, R. Lee; Dou, Huanyu; Boska, Michael D.; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Drug Delivery & Nanomed, Lincoln, NE 68583 USA; [Rabinow, Barrett E.] Baxter Healthcare Corp, Round Lake, IL USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Baxter International Inc	Beduneau, A (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	mboska@unmc.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012; Kabanov, Alexander V/N-3356-2013; Kabanov, Alexander/AAY-5751-2020	Kabanov, Alexander V/0000-0002-3665-946X; Kabanov, Alexander/0000-0002-3665-946X; Beduneau, Arnaud/0000-0001-7577-0374	National Institutes of Health [2R37 NS36126, PO1 NS31492, 2R01 NS034239, P20RR15635, P30 AI42845, U54NS43011-01, P01MH64570, 1T32 NS07488, P01 NS43985]; Baxter Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034239, P01NS043985, P01NS031492, T32NS007488, R37NS036126, U54NS043011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for the research was provided by National Institutes of Health Grants 2R37 NS36126, PO1 NS31492, 2R01 NS034239, P20RR15635, P20RR15635, P30 AI42845, U54NS43011-01, P01MH64570, 1T32 NS07488, P01 NS43985 and from Baxter Healthcare (to H.E.G.). Dr. Barrett Rabinow is an employee of Baxter Healthcare who played a role in study design and supplied reagents used in data acquisition.	AUDRAN R, 1995, NUCL MED BIOL, V22, P817, DOI 10.1016/0969-8051(95)00013-N; BETAGERI GV, 1993, J PHARM PHARMACOL, V45, P48, DOI 10.1111/j.2042-7158.1993.tb03678.x; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; Ciborowski P, 2006, CURR HIV RES, V4, P279, DOI 10.2174/157016206777709474; CONNOR RI, 1991, P NATL ACAD SCI USA, V88, P9593, DOI 10.1073/pnas.88.21.9593; DALEKE DL, 1990, BIOCHIM BIOPHYS ACTA, V1024, P352, DOI 10.1016/0005-2736(90)90365-U; DOBROVOLSKAIA MA, 2008, MOL PHARM; Dou HY, 2007, VIROLOGY, V358, P148, DOI 10.1016/j.virol.2006.08.012; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dutta T, 2007, J DRUG TARGET, V15, P89, DOI 10.1080/10611860600965914; Engberink RDO, 2008, J CEREBR BLOOD F MET, V28, P841, DOI 10.1038/sj.jcbfm.9600580; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Fujiwara H, 1996, Kekkaku, V71, P43; Gorantla S, 2006, J LEUKOCYTE BIOL, V80, P1165, DOI 10.1189/jlb.0206110; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2; Kadiu I, 2005, NEUROTOX RES, V8, P25, DOI 10.1007/BF03033818; Khan MA, 2005, J ANTIMICROB CHEMOTH, V55, P223, DOI 10.1093/jac/dkh522; Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4; Kuwata T, 2007, AIDS RES HUM RETROV, V23, P372, DOI 10.1089/aid.2006.0208; Manjunath K, 2006, J DRUG TARGET, V14, P632, DOI 10.1080/10611860600888850; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X; Moghimi SM, 2001, CRIT REV THER DRUG, V18, P527; Nelson JA, 2005, J NEUROSCI RES, V80, P562, DOI 10.1002/jnr.20466; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Paul M, 1998, J DRUG TARGET, V5, P481, DOI 10.3109/10611869808997874; Pereboeva L, 2004, BIODRUGS, V18, P361, DOI 10.2165/00063030-200418060-00003; PERRY VH, 1995, CURR OPIN NEUROBIOL, V5, P636, DOI 10.1016/0959-4388(95)80069-7; Pietruska M, 2006, Adv Med Sci, V51 Suppl 1, P166; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Zelivyanskaya ML, 2003, J NEUROSCI RES, V73, P284, DOI 10.1002/jnr.10693; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	39	114	119	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4343	10.1371/journal.pone.0004343	http://dx.doi.org/10.1371/journal.pone.0004343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183814	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483200013
J	Collins, A; Hill, LE; Chandramohan, Y; Whitcomb, D; Droste, SK; Reul, JMHM				Collins, Andrew; Hill, Louise E.; Chandramohan, Yalini; Whitcomb, Daniel; Droste, Susanne K.; Reul, Johannes M. H. M.			Exercise Improves Cognitive Responses to Psychological Stress through Enhancement of Epigenetic Mechanisms and Gene Expression in the Dentate Gyrus	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; HISTONE H3 PHOSPHORYLATION; REGULAR VOLUNTARY EXERCISE; GLUCOCORTICOID-RECEPTOR; GRANULE NEURONS; C-FOS; STEREOTYPIC BEHAVIOR; SYNAPTIC PLASTICITY; PHOSPHO-ACETYLATION; BANK VOLES	Background: We have shown previously that exercise benefits stress resistance and stress coping capabilities. Furthermore, we reported recently that epigenetic changes related to gene transcription are involved in memory formation of stressful events. In view of the enhanced coping capabilities in exercised subjects we investigated epigenetic, gene expression and behavioral changes in 4-weeks voluntarily exercised rats. Methodology/Principal Findings: Exercised and control rats coped differently when exposed to a novel environment. Whereas the control rats explored the new cage for the complete 30-min period, exercised animals only did so during the first 15 min after which they returned to sleeping or resting behavior. Both groups of animals showed similar behavioral responses in the initial forced swim session. When re-tested 24 h later however the exercised rats showed significantly more immobility behavior and less struggling and swimming. If rats were killed at 2 h after novelty or the initial swim test, i.e. at the peak of histone H3 phospho-acetylation and c-Fos induction, then the exercised rats showed a significantly higher number of dentate granule neurons expressing the histone modifications and immediate-early gene induction. Conclusions/Significance: Thus, irrespective of the behavioral response in the novel cage or initial forced swim session, the impact of the event at the dentate gyrus level was greater in exercised rats than in control animals. Furthermore, in view of our concept that the neuronal response in the dentate gyrus after forced swimming is involved in memory formation of the stressful event, the observations in exercised rats of enhanced neuronal responses as well as higher immobility responses in the re-test are consistent with the reportedly improved cognitive performance in these animals. Thus, improved stress coping in exercised subjects seems to involve enhanced cognitive capabilities possibly resulting from distinct epigenetic mechanisms in dentate gyrus neurons.	[Collins, Andrew; Hill, Louise E.; Chandramohan, Yalini; Whitcomb, Daniel; Droste, Susanne K.; Reul, Johannes M. H. M.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of Bristol	Collins, A (corresponding author), Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	Hans.Reul@bristol.ac.uk	Reul, Johannes/B-4132-2019	Reul, Johannes/0000-0002-8787-4012; Whitcomb, Daniel/0000-0003-2703-1643	Medical Research Council; Neuroendocrinology Charitable Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neuroendocrinology Charitable Trust	This work was supported by the Medical Research Council and the Neuroendocrinology Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda L, 2006, BEHAV BRAIN RES, V167, P156, DOI 10.1016/j.bbr.2005.09.002; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; BYRNE A, 1993, J PSYCHOSOM RES, V37, P565, DOI 10.1016/0022-3999(93)90050-P; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cooper JJ, 1996, ANIM WELFARE, V5, P245; COOPER JJ, 1991, ANIM BEHAV, V41, P971, DOI 10.1016/S0003-3472(05)80635-9; DEPABLO JM, 1989, PHYSIOL BEHAV, V46, P229, DOI 10.1016/0031-9384(89)90261-8; Dietrich MO, 2005, BRAIN RES, V1065, P20, DOI 10.1016/j.brainres.2005.09.038; Dijkstra I, 1998, J NEUROSCI, V18, P3909; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; Droste SK, 2006, J NEUROENDOCRINOL, V18, P915, DOI 10.1111/j.1365-2826.2006.01489.x; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Friedman JE, 1997, HORM METAB RES, V29, P214, DOI 10.1055/s-2007-979024; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gielen S, 2001, CIRCULATION, V103, pE1; Harri M, 1999, LAB ANIM SCI, V49, P401; HILL LE, 2008, J PSYCHOPHA IN PRESS; Jonsdottir IH, 2000, IMMUNOL CELL BIOL, V78, P562, DOI 10.1046/j.1440-1711.2000.00961.x; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Korte SM, 1996, EUR J PHARMACOL, V301, P19, DOI 10.1016/0014-2999(96)00064-7; Kramer KM, 2000, BRAIN RES BULL, V53, P77; Lambert GW, 1998, J APPL PHYSIOL, V85, P962, DOI 10.1152/jappl.1998.85.3.962; Lancel M, 2003, EUR J NEUROSCI, V17, P2171, DOI 10.1046/j.1460-9568.2003.02658.x; Linthorst ACE, 1995, EUR J NEUROSCI, V7, P2418, DOI 10.1111/j.1460-9568.1995.tb01040.x; Linthorst ACE, 2002, EUR J NEUROSCI, V16, P2441, DOI 10.1046/j.1460-9568.2002.02400.x; Linthorst ACE, 1998, ANN NY ACAD SCI, V840, P139, DOI 10.1111/j.1749-6632.1998.tb09558.x; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reul JMHM, 2008, J PSYCHOPHARMACOL, V22, P469, DOI 10.1177/0269881108094617; REUL JMH, 2006, P 6 INT C NEUR JUN 1; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Reul JMHM, 2007, PSYCHONEUROENDOCRINO, V32, pS21, DOI 10.1016/j.psyneuen.2007.03.016; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Steckler T., 2005, TEC BEHAV N 1, P95; STECKLER T, 1999, BAILLIERES BEST PRAC, P597; STEPTOE A, 1989, J PSYCHOSOM RES, V33, P537, DOI 10.1016/0022-3999(89)90061-5; Swanson L W, 1977, Ciba Found Symp, P25; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vasuta C, 2007, HIPPOCAMPUS, V17, P1201, DOI 10.1002/hipo.20349; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; WYSS JM, 1979, NEUROSCIENCE, V4, P463, DOI 10.1016/0306-4522(79)90124-6	52	108	109	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4330	10.1371/journal.pone.0004330	http://dx.doi.org/10.1371/journal.pone.0004330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180197	Green Published, Green Submitted, gold			2022-12-27	WOS:000274089700013
J	Zheng, L; Nikolaev, A; Wardill, TJ; O'Kane, CJ; de Polavieja, GG; Juusola, M				Zheng, Lei; Nikolaev, Anton; Wardill, Trevor J.; O'Kane, Cahir J.; de Polavieja, Gonzalo G.; Juusola, Mikko			Network Adaptation Improves Temporal Representation of Naturalistic Stimuli in Drosophila Eye: I Dynamics	PLOS ONE			English	Article							ADAPTED BLOWFLY PHOTORECEPTORS; LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; FLY COMPOUND EYE; LIGHT ADAPTATION; VISUAL-SYSTEM; INFORMATION-TRANSMISSION; GRADED POTENTIALS; PATTERN-RECOGNITION; MUSCA-DOMESTICA	Because of the limited processing capacity of eyes, retinal networks must adapt constantly to best present the ever changing visual world to the brain. However, we still know little about how adaptation in retinal networks shapes neural encoding of changing information. To study this question, we recorded voltage responses from photoreceptors (R1-R6) and their output neurons (LMCs) in the Drosophila eye to repeated patterns of contrast values, collected from natural scenes. By analyzing the continuous photoreceptor-to-LMC transformations of these graded-potential neurons, we show that the efficiency of coding is dynamically improved by adaptation. In particular, adaptation enhances both the frequency and amplitude distribution of LMC output by improving sensitivity to under-represented signals within seconds. Moreover, the signal-to-noise ratio of LMC output increases in the same time scale. We suggest that these coding properties can be used to study network adaptation using the genetic tools in Drosophila, as shown in a companion paper (Part II).	[Zheng, Lei; Nikolaev, Anton; Wardill, Trevor J.; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain; [Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China	University of Sheffield; University of Cambridge; Autonomous University of Madrid; Autonomous University of Madrid; Beijing Normal University	Zheng, L (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	O'Kane, Cahir/Q-6681-2019; O'Kane, Cahir J/C-4413-2011; Juusola, Mikko/E-6948-2011	O'Kane, Cahir/0000-0002-3488-2078; Juusola, Mikko/0000-0002-4428-5330; de Polavieja, Gonzalo/0000-0001-5359-3426; Wardill, Trevor/0000-0002-2049-113X	Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Royal Society; MEC; Biociencia program; CAM-UAM; Biotechnology and Biological Sciences Research Council [BB/D001900/1, BB/F012071/1] Funding Source: researchfish; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Royal Society(Royal Society of London); MEC(European Commission); Biociencia program; CAM-UAM; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Biotechnology and Biological Sciences Research Council (MJ, CJO'K), the Gatsby Charitable Foundation (MJ), the Royal Society (MJ, GGdP), MEC (GGdP), Biociencia program (GGdP) and CAM-UAM (GGdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; ARMITAGE JD, 1965, APPL OPTICS, V4, P445, DOI 10.1364/AO.4.000445; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H.B., 1961, SENSORY COMMUNICATIO, V1; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brinkworth RSA, 2008, J VISION, V8, DOI 10.1167/8.11.8; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Burton BG, 2003, J EXP BIOL, V206, P3963, DOI 10.1242/jeb.00600; Burton BG, 2002, J COMP PHYSIOL A, V188, P527, DOI 10.1007/s00359-002-0327-5; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; Cover T. M., 1991, ELEMENTS INFORM THEO; Dan Y, 1996, J NEUROSCI, V16, P3351; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; de Polavieja GG, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061910; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; De Polavieja GG, 2002, J THEOR BIOL, V214, P657, DOI 10.1006/jtbi.2001.2498; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Fairhall AL, 2006, J NEUROPHYSIOL, V96, P2724, DOI 10.1152/jn.00995.2005; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Heisenberg M., 1984, VISION DROSOPHILA GE; HEISENBERG M, 1977, J COMP PHYSIOL A, V117, P163; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; HUMMEL R, 1977, COMPUT VISION GRAPH, V6, P184, DOI 10.1016/S0146-664X(77)80011-7; JARVILEHTO M, 1971, Z VERGL PHYSIOL, V75, P422, DOI 10.1007/BF00630561; JUUSOLA M, 1993, J COMP PHYSIOL A, V172, P511, DOI 10.1007/BF00213533; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Juusola M, 1995, J NEUROPHYSIOL, V74, P2538, DOI 10.1152/jn.1995.74.6.2538; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; Juusola M, 2007, BIOESSAYS, V29, P178, DOI 10.1002/bies.20532; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Linsker R., 1989, ADV NEURAL INFORMATI, P186; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Mah EL, 2008, BIOL CYBERN, V98, P357, DOI 10.1007/s00422-008-0222-4; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schwartz G, 2008, J NEUROPHYSIOL, V99, P1787, DOI 10.1152/jn.01025.2007; Segev R, 2007, J NEUROPHYSIOL, V98, P1380, DOI 10.1152/jn.00395.2007; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SHAW SR, 1984, J EXP BIOL, V112, P225; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Straw AD, 2008, J VISION, V8, DOI 10.1167/8.3.32; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; UUSITALO RO, 1995, J NEUROPHYSIOL, V73, P1782, DOI 10.1152/jn.1995.73.5.1782; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.3.3; van Hateren JH, 2006, J COMP PHYSIOL A, V192, P187, DOI 10.1007/s00359-005-0060-y; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Wolfram V, 2004, J NEUROPHYSIOL, V92, P1918, DOI 10.1152/jn.00201.2004; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	93	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4307	10.1371/journal.pone.0004307	http://dx.doi.org/10.1371/journal.pone.0004307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180196	Green Published, gold, Green Accepted			2022-12-27	WOS:000274089700006
J	Sapin, E; Lapray, D; Berod, A; Goutagny, R; Leger, L; Ravassard, P; Clement, O; Hanriot, L; Fort, P; Luppi, PH				Sapin, Emilie; Lapray, Damien; Berod, Anne; Goutagny, Romain; Leger, Lucienne; Ravassard, Pascal; Clement, Olivier; Hanriot, Lucie; Fort, Patrice; Luppi, Pierre-Herve			Localization of the Brainstem GABAergic Neurons Controlling Paradoxical (REM) Sleep	PLOS ONE			English	Article								Paradoxical sleep (PS) is a state characterized by cortical activation, rapid eye movements and muscle atonia. Fifty years after its discovery, the neuronal network responsible for the genesis of PS has been only partially identified. We recently proposed that GABAergic neurons would have a pivotal role in that network. To localize these GABAergic neurons, we combined immunohistochemical detection of Fos with non-radioactive in situ hybridization of GAD67 mRNA (GABA synthesis enzyme) in control rats, rats deprived of PS for 72 h and rats allowed to recover after such deprivation. Here we show that GABAergic neurons gating PS (PS-off neurons) are principally located in the ventrolateral periaqueductal gray (vlPAG) and the dorsal part of the deep mesencephalic reticular nucleus immediately ventral to it (dDpMe). Furthermore, iontophoretic application of muscimol for 20 min in this area in head-restrained rats induced a strong and significant increase in PS quantities compared to saline. In addition, we found a large number of GABAergic PS-on neurons in the vlPAG/dDPMe region and the medullary reticular nuclei known to generate muscle atonia during PS. Finally, we showed that PS-on neurons triggering PS localized in the SLD are not GABAergic. Altogether, our results indicate that multiple populations of PS-on GABAergic neurons are distributed in the brainstem while only one population of PS-off GABAergic neurons localized in the vlPAG/dDpMe region exist. From these results, we propose a revised model for PS control in which GABAergic PS-on and PS-off neurons localized in the vlPAG/dDPMe region play leading roles.	[Sapin, Emilie; Lapray, Damien; Goutagny, Romain; Leger, Lucienne; Ravassard, Pascal; Clement, Olivier; Hanriot, Lucie; Fort, Patrice; Luppi, Pierre-Herve] CNRS, UMR5167, Lyon, France; [Berod, Anne] Univ Lyon 1, CNRS, FRE3006, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sapin, E (corresponding author), CNRS, UMR5167, Lyon, France.	luppi@sommeil.univ-lyon1.fr	FORT, Patrice/G-6851-2017; goutagny, romain/C-1461-2018; Luppi, Pierre-Hervé/C-4333-2014	FORT, Patrice/0000-0003-1211-8631; goutagny, romain/0000-0002-1268-533X; Luppi, Pierre-Hervé/0000-0002-0503-423X; Clement, Olivier/0000-0002-7193-8931; Ravassard, Pascal/0000-0002-7500-3623	Universite Claude Bernard Lyon1; CNRS; Universite de Lyon; Universite Lyon 1; Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC)	Universite Claude Bernard Lyon1; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; Universite Lyon 1; Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC)	Our sponsors are Universite Claude Bernard Lyon1, CNRS and CNRS, Universite de Lyon, Universite Lyon 1 and the Association francaise de Narcolepsie-Cataplexie et d'hypersomnie (ANC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; CHASE MH, 1989, J NEUROSCI, V9, P743; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Greco MA, 2001, MOL BRAIN RES, V88, P176, DOI 10.1016/S0169-328X(01)00039-0; GUILLEMINAULT C, 2000, PRINCIPLES PRACTICE; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P33; Peyron C, 1998, J NEUROSCI, V18, P9996; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; RAVASSARD P, SLEEP IN PRESS; Sakai K, 1981, BRAIN MECH PERCEPTUA, P405; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; Swanson LW, 1998, BRAIN MAPS STRUCTURE, p[vii, 267]; Vanini G, 2007, NEUROSCIENCE, V145, P1157, DOI 10.1016/j.neuroscience.2006.12.051; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19	35	167	168	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4272	10.1371/journal.pone.0004272	http://dx.doi.org/10.1371/journal.pone.0004272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169414	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482800002
J	Sagara, J; Arata, T; Taniguchi, S				Sagara, Junji; Arata, Toshiaki; Taniguchi, Shunichiro			Scapinin, the Protein Phosphatase 1 Binding Protein, Enhances Cell Spreading and Motility by Interacting with the Actin Cytoskeleton	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; NUCLEAR ACTIN; RHO-GTPASES; MEMBRANE; DYNAMICS; FAMILY; DOMAIN; LINK	Scapinin, also named phactr3, is an actin and protein phosphatase 1 (PP1) binding protein, which is expressed in the adult brain and some tumor cells. At present, the role(s) of scapinin in the brain and tumors are poorly understood. We show that the RPEL-repeat domain of scapinin, which is responsible for its direct interaction with actin, inhibits actin polymerization in vitro. Next, we established a Hela cell line, where scapinin expression was induced by tetracycline. In these cells, expression of scapinin stimulated cell spreading and motility. Scapinin was colocalized with actin at the edge of spreading cells. To explore the roles of the RPEL-repeat and PP1-binding domains, we expressed wild-type and mutant scapinins as fusion proteins with green fluorescence protein (GFP) in Cos7 cells. Expression of GFP-scapinin (wild type) also stimulated cell spreading, but mutation in the RPEL-repeat domain abolished both the actin binding and the cell spreading activity. PP1-binding deficient mutants strongly induced cell retraction. Long and branched cytoplasmic processes were developed during the cell retraction. These results suggest that scapinin enhances cell spreading and motility through direct interaction with actin and that PP1 plays a regulatory role in scapinin-induced morphological changes.	Shinshu Univ, Sch Hlth Sci, Dept Biomed Lab Sci, Nagano, Japan; [Taniguchi, Shunichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano, Japan; [Arata, Toshiaki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 565, Japan	Shinshu University; Shinshu University; Osaka University	Sagara, J (corresponding author), Shinshu Univ, Sch Hlth Sci, Dept Biomed Lab Sci, Nagano, Japan.	sagaraj@shinshu-u.ac.jp			Minister of Education, Science and Culture, Japan [16570156]	Minister of Education, Science and Culture, Japan	This work was supported by a Grant-in aid 16570156 (to J. S.) from Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; ARATA T, 1991, J BIOCHEM-TOKYO, V109, P335; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cohen PTW, 2002, J CELL SCI, V115, P241; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Favot L, 2005, FEBS LETT, V579, P100, DOI 10.1016/j.febslet.2004.11.054; FERNANDEZ A, 1990, J CELL BIOL, V111, P103, DOI 10.1083/jcb.111.1.103; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sagara J, 2003, J BIOL CHEM, V278, P45611, DOI 10.1074/jbc.M305227200; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Worch S, 2006, CYTOGENET GENOME RES, V115, P23, DOI 10.1159/000094797; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	31	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4247	10.1371/journal.pone.0004247	http://dx.doi.org/10.1371/journal.pone.0004247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158953	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482200004
J	Tiziani, S; Lodi, A; Khanim, FL; Viant, MR; Bunce, CM; Gunther, UL				Tiziani, Stefano; Lodi, Alessia; Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.; Guenther, Ulrich L.			Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines	PLOS ONE			English	Article								Combined bezafibrate (BEZ) and medroxyprogesterone acetate (MPA) exert unexpected antileukaemic activities against acute myeloid leukaemia (AML) and these activities are associated with the generation of reactive oxygen species (ROS) within the tumor cells. Although the generation of ROS by these drugs is supported by preceding studies including our own, the interrelationship between the cellular effects of the drugs and ROS generation is not well understood. Here we report the use of NMR metabolomic profiling to further study the effect of BEZ and MPA on three AML cell lines and to shed light on the underlying mechanism of action. For this we focused on drug effects induced during the initial 24 hours of treatment prior to the onset of overt cellular responses and examined these in the context of basal differences in metabolic profiles between the cell lines. Despite their ultimately profound cellular effects, the early changes in metabolic profiles engendered by these drugs were less pronounced than the constitutive metabolic differences between cell types. Nonetheless, drug treatments engendered common metabolic changes, most markedly in the response to the combination of BEZ and MPA. These responses included changes to TCA cycle intermediates consistent with recently identified chemical actions of ROS. Notable amongst these was the conversion of alpha-ketoglutarate to succinate which was recapitulated by the treatment of cell extracts with exogenous hydrogen peroxide. These findings indicate that the actions of combined BEZ and MPA against AML cells are indeed mediated downstream of the generation of ROS rather than some hitherto unsuspected mechanism. Moreover, our findings demonstrate that metabolite profiles represent highly sensitive markers for genomic differences between cells and their responses to external stimuli. This opens new perspectives to use metabolic profiling as a tool to study the rational redeployment of drugs in new disease settings.	[Tiziani, Stefano; Lodi, Alessia; Guenther, Ulrich L.] Univ Birmingham, CR UK Inst Canc Studies, Birmingham, W Midlands, England; [Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Tiziani, S (corresponding author), Univ Birmingham, CR UK Inst Canc Studies, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England.	u.l.gunther@bham.ac.uk	Viant, Mark R/B-6339-2009	Viant, Mark R/0000-0001-5898-4119; Bunce, Chris/0000-0003-4084-8973	Marie Curie Transfer of Knowledge (ToK) award (MOTET); NERC Fellowship [NER/J/S/2002/00618]; Natural Environment Research Council [NER/J/S/2002/00618] Funding Source: researchfish	Marie Curie Transfer of Knowledge (ToK) award (MOTET)(European Commission); NERC Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Marie Curie Transfer of Knowledge (ToK) award (MOTET) and the NERC Fellowship (NER/J/S/2002/00618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1995, LEUKEMIA RES, V19, P263, DOI 10.1016/0145-2126(94)00158-7; AUE WP, 1976, J CHEM PHYS, V64, P4226, DOI 10.1063/1.431994; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Brookes PS, 2006, FREE RADICAL BIO MED, V41, P41, DOI 10.1016/j.freeradbiomed.2006.03.019; Bunce CM, 1996, BBA-MOL CELL RES, V1311, P189, DOI 10.1016/0167-4889(96)00005-5; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; Bundy JG, 2006, CANCER RES, V66, P7606, DOI 10.1158/0008-5472.CAN-05-2999; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cohen FJ, 2005, NAT REV DRUG DISCOV, V4, P78, DOI 10.1038/nrd1610; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fan TWM, 2005, METABOLOMICS, V1, P325, DOI 10.1007/s11306-005-0012-0; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Fenton SL, 2003, LEUKEMIA, V17, P568, DOI 10.1038/sj.leu.2402843; FUKUDA M, 1981, P NATL ACAD SCI-BIOL, V78, P6299, DOI 10.1073/pnas.78.10.6299; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Gonzalez-Aragon D, 2007, BIOCHEM PHARMACOL, V73, P427, DOI 10.1016/j.bcp.2006.10.016; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2003, BBA-GEN SUBJECTS, V1619, P151, DOI 10.1016/S0304-4165(02)00475-0; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kettunen MI, 2005, PROG NUCL MAG RES SP, V47, P175, DOI 10.1016/j.pnmrs.2005.08.005; KHANIM F, 2008, RATIONAL REDEP UNPUB; LUCAS DL, 1983, J CLIN INVEST, V72, P1889, DOI 10.1172/JCI111152; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Martin DS, 2000, CANCER RES, V60, P6776; Neves AA, 2006, BBA-REV CANCER, V1766, P242, DOI 10.1016/j.bbcan.2006.10.002; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Scatena R, 1999, CELL DEATH DIFFER, V6, P781, DOI 10.1038/sj.cdd.4400551; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Thrippleton MJ, 2005, J MAGN RESON, V174, P97, DOI 10.1016/j.jmr.2005.01.012; Tiziani S, 2008, ANAL CHIM ACTA, V610, P80, DOI 10.1016/j.aca.2008.01.030; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002	38	98	102	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4251	10.1371/journal.pone.0004251	http://dx.doi.org/10.1371/journal.pone.0004251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158949	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482200008
J	Finn, J; Tregenza, T; Norman, M				Finn, Julian; Tregenza, Tom; Norman, Mark			Preparing the Perfect Cuttlefish Meal: Complex Prey Handling by Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; FORAGING BEHAVIOR; SPECIALIZATION; CULTURES; WHALES	Dolphins are well known for their complex social and foraging behaviours. Direct underwater observations of wild dolphin feeding behaviour however are rare. At mass spawning aggregations of giant cuttlefish (Sepia apama) in the Upper Spencer Gulf in South Australia, a wild female Indo-Pacific bottlenose dolphin (Tursiops aduncus) was observed and recorded repeatedly catching, killing and preparing cuttlefish for consumption using a specific and ordered sequence of behaviours. Cuttlefish were herded to a sand substrate, pinned to the seafloor, killed by downward thrust, raised mid-water and beaten by the dolphin with its snout until the ink was released and drained. The deceased cuttlefish was then returned to the seafloor, inverted and forced along the sand substrate in order to strip the thin dorsal layer of skin off the mantle, thus releasing the buoyant calcareous cuttlebone. This stepped behavioural sequence significantly improves prey quality through 1) removal of the ink (with constituent melanin and tyrosine), and 2) the calcareous cuttlebone. Observations of foraging dolphin pods from above-water at this site (including the surfacing of intact clean cuttlebones) suggest that some or all of this prey handling sequence may be used widely by dolphins in the region. Aspects of the unique mass spawning aggregations of giant cuttlefish in this region of South Australia may have contributed to the evolution of this behaviour through both high abundances of spawning and weakened post-spawning cuttlefish in a small area (>10,000 animals on several kilometres of narrow rocky reef), as well as potential long-term and regular visitation by dolphin pods to this site.	[Norman, Mark] Museum Victoria, Melbourne, Vic, Australia; [Finn, Julian] La Trobe Univ, Dept Zool, Victoria, BC, Canada; [Tregenza, Tom] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Exeter EX4 4QJ, Devon, England	Museum Victoria; University of Exeter	Finn, J (corresponding author), Museum Victoria, Melbourne, Vic, Australia.	jfinn@museum.vic.gov.au		Tregenza, Thomas/0000-0003-4182-2222	Hermon Slade Foundation; Australian Biological Resources Study; Australian Research Council; Royal Society [Fellowship]	Hermon Slade Foundation; Australian Biological Resources Study; Australian Research Council(Australian Research Council); Royal Society(Royal Society of London)	The authors wish to thank Tokyo Broadcasting System - Live Inc., Tony Bramley of Whyalla Diving Services, Graham Ross and Alpha Diving Products for assistance with this project. JF and MN wish to thank the following bodies for research funding support: Hermon Slade Foundation, Australian Biological Resources Study and the Australian Research Council. TT was funded by a Royal Society Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connor RC, 2000, CETACEAN SOCIETIES, P91; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; Gazda SK, 2005, P ROY SOC B-BIOL SCI, V272, P135, DOI 10.1098/rspb.2004.2937; Hall KC, 2002, MAR BIOL, V140, P533; Hanson Mark T., 1993, Aquatic Mammals, V19, P127; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; MIMURA T, 1982, CHEM PHARM BULL, V30, P1381; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; Nowacek DP, 2002, BEHAVIOUR, V139, P1125, DOI 10.1163/15685390260437290; PROTA G, 1981, COMP BIOCHEM PHYS B, V68, P415, DOI 10.1016/0305-0491(81)90149-8; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whitehead H, 2005, MAR MAMMAL SCI, V21, P58, DOI 10.1111/j.1748-7692.2005.tb01208.x; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415	20	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4217	10.1371/journal.pone.0004217	http://dx.doi.org/10.1371/journal.pone.0004217			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156212	Green Published, gold			2022-12-27	WOS:000265482100002
J	Mandairon, N; Poncelet, J; Bensafi, M; Didier, A				Mandairon, Nathalie; Poncelet, Johan; Bensafi, Moustafa; Didier, Anne			Humans and Mice Express Similar Olfactory Preferences	PLOS ONE			English	Article								In humans, the pleasantness of odors is a major contributor to social relationships and food intake. Smells evoke attraction and repulsion responses, reflecting the hedonic value of the odorant. While olfactory preferences are known to be strongly modulated by experience and learning, it has been recently suggested that, in humans, the pleasantness of odors may be partly explained by the physicochemical properties of the odorant molecules themselves. If odor hedonic value is indeed predetermined by odorant structure, then it could be hypothesized that other species will show similar odor preferences to humans. Combining behavioral and psychophysical approaches, we here show that odorants rated as pleasant by humans were also those which, behaviorally, mice investigated longer and human subjects sniffed longer, thereby revealing for the first time a component of olfactory hedonic perception conserved across species. Consistent with this, we further show that odor pleasantness rating in humans and investigation time in mice were both correlated with the physicochemical properties of the molecules, suggesting that olfactory preferences are indeed partly engraved in the physicochemical structure of the odorant. That odor preferences are shared between mammal species and are guided by physicochemical features of odorant stimuli strengthens the view that odor preference is partially predetermined. These findings open up new perspectives for the study of the neural mechanisms of hedonic perception.	[Mandairon, Nathalie; Poncelet, Johan; Bensafi, Moustafa; Didier, Anne] Univ Lyon 1, CNRS, UMR5020, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Mandairon, N (corresponding author), Univ Lyon 1, CNRS, UMR5020, F-69365 Lyon, France.	nathalie.mandairon@olfac.univ-lyon1.fr	DIDIER, Anne/H-4413-2017; Mandairon, Nathalie/H-4439-2017; Bensafi, Moustafa/H-6618-2017	DIDIER, Anne/0000-0003-3118-9961; Mandairon, Nathalie/0000-0001-7935-5215; Bensafi, Moustafa/0000-0002-2991-3036	Marie Curie Foundation [MOIF-CT-2005-51474]; CNRS	Marie Curie Foundation(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This research was supported by the Marie Curie Foundation, MOIF-CT-2005-51474, and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkat S, 2008, NEUROSCI LETT, V434, P108, DOI 10.1016/j.neulet.2008.01.037; Bensafi M, 2005, CHEM SENSES, V30, P521, DOI 10.1093/chemse/bji045; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bensafi M, 2007, J NEUROPHYSIOL, V98, P3254, DOI 10.1152/jn.00349.2007; Bensafi M, 2007, CHEM SENSES, V32, P855, DOI 10.1093/chemse/bjm055; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; DOTY RL, 2002, HDB OLFACTION GUSTAT, P403; DRAVNIEKS, 1985, ATLAS ODOR CHARACTER; Engen T., 1988, PERFUMERY PSYCHOL BI, P79; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Hebb ALO, 2004, EUR J NEUROSCI, V20, P2415, DOI 10.1111/j.1460-9568.2004.03704.x; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; KINDERMANN U, 1994, DEV PSYCHOBIOL, V27, P111, DOI 10.1002/dev.420270205; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; PRESCOTT J, 2008, CHEMOSENSOR IN PRESS; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; ROLLS ET, 2000, BEHAV BRAIN SCI, V23, P192; Schaal B, 2004, CLIN PERINATOL, V31, P261, DOI 10.1016/j.clp.2004.04.003; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Stagnetto JM, 2006, EUR REV APPL PSYCHOL, V56, P253, DOI 10.1016/j.erap.2005.09.012; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; SULLIVAN RM, 1991, PEDIATRICS, V87, P511; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2005, CURR BIOL, V15, pR255, DOI 10.1016/j.cub.2005.03.027; Wilson D.A., 2006, LEARNING SMELL	34	60	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4209	10.1371/journal.pone.0004209	http://dx.doi.org/10.1371/journal.pone.0004209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148286	gold, Green Published, Green Submitted			2022-12-27	WOS:000265479900003
J	Ihm, Y; Sparks, WO; Lee, JH; Cao, HB; Carpenter, S; Wang, CZ; Ho, KM; Dobbs, D				Ihm, Yungok; Sparks, Wendy O.; Lee, Jae-Hyung; Cao, Haibo; Carpenter, Susan; Wang, Cai-Zhuang; Ho, Kai-Ming; Dobbs, Drena			Structural Model of the Rev Regulatory Protein from Equine Infectious Anemia Virus	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; HIV-1 REV; NUCLEAR-EXPORT; ACTIVATION DOMAIN; AMINO-ACIDS; BINDING; SEQUENCES; SUGGESTS; ELEMENT; FOLD	Rev is an essential regulatory protein in the equine infectious anemia virus (EIAV) and other lentiviruses, including HIV-1. It binds incompletely spliced viral mRNAs and shuttles them from the nucleus to the cytoplasm, a critical prerequisite for the production of viral structural proteins and genomic RNA. Despite its important role in production of infectious virus, the development of antiviral therapies directed against Rev has been hampered by the lack of an experimentally-determined structure of the full length protein. We have used a combined computational and biochemical approach to generate and evaluate a structural model of the Rev protein. The modeled EIAV Rev (ERev) structure includes a total of 6 helices, four of which form an anti-parallel four-helix bundle. The first helix contains the leucine-rich nuclear export signal (NES). An arginine-rich RNA binding motif, RRDRW, is located in a solvent-exposed loop region. An ERLE motif required for Rev activity is predicted to be buried in the core of modeled structure where it plays an essential role in stabilization of the Rev fold. This structural model is supported by existing genetic and functional data as well as by targeted mutagenesis of residues predicted to be essential for overall structural integrity. Our predicted structure should increase understanding of structure-function relationships in Rev and may provide a basis for the design of new therapies for lentiviral diseases.	[Cao, Haibo; Ho, Kai-Ming] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Sparks, Wendy O.; Carpenter, Susan] Iowa State Univ, Dept Vet Microbiol & Preventive Med, Ames, IA 50011 USA; [Lee, Jae-Hyung; Carpenter, Susan; Ho, Kai-Ming; Dobbs, Drena] Iowa State Univ, Bioinformat Computat Biol Program, Ames, IA 50011 USA; [Wang, Cai-Zhuang; Ho, Kai-Ming] Iowa State Univ, US DOE, Ames Lab, Ames, IA 50011 USA; [Dobbs, Drena] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Carpenter, Susan] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Washington State University	Ihm, Y (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.	yihm@spring8.or.jp	Lee, Jae-Hyung/E-6827-2011; Lee, Jae-Hyung/AAI-9813-2020	Dobbs, Drena/0000-0003-4404-9554; Lee, Jae-Hyung/0000-0002-5085-6988	NIH [CA97936]; Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University; NATIONAL CANCER INSTITUTE [R01CA128568, R21CA097936] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank NIH grant CA97936 to S.C. and a grant from Laurence H. Baker Center for Bioinformatics and Biological Statistics at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Baccam P, 2003, J VIROL, V77, P12122, DOI 10.1128/JVI.77.22.12122-12131.2003; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; Belshan M, 2001, VIROLOGY, V279, P185, DOI 10.1006/viro.2000.0696; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cao HB, 2004, POLYMER, V45, P687, DOI 10.1016/j.polymer.2003.10.091; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Chung HK, 2001, J BIOL CHEM, V276, P18960, DOI 10.1074/jbc.M008996200; CORNISH VW, 1994, BIOCHEMISTRY-US, V33, P12022, DOI 10.1021/bi00206a003; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FRIDELL RA, 1993, J VIROL, V67, P7317, DOI 10.1128/JVI.67.12.7317-7323.1993; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Harris ME, 1998, MOL CELL BIOL, V18, P3889, DOI 10.1128/MCB.18.7.3889; Havlin RH, 2007, BIOCHEMISTRY-US, V46, P3586, DOI 10.1021/bi0622928; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Hulsmeyer M, 2001, ACTA CRYSTALLOGR D, V57, P1334, DOI 10.1107/S0907444901009799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; Li H, 1997, PHYS REV LETT, V79, P765, DOI 10.1103/PhysRevLett.79.765; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANCUSO VA, 1994, J VIROL, V68, P1998, DOI 10.1128/JVI.68.3.1998-2001.1994; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sparks WO, 2008, J GEN VIROL, V89, P1043, DOI 10.1099/vir.0.83195-0; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Tang HL, 1999, ANNU REV GENET, V33, P133, DOI 10.1146/annurev.genet.33.1.133; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; Thomas SL, 1997, PROTEIN ENG, V10, P103, DOI 10.1093/protein/10.2.103; Truant R, 1999, MOL CELL BIOL, V19, P1210; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; Zanotti G, 2000, BBA-PROTEIN STRUCT M, V1478, P232, DOI 10.1016/S0167-4838(00)00040-6	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4178	10.1371/journal.pone.0004178	http://dx.doi.org/10.1371/journal.pone.0004178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137065	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479500009
J	Heslop, CL; Miller, GE; Hill, JS				Heslop, Claire L.; Miller, Gregory E.; Hill, John S.			Neighbourhood Socioeconomics Status Predicts Non-Cardiovascular Mortality in Cardiac Patients with Access to Universal Health Care	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; HDL-CHOLESTEROL; RISK-FACTOR; SURVIVAL; EVENTS; DEATH; RATES	Background: Although the Canadian health care system provides essential services to all residents, evidence suggests that socioeconomic gradients in disease outcomes still persist. The main objective of our study was to investigate whether mortality, from cardiovascular disease or other causes, varies by neighbourhood socioeconomic gradients in patients accessing the healthcare system for cardiovascular disease management. Methods and Findings: A cohort of 485 patients with angiographic evidence of coronary artery disease (CAD) and neighbourhood socioeconomic status information was followed for 13.3 years. Survival analyses were completed with adjustment for potentially confounding risk factors. There were 64 cases of cardiovascular mortality and 66 deaths from non-cardiovascular chronic diseases. No socioeconomic differentials in cardiovascular mortality were observed. However, lower neighbourhood employment, education, and median family income did predict an increased risk of mortality from non-cardiovascular chronic diseases. For each quintile decrease in neighbourhood socioeconomic status, non-cardiovascular mortality risk rose by 21-30%. Covariate-adjusted hazard ratios (95% confidence interval) for non-cardiovascular mortality were 1.21 (1.02-1.42), 1.21 (1.01-1.46), and 1.30 (1.06-1.60), for each quintile decrease in neighbourhood education, employment, and income, respectively. These patterns were primarily attributable to mortality from cancer. Estimated risks for mortality from cancer rose by 42% and 62% for each one quintile decrease in neighbourhood median income and employment rate, respectively. Although only baseline clinical information was collected and patient-level socioeconomic data were not available, our results suggest that environmental socioeconomic factors have a significant impact on CAD patient survival. Conclusions: Despite public health care access, CAD patients who reside in lower-socioeconomic neighbourhoods show increased vulnerability to non-cardiovascular chronic disease mortality, particularly in the domain of cancer. These findings prompt further research exploring mechanisms of neighbourhood effects on health, and ways they may be ameliorated.	[Hill, John S.] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Heart & Lung Inst,Dept Pathol & Lab Me, St Pauls Hosp,Atherosclerosis Specialty Lab, Vancouver, BC V5Z 1M9, Canada; [Miller, Gregory E.] Univ British Columbia, Fac Arts, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia	Heslop, CL (corresponding author), Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Providence Heart & Lung Inst,Dept Pathol & Lab Me, St Pauls Hosp,Atherosclerosis Specialty Lab, Vancouver, BC V5Z 1M9, Canada.	clheslop@interchange.ubc.ca			Canadian Institutes of Health Research [MD/PhD Studentship Award]; Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada [McDonald Scholarship Award]; Providence Health Care Research Institute [MD/PhD Studentship Award]; Michael Smith Foundation for Health Research [senior graduate studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Providence Health Care Research Institute; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	The recruitment of study patients in 1993 to 1995 was funded by a research grant from the Canadian Institutes of Health Research, and subsequent analyses were funded by the Heart and Stroke Foundation of British Columbia and Yukon. GEM is supported by a McDonald Scholarship Award from the Heart and Stroke Foundation of Canada. CLH is supported by a Canadian Institutes of Health Research and Providence Health Care Research Institute MD/PhD Studentship Award, and a senior graduate studentship from the Michael Smith Foundation for Health Research. The authors received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; AKRITAS MG, 1994, ANN STAT, V22, P1299, DOI 10.1214/aos/1176325630; Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Cohen S, 1999, J APPL SOC PSYCHOL, V29, P445, DOI 10.1111/j.1559-1816.1999.tb01396.x; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; *CTR CHRON DIS PRE, 2005, CHRON DIS CLOCK EXPL; Demeter S, 2005, CAN MED ASSOC J, V173, P1173, DOI 10.1503/cmaj.050609; DRAGANO N, 2008, EUR J EPIDEMIOL; Francis MC, 2001, ATHEROSCLEROSIS, V155, P165, DOI 10.1016/S0021-9150(00)00528-1; Frohlich J, 2003, CLIN CHEM, V49, P1873, DOI 10.1373/clinchem.2003.022558; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAFT JI, 1988, CHEST, V94, P731, DOI 10.1378/chest.94.4.731; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hemingway H, 2000, J EPIDEMIOL COMMUN H, V54, P510, DOI 10.1136/jech.54.7.510; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lemstra M, 2006, CAN J PUBLIC HEALTH, V97, P435, DOI 10.1007/BF03405223; Manderbacka K, 2006, J EPIDEMIOL COMMUN H, V60, P442, DOI 10.1136/jech.2005.041566; MCGRAIL KM, 2004, BRIT COLUMBIA HLTH A; MCGRAIL KM, 2008, INCOME RELATED INEQU; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; MYLES J, 2000, NEIGHBOURHOOD INEQUA; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peltonen M, 2000, AM J EPIDEMIOL, V151, P283, DOI 10.1093/oxfordjournals.aje.a010204; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; *STAT CAN, 2005, 2001 POP CENS; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; *U BRIT COL, HUM EARL LEARN PARTN; WEINBLATT E, 1978, NEW ENGL J MED, V299, P60, DOI 10.1056/NEJM197807132990202; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Winkleby M, 2006, AM J PUBLIC HEALTH, V96, P2145, DOI 10.2105/AJPH.2004.060970; World Health Organization, 1992, INT STAT CLASS DIS R	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4120	10.1371/journal.pone.0004120	http://dx.doi.org/10.1371/journal.pone.0004120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127285	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473300005
J	Levin, A; Hayouka, Z; Helfer, M; Brack-Werner, R; Friedler, A; Loyter, A				Levin, Aviad; Hayouka, Zvi; Helfer, Markus; Brack-Werner, Ruth; Friedler, Assaf; Loyter, Abraham			Peptides Derived from HIV-1 Integrase that Bind Rev Stimulate Viral Genome Integration	PLOS ONE			English	Article								Background: The human immunodeficiency virus type 1 (HIV-1) integrase protein (IN), catalyzes the integration of viral DNA into the host cell genome. IN catalyzes the first step of the integration process, namely the 3'-end processing in which IN removes a pGT dinucleotide from the 3' end of each viral long terminal repeat (LTR). Following nuclear import of the viral preintegration complex, the host chromosomal DNA becomes accessible to the viral cDNA and the second step of the integration process, namely the strand-transfer step takes place. This ordered sequence of events, centered on integration, is mandatory for HIV replication. Methodology/Principal Findings: Using an integrase peptide library, we selected two peptides, designated INr-1 and INr-2, which interact with the Rev protein and probably mediate the Rev-integrase interaction. Using an in-vitro assay system, we show that INr-1 and INr-2 are able to abrogate the inhibitory effects exerted by Rev and Rev-derived peptides on integrase activity. Both INr-1 and INr-2 were found to be cell-permeable and nontoxic, allowing a study of their effect in HIV-1-infected cultured cells. Interestingly, both INr peptides stimulated virus infectivity as estimated by production of the viral P24 protein, as well as by determination of the appearance of newly formed virus particles. Furthermore, kinetics studies revealed that the cell-permeable INr peptides enhance the integration process, as was indeed confirmed by direct determination of viral DNA integration by real-time PCR. Conclusions/Significance: The results of the present study raise the possibility that in HIV-infected cells, the Rev protein may be involved in the integration of proviral DNA by controlling/regulating the activity of the integrase. Release from such inhibition leads to stimulation of IN activity and multiple viral DNA integration events.	[Loyter, Abraham] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hayouka, Zvi; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91905 Jerusalem, Israel; [Helfer, Markus; Brack-Werner, Ruth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Virol, Neuherberg, Germany; [Brack-Werner, Ruth] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Clin Cooperat Grp Immune Monitoring, Neuherberg, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Levin, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	loyter@mail.ls.huji.ac.il	Brack-Werner, Ruth/M-4615-2014	Brack-Werner, Ruth/0000-0002-8651-9318	Israel Science Foundation, Israel Ministry of Health [888/05]; European Research Council; Austrian National Bank; Horowitz Foundation	Israel Science Foundation, Israel Ministry of Health(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Austrian National Bank; Horowitz Foundation	This work was supported in part by grants from the Israel Science Foundation, Israel Ministry of Health (grant no. 888/05) by starting grant from the European Research Council (ERC) (to A.F.) and Austrian National Bank (to A.L.), and by the Horowitz Foundation (to A.L. and A.F.).	Afanasieva TA, 2001, J NEUROVIROL, V7, P169; Armon-Omer A, 2008, J MOL BIOL, V376, P971, DOI 10.1016/j.jmb.2007.11.095; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; BRACKWERNER R, 1992, AIDS, V6, P273, DOI 10.1097/00002030-199203000-00003; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; CHESEBRO B, 1990, J VIROL, V64, P215, DOI 10.1128/JVI.64.1.215-221.1990; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1997, HIST INTRO GEN PROPE, P1; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Field FJ, 2002, BIOCHEM J, V368, P855, DOI 10.1042/BJ20020731; Fineberg K, 2003, BIOCHEMISTRY-US, V42, P2625, DOI 10.1021/bi0206199; Freed E. O., 2001, FIELDS VIROLOGY, P1971; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Gummuluru S, 2000, J VIROL, V74, P10882, DOI 10.1128/JVI.74.23.10882-10891.2000; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hariton-Gazal E, 2005, BIOCHEMISTRY-US, V44, P11555, DOI 10.1021/bi050752b; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hwang Y, 2000, NUCLEIC ACIDS RES, V28, P4884, DOI 10.1093/nar/28.24.4884; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KOHLER F, 1989, PLANT MOL BIOL, V12, P189, DOI 10.1007/BF00020504; Kramer-Hammerle S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-20; LI CKN, 1985, MOL IMMUNOL, V22, P321, DOI 10.1016/0161-5890(85)90168-3; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; NAKASHIMA H, 1989, ANTIVIR RES, V11, P233, DOI 10.1016/0166-3542(89)90033-8; Odawara T, 1998, J VIROL, V72, P5414, DOI 10.1128/JVI.72.7.5414-5424.1998; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Paul TA, 2006, J VIROL, V80, P2941, DOI 10.1128/JVI.80.6.2941-2948.2006; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rigourd M, 2000, J BIOL CHEM, V275, P26944; Rosenbluh J, 2007, J BIOL CHEM, V282, P15743, DOI 10.1074/jbc.M609864200; Rosenbluh J, 2006, ANAL BIOCHEM, V352, P157, DOI 10.1016/j.ab.2006.03.002; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Tai CK, 2008, FRONT BIOSCI-LANDMRK, V13, P3083, DOI 10.2741/2910; TSURUO T, 1977, J VIROL, V23, P533, DOI 10.1128/JVI.23.3.533-542.1977; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; WOLFF B, 1995, EXP CELL RES, V217, P31, DOI 10.1006/excr.1995.1060; Wolff H, 2006, EXP CELL RES, V312, P443, DOI 10.1016/j.yexcr.2005.11.020; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-61; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	63	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4155	10.1371/journal.pone.0004155	http://dx.doi.org/10.1371/journal.pone.0004155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127291	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473300018
J	Long, JE; Renzette, N; Centore, RC; Sandler, SJ				Long, Jarukit Edward; Renzette, Nicholas; Centore, Richard C.; Sandler, Steven J.			Differential Requirements of Two recA Mutants for Constitutive SOS Expression in Escherichia coli K-12	PLOS ONE			English	Article								Background: Repairing DNA damage begins with its detection and is often followed by elicitation of a cellular response. In E. coli, RecA polymerizes on ssDNA produced after DNA damage and induces the SOS Response. The RecA-DNA filament is an allosteric effector of LexA auto-proteolysis. LexA is the repressor of the SOS Response. Not all RecA-DNA filaments, however, lead to an SOS Response. Certain recA mutants express the SOS Response (recA(C)) in the absence of external DNA damage in log phase cells. Methodology/Principal Findings: Genetic analysis of two recA(C) mutants was used to determine the mechanism of constitutive SOS (SOSC) expression in a population of log phase cells using fluorescence of single cells carrying an SOS reporter system (sulAp-gfp). SOSC expression in recA4142 mutants was dependent on its initial level of transcription, recBCD, recFOR, recX, dinl, xthA and the type of medium in which the cells were grown. SOSC expression in recA730 mutants was affected by none of the mutations or conditions tested above. Conclusions/Significance: It is concluded that not all recA(C) alleles cause SOSC expression by the same mechanism. It is hypothesized that RecA4142 is loaded on to a double-strand end of DNA and that the RecA filament is stabilized by the presence of DinI and destabilized by RecX. RecFOR regulate the activity of RecX to destabilize the RecA filament. RecA730 causes SOSC expression by binding to ssDNA in a mechanism yet to be determined.	[Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N203, Amherst, MA 01003 USA; [Renzette, Nicholas; Centore, Richard C.; Sandler, Steven J.] Univ Massachusetts, Morrill Sci Ctr, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Long, JE (corresponding author), Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N203, Amherst, MA 01003 USA.	sandler@microbio.umass.edu			National Institutes of Health [AI059027]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI059027 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; Blazquez J, 2006, MOL MICROBIOL, V62, P84, DOI 10.1111/j.1365-2958.2006.05366.x; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Centore RC, 2008, MOL MICROBIOL, V67, P88, DOI 10.1111/j.1365-2958.2007.06026.x; Centore RC, 2007, J BACTERIOL, V189, P2915, DOI 10.1128/JB.01777-06; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Zutter JK, 2001, STRUCTURE, V9, P47, DOI 10.1016/S0969-2126(00)00552-9; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; FU Y, 2008, FEMS MICROBIOLOGY RE, P1; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Huang LC, 1997, J BACTERIOL, V179, P6076, DOI 10.1128/jb.179.19.6076-6083.1997; Ivancic-Bace I, 2003, GENETICS, V163, P485; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; KIRBY EP, 1967, P NATL ACAD SCI USA, V58, P1903, DOI 10.1073/pnas.58.5.1903; KNIGHT KL, 1984, J BIOL CHEM, V259, P1279; KONRAD EB, 1977, J BACTERIOL, V130, P167, DOI 10.1128/JB.130.1.167-172.1977; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Lestini R, 2008, J BACTERIOL, V190, P5995, DOI 10.1128/JB.00620-08; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; Ramirez BE, 2000, PROTEIN SCI, V9, P2161, DOI 10.1110/ps.9.11.2161; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Renzette N, 2007, MOL MICROBIOL, V63, P103, DOI 10.1111/j.1365-2958.2006.05496.x; Sandler SJ, 1996, GENETICS, V143, P5; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; Scully R, 2004, CANCER BIOL THER, V3, P521, DOI 10.4161/cbt.3.6.842; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Steiner WW, 1998, J BACTERIOL, V180, P6269; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; TESSMAN ES, 1985, J BACTERIOL, V163, P677, DOI 10.1128/JB.163.2.677-687.1985; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; Yasuda T, 2001, EMBO J, V20, P1192, DOI 10.1093/emboj/20.5.1192; Yoshimasu M, 2003, NUCLEIC ACIDS RES, V31, P1735, DOI 10.1093/nar/gkg256; ZIEG J, 1977, J BACTERIOL, V131, P123, DOI 10.1128/JB.131.1.123-132.1977	76	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4100	10.1371/journal.pone.0004100	http://dx.doi.org/10.1371/journal.pone.0004100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116657	Green Published, gold			2022-12-27	WOS:000265466600018
J	Sano, K; Miyaji-Yamaguchi, M; Tsutsui, KM; Tsutsui, K				Sano, Kuniaki; Miyaji-Yamaguchi, Mary; Tsutsui, Kimiko M.; Tsutsui, Ken			Topoisomerase II beta Activates a Subset of Neuronal Genes that Are Repressed in AT-Rich Genomic Environment	PLOS ONE			English	Article								DNA topoisomerase II (topo II) catalyzes a strand passage reaction in that one duplex is passed through a transient brake or gate in another. Completion of late stages of neuronal development depends on the presence of active beta isoform (topo II beta). The enzyme appears to aid the transcriptional induction of a limited number of genes essential for neuronal maturation. However, this selectivity and underlying molecular mechanism remains unknown. Here we show a strong correlation between the genomic location of topo II beta action sites and the genes it regulates. These genes, termed group A1, are functionally biased towards membrane proteins with ion channel, transporter, or receptor activities. Significant proportions of them encode long transcripts and are juxtaposed to a long AT-rich intergenic region (termed LAIR). We mapped genomic sites directly targeted by topo II beta using a functional immunoprecipitation strategy. These sites can be classified into two distinct classes with discrete local GC contents. One of the classes, termed c2, appears to involve a strand passage event between distant segments of genomic DNA. The c2 sites are concentrated both in A1 gene boundaries and the adjacent LAIR, suggesting a direct link between the action sites and the transcriptional activation. A higher-order chromatin structure associated with AT richness and gene poorness is likely to serve as a silencer of gene expression, which is abrogated by topo II beta releasing nearby genes from repression. Positioning of these genes and their control machinery may have developed recently in vertebrate evolution to support higher functions of central nervous system.	[Sano, Kuniaki; Miyaji-Yamaguchi, Mary; Tsutsui, Kimiko M.] Okayama Univ, Dept Neurogenom, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Tsutsui, Ken] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Genome Dynam, Okayama, Japan	Okayama University; Okayama University	Sano, K (corresponding author), Okayama Univ, Dept Neurogenom, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	tsukken@cc.okayama-u.ac.jp	MIYAJI, Mary/B-2294-2011; TSUTSUI, Kimiko M/B-1955-2011; Tsutsui, Ken/B-1863-2011		MEXT, Japan [Grant-in-Aid]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grant-in-Aid for Scientific Research funding to K. T. from the MEXT, Japan. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Borde V, 1998, BIOCHIMIE, V80, P223, DOI 10.1016/S0300-9084(98)80005-9; Burden DA, 1999, J BIOL CHEM, V274, P5227, DOI 10.1074/jbc.274.8.5227; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; DRAKE FH, 1987, J BIOL CHEM, V262, P16739; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; LEE MP, 1992, NUCLEIC ACIDS RES, V20, P5027, DOI 10.1093/nar/20.19.5027; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martins RP, 2007, P NATL ACAD SCI USA, V104, P8340, DOI 10.1073/pnas.0700076104; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Raetzman LT, 1999, J NEUROBIOL, V38, P559; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Salceda J, 2006, EMBO J, V25, P2575, DOI 10.1038/sj.emboj.7601142; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	33	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4103	10.1371/journal.pone.0004103	http://dx.doi.org/10.1371/journal.pone.0004103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116664	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600021
J	Church, TS; Martin, CK; Thompson, AM; Earnest, CP; Mikus, CR; Blair, SN				Church, Timothy S.; Martin, Corby K.; Thompson, Angela M.; Earnest, Conrad P.; Mikus, Catherine R.; Blair, Steven N.			Changes in Weight, Waist Circumference and Compensatory Responses with Different Doses of Exercise among Sedentary, Overweight Postmenopausal Women	PLOS ONE			English	Article								Background: It has been suggested that exercise training results in compensatory mechanisms that attenuate weight loss. However, this has only been examined with large doses of exercise. The goal of this analysis was to examine actual weight loss compared to predicted weight loss (compensation) across different doses of exercise in a controlled trial of sedentary, overweight or obese postmenopausal women (n = 411). Methodology/Principal Findings: Participants were randomized to a non-exercise control (n = 94) or 1 of 3 exercise groups; exercise energy expenditure of 4 (n = 139), 8 (n = 85), or 12 (n = 93) kcal/kg/week (KKW). Training intensity was set at the heart rate associated with 50% of each woman's peak VO(2) and the intervention period was 6 months. All exercise was supervised. The main outcomes were actual weight loss, predicted weight loss (exercise energy expenditure/7700 kcal per kg), compensation (actual minus predicted weight loss) and waist circumference. The study sample had a mean (SD) age 57.2 (6.3) years, BMI of 31.7 (3.8) kg/m(2), and was 63.5% Caucasian. The adherence to the intervention was > 99% in all exercise groups. The mean (95% CI) weight loss in the 4, 8 and 12 KKW groups was -1.4 (-2.0, -0.8), -2.1 (-2.9, -1.4) and -1.5 (-2.2, -0.8) kg, respectively. In the 4 and 8 KKW groups the actual weight loss closely matched the predicted weight loss of -1.0 and -2.0 kg, respectively, resulting in no significant compensation. In the 12 KKW group the actual weight loss was less than the predicted weight loss (-2.7 kg) resulting in 1.2 (0.5, 1.9) kg of compensation (P<0.05 compared to 4 and 8 KKW groups). All exercise groups had a significant reduction in waist circumference which was independent of changes in weight. Conclusion: In this study of previously sedentary, overweight or obese, postmenopausal women we observed no difference in the actual and predicted weight loss with 4 and 8 KKW of exercise (72 and 136 minutes respectively), while the 12 KKW (194 minutes) produced only about half of the predicted weight loss. However, all exercise groups had a significant reduction in waist circumference which was independent of changes in weight. Trial Registration: ClinicalTrials.gov NCT 00011193	[Church, Timothy S.; Martin, Corby K.; Thompson, Angela M.; Earnest, Conrad P.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Mikus, Catherine R.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, MD USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Missouri System; University of Missouri Columbia; University of South Carolina	Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	tim.church@pbrc.edu	Earnest, Conrad P./M-6849-2017; Earnest, Conrad P/A-7860-2009; Thompson-Paul, Angela/N-7067-2016; Martin, Corby K./N-1976-2017	Earnest, Conrad P./0000-0002-6546-1268; Thompson-Paul, Angela/0000-0003-1186-9150; Martin, Corby K./0000-0002-8125-4015	NIH [HL66262]; K award [DK068052-01A2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK068052] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant # HL66262. We thank Life Fitness for providing exercise equipment. Dr. Martin's work is support by a K award (K23 DK068052-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Donnelly JE, 2005, EXERC SPORT SCI REV, V33, P169, DOI 10.1097/00003677-200510000-00004; Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343; Dunn AL, 1998, MED SCI SPORT EXER, V30, P1076, DOI 10.1097/00005768-199807000-00009; Dunn AL, 1997, PREV MED, V26, P883, DOI 10.1006/pmed.1997.0218; HASKELL WL, 2007, PHYS ACTIVITY PUBLIC, P1423; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; King NA, 2008, INT J OBESITY, V32, P177, DOI 10.1038/sj.ijo.0803712; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Lohman TG, 1988, ANTROPOMETRIC STANDA; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Luepker RV, 1996, JAMA-J AM MED ASSOC, V276, P241; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2002, J CLIN ENDOCR METAB, V87, P5044, DOI 10.1210/jc.2002-020570; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Seidell JC, 1997, J INTERN MED, V242, P401, DOI 10.1046/j.1365-2796.1997.00235.x; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *U TEX HSOPH, 1996, FOOD INT AN SYST VER; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Welham WC, 1942, J AMER MED ASSOC, V118, P498, DOI 10.1001/jama.1942.02830070004002; World Health Organization,, 1998, WHO TECHN REP SER	30	176	180	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4515	10.1371/journal.pone.0004515	http://dx.doi.org/10.1371/journal.pone.0004515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223984	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485800015
J	Wang, ZP; Zhang, SC; Tong, Z; Li, L; Wang, GF				Wang, Zhiping; Zhang, Shicui; Tong, Zhou; Li, Lei; Wang, Guangfeng			Maternal Transfer and Protective Role of the Alternative Complement Components in Zebrafish Danio rerio	PLOS ONE			English	Article								Embryos of most fish develop externally and are exposed to an aquatic environment full of potential pathogens, whereas they have little or only limited ability to mount an efficient and protective response. How fish embryos survive pathogenic attacks remains poorly defined. Here we demonstrate that the maternal immunization of female zebrafish with formalin-killed Aeromonas hydrophila causes a significant increase in C3 and Bf contents in the mother, a corresponding rise in the offspring, and induces a remarkable increase in the hemolytic activities in both the mother and offspring. In addition, the embryos derived from the immunized mother are significantly more tolerant to A. hydrophila challenge than those from the unimmunized fish, and blocking C3 and Bf activities by injection of the antibodies against C3 and Bf into the embryos render them more susceptible to A. hydrophila. These results clearly show that the protection of zebrafish embryos against A. hydrophila can be achieved by the maternally-transferred immunity of the complement system operating via the alternative pathway. This appears to be the first report providing in vivo evidences for the protective role of the alternative complement components in the early embryos of zebrafish, paving the way for insights into the in vivo function of other maternally-transferred factors in fish.	[Wang, Zhiping; Zhang, Shicui; Tong, Zhou; Li, Lei; Wang, Guangfeng] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China	Ocean University of China	Wang, ZP (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn			Natural Science Foundation of China (NSFC) [30730072]; Ministry of Science and Technology (MOST) of China [2006CB101805]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China)	This work was supported by grants (30730072) of Natural Science Foundation of China (NSFC) and grants (2006CB101805) of Ministry of Science and Technology (MOST) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILDFELL R J, 1992, Journal of Aquatic Animal Health, V4, P97, DOI 10.1577/1548-8667(1992)004&lt;0097:PAPCOA&gt;2.3.CO;2; BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; Brown LL, 1997, DIS AQUAT ORGAN, V31, P95, DOI 10.3354/dao031095; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Choi JH, 2002, FISHERIES SCI, V68, P1367, DOI 10.1046/j.1444-2906.2002.00576.x; Ekdahl KN, 2007, CLIN VACCINE IMMUNOL, V14, P549, DOI 10.1128/CVI.00486-06; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Ellis A. E., 1988, Fish vaccination., P20; Hanif A, 2004, FISH SHELLFISH IMMUN, V17, P411, DOI 10.1016/j.fsi.2004.04.013; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Holbech H, 2001, COMP BIOCHEM PHYS C, V130, P119, DOI 10.1016/S1532-0456(01)00229-0; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; Jung WK, 2003, INT J BIOCHEM CELL B, V35, P255, DOI 10.1016/S1357-2725(02)00176-0; KANLIS G, 1995, FISHERIES SCI, V61, P791, DOI 10.2331/fishsci.61.791; Li Jun-Feng, 2005, Yichuan, V27, P797; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Oshima S, 1996, J GEN VIROL, V77, P2441, DOI 10.1099/0022-1317-77-10-2441; Picchietti S, 2006, FISH SHELLFISH IMMUN, V20, P398, DOI 10.1016/j.fsi.2005.06.001; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; PLOUG M, 1985, ANAL BIOCHEM, V146, P411, DOI 10.1016/0003-2697(85)90560-3; SIN YM, 1994, AQUACULTURE, V120, P229, DOI 10.1016/0044-8486(94)90081-7; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Swain P, 2006, FISH SHELLFISH IMMUN, V20, P519, DOI 10.1016/j.fsi.2005.06.011; Takemura A, 1997, FISH SHELLFISH IMMUN, V7, P355, DOI 10.1006/fsim.1997.0090; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; van Loon J. J. A, 1981, ASPECTS DEV COMP IMM, P469; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; YOUSIF AN, 1991, DIS AQUAT ORGAN, V10, P45, DOI 10.3354/dao010045; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207	39	49	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4498	10.1371/journal.pone.0004498	http://dx.doi.org/10.1371/journal.pone.0004498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223977	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485800007
J	Abdullah, NM; Rosania, GR; Shedden, K				Abdullah, Newaj M.; Rosania, Gus R.; Shedden, Kerby			Selective Targeting of Tumorigenic Cancer Cell Lines by Microtubule Inhibitors	PLOS ONE			English	Article								For anticancer drug therapy, it is critical to kill those cells with highest tumorigenic potential, even when they comprise a relatively small fraction of the overall tumor cell population. We have used the established NCI/DTP 60 cell line growth inhibition assay as a platform for exploring the relationship between chemical structure and growth inhibition in both tumorigenic and non-tumorigenic cancer cell lines. Using experimental measurements of "take rate'' in ectopic implants as a proxy for tumorigenic potential, we identified eight chemical agents that appear to strongly and selectively inhibit the growth of the most tumorigenic cell lines. Biochemical assay data and structure-activity relationships indicate that these compounds act by inhibiting tubulin polymerization. Yet, their activity against tumorigenic cell lines is more selective than that of the other microtubule inhibitors in clinical use. Biochemical differences in the tubulin subunits that make up microtubules, or differences in the function of microtubules in mitotic spindle assembly or cell division may be associated with the selectivity of these compounds.	[Rosania, Gus R.] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Shedden, Kerby] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Rosania, Gus R.; Shedden, Kerby] MACE, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Abdullah, NM (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	grosania@umich.edu; kshedden@umich.edu		Shedden, Kerby/0000-0001-7222-6664	United States National Institutes of Health [P20HG003890]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078200] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	United States National Institutes of Health grant P20HG003890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; Chen K, 1997, J MED CHEM, V40, P3049, DOI 10.1021/jm970146h; Chen K, 1997, J MED CHEM, V40, P2266, DOI 10.1021/jm960858s; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; KOU SC, 1993, J MED CHEM, V36, P1146; LI L, 1994, J MED CHEM, V37, P1126, DOI 10.1021/jm00034a010; LI LP, 1994, J MED CHEM, V37, P3400, DOI 10.1021/jm00046a025; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; PETTIT GR, 1995, J MED CHEM, V38, P1666, DOI 10.1021/jm00010a011; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SCHATTEN G, 1986, DEV BIOL, V130, P74; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TEICHER BA, 1997, ANTICANCER DRUG DEV, P104; VANOSDOL WW, 1994, J NATL CANCER I, V86, P1855; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WARN RM, 1990, CELL MOTIL CYTOSKEL, V17, P34, DOI 10.1002/cm.970170106; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wilson PG, 1997, DEV BIOL, V184, P207, DOI 10.1006/dbio.1997.8545; Xia Y, 1998, J MED CHEM, V41, P1155, DOI 10.1021/jm9707479; Xia Y, 2001, J MED CHEM, V44, P3932, DOI 10.1021/jm0101085	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4470	10.1371/journal.pone.0004470	http://dx.doi.org/10.1371/journal.pone.0004470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214225	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484300009
J	Hu, M; Qin, ZHS				Hu, Ming; Qin, Zhaohui S.			Query Large Scale Microarray Compendium Datasets Using a Model-Based Bayesian Approach with Variable Selection	PLOS ONE			English	Article							GENE-EXPRESSION DATA; GENOME; IDENTIFICATION; ALGORITHM; NETWORKS; PATTERNS; FAMILY; GUILT	In microarray gene expression data analysis, it is often of interest to identify genes that share similar expression profiles with a particular gene such as a key regulatory protein. Multiple studies have been conducted using various correlation measures to identify co-expressed genes. While working well for small datasets, the heterogeneity introduced from increased sample size inevitably reduces the sensitivity and specificity of these approaches. This is because most co-expression relationships do not extend to all experimental conditions. With the rapid increase in the size of microarray datasets, identifying functionally related genes from large and diverse microarray gene expression datasets is a key challenge. We develop a model-based gene expression query algorithm built under the Bayesian model selection framework. It is capable of detecting co-expression profiles under a subset of samples/experimental conditions. In addition, it allows linearly transformed expression patterns to be recognized and is robust against sporadic outliers in the data. Both features are critically important for increasing the power of identifying co-expressed genes in large scale gene expression datasets. Our simulation studies suggest that this method outperforms existing correlation coefficients or mutual information-based query tools. When we apply this new method to the Escherichia coli microarray compendium data, it identifies a majority of known regulons as well as novel potential target genes of numerous key transcription factors.	[Hu, Ming; Qin, Zhaohui S.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hu, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	qin@umich.edu	Qin, Zhaohui S/E-8196-2011; Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui S/0000-0002-1583-146X; Qin, Zhaohui/0000-0002-1583-146X; Hu, Ming/0000-0002-6062-8794	University of Michigan [CCMB pilot grant]; University of Michigan Rackham Graduate School; Department of Biostatistics at the University of Michigan [Richard G. Cornell Fellowship]	University of Michigan(University of Michigan System); University of Michigan Rackham Graduate School(University of Michigan System); Department of Biostatistics at the University of Michigan	This work is partially supported by a University of Michigan CCMB pilot grant, a spring/summer research grant from the University of Michigan Rackham Graduate School and the Richard G. Cornell Fellowship from the Department of Biostatistics at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Butte A J, 2000, Pac Symp Biocomput, P418; Chen R, 1996, J ROY STAT SOC B MET, V58, P397; Cheng Y., 2000, P 8 INT C INT SYST M, P93; DHOLLANDER T, 2007, BIOINFORMATICS; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GELMAN A, 1995, BAYESIAN DATA ANAL, pR19; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Ghosh D, 2002, BIOINFORMATICS, V18, P275, DOI 10.1093/bioinformatics/18.2.275; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kim S, 2006, BIOMETRIKA, V93, P877, DOI 10.1093/biomet/93.4.877; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Liu J.S., 2001, MONTE CARLO STRATEGI; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; Medvedovic M, 2002, BIOINFORMATICS, V18, P1194, DOI 10.1093/bioinformatics/18.9.1194; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Owen AB, 2003, GENOME RES, V13, P1828, DOI 10.1101/gr.1125403; Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219; Qin ZS, 2006, BIOINFORMATICS, V22, P1988, DOI 10.1093/bioinformatics/btl284; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sheng QZ, 2003, BIOINFORMATICS, V19, pII196, DOI 10.1093/bioinformatics/btg1078; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4495	10.1371/journal.pone.0004495	http://dx.doi.org/10.1371/journal.pone.0004495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214232	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484300018
J	Dahlberg, C; Auger, H; Dupont, S; Sasakura, Y; Thorndyke, M; Joly, JS				Dahlberg, Carl; Auger, Helene; Dupont, Sam; Sasakura, Yasunori; Thorndyke, Mike; Joly, Jean-Stephane			Refining the Ciona intestinalis Model of Central Nervous System Regeneration	PLOS ONE			English	Article								Background: New, practical models of central nervous system regeneration are required and should provide molecular tools and resources. We focus here on the tunicate Ciona intestinalis, which has the capacity to regenerate nerves and a complete adult central nervous system, a capacity unusual in the chordate phylum. We investigated the timing and sequence of events during nervous system regeneration in this organism. Methodology/Principal Findings: We developed techniques for reproducible ablations and for imaging live cellular events in tissue explants. Based on live observations of more than 100 regenerating animals, we subdivided the regeneration process into four stages. Regeneration was functional, as shown by the sequential recovery of reflexes that established new criteria for defining regeneration rates. We used transgenic animals and labeled nucleotide analogs to describe in detail the early cellular events at the tip of the regenerating nerves and the first appearance of the new adult ganglion anlage. Conclusions/Significance: The rate of regeneration was found to be negatively correlated with adult size. New neural structures were derived from the anterior and posterior nerve endings. A blastemal structure was implicated in the formation of new neural cells. This work demonstrates that Ciona intestinalis is as a useful system for studies on regeneration of the brain, brain-associated organs and nerves.			Dahlberg, C (corresponding author), Univ Gothenburg, Dept Marine Ecol, Fiskebacksill, Sweden.	carl.dahlberg@marecol.gu.se; auger@inaf.cnrs-gif.fr	Dupont, Sam T/F-5527-2013	Dahlberg, Carl Martin Olof/0000-0002-9384-2666	INRA; CNRS; French GIS Institut de la Genomique Marine; Plurigenes STREP project [LSHG-CT-2005-018673]; Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; MRT [PhD fellowship]; ARC [PhD fellowship]; Marine Genomics Network for Women in Science Gender Action Plan [fellowship]; MEXT [17018018]; NIG Cooperative Research Program [2008-B02]; National Bioresource Project [07128019, 07128021]	INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); French GIS Institut de la Genomique Marine; Plurigenes STREP project; Marine Genomics Network of Excellence; MRT; ARC(Australian Research Council); Marine Genomics Network for Women in Science Gender Action Plan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIG Cooperative Research Program; National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work carried out at Gif was supported by INRA, CNRS, the French GIS Institut de la Genomique Marine, the Plurigenes STREP project LSHG-CT-2005-018673, the Marine Genomics Network of Excellence (EU-FP6 contract no. GOCE-CT-2004-505403). H. Auger held a PhD fellowship from MRT and ARC and a fellowship from the Marine Genomics Network for Women in Science Gender Action Plan. Y. Sasakura was supported by Grants-in-Aid for Scientific Research for a Priority Area from MEXT (17018018) and the NIG Cooperative Research Program (2008-B02). The E15 transgenic line was provided by the National Bioresource Project (07128019 and 07128021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Awazu S, 2007, GENESIS, V45, P307, DOI 10.1002/dvg.20290; BOLLNER T, 1993, CELL TISSUE RES, V272, P553, DOI 10.1007/BF00318562; BOLLNER T, 1992, J COMP NEUROL, V325, P572, DOI 10.1002/cne.903250409; Bollner T, 1997, P ROY SOC B-BIOL SCI, V264, P1117, DOI 10.1098/rspb.1997.0154; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bullock T., 1965, STRUCTURE FUNCTION N; Carnevali MDC, 2001, MAR ECOL PROG SER, V215, P155, DOI 10.3354/meps215155; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; CHAMBOST D, 1966, CR ACAD SCI D NAT, P969; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deyts C, 2006, EUR J NEUROSCI, V24, P2299, DOI 10.1111/j.1460-9568.2006.05073.x; Dupont S, 2006, J EXP BIOL, V209, P3873, DOI 10.1242/jeb.02445; Gould RM, 2005, BIOL BULL-US, V209, P49, DOI 10.2307/3593141; Gunnarsson JS, 1999, ENVIRON TOXICOL CHEM, V18, P1534, DOI 10.1002/etc.5620180728; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; JOLY JS, 2007, SEMINARS CELL DEV BI; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kawamura K, 2008, DEV DYNAM, V237, P1812, DOI 10.1002/dvdy.21592; Koster RW, 2006, J NEUROSCI, V26, P7293, DOI 10.1523/JNEUROSCI.0095-06.2006; KOYAMA H, 1993, J COMP NEUROL, V338, P549, DOI 10.1002/cne.903380405; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lender T., 1964, Bulletin de la Societe Zoologique de France, V89, P546; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Mackie GO, 2006, CAN J ZOOL, V84, P1146, DOI 10.1139/Z06-106; MACKIE GO, 1995, J MAR BIOL ASSOC UK, V75, P141, DOI 10.1017/S0025315400015253; Mackie GO, 2000, CAN J ZOOL, V78, P1626, DOI 10.1139/cjz-78-9-1626; MILLAR R, 1953, CIONA LIVERPOOL; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Petersen JK, 1997, J EXP MAR BIOL ECOL, V218, P1; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rinkevich Y, 2007, DEV BIOL, V312, P131, DOI 10.1016/j.ydbio.2007.09.005; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y	39	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4458	10.1371/journal.pone.0004458	http://dx.doi.org/10.1371/journal.pone.0004458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212465	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484200013
J	Rosu, V; Ahmed, N; Paccagnini, D; Gerlach, G; Fadda, G; Hasnain, SE; Zanetti, S; Sechi, LA				Rosu, Valentina; Ahmed, Niyaz; Paccagnini, Daniela; Gerlach, Gerald; Fadda, Giovanni; Hasnain, Seyed E.; Zanetti, Stefania; Sechi, Leonardo A.			Specific Immunoassays Confirm Association of Mycobacterium avium Subsp paratuberculosis with Type-1 but Not Type-2 Diabetes Mellitus	PLOS ONE			English	Article								Background: Mycobacterium avium subspecies paratuberculosis ( MAP) is a versatile pathogen with a broad host range. Its association with type-1 diabetes mellitus (T1DM) has been recently proposed. Rapid identification of infectious agents such as MAP in diabetic patients at the level of clinics might be helpful in deciphering the role of chronic bacterial infection in the development of autoimmune diseases such as T1DM. Methodology/Principal Findings: We describe use of an ELISA method to identify live circulating MAP through the detection of a cell envelope protein, MptD by a specific M13 phage - fMptD. We also used another ELISA format to detect immune response to MptD peptide. Both the methods were tested with blood plasma obtained from T1DM, type-2 diabetes (T2DM) patients and non-diabetic controls. Our results demonstrate MptD and fMptD ELISA assays to be accurate and sensitive to detect MAP bacilli in a large fraction (47.3%) of T1DM patients as compared to non-diabetic controls (12.6%) and those with confirmed T2DM (7.7%). Comparative analysis of ELISA assays performed here with 3 other MAP antigen preparations, namely HbHA, Gsd and whole cell MAP lysates confirmed comparable sensitivity of the MptD peptide and the fMptD based ELISA assays. Moreover, we were successful in demonstrating positive bacterial culture in two of the clinical specimen derived from T1DM patients. Conclusions and Significance: The MptD peptide/fMptD based ELISA or similar tests could be suggested as rapid and specific field level diagnostic tests for the identification of MAP in diabetic patients and for finding the explanations towards the occurrence of type-1 or type-2 diabetes in the light of an active infectious trigger.	[Rosu, Valentina; Paccagnini, Daniela; Zanetti, Stefania; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol, I-07100 Sassari, Italy; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Lab Pathogen Biol, Hyderabad 500134, Andhra Pradesh, India; [Gerlach, Gerald] Univ Vet Med, Hannover, Germany; [Fadda, Giovanni] Univ Cattolica Sacro Cuore, Ist Microbiol, Rome, Italy; [Hasnain, Seyed E.] Univ Hyderabad, Inst Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	University of Sassari; University of Hyderabad; University of Veterinary Medicine Hannover, Foundation; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Rosu, V (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol, I-07100 Sassari, Italy.	sechila@uniss.it	Sechi, Leonardo Antonio/Y-3109-2018; Fadda, Giovanni/K-6224-2012; Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583; sechi, leonardo antonio/0000-0003-0566-2049; Hasnain, Seyed/0000-0002-2967-0791	MIUR; University of Sassari; Italian Government/University of Sassari [visiting scientist]; Department of Biotechnology of the Indian Government, Mycobacterium-w program; University of Hyderabad [Bose National Fellow]	MIUR(Ministry of Education, Universities and Research (MIUR)); University of Sassari; Italian Government/University of Sassari; Department of Biotechnology of the Indian Government, Mycobacterium-w program; University of Hyderabad(University of Hyderabad)	LAS would like to acknowledge support from the MIUR and the University of Sassari. NA was supported through a visiting scientist scheme of the Italian Government/University of Sassari and also would like to acknowledge the Department of Biotechnology of the Indian Government for funding support through a grant under Mycobacterium-w program. SEH is a JC Bose National Fellow at the University of Hyderabad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannantine JP, 2008, INFECT IMMUN, V76, P739, DOI 10.1128/IAI.00915-07; Bromeyer L, 2005, MED HYPOTHESES, V65, P433, DOI 10.1016/j.mehy.2005.04.017; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; CHILD DF, 1995, DIABETIC MED, V12, P595, DOI 10.1111/j.1464-5491.1995.tb00548.x; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Davies JM, 1997, IMMUNOL CELL BIOL, V75, P113, DOI 10.1038/icb.1997.16; Dow CT, 2006, MED HYPOTHESES, V67, P782, DOI 10.1016/j.mehy.2006.04.029; Feige U, 1996, EXS, V77, P359; Frongia O, 2001, DIABETES CARE, V24, P1846, DOI 10.2337/diacare.24.10.1846; HEINZMANN J, 2008, VET MICROBI IN PRESS; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; MARTIN LALANDE J, 1964, Rev Tuberc Pneumol (Paris), V28, P342; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pickup RW, 2006, APPL ENVIRON MICROB, V72, P4067, DOI 10.1128/AEM.02490-05; Polymeros D, 2006, GASTROENTEROLOGY, V131, P85, DOI 10.1053/j.gastro.2006.04.021; Rosu Valentina, 2008, Ann Clin Microbiol Antimicrob, V7, P9, DOI 10.1186/1476-0711-7-9; Rowe MT, 2006, LETT APPL MICROBIOL, V42, P305, DOI 10.1111/j.1472-765X.2006.01873.x; Scanu AM, 2007, J CLIN MICROBIOL, V45, P3883, DOI 10.1128/JCM.01371-07; Sechi LA, 2006, VACCINE, V24, P236, DOI 10.1016/j.vaccine.2005.11.030; Sechi LA, 2005, J CLIN MICROBIOL, V43, P5275, DOI 10.1128/JCM.43.10.5275-5277.2005; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Sechi LA, 2006, WORLD J GASTROENTERO, V12, P7161, DOI 10.3748/wjg.v12.i44.7161; Stratmann J, 2004, INFECT IMMUN, V72, P1265, DOI 10.1128/IAI.72.3.1265-1274.2004; Stratmann J, 2006, APPL ENVIRON MICROB, V72, P5150, DOI 10.1128/AEM.00590-06; TOBA M, 1954, Kekkaku, V29, P86; van Halteren AGS, 2002, J AUTOIMMUN, V18, P139, DOI 10.1006/jaut.2001.0578	30	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4386	10.1371/journal.pone.0004386	http://dx.doi.org/10.1371/journal.pone.0004386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204799	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484000003
J	Wee, KB; Surana, U; Aguda, BD				Wee, Keng Boon; Surana, Uttam; Aguda, Baltazar D.			Oscillations of the p53-Akt Network: Implications on Cell Survival and Death	PLOS ONE			English	Article								Intracellular protein levels of p53 and MDM2 have been shown to oscillate in response to ionizing radiation (IR), but the physiological significance of these oscillations remains unclear. The p53-MDM2 negative feedback loop - the putative cause of the oscillations - is embedded in a network involving a mutual antagonism (or positive feedback loop) between p53 and AKT. We have shown earlier that this p53-AKT network predicts an all-or-none switching behavior between a pro-survival cellular state (low p53 and high AKT levels) and a pro-apoptotic state (high p53 and low AKT levels). Here, we show that upon exposure to IR, the p53-AKT network can also reproduce the experimentally observed p53 and MDM2 oscillations. The present work is based on the hypothesis that the physiological significance of the experimentally observed oscillations could be found in their role in regulating the switching behavior of the p53-AKT network between pro-survival and proapoptotic states. It is shown here that these oscillations are associated with a significant decrease in the threshold level of IR at which switching from a pro-survival to a pro-apoptotic state occurs. Moreover, oscillations in p53 protein levels induce higher levels of expression of p53-target genes compared to non-oscillatory p53, and thus influence cell-fate decisions between cell cycle arrest/DNA damage repair versus apoptosis.	[Surana, Uttam] ASTAR, Inst Mol & Cell Biol, Proteos, Singapore; [Aguda, Baltazar D.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Aguda, Baltazar D.] Ohio State Univ, OSU Med Ctr, Ctr Critical Care, Columbus, OH 43210 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wee, KB (corresponding author), ASTAR, Inst Mol & Cell Biol, Proteos, Singapore.	bdaguda@mbi.osu.edu	Surana, Uttam/H-1142-2011	Surana, Uttam/0000-0002-4785-6514	A*STAR [Graduate Scholarship]; Mathematical Biosciences Institute; Center for Critical Care, Medical Center, at The Ohio State University	A*STAR(Agency for Science Technology & Research (A*STAR)); Mathematical Biosciences Institute; Center for Critical Care, Medical Center, at The Ohio State University	K. B. Wee is a recipient of an A*STAR Graduate Scholarship. B. D. Aguda is supported by the Mathematical Biosciences Institute, and the Center for Critical Care, Medical Center, at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Collister M, 1998, CARCINOGENESIS, V19, P2115, DOI 10.1093/carcin/19.12.2115; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Grill CJ, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290153; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Jiang P, 2007, CELL RES, V17, P283, DOI 10.1038/cr.2007.19; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Maier D, 1998, ONCOGENE, V16, P3331, DOI 10.1038/sj.onc.1201832; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; MIYASHITA T, 1995, CELL, V80, P293; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohnishi T, 1999, RADIAT RES, V151, P368, DOI 10.2307/3579950; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Tyson JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100060; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wee KB, 2006, BIOPHYS J, V91, P857, DOI 10.1529/biophysj.105.077693; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhao RB, 2000, GENE DEV, V14, P981; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	83	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4407	10.1371/journal.pone.0004407	http://dx.doi.org/10.1371/journal.pone.0004407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197384	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483700014
J	Turakainen, H; Saarimaki-Vire, J; Sinjushina, N; Partanen, J; Savilahti, H				Turakainen, Hilkka; Saarimaeki-Vire, Jonna; Sinjushina, Natalia; Partanen, Juha; Savilahti, Harri			Transposition-Based Method for the Rapid Generation of Gene-Targeting Vectors to Produce Cre/Flp-Modifiable Conditional Knock-Out Mice	PLOS ONE			English	Article							VITRO DNA TRANSPOSITION; SITE-SPECIFIC RECOMBINATION; IN-VITRO; ESCHERICHIA-COLI; BACTERIOPHAGE MU; MAMMALIAN-CELLS; CRE RECOMBINASE; TRANSGENIC MICE; MOUSE; ACTIVATION	Conditional gene targeting strategies are progressively used to study gene function tissue-specifically and/or at a defined time period. Instrumental to all of these strategies is the generation of targeting vectors, and any methodology that would streamline the procedure would be highly beneficial. We describe a comprehensive transposition-based strategy to produce gene-targeting vectors for the generation of mouse conditional alleles. The system employs a universal cloning vector and two custom-designed mini-Mu transposons. It produces targeting constructions directly from BAC clones, and the alleles generated are modifiable by Cre and Flp recombinases. We demonstrate the applicability of the methodology by modifying two mouse genes, Chd22 and Drapc1. This straightforward strategy should be readily suitable for high-throughput targeting vector production.	[Savilahti, Harri] Univ Helsinki, Inst Biotechnol, Program Cellular Biotechnol, Viikki Bioctr, Helsinki, Finland; [Saarimaeki-Vire, Jonna; Sinjushina, Natalia; Partanen, Juha] Univ Helsinki, Viikki Bioctr, Inst Biotechnol, Program Dev Biol, FIN-00014 Helsinki, Finland; [Savilahti, Harri] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Helsinki; University of Helsinki; University of Turku	Turakainen, H (corresponding author), Univ Helsinki, Inst Biotechnol, Program Cellular Biotechnol, Viikki Bioctr, Helsinki, Finland.	harri.savilahti@utu.fi		Partanen, Juha/0000-0001-8850-4825; Saarimaki-Vire, Jonna/0000-0002-8865-7060; Savilahti, Harri/0000-0002-6246-2572	Academy of Finland; National Technology Agency of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology; Viikki Graduate School of Biosciences	Academy of Finland(Academy of Finland); National Technology Agency of Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki Graduate School in Biotechnology and Molecular Biology; Viikki Graduate School of Biosciences	This study was supported by the Academy of Finland and the National Technology Agency of Finland (TEKES). Additional financial support was provided by the Sigrid Juselius Foundation and the Finnish Cultural Foundation as well as the Helsinki Graduate School in Biotechnology and Molecular Biology (J.S.-V.) and the Viikki Graduate School of Biosciences (N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin A, 1996, MOL CELL BIOL, V16, P1851; Aoyama M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni055; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Chaconas George, 2002, P384; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Haapa S, 1999, GENOME RES, V9, P308; Haapa-Paananen S, 2002, J BIOL CHEM, V277, P2843, DOI 10.1074/jbc.M108044200; HOGAN B, 1994, MANIPULATING MOUSE G; Jukkola T, 2005, GENESIS, V43, P148, DOI 10.1002/gene.20163; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kekarainen T, 2002, GENOME RES, V12, P584, DOI 10.1101/gr.220702; KOES R, 1995, P NATL ACAD SCI USA, V92, P8149, DOI 10.1073/pnas.92.18.8149; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Laurent LC, 2000, J VIROL, V74, P2760, DOI 10.1128/JVI.74.6.2760-2769.2000; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;200::AID-BIES3&gt;3.0.CO;2-V; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Orsini L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm070; Pajunen M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm563; Poussu E, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni102; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sambrook J., 2001, MOL CLONING LAB MANU; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sugimoto K, 1996, J BIOL CHEM, V271, P11548, DOI 10.1074/jbc.271.19.11548; Taira S, 1999, MOL MICROBIOL, V34, P736, DOI 10.1046/j.1365-2958.1999.01635.x; Vilen H, 2003, J VIROL, V77, P123, DOI 10.1128/JVI.77.1.123-134.2003; Vilen H, 2001, TRANSGENIC RES, V10, P69, DOI 10.1023/A:1008959231644; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7; Zhang CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni014; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; ZON LI, 1989, BIOTECHNIQUES, V7, P696; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	41	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4341	10.1371/journal.pone.0004341	http://dx.doi.org/10.1371/journal.pone.0004341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194496	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483600002
J	Meyer-Hoffert, U; Wu, ZH; Schroder, JM				Meyer-Hoffert, Ulf; Wu, Zhihong; Schroeder, Jens-Michael			Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor	PLOS ONE			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; STRATUM-CORNEUM; LAMELLAR GRANULES; SERINE PROTEASES; HUMAN EPIDERMIS; LEKTI; EXPRESSION; BLAST; PROLIFERATION; DESQUAMATION	Kallikreins-related peptidases (KLKs) are serine proteases and have been implicated in the desquamation process of the skin. Their activity is tightly controlled by epidermal protease inhibitors like the lympho-epithelial Kazal-type inhibitor ( LEKTI). Defects of the LEKTI-encoding gene serine protease inhibitor Kazal type (Spink) 5 lead to the absence of LEKTI and result in the genodermatose Netherton syndrome, which mimics the common skin disease atopic dermatitis. Since many KLKs are expressed in human skin with KLK5 being considered as one of the most important KLKs in skin desquamation, we proposed that more inhibitors are present in human skin. Herein, we purified from human stratum corneum by HPLC techniques a new KLK5-inhibiting peptide encoded by a member of the Spink family, designated as Spink9 located on chromosome 5p33.1. This peptide is highly homologous to LEKTI and was termed LEKTI-2. Recombinant LEKTI-2 inhibited KLK5 but not KLK7, 14 or other serine proteases tested including trypsin, plasmin and thrombin. Spink9 mRNA expression was detected in human skin samples and in cultured keratinocytes. LEKTI-2 immune-expression was focally localized at the stratum granulosum and stratum corneum at palmar and plantar sites in close localization to KLK5. At sites of plantar hyperkeratosis, LEKTI-2 expression was increased. We suggest that LEKTI-2 contributes to the regulation of the desquamation process in human skin by specifically inhibiting KLK5.	[Meyer-Hoffert, Ulf; Wu, Zhihong; Schroeder, Jens-Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Meyer-Hoffert, U (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Campus Kiel, Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Wu, Zhihong/G-3569-2011; Wu, Zhihong/AAK-3433-2020; Schroeder, Jens M/B-3994-2009	Meyer-Hoffert, Ulf/0000-0003-2305-1428; 	Deutsche Forschungsgemeinschaft [SFB 617, SCHR305/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SFB 617 and SCHR305/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; GRIFFITHS WA, 1998, TXB DERMATOLOGY, P1486; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knies Y, 2006, EXP DERMATOL, V15, P347, DOI 10.1111/j.0906-6705.2006.00422.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer-Hoffert U, 2004, J INVEST DERMATOL, V123, P338, DOI 10.1111/j.0022-202X.2004.23202.x; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; Schroder JM, 1997, METHOD ENZYMOL, V288, P266; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SONDELL B, 1995, J INVEST DERMATOL, V104, P819, DOI 10.1111/1523-1747.ep12607007; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yano S, 2006, EXP DERMATOL, V15, P356, DOI 10.1111/j.0906-6705.2006.00425.x; Yano S, 2004, J INVEST DERMATOL, V122, P783, DOI 10.1111/j.0022-202X.2004.22328.x; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	40	52	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4372	10.1371/journal.pone.0004372	http://dx.doi.org/10.1371/journal.pone.0004372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190773	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483300011
J	Slominski, AT; Zmijewski, MA; Semak, I; Sweatman, T; Janjetovic, Z; Li, W; Zjawiony, JK; Tuckey, RC				Slominski, Andrzej T.; Zmijewski, Michal A.; Semak, Igor; Sweatman, Trevor; Janjetovic, Zorica; Li, Wei; Zjawiony, Jordan K.; Tuckey, Robert C.			Sequential Metabolism of 7-Dehydrocholesterol to Steroidal 5,7-Dienes in Adrenal Glands and Its Biological Implication in the Skin	PLOS ONE			English	Article							LEMLI-OPITZ-SYNDROME; SIDE-CHAIN CLEAVAGE; CYTOCHROME P450SCC; STEROIDOGENIC ENZYMES; CELL-LINE; VITAMIN-D; HPA AXIS; CHOLESTEROL; PATHWAY; MITOCHONDRIA	Since P450scc transforms 7-dehydrocholesterol (7DHC) to 7-dehydropregnenolone (7DHP) in vitro, we investigated sequential 7DHC metabolism by adrenal glands ex vivo. There was a rapid, time- and dose-dependent metabolism of 7DHC by adrenals from rats, pigs, rabbits and dogs with production of more polar 5,7-dienes as detected by RP-HPLC. Based on retention time (RT), UV spectra and mass spectrometry, we identified the major products common to all tested species as 7DHP, 22-hydroxy-7DHC and 20,22-dihydroxy-7DHC. The involvement of P450scc in adrenal metabolic transformation was confirmed by the inhibition of this process by DL-aminoglutethimide. The metabolism of 7DHC with subsequent production of 7DHP was stimulated by forscolin indicating involvement of cAMP dependent pathways. Additional minor products of 7DHC metabolism that were more polar than 7DHP were identified as 17-hydroxy-7DHP ( in pig adrenals but not those of rats) and as pregna-4,7-diene-3,20-dione (7-dehydroprogesterone). Both products represented the major identifiable products of 7DHP metabolism in adrenal glands. Studies with purified enzymes show that StAR protein likely transports 7DHC to the inner mitochondrial membrane, that 7DHC can compete effectively with cholesterol for the substrate binding site on P450scc and that the catalytic efficiency of 3bHSD for 7DHP (V-m/K-m) is 40% of that for pregnenolone. Skin mitochondria are capable of transforming 7DHC to 7DHP and the 7DHP is metabolized further by skin extracts. Finally, 7DHP, its photoderivative 20-oxopregnacalciferol, and pregnenolone exhibited biological activity in skin cells including inhibition of proliferation of epidermal keratinocytes and melanocytes, and melanoma cells. These findings define a novel steroidogenic pathway: 7DHC -> 22(OH)7DH-C -> 20,22(OH)(2)7DHC -> 7DHP, with potential further metabolism of 7DHP mediated by 3 beta HSD or CYP17, depending on mammalian species. The 5-7 dienal intermediates of the pathway can be a source of biologically active vitamin D3 derivatives after delivery to or production in the skin, an organ intermittently exposed to solar radiation.	[Zmijewski, Michal A.; Janjetovic, Zorica] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA; [Sweatman, Trevor] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN USA; [Semak, Igor] Belarusian State Univ, Dept Biochem, Minsk 220050, BELARUS; [Li, Wei] Univ Tennessee, Hlth Sci Ctr, Dept Pharm Sci, Memphis, TN USA; [Zjawiony, Jordan K.] Univ Mississippi, Dept Pharmacognosy, Oxford, MS USA; [Tuckey, Robert C.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Belarusian State University; University of Tennessee System; University of Tennessee Health Science Center; University of Mississippi; University of Western Australia	Slominski, AT (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA.	aslominski@utmem.edu	Tuckey, Robert/H-5983-2014; Ding, Cheng-Qiang/B-6287-2011; Semak, Igor/AAT-9273-2020	Semak, Igor/0000-0001-9430-8492; Li, Wei/0000-0002-9522-4474; Zjawiony, Jordan/0000-0001-5242-2799; Tuckey, Robert/0000-0002-5022-4729; Slominski, Andrzej/0000-0001-8963-3995; Zmijewski, Michal/0000-0003-2206-3531	NIH [R01AR052190, 1R15CA125623]; University of Western Australia; Belarus State University; NATIONAL CANCER INSTITUTE [R15CA125623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Western Australia; Belarus State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant R01AR052190, grant #1R15CA125623, University of Western Australia and Belarus State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR JR, 1974, EUR J BIOCHEM, V49, P117, DOI 10.1111/j.1432-1033.1974.tb03817.x; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; BURSTEIN S, 1976, STEROIDS, V28, P115, DOI 10.1016/0039-128X(76)90131-8; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cooke GM, 1996, J STEROID BIOCHEM, V58, P95, DOI 10.1016/0960-0760(96)00002-7; Dalla Valle L, 2004, J STEROID BIOCHEM, V88, P79, DOI 10.1016/j.jsbmb.2003.11.001; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; GURYEV O, 2003, P NATL ACAD SCI US; Hauet T, 2002, ENDOCR RES, V28, P395, DOI 10.1081/ERC-120016814; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HOLICK MF, 1975, J BIOL CHEM, V250, P226; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; HUME R, 1984, EUR J BIOCHEM, V140, P583, DOI 10.1111/j.1432-1033.1984.tb08142.x; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; KANDUTSCH AA, 1960, J BIOL CHEM, V235, P2256; LAMBETH JD, 1982, MOL CELL BIOCHEM, V45, P13, DOI 10.1007/BF01283159; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Marcos J, 2004, STEROIDS, V69, P51, DOI 10.1016/j.steroids.2003.09.013; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; MURARI MP, 1982, J STEROID BIOCHEM, V17, P615, DOI 10.1016/0022-4731(82)90562-3; NAKAJIN S, 1984, J BIOL CHEM, V259, P3971; Nowaczyk MJM, 1998, AM J MED GENET, V78, P419, DOI 10.1002/(SICI)1096-8628(19980806)78:5<419::AID-AJMG5>3.0.CO;2-G; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pignatelli D, 2006, J ENDOCRINOL, V191, P301, DOI 10.1677/joe.1.06972; Pisarchik A, 2004, EUR J BIOCHEM, V271, P2821, DOI 10.1111/j.1432-1033.2004.04216.x; Semak I, 2005, BIOCHEMISTRY-US, V44, P9300, DOI 10.1021/bi050202d; Semak I, 2004, ARCH BIOCHEM BIOPHYS, V421, P61, DOI 10.1016/j.abb.2003.08.036; SEMAK I, 2008, J PINEAL RES; Shackleton C, 2002, J STEROID BIOCHEM, V82, P225, DOI 10.1016/S0960-0760(02)00155-3; Shackleton CHL, 1999, STEROIDS, V64, P481, DOI 10.1016/S0039-128X(99)00022-7; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, CHEM BIOL, V12, P931, DOI 10.1016/j.chembiol.2005.06.010; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; SLOMINSKI A, 1993, EXP CELL RES, V206, P189, DOI 10.1006/excr.1993.1137; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; TAIT AD, 1985, FEBS LETT, V182, P107, DOI 10.1016/0014-5793(85)81164-9; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Tian XQ, 1999, J BIOL CHEM, V274, P4174, DOI 10.1074/jbc.274.7.4174; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; TOAFF ME, 1982, ENDOCRINOLOGY, V111, P1785, DOI 10.1210/endo-111-6-1785; TUCKEY RC, 1992, J STEROID BIOCHEM, V42, P883, DOI 10.1016/0960-0760(92)90097-3; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; Tuckey RC, 1999, EUR J BIOCHEM, V263, P319, DOI 10.1046/j.1432-1327.1999.00483.x; TUCKEY RC, 1984, INT J BIOCHEM, V16, P497, DOI 10.1016/0020-711X(84)90166-6; Tuckey RC, 2008, INT J BIOCHEM CELL B, V40, P2619, DOI 10.1016/j.biocel.2008.05.006; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Zbytek B, 2006, PEPTIDES, V27, P3276, DOI 10.1016/j.peptides.2006.07.017; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zmijewski MA, 2009, STEROIDS, V74, P218, DOI 10.1016/j.steroids.2008.10.017; Zmijewski MA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1570, DOI 10.1039/b809005j	59	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4309	10.1371/journal.pone.0004309	http://dx.doi.org/10.1371/journal.pone.0004309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190754	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483300001
J	Balasubramanian, S; Schwartz, C; Singh, A; Warthmann, N; Kim, MC; Maloof, JN; Loudet, O; Trainer, GT; Dabi, T; Borevitz, JO; Chory, J; Weigel, D				Balasubramanian, Sureshkumar; Schwartz, Christopher; Singh, Anandita; Warthmann, Norman; Kim, Min Chul; Maloof, Julin N.; Loudet, Olivier; Trainer, Gabriel T.; Dabi, Tsegaye; Borevitz, Justin O.; Chory, Joanne; Weigel, Detlef			QTL Mapping in New Arabidopsis thaliana Advanced Intercross-Recombinant Inbred Lines	PLOS ONE			English	Article								Background: Even when phenotypic differences are large between natural or domesticated strains, the underlying genetic basis is often complex, and causal genomic regions need to be identified by quantitative trait locus (QTL) mapping. Unfortunately, QTL positions typically have large confidence intervals, which can, for example, lead to one QTL being masked by another, when two closely linked loci are detected as a single QTL. One strategy to increase the power of precisely localizing small effect QTL, is the use of an intercross approach before inbreeding to produce Advanced Intercross RILs (AI-RILs). Methodology/Principal Findings: We present two new AI-RIL populations of Arabidopsis thaliana genotyped with an average intermarker distance of 600 kb. The advanced intercrossing design led to expansion of the genetic map in the two populations, which contain recombination events corresponding to 50 kb/cM in an F-2 population. We used the AI-RILs to map QTL for light response and flowering time, and to identify segregation distortion in one of the AI-RIL populations due to a negative epistatic interaction between two genomic regions. Conclusions/Significance: The two new AI-RIL populations, EstC and KendC, derived from crosses of Columbia (Col) to Estland (Est-1) and Kendallville (Kend-L) provide an excellent resource for high precision QTL mapping. Moreover, because they have been genotyped with over 100 common markers, they are also excellent material for comparative QTL mapping.	[Singh, Anandita; Warthmann, Norman; Kim, Min Chul; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Schwartz, Christopher; Warthmann, Norman; Maloof, Julin N.; Loudet, Olivier; Trainer, Gabriel T.; Dabi, Tsegaye; Borevitz, Justin O.; Chory, Joanne; Weigel, Detlef] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA USA; [Maloof, Julin N.] Univ Calif Davis, Sect Plant Biol, Davis, CA USA; [Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Loudet, Olivier] INRA, SGAP, Versailles, France; [Balasubramanian, Sureshkumar] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4067, Australia; [Schwartz, Christopher] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, San Diego, CA 92138 USA	Max Planck Society; Salk Institute; University of California System; University of California Davis; University of Chicago; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Salk Institute	Balasubramanian, S (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Warthmann, Norman/E-1069-2011; Weigel, Detlef/C-1418-2008; Loudet, Olivier/CAF-7559-2022; Balasubramanian, Sureshkumar/AAS-6919-2020; Loudet, Olivier/K-8266-2012; Borevitz, Justin/B-5423-2012	Weigel, Detlef/0000-0002-2114-7963; Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Loudet, Olivier/0000-0003-3717-0137; Borevitz, Justin/0000-0001-8408-3699; Singh, Anandita/0000-0002-4568-7331; Maloof, Julin/0000-0002-9623-2599	NIH NRSA [F23-GM65032-1]; EMBO Long-Term Fellowship [ALTF-473]; NIH [GM62932]; ERA-PG [ARABRAS]; DFG [Gottfried Wilhelm Leibniz Award]; Howard Hughes Medical Institute; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932, F32GM065032] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-PG; DFG(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NRSA Grant F23-GM65032-1 (CS), an EMBO Long-Term Fellowship ALTF-473 (SB), NIH grant GM62932 (JC & DW), ERA-PG (BMBF) Grant ARABRAS, and a Gottfried Wilhelm Leibniz Award from the DFG (DW), the Howard Hughes Medical Institute, and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1998, GENETICS, V149, P749; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Borevitz JO, 2002, GENETICS, V160, P683; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BURR B, 1991, TRENDS GENET, V7, P55, DOI 10.1016/0168-9525(91)90232-F; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Darvasi A, 2005, TRENDS GENET, V21, P373, DOI 10.1016/j.tig.2005.05.003; DARVASI A, 1995, GENETICS, V141, P1199; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Jurinke C, 2001, Methods Mol Biol, V170, P103; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Magliano TMA, 2005, PLANT PHYSIOL, V138, P1126, DOI 10.1104/pp.104.059071; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Rikke BA, 1998, MAMM GENOME, V9, P963, DOI 10.1007/s003359900907; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Torjek O, 2006, THEOR APPL GENET, V113, P1551, DOI 10.1007/s00122-006-0402-3; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wilson IW, 2001, GENETICS, V158, P1301; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Wu RL, 2006, NAT REV GENET, V7, P229, DOI 10.1038/nrg1804; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	49	77	77	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4318	10.1371/journal.pone.0004318	http://dx.doi.org/10.1371/journal.pone.0004318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183806	gold, Green Published			2022-12-27	WOS:000265483200005
J	Schule, C; Baghai, TC; Eser, D; Hafner, S; Born, C; Herrmann, S; Rupprecht, R				Schuele, Cornelius; Baghai, Thomas C.; Eser, Daniela; Haefner, Sibylle; Born, Christoph; Herrmann, Sascha; Rupprecht, Rainer			The Combined Dexamethasone/CRH Test (DEX/CRH Test) and Prediction of Acute Treatment Response in Major Depression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENOCORTICAL SYSTEM; MESSENGER-RNA EXPRESSION; FREE CORTISOL EXCRETION; HEALTHY MALE-SUBJECTS; DEX-CRH TEST; SUPPRESSION TEST; NEUROENDOCRINE REGULATION; PARAVENTRICULAR NUCLEUS; CLINICAL IMPROVEMENT	Background: In this study the predictive value of the combined dexamethasone/CRH test (DEX/CRH test) for acute antidepressant response was investigated. Methodology/Principal Findings: In 114 depressed inpatients suffering from unipolar or bipolar depression (sample 1) the DEX/CRH test was performed at admission and shortly before discharge. During their stay in the hospital patients received different antidepressant treatment regimens. At admission, the rate of nonsuppression (basal cortisol levels > 75.3 nmol/l) was 24.6% and was not related to the later therapeutic response. Moreover, 45 out of 114 (39.5%) patients showed an enhancement of HPA axis function at discharge in spite of clinical improvement. In a second sample, 40 depressed patients were treated either with reboxetine or mirtazapine for 5 weeks. The DEX/CRH test was performed before, after 1 week, and after 5 weeks of pharmacotherapy. Attenuation of HPA axis activity after 1 week was associated with a more pronounced alleviation of depressive symptoms after 5-week mirtazapine treatment, whereas downregulation of HPA system activity after 5 weeks was related to clinical response to reboxetine. However, early improvement of HPA axis dysregulation was not necessarily followed by a beneficial treatment outcome. Conclusions/Significance: Taken together, performance of a single DEX/CRH test does not predict the therapeutic response. The best predictor for response seems to be an early attenuation of HPA axis activity within 1 or 2 weeks. However, early improvement of HPA system dysfunction is not a sufficient condition for a favourable response. Since a substantial part of depressive patients display a persistence of HPA axis hyperactivity at discharge, downregulation of HPA system function is not a necessary condition for acute clinical improvement either. Our data underline the importance of HPA axis dysregulation for treatment outcome in major depression, although restoration of HPA system dysfunction seems to be neither a necessary nor a sufficient determinant for acute treatment response.	[Schuele, Cornelius; Baghai, Thomas C.; Eser, Daniela; Haefner, Sibylle; Born, Christoph; Herrmann, Sascha; Rupprecht, Rainer] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany	University of Munich	Schule, C (corresponding author), Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany.	Cornelius.Schuele@med.uni-muenchen.de		Baghai, Thomas C/0000-0002-7873-4130				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AMSTERDAM JD, 1983, ACTA PSYCHIAT SCAND, V67, P43, DOI 10.1111/j.1600-0447.1983.tb00329.x; Appelhof BC, 2006, BIOL PSYCHIAT, V59, P696, DOI 10.1016/j.biopsych.2005.09.008; ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193; ASNIS GM, 1985, PSYCHIAT RES, V14, P225, DOI 10.1016/0165-1781(85)90017-4; ASNIS GM, 1992, PSYCHIAT RES, V44, P237, DOI 10.1016/0165-1781(92)90027-Z; AUBRY JM, 2006, J PSYCHIAT RES; BARDEN N, 1995, TRENDS NEUROSCI, V18, P6, DOI 10.1016/0166-2236(95)93942-Q; BOARD F, 1957, ARCH NEURO PSYCHIATR, V78, P612, DOI 10.1001/archneurpsyc.1957.02330420072015; BOWIE PCW, 1985, BRIT J PSYCHIAT, V147, P30, DOI 10.1192/bjp.147.1.30; BRADY LS, 1991, J CLIN INVEST, V87, P831, DOI 10.1172/JCI115086; CARROLL BJ, 1980, LANCET, V2, P1249; CARROLL BJ, 1984, ADV BIOCHEM PSYCHOPH, V39, P179; CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1051; CARROLL BJ, 1976, PSYCHOL MED, V6, P43, DOI 10.1017/S0033291700007480; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; CHARLES GA, 1989, J AFFECT DISORDERS, V17, P271, DOI 10.1016/0165-0327(89)90010-4; CORYELL W, 1983, BIOL PSYCHIAT, V18, P21; Deuschle M, 1997, J CLIN PSYCHOPHARM, V17, P156, DOI 10.1097/00004714-199706000-00003; Forsythe AI, 1969, COMPUTER SCI 1 COURS; Frieboes RM, 2003, PHARMACOPSYCHIATRY, V36, P12, DOI 10.1055/s-2003-38087; GERKEN A, 1986, PSYCHONEUROENDOCRINO, V11, P185, DOI 10.1016/0306-4530(86)90053-3; GERKEN A, 1985, PSYCHONEUROENDOCRINO, V10, P261, DOI 10.1016/0306-4530(85)90003-4; GIBBONS JL, 1963, PSYCHIAT RES, V1, P162; GOLD PW, 1984, AM J PSYCHIAT, V141, P619; GREDEN JF, 1983, ARCH GEN PSYCHIAT, V40, P493; HALBREICH U, 1985, ARCH GEN PSYCHIAT, V42, P904; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hatzinger M, 2002, J PSYCHIATR RES, V36, P287, DOI 10.1016/S0022-3956(02)00021-3; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; HOLSBOER F, 1984, NEW ENGL J MED, V311, P1127; Holsboer F, 2001, J AFFECT DISORDERS, V62, P77, DOI 10.1016/S0165-0327(00)00352-9; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; HOLSBOER F, 1982, J AFFECT DISORDERS, V4, P93, DOI 10.1016/0165-0327(82)90039-8; HOLSBOERTRACHSLER E, 1994, J PSYCHIATR RES, V28, P381, DOI 10.1016/0022-3956(94)90020-5; HOLSBOERTRACHSLER E, 1991, PSYCHIAT RES, V38, P163, DOI 10.1016/0165-1781(91)90041-M; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; JAECKLE RS, 1987, ARCH GEN PSYCHIAT, V44, P233; Jensen JB, 2001, J NEUROENDOCRINOL, V13, P887, DOI 10.1046/j.1365-2826.2001.00712.x; KATONA CLE, 1987, BRIT J PSYCHIAT, V150, P315, DOI 10.1192/bjp.150.3.315; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Kunugi H, 2004, J PSYCHIATR RES, V38, P123, DOI 10.1016/S0022-3956(03)00103-1; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Modell S, 1998, NEUROPSYCHOPHARMACOL, V18, P253; Mori S, 1998, J PSYCHIAT RES, V32, P111, DOI 10.1016/S0022-3956(98)00003-X; NEMEROFF CB, 1992, ARCH GEN PSYCHIAT, V49, P384; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nickel T, 2003, J CLIN PSYCHOPHARM, V23, P155, DOI 10.1097/00004714-200304000-00008; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; PESELOW ED, 1987, AM J PSYCHIAT, V144, P30; Purba JS, 1996, ARCH GEN PSYCHIAT, V53, P137; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; REUL JMHM, 1994, NEUROENDOCRINOLOGY, V60, P509, DOI 10.1159/000126788; REUL JMHM, 1993, ENDOCRINOLOGY, V133, P312, DOI 10.1210/en.133.1.312; RIBEIRO SCM, 1993, AM J PSYCHIAT, V150, P1618; Rubin RT, 2006, PSYCHIAT RES, V143, P43, DOI 10.1016/j.psychres.2005.10.003; RUBIN RT, 1995, ARCH GEN PSYCHIAT, V52, P213; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Schule C, 2007, J NEUROENDOCRINOL, V19, P213, DOI 10.1111/j.1365-2826.2006.01516.x; Schule C, 2006, PSYCHOPHARMACOLOGY, V186, P601, DOI 10.1007/s00213-006-0382-7; Schule C, 2004, PSYCHONEUROENDOCRINO, V29, P185, DOI 10.1016/S0306-4530(03)00022-2; Schule C, 2003, PSYCHIAT RES, V120, P257, DOI 10.1016/S0165-1781(03)00204-X; Schule C, 2003, PSYCHOPHARMACOLOGY, V166, P271, DOI 10.1007/s00213-002-1356-z; Schule C, 2002, PSYCHOPHARMACOLOGY, V163, P95, DOI 10.1007/s00213-002-1148-5; SCHWEITZER I, 1987, BRIT J PSYCHIAT, V151, P780, DOI 10.1192/bjp.151.6.780; SECKL JR, 1992, NEUROENDOCRINOLOGY, V55, P621, DOI 10.1159/000126180; Stout SC, 2002, J PHARMACOL EXP THER, V300, P1085, DOI 10.1124/jpet.300.3.1085; TRASKMAN L, 1980, ARCH GEN PSYCHIAT, V37, P761; VONBARDELEBEN U, 1989, J NEUROENDOCRINOL, V1, P485, DOI 10.1111/j.1365-2826.1989.tb00150.x; VONBARDELEBEN U, 1991, BIOL PSYCHIAT, V29, P1042, DOI 10.1016/0006-3223(91)90360-X; Wittchen H.-U., 1997, SKID STRUKTURIERTES; YEREVANIAN BI, 1983, J AFFECT DISORDERS, V5, P191, DOI 10.1016/0165-0327(83)90041-1; Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	77	67	71	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4324	10.1371/journal.pone.0004324	http://dx.doi.org/10.1371/journal.pone.0004324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549YF	19177168	Green Submitted, Green Published, gold			2022-12-27	WOS:000274089700010
J	Reeves, PA; Richards, CM				Reeves, Patrick A.; Richards, Christopher M.			Accurate Inference of Subtle Population Structure (and Other Genetic Discontinuities) Using Principal Coordinates	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; PHYLOGENETIC INFERENCE; EVOLUTIONARY HISTORY; AFLP; DIFFERENTIATION; IDENTIFICATION; DIVERSITY; TAXA; STRATIFICATION; PERFORMANCE	Background: Accurate inference of genetic discontinuities between populations is an essential component of intraspecific biodiversity and evolution studies, as well as associative genetics. The most widely-used methods to infer population structure are model-based, Bayesian MCMC procedures that minimize Hardy-Weinberg and linkage disequilibrium within subpopulations. These methods are useful, but suffer from large computational requirements and a dependence on modeling assumptions that may not be met in real data sets. Here we describe the development of a new approach, PCO-MC, which couples principal coordinate analysis to a clustering procedure for the inference of population structure from multilocus genotype data. Methodology/Principal Findings: PCO-MC uses data from all principal coordinate axes simultaneously to calculate a multidimensional "density landscape'', from which the number of subpopulations, and the membership within subpopulations, is determined using a valley-seeking algorithm. Using extensive simulations, we show that this approach outperforms a Bayesian MCMC procedure when many loci (e. g. 100) are sampled, but that the Bayesian procedure is marginally superior with few loci (e. g. 10). When presented with sufficient data, PCO-MC accurately delineated subpopulations with population F-st values as low as 0.03 (G(st)'>0.2), whereas the limit of resolution of the Bayesian approach was F-st = 0.05 (G(st)'>0.35). Conclusions/Significance: We draw a distinction between population structure inference for describing biodiversity as opposed to Type I error control in associative genetics. We suggest that discrete assignments, like those produced by PCO-MC, are appropriate for circumscribing units of biodiversity whereas expression of population structure as a continuous variable is more useful for case-control correction in structured association studies.	[Reeves, Patrick A.; Richards, Christopher M.] ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO USA	United States Department of Agriculture (USDA)	Reeves, PA (corresponding author), ARS, USDA, Natl Ctr Genet Resources Preservat, Ft Collins, CO USA.	crichard@lamar.colostate.edu	Richards, Christopher/A-8328-2013	Richards, Christopher/0000-0002-9978-6079; Reeves, Patrick/0000-0001-9991-1397	USDA-ARS; CRIS [5402-21000-012-00]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); CRIS	This research was funded by USDA-ARS, CRIS project 5402-21000-012-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albach DC, 2004, TAXON, V53, P429, DOI 10.2307/4135620; Albach DC, 2004, PLANT SYST EVOL, V246, P177, DOI 10.1007/s00606-004-0148-9; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; Badr A, 2002, CAN J BOT, V80, P962, DOI [10.1139/b02-084, 10.1139/B02-084]; Bakkeren G, 2000, MYCOLOGIA, V92, P510, DOI 10.2307/3761510; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Beardsley PM, 2003, EVOLUTION, V57, P1397, DOI 10.1111/j.0014-3820.2003.tb00347.x; Brysting AK, 2004, TAXON, V53, P365, DOI 10.2307/4135615; Corander J, 2003, GENETICS, V163, P367; Dawson KJ, 2001, GENET RES, V78, P59, DOI 10.1017/S001667230100502X; de Knijff P, 2001, J MOL EVOL, V52, P85, DOI 10.1007/s002390010137; Despres L, 2002, MOL ECOL, V11, P2337, DOI 10.1046/j.1365-294X.2002.01618.x; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1995, AM J HUM GENET, V57, P455; EXCOFFIER L, 1992, GENETICS, V131, P479; Goldman DH, 2004, AM J BOT, V91, P707, DOI 10.3732/ajb.91.5.707; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grunig CR, 2002, CAN J BOT, V80, P1239, DOI [10.1139/b02-115, 10.1139/B02-115]; Gusfield D, 2002, INFORM PROCESS LETT, V82, P159, DOI 10.1016/S0020-0190(01)00263-0; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hipp Andrew L., 2007, Aliso, V23, P193; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Krauss SL, 2001, AUST J BOT, V49, P611, DOI 10.1071/BT00072; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Landry PA, 1996, ZOOL SCR, V25, P283, DOI 10.1111/j.1463-6409.1996.tb00167.x; Larson SR, 2003, CAN J BOT, V81, P789, DOI [10.1139/B03-077, 10.1139/b03-077]; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LEFKOVITCH LP, 1976, MATH BIOSCI, V31, P157, DOI 10.1016/0025-5564(76)90047-X; LEWIS PO, 2002, GDA GENETIC DATA ANA; Liu Nianjun, 2006, Human Genomics, V2, P353; LOCKWOOD DR, 2007, PLANT BREEDING REV, V29, P285; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Marhold K, 2004, ANN BOT-LONDON, V93, P507, DOI 10.1093/aob/mch073; Martinez-Ortega MM, 2004, SYST BOT, V29, P965, DOI 10.1600/0363644042451071; MARTINEZORTEGA MM, 1999, THESIS U SALAMANCA S; Mock KE, 2004, MOL ECOL, V13, P1085, DOI 10.1111/j.1365-294X.2004.02143.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Pella J, 2006, CAN J FISH AQUAT SCI, V63, P576, DOI 10.1139/f05-224; Perrie LR, 2003, J BIOGEOGR, V30, P1729, DOI 10.1046/j.1365-2699.2003.00938.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Quagliaro J, 2001, J HERED, V92, P38, DOI 10.1093/jhered/92.1.38; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Reeves PA, 2007, SYST BIOL, V56, P302, DOI 10.1080/10635150701324225; RICHARDS CM, TREE GENETI IN PRESS; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruas PM, 2003, GENET MOL BIOL, V26, P319, DOI 10.1590/S1415-47572003000300017; Silverman BW., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sudupak MA, 2004, EUPHYTICA, V135, P229, DOI 10.1023/B:EUPH.0000014938.02019.f3; Sullivan JP, 2004, EVOLUTION, V58, P825; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Torpdahl M, 2004, J APPL MICROBIOL, V97, P566, DOI 10.1111/j.1365-2672.2004.02337.x; Vandemark G, 2000, MYCOLOGIA, V92, P656, DOI 10.2307/3761423; VICKERY RK, 1987, SYST BOT, V12, P339, DOI 10.2307/2419258; Wang ZY, 2004, BIOCHEM SYST ECOL, V32, P399, DOI 10.1016/j.bse.2003.10.006; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x	76	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4269	10.1371/journal.pone.0004269	http://dx.doi.org/10.1371/journal.pone.0004269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172174	Green Published, gold			2022-12-27	WOS:000265482900002
J	Wolfe, DN; Buboltz, AM; Harvill, ET				Wolfe, Daniel N.; Buboltz, Anne M.; Harvill, Eric T.			Inefficient Toll-Like Receptor-4 Stimulation Enables Bordetella parapertussis to Avoid Host Immunity	PLOS ONE			English	Article							CELL PERTUSSIS-VACCINE; LIPID-A; WHOLE-CELL; SIGNAL-TRANSDUCTION; MEDIATED CLEARANCE; YERSINIA-PESTIS; IN-VITRO; LIPOPOLYSACCHARIDE; BRONCHISEPTICA; INFECTIONS	The recognition of bacterial lipopolysaccharide (LPS) by host Toll-like receptor (TLR)4 is a crucial step in developing protective immunity against several gram negative bacterial pathogens. Bordetella bronchiseptica and B. pertussis stimulate robust TLR4 responses that are required to control the infection, but a close relative, B. parapertussis, poorly stimulates this receptor, and TLR4 deficiency does not affect its course of infection. This led us to hypothesize that inefficient TLR4 stimulation enables B. parapertussis to evade host immunity. In a mouse model of infection, B. parapertussis grew rapidly in the lungs, but no measurable increase in TLR4-mediated cytokine, chemokine, or leukocyte responses were observed over the first few days of infection. Delivery of a TLR4 stimulant in the inoculum resulted in a robust inflammatory response and a 10- to 100-fold reduction of B. parapertussis numbers. As we have previously shown, B. parapertussis grows efficiently during the first week of infection even in animals passively immunized with antibodies. We show that this evasion of antibody-mediated clearance is dependent on the lack of TLR4 stimulation by B. parapertussis as co-inoculation with a TLR4 agonist resulted in 10,000-fold lower B. parapertussis numbers on day 3 in antibody-treated wild type, but not TLR4-deficient, mice. Together, these results indicate that inefficient TLR4 stimulation by B. parapertussis enables it to avoid host immunity and grow to high numbers in the respiratory tract of naive and immunized hosts.	[Wolfe, Daniel N.; Buboltz, Anne M.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Buboltz, Anne M.] Penn State Univ, Grad Program Biochem Microbiol & Molecular Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wolfe, DN (corresponding author), Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA.	harvill@psu.edu		Russell, Anne/0000-0003-4533-5069; Harvill, Eric/0000-0001-8893-2133	NIH [AI 053075]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH grant AI 053075 (E.T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; Barnard A, 1996, IMMUNOLOGY, V87, P372, DOI 10.1046/j.1365-2567.1996.497560.x; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Caroff M, 2001, J ENDOTOXIN RES, V7, P63, DOI 10.1177/09680519010070011101; *CDCP, 2002, JAMA-J AM MED ASSOC, P977; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry J. D., 2004, TXB PEDIAT INFECT DI; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Heininger U, 1998, VACCINE, V16, P1255, DOI 10.1016/S0264-410X(97)00078-9; Heininger U, 2002, INFECT IMMUN, V70, P3777, DOI 10.1128/IAI.70.7.3777-3784.2002; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kawasaki K, 2004, J ENDOTOXIN RES, V10, P439, DOI 10.1179/096805104225006264; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kielian T, 2007, J IMMUNOL, V178, P4528, DOI 10.4049/jimmunol.178.7.4528; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kirimanjeswara GS, 2005, J IMMUNOL, V175, P7504, DOI 10.4049/jimmunol.175.11.7504; Knirel YA, 2005, BIOCHEMISTRY-US, V44, P1731, DOI 10.1021/bi048430f; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Skowronski DM, 2002, J INFECT DIS, V185, P1448, DOI 10.1086/340280; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; Supajatura V, 2001, J IMMUNOL, V167, P2250, DOI 10.4049/jimmunol.167.4.2250; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Willems RJL, 1998, VACCINE, V16, P410, DOI 10.1016/S0264-410X(97)80919-X; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005	52	23	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4280	10.1371/journal.pone.0004280	http://dx.doi.org/10.1371/journal.pone.0004280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169359	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482800010
J	Cui, XQ; Loraine, AE				Cui, Xiangqin; Loraine, Ann E.			Consistency Analysis of Redundant Probe Sets on Affymetrix Three-Prime Expression Arrays and Applications to Differential mRNA Processing	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAYS; NETAFFX; TESTS; CALL	Affymetrix three-prime expression microarrays contain thousands of redundant probe sets that interrogate different regions of the same gene. Differential expression analysis methods rarely consider probe redundancy, which can lead to inaccurate inference about overall gene expression or cause investigators to overlook potentially valuable information about differential regulation of variant mRNA products. We investigated the behaviour and consistency of redundant probe sets in a publicly-available data set containing samples from mouse brain amygdala and hippocampus and asked how applying filtering methods to the data affected consistency of results obtained from redundant probe sets. A genome-based filter that screens and groups probe sets according to their overlapping genomic alignments significantly improved redundant probe set consistency. Screening based on qualitative Present-Absent calls from MAS5 also improved consistency. However, even after applying these filters, many redundant probe sets showed significant fold-change differences relative to each other, suggesting differential regulation of alternative transcript production. Visual inspection of these loci using an interactive genome visualization tool (igb.bioviz.org) exposed thirty putative examples of differential regulation of alternative splicing or polyadenylation across brain regions in mouse. This work demonstrates how P/A-call and genome-based filtering can improve consistency among redundant probe sets while at the same time exposing possible differential regulation of RNA processing pathways across sample types.	Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Loraine, Ann E.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Charlotte	Cui, XQ (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	aloraine@uncc.edu		Cui, Xiangqin/0000-0003-0621-9313	NIH/NCI [U54 CA100949]; NATIONAL CANCER INSTITUTE [U54CA100949] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by NIH/NCI U54 CA100949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2002, STAT ALG DESCR DOC; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Cline MS, 2005, BIOINFORMATICS, V21, pI107, DOI 10.1093/bioinformatics/bti1010; CUI X, 2006, GLOBAL CORRELATION A, P223; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; D'mello Veera, 2006, Appl Bioinformatics, V5, P249, DOI 10.2165/00822942-200605040-00007; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kennedy PE, 1996, COMMUN STAT-SIMUL C, V25, P923, DOI 10.1080/03610919608813350; Li H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-188; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; *NAT CANC I, 2008, CANC GEN ATL DAT POR; Perez-Iratxeta C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-183; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Yang HU, 2007, BIOINFORMATICS, V23, P38, DOI 10.1093/bioinformatics/btl548; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	26	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4229	10.1371/journal.pone.0004229	http://dx.doi.org/10.1371/journal.pone.0004229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165320	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482400001
J	Chang, DK; Lin, CT; Wu, CH; Wu, HC				Chang, De-Kuan; Lin, Chin-Tarng; Wu, Chien-Hsun; Wu, Han-Chung			A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; SOLID TUMORS; CHEMOTHERAPEUTIC-AGENTS; DOXORUBICIN DOXIL; SMALL-CELL; DELIVERY; PHARMACOKINETICS; EPITOPE; PHAGE; ACCUMULATION	Lung cancer is the leading cause of cancer-related mortality worldwide. The lack of tumor specificity remains a major drawback for effective chemotherapies and results in dose-limiting toxicities. However, a ligand-mediated drug delivery system should be able to render chemotherapy more specific to tumor cells and less toxic to normal tissues. In this study, we isolated a novel peptide ligand from a phage-displayed peptide library that bound to non-small cell lung cancer (NSCLC) cell lines. The targeting phage bound to several NSCLC cell lines but not to normal cells. Both the targeting phage and the synthetic peptide recognized the surgical specimens of NSCLC with a positive rate of 75% ( 27 of 36 specimens). In severe combined immunodeficiency (SCID) mice bearing NSCLC xenografts, the targeting phage specifically bound to tumor masses. The tumor homing ability of the targeting phage was inhibited by the cognate synthetic peptide, but not by a control or a WTY-mutated peptide. When the targeting peptide was coupled to liposomes carrying doxorubicin or vinorelbine, the therapeutic index of the chemotherapeutic agents and the survival rates of mice with human lung cancer xenografts markedly increased. Furthermore, the targeting liposomes increased drug accumulation in tumor tissues by 5.7-fold compared with free drugs and enhanced cancer cell apoptosis resulting from a higher concentration of bioavailable doxorubicin. The current study suggests that this tumor-specific peptide may be used to create chemotherapies specifically targeting tumor cells in the treatment of NSCLC and to design targeted gene transfer vectors or it may be used one in the diagnosis of this malignancy.	[Chang, De-Kuan; Wu, Chien-Hsun; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chang, De-Kuan; Lin, Chin-Tarng; Wu, Han-Chung] Natl Taiwan Univ, Coll Med, Inst Pathol, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chang, DK (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Academia Sinica [5202402020-0]; National Science Council [NSC-96-2323-B-002-015, NSC96-3114-P-001-006-Y02]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Research Grants from Academia Sinica (#5202402020-0 to HCW) and National Science Council (NSC-96-2323-B-002-015 and NSC96-3114-P-001-006-Y02 to HCW).	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bosslet K, 1998, CANCER RES, V58, P1195; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOYLE P, 2000, EPIDEMIOLOGY LUNG CA, P13; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Colbern GT, 1999, J LIPOSOME RES, V9, P523, DOI 10.3109/08982109909035551; Dharap SS, 2005, P NATL ACAD SCI USA, V102, P12962, DOI 10.1073/pnas.0504274102; DMello F, 1997, VIROLOGY, V237, P319, DOI 10.1006/viro.1997.8774; Drummond DC, 1999, PHARMACOL REV, V51, P691; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; HUANG SK, 1992, CANCER RES, V52, P6774; Jain RK, 1996, ANN BIOMED ENG, V24, P457, DOI 10.1007/BF02648108; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; LI B, 1995, SCIENCE, V270, P1657, DOI 10.1126/science.270.5242.1657; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Marina NM, 2002, CLIN CANCER RES, V8, P413; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; MINNA JD, 1982, CANCER PRINCIPLES PR, P396; Muggia F, 2001, EUR J CANCER, V37, pS15; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Park JW, 2002, BREAST CANCER RES, V4, P93; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Vaage J, 1997, BRIT J CANCER, V75, P482, DOI 10.1038/bjc.1997.84; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; YUAN F, 1995, CANCER RES, V55, P3752	49	112	122	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4171	10.1371/journal.pone.0004171	http://dx.doi.org/10.1371/journal.pone.0004171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137069	Green Published, gold			2022-12-27	WOS:000265479500002
J	Palacios, R; Gazave, E; Goni, J; Piedrafita, G; Fernando, O; Navarro, A; Villoslada, P				Palacios, Ricardo; Gazave, Elodie; Goni, Joaquin; Piedrafita, Gabriel; Fernando, Olga; Navarro, Arcadi; Villoslada, Pablo			Allele-Specific Gene Expression Is Widespread Across the Genome and Biological Processes	PLOS ONE			English	Article								Allelic specific gene expression (ASGE) appears to be an important factor in human phenotypic variability and as a consequence, for the development of complex traits and diseases. In order to study ASGE across the human genome, we have performed a study in which genotyping was coupled with an analysis of ASGE by screening 11,500 SNPs using the Mapping 10 K Array to identify differential allelic expression. We found that from the 5,133 SNPs that were suitable for analysis ( heterozygous in our sample and expressed in peripheral blood mononuclear cells), 2,934 (57%) SNPs had differential allelic expression. Such SNPs were equally distributed along human chromosomes and biological processes. We validated the presence or absence of ASGE in 18 out 20 SNPs (90%) randomly selected by real time PCR in 48 human subjects. In addition, we observed that SNPs close to -but not included in- segmental duplications had increased levels of ASGE. Finally, we found that transcripts of unknown function or non-coding RNAs, also display ASGE: from a total of 2,308 intronic SNPs, 1510 (65%) SNPs underwent differential allelic expression. In summary, ASGE is a widespread mechanism in the human genome whose regulation seems to be far more complex than expected.	[Goni, Joaquin; Piedrafita, Gabriel; Villoslada, Pablo] Univ Navarra, Ctr Appl Med Res CIMA, Neuroimmunol Lab, E-31080 Pamplona, Spain; [Gazave, Elodie; Fernando, Olga; Navarro, Arcadi] Univ Pompeu Fabra, Unitat Biol Evolut, Barcelona, Spain; [Goni, Joaquin] Univ Navarra, Dept Phys & Appl Math, E-31080 Pamplona, Spain; [Fernando, Olga] Univ Nova Lisboa, ITQB, P-1200 Lisbon, Portugal; [Navarro, Arcadi] ICREA, Barcelona, Spain; [Navarro, Arcadi] CIBERESP, Barcelona, Spain; [Villoslada, Pablo] Hosp Clin Barcelona, IDIBAPS, Dept Neurol, Barcelona, Spain	University of Navarra; Pompeu Fabra University; University of Navarra; Universidade Nova de Lisboa; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Palacios, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Neuroimmunol Lab, E-31080 Pamplona, Spain.	pvilloslada@clinic.ub.es	Piedrafita, Gabriel/A-4529-2013; Navarro, Arcadi/F-1592-2011; Villoslada, Pablo/AAF-9547-2019	Piedrafita, Gabriel/0000-0001-8701-1084; Navarro, Arcadi/0000-0003-2162-8246; Gazave, Elodie/0000-0002-6972-7051; Villoslada, Pablo/0000-0002-8735-6119	Ministerio de Ciencia y Tecnologia, Spain [BFU2006 15413-C02-01]; National Institute of Bioinformatics; Genoma Espana; Government of Navarra; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/15856/2005]; Spanish Ministry of Health [FIS PI060117]; CIMA UTE; ICREA Funding Source: Custom	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute of Bioinformatics; Genoma Espana; Government of Navarra; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIMA UTE; ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Health (FIS PI060117), by the CIMA UTE project to PV, by a grant to A.N. from the Ministerio de Ciencia y Tecnologia (Spain, BFU2006 15413-C02-01) and by the National Institute of Bioinformatics (www.inab.org), a platform of Genoma Espana. JG was supported by the Government of Navarra and OF was supported by a PhD fellowship (SFRH/BD/15856/2005) from the Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Craig IW, 2004, ANN HUM GENET, V68, P269, DOI 10.1046/j.1529-8817.2004.00098.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Erdmann VA, 2000, NUCLEIC ACIDS RES, V28, P197, DOI 10.1093/nar/28.1.197; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kantarci OH, 2008, ARCH NEUROL-CHICAGO, V65, P349, DOI 10.1001/archneurol.2007.66; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	31	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4150	10.1371/journal.pone.0004150	http://dx.doi.org/10.1371/journal.pone.0004150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127300	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473300014
J	Yoder, L				Yoder, Lane			Explicit Logic Circuits Discriminate Neural States	PLOS ONE			English	Article							OPPONENT-COLORS THEORY; QUANTITATIVE ASPECTS; RECEPTIVE-FIELDS; HUE; ODORANTS; NEURONS	The magnitude and apparent complexity of the brain's connectivity have left explicit networks largely unexplored. As a result, the relationship between the organization of synaptic connections and how the brain processes information is poorly understood. A recently proposed retinal network that produces neural correlates of color vision is refined and extended here to a family of general logic circuits. For any combination of high and low activity in any set of neurons, one of the logic circuits can receive input from the neurons and activate a single output neuron whenever the input neurons have the given activity state. The strength of the output neuron's response is a measure of the difference between the smallest of the high inputs and the largest of the low inputs. The networks generate correlates of known psychophysical phenomena. These results follow directly from the most cost-effective architectures for specific logic circuits and the minimal cellular capabilities of excitation and inhibition. The networks function dynamically, making their operation consistent with the speed of most brain functions. The networks show that well-known psychophysical phenomena do not require extraordinarily complex brain structures, and that a single network architecture can produce apparently disparate phenomena in different sensory systems.	Univ Hawaii, Dept Math, Honolulu, HI 96822 USA	University of Hawaii System	Yoder, L (corresponding author), Univ Hawaii, Dept Math, Honolulu, HI 96822 USA.	LDYoder@gmail.com						[Anonymous], 1998, NEURAL NETWORKS BRAI; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BOYNTON RM, 1965, J OPT SOC AM, V55, P78, DOI 10.1364/JOSA.55.000078; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Eggermann E, 2003, J NEUROSCI, V23, P1557; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; JELLINEK JS, 1979, J SOC COSMET CHEM, V30, P253; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P160; Koch Christof, 1999, P1; KUPFERMANN I, 1969, SCIENCE, V164, P847, DOI 10.1126/science.164.3881.847; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAING DG, 1994, HDB OLFACTION GUSTAT, P283; LAING DG, 1991, HUMAN SENSE SMELL, P246; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MOSKOWITZ HR, 1977, SENS PROCESS, V1, P212; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Purdy DM, 1931, AM J PSYCHOL, V43, P541, DOI 10.2307/1415157; VONBEZOLD W, 1873, ANN PHYS CHEM, V150, P221; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; Yoder L, 2005, COLOR RES APPL, V30, P252, DOI 10.1002/col.20121; ZADEH LA, 1962, P IRE, V50, P856, DOI 10.1109/JRPROC.1962.288302	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4154	10.1371/journal.pone.0004154	http://dx.doi.org/10.1371/journal.pone.0004154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127299	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473300017
J	Haag, JR; Pontes, O; Pikaard, CS				Haag, Jeremy R.; Pontes, Olga; Pikaard, Craig S.			Metal A and Metal B Sites of Nuclear RNA Polymerases Pol IV and Pol V Are Required for siRNA-Dependent DNA Methylation and Gene Silencing	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSCRIPTION; MUTAGENESIS	Plants are unique among eukaryotes in having five multi-subunit nuclear RNA polymerases: the ubiquitous RNA polymerases I, II and III plus two plant-specific activities, nuclear RNA polymerases IV and V (previously known as Polymerases IVa and IVb). Pol IV and Pol V are not required for viability but play non-redundant roles in small interfering RNA (siRNA)-mediated pathways, including a pathway that silences retrotransposons and endogenous repeats via siRNA-directed DNA methylation. RNA polymerase activity has not been demonstrated for Polymerases IV or V in vitro, making it unclear whether they are catalytically active enzymes. Their largest and second-largest subunit sequences have diverged considerably from Pol I, II and III in the vicinity of the catalytic center, yet retain the invariant Metal A and Metal B amino acid motifs that bind magnesium ions essential for RNA polymerization. By using site-directed mutagenesis in conjunction with in vivo functional assays, we show that the Metal A and Metal B motifs of Polymerases IV and V are essential for siRNA production, siRNA-directed DNA methylation, retrotransposon silencing, and the punctate nuclear localization patterns typical of both polymerases. Collectively, these data show that the minimal core sequences of polymerase active sites, the Metal A and B sites, are essential for Pol IV and Pol V biological functions, implying that both are catalytically active.	[Haag, Jeremy R.; Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Haag, JR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012; Pontes, Olga MF/F-9768-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145	National Institutes of Health [GM077590]; Edward Mallinckrodt Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Pikaard lab is supported by National Institutes of Health grant GM077590. The Pontes laboratory is supported by a grant from the Edward Mallinckrodt Foundation. The content of this paper is solely the responsibility of the authors and does not necessarily reflect the views of the NIH or the Edward Mallinckrodt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cramer P, 2006, BIOCHEM SOC T, V34, P1058, DOI 10.1042/BST0341058; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Ding B, 2007, MOL PLANT MICROBE IN, V20, P7, DOI 10.1094/MPMI-20-0007; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greco-Stewart VS, 2007, VIROLOGY, V357, P68, DOI 10.1016/j.virol.2006.08.010; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; Matzke M, 2006, COLD SPRING HARB SYM, V71, P449, DOI 10.1101/sqb.2006.71.028; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; ONODERA Y, 2008, GENETICS IN PRESS; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Sambrook J., 2001, MOL CLONING LAB MANU; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Vaucheret H, 2005, NAT GENET, V37, P659, DOI 10.1038/ng0705-659; Vaughn MW, 2005, MOL CELL, V17, P754, DOI 10.1016/j.molcel.2005.03.003; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	39	41	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4110	10.1371/journal.pone.0004110	http://dx.doi.org/10.1371/journal.pone.0004110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119310	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472600009
J	Shaish, L; Rinkevich, B				Shaish, Lee; Rinkevich, Baruch			Critical Evaluation of Branch Polarity and Apical Dominance as Dictators of Colony Astogeny in a Branching Coral	PLOS ONE			English	Article							REEF-CORAL; MORPHOLOGICAL PLASTICITY; EVOLUTIONARY ECOLOGY; GROWTH; FORM; RESTORATION; COMPETITION; ADAPTATION; SIMULATION; PRINCIPLES	The high morphological resemblance between branching corals and trees, can lead to comparative studies on pattern formation traits, best exemplified in plants and in some cnidarians. Here, 81 branches of similar size of the hermatypic coral Stylophora pistillata were lopped of three different genets, their skeletons marked with alizarin red-S, and divided haphazardly into three morphometric treatment groups: (I) upright position; (II) horizontal position, intact tip; and (III) horizontal position, cut tip. After 1 y of in-situ growth, the 45 surviving ramets were brought to the laboratory, their tissues removed and their architectures analyzed by 22 morphological parameters (MPs). We found that within 1 y, isolated branches developed into small coral colonies by growing new branches from all branch termini, in all directions. No architectural dissimilarity was assigned among the three studied genets of treatment I colonies. However, a major architectural disparity between treatment I colonies and colonies of treatments II and III was documented as the development of mirror structures from both sides of treatments II and III settings as compared to tip-borne architectures in treatment I colonies. We did not observe apical dominance since fragments grew equally from all branch sides without documented dominant polarity along branch axis. In treatment II colonies, no MP for new branches originating either from tips or from branch bases differed significantly. In treatment III colonies, growth from the cut tip areas was significantly lower compared to the base, again, suggesting lack of apical dominance in this species. Changes in branch polarity revealed genet associated plasticity, which in one of the studied genets, led to enhanced growth. Different genets exhibited canalization flexibility of growth patterns towards either lateral growth, or branch axis extension (skeletal weight and not porosity was measured). This study revealed that colony astogeny in S. pistillata is a regulated process expressed through programmed events and not directly related to simple energy trade-off principles or to environmental conditions, and that branch polarity and apical dominance do not dictate colony astogeny. Therefore, plasticity and astogenic disparities encompass a diversity of genetic (fixed and flexible) induced responses.	[Shaish, Lee; Rinkevich, Baruch] Natl Inst Oceanog, IL-31080 Haifa, Israel	Israel Oceanographic & Limnological Research Institute	Shaish, L (corresponding author), Natl Inst Oceanog, IL-31080 Haifa, Israel.	buki@ocean.org.il			EC-INCO-DEV; GEF/World Bank; AID-CDR project [C23-004]; EC collective research project	EC-INCO-DEV; GEF/World Bank; AID-CDR project; EC collective research project	The study was supported by the EC-INCO-DEV (REEFRES project), by the GEF/World Bank (Remediation and Restoration working Group project), by the AID-CDR project (no C23-004) and by the EC collective research (CORALZOO) project.	Abraham ER, 2001, MAR BIOL, V138, P503, DOI 10.1007/s002270000479; BARKI Y, 1999, THESIS TEL AVIV U IS; BELL AD, 1986, PHILOS T ROY SOC B, V313, P143, DOI 10.1098/rstb.1986.0030; Berking S, 2006, INT J DEV BIOL, V50, P123, DOI 10.1387/ijdb.052043sb; Berking S, 2002, INT J DEV BIOL, V46, P301; BUSS LW, 1991, PHILOS T ROY SOC B, V332, P49, DOI 10.1098/rstb.1991.0032; Cline MG, 1997, AM J BOT, V84, P1064, DOI 10.2307/2446149; DAUGET JM, 1991, CR ACAD SCI III-VIE, V313, P45; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; Foster A.B., 1983, Coral Reefs, V2, P19, DOI 10.1007/BF00304728; Gateno D, 2003, MAR BIOL, V142, P971, DOI 10.1007/s00227-003-1009-8; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; HUGHES RN, 1983, BIOL J LINN SOC, V20, P39, DOI 10.1111/j.1095-8312.1983.tb01588.x; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Ingber D, 1999, FASEB J, V13, pS3; JACKSON JBC, 1979, BIOL SYSTEMATICS COL, V11, P499; Kaandorp JA, 2005, P ROY SOC B-BIOL SCI, V272, P127, DOI 10.1098/rspb.2004.2934; Kaandorp JA, 2001, VIRTUAL LAB, P1; Kaandorp JA, 1997, BIOSYSTEMS, V44, P181, DOI 10.1016/S0303-2647(97)00052-X; KAWAGUTI S, 1973, PALAU TROP BIOL STAT, V12, P209; Kim K, 1997, J EXP MAR BIOL ECOL, V215, P49, DOI 10.1016/S0022-0981(97)00015-4; Kosevich IA, 2006, ZOOLOGY, V109, P244, DOI 10.1016/j.zool.2006.03.004; Lasker HR, 2002, REPRO BIOL, V11, P207; LIDDLE MJ, 1987, BIOL CONSERV, V42, P1, DOI 10.1016/0006-3207(87)90049-8; LOYA Y, 1976, NATURE, V261, P490, DOI 10.1038/261490a0; Marfenin NN, 1997, HYDROBIOLOGIA, V355, P153, DOI 10.1023/A:1003069831832; MARFENIN NN, 1995, RUSSIAN ACAD SCI P Z, V261, P71; Merks RMH, 2004, J THEOR BIOL, V228, P559, DOI 10.1016/j.jtbi.2004.02.020; Meroz E, 2002, P ROY SOC B-BIOL SCI, V269, P717, DOI 10.1098/rspb.2001.1924; Muko S, 2000, B MAR SCI, V66, P225; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Oren U, 1997, MAR ECOL PROG SER, V161, P117, DOI 10.3354/meps161117; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Prusinkiewicz P, 1998, SCI HORTIC-AMSTERDAM, V74, P113, DOI 10.1016/S0304-4238(98)00084-3; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; RINKEVICH B, 1985, OECOLOGIA, V66, P100, DOI 10.1007/BF00378559; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; RINKEVICH B, 1984, MAR BIOL, V80, P7, DOI 10.1007/BF00393121; ROOM PM, 1994, ADV ECOL RES, V25, P105, DOI 10.1016/S0065-2504(08)60214-7; ROSEN BR, 1986, PHILOS T ROY SOC B, V313, P115, DOI 10.1098/rstb.1986.0029; RYLAND JS, 1986, PHILOS T ROY SOC B, V313, P53; Sanchez JA, 2004, AM NAT, V163, pE24, DOI 10.1086/382139; SANCHEZ JA, 2003, P R SOC LOND, V271, pS117; Shaish L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000644; Shaish L, 2006, DEV DYNAM, V235, P2111, DOI 10.1002/dvdy.20861; Sokal RR, 1984, BIOMETRY PRINCIPLES; TAYLOR DL, 1977, P 3 INT COR REEF S, P431; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Waddington CH, 1942, J EXP BIOL, V19, P101; WALLER DM, 1985, ECOLOGY EVOLUTION CL, P225; Weinbauer MG, 1998, CAH BIOL MAR, V39, P41; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9	56	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4095	10.1371/journal.pone.0004095	http://dx.doi.org/10.1371/journal.pone.0004095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119311	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472600003
J	Prieto, JH; Koncarevic, S; Park, SK; Yates, J; Becker, K				Prieto, Judith Helena; Koncarevic, Sasa; Park, Sung Kyu; Yates, John, III; Becker, Katja			Large-Scale Differential Proteome Analysis in Plasmodium falciparum under Drug Treatment	PLOS ONE			English	Article								Proteome studies contribute markedly to our understanding of parasite biology, host-parasite interactions, and mechanisms of drug action. For most antimalarial drugs neither mode of action nor mechanisms of resistance development are fully elucidated although this would be important prerequisites for successfully developing urgently required novel antimalarials. Here, we establish a large-scale quantitative proteomic approach to examine protein expression changes in trophozoite stages of the malarial parasite Plasmodium falciparum following chloroquine and artemisinin treatment. For this purpose SIL (stable isotope labeling) using (14)N-isoleucine and (13)C(6), (15)N(1)-isoleucine was optimized to obtain 99% atomic percent enrichment. Proteome fractionation with anion exchange chromatography was used to reduce sample complexity and increase quantitative coverage of protein expression. Tryptic peptides of subfractions were subjected to SCX/RP separation, measured by LC-MS/MS and quantified using the novel software tool Census. In drug treated parasites, we identified a total number of 1,253 proteins, thus increasing the overall number of proteins identified in the trophozoite stage by 30%. A relative quantification was obtained for more than 800 proteins. Under artemisinin and chloroquine treatment 41 and 38 proteins respectively were upregulated (>1.5) whereas 14 and 8 proteins were down-regulated (<0.5). Apart from specifically regulated proteins we also identified sets of proteins which were regulated as a general response to drug treatment. The proteomic data was confirmed by Western blotting. The methodology described here allows for the efficient large-scale differential proteome analysis of P. falciparum study the response to drug treatment or environmental changes. Only 100 mu g of protein is required for the analysis suggesting that the method can also be transferred to other apicomplexan parasites.	[Prieto, Judith Helena; Park, Sung Kyu; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Koncarevic, Sasa; Becker, Katja] Univ Giessen, Interdisciplin Res Ctr, D-35390 Giessen, Germany	Scripps Research Institute; Justus Liebig University Giessen	Prieto, JH (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	jyates@scripps.edu; becker.katja@gmx.de		Prieto, Judith/0000-0003-3314-0993	NIH [AI072615-02, P41 RR011823]; German Research Council [Be 1540/9-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the NIH (AI072615-02), P41 RR011823 and the German Research Council (Be 1540/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Cociorva D., 2006, CURR PROTOC BIOINFOR, P1341; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fournier ML, 2007, CHEM REV, V107, P3654, DOI 10.1021/cr068279a; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gunasekera AM, 2003, MOL MICROBIOL, V50, P1229, DOI 10.1046/j.1365-2958.2003.03787.x; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Koncarevic S, 2007, PROTEOMICS, V7, P711, DOI 10.1002/pmic.200600552; KUHN T, 2008, PROG DRUG RES, V66; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lelievre J, 2007, CURR OPIN INVEST DR, V8, P117; List E. O., 2008, Infectious Disorders - Drug Targets, V8, P31; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Maerki S, 2006, J ANTIMICROB CHEMOTH, V58, P52, DOI 10.1093/jac/dkl209; McClatchy DB, 2007, GENOME RES, V17, P1378, DOI 10.1101/gr.6375007; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Olliaro P, 2001, PHARMACOL THERAPEUT, V89, P207, DOI 10.1016/S0163-7258(00)00115-7; PARK SK, 2006, PROT ORG 5 ANN WORLD; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Radfar A, 2008, FREE RADICAL BIO MED, V44, P2034, DOI 10.1016/j.freeradbiomed.2008.03.010; Roberts L, 2008, ANTIMICROB AGENTS CH, V52, P1840, DOI 10.1128/AAC.01478-07; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TERKUILE F, 1993, EXP PARASITOL, V76, P85, DOI 10.1006/expr.1993.1010; Venable JD, 2007, ANAL CHEM, V79, P3056, DOI 10.1021/ac062054i; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	31	66	69	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4098	10.1371/journal.pone.0004098	http://dx.doi.org/10.1371/journal.pone.0004098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116658	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600016
J	Moodie, EEM; Pai, NP; Klein, MB				Moodie, Erica E. M.; Pai, Nitika Pant; Klein, Marina B.			Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV/Hepatitis C Co-Infected Cohorts	PLOS ONE			English	Article								The effects of highly active antiretroviral therapy (HAART) on progression of hepatic fibrosis in HIV-hepatitis C virus (HCV) co-infection are not well understood. Deaths from liver diseases have risen in the post-HAART era, yet some cross-sectional studies have suggested that HAART use is associated with improved fibrosis rates. In a retrospective cohort of 533 HIV mono-infected and 127 HIV/HCV co-infected patients, followed between January 1991 and July 2005 at a university-based HIV clinic, we investigated the relationship between cumulative HAART exposure and hepatic fibrosis, as measured by the aspartate aminotransferase-to-platelet ratio index (APRI). We used a novel methodological approach to estimate the dose-response relationship of the effect of HAART exposure on APRI. HAART was associated with increasing APRI over time in HIV/ HCV co-infected patients suggesting that they may be experiencing cumulative hepatotoxicity from antiretrovirals. The estimated median change (95% confidence interval) in APRI per one year of HAART intake was of -0.46% (-1.61% to 0.71%) in HIV mono-infected compared to 2.54% (-1.77% to 7.03%) in HIV/ HCV co-infected patients. Similar results were found when the direct effect of HAART intake since the last visit was estimated on the change in APRI. HAART use associated is with increased APRI in patients with HIV/ HCV co-infection. Therefore treatment for HCV infection may be required to slow the growing epidemic of end-stage liver disease in this population.	McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Nitika Pant; Klein, Marina B.] McGill Univ Hlth Ctr, Royal Victoria Hosp, Dept Med, Div Infect Dis Immunodeficiency, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; Royal Victoria Hospital	Moodie, EEM (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	marina.klein@muhc.mcgill.ca		Pant Pai, Nitika/0000-0002-4672-0500; Klein, Marina/0000-0002-3063-8430	Fonds de la recherche en sante du Quebec (FRSQ) [Chercheur-Boursier salary award]; Reseau SIDA et Maladies Infectieuses; Natural Sciences and Engineering Research Council of Canada [University Faculty Award, Discovery Grant]; Canadian HIV Clinical Trials Network [Post-doctoral fellowship]	Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Reseau SIDA et Maladies Infectieuses; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian HIV Clinical Trials Network	This work was supported by an infrastructure grant from le Fonds de la recherche en sante du Quebec (FRSQ) Reseau SIDA et Maladies Infectieuses. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Moodie is the recipient of a University Faculty Award and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada. Dr. Pant Pai is supported by a Post-doctoral fellowship from the Canadian HIV Clinical Trials Network. Dr. Marina Klein is supported by a Chercheur-Boursier salary award from the FRSQ.	Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x; Al-Mohri H, 2007, JAIDS-J ACQ IMM DEF, V44, P463, DOI 10.1097/QAI.0b013e318030ff8e; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; *CTR INF DIS PREV, 2005, HIV AIDS EPI UPD; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fuster D, 2004, AIDS RES HUM RETROV, V20, P1293, DOI 10.1089/aid.2004.20.1293; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Hirano K., 2004, APPL BAYESIAN MODELI; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Macias J, 2004, AIDS, V18, P767, DOI [10.1097/01.aids.0000111417.91384.fd, 10.1097/00002030-200403260-00007]; Macias J, 2002, EUR J CLIN MICROBIOL, V21, P775, DOI 10.1007/s10096-002-0823-0; MAHARAJ B, 1986, LANCET, V1, P523; Marine-Barjoan E, 2004, AIDS, V18, P2163, DOI 10.1097/00002030-200411050-00008; Mehta SH, 2005, HEPATOLOGY, V41, P123, DOI 10.1002/hep.20541; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Nunes D, 2005, JAIDS-J ACQ IMM DEF, V40, P538, DOI 10.1097/01.qai.0000184856.31695.bf; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Robins J. M, 1997, CAUSAL INFERENCE COM; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENTHAL E, 2004, LIVER RELATED MORTAL; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; SanchezQuijano A, 1995, EUR J CLIN MICROBIOL, V14, P949, DOI 10.1007/BF01691375; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; STERLING R, 2005, CAN ROUTINE NONINVAS; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Tatsunami S, 2004, ACTA HAEMATOL-BASEL, V111, P181, DOI 10.1159/000077549; THOMAS D, 2007, STAGING LIVER DIS HI; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yasui H, 2003, ANN NY ACAD SCI, V1010, P273, DOI 10.1196/annals.1299.047; Zylberberg H, 1998, CLIN INFECT DIS, V27, P1255, DOI 10.1086/514987	37	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4517	10.1371/journal.pone.0004517	http://dx.doi.org/10.1371/journal.pone.0004517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223976	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485800017
J	Vu, I; Smelick, G; Harris, S; Lee, SC; Weil, E; Whitehead, RF; Bruno, JF				Vu, Ivana; Smelick, Gillian; Harris, Sam; Lee, Sarah C.; Weil, Ernesto; Whitehead, Robert F.; Bruno, John F.			Macroalgae Has No Effect on the Severity and Dynamics of Caribbean Yellow Band Disease	PLOS ONE			English	Article								By removing herbivores and promoting increases in macroalgae, overfishing is thought to indirectly cause coral disease and mortality. We performed three field manipulations to test the general hypothesis that overfishing and the subsequent alteration of coral reef trophic dynamics are a cause of coral epizootics. Specifically, we asked whether the presence of macroalgae can influence within- and among-colony spread rates of Caribbean Yellow Band Disease in Montastraea faveolata. Macroalgae were placed next to infected and healthy, adult and small coral colonies to measure effects on disease spread rate, coral growth and coral survival. Surprisingly, the addition of macroalgae did not affect disease severity or coral fitness. Our results indicate that macroalgae have no effect on the severity and dynamics of Caribbean Yellow Band Disease and that fisheries management alone will not mitigate the effects of this important epizootic.	[Vu, Ivana; Smelick, Gillian; Harris, Sam; Lee, Sarah C.; Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, San Juan, PR 00936 USA; [Whitehead, Robert F.] Univ N Carolina Wilmington, Ctr Marine Sci, Wilmington, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Puerto Rico; University of North Carolina; University of North Carolina Wilmington	Vu, I (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	jbruno@unc.edu	Weil, Ernesto/AAI-3591-2020; Lee, Sarah/Q-3372-2017; Weil, Ernesto/ABF-1290-2020	Weil, Ernesto/0000-0001-5275-1584	National Science Foundation [OCE-0326705]; University of North Carolina at Chapel Hill; GEF-World Bank CRTR program; NOAA-CRES [NA170P2919]; University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development	National Science Foundation(National Science Foundation (NSF)); University of North Carolina at Chapel Hill; GEF-World Bank CRTR program; NOAA-CRES(National Oceanic Atmospheric Admin (NOAA) - USA); University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development	This research was funded in part the National Science Foundation (OCE-0326705 to JFB), The University of North Carolina at Chapel Hill, the GEF-World Bank CRTR program through the disease working group and a NOAA-CRES grant (NA170P2919) to EW. The University of North Carolina at Chapel Hill's Office of the Vice Chancellor for Research and Economic Development provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES NG, 1995, MAR ECOL PROG SER, V118, P305, DOI 10.3354/meps118305; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; BENNER R, 1993, MAR CHEM, V41, P153, DOI 10.1016/0304-4203(93)90113-3; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruckner AW, 2006, DIS AQUAT ORGAN, V69, P67, DOI 10.3354/dao069067; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Budd A.F., 1991, Bulletins of American Paleontology, V101, P1; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Cervino J, 2001, HYDROBIOLOGIA, V460, P53, DOI 10.1023/A:1013166617140; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, SYMBIOSIS, V37, P63; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; DAVIES PS, 1989, MAR BIOL, V101, P389; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gil-Agudelo DL, 2004, CORAL HEALTH AND DISEASE, P337; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HARVELL CD, 2008, ECOLOGY IN PRESS; Hayes ML, 2001, HYDROBIOLOGIA, V460, P213, DOI 10.1023/A:1013121503937; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Precht WF, 2005, SCIENCE, V308, P1741; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Santavy DL, 1999, CORAL REEFS, V18, P97, DOI 10.1007/s003380050162; Selig ER., 2006, ANALYZING RELATIONSH, P111; Sharp JH, 2002, MAR CHEM, V77, P239, DOI 10.1016/S0304-4203(02)00002-6; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E., 2000, PROC 9 INT CORAL REE, V2, P1231	48	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4514	10.1371/journal.pone.0004514	http://dx.doi.org/10.1371/journal.pone.0004514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223986	Green Submitted, gold, Green Published			2022-12-27	WOS:000265485800014
J	Klarkowski, DB; Wazome, JM; Lokuge, KM; Shanks, L; Mills, CF; O'Brien, DP				Klarkowski, Derryck B.; Wazome, Joseph M.; Lokuge, Kamalini M.; Shanks, Leslie; Mills, Clair F.; O'Brien, Daniel P.			The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic Algorithm	PLOS ONE			English	Article								Background: Concerns about false-positive HIV results led to a review of testing procedures used in a Medecins Sans Frontieres (MSF) HIV programme in Bukavu, eastern Democratic Republic of Congo. In addition to the WHO HIV rapid diagnostic test algorithm(RDT) (two positive RDTs alone for HIV diagnosis) used in voluntary counselling and testing (VCT) sites we evaluated in situ a practical field-based confirmation test against western blot WB. In addition, we aimed to determine the false-positive rate of the WHO two-test algorithm compared with our adapted protocol including confirmation testing, and whether weakly reactive compared with strongly reactive rapid test results were more likely to be false positives. Methodology/Principal Findings: 2864 clients presenting to MSF VCT centres in Bukavu during January to May 2006 were tested using Determine HIV-1/2 (R) and UniGold HIV (R) rapid tests in parallel by nurse counsellors. Plasma samples on 229 clients confirmed as double RDT positive by laboratory retesting were further tested using both WB and the Orgenics Immunocomb Combfirm (R) HIV confirmation test (OIC-HIV). Of these, 24 samples were negative or indeterminate by WB representing a false-positive rate of the WHO two-test algorithm of 10.5% (95% CI 6.6-15.2). 17 of the 229 samples were weakly positive on rapid testing and all were negative or indeterminate by WB. The false-positive rate fell to 3.3% (95% CI 1.3-6.7) when only strong-positive rapid test results were considered. Agreement between OIC-HIV and WB was 99.1% (95% CI 96.9-99.9%) with no false OIC-HIV positives if stringent criteria for positive OIC-HIV diagnoses were used. Conclusions: The WHO HIV two-test diagnostic algorithm produced an unacceptably high level of false-positive diagnoses in our setting, especially if results were weakly positive. The most probable causes of the false-positive results were serological cross-reactivity or non-specific immune reactivity. Our findings show that the OIC-HIV confirmation test is practical and effective in field contexts. We propose that all double-positive HIV RDT samples should undergo further testing to confirm HIV seropositivity until the accuracy of the RDT testing algorithm has been established at programme level.	[Klarkowski, Derryck B.; Wazome, Joseph M.; Lokuge, Kamalini M.; Shanks, Leslie; Mills, Clair F.; O'Brien, Daniel P.] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands	Doctors Without Borders	Klarkowski, DB (corresponding author), Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands.	derryck.klarkowski@amsterdam.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; Lokuge, Kamalini/0000-0002-6287-1296				*AG NAT ACCR EV SA, 2000, STRAT DIAGN BIOL INF; Aidoo S, 2001, J CLIN MICROBIOL, V39, P2572, DOI 10.1128/JCM.39.7.2572-2575.2001; Alves Crésio, 2006, Braz J Infect Dis, V10, P122, DOI 10.1590/S1413-86702006000200010; BARTHEL HR, 1993, SEMIN ARTHRITIS RHEU, V23, P1, DOI 10.1016/S0049-0172(05)80021-6; Branson B., 2003, LAB MED, V27, P288; CELUM CL, 1994, ARCH INTERN MED, V154, P1129, DOI 10.1001/archinte.154.10.1129; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Chanbancherd P, 1999, AIDS, V13, P2182, DOI 10.1097/00002030-199910220-00031; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Clerici M, 2001, CLIN DIAGN LAB IMMUN, V8, P864, DOI 10.1128/CDLI.8.5.864-866.2001; CRASKE J, 1990, VOX SANG, V59, P160, DOI 10.1111/j.1423-0410.1990.tb00851.x; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Elm Joe, 1998, Papua New Guinea Medical Journal, V41, P15; Foglia G, 2004, J CLIN MICROBIOL, V42, P3850, DOI 10.1128/JCM.42.8.3850-3852.2004; Gasasira AF, 2006, J CLIN MICROBIOL, V44, P3021, DOI 10.1128/JCM.02207-05; Granade TC, 2005, CLIN DIAGN LAB IMMUN, V12, P855, DOI 10.1128/CDLI.12.7.855-860.2005; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; HEALEY DS, 1993, AIDS, V7, P655, DOI 10.1097/00002030-199305000-00007; HILL AVS, 1992, P NATL ACAD SCI USA, V89, P2277, DOI 10.1073/pnas.89.6.2277; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Meles H, 2002, CLIN DIAGN LAB IMMUN, V9, P160, DOI 10.1128/CDLI.9.1.160-163.2002; Messele T, 1999, CLIN EXP IMMUNOL, V115, P443; NG VL, 1991, CLIN CHEM, V37, P1667; Ngan CCL, 2002, J CLIN MICROBIOL, V40, P314, DOI 10.1128/JCM.40.1.314-315.2002; Ramalingam S, 2002, J CLIN MICROBIOL, V40, P1553, DOI 10.1128/JCM.40.4.1553-1554.2002; Sayre KR, 1996, TRANSFUSION, V36, P45, DOI 10.1046/j.1537-2995.1996.36196190514.x; Singer DE, 2005, J CLIN MICROBIOL, V43, P5312, DOI 10.1128/JCM.43.10.5312-5315.2005; Sudha T, 2006, Indian J Dermatol Venereol Leprol, V72, P357; Thakral B, 2006, J POSTGRAD MED, V52, P106; Thomas HIJ, 1996, CLIN EXP IMMUNOL, V103, P185, DOI 10.1046/j.1365-2249.1996.951642.x; Urassa W, 1999, J CLIN VIROL, V14, P25, DOI 10.1016/S1386-6532(99)00043-8; *WHO RAP HIV TESTS, 2004, GUID US HIV TEST COU; 2003, PROGRAMME NATL LUTTE	34	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4351	10.1371/journal.pone.0004351	http://dx.doi.org/10.1371/journal.pone.0004351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197370	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483700001
J	Aronson, RB; Moody, RM; Ivany, LC; Blake, DB; Werner, JE; Glass, A				Aronson, Richard B.; Moody, Ryan M.; Ivany, Linda C.; Blake, Daniel B.; Werner, John E.; Glass, Alexander			Climate Change and Trophic Response of the Antarctic Bottom Fauna	PLOS ONE			English	Article							BRACHIOPODS; EOCENE; SHELF; PREDATION; COMMUNITY; BIOLOGY; RECORD	Background: As Earth warms, temperate and subpolar marine species will increasingly shift their geographic ranges poleward. The endemic shelf fauna of Antarctica is especially vulnerable to climate-mediated biological invasions because cold temperatures currently exclude the durophagous (shell-breaking) predators that structure shallow-benthic communities elsewhere. Methodology/Principal Findings: We used the Eocene fossil record from Seymour Island, Antarctic Peninsula, to project specifically how global warming will reorganize the nearshore benthos of Antarctica. A long-term cooling trend, which began with a sharp temperature drop similar to 41 Ma (million years ago), eliminated durophagous predators-teleosts (modern bony fish), decapod crustaceans (crabs and lobsters) and almost all neoselachian elasmobranchs (modern sharks and rays) from Antarctic nearshore waters after the Eocene. Even prior to those extinctions, durophagous predators became less active as coastal sea temperatures declined from 41 Ma to the end of the Eocene, similar to 33.5 Ma. In response, dense populations of suspension-feeding ophiuroids and crinoids abruptly appeared. Dense aggregations of brachiopods transcended the cooling event with no apparent change in predation pressure, nor were there changes in the frequency of shell-drilling predation on venerid bivalves. Conclusions/Significance: Rapid warming in the Southern Ocean is now removing the physiological barriers to shell-breaking predators, and crabs are returning to the Antarctic Peninsula. Over the coming decades to centuries, we predict a rapid reversal of the Eocene trends. Increasing predation will reduce or eliminate extant dense populations of suspension-feeding echinoderms from nearshore habitats along the Peninsula while brachiopods will continue to form large populations, and the intensity of shell-drilling predation on infaunal bivalves will not change appreciably. In time the ecological effects of global warming could spread to other portions of the Antarctic coast. The differential responses of faunal components will reduce the endemic character of Antarctic subtidal communities, homogenizing them with nearshore communities at lower latitudes.	[Aronson, Richard B.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Aronson, Richard B.; Moody, Ryan M.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Moody, Ryan M.] Univ S Alabama, Dept Marine Sci, Mobile, AL USA; [Ivany, Linda C.] Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; [Blake, Daniel B.; Werner, John E.; Glass, Alexander] Univ Illinois, Dept Geol, Urbana, IL USA	Florida Institute of Technology; Dauphin Island Sea Lab; University of South Alabama; Syracuse University; University of Illinois System; University of Illinois Urbana-Champaign	Aronson, RB (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	raronson@fit.edu		Aronson, Richard/0000-0003-0383-3844	Office of Polar Programs, US National Science Foundation [OPP-9908828, ANT-0245563, OPP-9908856, OPP-0125409]	Office of Polar Programs, US National Science Foundation(National Science Foundation (NSF))	This study was funded by the Office of Polar Programs, US National Science Foundation (grants OPP-9908828 and ANT-0245563 to RBA, OPP-9908856 to DBB, and OPP-0125409 to LCI). NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON RB, 1992, MAR ECOL PROG SER, V89, P1, DOI 10.3354/meps089001; Aronson RB, 1997, GEOLOGY, V25, P903, DOI 10.1130/0091-7613(1997)025<0903:RCSITL>2.3.CO;2; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Carroll M, 2003, PALEOBIOLOGY, V29, P381, DOI 10.1666/0094-8373(2003)029<0381:QEOTIT>2.0.CO;2; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Dearborn JH, 1977, ADAPTATIONS ANTARCTI, P293; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; FOSTER MW, 1974, AM GEOPHYS UNION ANT, V22; Frederich M, 2001, POLAR BIOL, V24, P719, DOI 10.1007/s003000100270; Gili JM, 2006, DEEP-SEA RES PT II, V53, P1029, DOI 10.1016/j.dsr2.2005.10.021; Harper EM, 2003, T GEOBIOL, V20, P433; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Kowalewski M, 2002, PALAIOS, V17, P277, DOI 10.1669/0883-1351(2002)017<0277:ABOATU>2.0.CO;2; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Leighton LR, 2003, T GEOBIOL, V20, P215; Marenssi SA, 1998, ASOC PAL ARGENT PUBL, P137; MCCAMMON HM, 1973, J PALEONTOL, V47, P266; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; MEYER D L, 1977, Paleobiology, V3, P74; Oji T, 1996, PALEOBIOLOGY, V22, P339, DOI 10.1017/S0094837300016328; PECK LS, 2007, T ROY SOC EDIN-EARTH, V98, P1; Porbski SJ, 1995, STUDIA GEOLOGICA POL, V107, P7; Ragua-Gil JM, 2004, MAR BIOL, V144, P829, DOI 10.1007/s00227-003-1269-3; RHODES MC, 1993, PALEOBIOLOGY, V19, P322, DOI 10.1017/S0094837300000300; Sadler P. M, 1988, GEOLOGY PALEONTOLOGY, V169, P303, DOI DOI 10.1130/MEM169-P303; Simoes MG, 2007, PALAIOS, V22, P143, DOI 10.2110/palo.2006.p06-040r; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; STILWELL JD, 1992, AM GEOPHYS UNION ANT, V55; Thatje S, 2005, ECOLOGY, V86, P619, DOI 10.1890/04-0620; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij GJ, 2008, SCIENCE, V321, P780, DOI 10.1126/science.1160852; VERMEIJ GJ, 1982, AM NAT, V120, P701, DOI 10.1086/284025; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZINSMEISTER WJ, 1984, SCIENCE, V224, P281, DOI 10.1126/science.224.4646.281	41	47	47	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4385	10.1371/journal.pone.0004385	http://dx.doi.org/10.1371/journal.pone.0004385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194490	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483600012
J	Atkinson, HJ; Morris, JH; Ferrin, TE; Babbitt, PC				Atkinson, Holly J.; Morris, John H.; Ferrin, Thomas E.; Babbitt, Patricia C.			Using Sequence Similarity Networks for Visualization of Relationships Across Diverse Protein Superfamilies	PLOS ONE			English	Article								The dramatic increase in heterogeneous types of biological data-in particular, the abundance of new protein sequences requires fast and user-friendly methods for organizing this information in a way that enables functional inference. The most widely used strategy to link sequence or structure to function, homology-based function prediction, relies on the fundamental assumption that sequence or structural similarity implies functional similarity. New tools that extend this approach are still urgently needed to associate sequence data with biological information in ways that accommodate the real complexity of the problem, while being accessible to experimental as well as computational biologists. To address this, we have examined the application of sequence similarity networks for visualizing functional trends across protein superfamilies from the context of sequence similarity. Using three large groups of homologous proteins of varying types of structural and functional diversity-GPCRs and kinases from humans, and the crotonase superfamily of enzymes-we show that overlaying networks with orthogonal information is a powerful approach for observing functional themes and revealing outliers. In comparison to other primary methods, networks provide both a good representation of group-wise sequence similarity relationships and a strong visual and quantitative correlation with phylogenetic trees, while enabling analysis and visualization of much larger sets of sequences than trees or multiple sequence alignments can easily accommodate. We also define important limitations and caveats in the application of these networks. As a broadly accessible and effective tool for the exploration of protein superfamilies, sequence similarity networks show great potential for generating testable hypotheses about protein structure-function relationships.	Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA; [Atkinson, Holly J.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Inst Quantitative Biosci, San Francisco, CA 94143 USA; [Morris, John H.; Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharm Chem, San Francisco, CA 94143 USA; [Ferrin, Thomas E.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Biopharm Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Atkinson, HJ (corresponding author), Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA.	babbitt@cgl.ucsf.edu	Ferrin, Thomas E./W-8842-2019	Ferrin, Thomas E./0000-0001-6227-0637; Morris, John "Scooter"/0000-0003-0290-7979	NIH [GM60595, T32 GM067547]; NSF [DBI 0640476, P41 RR01081];  [P01 GM071790]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, R01GM060595, P01GM071790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM60595 and NSF grant DBI 0640476 to P.C.B. and P41 RR01081 to T.E.F.. H.J.A. received support from NIH grant T32 GM067547. Initial exploration of sequence similarity networks used the enolases and amidohydrolases superfamilies as example data sets, and was supported by P01 GM071790 to P.C.B.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 2001, BIOINFORMATICS, V17, P853, DOI 10.1093/bioinformatics/17.9.853; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Huang CL, 2007, EXP MOL MED, V39, P565, DOI 10.1038/emm.2007.62; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; MORRIS JH, VISUALIZATION ANAL B; Morris JH, 2007, BIOINFORMATICS, V23, P2345, DOI 10.1093/bioinformatics/btm329; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nguyen TT, 2008, BIOCHEMISTRY-US, V47, P1194, DOI 10.1021/bi7017738; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; WIESE R, YFILES ORGANIC LAYOU; WIESE R, 2001, P 9 INT S GRAPH DRAW, P453; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535	49	288	290	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4345	10.1371/journal.pone.0004345	http://dx.doi.org/10.1371/journal.pone.0004345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190775	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483300004
J	Liang, S; Yang, N; Pan, Y; Deng, S; Lin, XJ; Yang, XJ; Katsaros, D; Roby, KF; Hamilton, TC; Connolly, DC; Coukos, G; Zhang, L				Liang, Shun; Yang, Nuo; Pan, Yue; Deng, Shan; Lin, Xiaojuan; Yang, Xiaojun; Katsaros, Dionyssios; Roby, Katherine F.; Hamilton, Thomas C.; Connolly, Denise C.; Coukos, George; Zhang, Lin			Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation	PLOS ONE			English	Article								Background: The Phosphatidylinositol 3'-kinase is a key regulator in various cancer-associated signal transduction pathways. Genetic alterations of its catalytic subunit alpha, PIK3CA, have been identified in ovarian cancer. Our in vivo data suggests that PIK3CA activation is one of the early genetic events in ovarian cancer. However, its role in malignant transformation of ovarian surface epithelium (OSE) is largely unclear. Methodology/Principal Findings: Using the Mullerian inhibiting substance type II receptor (MISIIR) promoter, we generated transgenic mice that expressed activated PIK3CA in the Mullerian epithelium. Overexpression of PIK3CA in OSE induced remarkable hyperplasia, but was not able to malignantly transform OSE in vivo. The consistent result was also observed in primary cultured OSEs. Although enforced expression of PIK3CA could not induce OSE anchorage-independent growth, it significantly increased anchorage-independent growth of OSE transformed by mutant K-ras. Conclusions/Significance: While PIK3CA activation may not be able to initiate OSE transformation, we conclude that activation of PIK3CA may be an important molecular event contributing to the maintenance of OSE transformation initiated by oncogenes such as K-ras.	[Liang, Shun; Yang, Nuo; Pan, Yue; Deng, Shan; Lin, Xiaojuan; Yang, Xiaojun; Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, I-10124 Turin, Italy; [Roby, Katherine F.] Univ Kansas, Med Ctr, Ctr Reproductive Sci, Kansas City, KS USA; [Hamilton, Thomas C.; Connolly, Denise C.] Fox Chase Canc Ctr, Ovarian Canc Program, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Turin; University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center	Liang, S (corresponding author), Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Coukos, George/0000-0001-8813-7367	Ovarian Cancer Research Fund; NCI [P50-CA83638]; American Cancer Society [IRG-78-002-30]; Mary Kay Ash Charitable Foundation; Italian Association for Cancer Research (AIRC); NATIONAL CANCER INSTITUTE [P50CA083638, R01CA142776] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Kay Ash Charitable Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ovarian Cancer Research Found (LZ), NCI Ovarian Cancer SPORE P50-CA83638 (Career Development Award, LZ), American Cancer Society IRG-78-002-30 (LZ), and Mary Kay Ash Charitable Foundation (LZ). DK was partly supported by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chodankar R, 2005, CURR BIOL, V15, P561, DOI 10.1016/j.cub.2005.01.052; Connolly DC, 2003, CANCER RES, V63, P1389; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu LM, 2005, CLIN CANCER RES, V11, P8208, DOI 10.1158/1078-0432.CCR-05-0206; Hu LM, 2002, CANCER RES, V62, P1087; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JIA S, 2008, NATURE; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Parsons R, 2005, CLIN CANCER RES, V11, P7965, DOI 10.1158/1078-0432.CCR-05-1681; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; Suzuki S, 2000, CANCER RES, V60, P5382; Teixeira J, 2001, ENDOCR REV, V22, P657, DOI 10.1210/er.22.5.657; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2003, CANCER RES, V63, P4225; Zhang L, 2003, CANCER RES, V63, P3403; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4295	10.1371/journal.pone.0004295	http://dx.doi.org/10.1371/journal.pone.0004295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172191	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482900010
J	Langmesser, S; Franken, P; Feil, S; Emmenegger, Y; Albrecht, U; Feil, R				Langmesser, Sonja; Franken, Paul; Feil, Susanne; Emmenegger, Yann; Albrecht, Urs; Feil, Robert			cGMP-Dependent Protein Kinase Type I Is Implicated in the Regulation of the Timing and Quality of Sleep and Wakefulness	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EYE-MOVEMENT SLEEP; MALE-MICE LACKING; SUPRACHIASMATIC NUCLEUS; RAT; GENE; BRAIN; EXPRESSION; INHIBITOR; FRAGMENTATION	Many effects of nitric oxide (NO) are mediated by the activation of guanylyl cyclases and subsequent production of the second messenger cyclic guanosine-3',5'-monophosphate (cGMP). cGMP activates cGMP-dependent protein kinases (PRKGs), which can therefore be considered downstream effectors of NO signaling. Since NO is thought to be involved in the regulation of both sleep and circadian rhythms, we analyzed these two processes in mice deficient for cGMP-dependent protein kinase type I (PRKG1) in the brain. Prkg1 mutant mice showed a strikingly altered distribution of sleep and wakefulness over the 24 hours of a day as well as reductions in rapid-eye-movement sleep (REMS) duration and in non-REM sleep (NREMS) consolidation, and their ability to sustain waking episodes was compromised. Furthermore, they displayed a drastic decrease in electroencephalogram (EEG) power in the delta frequency range (1-4 Hz) under baseline conditions, which could be normalized after sleep deprivation. In line with the re-distribution of sleep and wakefulness, the analysis of wheel-running and drinking activity revealed more rest bouts during the activity phase and a higher percentage of daytime activity in mutant animals. No changes were observed in internal period length and phase-shifting properties of the circadian clock while chi-squared periodogram amplitude was significantly reduced, hinting at a less robust oscillator. These results indicate that PRKG1 might be involved in the stabilization and output strength of the circadian oscillator in mice. Moreover, PRKG1 deficiency results in an aberrant pattern, and consequently a reduced quality, of sleep and wakefulness, possibly due to a decreased wake-promoting output of the circadian system impinging upon sleep.	[Albrecht, Urs] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland; [Franken, Paul; Emmenegger, Yann] Univ Lausanne, Ctr Integrative Genom, CH-1015 Lausanne, Switzerland; [Feil, Susanne; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72074 Tubingen, Germany	University of Fribourg; University of Lausanne; Eberhard Karls University of Tubingen	Langmesser, S (corresponding author), Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011; Feil, Susanne/AAF-7032-2019; Feil, Robert/B-8918-2014; Franken, Paul/A-9633-2018	Albrecht, Urs/0000-0002-0663-8676; Feil, Robert/0000-0002-7335-4841; Franken, Paul/0000-0002-2500-2921	University of Lausanne [3100A0-111974]; NIH [MH67752]; Universitat Tubingen [1774-0-0]; Deutsche Forschungsgemeinschaft; VolkswagenStiftung; Swiss National Science Foundation [3100A0-115984]; State of Fribourg; FP6 Integrated Programm EUCLOCK; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067752] Funding Source: NIH RePORTER	University of Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universitat Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Fribourg; FP6 Integrated Programm EUCLOCK; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	PF was supported by the University of Lausanne, an SNSF grant (3100A0-111974) and an NIH grant (MH67752). SF: Dr. Karl Kuhn-Stiftung and fortune-Programm der Medizinischen Fakultat der Universitat Tubingen (grant #1774-0-0). RF: Deutsche Forschungsgemeinschaft and VolkswagenStiftung. UA: Swiss National Science Foundation (3100A0-115984), State of Fribourg and FP6 Integrated Programm EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2007, P NATL ACAD SCI USA, V104, P9834, DOI 10.1073/pnas.0703388104; Aschoff, 1965, CIRCADIAN CLOCKS, P95; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; Burlet S, 1997, NEUROSCI LETT, V226, P131, DOI 10.1016/S0304-3940(97)00247-4; Burlet S, 1999, NEUROSCIENCE, V92, P627, DOI 10.1016/S0306-4522(99)00031-7; Cavas M, 2006, PROG NEURO-PSYCHOPH, V30, P56, DOI 10.1016/j.pnpbp.2005.06.013; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; Cudeiro J, 2000, SLEEP, V23, P829; Dzoljic MR, 1996, BRAIN RES, V718, P145, DOI 10.1016/0006-8993(96)00102-3; Easton A, 2004, SLEEP, V27, P1307, DOI 10.1093/sleep/27.7.1307; EDGAR DM, 1993, J NEUROSCI, V13, P1065; El-Husseini AED, 1999, J CHEM NEUROANAT, V17, P45, DOI 10.1016/S0891-0618(99)00023-X; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Hars B, 1999, BRAIN RES, V816, P209, DOI 10.1016/S0006-8993(98)01183-4; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kalinchuk AV, 2006, J NEUROCHEM, V99, P483, DOI 10.1111/j.1471-4159.2006.04077.x; KAPAS L, 1994, BRAIN RES, V664, P189, DOI 10.1016/0006-8993(94)91969-0; Kapas L, 1996, BRAIN RES BULL, V41, P293, DOI 10.1016/S0361-9230(96)00227-4; Kriegsfeld LJ, 2001, J BIOL RHYTHM, V16, P142, DOI 10.1177/074873001129001845; Kriegsfeld LJ, 1999, J BIOL RHYTHM, V14, P20, DOI 10.1177/074873099129000407; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Lax P, 1998, AM J PHYSIOL-REG I, V275, pR580, DOI 10.1152/ajpregu.1998.275.2.R580; Marino J, 2003, J NEUROSCI, V23, P4299; McKenna JT, 2007, NEUROSCIENCE, V146, P1462, DOI 10.1016/j.neuroscience.2007.03.009; Mongrain V, 2007, SLEEP, V30, P773, DOI 10.1093/sleep/30.6.773; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Obal F, 2003, FRONT BIOSCI-LANDMRK, V8, pD520, DOI 10.2741/1033; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Perlis ML, 2001, J SLEEP RES, V10, P93, DOI 10.1046/j.1365-2869.2001.00247.x; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Revermann M, 2002, NEUROSCI LETT, V334, P119, DOI 10.1016/S0304-3940(02)01118-7; Ribeiro AC, 2005, AM J PHYSIOL-REG I, V289, pR521, DOI 10.1152/ajpregu.00605.2004; Ribeiro AC, 2005, BRAIN RES, V1049, P25, DOI 10.1016/j.brainres.2005.04.067; Ribeiro AC, 2000, AM J PHYSIOL-REG I, V278, pR1048, DOI 10.1152/ajpregu.2000.278.4.R1048; Rosenwasser AM, 2005, ALCOHOL, V36, P69, DOI 10.1016/j.alcohol.2005.07.001; Schlossmann J, 2003, ANN MED, V35, P21, DOI 10.1080/07853890310004093; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Williams JA, 1997, J NEUROSCI, V17, P420, DOI 10.1523/JNEUROSCI.17-01-00420.1997; Zhdanova IV, 1999, J BIOL RHYTHM, V14, P307, DOI 10.1177/074873099129000722	58	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4238	10.1371/journal.pone.0004238	http://dx.doi.org/10.1371/journal.pone.0004238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156199	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482100010
J	Benetkiewicz, M; Idbaih, A; Cousin, PY; Boisselier, B; Marie, Y; Criniere, E; Hoang-Xuan, K; Delattre, JY; Sanson, M; Delattre, O				Benetkiewicz, Magdalena; Idbaih, Ahmed; Cousin, Pierre-Yves; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc; Delattre, Olivier			NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas	PLOS ONE			English	Article							DNA HYPOMETHYLATION; ALLELIC LOSSES; 19Q; 1P; SURVIVAL; REGIONS; TRANSLOCATIONS; ASTROCYTOMAS; CHROMOSOME-1; PREDICTORS	The combined deletion of 1p and 19q chromosomal arms is frequent in oligodendrogliomas (OD) and has recently been shown to be mediated by an unbalanced t(1; 19) translocation. Recent studies of 1p/19q co-deleted OD suggest that the NOTCH2 gene is implicated in oligodendrocyte differentiation and may be involved in this rearrangement. The objective of the present study was to analyze the NOTCH2 locus either as a chromosomal translocation locus that may be altered by the 1p/19q recurrent rearrangement or as a gene that may be inactivated by a two hit process. We performed an array-CGH analysis of 15 ODs presenting 1p/19q co-deletion using a high-density oligonucleotide microarray spanning 1p and 19q pericentromeric regions with 377 bp average probe spacing. We showed that the 1p deletion extends to the centromere of chromosome 1 and includes the entire NOTCH2 gene. No internal rearrangement of this gene was observed. This strongly suggests that the t(1; 19) translocation does not lead to an abnormal NOTCH2 structure. The analysis of the entire NOTCH2 coding sequence was performed in four cases and did not reveal any mutation therefore indicating that NOTCH2 does not harbor genetic characteristics of a tumor suppressor gene. Finally, the detailed analysis of chromosome 19 pericentromeric region led to the identification of two breakpoint clusters at 19p12 and 19q11-12. Interestingly, these two regions share a large stretch of homology. Together with previous observations of similarities between chromosome 1 and 19 alphoid sequences, this suggests that the t(1; 19) translocation arises from complex intra and interchromosomal rearrangements. This is the first comprehensive deletion mapping by high density oligo-array of the 1p/19q co-deletion in oligodendroglioma tumors using a methodological approach superior to others previously applied. As such this paper provides clear evidence that the NOTCH2 gene is not physically rearranged by t(1; 19) translocation of oligodendroglioma tumors.	[Benetkiewicz, Magdalena; Cousin, Pierre-Yves; Delattre, Olivier] INSERM, U830, Paris, France; [Benetkiewicz, Magdalena; Cousin, Pierre-Yves; Delattre, Olivier] Inst Curie, Sect Rech, Unite Genet Biol Canc, Paris, France; [Idbaih, Ahmed; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] INSERM, Grp Hosp Pitie Salpetriere, Unite 711, Paris, France; [Idbaih, Ahmed; Boisselier, Blandine; Marie, Yannick; Criniere, Emmanuelle; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] Univ Paris 06, Lab Biol Interact Neurone Glie, Grp Hosp Pitie Salpetriere, Paris, France; [Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves; Sanson, Marc] AP HP, Grp Hosp Pitie Salpetriere, Serv Neurol Mazarin, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Benetkiewicz, M (corresponding author), INSERM, U830, Paris, France.	Olivier.Delattre@curie.fr	BOISSELIER, Blandine/K-4377-2015; Hoang-Xuan, Khe/O-7527-2017; Idbaih, Ahmed/N-8746-2017	delattre, olivier/0000-0002-8730-2276; Idbaih, Ahmed/0000-0001-5290-1204	Canceropole Ile-de-France [fellowship]; INCa; INSERM; Ligue Nationale Contre le Cancer (Equipe Labellisee); Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer	Canceropole Ile-de-France(Region Ile-de-France); INCa(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer	Magdalena Benetkiewicz is supported by a fellowship from Canceropole Ile-de-France. This work was supported by grants from the INCa, the INSERM and the Ligue Nationale Contre le Cancer (Equipe Labellisee). The BAC-array was supported by grant from the Carte d'Identite des Tumeurs (CIT) program of the Ligue Nationale Contre le Cancer.	Abrey LE, 2006, NEURO-ONCOLOGY, V8, P183, DOI 10.1215/15228517-2005-009; Al-Taie OH, 2002, EUR J HUM GENET, V10, P499, DOI 10.1038/sj.ejhg.5200811; BALDINI A, 1989, GENOMICS, V5, P822, DOI 10.1016/0888-7543(89)90124-9; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; BLANCO B, 1994, J MED GENET, V31, P74, DOI 10.1136/jmg.31.1.74; Boulay JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000576; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; DiazCastanos L, 1997, GENET COUNSEL, V8, P33; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2003, CANCER GENET CYTOGEN, V141, P97, DOI 10.1016/S0165-4608(02)00668-4; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hoang-Xuan K, 2001, NEUROLOGY, V57, P1278, DOI 10.1212/WNL.57.7.1278; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jeuken JWM, 2004, J NEURO-ONCOL, V70, P161, DOI 10.1007/s11060-004-2748-1; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Sawyer JR, 1998, BLOOD, V91, P1732, DOI 10.1182/blood.V91.5.1732.1732_1732_1741; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Tsuda H, 2002, AM J PATHOL, V161, P859, DOI 10.1016/S0002-9440(10)64246-0; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4107	10.1371/journal.pone.0004107	http://dx.doi.org/10.1371/journal.pone.0004107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119320	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472600007
J	Hashiguchi, Y; Furuta, Y; Nishida, M				Hashiguchi, Yasuyuki; Furuta, Yoshimi; Nishida, Mutsumi			Evolutionary Patterns and Selective Pressures of Odorant/Pheromone Receptor Gene Families in Teleost Fishes	PLOS ONE			English	Article							CHEMOSENSORY RECEPTORS; VOMERONASAL; ODORANT; RECOGNITION; REPERTOIRE; POLYAMINES; PEPTIDES; SYSTEM; MAIN	Background: Teleost fishes do not have a vomeronasal organ (VNO), and their vomeronasal receptors (V1Rs, V2Rs) are expressed in the main olfactory epithelium (MOE), as are odorant receptors (ORs) and trace amine-associated receptors (TAARs). In this study, to obtain insights into the functional distinction among the four chemosensory receptor families in teleost fishes, their evolutionary patterns were examined in zebrafish, medaka, stickleback, fugu, and spotted green pufferfish. Methodology/Principal Findings: Phylogenetic analysis revealed that many lineage-specific gene gains and losses occurred in the teleost fish TAARs, whereas only a few gene gains and losses have taken place in the teleost fish vomeronasal receptors. In addition, synonymous and nonsynonymous nucleotide substitution rate ratios (K-A/K-S) in TAARs tended to be higher than those in ORs and V2Rs. Conclusions/Significance: Frequent gene gains/losses and high K-A/K-S in teleost TAARs suggest that receptors in this family are used for detecting some species-specific chemicals such as pheromones. Conversely, conserved repertoires of V1R and V2R families in teleost fishes may imply that receptors in these families perceive common odorants for teleosts, such as amino acids. Teleost ORs showed intermediate evolutionary pattern between TAARs and vomeronasal receptors. Many teleost ORs seem to be used for common odorants, but some ORs may have evolved to recognize lineage-specific odors.	[Hashiguchi, Yasuyuki; Furuta, Yoshimi; Nishida, Mutsumi] Univ Tokyo, Ocean Res Inst, Div Mol Marine Biol, Tokyo, Japan	University of Tokyo	Hashiguchi, Y (corresponding author), Univ Tokyo, Ocean Res Inst, Div Mol Marine Biol, Tokyo, Japan.	yhashi@ori.u-tokyo.ac.jp	Hashiguchi, Yasuyuki/AAA-4179-2019		Japan Society for Promotion of Science [19207707]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors are supported by Grant-in-Aid from the Japan Society for Promotion of Science (no. 19207707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Asano-Miyoshi M, 2000, J BIOCHEM, V127, P915, DOI 10.1093/oxfordjournals.jbchem.a022687; Baxi KN, 2006, TRENDS NEUROSCI, V29, P1, DOI 10.1016/j.tins.2005.10.002; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Hansen A, 2003, J NEUROSCI, V23, P9328; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Hashiguchi Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-76; Hubbard PC, 2003, CHEM SENSES, V28, P207, DOI 10.1093/chemse/28.3.207; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Michel WC, 2003, J EXP BIOL, V206, P1697, DOI 10.1242/jeb.00339; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; NEI M, 1986, MOL BIOL EVOL, V3, P418; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Rafferty NE, 2006, BEHAV ECOL, V17, P965, DOI 10.1093/beheco/arl030; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Sorensen PW, 2005, CHEM SENSES, V30, pI315, DOI 10.1093/chemse/bjh241; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29	29	37	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4083	10.1371/journal.pone.0004083	http://dx.doi.org/10.1371/journal.pone.0004083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116654	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466600006
J	Smith, L; Willan, J; Warr, N; Brook, FA; Cheeseman, M; Sharpe, R; Siggers, P; Greenfield, A				Smith, Lee; Willan, John; Warr, Nick; Brook, Frances A.; Cheeseman, Michael; Sharpe, Richard; Siggers, Pam; Greenfield, Andy			The Maestro (Mro) Gene Is Dispensable for Normal Sexual Development and Fertility in Mice	PLOS ONE			English	Article								The mammalian gonad arises as a bipotential primordium from which a testis or ovary develops depending on the chromosomal sex of the individual. We have previously used DNA microarrays to screen for novel genes controlling the developmental fate of the indifferent embryonic mouse gonad. Maestro (Mro), which encodes a HEAT-repeat protein, was originally identified as a gene exhibiting sexually dimorphic expression during mouse gonad development. Wholemount in situ hybridisation analysis revealed Mro to be expressed in the embryonic male gonad from approximately 11.5 days post coitum, prior to overt sexual differentiation. No significant expression was detected in female gonads at the same developmental stage. In order to address its physiological function, we have generated mice lacking Maestro using gene targeting. Male and female mice homozygous for a Mro null allele are viable and fertile. We examined gonad development in homozygous male embryos in detail and observed no differences when compared to wild-type controls. Immunohistochemical analysis of homozygous mutant testes of adult mice revealed no overt abnormalities. Expression profiling using DNA microarrays also indicated no significant differences between homozygote embryonic male gonads and controls. We conclude that Maestro is dispensable for normal male sexual development and fertility in laboratory mice; however, the Mro locus itself does have utility as a site for insertion of transgenes for future studies in the fields of sexual development and Sertoli cell function.	[Smith, Lee; Willan, John; Warr, Nick; Cheeseman, Michael; Siggers, Pam; Greenfield, Andy] MRC Harwell, Mammal Genet Unit, Oxford, England; [Brook, Frances A.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England; [Sharpe, Richard] Queens Med Res Inst, MRC Human Reproduct Sci Unit, Edinburgh, Midlothian, Scotland	MRC Harwell; University of Oxford; University of Edinburgh	Smith, L (corresponding author), Queens Med Res Inst, MRC Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	l.smith@hrsu.mrc.ac.uk	Sharpe, Richard M/D-2725-2013; willan, john/ABD-8708-2020; Willan, John/AAP-7309-2020; Smith, Lee B/J-4861-2013; Greenfield, Andy/F-5099-2017	Sharpe, Richard M/0000-0003-1686-8085; Willan, John/0000-0001-8700-2073; Warr, Nick/0000-0003-0767-1360; Smith, Lee/0000-0002-4103-3074; Greenfield, Andy/0000-0002-1477-1776	UK Medical Research Council [U.1426.00.004.00001.01]; MRC [MC_UP_1502/1, MC_U142670371, MC_U127685841, MC_U142684167] Funding Source: UKRI; Medical Research Council [MC_UP_1502/1, MC_U142684167, MC_U142670371, MC_U127685841] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council through Unit funding to AG (ref# U.1426.00.004.00001.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Scherer G, 2002, NOVART FDN SYMP, V244, P225; Siggers P, 2002, MECH DEVELOP, V111, P159, DOI 10.1016/S0925-4773(01)00602-5; Smith L, 2003, DEV DYNAM, V227, P600, DOI 10.1002/dvdy.10342; Smith L, 2003, HUM MOL GENET, V12, pR1, DOI 10.1093/hmg/ddg053; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4091	10.1371/journal.pone.0004091	http://dx.doi.org/10.1371/journal.pone.0004091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116663	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600012
J	Eagle, RA; Flack, G; Warford, A; Martinez-Borra, J; Jafferji, I; Traherne, JA; Ohashi, M; Boyle, LH; Barrow, AD; Caillat-Zucman, S; Young, NT; Trowsdale, J				Eagle, Robert A.; Flack, Gillian; Warford, Anthony; Martinez-Borra, Jesus; Jafferji, Insiya; Traherne, James A.; Ohashi, Maki; Boyle, Louise H.; Barrow, Alexander D.; Caillat-Zucman, Sophie; Young, Neil T.; Trowsdale, John			Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G	PLOS ONE			English	Article							I-RELATED CHAIN; DOWN-REGULATION; NKG2D RECEPTOR; NK CELLS; T-CELLS; NATURAL CYTOTOXICITY; KILLER-CELLS; MIC LIGANDS; TUMOR; GENE	Background: The activating immunoreceptor NKG2D is expressed on Natural Killer (NK) cells and subsets of T cells. NKG2D contributes to anti-tumour and anti-viral immune responses in vitro and in vivo. The ligands for NKG2D in humans are diverse proteins of the MIC and ULBP/RAET families that are upregulated on the surface of virally infected cells and tumours. Two splicing variants of ULBP5/RAET1G have been cloned previously, but not extensively characterised. Methodology/Principal Findings: We pursue a number of approaches to characterise the expression, trafficking, and function of the two isoforms of ULBP5/RAET1G. We show that both transcripts are frequently expressed in cell lines derived from epithelial cancers, and in primary breast cancers. The full- length transcript, RAET1G1, is predicted to encode a molecule with transmembrane and cytoplasmic domains that are unique amongst NKG2D ligands. Using specific anti- RAET1G1 antiserum to stain tissue microarrays we show that RAET1G1 expression is highly restricted in normal tissues. RAET1G1 was expressed at a low level in normal gastrointestinal epithelial cells in a similar pattern to MICA. Both RAET1G1 and MICA showed increased expression in the gut of patients with celiac disease. In contrast to healthy tissues the RAET1G1 antiserum stained a wide variety or different primary tumour sections. Both endogenously expressed and transfected RAET1G1 was mainly found inside the cell, with a minority of the protein reaching the cell surface. Conversely the truncated splicing variant of RAET1G2 was shown to encode a solublemolecule that could be secreted from cells. Secreted RAET1G2 was shown to downregulate NKG2D receptor expression on NK cells and hence may represent a novel tumour immune evasion strategy. Conclusions/Significance: We demonstrate that the expression patterns of ULBP5RAET1G are very similar to the well-characterised NKG2D ligand, MICA. However the two isoforms of ULBP5/RAET1G have very different cellular localisations that are likely to reflect unique functionality.	[Eagle, Robert A.; Martinez-Borra, Jesus; Jafferji, Insiya; Traherne, James A.; Ohashi, Maki; Boyle, Louise H.; Barrow, Alexander D.; Trowsdale, John] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Flack, Gillian; Warford, Anthony] Wellcome Trust Sanger Inst, Atlas Protein Express Grp, Hinxton, England; [Caillat-Zucman, Sophie] Hop St Vincent De Paul, INSERM, U561, AVENIR Team, Paris, France; [Young, Neil T.] Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England; [Eagle, Robert A.] CALTECH, MC170 25, Pasadena, CA 91125 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; California Institute of Technology	Eagle, RA (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge, England.	robeagle@caltech.edu	Boyle, Louise/AFU-1885-2022; Eagle, Robert/A-2679-2011	Barrow, Alexander/0000-0001-5833-0537; Eagle, Robert/0000-0003-0304-6111; Boyle, Louise/0000-0002-3105-6555; Caillat-Zucman, Sophie/0000-0002-4535-3550	Cancer Research UK; The Isaac Newton Trust; The Leukaemia Research Fund; The Wellcome Trust; Medical Research Council [G9800943] Funding Source: researchfish; MRC [G9800943] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); The Isaac Newton Trust; The Leukaemia Research Fund; The Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is funded by grants from Cancer Research UK and The Isaac Newton Trust to RAE, The Leukaemia Research Fund to NTY, and The Wellcome Trust to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bahram S, 2005, CURR OPIN IMMUNOL, V17, P505, DOI 10.1016/j.coi.2005.07.016; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Boyle LH, 2007, J NEUROCHEM, V102, P1853, DOI 10.1111/j.1471-4159.2007.04687.x; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cao W, 2008, INT IMMUNOL, V20, P981, DOI 10.1093/intimm/dxn057; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Coudert JD, 2006, SEMIN CANCER BIOL, V16, P333, DOI 10.1016/j.semcancer.2006.07.008; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Fuertes MB, 2008, J IMMUNOL, V180, P4606, DOI 10.4049/jimmunol.180.7.4606; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; GUERRA N, 2008, IMMUNITY, V28, P492; HALE G, 1993, J REPROD IMMUNOL, V23, P189, DOI 10.1016/0165-0378(93)90007-5; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hue S, 2003, J IMMUNOL, V171, P1909, DOI 10.4049/jimmunol.171.4.1909; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Pende D, 2002, CANCER RES, V62, P6178; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; STUART AE, 1983, J CLIN PATHOL, V36, P1176, DOI 10.1136/jcp.36.10.1176; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104	55	33	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4503	10.1371/journal.pone.0004503	http://dx.doi.org/10.1371/journal.pone.0004503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223974	Green Published, gold, Green Accepted			2022-12-27	WOS:000265485800009
J	Song, R; Qian, F; Li, YP; Sheng, X; Cao, SX; Xu, Q				Song, Ran; Qian, Feng; Li, Yu-Pei; Sheng, Xia; Cao, Shao-Xian; Xu, Qiang			Phosphatase of Regenerating Liver-3 Localizes to Cyto-Membrane and Is Required for B16F1 Melanoma Cell Metastasis In Vitro and In Vivo	PLOS ONE			English	Article								Background: Phosphatase of regenerating liver-3 (PRL-3) is a member of the novel phosphatases of regenerating liver family, characterized by one protein tyrosine phosphatase active domain and a C-terminal prenylation (CCVM) motif. Though widely proposed to facilitate metastasis in many cancer types, PRL-3's cellular localization and the function of its CCVM motif in metastatic process remain unknown. Methodology/Principal Findings: In the present study, a series of Myc tagged PRL-3 wild type or mutant plasmids were expressed in B16F1 melanoma cells to investigate the relationship between PRL-3's cellular localization and metastasis. With immuno-fluorescence microcopy and cell adhesion/migration assay in vitro, and an experimental passive metastasis model in vivo, we found that CCVM motif is critical for the localization of PRL-3 on cell plasma membrane and the lung metastasis of melanoma. In particular, Cystine 170 is the key site for prenylation in this process. Conclusions/Significance: These results suggest that cellular localization of PRL-3 is highly correlated with its function in tumor metastasis, and inhibition of PRL-3 prenylation might be a new approach to cancer therapy.	[Song, Ran; Qian, Feng; Li, Yu-Pei; Sheng, Xia; Cao, Shao-Xian; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Song, R (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	molpharm@163.com			National Natural Science Foundation of China [30500619]; Natural Science Foundation of Jiangsu Province, China [BK2007716, BK2008022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (No. 30500619) and the Natural Science Foundation of Jiangsu Province, China (No. BK2007716 and No. BK2008022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; BOS JL, 1989, CANCER RES, V49, P4682; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi JK, 2000, MOL VIS, V6, P222; de Bono JS, 2003, SEMIN ONCOL, V30, P79, DOI 10.1053/j.seminoncol.2003.08.010; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Heiskanen MA, 2000, CANCER RES, V60, P799; Kim KA, 2004, FEBS LETT, V565, P181, DOI 10.1016/j.febslet.2004.03.062; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Peng LR, 2006, BIOCHEM BIOPH RES CO, V342, P179, DOI 10.1016/j.bbrc.2006.01.102; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zhang XM, 2001, CLIN EXP METASTAS, V18, P415, DOI 10.1023/A:1010960615370	28	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4450	10.1371/journal.pone.0004450	http://dx.doi.org/10.1371/journal.pone.0004450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214221	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484300005
J	Flierl, MA; Rittirsch, D; Nadeau, BA; Sarma, JV; Day, DE; Lentsch, AB; Huber-Lang, MS; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Sarma, J. Vidya; Day, Danielle E.; Lentsch, Alex B.; Huber-Lang, Markus S.; Ward, Peter A.			Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response	PLOS ONE			English	Article								Following our recent report that phagocytic cells (neutrophils, PMNs, and macrophages) are newly discovered sources of catecholamines, we now show that both epinephrine and norepinephrine directly activate NF kappa B in macrophages, causing enhanced release of proinflammatory cytokines (TNF alpha, IL-1 beta, IL-6). Both adrenal-intact (AD+) and adrenalectomized (ADX) rodents were used, because ADX animals had greatly enhanced catecholamine release from phagocytes, facilitating our efforts to understand the role of catecholamines released from phagocytes. Phagocytes isolated from adrenalectomized rats displayed enhanced expression of tyrosine-hydroxylase and dopamine-beta-hydroxylase, two key enzymes for catecholamine production and exhibited higher baseline secretion of norepinephrine and epinephrine. The effects of upregulation of phagocyte-derived catecholamines were investigated in two models of acute lung injury (ALI). Increased levels of phagocyte-derived catecholamines were associated with intensification of the acute inflammatory response, as assessed by increased plasma leak of albumin, enhanced myeloperoxidase content in lungs, augmented levels of proinflammatory mediators in bronchoalveolar lavage fluids, and elevated expression of pulmonary ICAM-1 and VCAM-1. In adrenalectomized rats, development of ALI was enhanced and related to alpha(2)-adrenoceptors engagement but not to involvement of mineralocorticoid or glucocorticoid receptors. Collectively, these data demonstrate that catecholamines are potent inflammatory activators of macrophages, upregulating NF kappa B and further downstream cytokine production of these cells. In adrenalectomized animals, which have been used to further assess the role of catecholamines, there appears to be a compensatory increase in catecholamine generating enzymes and catecholamines in macrophages, resulting in amplification of the acute inflammatory response via engagement of alpha(2)-adrenoceptors.	[Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Sarma, J. Vidya; Day, Danielle E.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Lab Trauma, Sepsis & Inflammat Res, Cincinnati, OH 45221 USA; [Huber-Lang, Markus S.] Univ Ulm, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-89069 Ulm, Germany	University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; Ulm University	Flierl, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431	NIH [GM29507, GM61656, HL-31963, DK56029, AG025881]; Deutsche Forschungsgemeinschaft [HU 823/2-2, HU 823/2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH grants GM29507, GM61656 and HL-31963 (P.A.W.), NIH grants DK56029 and AG025881 (A.B.L.) and Deutsche Forschungsgemeinschaft grants HU 823/2-2 and HU 823/2-3 (M.H.-L.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN KD, 1991, BRAIN BEHAV IMMUN, V5, P235, DOI 10.1016/0889-1591(91)90021-2; BENSCHOP RJ, 1994, CIRCULATION, V89, P762, DOI 10.1161/01.CIR.89.2.762; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 1997, ELECTROPHORESIS, V18, P1760, DOI 10.1002/elps.1150181009; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; BUU NT, 1993, J NEUROCHEM, V61, P1557, DOI 10.1111/j.1471-4159.1993.tb13656.x; CHELMICKASCHORR E, 1988, J NEUROIMMUNOL, V17, P347, DOI 10.1016/0165-5728(88)90125-7; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; FARAJ BA, 1995, BIOCHEM PHARMACOL, V50, P1007, DOI 10.1016/0006-2952(95)00230-W; FARAJ BA, 1991, PHARMACOLOGY, V42, P135, DOI 10.1159/000138790; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Kradin R, 2001, EXP MOL PATHOL, V70, P1, DOI 10.1006/exmp.2000.2342; Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786; Lentsch AB, 2001, RESP PHYSIOL, V128, P17, DOI 10.1016/S0034-5687(01)00260-2; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; MADDEN K S, 1989, Brain Behavior and Immunity, V3, P72, DOI 10.1016/0889-1591(89)90007-X; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Maestroni GJM, 2003, J NEUROIMMUNOL, V144, P91, DOI 10.1016/j.jneuroim.2003.08.039; Marino F, 1999, EXP HEMATOL, V27, P489, DOI 10.1016/S0301-472X(98)00057-5; Morken JJ, 2002, SHOCK, V18, P46, DOI 10.1097/00024382-200207000-00009; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Ozturk H, 2007, INT UROL NEPHROL, V39, P267, DOI 10.1007/s11255-006-0074-6; Rudolph AE, 2000, MOL CELL ENDOCRINOL, V165, P221, DOI 10.1016/S0303-7207(00)00258-6; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; SPENGLER RN, 1994, J IMMUNOL, V152, P3024; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 1996, AM J PATHOL, V149, P1079; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791	42	114	120	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4414	10.1371/journal.pone.0004414	http://dx.doi.org/10.1371/journal.pone.0004414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212441	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200001
J	Koehncke, A; Telschow, A; Werren, JH; Hammerstein, P				Koehncke, Arnulf; Telschow, Arndt; Werren, John H.; Hammerstein, Peter			Life and Death of an Influential Passenger: Wolbachia and the Evolution of CI-Modifiers by Their Hosts	PLOS ONE			English	Article								Background: Wolbachia are intracellular bacteria widely distributed among arthropods and nematodes. In many insect species these bacteria induce a cytoplasmic incompatibility (CI) between sperm of infected males and eggs of uninfected females. From an evolutionary point of view, CI is puzzling: In order to induce this modification-rescue system, Wolbachia affect sperm of infected males even though Wolbachia are only transmitted maternally. Phylogenetic studies of Wolbachia and hosts show that the bacteria rarely cospeciate with their hosts, indicating that infections are lost in host species. However, the mechanisms leading to Wolbachia loss are not well understood. Results: Using a population genetic model, we investigate the spread of host mutants that enhance or repress Wolbachia action by affecting either bacterial transmission or the level of CI. We show that host mutants that decrease CI-levels in males (e.g. by reducing Wolbachia-density during spermatogenesis) spread, even at cost to mutant males. Increase of these mutants can lead to loss of Wolbachia infections, either as a direct consequence of their increase or in a step-wise manner, and we derive analytically a threshold penetrance above which a mutation's spread leads to extinction of Wolbachia. Selection on host modifiers is sexually antagonistic in that, conversely, host mutants that enhance Wolbachia in females are favoured whereas suppressors are not. Conclusions: Our results indicate that Wolbachia is likely to be lost from host populations on long evolutionary time scales due to reduction of CI levels in males. This can occur either by evolution of single host modifiers with large effects or through accumulation of several modifier alleles with small effects on Wolbachia action, even at cost to mutant males and even if infected hosts do not incur fecundity costs. This possibility is consistent with recent findings and may help to explain the apparent short evolutionary persistence times of Wolbachia in many host systems.	[Koehncke, Arnulf; Hammerstein, Peter] Humboldt Univ, Biol Therapy Inst, Berlin, Germany; [Telschow, Arndt] Kyoto Univ, Ctr Ecol Res, Kyoto, Japan; [Telschow, Arndt] Univ Munster, Inst Evolut & Biodivers, D-4400 Munster, Germany; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Humboldt University of Berlin; Kyoto University; University of Munster; University of Rochester	Koehncke, A (corresponding author), Humboldt Univ, Biol Therapy Inst, Berlin, Germany.	arnulf.koehncke@biologie.hu-berlin.de	Koehncke, Arnulf/A-2839-2011	Werren, John/0000-0001-9353-2070; Kohncke, Arnulf/0000-0002-4104-0477	U.S. NSF [EF0328363]; Japanese Society for the Promotion of Science (JSPS); Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 618]; German National Merit Foundation	U.S. NSF(National Science Foundation (NSF)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Merit Foundation	Contributions of JHW were supported by the U.S. NSF grant EF0328363, those of AT by the Japanese Society for the Promotion of Science (JSPS) and the Volkswagenstiftung, and those of PH and AK by the Deutsche Forschungsgemeinschaft (SFB 618). AK received additional support from the German National Merit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BREEUWER JAJ, 1993, GENETICS, V135, P565; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; CAVALCANTI AGL, 1957, NUCL GENES CYTOPLASM, V91, P327; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Charlat S, 2006, CURR BIOL, V16, P2453, DOI 10.1016/j.cub.2006.10.062; Charlat S, 2007, SCIENCE, V317, P214, DOI 10.1126/science.1143369; Clark ME, 2008, HEREDITY, V101, P420, DOI 10.1038/hdy.2008.71; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Clark ME, 2002, MECH DEVELOP, V111, P3, DOI 10.1016/S0925-4773(01)00594-9; Engelstadter J, 2004, J THEOR BIOL, V231, P345, DOI 10.1016/j.jtbi.2004.06.029; Engelstadter J, 2008, THEOR POPUL BIOL, V73, P125, DOI 10.1016/j.tpb.2007.08.004; Ferree PM, 2006, GENETICS, V173, P839, DOI 10.1534/genetics.105.053272; FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7; Hammerstein P, 1996, J MATH BIOL, V34, P511; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1990, GENETICS, V126, P933; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283; Hurst LD, 1996, P ROY SOC B-BIOL SCI, V263, P97, DOI 10.1098/rspb.1996.0016; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Maroja LS, 2008, HEREDITY, V101, P435, DOI 10.1038/hdy.2008.75; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Opijnen T, 2005, INSECT MOL BIOL, V14, P653, DOI 10.1111/j.1365-2583.2005.00595.x; RIGAUD T, 1992, HEREDITY, V68, P47, DOI 10.1038/hdy.1992.6; Serbus LR, 2007, PLOS PATHOG, V3, P1930, DOI 10.1371/journal.ppat.0030190; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Vala F, 2002, EVOLUTION, V56, P1331, DOI 10.1111/j.0014-3820.2002.tb01447.x; Vavre F, 2003, EVOLUTION, V57, P421; Vavre F, 2001, EVOLUTION, V55, P1710, DOI 10.1111/j.0014-3820.2001.tb00691.x; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	46	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4425	10.1371/journal.pone.0004425	http://dx.doi.org/10.1371/journal.pone.0004425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209229	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484100004
J	Andreotti, A; Minicuci, N; Kowal, P; Chatterji, S				Andreotti, Alessandra; Minicuci, Nadia; Kowal, Paul; Chatterji, Somnath			Multidimensional Profiles of Health Status: An Application of the Grade of Membership Model to the World Health Survey	PLOS ONE			English	Article							OLDER WOMEN; FRAILTY; CLASSIFICATION; DISABILITY; MORTALITY; PATTERNS	Background: The World Health Organization (WHO) conducted the World Health Survey (WHS) between 2002 and 2004 in 70 countries to provide cross-population comparable data on health, health-related outcomes and risk factors. The aim of this study was to apply Grade of Membership (GoM) modelling as a means to condense extensive health information from the WHS into a set of easily understandable health profiles and to assign the degree to which an individual belongs to each profile. Principal Findings: This paper described the application of the GoM models to summarize population health status using World Health Survey data. Grade of Membership analysis is a flexible, non-parametric, multivariate method, used to calculate health profiles from WHS self-reported health state and health conditions. The WHS dataset was divided into four country economic categories based on the World Bank economic groupings (high, upper-middle, lower-middle and low income economies) for separate GoM analysis. Three main health profiles were produced for each of the four areas: I. Robust; II. Intermediate; III. Frail; moreover population health, wealth and inequalities are defined for countries in each economic area as a means to put the health results into perspective. Conclusions: These analyses have provided a robust method to better understand health profiles and the components which can help to identify healthy and non-healthy individuals. The obtained profiles have described concrete levels of health and have clearly delineated characteristics of healthy and non-healthy respondents. The GoM results provided both a useable way of summarising complex individual health information and a selection of intermediate determinants which can be targeted for interventions to improve health. As populations' age, and with limited budgets for additional costs for health care and social services, applying the GoM methods may assist with identifying higher risk profiles for decision-making and resource allocations.	[Minicuci, Nadia] CNR, Inst Neurosci, Padova Sect, Padua, Italy; [Kowal, Paul; Chatterji, Somnath] WHO, HSI, Multi Country Stud Unit, Geneva, Switzerland	Consiglio Nazionale delle Ricerche (CNR); World Health Organization	Andreotti, A (corresponding author), CNR, Inst Neurosci, Padova Sect, Padua, Italy.	alessandra.andreotti@in.cnr.it	MINICUCI, NADIA/D-5237-2016; CHATTERJI, Somnath/ABE-6832-2020	MINICUCI, NADIA/0000-0002-0970-6531; Kowal, Paul/0000-0002-6314-8753				Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Andrew MK, 2008, AM J MED, V121, pE21, DOI 10.1016/j.amjmed.2007.09.017; [Anonymous], 2007, WORLD DEV IND DAT; BERKMAN L, 1989, DEMOGRAPHY, V26, P661, DOI 10.2307/2061264; Cassidy F, 2001, NEUROPSYCHOPHARMACOL, V25, P373, DOI 10.1016/S0893-133X(01)00223-8; Corder EH, 2001, ANN HUM GENET, V65, P387, DOI 10.1017/S0003480001008685; Decision System Inc., 1999, US DOC DSIGOM VERS 1; Deeg DJH, 2002, J WOMEN AGING, V14, P27, DOI 10.1300/J074v14n01_03; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Lamb VL, 1996, SOC SCI MED, V42, P363, DOI 10.1016/0277-9536(95)00146-8; Manton K.G., 1994, STAT APPL USING FUZZ; Manton KG, 2004, STAT METHODS MED RES, V13, P395, DOI 10.1191/0962280204sm374ra; MANTON KG, 1982, METHODS INFORM MED, V21; McNamee P, 2004, HEALTH ECON, V13, P379, DOI 10.1002/hec.833; Mitnitski AB, 2004, J GERONTOL A-BIOL, V59, P627, DOI 10.1093/gerona/59.6.M627; Nurnberg HG, 1999, COMPR PSYCHIAT, V40, P61, DOI 10.1016/S0010-440X(99)90079-2; Portrait F, 1999, HEALTH ECON, V8, P441, DOI 10.1002/(SICI)1099-1050(199908)8:5<441::AID-HEC452>3.0.CO;2-O; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Szadoczky E, 2003, J AFFECT DISORDERS, V77, P31, DOI 10.1016/S0165-0327(02)00096-4; Ustun TB., 2003, WORLD HLTH SURVEYS H; WHO(World Health Organization), 1946, CONST	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4426	10.1371/journal.pone.0004426	http://dx.doi.org/10.1371/journal.pone.0004426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JO	19204797	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484000014
J	Hulth, A; Rydevik, G; Linde, A				Hulth, Anette; Rydevik, Gustaf; Linde, Annika			Web Queries as a Source for Syndromic Surveillance	PLOS ONE			English	Article							OUTBREAKS; SEARCHES	In the field of syndromic surveillance, various sources are exploited for outbreak detection, monitoring and prediction. This paper describes a study on queries submitted to a medical web site, with influenza as a case study. The hypothesis of the work was that queries on influenza and influenza-like illness would provide a basis for the estimation of the timing of the peak and the intensity of the yearly influenza outbreaks that would be as good as the existing laboratory and sentinel surveillance. We calculated the occurrence of various queries related to influenza from search logs submitted to a Swedish medical web site for two influenza seasons. These figures were subsequently used to generate two models, one to estimate the number of laboratory verified influenza cases and one to estimate the proportion of patients with influenza-like illness reported by selected General Practitioners in Sweden. We applied an approach designed for highly correlated data, partial least squares regression. In our work, we found that certain web queries on influenza follow the same pattern as that obtained by the two other surveillance systems for influenza epidemics, and that they have equal power for the estimation of the influenza burden in society. Web queries give a unique access to ill individuals who are not (yet) seeking care. This paper shows the potential of web queries as an accurate, cheap and labour extensive source for syndromic surveillance.	[Hulth, Anette; Rydevik, Gustaf; Linde, Annika] Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden	Swedish Institute for Infectious Disease Control	Hulth, A (corresponding author), Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden.	anette.hulth@smi.se	Rydevik, Gustaf/I-7510-2019; Hulth, Anette/E-2162-2017	Hulth, Anette/0000-0002-3132-808X; Rydevik, Gustaf/0000-0002-5066-6092	Swedish Emergency Management Agency (Krisberedskapsmyndigheten)	Swedish Emergency Management Agency (Krisberedskapsmyndigheten)	The Swedish Emergency Management Agency (Krisberedskapsmyndigheten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2008, SCAND J PUBLIC HEALT, V36, P475, DOI 10.1177/1403494808089566; ARMITAGE P, 2005, ENCY BIOSTATISTICS, V2, P1323; Bork K H, 2006, Euro Surveill, V11, P229; Chapman WW, 2005, ARTIF INTELL MED, V33, P31, DOI 10.1016/j.artmed.2004.04.001; Das Debjani, 2005, MMWR Suppl, V54, P41; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fienberg SE, 2005, STAT MED, V24, P513, DOI 10.1002/sim.2032; GINSBERG J, 2008, NATURE          1119; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; JOHNSON HA, 2004, MEDINFO, V11, P1202; Jormanainen V, 2001, EMERG INFECT DIS, V7, P474, DOI 10.3201/eid0703.017324; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; MOSTASHARI F, 2003, J URBAN HLTH S1, V80, P43; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; R Core Team, 2018, R LANG ENV STAT COMP; Rolland E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-10; *SMI NAT INFL REF, INFL ANN REP 2006 20; Smith G E, 2006, Euro Surveill, V11, P220; *VARDG LABS, 2008, VAD TYCK ANV VARDG; WEHRENS R, 2007, JSS, V18; Wehrens R., 2007, PLS PARTIAL LEAST SQ; Zeng XM, 2002, J AM MED INFORM ASSN, V9, pS17, DOI 10.1197/jamia.M1219	24	134	140	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4378	10.1371/journal.pone.0004378	http://dx.doi.org/10.1371/journal.pone.0004378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197389	gold, Green Submitted, Green Published			2022-12-27	WOS:000265483700004
J	Bui, T; Sequeira, J; Wen, TC; Sola, A; Higashi, Y; Kondoh, H; Genetta, T				Bui, Thai; Sequeira, Judith; Wen, Tong Chun; Sola, Augusto; Higashi, Yujiro; Kondoh, Hisato; Genetta, Tom			ZEB1 Links p63 and p73 in a Novel Neuronal Survival Pathway Rapidly Induced in Response to Cortical Ischemia	PLOS ONE			English	Article								Background: Acute hypoxic/ischemic insults to the forebrain, often resulting in significant cellular loss of the cortical parenchyma, are a major cause of debilitating injury in the industrialized world. A clearer understanding of the pro-death/pro-survival signaling pathways and their downstream targets is critical to the development of therapeutic interventions to mitigate permanent neurological damage. Methodology/Principal Findings: We demonstrate here that the transcriptional repressor ZEB1, thought to be involved in regulating the timing and spatial boundaries of basic-Helix-Loop-Helix transactivator-mediated neurogenic determination/differentiation programs, functions to link a pro-survival transcriptional cascade rapidly induced in cortical neurons in response to experimentally induced ischemia. Employing histological, tissue culture, and molecular biological read-outs, we show that this novel pro-survival response, initiated through the rapid induction of p63, is mediated ultimately by the transcriptional repression of a pro-apoptotic isoform of p73 by ZEB1. We show further that this phylogenetically conserved pathway is induced as well in the human cortex subjected to episodes of clinically relevant stroke. Conclusions/Significance: The data presented here provide the first evidence that ZEB1 induction is part of a protective response by neurons to ischemia. The stroke-induced increase in ZEB1 mRNA and protein levels in cortical neurons is both developmentally and phylogenetically conserved and may therefore be part of a fundamental cellular response to this insult. Beyond the context of stroke, the finding that ZEB1 is regulated by a member of the p53 family has implications for cell survival in other tissue and cellular environments subjected to ischemia, such as the myocardium and, in particular, tumor masses.	[Genetta, Tom] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Sequeira, Judith] Emory Univ, Sch Med, Dept Pathol, Lab Med, Atlanta, GA 30322 USA; [Wen, Tong Chun; Sola, Augusto] MidAtlantic Neonatol Assoc, Mooristown, NJ USA; [Higashi, Yujiro] Inst Dev Res, Aichi, Japan; [Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan	Emory University; Emory University; Osaka University	Bui, T (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.	tgenett@emory.edu			The Cerebral Palsy International Research Foundation, Inc; Emory-Egleston Research Center; Emory Goddard Scholar Fund	The Cerebral Palsy International Research Foundation, Inc; Emory-Egleston Research Center; Emory Goddard Scholar Fund	Funding for this work was provided by the following sources: The Cerebral Palsy International Research Foundation, Inc, the Emory-Egleston Research Center and the Emory Goddard Scholar Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, CURRENT PROTOCOLS MO; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; Dobbelstein M, 2005, BIOCHEM BIOPH RES CO, V331, P688, DOI 10.1016/j.bbrc.2005.03.155; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fontemaggi G, 2001, MOL CELL BIOL, V21, P8461, DOI 10.1128/MCB.21.24.8461-8470.2001; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; Genetta T, 2007, J NEUROSCI RES, V85, P131, DOI 10.1002/jnr.21067; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Haupt Y, 2004, CELL CYCLE, V3, P884; Jacobs WB, 2006, J NEUROCHEM, V97, P1571, DOI 10.1111/j.1471-4159.2006.03980.x; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Janardhan Vallabh, 2004, Curr Cardiol Rep, V6, P117, DOI 10.1007/s11886-004-0009-8; Jefferson BK, 2005, CURR PROB CARDIOLOGY, V30, P333, DOI 10.1016/j.cpcardiol.2005.02.002; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; KUAN CH, 2000, TRENDS NEURO, V23, P454; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Lipton SA, 1999, CELL DEATH DIFFER, V6, P943, DOI 10.1038/sj.cdd.4400580; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Nakamura T, 2008, ANTIOXID REDOX SIGN, V10, P87, DOI 10.1089/ars.2007.1858; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SCHUG J, 1997, CBILTR19971001V00; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Takagi T, 1998, DEVELOPMENT, V125, P21; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vinten-Johansen J, 2007, J APPL PHYSIOL, V103, P1441, DOI 10.1152/japplphysiol.00642.2007; Wen TC, 2004, BRAIN RES PROTOC, V13, P76, DOI 10.1016/j.brainresprot.2004.02.003; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang B, 1998, J Stroke Cerebrovasc Dis, V7, P1, DOI 10.1016/S1052-3057(98)80015-3; Zhang QH, 2002, SCIENCE, V295, P1895; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	53	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4373	10.1371/journal.pone.0004373	http://dx.doi.org/10.1371/journal.pone.0004373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194497	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483500012
J	Corlazzoli, F; Rossetti, S; Bistulfi, G; Ren, MQ; Sacchi, N				Corlazzoli, Francesca; Rossetti, Stefano; Bistulfi, Gaia; Ren, Mingqiang; Sacchi, Nicoletta			Derangement of a Factor Upstream of RAR alpha Triggers the Repression of a Pleiotropic Epigenetic Network	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; BINDING PROTEIN-II; PROMOTER; CYP26A1; SIGNAL	Background: Chromatin adapts and responds to extrinsic and intrinsic cues. We hypothesize that inheritable aberrant chromatin states in cancer and aging are caused by genetic/environmental factors. In previous studies we demonstrated that either genetic mutations, or loss, of retinoic acid receptor alpha (RAR alpha), can impair the integration of the retinoic acid (RA) signal at the chromatin of RA-responsive genes downstream of RAR alpha, and can lead to aberrant repressive chromatin states marked by epigenetic modifications. In this study we tested whether the mere interference with the availability of RA signal at RAR alpha, in cells with an otherwise functional RAR alpha, can also induce epigenetic repression at RA-responsive genes downstream of RAR alpha. Methodology/Principal Findings: To hamper the availability of RA at RAR alpha in untransformed human mammary epithelial cells, we targeted the cellular RA-binding protein 2 (CRABP2), which transports RA from the cytoplasm onto the nuclear RARs. Stable ectopic expression of a CRABP2 mutant unable to enter the nucleus, as well as stable knock down of endogenous CRABP2, led to the coordinated transcriptional repression of a few RA-responsive genes downstream of RAR alpha. The chromatin at these genes acquired an exacerbated repressed state, or state "of no return''. This aberrant state is unresponsive to RA, and therefore differs from the physiologically repressed, yet "poised'' state, which is responsive to RA. Consistent with development of homozygosis for epigenetically repressed loci, a significant proportion of cells with a defective CRABP2-mediated RA transport developed heritable phenotypes indicative of loss of function. Conclusion/Significance: Derangement/lack of a critical factor necessary for RARa function induces epigenetic repression of a RA-regulated gene network downstream of RARa, with major pleiotropic biological outcomes.	[Corlazzoli, Francesca; Rossetti, Stefano; Bistulfi, Gaia; Ren, Mingqiang; Sacchi, Nicoletta] Roswell Pk Canc Inst, Canc Genet Program, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Corlazzoli, F (corresponding author), Roswell Pk Canc Inst, Canc Genet Program, Buffalo, NY 14263 USA.	nicoletta.sacchi@roswellpark.org			NCI [R01-CA127614-01A2]; Predoctoral US Army Award [W81XWH0510222]; University of Milan Foreign Exchange Program; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA127614] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Predoctoral US Army Award; University of Milan Foreign Exchange Program; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI R01-CA127614-01A2 grant (NS). GB and FC were supported by the Predoctoral US Army Award W81XWH0510222 and the University of Milan Foreign Exchange Program, SR was supported by a postdoctoral Susan Komen Foundation award.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiba H, 1997, MOL CELL BIOL, V17, P3013, DOI 10.1128/MCB.17.6.3013; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jing YK, 1997, CANCER RES, V57, P1668; Kikuchi K, 2001, BIOORG MED CHEM LETT, V11, P1215, DOI 10.1016/S0960-894X(01)00177-9; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Pozzi S, 2006, ONCOGENE, V25, P1400, DOI 10.1038/sj.onc.1209173; Pozzi S, 2006, CANCER RES, V66; Ren MQ, 2005, MOL CELL BIOL, V25, P10591, DOI 10.1128/MCB.25.23.10591-10603.2005; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456; Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381	21	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4305	10.1371/journal.pone.0004305	http://dx.doi.org/10.1371/journal.pone.0004305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19173001	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483500001
J	Wu, GQ; Arzeno, NM; Shen, LL; Tang, DK; Zheng, DA; Zhao, NQ; Eckberg, DL; Poon, CS				Wu, Guo-Qiang; Arzeno, Natalia M.; Shen, Lin-Lin; Tang, Da-Kan; Zheng, Da-An; Zhao, Nai-Qing; Eckberg, Dwain L.; Poon, Chi-Sang			Chaotic Signatures of Heart Rate Variability and Its Power Spectrum in Health, Aging and Heart Failure	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; SYMPATHOVAGAL INTERACTION; NONLINEAR DYNAMICS; VENTILATORY FLOW; HUMANS; MODULATION; COMPLEXITY; COMPONENTS; INDEXES; SYSTEM	A paradox regarding the classic power spectral analysis of heart rate variability (HRV) is whether the characteristic high-(HF) and low-frequency (LF) spectral peaks represent stochastic or chaotic phenomena. Resolution of this fundamental issue is key to unraveling the mechanisms of HRV, which is critical to its proper use as a noninvasive marker for cardiac mortality risk assessment and stratification in congestive heart failure (CHF) and other cardiac dysfunctions. However, conventional techniques of nonlinear time series analysis generally lack sufficient sensitivity, specificity and robustness to discriminate chaos from random noise, much less quantify the chaos level. Here, we apply a 'litmus test' for heartbeat chaos based on a novel noise titration assay which affords a robust, specific, time-resolved and quantitative measure of the relative chaos level. Noise titration of running short-segment Holter tachograms from healthy subjects revealed circadian-dependent (or sleep/wake-dependent) heartbeat chaos that was linked to the HF component (respiratory sinus arrhythmia). The relative 'HF chaos' levels were similar in young and elderly subjects despite proportional age-related decreases in HF and LF power. In contrast, the near-regular heartbeat in CHF patients was primarily nonchaotic except punctuated by undetected ectopic beats and other abnormal beats, causing transient chaos. Such profound circadian-, age- and CHF-dependent changes in the chaotic and spectral characteristics of HRV were accompanied by little changes in approximate entropy, a measure of signal irregularity. The salient chaotic signatures of HRV in these subject groups reveal distinct autonomic, cardiac, respiratory and circadian/sleep-wake mechanisms that distinguish health and aging from CHF.	Fudan Univ, Dept Engn Sci & Mech, Shanghai 200433, Peoples R China; [Arzeno, Natalia M.; Poon, Chi-Sang] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Arzeno, Natalia M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Shen, Lin-Lin] Fudan Univ, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Tang, Da-Kan; Zheng, Da-An] Fudan Univ, Sch Informat Sci & Engn, Shanghai, Peoples R China; [Zhao, Nai-Qing] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Eckberg, Dwain L.] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23284 USA	Fudan University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Fudan University; Fudan University; Fudan University; Virginia Commonwealth University	Wu, GQ (corresponding author), Fudan Univ, Dept Engn Sci & Mech, Shanghai 200433, Peoples R China.	cpoon@mit.edu			NIH [HL079503-02S1, HL079503, HL075014, HL072849]; Shanghai Leading Academic Discipline Project [B112]; National Natural Science Foundation of China [30370353, 30370529]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079503, R21HL075014, R01HL072849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NMA was recipient of an NIH graduate research training award HL079503-02S1. This work was supported in part by Shanghai Leading Academic Discipline Project, No B112 (GQW), National Natural Science Foundation of China grant No. 30370353 (GQW) and, No. 30370529 (LLS), and U.S. National Institutes of Health grants HL079503, HL075014 and HL072849 (CSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bilan A, 2005, J ELECTROCARDIOL, V38, P239, DOI 10.1016/j.jelectrocard.2005.01.012; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Cevese A, 2001, J PHYSIOL-LONDON, V531, P235, DOI 10.1111/j.1469-7793.2001.0235j.x; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 1999, J CARDIOVASC ELECTR, V10, P1350, DOI 10.1111/j.1540-8167.1999.tb00190.x; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Eckberg DL, 1995, REGULATION BREATHING, P669; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Glass L, 1999, J CARDIOVASC ELECTR, V10, P1358, DOI 10.1111/j.1540-8167.1999.tb00191.x; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HEDMAN AE, 1995, ACTA PHYSIOL SCAND, V155, P205, DOI 10.1111/j.1748-1716.1995.tb09965.x; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; Kamath M, 1995, HEART RATE VARIABILI, P75; KANTERS JK, 1994, J CARDIOVASC ELECTR, V5, P591, DOI 10.1111/j.1540-8167.1994.tb01300.x; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Li C, 2009, ACTA PHYS SIN-CH ED, V58, P1348, DOI 10.7498/aps.58.1348; MALIA M, 1995, HISTOIRE, P99; MANCIA G, 1993, NEW ENGL J MED, V328, P347, DOI 10.1056/NEJM199302043280511; OSAKA M, 1995, J CARDIOVASC ELECTR, V6, P441, DOI 10.1111/j.1540-8167.1995.tb00417.x; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PARATI G, 1995, AM J PHYSIOL-HEART C, V268, pH1606, DOI 10.1152/ajpheart.1995.268.4.H1606; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Piepoli M, 1997, CIRCULATION, V95, P1813; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2000, J CARDIOVASC ELECTR, V11, P235, DOI 10.1111/j.1540-8167.2000.tb00329.x; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Pyetan E, 2003, IEEE T BIO-MED ENG, V50, P777, DOI 10.1109/TBME.2003.812158; Rachmuth G, 2008, HFSP J, V2, P156, DOI 10.2976/1.2905393; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; Sandercock GRH, 2006, PACE, V29, P892, DOI 10.1111/j.1540-8159.2006.00457.x; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Sugihara G, 1996, P NATL ACAD SCI USA, V93, P2608, DOI 10.1073/pnas.93.6.2608; Taylor J Andrew, 2006, J Appl Physiol (1985), V101, P678, DOI 10.1152/japplphysiol.00446.2006; Taylor JA, 2001, AM J PHYSIOL-HEART C, V280, pH2804, DOI 10.1152/ajpheart.2001.280.6.H2804; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; Turcott RG, 1996, ANN BIOMED ENG, V24, P269, DOI 10.1007/BF02667355; Wessel N, 2007, INT J BIFURCAT CHAOS, V17, P3325, DOI 10.1142/S0218127407019093; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105; WOO MA, 1994, J AM COLL CARDIOL, V23, P565, DOI 10.1016/0735-1097(94)90737-4; Wu GQ, 2005, P ANN INT IEEE EMBS, P764, DOI 10.1109/IEMBS.2005.1616527; Wysocki M, 2006, RESP PHYSIOL NEUROBI, V153, P54, DOI 10.1016/j.resp.2005.09.008; [No title captured], DOI DOI 10.1063/1.3141426	58	64	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4323	10.1371/journal.pone.0004323	http://dx.doi.org/10.1371/journal.pone.0004323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183809	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483200008
J	Kallio, JM; Hakulinen, N; Kallio, JP; Niemi, MH; Karkkainen, S; Rouvinen, J				Kallio, Johanna M.; Hakulinen, Nina; Kallio, Juha P.; Niemi, Merja H.; Karkkainen, Susanna; Rouvinen, Juha			The Contribution of Polystyrene Nanospheres towards the Crystallization of Proteins	PLOS ONE			English	Article							ATOMIC-RESOLUTION STRUCTURE; TRICHODERMA-REESEI; HETEROGENEOUS NUCLEATION; CRYSTAL-STRUCTURES; HYDROPHOBIN; EXPRESSION; GROWTH; HFBII	Background: Protein crystallization is a slow process of trial and error and limits the amount of solved protein structures. Search of a universal heterogeneous nucleant is an effort to facilitate crystallizability of proteins. Methodology: The effect of polystyrene nanospheres on protein crystallization were tested with three commercial proteins: lysozyme, xylanase, xylose isomerase, and with five research target proteins: hydrophobins HFBI and HFBII, laccase, sarcosine dimethylglycine N-methyltransferase (SDMT), and anti-testosterone Fab fragment 5F2. The use of nanospheres both in screening and as an additive for known crystallization conditions was studied. In screening, the addition of an aqueous solution of nanosphere to the crystallization drop had a significant positive effect on crystallization success in comparison to the control screen. As an additive in hydrophobin crystallization, the nanospheres altered the crystal packing, most likely due to the amphiphilic nature of hydrophobins. In the case of laccase, nanospheres could be used as an alternative for streak-seeding, which insofar had remained the only technique to produce high-diffracting crystals. With methyltransferase SDMT the nanospheres, used also as an additive, produced fewer, larger crystals in less time. Nanospheres, combined with the streak-seeding method, produced single 5F2 Fab crystals in shorter equilibration times. Conclusions: All in all, the use of nanospheres in protein crystallization proved to be beneficial, both when screening new crystallization conditions to promote nucleation and when used as an additive to produce better quality crystals, faster. The polystyrene nanospheres are easy to use, commercially available and close to being inert, as even with amphiphilic proteins only the crystal packing is altered and the nanospheres do not interfere with the structure and function of the protein.	[Kallio, Johanna M.; Hakulinen, Nina; Kallio, Juha P.; Niemi, Merja H.; Karkkainen, Susanna; Rouvinen, Juha] Univ Joensuu, Dept Chem, FIN-80101 Joensuu, Finland	University of Eastern Finland	Kallio, JM (corresponding author), Univ Joensuu, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	juha.rouvinen@joensuu.fi	Kallio, Juha/AAE-4318-2021; Hakanpää, Johanna M/A-6958-2011	Hakanpää, Johanna M/0000-0003-0110-1439; Hakulinen, Nina/0000-0003-4471-7188; Kallio, Juha Pekka/0000-0003-3092-4012; Rouvinen, Juha/0000-0003-1843-5718; Kallio, Johanna/0000-0001-7330-8928	MaBio-project by European Social Fund; State Provincial Office of Eastern Finland; Department of Education and culture; Academy of Finland [115085]; National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation; European Community, Research Infrastructure Action [RII3-CT-2004-506008]	MaBio-project by European Social Fund; State Provincial Office of Eastern Finland; Department of Education and culture; Academy of Finland(Academy of Finland); National Graduate School in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Community, Research Infrastructure Action(European Commission)	Funding from MaBio-project by European Social Fund and the State Provincial Office of Eastern Finland, Department of Education and culture (J.M.K.), the Academy of Finland, Project 115085 (N.H., J.P.K.), and the National Graduate School in Informational and Structural Biology (M.H.N.) is gratefully acknowledged. This work was also supported by the Sigrid Juselius Foundation. The support of the European Community, Research Infrastructure Action under the FP6 "Structuring the European Research Area Specific Programme" to the EMBL Hamburg Outstation, Contract Number RII3-CT-2004-506008, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1945, J BIOL CHEM, V157, P43; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; CARRELL HL, 1989, P NATL ACAD SCI USA, V86, P4440, DOI 10.1073/pnas.86.12.4440; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Fermani S, 2001, J CRYST GROWTH, V224, P327, DOI 10.1016/S0022-0248(01)00797-7; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hakanpaa J, 2004, ACTA CRYSTALLOGR D, V60, P163, DOI 10.1107/S0907444903024430; Hakanpaa J, 2006, PROTEIN SCI, V15, P2129, DOI 10.1110/ps.062326706; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Ireton GC, 2004, ACTA CRYSTALLOGR D, V60, P601, DOI 10.1107/S0907444903029664; Kallio JM, 2007, J BIOL CHEM, V282, P28733, DOI 10.1074/jbc.M704238200; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; NakariSetala T, 1997, EUR J BIOCHEM, V248, P415, DOI 10.1111/j.1432-1033.1997.00415.x; Nyyssola A, 2001, APPL ENVIRON MICROB, V67, P2044, DOI 10.1128/AEM.67.5.2044-2050.2001; Pechkova E, 2005, ACTA CRYSTALLOGR D, V61, P809, DOI 10.1107/S0907444905006566; Pechkova E, 2004, TRENDS BIOTECHNOL, V22, P117, DOI 10.1016/j.tibtech.2004.01.011; Pechkova E, 2001, J CRYST GROWTH, V231, P599, DOI 10.1016/S0022-0248(01)01450-6; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x	27	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4198	10.1371/journal.pone.0004198	http://dx.doi.org/10.1371/journal.pone.0004198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145241	Green Submitted, Green Published, gold			2022-12-27	WOS:000265479800005
J	Ling, DJ; Song, HJ; Garza, D; Neufeld, TP; Salvaterra, PM				Ling, Daijun; Song, Ho-Juhn; Garza, Dan; Neufeld, Thomas P.; Salvaterra, Paul M.			Abeta42-Induced Neurodegeneration via an Age-Dependent Autophagic-Lysosomal Injury in Drosophila	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PROTEIN-DEGRADATION; AMYLOID-BETA; TOXICITY; NEURONS; MACROAUTOPHAGY; BIOGENESIS; EXPRESSION; PATHWAY; PLAQUES	The mechanism of widespread neuronal death occurring in Alzheimer's disease (AD) remains enigmatic even after extensive investigation during the last two decades. Amyloid beta 42 peptide (A beta(1-42)) is believed to play a causative role in the development of AD. Here we expressed human A beta(1-42) and amyloid beta 40 (A beta(1-40)) in Drosophila neurons. A beta(1-42) but not A beta(1-40) causes an extensive accumulation of autophagic vesicles that become increasingly dysfunctional with age. A beta(1-42)-induced impairment of the degradative function, as well as the structural integrity, of post-lysosomal autophagic vesicles triggers a neurodegenerative cascade that can be enhanced by autophagy activation or partially rescued by autophagy inhibition. Compromise and leakage from post-lysosomal vesicles result in cytosolic acidification, additional damage to membranes and organelles, and erosive destruction of cytoplasm leading to eventual neuron death. Neuronal autophagy initially appears to play a pro-survival role that changes in an age-dependent way to a pro-death role in the context of A beta(1-42) expression. Our in vivo observations provide a mechanistic understanding for the differential neurotoxicity of A beta(1-42) and A beta(1-40), and reveal an A beta(1-42)-induced death execution pathway mediated by an age-dependent autophagic-lysosomal injury.	[Salvaterra, Paul M.] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA; [Salvaterra, Paul M.] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA USA; [Song, Ho-Juhn; Garza, Dan] Novartis Inst Biomed Rese, Dept Dev & Mol Pathway, Cambridge, MA USA; [Neufeld, Thomas P.] Univ Minnesota, Dept Genet, Minneapolis, MN 55455 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Novartis; University of Minnesota System; University of Minnesota Twin Cities	Ling, DJ (corresponding author), Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA.	psalv@coh.org		Neufeld, Thomas/0000-0001-5659-4811	American Health Assistant Foundation; Sidell-Kagan Foundation; John Douglas French Alzheimer's Foundation [fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062509] Funding Source: NIH RePORTER	American Health Assistant Foundation; Sidell-Kagan Foundation; John Douglas French Alzheimer's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the American Health Assistant Foundation and Sidell-Kagan Foundation to P.M.S. and a fellowship from the John Douglas French Alzheimer's Foundation to D.L. (2005 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Drachman DA, 2007, CURR NEUROL NEUROSCI, V7, P265, DOI 10.1007/s11910-007-0040-4; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; PICKFORD F, 2008, J CLIN INVEST; Pramatarova A, 2006, MOL CELL BIOL, V26, P1510, DOI 10.1128/MCB.26.4.1510-1517.2006; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Vellai T, 2007, AUTOPHAGY, V3, P461, DOI 10.4161/auto.4282; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Wong E.S., 2008, HUM MOL GENET; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	42	131	141	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4201	10.1371/journal.pone.0004201	http://dx.doi.org/10.1371/journal.pone.0004201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145255	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479800007
J	Uchimura, A; Hidaka, Y; Hirabayashi, T; Hirabayashi, M; Yagi, T				Uchimura, Arikuni; Hidaka, Yuko; Hirabayashi, Takahiro; Hirabayashi, Masumi; Yagi, Takeshi			DNA Polymerase delta Is Required for Early Mammalian Embryogenesis	PLOS ONE			English	Article								Background: In eukaryotic cells, DNA polymerase delta ( Pol delta), whose catalytic subunit p125 is encoded in the Pold1 gene, plays a central role in chromosomal DNA replication, repair, and recombination. However, the physiological role of the Pol delta in mammalian development has not been thoroughly investigated. Methodology/Principal Findings: To examine this role, we used a gene targeting strategy to generate two kinds of Pold1 mutant mice: Pol delta-null ( Pold1(-/-)) mice and D400A exchanged Pol delta (Pold1(exo/exo)) mice. The D400A exchange caused deficient 3'-5' exonuclease activity in the Pol delta protein. In Pol delta-null mice, heterozygous mice developed normally despite a reduction in Pold1 protein quantity. In contrast, homozygous Pold1(-/-) mice suffered from peri-implantation lethality. Although Pold1(-/-) blastocysts appeared normal, their in vitro culture showed defects in outgrowth proliferation and DNA synthesis and frequent spontaneous apoptosis, indicating Pol delta participates in DNA replication during mouse embryogenesis. In Pold1(exo/exo) mice, although heterozygous Pold1(exo/+) mice were normal and healthy, Pold1(exo/exo) and Pold1(exo/-) mice suffered from tumorigenesis. Conclusions: These results clearly demonstrate that DNA polymerase delta is essential for mammalian early embryogenesis and that the 3'-5' exonuclease activity of DNA polymerase delta is dispensable for normal development but necessary to suppress tumorigenesis.	[Uchimura, Arikuni; Hirabayashi, Takahiro; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Hidaka, Yuko] Neo Morgan Lab Inc, Tokyo, Japan; [Hirabayashi, Masumi] Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Uchimura, A (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	uchimura@fbs.osaka-u.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Uchimura, Arikuni/0000-0003-2435-7082	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute for Physiological Sciences, Japan; Neo-Morgan Laboratory Inc	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences, Japan; Neo-Morgan Laboratory Inc	This work was supported by a Grant-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T.Y.), a grant from the Co-operative Study Program of National Institute for Physiological Sciences, Japan, and Neo-Morgan Laboratory Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; FRANCESCONI S, 1993, NUCLEIC ACIDS RES, V21, P3821, DOI 10.1093/nar/21.16.3821; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Kamel D, 1997, BIOL REPROD, V57, P1367, DOI 10.1095/biolreprod57.6.1367; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Ueno M, 2005, MOL CELL BIOL, V25, P10528, DOI 10.1128/MCB.25.23.10528-10532.2005; VARMUZA S, 1988, DEVELOPMENT, V102, P127; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001	39	35	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4184	10.1371/journal.pone.0004184	http://dx.doi.org/10.1371/journal.pone.0004184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145245	gold, Green Submitted, Green Published			2022-12-27	WOS:000265479800002
J	Huang, XX; Lu, B; Yu, WB; Fang, Q; Liu, L; Zhuang, K; Shen, TT; Wang, HB; Tian, P; Zhang, LQ; Chen, ZW				Huang, Xiaoxing; Lu, Bin; Yu, Wenbo; Fang, Qing; Liu, Li; Zhuang, Ke; Shen, Tingting; Wang, Haibo; Tian, Po; Zhang, Linqi; Chen, Zhiwei			A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination	PLOS ONE			English	Article								Mucosal vaccination offers great advantage for inducing protective immune response to prevent viral transmission and dissemination. Here, we report our findings of a head-to-head comparison of two viral vectors modified vaccinia Ankara (MVA) and a novel replication-competent modified vaccinia Tian Tan (MVTT) for inducing neutralizing antibodies (Nabs) via intramuscular and mucosal vaccinations in mice. MVTT is an attenuated variant of the wild-type VTT, which was historically used as a smallpox vaccine for millions of Chinese people. The spike glycoprotein (S) of SARS-CoV was used as the test antigen after the S gene was constructed in the identical genomic location of two vectors to generate vaccine candidates MVTT-S and MVA-S. Using identical doses, MVTT-S induced lower levels (similar to 2-3-fold) of anti- SARS-CoV neutralizing antibodies (Nabs) than MVA-S through intramuscular inoculation. MVTT-S, however, was capable of inducing consistently 20-to-100-fold higher levels of Nabs than MVA-S when inoculated via either intranasal or intraoral routes. These levels of MVTT-S-induced Nab responses were substantially (similar to 10-fold) higher than that induced via the intramuscular route in the same experiments. Moreover, pre-exposure to the wild-type VTT via intranasal or intraoral route impaired the Nab response via the same routes of MVTT-S vaccination probably due to the pre-existing anti- VTT Nab response. The efficacy of intranasal or intraoral vaccination, however, was still 20-to-50-fold better than intramuscular inoculation despite the subcutaneous pre-exposure to wild-type VTT. Our data have implications for people who maintain low levels of anti-VTT Nabs after historical smallpox vaccination. MVTT is therefore an attractive live viral vector for mucosal vaccination.	[Huang, Xiaoxing; Lu, Bin; Yu, Wenbo; Fang, Qing; Zhuang, Ke; Shen, Tingting; Wang, Haibo; Tian, Po] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Modern Virol Res Ctr & AIDS Ctr, Hubei, Peoples R China; [Yu, Wenbo; Liu, Li; Wang, Haibo; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Comprehensive AIDS Res Ctr, Beijing, Peoples R China	Wuhan University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Tsinghua University	Huang, XX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Modern Virol Res Ctr & AIDS Ctr, Hubei, Peoples R China.	zchenai@hku.hk	Tang, Xian/C-5535-2015; Liu, Li/ABA-8315-2020; ZHANG, LIN/GYD-9123-2022; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Yu, Wenbo/0000-0002-9237-272X	National Basic Research Program of China [2006CB504208]; HK-RGC [762208]; University Development Fund of the University of Hong Kong to its AIDS Institute	National Basic Research Program of China(National Basic Research Program of China); HK-RGC(Hong Kong Research Grants Council); University Development Fund of the University of Hong Kong to its AIDS Institute	This work was supported by the National Basic Research Program of China (the 973 project 2006CB504208), HK-RGC 762208 and the University Development Fund of the University of Hong Kong to its AIDS Institute. Sponsors were not involved in the study.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Antonis AFG, 2007, VACCINE, V25, P4818, DOI 10.1016/j.vaccine.2007.04.002; Ba L, 2007, APPL MICROBIOL BIOT, V76, P1131, DOI 10.1007/s00253-007-1073-y; Belyakov IM, 1998, J VIROL, V72, P8264, DOI 10.1128/JVI.72.10.8264-8272.1998; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Chen ZW, 2008, JAIDS-J ACQ IMM DEF, V47, P412, DOI 10.1097/QAI.0b013e3181651bb2; Chen ZW, 2005, J VIROL, V79, P2678, DOI 10.1128/JVI.79.5.2678-2688.2005; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gallwitz S, 2003, J CLIN MICROBIOL, V41, P4068, DOI 10.1128/JCM.41.9.4068-4070.2003; Gherardi MM, 2005, J GEN VIROL, V86, P2925, DOI 10.1099/vir.0.81181-0; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; HENDERSON DA, 1976, SCI AM, V235, P25, DOI 10.1038/scientificamerican1076-25; Heymann DL, 2004, INT J INFECT DIS, V8, pS15, DOI 10.1016/j.ijid.2004.09.005; HOU YT, 1985, J GEN VIROL, V66, P1819, DOI 10.1099/0022-1317-66-8-1819; HU SL, 1986, NATURE, V320, P537, DOI 10.1038/320537a0; Huang XG, 2007, VACCINE, V25, P8874, DOI 10.1016/j.vaccine.2007.08.066; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; KANTOR J, 1992, CANCER RES, V52, P6917; Karkhanis LU, 2007, CURR PHARM DESIGN, V13, P2015; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; LIU GQ, 1990, SCI CHINA SER B, V33, P188; Liu V J, 1989, Proc Chin Acad Med Sci Peking Union Med Coll, V4, P215; Mackett M, 1992, Biotechnology, V24, P495; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; MOSS B, 1992, CURR TOP MICROBIOL, V158, P25; Naito T, 2007, J GEN VIROL, V88, P61, DOI 10.1099/vir.0.82216-0; NAM J H, 2007, Acta Virol, V51, P125; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Olszewska W, 2004, VACCINE, V23, P215, DOI 10.1016/j.vaccine.2004.05.015; PAOLETTI E, 1995, DEV BIOL STAND, V84, P159; Sauri MA, 2002, NEW ENGL J MED, V347, P689; Slifka Mark K, 2005, Med Immunol, V4, P2, DOI 10.1186/1476-9433-4-2; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; SULLIVAN V, 1987, J GEN VIROL, V68, P2587, DOI 10.1099/0022-1317-68-10-2587; Weyer J, 2007, VACCINE, V25, P4213, DOI 10.1016/j.vaccine.2007.02.084; Wyatt LS, 2004, AIDS RES HUM RETROV, V20, P645, DOI 10.1089/0889222041217428; YILMA TD, 1989, VACCINE, V7, P484, DOI 10.1016/0264-410X(89)90266-1; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	44	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2009	4	1							e4180	10.1371/journal.pone.0004180	http://dx.doi.org/10.1371/journal.pone.0004180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IE	19159014	Green Submitted, Green Published, gold			2022-12-27	WOS:000265479600001
J	Xia, XH; Holcik, M				Xia, Xuhua; Holcik, Martin			Strong Eukaryotic IRESs Have Weak Secondary Structure	PLOS ONE			English	Article								Background: The objective of this work was to investigate the hypothesis that eukaryotic Internal Ribosome Entry Sites (IRES) lack secondary structure and to examine the generality of the hypothesis. Methodology/Principal Findings: IRESs of the yeast and the fruit fly are located in the 5'UTR immediately upstream of the initiation codon. The minimum folding energy (MFE) of 60 nt RNA segments immediately upstream of the initiation codons was calculated as a proxy of secondary structure stability. MFE of the reverse complements of these 60 nt segments was also calculated. The relationship between MFE and empirically determined IRES activity was investigated to test the hypothesis that strong IRES activity is associated with weak secondary structure. We show that IRES activity in the yeast and the fruit fly correlates strongly with the structural stability, with highest IRES activity found in RNA segments that exhibit the weakest secondary structure. Conclusions: We found that a subset of eukaryotic IRESs exhibits very low secondary structure in the 5'-UTR sequences immediately upstream of the initiation codon. The consistency in results between the yeast and the fruit fly suggests a possible shared mechanism of cap-independent translation initiation that relies on an unstructured RNA segment.	Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ctr Advanced Res Environm Genom, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1N 6N5, Canada; [Holcik, Martin] Childrens Hosp East Ontario, Apoptosis Res Ctr, Ottawa, ON, Canada; [Holcik, Martin] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Holcik, Martin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	martin@arc.cheo.ca	Holcik, Martin/E-5372-2011; Holcik, Martin/AAC-6660-2019; Xia, Xuhua/E-5264-2010	Holcik, Martin/0000-0002-1922-5299; Xia, Xuhua/0000-0002-3092-7566	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Dorokhov YL, 2002, P NATL ACAD SCI USA, V99, P5301, DOI 10.1073/pnas.082107599; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hernandez G, 2004, RNA, V10, P1783, DOI 10.1261/rna.7154104; Hernandez G, 2008, TRENDS BIOCHEM SCI, V33, P58, DOI 10.1016/j.tibs.2007.11.002; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 2007, GENE, V5, P5; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; SCHULER M, 2006, NAT STRUCT MOL BIOL, V19, P19; Terenin IM, 2005, MOL CELL BIOL, V25, P7879, DOI 10.1128/MCB.25.17.7879-7888.2005; Vazquez-Pianzola P, 2007, CELL DEATH DIFFER, V14, P286, DOI 10.1038/sj.cdd.4401990; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4136	10.1371/journal.pone.0004136	http://dx.doi.org/10.1371/journal.pone.0004136			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125192	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473100010
J	Rotolo, T; Smallwood, PM; Williams, J; Nathans, J				Rotolo, Thomas; Smallwood, Philip M.; Williams, John; Nathans, Jeremy			Genetically-Directed, Cell Type-Specific Sparse Labeling for the Analysis of Neuronal Morphology	PLOS ONE			English	Article								Background: In mammals, genetically-directed cell labeling technologies have not yet been applied to the morphologic analysis of neurons with very large and complex arbors, an application that requires extremely sparse labeling and that is only rendered practical by limiting the labeled population to one or a few predetermined neuronal subtypes. Methods and Findings: In the present study we have addressed this application by using CreER technology to non-invasively label very small numbers of neurons so that their morphologies can be fully visualized. Four lines of IRES-CreER knock-in mice were constructed to permit labeling selectively in cholinergic or catecholaminergic neurons [choline acetyltransferase (ChAT)-IRES-CreER or tyrosine hydroxylase (TH)-IRES-CreER], predominantly in projection neurons [neurofilament light chain (NFL)-IRES-CreER], or broadly in neurons and some glia [vesicle-associated membrane protein2 (VAMP2)-IRES-CreER]. When crossed to the Z/AP reporter and exposed to 4-hydroxytamoxifen in the early postnatal period, the number of neurons expressing the human placental alkaline phosphatase reporter can be reproducibly lowered to fewer than 50 per brain. Sparse Cre-mediated recombination in ChAT-IRES-CreER;Z/AP mice shows the full axonal and dendritic arbors of individual forebrain cholinergic neurons, the first time that the complete morphologies of these very large neurons have been revealed in any species. Conclusions: Sparse genetically-directed, cell type-specific neuronal labeling with IRES-creER lines should prove useful for studying a wide variety of questions in neuronal development and disease.	[Rotolo, Thomas; Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21218 USA; [Smallwood, Philip M.; Williams, John; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Rotolo, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute, National Eye Institute (NIH)	Howard Hughes Medical Institute, National Eye Institute (NIH)(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Howard Hughes Medical Institute, National Eye Institute (NIH).	Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Beitz Alvin J., 1995, P173; Bestman JE, 2006, NAT PROTOC, V1, P1267, DOI 10.1038/nprot.2006.186; Burns A, 2006, J PSYCHOPHARMACOL, V20, P732, DOI 10.1177/0269881106068299; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; D'Apuzzo M, 2001, J NEUROPHYSIOL, V86, P1037, DOI 10.1152/jn.2001.86.2.1037; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DAVIES P, 1976, LANCET, V2, P1403; Duque A, 2007, BRAIN STRUCT FUNCT, V212, P55, DOI 10.1007/s00429-007-0143-3; FAMIGLIETTI EV, 1983, VISION RES, V23, P1265, DOI 10.1016/0042-6989(83)90102-5; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; PEICHL L, 1993, J NEUROSCI, V13, P4091; PRICE DL, 1993, PROG BRAIN RES, V98, P51; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; Szmajda BA, 2008, J COMP NEUROL, V510, P251, DOI 10.1002/cne.21783; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; WAINER BH, 1993, PROG BRAIN RES, V98, P9; Wellmann H, 1999, J NEUROSCI METH, V92, P55, DOI 10.1016/S0165-0270(99)00094-1; WHITEHOUSE PJ, 1983, ANN NEUROL, V13, P243, DOI 10.1002/ana.410130304; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; WONG YW, 1994, BIOCHEM J, V301, P205, DOI 10.1042/bj3010205; YATES CM, 1980, LANCET, V2, P979; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	49	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4099	10.1371/journal.pone.0004099	http://dx.doi.org/10.1371/journal.pone.0004099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116659	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600017
J	Dowdy, DW; Lourenco, MC; Cavalcante, SC; Saraceni, V; King, B; Golub, JE; Bishai, D; Durovni, B; Chaisson, RE; Dorman, SE				Dowdy, David W.; Lourenco, Maria C.; Cavalcante, Solange C.; Saraceni, Valeria; King, Bonnie; Golub, Jonathan E.; Bishai, David; Durovni, Betina; Chaisson, Richard E.; Dorman, Susan E.			Impact and Cost-Effectiveness of Culture for Diagnosis of Tuberculosis in HIV-Infected Brazilian Adults	PLOS ONE			English	Article								Background: Culture of Mycobacterium tuberculosis currently represents the closest "gold standard" for diagnosis of tuberculosis (TB), but operational data are scant on the impact and cost-effectiveness of TB culture for human immunodeficiency (HIV-) infected individuals in resource-limited settings. Methodology/Principal Findings: We recorded costs, laboratory results, and dates of initiating TB therapy in a centralized TB culture program for HIV- infected patients in Rio de Janeiro, Brazil, constructing a decision-analysis model to estimate the incremental cost-effectiveness of TB culture from the perspective of a public-sector TB control program. Of 217 TB suspects presenting between January 2006 and March 2008, 33 (15%) had culture-confirmed active tuberculosis; 23 (70%) were smear-negative. Among smear- negative, culture-positive patients, 6 (26%) began TB therapy before culture results were available, 11 (48%) began TB therapy after culture result availability, and 6 ( 26%) did not begin TB therapy within 180 days of presentation. The cost per negative culture was US$ 17.52 (solid media)-$23.50 ( liquid media). Per 1,000 TB suspects and compared with smear alone, TB culture with solid media would avert an estimated eight TB deaths (95% simulation interval [SI]: 4, 15) and 37 disability-adjusted life years (DALYs) ( 95% SI: 13, 76), at a cost of $36( 95% SI: $25, $50) per TB suspect or $962 (95% SI: $469, $2642) per DALY averted. Replacing solid media with automated liquid culture would avert one further death (95% SI: 21, 4) and eight DALYs (95% SI: 24, 23) at $2751 per DALY 95% SI: $680, dominated). The cost-effectiveness of TB culture was more sensitive to characteristics of the existing TB diagnostic system than to the accuracy or cost of TB culture. Conclusions/Significance: TB culture is potentially effective and cost-effective for HIV- positive patients in resource-constrained settings. Reliable transmission of culture results to patients and integration with existing systems are essential.	[Dowdy, David W.; King, Bonnie; Golub, Jonathan E.; Chaisson, Richard E.; Dorman, Susan E.] Johns Hopkins Univ Hosp, Sch Med, Ctr TB Res, Baltimore, MD 21287 USA; [Dowdy, David W.; Golub, Jonathan E.; Chaisson, Richard E.] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Lourenco, Maria C.] Fundacao Oswaldo Cruz, Mycobacteriol Lab, Rio De Janeiro, Brazil; [Cavalcante, Solange C.; Saraceni, Valeria; Durovni, Betina] Municipal Hlth Secretariat, Communicable Dis Program, Rio De Janeiro, Brazil; [Bishai, David] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21287 USA; [Chaisson, Richard E.; Dorman, Susan E.] Johns Hopkins Univ Hosp, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine	Dowdy, DW (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	dsusan1@jhmi.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062	Bill & Melinda Gates Foundation [19790-01]; Foundation for Innovative New Diagnostics; National Institutes of Health [5 T32 GMO7309, K24 AI 16137, K23 AI 51528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI016137, K23AI051528, R01AI016137, R22AI016137] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for Innovative New Diagnostics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Bill & Melinda Gates Foundation (Grant 19790-01), the Foundation for Innovative New Diagnostics, and the National Institutes of Health (Medical Scientist Training Program Award 5 T32 GMO7309 to DWD; K24 AI 16137 to REC, and K23 AI 51528 to SED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2004, INT J TUBERC LUNG D, V8, P240; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2007, GLOB TUB CONTR SURV; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Apers L, 2003, INT J TUBERC LUNG D, V7, P376; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Burgess AL, 2001, AIDS, V15, P1875, DOI 10.1097/00002030-200109280-00018; *CENTR INT AG, 2007, WORLD FACTB; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DELLALATTA P, 2004, CLIN MICROBIOLOGY PR, P7114; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; McGrath EE, 2007, LANCET, V370, P28, DOI 10.1016/S0140-6736(07)61044-7; MOHAN CI, 2005, THESIS J HOPKINS BLO; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Moulton LH, 2007, CLIN TRIALS, V4, P190, DOI 10.1177/1740774507076937; Page K, 2006, REICHMAN HERSHFELDS, P371; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Thomsen VO, 2002, SCAND J INFECT DIS, V34, P648, DOI 10.1080/00365540210147813; Wang JY, 2007, DIAGN MICR INFEC DIS, V59, P395, DOI 10.1016/j.diagmicrobio.2007.06.010; WHO, 2007, GLOB TB DAT; Woods GL, 2002, INFECT DIS CLIN N AM, V16, P127, DOI 10.1016/S0891-5520(03)00049-7	34	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2008	3	12							e4057	10.1371/journal.pone.0004057	http://dx.doi.org/10.1371/journal.pone.0004057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DI	19129940	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466000017
J	Chen, K; Kurgan, L				Chen, Ke; Kurgan, Lukasz			Investigation of Atomic Level Patterns in Protein-Small Ligand Interactions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INTERACTION SITES; BINDING-SITES; RESOLUTION; RESIDUES	Background: Shape complementarity and non-covalent interactions are believed to drive protein-ligand interaction. To date protein-protein, protein-DNA, and protein-RNA interactions were systematically investigated, which is in contrast to interactions with small ligands. We investigate the role of covalent and non-covalent bonds in protein-small ligand interactions using a comprehensive dataset of 2,320 complexes. Methodology and Principal Findings: We show that protein-ligand interactions are governed by different forces for different ligand types, i.e., protein-organic compound interactions are governed by hydrogen bonds, van der Waals contacts, and covalent bonds; protein-metal ion interactions are dominated by electrostatic force and coordination bonds; protein-anion interactions are established with electrostatic force, hydrogen bonds, and van der Waals contacts; and protein-inorganic cluster interactions are driven by coordination bonds. We extracted several frequently occurring atomic-level patterns concerning these interactions. For instance, 73% of investigated covalent bonds were summarized with just three patterns in which bonds are formed between thiol of Cys and carbon or sulfur atoms of ligands, and nitrogen of Lys and carbon of ligands. Similar patterns were found for the coordination bonds. Hydrogen bonds occur in 67% of protein-organic compound complexes and 66% of them are formed between NH- group of protein residues and oxygen atom of ligands. We quantify relative abundance of specific interaction types and discuss their characteristic features. The extracted protein-organic compound patterns are shown to complement and improve a geometric approach for prediction of binding sites. Conclusions and Significance: We show that for a given type (group) of ligands and type of the interaction force, majority of protein-ligand interactions are repetitive and could be summarized with several simple atomic-level patterns. We summarize and analyze 10 frequently occurring interaction patterns that cover 56% of all considered complexes and we show a practical application for the patterns that concerns interactions with organic compounds.	[Chen, Ke; Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	University of Alberta	Chen, K (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.	lkurgan@ece.ualberta.ca	Kurgan, Lukasz/B-5721-2009	Kurgan, Lukasz/0000-0002-7749-0314; Chen, Ke/0000-0002-6962-1724	Informatics Circle of Research Excellence (iCORE) [scholarship]; Alberta Ingenuity Fund (AIF); Natural Sciences and Engineering Research Council (NSERC) [Discovery grant]	Informatics Circle of Research Excellence (iCORE); Alberta Ingenuity Fund (AIF); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a scholarship awarded by Informatics Circle of Research Excellence (iCORE) and Alberta Ingenuity Fund (AIF) to K.C. and by Discovery grant awarded by the Natural Sciences and Engineering Research Council (NSERC) of Canada to L.K.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Ansari S, 2005, PROTEINS, V61, P344, DOI 10.1002/prot.20593; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079; Carlsson J, 2005, J PHYS CHEM B, V109, P6448, DOI 10.1021/jp046022f; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; Davis AM, 2003, ANGEW CHEM INT EDIT, V42, P2718, DOI 10.1002/anie.200200539; Declercq JP, 1999, PROTEIN SCI, V8, P2194, DOI 10.1110/ps.8.10.2194; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2008, ANNU REV BIOPHYS, V37, P97, DOI 10.1146/annurev.biophys.37.032807.125811; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Liu DL, 2007, BIOCHEMISTRY-US, V46, P11789, DOI 10.1021/bi7012849; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Ochiai A, 2007, J BIOL CHEM, V282, P37134, DOI 10.1074/jbc.M704663200; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Scapin G, 2006, CURR PHARM DESIGN, V12, P2087, DOI 10.2174/138161206777585201; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Teplyakov A, 2003, PROTEINS, V51, P315, DOI 10.1002/prot.10352; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zauhar RJ, 2003, J MED CHEM, V46, P5674, DOI 10.1021/jm030242k; Zhu H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001926; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	45	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4473	10.1371/journal.pone.0004473	http://dx.doi.org/10.1371/journal.pone.0004473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221587	Green Submitted, Green Published, gold			2022-12-27	WOS:000265485700006
J	Tang, S; Le, PK; Tse, S; Wallace, DC; Huang, TS				Tang, Sha; Le, Phung Khanh; Tse, Stephanie; Wallace, Douglas C.; Huang, Taosheng			Heterozygous Mutation of Opa1 in Drosophila Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MITOCHONDRIAL MORPHOLOGY; OXIDATIVE STRESS; CYTOCHROME-C; IN-VIVO; EXTENSION; APOPTOSIS; FISSION; GENE; SEX	Optic atrophy 1 (OPA1) is a dynamin-like GTPase located in the inner mitochondrial membrane and mutations in OPA1 are associated with autosomal dominant optic atrophy (DOA). OPA1 plays important roles in mitochondrial fusion, cristae remodeling and apoptosis. Our previous study showed that dOpa1 mutation caused elevated reactive oxygen species (ROS) production and resulted in damage and death of the cone and pigment cells in Drosophila eyes. Since ROS-induced oxidative damage to the cells is one of the primary causes of aging, in this study, we examined the effects of heterozygous dOpa1 mutation on the lifespan. We found that heterozygous dOpa1 mutation caused shortened lifespan, increased susceptibility to oxidative stress and elevated production of ROS in the whole Drosophila. Antioxidant treatment partially restored lifespan in the male dOpa1 mutants, but had no effects in the females. Heterozygous dOpa1 mutation caused an impairment of respiratory chain complex activities, especially complexes II and III, and reversible decreased aconitase activity. Heterozygous dOpa1 mutation is also associated with irregular and dysmorphic mitochondria in the muscle. Our results, for the first time, demonstrate the important role of OPA1 in aging and lifespan, which is most likely mediated through augmented ROS production.	[Tang, Sha; Le, Phung Khanh; Tse, Stephanie; Huang, Taosheng] Univ Calif Irvine, Dept Pediat, Div Human Genet, Irvine, CA 92717 USA; [Wallace, Douglas C.; Huang, Taosheng] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Huang, Taosheng] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Huang, Taosheng] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Tang, S (corresponding author), Univ Calif Irvine, Dept Pediat, Div Human Genet, Irvine, CA 92717 USA.	huangts@uci.edu		Huang, Taosheng/0000-0001-6601-6687	Helen & Larry Hoag Foundation; NIH [Clinical Associate Physician Award, NS21328, AG24373, DK73691, AG13154]; Howard Hughes Biomedical Science Program; UCI [Junior Physician-Scientists Award]; NEI [1R01EY018876]; Cystinosis Research Foundation; NATIONAL EYE INSTITUTE [R01EY018876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, R01AG013154] Funding Source: NIH RePORTER	Helen & Larry Hoag Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Biomedical Science Program; UCI; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cystinosis Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was partially supported by the Helen & Larry Hoag Foundation, an NIH Clinical Associate Physician Award, the Howard Hughes Biomedical Science Program, a UCI Junior Physician-Scientists Award and NEI 1R01EY018876 to TH. ST is supported by the Cystinosis Research Foundation. DCW is supported by the following NIH research grant NS21328, AG24373, DK73691, AG13154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Ballard JWO, 2007, AGING CELL, V6, P699, DOI 10.1111/j.1474-9726.2007.00331.x; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hartman P, 2004, MECH AGEING DEV, V125, P417, DOI 10.1016/j.mad.2004.02.007; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; SPINAZZI M, 2008, HUM MOL GENET; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Walker DW, 2006, P NATL ACAD SCI USA, V103, P16382, DOI 10.1073/pnas.0607918103; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; AM J HUM GENET, V65, P1428	49	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4492	10.1371/journal.pone.0004492	http://dx.doi.org/10.1371/journal.pone.0004492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221591	Green Published, gold			2022-12-27	WOS:000265485700016
J	Porwal, S; Lal, S; Cheema, S; Kalia, VC				Porwal, Shalini; Lal, Sadhana; Cheema, Simrita; Kalia, Vipin Chandra			Phylogeny in Aid of the Present and Novel Microbial Lineages: Diversity in Bacillus	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; 16S RIBOSOMAL-RNA; MULTIPLE SEQUENCE ALIGNMENT; RESTRICTION ANALYSIS ARDRA; COMPLETE GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; THURINGIENSIS STRAINS; SPHAERICUS STRAINS; GENETIC DIVERSITY; CEREUS GROUP	Bacillus represents microbes of high economic, medical and biodefense importance. Bacillus strain identification based on 16S rRNA sequence analyses is invariably limited to species level. Secondly, certain discrepancies exist in the segregation of Bacillus subtilis strains. In the RDP/NCBI databases, out of a total of 2611 individual 16S rDNA sequences belonging to the 175 different species of the genus Bacillus, only 1586 have been identified up to species level. 16S rRNA sequences of Bacillus anthracis (153 strains), B. cereus (211 strains), B. thuringiensis (108 strains), B. subtilis (271 strains), B. licheniformis (131 strains), B. pumilus (83 strains), B. megaterium (47 strains), B. sphaericus (42 strains), B. clausii (39 strains) and B. halodurans (36 strains) were considered for generating species-specific framework and probes as tools for their rapid identification. Phylogenetic segregation of 1121, 16S rDNA sequences of 10 different Bacillus species in to 89 clusters enabled us to develop a phylogenetic frame work of 34 representative sequences. Using this phylogenetic framework, 305 out of 1025, 16S rDNA sequences presently classified as Bacillus sp. could be identified up to species level. This identification was supported by 20 to 30 nucleotides long signature sequences and in silico restriction enzyme analysis specific to the 10 Bacillus species. This integrated approach resulted in identifying around 30% of Bacillus sp. up to species level and revealed that B. subtilis strains can be segregated into two phylogenetically distinct groups, such that one of them may be renamed.	[Porwal, Shalini; Lal, Sadhana; Cheema, Simrita; Kalia, Vipin Chandra] CSIR, IGIB, Delhi, India; [Porwal, Shalini] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Porwal, S (corresponding author), CSIR, IGIB, Delhi Univ Campus, Delhi, India.	vckalia@igib.res.in		Porwal, Shalini/0000-0003-3862-4671	Task Force project, Council of Scientific and Industrial Research	Task Force project, Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by the Task Force project, Council of Scientific and Industrial Research and granted permission to publish. The funders had a role in decision to publish. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Al-Ajlani MM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-17; ALEXANDER B, 1990, J GEN MICROBIOL, V136, P367, DOI 10.1099/00221287-136-2-367; ARBER W, 1979, SCIENCE, V205, P361, DOI 10.1126/science.377489; Arcuri EF, 2000, MICROBIOL-SGM, V146, P1593, DOI 10.1099/00221287-146-7-1593; ASH C, 1991, LETT APPL MICROBIOL, V13, P202, DOI 10.1111/j.1472-765X.1991.tb00608.x; ASH C, 1992, FEMS MICROBIOL LETT, V94, P75; ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BAILEY TL, 2006, MEME DISCOVERING ANA, pW369; Baldauf SL, 2003, TRENDS GENET, V19, P345, DOI 10.1016/S0168-9525(03)00112-4; Barbosa TM, 2005, APPL ENVIRON MICROB, V71, P968, DOI 10.1128/AEM.71.2.968-978.2005; Bavykin SG, 2004, J CLIN MICROBIOL, V42, P3711, DOI 10.1128/jcm.42.8.3711-3730.2004; BERGEY D.H, 1939, BERGEYS MANUAL DETER; Bjorkroth J, 1999, INT J SYST BACTERIOL, V49, P983, DOI 10.1099/00207713-49-3-983; BLANC DS, 1993, J CLIN MICROBIOL, V31, P71, DOI 10.1128/JCM.31.1.71-77.1993; Blanc M, 1997, INT J SYST BACTERIOL, V47, P1246, DOI 10.1099/00207713-47-4-1246; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; Borin S, 1997, FEMS MICROBIOL LETT, V157, P87, DOI 10.1016/S0378-1097(97)00458-8; BOURQUE SN, 1995, APPL ENVIRON MICROB, V61, P1623, DOI 10.1128/AEM.61.4.1623-1626.1995; BOUVET A, 1991, INT J SYST BACTERIOL, V41, P483, DOI 10.1099/00207713-41-4-483; BRADBURY JM, 2001, INT J SYST EVOL MICR, V51, P2227; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Buchanan R.E, 1974, BERGEYS MANUAL DETER, V8th ed., DOI 10.1007/bergeysoutline200405; Bujnicki JM, 2003, CURR PROTEIN PEPT SC, V4, P327, DOI 10.2174/1389203033487072; Carlson CR, 1996, FEMS MICROBIOL LETT, V141, P163, DOI 10.1016/0378-1097(96)00216-9; CARLSON CR, 1994, MOL MICROBIOL, V13, P161, DOI 10.1111/j.1365-2958.1994.tb00411.x; CARLSON CR, 1993, J BACTERIOL, V175, P1053, DOI 10.1128/JB.175.4.1053-1060.1993; CARLSON CR, 1994, APPL ENVIRON MICROB, V60, P1719, DOI 10.1128/AEM.60.6.1719-1725.1994; Cheney G., 2002, MANAGE COMMUN Q, V16, P92, DOI DOI 10.1177/0893318902161006; Chun J, 2000, ANTON LEEUW INT J G, V78, P123, DOI 10.1023/A:1026555830014; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; da Silva KRA, 1999, RES MICROBIOL, V150, P153, DOI 10.1016/S0923-2508(99)80032-1; Daffonchio D, 2006, APPL ENVIRON MICROB, V72, P1295, DOI 10.1128/AEM.72.2.1295-1301.2006; Daffonchio D, 1998, INT J SYST BACTERIOL, V48, P107, DOI 10.1099/00207713-48-1-107; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; DAVIDSON EW, 1995, MEM I OSWALDO CRUZ, V90, P81, DOI 10.1590/S0074-02761995000100018; de Barjac H, 1980, Ann Microbiol (Paris), V131B, P191; De Clerck E, 2004, FEMS MICROBIOL LETT, V231, P91, DOI 10.1016/S0378-1097(03)00935-2; De Clerck E, 2002, SYST APPL MICROBIOL, V25, P611, DOI 10.1078/07232020260517751; De Gheldre Y, 1999, INT J SYST BACTERIOL, V49, P1591, DOI 10.1099/00207713-49-4-1591; DEBARJAC H, 1985, APPL MICROBIOL BIOT, V21, P85, DOI 10.1007/BF00252367; Djordjevic SP, 2000, APPL ENVIRON MICROB, V66, P1098, DOI 10.1128/AEM.66.3.1098-1106.2000; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; DUNCAN KE, 1994, EVOLUTION, V48, P2002, DOI 10.1111/j.1558-5646.1994.tb02229.x; Ehrenstein B, 1996, J CLIN MICROBIOL, V34, P2414, DOI 10.1128/JCM.34.10.2414-2420.1996; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FRACHON E, 1991, APPL ENVIRON MICROB, V57, P3394, DOI 10.1128/AEM.57.11.3394-3398.1991; Fritze D, 2004, PHYTOPATHOLOGY, V94, P1245, DOI 10.1094/PHYTO.2004.94.11.1245; From C, 2005, APPL ENVIRON MICROB, V71, P1178, DOI 10.1128/AEM.71.3.1178-1183.2005; FUKUNAGA M, 1993, J GEN MICROBIOL, V139, P1141, DOI 10.1099/00221287-139-6-1141; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Green DH, 1999, APPL ENVIRON MICROB, V65, P4288; GUERINEAU M, 1991, J INVERTEBR PATHOL, V57, P325, DOI 10.1016/0022-2011(91)90136-E; Guinebretiere MH, 2001, APPL ENVIRON MICROB, V67, P4520, DOI 10.1128/AEM.67.10.4520-4530.2001; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Han B, 2007, APPL ENVIRON MICROB, V73, P3581, DOI 10.1128/AEM.02863-06; Hansen BM, 2001, FEMS MICROBIOL LETT, V202, P209, DOI 10.1016/S0378-1097(01)00309-3; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Helgason E, 1998, CURR MICROBIOL, V37, P80, DOI 10.1007/s002849900343; Herman L, 2000, RES MICROBIOL, V151, P255, DOI 10.1016/S0923-2508(00)00146-7; Heyndrickx M, 1999, INT J SYST BACTERIOL, V49, P1083, DOI 10.1099/00207713-49-3-1083; Heyndrickx M, 1996, J MICROBIOL METH, V26, P247, DOI 10.1016/0167-7012(96)00916-5; HEYNDRICKX M, 2002, APPL SYSTEMATICS BAC; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; HOFTE H, 1989, MICROBIOL REV, V53, P242; ISHIHARA H, 1968, BIOCHIM BIOPHYS ACTA, V166, P496, DOI 10.1016/0005-2787(68)90237-2; Ishihara H, 2002, CURR MICROBIOL, V45, P18, DOI 10.1007/s00284-001-0041-5; JACKSON SG, 1995, LETT APPL MICROBIOL, V21, P103, DOI 10.1111/j.1472-765X.1995.tb01017.x; Jalava K, 1999, LETT APPL MICROBIOL, V28, P269, DOI 10.1046/j.1365-2672.1999.00527.x; Jensen GB, 1996, CURR MICROBIOL, V33, P228, DOI 10.1007/s002849900105; Joung KB, 2002, J APPL MICROBIOL, V93, P1075, DOI 10.1046/j.1365-2672.2002.01788.x; KALIA VC, 1994, WORLD J MICROB BIOT, V10, P224, DOI 10.1007/BF00360893; Kasai H, 2000, J CLIN MICROBIOL, V38, P301; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lal S, 2008, INDIAN J MICROBIOL, V48, P228, DOI 10.1007/s12088-008-0034-1; Lapidus A, 2002, FEMS MICROBIOL LETT, V209, P23, DOI 10.1111/j.1574-6968.2002.tb11104.x; Lee H, 2000, J CLIN MICROBIOL, V38, P2966, DOI 10.1128/JCM.38.8.2966-2971.2000; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; LOWE T, 1990, NUCLEIC ACIDS RES, V18, P1757, DOI 10.1093/nar/18.7.1757; Maes N, 1997, J CLIN MICROBIOL, V35, P2477, DOI 10.1128/JCM.35.10.2477-2481.1997; Manachini PL, 1998, SYST APPL MICROBIOL, V21, P520, DOI 10.1016/S0723-2020(98)80064-7; Martirani L, 2002, MICROB CELL FACT, V1, DOI 10.1186/1475-2859-1-1; MITSUHASHI M, 1994, NATURE, V367, P759, DOI 10.1038/367759a0; Nakamura LK, 1999, INT J SYST BACTERIOL, V49, P1211, DOI 10.1099/00207713-49-3-1211; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; Ning W, 1997, SYST APPL MICROBIOL, V20, P423, DOI 10.1016/S0723-2020(97)80011-2; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmisano MM, 2001, INT J SYST EVOL MICR, V51, P1671, DOI 10.1099/00207713-51-5-1671; Perez C, 2007, CELL MICROBIOL, V9, P2931, DOI 10.1111/j.1462-5822.2007.01007.x; Persson A, 1999, J CLIN MICROBIOL, V37, P3815, DOI 10.1128/JCM.37.12.3815-3821.1999; PETERSEN DJ, 1995, FEMS MICROBIOL LETT, V133, P71, DOI 10.1111/j.1574-6968.1995.tb07863.x; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Porwal S, 2008, BIORESOURCE TECHNOL, V99, P5444, DOI 10.1016/j.biortech.2007.11.011; PRICE C, 1986, MICROBIOL SCI, V3, P296; Priest F, 1981, AEROBIC ENDOSPORE FO, P35; Priest Fergus G., 1993, P3; Pruss BM, 1999, J BACTERIOL, V181, P2624; Purohit HJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-19; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rippere KE, 1997, INT J SYST BACTERIOL, V47, P214, DOI 10.1099/00207713-47-1-214; Rowan NJ, 2001, APPL ENVIRON MICROB, V67, P3873, DOI 10.1128/AEM.67.9.3873-3881.2001; SCHENKEL RGM, 1993, REV MICROBIOL, V24, P166; Senesi S, 2001, APPL ENVIRON MICROB, V67, P834, DOI 10.1128/AEM.67.2.834-839.2001; Skerman V. B. D., 1980, APPROVED LISTS BACTE; Sonakya V, 2001, BIOTECHNOL LETT, V23, P1463, DOI 10.1023/A:1011664912970; Sorokulova IB, 2003, LETT APPL MICROBIOL, V37, P169, DOI 10.1046/j.1472-765X.2003.01372.x; STACKEBRANDT E, 2002, APPL SYSTEMATICS BAC; Stakenborg T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-46; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Suihko ML, 2003, J APPL MICROBIOL, V94, P25, DOI 10.1046/j.1365-2672.2003.01803.x; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 1999, BIOSCI BIOTECH BIOCH, V63, P943, DOI 10.1271/bbb.63.943; teGiffel MC, 1997, FEMS MICROBIOL LETT, V146, P47, DOI 10.1111/j.1574-6968.1997.tb10169.x; Tena D, 2007, CLIN INFECT DIS, V44, pE40, DOI 10.1086/511077; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Ticknor LO, 2001, APPL ENVIRON MICROB, V67, P4863, DOI 10.1128/AEM.67.10.4863-4873.2001; Vaerewijck MJM, 2001, J APPL MICROBIOL, V91, P1074, DOI 10.1046/j.1365-2672.2001.01477.x; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vary PS, 2007, APPL MICROBIOL BIOT, V76, P957, DOI 10.1007/s00253-007-1089-3; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; VOLD BS, 1985, MICROBIOL REV, V49, P71, DOI 10.1128/MMBR.49.1.71-80.1985; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wattiau P, 2001, APPL MICROBIOL BIOT, V56, P816, DOI 10.1007/s002530100691; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu XY, 2006, J MICROBIOL METH, V64, P107, DOI 10.1016/j.mimet.2005.04.021; Xu D, 2003, INT J SYST EVOL MICR, V53, P695, DOI 10.1099/ijs.0.02346-0; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Yamada Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1244, DOI 10.1271/bbb.61.1244; Yamamoto S, 1998, INT J SYST BACTERIOL, V48, P813, DOI 10.1099/00207713-48-3-813; Yamamoto S, 1999, INT J SYST BACTERIOL, V49, P87, DOI 10.1099/00207713-49-1-87; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P1079, DOI 10.1099/00207713-51-3-1079; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P2087, DOI 10.1099/00207713-51-6-2087; YOUSTEN AA, 1980, ANN INST PASTEUR MIC, VB131, P297; ZAHNER V, 1994, J APPL BACTERIOL, V76, P327, DOI 10.1111/j.1365-2672.1994.tb01636.x; ZEIGLER DR, 2001, GENUS GEOBACILLUS, V3; 2007, NEW ENGLAND BIOLABS	152	83	89	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4438	10.1371/journal.pone.0004438	http://dx.doi.org/10.1371/journal.pone.0004438			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212464	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200005
J	Hager, JH; Ulanet, DB; Hennighausen, L; Hanahan, D				Hager, Jeffrey H.; Ulanet, Danielle B.; Hennighausen, Lothar; Hanahan, Douglas			Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer	PLOS ONE			English	Article								Tumor cell death is modulated by an intrinsic cell death pathway controlled by the pro-and anti-apoptotic members of the Bcl-2 family. Up-regulation of anti-apoptotic Bcl-2 family members has been shown to suppress cell death in pre-clinical models of human cancer and is implicated in human tumor progression. Previous gain-of-function studies in the RIP1-Tag2 model of pancreatic islet carcinogenesis, involving uniform or focal/temporal over-expression of Bcl-x(L), demonstrated accelerated tumor formation and growth. To specifically assess the role of endogenous Bcl-x in regulating apoptosis and tumor progression in this model, we engineered a pancreatic beta-cell-specific knockout of both alleles of Bcl-x using the Cre-LoxP system of homologous recombination. Surprisingly, there was no appreciable effect on tumor cell apoptosis rates or on tumor growth in the Bcl-x knockout mice. Other anti-apoptotic Bcl-2 family members were expressed but not substantively altered at the mRNA level in the Bcl-x-null tumors, suggestive of redundancy without compensatory transcriptional up-regulation. Interestingly, the incidence of invasive carcinomas was reduced, and tumor cells lacking Bcl-x were impaired in invasion in a two-chamber trans-well assay under conditions mimicking hypoxia. Thus, while the function of Bcl-x in suppressing apoptosis and thereby promoting tumor growth is evidently redundant, genetic ablation implicates Bcl-x in selectively facilitating invasion, consistent with a recent report documenting a pro-invasive capability of Bcl-x(L) upon exogenous over-expression.	[Hager, Jeffrey H.; Ulanet, Danielle B.; Hanahan, Douglas] Univ Calif San Francisco, Diabetes & Hellen Diller Family Comprehens Canc, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Hennighausen, Lothar] NIDDK, NIH, Lab Genet & Physiol, Bethesda, MD USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hager, JH (corresponding author), Apoptos Inc, San Diego, CA USA.	dh@biochem.ucsf.edu		Hennighausen, Lothar/0000-0001-8319-9841	A.P. Giannini Foundation for Medical Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Cancer Institute [R01CA45234]; NATIONAL CANCER INSTITUTE [R01CA045234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061000] Funding Source: NIH RePORTER	A.P. Giannini Foundation for Medical Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the A.P. Giannini Foundation for Medical Research (D.B.U), The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (L.H.), and grants from the National Cancer Institute (D.H.; R01CA45234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Ban J, 1998, BIOCHEM BIOPH RES CO, V248, P147, DOI 10.1006/bbrc.1998.8907; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choi J, 2005, CANCER RES, V65, P5554, DOI 10.1158/0008-5472.CAN-04-4570; CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; EFRAT S, 1987, EMBO J, V6, P2699, DOI 10.1002/j.1460-2075.1987.tb02562.x; Elson DA, 2000, CANCER RES, V60, P6189; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gort EH, 2008, CURR MOL MED, V8, P60; Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hickman JA, 2002, CURR OPIN GENET DEV, V12, P67, DOI 10.1016/S0959-437X(01)00266-0; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; NAIK P, 1994, COLD SPRING HARB SYM, V59, P459, DOI 10.1101/SQB.1994.059.01.051; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PARANGI S, 1995, CANCER RES, V55, P6071; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Spandidos DA, 2002, INT J ONCOL, V21, P237; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Thomadaki H, 2006, CRIT REV CL LAB SCI, V43, P1, DOI 10.1080/10408360500295626; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Wagner KU, 2000, DEVELOPMENT, V127, P4949; WANG GL, 1993, BLOOD, V82, P3610; Weiler M, 2006, CELL DEATH DIFFER, V13, P1156, DOI 10.1038/sj.cdd.4401786; Wick W, 2004, J NEUROCHEM, V91, P1275, DOI 10.1111/j.1471-4159.2004.02806.x	49	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4455	10.1371/journal.pone.0004455	http://dx.doi.org/10.1371/journal.pone.0004455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209227	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484100013
J	Lehnert, S; Van Loo, P; Thilakarathne, PJ; Marynen, P; Verbeke, G; Schuit, FC				Lehnert, Stefan; Van Loo, Peter; Thilakarathne, Pushpike J.; Marynen, Peter; Verbeke, Geert; Schuit, Frans C.			Evidence for Co-Evolution between Human MicroRNAs and Alu-Repeats	PLOS ONE			English	Article							MESSENGER-RNA; GENOME EVOLUTION; MOBILE ELEMENTS; CLEAVAGE; TARGETS; BIOGENESIS; INSIGHTS; DISEASE; DOMAIN; GENES	This paper connects Alu repeats, the most abundant repetitive elements in the human genome and microRNAs, small RNAs that alter gene expression at the post-transcriptional level. Base-pair complementarity could be demonstrated between the seed sequence of a subset of human microRNAs and Alu repeats that are integrated parallel (sense) in mRNAs. The most common target site coincides with the evolutionary most conserved part of Alu. A primate-specific gene cluster on chromosome 19 encodes the majority of miRNAs that target the most conserved sense Alu site. The individual miRNA genes within this cluster are flanked by an Alu-LINE signature, which has been duplicated with the clustered miRNA genes. Gene duplication events in this locus are supported by comparing repeat length variations of the LINE elements within the cluster with those in the rest of the chromosome. Thus, a dual relationship exists between an evolutionary young miRNA cluster and their Alu targets that may have evolved in the same time window. One hypothesis for this dual relationship is that these miRNAs could protect against too high rates of duplicative transposition, which would destroy the genome.	[Schuit, Frans C.] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium; [Van Loo, Peter; Marynen, Peter] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Van Loo, Peter; Marynen, Peter] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Elect Engn, Bioinformatics Grp, Louvain, Belgium; [Thilakarathne, Pushpike J.; Verbeke, Geert] Katholieke Univ Leuven, UZ Sint Rafael, Biostat Ctr, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Lehnert, S (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium.	frans.schuit@med.kuleuven.be	Van Loo, Peter/A-3287-2012; Verbeke, Geert/I-5587-2015	Verbeke, Geert/0000-0001-8430-7576; Van Loo, Peter/0000-0003-0292-1949	FS laboratory [GOA 2004/11]; SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology	FS laboratory; SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology	This work was financially supported by a research grant to the FS laboratory (GOA 2004/11) and by SymBioSys, the K.U.Leuven Center of Excellence in Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; BORCHERT GM, 2006, NAT STRUCT MOL BIOL; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEBEDEV YB, 2006, GENE; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Ray DA, 2007, MOL ECOL, V16, P19, DOI 10.1111/j.1365-294X.2006.03104.x; Royo H, 2006, CYTOGENET GENOME RES, V113, P99, DOI 10.1159/000090820; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; ZHANG R, 2008, MOL BIOL EVOL	33	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4456	10.1371/journal.pone.0004456	http://dx.doi.org/10.1371/journal.pone.0004456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209240	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484100014
J	Konduru, NV; Tyurina, YY; Feng, WH; Basova, LV; Belikova, NA; Bayir, H; Clark, K; Rubin, M; Stolz, D; Vallhov, H; Scheynius, A; Witasp, E; Fadeel, B; Kichambare, PD; Star, A; Kisin, ER; Murray, AR; Shvedova, AA; Kagan, VE				Konduru, Nagarjun V.; Tyurina, Yulia Y.; Feng, Weihong; Basova, Liana V.; Belikova, Natalia A.; Bayir, Huelya; Clark, Katherine; Rubin, Marc; Stolz, Donna; Vallhov, Helen; Scheynius, Annika; Witasp, Erika; Fadeel, Bengt; Kichambare, Padmakar D.; Star, Alexander; Kisin, Elena R.; Murray, Ashley R.; Shvedova, Anna A.; Kagan, Valerian E.			Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes In Vitro and In Vivo	PLOS ONE			English	Article							APOPTOTIC CELLS; CYTOCHROME-C; MACROPHAGES; LUNG; RELEASE; NANOPARTICLES; BIODISTRIBUTION; IDENTIFICATION; TRANSLOCATION; TRANSPORTERS	Broad applications of single-walled carbon nanotubes (SWCNT) dictate the necessity to better understand their health effects. Poor recognition of non-functionalized SWCNT by phagocytes is prohibitive towards controlling their biological action. We report that SWCNT coating with a phospholipid "eat-me'' signal, phosphatidylserine (PS), makes them recognizable in vitro by different phagocytic cells-murine RAW264.7 macrophages, primary monocyte-derived human macrophages, dendritic cells, and rat brain microglia. Macrophage uptake of PS-coated nanotubes was suppressed by the PS-binding protein, Annexin V, and endocytosis inhibitors, and changed the pattern of pro- and anti-inflammatory cytokine secretion. Loading of PS-coated SWCNT with pro-apoptotic cargo (cytochrome c) allowed for the targeted killing of RAW264.7 macrophages. In vivo aspiration of PS-coated SWCNT stimulated their uptake by lung alveolar macrophages in mice. Thus, PS-coating can be utilized for targeted delivery of SWCNT with specified cargoes into professional phagocytes, hence for therapeutic regulation of specific populations of immune-competent cells.	[Konduru, Nagarjun V.; Tyurina, Yulia Y.; Feng, Weihong; Basova, Liana V.; Belikova, Natalia A.; Bayir, Huelya; Kagan, Valerian E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA; [Clark, Katherine; Rubin, Marc; Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Kichambare, Padmakar D.; Star, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kisin, Elena R.; Murray, Ashley R.; Shvedova, Anna A.] NIOSH, HELD, Pathol Physiol Res Branch, Morgantown, WV USA; [Vallhov, Helen; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, S-10401 Stockholm, Sweden; [Witasp, Erika; Fadeel, Bengt; Kagan, Valerian E.] Karolinska Inst, Inst Environm Med, Div Biochem Toxicol, S-10401 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Karolinska Institutet; Karolinska Institutet	Konduru, NV (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15261 USA.	kagan@pitt.edu	Star, Alexander/C-3399-2013	Star, Alexander/0000-0001-7863-5987; Kagan, Valerian E./0000-0002-7245-1885; Tyurina, Yulia/0000-0003-0287-2091	NIOSH [OH008282]; NORA [92700Y]; Swedish Research Council; Swedish Council for Working Life and Social Research; Human Frontier Science Program (HFSP); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER	NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NORA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by NIOSH OH008282, NORA 92700Y, the Swedish Research Council, the Swedish Council for Working Life and Social Research, and the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arepalli S, 2004, CARBON, V42, P1783, DOI 10.1016/j.carbon.2004.03.038; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; BIRCH ME, 2003, MONITORING DIESEL PA, P229; BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X; Borm PJA, 2004, J NANOSCI NANOTECHNO, V4, P521, DOI 10.1166/jnn.2004.081; Buentke E, 2001, CLIN EXP ALLERGY, V31, P1583, DOI 10.1046/j.1365-2222.2001.01199.x; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044; Chen X, 2004, ANGEW CHEM INT EDIT, V43, P6111, DOI 10.1002/anie.200460620; Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s; Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Elder Alison, 2006, Clin Occup Environ Med, V5, P785; Fadeel B, 2007, NANOTOXICOLOGY, V1, P73, DOI 10.1080/17435390701565578; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gonzalez-Flecha Beatriz, 2004, Molecular Aspects of Medicine, V25, P169, DOI 10.1016/j.mam.2004.02.017; Gorelik O, 2000, PURIFICATION PROCEDU; Gotovac S, 2007, J COLLOID INTERF SCI, V314, P18, DOI 10.1016/j.jcis.2007.04.080; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jiang JF, 2003, FREE RADICAL BIO MED, V35, P814, DOI 10.1016/S0891-5849(03)00429-5; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; KISIN E, 2005, TOXICOLOGIST, V84, pA1041; Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Larroche C, 2004, AUTOIMMUN REV, V3, P159, DOI 10.1016/S1568-9972(03)00091-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lecaroz C, 2006, J NANOSCI NANOTECHNO, V6, P3296, DOI 10.1166/jnn.2006.478; LEU D, 1984, J PHARM SCI, V73, P1433, DOI 10.1002/jps.2600731028; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Longhi C, 2005, INT J IMMUNOPATH PH, V18, P317, DOI 10.1177/039463200501800214; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mohanty B, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445102; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Scott CD, 2003, J NANOSCI NANOTECHNO, V3, P63, DOI 10.1166/jnn.2003.164; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Service RF, 2004, SCIENCE, V304, P1732, DOI 10.1126/science.304.5678.1732; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; Twigg HL, 2004, SEMIN RESP CRIT CARE, V25, P21, DOI 10.1055/s-2004-822302; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Vadiveloo PK, 1999, J LEUKOCYTE BIOL, V66, P579, DOI 10.1002/jlb.66.4.579; Vallhov H, 2006, NANO LETT, V6, P1682, DOI 10.1021/nl060860z; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146; Wang SR, 2006, NANOTECHNOLOGY, V17, P634, DOI 10.1088/0957-4484/17/3/003; White B, 2007, J PHYS CHEM C, V111, P13684, DOI 10.1021/jp070853e; Yang H, 2006, CHEM COMMUN, P1425, DOI 10.1039/b515896f	82	99	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4398	10.1371/journal.pone.0004398	http://dx.doi.org/10.1371/journal.pone.0004398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198650	Green Accepted, gold, Green Published			2022-12-27	WOS:000265483900007
J	Desguerre, I; Christov, C; Mayer, M; Zeller, R; Becane, HM; Bastuji-Garin, S; Leturcq, F; Chiron, C; Chelly, J; Gherardi, RK				Desguerre, Isabelle; Christov, Christo; Mayer, Michele; Zeller, Reinhard; Becane, Henri-Marc; Bastuji-Garin, Sylvie; Leturcq, France; Chiron, Catherine; Chelly, Jamel; Gherardi, Romain K.			Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up	PLOS ONE			English	Article							PROGRESSION; PREVALENCE; MUTATIONS; CHILDREN	Background: To explore clinical heterogeneity of Duchenne muscular dystrophy (DMD), viewed as a major obstacle to the interpretation of therapeutic trials Methodology/Principal Findings: A retrospective single institution long-term follow-up study was carried out in DMD patients with both complete lack of muscle dystrophin and genotyping. An exploratory series (series 1) was used to assess phenotypic heterogeneity and to identify early criteria predicting future outcome; it included 75 consecutive steroid-free patients, longitudinally evaluated for motor, respiratory, cardiac and cognitive functions (median follow-up: 10.5 yrs). A validation series (series 2) was used to test robustness of the selected predictive criteria; it included 34 more routinely evaluated patients (age>12 yrs). Multivariate analysis of series 1 classified 70/75 patients into 4 clusters with distinctive intellectual and motor outcomes: A (early infantile DMD, 20%): severe intellectual and motor outcomes; B (classical DMD, 28%): intermediate intellectual and poor motor outcome; C ( moderate pure motor DMD, 22%): normal intelligence and delayed motor impairment; and D (severe pure motor DMD, 30%): normal intelligence and poor motor outcome. Group A patients had the most severe respiratory and cardiac involvement. Frequency of mutations upstream to exon 30 increased from group A to D, but genotype/phenotype correlations were restricted to cognition (IQ>71: OR 7.7, 95%CI 1.6-20.4, p<0.003). Diagnostic accuracy tests showed that combination of "clinical onset <2 yrs" with "mental retardation" reliably assigned patients to group A (sensitivity 0.93, specificity 0.98). Combination of "lower limb MMT score>6 at 8 yrs" with "normal or borderline mental status" reliably assigned patients to group C (sensitivity: 1, specificity: 0.94). These criteria were also predictive of "early infantile DMD" and "moderate pure motor DMD" in series 2. Conclusions/Significance: DMD can be divided into 4 sub-phenotypes differing by severity of muscle and brain dysfunction. Simple early criteria can be used to include patients with similar outcomes in future therapeutic trials.	[Desguerre, Isabelle; Gherardi, Romain K.] Hop Necker Enfants Malad, Dept Neuropediat, Neuromuscular Dis Reference Ctr Garches Necker Mo, Paris, France; [Desguerre, Isabelle; Christov, Christo; Gherardi, Romain K.] Univ Paris 12, Mondor Biomed Res Inst, INSERM U841, Dept Neurosci, F-94010 Creteil, France; [Christov, Christo] Mondor Biomed Res Inst, INSERM U841, Creteil, France; [Mayer, Michele] Trousseau Hosp, Dept Neuropediat, Paris, France; [Zeller, Reinhard; Leturcq, France; Chelly, Jamel] Cochin St Vincent de Paul Hosp Grp, Dept Biochem & Genet, Paris, France; [Becane, Henri-Marc; Leturcq, France; Chelly, Jamel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Bastuji-Garin, Sylvie] Henri Mondor Hospital, Dept Publ Hlth & Stat Dept, Creteil, France; [Chiron, Catherine] Univ Paris 05, INSERM, U663, F-75270 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Desguerre, I (corresponding author), Hop Necker Enfants Malad, Dept Neuropediat, Neuromuscular Dis Reference Ctr Garches Necker Mo, Paris, France.	romain.gherardi@hmn.aphp.fr	Bastuji-Garin, Sylvie/R-3479-2018; Chelly, Jamel/J-7528-2015; Chiron, Catherine/E-8506-2016; Zeller, Reinhard/AAZ-7583-2020	Bastuji-Garin, Sylvie/0000-0001-9855-5183; Chelly, Jamel/0000-0002-0939-8719; Chiron, Catherine/0000-0002-9096-1694; Zeller, Reinhard/0000-0002-9504-5521	Association Francaise contre les Myopathies (AFM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOP KG, 1981, ARCH NEUROL-CHICAGO, V38, P406, DOI 10.1001/archneur.1981.00510070040004; Bouvier P, 1999, CHILD ABUSE NEGLECT, V23, P779, DOI 10.1016/S0145-2134(99)00050-2; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; BUSHBY KMD, 1995, DEV MED CHILD NEUROL, V37, P260; BUSHBY KMD, 1992, J INHERIT METAB DIS, V15, P551, DOI 10.1007/BF01799614; Chung BHY, 2004, PEDIATRICS, V114, pE548, DOI 10.1542/peds.2004-0668; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; Escolar DM, 2005, ANN NEUROL, V58, P151, DOI 10.1002/ana.20523; Jeppesen J, 2003, NEUROMUSCULAR DISORD, V13, P804, DOI 10.1016/S0960-8966(03)00162-7; Kaminska A, 1999, EPILEPSY RES, V36, P15, DOI 10.1016/S0920-1211(99)00021-2; Kapsa R, 2003, LANCET NEUROL, V2, P299, DOI 10.1016/S1474-4422(03)00382-X; KILMER DD, 1993, ARCH PHYS MED REHAB, V74, P1168; Knottnerus JA, 2002, BMJ-BRIT MED J, V324, P477, DOI 10.1136/bmj.324.7335.477; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; MENDELL JR, 1987, ARCH NEUROL-CHICAGO, V44, P808, DOI 10.1001/archneur.1987.00520200012009; Mok E, 2006, AM J CLIN NUTR, V83, P65; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NICHOLSON LVB, 1993, J MED GENET, V30, P728, DOI 10.1136/jmg.30.9.728; PRELLE A, 1992, J NEUROL, V239, P76, DOI 10.1007/BF00862976; Sifringer M, 2004, HUM GENET, V114, P149, DOI 10.1007/s00439-003-1041-2; SUTHERS GK, 1992, AM J HUM GENET, V50, P887; UITENBROEK DG, 1997, SISA DIAGNOSTIC ACCU; Van der Kooij A. J., 2004, SAGE HDB QUANTITATIV, P49; Van Essen AJ, 2004, NATURAL HIST DUCHENN; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Wilcox MA, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S15; WILCOX MA, 2005, ARTHRITIS RHEUM, V53, P263	31	110	114	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4347	10.1371/journal.pone.0004347	http://dx.doi.org/10.1371/journal.pone.0004347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194511	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483600003
J	Kenny, JG; Ward, D; Josefsson, E; Jonsson, IM; Hinds, J; Rees, HH; Lindsay, JA; Tarkowski, A; Horsburgh, MJ				Kenny, John G.; Ward, Deborah; Josefsson, Elisabet; Jonsson, Ing-Marie; Hinds, Jason; Rees, Huw H.; Lindsay, Jodi A.; Tarkowski, Andrej; Horsburgh, Malcolm J.			The Staphylococcus aureus Response to Unsaturated Long Chain Free Fatty Acids: Survival Mechanisms and Virulence Implications	PLOS ONE			English	Article								Staphylococcus aureus is an important human commensal and opportunistic pathogen responsible for a wide range of infections. Long chain unsaturated free fatty acids represent a barrier to colonisation and infection by S. aureus and act as an antimicrobial component of the innate immune system where they are found on epithelial surfaces and in abscesses. Despite many contradictory reports, the precise anti-staphylococcal mode of action of free fatty acids remains undetermined. In this study, transcriptional (microarrays and qRT-PCR) and translational (proteomics) analyses were applied to ascertain the response of S. aureus to a range of free fatty acids. An increase in expression of the sigma(B) and CtsR stress response regulons was observed. This included increased expression of genes associated with staphyloxanthin synthesis, which has been linked to membrane stabilisation. Similarly, up-regulation of genes involved in capsule formation was recorded as were significant changes in the expression of genes associated with peptidoglycan synthesis and regulation. Overall, alterations were recorded predominantly in pathways involved in cellular energetics. In addition, sensitivity to linoleic acid of a range of defined (sigB, arcA, sasF, sarA, agr, crtM) and transposon-derived mutants (vraE, SAR2632) was determined. Taken together, these data indicate a common mode of action for long chain unsaturated fatty acids that involves disruption of the cell membrane, leading to interference with energy production within the bacterial cell. Contrary to data reported for other strains, the clinically important EMRSA-16 strain MRSA252 used in this study showed an increase in expression of the important virulence regulator RNAIII following all of the treatment conditions tested. An adaptive response by S. aureus of reducing cell surface hydrophobicity was also observed. Two fatty acid sensitive mutants created during this study were also shown to diplay altered pathogenesis as assessed by a murine arthritis model. Differences in the prevalence and clinical importance of S. aureus strains might partly be explained by their responses to antimicrobial fatty acids.	[Kenny, John G.; Ward, Deborah; Rees, Huw H.; Horsburgh, Malcolm J.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Josefsson, Elisabet; Jonsson, Ing-Marie; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Hinds, Jason; Lindsay, Jodi A.] Univ London, Div Cellular & Molecular Med, London WC1E 7HU, England	University of Liverpool; University of Gothenburg; University of London	Kenny, JG (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	M.J.Horsburgh@Liverpool.ac.uk	Kenny, John/HCI-1952-2022; Lindsay, Jodi/ABH-8205-2020; Lindsay, Jodi/B-9565-2008; Horsburgh, Malcolm J/H-9657-2013; Arora, Rajesh/AAE-4596-2021	Kenny, John/0000-0003-2994-6169; Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Arora, Rajesh/0000-0001-7307-9221; Hinds, Jason/0000-0002-2739-1908	BBSRC [BB/D003563/1]; LUA/ALF; Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; Swedish Research Council; Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; Family Tholens and Kristlers Foundation; Biotechnology and Biological Sciences Research Council [BB/D003563/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); LUA/ALF; Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; Family Tholens and Kristlers Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was enabled by the BBSRC grant BB/D003563/1 awarded to MJH. EJ, IMJ and AT were supported by LUA/ALF, Goteborg Medical Society, Goteborg Rheumatism Association, King Gustaf V's 80 Years Foundation, Swedish Research Council, Swedish Rheumatism Association, The Sigurd and Elsa Golje Memorial Foundation and the Family Tholens and Kristlers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI MNA, 1970, LIPIDS, V5, P838, DOI 10.1007/BF02531977; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; CAMILLI A, 1990, J BACTERIOL, V172, P3738, DOI 10.1128/jb.172.7.3738-3744.1990; CAMPBELL IM, 1983, J CLIN MICROBIOL, V18, P408, DOI 10.1128/JCM.18.2.408-415.1983; Chamberlain NR, 1997, J MED MICROBIOL, V46, P693, DOI 10.1099/00222615-46-8-693; Chamberlain NR, 1996, J MED MICROBIOL, V44, P125, DOI 10.1099/00222615-44-2-125; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332, DOI 10.1128/IAI.59.12.4332-4337.1991; Chan PF, 1998, J BACTERIOL, V180, P6082; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Dufour M, 2007, APPL ENVIRON MICROB, V73, P5507, DOI 10.1128/AEM.01013-07; DYE ES, 1981, INFECT IMMUN, V32, P98, DOI 10.1128/IAI.32.1.98-104.1981; ENGLER HD, 1992, J MED MICROBIOL, V37, P238, DOI 10.1099/00222615-37-4-238; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Freiberg C, 2005, ANTIMICROB AGENTS CH, V49, P749, DOI 10.1128/AAC.49.2.749-759.2005; GALBRAITH H, 1973, J APPL BACTERIOL, V36, P659, DOI 10.1111/j.1365-2672.1973.tb04151.x; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; GRINSTED J, 1973, J GEN MICROBIOL, V75, P259, DOI 10.1099/00221287-75-2-259; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HECZKO PB, 1979, J CLIN MICROBIOL, V9, P333; Hilmarsson H, 2007, ARCH VIROL, V152, P2225, DOI 10.1007/s00705-007-1063-5; Hilmarsson H, 2006, ARCH VIROL, V151, P1217, DOI 10.1007/s00705-005-0699-2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2004, INFECT IMMUN, V72, P3073, DOI 10.1128/IAI.72.5.3073-3076.2004; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Johnson AP, 2005, J ANTIMICROB CHEMOTH, V56, P455, DOI 10.1093/jac/dki266; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Josefsson E, 2008, MICROB PATHOGENESIS, V44, P103, DOI 10.1016/j.micpath.2007.08.010; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; KAPRAL FA, 1992, J MED MICROBIOL, V37, P235, DOI 10.1099/00222615-37-4-235; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; KNAPP HR, 1986, J INFECT DIS, V154, P84, DOI 10.1093/infdis/154.1.84; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; LONG JP, 1992, J MED MICROBIOL, V37, P232, DOI 10.1099/00222615-37-4-232; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; MORTENSEN JE, 1992, J MED MICROBIOL, V36, P293, DOI 10.1099/00222615-36-4-293; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NIEMAN C, 1954, BACTERIOL REV, V18, P147, DOI 10.1128/MMBR.18.2.147-163.1954; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Qoronfleh MW, 1998, FEMS MICROBIOL LETT, V166, P103, DOI 10.1016/S0378-1097(98)00317-6; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Riordan JT, 2006, INT J ANTIMICROB AG, V28, P54, DOI 10.1016/j.ijantimicag.2006.01.013; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Ruzin A, 1998, J BACTERIOL, V180, P182, DOI 10.1128/JB.180.1.182-185.1998; Ruzin A, 2000, J BACTERIOL, V182, P2668, DOI 10.1128/JB.182.9.2668-2671.2000; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; SCHAFER L, 1991, J INVEST DERMATOL, V96, P10, DOI 10.1111/1523-1747.ep12514648; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; SHRYOCK TR, 1992, J MED MICROBIOL, V36, P288, DOI 10.1099/00222615-36-4-288; SPEERT DP, 1979, INFECT IMMUN, V26, P1202, DOI 10.1128/IAI.26.3.1202-1210.1979; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Won SR, 2007, FEBS LETT, V581, P4999, DOI 10.1016/j.febslet.2007.09.045; Wydro P, 2007, BIOMACROMOLECULES, V8, P2611, DOI 10.1021/bm700453x; XIONG Z, 1992, J MED MICROBIOL, V37, P192, DOI 10.1099/00222615-37-3-192; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	92	119	121	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4344	10.1371/journal.pone.0004344	http://dx.doi.org/10.1371/journal.pone.0004344			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183815	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265483200014
J	Cameron, HL; Foster, WG				Cameron, Heather L.; Foster, Warren G.			Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic Mice	PLOS ONE			English	Article								Breast cancer is the most common cancer in Western women and while its precise etiology is unknown, environmental factors are thought to play a role. The organochlorine pesticide dieldrin is a persistent environmental toxicant thought to increase the risk of breast cancer and reduce survival in the human population. The objective of this study was to define the effect of developmental exposure to environmentally relevant concentrations of dieldrin, on mammary tumor development in the offspring. Sexually mature FVB-MMTV/neu female mice were treated with vehicle (corn oil), or dieldrin (0.45, 2.25, and 4.5 mu g/g body weight) daily by gavage for 5 days prior to mating and then once weekly throughout gestation and lactation until weaning. Dieldrin concentrations were selected to produce serum levels representative of human background body burdens, occupational exposure, and overt toxicity. Treatment had no effect on litter size, birth weight or the number of pups surviving to weaning. The highest dose of dieldrin significantly increased the total tumor burden and the volume and number of tumors found in the thoracic mammary glands. Increased mRNA and protein expression of the neurotrophin BDNF and its receptor TrkB was increased in tumors from the offspring of dieldrin treated dams. This study indicates that developmental exposure to the environmental contaminant dieldrin causes increased tumor burden in genetically predisposed mice. Dieldrin exposure also altered the expression of BNDF and TrkB, novel modulators of cancer pathogenesis.	[Cameron, Heather L.; Foster, Warren G.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada	McMaster University	Cameron, HL (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.	fosterw@mcmaster.ca		Cameron, Heather/0000-0002-3886-8257	American Chemistry Council; Natural Sciences and Engineering Research Council [WG 261905-03]	American Chemistry Council; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support for this project was provided by an unrestricted research grant from the American Chemistry Council and a grant in aid from the Natural Sciences and Engineering Research Council (WG 261905-03). Sponsors of this project did not participate in any phase of the study design, data collection and analysis, decision to publish or preparation of the manuscript. Salary support for Drs. Foster and Cameron from the Canadian Institutes of Health Research and the Ontario Women's Health Council is gratefully acknowledged.	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Bachowski S, 1998, TOXICOL APPL PHARM, V150, P301, DOI 10.1006/taap.1998.8372; Birgo B B, 1975, Environ Physiol Biochem, V5, P440; Blasco-Gutierrez MJ, 2007, CANCER INVEST, V25, P405, DOI 10.1080/07357900701206349; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; BUELL P, 1973, J NATL CANCER I, V51, P1479, DOI 10.1093/jnci/51.5.1479; Cameron HL, 2008, REPROD TOXICOL, V25, P256, DOI 10.1016/j.reprotox.2007.11.013; *CAN CANC SOC NAT, 2008, CAN CAN STAT 2008; Cantor KP, 2003, ENVIRON HEALTH PERSP, V111, P179, DOI 10.1289/ehp.4347; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; DAVIES K, 1988, CHEMOSPHERE, V17, P263, DOI 10.1016/0045-6535(88)90219-6; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Engel LS, 2005, AM J EPIDEMIOL, V161, P121, DOI 10.1093/aje/kwi022; Entschladen F, 2006, MED HYPOTHESES, V67, P33, DOI 10.1016/j.mehy.2006.01.015; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Foster WG, 2008, ENVIRON RES, V108, P21, DOI 10.1016/j.envres.2008.05.001; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P686; Hoyer AP, 2000, J CLIN EPIDEMIOL, V53, P323, DOI 10.1016/S0895-4356(99)00165-1; Hoyer AP, 1998, LANCET, V352, P1816, DOI 10.1016/S0140-6736(98)04504-8; Jaboin J, 2002, CANCER RES, V62, P6756; Kang KS, 1996, ENVIRON HEALTH PERSP, V104, P192, DOI 10.2307/3432789; Kannan K, 1997, Rev Environ Contam Toxicol, V152, P1; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacIntosh DL, 1996, ENVIRON HEALTH PERSP, V104, P202, DOI 10.2307/3432790; Mathur V, 2002, ENVIRON INT, V28, P331, DOI 10.1016/S0160-4120(02)00031-4; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEWSOME WH, 1995, CHEMOSPHERE, V30, P2143, DOI 10.1016/0045-6535(95)00086-N; Popnikolov NK, 2005, MODERN PATHOL, V18, P1535, DOI 10.1038/modpathol.3800487; Ramamoorthy K, 1997, ENDOCRINOLOGY, V138, P1520, DOI 10.1210/en.138.4.1520; Reis JS, 2006, MODERN PATHOL, V19, P307, DOI 10.1038/modpathol.3800542; Ricci A, 2005, GROWTH FACTORS, V23, P303, DOI 10.1080/08977190500233813; Ries LAG, 2008, SEER CANC STAT REV; ROGAN WJ, 1994, ENVIRON HEALTH PERSP, V102, P89, DOI 10.1289/ehp.94102s1189; SHEN H, 2007, HUM REPROD DEM199; Shibayama E, 1996, AM J PATHOL, V148, P1807; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Tarraf C, 2003, FOOD ADDIT CONTAM A, V20, P819, DOI 10.1080/0265203031000138231; Verkasalo PK, 1999, INT J CANCER, V83, P743, DOI 10.1002/(SICI)1097-0215(19991210)83:6<743::AID-IJC8>3.0.CO;2-Q; WASSERMANN M, 1976, B ENVIRON CONTAM TOX, V15, P478, DOI 10.1007/BF01685076; Zhang Y, 2008, ONCOLOGY-BASEL, V75, P17, DOI 10.1159/000151615; Zhu ZW, 2002, MOL CARCINOGEN, V35, P138, DOI 10.1002/mc.10083; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	50	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4303	10.1371/journal.pone.0004303	http://dx.doi.org/10.1371/journal.pone.0004303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173004	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483000012
J	Wang, HY; Burns, LH				Wang, Hoau-Yan; Burns, Lindsay H.			Naloxone's Pentapeptide Binding Site on Filamin A Blocks Mu Opioid Receptor-Gs Coupling and CREB Activation of Acute Morphine	PLOS ONE			English	Article							G-BETA-GAMMA; ADENYLYL-CYCLASE; G-PROTEIN; TOLERANCE; NALTREXONE; DEPENDENCE; POTENCY; FACES	Chronic morphine causes the mu opioid receptor (MOR) to switch its coupling from Gi/o to Gs, resulting in excitatory signaling via both G alpha s and its G beta gamma dimer. Ultra-low-dose naloxone (NLX) prevents this switch and attenuates opioid tolerance and dependence. This protective effect is mediated via a high-affinity interaction of NLX to a pentapeptide region in c-terminal filamin A (FLNA), a scaffolding protein interacting with MOR. In organotypic striatal slice cultures, we now show that acute morphine induces a dose-dependent Go-to-Gs coupling switch at 5 and 15 min that resolves by 1 hr. The acute Gs coupling induced by 100 mu M morphine was completely prevented by co-treatment with 100 pM NLX, (+) NLX, or naltrexone (NTX), or their pentapeptide binding site (FLNA(2561-2565)), which we show can act as a decoy for MOR or bind to FLNA itself. All of these co-treatments presumably prevent the MOR-FLNA interaction. Since ultra-low-dose NTX also attenuates the addictive properties of opioids, we assessed striatal cAMP production and CREB phosphorylation at S-133. Correlating with the Gs coupling, acute morphine induced elevated cAMP levels and a several-fold increase in pS(133) CREB that were also completely blocked by NLX, NTX or the FLNA pentapeptide. We propose that acute, robust stimulation of MOR causes an interaction with FLNA that allows an initially transient MOR-Gs coupling, which recovers with receptor recycling but persists when MOR stimulation is repeated or prolonged. The complete prevention of this acute, morphine-induced MOR-Gs coupling by 100 pM NLX/NTX or 10 mu M pentapeptide segment of FLNA further elucidates both MOR signaling and the mechanism of action of ultra-low-dose NLX or NTX in attenuating opioid tolerance, dependence and addictive potential.	CUNY, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; [Burns, Lindsay H.] Pain Therapeut Inc, San Mateo, CA USA	City University of New York (CUNY) System	Wang, HY (corresponding author), CUNY, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	hywang@sci.ccny.cuny.edu			Pain Therapeutics, Inc	Pain Therapeutics, Inc	This study was funded by Pain Therapeutics, Inc., and LHB is an employee of this company. The funders had no role in study design, data collection and analysis. LHB contributed to the decision to publish, and LHB was the primary author in preparation of the manuscript.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chakrabarti S, 1998, MOL PHARMACOL, V54, P655; Chakrabarti S, 2005, MOL BRAIN RES, V135, P217, DOI 10.1016/j.molbrainres.2004.12.016; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; CRAIN SM, 1995, P NATL ACAD SCI USA, V92, P10540, DOI 10.1073/pnas.92.23.10540; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GUITART X, 1992, J NEUROCHEM, V58, P1168, DOI 10.1111/j.1471-4159.1992.tb09377.x; Leri F, 2005, PHARMACOL BIOCHEM BE, V82, P252, DOI 10.1016/j.pbb.2005.08.008; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Nestler EJ, 2004, NEUROPHARMACOLOGY, V47, P24, DOI 10.1016/j.neuropharm.2004.06.031; Olmstead MC, 2005, PSYCHOPHARMACOLOGY, V181, P576, DOI 10.1007/s00213-005-0022-7; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Powell KJ, 2002, J PHARMACOL EXP THER, V300, P588, DOI 10.1124/jpet.300.2.588; SAKAGAMI H, 1995, MOL BRAIN RES, V33, P185, DOI 10.1016/0169-328X(95)00123-A; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; SHEN KF, 2002, J PAIN, V3, P49; SHEN KF, 2002, J PAIN, V3, P50; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Wang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001554; Wang HY, 2006, J NEUROBIOL, V66, P1302, DOI 10.1002/neu.20286; Wang HY, 2005, NEUROSCIENCE, V135, P247, DOI 10.1016/j.neuroscience.2005.06.003; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923	27	52	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4282	10.1371/journal.pone.0004282	http://dx.doi.org/10.1371/journal.pone.0004282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172190	Green Published, gold			2022-12-27	WOS:000265482900003
J	Wu, DY; Raymond, J; Wu, M; Chatterji, S; Ren, QH; Graham, JE; Bryant, DA; Robb, F; Colman, A; Tallon, LJ; Badger, JH; Madupu, R; Ward, NL; Eisen, JA				Wu, Dongying; Raymond, Jason; Wu, Martin; Chatterji, Sourav; Ren, Qinghu; Graham, Joel E.; Bryant, Donald A.; Robb, Frank; Colman, Albert; Tallon, Luke J.; Badger, Jonathan H.; Madupu, Ramana; Ward, Naomi L.; Eisen, Jonathan A.			Complete Genome Sequence of the Aerobic CO-Oxidizing Thermophile Thermomicrobium roseum	PLOS ONE			English	Article							LONG-CHAIN DIOLS; CHLOROFLEXUS-AURANTIACUS; SIGNAL-TRANSDUCTION; CHLOROBIUM-TEPIDUM; SALINIBACTER-RUBER; EARLY EVOLUTION; BACILLUS; PATHWAY; PROTEIN; ENZYMES	In order to enrich the phylogenetic diversity represented in the available sequenced bacterial genomes and as part of an "Assembling the Tree of Life" project, we determined the genome sequence of Thermomicrobium roseum DSM 5159. T. roseum DSM 5159 is a red-pigmented, rod-shaped, Gram-negative extreme thermophile isolated from a hot spring that possesses both an atypical cell wall composition and an unusual cell membrane that is composed entirely of long-chain 1,2-diols. Its genome is composed of two circular DNA elements, one of 2,006,217 bp (referred to as the chromosome) and one of 919,596 bp (referred to as the megaplasmid). Strikingly, though few standard housekeeping genes are found on the megaplasmid, it does encode a complete system for chemotaxis including both chemosensory components and an entire flagellar apparatus. This is the first known example of a complete flagellar system being encoded on a plasmid and suggests a straightforward means for lateral transfer of flagellum-based motility. Phylogenomic analyses support the recent rRNA-based analyses that led to T. roseum being removed from the phylum Thermomicrobia and assigned to the phylum Chloroflexi. Because T. roseum is a deep-branching member of this phylum, analysis of its genome provides insights into the evolution of the Chloroflexi. In addition, even though this species is not photosynthetic, analysis of the genome provides some insight into the origins of photosynthesis in the Chloroflexi. Metabolic pathway reconstructions and experimental studies revealed new aspects of the biology of this species. For example, we present evidence that T. roseum oxidizes CO aerobically, making it the first thermophile known to do so. In addition, we propose that glycosylation of its carotenoids plays a crucial role in the adaptation of the cell membrane to this bacterium's thermophilic lifestyle. Analyses of published metagenomic sequences from two hot springs similar to the one from which this strain was isolated, show that close relatives of T. roseum DSM 5159 are present but have some key differences from the strain sequenced.	[Wu, Dongying; Wu, Martin; Chatterji, Sourav; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA USA; [Raymond, Jason] Lawrence Livermore Natl Lab, Microb Syst Div, Biosci Directorate, Livermore, CA USA; [Graham, Joel E.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Robb, Frank; Colman, Albert] Univ Maryland, Biotechnol Inst, Baltimore, MD USA; [Ren, Qinghu; Tallon, Luke J.; Badger, Jonathan H.; Madupu, Ramana; Ward, Naomi L.] J Craig Venter Inst, Rockville, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland Baltimore; J. Craig Venter Institute	Wu, DY (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Robb, Frank/0000-0001-5833-6496; Wu, Martin/0000-0003-3093-4077	National Science Foundation [0228651, MCB-0519743, MCB0605301]	National Science Foundation(National Science Foundation (NSF))	The project is supported by the National Science Foundation Assembling the Tree of Life Grant No. 0228651 rewarded to Jonathan A. Eisen and Naomi Ward; the National Science Foundation Photosystem I: Biogenesis, Broken Symmetry, and Hydrogenase Chimeras Grant No. MCB-0519743 rewarded to Donald A. Bryant; National Science Foundation Interspecies Metabolic Complementation in Geothermal Microbial Mats Grant No. MCB0605301 awarded to Frank Robb and Albert Colman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Atomi H, 2002, J BIOSCI BIOENG, V94, P497, DOI 10.1016/S1389-1723(02)80186-4; Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Caspi R, 2006, NUCLEIC ACIDS RES, V34, pD511, DOI 10.1093/nar/gkj128; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; DRACHEVA S, 1991, BIOCHEMISTRY-US, V30, P11451, DOI 10.1021/bi00112a012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EUGESTER C, 1995, CAROTENOIDS A, V1, P71; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, P447; GISH W, 2004, WU BLAST; GRAHAM JE, 2008, THESIS PENNSYLVANIA; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Hugenholtz P, 2004, INT J SYST EVOL MICR, V54, P2049, DOI 10.1099/ijs.0.03028-0; Hugenholtz P, 2002, GENOME BIOL, V3; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; JACKSON TJ, 1973, INT J SYST BACTERIOL, V23, P28, DOI 10.1099/00207713-23-1-28; JURGENS UJ, 1987, ARCH MICROBIOL, V148, P72, DOI 10.1007/BF00429651; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Lobry JR, 1996, SCIENCE, V272, P745, DOI 10.1126/science.272.5262.745; Lutnaes BF, 2002, J NAT PROD, V65, P1340, DOI 10.1021/np020125c; MACDONALD H, 1985, MOL GEN GENET, V200, P328, DOI 10.1007/BF00425444; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; MCMANUS JD, 1992, J BIOL CHEM, V267, P6531; MERKEL GJ, 1980, CAN J MICROBIOL, V26, P556, DOI 10.1139/m80-097; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; POND JL, 1987, J BACTERIOL, V169, P1328, DOI 10.1128/jb.169.3.1328-1330.1987; POND JL, 1986, SCIENCE, V231, P1134, DOI 10.1126/science.231.4742.1134; RAGSDALE SW, 1991, CRIT REV BIOCHEM MOL, V26, P261, DOI 10.3109/10409239109114070; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Santiago B, 1997, J BACTERIOL, V179, P6053, DOI 10.1128/jb.179.19.6053-6060.1997; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wisniewska A, 2006, ACTA BIOCHIM POL, V53, P475; WOOD HG, 1989, AUTOTROPHIC BACTERIA, P33; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	74	80	201	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4207	10.1371/journal.pone.0004207	http://dx.doi.org/10.1371/journal.pone.0004207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148287	Green Published, gold			2022-12-27	WOS:000265479900001
J	Hospedales, T; Vijayakumar, S				Hospedales, Timothy; Vijayakumar, Sethu			Multisensory Oddity Detection as Bayesian Inference	PLOS ONE			English	Article							CUE COMBINATION; TEXTURE; INFORMATION; PERCEPTION; VISION; INTEGRATION; SIGNALS; SLANT; TOUCH	A key goal for the perceptual system is to optimally combine information from all the senses that may be available in order to develop the most accurate and unified picture possible of the outside world. The contemporary theoretical framework of ideal observer maximum likelihood integration (MLI) has been highly successful in modelling how the human brain combines information from a variety of different sensory modalities. However, in various recent experiments involving multisensory stimuli of uncertain correspondence, MLI breaks down as a successful model of sensory combination. Within the paradigm of direct stimulus estimation, perceptual models which use Bayesian inference to resolve correspondence have recently been shown to generalize successfully to these cases where MLI fails. This approach has been known variously as model inference, causal inference or structure inference. In this paper, we examine causal uncertainty in another important class of multi-sensory perception paradigm - that of oddity detection and demonstrate how a Bayesian ideal observer also treats oddity detection as a structure inference problem. We validate this approach by showing that it provides an intuitive and quantitative explanation of an important pair of multi-sensory oddity detection experiments involving cues across and within modalities - for which MLI previously failed dramatically, allowing a novel unifying treatment of within and cross modal multisensory perception. Our successful application of structure inference models to the new 'oddity detection' paradigm, and the resultant unified explanation of across and within modality cases provide further evidence to suggest that structure inference may be a commonly evolved principle for combining perceptual information in the brain.	[Hospedales, Timothy; Vijayakumar, Sethu] Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hospedales, T (corresponding author), Univ Edinburgh, Sch Informat, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland.	t.hospedales@ed.ac.uk		Hospedales, Timothy/0000-0003-4867-7486	Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh; Royal Academy of Engineering in Learning Robotics [fellowship]; Microsoft Research	Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh; Royal Academy of Engineering in Learning Robotics; Microsoft Research(Microsoft)	TMH was supported by the Neuroinformatics Doctoral Training Center (Neuroinformatics DTC) at the University of Edinburgh. SV is supported by a fellowship of the Royal Academy of Engineering in Learning Robotics, co-sponsored by Microsoft Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BARSHALOM Y, 1975, AUTOMATICA, V11, P451, DOI 10.1016/0005-1098(75)90021-7; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; ERNST M, 2005, BAYESIAN VIEW MULTIM, P105; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Geiger D, 1996, ARTIF INTELL, V82, P45, DOI 10.1016/0004-3702(95)00014-3; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gepshtein S, 2005, J VISION, V5, P1013, DOI 10.1167/5.11.7; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HOSPEDALES T, 2007, INT JOINT C ART INT; Hospedales TM, 2008, IEEE T PATTERN ANAL, V30, P2140, DOI 10.1109/TPAMI.2008.25; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KNILL DC, 2007, J VIS, V7; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Landy MS, 2001, J OPT SOC AM A, V18, P2307, DOI 10.1364/JOSAA.18.002307; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacKay D. J. C., 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Macmillan NA, 2005, DETECTION THEORY USE; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9	37	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4205	10.1371/journal.pone.0004205	http://dx.doi.org/10.1371/journal.pone.0004205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145254	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479800011
J	Hoshino, Y; Hayashi, N; Taniguchi, S; Kobayashi, N; Sakai, K; Otani, T; Iritani, A; Saeki, K				Hoshino, Yoichiro; Hayashi, Noboru; Taniguchi, Shunji; Kobayashi, Naohiko; Sakai, Kenji; Otani, Tsuyoshi; Iritani, Akira; Saeki, Kazuhiro			Resurrection of a Bull by Cloning from Organs Frozen without Cryoprotectant in a -80 degrees C Freezer for a Decade	PLOS ONE			English	Article							NUCLEAR TRANSFER; SOMATIC-CELLS; MICE; SPERMATOZOA; EMBRYOS; BOVINE; BODIES; GENOME; ADULT; FETAL	Frozen animal tissues without cryoprotectant have been thought to be inappropriate for use as a nuclear donor for somatic cell nuclear transfer (SCNT). We report the cloning of a bull using cells retrieved from testicles that had been taken from a dead animal and frozen without cryoprotectant in a -80 degrees C freezer for 10 years. We obtained live cells from defrosted pieces of the spermatic cords of frozen testicles. The cells proliferated actively in culture and were apparently normal. We transferred 16 SCNT embryos from these cells into 16 synchronized recipient animals. We obtained five pregnancies and four cloned calves developed to term. Our results indicate that complete genome sets are maintained in mammalian organs even after long-term frozen-storage without cryoprotectant, and that live clones can be produced from the recovered cells.	[Hoshino, Yoichiro; Hayashi, Noboru; Kobayashi, Naohiko; Sakai, Kenji; Otani, Tsuyoshi] Gifu Prefectural Livestock Res Inst, Gifu, Japan; [Hayashi, Noboru; Taniguchi, Shunji; Kobayashi, Naohiko; Sakai, Kenji; Otani, Tsuyoshi; Iritani, Akira; Saeki, Kazuhiro] Kinki Univ, Dept Genet Engn, Kinokawa Wakayama, Japan; [Hoshino, Yoichiro; Hayashi, Noboru; Taniguchi, Shunji; Kobayashi, Naohiko; Iritani, Akira; Saeki, Kazuhiro] Wakayama Ind Promot Fdn, Wakayama, Japan	Kindai University (Kinki University)	Hoshino, Y (corresponding author), Gifu Prefectural Livestock Res Inst, Gifu, Japan.	saeki@waka.kindai.ac.jp			Kinki University; Gifu Prefecture; Wakayama Prefectural Collaboration of Regional Entities for the Advancement of Technological Excellence, JST	Kinki University; Gifu Prefecture; Wakayama Prefectural Collaboration of Regional Entities for the Advancement of Technological Excellence, JST(Japan Science & Technology Agency (JST))	We received research grants from Kinki University and Gifu Prefecture. We were also supported by the project of Wakayama Prefectural Collaboration of Regional Entities for the Advancement of Technological Excellence, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth D, 1998, NATURE, V394, P329, DOI 10.1038/28521; Corley-Smith GE, 1999, MOL REPROD DEV, V53, P363, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;363::AID-MRD12&gt;3.0.CO;2-0; Heyligers Ide C., 2005, Cell and Tissue Banking, V6, P25, DOI 10.1007/s10561-005-1089-4; Inoue-Murayama Miho, 1997, Animal Science and Technology, V68, P443; Kasamatsu A, 2007, J REPROD DEVELOP, V53, P623, DOI 10.1262/jrd.19005; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Lanza R P, 2000, Cloning, V2, P79, DOI 10.1089/152045500436104; Laowtammathron C, 2005, THERIOGENOLOGY, V64, P1185, DOI 10.1016/j.theriogenology.2005.02.001; LI J, 2008, BIOL REPROD, DOI DOI 10.1095/BIOLREPROD.1108.069583; Loi P, 2002, BIOL REPROD, V67, P126, DOI 10.1095/biolreprod67.1.126; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Loi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002978; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; POLLARD J, 1997, BASIC CELL CULTURE P, P1; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Ryder OA, 1997, ZOO BIOL, V16, P295, DOI 10.1002/(SICI)1098-2361(1997)16:4<295::AID-ZOO1>3.0.CO;2-5; Sansinena MJ, 2005, THERIOGENOLOGY, V63, P1081, DOI 10.1016/j.theriogenology.2004.05.025; Wakayama S, 2008, P NATL ACAD SCI USA, V105, P17318, DOI 10.1073/pnas.0806166105; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079	25	43	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4142	10.1371/journal.pone.0004142	http://dx.doi.org/10.1371/journal.pone.0004142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129919	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473500002
J	Sussman, M; Mieog, JC; Doyle, J; Victor, S; Willis, BL; Bourne, DG				Sussman, Meir; Mieog, Jos C.; Doyle, Jason; Victor, Steven; Willis, Bette L.; Bourne, David G.			Vibrio Zinc-Metalloprotease Causes Photoinactivation of Coral Endosymbionts and Coral Tissue Lesions	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OUTER ENVELOPE MEMBRANE; POCILLOPORA-DAMICORNIS; HEMAGGLUTININ PROTEASE; PHOTOSYSTEM-II; CLIMATE-CHANGE; SP-NOV.; VULNIFICUS METALLOPROTEASE; ELEVATED-TEMPERATURES; YELLOW BLOTCH/BAND	Background: Coral diseases are emerging as a serious threat to coral reefs worldwide. Of nine coral infectious diseases, whose pathogens have been characterized, six are caused by agents from the family Vibrionacae, raising questions as to their origin and role in coral disease aetiology. Methodology/Principal Findings: Here we report on a Vibrio zinc-metalloprotease causing rapid photoinactivation of susceptible Symbiodinium endosymbionts followed by lesions in coral tissue. Symbiodinium photosystem II inactivation was diagnosed by an imaging pulse amplitude modulation fluorometer in two bioassays, performed by exposing Symbiodinium cells and coral juveniles to non-inhibited and EDTA-inhibited supernatants derived from coral white syndrome pathogens. Conclusion/Significance: These findings demonstrate a common virulence factor from four phylogenetically related coral pathogens, suggesting that zinc-metalloproteases may play an important role in Vibrio pathogenicity in scleractinian corals.	[Sussman, Meir; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Sussman, Meir; Mieog, Jos C.; Doyle, Jason; Bourne, David G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Mieog, Jos C.] AIMS, Townsville, Qld, Australia; [Victor, Steven] Univ Groningen, Biol Ctr, Dept Marine Bent Ecol & Evolut, Haren, Netherlands; PICRC, Koror, Palau	James Cook University; James Cook University; Australian Institute of Marine Science; University of Groningen	Sussman, M (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	dsmb007@jcu.edu.au	Bourne, David G/B-5073-2008; Mieog, Jos/N-6522-2014; Mieog, Jos/AAV-3371-2021	Bourne, David G/0000-0002-1492-8710; Mieog, Jos/0000-0002-2153-8956; Mieog, Jos/0000-0002-2153-8956	ARC [Discovery grant]; James Cook University CRIG; NWO-WOTRO [W84-576]; Australian Institute of Marine Science	ARC(Australian Research Council); James Cook University CRIG; NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Australian Institute of Marine Science	This study was funded by an ARC Discovery grant and a James Cook University CRIG grant to BL Willis. JC Mieog was supported by a NWO-WOTRO grant (the Netherlands, project nr. W84-576). Work at the Cape Ferguson laboratories was supported by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguirre-Guzman G, 2004, AQUAC RES, V35, P1395, DOI 10.1111/j.1365-2109.2004.01165.x; Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony SL, 2008, DIS AQUAT ORGAN, V81, P255, DOI 10.3354/dao01962; Asada K, 1996, PHOTOSYNTHESIS ENV, P123, DOI DOI 10.1007/0-306-48135-9_5; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barash Y, 2005, AQUAT MICROB ECOL, V40, P183, DOI 10.3354/ame040183; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BOOTH BA, 1983, INFECT IMMUN, V42, P639, DOI 10.1128/IAI.42.2.639-644.1983; BOOTH BA, 1986, J INFECT DIS, V154, P183, DOI 10.1093/infdis/154.1.183; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Breitbart M, 2005, FEMS MICROBIOL LETT, V243, P431, DOI 10.1016/j.femsle.2005.01.004; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cervino JM, 2004, SYMBIOSIS, V37, P63; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; CROWTHER RS, 1987, BIOCHIM BIOPHYS ACTA, V924, P393, DOI 10.1016/0304-4165(87)90153-X; Denkin SM, 1999, APPL ENVIRON MICROB, V65, P3555; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; EGIDIUS E, 1987, AQUACULTURE, V67, P15, DOI 10.1016/0044-8486(87)90004-4; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOW S, 1988, REV INFECT DIS, V10, pS274; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P3432, DOI 10.1021/bi00228a012; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Foulongne V, 2004, PATHOL BIOL, V52, P104, DOI 10.1016/j.patbio.2003.06.001; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; Goarant C, 1998, AQUACULTURE, V169, P291, DOI 10.1016/S0044-8486(98)00380-9; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Havaux M, 2003, PLANT PHYSIOL, V132, P300, DOI 10.1104/pp.102.017178; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; JOYARD J, 1983, J BIOL CHEM, V258, P1; KARUNASAGAR I, 1994, AQUACULTURE, V128, P203, DOI 10.1016/0044-8486(94)90309-3; Kimura M., 1983, NEUTRAL THEORY MOL E; KOCH R, 1891, BAKT FORSCH VERH 10; KOTHARY MH, 1985, INFECT IMMUN, V50, P534, DOI 10.1128/IAI.50.2.534-540.1985; KUOKAU L, 1997, CURR MICROBIOL, V34, P110; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LARSEN KS, 1991, BIOCHEMISTRY-US, V30, P2613, DOI 10.1021/bi00224a007; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Miyoshi S, 2001, TOXICON, V39, P1883, DOI 10.1016/S0041-0101(01)00171-4; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Murray AG, 2009, PREV VET MED, V88, P167, DOI 10.1016/j.prevetmed.2008.09.006; NORQVIST A, 1990, INFECT IMMUN, V58, P3731, DOI 10.1128/IAI.58.11.3731-3736.1990; OLIVER JD, 1986, DIAGN MICR INFEC DIS, V5, P99, DOI 10.1016/0732-8893(86)90112-4; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Piskorska M, 2007, AFRICAN J ENV SCI TE, V1, P93; Pochon X, 2001, MAR BIOL, V139, P1069; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Retief J D, 2000, Methods Mol Biol, V132, P243; Roff G, 2008, J PHYCOL, V44, P526, DOI 10.1111/j.1529-8817.2008.00480.x; Rosenberg E, 2004, ANNU REV MICROBIOL, V58, P143, DOI 10.1146/annurev.micro.58.030603.123610; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosenberg E, 2009, ISME J, V3, P139, DOI 10.1038/ismej.2008.104; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santiago-Vazquez LZ, 2007, MAR BIOL, V152, P549, DOI 10.1007/s00227-007-0704-2; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; SCHREIBER E., 1927, WISS MEERESUNTERSUCH ABT HELGOLAND, V16, P1; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; Schroda M, 1999, PLANT CELL, V11, P1165, DOI 10.1105/tpc.11.6.1165; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2006, DIS AQUAT ORGAN, V69, P111, DOI 10.3354/dao069111; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; UTZ JP, 1962, LAB INVEST, V11, P1018; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P2617, DOI 10.1098/rspb.2001.2007; VANOPPEN MJ, 2001, P BIOL SCI, V1478, P1759; Varina M, 2008, J BACTERIOL, V190, P6589, DOI 10.1128/JB.00535-08; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; WOO PTK, 1999, FISH DIS DISORDERS, V3; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yoshida Takashi, 2003, Microbes and Environments, V18, P216, DOI 10.1264/jsme2.18.216; [No title captured]	136	73	74	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4511	10.1371/journal.pone.0004511	http://dx.doi.org/10.1371/journal.pone.0004511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225559	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000265486000003
J	Hnasko, R; Bruederle, CE				Hnasko, Robert; Bruederle, Cathrin E.			Inoculation of Scrapie with the Self-Assembling RADA-Peptide Disrupts Prion Accumulation and Extends Hamster Survival	PLOS ONE			English	Article							NANOFIBER SCAFFOLD; LAMININ RECEPTOR; TRANSGENIC MICE; BETA-SHEET; CONGO RED; PROTEIN; PRP; INHIBITION; PROPAGATION; CONVERSION	Intracerebral inoculation of 263K Scrapie brain homogenate (PrPsc) with a self-assembling RADA-peptide (RADA) significantly delayed disease onset and increased hamster survival. Time of survival was dependent on the dose of RADA and pre-incubation with PrPsc prior to inoculation. RADA treatment resulted in the absence of detectable PrPsc at 40 d followed by an increased rate of PrPsc accumulation at 75 d up to sacrifice. In all PrPsc inoculated animals, clinical symptoms were observed similar to 10 d prior to sacrifice and brains showed spongiform degeneration with Congo red positive plaques. A time-dependent increase in reactive gliosis was observed in both groups with more GFAP detected in RADA treated animals at all time points. The PrP protein showed dose-dependent binding to RADA and this binding was competitively inhibited by Congo Red. We conclude that RADA disrupts the efficacy of prion transmission by altering the rate of PrPsc accumulation. This is the first demonstration that a self-assembling biomolecular peptide can interact with PrPsc, disrupt the course of Scrapie disease process, and extend survival.	[Hnasko, Robert; Bruederle, Cathrin E.] USDA ARS, PWA, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA	United States Department of Agriculture (USDA)	Hnasko, R (corresponding author), USDA ARS, PWA, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA.	Robert.Hnasko@ars.usda.gov			USDA-ARS National Program in AnimalHealth [5325-32000-008-00D]	USDA-ARS National Program in AnimalHealth	This work was supported and administered under the USDA-ARS National Program in AnimalHealth (CRIS # 5325-32000-008-00D). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funding agency has approved the publication of this manuscript.	BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Caspi S, 1998, J BIOL CHEM, V273, P3484, DOI 10.1074/jbc.273.6.3484; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DE GL, 1994, J BIOL CHEM, V269, P7859; DEARMOND SJ, 1994, PHILOS T R SOC B, V343, P415, DOI 10.1098/rstb.1994.0038; DeArmond SJ, 2003, CLIN LAB MED, V23, P1, DOI 10.1016/S0272-2712(02)00041-0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Demaimay R, 1998, J NEUROCHEM, V71, P2534; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Lu X, 2006, CURR PHARM DESIGN, V12, P2749, DOI 10.2174/138161206777947713; Ludewigs H, 2007, EXPERT REV ANTI-INFE, V5, P613, DOI 10.1586/14787210.5.4.613; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roterman I, 2001, Med Sci Monit, V7, P771; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Scott MR, 2000, ARCH VIROL, P113; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23; Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a	41	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4440	10.1371/journal.pone.0004440	http://dx.doi.org/10.1371/journal.pone.0004440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212437	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484200006
J	Singh, A; Mohan, ML; Isaac, AO; Luo, X; Petrak, J; Vyoral, D; Singh, N				Singh, Ajay; Mohan, Maradumane L.; Isaac, Alfred Orina; Luo, Xiu; Petrak, Jiri; Vyoral, Daniel; Singh, Neena			Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NEURONAL PRP; COPPER; TRAFFICKING; MECHANISMS; BRAIN; REPLICATION; TRANSFERRIN; ENDOCYTOSIS; INSIGHTS	Converging evidence leaves little doubt that a change in the conformation of prion protein (PrPC) from a mainly alpha-helical to a beta-sheet rich PrP-scrapie (PrPSc) form is the main event responsible for prion disease associated neurotoxicity. However, neither the mechanism of toxicity by PrPSc, nor the normal function of PrPC is entirely clear. Recent reports suggest that imbalance of iron homeostasis is a common feature of prion infected cells and mouse models, implicating redox-iron in prion disease pathogenesis. In this report, we provide evidence that PrPC mediates cellular iron uptake and transport, and mutant PrP forms alter cellular iron levels differentially. Using human neuroblastoma cells as models, we demonstrate that over-expression of PrPC increases intra-cellular iron relative to non-transfected controls as indicated by an increase in total cellular iron, the cellular labile iron pool (LIP), and iron content of ferritin. As a result, the levels of iron uptake proteins transferrin (Tf) and transferrin receptor (TfR) are decreased, and expression of iron storage protein ferritin is increased. The positive effect of PrPC on ferritin iron content is enhanced by stimulating PrPC endocytosis, and reversed by cross-linking PrPC on the plasma membrane. Expression of mutant PrP forms lacking the octapeptide-repeats, the membrane anchor, or carrying the pathogenic mutation PrP102L decreases ferritin iron content significantly relative to PrPC expressing cells, but the effect on cellular LIP and levels of Tf, TfR, and ferritin is complex, varying with the mutation. Neither PrPC nor the mutant PrP forms influence the rate or amount of iron released into the medium, suggesting a functional role for PrPC in cellular iron uptake and transport to ferritin, and dysfunction of PrPC as a significant contributing factor of brain iron imbalance in prion disorders.	[Singh, Ajay; Mohan, Maradumane L.; Isaac, Alfred Orina; Luo, Xiu; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Petrak, Jiri; Vyoral, Daniel] Charles Univ Prague, Fac Med 1, Dept Pathol Physiol, CR-11636 Prague, Czech Republic	Case Western Reserve University; Charles University Prague	Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Petrak, Jiri/I-8950-2017; Isaac, Alfred Orina/AEO-1445-2022; Mohan, Maradumane L/F-4700-2013	Petrak, Jiri/0000-0002-8695-4803; Isaac, Alfred Orina/0000-0003-3338-2239; 	NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039089, R29NS035962, R01NS035962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding source, NIH. Sponsor had no role at all in the study.	Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Campana V, 2007, J BIOL CHEM, V282, P22747, DOI 10.1074/jbc.M701468200; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Choi CJ, 2007, TOXICOL SCI, V98, P495, DOI 10.1093/toxsci/kfm099; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Erel O, 1998, CLIN CHEM, V44, P2313; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hur K, 2002, MECH AGEING DEV, V123, P1637, DOI 10.1016/S0047-6374(02)00099-4; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jin TC, 2000, J BIOL CHEM, V275, P38699, DOI 10.1074/jbc.M005543200; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim NH, 2000, BRAIN RES, V884, P98, DOI 10.1016/S0006-8993(00)02907-3; Liu XF, 2005, ANN NY ACAD SCI, V1054, P136, DOI 10.1196/annals.1345.016; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Petrak JF, 2001, J INORG BIOCHEM, V86, P669, DOI 10.1016/S0162-0134(01)00232-X; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; SINGH A, 2009, PLOS PATHOG IN PRESS; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Tenopoulou M, 2007, BIOCHEM J, V403, P261, DOI 10.1042/BJ20061840; Vyoral D, 1998, BIOL TRACE ELEM RES, V61, P263, DOI 10.1007/BF02789087; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zivny JH, 2008, BLOOD CELL MOL DIS, V40, P302, DOI 10.1016/j.bcmd.2007.09.009	45	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4468	10.1371/journal.pone.0004468	http://dx.doi.org/10.1371/journal.pone.0004468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212444	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484200016
J	Miao, W; Xiong, J; Bowen, J; Wang, W; Liu, YF; Braguinets, O; Grigull, J; Pearlman, RE; Orias, E; Gorovsky, MA				Miao, Wei; Xiong, Jie; Bowen, Josephine; Wang, Wei; Liu, Yifan; Braguinets, Olga; Grigull, Jorg; Pearlman, Ronald E.; Orias, Eduardo; Gorovsky, Martin A.			Microarray Analyses of Gene Expression during the Tetrahymena thermophila Life Cycle	PLOS ONE			English	Article								Background: The model eukaryote, Tetrahymena thermophila, is the first ciliated protozoan whose genome has been sequenced, enabling genome-wide analysis of gene expression. Methodology/Principal Findings: A genome-wide microarray platform containing the predicted coding sequences (putative genes) for T. thermophila is described, validated and used to study gene expression during the three major stages of the organism's life cycle: growth, starvation and conjugation. Conclusions/Significance: Of the,27,000 predicted open reading frames, transcripts homologous to only,5900 are not detectable in any of these life cycle stages, indicating that this single-celled organism does indeed contain a large number of functional genes. Transcripts from over 5000 predicted genes are expressed at levels >5x corrected background and 95 genes are expressed at >250x corrected background in all stages. Transcripts homologous to 91 predicted genes are specifically expressed and 155 more are highly up-regulated in growing cells, while 90 are specifically expressed and 616 are up-regulated during starvation. Strikingly, transcripts homologous to 1068 predicted genes are specifically expressed and 1753 are significantly up-regulated during conjugation. The patterns of gene expression during conjugation correlate well with the developmental stages of meiosis, nuclear differentiation and DNA elimination. The relationship between gene expression and chromosome fragmentation is analyzed. Genes encoding proteins known to interact or to function in complexes show similar expression patterns, indicating that co-ordinate expression with putative genes of known function can identify genes with related functions. New candidate genes associated with the RNAi-like process of DNA elimination and with meiosis are identified and the late stages of conjugation are shown to be characterized by specific expression of an unexpectedly large and diverse number of genes not involved in nuclear functions.	[Miao, Wei; Bowen, Josephine; Wang, Wei; Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Miao, Wei; Xiong, Jie] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Wang, Wei] Shanxi Univ, Inst Biotechnol, Taiyuan, Peoples R China; [Liu, Yifan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Braguinets, Olga; Pearlman, Ronald E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, N York, ON M3J 1P3, Canada; [Orias, Eduardo] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA USA	University of Rochester; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Shanxi University; University of Michigan System; University of Michigan; York University - Canada; York University - Canada; University of California System; University of California Santa Barbara	Miao, W (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	miaowei530@yeah.net; goro@mail.rochester.edu		Xiong, Jie/0000-0001-8923-0424; miao, wei/0000-0003-3440-8322; Liu, Yifan/0000-0002-3896-0002	National Institutes of Health [GM021793, GM072752]; Projects of International Cooperation from the Ministry of Science and Technology of China [2006DFA31960]; Natural Sciences Foundation of China [30670298]; NCRR (NIH) [RR009231]; University of California Toxic Substance Research and Teaching Program [SB060007]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR009231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072752, R01GM021793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Projects of International Cooperation from the Ministry of Science and Technology of China; Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NCRR (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of California Toxic Substance Research and Teaching Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM021793 and GM072752 to M.G., and Projects of International Cooperation from the Ministry of Science and Technology of China (No.2006DFA31960) and Natural Sciences Foundation of China (No.30670298) to W. M. E.O. was supported by NCRR (NIH) grant RR009231 and a University of California Toxic Substance Research and Teaching Program grant, SB060007. R.E.P. was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng035; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Asai DJ, 2000, METHODS CELL BIOL; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borst P, 1998, MOL BIOCHEM PARASIT, V91, P67, DOI 10.1016/S0166-6851(97)00184-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BRUNS PJ, 1974, J EXP ZOOL, V188, P337, DOI 10.1002/jez.1401880309; BRUNS PJ, 1975, DEV BIOL, V42, P75, DOI 10.1016/0012-1606(75)90315-2; CALZONE FJ, 1983, J BIOL CHEM, V258, P6887; CassidyHanley D, 1997, GENETICS, V146, P135; Cole ES, 1997, DEV BIOL, V189, P215, DOI 10.1006/dbio.1997.8648; Coyne RS, 1996, GENETICS, V144, P1479; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fan QC, 2000, METHOD CELL BIOL, V62, P533; Feng LF, 2007, AQUAT TOXICOL, V81, P99, DOI 10.1016/j.aquatox.2006.11.005; FINLEY MJ, 1980, DEV BIOL, V79, P81, DOI 10.1016/0012-1606(80)90074-3; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Frankel J, 2000, METHOD CELL BIOL, V62, P27; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; GAERTIG J, 1993, CELL MOTIL CYTOSKEL, V25, P243, DOI 10.1002/cm.970250305; GIBBONS IR, 1963, P NATL ACAD SCI USA, V50, P1002, DOI 10.1073/pnas.50.5.1002; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Guerra RF, 2007, BIOPHYS J, V93, P176, DOI 10.1529/biophysj.106.099929; Hamilton EP, 2006, GENOMICS, V88, P443, DOI 10.1016/j.ygeno.2006.05.002; Hamilton EP, 2006, EUKARYOT CELL, V5, P771, DOI 10.1128/EC.5.4.771-780.2006; HOROWITZ S, 1985, P NATL ACAD SCI USA, V82, P2452, DOI 10.1073/pnas.82.8.2452; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenuwein H, 2002, SCIENCE, V297, P2215, DOI 10.1126/science.1077903; KAPLER GM, 1994, GENETICS, V137, P455; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Li SQ, 2006, DEV BIOL, V295, P633, DOI 10.1016/j.ydbio.2006.03.048; Liu YF, 2005, EUKARYOT CELL, V4, P421, DOI 10.1128/EC.4.2.421-431.2005; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; MARTINDALE DW, 1982, EXP CELL RES, V140, P227, DOI 10.1016/0014-4827(82)90172-0; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; Miao W, 2006, ENVIRON MICROBIOL, V8, P1122, DOI 10.1111/j.1462-2920.2006.00988.x; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, EUKARYOT CELL, V3, P1233, DOI 10.1128/EC.3.5.1233-1240.2004; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2008, J CELL SCI, V121, P2148, DOI 10.1242/jcs.031799; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; NELSEN EM, 1978, J PROTOZOOL, V25, P113, DOI 10.1111/j.1550-7408.1978.tb03880.x; NELSEN EM, 1978, DEV BIOL, V66, P17, DOI 10.1016/0012-1606(78)90270-1; Nikiforov MA, 1999, GENE DEV, V13, P2852, DOI 10.1101/gad.13.21.2852; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Orias E, 2000, J EUKARYOT MICROBIOL, V47, P328, DOI 10.1111/j.1550-7408.2000.tb00057.x; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Shrimali RK, 2005, BIOCHEM BIOPH RES CO, V329, P147, DOI 10.1016/j.bbrc.2005.01.120; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smothers JF, 1997, DEVELOPMENT, V124, P4537; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P180, DOI 10.1093/nar/22.2.180; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Udani RA, 2002, MECH DEVELOP, V118, P215, DOI 10.1016/S0925-4773(02)00259-9; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Wei Z, 2006, DEV BIOL, V300, P476, DOI 10.1016/j.ydbio.2006.08.034; Weinstein JN, 2008, SCIENCE, V319, P1772, DOI 10.1126/science.1151888; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; YAO MC, 1987, CELL, V48, P779, DOI 10.1016/0092-8674(87)90075-4; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	82	137	160	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4429	10.1371/journal.pone.0004429	http://dx.doi.org/10.1371/journal.pone.0004429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204800	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000015
J	Xiang, J; Yang, HB; Che, C; Zou, HX; Yang, HS; Wei, YQ; Quan, JM; Zhang, H; Yang, Z; Lin, S				Xiang, Jing; Yang, Hongbo; Che, Chao; Zou, Haixia; Yang, Hanshuo; Wei, Yuquan; Quan, Junmin; Zhang, Hui; Yang, Zhen; Lin, Shuo			Identifying Tumor Cell Growth Inhibitors by Combinatorial Chemistry and Zebrafish Assays	PLOS ONE			English	Article								Cyclin-dependent kinases (CDKs) play important roles in regulating cell cycle progression, and altered cell cycles resulting from over-expression or abnormal activation of CDKs observed in many human cancers. As a result, CDKs have become extensive studied targets for developing chemical inhibitors for cancer therapies; however, protein kinases share a highly conserved ATP binding pocket at which most chemical inhibitors bind, therefore, a major challenge in developing kinase inhibitors is achieving target selectivity. To identify cell growth inhibitors with potential applications in cancer therapy, we used an integrated approach that combines one-pot chemical synthesis in a combinatorial manner to generate diversified small molecules with new chemical scaffolds coupled with growth inhibition assay using developing zebrafish embryos. We report the successful identification of a novel lead compound that displays selective inhibitory effects on CDK2 activity, cancer cell proliferation, and tumor progression in vivo. Our approaches should have general applications in developing cell proliferation inhibitors using an efficient combinatorial chemical genetic method and integrated biological assays. The novel cell growth inhibitor we identified should have potential as a cancer therapeutic agent.	[Zou, Haixia; Yang, Zhen] Peking Univ, Coll Chem, Key Lab Bioorgan Chem & Mol Engn, Minist Educ, Beijing 100871, Peoples R China; [Xiang, Jing; Che, Chao; Zou, Haixia; Quan, Junmin; Zhang, Hui; Yang, Zhen; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen, Peoples R China; [Yang, Hongbo; Lin, Shuo] Peking Univ, Minist Educ, Coll Life Sci, Ctr Dev Biol & Genet, Beijing, Peoples R China; [Yang, Hanshuo; Wei, Yuquan] Sichuan Univ, W China Med Sch, W China Hosp, Biotherapy & Canc Ctr, State Key Lab, Chengdu, Peoples R China; [Zhang, Hui] Nevada Canc Inst, Las Vegas, NV USA; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol, Cell, & Dev Biol, Los Angeles, CA 90024 USA	Peking University; Peking University; University Town of Shenzhen; Peking University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Xiang, J (corresponding author), Peking Univ, Coll Chem, Key Lab Bioorgan Chem & Mol Engn, Minist Educ, Beijing 100871, Peoples R China.	zyang@pku.edu.cn; shuolin@ucla.edu	Yang, Zhen/J-6306-2015	Yang, Zhen/0000-0001-8036-934X; Che, Chao/0000-0001-7773-0907	National Science Foundation of China [20325208, 20225318, 20521202, 20672004]; Ministry of Education of China (985 program); Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China (985 program)(Ministry of Education, China); Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University	National Science Foundation of China (Grants 20325208, 20225318, 20521202, and 20672004), the Ministry of Education of China (985 program), Shenzhen Science and Technology Key Laboratory Promotion Fund, and the Instrumental Analysis Fund of Peking University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; Armstrong RW, 1996, ACCOUNTS CHEM RES, V29, P123, DOI 10.1021/ar9502083; Balme G, 2003, EUR J ORG CHEM, V2003, P4101, DOI 10.1002/ejoc.200300378; Bienayme H, 1998, ANGEW CHEM INT EDIT, V37, P2234, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R; Bienayme H, 2000, CHEM-EUR J, V6, P3321, DOI 10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO;2-A; Byth KF, 2004, BIOORG MED CHEM LETT, V14, P2249, DOI 10.1016/j.bmcl.2004.02.008; Cantrell CL, 1999, NAT PROD LETT, V14, P39, DOI 10.1080/10575639908045433; CHE C, 2007, J COMB CHEM; Cohen P, 1999, CURR OPIN CHEM BIOL, V3, P459, DOI 10.1016/S1367-5931(99)80067-2; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FANTL V, 1993, CANCER SURV, V18, P77; Fischer PM, 2000, CURR MED CHEM, V7, P1213, DOI 10.2174/0929867003374048; Hardcastle IR, 2004, J MED CHEM, V47, P3710, DOI 10.1021/jm0311442; Hirai H, 2005, CURR TOP MED CHEM, V5, P167, DOI 10.2174/1568026053507688; Huwe A, 2003, ANGEW CHEM INT EDIT, V42, P2122, DOI 10.1002/anie.200200540; Kato N, 2003, J CANCER RES CLIN, V129, P222, DOI 10.1007/s00432-003-0426-x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koeller KM, 2000, CHEM REV, V100, P4465, DOI 10.1021/cr990297n; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lemeer S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000581; Lonardo F, 1999, CANCER RES, V59, P2470; Luk KC, 2004, BIOORG MED CHEM LETT, V14, P913, DOI 10.1016/j.bmcl.2003.12.009; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McMahon G, 1998, Curr Opin Drug Discov Devel, V1, P131; Meijer L, 1999, PHARMACOL THERAPEUT, V82, P279, DOI 10.1016/S0163-7258(98)00057-6; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nicolaou KC, 2003, CHEM COMMUN, P551, DOI 10.1039/b209440c; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pevarello P, 2004, J MED CHEM, V47, P3367, DOI 10.1021/jm031145u; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sharma V, 2004, J MED CHEM, V47, P3700, DOI 10.1021/jm040013d; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sielecki TM, 2000, J MED CHEM, V43, P1, DOI 10.1021/jm990256j; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; SUMANAS S, 2004, TARGET; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tang J, 2003, BIOORG MED CHEM LETT, V13, P2985, DOI 10.1016/S0960-894X(03)00630-9; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; WOLOWIEC D, 1995, LEUKEMIA, V9, P1382; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129; Zhu JP, 2003, EUR J ORG CHEM, V2003, P1133, DOI 10.1002/ejoc.200390167	49	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4361	10.1371/journal.pone.0004361	http://dx.doi.org/10.1371/journal.pone.0004361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194508	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483600006
J	Battaglia, S; Benzoubir, N; Nobilet, S; Charneau, P; Samuel, D; Zignego, AL; Atfi, A; Brechot, C; Bourgeade, MF				Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Charneau, Pierre; Samuel, Didier; Zignego, Anna Linda; Atfi, Azeddine; Brechot, Christian; Bourgeade, Marie-Francoise			Liver Cancer-Derived Hepatitis C Virus Core Proteins Shift TGF-Beta Responses from Tumor Suppression to Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Background: Chronic hepatitis C virus (HCV) infection and associated liver cirrhosis represent a major risk factor for hepatocellular carcinoma (HCC) development. TGF-beta is an important driver of liver fibrogenesis and cancer; however, its actual impact in human cancer progression is still poorly known. The aim of this study was to investigate the role of HCC-derived HCV core natural variants on cancer progression through their impact on TGF-beta signaling. Principal Findings: We provide evidence that HCC-derived core protein expression in primary human or mouse hepatocyte alleviates TGF-beta responses in terms or growth inhibition or apoptosis. Instead, in these hepatocytes TGF-beta was still able to induce an epithelial to mesenchymal transition (EMT), a process that contributes to the promotion of cell invasion and metastasis. Moreover, we demonstrate that different thresholds of Smad3 activation dictate the TGF-beta responses in hepatic cells and that HCV core protein, by decreasing Smad3 activation, may switch TGF-beta growth inhibitory effects to tumor promoting responses. Conclusion/Significance: Our data illustrate the capacity of hepatocytes to develop EMT and plasticity under TGF-beta, emphasize the role of HCV core protein in the dynamic of these effects and provide evidence for a paradigm whereby a viral protein implicated in oncogenesis is capable to shift TGF-beta responses from cytostatic effects to EMT development.	[Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Samuel, Didier; Brechot, Christian; Bourgeade, Marie-Francoise] INSERM, U 785, Villejuif, France; [Battaglia, Serena; Benzoubir, Nassima; Nobilet, Soizic; Samuel, Didier; Bourgeade, Marie-Francoise] Univ Paris Sud, UMR S 785, Villejuif, France; [Charneau, Pierre] Inst Pasteur, Grp Vectorol, Paris, France; [Samuel, Didier; Bourgeade, Marie-Francoise] AP HP, Hop Paul Brousse, Ctr Hepato Biliaire, Villejuif, France; [Zignego, Anna Linda] Univ Florence, Dept Internal Med, I-50121 Florence, Italy; [Atfi, Azeddine] INSERM, U 673, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm)	Battaglia, S (corresponding author), INSERM, U 785, Villejuif, France.	marion.bourgeade@inserm.fr	CHARNEAU, Pierre/M-1565-2017; Ibrahim, Essam Hassan/G-1960-2018; Zignego, Anna Linda/AAL-8205-2021	CHARNEAU, Pierre/0000-0003-1184-5773; Ibrahim, Essam Hassan/0000-0003-0130-2257; BENZOUBIR, Nassima/0000-0001-7502-7441	INSERM; Association pour la Recherche sur le Cancer (ARC); Agence Nationale de Recherche sur le SIDA (ANRS); European Community (VIRGIL)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); European Community (VIRGIL)(European Commission)	This work was supported by INSERM, Association pour la Recherche sur le Cancer (ARC), Agence Nationale de Recherche sur le SIDA (ANRS) and European Community (VIRGIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; BAUM B, 2008, SEMIN CELL DEV BIOL; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Delhem N, 2001, ONCOGENE, V20, P5836, DOI 10.1038/sj.onc.1204744; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Giannini C, 2003, HEPATOLOGY, V38, P114, DOI 10.1053/jhep.2003.50265; GRESSNER OA, 2008, J GASTROENTEROL HEPA; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kao CF, 2004, ONCOGENE, V23, P2472, DOI 10.1038/sj.onc.1207368; Lai MMC, 2000, CURR TOP MICROBIOL, V242, P117; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McIntyre M, 1999, ONCOGENE, V18, P4577, DOI 10.1038/sj.onc.1202815; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Pawlotsky Jean-Michel, 2003, Clin Liver Dis, V7, P45, DOI 10.1016/S1089-3261(02)00065-X; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3; Rullier A, 2001, MODERN PATHOL, V14, P496, DOI 10.1038/modpathol.3880338; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schrantz N, 2001, MOL BIOL CELL, V12, P3139, DOI 10.1091/mbc.12.10.3139; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Serra R, 2005, ENDOCR-RELAT CANCER, V12, P749, DOI 10.1677/erc.1.00936; Sobesky R, 2007, HEPATOLOGY, V46, P1704, DOI 10.1002/hep.21898; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu NL, 1998, J VIROL, V72, P3691, DOI 10.1128/JVI.72.5.3691-3697.1998	47	100	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4355	10.1371/journal.pone.0004355	http://dx.doi.org/10.1371/journal.pone.0004355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190755	gold, Green Published			2022-12-27	WOS:000265483300005
J	Hammond, KL; Loynes, HE; Mowbray, C; Runke, G; Hammerschmidt, M; Mullins, MC; Hildreth, V; Chaudhry, B; Whitfield, TT				Hammond, Katherine L.; Loynes, Helen E.; Mowbray, Catriona; Runke, Greg; Hammerschmidt, Matthias; Mullins, Mary C.; Hildreth, Victoria; Chaudhry, Bill; Whitfield, Tanya T.			A Late Role for bmp2b in the Morphogenesis of Semicircular Canal Ducts in the Zebrafish Inner Ear	PLOS ONE			English	Article								Background: The Bone Morphogenetic Protein (BMP) genes bmp2 and bmp4 are expressed in highly conserved patterns in the developing vertebrate inner ear. It has, however, proved difficult to elucidate the function of BMPs during ear development as mutations in these genes cause early embryonic lethality. Previous studies using conditional approaches in mouse and chicken have shown that Bmp4 has a role in semicircular canal and crista development, but there is currently no direct evidence for the role of Bmp2 in the developing inner ear. Methodology/Principal Findings: We have used an RNA rescue strategy to test the role of bmp2b in the zebrafish inner ear directly. Injection of bmp2b or smad5 mRNA into homozygous mutant swirl (bmp2b(-/-)) embryos rescues the early patterning defects in these mutants and the fish survive to adulthood. As injected RNA will only last, at most, for the first few days of embryogenesis, all later development occurs in the absence of bmp2b function. Although rescued swirl adult fish are viable, they have balance defects suggestive of vestibular dysfunction. Analysis of the inner ears of these fish reveals a total absence of semicircular canal ducts, structures involved in the detection of angular motion. All other regions of the ear, including the ampullae and cristae, are present and appear normal. Early stages of otic development in rescued swirl embryos are also normal. Conclusions/Significance: Our findings demonstrate a critical late role for bmp2b in the morphogenesis of semicircular canals in the zebrafish inner ear. This is the first demonstration of a developmental role for any gene during post-embryonic stages of otic morphogenesis in the zebrafish. Despite differences in the early stages of semicircular canal formation between zebrafish and amniotes, the role of Bmp2 in semicircular canal duct outgrowth is likely to be conserved between different vertebrate species.	[Hammond, Katherine L.; Loynes, Helen E.; Mowbray, Catriona; Whitfield, Tanya T.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Hammerschmidt, Matthias] Max Planck Inst Immunobiol, Freiburg, Germany; [Runke, Greg; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Hildreth, Victoria; Chaudhry, Bill] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England	University of Sheffield; Max Planck Society; University of Pennsylvania; Newcastle University - UK	Hammond, KL (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	t.whitfield@sheffield.ac.uk	Whitfield, Tanya/E-6203-2010	Whitfield, Tanya/0000-0003-1575-1504	Wellcome Trust [057101]; MRC [G78/5898, G0400100, G0700091]; NIH [R01-GM56326]; British Heart Foundation; Yorkshire Cancer Research; Medical Research Council [G0700091B, G0400100, G0400100B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056326] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Yorkshire Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Wellcome Trust (057101) and the MRC (G78/5898) to TW, from the NIH (R01-GM56326) to MCM, and from the British Heart Foundation to BC. Funding for the confocal imaging in Fig. 3 was provided by Yorkshire Cancer Research. The CDBG zebrafish aquaria were supported by the MRC (G0400100, G0700091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer H, 2001, DEVELOPMENT, V128, P849; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Cecconi F, 2004, DEVELOPMENT, V131, P2125, DOI 10.1242/dev.01082; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Dick A, 2000, DEVELOPMENT, V127, P343; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Fekete DM, 1997, DEVELOPMENT, V124, P2451; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Gerlach-Bank LM, 2004, DEV DYNAM, V229, P219, DOI 10.1002/dvdy.10414; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Hild M, 1999, DEVELOPMENT, V126, P2149; Kappler JA, 2004, P NATL ACAD SCI USA, V101, P13056, DOI 10.1073/pnas.0405224101; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kobayashi Y, 2008, TOHOKU J EXP MED, V215, P207, DOI 10.1620/tjem.215.207; Kramer C, 2002, DEV BIOL, V250, P263, DOI 10.1006/dbio.2002.0805; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lambert FM, 2008, J NEUROSCI, V28, P8086, DOI 10.1523/JNEUROSCI.1288-08.2008; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Morsli H, 1998, J NEUROSCI, V18, P3327; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; MOWBRAY C, 2002, THESIS U SHEFFIELD; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Oh SH, 1996, J NEUROSCI, V16, P6463; Orlovsky G N, 1991, Curr Opin Neurobiol, V1, P621, DOI 10.1016/S0959-4388(05)80039-X; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Robledo RF, 2006, GENESIS, V44, P425, DOI 10.1002/dvg.20233; Salminen M, 2000, DEVELOPMENT, V127, P13; Schmid B, 2000, DEVELOPMENT, V127, P957; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Shawi M, 2008, GENE EXPR PATTERNS, V8, P369, DOI 10.1016/j.gep.2008.05.004; Sidi S, 2004, J NEUROSCI, V24, P4213, DOI 10.1523/JNEUROSCI.0223-04.2004; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang WD, 2004, DEV CELL, V7, P439, DOI 10.1016/j.devcel.2004.06.016; Wang WD, 2001, DEVELOPMENT, V128, P5017; WATERMAN RE, 1984, ANAT REC, V210, P101, DOI 10.1002/ar.1092100113; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu DK, 1996, J NEUROSCI, V16, P6454	55	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4368	10.1371/journal.pone.0004368	http://dx.doi.org/10.1371/journal.pone.0004368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190757	Green Published, gold, Green Accepted			2022-12-27	WOS:000265483300007
J	Weber, P; Kula-Eversole, E; Pyza, E				Weber, Pawel; Kula-Eversole, Elzbieta; Pyza, Elzbieta			Circadian Control of Dendrite Morphology in the Visual System of Drosophila melanogaster	PLOS ONE			English	Article							PERIOD GENE-PRODUCT; 1ST OPTIC NEUROPIL; MUSCA-DOMESTICA L; RHYTHMIC CHANGES; SIZE CHANGES; CRYPTOCHROME; CLOCK; FLUCTUATIONS; EXPRESSION; PIGMENT	Background: In the first optic neuropil (lamina) of the fly's visual system, monopolar cells L1 and L2 and glia show circadian rhythms in morphological plasticity. They change their size and shape during the day and night. The most pronounced changes have been detected in circadian size of the L2 axons. Looking for a functional significance of the circadian plasticity observed in axons, we examined the morphological plasticity of the L2 dendrites. They extend from axons and harbor postsynaptic sites of tetrad synaptic contacts from the photoreceptor terminals. Methodology/Principal Findings: The plasticity of L2 dendrites was evaluated by measuring an outline of the L2 dendritic trees. These were from confocal images of cross sections of L2 cells labeled with GFP. They were in wild-type and clock mutant flies held under different light conditions and sacrified at different time points. We found that the L2 dendrites are longest at the beginning of the day in both males and females. This rhythm observed under a day/night regime (LD) was maintained in constant darkness (DD) but not in continuous light (LL). This rhythm was not present in the arrhythmic per(01) mutant in LD or in DD. In the clock photoreceptor cry(b) mutant the rhythm was maintained but its pattern was different than that observed in wild-type flies. Conclusions/Significance: The results obtained showed that the L2 dendrites exhibit circadian structural plasticity. Their morphology is controlled by the per gene-dependent circadian clock. The L2 dendrites are longest at the beginning of the day when the daytime tetrad presynaptic sites are most numerous and L2 axons are swollen. The presence of the rhythm, but with a different pattern in cry(b) mutants in LD and DD indicates a new role of cry in the visual system. The new role is in maintaining the circadian pattern of changes of the L2 dendrite length and shape.	[Weber, Pawel; Kula-Eversole, Elzbieta; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cytol & Histol, PL-30060 Krakow, Poland; [Kula-Eversole, Elzbieta] Howard Hughes Med Inst, Dept Biol, Waltham, MA USA; [Kula-Eversole, Elzbieta] Brandeis Univ, Natl Ctr Behavioral Genom, Waltham, MA 02254 USA	Jagiellonian University; Howard Hughes Medical Institute; Brandeis University	Weber, P (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cytol & Histol, PL-30060 Krakow, Poland.	elzbieta.pyza@uj.edu.pl			Polish Ministry of Science and High Education [N303 040 32/1400]; Jagiellonian University; NIH [NS44232, P30 NS45713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland); Jagiellonian University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by Polish Ministry of Science and High Education grant no N303 040 32/1400 and Jagiellonian University grant DS ZCH 2007/2008 to Elzbieta Pyza, and in part by NIH grants NS44232 and P30 NS45713 to Michael Rosbash. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balys M, 2001, J EXP BIOL, V204, P3303; BRAND AH, 1993, DEVELOPMENT, V118, P401; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CHEN DM, 1992, VISUAL NEUROSCI, V9, P125, DOI 10.1017/S0952523800009585; Cheng YZ, 1998, J NEUROSCI, V18, P741; COLLINS B, 2006, CELL, V95, P669; EWER J, 1992, J NEUROSCI, V12, P3321; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; GORSKAANDRZEJAK J, 2003, J INSECT PH IN PRESS; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Miskiewicz K, 2008, J COMP NEUROL, V509, P422, DOI 10.1002/cne.21765; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; PYZA E, 1993, P ROY SOC B-BIOL SCI, V254, P97, DOI 10.1098/rspb.1993.0133; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 1997, J NEUROBIOL, V32, P517, DOI 10.1002/(SICI)1097-4695(199705)32:5<517::AID-NEU6>3.0.CO;2-8; Shafer OT, 2002, J NEUROSCI, V22, P5946; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; ZERR DM, 1990, J NEUROSCI, V10, P2749	31	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4290	10.1371/journal.pone.0004290	http://dx.doi.org/10.1371/journal.pone.0004290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173003	gold, Green Published			2022-12-27	WOS:000265483000005
J	Honda, M; Eriksson, KS; Zhang, SW; Tanaka, S; Lin, L; Salehi, A; Hesla, PE; Maehlen, J; Gaus, SE; Yanagisawa, M; Sakurai, T; Taheri, S; Tsuchiya, K; Honda, Y; Mignot, E				Honda, Makoto; Eriksson, Krister S.; Zhang, Shengwen; Tanaka, Susumu; Lin, Ling; Salehi, Ahmad; Hesla, Per Egil; Maehlen, Jan; Gaus, Stephanie E.; Yanagisawa, Masashi; Sakurai, Takeshi; Taheri, Shahrad; Tsuchiya, Kuniaki; Honda, Yutaka; Mignot, Emmanuel			IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; GENE-EXPRESSION; LATERAL HYPOTHALAMUS; CEREBROSPINAL-FLUID; HUMAN NARCOLEPSY; TRANSGENIC MICE; KNOCKOUT MICE; CANCER CELLS; GROWTH; NEURONS	Background: The sleep disorder narcolepsy is caused by a vast reduction in neurons producing the hypocretin (orexin) neuropeptides. Based on the tight association with HLA, narcolepsy is believed to result from an autoimmune attack, but the cause of hypocretin cell loss is still unknown. We performed gene expression profiling in the hypothalamus to identify novel genes dysregulated in narcolepsy, as these may be the target of autoimmune attack or modulate hypocretin gene expression. Methodology/Principal Findings: We used microarrays to compare the transcriptome in the posterior hypothalamus of (1) narcoleptic versus control postmortem human brains and (2) transgenic mice lacking hypocretin neurons versus wild type mice. Hypocretin was the most downregulated gene in human narcolepsy brains. Among many additional candidates, only one, insulin-like growth factor binding protein 3 (IGFBP3), was downregulated in both human and mouse models and co-expressed in hypocretin neurons. Functional analysis indicated decreased hypocretin messenger RNA and peptide content, and increased sleep in transgenic mice overexpressing human IGFBP3, an effect possibly mediated through decreased hypocretin promotor activity in the presence of excessive IGFBP3. Although we found no IGFBP3 autoantibodies nor a genetic association with IGFBP3 polymorphisms in human narcolepsy, we found that an IGFBP3 polymorphism known to increase serum IGFBP3 levels was associated with lower CSF hypocretin-1 in normal individuals. Conclusions/Significance: Comparison of the transcriptome in narcolepsy and narcolepsy model mouse brains revealed a novel dysregulated gene which colocalized in hypocretin cells. Functional analysis indicated that the identified IGFBP3 is a new regulator of hypocretin cell physiology that may be involved not only in the pathophysiology of narcolepsy, but also in the regulation of sleep in normal individuals, most notably during adolescence. Further studies are required to address the hypothesis that excessive IGFBP3 expression may initiate hypocretin cell death and cause narcolepsy.	[Tanaka, Susumu] Tokyo Inst Psychiat, Sleep Disorder Res Project, Tokyo, Japan; [Honda, Makoto; Eriksson, Krister S.; Zhang, Shengwen; Lin, Ling; Gaus, Stephanie E.; Mignot, Emmanuel] Stanford Univ, Ctr Narcolepsy, Palo Alto, CA USA; [Salehi, Ahmad] Stanford Univ, Dept Neurol, Palo Alto, CA USA; [Hesla, Per Egil; Maehlen, Jan] Univ Oslo, Dept Pathol, N-0316 Oslo, Norway; [Yanagisawa, Masashi] Univ Texas, Dept Molecular Genet, Dallas, TX USA; [Sakurai, Takeshi] Kanagawa Univ, Dept Molecular Neurosci & Integrative Physiol, Kanazawa, Ishikawa, Japan; [Taheri, Shahrad] Univ Bristol, Lab Integrative Neurosci & Endocrinol, Bristol BS8 1TH, Avon, England; [Tsuchiya, Kuniaki] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Honda, Yutaka] Neuropsychiat Inst, Japan Somnol Ctr, Tokyo, Japan; [Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA USA	Tokyo Institute of Psychiatry; Stanford University; Stanford University; University of Oslo; University of Texas System; University of Texas Dallas; Kanagawa University; University of Bristol; Howard Hughes Medical Institute; Stanford University	Honda, M (corresponding author), Tokyo Inst Psychiat, Sleep Disorder Res Project, Tokyo, Japan.	honda@prit.go.jp; mignot@stanford.edu	Tanaka, Susumu/AAC-4739-2019; Salehi, Ahmad/H-2746-2019; Taheri, Shahrad/O-9721-2016	Tanaka, Susumu/0000-0003-4804-7839; Salehi, Ahmad/0000-0001-8257-3280; Taheri, Shahrad/0000-0001-8314-1500; Zhang, Shengwen/0000-0001-7318-3870	NIH [MH073435]; Ministry of Education, Science, Sports and Culture; Science Research on Priority Areas Comprehensive Genomics; Uehara Memorial Foundation; Howard Hughes Medical Institute;  [19390310];  [1739034]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science Research on Priority Areas Comprehensive Genomics; Uehara Memorial Foundation(Uehara Memorial Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH-MH073435 to E. Mignot and by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research 19390310, 1739034 and Science Research on Priority Areas Comprehensive Genomics and in part by Uehara Memorial Foundation to M. Honda. E. Mignot (Investigator) is funded by the Howard Hughes Medical Institute.	Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Blouin AM, 2005, NEUROLOGY, V65, P1189, DOI 10.1212/01.wnl.0000175219.01544.c8; Broberger C, 1998, J COMP NEUROL, V402, P460; Bunn RC, 2005, PEDIATR RES, V58, P89, DOI 10.1203/01.PDR.0000156369.62787.96; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Fang Peng, 2004, Novartis Found Symp, V262, P215; Franz H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r112; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Jernstrom H, 2001, CANCER EPIDEM BIOMAR, V10, P377; Katsuki H, 2004, NEUROBIOL DIS, V15, P61, DOI 10.1016/j.nbd.2003.09.003; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin L, 2002, PEPTIDES, V23, P2203, DOI 10.1016/S0196-9781(02)00251-6; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Modric T, 2001, ENDOCRINOLOGY, V142, P1958, DOI 10.1210/en.142.5.1958; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Obal F, 2001, REV NEUROL-FRANCE, V157, pS12; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Reti IM, 2002, J NEUROCHEM, V82, P1561, DOI 10.1046/j.1471-4159.2002.01141.x; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, pU29; Santer FR, 2006, CANCER RES, V66, P3024, DOI 10.1158/0008-5472.CAN-05-2013; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Schneider HJ, 2003, EUR J ENDOCRINOL, V149, P377, DOI 10.1530/eje.0.1490377; Silha JV, 2005, ENDOCRINOLOGY, V146, P1523, DOI 10.1210/en.2004-0905; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Taheri S, 2004, SLEEP, V27, P243; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel-Hopker A, 2002, DEVELOPMENT, V129, P983; Zhang SW, 2007, J PHYSIOL-LONDON, V581, P649, DOI 10.1113/jphysiol.2007.129510	46	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4254	10.1371/journal.pone.0004254	http://dx.doi.org/10.1371/journal.pone.0004254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158946	gold, Green Submitted, Green Published			2022-12-27	WOS:000265482200010
J	Dupouy, S; Viardot-Foucault, V; Alifano, M; Souaze, F; Plu-Bureau, G; Chaouat, M; Lavaur, A; Hugol, D; Gespach, C; Gompel, A; Forgez, P				Dupouy, Sandra; Viardot-Foucault, Veronique; Alifano, Marco; Souaze, Frederique; Plu-Bureau, Genevieve; Chaouat, Marc; Lavaur, Anne; Hugol, Danielle; Gespach, Christian; Gompel, Anne; Forgez, Patricia			The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression	PLOS ONE			English	Article								Background: The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1), are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series of transforming functions including cellular migration and invasion. Methods and Results: we investigated the expression of NTS and NTSR1 in normal human breast tissue and in invasive ductal breast carcinomas (IDCs) by immunohistochemistry and RT-PCR. NTS is expressed and up-regulated by estrogen in normal epithelial breast cells. NTS is also found expressed in the ductal and invasive components of IDCs. The high expression of NTSR1 is associated with the SBR grade, the size of the tumor, and the number of metastatic lymph nodes. Furthermore, the NTSR1 high expression is an independent factor of prognosis associated with the death of patients. Conclusion: these data support the activation of neurotensinergic deleterious pathways in breast cancer progression.	[Dupouy, Sandra; Viardot-Foucault, Veronique; Souaze, Frederique; Gespach, Christian; Gompel, Anne; Forgez, Patricia] UPMC, Hop St Antoine, INSERM, CDR St Antoine EQ 5, Paris, France; [Viardot-Foucault, Veronique; Plu-Bureau, Genevieve; Lavaur, Anne; Gompel, Anne] Univ Paris 05, AP HP, Hotel Dieu Paris, Unite Gynecol, Paris, France; [Alifano, Marco] Univ Paris 05, AP HP, Hotel Dieu Paris, Serv Chirurg Thorac, Paris, France; [Chaouat, Marc] Hop Rotschild, AP HP, Serv Chirurg Plastique, Paris, France; [Hugol, Danielle] Univ Paris 05, AP HP, Hotel Dieu Paris, Dept Anatomo Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dupouy, S (corresponding author), UPMC, Hop St Antoine, INSERM, CDR St Antoine EQ 5, Paris, France.	patricia.forgez@inserm.fr	Gompel, Anne/AAV-3132-2020; Souazé, Frédérique/K-7937-2015; souazé, frédérique/AAE-6478-2021; Alifano, Marco/AAN-7800-2020; FORGEZ, Patricia/N-2960-2018	Frederique, Souaze/0000-0003-0476-2603	INSERM; UPMC; ARC Association pour la Recherche sur le Cancer [3543]; LNC (Ligue Nationale Contre le cancer) [75/00-RS/40, 07/75-85]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; ARC Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); LNC (Ligue Nationale Contre le cancer)	This work has been supported by INSERM, UPMC and a Grant from ARC (Association pour la Recherche sur le Cancer # 3543) and LNC (Ligue Nationale Contre le cancer) # 75/00-RS/40 and 07/75-85 France. Sandra Dupouy was supported by the Ligue nationale contre le cancer.	ALEXANDER MJ, 1993, ENDOCRINOLOGY, V133, P1809, DOI 10.1210/en.133.4.1809; ALEXANDER MJ, 1994, J COMP NEUROL, V345, P496, DOI 10.1002/cne.903450403; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1982, DIGESTION, V23, P174, DOI 10.1159/000198725; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Dong ZZ, 1998, AM J PHYSIOL-GASTR L, V274, pG535, DOI 10.1152/ajpgi.1998.274.3.G535; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; GOMPEL A, 1986, J CLIN ENDOCR METAB, V63, P1174, DOI 10.1210/jcem-63-5-1174; Hassan S, 2004, REGUL PEPTIDES, V120, P155, DOI 10.1016/j.regpep.2004.03.004; KAPUSCINSKI M, 1990, J CLIN ENDOCR METAB, V70, P100, DOI 10.1210/jcem-70-1-100; Leyton J, 2002, EUR J PHARMACOL, V442, P179, DOI 10.1016/S0014-2999(02)01539-X; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; REINECKE M, 1985, PROG HISTOCHEM CYTOC, V16, P1; Rostene WH, 1997, FRONT NEUROENDOCRIN, V18, P115, DOI 10.1006/frne.1996.0146; Somai S, 2002, BIOCHEM BIOPH RES CO, V295, P482, DOI 10.1016/S0006-291X(02)00703-9; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 1997, J BIOL CHEM, V272, P10087; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Toy-Miou-Leong M, 2004, J BIOL CHEM, V279, P12636, DOI 10.1074/jbc.M303384200; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; Wang QD, 2006, NEOPLASIA, V8, P781, DOI 10.1593/neo.06259; Watters JJ, 1998, J NEUROSCI, V18, P6672; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002	30	70	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4223	10.1371/journal.pone.0004223	http://dx.doi.org/10.1371/journal.pone.0004223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156213	gold, Green Published, Green Submitted			2022-12-27	WOS:000265481900005
J	Jackson, JC; Higgins, LA; Lin, XR				Jackson, Jennifer C.; Higgins, Laura A.; Lin, Xiaorong			Conidiation Color Mutants of Aspergillus fumigatus Are Highly Pathogenic to the Heterologous Insect Host Galleria mellonella	PLOS ONE			English	Article							CANDIDA-ALBICANS MUTANTS; CRYPTOCOCCUS-NEOFORMANS; CAENORHABDITIS-ELEGANS; MELANIN BIOSYNTHESIS; PIGMENT BIOSYNTHESIS; VIRULENCE FACTORS; MODEL; GENE; LARVAE; SYSTEM	The greater wax moth Galleria mellonella has been widely used as a heterologous host for a number of fungal pathogens including Candida albicans and Cryptococcus neoformans. A positive correlation in pathogenicity of these yeasts in this insect model and animal models has been observed. However, very few studies have evaluated the possibility of applying this heterologous insect model to investigate virulence traits of the filamentous fungal pathogen Aspergillus fumigatus, the leading cause of invasive aspergillosis. Here, we have examined the impact of mutations in genes involved in melanin biosynthesis on the pathogenicity of A. fumigatus in the G. mellonella model. Melanization in A. fumigatus confers bluish-grey color to conidia and is a known virulence factor in mammal models. Surprisingly, conidial color mutants in B5233 background that have deletions in the defined six-gene cluster required for DHN-melanin biosynthesis caused enhanced insect mortality compared to the parent strain. To further examine and confirm the relationship between melanization defects and enhanced virulence in the wax moth model, we performed random insertional mutagenesis in the Af293 genetic background to isolate mutants producing altered conidia colors. Strains producing conidia of previously identified colors and of novel colors were isolated. Interestingly, these color mutants displayed a higher level of pathogenicity in the insect model compared to the wild type. Although some of the more virulent color mutants showed increased resistance to hydrogen peroxide, overall phenotypic characterizations including secondary metabolite production, metalloproteinase activity, and germination rate did not reveal a general mechanism accountable for the enhanced virulence of these color mutants observed in the insect model. Our observations indicate instead, that exacerbated immune response of the wax moth induced by increased exposure of PAMPs (pathogen-associated molecular patterns) may cause self-damage that results in increased mortality of larvae infected with the color mutants. The current study underscores the limitations of using this insect model for inferring the pathogenic potential of A. fumigatus strains in mammals, but also points to the importance of understanding the innate immunity of the insect host in providing insights into the pathogenicity level of different fungal strains in this model. Additionally, our observations that melanization defective color mutants demonstrate increased virulence in the insect wax moth, suggest the potential of using melanization defective mutants of native insect fungal pathogens in the biological control of insect populations.	[Jackson, Jennifer C.; Higgins, Laura A.; Lin, Xiaorong] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Jackson, JC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	xlin@mail.bio.tamu.edu	Lin, Xiaorong/ABC-4163-2021	Lin, Xiaorong/0000-0002-3390-8387	Biology Department of Texas A & M University	Biology Department of Texas A & M University	Startup fund to XL from Biology Department of Texas A & M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2007, INFECT IMMUN, V75, P175, DOI 10.1128/IAI.01385-06; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brush L, 1999, FUNGAL GENET BIOL, V28, P190, DOI 10.1006/fgbi.1999.1176; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Burgos A, 2008, PEDIATRICS, V121, pE1286, DOI 10.1542/peds.2007-2117; Casadevall A, 2005, INFECT IMMUN, V73, P3829, DOI 10.1128/IAI.73.7.3829-3832.2005; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; DEHOOG GS, 1993, ANTON LEEUW INT J G, V63, P105, DOI 10.1007/BF00872386; DIXON DM, 1987, J MED VET MYCOL, V25, P97; Dunphy GB, 2003, CAN J MICROBIOL, V49, P514, DOI 10.1139/W03-064; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Golebiowski M, 2008, INSECT BIOCHEM MOLEC, V38, P619, DOI 10.1016/j.ibmb.2008.03.005; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Hamilton A J, 1996, Curr Top Med Mycol, V7, P19; Held KG, 2007, APPL ENVIRON MICROB, V73, P7622, DOI 10.1128/AEM.01000-07; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Lionakis MS, 2005, MED MYCOL, V43, pS111, DOI 10.1080/13693780400020030; London R, 2006, FEMS YEAST RES, V6, P567, DOI 10.1111/j.1567-1364.2006.00056.x; Lumbreras Carlos, 2003, Revista Iberoamericana de Micologia, V20, P79; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Magill SS, 2008, EXPERT OPIN PHARMACO, V9, P193, DOI 10.1517/14656566.9.2.193 ; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Mylonakis Eleftherios, 2003, Expert Rev Anti Infect Ther, V1, P167, DOI 10.1586/14787210.1.1.167; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nosanchuk JD, 1999, MOL CELL BIOL, V19, P745; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RATCLIFFE NA, 1985, IMMUNOL LETT, V10, P253, DOI 10.1016/0165-2478(85)90100-2; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Revankar SG, 2007, MYCOSES, V50, P91, DOI 10.1111/j.1439-0507.2006.01331.x; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; SAKEMI S, 1995, J ANTIBIOT, V48, P134, DOI 10.7164/antibiotics.48.134; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS157, DOI 10.1086/376523; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tang RJ, 2005, INFECT IMMUN, V73, P8219, DOI 10.1128/IAI.73.12.8219-8225.2005; TAYLOR RL, 1969, J INVERTEBR PATHOL, V14, P427, DOI 10.1016/0022-2011(69)90178-5; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; Tojo S, 2000, J INSECT PHYSIOL, V46, P1129, DOI 10.1016/S0022-1910(99)00223-1; Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1997, MOL MICROBIOL, V26, P175, DOI 10.1046/j.1365-2958.1997.5681921.x; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Vaideeswar P, 2004, J Postgrad Med, V50, P21; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177	84	81	99	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4224	10.1371/journal.pone.0004224	http://dx.doi.org/10.1371/journal.pone.0004224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156203	Green Published, Green Submitted, gold			2022-12-27	WOS:000265481900006
J	Cameron, EZ; Dalerum, F				Cameron, Elissa Z.; Dalerum, Fredrik			A Trivers-Willard Effect in Contemporary Humans: Male-Biased Sex Ratios among Billionaires	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BOVINE EMBRYOS; OFFSPRING SEX; BIRTH; SONS; BLASTOCYST; INVESTMENT; ADJUSTMENT; HYPOTHESIS; DAUGHTERS	Background: Natural selection should favour the ability of mothers to adjust the sex ratio of offspring in relation to the offspring's potential reproductive success. In polygynous species, mothers in good condition would be advantaged by giving birth to more sons. While studies on mammals in general provide support for the hypothesis, studies on humans provide particularly inconsistent results, possibly because the assumptions of the model do not apply. Methodology/Principal Findings: Here, we take a subset of humans in very good condition: the Forbe's billionaire list. First, we test if the assumptions of the model apply, and show that mothers leave more grandchildren through their sons than through their daughters. We then show that billionaires have 60% sons, which is significantly different from the general population, consistent with our hypothesis. However, women who themselves are billionaires have fewer sons than women having children with billionaires, suggesting that maternal testosterone does not explain the observed variation. Furthermore, paternal masculinity as indexed by achievement, could not explain the variation, since there was no variation in sex ratio between self-made or inherited billionaires. Conclusions/Significance: Humans in the highest economic bracket leave more grandchildren through sons than through daughters. Therefore, adaptive variation in sex ratios is expected, and human mothers in the highest economic bracket do give birth to more sons, suggesting similar sex ratio manipulation as seen in other mammals.	[Cameron, Elissa Z.; Dalerum, Fredrik] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Pretoria	Cameron, EZ (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	ezcameron@zoology.up.ac.za	Cameron, Elissa Z/E-4280-2010; Cameron, Elissa/B-8053-2014; Dalerum, Fredrik/M-6068-2017	Cameron, Elissa/0000-0002-9243-0547; Dalerum, Fredrik/0000-0001-9737-8242	University of Pretoria Research Development Fund	University of Pretoria Research Development Fund	University of Pretoria Research Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Ayadhi LY, 2004, SAUDI MED J, V25, P711; Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Barker DJP, 1998, MOTHER BABIES HLTH L; Bartlett MS., 1936, J R STAT SOC, V3, P185; BORGERHOFFMULDE.M, 1998, HUM NATURE, V9, P119; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; GOMENDIO M, 1990, NATURE, V343, P261, DOI 10.1038/343261a0; Grant VJ, 2008, BIOL REPROD, V78, P812, DOI 10.1095/biolreprod.107.066050; Grant V. J., 1998, MATERNAL PERSONALITY; Grant VJ, 2003, HUM BIOL, V75, P917, DOI 10.1353/hub.2004.0005; Gutierrez-Adan A, 2001, REPROD FERT DEVELOP, V13, P361, DOI 10.1071/RD00039; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Helle S, 2008, J THEOR BIOL, V252, P773, DOI 10.1016/j.jtbi.2008.02.032; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; Kanazawa S, 2005, J THEOR BIOL, V235, P583, DOI 10.1016/j.jtbi.2005.02.010; Kanazawa S, 2005, J THEOR BIOL, V233, P589, DOI 10.1016/j.jtbi.2004.11.009; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Keller MC, 2001, EVOL HUM BEHAV, V22, P343, DOI 10.1016/S1090-5138(01)00075-7; Larson MA, 2001, P NATL ACAD SCI USA, V98, P9677, DOI 10.1073/pnas.171305398; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; Luna M, 2007, FERTIL STERIL, V87, P519, DOI 10.1016/j.fertnstert.2006.06.058; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; MYERS JH, 1978, AM NAT, V112, P381, DOI 10.1086/283280; Nevison C, 1997, APPL ANIM BEHAV SCI, V51, P285, DOI 10.1016/S0168-1591(96)01111-2; Phillips DIW, 2001, BRIT MED J, V322, P771, DOI 10.1136/bmj.322.7289.771; Potts M, 1997, POPUL DEV REV, V23, P1, DOI 10.2307/2137459; Rickard IJ, 2007, P ROY SOC B-BIOL SCI, V274, P2981, DOI 10.1098/rspb.2007.1051; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Stein AD, 2000, HUM BIOL, V72, P641; Tovee MJ, 2001, P ROY SOC B-BIOL SCI, V268, P1007, DOI 10.1098/rspb.2001.1618; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WHITE RE, 2006, ENTREPRENEURS EVOLUT	44	47	49	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4195	10.1371/journal.pone.0004195	http://dx.doi.org/10.1371/journal.pone.0004195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142225	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479700015
J	Kau, JH; Sun, DS; Huang, HH; Wong, MS; Lin, HC; Chang, HH				Kau, Jyh-Hwa; Sun, Der-Shan; Huang, Hsin-Hsien; Wong, Ming-Show; Lin, Hung-Chi; Chang, Hsin-Hou			Role of Visible Light-Activated Photocatalyst on the Reduction of Anthrax Spore-Induced Mortality in Mice	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; LETHAL TOXIN; INACTIVATION; TIO2; DISINFECTION; DESTRUCTION; GERMINATION; RESISTANCE	Background: Photocatalysis of titanium dioxide (TiO2) substrates is primarily induced by ultraviolet light irradiation. Anion-doped TiO2 substrates were shown to exhibit photocatalytic activities under visible-light illumination, relative environmentally-friendly materials. Their anti-spore activity against Bacillus anthracis, however, remains to be investigated. We evaluated these visible-light activated photocatalysts on the reduction of anthrax spore-induced pathogenesis. Methodology/Principal Findings: Standard plating method was used to determine the inactivation of anthrax spore by visible light-induced photocatalysis. Mouse models were further employed to investigate the suppressive effects of the photocatalysis on anthrax toxin- and spore-mediated mortality. We found that anti-spore activities of visible light illuminated nitrogen- or carbon-doped titania thin films significantly reduced viability of anthrax spores. Even though the spore-killing efficiency is only approximately 25%, our data indicate that spores from photocatalyzed groups but not untreated groups have a less survival rate after macrophage clearance. In addition, the photocatalysis could directly inactivate lethal toxin, the major virulence factor of B. anthracis. In agreement with these results, we found that the photocatalyzed spores have tenfold less potency to induce mortality in mice. These data suggest that the photocatalysis might injury the spores through inactivating spore components. Conclusion/Significance: Photocatalysis induced injuries of the spores might be more important than direct killing of spores to reduce pathogenicity in the host.	[Kau, Jyh-Hwa; Huang, Hsin-Hsien; Lin, Hung-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Mol Biol & Human Genet, Hualien, Taiwan; [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wong, Ming-Show] Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan	National Defense Medical Center; Tzu Chi University; Tzu Chi University; National Dong Hwa University	Kau, JH (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	hhchang@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council of Taiwan ROC [94-2216-E-259-002, 94-2120-M-259-003, 95-2314-B-320-009-MY3, 095-2811-B-320-001]	National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan ROC under grant no. NSC 94-2216-E-259-002, NSC 94-2120-M-259-003, NSC 95-2314-B-320-009-MY3 and 095-2811-B-320-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2; Bizani D, 2004, APPL MICROBIOL BIOT, V65, P158, DOI 10.1007/s00253-004-1570-1; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Chang HH, 2000, J BIOMED SCI, V7, P42, DOI 10.1159/000025428; Chang HH, 2006, J BIOTECHNOL, V126, P277, DOI 10.1016/j.jbiotec.2006.04.038; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; CHENG CL, 2009, J BIOMED SC IN PRESS, V16; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Elahifard MR, 2007, J AM CHEM SOC, V129, P9552, DOI 10.1021/ja072492m; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; Hamburg MA, 2002, TRENDS BIOTECHNOL, V20, P296, DOI 10.1016/S0167-7799(02)01989-3; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668, DOI 10.1128/AEM.59.5.1668-1670.1993; Iwasaki M, 2000, J COLLOID INTERF SCI, V224, P202, DOI 10.1006/jcis.1999.6694; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kort R, 2005, APPL ENVIRON MICROB, V71, P3556, DOI 10.1128/AEM.71.7.3556-3564.2005; Kudva IT, 2005, INFECT IMMUN, V73, P5685, DOI 10.1128/IAI.73.9.5685-5696.2005; Leahy MB, 1997, J VIROL, V71, P8352, DOI 10.1128/JVI.71.11.8352-8356.1997; LI E, 1975, APPL MICROBIOL, V30, P354, DOI 10.1128/AEM.30.3.354-361.1975; Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; RUSSELL AD, 1990, CLIN MICROBIOL REV, V3, P99, DOI 10.1128/CMR.3.2.99-119.1990; Sagripanti JL, 1996, APPL ENVIRON MICROB, V62, P545, DOI 10.1128/AEM.62.2.545-551.1996; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shieh KJ, 2006, NANOMED-NANOTECHNOL, V2, P121, DOI 10.1016/j.nano.2006.04.001; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6; Wang H, 2006, J PHYS-CONDENS MAT, V18, P421, DOI 10.1088/0953-8984/18/2/006; Weber MHW, 2002, PHILOS T R SOC B, V357, P895, DOI 10.1098/rstb.2002.1078; Whitney EAS, 2003, EMERG INFECT DIS, V9, P623; Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05; Yang MC, 2004, THIN SOLID FILMS, V469, P1, DOI 10.1016/j.tsf.2004.06.189; Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044; Zan L, 2007, J PHOTOCH PHOTOBIO B, V86, P165, DOI 10.1016/j.jphotobiol.2006.09.002	47	39	39	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4167	10.1371/journal.pone.0004167	http://dx.doi.org/10.1371/journal.pone.0004167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132100	Green Submitted, gold, Green Published			2022-12-27	WOS:000265473700006
J	Lu, FP; Lin, KP; Kuo, HK				Lu, Feng-Ping; Lin, Kun-Pei; Kuo, Hsu-Ko			Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; COGNITIVE DECLINE; DEPRESSIVE SYMPTOMS; ALZHEIMERS-DISEASE; OLDER-ADULTS; NONENZYMATIC GLYCOSYLATION; URINARY-INCONTINENCE; VASCULAR DEMENTIA; NATIONAL-HEALTH; WOMENS HEALTH	Background: Observational studies suggested an association between diabetes and the risk of various geriatric conditions (i.e., cognitive impairment, dementia, depression, mobility impairment, disability, falls, and urinary incontinence). However, the magnitude and impact of diabetes on older adults have not been reviewed. Methodology/Principal Findings: MEDLINE and PSYCINFO databases were searched through November 2007 for published studies, supplemented by manual searches of bibliographies of key articles. Population-based, prospective cohort studies that reported risk of geriatric outcomes in relation to diabetes status at baseline were selected. Two authors independently extracted the data, including study population and follow-up duration, ascertainment of diabetes status at baseline, outcomes of interest and their ascertainment, adjusted covariates, measures of association, and brief results. Fifteen studies examined the association of DM with cognitive dysfunction. DM was associated with a faster decline in cognitive function among older adults. The pooled adjusted risk ratio (RR) for all dementia when persons with DM were compared to those without was 1.47 (95% CI, 1.25 to 1.73). Summary RRs for Alzheimer's disease and vascular dementia comparing persons with DM to those without were 1.39 (CI, 1.16 to 1.66) and 2.38 (CI, 1.79 to 3.18), respectively. Four of 5 studies found significant association of DM with faster mobility decline and incident disability. Two studies examined the association of diabetes with falls in older women. Both found statistically significant associations. Insulin users had higher RR for recurrent falls. One study for urinary incontinence in older women found statistically significant associations. Two studies for depression did not suggest that DM was an independent predictor of incident depression. Conclusions/Significance: Current evidence supports that DM is associated with increased risk for selected geriatric conditions. Clinicians should increase their awareness and provide appropriate care. Future research is required to elucidate the underlying pathological pathway.	[Lin, Kun-Pei; Kuo, Hsu-Ko] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Lu, Feng-Ping] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan; [Lin, Kun-Pei] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei, Taiwan; [Kuo, Hsu-Ko] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Kuo, Hsu-Ko] Natl Hlth Res Inst, Div Gerontol Res, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Lu, FP (corresponding author), Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan.	hsukokuo@yahoo.com		LU, FENG-PING/0000-0002-7815-8030	National Health Research Institutes [GE-095-CP0]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	The study was supported by the National Health Research Institutes (Project Code: GE-095-CP0). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2005, NAT DIAB FACT SHEET; Bisschop MI, 2004, J CLIN EPIDEMIOL, V57, P187, DOI 10.1016/j.jclinepi.2003.01.001; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Brown JS, 2006, DIABETES CARE, V29, P1307, DOI 10.2337/dc05-2463; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Carnethon MR, 2007, ARCH INTERN MED, V167, P802, DOI 10.1001/archinte.167.8.802; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Collins R, 2003, LANCET, V361, P2005; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; Crooks VC, 2003, ANN EPIDEMIOL, V13, P613, DOI 10.1016/S1047-2797(03)00059-0; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x; de Rekeneire N, 2006, DIABETES CARE, V29, P1902, DOI 10.2337/dc05-2327; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Figaro MK, 2006, DIABETES CARE, V29, P2039, DOI 10.2337/dc06-0245; Fishel MA, 2005, ARCH NEUROL-CHICAGO, V62, P1539, DOI 10.1001/archneur.62.10.1539; Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366; Forrest KYZ, 2006, J GERONTOL A-BIOL, V61, P1194, DOI 10.1093/gerona/61.11.1194; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Gerstein HC, 2000, LANCET, V355, P253; Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100; Hassing LB, 2002, INT PSYCHOGERIATR, V14, P239, DOI 10.1017/S104161020200844X; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730; Kanaya AM, 2004, ARCH INTERN MED, V164, P1327, DOI 10.1001/archinte.164.12.1327; Katayama S, 2004, FEBS LETT, V575, P9, DOI 10.1016/j.febslet.2004.08.029; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kuleva NV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1119; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lifford KL, 2005, J AM GERIATR SOC, V53, P1851, DOI 10.1111/j.1532-5415.2005.53565.x; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3; MacKnight C, 2002, DEMENT GERIATR COGN, V14, P77, DOI 10.1159/000064928; Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; McAulay V, 2001, DIABETES CARE, V24, P1745, DOI 10.2337/diacare.24.10.1745; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x; Park SW, 2007, DIABETES CARE, V30, P1507, DOI 10.2337/dc06-2537; Payne GW, 2006, MICROCIRCULATION, V13, P315, DOI 10.1080/10739680600618918; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Petersen M, 2003, DIABETES CARE, V26, P917; Pugh KG, 2003, J AM GERIATR SOC, V51, P1439, DOI 10.1046/j.1532-5415.2003.51463.x; Qiu WQ, 2006, J AM GERIATR SOC, V54, P496, DOI 10.1111/j.1532-5415.2005.00632.x; Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Snow LM, 2006, PATHOBIOLOGY, V73, P244, DOI 10.1159/000098210; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SYROVY I, 1992, GEN PHYSIOL BIOPHYS, V11, P301; Volpato S, 2003, DIABETES CARE, V26, P70, DOI 10.2337/diacare.26.1.70; Wray LA, 2005, J GERONTOL A-BIOL, V60, P1206, DOI 10.1093/gerona/60.9.1206; Wu JH, 2003, DIABETES CARE, V26, P314, DOI 10.2337/diacare.26.2.314; Wu JH, 2003, J CLIN EPIDEMIOL, V56, P686, DOI 10.1016/S0895-4356(03)00077-5; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yoshimura N, 2005, BJU INT, V95, P733, DOI 10.1111/j.1464-410X.2005.05392.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	79	237	249	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4144	10.1371/journal.pone.0004144	http://dx.doi.org/10.1371/journal.pone.0004144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127292	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473300009
J	Alcina, A; Fedetz, M; Ndagire, D; Fernandez, O; Leyva, L; Guerrero, M; Abad-Grau, MM; Arnal, C; Delgado, C; Lucas, M; Izquierdo, G; Matesanz, F				Alcina, Antonio; Fedetz, Maria; Ndagire, Dorothy; Fernandez, Oscar; Leyva, Laura; Guerrero, Miguel; Abad-Grau, Maria M.; Arnal, Carmen; Delgado, Concepcion; Lucas, Miguel; Izquierdo, Guillermo; Matesanz, Fuencisla			IL2RA/CD25 Gene Polymorphisms: Uneven Association with Multiple Sclerosis (MS) and Type 1 Diabetes (T1D)	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE PTPN22; INTERLEUKIN-7 RECEPTOR; AUTOIMMUNE-DISEASES; FC RECEPTOR-LIKE-3; FUNCTIONAL VARIANT; POPULATION; FAMILIES; LOCUS; FCRL3; RISK	Background: IL-2 receptor (IL2R) alpha is the specific component of the high affinity IL2R system involved in the immune response and in the control of autoimmunity. Methods and Results: Here we perform a replication and fine mapping of the IL2RA gene region analyzing 3 SNPs previously associated with multiple sclerosis (MS) and 5 SNPs associated with type 1 diabetes (T1D) in a collection of 798 MS patients and 927 matched Caucasian controls from the south of Spain. We observed association with MS in 6 of 8 SNPs. The rs1570538, at the 3'-UTR extreme of the gene, previously reported to have a weak association with MS, is replicated here (P = 0.032). The most associated T1D SNP (rs41295061) was not associated with MS in the present study. However, the rs35285258, belonging to another independent group of SNPs associated with T1D, showed the maximal association in this study but different risk allele. We replicated the association of only one (rs2104286) of the two IL2RA SNPs identified in the recently performed genome-wide association study of MS. Conclusions: These findings confirm and extend the association of this gene with MS and reveal a genetic heterogeneity of the associated polymorphisms and risk alleles between MS and T1D suggesting different immunopathological roles of IL2RA in these two diseases.	[Fedetz, Maria; Ndagire, Dorothy; Matesanz, Fuencisla] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Fernandez, Oscar; Leyva, Laura; Guerrero, Miguel] Hosp Carlos Haya, Inst Neuroci Clin, Serv Neurol, Malaga, Spain; [Abad-Grau, Maria M.] Univ Granada, Dept Lenguajes Sist Informat, Granada, Spain; [Arnal, Carmen] Hosp Virgen Nieves, Serv Neurol, Granada, Spain; [Delgado, Concepcion] Ctr Region Transfus Sanguinea Granada Almeria, Granada, Spain; [Lucas, Miguel] Hosp Virgen Macarena, Serv Biol Mol, Seville, Spain; [Izquierdo, Guillermo] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Hospital Carlos Haya; University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena	Alcina, A (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	pulgoso@ipb.csic.es	Matesanz, Fuencisla/F-3715-2016; Alcina, Antonio/T-1893-2017; Leyva, Laura/B-5574-2019; Abad Grau, María del Mar/B-2172-2012; Leyva, Laura/R-2187-2019	Matesanz, Fuencisla/0000-0002-9429-1819; Alcina, Antonio/0000-0001-7294-0948; Leyva, Laura/0000-0003-0620-9625; Abad Grau, María del Mar/0000-0001-8470-9719; Leyva, Laura/0000-0003-0620-9625	Ministerio de Educacion y Ciencia [PN-SAF2006-02023, TIN2007-67418-C03-03]; Junta de Andalucia [P07-CVI-02551]; Servicio Andaluz de Salud de la Junta de Andalucia [PI0168/2007]; Fundacion IMABIS [fellowship]; AECI-Ministerio de Asuntos Exteriores [fellowship]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Andalucia(Junta de Andalucia); Servicio Andaluz de Salud de la Junta de Andalucia(Junta de Andalucia); Fundacion IMABIS; AECI-Ministerio de Asuntos Exteriores	Financial support for the study was provided by the Ministerio de Educacion y Ciencia (grants PN-SAF2006-02023 and TIN2007-67418-C03-03) and Junta de Andalucia (P07-CVI-02551) to A. Alcina and Servicio Andaluz de Salud de la Junta de Andalucia (grant PI0168/2007) to F. Matesanz. Maria Fedetz is a holder of a fellowship from Fundacion IMABIS. Dorothy Ndagire is a holder of AECI-Ministerio de Asuntos Exteriores fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2007, J NEUROL, V254, P1736, DOI 10.1007/s00415-007-0602-z; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barcellos LF, 2006, LANCET NEUROL, V5, P924, DOI 10.1016/S1474-4422(06)70552-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Corporaal S, 2002, CLIN RHEUMATOL, V21, P108, DOI 10.1007/PL00011215; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Karni A, 1999, NEUROLOGY, V53, P883, DOI 10.1212/WNL.53.4.883; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lindsey JW, 2005, AM J MED GENET A, V135A, P53, DOI 10.1002/ajmg.a.30702; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Matesanz F, 2008, J NEUROIMMUNOL, V195, P146, DOI 10.1016/j.jneuroim.2008.01.004; Matesanz Fuencisla, 2007, N Engl J Med, V357, P2200; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Owen CJ, 2007, J CLIN ENDOCR METAB, V92, P1106, DOI 10.1210/jc.2006-2183; Pitzalis M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-3; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Rueda B, 2006, ARTHRITIS RHEUM, V54, P3815, DOI 10.1002/art.22271; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843	33	58	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4137	10.1371/journal.pone.0004137	http://dx.doi.org/10.1371/journal.pone.0004137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125193	Green Published, gold			2022-12-27	WOS:000265473100011
J	Campino, S; Forton, J; Raj, S; Mohr, B; Auburn, S; Fry, A; Mangano, VD; Vandiedonck, C; Richardson, A; Rockett, K; Clark, TG; Kwiatkowski, DP				Campino, Susana; Forton, Julian; Raj, Srilakshmi; Mohr, Bert; Auburn, Sarah; Fry, Andrew; Mangano, Valentina D.; Vandiedonck, Claire; Richardson, Anna; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.			Validating Discovered Cis-Acting Regulatory Genetic Variants: Application of an Allele Specific Expression Approach to HapMap Populations	PLOS ONE			English	Article								Background: Localising regulatory variants that control gene expression is a challenge for genome research. Several studies have recently identified non-coding polymorphisms associated with inter-individual differences in gene expression. These approaches rely on the identification of signals of association against a background of variation due to other genetic and environmental factors. A complementary approach is to use an Allele-Specific Expression (ASE) assay, which is more robust to the effects of environmental variation and trans-acting genetic factors. Methodology/Principal Findings: Here we apply an ASE method which utilises heterozygosity within an individual to compare expression of the two alleles of a gene in a single cell. We used individuals from three HapMap population groups and analysed the allelic expression of genes with cis-regulatory regions previously identified using total gene expression studies. We were able to replicate the results in five of the six genes tested, and refined the cis-associated regions to a small number of variants. We also showed that by using multi-populations it is possible to refine the associated cis-effect DNA regions. Conclusions/Significance: We discuss the efficacy and drawbacks of both total gene expression and ASE approaches in the discovery of cis-acting variants. We show that the ASE approach has significant advantages as it is a cleaner representation of cis-acting effects. We also discuss the implication of using different populations to map cis-acting regions and the importance of finding regulatory variants which contribute to human phenotypic variation.	[Campino, Susana; Forton, Julian; Mohr, Bert; Auburn, Sarah; Fry, Andrew; Mangano, Valentina D.; Vandiedonck, Claire; Richardson, Anna; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Campino, Susana; Auburn, Sarah; Vandiedonck, Claire; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Forton, Julian] John Radcliffe Hosp, Univ Dept Paediat, Oxford, England; [Raj, Srilakshmi] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, JDRF, WT Diabetes & Inflammat Lab, Cambridge CB2 1TN, England; [Campino, Susana; Forton, Julian; Mangano, Valentina D.] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Sapienza University Rome	Campino, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	sc11@sanger.ac.uk	Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020; Fry, Andrew/AAN-2730-2020; Fry, Andrew/AFK-7448-2022; mangano, valentina/I-2456-2012; Auburn, Sarah/N-2266-2013	Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Fry, Andrew/0000-0001-9778-6924; Fry, Andrew/0000-0001-9778-6924; Auburn, Sarah/0000-0002-4638-536X; vandiedonck, claire/0000-0002-6669-6923; Mangano, Valentina D/0000-0002-2021-6162; Kwiatkowski, Dominic/0000-0002-5023-0176; Forton, Julian/0000-0002-0580-0432	Bill and Melinda Gates Foundation; Wellcome Trust [Clinical Research Training Fellowship]; Medical Research Council UK; Fundacao para a Ciencia e Tecnologia, Ministerio da Ciencia e Tecnologia [Portuguese Post-Doc fellowship]; MRC [G19/9, G0600230] Funding Source: UKRI; Medical Research Council [G0600230, G19/9] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e Tecnologia, Ministerio da Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Bill and Melinda Gates Foundation, Wellcome Trust, and Medical Research Council UK. SC was funded by a Portuguese Post-Doc fellowship from the Fundacao para a Ciencia e Tecnologia, Ministerio da Ciencia e Tecnologia. JF and AF were funded by a Wellcome Trust Clinical Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; SERRE SGD, 2008, PLOS GENET, V4, P1; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Teare MD, 2006, AM J HUM GENET, V79, P539, DOI 10.1086/506968	18	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4105	10.1371/journal.pone.0004105	http://dx.doi.org/10.1371/journal.pone.0004105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116668	Green Accepted, gold, Green Published			2022-12-27	WOS:000265466600022
J	Capra, EJ; Skrovanek, SM; Kruglyak, L				Capra, Emily J.; Skrovanek, Sonja M.; Kruglyak, Leonid			Comparative Developmental Expression Profiling of Two C-elegans Isolates	PLOS ONE			English	Article							SUPPLEMENTARY NUCLEAR RECEPTOR; INNATE IMMUNE-SYSTEM; GENOME-WIDE ANALYSIS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; CELL-CYCLE; TRANSCRIPTION FACTOR; RNAI SCREEN; GATA-FACTOR; LIFE-CYCLE	Gene expression is known to change during development and to vary among genetically diverse strains. Previous studies of temporal patterns of gene expression during C. elegans development were incomplete, and little is known about how these patterns change as a function of genetic background. We used microarrays that comprehensively cover known and predicted worm genes to compare the landscape of genetic variation over developmental time between two isolates of C. elegans. We show that most genes vary in expression during development from egg to young adult, many genes vary in expression between the two isolates, and a subset of these genes exhibit isolate-specific changes during some developmental stages. This subset is strongly enriched for genes with roles in innate immunity. We identify several novel motifs that appear to play a role in regulating gene expression during development, and we propose functional annotations for many previously unannotated genes. These results improve our understanding of gene expression and function during worm development and lay the foundation for linkage studies of the genetic basis of developmental variation in gene expression in this important model organism.	[Capra, Emily J.; Skrovanek, Sonja M.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Capra, Emily J.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Skrovanek, Sonja M.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Capra, EJ (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu			National Institutes of Health [R01 HG004321]; Lewis-Sigler Institute [P50 GM071508]; James S. McDonnell Foundation [Centennial Fellowship]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lewis-Sigler Institute; James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01 HG004321 to LK and P50 GM071508 to the Lewis-Sigler Institute) and a James S. McDonnell Foundation Centennial Fellowship (LK).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Alegado RA, 2003, CELL MICROBIOL, V5, P435, DOI 10.1046/j.1462-5822.2003.00287.x; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AVERY L, 1993, GENETICS, V133, P897; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; BRENNER S, 1974, GENETICS, V77, P71; Brozova E, 2006, MECH DEVELOP, V123, P689, DOI 10.1016/j.mod.2006.06.006; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cutter AD, 2005, MOL BIOL EVOL, V22, P178, DOI 10.1093/molbev/msh267; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fay DS, 2004, DEV BIOL, V271, P11, DOI 10.1016/j.ydbio.2004.03.022; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hwang BJ, 2007, DEVELOPMENT, V134, P669, DOI 10.1242/dev.02769; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Karashima T, 2000, DEVELOPMENT, V127, P1069; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Lee Min-Ho, 2006, WormBook, P1; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Loria PM, 2003, CURR BIOL, V13, P1317, DOI 10.1016/S0960-9822(03)00532-3; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; Page BD, 2001, MOL CELL, V7, P451, DOI 10.1016/S1097-2765(01)00193-9; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Reddien PW, 2007, GENETICS, V175, P1719, DOI 10.1534/genetics.106.068148; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Simeckova K, 2007, FOLIA BIOL-PRAGUE, V53, P85; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Stiernagle Theresa, 2006, WormBook, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tan MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-268; Thoemke K, 2005, DEV BIOL, V284, P500, DOI 10.1016/j.ydbio.2005.05.017; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	76	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4055	10.1371/journal.pone.0004055	http://dx.doi.org/10.1371/journal.pone.0004055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116648	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466600001
J	Young, JD; Martel, J; Young, L; Wu, CY; Young, A; Young, D				Young, John D.; Martel, Jan; Young, Lena; Wu, Cheng-Yeu; Young, Andrew; Young, David			Putative Nanobacteria Represent Physiological Remnants and Culture By-Products of Normal Calcium Homeostasis	PLOS ONE			English	Article							FETUIN-A; CALCIFYING NANOPARTICLES; GLYCOPROTEIN/FETUIN-A; RANDALLS PLAQUE; SERUM; CARBONATE; PHOSPHATE; CALCIFICATION; PROTEIN; HYDROXYAPATITE	Putative living entities called nanobacteria (NB) are unusual for their small sizes (50-500 nm), pleomorphic nature, and accumulation of hydroxyapatite (HAP), and have been implicated in numerous diseases involving extraskeletal calcification. By adding precipitating ions to cell culture medium containing serum, mineral nanoparticles are generated that are morphologically and chemically identical to the so-called NB. These nanoparticles are shown here to be formed of amorphous mineral complexes containing calcium as well as other ions like carbonate, which then rapidly acquire phosphate, forming HAP. The main constituent proteins of serum-derived NB are albumin, fetuin-A, and apolipoprotein A1, but their involvement appears circumstantial since so-called NB from different body fluids harbor other proteins. Accordingly, by passage through various culture media, the protein composition of these particles can be modulated. Immunoblotting experiments reveal that antibodies deemed specific for NB react in fact with either albumin, fetuin-A, or both, indicating that previous studies using these reagents may have detected these serum proteins from the same as well as different species, with human tissue nanoparticles presumably absorbing bovine serum antigens from the culture medium. Both fetal bovine serum and human serum, used earlier by other investigators as sources of NB, paradoxically inhibit the formation of these entities, and this inhibition is trypsin-sensitive, indicating a role for proteins in this inhibitory process. Fetuin-A, and to a lesser degree albumin, inhibit nanoparticle formation, an inhibition that is overcome with time, ending with formation of the so-called NB. Together, these data demonstrate that NB are most likely formed by calcium or apatite crystallization inhibitors that are somehow overwhelmed by excess calcium or calcium phosphate found in culture medium or in body fluids, thereby becoming seeds for calcification. The structures described earlier as NB may thus represent remnants and by-products of physiological mechanisms used for calcium homeostasis, a concept which explains the vast body of NB literature as well as explains the true origin of NB as lifeless protein-mineralo entities with questionable role in pathogenesis.	[Young, John D.; Martel, Jan; Young, Lena; Wu, Cheng-Yeu; Young, Andrew; Young, David] Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan; [Martel, Jan] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacter Pathogenesis, Tao Yuan, Taiwan; [Young, John D.] Rockefeller Univ, Adjunct Fac, Lab Cellular Physiol & Immunol, New York, NY USA; [Young, Lena] Harvard Univ, Cambridge, MA 02138 USA	Chang Gung University; Chang Gung University; Chang Gung University; Rockefeller University; Harvard University	Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Gueishan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [FMRPD2T02]	Primordia Institute of New Sciences and Medicine; Chang Gung University	This study was supported by Primordia Institute of New Sciences and Medicine and by a grant from Chang Gung University (FMRPD2T02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Barr SC, 2003, AM J VET RES, V64, P176, DOI 10.2460/ajvr.2003.64.176; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2077-2086.2002; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; CLARK JS, 1955, CAN J CHEM, V33, P665, DOI 10.1139/v55-078; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Frank PG, 2000, J LIPID RES, V41, P853; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; GARNETT J, 1990, BIOCHEM J, V266, P863; GEER DE, 1972, J WATER POLLUT CON F, V44, P2342; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; HOUSE WA, 1986, J COLLOID INTERF SCI, V112, P309, DOI 10.1016/0021-9797(86)90101-3; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; JONES JA, 2008, UROL IN PRESS; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MATHEW G, INT J NANOMEDICINE, V3, P265; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Miller VM, 2004, AM J PHYSIOL-HEART C, V287, pH1115, DOI 10.1152/ajpheart.00075.2004; Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9; POSNER AS, 1969, PHYSIOL REV, V49, P760, DOI 10.1152/physrev.1969.49.4.760; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.0.CO;2-6; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; RUOSLAHTI E, 1976, P NATL ACAD SCI USA, V73, P4641, DOI 10.1073/pnas.73.12.4641; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Sillitoe RH, 1996, SCIENCE, V272, P1153, DOI 10.1126/science.272.5265.1153; Simonetti AB, 2007, BRAZ J MICROBIOL, V38, P153, DOI 10.1590/S1517-83822007000100032; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vuckovic M, 2005, J SERB CHEM SOC, V70, P1255, DOI 10.2298/JSC0511255V; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wen Y, 2005, CHINESE MED J-PEKING, V118, P421; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	77	84	92	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4417	10.1371/journal.pone.0004417	http://dx.doi.org/10.1371/journal.pone.0004417			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198665	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900014
J	Karita, E; Ketter, N; Price, MA; Kayitenkore, K; Kaleebu, P; Nanvubya, A; Anzala, O; Jaoko, W; Mutua, G; Ruzagira, E; Mulenga, J; Sanders, EJ; Mwangome, M; Allen, S; Bwanika, A; Bahemuka, U; Awuondo, K; Omosa, G; Farah, B; Amornkul, P; Birungi, J; Yates, S; Stoll-Johnson, L; Gilmour, J; Stevens, G; Shutes, E; Manigart, O; Hughes, P; Dally, L; Scott, J; Stevens, W; Fast, P; Kamali, A				Karita, Etienne; Ketter, Nzeera; Price, Matt A.; Kayitenkore, Kayitesi; Kaleebu, Pontiano; Nanvubya, Annet; Anzala, Omu; Jaoko, Walter; Mutua, Gaudensia; Ruzagira, Eugene; Mulenga, Joseph; Sanders, Eduard J.; Mwangome, Mary; Allen, Susan; Bwanika, Agnes; Bahemuka, Ubaldo; Awuondo, Ken; Omosa, Gloria; Farah, Bashir; Amornkul, Pauli; Birungi, Josephine; Yates, Sarah; Stoll-Johnson, Lisa; Gilmour, Jill; Stevens, Gwynn; Shutes, Erin; Manigart, Olivier; Hughes, Peter; Dally, Len; Scott, Janet; Stevens, Wendy; Fast, Pat; Kamali, Anatoli			CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; REFERENCE VALUES; OUTLIERS; HIV-1; COUNT	Background: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. Using laboratory reference intervals derived from other populations excludes potential trial volunteers in Africa and makes AE assessment challenging. The objective of this study was to establish clinical laboratory reference intervals for 25 hematology, immunology and biochemistry values among healthy African adults typical of those who might join a clinical trial. Methods and Findings: Equal proportions of men and women were invited to participate in a cross sectional study at seven clinical centers (Kigali, Rwanda; Masaka and Entebbe, Uganda; two in Nairobi and one in Kilifi, Kenya; and Lusaka, Zambia). All laboratories used hematology, immunology and biochemistry analyzers validated by an independent clinical laboratory. Clinical and Laboratory Standards Institute guidelines were followed to create study consensus intervals. For comparison, AE grading criteria published by the U. S. National Institute of Allergy and Infectious Diseases Division of AIDS (DAIDS) and other U. S. reference intervals were used. 2,990 potential volunteers were screened, and 2,105 (1,083 men and 1,022 women) were included in the analysis. While some significant gender and regional differences were observed, creating consensus African study intervals from the complete data was possible for 18 of the 25 analytes. Compared to reference intervals from the U. S., we found lower hematocrit and hemoglobin levels, particularly among women, lower white blood cell and neutrophil counts, and lower amylase. Both genders had elevated eosinophil counts, immunoglobulin G, total and direct bilirubin, lactate dehydrogenase and creatine phosphokinase, the latter being more pronounced among women. When graded against U.S.-derived DAIDS AE grading criteria, we observed 774 (35.3%) volunteers with grade one or higher results; 314 (14.9%) had elevated total bilirubin, and 201 (9.6%) had low neutrophil counts. These otherwise healthy volunteers would be excluded or would require special exemption to participate in many clinical trials. Conclusions: To accelerate clinical trials in Africa, and to improve their scientific validity, locally appropriate reference ranges should be used. This study provides ranges that will inform inclusion criteria and evaluation of adverse events for studies in these regions of Africa.	[Kayitenkore, Kayitesi; Shutes, Erin] Projet San Francisco PSF, Kigali, Rwanda; [Kaleebu, Pontiano; Nanvubya, Annet; Hughes, Peter] Uganda Virus Res Inst UVRI, Entebbe, Uganda; [Anzala, Omu; Jaoko, Walter; Mutua, Gaudensia; Omosa, Gloria; Farah, Bashir] Kenya AIDS Vaccine Initiative KAVI, Nairobi, Kenya; [Ruzagira, Eugene; Bwanika, Agnes; Bahemuka, Ubaldo; Kamali, Anatoli] UVRI, MRC, Uganda Virus Res Unit AIDS, Masaka, Uganda; [Mulenga, Joseph; Manigart, Olivier] Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia; [Sanders, Eduard J.; Mwangome, Mary; Awuondo, Ken] Ctr Geograph Med Res Coast CGMRC, Kenya Med Res Inst KEMRI, Kilifi, Kenya; [Allen, Susan] Emory Univ, Atlanta, GA 30322 USA; [Price, Matt A.; Amornkul, Pauli; Birungi, Josephine; Yates, Sarah; Stevens, Gwynn; Fast, Pat] Int AIDS Vaccine Initiative, New York, NY USA; [Sanders, Eduard J.; Gilmour, Jill] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX1 2JD, England; [Dally, Len] EMMES Corp, Rockville, MD USA; [Stevens, Wendy] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Ketter, Nzeera] Johnson & Johnson, New Brunswick, NJ USA; [Scott, Janet] Univ Oxford, Oxford OX1 2JD, England	Kenya Medical Research Institute; Emory University; International AIDS Vaccine Initiative; University of Oxford; Emmes Corporation; National Health Laboratory Service; University of Witwatersrand; Johnson & Johnson; Johnson & Johnson USA; University of Oxford	Karita, E (corresponding author), Projet San Francisco PSF, Kigali, Rwanda.	mprice@iavi.org	Price, Matt/AAK-6881-2021; Jaoko, Walter/AAN-5048-2020	Price, Matt/0000-0002-2918-1373; Bwanika Naggirinya, Agnes/0000-0001-6795-3138; Jaoko, Walter/0000-0002-7134-6581; Ruzagira, Eugene/0000-0002-7291-1693	United States Agency for International Development (USAID); Klingenstein Fund; Gates Challenge Fund; Government of Netherlands TMF; Government of Norway; European Union East Africa Fund; Canadian International Development Agency; Development Cooperation Ireland; Department for International Development; Danish Ministry for Foreign Affairs; Swedish Ministry of Foreign Affairs; World Bank; MRC [MC_U950080930, MC_U950097145] Funding Source: UKRI; Medical Research Council [MC_U950097145, MC_U950080930] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Klingenstein Fund(Klingenstein Philanthropies); Gates Challenge Fund; Government of Netherlands TMF; Government of Norway; European Union East Africa Fund; Canadian International Development Agency; Development Cooperation Ireland; Department for International Development; Danish Ministry for Foreign Affairs; Swedish Ministry of Foreign Affairs; World Bank(The World Bank India); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study and report were made possible in part by the generous support of the American people through the United States Agency for International Development (USAID), the Klingenstein Fund, Gates Challenge Fund, Government of Netherlands TMF, Government of Norway, European Union East Africa Fund, Canadian International Development Agency, Development Cooperation Ireland, Department for International Development, Danish Ministry for Foreign Affairs, Swedish Ministry of Foreign Affairs, and the World Bank. The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government.	AZIKIWE AN, 1984, E AFR MED J, V61, P482; BADENHORST CJ, 1995, E AFR MED J, V72, P19; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAKERMAN S, 2002, ABCS INTERPRETIVE LA; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Canguilhem G., 2012, NORMAL PATHOLOGICAL, V3; COOPER DH, 2007, WASHINGTON MANUAL ME; DAIDS, 2004, DIV AIDS TABL GRAD S; Excler JL, 2006, EXPERT REV VACCINES, V5, P167, DOI 10.1586/14760584.5.2.167; EZEILO GC, 1972, LANCET, V2, P1003; FAST P, 2007, AIDS VACCINE DEV; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; GILL GV, 1979, T ROY SOC TROP MED H, V73, P111, DOI 10.1016/0035-9203(79)90142-1; GITLIN N, 1977, S AFR MED J, V52, P19; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; HSIEH MM, 2007, PREVALENCE NEUTROPEN, P486; *IAVI, 2004, GEND AIDS VACC TRIAL; JAOKO W, 2006, SCREENING FAILURE PH; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; KARITA E, 2006, SEASONAL VARIATION C; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, SCAND J IMMUNOL, V59, P203, DOI 10.1111/j.0300-9475.2004.01376.x; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MEHENDALE S, 2006, FREQUENT LARGE BLOOD; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; National Committee on Clinical Laboratory Standards (NCCLS), 2000, C28A2 NCCLS, V20; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Solberg HE, 2005, CLIN CHEM, V51, P2326, DOI 10.1373/clinchem.2005.058339; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; STILES T, 2003, QUALITY SYSTEM LAB U; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Urassa WK, 2003, J IMMUNOL METHODS, V277, P65, DOI 10.1016/S0022-1759(03)00174-1; WANE J, 1985, ETUDE VALEURS REFERE	37	114	116	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4401	10.1371/journal.pone.0004401	http://dx.doi.org/10.1371/journal.pone.0004401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197365	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265483700010
J	Kerr, KCR; Lijtmaer, DA; Barreira, AS; Hebert, PDN; Tubaro, PL				Kerr, Kevin C. R.; Lijtmaer, Dario A.; Barreira, Ana S.; Hebert, Paul D. N.; Tubaro, Pablo L.			Probing Evolutionary Patterns in Neotropical Birds through DNA Barcodes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; GENUS; SPECIATION; DIVERSIFICATION; DIFFERENTIATION; CONSERVATION; BIOGEOGRAPHY; GENETICS; RATES	Background: The Neotropical avifauna is more diverse than that of any other biogeographic region, but our understanding of patterns of regional divergence is limited. Critical examination of this issue is currently constrained by the limited genetic information available. This study begins to address this gap by assembling a library of mitochondrial COI sequences, or DNA barcodes, for Argentinian birds and comparing their patterns of genetic diversity to those of North American birds. Methodology and Principal Findings: Five hundred Argentinian species were examined, making this the first major examination of DNA barcodes for South American birds. Our results indicate that most southern Neotropical bird species show deep sequence divergence from their nearest-neighbour, corroborating that the high diversity of this fauna is not based on an elevated incidence of young species radiations. Although species ages appear similar in temperate North and South American avifaunas, patterns of regional divergence are more complex in the Neotropics, suggesting that the high diversity of the Neotropical avifauna has been fueled by greater opportunities for regional divergence. Deep genetic splits were observed in at least 21 species, though distribution patterns of these lineages were variable. The lack of shared polymorphisms in species, even in species with less than 0.5M years Conclusions: These findings confirm the efficacy of species delimitation in birds via DNA barcodes, even when tested on a global scale. Further, they demonstrate how large libraries of a standardized gene region provide insight into evolutionary processes.	[Kerr, Kevin C. R.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Lijtmaer, Dario A.; Barreira, Ana S.; Tubaro, Pablo L.] Museo Argentino Cienc Nat Bernardino Rivadavia, Div Ornitol, Buenos Aires, DF, Argentina	University of Guelph; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Kerr, KCR (corresponding author), Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	kkerr@uoguelph.ca	Kerr, Kevin/B-8510-2013; Hebert, Paul DN/C-4161-2013	Kerr, Kevin/0000-0002-6784-3884; Hebert, Paul DN/0000-0002-3081-6700; Barreira, Ana S./0000-0001-7568-488X	CONICET; Lounsbery Foundation; NSERC; Genome Canada through the Ontario Genomics Institute	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Lounsbery Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This research program was funded by grants from CONICET and from the Lounsbery Foundation to PLT and by grants from NSERC and from Genome Canada through the Ontario Genomics Institute to PDNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Arnaiz-Villena A, 1998, CELL MOL LIFE SCI, V54, P1031, DOI 10.1007/s000180050230; Bates JM, 1999, AUK, V116, P1093, DOI 10.2307/4089688; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Brumfield RT, 2005, AUK, V122, P414, DOI 10.1642/0004-8038(2005)122[0414:MVIBPO]2.0.CO;2; Brumfield RT, 1996, CONDOR, V98, P547, DOI 10.2307/1369567; Chesser RT, 2000, MOL PHYLOGENET EVOL, V15, P369, DOI 10.1006/mpev.1999.0774; Cicero C, 1998, MOL ECOL, V7, P1359, DOI 10.1046/j.1365-294x.1998.00483.x; Clements JF, 2007, CLEMENTS CHECKLIST B; Edelaar Pim, 2003, Vogelwarte, V42, P113; Fjeldsa J, 2007, ZOOL SCR, V36, P133, DOI 10.1111/j.1463-6409.2006.00270.x; Francisco MR, 2007, MOL ECOL, V16, P4908, DOI 10.1111/j.1365-294X.2007.03519.x; Friesen VL, 1997, COLON WATERBIRD, V20, P353, DOI 10.2307/1521703; Garcia-Moreno J, 1999, MOL PHYLOGENET EVOL, V12, P273, DOI 10.1006/mpev.1999.0617; Garcia-Moreno J, 1998, CONDOR, V100, P629, DOI 10.2307/1369744; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lijtmaer DA, 2004, MOL PHYLOGENET EVOL, V33, P562, DOI 10.1016/j.ympev.2004.07.011; Lovette IJ, 2001, AUK, V118, P211, DOI 10.1642/0004-8038(2001)118[0211:MPOTPR]2.0.CO;2; Mata JRR, 2006, FIELD GUIDE BIRDS S; Mazar Barnett J., 2001, ANNOTATED CHECKLIST; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Moore WS, 2006, BIOL J LINN SOC, V87, P611, DOI 10.1111/j.1095-8312.2006.00586.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; NAROSKY T, 2003, BIRDS ARGENTINA URUG; NEWTON I, 2000, SPECIATION BIOGEOGRA; NORES M, 1992, AUK, V109, P346, DOI 10.2307/4088203; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; PRUM RO, 1994, CONDOR, V96, P692, DOI 10.2307/1369472; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Snow D.W., 2004, HDB BIRDS WORLD, V9, P110; Straneck R. J., 1993, R MUS ARG CIENC NAT, V16, P51; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; TEAM RDC, 2007, R LANGUAGE ENV STAT; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; TRAYLOR M A JR, 1988, Fieldiana Zoology, P1; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Yoo HS, 2006, MOL CELLS, V22, P323; ZINK RM, 1995, CONDOR, V97, P639, DOI 10.2307/1369173	54	138	153	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4379	10.1371/journal.pone.0004379	http://dx.doi.org/10.1371/journal.pone.0004379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194495	Green Published, gold			2022-12-27	WOS:000265483600010
J	Baune, B				Baune, Bernhard			Conceptual Challenges of a Tentative Model of Stress-Induced Depression	PLOS ONE			English	Article							SOCIAL STRESS; DISORDERS; PSYCHOPATHOLOGY; RODENTS; BRAIN		James Cook Univ, Dept Psychiat & Psychiat Neurosci, Townsville, Qld, Australia	James Cook University	Baune, B (corresponding author), James Cook Univ, Dept Psychiat & Psychiat Neurosci, Townsville, Qld, Australia.	bernhard.baune@jcu.edu.au	Yan, Shuo/B-8381-2009					Aihara M, 2007, PSYCHIAT RES-NEUROIM, V155, P245, DOI 10.1016/j.pscychresns.2006.11.002; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Garcia-Bueno B, 2008, NEUROSCI BIOBEHAV R, V32, P1136, DOI 10.1016/j.neubiorev.2008.04.001; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McMahon SD, 2003, J CHILD PSYCHOL PSYC, V44, P107, DOI 10.1111/1469-7610.00105; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x	17	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4266	10.1371/journal.pone.0004266	http://dx.doi.org/10.1371/journal.pone.0004266			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549YF	19180238	Green Accepted, gold, Green Published			2022-12-27	WOS:000274089700003
J	Cooper, B; Fuchs, E; Flugge, G				Cooper, Ben; Fuchs, Eberhard; Fluegge, Gabriele			Expression of the Axonal Membrane Glycoprotein M6a Is Regulated by Chronic Stress	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ALTERS DENDRITIC MORPHOLOGY; CHRONIC PSYCHOSOCIAL STRESS; PYRAMIDAL NEURONS; GENE-EXPRESSION; HIPPOCAMPAL-FORMATION; APICAL DENDRITES; RAT; REORGANIZATION; IDENTIFICATION	It has been repeatedly shown that chronic stress changes dendrites, spines and modulates expression of synaptic molecules. These effects all may impair information transfer between neurons. The present study shows that chronic stress also regulates expression of M6a, a glycoprotein which is localised in axonal membranes. We have previously demonstrated that M6a is a component of glutamatergic axons. The present data reveal that it is the splice variant M6a-Ib, not M6a-Ia, which is strongly expressed in the brain. Chronic stress in male rats (3 weeks daily restraint) has regional effects: quantitative in situ hybridization demonstrated that M6a-Ib mRNA in dentate gyrus granule neurons and in CA3 pyramidal neurons is downregulated, whereas M6a-Ib mRNA in the medial prefrontal cortex is upregulated by chronic stress. This is the first study showing that expression of an axonal membrane molecule is differentially affected by stress in a region-dependent manner. Therefore, one may speculate that diminished expression of the glycoprotein in the hippocampus leads to altered output in the corresponding cortical projection areas. Enhanced M6a-Ib expression in the medial prefrontal cortex (in areas prelimbic and infralimbic cortex) might be interpreted as a compensatory mechanism in response to changes in axonal projections from the hippocampus. Our findings provide evidence that in addition to alterations in dendrites and spines chronic stress also changes the integrity of axons and may thus impair information transfer even between distant brain regions.	[Cooper, Ben; Fuchs, Eberhard; Fluegge, Gabriele] Leibniz Inst Primate Res, German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany; [Fuchs, Eberhard] Univ Gottingen, Sch Med, Dept Neurol, D-37075 Gottingen, Germany; [Fuchs, Eberhard; Fluegge, Gabriele] Univ Gottingen, CMPB, DFG, D-37075 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; German Research Foundation (DFG); University of Gottingen	Cooper, B (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	efuchs@gwdg.de		Cooper, Benjamin/0000-0003-2374-9922	DFG (German Science Foundation); Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen	DFG (German Science Foundation)(German Research Foundation (DFG)); Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen	This work was in part funded by the DFG (German Science Foundation) Research Center Molecular Physiology of the Brain (CMPB), University of Gottingen. DFG and CMPB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, J NEUROSCI RES, V78, P702, DOI 10.1002/jnr.20328; Alfonso J, 2004, EUR J NEUROSCI, V19, P659, DOI 10.1111/j.1460-9568.2004.03178.x; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cooper B, 2008, BRAIN RES, V1197, P1, DOI 10.1016/j.brainres.2007.11.066; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; DIORIO D, 1993, J NEUROSCI, V13, P3839; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Huminiecki L, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-31; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; Meijer OC, 2002, J NEUROENDOCRINOL, V14, P499, DOI 10.1046/j.1365-2826.2002.00795.x; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Perez-Cruz Claudia, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/46276; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCHEIBEL ME, 1970, INT REV NEUROBIOL, V13, P1; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Sullivan RM, 2004, STRESS, V7, P131, DOI 10.1080/102538900410001679310; Sullivan RM, 1999, J NEUROSCI, V19, P2834; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TERREBERRY RR, 1987, BRAIN RES BULL, V19, P639, DOI 10.1016/0361-9230(87)90050-5; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2	46	23	24	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e3659	10.1371/journal.pone.0003659	http://dx.doi.org/10.1371/journal.pone.0003659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19180239	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483100001
J	Cunningham, D; Fonager, J; Jarra, W; Carret, C; Preiser, P; Langhorne, J				Cunningham, Deirdre; Fonager, Jannik; Jarra, William; Carret, Celine; Preiser, Peter; Langhorne, Jean			Rapid Changes in Transcription Profiles of the Plasmodium yoelii yir Multigene Family in Clonal Populations: Lack of Epigenetic Memory?	PLOS ONE			English	Article								The pir multigene family, found in the genomes of Plasmodium vivax, P. knowlesi and the rodent malaria species, encode variant antigens that could be targets of the immune response. Individual parasites of the rodent malaria Plasmodium yoelii, selected by micromanipulation, transcribe only 1 to 3 different pir (yir) suggesting tight transcriptional control at the level of individual cells. Using microarray and quantitative RT-PCR, we show that despite this very restricted transcription in a single cell, many yir genes are transcribed throughout the intra-erythrocytic asexual cycle. The timing and level of transcription differs between genes, with some being more highly transcribed in ring and trophozoite stages, whereas others are more highly transcribed in schizonts. Infection of immunodeficient mice with single infected erythrocytes results in populations of parasites each with transcriptional profiles different from that of the parent parasite population and from each other. This drift away from the original 'set' of transcribed genes does not appear to follow a preset pattern and "epigenetic memory'' of the yir transcribed in the parent parasite can be rapidly lost. Thus, regulation of pir gene transcription may be different from that of the well-characterised multigene family, var, of Plasmodium falciparum.	[Cunningham, Deirdre; Fonager, Jannik; Jarra, William; Langhorne, Jean] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Carret, Celine] Wellcome Trust Sanger Inst, Pathogen Microarrays Grp, Cambridge, England; [Preiser, Peter] Nanyang Technol Univ, Biosci Res Ctr, Singapore, Singapore	MRC National Institute for Medical Research; Wellcome Trust Sanger Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cunningham, D (corresponding author), Natl Inst Med Res, Div Parasitol, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Preiser, Peter R/A-2201-2011; Fonager, Jannik/AAJ-8292-2020	Langhorne, Jean/0000-0002-2257-9733; , Peter/0000-0003-4331-7000; Fonager, Jannik/0000-0003-1688-1482	MRC, UK; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme [LSHP-CT-2004-503578]; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC, UK and is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARNWELL JW, 1982, J IMMUNOL, V128, P224; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CHOOKAJORN T, 2007, P NATL ACAD SCI US; Corredor V, 2004, MOL BIOCHEM PARASIT, V138, P37, DOI 10.1016/j.molbiopara.2004.05.017; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cunningham DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/j.1365-2958.2005.04840.x; Daily JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; del Portillo HA, 2004, INT J PARASITOL, V34, P1547, DOI 10.1016/j.ijpara.2004.10.012; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, MOL MICROBIOL, V59, P364, DOI 10.1111/j.1365-2958.2005.05007.x; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Fernandez-Becerra C, 2005, MOL MICROBIOL, V58, P648, DOI 10.1111/j.1365-2958.2005.04850.x; Fischer K, 2003, MOL MICROBIOL, V48, P1209, DOI 10.1046/j.1365-2958.2003.03491.x; Fonager J, 2007, MOL BIOCHEM PARASIT, V156, P1, DOI 10.1016/j.molbiopara.2007.06.006; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; JARRA W, 1989, PARASITE IMMUNOL, V11, P1, DOI 10.1111/j.1365-3024.1989.tb00644.x; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kaviratne Mallika, 2003, P291, DOI 10.1016/B978-012194851-1/50039-1; Korir CC, 2006, INFECT GENET EVOL, V6, P75, DOI 10.1016/j.meegid.2005.01.003; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; MCLEAN SA, 1982, EXP PARASITOL, V54, P296, DOI 10.1016/0014-4894(82)90038-8; MENDIS KN, 1988, AM J TROP MED HYG, V38, P42, DOI 10.4269/ajtmh.1988.38.42; Merino EF, 2006, MOL BIOCHEM PARASIT, V149, P10, DOI 10.1016/j.molbiopara.2006.04.002; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; VOSS TS, 2005, NATURE; WALLIKER D, 1983, TROPICAL MED SERIES	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4285	10.1371/journal.pone.0004285	http://dx.doi.org/10.1371/journal.pone.0004285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173007	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483000003
J	Shorning, BY; Zabkiewicz, J; McCarthy, A; Pearson, HB; Winton, DJ; Sansom, OJ; Ashworth, A; Clarke, AR				Shorning, Boris Y.; Zabkiewicz, Joanna; McCarthy, Afshan; Pearson, Helen B.; Winton, Douglas J.; Sansom, Owen J.; Ashworth, Alan; Clarke, Alan R.			Lkb1 Deficiency Alters Goblet and Paneth Cell Differentiation in the Small Intestine	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR; NOTCH; EXPRESSION; KINASE; CRE; ACTIVATION; POLARITY; LOCUS; FATE	The Lkb1 tumour suppressor is a multitasking kinase participating in a range of physiological processes. We have determined the impact of Lkb1 deficiency on intestinal homeostasis, particularly focussing on secretory cell differentiation and development since we observe strong expression of Lkb1 in normal small intestine Paneth and goblet cells. We crossed mice bearing an Lkb1 allele flanked with LoxP sites with those carrying a Cyp1a1-specific inducible Cre recombinase. Lkb1 was efficiently deleted from the epithelial cells of the mouse intestine after intraperitoneal injection of the inducing agent beta-naphthoflavone. Bi-allelic loss of Lkb1 led to the perturbed development of Paneth and goblet cell lineages. These changes were characterised by the lack of Delta ligand expression in Lkb1-deficient secretory cells and a significant increase in the levels of the downstream Notch signalling effector Hes5 but not Hes1. Our data show that Lkb1 is required for the normal differentiation of secretory cell lineages within the intestine, and that Lkb1 deficiency modulates Notch signalling modulation in post-mitotic cells.	[Clarke, Alan R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Zabkiewicz, Joanna] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [McCarthy, Afshan; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London, England; [Pearson, Helen B.] Peter MacCallum Canc Inst, Res Div, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Sansom, Owen J.] Beatson Inst Canc Res, Garscube Estate, Glasgow, Lanark, Scotland; [Winton, Douglas J.] Canc Res UK, Dept Oncol, Cambridge, England	Cardiff University; Cardiff University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Peter Maccallum Cancer Center; Beatson Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Shorning, BY (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	clarkear@Cardiff.ac.uk	Clarke, Alan R/A-6256-2008; clarke, alan r/P-2820-2014	Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X; Pearson, Helen/0000-0002-3284-0843	Cancer Research UK; The Wales Gene Park and Breakthrough Breast Cancer	Cancer Research UK(Cancer Research UK); The Wales Gene Park and Breakthrough Breast Cancer	Cancer Research UK, The Wales Gene Park and Breakthrough Breast Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bayraktar J, 2006, J CELL SCI, V119, P711, DOI 10.1242/jcs.02789; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pearson HB, 2008, CANCER RES, V68, P2223, DOI 10.1158/0008-5472.CAN-07-5169; Rowan A, 2000, J PATHOL, V192, P203; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; SELZMAN HM, 1962, J CELL BIOL, V15, P136, DOI 10.1083/jcb.15.1.136; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPICER SS, 1967, J HISTOCHEM CYTOCHEM, V15, P225, DOI 10.1177/15.4.225; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tomlinson IPM, 1997, J MED GENET, V34, P1007, DOI 10.1136/jmg.34.12.1007; TROUGHTON WD, 1969, J CELL BIOL, V41, P251, DOI 10.1083/jcb.41.1.251; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang ZJ, 1999, J PATHOL, V188, P9, DOI 10.1002/(SICI)1096-9896(199905)188:1<9::AID-PATH326>3.0.CO;2-E; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	34	49	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4264	10.1371/journal.pone.0004264	http://dx.doi.org/10.1371/journal.pone.0004264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165340	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265482400010
J	Johnston, C; Orem, J; Okuku, F; Kalinaki, M; Saracino, M; Katongole-Mbidde, E; Sande, M; Ronald, A; McAdam, K; Huang, ML; Drolette, L; Selke, S; Wald, A; Corey, L; Casper, C				Johnston, Christine; Orem, Jackson; Okuku, Fred; Kalinaki, Mary; Saracino, Misty; Katongole-Mbidde, Edward; Sande, Merle; Ronald, Allan; McAdam, Keith; Huang, Meei-Li; Drolette, Linda; Selke, Stacy; Wald, Anna; Corey, Lawrence; Casper, Corey			Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda	PLOS ONE			English	Article								Introduction: Kaposi sarcoma (KS) is the leading cause of cancer in Uganda and occurs in people with and without HIV. Human herpesvirus-8 (HHV-8) replication is important both in transmission of HHV-8 and progression to KS. We characterized the sites and frequency of HHV-8 detection in Ugandans with and without HIV and KS. Methods: Participants were enrolled into one of four groups on the basis of HIV and KS status (HIV negative/KS negative, HIV positive/KS negative, HIV negative/KS positive, and HIV positive/KS positive). Participants collected oral swabs daily and clinicians collected oral swabs, anogenital swabs, and plasma samples weekly over 4 weeks. HHV-8 DNA at each site was quantified by polymerase chain reaction (PCR). Results: 78 participants collected a total of 2063 orals swabs and 358 plasma samples. Of these, 428 (21%) oral swabs and 96 (27%) plasma samples had detectable HHV-8 DNA. HHV-8 was detected more frequently in both the oropharynx of persons with KS (24 (57%) of 42 persons with KS vs. 8 (22%) of 36 persons without, p = 0.002) and the peripheral blood (30 (71%) of 42 persons with KS vs. 8 (22%) of 36 persons without, p<0.001). In a multivariate model, HHV-8 viremia was more frequent among men (IRR = 3.3, 95% CI = 1.7-6.2, p<0.001), persons with KS (IRR = 3.9, 95% CI = 1.7-9.0, p = 0.001) and persons with HIV infection (IRR= 1.7, 95% CI = 1.0-2.7, p = 0.03). Importantly, oral HHV-8 detection predicted the subsequent HHV-8 viremia. HHV-8 viremia was significantly more common when HHV-8 DNA was detected from the oropharynx during the week prior than when oral HHV-8 was not detected (RR = 3.3, 95% CI = 1.8-5.9 p<0.001). Genital HHV-8 detection was rare (9 (3%) of 272 swabs). Conclusions: HHV-8 detection is frequent in the oropharynx and peripheral blood of Ugandans with endemic and epidemic KS. Replication at these sites is highly correlated, and viremia is increased in men and those with HIV. The high incidence of HHV-8 replication at multiple anatomic sites may be an important factor leading to and sustaining the high prevalence of KS in Uganda.	[Johnston, Christine; Sande, Merle; Wald, Anna; Corey, Lawrence; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Saracino, Misty; Huang, Meei-Li; Drolette, Linda; Selke, Stacy; Wald, Anna; Corey, Lawrence] Univ Washington, Seattle, WA 98195 USA; [Wald, Anna; Casper, Corey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Johnston, Christine; Wald, Anna; Corey, Lawrence; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA USA; [Orem, Jackson; Okuku, Fred; Kalinaki, Mary; Katongole-Mbidde, Edward] Makerere Univ, Mulago Hosp, Uganda Canc Inst, Kampala, Uganda; [Katongole-Mbidde, Edward] Uganda Virus Res Inst, Entebbe, Uganda; [Sande, Merle; Ronald, Allan; McAdam, Keith] Makerere Univ, Mulago Hosp, Infect Dis Inst, Kampala, Uganda; [Sande, Merle; Ronald, Allan] Acad Alliance AIDS Care Africa, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Makerere University; Mulago National Referral Hospital; Uganda Virus Research Institute; Makerere University; Mulago National Referral Hospital	Johnston, C (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	cjohnsto@u.washington.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Ronald, Allan/0000-0002-5746-3490; Johnston, Christine/0000-0002-3073-0843	Early Detection Initiative; Fred Hutchinson Cancer Research Center; Joel Meyers Infectious Disease Scholarship; Clinical Scientist Development Award; Doris Duke Charitable Foundation; National Institutes of Health [K23 A154162, K24 A1071113]; National Center for Research Resources [K30 RR022293]; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K23AI079394] Funding Source: NIH RePORTER	Early Detection Initiative; Fred Hutchinson Cancer Research Center; Joel Meyers Infectious Disease Scholarship; Clinical Scientist Development Award(American Heart Association); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Early Detection Initiative, Fred Hutchinson Cancer Research Center (LC) Joel Meyers Infectious Disease Scholarship Grant, Fred Hutchinson Cancer Research Center (CJ) Clinical Scientist Development Award, Doris Duke Charitable Foundation (CC), National Institutes of Health: K23 A154162 (CC), K24 A1071113 (AW), National Center for Research Resources K30 RR022293 (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2002, AIDS, V16, P2073, DOI 10.1097/00002030-200210180-00013; Beral V, 1991, AIDS, V5 Suppl 2, pS99, DOI 10.1097/00002030-199101001-00014; Campbell TB, 2003, CLIN INFECT DIS, V36, P1144, DOI 10.1086/374599; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Casper C, 2002, J INFECT DIS, V185, P990, DOI 10.1086/339605; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621; Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; Cottoni F, 1996, ACTA DERM-VENEREOL, V76, P59; Foster CB, 2000, BLOOD, V96, P2562; Gandhi M, 2004, J DENT RES, V83, P639, DOI 10.1177/154405910408300811; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gondos A, 2005, BRIT J CANCER, V92, P1808, DOI 10.1038/sj.bjc.6602540; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Guttman-Yassky E, 2007, DIAGN MICR INFEC DIS, V57, P387, DOI 10.1016/j.diagmicrobio.2006.09.012; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Lampinen TM, 2000, J INFECT DIS, V181, P1785, DOI 10.1086/315426; Laney AS, 2007, AIDS, V21, P1541, DOI 10.1097/QAD.0b013e3282202b7d; LOTHE F, 1963, ACTA PATHOL MICROB S, V161, P1; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Mbulaiteye S, 2006, J INFECT DIS, V193, P1250, DOI 10.1086/503052; Moore PS, 1998, AM J EPIDEMIOL, V147, P217, DOI 10.1093/oxfordjournals.aje.a009440; Nsubuga MM, 2008, CANCER LETT, V263, P182, DOI 10.1016/j.canlet.2007.12.025; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Plancoulaine S, 2003, J INFECT DIS, V187, P1944, DOI 10.1086/375345; Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; Taylor MM, 2004, J INFECT DIS, V190, P484, DOI 10.1086/421466; Vieira J, 1997, J VIROL, V71, P7083, DOI 10.1128/JVI.71.9.7083-7087.1997; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 2002, J INFECT DIS, V186, pS34, DOI 10.1086/342969; Wawer MJ, 2001, SEX TRANSM DIS, V28, P77, DOI 10.1097/00007435-200102000-00003; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	39	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2009	4	1							e4222	10.1371/journal.pone.0004222	http://dx.doi.org/10.1371/journal.pone.0004222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JA	19156206	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482000001
J	Agudelo, WA; Galindo, JF; Ortiz, M; Villaveces, JL; Daza, EE; Patarroyo, ME				Agudelo, William A.; Galindo, Johan F.; Ortiz, Marysol; Villaveces, Jose L.; Daza, Edgar E.; Patarroyo, Manuel E.			Variations in the Electrostatic Landscape of Class II Human Leukocyte Antigen Molecule Induced by Modifications in the Myelin Basic Protein Peptide: A Theoretical Approach	PLOS ONE			English	Article								The receptor-ligand interactions involved in the formation of the complex between Class II Major Histocompatibility Complex molecules and antigenic peptides, which are essential for establishing an adaptive immunological response, were analyzed in the Class II Human Leukocyte Antigen (HLA) - Myelin Basic Protein (MBP) peptide complex (HLA-DR beta 1*1501-MBP) using a multipolar molecular electrostatic potential approach. The Human Leukocyte Antigen - peptide complex system was divided into four pockets together with their respective peptide fragment and the corresponding occupying amino acid was replaced by each of the remaining 19 amino acids. Partial atomic charges were calculated by a quantum chemistry approach at the Hatree Fock/3-21*G level, to study the behavior of monopole, dipole and quadrupole electrostatic multipolar moments. Two types of electrostatic behavior were distinguished in the pockets' amino acids: "anchoring'' located in Pocket 1 and 4, and "recognition'' located in Pocket 4 and 7. According to variations in the electrostatic landscape, pockets were ordered as: Pocket 1>Pocket 9 >> Pocket 4 approximate to Pocket 7 which is in agreement with the binding ability reported for Class II Major Histocompatibility Complex pockets. In the same way, amino acids occupying the polymorphic positions beta 13R, beta 26F, beta 28D, beta 9W, beta 74A, beta 47F and beta 57D were shown to be key for this Receptor-Ligand interaction. The results show that the multipolar molecular electrostatic potential approach is appropriate for characterizing receptor-ligand interactions in the MHC-antigenic peptide complex, which could have potential implications for synthetic vaccine design.	[Galindo, Johan F.; Ortiz, Marysol; Patarroyo, Manuel E.] Fdn Inst Inmunol Colombia, Grp Biomatemat, Bogota, Colombia; [Agudelo, William A.; Galindo, Johan F.; Ortiz, Marysol; Villaveces, Jose L.; Daza, Edgar E.] Univ Nacl Colombia, Ctr Investigac Sistemas Complejos CEIBA, Bogota, Colombia; [Villaveces, Jose L.] Univ Andes, Ctr Investigac Sistemas Complejos CEIBA, Grp Quim Teorica, Bogota, Colombia	Universidad Nacional de Colombia; Universidad de los Andes (Colombia)	Agudelo, WA (corresponding author), Fdn Inst Inmunol Colombia, Grp Biomatemat, Bogota, Colombia.	mepatarr@gmail.com	; Patarroyo, Manuel-Elkin/S-1422-2017	Galindo, Johan/0000-0001-9968-362X; Patarroyo, Manuel-Elkin/0000-0002-1119-6040	Colciencias [RC-2008]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Supported by Colciencias contract RC-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1994, IMMUNOL TODAY, V15, P58, DOI 10.1016/0167-5699(94)90134-1; Balbin A, 2006, BIOCHIMIE, V88, P1307, DOI 10.1016/j.biochi.2006.05.009; BATCHRACH S, 1994, REV COMPUTATIONAL CH, V5, pCH3; Cardenas C, 2005, BIOCHEM BIOPH RES CO, V330, P1162, DOI 10.1016/j.bbrc.2005.03.102; Cardenas C, 2005, J STRUCT BIOL, V149, P38, DOI 10.1016/j.jsb.2004.08.003; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V323, P1265, DOI 10.1016/j.bbrc.2004.08.225; Cardenas C, 2007, J MOL GRAPH MODEL, V25, P605, DOI 10.1016/j.jmgm.2006.04.005; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Frisch M. J., 2001, GAUSSIAN 98 REVISION; Garcia JE, 2006, CLIN MICROBIOL REV, V19, P686, DOI 10.1128/CMR.00063-05; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khandogin J, 2004, PROTEINS, V56, P724, DOI 10.1002/prot.20171; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Marsh SG, 2000, HLA FACTS BOOK; Patarroyo ME, 2008, J CELL MOL MED, V12, P1915, DOI 10.1111/j.1582-4934.2008.00174.x; Patarroyo ME, 2006, IMMUNOGENETICS, V58, P598, DOI 10.1007/s00251-006-0128-z; Patarroyo ME, 2004, CHEMBIOCHEM, V5, P1588, DOI 10.1002/cbic.200400116; PATARROYO ME, 2008, ACCOUNTS CHEM RES, V41, P357; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; RODRIGUEZ LE, 2008, CHEM REV IN PRESS; Saito K, 2004, MICROBIOL IMMUNOL, V48, P53, DOI 10.1111/j.1348-0421.2004.tb03487.x; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Svensson AC, 1996, IMMUNOGENETICS, V43, P304, DOI 10.1007/BF02440998; Tukey JW, 1977, EXPLORATORY DATA ANA; VOGT AB, 1994, J IMMUNOL, V153, P1665; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279	37	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4164	10.1371/journal.pone.0004164	http://dx.doi.org/10.1371/journal.pone.0004164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132105	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473700003
J	Rollin, J; Blechet, C; Regina, S; Tenenhaus, A; Guyetant, S; Gidrol, X				Rollin, Jerome; Blechet, Claire; Regina, Sandra; Tenenhaus, Arthur; Guyetant, Serge; Gidrol, Xavier			The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung Cancer	PLOS ONE			English	Article								Background: ID2 is a member of a subclass of transcription regulators belonging to the general bHLH (basic-helix-loop-helix) family of transcription factors. In normal cells, ID2 is responsible for regulating the balance between proliferation and differentiation. More recent studies have demonstrated that ID2 is involved in tumor progression in several cancer types such as prostate or breast. Methodology/Principal Findings: In this work, we investigated, for the first time, the relationship between the expression of ID2 in non-small cell lung cancer (NSCLC) patients and the clinicopathological features and prognosis of these patients. Immunohistochemistry was performed on tissue microarrays, which included 62 NSCLC tumors. In malignant tissues, ID2 expression has been detected in both the nuclear and cytoplasmic compartments, but we have demonstrated that only nuclear expression of ID2 is inversely correlated with the differentiation grade of the tumor (p = 0.007). Interestingly, among patients with poorly differentiated tumors, high nuclear expression of ID2 was an independent and unfavorable prognostic factor for survival (p = 0.036). Conclusions: These results suggest that ID2 could be involved in tumor dedifferentiation processes of NSCLC, and could be used as prognostic marker for patients with poorly differentiated tumors.	[Tenenhaus, Arthur; Gidrol, Xavier] CEA, IRCM, DSV, Lab Explorat Fonctionnelle Genomes, Evry, France; [Blechet, Claire; Regina, Sandra; Guyetant, Serge] INSERM, U618, IFR 135, Tours, France; [Blechet, Claire; Guyetant, Serge] Bretonneau Hosp, Lab Anat Pathol, Tours, France; [Regina, Sandra] Trousseau Hosp, Serv Hematol Hemostase, Tours, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; CHU Tours	Rollin, J (corresponding author), CEA, IRCM, DSV, Lab Explorat Fonctionnelle Genomes, Evry, France.	xavier.gidrol@cea.fr	Jerome, Rollin/K-2157-2019	Gidrol, Xavier/0000-0002-4233-3749				Baghdoyan S, 2005, J BIOL CHEM, V280, P15836, DOI 10.1074/jbc.M414216200; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Daibata M, 2004, INT J CANCER, V108, P845, DOI 10.1002/ijc.11647; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Hua H, 2007, ENDOCRINE, V32, P329, DOI 10.1007/s12020-008-9039-0; Itahana Y, 2003, CANCER RES, V63, P7098; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kamalian L, 2008, CLIN CANCER RES, V14, P2318, DOI 10.1158/1078-0432.CCR-07-4716; Kleeff J, 1998, CANCER RES, V58, P3769; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2006, P NATL ACAD SCI USA, V103, P4976, DOI 10.1073/pnas.0600168103; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Melnikova IN, 1999, EXP CELL RES, V247, P94, DOI 10.1006/excr.1998.4330; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Stighall M, 2005, INT J CANCER, V115, P403, DOI 10.1002/ijc.20875; Vielh P, 2005, CRIT REV ONCOL HEMAT, V53, P193, DOI 10.1016/j.critrevonc.2004.10.007; Wilson JW, 2001, CANCER RES, V61, P8803; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602	30	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4158	10.1371/journal.pone.0004158	http://dx.doi.org/10.1371/journal.pone.0004158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129913	gold, Green Published, Green Submitted			2022-12-27	WOS:000265473500006
J	Hu, W; Metselaar, J; Ben, LH; Cravens, PD; Singh, MP; Frohman, EM; Eagar, TN; Racke, MK; Kieseier, BC; Stuve, O				Hu, Wei; Metselaar, Josbert; Ben, Li-Hong; Cravens, Petra D.; Singh, Mahendra P.; Frohman, Elliot M.; Eagar, Todd N.; Racke, Michael K.; Kieseier, Bernd C.; Stueve, Olaf			PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease	PLOS ONE			English	Article								Background: Minocycline is an oral tetracycline derivative with good bioavailability in the central nervous system (CNS). Minocycline, a potent inhibitor of matrix metalloproteinase (MMP)-9, attenuates disease activity in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Potential adverse effects associated with long-term daily minocycline therapy in human patients are concerning. Here, we investigated whether less frequent treatment with long-circulating polyethylene glycol (PEG) minocycline liposomes are effective in treating EAE. Findings: Performing in vitro time kinetic studies of PEG minocycline-liposomes in human peripheral blood mononuclear cells (PBMCs), we determined that PEG minocycline-liposome preparations stabilized with CaCl2 are effective in diminishing MMP-9 activity. Intravenous injections of PEG minocycline-liposomes every five days were as effective in ameliorating clinical EAE as daily intraperitoneal injections of minocycline. Treatment of animals with PEG minocycline-liposomes significantly reduced the number of CNS-infiltrating leukocytes, and the overall expression of MMP-9 in the CNS. There was also a significant suppression of MMP-9 expression and proteolytic activity in splenocytes of treated animals, but not in CNS-infiltrating leukocytes. Thus, leukocytes gaining access to the brain and spinal cord require the same absolute amount of MMP-9 in all treatment groups, but minocycline decreases the absolute cell number. Conclusions: Our data indicate that less frequent injections of PEG minocycline-liposomes are an effective alternative pharmacotherapy to daily minocycline injections for the treatment of CNS autoimmune diseases. Also, inhibition of MMP-9 remains a promising treatment target in EAE and patients with MS.			Hu, W (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	bernd.kieseier@uni-duesseldorf.de; olaf.stuve@va.gov			Dallas VA Research Corporation; VISN 17, Department of Veterans Affairs [New Investigator Award]; Department of Veterans Affairs [Merit Review Award]; National Multiple Sclerosis Society [RG3427A8/T, RG2969B7/T]; Viragh Family Foundation	Dallas VA Research Corporation; VISN 17, Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Viragh Family Foundation	OS was supported by a Start-up Grant from the Dallas VA Research Corporation, a New Investigator Award from VISN 17, Department of Veterans Affairs, a Merit Review Award from the Department of Veterans Affairs, Research Grants from National Multiple Sclerosis Society (NMSS; RG3427A8/T, and RG2969B7/T), and a grant from the Viragh Family Foundation. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; DAVIES MG, 1989, BRIT MED J, V298, P1523, DOI 10.1136/bmj.298.6686.1523-c; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Harel L, 1996, ANN PHARMACOTHER, V30, P481, DOI 10.1177/106002809603000509; Keilhoff G, 2007, DEV NEUROBIOL, V67, P1382, DOI 10.1002/dneu.20384; Kieseier BC, 1998, BRAIN, V121, P159, DOI 10.1093/brain/121.1.159; KLOPPENBURG M, 1994, ARTHRITIS RHEUM, V37, P629, DOI 10.1002/art.1780370505; Langevitz P, 2000, DRUG SAFETY, V22, P405, DOI 10.2165/00002018-200022050-00007; Leppert D, 1996, ANN NEUROL, V40, P846, DOI 10.1002/ana.410400606; LEPPERT D, 1995, J IMMUNOL, V154, P4379; MATSUURA T, 1992, LANCET, V340, P1553, DOI 10.1016/0140-6736(92)92810-3; Metselaar Josbert M, 2005, Expert Opin Drug Deliv, V2, P465, DOI 10.1517/17425247.2.3.465; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Nessler S, 2002, ANN NEUROL, V52, P689, DOI 10.1002/ana.10353; Pelletier F, 2003, EUR J DERMATOL, V13, P396; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Stueve O, 2008, DRUGS, V68, P73, DOI 10.2165/00003495-200868010-00005; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Stuve O, 1997, J NEUROIMMUNOL, V80, P38, DOI 10.1016/S0165-5728(97)00134-3; Stuve O, 2002, J IMMUNOL, V169, P6720, DOI 10.4049/jimmunol.169.12.6720; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4151	10.1371/journal.pone.0004151	http://dx.doi.org/10.1371/journal.pone.0004151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127301	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473300015
J	McClain, CR; Lundsten, L; Ream, M; Barry, J; DeVogelaere, A				McClain, Craig R.; Lundsten, Lonny; Ream, Micki; Barry, James; DeVogelaere, Andrew			Endemicity, Biogeography, Composition, and Community Structure On a Northeast Pacific Seamount	PLOS ONE			English	Article								The deep ocean greater than 1 km covers the majority of the earth's surface. Interspersed on the abyssal plains and continental slope are an estimated 14000 seamounts, topographic features extending 1000 m off the seafloor. A variety of hypotheses are posited that suggest the ecological, evolutionary, and oceanographic processes on seamounts differ from those governing the surrounding deep sea. The most prominent and oldest of these hypotheses, the seamount endemicity hypothesis (SMEH), states that seamounts possess a set of isolating mechanisms that produce highly endemic faunas. Here, we constructed a faunal inventory for Davidson Seamount, the first bathymetric feature to be characterized as a 'seamount', residing 120 km off the central California coast in approximately 3600 m of water (Fig 1). We find little support for the SMEH among megafauna of a Northeast Pacific seamount; instead, finding an assemblage of species that also occurs on adjacent continental margins. A large percentage of these species are also cosmopolitan with ranges extending over much of the Pacific Ocean Basin. Despite the similarity in composition between the seamount and non-seamount communities, we provide preliminary evidence that seamount communities may be structured differently and potentially serve as source of larvae for suboptimal, non-seamount habitats.	[McClain, Craig R.; Lundsten, Lonny; Barry, James] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Ream, Micki] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [DeVogelaere, Andrew] Monterey Bay Natl Marine Sanctuary, Monterey, CA USA	Monterey Bay Aquarium Research Institute; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	McClain, CR (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA USA.	cmcclain@mbari.org		Lundsten, Lonny/0000-0002-7464-7443; McClain, Craig/0000-0003-0574-428X	NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute [200002, 900703, 900608, Postdoctoral Fellowship]; Save the Earth Foundation; David and Lucile Packard Foundation; Monterey Bay National Marine Sanctuary Foundation	NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute; Save the Earth Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Monterey Bay National Marine Sanctuary Foundation	This work was supported NOAA'S Office of Ocean Exploration, the Monterey Bay National Marine Sanctuary, the Monterey Bay Aquarium Research Institute (projects 200002, 900703, 900608), the Save the Earth Foundation, and the David and Lucile Packard Foundation. CRM was supported by a Monterey Bay Aquarium Research Institute Postdoctoral Fellowship and a grant from the Monterey Bay National Marine Sanctuary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cairns Stephen D., 2007, Proceedings of the California Academy of Sciences, V58, P511; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cartes JE, 2004, DEEP-SEA RES PT I, V51, P263, DOI 10.1016/j.dsr.2003.10.001; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FROESE R, 2004, SEAMOUNTS BIODIVERSI, P25; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gaston KJ, 1998, PHILOS T R SOC B, V353, P219, DOI 10.1098/rstb.1998.0204; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; Harbison GR, 2001, B MAR SCI, V68, P299; Holt Robert D., 1993, P77; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Johnston PA, 2004, ARCH FISH MAR RES, V51, P305; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; LUNDSTEN L, MARINE ECOLOGY PROGR; LUNDSTEN L, 2007, BIOGEOGRAPHY DISTRIB, P73; MCCLAIN CR, 2007, GUEST EDITORIAL SEAM, P1; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; RIZK S, 2006, SEAMOUNT INFLUENCES; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roberts S, 2004, FRONT ECOL ENVIRON, V2, P123, DOI 10.2307/3868237; ROGERS AD, 1994, ADV MAR BIOL, V30, P304; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; SCHLINING B, 2006, P MAR TECHN SOC I EL, P1; Stocks K., 2004, SEAMOUNTS BIODIVERSI, P17; STONE G, 2003, DEF OC END C SAN LUC, P43; Vermeij GJ, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P239; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; WILSON RR, 1987, SEAMOUNTS ISLANDS AT, P227; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	37	83	86	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4141	10.1371/journal.pone.0004141	http://dx.doi.org/10.1371/journal.pone.0004141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127302	Green Submitted, gold, Green Published			2022-12-27	WOS:000265473300008
J	Herrmann, JL; Belloy, M; Porcher, R; Simonney, N; Aboutaam, R; Lebourgeois, M; Gaudelus, J; De LosAngeles, L; Chadelat, K; Scheinmann, P; Beydon, N; Fauroux, B; Bingen, M; Terki, M; Barraud, D; Cruaud, P; Offredo, C; Ferroni, A; Berche, P; Moissenet, D; Vuthien, H; Doit, C; Bingen, E; Lagrange, PH				Herrmann, Jean-Louis; Belloy, Marie; Porcher, Raphael; Simonney, Nancy; Aboutaam, Rola; Lebourgeois, Muriel; Gaudelus, Joel; De LosAngeles, Laure; Chadelat, Katarina; Scheinmann, Pierre; Beydon, Nicole; Fauroux, Brigitte; Bingen, Martine; Terki, Mustapha; Barraud, Dominique; Cruaud, Philippe; Offredo, Catherine; Ferroni, Agnes; Berche, Patrick; Moissenet, Didier; Vuthien, Hoang; Doit, Catherine; Bingen, Edouard; Lagrange, Philippe Henri			Temporal Dynamics of Interferon Gamma Responses in Children Evaluated for Tuberculosis	PLOS ONE			English	Article							CELL-BASED ASSAY; LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; LATENT TUBERCULOSIS; SKIN-TEST; T-CELLS; INFECTION; DIAGNOSIS; DISEASE	Background: Development of T-cells based-Interferon gamma (IFN gamma) assays has offered new possibilities for the diagnosis of latent tuberculosis infection (LTBI) and active disease in adults. Few studies have been performed in children, none in France. With reference to the published data on childhood TB epidemiology in the Paris and Ile de France Region, we considered it important to evaluate the performance of IGRA (QuantiFERON TB Gold In Tube (R), QF-TB-IT) in the diagnosis and the follow-up through treatment of LTBI and active TB in a cohort of French children. Methodology/Principal Findings: 131 children were recruited during a prospective and multicentre study (October 2005 and May 2007; Ethical Committee St Louis Hospital, Paris, study number 2005/32). Children were sampled at day 0, 10, 30, 60 (except Healthy Contacts, HC) and 90 for LTBI and HC, and a further day 120, and day 180 for active TB children. Median age was 7.4 years, with 91% of the children BCG vaccinated. LTBI and active TB children undergoing therapy produced significant higher IFN gamma values after 10 days of treatment (p = 0.035). In addition, IFN gamma values were significantly lower at the end of treatment compared to IFN gamma values at day 0, although the number of positive patients was not significantly different between day 0 and end of treatment. Conclusions/Significance: By following quantitative IFN gamma values in each enrolled child with LTBI or active TB and receiving treatment, we were able to detect an increase in the IFN gamma response at day 10 of treatment which might allow the confirmation of a diagnosis. In addition, a decline in IFN gamma values during treatment makes it possible for clinicians to monitor the effect of preventive or curative therapy.	[Herrmann, Jean-Louis; Simonney, Nancy; Lagrange, Philippe Henri] AP HP, UFR Denis Diderot, Hop St Louis Equipe dAccueil, Serv Microbiol, Paris, France; [Belloy, Marie; Bingen, Martine; Terki, Mustapha; Barraud, Dominique] Ctr Hosp Gonesse, Serv Pneumol Pediat Federat Biol, Gonesse, France; [Porcher, Raphael; Offredo, Catherine; Ferroni, Agnes; Berche, Patrick] AP HP, UFR Denis Diderot, Dept Biostat Informat Med, Paris, France; [Aboutaam, Rola; Lebourgeois, Muriel; Scheinmann, Pierre] AP HP, UFR Paris 5, Hop Necker Enfants Malades, Serv Pneumol Pediat Serv Microbiol, Paris, France; [Gaudelus, Joel; Cruaud, Philippe] Hop Jean Verdier, Serv Pediat Gen Serv Microbiol, Bondy, France; [De LosAngeles, Laure; Beydon, Nicole; Moissenet, Didier; Vuthien, Hoang] AP HP, UFR Denis Diderot, Hop R Debre, Serv Pediat Serv Microbiol, Paris, France; [Chadelat, Katarina; Fauroux, Brigitte; Doit, Catherine; Bingen, Edouard] AP HP, UFR Paris VI, Hop A Trousseau, Serv Pneumol Pediat Serv Microbiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Herrmann, JL (corresponding author), Hop Raymond Poincare, Microbiol Serv, Garches, France.	jean-louis.herrmann@rpc.aphp.fr; philippe-henri.lagrange@sls.aphp.fr		Herrmann, Jean-Louis/0000-0003-2347-6418; Porcher, Raphael/0000-0002-5277-4679				Aissa K, 2008, AM J RESP CRIT CARE, V177, P1041, DOI 10.1164/rccm.200711-1756OC; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Antoine D., 2008, Bulletin Epidemiologique Hebdomadaire, P69; ANTOINE D, 2007, BEH, V11, P85; ANTOUN F, 2005, B EPIDEMIOL HEBD, V17, P70; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; *CONS SUP HYG PUBL, TB CAS INV PRACT REC; Delacourt C, 2004, REV MAL RESPIR, V21, pS13; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; HERRMANNJL, 2008, PATHOL BIOL PARIS; Higuchi K, 2007, RESPIROLOGY, V12, P88, DOI 10.1111/j.1440-1843.2006.01000.x; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; LAGRANGE PH, 2001, PEDIAT PULMONOL, V23, pS61; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; LEYTEN EM, 2007, EUR RESPIR J, V29, P1282; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2007, ARCH DIS CHILD, V92, P446, DOI 10.1136/adc.2006.104976; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nicol MP, 2005, CLIN INFECT DIS, V40, P1301, DOI 10.1086/429245; NICOL MP, 2008, PEDIATRICS IN PRESS; OKADA K, 2007, EPIDEMIOL INFECT, V8, P1; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Simonney N, 2000, INT J TUBERC LUNG D, V4, P152; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Vekemans J, 2001, INFECT IMMUN, V69, P6554, DOI 10.1128/IAI.69.10.6554-6557.2001; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; WHO, 2008, GLOBAL TUBERCULOSIS; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Wilkinson RJ, 1998, J INFECT DIS, V178, P760, DOI 10.1086/515336; World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children, 2006, WHOHTMTB2006371	50	39	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4130	10.1371/journal.pone.0004130	http://dx.doi.org/10.1371/journal.pone.0004130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125189	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473100005
J	Vogel, P; Donoviel, MS; Read, R; Hansen, GM; Hazlewood, J; Anderson, SJ; Sun, WM; Swaffield, J; Oravecz, T				Vogel, Peter; Donoviel, Michael S.; Read, Robert; Hansen, Gwenn M.; Hazlewood, Jill; Anderson, Stephen J.; Sun, Weimei; Swaffield, Jonathan; Oravecz, Tamas			Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; SPHINGOSINE-1-PHOSPHATE LYASE; QUANTITATIVE MEASUREMENT; BARRIER INTEGRITY; CELL-DEVELOPMENT; IN-VITRO; T-CELLS; APOPTOSIS; INDUCTION; FTY720	Background: S1PL is an aldehyde-lyase that irreversibly cleaves sphingosine 1-phosphate (S1P) in the terminal step of sphingolipid catabolism. Because S1P modulates a wide range of physiological processes, its concentration must be tightly regulated within both intracellular and extracellular environments. Methodology: In order to better understand the function of S1PL in this regulatory pathway, we assessed the in vivo effects of different levels of S1PL activity using knockout (KO) and humanized mouse models. Principal Findings: Our analysis showed that all S1PL-deficient genetic models in this study displayed lymphopenia, with sequestration of mature T cells in the thymus and lymph nodes. In addition to the lymphoid phenotypes, S1PL KO mice (S1PL(-/-)) also developed myeloid cell hyperplasia and significant lesions in the lung, heart, urinary tract, and bone, and had a markedly reduced life span. The humanized knock-in mice harboring one allele (S1PL(H/-)) or two alleles (S1PL(H/H)) of human S1PL expressed less than 10 and 20% of normal S1PL activity, respectively. This partial restoration of S1PL activity was sufficient to fully protect both humanized mouse lines from the lethal non-lymphoid lesions that developed in S1PL(-/-) mice, but failed to restore normal T-cell development and trafficking. Detailed analysis of T-cell compartments indicated that complete absence of S1PL affected both maturation/development and egress of mature T cells from the thymus, whereas low level S1PL activity affected T-cell egress more than differentiation. Significance: These findings demonstrate that lymphocyte trafficking is particularly sensitive to variations in S1PL activity and suggest that there is a window in which partial inhibition of S1PL could produce therapeutic levels of immunosuppression without causing clinically significant S1P-related lesions in non-lymphoid target organs.	[Vogel, Peter; Donoviel, Michael S.; Read, Robert; Hansen, Gwenn M.; Hazlewood, Jill; Anderson, Stephen J.; Sun, Weimei; Swaffield, Jonathan; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Vogel, P (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	pvogel@lexgen.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	Lexicon Pharmaceuticals, Inc	Lexicon Pharmaceuticals, Inc	The work described in this paper was funded by Lexicon Pharmaceuticals, Inc. All authors are employees of Lexicon Pharmaceuticals, Inc and in this respect the company had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2001, TRANSPLANT P, V33, P3078, DOI 10.1016/S0041-1345(01)02312-0; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102; Grahler MH, 2005, J IMMUNOL, V174, P1997; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Hung WC, 1996, BIOCHEM BIOPH RES CO, V229, P11, DOI 10.1006/bbrc.1996.1750; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Isoyama N, 2006, TRANSPL IMMUNOL, V15, P265, DOI 10.1016/j.trim.2006.02.004; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Liao JJ, 2007, J BIOL CHEM, V282, P1964, DOI 10.1074/jbc.M608597200; LIESCHKE GJ, 1994, BLOOD, V84, P27; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Moore AN, 1999, NEUROSCIENCE, V94, P405, DOI 10.1016/S0306-4522(99)00288-2; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sillence DJ, 2003, TRENDS CELL BIOL, V13, P195, DOI 10.1016/S0962-8924(03)00033-3; Suzuki S, 1997, CLIN EXP IMMUNOL, V107, P103, DOI 10.1046/j.1365-2249.1997.d01-885.x; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P12502; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	59	132	136	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4112	10.1371/journal.pone.0004112	http://dx.doi.org/10.1371/journal.pone.0004112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119317	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472600011
J	Brandie, FM; Aran, V; Verma, A; McNew, JA; Bryant, NJ; Gould, GW				Brandie, Fiona M.; Aran, Veronica; Verma, Avani; McNew, James A.; Bryant, Nia J.; Gould, Gwyn W.			Negative Regulation of Syntaxin4/SNAP-23/VAMP2-Mediated Membrane Fusion by Munc18c In Vitro	PLOS ONE			English	Article								Background: Translocation of the facilitative glucose transporter GLUT4 from an intracellular store to the plasma membrane is responsible for the increased rate of glucose transport into fat and muscle cells in response to insulin. This represents a specialised form of regulated membrane trafficking. Intracellular membrane traffic is subject to multiple levels of regulation by conserved families of proteins in all eukaryotic cells. Notably, all intracellular fusion events require SNARE proteins and Sec1p/Munc18 family members. Fusion of GLUT4-containing vesicles with the plasma membrane of insulin-sensitive cells involves the SM protein Munc18c, and is regulated by the formation of syntaxin 4/SNAP23/VAMP2 SNARE complexes. Methodology/Principal Findings: Here we have used biochemical approaches to characterise the interaction(s) of Munc18c with its cognate SNARE proteins and to examine the role of Munc18c in regulating liposome fusion catalysed by syntaxin 4/SNAP23/VAMP2 SNARE complex formation. We demonstrate that Munc18c makes contacts with both t- and v-SNARE proteins of this complex, and directly inhibits bilayer fusion mediated by the syntaxin 4/SNAP23/VAMP2 SNARE complex. Conclusion/Significance: Our reductionist approach has enabled us to ascertain a direct inhibitory role for Munc18c in regulating membrane fusion mediated by syntaxin 4/SNAP23/VAMP2 SNARE complex formation. It is important to note that two different SM proteins have recently been shown to stimulate liposome fusion mediated by their cognate SNARE complexes. Given the structural similarities between SM proteins, it seems unlikely that different members of this family perform opposing regulatory functions. Hence, our findings indicate that Munc18c requires a further level of regulation in order to stimulate SNARE-mediated membrane fusion.	[Brandie, Fiona M.; Aran, Veronica; Bryant, Nia J.; Gould, Gwyn W.] Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland; [Verma, Avani; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of Glasgow; Rice University	Brandie, FM (corresponding author), Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland.	G.Gould@bio.gla.ac.uk	Bryant, Nia/AAS-5637-2021; Aran, Veronica/C-7085-2017; Gould, Gwyn/AAF-6721-2019; McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020	Aran, Veronica/0000-0003-2751-0986; Gould, Gwyn/0000-0001-6571-2875; McNew, James/0000-0001-8459-3664; Bryant, Nia Jane/0000-0001-7431-3809	BBSRC [BB/D000211/1]; Diabetes UK [Studentship]; The Wellcome Trust [Research Leave Award]; NIH [GM071832]; The Lister Institute of Preventive Medicine [Prize Fellow]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D000211/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); The Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Lister Institute of Preventive Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (Grant BB/D000211/1 to NJB and GWG), Diabetes UK (Studentship to VA), The Wellcome Trust (Research Leave Award to GWG) and The NIH (Grant GM071832 to JMcN). NJB is a Prize Fellow of The Lister Institute of Preventive Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; RODKEY TL, 2008, MOL BIOL CELL; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9	36	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4074	10.1371/journal.pone.0004074	http://dx.doi.org/10.1371/journal.pone.0004074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116655	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265466600004
J	Algar, EM; Muscat, A; Dagar, V; Rickert, C; Chow, CW; Biegel, JA; Ekert, PG; Saffery, R; Craig, J; Johnstone, RW; Ashley, DM				Algar, Elizabeth M.; Muscat, Andrea; Dagar, Vinod; Rickert, Christian; Chow, C. W.; Biegel, Jaclyn A.; Ekert, Paul G.; Saffery, Richard; Craig, Jeff; Johnstone, Ricky W.; Ashley, David M.			Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors	PLOS ONE			English	Article								SMARCB1 is deleted in rhabdoid tumor, an aggressive paediatric malignancy affecting the kidney and CNS. We hypothesized that the oncogenic pathway in rhabdoid tumors involved epigenetic silencing of key cell cycle regulators as a consequence of altered chromatin-remodelling, attributable to loss of SMARCB1, and that this hypothesis if proven could provide a biological rationale for testing epigenetic therapies in this disease. We used an inducible expression system to show that the imprinted cell cycle inhibitor CDKN1C is a downstream target for SMARCB1 and is transcriptionally activated by increased histone H3 and H4 acetylation at the promoter. We also show that CDKN1C expression induces cell cycle arrest, CDKN1C knockdown with siRNA is associated with increased proliferation, and is able to compete against the anti-proliferative effect of restored SMARCB1 expression. The histone deacetylase inhibitor (HDACi), Romidepsin, specifically restored CDKN1C expression in rhabdoid tumor cells through promoter histone H3 and H4 acetylation, recapitulating the effect of SMARCB1 on CDKNIC allelic expression, and induced cell cycle arrest in G401 and STM91-01 rhabdoid tumor cell lines. CDKN1C expression was also shown to be generally absent in clinical specimens of rhabdoid tumor, however CDKN1A and CDKN1B expression persisted. Our observations suggest that maintenance of CDKN1C expression plays a critical role in preventing rhabdoid tumor growth. Significantly, we report for the first time, parallels between the molecular pathways of SMARCB1 restoration and Romidepsin treatment, and demonstrate a biological basis for the further exploration of histone deacetylase inhibitors as relevant therapeutic reagents in the treatment of rhabdoid tumor.			Algar, EM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Res Lab, Childrens Canc Ctr, Flemington Rd, Parkville, Vic 3052, Australia.	elizabeth.algar@rch.org.au	Johnstone, Ricky w/H-3748-2014; Saffery, Richard/GLS-1976-2022; Craig, Jeffrey M/B-3484-2012; Algar, Elizabeth/B-3770-2012; Ekert, Paul/Q-1842-2015; Ekert, Paul G/C-7247-2013	Johnstone, Ricky w/0000-0001-7053-9237; Saffery, Richard/0000-0002-9510-4181; Craig, Jeffrey M/0000-0003-3979-7849; Ekert, Paul/0000-0002-2976-8617; Ekert, Paul G/0000-0002-2976-8617	NATIONAL CANCER INSTITUTE [R01CA046274] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA046274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algar E, 2000, HUM MUTAT, V15, P497, DOI 10.1002/1098-1004(200006)15:6<497::AID-HUMU2>3.0.CO;2-F; Algar EM, 1999, J MED GENET, V36, P524; Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Biegel JA, 2002, CLIN CANCER RES, V8, P3461; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jackson EM, 2007, AM J MED GENET A, V143A, P1767, DOI 10.1002/ajmg.a.31843; Jordan CT, 1996, EXP HEMATOL, V24, P1347; Judkins AR, 2004, AM J SURG PATHOL, V28, P644, DOI 10.1097/00000478-200405000-00013; Kikuchi T, 2002, ONCOGENE, V21, P2741, DOI 10.1038/sj.onc.1205376; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kobatake T, 2004, ONCOL REP, V12, P1087; Kuang SQ, 2007, ONCOGENE, V26, P1439, DOI 10.1038/sj.onc.1209907; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Lindemann RK, 2004, CELL CYCLE, V3, P779; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Merchant SH, 2005, HUM PATHOL, V36, P180, DOI 10.1016/j.humpath.2004.12.007; Merlo P, 2005, J BIOL CHEM, V280, P30354, DOI 10.1074/jbc.M500635200; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; OTA S, 1993, CANCER-AM CANCER SOC, V71, P2862, DOI 10.1002/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D; Pan XF, 2005, BIOCHEM BIOPH RES CO, V337, P1052, DOI 10.1016/j.bbrc.2005.09.155; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Reincke BS, 2003, J CELL PHYSIOL, V194, P303, DOI 10.1002/jcp.10201; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Savla J, 2000, JNCI-J NATL CANCER I, V92, P648, DOI 10.1093/jnci/92.8.648; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Shen LL, 2003, BLOOD, V101, P4131, DOI 10.1182/blood-2002-08-2466; Shin JY, 2000, CANCER RES, V60, P262; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Tsugu A, 2000, AM J PATHOL, V157, P919, DOI 10.1016/S0002-9440(10)64605-6; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Versteege I, 2002, ONCOGENE, V21, P6403, DOI 10.1038/sj.onc.1205841; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002	52	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4482	10.1371/journal.pone.0004482	http://dx.doi.org/10.1371/journal.pone.0004482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221586	Green Published, gold			2022-12-27	WOS:000265485700009
J	Cheng, L; Chen, H; Yao, XS; Qi, GQ; Liu, HW; Lee, K; Lee, K; Zhang, JT; Chen, SH; Lin, XL; Zhao, WC; Li, JK; Li, M				Cheng, Lei; Chen, Hao; Yao, Xinsheng; Qi, Guoqing; Liu, Hongwei; Lee, Kwongman; Lee, Kaho; Zhang, Jieting; Chen, Shihui; Lin, Xiaoli; Zhao, Wenchao; Li, Jiankuan; Li, Ming			A Plant-Derived Remedy for Repair of Infarcted Heart	PLOS ONE			English	Article								Background: Myocardial infarction (MI) due to coronary artery disease remains one of the leading causes of premature death. Replacement of infarcted heart tissue with regenerating myocardium from endogenous progenitor pools or exogenously introduced stem cells remains a therapeutic ideal. Their impracticality mainly lies in their low efficiency in cardiogenic differentiation (CD). Our recent studies with an acute MI animal model have already demonstrated the therapeutic effect of the MeOH extract of Geum japonicum (EGJ), providing clear evidence of myocardial regeneration. Methods and Findings: The present study further isolated the active component contained in EGJ using bioassay-guided isolation and investigated its efficacy in the treatment of infarcted heart in animal MI models. We demonstrated that substantial repair of infarcted heart in animal MI models by EGJ can be mimicked by the isolated candidate compound (cardiogenin) in MI animal models. Clear evidence of newly regenerated endogenous mesenchymal stem cells (MSCs) derived cardiomyocytes was observed throughout the infarct zone, accompanied by significantly improved functional performance of the heart. Transplantation of MSCs pretreated with EGJ or cardiogenin into a MI animal model also resulted in substantial regeneration of functional myocardium, implying that the activated MSCs carry all the necessary blueprints for myocardial regeneration. Signaling pathways specific to cell survival, CD identified in embryonic heart induction and angiogenesis were activated in both cardiogenin-treated MSCs and cardiogenin-induced regenerating myocardium. Conclusions: This study has demonstrated the therapeutic effects of cardiogenin in infarcted heart repair, and identified the associated signalling pathways for effective cardiogenic differentiation of MSCs, cell survival and angiogenesis. These findings should enable new treatment strategies for MI to be developed immediately.	[Cheng, Lei; Chen, Hao; Zhang, Jieting; Chen, Shihui; Lin, Xiaoli; Zhao, Wenchao; Li, Jiankuan; Li, Ming] Chinese Univ Hong Kong, Minist Educ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Cheng, Lei; Chen, Hao; Lee, Kwongman; Zhang, Jieting; Chen, Shihui; Li, Ming] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Lee, Kaho] Chinese Univ Hong Kong, Fac Med, Dept Anat, Hong Kong, Peoples R China; [Qi, Guoqing] Hebei Med Univ, Affiliated Hosp 1, Dept Cardiol, Shijiazhuang, Peoples R China; [Yao, Xinsheng] Jian Univ, Dept Pharmacol, Guangzhou, Peoples R China; [Liu, Hongwei] Chinese Acad Sci, Inst Microbiol, Key Lab Systemat Mycol & Lichenol, Beijing, Peoples R China	Chinese University of Hong Kong; Ministry of Education, China; Chinese University of Hong Kong; Chinese University of Hong Kong; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Cheng, L (corresponding author), Chinese Univ Hong Kong, Minist Educ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	li-ming@cuhk.edu.hk	Lee, Kenneth Ka Ho/H-6698-2013; Chen, Hao/D-3425-2012; Chen, Hao/AAH-4124-2020	Lee, Kenneth Ka Ho/0000-0002-6520-304X; Chen, Hao/0000-0001-8319-8101; Chen, Hao/0000-0001-8319-8101	CUHK [6901985]; VC of the Chinese University of Hong Kong [2140569]; CRF; NSFC [20502016];  [7103270]	CUHK(Chinese University of Hong Kong); VC of the Chinese University of Hong Kong; CRF; NSFC(National Natural Science Foundation of China (NSFC)); 	The work was supported by a CUHK Stem Cell grant (6901985), a private donation (7103270), an equipment grant from the VC of the Chinese University of Hong Kong, a RGC grant (2140569), a CRF grant and a NSFC grant (20502016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; CHEN U, 1993, DEV DYNAM, V197, P217, DOI 10.1002/aja.1001970306; Damjanov I, 1974, Curr Top Pathol, V59, P69; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Foley A, 2004, TRENDS CARDIOVAS MED, V14, P121, DOI 10.1016/j.tcm.2004.01.003; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Li M, 2006, CLIN CHEM, V52, P1460, DOI 10.1373/clinchem.2006.068247; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Menasche P, 2004, NAT BIOTECHNOL, V22, P1237, DOI 10.1038/nbt1004-1237; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Perry Lily M., 1980, MED PLANTS E SE ASIA; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; Yoo KJ, 2000, CIRCULATION, V102, P204	28	23	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2009	4	2							e4461	10.1371/journal.pone.0004461	http://dx.doi.org/10.1371/journal.pone.0004461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JS	19221596	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484400001
J	Gomes, JE; Corado, M; Schweisguth, F				Gomes, Jose-Eduardo; Corado, Maria; Schweisguth, Francois			Van Gogh and Frizzled Act Redundantly in the Drosophila Sensory Organ Precursor Cell to Orient Its Asymmetric Division	PLOS ONE			English	Article								Drosophila sensory organ precursor cells (SOPs) divide asymmetrically along the anterior-posterior (a-p) body axis to generate two different daughter cells. Planar Cell Polarity (PCP) regulates the a-p orientation of the SOP division. The localization of the PCP proteins Van Gogh (Vang) and Frizzled (Fz) define anterior and posterior apical membrane domains prior to SOP division. Here, we investigate the relative contributions of Vang, Fz and Dishevelled (Dsh), a membrane-associated protein acting downstream of Fz, in orienting SOP polarity. Genetic and live imaging analyses suggest that Dsh restricts the localization of a centrosome-attracting activity to the anterior cortex and that Vang is a target of Dsh in this process. Using a clone border assay, we provide evidence that the Vang and fz genes act redundantly in SOPs to orient its polarity axis in response to extrinsic local PCP cues. Additionally, we find that the activity of Vang is dispensable for the non-autonomous polarizing activity of fz. These observations indicate that both Vang and Fz act as cues for downstream effectors orienting the planar polarity axis of dividing SOPs.	[Gomes, Jose-Eduardo; Corado, Maria; Schweisguth, Francois] Inst Jacques Monod, F-75251 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Gomes, JE (corresponding author), Inst Jacques Monod, 2 Pl Jussieu, F-75251 Paris, France.	fschweis@pasteur.fr		Gomes, Jose Eduardo/0000-0001-7264-9448	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure (ENS); Fundacao para a Ciencia e a Tecnologia (FCT); National Science Foundation (NSF)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure (ENS); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by: Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure (ENS), Fundacao para a Ciencia e a Tecnologia (FCT), National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2000, MECH DEVELOP, V96, P197, DOI 10.1016/S0925-4773(00)00392-0; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bastock R, 2007, DEVELOPMENT, V134, P3055, DOI 10.1242/dev.010447; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; KLEIN TJ, 2005, ANN REV CELL DEV BIO; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lee H, 2002, GENETICS, V160, P1535; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; Zecca M, 2002, DEVELOPMENT, V129, P1357	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4485	10.1371/journal.pone.0004485	http://dx.doi.org/10.1371/journal.pone.0004485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214234	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484300015
J	Zimmermann, E; Kring, SII; Berentzen, TL; Holst, C; Pers, TH; Hansen, T; Pedersen, O; Sorensen, TIA; Jess, T				Zimmermann, Esther; Kring, Sofia I. I.; Berentzen, Tina L.; Holst, Claus; Pers, Tune H.; Hansen, Torben; Pedersen, Oluf; Sorensen, Thorkild I. A.; Jess, Tine			Fatness-Associated FTO Gene Variant Increases Mortality Independent of Fatness - in Cohorts of Danish Men	PLOS ONE			English	Article							BODY-MASS INDEX; ADULT OBESITY; YOUNG MEN; RS9939609; FAT; OVERWEIGHT; CHILDHOOD; SMOKING	Background: The A-allele of the single nucleotide polymorphism (SNP), rs9939609, in the FTO gene is associated with increased fatness. We hypothesized that the SNP is associated with morbidity and mortality through the effect on fatness. Methodology/Principal Findings: In a population of 362,200 Danish young men, examined for military service between 1943 and 1977, all obese (BMI >= 31.0 kg/m(2)) and a random 1% sample of the others were identified. In 1992-94, at an average age of 46 years, 752 of the obese and 876 of the others were re-examined, including measurements of weight, fat mass, height, and waist circumference, and DNA sampling. Hospitalization and death occurring during the following median 13.5 years were ascertained by linkage to national registers. Cox regression analyses were performed using a dominant effect model (TT vs. TA or AA). In total 205 men died. Mortality was 42% lower (p = 0.001) with the TT genotype than in A-allele carriers. This phenomenon was observed in both the obese and the randomly sampled cohort when analysed separately. Adjustment for fatness covariates attenuated the association only slightly. Exploratory analyses of cause-specific mortality and morbidity prior to death suggested a general protective effect of the TT genotype, whereas there were only weak associations with disease incidence, except for diseases of the nervous system. Conclusion: Independent of fatness, the A-allele of the FTO SNP appears to increase mortality of a magnitude similar to smoking, but without a particular underlying disease pattern barring an increase in the risk of diseases of the nervous system.	[Zimmermann, Esther; Kring, Sofia I. I.; Berentzen, Tina L.; Holst, Claus; Sorensen, Thorkild I. A.; Jess, Tine] Univ Copenhagen Hosp, Inst Prevent Med, Ctr Hlth & Soc, DK-2100 Copenhagen, Denmark; [Pers, Tune H.] Tech Univ Denmark, Ctr Biol Sequence Analysis, Lyngby, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Steno Diabetes Center	Zimmermann, E (corresponding author), Univ Copenhagen Hosp, Inst Prevent Med, Ctr Hlth & Soc, DK-2100 Copenhagen, Denmark.	tj@ipm.regionh.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Huicho, Luis/0000-0002-5272-5885; Zimmermann, Esther/0000-0001-5854-0542; Hansen, Torben/0000-0001-8748-3831; Pers, Tune/0000-0003-0207-4831	Cluster for Endocrinology and Metabolism, University of Copenhagen; Danish Council for Strategic Research [2101-06-0005]	Cluster for Endocrinology and Metabolism, University of Copenhagen; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen. Further, it is a part of the research program of the Danish Obesity Research Centre (DanORC, see www.danorc.dk). DanORC is supported by the Danish Council for Strategic Research (Grant 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; *DAN NAT BOARD HLT, 2006, NEW FIG NAT BOARD HL; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HEITMANN BL, 1994, EUR J CLIN NUTR, V48, P228; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Juel K, 1999, DAN MED BULL, V46, P354; Pedersen CB, 2006, DAN MED BULL, V53, P441; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; SCHNOHR P, 2001, J EUROPEAN SOC CARDI, V3; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200	26	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4428	10.1371/journal.pone.0004428	http://dx.doi.org/10.1371/journal.pone.0004428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214238	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484300001
J	Lind, M; Oden, A; Fahlen, M; Eliasson, B				Lind, Marcus; Oden, Anders; Fahlen, Martin; Eliasson, Bjorn			The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE BURDEN; MICROVASCULAR COMPLICATIONS; INSULIN-TREATMENT; HEMOGLOBIN; MODELS; RISK	Aim: The updated mean HbA1c has been used in risk estimates of diabetic complications, but it does not take into account the temporal relationship between HbA1c and diabetic complications. We studied whether the updated mean HbA1c underestimated the risk of diabetic complications. Method: Continuous HbA1c curves for 10,000 hypothetical diabetes patients were simulated over an average of 7 years. Simulations were based on HbA1c values encountered in clinical practice. We assumed that each short time interval of the continuous HbA1c curves had a long-lasting effect on diabetic complications, as evidenced by earlier studies. We tested several different HbA1c variables including various profiles, e.g. different duration, of such a long-lasting effect. The predictive power of these variables was compared with that of the updated mean HbA1c. Results: The predictive power of the constructed HbA1c variables differed considerably compared to that of the updated mean HbA1c. The risk increase per standard deviation could be almost 100% higher for a constructed predictor than the updated mean HbA1c. Conclusions: The importance of good glycemic control in preventing diabetic complications could have been underestimated in earlier hallmark studies by not taking the time-dependent effect of HbA1c into account.	Uddevalla Cent Hosp, Dept Med, Uddevalla, Sweden; [Oden, Anders] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Fahlen, Martin] Kungalv Hospital, Dept Med, Kungalv, Sweden; [Eliasson, Bjorn] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden	Voestalpine AG; Chalmers University of Technology; Sahlgrenska University Hospital	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022; Eliasson, Bjorn/H-5783-2016	Eliasson, Bjorn/0000-0003-2569-4160				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 1995, DIABETES, V44, P968; Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Bagust A, 2001, DIABETOLOGIA, V44, P2140, DOI 10.1007/s001250100023; *CONTR CARD RISK D, 2008, NEW ENGL J MED, V358, P2545; COX DR, 1972, J R STAT SOC B, V34, P187; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Eeg-Olofsson K, 2007, DIABETES CARE, V30, P496, DOI 10.2337/dc06-1406; Fahlen M, 2005, DIABETIC MED, V22, P382, DOI 10.1111/j.1464-5491.2004.01444.x; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; HOLMAN RR, 2008, N ENGL J MED    0910; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Lawes CMM, 2004, STROKE, V35, P1024, DOI 10.1161/01.STR.0000126208.14181.DD; LIND M, 2008, SYSTEMATIC REV HBA1C, P2282; LIND M, 2008, DIABET IN PRESS 0312; LIPTSER B, 2001, STAT RANDOM PROCESSE; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Nardi A, 2003, STAT MED, V22, P3597, DOI 10.1002/sim.1592; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Osterbrand M, 2007, EUR J EPIDEMIOL, V22, P151, DOI 10.1007/s10654-007-9107-4; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	28	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4412	10.1371/journal.pone.0004412	http://dx.doi.org/10.1371/journal.pone.0004412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209233	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484100003
J	Rutishauser, D; Mertz, KD; Moos, R; Brunner, E; Rulicke, T; Calella, AM; Aguzzi, A				Rutishauser, Dorothea; Mertz, Kirsten D.; Moos, Rita; Brunner, Erich; Ruelicke, Thomas; Calella, Anna Maria; Aguzzi, Adriano			The Comprehensive Native Interactome of a Fully Functional Tagged Prion Protein	PLOS ONE			English	Article							SCRAPIE; MICE; PRP; RESISTANT; INFECTIVITY; PROPAGATION; EXPRESSION; ISOFORMS; ABSENCE; DISEASE	The enumeration of the interaction partners of the cellular prion protein, PrPC, may help clarifying its elusive molecular function. Here we added a carboxy proximal myc epitope tag to PrPC. When expressed in transgenic mice, PrPmyc carried a GPI anchor, was targeted to lipid rafts, and was glycosylated similarly to PrPC. PrPmyc antagonized the toxicity of truncated PrP, restored prion infectibility of PrPC-deficient mice, and was physically incorporated into PrPSc aggregates, indicating that it possessed all functional characteristics of genuine PrPC. We then immunopurified myc epitope-containing protein complexes from PrPmyc transgenic mouse brains. Gentle differential elution with epitope-mimetic decapeptides, or a scrambled version thereof, yielded 96 specifically released proteins. Quantitative mass spectrometry with isotope-coded tags identified seven proteins which co-eluted equimolarly with PrPC and may represent component of a multiprotein complex. Selected PrPC interactors were validated using independent methods. Several of these proteins appear to exert functions in axomyelinic maintenance.	[Rutishauser, Dorothea; Mertz, Kirsten D.; Moos, Rita; Brunner, Erich; Calella, Anna Maria; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Rutishauser, Dorothea] Funct Genom Ctr Zurich, Zurich, Switzerland; [Brunner, Erich] Univ Zurich, Ctr Model Organism Proteomes, CH-8006 Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Res Ctr Biomodels Austria, Vienna, Austria	University of Zurich; University Zurich Hospital; University of Zurich; University of Veterinary Medicine Vienna	Rutishauser, D (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Mertz, Kirsten/AAY-1660-2020; Aguzzi, Adriano/A-3351-2008	Mertz, Kirsten/0000-0002-3074-6925; Rutishauser, Dorothea/0000-0003-2303-103X; Aguzzi, Adriano/0000-0002-0344-6708	National Prion Research Program [DAMD17-03-1-0456]; European Union; Swiss National Foundation; National Competence Center on Neural Plasticity and Repair; Stammbach foundation; DEFRA; Roche Research Foundation	National Prion Research Program; European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Competence Center on Neural Plasticity and Repair; Stammbach foundation; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Roche Research Foundation	AA is supported by the National Prion Research Program (DoD, DAMD17-03-1-0456), European Union contracts (TSEUR, Immunoprion), the Swiss National Foundation, the National Competence Center on Neural Plasticity and Repair, the Stammbach foundation, DEFRA and the Roche Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2005, IMMUNITY, V22, P145, DOI 10.1016/j.immuni.2004.12.007; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; AGUZZI A, 2007, MOL MECH PRION PATHO; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Bian JF, 2006, BIOCHEM BIOPH RES CO, V340, P894, DOI 10.1016/j.bbrc.2005.12.085; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Ledesma MD, 2003, EMBO REP, V4, P1190, DOI 10.1038/sj.embor.7400021; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lipart C, 2002, J VIROL METHODS, V101, P1, DOI 10.1016/S0166-0934(01)00413-X; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nishida N, 1999, LAB INVEST, V79, P689; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; PATTISON IH, 1965, VET REC, V77, P1388, DOI 10.1136/vr.77.47.1388; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmalfeldt M, 2000, J CELL SCI, V113, P807; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; von Haller PD, 2001, PROTEOMICS, V1, P1010; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; 2004, J BIOL CHEM, P36497	57	64	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4446	10.1371/journal.pone.0004446	http://dx.doi.org/10.1371/journal.pone.0004446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209230	Green Published, gold, Green Accepted			2022-12-27	WOS:000265484100010
J	Asrar, S; Zhou, ZK; Ren, W; Jia, ZP				Asrar, Suhail; Zhou, Zikai; Ren, Wei; Jia, Zhengping			Ca2+ Permeable AMPA Receptor Induced Long-Term Potentiation Requires PI3/MAP Kinases but Not Ca/CaM-Dependent Kinase II	PLOS ONE			English	Article								Ca2+ influx via GluR2-lacking Ca2+-permeable AMPA glutamate receptors (CP-AMPARs) can trigger changes in synaptic efficacy in both interneurons and principle neurons, but the underlying mechanisms remain unknown. We took advantage of genetically altered mice with no or reduced GluR2, thus allowing the expression of synaptic CP-AMPARs, to investigate the molecular signaling process during CP-AMPAR-induced synaptic plasticity at CA1 synapses in the hippocampus. Utilizing electrophysiological techniques, we demonstrated that these receptors were capable of inducing numerous forms of long-term potentiation (referred to as CP-AMPAR dependent LTP) through a number of different induction protocols, including high-frequency stimulation (HFS) and theta-burst stimulation (TBS). This included a previously undemonstrated form of protein-synthesis dependent late-LTP (L-LTP) at CA1 synapses that is NMDA-receptor independent. This form of plasticity was completely blocked by the selective CP-AMPAR inhibitor IEM-1460, and found to be dependent on postsynaptic Ca2+ ions through calcium chelator (BAPTA) studies. Surprisingly, Ca/CaM-dependent kinase II ( CaMKII), the key protein kinase that is indispensable for NMDA-receptor dependent LTP at CA1 synapses appeared to be not required for the induction of CP-AMPAR dependent LTP due to the lack of effect of two separate pharmacological inhibitors (KN-62 and staurosporine) on this form of potentiation. Both KN-62 and staurosporine strongly inhibited NMDA-receptor dependent LTP in control studies. In contrast, inhibitors for PI3-kinase (LY294002 and wortmannin) or the MAPK cascade (PD98059 and U0126) significantly attenuated this CP-AMPAR-dependent LTP. Similarly, postsynaptic infusion of tetanus toxin (TeTx) light chain, an inhibitor of exocytosis, also had a significant inhibitory effect on this form of LTP. These results suggest that distinct synaptic signaling underlies GluR2-lacking CP-AMPAR-dependent LTP, and reinforces the recent notions that CP-AMPARs are important facilitators of synaptic plasticity in the brain.	[Asrar, Suhail; Zhou, Zikai; Jia, Zhengping] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Asrar, Suhail; Zhou, Zikai; Jia, Zhengping] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ren, Wei] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Shaanxi Normal University	Asrar, S (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	zpjia@hotmail.com	Jia, zhengping/AAZ-4190-2021	Zhou, Zikai/0000-0002-4577-9826	Canadian Institutes of Health Research (CIHR) [MOP-42396]; Ontario Mental Health Foundation; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR MOP-42396) and Ontario Mental Health Foundation. Suhail Asrar was supported by the Ontario Graduate Scholarship (OGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Buldakova SL, 2007, NEUROSCIENCE, V144, P88, DOI 10.1016/j.neuroscience.2006.09.005; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Opazo P, 2003, J NEUROSCI, V23, P3679; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sanchez-Martinez C, 2003, BIOORG MED CHEM LETT, V13, P3835, DOI 10.1016/S0960-894X(03)00791-1; Sanna PP, 2002, J NEUROSCI, V22, P3359; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Wang S, 2002, J NEUROPHYSIOL, V88, P29, DOI 10.1152/jn.2002.88.1.29	49	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4339	10.1371/journal.pone.0004339	http://dx.doi.org/10.1371/journal.pone.0004339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190753	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483300003
J	Lebrecht, S; Pierce, LJ; Tarr, MJ; Tanaka, JW				Lebrecht, Sophie; Pierce, Lara J.; Tarr, Michael J.; Tanaka, James W.			Perceptual Other-Race Training Reduces Implicit Racial Bias	PLOS ONE			English	Article							FUSIFORM FACE AREA; SAME-RACE; RECOGNITION; OWN; ACTIVATION; EXPERTISE; PREJUDICE; ATTITUDES; COGNITION; AFRICAN	Background: Implicit racial bias denotes socio-cognitive attitudes towards other-race groups that are exempt from conscious awareness. In parallel, other-race faces are more difficult to differentiate relative to own-race faces - the "OtherRace Effect.'' To examine the relationship between these two biases, we trained Caucasian subjects to better individuate other-race faces and measured implicit racial bias for those faces both before and after training. Methodology/Principal Findings: Two groups of Caucasian subjects were exposed equally to the same African American faces in a training protocol run over 5 sessions. In the individuation condition, subjects learned to discriminate between African American faces. In the categorization condition, subjects learned to categorize faces as African American or not. For both conditions, both pre- and post-training we measured the Other-Race Effect using old-new recognition and implicit racial biases using a novel implicit social measure - the "Affective Lexical Priming Score'' (ALPS). Subjects in the individuation condition, but not in the categorization condition, showed improved discrimination of African American faces with training. Concomitantly, subjects in the individuation condition, but not the categorization condition, showed a reduction in their ALPS. Critically, for the individuation condition only, the degree to which an individual subject's ALPS decreased was significantly correlated with the degree of improvement that subject showed in their ability to differentiate African American faces. Conclusions/Significance: Our results establish a causal link between the Other-Race Effect and implicit racial bias. We demonstrate that training that ameliorates the perceptual Other-Race Effect also reduces socio-cognitive implicit racial bias. These findings suggest that implicit racial biases are multifaceted, and include malleable perceptual skills that can be modified with relatively little training.	[Tarr, Michael J.] Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; [Pierce, Lara J.; Tanaka, James W.] Univ Victoria, Dept Psychol, Victoria, BC V8W 2Y2, Canada	Brown University; University of Victoria	Lebrecht, S (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	Michael_Tarr@brown.edu		Lauwereyns, Jan/0000-0003-0551-2550	Perceptual Expertise Network [15573-S6]; James S. McDonnell Foundation; Temporal Dynamics of Learning Center at UCSD; NSF Science of Learning Center [SBE-0542013, 0339122]; National Sciences and Engineering Research Council of Canada; Brown University NEI graduate training award	Perceptual Expertise Network; James S. McDonnell Foundation; Temporal Dynamics of Learning Center at UCSD; NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Brown University NEI graduate training award	Funding for collaborating across universities was provided by the Perceptual Expertise Network (#15573-S6), a collaborative award from James S. McDonnell Foundation, and by the Temporal Dynamics of Learning Center at UCSD (NSF Science of Learning Center SBE-0542013); a National Science Foundation award #0339122 to MJT supported the development of the ALPS measure; a National Sciences and Engineering Research Council of Canada award to JWT supported the development of the other-race face training procedure; and SL was supported by a Brown University NEI graduate training grant award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Couzin J, 2008, SCIENCE, V322, P180, DOI 10.1126/science.322.5899.180; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Ferguson DP, 2001, BRIT J PSYCHOL, V92, P567, DOI 10.1348/000712601162347; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hugenberg K, 2007, J EXP SOC PSYCHOL, V43, P334, DOI 10.1016/j.jesp.2006.02.010; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Tanaka JW, 2005, PSYCHOL SCI, V16, P145, DOI 10.1111/j.0956-7976.2005.00795.x; TANAKA JW, 2008, COGNITIVE A IN PRESS; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Walker PM, 2008, APPL COGNITIVE PSYCH, V22, P441, DOI 10.1002/acp.1382; Zernike Kate, 2008, NY TIMES	26	118	119	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4215	10.1371/journal.pone.0004215	http://dx.doi.org/10.1371/journal.pone.0004215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JB	19156226	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482100001
J	Herz, HM; Woodfield, SE; Chen, ZH; Bolduc, C; Bergmann, A				Herz, Hans-Martin; Woodfield, Sarah E.; Chen, Zhihong; Bolduc, Clare; Bergmann, Andreas			Common and Distinct Genetic Properties of ESCRT-II Components in Drosophila	PLOS ONE			English	Article								Background: Genetic studies in yeast have identified class E vps genes that form the ESCRT complexes required for protein sorting at the early endosome. In Drosophila, mutations of the ESCRT-II component vps25 cause endosomal defects leading to accumulation of Notch protein and increased Notch pathway activity. These endosomal and signaling defects are thought to account for several phenotypes. Depending on the developmental context, two different types of overgrowth can be detected. Tissue predominantly mutant for vps25 displays neoplastic tumor characteristics. In contrast, vps25 mutant clones in a wild-type background trigger hyperplastic overgrowth in a non-autonomous manner. In addition, vps25 mutant clones also promote apoptotic resistance in a non-autonomous manner. Principal Findings: Here, we genetically characterize the remaining ESCRT-II components vps22 and vps36. Like vps25, mutants of vps22 and vps36 display endosomal defects, accumulate Notch protein and - when the tissue is predominantly mutant - show neoplastic tumor characteristics. However, despite these common phenotypes, they have distinct non-autonomous phenotypes. While vps22 mutations cause strong non-autonomous overgrowth, they do not affect apoptotic resistance. In contrast, vps36 mutations increase apoptotic resistance, but have little effect on non-autonomous proliferation. Further characterization reveals that although all ESCRT-II mutants accumulate Notch protein, only vps22 and vps25 mutations trigger Notch activity. Conclusions/Significance: The ESCRT-II components vps22, vps25 and vps36 display common and distinct genetic properties. Our data redefine the role of Notch for hyperplastic and neoplastic overgrowth in these mutants. While Notch is required for hyperplastic growth, it appears to be dispensable for neoplastic transformation.	[Herz, Hans-Martin; Woodfield, Sarah E.; Chen, Zhihong; Bolduc, Clare; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Genes & Development Grad Program, Houston, TX USA; [Woodfield, Sarah E.] Baylor Coll Med, Grad Program Developmental Biol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Herz, HM (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	abergman@mdanderson.org	Herz, Hans-Martin/N-2594-2018; Woodfield, Sarah/AEW-0563-2022	Herz, Hans-Martin/0000-0003-4780-9176; Bolduc, Clare/0000-0002-1321-6017	National Institute of General Medical Sciences, NIH [R01 GM081543]; Robert A. Welch Foundation [G-1496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081543] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number R01 GM081543 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not represent the official views of the NIGMS or NIH. A.B. gratefully acknowledges support by the Robert A. Welch Foundation (G-1496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Lee TV, 2008, DEVELOPMENT, V135, P43, DOI 10.1242/dev.011288; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Lin SY, 1998, J GASTROEN HEPATOL, V13, P1111, DOI 10.1111/j.1440-1746.1998.tb00585.x; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stowers RS, 1999, GENETICS, V152, P1631; Sun ZJ, 1997, ONCOGENE, V15, P3121, DOI 10.1038/sj.onc.1201521; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yu SY, 2002, DEVELOPMENT, V129, P3269	53	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4165	10.1371/journal.pone.0004165	http://dx.doi.org/10.1371/journal.pone.0004165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132102	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473700004
J	Sturlan, S; Sachet, M; Baumann, S; Kuznetsova, I; Spittler, A; Bergmann, M				Sturlan, Sanda; Sachet, Monika; Baumann, Suzann; Kuznetsova, Irina; Spittler, Andreas; Bergmann, Michael			Influenza A Virus Induces an Immediate Cytotoxic Activity in All Major Subsets of Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article								Background: A replication defective influenza A vaccine virus (delNS1 virus) was developed. Its attenuation is due to potent stimulation of the innate immune system by the virus. Since the innate immune system can also target cancer cells, we reasoned that delNS1 virus induced immune-stimulation should also lead to the induction of innate cytotoxic effects towards cancer cells. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMCs), isolated CD56+, CD3+, CD14+ and CD19+ subsets and different combinations of the above subsets were stimulated by delNS1, wild type (wt) virus or heat inactivated virus and co-cultured with tumor cell lines in the presence or absence of antibodies against the interferon system. Stimulation of PBMCs by the delNS1 virus effectively induced cytotoxicity against different cancer cell lines. Surprisingly, virus induced cytotoxicity was exerted by all major subtypes of PBMCs including CD56+, CD3+, CD14+ and CD19+ cells. Virus induced cytotoxicity in CD3+, CD14+ and CD19+ cells was dependent on virus replication, whereas virus induced cytotoxicity in CD56+ cells was only dependent on the binding of the virus. Virus induced cytotoxicity of isolated cell cultures of CD14+, CD19+ or CD56+ cells could be partially blocked by antibodies against type I and type II (IFN) interferon. In contrast, virus induced cytotoxicity in the complete PBMC preparation could not be inhibited by blocking type I or type II IFN, indicating a redundant system of activation in whole blood. Conclusions/Significance: Our data suggest that apart from their well known specialized functions all main subsets of peripheral blood cells also initially exert a cytotoxic effect upon virus stimulation. This closely links the innate immune system to the adaptive immune response and renders delNS1 virus a potential therapeutic tool for viro-immunotherapy of cancer.	[Sturlan, Sanda; Sachet, Monika; Baumann, Suzann; Kuznetsova, Irina; Spittler, Andreas; Bergmann, Michael] Med Univ Vienna, Dept Surg, Div Gen Surg, Vienna, Austria	Medical University of Vienna	Sturlan, S (corresponding author), Med Univ Vienna, Dept Surg, Div Gen Surg, Vienna, Austria.	michael.bergmann@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022	Bergmann, Michael/0000-0001-8529-1166; Spittler, Andreas/0000-0003-2657-6836	EU [518281]	EU(European Commission)	The work was supported by the grant of the EU-commission Nr. 518281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Chawla-Sarkar M, 2002, J IMMUNOL, V169, P847, DOI 10.4049/jimmunol.169.2.847; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; Hicks Amy M, 2006, Cancer Immun, V6, P11; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Kemp TJ, 2004, J IMMUNOL, V173, P892, DOI 10.4049/jimmunol.173.2.892; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mozdzanowska K, 2000, J IMMUNOL, V164, P2635, DOI 10.4049/jimmunol.164.5.2635; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2001, EUR J IMMUNOL, V31, P3525, DOI 10.1002/1521-4141(200112)31:12<3525::AID-IMMU3525>3.0.CO;2-5; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Ullrich E, 2008, CYTOKINE GROWTH F R, V19, P79, DOI 10.1016/j.cytogfr.2007.10.009; Urosevic M, 2007, J CLIN INVEST, V117, P2834, DOI 10.1172/JCI32077; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Washburn B, 2003, J IMMUNOL, V170, P1814, DOI 10.4049/jimmunol.170.4.1814; Woo Y, 2006, CURR OPIN INVEST DR, V7, P549	33	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4122	10.1371/journal.pone.0004122	http://dx.doi.org/10.1371/journal.pone.0004122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125202	gold, Green Submitted, Green Published			2022-12-27	WOS:000265473100002
J	Jain, S				Jain, Siddharth			Performance Characterization of Watson Ahumada Motion Detector Using Random Dot Rotary Motion Stimuli	PLOS ONE			English	Article							VISUAL AREA MT; COHERENT GLOBAL MOTION; STOCHASTIC RESONANCE; IMPLIED MOTION; COMPLEX CELLS; MST NEURONS; MODEL; PERCEPTION; CORTEX; NOISE	The performance of Watson & Ahumada's model of human visual motion sensing is compared against human psychophysical performance. The stimulus consists of random dots undergoing rotary motion, displayed in a circular annulus. The model matches psychophysical observer performance with respect to most parameters. It is able to replicate some key psychophysical findings such as invariance of observer performance to dot density in the display, and decrease of observer performance with frame duration of the display. Associated with the concept of rotary motion is the notion of a center about which rotation occurs. One might think that for accurate estimation of rotary motion in the display, this center must be accurately known. A simple vector analysis reveals that this need not be the case. Numerical simulations confirm this result, and may explain the position invariance of MST(d) cells. Position invariance is the experimental finding that rotary motion sensitive cells are insensitive to where in their receptive field rotation occurs. When all the dots in the display are randomly drawn from a uniform distribution, illusory rotary motion is perceived. This case was investigated by Rose & Blake previously, who termed the illusory rotary motion the omega effect. Two important experimental findings are reported concerning this effect. First, although the display of random dots evokes perception of rotary motion, the direction of motion perceived does not depend on what dot pattern is shown. Second, the time interval between spontaneous flips in perceived direction is lognormally distributed (mode approximate to 2 s). These findings suggest the omega effect fits in the category of a typical bistable illusion, and therefore the processes that give rise to this illusion may be the same processes that underlie much of other bistable phenomenon.				fd97207@yahoo.com	Jain, Siddharth/G-6644-2011					ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Barlow H, 1997, J NEUROSCI, V17, P7954; Barlow HB, 2004, J VISION, V4, P415, DOI 10.1167/4.6.1; Benton CP, 2007, BIOLOGY LETT, V3, P306, DOI 10.1098/rsbl.2007.0056; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Burr D, 2006, VISION RES, V46, P1139, DOI 10.1016/j.visres.2005.09.018; Cavanagh P, 1991, Spat Vis, V5, P303, DOI 10.1163/156856891X00065; DAWSON MRW, 1991, PSYCHOL REV, V98, P569, DOI 10.1037/0033-295X.98.4.569; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DEANGELIS GC, 1996, TRENDS NEUROSCI, V19, P386; Derrington AM, 2004, ANNU REV PSYCHOL, V55, P181, DOI 10.1146/annurev.psych.55.090902.141903; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Green DM, 1966, SIGNAL DETECTION THE; GRZYWACZ NM, 1995, VISION RES, V35, P3183, DOI 10.1016/0042-6989(95)00102-6; GRZYWACZ NM, 2003, ENCY COGNITIVE SCI, V3, P86; HEEGER DJ, 1987, J OPT SOC AM A, V4, P1455, DOI 10.1364/JOSAA.4.001455; JAIN S, 2007, OPTICAL FLOW MOTION; JOHNSTON A, 1992, P ROY SOC B-BIOL SCI, V250, P297, DOI 10.1098/rspb.1992.0162; Krekelberg B, 2005, J NEUROPHYSIOL, V94, P4373, DOI 10.1152/jn.00690.2005; Krekelberg B, 2003, NATURE, V424, P674, DOI 10.1038/nature01852; Krekelberg B, 2008, SENSES COMPREHENSIVE; Kumar T, 2006, P NATL ACAD SCI USA, V103, P1947, DOI 10.1073/pnas.0510236103; MACKAY DM, 1965, J GEN PSYCHOL, V72, P181, DOI 10.1080/00221309.1965.9710688; MORGAN MJ, 1980, PHILOS T ROY SOC B, V290, P117, DOI 10.1098/rstb.1980.0086; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Perrone JA, 2005, J VISION, V5, P28, DOI 10.1167/5.1.3; Perrone JA, 2002, VISION RES, V42, P1035, DOI 10.1016/S0042-6989(02)00029-9; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; RIANI M, 1994, PHYS REV LETT, V72, P3120, DOI 10.1103/PhysRevLett.72.3120; Rose D, 1998, PHILOS T ROY SOC B, V353, P967, DOI 10.1098/rstb.1998.0261; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SAKATA H, 1994, EXP BRAIN RES, V101, P183, DOI 10.1007/BF00228740; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Shermer M, 2008, SCI AM, V299, P48, DOI 10.1038/scientificamerican1208-48; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VIVA MMD, 2006, J NEUROPHYSIOL, V95, P3928; WATAMANIUK SNJ, 1995, VISION RES, V35, P65, DOI 10.1016/0042-6989(94)E0047-O; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WATSON AB, 1986, J OPT SOC AM A, V3, P300, DOI 10.1364/JOSAA.3.000300; WATSON AB, 1983, 84352 NASA; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5	58	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4536	10.1371/journal.pone.0004536	http://dx.doi.org/10.1371/journal.pone.0004536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KI	19225571	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486000011
J	Lu, HY; Zhang, JP; Wu, NQ; Liu, KB; Xu, D; Li, Q				Lu, Houyuan; Zhang, Jianping; Wu, Naiqin; Liu, Kam-Biu; Xu, Deke; Li, Quan			Phytoliths Analysis for the Discrimination of Foxtail Millet (Setaria italica) and Common Millet (Panicum miliaceum)	PLOS ONE			English	Article							WHEAT TRITICUM-MONOCOCCUM; ORYZA-SATIVA POACEAE; INFLORESCENCE BRACTS; SILICA BODIES; RICE; GRASSES; CHINA; WILD; AESTIVUM; CARCINOGENESIS	Foxtail millet (Setaria italica) and Common millet (Panicum miliaceum) are the oldest domesticated dry farming crops in Eurasia. Identifying these two millets in the archaeobotanical remains are still problematic, especially because the millet grains preserve only when charred. Phytoliths analysis provides a viable method for identifying this important crop. However, to date, the identification of millet phytoliths has been questionable, because very little study has been done on their morphometry and taxonomy. Particularly, no clear diagnostic feature has been used to distinguish between Foxtail millet and Common millet. Here we examined the anatomy and silicon structure patterns in the glumes, lemmas, and paleas from the inflorescence bracts in 27 modern plants of Foxtail millet, Common millet, and closely related grasses, using light microscopy with phase-contrast and microscopic interferometer. Our research shows that five key diagnostic characteristics in phytolith morphology can be used to distinguish Foxtail millet from Common millet based on the presence of cross-shaped type, regularly arranged papillae, V-undulated type, endings structures of epidermal long cell, and surface ridgy line sculpture in the former species. We have established identification criteria that, when used together, give the only reliable way of distinguishing between Foxtail millet and Common millet species based on their phytoliths characteristics, thus making a methodological contribution to phytolith research. Our findings also have important implications in the fields of plant taxonomy, agricultural archaeology, and the culture history of ancient civilizations.	[Lu, Houyuan; Zhang, Jianping; Wu, Naiqin; Xu, Deke; Li, Quan] Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China; [Liu, Kam-Biu] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Louisiana State University System; Louisiana State University	Lu, HY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China.	houyuanlu@mail.iggcas.ac.cn	Liu, Kam-Biu/B-4966-2012; Lu, houyuan/L-8661-2019; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014	Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X	Chinese Academy of Sciences [kzcx2-yw-117]; NSFC [40771216, 40325002]; Chinese Civilization Origin projects [2006BAK21B02]; U.S. NSF [BCS-0623514, ATM-0402475]	Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); Chinese Civilization Origin projects; U.S. NSF(National Science Foundation (NSF))	This work was supported by the Chinese Academy of Sciences (100 Talents Programme, kzcx2-yw-117), NSFC (40771216; 40325002), Chinese Civilization Origin projects (2006BAK21B02), and the U.S. NSF(BCS-0623514, ATM-0402475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo C, 2001, ANN BOT FENN, V38, P1; Ball T, 1996, J ARCHAEOL SCI, V23, P619, DOI 10.1006/jasc.1996.0058; BALL TB, 1993, CAN J BOT, V71, P1182, DOI 10.1139/b93-139; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Berlin AM, 2003, J ARCHAEOL SCI, V30, P115, DOI 10.1006/jasc.2002.0812; Costea Mihai, 2002, SIDA Contributions to Botany, V20, P525; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; CRAWFORD GW, 1992, ORIGINS AGR; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Harvey EL, 2005, J ARCHAEOL SCI, V32, P739, DOI 10.1016/j.jas.2004.12.010; HODSON MJ, 1985, ANN BOT-LONDON, V55, P649, DOI 10.1093/oxfordjournals.aob.a086944; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jacobs S. W. L., 2001, Telopea, V9, P439; Krishnan S, 2000, BOT J LINN SOC, V132, P241, DOI 10.1111/j.1095-8339.2000.tb01529.x; LIU CJ, 2004, KAOGU, P748; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 1998, THESIS CHINESE ACAD; Lu TLD, 1998, ANTIQUITY, V72, P902, DOI 10.1017/S0003598X00087548; Madella M., 2003, INDUS ETHNOBIOLOGY N, P199; MULHOLLAND SC, 1990, CAN J BOT, V68, P1638, DOI 10.1139/b90-210; MULHOLLAND SC, 1988, CAN J BOT, V66, P2001, DOI 10.1139/b88-273; MUSIL AF, 1963, AGR HDB USDA, V219; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; Nesbitt M.G., 2005, CULTURAL HIST PLANTS, P45; PAHRRY DW, 1966, ANN BOT, V30, P525; PARRY DW, 1982, ANN BOT-LONDON, V49, P531, DOI 10.1093/oxfordjournals.aob.a086278; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D. R., 2006, PHYTOLITHS COMPREHEN, P238; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1984, AM ANTIQUITY, V49, P361, DOI 10.2307/280024; Portillo M, 2006, ECON BOT, V60, P121, DOI 10.1663/0013-0001(2006)60[121:MAOIPP]2.0.CO;2; Renfrew J. M., 1973, Palaeoethnobotany. The prehistoric food plants of the Near East and Europe.; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P132; SANGSTER AG, 1983, NEW PHYTOL, V93, P105, DOI 10.1111/j.1469-8137.1983.tb02696.x; TAKEOKA Y, 1984, JPN J CROP SCI, V53, P197, DOI 10.1626/jcs.53.197; TERRELL EE, 1981, AM J BOT, V68, P697, DOI 10.2307/2442797; TUBB HJ, 1993, ANN BOT-LONDON, V72, P537, DOI 10.1006/anbo.1993.1142; Wang Y., 1993, STUDY PHYTOLITH ITS, P228; Whang SS, 1998, AM J BOT, V85, P461, DOI 10.2307/2446428; You XL., 1993, AGR HIST CHINA, V12, P1; Zhao Z, 2006, I ARCHAEOLOGY CHINES, P97; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zheng D.S, 2005, J PLANT GENETIC RESO, V6, P354	46	145	186	8	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4448	10.1371/journal.pone.0004448	http://dx.doi.org/10.1371/journal.pone.0004448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212442	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484200009
J	Yamakawa, Y; Kanai, R; Matsumura, M; Naito, E				Yamakawa, Yoshinori; Kanai, Ryota; Matsumura, Michikazu; Naito, Eiichi			Social Distance Evaluation in Human Parietal Cortex	PLOS ONE			English	Article							ASSOCIATION CORTEX; PERCEPTION; SPACE; REPRESENTATIONS; MAGNITUDE; DICTATOR; NUMBER; WINDOW; COMMON; TARGET	Across cultures, social relationships are often thought of, described, and acted out in terms of physical space (e.g. "close friends'' "high lord''). Does this cognitive mapping of social concepts arise from shared brain resources for processing social and physical relationships? Using fMRI, we found that the tasks of evaluating social compatibility and of evaluating physical distances engage a common brain substrate in the parietal cortex. The present study shows the possibility of an analytic brain mechanism to process and represent complex networks of social relationships. Given parietal cortex's known role in constructing egocentric maps of physical space, our present findings may help to explain the linguistic, psychological and behavioural links between social and physical space.	[Yamakawa, Yoshinori] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Yamakawa, Yoshinori] Japan Soc Promot Sci, Tokyo, Japan; [Yamakawa, Yoshinori; Naito, Eiichi] ATR Comput Neurosci Lab, Kyoto, Japan; [Yamakawa, Yoshinori] NEC Corp Ltd, Corp Corp Planning Div, Tokyo, Japan; [Kanai, Ryota] UCL, Inst Cognit Neurosci, London WC1E 6BT, England; [Matsumura, Michikazu] Kyoto Univ, Grad Sch Human & Environm Stud, Kyoto, Japan; [Naito, Eiichi] Kobe Advanced ICT Res Ctr, Natl Inst Informat & Communication Technol, Dept Res 1, Biophys ICT Grp, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; NEC Corporation; University of London; University College London; Kyoto University	Yamakawa, Y (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	enaito@atr.jp		Kanai, Ryota/0000-0002-0186-2687; yamakawa, yoshinori/0000-0002-7995-1794	Kyoto University COE Program "Center of Excellence for Psychological Studies"; Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan [19500290]; Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory; Human Frontier Science Foundation	Kyoto University COE Program "Center of Excellence for Psychological Studies"; Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan; Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Foundation(Human Frontier Science Program)	This study was supported by Kyoto University COE Program "Center of Excellence for Psychological Studies" and Kyoto University Global COE Program "Informatics Center for the Development of Knowledge Society Infrastructure", MEXT, Japan and by the Grant-in-Aid for Scientific Research (C), 19500290, MEXT, Japan. Y.Y. is supported by the Japan Society for the Promotion of Science and the Kyoto University Venture Business Laboratory. R.K. is supported by Human Frontier Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlof GA, 1997, ECONOMETRICA, V65, P1005, DOI 10.2307/2171877; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bogardus Emory S., 1959, SOCIAL DISTANCE; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Bottero W, 2003, BRIT J SOCIOL, V54, P177, DOI 10.1080/0007131032000080195; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Charness G, 2008, J ECON BEHAV ORGAN, V68, P29, DOI 10.1016/j.jebo.2008.03.001; CHIAO JY, 2008, NEUROPSYCHOLOGIA; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith C., 2004, NEUROSCIENCE SOCIAL; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Goleman D., 2006, SOCIAL INTELLIGENCE; Hagura N, 2007, J NEUROSCI, V27, P7047, DOI 10.1523/JNEUROSCI.0970-07.2007; Hall E.T., 1966, HIDDEN DIMENSION, V609; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hoffman E, 1996, AM ECON REV, V86, P653; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Milner A. D., 1995, VISUAL BRAIN ACTION; Naito E, 2008, J NEUROPHYSIOL, V99, P695, DOI 10.1152/jn.00529.2007; Neggers SFW, 2006, NEUROIMAGE, V31, P320, DOI 10.1016/j.neuroimage.2005.12.028; OSSOWSKI S, 1963, CLASS STRUCTURE SOCI; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RAPCSAK SZ, 1995, BRAIN COGNITION, V27, P213, DOI 10.1006/brcg.1995.1018; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P118, DOI 10.1152/jn.1980.43.1.118; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M; Zebrowitz L. A., 1997, READING FACES WINDOW; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	42	39	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4360	10.1371/journal.pone.0004360	http://dx.doi.org/10.1371/journal.pone.0004360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JO	19204791	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000265484000001
J	Hormannsperger, G; Clavel, T; Hoffmann, M; Reiff, C; Kelly, D; Loh, G; Blaut, M; Holzlwimmer, G; Laschinger, M; Haller, D				Hoermannsperger, Gabriele; Clavel, Thomas; Hoffmann, Micha; Reiff, Caroline; Kelly, Denise; Loh, Gunnar; Blaut, Michael; Hoelzlwimmer, Gabriele; Laschinger, Melanie; Haller, Dirk			Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation	PLOS ONE			English	Article								Background: Clinical and experimental studies suggest that the probiotic mixture VSL#3 has protective activities in the context of inflammatory bowel disease (IBD). The aim of the study was to reveal bacterial strain-specific molecular mechanisms underlying the anti-inflammatory potential of VSL#3 in intestinal epithelial cells (IEC). Methodology/Principal Findings: VSL#3 inhibited TNF-induced secretion of the T-cell chemokine interferon-inducible protein (IP-10) in Mode-K cells. Lactobacillus casei (L. casei) cell surface proteins were identified as active anti-inflammatory components of VSL#3. Interestingly, L. casei failed to block TNF-induced IP-10 promoter activity or IP-10 gene transcription at the mRNA expression level but completely inhibited IP-10 protein secretion as well as IP-10-mediated T-cell transmigration. Kinetic studies, pulse-chase experiments and the use of a pharmacological inhibitor for the export machinery (brefeldin A) showed that L. casei did not impair initial IP-10 production but decreased intracellular IP-10 protein stability as a result of blocked IP-10 secretion. Although L. casei induced IP-10 ubiquitination, the inhibition of proteasomal or lysosomal degradation did not prevent the loss of intracellular IP-10. Most important for the mechanistic understanding, the inhibition of vesicular trafficking by 3-methyladenine (3-MA) inhibited IP-10 but not IL-6 expression, mimicking the inhibitory effects of L. casei. These findings suggest that L. casei impairs vesicular pathways important for the secretion of IP-10, followed by subsequent degradation of the proinflammatory chemokine. Feeding studies in TNF Delta ARE and IL-10(-/-) mice revealed a compartimentalized protection of VSL#3 on the development of cecal but not on ileal or colonic inflammation. Consistent with reduced tissue pathology in IL-10(-/-) mice, IP-10 protein expression was reduced in primary epithelial cells. Conclusions/Significance: We demonstrate segment specific effects of probiotic intervention that correlate with reduced IP-10 protein expression in the native epithelium. Furthermore, we revealed post-translational degradation of IP-10 protein in IEC to be the molecular mechanism underlying the anti-inflammatory effect.	[Hoermannsperger, Gabriele; Clavel, Thomas; Hoffmann, Micha; Haller, Dirk] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Chair Biofunct, D-8050 Freising Weihenstephan, Germany; [Reiff, Caroline; Kelly, Denise] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB9 1FX, Scotland; [Loh, Gunnar; Blaut, Michael] Deutsches Inst Ernahrungsforsch, Potsdam, Germany; [Hoelzlwimmer, Gabriele] Helmholz Zent Munchen, Inst Pathol, Munich, Germany; [Laschinger, Melanie] Tech Univ Munich, Dept Surg, Munich, Germany	Technical University of Munich; University of Aberdeen; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hormannsperger, G (corresponding author), Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Chair Biofunct, D-8050 Freising Weihenstephan, Germany.	haller@wzw.tum.de		Meharg, Caroline/0000-0003-0573-9528; Haller, Dirk/0000-0002-6977-4085; Blaut, Michael/0000-0002-6628-2907	European Nutrigenomics Organisation [FP6-506360]; Bundesministerium fur Bildung und Forschung [AZ0313814]	European Nutrigenomics Organisation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Financial support for this study was obtained from the European Nutrigenomics Organisation, contract nr. FP6-506360 and the Bundesministerium fur Bildung und Forschung, AZ0313814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chapman TM, 2006, DRUGS, V66, P1371, DOI 10.2165/00003495-200666100-00006; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clovel T, 2007, INFLAMM BOWEL DIS, V13, P1153, DOI 10.1002/ibd.20174; Dardalhon V, 2002, CELL BIOL INT, V26, P669, DOI 10.1006/cbir.2002.0917; Giacinto CD, 2005, J IMMUNOL, V174, P3237; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Gionchetti P, 2007, DIS COLON RECTUM, V50, P2075, DOI 10.1007/s10350-007-9068-4; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hensbergen PJ, 2004, J BIOL CHEM, V279, P13402, DOI 10.1074/jbc.M312814200; HEO J, 2006, TOXICOL SCI, V96, P92; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Inatomi O, 2005, J GASTROENTEROL, V40, P483, DOI 10.1007/s00535-005-1573-4; Isaacs K, 2008, INFLAMM BOWEL DIS, V14, P1597, DOI 10.1002/ibd.20465; Isowa N, 2000, AM J PHYSIOL-LUNG C, V279, pL1075, DOI 10.1152/ajplung.2000.279.6.L1075; Kamada N, 2008, INFECT IMMUN, V76, P214, DOI 10.1128/IAI.01193-07; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; LAHAT N, 2008, AM J PHYSL IN PRESS; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Marinari Umberto Maria, 2003, Molecular Aspects of Medicine, V24, P205, DOI 10.1016/S0098-2997(03)00015-3; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Proost P, 2006, BIOCHEM SOC T, V34, P997, DOI 10.1042/BST0340997; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ruiz PA, 2005, J IMMUNOL, V174, P2990, DOI 10.4049/jimmunol.174.5.2990; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; SCHAHS P, 2008, EXP CELL RE IN PRESS; Shanmugam N, 2006, J BIOL CHEM, V281, P31212, DOI 10.1074/jbc.M602445200; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; Tebo JM, 1998, BLOOD, V92, P4742, DOI 10.1182/blood.V92.12.4742.424k26_4742_4749; Tien MT, 2006, J IMMUNOL, V176, P3841, DOI 10.4049/jimmunol.176.6.3841-b; TilsalaTimisjarvi A, 1997, INT J FOOD MICROBIOL, V35, P49, DOI 10.1016/S0168-1605(97)88066-X; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; Van den Steen PE, 2003, BIOCHEM BIOPH RES CO, V310, P889, DOI 10.1016/j.bbrc.2003.09.098; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002	52	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4365	10.1371/journal.pone.0004365	http://dx.doi.org/10.1371/journal.pone.0004365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197385	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483700003
J	Ambalavanan, N; El-Ferzli, GT; Roane, C; Johnson, R; Carlo, WA				Ambalavanan, Namasivayam; El-Ferzli, George T.; Roane, Claire; Johnson, Robert; Carlo, Waldemar A.			Nitric Oxide Administration Using an Oxygen Hood: A Pilot Trial	PLOS ONE			English	Article								Background: We have shown earlier that inhaled nitric oxide (iNO) administered by oxygen hood reduces pulmonary hypertension in an animal model (J Perinatol 2002; 22: 50-6). Our objective in this study was to determine feasibility of iNO by oxygen hood in neonates with elevated alveolar-arterial oxygen gradients (A-aDO(2)). Methods/Principal Findings: Masked randomized controlled pilot trial. Inclusion criteria were: gestation >= 34 weeks, age, 7 days, with post-ductal arterial line, and A-aDO(2) 400-600. Infants were randomized to study gas (iNO 20 ppm or equivalent O-2 flow) for 1 hr which was then weaned over the next 4 hours. Primary outcome was PaO2 one hour post-randomization. Four infants each were randomized to iNO or O-2 (controls). Two of the four infants given iNO had an increase in PaO2 of > 100 torr, while oxygenation was unchanged in the controls. Methemoglobinemia and other adverse effects were not noted in any infant. Environmental levels of NO and NO2 were minimal (< 1 ppm) at > 0.3 m from the hood. Conclusions: Administration of iNO by oxygen hood is feasible. Larger randomized controlled trials are required to measure the efficacy and determine an appropriate target population for this technique.	[Ambalavanan, Namasivayam; El-Ferzli, George T.; Roane, Claire; Johnson, Robert; Carlo, Waldemar A.] Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Ambalavanan, N (corresponding author), Univ Alabama, Dept Pediat, Birmingham, AL 35294 USA.	ambal@uab.edu	Ambalavanan, Namasivayam/AAL-3832-2020; Ambalavanan, Namasivayam/AAI-4088-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092	National Institute of Child Health and Human Development [K08 HD046513]; Pulmonary Hypertension Association [0526041H]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD046513] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Pulmonary Hypertension Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded in part by National Institute of Child Health and Human Development K08 HD046513 and by the Pulmonary Hypertension Association PHA 0526041H. Nitric Oxide for this pilot trial was provided by INO Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Finer NN., 2000, COCHRANE DATAB SYSTE, pCD000399, DOI [DOI 10.1002/14651858.CD000399, 10.1002/14651858.CD000399]; Ivy DD, 1998, J PEDIATR-US, V133, P453, DOI 10.1016/S0022-3476(98)70287-2; Kakuya F, 1998, ACTA PAEDIATR JAPON, V40, P155; KINSELLA JP, 1992, LANCET, V340, P819, DOI 10.1016/0140-6736(92)92687-B; Konduri GG, 2004, PEDIATRICS, V113, P559, DOI 10.1542/peds.113.3.559; ROBERTS JD, 1992, LANCET, V340, P818, DOI 10.1016/0140-6736(92)92686-A; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Stork E, 1997, NEW ENGL J MED, V336, P597; Truog WE, 1998, PEDIATRICS, V101, P696, DOI 10.1542/peds.101.4.696; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Wessel DL, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e7	11	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4312	10.1371/journal.pone.0004312	http://dx.doi.org/10.1371/journal.pone.0004312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183804	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483200003
J	Asberg, M; Nygren, A; Leopardi, R; Rylander, G; Peterson, U; Wilczek, L; Kallmen, H; Ekstedt, M; Akerstedt, T; Lekander, M; Ekman, R				Asberg, Marie; Nygren, Ake; Leopardi, Rosario; Rylander, Gunnar; Peterson, Ulla; Wilczek, Lukas; Kallmen, Hakan; Ekstedt, Mirjam; Akerstedt, Torbjorn; Lekander, Mats; Ekman, Rolf			Novel Biochemical Markers of Psychosocial Stress in Women	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BIOCHIP ARRAY TECHNOLOGY; NF-KAPPA-B; SLEEP; DISORDERS; CYTOKINES; PATHWAYS; CORTISOL; RHYTHMS; BURNOUT	Background: Prolonged psychosocial stress is a condition assessed through self-reports. Here we aimed to identify biochemical markers for screening and early intervention in women. Methods: Plasma concentrations of interleukin (IL) 1-alpha, IL1-beta, IL-2, IL-4, IL-6, IL-8, IL-10, interferon-gamma (INF-gamma), tumor necrosis factor-alpha (TNF-alpha), monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), thyroid stimulating hormone (TSH), total tri-iodothyronine (TT3), total thyroxine (TT4), prolactin, and testosterone were measured in: 195 women on long-term sick-leave for a stress-related affective disorder, 45 women at risk for professional burnout, and 84 healthy women. Results: We found significantly increased levels of MCP-1, VEGF and EGF in women exposed to prolonged psychosocial stress. Statistical analysis indicates that they independently associate with a significant risk for being classified as ill. Conclusions: MCP-1, EGF, and VEGF are potential markers for screening and early intervention in women under prolonged psychosocial stress.	[Asberg, Marie; Nygren, Ake; Peterson, Ulla; Wilczek, Lukas; Kallmen, Hakan] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Leopardi, Rosario; Rylander, Gunnar; Lekander, Mats] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ekstedt, Mirjam; Akerstedt, Torbjorn] Karolinska Inst, Inst Psychosocial Med, Stockholm, Sweden; [Ekstedt, Mirjam; Akerstedt, Torbjorn] Karolinska Inst, Dept Publ Hlth, Stockholm, Sweden; [Ekman, Rolf] Gothenburg Univ, Inst Clin Neurosci, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Asberg, M (corresponding author), Karolinska Inst, Dept Clin Sci, Stockholm, Sweden.	rosleo@ki.se	Ekstedt, Mirjam/N-4513-2014	Ekstedt, Mirjam/0000-0002-4108-391X	Swedish Science Council [5454 My, 07517 RE]; Sylvan s foundation; State of Sweden	Swedish Science Council; Sylvan s foundation; State of Sweden	The study was supported by the Swedish Science Council (5454 My, 07517 RE), the Sylvan s foundation, the State of Sweden under the LUA agreement, and the insurance companies AFA and Alecta. The Randox Laboratories Ltd (Crumlin, UK) supplied the assay kits and performed the measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASYALI B, 2008, INT J CARDI IN PRESS; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anisman H, 2002, BRAIN BEHAV IMMUN, V16, P513, DOI 10.1016/S0889-1591(02)00009-0; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Ekstedt M, 2006, SCAND J WORK ENV HEA, V32, P121, DOI 10.5271/sjweh.987; Eskandari F, 2003, ARTHRITIS RES THER, V5, P251, DOI 10.1186/ar1002; First M. B., 1997, STRUCTURED CLIN INTE; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Granger DN, 2004, HYPERTENSION, V43, P924, DOI 10.1161/01.HYP.0000123070.31763.55; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Haus E, 2001, CHRONOBIOL INT, V18, P709, DOI 10.1081/CBI-100106083; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hetland ML, 2008, DIS MARKERS, V24, P1; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Hu J, 2003, BRAIN BEHAV IMMUN, V17, P498, DOI 10.1016/j.bbi.2003.03.001; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; KRIEGER DT, 1976, ENDOCRINOLOGY, V99, P1589, DOI 10.1210/endo-99-6-1589; Levi L., 2000, GUIDANCE WORK RELATE; Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Molloy RM, 2005, CLIN CHEM LAB MED, V43, P1303, DOI 10.1515/CCLM.2005.224; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; ROBERTSON D, 1995, HUM REPROD, V10, P2478; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Smith NJ, 2004, CELL MOL LIFE SCI, V61, P2695, DOI 10.1007/s00018-004-4244-3; Tennant C, 2001, J PSYCHOSOM RES, V51, P697, DOI 10.1016/S0022-3999(01)00255-0; Teramoto S, 2003, INTERNAL MED, V42, P681, DOI 10.2169/internalmedicine.42.681; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Vogel G, 2005, SCIENCE, V307, P665, DOI 10.1126/science.307.5710.665; Wilkinson-Berka JL, 2006, CURR MED CHEM, V13, P3307, DOI 10.2174/092986706778773086; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	39	62	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e3590	10.1371/journal.pone.0003590	http://dx.doi.org/10.1371/journal.pone.0003590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19177163	Green Published, Green Submitted, gold			2022-12-27	WOS:000274089700001
J	Nagyvary, J; Guillemette, RN; Spiegelman, CH				Nagyvary, Joseph; Guillemette, Renald N.; Spiegelman, Clifford H.			Mineral Preservatives in the Wood of Stradivari and Guarneri	PLOS ONE			English	Article								Following the futile efforts of generations to reach the high standard of excellence achieved by the luthiers in Cremona, Italy, by variations of design and plate tuning, current interest is being focused on differences in material properties. The long-standing question whether the wood of Stradivari and Guarneri were treated with wood preservative materials could be answered only by the examination of wood specimens from the precious antique instruments. In a recent communication (Nature, 2006), we reported about the degradation of the wood polymers in instruments of Stradivari and Guarneri, which could be explained only by chemical manipulations, possibly by preservatives. The aim of the current work was to identify the minerals from the small samples of the maple wood which were available to us from the antique instruments. The ashes of wood from one violin and one cello by Stradivari, two violins by Guarneri, one viola by H. Jay, one violin by Gand-Bernardel were analyzed and compared with a variety of commercial tone woods. The methods of analysis were the following: back-scattered electron imaging, X-ray fluorescence maps for individual elements, wave-length dispersive spectroscopy, energy dispersive X-ray spectroscopy and quantitative microprobe analysis. All four Cremonese instruments showed the unmistakable signs of chemical treatments in the form of chemicals which are not present in natural woods, such as BaSO(4), CaF(2), borate, and ZrSiO(4). In addition to these, there were also changes in the common wood minerals. Statistical evaluation of 12 minerals by discriminant analysis revealed: a. a difference among all four Cremona instruments, b. the difference of the Cremonese instruments from the French and English antiques, and c. only the Cremonese instruments differed from all commercial woods. These findings may provide the answer why all attempts to recreate the Stradivarius from natural wood have failed. There are many obvious implications with regard to how the green tone wood should be treated, which chould lead to changes in the practice of violin-making. This research should inspire others to analyze more antique violins for their chemical contents.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Guillemette, Renald N.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX USA; [Spiegelman, Clifford H.] Texas A&M Univ, Dept Statist, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Nagyvary, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	j-nagyvary@neo.tamu.edu						BARLOW CY, 1990, J MICROSC-OXFORD, V160, P203, DOI 10.1111/j.1365-2818.1990.tb03058.x; BARLOW CY, 1988, NATURE, V332, P313, DOI 10.1038/332313a0; Barnes H. M., 1986, AM WOOD PRESERV ASS, V82, P95; Bucur V., 2006, ACOUSTICS WOOD, V2nd ed., P403; Burckle Lloyd, 2003, Dendrochronologia, V21, P41, DOI 10.1078/1125-7865-00033; DIETZ MG, 1988, FOREST PROD J, V38, P9; Dipper A., 1987, COUNT COZIO SALABUE, V64; DUNLEAVY JA, 1970, J I WOOD SCI, V5, P20; Ellis E. L., 1962, Forest Products Journal, V12, P271; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; GUG R, 1988, FELLOWSHIP MAKERS C, V881, pQ52; Guilherme MS, 2008, AEROSP SCI TECHNOL, V12, P365, DOI 10.1016/j.ast.2007.09.002; GUILLEMETTE RN, 2008, SSA BOOK SERIES, V5, P335; Haines D., 1980, CATGUT ACOUST SOC NE, V33, P19; Jarosewich E, 2002, J RES NATL INST STAN, V107, P681, DOI 10.6028/jres.107.054; Jarosewich E., 1980, GEOSTANDARD NEWSLETT, V4, P43, DOI [10.1111/j.1751-908X.1980.tb00273.x, DOI 10.1111/J.1751-908X.1980.TB00273.X]; *JMP, 2007, DOC SET; Johnson RA., 2007, APPL MULTIVARIATE ST; MCINTYRE ME, 1988, ACTA METALL MATER, V36, P1397, DOI 10.1016/0001-6160(88)90209-X; MISRA MK, 1993, BIOMASS BIOENERG, V4, P103, DOI 10.1016/0961-9534(93)90032-Y; NAGYVARY J, 1988, CHEM ENG NEWS, V66, P24, DOI 10.1021/cen-v066n021.p024; NAGYVARY J, 1984, J VIOLIN SOC AM, V7, P89; NAGYVARY J, 1981, J VIOLIN SOC AM, V6, P53; NAGYVARY J, 1978, J VIOLIN SOC AM, V4, P147; Nagyvary J., 2005, EDUC CHEM, V42, P96; Nagyvary J., 1996, CHEM INTELLIGENCER, V2, P24; Nagyvary J, 2006, NATURE, V444, P565, DOI 10.1038/444565a; SACCONI SF, 1972, SEGRETI STRADIVARI P; Schelleng J.C., 1982, J CATGUT ACOUST SOC, V37, P8; Schwarze FWMR, 2008, NEW PHYTOL, V179, P1095, DOI 10.1111/j.1469-8137.2008.02524.x; SJOSTROM E, 1989, WOOD CHEM; Stoel BC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002554; TIEPOLO MF, 1987, BOSCHI SERENISSIMA E; TOVE PA, 1974, CATGUT ACOUST SOC NE, V22, P5; TRAVIS NJ, 1984, TINCAL TRAIL HIST BO; Waite AE., 1976, HERMETIC ALCHEMICAL; WINANDY JE, 1984, ADV CHEM SER, V207, pCH11	37	20	20	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4245	10.1371/journal.pone.0004245	http://dx.doi.org/10.1371/journal.pone.0004245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158950	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482200002
J	Mahller, YY; Williams, JP; Baird, WH; Mitton, B; Grossheim, J; Saeki, Y; Cancelas, JA; Ratner, N; Cripe, TP				Mahller, Yonatan Y.; Williams, Jon P.; Baird, William H.; Mitton, Bryan; Grossheim, Jonathan; Saeki, Yoshinaga; Cancelas, Jose A.; Ratner, Nancy; Cripe, Timothy P.			Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus	PLOS ONE			English	Article								Background: Although disease remission can frequently be achieved for patients with neuroblastoma, relapse is common. The cancer stem cell theory suggests that rare tumorigenic cells, resistant to conventional therapy, are responsible for relapse. If true for neuroblastoma, improved cure rates may only be achieved via identification and therapeutic targeting of the neuroblastoma tumor initiating cell. Based on cues from normal stem cells, evidence for tumor populating progenitor cells has been found in a variety of cancers. Methodology/Principal Findings: Four of eight human neuroblastoma cell lines formed tumorspheres in neural stem cell media, and all contained some cells that expressed neurogenic stem cell markers including CD133, ABCG2, and nestin. Three lines tested could be induced into multi-lineage differentiation. LA-N-5 spheres were further studied and showed a verapamil-sensitive side population, relative resistance to doxorubicin, and CD133+ cells showed increased sphere formation and tumorigenicity. Oncolytic viruses, engineered to be clinically safe by genetic mutation, are emerging as next generation anticancer therapeutics. Because oncolytic viruses circumvent typical drug-resistance mechanisms, they may represent an effective therapy for chemotherapy-resistant tumor initiating cells. A Nestin-targeted oncolytic herpes simplex virus efficiently replicated within and killed neuroblastoma tumor initiating cells preventing their ability to form tumors in athymic nude mice. Conclusions/Significance: These results suggest that human neuroblastoma contains tumor initiating cells that may be effectively targeted by an oncolytic virus.	[Baird, William H.; Mitton, Bryan; Cripe, Timothy P.] Cincinnati Childrens Hosp, Med Ctr, Div Hematol & Oncol, Cincinnati, OH USA; [Mahller, Yonatan Y.; Williams, Jon P.; Baird, William H.; Cancelas, Jose A.; Ratner, Nancy; Cripe, Timothy P.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH USA; [Grossheim, Jonathan] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH USA; [Mahller, Yonatan Y.; Baird, William H.; Mitton, Bryan] Univ Cincinnati, Coll Med, Physician Scientist Training Program, Cincinnati, OH 45221 USA; [Mahller, Yonatan Y.; Baird, William H.] Univ Cincinnati, Coll Med, Graduate Program Mol & Dev Biol, Cincinnati, OH 45221 USA; [Saeki, Yoshinaga] Ohio State Univ, Dept Neurol Surg, Dardinger Lab NeuroOncol & Neurosci, Columbus, OH 43210 USA; [Saeki, Yoshinaga] Ohio State Univ, Comprehensive Canc Ctr, Columbus, OH 43210 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Mahller, YY (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Hematol & Oncol, Cincinnati, OH USA.	timothy.cripe@cchmc.org	Williams, Jon/AAP-2761-2020; Cancelas, Jose/AAR-9324-2020	RATNER, NANCY/0000-0001-5030-9354	Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology; TeeOffAgainstCancer.org; NIH [R01-CA114004, R21-CA133663]; NATIONAL CANCER INSTITUTE [T32CA117846, R21CA133663, R01CA114004] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology; TeeOffAgainstCancer.org; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cincinnati Children's Hospital Medical Center Division of Hematology/Oncology, by TeeOffAgainstCancer.org, and NIH grants R01-CA114004 and R21-CA133663 to TPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2006, J GENE MED, V8, P603, DOI 10.1002/jgm.877; Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bapat SA, 2007, SEMIN CANCER BIOL, V17, P204, DOI 10.1016/j.semcancer.2006.05.001; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; BRODEUR G, 2001, PRINCIPLES PRACTICE, P896; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chojnacki A, 2003, J NEUROSCI, V23, P1730; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fukuhara H, 2005, CANCER RES, V65, P10663, DOI 10.1158/0008-5472.CAN-05-2534; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Keshelava N, 1998, CANCER RES, V58, P5396; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Li H, 2007, CLIN CANCER RES, V13, P316, DOI 10.1158/1078-0432.CCR-06-1625; Lin E, 2004, CANCER GENE THER, V11, P643, DOI 10.1038/sj.cgt.7700733; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Luo L, 2006, INT J HEMATOL, V84, P123, DOI 10.1532/IJH97.A10503; Mahller YY, 2007, MOL THER, V15, P279, DOI 10.1038/sj.mt.6300038; Mahller YY, 2006, PEDIATR BLOOD CANCER, V46, P745, DOI 10.1002/pbc.20565; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagato M, 2005, J NEUROSCI RES, V80, P456, DOI 10.1002/jnr.20442; Olshan AF, 2000, NEUROBLASTOMA, P33; Parikh NS, 2005, PEDIATR BLOOD CANCER, V44, P469, DOI 10.1002/pbc.20268; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Prabhakar S, 2007, CANCER GENE THER, V14, P460, DOI 10.1038/sj.cgt.7701037; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sakariassen PO, 2007, NEOPLASIA, V9, P882, DOI 10.1593/neo.07658; Sales-Pardo I, 2006, BLOOD, V108, P1774, DOI 10.1182/blood-2006-03-013615; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; SHEN Y, 2006, CANCER GENE THER, V7, P7; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TERADA K, 2006, GENE THER, V19, P19; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Zhou F C, 1998, Wound Repair Regen, V6, P337, DOI 10.1046/j.1524-475X.1998.60409.x	64	113	118	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4235	10.1371/journal.pone.0004235	http://dx.doi.org/10.1371/journal.pone.0004235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156211	Green Submitted, gold, Green Published			2022-12-27	WOS:000265482100007
J	Kim, TS; Braciale, TJ				Kim, Taeg S.; Braciale, Thomas J.			Respiratory Dendritic Cell Subsets Differ in Their Capacity to Support the Induction of Virus-Specific Cytotoxic CD8(+) T Cell Responses	PLOS ONE			English	Article							ANTIGEN-PRESENTING FUNCTIONS; LYMPH-NODE; INFLUENZA-VIRUS; VIRAL IMMUNITY; LUNG; MIGRATION; ACTIVATION; INFECTION; CD4; RECRUITMENT	Dendritic cells located at the body surfaces, e. g. skin, respiratory and gastrointestinal tract, play an essential role in the induction of adaptive immune responses to pathogens and inert antigens present at these surfaces. In the respiratory tract, multiple subsets of dendritic cells ( RDC) have been identified in both the normal and inflamed lungs. While the importance of RDC in antigen transport from the inflamed or infected respiratory tract to the lymph nodes draining this site is well recognized, the contribution of individual RDC subsets to this process and the precise role of migrant RDC within the lymph nodes in antigen presentation to T cells is not clear. In this report, we demonstrate that two distinct subsets of migrant RDC - exhibiting the CD103(+) and CD11b(hi) phenotype, respectively - are the primary DC presenting antigen to naive CD4(+) and CD8(+) T lymphocytes in the draining nodes in response to respiratory influenza virus infection. Furthermore, the migrant CD103(+) RDC subset preferentially drives efficient proliferation and differentiation of naive CD8(+) T cells responding to infection into effector cells, and only the CD103(+) RDC subset can present to naive CD8(+) T cells non-infectious viral vaccine introduced into the respiratory tract. These results identify CD103(+) and CD11b(hi) RDC as critical regulators of the adaptive immune response to respiratory tract infection and potential targets in the design of mucosal vaccines.	[Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Braciale, Thomas J.] Univ Virginia, Dept Microbiol & Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Kim, TS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037293] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL033391, R01 HL033391-27] Funding Source: Medline; NIAID NIH HHS [R01 AI037293] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geiss GK, 2001, J VIROL, V75, P4321, DOI 10.1128/JVI.75.9.4321-4331.2001; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Grayson MH, 2006, ANN ALLERG ASTHMA IM, V96, P643, DOI 10.1016/S1081-1206(10)61061-7; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Martin P, 2002, BLOOD, V99, P1282, DOI 10.1182/blood.V99.4.1282; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yoon H, 2007, J IMMUNOL, V179, P391, DOI 10.4049/jimmunol.179.1.391; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	55	205	207	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4204	10.1371/journal.pone.0004204	http://dx.doi.org/10.1371/journal.pone.0004204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145246	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479800010
J	Serwanga, J; Shafer, LA; Pimego, E; Auma, B; Watera, C; Rowland, S; Yirrell, D; Pala, P; Grosskurth, H; Whitworth, J; Gotch, F; Kaleebu, P				Serwanga, Jennifer; Shafer, Leigh Anne; Pimego, Edward; Auma, Betty; Watera, Christine; Rowland, Samantha; Yirrell, David; Pala, Pietro; Grosskurth, Heiner; Whitworth, Jimmy; Gotch, Frances; Kaleebu, Pontiano			Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naive Ugandans	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL LOAD; HIV-1-INFECTED INDIVIDUALS; IMMUNE-RESPONSES; CD4 DECLINE; PROVIRAL LOAD; LARGE COHORT; SET-POINT; INFECTION; REPLICATION	Background: Some HIV infected individuals remain asymptomatic for protracted periods of time in the absence of antiretroviral therapy (ART). Virological control, CD4 T cell loss and HIV-specific responses are some of the key interrelated determinants of HIV-1 disease progression. In this study, possible interactions between viral load, CD4 T cell slopes, host genetics and HIV-specific IFN-gamma responses were evaluated in chronically HIV-1-infected adults. Methodolology/Principal Findings: Multilevel regression modeling was used to stratify clade A or D HIV-infected individuals into disease progression groups based on CD4 T cell slopes. ELISpot assays were used to quantify the frequency and magnitude of HIV-induced IFN-gamma responses in 7 defined rapid progressors (RPs) and 14 defined slow progressors (SPs) at a single time point. HLA typing was performed using reference strand conformational analysis (RSCA). Although neither the breadth nor the magnitude of the proteome-wide HIV-specific IFN-gamma response correlated with viral load, slow disease progression was associated with over-representation of host immunogenetic protective HLA B* alleles (10 of 14 SPs compared to 0 of 7; p = 0.004, Fisher's Exact) especially B*57 and B*5801, multiclade Gag T-cell targeting (71%, 10 of 14 SPs compared to 14%, 1 of 7 RPs); p = 0.029, Fisher's Exact test and evident virological control (3.65 compared to 5.46 log10 copies/mL in SPs and RPs respectively); p < 0.001, unpaired student's t-test Conclusions: These data are consistent with others that associated protection from HIV disease with inherent host HLA B allele-mediated ability to induce broader Gag T-cell targeting coupled with apparent virological control. These immunogenetic features of Gag-specific immune response which could influence disease progression may provide useful insight in future HIV vaccine design.	[Serwanga, Jennifer; Shafer, Leigh Anne; Pimego, Edward; Auma, Betty; Watera, Christine; Pala, Pietro; Grosskurth, Heiner; Whitworth, Jimmy; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Rowland, Samantha; Gotch, Frances] Imperial Coll, Chelsea & Westminster Hosp, Dept Immunol, London, England; [Yirrell, David] Ninewells Hosp, Dept Med Microbiol, Dundee, Scotland	Uganda Virus Research Institute; Imperial College London; University of Dundee	Serwanga, J (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	jennifer.serwanga@mrcuganda.org		Grosskurth, Heiner/0000-0001-9960-7280	Wellcome Trust, UK [059437]; NIH [ROIA/146254.01]; MRC [G0501957, MC_U950081327] Funding Source: UKRI; Medical Research Council [G0501957, MC_U950081327] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by programme grant 059437 from the Wellcome Trust, UK, and NIH grant ROIA/146254.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; Barugahare B, 2005, J VIROL, V79, P4132, DOI 10.1128/JVI.79.7.4132-4139.2005; Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bratt G, 1998, AIDS, V12, P729, DOI 10.1097/00002030-199807000-00009; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferrari G, 2008, AIDS RES HUM RETROV, V24, P20; Foxall RB, 2008, J VIROL, V82, P9795, DOI 10.1128/JVI.01217-08; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gupta SB, 2006, JAIDS-J ACQ IMM DEF, V42, P135, DOI 10.1097/01.qai.0000223017.01568.e7; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jiao Y, 2006, JAIDS-J ACQ IMM DEF, V42, P263, DOI 10.1097/01.qai.0000221692.00091.a2; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kebba A, 2004, AIDS RES HUM RETROV, V20, P67, DOI 10.1089/088922204322749512; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Lepri AC, 1998, EPIDEMIOL INFECT, V121, P369, DOI 10.1017/S095026889800140X; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lopez M, 2008, AIDS RES HUM RETROV, V24, P1185, DOI 10.1089/aid.2008.0006; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McAdam S, 1998, AIDS, V12, P571, DOI 10.1097/00002030-199806000-00005; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky VA, 2006, VIROLOGY, V349, P142, DOI 10.1016/j.virol.2006.02.006; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Patke DS, 2002, J INFECT DIS, V186, P1177, DOI 10.1086/343811; Peretz Y, 2005, J VIROL, V79, P4908, DOI 10.1128/JVI.79.8.4908-4917.2005; Peretz Y, 2008, AIDS, V22, P1222, DOI 10.1097/QAD.0b013e3283021a76; Rutebemberwa A, 2004, AIDS RES HUM RETROV, V20, P763, DOI 10.1089/0889222041524643; Schellens IMM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002745; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Tsegaye A, 2007, AIDS, V21, P369, DOI 10.1097/QAD.0b013e32801222e3; Valentine LE, 2008, J VIROL, V82, P575, DOI 10.1128/JVI.00275-07; van Benthem BHB, 2002, AIDS, V16, P919, DOI 10.1097/00002030-200204120-00012; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Wang B, 2002, VIROLOGY, V304, P246, DOI 10.1006/viro.2002.1706; Yirrell DL, 2002, AIDS, V16, P279, DOI 10.1097/00002030-200201250-00018; YIRRELL DL, 2007, EPIDEMIOL INFECT, V9, P1	63	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4188	10.1371/journal.pone.0004188	http://dx.doi.org/10.1371/journal.pone.0004188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142234	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265479700009
J	Qin, W; Ho, L; Wang, J; Peskind, E; Pasinetti, GM				Qin, Weiping; Ho, Lap; Wang, Jun; Peskind, Elaine; Pasinetti, Giulio Maria			S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic alpha-Secretase Activity Acts via Selective Promotion of ADAM-10	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PRECURSOR PROTEIN; GAMMA; ADAM10; ASSAY; HIPPOCAMPAL; CLEAVAGE	Alzheimer's disease (AD) is the most common cause of dementia among older people. At present, there is no cure for the disease and as of now there are no early diagnostic tests for AD. There is an urgency to develop a novel promising biomarker for early diagnosis of AD. Using surface-enhanced laser desorption ionization-mass spectrometry SELDI-(MS) proteomic technology, we identified and purified a novel 11.7-kDa metal-binding protein biomarker whose content is increased in the cerebrospinal fluid (CSF) and in the brain of AD dementia subjects as a function of clinical dementia. Following purification and protein-sequence analysis, we identified and classified this biomarker as S100A7, a protein known to be involved in immune responses. Using an adenoviral- S100A7 expression system, we continued to examine the potential role of S100A7 in AD amyloid neuropathology in in vitro model of AD. We found that the expression of exogenous S100A7 in primary cortico-hippocampal neuron cultures derived from Tg2576 transgenic embryos inhibits the generation of beta-amyloid (A beta)(1-42) and A beta(1-40) peptides, coincidental with a selective promotion of "non- amyloidogenic'' alpha-secretase activity via promotion of ADAM (a disintegrin and metalloproteinase)-10. Finally, a selective expression of human S100A7 in the brain of transgenic mice results in significant promotion of alpha-secretase activity. Our study for the first time suggests that S100A7 may be a novel biomarker of AD dementia and supports the hypothesis that promotion of S100A7 expression in the brain may selectively promote alpha-secretase activity in the brain of AD precluding the generation of amyloidogenic peptides. If in the future we find that S1000A7 protein content in CSF is sensitive to drug intervention experimentally and eventually in the clinical setting, S100A7 might be developed as novel surrogate index (biomarker) of therapeutic efficacy in the characterization of novel drug agents for the treatment of AD.	[Qin, Weiping; Ho, Lap; Wang, Jun; Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Ho, Lap; Wang, Jun; Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, GCRC, Bronx, NY USA; [Peskind, Elaine] Univ Washington, Sch Med, Seattle, WA 98195 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Washington; University of Washington Seattle	Qin, W (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY USA.	giulio.pasinetti@mssm.edu		Pasinetti, Giulio/0000-0002-1524-5196	James J. Peters VA GRECC Program; NIA [AG02219]; NATIONAL INSTITUTE ON AGING [P01AG002219, P50AG005136] Funding Source: NIH RePORTER	James J. Peters VA GRECC Program; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by James J. Peters VA GRECC Program and NIA AG02219 to GMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bonafe JL, 1998, ARCH DERMATOL, V134, P1300, DOI 10.1001/archderm.134.10.1300; BOSMAN GJCGM, 1991, NEUROBIOL AGING, V12, P13, DOI 10.1016/0197-4580(91)90033-G; Burns M, 2003, J NEUROSCI, V23, P5645; Bussiere T, 2003, J COMP NEUROL, V463, P281, DOI 10.1002/cne.10760; Castellani RJ, 2006, ACTA NEUROPATHOL, V111, P503, DOI 10.1007/s00401-006-0071-y; Cheng HJ, 2000, METH MOL B, V124, P313; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Ghanbari H, 1998, J CLIN LAB ANAL, V12, P285, DOI 10.1002/(SICI)1098-2825(1998)12:5<285::AID-JCLA6>3.0.CO;2-5; Gustaw KA, 2008, J NEUROCHEM, V106, P1350, DOI 10.1111/j.1471-4159.2008.05477.x; HEINONEN O, 1994, ARCH NEUROL-CHICAGO, V51, P799, DOI 10.1001/archneur.1994.00540200075019; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JOHNSON VA, 1990, TECHNIQUES HIV RES, P71; Keating CD, 2005, P NATL ACAD SCI USA, V102, P2263, DOI 10.1073/pnas.0500024102; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee Hyoung-gon, 2006, Current Alzheimer Research, V3, P75, DOI 10.2174/156720506775697124; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; McLendon C, 2000, FASEB J, V14, P2383; Mills J, 1997, J NEUROSCI, V17, P9415; Mills J, 1999, NEUROSCIENCE, V94, P1333, DOI 10.1016/S0306-4522(99)00381-4; Mobbs CV, 2004, NEUROCHEM RES, V29, P1093, DOI 10.1023/B:NERE.0000023596.49140.e0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; *NAT I AG ALZH DIS, PREV COSTS ALZH DIS; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; PIRTTILA T, 1992, J NEUROL SCI, V107, P160, DOI 10.1016/0022-510X(92)90284-R; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Qin WP, 2003, J BIOL CHEM, V278, P50970, DOI 10.1074/jbc.M307699200; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Steinerman JR, 2007, CURR NEUROL NEUROSCI, V7, P381, DOI 10.1007/s11910-007-0059-6; Takeuchi M, 2007, MED HYPOTHESES, V69, P1358, DOI 10.1016/j.mehy.2006.12.017; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Ward M, 2007, EXPERT REV MOL DIAGN, V7, P635, DOI 10.1586/14737159.7.5.635; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6	41	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2009	4	1							e4183	10.1371/journal.pone.0004183	http://dx.doi.org/10.1371/journal.pone.0004183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IE	19159013	gold, Green Submitted, Green Published			2022-12-27	WOS:000265479600002
J	Ellenbogen, JM; Hulbert, JC; Jiang, Y; Stickgold, R				Ellenbogen, Jeffrey M.; Hulbert, Justin C.; Jiang, Ying; Stickgold, Robert			The Sleeping Brain's Influence on Verbal Memory: Boosting Resistance to Interference	PLOS ONE			English	Article							SLOW-WAVE SLEEP; DECLARATIVE MEMORY; CONSOLIDATION; HIPPOCAMPUS; PLASTICITY; SYSTEMS; WAKING; CORTEX	Memories evolve. After learning something new, the brain initiates a complex set of post-learning processing that facilitates recall (i.e., consolidation). Evidence points to sleep as one of the determinants of that change. But whenever a behavioral study of episodic memory shows a benefit of sleep, critics assert that sleep only leads to a temporary shelter from the damaging effects of interference that would otherwise accrue during wakefulness. To evaluate the potentially active role of sleep for verbal memory, we compared memory recall after sleep, with and without interference before testing. We demonstrated that recall performance for verbal memory was greater after sleep than after wakefulness. And when using interference testing, that difference was even more pronounced. By introducing interference after sleep, this study confirms an experimental paradigm that demonstrates the active role of sleep in consolidating memory, and unmasks the large magnitude of that benefit.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hulbert, Justin C.] Univ St Andrews, St Andrews, Fife, Scotland; [Jiang, Ying] Dartmouth Coll, Hanover, NH 03755 USA; [Stickgold, Robert] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of St Andrews; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ellenbogen, JM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	jeffrey_ellenbogen@hms.harvard.edu	Hulbert, Justin/AAD-1933-2021	Hulbert, Justin/0000-0002-2889-0901	National Institutes of Health [R01-MH048832, K30-HL04095, T32-HL007901]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K30HL004095, T32HL007901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638, R01MH048832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health: NIH-R01-MH048832 (RS); NIH-K30-HL04095 (JME); and NIH-T32-HL007901 (JME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1927, PSYCHOL BULL, V24, P284, DOI 10.1037/h0073629; AXMACHER N, 2008, BRAIN; BARNES JM, 1959, J EXP PSYCHOL, V58, P97, DOI 10.1037/h0047507; BOWER GH, 1994, J EXP PSYCHOL LEARN, V20, P51, DOI 10.1037/0278-7393.20.1.51; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BRIGGS GE, 1954, J EXP PSYCHOL, V47, P285, DOI 10.1037/h0060251; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FRIENDLY M, 1982, BEHAV RES METH INSTR, V14, P375, DOI 10.3758/BF03203275; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kahana MJ, 2000, OXFORD HDB MEMORY, P59; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Norman KA, 2005, NEURAL NETWORKS, V18, P1212, DOI 10.1016/j.neunet.2005.08.010; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Suzuki WA, 2006, NEURON, V50, P19, DOI 10.1016/j.neuron.2006.03.029; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307	25	86	87	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4117	10.1371/journal.pone.0004117	http://dx.doi.org/10.1371/journal.pone.0004117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127287	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473300003
J	Bull, JJ; Harcombe, WR				Bull, James J.; Harcombe, William R.			Population Dynamics Constrain the Cooperative Evolution of Cross-Feeding	PLOS ONE			English	Article							ALTRUISM; MODEL	Cross-feeding is the exchange of nutrients among species of microbes. It has two potential evolutionary origins, one as an exchange of metabolic wastes or byproducts among species, the other as a form of cooperation known as reciprocal altruism. This paper explores the conditions favoring the origin of cooperative cross-feeding between two species. There is an extensive literature on the evolution of cooperation, and some of the requirements for the evolution of cooperative cross-feeding follow from this prior work-specifically the requirement that interactions be limited to small groups of individuals, such as colonies in a spatially structured environment. Evolution of cooperative cross- feeding by a species also requires that cross-feeding from the partner species already exists, so that the cooperating mutant will automatically be reciprocated for its actions. Beyond these considerations, some unintuitive dynamical constraints apply. In particular, the benefit of cooperative cross- feeding applies only in the range of intermediate cell densities. At low density, resource concentrations are too low to offset the cost of cooperation. At high density, resources shared by both species become limiting, and the two species become competitors. These considerations suggest that the evolution of cooperative cross-feeding in nature may be more challenging than for other types of cooperation. However, the principles identified here may enable the experimental evolution of cross- feeding, as born out by a recent study.	[Bull, James J.; Harcombe, William R.] Univ Texas Austin, Austin, TX 78712 USA; [Bull, James J.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX USA; [Bull, James J.] Univ Texas, Ctr Computat Biol & Bioinformat, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bull, JJ (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	bull@mail.utexas.edu			NIH [GM57756]; NSF [Predoctoral Fellowship]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIH GM57756 to JJB; by an NSF Predoctoral Fellowship to WRH. JJB is also supported as the Miescher Regents Professor at the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Eigen M, 1979, THE HYPERCYCLE, P60; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Maynard Smith J., 1982, pi; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Overmann J, 2002, ARCH MICROBIOL, V177, P201, DOI 10.1007/s00203-001-0377-z; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SCHAFFER WM, 1978, AM NAT, V112, P250, DOI 10.1086/283268; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Schink B, 1991, PROKARYOTES, P276; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	22	56	56	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4115	10.1371/journal.pone.0004115	http://dx.doi.org/10.1371/journal.pone.0004115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19127304	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472900002
J	Xu, JL; Bae, E; Zhang, QH; Annis, DS; Erickson, HP; Mosher, DF				Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Erickson, Harold P.; Mosher, Deane F.			Display of Cell Surface Sites for Fibronectin Assembly Is Modulated by Cell Adherence to (1)F3 and C-Terminal Modules of Fibronectin	PLOS ONE			English	Article								Background: Fibronectin-null cells assemble soluble fibronectin shortly after adherence to a substrate coated with intact fibronectin but not when adherent to the cell-binding domain of fibronectin (modules (7)F3-(10)F3). Interactions of adherent cells with regions of adsorbed fibronectin other than modules (7)F3-(10)F3, therefore, are required for early display of the cell surface sites that initiate and direct fibronectin assembly. Methodology/Principal Findings: To identify these regions, coatings of proteolytically derived or recombinant pieces of fibronectin containing modules in addition to (7)F3-(10)F3 were tested for effects on fibronectin assembly by adherent fibronectin-null fibroblasts. Pieces as large as one comprising modules (2)F3-(14)F3, which include the heparin-binding and cell adhesion domains, were not effective in supporting fibronectin assembly. Addition of module (1)F3 or the C-terminal modules to modules (2)F3-(14)F3 resulted in some activity, and addition of both (1)F3 and the C-terminal modules resulted in a construct, (1)F3-C, that best mimicked the activity of a coating of intact fibronectin. Constructs (1)F3-C V0, (1)F3-C V64, and (1)F3-C Delta(V(15)F3(10)F1) were all able to support fibronectin assembly, suggesting that (1)F3 through (11)F1 and/or (12)F1 were important for activity. Coatings in which the active parts of (1)F3-C were present in different proteins were much less active than intact (1)F3-C. Conclusions: These results suggest that (1)F3 acts together with C-terminal modules to induce display of fibronectin assembly sites on adherent cells.	[Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Xu, Jielin; Bae, Eunnyung; Zhang, Qinghong; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University	Xu, JL (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfmosher@wisc.edu			NIH [21644]; NATIONAL CANCER INSTITUTE [R01CA115468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH 21644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; BALIAN G, 1979, J BIOL CHEM, V254, P1429; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; BERNARD MP, 1985, BIOCHEMISTRY-US, V24, P2698, DOI 10.1021/bi00332a016; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Burton-Wurster N, 1998, MATRIX BIOL, V17, P193, DOI 10.1016/S0945-053X(98)90058-0; Burton-Wurster N, 1999, BIOCHEM J, V341, P555, DOI 10.1042/0264-6021:3410555; Campbell ID, 1998, NAT STRUCT BIOL, V5, P496, DOI 10.1038/733; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Chung CY, 1997, J CELL SCI, V110, P1413; Couchman JR, 1999, J CELL SCI, V112, P3415; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; GARCIAPARDO A, 1985, J BIOL CHEM, V260, P320; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Hocking DC, 1999, J BIOL CHEM, V274, P27257, DOI 10.1074/jbc.274.38.27257; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Klass CM, 2000, J CELL SCI, V113, P493; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MERCURIUS KO, 2001, BMC CELL BIOL, V18, P1; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Monaghan E, 2004, J BIOL CHEM, V279, P1400, DOI 10.1074/jbc.M310374200; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; MOSHER DF, 1980, J BIOL CHEM, V255, P1181; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Moyano JV, 1999, J BIOL CHEM, V274, P135, DOI 10.1074/jbc.274.1.135; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; PETERS DMP, 1987, J CELL BIOL, V104, P121, DOI 10.1083/jcb.104.1.121; Peterson JA, 2005, J BIOL CHEM, V280, P6915, DOI 10.1074/jbc.M406625200; Santas AJ, 2002, J BIOL CHEM, V277, P13650, DOI 10.1074/jbc.M111361200; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; SMITH DE, 1982, J BIOL CHEM, V257, P5831; Sottile J, 2000, J CELL SCI, V113, P4287; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; UMEZAWA K, 1985, FEBS LETT, V186, P31, DOI 10.1016/0014-5793(85)81333-8; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vial D, 2008, J CELL SCI, V121, P1661, DOI 10.1242/jcs.020149; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WILLIAMS EC, 1983, J BIOL CHEM, V258, P5911; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yamada KM, 1989, FIBRONECTIN, P47; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447; Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	79	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4113	10.1371/journal.pone.0004113	http://dx.doi.org/10.1371/journal.pone.0004113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119318	Green Submitted, gold, Green Published			2022-12-27	WOS:000265472600012
J	Hollands, A; Aziz, RK; Kansal, R; Kotb, M; Nizet, V; Walker, MJ				Hollands, Andrew; Aziz, Ramy K.; Kansal, Rita; Kotb, Malak; Nizet, Victor; Walker, Mark J.			A Naturally Occurring Mutation in ropB Suppresses SpeB Expression and Reduces M1T1 Group A Streptococcal Systemic Virulence	PLOS ONE			English	Article							CYSTEINE PROTEASE; RGG REGULATOR; PYOGENES; PATHOGENESIS; GENES; INTERNALIZATION; STREPTOKINASE; PHAGOCYTOSIS; INFECTIONS; PROTEINASE	Epidemiological studies of group A streptococcus (GAS) have noted an inverse relationship between SpeB expression and invasive disease. However, the role of SpeB in the course of infection is still unclear. In this study we utilize a SpeB-negative M1T1 clinical isolate, 5628, with a naturally occurring mutation in the gene encoding the regulator RopB, to elucidate the role of RopB and SpeB in systemic virulence. Allelic exchange mutagenesis was used to replace the mutated ropB allele in 5628 with the intact allele from the well characterized isolate 5448. The inverse allelic exchange was also performed to replace the intact ropB in 5448 with the mutated allele from 5628. An intact ropB was found to be essential for SpeB expression. While the ropB mutation was shown to have no effect on hemolysis of RBC's, extracellular DNase activity or survival in the presence of neutrophils, strains with the mutated ropB allele were less virulent in murine systemic models of infection. An isogenic SpeB knockout strain containing an intact RopB showed similarly reduced virulence. Microarray analysis found genes of the SpeB operon to be the primary target of RopB regulation. These data show that an intact RopB and efficient SpeB production are necessary for systemic infection with GAS.	[Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Kansal, Rita; Kotb, Malak] VA Hosp, Memphis, TN USA; [Hollands, Andrew; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet, Biochem & Microbiol, Cincinnati, OH 45221 USA; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Wollongong; Egyptian Knowledge Bank (EKB); Cairo University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; University of California System; University of California San Diego	Hollands, A (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mwalker@uow.edu	Nizet, Victor/AAF-3190-2019; Walker, Mark J./F-6940-2011; Aziz, Ramy/B-2918-2009	Aziz, Ramy/0000-0002-4448-7100; Nizet, Victor/0000-0003-3847-0422; Walker, Mark/0000-0001-7423-2769	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Ashbaugh CD, 2001, INFECT IMMUN, V69, P6683, DOI 10.1128/IAI.69.11.6683-6686.2001; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Chaussee MS, 2002, INFECT IMMUN, V70, P762, DOI 10.1128/IAI.70.2.762-770.2002; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEMERS B, 1993, CLIN INFECT DIS, V16, P792, DOI 10.1093/clind/16.6.792; Dmitriev AV, 2008, FEMS MICROBIOL LETT, V284, P43, DOI 10.1111/j.1574-6968.2008.01171.x; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Hynes W, 2004, FRONT BIOSCI-LANDMRK, V9, P3399, DOI 10.2741/1491; JENG A, 2003, MOL GENETIC ANAL GRO, P1208; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; KAPLAN EL, 1991, EUR J CLIN MICROBIOL, V10, P55, DOI 10.1007/BF01964407; KAZMI SU, 2001, RECIPROCAL TEMPORAL, P4988; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nyberg P, 2004, MICROBIOL-SGM, V150, P1559, DOI 10.1099/mic.0.27076-0; Pulliainen AT, 2008, J BACTERIOL, V190, P3225, DOI 10.1128/JB.01843-07; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006	43	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4102	10.1371/journal.pone.0004102	http://dx.doi.org/10.1371/journal.pone.0004102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116661	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600020
J	Takagaki, K; Lippert, MT; Dann, B; Wanger, T; Ohl, FW				Takagaki, Kentaroh; Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.			Normalization of Voltage-Sensitive Dye Signal with Functional Activity Measures	PLOS ONE			English	Article								In general, signal amplitude in optical imaging is normalized using the well-established Delta F/F method, where functional activity is divided by the total fluorescent light flux. This measure is used both directly, as a measure of population activity, and indirectly, to quantify spatial and spatiotemporal activity patterns. Despite its ubiquitous use, the stability and accuracy of this measure has not been validated for voltage-sensitive dye imaging of mammalian neocortex in vivo. In this report, we find that this normalization can introduce dynamic biases. In particular, the Delta F/F is influenced by dye staining quality, and the ratio is also unstable over the course of experiments. As methods to record and analyze optical imaging signals become more precise, such biases can have an increasingly pernicious impact on the accuracy of findings, especially in the comparison of cytoarchitechtonic areas, in area-of-activation measurements, and in plasticity or developmental experiments. These dynamic biases of the Delta F/F method may, to an extent, be mitigated by a novel method of normalization, Delta F/DFepileptiform. This normalization uses as a reference the measured activity of epileptiform spikes elicited by global disinhibition with bicuculline methiodide. Since this normalization is based on a functional measure, i.e. the signal amplitude of "hypersynchronized'' bursts of activity in the cortical network, it is less influenced by staining of non-functional elements. We demonstrate that such a functional measure can better represent the amplitude of population mass action, and discuss alternative functional normalizations based on the amplitude of synchronized spontaneous sleep-like activity. These findings demonstrate that the traditional Delta F/F normalization of voltage-sensitive dye signals can introduce pernicious inaccuracies in the quantification of neural population activity. They further suggest that normalization-independent metrics such as waveform propagation patterns, oscillations in single detectors, and phase relationships between detector pairs may better capture the biological information which is obtained by high-sensitivity imaging.	[Takagaki, Kentaroh; Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Takagaki, Kentaroh] Georgetown Univ, Sch Med, Washington, DC 20057 USA; [Lippert, Michael Thomas] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Dann, Benjamin] Max Planck Inst Brain Res, Frankfurt, Germany; [Lippert, Michael Thomas; Dann, Benjamin; Wanger, Tim; Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Georgetown University; Max Planck Society; Max Planck Society; Otto von Guericke University	Takagaki, K (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	frank.ohl@ifn-magdeburg.de	Takagaki, Kentaroh/A-9829-2009	Takagaki, Kentaroh/0000-0002-1852-529X; Dann, Benjamin/0000-0003-4332-0285	German Ministry of Science and Technology [0311891]; Bernstein Cooperation [01GQ0733]; European Community [FP6-IST-027787]	German Ministry of Science and Technology; Bernstein Cooperation; European Community(European Commission)	This work was supported by German Ministry of Science and Technology Grant BMBF BioFuture 0311891, Bernstein Cooperation Grant 01GQ0733 and European Community Grant FP6-IST-027787. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Bai L, 2006, J NEUROPHYSIOL, V96, P2528, DOI 10.1152/jn.00645.2006; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A., 2002, OPTICAL IMAGING ELEC; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; Ma HT, 2004, J NEUROPHYSIOL, V91, P934, DOI 10.1152/jn.00274.2003; Miyakawa N, 2003, NEUROIMAGE, V18, P622, DOI 10.1016/S1053-8119(02)00056-3; MOLOKANOVA E, 2007, QDOT NANOPARTICLE BA; Momose-Sato Y, 2001, PROG NEUROBIOL, V63, P151, DOI 10.1016/S0301-0082(00)00023-X; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Patrick MJ, 2007, ORG BIOMOL CHEM, V5, P3347, DOI 10.1039/b711438a; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; ROHR S, 1994, J GEN PHYSIOL, V104, P287, DOI 10.1085/jgp.104.2.287; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Salama G, 2007, J ELECTROCARDIOL, V40, pS56, DOI 10.1016/j.jelectrocard.2007.06.021; Salzberg B.M., 1983, CURRENT METHODS CELL, V3, P139; Schwartz TH, 2001, NAT MED, V7, P1063, DOI 10.1038/nm0901-1063; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; TAKAGAKI K, 2007, NEUROSCI LE IN PRESS; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Wu J.-Y., 1993, FLUORESCENT LUMINESC, P389; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2008	3	12							e4041	10.1371/journal.pone.0004041	http://dx.doi.org/10.1371/journal.pone.0004041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437CF	19116673	Green Published, Green Submitted, gold			2022-12-27	WOS:000265463000029
J	Middelbos, IS; Vester, BM; Karr-Lilienthal, LK; Schook, LB; Swanson, KS				Middelbos, Ingmar S.; Vester, Brittany M.; Karr-Lilienthal, Lisa K.; Schook, Lawrence B.; Swanson, Kelly S.			Age and Diet Affect Gene Expression Profile in Canine Skeletal Muscle	PLOS ONE			English	Article							MONOAMINE-OXIDASE; PROTEIN; DNA; IDENTIFICATION; METABOLISM; RECEPTOR; BINDING; GROWTH; TRANSCRIPTION; LOCALIZATION	We evaluated gene transcription in canine skeletal muscle (biceps femoris) using microarray analysis to identify effects of age and diet on gene expression. Twelve female beagles were used (six 1-year olds and six 12-year olds) and they were fed one of two experimental diets for 12 months. One diet contained primarily plant-based protein sources (PPB), whereas the second diet contained primarily animal-based protein sources (APB). Affymetrix GeneChip Canine Genome Arrays were used to hybridize extracted RNA. Age had the greatest effect on gene transcription (262 differentially expressed genes), whereas the effect of diet was relatively small (22 differentially expressed genes). Effects of age (regardless of diet) were most notable on genes related to metabolism, cell cycle and cell development, and transcription function. All these genes were predominantly down-regulated in geriatric dogs. Age-affected genes that were differentially expressed on only one of two diets were primarily noted in the PPB diet group (144/165 genes). Again, genes related to cell cycle (22/35) and metabolism (15/19) had predominantly decreased transcription in geriatric dogs, but 6/8 genes related to muscle development had increased expression. Effects of diet on muscle gene expression were mostly noted in geriatric dogs, but no consistent patterns in transcription were observed. The insight these data provide into gene expression profiles of canine skeletal muscle as affected by age, could serve as a foundation for future research pertaining to age-related muscle diseases.	[Middelbos, Ingmar S.; Vester, Brittany M.; Karr-Lilienthal, Lisa K.; Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Middelbos, IS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Schook, Lawrence/0000-0002-6580-8364; Swanson, Kelly/0000-0001-5518-3076	National Center for Supercomputing Applications; University of Illinois; NCSA/UIUC Faculty Fellows Program; Pyxis Genomics, Inc., Chicago, IL	National Center for Supercomputing Applications; University of Illinois; NCSA/UIUC Faculty Fellows Program; Pyxis Genomics, Inc., Chicago, IL	This work was funded in part by the National Center for Supercomputing Applications and the University of Illinois, under auspices of the NCSA/UIUC Faculty Fellows Program, and in part by Pyxis Genomics, Inc., Chicago, IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAFCO, 2007, OFF PUBL AAFCO; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; Basso D, 2004, GUT, V53, P1159, DOI 10.1136/gut.2003.024471; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bolstad BM, 2004, THESIS U CALIFORNIA; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Del Rio M, 2007, J CLIN ONCOL, V25, P773, DOI 10.1200/JCO.2006.07.4187; Demarchi F, 2007, CELL CYCLE, V6, P136; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; *GENECHIP, 2002, EXPR AN DAT AN FUND; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Helman EE, 2003, J ANIM SCI, V81, P2199; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kami K, 1999, MUSCLE NERVE, V22, P1576, DOI 10.1002/(SICI)1097-4598(199911)22:11<1576::AID-MUS14>3.0.CO;2-T; Knight BC, 1998, BIOCHEM J, V331, P161, DOI 10.1042/bj3310161; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEVY R, 1997, INT PSYCHOGERIATR, V6, P63; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; LIOU J, CURRENT BIOL, V15, P1235; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Mellick GD, 1999, MOVEMENT DISORD, V14, P219, DOI 10.1002/1531-8257(199903)14:2<219::AID-MDS1003>3.3.CO;2-0; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Naguib M, 2002, ANESTHESIOLOGY, V96, P202, DOI 10.1097/00000542-200201000-00035; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Ohinata Y, 2003, FEBS LETT, V537, P1, DOI 10.1016/S0014-5793(03)00036-X; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Ploner A., 2006, HEATPLUS HEAT MAP DI; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Slizhikova DK, 2005, RUSS J BIOORG CHEM+, V31, P178, DOI 10.1007/s11171-005-0024-6; Swanson KS, 2004, J ANIM SCI, V82, P1713; SWANSON KS, 2007, NEUROBIOL AGING, P10017; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wakshlag JJ, 2003, J ANIM PHYSIOL AN N, V87, P408, DOI 10.1046/j.0931-2439.2003.00452.x; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zeng J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1117	77	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4481	10.1371/journal.pone.0004481	http://dx.doi.org/10.1371/journal.pone.0004481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221602	Green Published, gold			2022-12-27	WOS:000265485700008
J	Coulon, M; Deputte, BL; Heyman, Y; Baudoin, C				Coulon, Marjorie; Deputte, Bertrand L.; Heyman, Yvan; Baudoin, Claude			Individual Recognition in Domestic Cattle (Bos taurus): Evidence from 2D-Images of Heads from Different Breeds	PLOS ONE			English	Article							RIGHT-HEMISPHERE ADVANTAGE; FACE RECOGNITION; TEMPORAL CORTEX; SHEEP; DISCRIMINATION; ANIMALS; REPRESENTATIONS; CHIMPANZEES; BEHAVIOR; FAMILIARITY	Background: In order to maintain cohesion of groups, social animals need to process social information efficiently. Visual individual recognition, which is distinguished from mere visual discrimination, has been studied in only few mammalian species. In addition, most previous studies used either a small number of subjects or a few various views as test stimuli. Dairy cattle, as a domestic species allow the testing of a good sample size and provide a large variety of test stimuli due to the morphological diversity of breeds. Hence cattle are a suitable model for studying individual visual recognition. This study demonstrates that cattle display visual individual recognition and shows the effect of both familiarity and coat diversity in discrimination. Methodology/Principal Findings: We tested whether 8 Prim'Holstein heifers could recognize 2D-images of heads of one cow (face, profiles, 3/4 views) from those of other cows. Experiments were based on a simultaneous discrimination paradigm through instrumental conditioning using food rewards. In Experiment 1, all images represented familiar cows (belonging to the same social group) from the Prim'Holstein breed. In Experiments 2, 3 and 4, images were from unfamiliar (unknown) individuals either from the same breed or other breeds. All heifers displayed individual recognition of familiar and unfamiliar individuals from their own breed. Subjects reached criterion sooner when recognizing a familiar individual than when recognizing an unfamiliar one (Exp 1: 3.1+/-0.7 vs. Exp 2: 5.2+/-1.2 sessions; Z = 1.99, N = 8, P = 0.046). In addition almost all subjects recognized unknown individuals from different breeds, however with greater difficulty. Conclusions/Significance: Our results demonstrated that cattle have efficient individual recognition based on categorization capacities. Social familiarity improved their performance. The recognition of individuals with very different coat characteristics from the subjects was the most difficult task. These results call for studies exploring the mechanisms involved in face recognition allowing interspecies comparisons, including humans.	[Coulon, Marjorie; Deputte, Bertrand L.; Baudoin, Claude] Univ Paris 13, CNRS, UMR 7153, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France; [Deputte, Bertrand L.] ENVA, Dept Ethol, Maisons Alfort, France; [Heyman, Yvan] INRA, UMR 1198 Biol Dev Reproduct, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); Universite Paris 13; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Coulon, M (corresponding author), Univ Paris 13, CNRS, UMR 7153, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	marjorie.coulon@leec.univ-paris13.fr			Ministere de l'Enseignement et de la Recherche	Ministere de l'Enseignement et de la Recherche	This work was supported by a grant from the Ministere de l'Enseignement et de la Recherche to Marjorie Coulon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; BOUISSOU MF, 1965, ANN BIOL ANIM BIOCH, V5, P327, DOI 10.1051/rnd:19650301; BOUISSOU MF, 1972, ANIM BEHAV, V20, P474, DOI 10.1016/S0003-3472(72)80011-3; Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; BRUCE V, 1987, APPL COGNITIVE PSYCH, V1, P109, DOI 10.1002/acp.2350010204; Coulon M, 2007, J COMP PSYCHOL, V121, P198, DOI 10.1037/0735-7036.121.2.198; CUMMINS K A, 1991, Journal of Dairy Science, V74, P301; DASSER V, 1987, ETHOLOGY, V76, P65; Ferreira G, 2004, BEHAV PROCESS, V67, P491, DOI 10.1016/j.beproc.2004.08.005; Fox M. W., 1975, WILD CANIDS THEIR SY; Hagen K, 2003, APPL ANIM BEHAV SCI, V82, P13, DOI 10.1016/S0168-1591(03)00053-4; HALE E. B., 1956, BEHAVIOUR, V10, P240, DOI 10.1163/156853956X00174; HALPIN ZT, 1980, BIOL BEHAV, V5, P233; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; Houpt K., 2005, DOMESTIC ANIMAL BEHA; Johnston RE, 2001, ANIM BEHAV, V61, P545, DOI 10.1006/anbe.2000.1637; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; KENDRICK KM, 1991, J ANIM SCI, V69, P5008, DOI 10.2527/1991.69125008x; Kendrick KM, 2001, NATURE, V414, P165, DOI 10.1038/35102669; Lambrechts Marcel M., 1995, V12, P115; Moe RO, 2006, APPL ANIM BEHAV SCI, V101, P362, DOI 10.1016/j.applanim.2006.02.004; OLSSON M, 1994, BEHAV ECOL SOCIOBIOL, V35, P249, DOI 10.1007/s002650050095; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Parr L., 1998, EVOL COMMUN, V2, P1, DOI [10.1075/eoc.2.1.02par, DOI 10.1075/EOC.2.1.02PAR]; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 2008, EMOTION, V8, P216, DOI 10.1037/1528-3542.8.2.216; Parr LA, 2006, BRAIN COGNITION, V62, P30, DOI 10.1016/j.bandc.2006.03.006; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; Peirce JW, 2002, NEUROREPORT, V13, P2395, DOI 10.1097/00001756-200212200-00004; PERRETT DI, 1985, BEHAV BRAIN RES, V16, P153, DOI 10.1016/0166-4328(85)90089-0; RUIZ M, 1993, APP ANIM BEHAV SCI, V36, P317; RYAN CME, 1994, BEHAV PROCESS, V33, P155, DOI 10.1016/0376-6357(94)90064-7; RYAN CME, 1982, BEHAV ANAL LETT, V2, P213; Sato Shusuke, 1996, Animal Science and Technology, V67, P36; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Van der Velden J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001695; Waring G.H., 2003, HORSE BEHAV, V2; WATANABE S, 1991, BIRD BEHAV, V9, P20, DOI 10.3727/015613890791749136; ZAYAN R, 1994, BEHAV PROCESS, V33, P233, DOI 10.1016/0376-6357(94)90068-X; Zayan R, 1998, BEHAV PROCESS, V42, P87, DOI 10.1016/S0376-6357(97)00064-8	45	44	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4441	10.1371/journal.pone.0004441	http://dx.doi.org/10.1371/journal.pone.0004441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212439	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200007
J	Casalbore, P; Budoni, M; Ricci-Vitiani, L; Cenciarelli, C; Petrucci, G; Milazzo, L; Montano, N; Tabolacci, E; Maira, G; Larocca, LM; Pallini, R				Casalbore, Patrizia; Budoni, Manuela; Ricci-Vitiani, Lucia; Cenciarelli, Carlo; Petrucci, Giovanna; Milazzo, Luisa; Montano, Nicola; Tabolacci, Elisabetta; Maira, Giulio; Larocca, Luigi M.; Pallini, Roberto			Tumorigenic Potential of Olfactory Bulb-Derived Human Adult Neural Stem Cells Associates with Activation of TERT and NOTCH1	PLOS ONE			English	Article								Background: Multipotent neural stem cells (NSCs) have been isolated from neurogenic regions of the adult brain. Reportedly, these cells can be expanded in vitro under prolonged mitogen stimulation without propensity to transform. However, the constitutive activation of the cellular machinery required to bypass apoptosis and senescence places these cells at risk for malignant transformation. Methodology/Principal Findings: Using serum-free medium supplemented with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), we established clonally derived NS/ progenitor cell (NS/PC) cultures from the olfactory bulb (OB) of five adult patients. The NS/ PC cultures obtained from one OB specimen lost growth factor dependence and neuronal differentiation at early passage. These cells developed glioblastoma tumors upon xenografting in immunosuppressed mice. The remaining NS/ PC cultures were propagated either as floating neurospheres or as adherent monolayers with mainteinance of growth factor dependence and multipotentiality at late passage. These cells were engrafted onto the CNS of immunosuppressed rodents. Overall, the grafted NS/PCs homed in the host parenchyma showing ramified morphology and neuronal marker expression. However, a group of animals transplanted with NS/PCs obtained from an adherent culture developed fast growing tumors histologically resembling neuroesthesioblastoma. Cytogenetic and molecular analyses showed that the NS/ PC undergo chromosomal changes with repeated in vitro passages under mitogen stimulation, and that up-regulation of hTERT and NOTCH1 associates with in vivo tumorigenicity. Conclusions/Significance: Using culturing techniques described in current literature, NS/PCs arise from the OB of adult patients which in vivo either integrate in the CNS parenchyma showing neuron-like features or initiate tumor formation. Extensive xenografting studies on each human derived NS cell line appear mandatory before any use of these cells in the clinical setting.	[Casalbore, Patrizia; Budoni, Manuela; Cenciarelli, Carlo] CNR, Inst Neurobiol & Mol Med, Rome, Italy; [Ricci-Vitiani, Lucia; Milazzo, Luisa] Ist Superiore Sanita, Dept Hematol Oncolo & Mol Med, Rome, Italy; [Petrucci, Giovanna; Larocca, Luigi M.] Catholic Univ, Sch Med, Inst Pathol, Rome, Italy; [Budoni, Manuela; Cenciarelli, Carlo; Montano, Nicola; Maira, Giulio; Pallini, Roberto] Catholic Univ, Sch Med, Inst Neurosurg, Rome, Italy; [Tabolacci, Elisabetta] Catholic Univ, Sch Med, Inst Genet, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Casalbore, P (corresponding author), CNR, Inst Neurobiol & Mol Med, Rome, Italy.	pallini@rm.unicatt.it	Larocca, Luigi M/A-1577-2008; Montano, Nicola/M-4565-2016; Larocca, Luigi Maria/M-9590-2019; PALLINI, Roberto/AAA-3747-2019; TABOLACCI, Elisabetta/AAR-6538-2020; Petrucci, Giovanna/AAB-9192-2022; Ricci Vitiani, Lucia/J-8320-2016; Pallini, Roberto/AAA-3760-2019; CENCIARELLI, CARLO/AAC-1603-2019	Larocca, Luigi M/0000-0003-1739-4758; Montano, Nicola/0000-0002-4965-1950; Larocca, Luigi Maria/0000-0003-1739-4758; PALLINI, Roberto/0000-0002-4611-8827; TABOLACCI, Elisabetta/0000-0002-4707-2242; Petrucci, Giovanna/0000-0002-9280-3673; Ricci Vitiani, Lucia/0000-0001-7336-5615; CENCIARELLI, CARLO/0000-0001-7480-4608	Fondi dAteneo (Progetti D1); ATENA Onlus; Nando Peretti Foundations	Fondi dAteneo (Progetti D1); ATENA Onlus; Nando Peretti Foundations	This work was supported by grants from Fondi dAteneo (Progetti D1), from ATENA Onlus, and Nando Peretti Foundations, and from Mrs. Paola Krajnik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DAVIS GA, 1995, NEUROSURGERY, V36, P599, DOI 10.1227/00006123-199503000-00023; Falchetti ML, 2003, CANCER RES, V63, P3750; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Siebzehnrubl FA, 2009, BRAIN PATHOL, V19, P399, DOI 10.1111/j.1750-3639.2008.00189.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022	25	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4434	10.1371/journal.pone.0004434	http://dx.doi.org/10.1371/journal.pone.0004434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209236	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484100006
J	Chen, QL; Panksepp, JB; Lahvis, GP				Chen, QiLiang; Panksepp, Jules B.; Lahvis, Garet P.			Empathy Is Moderated by Genetic Background in Mice	PLOS ONE			English	Article							INDUCED CONDITIONED ANALGESIA; BITING FLIES; SOCIAL REWARD; BEHAVIOR; FEAR; COPE; COMMUNICATION; C57BL/6J; ANIMALS; PUPS	Empathy, as originally defined, refers to an emotional experience that is shared among individuals. When discomfort or alarm is detected in another, a variety of behavioral responses can follow, including greater levels of nurturing, consolation or increased vigilance towards a threat. Moreover, changes in systemic physiology often accompany the recognition of distressed states in others. Employing a mouse model of cue-conditioned fear, we asked whether exposure to conspecific distress influences how a mouse subsequently responds to environmental cues that predict this distress. We found that mice are responsive to environmental cues that predict social distress, that their heart rate changes when distress vocalizations are emitted from conspecifics, and that genetic background substantially influences the magnitude of these responses. Specifically, during a series of pre-exposure sessions, repeated experiences of object mice that were exposed to a tone-shock (CS-UCS) contingency resulted in heart rate deceleration in subjects from the gregarious C57BL/6J (B6) strain, but not in subjects from the less social BALB/cJ (BALB) strain. Following the pre-exposure sessions, subjects were individually presented with the CS-only for 5 consecutive trials followed by 5 consecutive pairings of the CS with the UCS. Pre-exposure to object distress increased the freezing responses of B6 mice, but not BALB mice, on both the CS-only and the CS- UCS trials. These physiological and behavioral responses of B6 mice to social distress parallel features of human empathy. Our paradigm thus has construct and face validity with contemporary views of empathy, and provides unequivocal evidence for a genetic contribution to the expression of empathic behavior.	Univ Wisconsin, Undergrad Program Clin Lab Sci, Madison, WI 53706 USA; [Panksepp, Jules B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Lahvis, Garet P.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University	Chen, QL (corresponding author), Univ Wisconsin, Undergrad Program Clin Lab Sci, Madison, WI 53706 USA.	lahvisg@ohsu.edu		Lahvis, Garet/0000-0002-1986-8251; Chen, QiLiang/0000-0002-9588-1423	NIH [R03HD046716, R01DA022543, P30HD03352, T32GM07507, T32MH018931]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD046716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R03HD046716, R01DA022543 and P30HD03352. J.B.P. was additionally supported by NIH training grants to the Neuroscience Training Program (T32GM07507) and the Health Emotions Training Program (T32MH018931), both at UW-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack JK, 2000, ETHOLOGY, V106, P1057, DOI 10.1046/j.1439-0310.2000.00619.x; Carlier P, 2006, BEHAV BRAIN RES, V174, P125, DOI 10.1016/j.bbr.2006.07.014; Choleris E, 1999, PHARMACOL BIOCHEM BE, V64, P767, DOI 10.1016/S0091-3057(99)00141-0; COLLINS RL, 1988, J COMP PSYCHOL, V102, P222, DOI 10.1037/0735-7036.102.3.222; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; D'Amato FR, 2006, BEHAV GENET, V36, P471, DOI 10.1007/s10519-006-9074-7; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Depino AM, 2007, BEHAV BRAIN RES, V177, P254, DOI 10.1016/j.bbr.2006.11.025; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Farrow TFD, 2007, EMPATHY IN MENTAL ILLNESS, P201, DOI 10.1017/CBO9780511543753.013; Galef B.G., 1976, ADV STUDY BEHAV VOL, V6, P77, DOI DOI 10.1016/S0065-3454(08)60082-0; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; HOFFMAN ML, 1975, DEV PSYCHOL, V11, P607, DOI 10.1037/0012-1649.11.5.607; Kavaliers M, 1999, BEHAV NEUROSCI, V113, P126, DOI 10.1037/0735-7044.113.1.126; Kavaliers M, 2005, BEHAV ECOL SOCIOBIOL, V58, P60, DOI 10.1007/s00265-004-0896-0; Kavaliers M, 2003, HORM BEHAV, V43, P99, DOI 10.1016/S0018-506X(02)00021-1; Kavaliers M, 2001, BEHAV NEUROSCI, V115, P661, DOI 10.1037/0735-7044.115.3.661; Kavaliers M, 2001, NEUROREPORT, V12, P663, DOI 10.1097/00001756-200103260-00009; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Kuzyk Gerald W., 2001, Alberta Naturalist, V31, P53; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LeDoux J., 1998, EMOTIONAL BRAIN MYST; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; Lipps T, 1903, ARCH GESAMTE PSYCHOL, V1, P185; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Mateo JM, 1996, ANIM BEHAV, V52, P489, DOI 10.1006/anbe.1996.0192; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; OHMAN A, 2001, HDB PSYCHOPHYSIOLOGY, P533; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Panksepp JB, 2008, BEHAV BRAIN RES, V195, P239, DOI 10.1016/j.bbr.2008.09.010; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Smith DR, 2007, LEARN MEMORY, V14, P597, DOI 10.1101/lm.614807; Valsecchi P, 2002, ETHOLOGY, V108, P1115, DOI 10.1046/j.1439-0310.2002.00842.x; Zahn-Waxler C., 1998, DEV PSYCHOL, V7, P1; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	43	139	139	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4387	10.1371/journal.pone.0004387	http://dx.doi.org/10.1371/journal.pone.0004387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JP	19209221	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484100002
J	Banzhoff, A; Gasparini, R; Laghi-Pasini, F; Staniscia, T; Durando, P; Montomoli, E; Capecchi, P; di Giovanni, P; Sticchi, L; Gentile, C; Hilbert, A; Brauer, V; Tilman, S; Podda, A				Banzhoff, Angelika; Gasparini, Roberto; Laghi-Pasini, Franco; Staniscia, Tommaso; Durando, Paolo; Montomoli, Emanuele; Capecchi, Pamela; di Giovanni, Pamela; Sticchi, Laura; Gentile, Chiara; Hilbert, Anke; Brauer, Volker; Tilman, Sandrine; Podda, Audino			MF59 (R)-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults	PLOS ONE			English	Article							MF59-ADJUVANTED INFLUENZA VACCINE; SINGLE-RADIAL-HEMOLYSIS; AVIAN INFLUENZA; SUBUNIT VACCINE; IMMUNE-RESPONSE; IMMUNOGENICITY; SAFETY; PROTECTION; ASSAY	Background: Pathogenic avian influenza virus (H5N1) has the potential to cause a major global pandemic in humans. Safe and effective vaccines that induce immunologic memory and broad heterotypic response are needed. Methods and Findings: Healthy adults aged 18-60 and >60 years (n = 313 and n = 173, respectively) were randomized (1:1) to receive two primary and one booster injection of 7.5 mu g or 15 mg doses of a subunit MF59-adjuvanted H5N1 (A/Vietnam/1194/2004) (clade 1) vaccine. Safety was monitored until 6 months after booster. Immunogenicity was assessed by hemagglutination inhibition (HI), single radial hemolysis (SRH) and microneutralization assays (MN). Mild injection-site pain was the most common adverse reaction. No serious adverse events relating to the vaccine were reported. The humoral immune responses to 7.5 mg and 15 mg doses were comparable. The rates for seroprotection (HI>40; SRH>25mm(2); MN >= 40) after the primary vaccination ranged 72-87%. Six months after primary vaccination with the 7.5 mg dose, 18% and 21% of non-elderly and elderly adults were seroprotected; rates increased to 90% and 84%, respectively, after the booster vaccination. In the 15 mg group, seroprotection rates among non-elderly and elderly adults increased from 25% and 62% after primary vaccination to 92% and 88% after booster vaccination, respectively. A heterologous immune response to the H5N1/turkey/Turkey/05 strain was elicited after second and booster vaccinations. Conclusions: Both formulations of MF59-adjuvanted influenza H5N1 vaccine were well tolerated. The European Union requirement for licensure for pre-pandemic vaccines was met by the lower dose tested. The presence of cross-reactive antibodies to a clade 2 heterologous strain demonstrates that this vaccine may be appropriate for pre-pandemic programs.	[Banzhoff, Angelika; Hilbert, Anke; Brauer, Volker] Novartis Vaccines, Marburg, Germany; [Gasparini, Roberto; Durando, Paolo; Sticchi, Laura] Univ Genoa, Dept Hlth Sci, Sect Hygiene & Prevent Med, I-16126 Genoa, Italy; [Laghi-Pasini, Franco; Capecchi, Pamela] Univ Siena, Le Scotte Univ Hosp, Dept Allergol & Clin Immunol, I-53100 Siena, Italy; [Staniscia, Tommaso] Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy; [Montomoli, Emanuele; Gentile, Chiara] Univ Siena, Dept Pathophysiol Expt Med & Publ Hlth, Lab Mol Epidemiol, I-53100 Siena, Italy; [di Giovanni, Pamela] Univ G DAnnunzio, Dept Drug Sci, Chieti, Italy; [Tilman, Sandrine] Novartis Vaccines, Amsterdam, Netherlands; [Podda, Audino] Novartis Vaccines, Siena, Italy	Novartis; University of Genoa; University of Siena; University Hospital of Siena; G d'Annunzio University of Chieti-Pescara; University of Siena; G d'Annunzio University of Chieti-Pescara; Novartis; Novartis	Banzhoff, A (corresponding author), Novartis Vaccines, Marburg, Germany.	angelika.banzhoff@novartis.com	Podda, Audino/N-1680-2013; Bragazzi, Nicola Luigi/G-1672-2011; MONTOMOLI, EMANUELE/Q-2122-2015; Laghi Pasini, Franco/P-8994-2016	Podda, Audino/0000-0002-1340-4982; Bragazzi, Nicola Luigi/0000-0001-8409-868X; MONTOMOLI, EMANUELE/0000-0001-7595-4974; Laghi Pasini, Franco/0000-0003-0146-4416; DI GIOVANNI, PAMELA/0000-0002-6448-8960; Gasparini, Roberto/0000-0002-1012-6913	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	As the study sponsor, Novartis Vaccines and Diagnostics, in collaboration with the investigators and their teams, was involved in the design, analysis and interpretation of data, writing and preparing the paper and was involved also involved in the decision to submit for publication. The study sponsor had no role in on-site data collection.	[Anonymous], RESP AV INFL PAND TH; Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Banzhoff A, 2003, GERONTOLOGY, V49, P177, DOI 10.1159/000069172; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; *CHMP, 1997, CPMPBWP21496 CHMP; de Roux A, 2006, VACCINE, V24, P1537, DOI 10.1016/j.vaccine.2005.10.007; Del Giudice G, 2006, VACCINE, V24, P3063, DOI 10.1016/j.vaccine.2006.01.015; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gasparini R, 2001, EUR J EPIDEMIOL, V17, P135, DOI 10.1023/A:1017919305501; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Iorio AM, 2003, VACCINE, V21, P3629, DOI 10.1016/S0264-410X(03)00408-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Minutello M, 1999, VACCINE, V17, P99, DOI 10.1016/S0264-410X(98)00185-6; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P43; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; WHO, 2021, CUM NUMB CONF HUM CA; *WHO, 2005, DEV EV INFL PAND VAC; *WHO, 2008, EMERG INFECT DIS, V11, P1515; Wood JM, 2001, INT CONGR SER, V1219, P761, DOI 10.1016/S0531-5131(01)00410-1; 2006, VACCINE, V24, P6766	32	151	161	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4384	10.1371/journal.pone.0004384	http://dx.doi.org/10.1371/journal.pone.0004384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197383	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483700006
J	Petit, AC; Nicolas, JF				Petit, Anne-Cecile; Nicolas, Jean-Francois			Large-Scale Clonal Analysis Reveals Unexpected Complexity in Surface Ectoderm Morphogenesis	PLOS ONE			English	Article								Background: Understanding the series of morphogenetic processes that underlie the making of embryo structures is a highly topical issue in developmental biology, essential for interpreting the massive molecular data currently available. In mouse embryo, long-term in vivo analysis of cell behaviours and movements is difficult because of the development in utero and the impossibility of long-term culture. Methodology/Principal Findings: We improved and combined two genetic methods of clonal analysis that together make practicable large-scale production of labelled clones. Using these methods we performed a clonal analysis of surface ectoderm (SE), a poorly understood structure, for a period that includes gastrulation and the establishment of the body plan. We show that SE formation starts with the definition at early gastrulation of a pool of founder cells that is already dorso-ventrally organized. This pool is then regionalized antero-posteriorly into three pools giving rise to head, trunk and tail. Each pool uses its own combination of cell rearrangements and mode of proliferation for elongation, despite a common clonal strategy that consists in disposing along the antero-posterior axis precursors of dorso-ventrally-oriented stripes of cells. Conclusions/Significance: We propose that these series of morphogenetic processes are organized temporally and spatially in a posterior zone of the embryo crucial for elongation. The variety of cell behaviours used by SE precursor cells indicates that these precursors are not equivalent, regardless of a common clonal origin and a common clonal strategy. Another major result is the finding that there are founder cells that contribute only to the head and tail. This surprising observation together with others can be integrated with ideas about the origin of axial tissues in bilaterians.	[Petit, Anne-Cecile; Nicolas, Jean-Francois] Inst Pasteur, Unite Biol Mol Dev, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Petit, AC (corresponding author), Inst Pasteur, Unite Biol Mol Dev, Paris, France.	jfnicola@pasteur.fr	Nicolas, Jean-François/AAW-9289-2020; Petit, Anne-Cecile/AAH-2658-2020	PETIT, Anne-Cecile/0000-0003-4143-9848	Cells into Organs; EuroStemCell; Association Francaise contre les Myopathies; Institut National de la Recherche Medicale; Universite Pierre et Marie Curie	Cells into Organs; EuroStemCell(European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut National de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie	This work was supported by grants from Cells into Organs (European Network of excellence), EuroStemCell (European consortium for stem cell research) and the Association Francaise contre les Myopathies. J.F.N. is from the Institut National de la Recherche Medicale, and A.C.P. from Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D., 2004, P679; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BONNEROT C, 1993, CR ACAD SCI III-VIE, V316, P1207; Bruce AEE, 1998, DEV BIOL, V201, P101, DOI 10.1006/dbio.1998.8968; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eloy-Trinquet S, 2000, CURR TOP DEV BIOL, V47, P33; Eloy-Trinquet S, 2002, DEVELOPMENT, V129, P3609; Eloy-Trinquet S, 2002, DEVELOPMENT, V129, P111; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Garcia-Bellido AC, 1998, INT J DEV BIOL, V42, P353; Gardner R.L., 1985, Philosophical Transactions of the Royal Society of London B Biological Sciences, V312, P1; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JAEGERSTEN G, 1955, ZOOL BIDR UPPS, V30, P321; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Luria SE, 1943, GENETICS, V28, P491; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mathis L, 2002, TRENDS GENET, V18, P627, DOI 10.1016/S0168-9525(02)02806-8; Mathis L, 1997, DEVELOPMENT, V124, P4089; MATHIS L, 1998, MICROINJECTIONS TRAN, P439; MATHIS L, 1997, ANN I PASTEUR ACTUAL, V8, P3; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; Nielsen C., 1995, ANIMAL EVOLUTION INT; Petit AC, 2005, REPROD NUTR DEV, V45, P321, DOI 10.1051/rnd:2005024; PETIT AC, 2008, THESIS U PIERRE MARI; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Raff RA, 2000, EVOL DEV, V2, P102, DOI 10.1046/j.1525-142x.2000.00035.x; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; Rolland-Lagan AG, 2005, J THEOR BIOL, V232, P157, DOI 10.1016/j.jtbi.2004.04.045; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schlosser G., 2004, MODULARITY DEV EVOLU; SELLECK MAJ, 1992, NATO ADV SCI I A-LIF, V231, P23; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steinmetz PRH, 2007, P NATL ACAD SCI USA, V104, P2727, DOI 10.1073/pnas.0606589104; Stern C.D., 2004, GASTRULATION CELLS E; Stern CD, 2001, NAT CELL BIOL, V3, pE216, DOI 10.1038/ncb0901-e216; TZOUANACOU E, 2009, REDEFINING PRO UNPUB; VALENTINE JW, 2004, ORIGIN PHYLA; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; WILSON V, 1995, DEVELOPMENT, V121, P877; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	68	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4353	10.1371/journal.pone.0004353	http://dx.doi.org/10.1371/journal.pone.0004353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197371	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483700002
J	Swenson, NG				Swenson, Nathan G.			Phylogenetic Resolution and Quantifying the Phylogenetic Diversity and Dispersion of Communities	PLOS ONE			English	Article								Conservation biologists and community ecologists have increasingly begun to quantify the phylogenetic diversity and phylogenetic dispersion in species assemblages. In some instances, the phylogenetic trees used for such analyses are fully bifurcating, but in many cases the phylogenies being used contain unresolved nodes (i.e. polytomies). The lack of phylogenetic resolution in such studies, while certainly not preferred, is likely to continue particularly for those analyzing diverse communities and datasets with hundreds to thousands of taxa. Thus it is imperative that we quantify potential biases and losses of statistical power in studies that use phylogenetic trees that are not completely resolved. The present study is designed to meet both of these goals by quantifying the phylogenetic diversity and dispersion of simulated communities using resolved and gradually 'unresolved' phylogenies. The results show that: (i) measures of community phylogenetic diversity and dispersion are generally more sensitive to loss of resolution basally in the phylogeny and less sensitive to loss of resolution terminally; and (ii) the loss of phylogenetic resolution generally causes false negative results rather than false positives.	Harvard Univ, Ctr Trop Forest Sci, Asia Program, Cambridge, MA 02138 USA	Harvard University	Swenson, NG (corresponding author), Harvard Univ, Ctr Trop Forest Sci, Asia Program, Cambridge, MA 02138 USA.	nswenson@oeb.harvard.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	Institute for the Study of Planet Earth at University of Arizona [Dissertation Improvement Grant]	Institute for the Study of Planet Earth at University of Arizona	Dissertation Improvement Grant from the Institute for the Study of Planet Earth at University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GM, 2002, BIOL J LINN SOC, V76, P165, DOI 10.1111/j.1095-8312.2002.tb02081.x; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Faith DP, 2002, CONSERV BIOL, V16, P248, DOI 10.1046/j.1523-1739.2002.00503.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 2006, EVOL BIOINFORM ONLIN, V2, P70; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRAFEN A, 1992, J THEOR BIOL, V156, P405, DOI 10.1016/S0022-5193(05)80635-6; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; MARTINS EP, 1991, EVOLUTION, V45, P534, DOI [10.2307/2409910, 10.1111/j.1558-5646.1991.tb04328.x]; Minh BQ, 2006, SYST BIOL, V55, P769, DOI 10.1080/10635150600981604; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378	27	159	161	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4390	10.1371/journal.pone.0004390	http://dx.doi.org/10.1371/journal.pone.0004390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194509	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483600015
J	Vernis, L; Facca, C; Delagoutte, E; Soler, N; Chanet, R; Guiard, B; Faye, G; Baldacci, G				Vernis, Laurence; Facca, Celine; Delagoutte, Emmanuelle; Soler, Nicolas; Chanet, Roland; Guiard, Bernard; Faye, Gerard; Baldacci, Giuseppe			A Newly Identified Essential Complex, Dre2-Tah18, Controls Mitochondria Integrity and Cell Death after Oxidative Stress in Yeast	PLOS ONE			English	Article								A mutated allele of the essential gene TAH18 was previously identified in our laboratory in a genetic screen for new proteins interacting with the DNA polymerase delta in yeast [1]. The present work shows that Tah18 plays a role in response to oxidative stress. After exposure to lethal doses of H(2)O(2), GFP-Tah18 relocalizes to the mitochondria and controls mitochondria integrity and cell death. Dre2, an essential Fe/S cluster protein and homologue of human anti-apoptotic Ciapin1, was identified as a molecular partner of Tah18 in the absence of stress. Moreover, Ciapin1 is able to replace yeast Dre2 in vivo and physically interacts with Tah18. Our results are in favour of an oxidative stress-induced cell death in yeast that involves mitochondria and is controlled by the newly identified Dre2-Tah18 complex.	[Vernis, Laurence; Facca, Celine; Delagoutte, Emmanuelle; Soler, Nicolas; Chanet, Roland; Baldacci, Giuseppe] Univ Paris 11, INSERM, Regulat Replicat ADN Eucaryotes, UMR2027,CNRS,Inst Curie, F-91405 Orsay, France; [Guiard, Bernard] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Faye, Gerard] Inst Curie, CNRS, UMR2027, Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Vernis, L (corresponding author), Univ Paris 11, INSERM, Regulat Replicat ADN Eucaryotes, UMR2027,CNRS,Inst Curie, F-91405 Orsay, France.	laurence.vernis-beringue@curie.u-psud.fr	Vernis, Laurence/B-7414-2019; Soler, Nicolas/B-7720-2016; /L-1666-2018	Soler, Nicolas/0000-0002-4292-4020; /0000-0001-7878-0877	french CNRS [post-doctoral fellowship]; INSERM; Institut Curie	french CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie	This work was supported financially by french CNRS, INSERM and Institut Curie. NS is a recipient of French CNRS post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Burkart W, 1999, CR ACAD SCI III-VIE, V322, P89, DOI 10.1016/S0764-4469(99)80029-8; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; Del Carratore R, 2002, MUTAT RES-GEN TOX EN, V513, P183, DOI 10.1016/S1383-5718(01)00310-2; DUTTA C, 1990, ANAL BIOCHEM, V184, P96, DOI 10.1016/0003-2697(90)90018-5; Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848; Feng YM, 2005, BIOCHEM J, V392, P65, DOI 10.1042/BJ20050195; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Fiorani P, 2000, ANN NY ACAD SCI, V922, P65; FLINT DH, 1993, J BIOL CHEM, V268, P25547; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ivanovska I, 2005, J CELL BIOL, V170, P391, DOI 10.1083/jcb.200503069; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludovico P, 2003, FEMS YEAST RES, V3, P91, DOI 10.1016/S1567-1356(02)00166-6; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MACIERZYNSKA E, 2007, CELL MOL BIOL LETT; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Maris AF, 2000, CURR GENET, V37, P175, DOI 10.1007/s002940050516; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Reid RJD, 1999, P NATL ACAD SCI USA, V96, P11440, DOI 10.1073/pnas.96.20.11440; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1993, GENE, V127, P139, DOI 10.1016/0378-1119(93)90629-H; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang H, 2008, MOL BIOL CELL, V19, P2127, DOI 10.1091/mbc.E07-11-1113; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	57	62	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4376	10.1371/journal.pone.0004376	http://dx.doi.org/10.1371/journal.pone.0004376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194512	Green Published, gold			2022-12-27	WOS:000265483600009
J	Curlin, FA; Lawrence, RE; Fredrickson, J				Curlin, Farr A.; Lawrence, Ryan E.; Fredrickson, Julie			An Ethical Facade? Medical Students' Miscomprehensions of Substituted Judgment	PLOS ONE			English	Article							SURROGATE DECISION-MAKING; QUALITATIVE RESEARCH; OF-LIFE; ACCURACY; CARE	Background: We studied how well first-year medical students understand and apply the concept of substituted judgment, following a course on clinical ethics. Method: Students submitted essays on one of three ethically controversial scenarios presented in class. One scenario involved a patient who had lost decisional capacity. Through an iterative process of textual analysis, the essays were studied and coded for patterns in the ways students misunderstood or misapplied the principle of substituted judgment. Results: Students correctly articulated course principles regarding patient autonomy, substituted judgment, and nonimposition of physician values. However, students showed misunderstanding by giving doctors the responsibility of balancing the interests of the patient against the interests of the family, by stating doctors and surrogates should be guided primarily by a best-interest standard, and by suggesting that patient autonomy becomes the guiding principle only when patients can no longer express their wishes. Conclusion: Students did not appear to internalize or correctly apply the substituted judgment standard, even though they could describe it accurately. This suggests the substituted judgment standard may run counter to students' moral intuitions, making it harder to apply in clinical practice.	Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA; [Curlin, Farr A.] Univ Chicago, MacLean Ctr Clin Med Ethics, Chicago, IL 60637 USA; [Lawrence, Ryan E.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Fredrickson, Julie] Univ Chicago, Undergrad Coll, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Curlin, FA (corresponding author), Univ Chicago, Dept Med, Gen Internal Med Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	fcurlin@medicine.bsd.uchicago.edu						Azoulay E, 2004, CRIT CARE MED, V32, P2323, DOI 10.1097/01.CCM.0000145950.57614.04; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bramstedt KA, 2003, INTERN MED J, V33, P257, DOI 10.1046/j.1445-5994.2003.00386.x; Buchanan Allen E., 1989, DECIDING OTHERS ETHI; DRANE JF, 1995, J CLIN ETHIC, V6, P20; Drought Theresa S, 2002, Gerontologist, V42 Spec No 3, P114; Fried TR, 2003, ARCH INTERN MED, V163, P2073, DOI 10.1001/archinte.163.17.2073; FRIED TR, 1995, CAMB Q HEALTHC ETHIC, V4, P524, DOI 10.1017/S0963180100006368; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; HARE J, 1992, ARCH INTERN MED, V152, P1049, DOI 10.1001/archinte.152.5.1049; Janesick V. J, 2003, STRATEGIES QUALITATI, P46; Jonsen AR, 2002, CLIN ETHICS PRACTICA; Laine C, 1996, JAMA-J AM MED ASSOC, V275, P152, DOI 10.1001/jama.275.2.152; Lysaught MT, 2004, J MED PHILOS, V29, P665, DOI 10.1080/03605310490883028; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Martyn S R, 1994, Camb Q Healthc Ethics, V3, P195; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V269, P1158, DOI 10.1001/jama.269.9.1158; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; SULMASY DP, 1994, AM J MED, V96, P432, DOI 10.1016/0002-9343(94)90170-8; Terry PB, 1999, J CLIN ETHIC, V10, P286; Torke AM, 2008, J CLIN ETHIC, V19, P110	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4374	10.1371/journal.pone.0004374	http://dx.doi.org/10.1371/journal.pone.0004374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JK	19194491	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483500013
J	Gondois-Rey, F; Dental, C; Halfon, P; Baumert, TF; Olive, D; Hirsch, I				Gondois-Rey, Francoise; Dental, Clelia; Halfon, Philippe; Baumert, Thomas F.; Olive, Daniel; Hirsch, Ivan			Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1	PLOS ONE			English	Article								Plasmacytoid dendritic cells (pDCs) are responsible for the production of type I IFN during viral infection. Viral elimination by IFN-alpha-based therapy in more than 50% of patients chronically infected with hepatitis C virus (HCV) suggests a possible impairment of production of endogenous IFN-alpha by pDCs in infected individuals. In this study, we investigated the impact of HCV on pDC function. We show that exposure of pDCs to patient serum- and cell culture-derived HCV resulted in production of IFN-alpha by pDCs isolated from some donors, although this production was significantly lower than that induced by influenza and human herpesvirus type 1 (HHV-1). Using specific inhibitors we demonstrate that endocytosis and endosomal acidification were required for IFN-alpha production by pDCs in response to cell culture-derived HCV. HCV and noninfectious HCV-like particles inhibited pDC-associated production of IFN-alpha stimulated with Toll-like receptor 9 (TLR9) agonists (CpG-A or HHV-1) but not that of IFN-alpha stimulated with TLR7 agonists (resiquimod or influenza virus). The blockade of TLR9-mediated production of IFN-alpha, effective only when pDCs were exposed to virus prior to or shortly after CpG-A stimulation, was already detectable at the IFN-alpha transcription level 2 h after stimulation with CpG-A and correlated with down-regulation of the transcription factor IRF7 expression and of TLR9 expression. In conclusion, rapidly and early occurring particle-host cell protein interaction during particle internalization and endocytosis followed by blockade of TLR9 function could result in less efficient sensing of HCV RNA by TLR7, with impaired production of IFN-alpha. This finding is important for our understanding of HCV-DC interaction and immunopathogenesis of HCV infection.	[Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Ctr Rech Cancerol Marseille, INSERM, UMR891, Marseille, France; [Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Inst Paoli Calmettes, Marseille, France; [Gondois-Rey, Francoise; Dental, Clelia; Olive, Daniel; Hirsch, Ivan] Univ Aix Marseille 2, Marseille, France; [Halfon, Philippe] Alphabio Lab, Dept Virol, Marseille, France; [Baumert, Thomas F.] Univ Louis Pasteur, INSERM, U748, F-67070 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gondois-Rey, F (corresponding author), Ctr Rech Cancerol Marseille, INSERM, UMR891, Marseille, France.	ivan.hirsch@inserm.fr	Baumert, Thomas/ABF-4718-2020; Hirsch, Ivan/J-7726-2015	Baumert, Thomas/0000-0002-8864-2168; Hirsch, Ivan/0000-0003-1701-1438	ANRS; INSERM; Institut Paoli-Calmettes; Plateform Cancer Immuno-Monitoring IBiSA; EU; ANR	ANRS(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Plateform Cancer Immuno-Monitoring IBiSA; EU(European Commission); ANR(French National Research Agency (ANR))	This work was financially supported by ANRS, INSERM, Institut Paoli-Calmettes, and by Plateform Cancer Immuno-Monitoring IBiSA, and by funds (to TFB) from the EU (FP5) and ANR (chair of excellence).	Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Amjad M, 2008, MICROBIOL IMMUNOL, V52, P499, DOI 10.1111/j.1348-0421.2008.00067.x; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Bai X, 1997, CLIN CHEM, V43, P1843; Barth H, 2005, BLOOD, V105, P3605, DOI 10.1182/blood-2004-05-1952; Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Baumert TF, 1998, J VIROL, V72, P3827, DOI 10.1128/JVI.72.5.3827-3836.1998; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Decalf J, 2007, J EXP MED, V204, P2423, DOI 10.1084/jem.20070814; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gondois-Rey F, 2001, AIDS, V15, P1931, DOI 10.1097/00002030-200110190-00004; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; LAMBERT AA, 2008, BLOOD; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Schroeder JT, 2008, J ALLERGY CLIN IMMUN, V121, P486, DOI 10.1016/j.jaci.2007.09.049; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Ulsenheimer A, 2005, HEPATOLOGY, V41, P643, DOI 10.1002/hep.20592; VINCENT IE, 2007, HEPATITIS B VIRUS IN; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200; Wellnitz S, 2002, J VIROL, V76, P1181, DOI 10.1128/JVI.76.3.1181-1193.2002; Wertheimer AM, 2004, HEPATOLOGY, V40, P335, DOI 10.1002/hep.20306; Yi AK, 1998, J IMMUNOL, V160, P4755; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	73	36	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4319	10.1371/journal.pone.0004319	http://dx.doi.org/10.1371/journal.pone.0004319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183807	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483200006
J	Seidman, MA; Chew, TW; Schenkel, AR; Muller, WA				Seidman, Michael A.; Chew, Tina W.; Schenkel, Alan R.; Muller, William A.			PECAM-Independent Thioglycollate Peritonitis Is Associated With a Locus on Murine Chromosome 2	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; QUANTITATIVE TRAIT LOCI; PERIVASCULAR BASEMENT-MEMBRANE; COMPLEMENT COMPONENT C5; IN-VIVO; LEUKOCYTE MIGRATION; BACILLUS-ANTHRACIS; INBRED MICE; INFLAMMATION; CD31	Background: Previous studies have demonstrated that knockout or inhibition of Platelet/Endothelial Cell Adhesion Molecule (PECAM, CD31) in a number of murine strains results in impaired inflammatory responses, but that no such phenotype is seen in the C57BL/6 (B6) murine background. Methodology/Principal Findings: We have undertaken a quantitative trait locus (QTL) mapping effort between FVB/n (FVB) and B6 mice deficient for PECAM to identify the gene or genes responsible for this unique feature of B6 mice. We have identified a locus on murine chromosome 2 at approximately 35.8 Mb that is strongly associated (LOD score = 9.0) with inflammatory responses in the absence of PECAM. Conclusions/Significance: These data potentiate further study of the diapedesis machinery, as well as potential identification of new components of this machinery. As such, this study is an important step to better understanding the processes of inflammation.	[Seidman, Michael A.; Chew, Tina W.; Muller, William A.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Schenkel, Alan R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biol Sci, Ft Collins, CO 80523 USA	Cornell University; Colorado State University	Seidman, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol, New York, NY USA.	wamuller@northwestern.edu	Seidman, Michael/J-4731-2019; Schenkel, Alan/G-1880-2017	Seidman, Michael/0000-0002-9594-827X; Schenkel, Alan/0000-0002-1603-5713	NIH [GM07739, R01 HL046849, R01 HL064774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064774, R01HL064774, R01HL046849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for M.A.S. comes from the Tri-Institutional M.D./Ph.D. Program, NIH MSTP grant GM07739. Support for this W. A. M. comes from NIH R01 grants HL046849 and HL064774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer K, 2004, ARTHRITIS RHEUM-US, V50, P3721, DOI 10.1002/art.20624; Biswas P, 2003, BIOCHEM BIOPH RES CO, V303, P212, DOI 10.1016/S0006-291X(03)00313-9; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; BOGEN SA, 1992, AM J PATHOL, V141, P843; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BROWNSTEIN DG, 1991, J VIROL, V65, P1946, DOI 10.1128/JVI.65.4.1946-1951.1991; CINADER B, 1964, J EXP MED, V120, P897, DOI 10.1084/jem.120.5.897; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Duncan GS, 1999, J IMMUNOL, V162, P3022; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Langenbach R, 1999, ANN NY ACAD SCI, V889, P52, DOI 10.1111/j.1749-6632.1999.tb08723.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liao F, 1999, J IMMUNOL, V163, P5640; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Mahooti S, 2000, AM J PATHOL, V157, P75, DOI 10.1016/S0002-9440(10)64519-1; McIndoe RA, 1999, P NATL ACAD SCI USA, V96, P2210, DOI 10.1073/pnas.96.5.2210; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 2007, ADHESION MOL FUNCTIO, P201; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI200113455; NILSSON UR, 1967, J EXP MED, V125, P1, DOI 10.1084/jem.125.1.1; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Schenkel AR, 2004, J IMMUNOL, V173, P6403, DOI 10.4049/jimmunol.173.10.6403; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Thompson RD, 2001, BLOOD, V97, P1854, DOI 10.1182/blood.V97.6.1854; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wilkinson R, 2002, BLOOD, V100, P184, DOI 10.1182/blood-2002-01-0027; Wong MX, 2002, J IMMUNOL, V168, P6455, DOI 10.4049/jimmunol.168.12.6455	46	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4316	10.1371/journal.pone.0004316	http://dx.doi.org/10.1371/journal.pone.0004316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180231	Green Published, Green Submitted, gold			2022-12-27	WOS:000274089700008
J	Malekzadeh, F; Alberti, C; Nouraei, M; Vahedi, H; Zaccaria, I; Meinzer, U; Nasseri-Moghaddam, S; Sotoudehmanesh, R; Momenzadeh, S; Khaleghnejad, R; Rashtak, S; Olfati, G; Malekzadeh, R; Hugot, JP				Malekzadeh, Fatemeh; Alberti, Corinne; Nouraei, Mehdi; Vahedi, Homayoon; Zaccaria, Isabelle; Meinzer, Ulrich; Nasseri-Moghaddam, Siavosh; Sotoudehmanesh, Rasoul; Momenzadeh, Sara; Khaleghnejad, Reza; Rashtak, Shahrooz; Olfati, Golrokh; Malekzadeh, Reza; Hugot, Jean-Pierre			Crohn's Disease and Early Exposure to Domestic Refrigeration	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; OLMSTED COUNTY; PREVALENCE; POPULATION; SUSCEPTIBILITY; ASSOCIATION; EPIDEMIOLOGY; MINNESOTA; VARIANTS	Background: Environmental risk factors playing a causative role in Crohn's Disease (CD) remain largely unknown. Recently, it has been suggested that refrigerated food could be involved in disease development. We thus conducted a pilot case control study to explore the association of CD with the exposure to domestic refrigeration in childhood. Methodology/Principal Findings: Using a standard questionnaire we interviewed 199 CD cases and 207 age-matched patients with irritable bowel syndrome (IBS) as controls. Cases and controls were followed by the same gastroenterologists of tertiary referral clinics in Tehran, Iran. The questionnaire focused on the date of the first acquisition of home refrigerator and freezer. Data were analysed by a multivariate logistic model. The current age was in average 34 years in CD cases and the percentage of females in the case and control groups were respectively 48.3% and 63.7%. Patients were exposed earlier than controls to the refrigerator (X2 = 9.9, df = 3, P = 0.04) and refrigerator exposure at birth was found to be a risk factor for CD (OR = 2.08 (95% CI: 1.01-4.29), P = 0.05). Comparable results were obtained looking for the exposure to freezer at home. Finally, among the other recorded items reflecting the hygiene and comfort at home, we also found personal television, car and washing machine associated with CD. Conclusion: This study supports the opinion that CD is associated with exposure to domestic refrigeration, among other household factors, during childhood.	[Malekzadeh, Fatemeh; Nouraei, Mehdi; Vahedi, Homayoon; Nasseri-Moghaddam, Siavosh; Sotoudehmanesh, Rasoul; Momenzadeh, Sara; Khaleghnejad, Reza; Rashtak, Shahrooz; Olfati, Golrokh; Malekzadeh, Reza] Univ Tehran, Digest Dis Res Ctr, Tehran, Iran; [Alberti, Corinne; Zaccaria, Isabelle] Hop Robert Debre, Unite Epidemiol Clin, APHP, Paris, France; [Alberti, Corinne; Zaccaria, Isabelle] INSERM, CIE5, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Hop Robert Debre, Serv Gastroenterol Pediat, AP HP, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Univ Paris Diderot, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] INSERM, U843, Paris, France	University of Tehran; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Malekzadeh, F (corresponding author), Univ Tehran, Digest Dis Res Ctr, Tehran, Iran.	jean-pierre.hugot@rdb.aphp.fr	Malekzadeh, Reza/U-1382-2017; Hugot, Jean-Pierre/F-6594-2012; Meinzer, Ulrich/N-4282-2019	Malekzadeh, Reza/0000-0002-9820-6335; Malekzadeh, Reza/0000-0003-1043-3814; Hugot, Jean-Pierre/0000-0002-8446-6056	INSERM, France; faculty of medicine Paris Diderot, Freance; mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); faculty of medicine Paris Diderot, Freance; mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran(Tehran University of Medical Sciences)	This work was supported by the INSERM, France; the faculty of medicine Paris Diderot, Freance; the mairie de Paris and the Digestive Disease Research Center, Tehran university of medical sciences, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh R, 2005, J GASTROEN HEPATOL, V20, P1691, DOI 10.1111/j.1440-1746.2005.03905.x; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; BRAHME F, 1975, GASTROENTEROLOGY, V69, P342; CHITKARA DK, 2007, AM J GASTROENTEROL, V102, P1; EASON RJ, 1982, AUST NZ J MED, V12, P125, DOI 10.1111/j.1445-5994.1982.tb02443.x; EVANS JG, 1965, GUT, V6, P311, DOI 10.1136/gut.6.4.311; FELLOWS IW, 1990, GUT, V31, P1262, DOI 10.1136/gut.31.11.1262; Forbes A, 2006, INT J COLORECTAL DIS, V21, P399, DOI 10.1007/s00384-005-0003-7; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; GHAVAMI A, 1969, DIS COLON RECTUM, V12, P462, DOI 10.1007/BF02617735; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hellers G, 1979, Acta Chir Scand Suppl, V490, P1; Heresbach D, 2005, GUT, V54, P215, DOI 10.1136/gut.2004.041715; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2003, EUR J HUM GENET, V11, P179, DOI 10.1038/sj.ejhg.5200932; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; IBBOTSON JP, 1992, CLIN EXP IMMUNOL, V87, P224, DOI 10.1111/j.1365-2249.1992.tb02979.x; Jacobsen BA, 2006, EUR J GASTROEN HEPAT, V18, P601, DOI 10.1097/00042737-200606000-00005; Kallinowski F, 1998, HEPATO-GASTROENTEROL, V45, P1552; Karlinger K, 2000, EUR J RADIOL, V35, P154, DOI 10.1016/S0720-048X(00)00238-2; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; KYLE J, 1971, GASTROENTEROLOGY, V61, P826; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P75, DOI 10.3748/wjg.v12.i1.75; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Malekzadeh R, 2000, GASTROENTEROLOGY, V118, pA1356, DOI 10.1016/S0016-5085(00)81293-7; MALEKZADEH R, 1986, IRANIAN J MED, V13, P54; MALEKZADEH R, 2000, IRN J MED SCI, V25, P138; MAYBERRY JF, 1984, GUT, V25, P886, DOI 10.1136/gut.25.8.886; McCormick P, 2001, Ir Med J, V94, P203; MIRMADJLESSI SH, 1985, AM J GASTROENTEROL, V80, P862; Molinie F, 2004, GUT, V53, P843, DOI 10.1136/gut.2003.025346; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Saebo Arve, 2005, Eur J Intern Med, V16, P176, DOI 10.1016/j.ejim.2004.11.008; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; Timmer A, 1999, INFLAMM BOWEL DIS, V5, P79, DOI 10.1097/00054725-199905000-00002; WRIGHT JP, 1986, S AFR MED J, V70, P10	46	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4288	10.1371/journal.pone.0004288	http://dx.doi.org/10.1371/journal.pone.0004288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177167	gold, Green Submitted, Green Published			2022-12-27	WOS:000265483100003
J	Schweizer, MC; Henniger, MSH; Sillaber, I				Schweizer, Martin C.; Henniger, Markus S. H.; Sillaber, Inge			Chronic Mild Stress (CMS) in Mice: Of Anhedonia, 'Anomalous Anxiolysis' and Activity	PLOS ONE			English	Article								Background: In a substantial proportion of depressed patients, stressful life events play a role in triggering the evolution of the illness. Exposure to stress has effects on different levels in laboratory animals as well and for the rat it has been shown that chronic mild stress (CMS) can cause antidepressant-reversible depressive-like effects. The adoption of the model to the mouse seems to be problematic, depending on the strain used and behavioural endpoint defined. Our aim was to evaluate the applicability of CMS to mice in order to induce behavioural alterations suggested to reflect depression-like symptoms. Methodology/Principal Findings: A weekly CMS protocol was applied to male mice of different mouse strains (D2Ola, BL/6J and BL/6N) and its impact on stress-sensitive behavioural measures (anhedonia-, anxiety- and depression-related parameters) and body weight was assessed. Overnight illumination as commonly used stressor in CMS protocols was particularly investigated in terms of its effect on general activity and subsequently derived saccharin intake. CMS application yielded strain-dependent behavioural and physiological responses including 'paradox' anxiolytic-like effects. Overnight illumination was found to be sufficient to mimic anhedonic-like behaviour in BL/6J mice when being applied as sole stressor. Conclusions/Significance: The CMS procedure induced some behavioural changes that are compatible with the common expectations, i.e. 'anhedonic' behaviour, but in parallel behavioural alterations were observed which would be described as 'anomalous' (e. g. decreased anxiety). The results suggest that a shift in the pattern of circadian activity has a particular high impact on the anhedonic profile. Changes in activity in response to novelty seem to drive the 'anomalous' behavioural alterations as well.	[Schweizer, Martin C.; Henniger, Markus S. H.; Sillaber, Inge] Affectis Pharmaceut AG, Martinsried, Germany; [Sillaber, Inge] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Schweizer, MC (corresponding author), Affectis Pharmaceut AG, Martinsried, Germany.	schweizer@affectis.com			Bundesministerium fur Bildung und Forschung [313685]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The research was supported in part by the Bundesministerium fur Bildung und Forschung (FKZ 313685). There was no role of any sponsors in the design, data collection, analysis, interpretation, etc. of the study.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Cabib S, 1996, NEUROSCIENCE, V73, P375, DOI 10.1016/0306-4522(96)00750-6; CANCELA LM, 1995, BRAIN RES BULL, V36, P209, DOI 10.1016/0361-9230(94)00185-4; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; DAquila PS, 1997, PHYSIOL BEHAV, V62, P421, DOI 10.1016/S0031-9384(97)00042-5; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Ducottet C, 2004, PHYSIOL BEHAV, V81, P417, DOI 10.1016/j.physbeh.2004.01.013; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; GRIFFITHS J, 1992, PHARMACOL BIOCHEM BE, V42, P219, DOI 10.1016/0091-3057(92)90519-L; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Harkin A, 2002, J PSYCHOPHARMACOL, V16, P115, DOI 10.1177/026988110201600201; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; IBARGUENVARGAS Y, 2008, PSYCHONEUROENDOCRINO; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kompagne H, 2008, BEHAV BRAIN RES, V193, P311, DOI 10.1016/j.bbr.2008.06.008; Kopp C, 2001, BEHAV BRAIN RES, V125, P93, DOI 10.1016/S0166-4328(01)00289-3; Kopp C, 1999, BEHAV PHARMACOL, V10, P73, DOI 10.1097/00008877-199902000-00007; Li S, 2008, LIFE SCI, V82, P934, DOI 10.1016/j.lfs.2008.02.010; Li S, 2007, LIFE SCI, V80, P1373, DOI 10.1016/j.lfs.2006.12.027; Linthorst ACE, 2008, PHARMACOL BIOCHEM BE, V90, P163, DOI 10.1016/j.pbb.2007.09.019; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; MOREAU JL, 1995, BEHAV PHARMACOL, V6, P682; NEMEROFF CB, 1988, PHARMACOPSYCHIATRY, V21, P76, DOI 10.1055/s-2007-1014652; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Papp M, 2003, NEUROPSYCHOPHARMACOL, V28, P694, DOI 10.1038/sj.npp.1300091; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rossler AS, 2000, BEHAV PROCESS, V49, P163, DOI 10.1016/S0376-6357(00)00080-2; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Strekalova T, 2005, BEHAV PHARMACOL, V16, P171, DOI 10.1097/00008877-200505000-00006; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tanaka M, 2003, NEUROSCI LETT, V352, P159, DOI 10.1016/j.neulet.2003.08.051; Tang XD, 2005, PHYSIOL BEHAV, V85, P419, DOI 10.1016/j.physbeh.2005.05.008; Thoeringer CK, 2007, PSYCHONEUROENDOCRINO, V32, P746, DOI 10.1016/j.psyneuen.2007.05.005; WEHR TA, 1982, PHARMACOPSYCHIATRIA, V15, P31, DOI 10.1055/s-2007-1019506; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456	53	116	119	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4326	10.1371/journal.pone.0004326	http://dx.doi.org/10.1371/journal.pone.0004326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177164	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483100009
J	Joppa, LN; Loarie, SR; Pimm, SL				Joppa, Lucas N.; Loarie, Scott R.; Pimm, Stuart L.			On Population Growth Near Protected Areas	PLOS ONE			English	Article								Background: Protected areas are the first, and often only, line of defense in efforts to conserve biodiversity. They might be detrimental or beneficial to rural communities depending on how they alter economic opportunities and access to natural resources. As such, protected areas may attract or repel human settlement. Disproportionate increases in population growth near protected area boundaries may threaten their ability to conserve biodiversity. Methodology/Principal Findings: Using decadal population datasets, we analyze population growth across 45 countries and 304 protected areas. We find no evidence for population growth near protected areas to be greater than growth of rural areas in the same country. Furthermore, we argue that what growth does occur near protected areas likely results from a general expansion of nearby population centers. Conclusions/Significance: Our results contradict those from a recent study by Wittemyer et al., who claim overwhelming evidence for increased human population growth near protected areas. To understand the disagreement, we re-analyzed the protected areas in Wittemyer et al.'s paper. Their results are simply artifacts of mixing two incompatible datasets. Protected areas may experience unusual population pressures near their edges; indeed, individual case studies provide examples. There is no evidence, however, of a general pattern of disproportionate population growth near protected areas.	[Joppa, Lucas N.; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Loarie, Scott R.] Carnegie Inst, Dept Glob Ecol, Stanford, CA USA	Duke University; Carnegie Institution for Science	Joppa, LN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	StuartPimm@me.com	pimm, stuart/ABF-1082-2020		National Science Foundation [Graduate Research Fellowship]; NASA [Earth Systems Sciences Graduate Fellowship]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	LNJ is supported by a National Science Foundation Graduate Research Fellowship. SRL is supported by a NASA Earth Systems Sciences Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Anderson A., 2006, APPL NATURES DESIGN; CIESIN (Center for International Earth Science Information NEtweok - Columbia University) IFPRI (International Food Policy Research Institute) The World Bank CIAT (Centro Internacional de Agricultura Tropical), GLOB RUR URB MAPP PR; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Loarie SR, 2007, TRENDS ECOL EVOL, V22, P630, DOI 10.1016/j.tree.2007.08.018; Myers N., 2004, NEW CONSUMERS INFLUE; PELUSO NL, 1993, GLOBAL ENVIRON CHANG, V3, P199, DOI 10.1016/0959-3780(93)90006-7; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Scherl LM, 2004, OPPORTUNITIES LIMITA; *UNEP CTR INT EART, 2004, AFR POP DISTR DAT; *UNEP INT CTR TROP, 2004, LAT AM POP DISTR DAT; *UNEP WORLD CONS M, 2003, WORLD DAT PROT AR; United Nations (UN) Population Division, 2007, WORLD URB PROSP 2007; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900	18	71	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4279	10.1371/journal.pone.0004279	http://dx.doi.org/10.1371/journal.pone.0004279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169358	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482800009
J	Slater, BJ; Liu, KJ; Kwan, MD; Quarto, N; Longaker, MT				Slater, Bethany J.; Liu, Karen J.; Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.			Cranial Osteogenesis and Suture Morphology in Xenopus laevis: A Unique Model System for Studying Craniofacial Development	PLOS ONE			English	Article								Background: The tremendous diversity in vertebrate skull formation illustrates the range of forms and functions generated by varying genetic programs. Understanding the molecular basis for this variety may provide us with insights into mechanisms underlying human craniofacial anomalies. In this study, we provide evidence that the anuran Xenopus laevis can be developed as a simplified model system for the study of cranial ossification and suture patterning. The head structures of Xenopus undergo dramatic remodelling during metamorphosis; as a result, tadpole morphology differs greatly from the adult bony skull. Because of the extended larval period in Xenopus, the molecular basis of these alterations has not been well studied. Methodology/Principal Findings: We examined late larval, metamorphosing, and post-metamorphosis froglet stages in intact and sectioned animals. Using micro-computed tomography (mCT) and tissue staining of the frontoparietal bone and surrounding cartilage, we observed that bone formation initiates from lateral ossification centers, proceeding from posterior-to-anterior. Histological analyses revealed midline abutting and posterior overlapping sutures. To determine the mechanisms underlying the large-scale cranial changes, we examined proliferation, apoptosis, and proteinase activity during remodelling of the skull roof. We found that tissue turnover during metamorphosis could be accounted for by abundant matrix metalloproteinase (MMP) activity, at least in part by MMP-1 and -13. Conclusion: A better understanding of the dramatic transformation from cartilaginous head structures to bony skull during Xenopus metamorphosis may provide insights into tissue remodelling and regeneration in other systems. Our studies provide some new molecular insights into this process.	[Slater, Bethany J.; Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Pediat Regenerative Med, Stanford, CA 94305 USA; [Liu, Karen J.] Kings Coll London, Dept Craniofac Dev, London, England; [Quarto, Natalina] Univ Naples Federico II, Dept Structural & Funct Biol, Naples, Italy	Stanford University; Stanford University; University of London; King's College London; University of Naples Federico II	Slater, BJ (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.	karen.liu@kcl.ac.uk; Longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165				Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; CAROL C, 1996, J MORPHOL, V229, P121; Chipman AD, 2002, EVOL DEV, V4, P86, DOI 10.1046/j.1525-142X.2002.01064.x; COULY GF, 1993, DEVELOPMENT, V117, P409; de Beer G., 1937, DEV VERTEBRATE SKULL; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Geisler R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-11; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Gross JB, 2005, J EXP ZOOL PART B, V304B, P169, DOI 10.1002/jez.b.21028; Gross JB, 2004, DEV DYNAM, V230, P100, DOI 10.1002/dvdy.20036; Gross JB, 2006, J ANAT, V209, P401, DOI 10.1111/j.1469-7580.2006.00608.x; Hanken J, 2005, J ANAT, V207, P437, DOI 10.1111/j.1469-7580.2005.00481.x; HANKEN J, 1988, J MORPHOL, V195, P247, DOI 10.1002/jmor.1051950303; Hanken J., 1993, SKULL; Harrison M, 2004, DEV DYNAM, V231, P214, DOI 10.1002/dvdy.20113; Hasebe T, 2006, CELL TISSUE RES, V324, P105, DOI 10.1007/s00441-005-0099-7; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JENNIFER Y, 2002, EVOLUTION, V56, P2484; Lenton KA, 2005, CURR TOP DEV BIOL, V66, P287, DOI 10.1016/S0070-2153(05)66009-7; Miura S, 2008, BONE, V43, P901, DOI 10.1016/j.bone.2008.07.005; Morriss-Kay GM, 2001, J ANAT, V199, P143; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; NIEWKOOP P.D., 1994, NORMAL TABLE XENOPUS; NODEN DM, 1986, J CRAN GENET DEV BIO, P15; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Olsson L, 1996, J MORPHOL, V229, P105, DOI 10.1002/(SICI)1097-4687(199607)229:1<105::AID-JMOR7>3.0.CO;2-2; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; ORAHILLY R, 1972, AM J ANAT, V134, P291, DOI 10.1002/aja.1001340303; PATERSON NF, Q J MICROSCOPIAL S S, V2, P161; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; RICE DP, 2008, FRONTIERS ORAL BIOL; Ritman EL, 2004, ANNU REV BIOMED ENG, V6, P185, DOI 10.1146/annurev.bioeng.6.040803.140130; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; SANSOM IJ, 1992, SCIENCE, V256, P1308, DOI 10.1126/science.1598573; SEDRA SN, VERH KON AKAD WETENS, V51, P1; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Trueb L, 2000, J MORPHOL, V243, P75, DOI 10.1002/(SICI)1097-4687(200001)243:1<75::AID-JMOR4>3.0.CO;2-L; WANG Z, 1993, J BIOL CHEM, V268, P16270; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e3914	10.1371/journal.pone.0003914	http://dx.doi.org/10.1371/journal.pone.0003914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156194	Green Published, Green Submitted, gold			2022-12-27	WOS:000265481900001
J	Driscoll, CA; Yamaguchi, N; Bar-Gal, GK; Roca, AL; Luo, SJ; Macdonald, DW; O'Brien, SJ				Driscoll, Carlos A.; Yamaguchi, Nobuyuki; Bar-Gal, Gila Kahila; Roca, Alfred L.; Luo, Shujin; Macdonald, David W.; O'Brien, Stephen J.			Mitochondrial Phylogeography Illuminates the Origin of the Extinct Caspian Tiger and Its Relationship to the Amur Tiger	PLOS ONE			English	Article							GENOME; DNA; ALIGNMENT; NUMT	The Caspian tiger (Panthera tigris virgata) flourished in Central Asian riverine forest systems in a range disjunct from that of other tigers, but was driven to extinction in 1970 prior to a modern molecular evaluation. For over a century naturalists puzzled over the taxonomic validity, placement, and biogeographic origin of this enigmatic animal. Using ancient-DNA (aDNA) methodology, we generated composite mtDNA haplotypes from twenty wild Caspian tigers from throughout their historic range sampled from museum collections. We found that Caspian tigers carry a major mtDNA haplotype differing by only a single nucleotide from the monomorphic haplotype found across all contemporary Amur tigers (P. t. altaica). Phylogeographic analysis with extant tiger subspecies suggests that less than 10,000 years ago the Caspian/Amur tiger ancestor colonized Central Asia via the Gansu Corridor (Silk Road) from eastern China then subsequently traversed Siberia eastward to establish the Amur tiger in the Russian Far East. The conservation implications of these findings are far reaching, as the observed genetic depletion characteristic of modern Amur tigers likely reflects these founder migrations and therefore predates human influence. Also, due to their evolutionary propinquity, living Amur tigers offer an appropriate genetic source should reintroductions to the former range of the Caspian tiger be implemented.	[Driscoll, Carlos A.; Yamaguchi, Nobuyuki; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England; [Driscoll, Carlos A.; Luo, Shujin; O'Brien, Stephen J.] NCI, Lab Genom Diversity, Bethesda, MD 20892 USA; [Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Fac Agr Food & Environm Quality Sci, Koret Sch Vet Med, IL-91905 Jerusalem, Israel; [Roca, Alfred L.] NCI Frederick, SAIC Frederick, Lab Genom Diversity, Frederick, MD USA; [Roca, Alfred L.] Univ Illinois, Dept Animal Sci, Urbana, IL USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Illinois System; University of Illinois Urbana-Champaign	Driscoll, CA (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England.	bigscience@ncifcrf.gov; obrien@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Yamaguchi, Nobuyuki/AAN-4884-2020	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Driscoll, Carlos/0000-0003-2392-505X; OBRIEN, STEPHEN/0000-0001-7857-0757; Roca, Alfred/0000-0001-9217-5593	National Cancer Institute, National Institutes of Health [N01-CO-12400]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005385] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The contents of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1999, ICZN INT COD ZOOL NO, Vxxix, px306; Avise J, 2004, MOL MARKERS NATURAL; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CAN OE, 2004, STATUS CONSERVATION, P8; Cooper A, 2000, SCIENCE, V289, P1139; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; HEMMER H, 1987, TIGERS WORLD BIOL BI; Heptner V. H., 1972, CARNIVORES HYENAS CA; HERRINGTON SJ, 1987, TIGERS WORLD BIOL BI; Hilzheimer M., 1905, Zoologischer Anzeiger, Vxxviii, P594; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; ILLIGER C, 1815, ABHANDLUNGEN PHYS KL, V1804-1811, P39; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; KITCHENER A, 1999, RIDING TIGER TIGER C; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Linnaeus C., 1758, SYSTEMA NATURAE PER, V1; Lopez JV, 1996, GENOMICS, V33, P229, DOI 10.1006/geno.1996.0188; Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; Marris E, 2007, NATURE, V450, P152, DOI 10.1038/450152a; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; MAZAK V, 1968, Mammalia, V32, P104, DOI 10.1515/mamm.1968.32.1.104; MAZAK V, 1983, TIGER PANTHERA TIGRI, V1758; MAZAK V, 1981, MAMMALIAN SPECIES, V152, P1, DOI DOI 10.2307/3504004; NOWELL K, 1996, WILD CATS STATUS SUR, pR24; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rozen S, 2000, Methods Mol Biol, V132, P365; Russello MA, 2004, CONSERV GENET, V5, P707, DOI 10.1007/s10592-004-1860-2; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schwarz E., 1912, Annals & Magazine of Natural History Series 8, V10; SEIDENSTICKER J, 1999, RIDING TIGER TIGER C, pR19; Smith J.L.D., 1987, P97; SUNQUIST ME, 1999, RIDING TIGER TIGER C; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Temminck C, 1844, FAUNA JAPONICA, P25; WEI L, 2008, MOL BIOL REP; WEI LW, 2008, EF551002 GENBANK; Wu XB, 2007, GENOME, V50, P252, DOI 10.1139/G06-143	44	39	44	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4125	10.1371/journal.pone.0004125	http://dx.doi.org/10.1371/journal.pone.0004125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142238	Green Submitted, gold, Green Published			2022-12-27	WOS:000265479700002
J	Watanabe, K; Morishima, Y; Toigawa, M; Hata, Y				Watanabe, Kana; Morishima, Yu; Toigawa, Masahito; Hata, Yoshio			Experience-Driven Axon Retraction in the Pharmacologically Inactivated Visual Cortex Does Not Require Synaptic Transmission	PLOS ONE			English	Article								Background: Experience during early postnatal development plays an important role in the refinement of specific neural connections in the brain. In the mammalian visual system, altered visual experiences induce plastic adaptation of visual cortical responses and guide rearrangements of afferent axons from the lateral geniculate nucleus. Previous studies using visual deprivation demonstrated that the afferents serving an open eye significantly retract when cortical neurons are pharmacologically inhibited by applying a gamma-aminobutyric acid type A receptor agonist, muscimol, whereas those serving a deprived eye are rescued from retraction, suggesting that presynaptic activity can lead to the retraction of geniculocortical axons in the absence of postsynaptic activity. Because muscimol application suppresses the spike activity of cortical neurons leaving transmitter release intact at geniculocortical synapses, local synaptic interaction may underlie the retraction of active axons in the inhibited cortex. Method and Findings: New studies reported here determined whether experience-driven axon retraction can occur in the visual cortex inactivated by blocking synaptic inputs. We inactivated the primary visual cortex of kittens by suppressing synaptic transmission with cortical injections of botulinum neurotoxin type E, which cleaves a synaptic protein, SNAP-25, and blocks transmitter release, and examined the geniculocortical axon morphology in the animals with normal vision and those deprived of vision binocularly. We found that afferent axons in the animals with normal vision showed a significant retraction in the inactivated cortex, as similarly observed in the muscimol-treated cortex, whereas the axons in the binocularly deprived animals were preserved. Conclusions: Therefore, the experience-driven axon retraction in the inactivated cortex can proceed in the absence of synaptic transmission. These results suggest that presynaptic mechanisms play an important role in the experience-driven refinement of geniculocortical axons.	[Watanabe, Kana; Morishima, Yu; Toigawa, Masahito; Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan	Tottori University	Watanabe, K (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Integrat Biosci, Yonago, Tottori, Japan.	yhata@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17023033]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas- Elucidation of neural network function in the brain from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 17023033) to Y.H.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI A, 1993, J NEUROSCI, V13, P3549; Antonini A, 1996, J COMP NEUROL, V369, P64; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Elliott RC, 2001, J NEUROSCI RES, V66, P83, DOI 10.1002/jnr.1199; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Haruta M, 2007, CURR BIOL, V17, P37, DOI 10.1016/j.cub.2006.10.064; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; Ichisaka S, 2003, NEUROSCIENCE, V117, P361, DOI 10.1016/S0306-4522(02)00771-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; NEEDLER MC, 1984, BRAIN RES, V308, P347, DOI 10.1016/0006-8993(84)91076-X; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shimegi S, 2003, J NEUROPHYSIOL, V90, P4027, DOI 10.1152/jn.00313.2003; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	29	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4193	10.1371/journal.pone.0004193	http://dx.doi.org/10.1371/journal.pone.0004193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142221	Green Submitted, gold, Green Published			2022-12-27	WOS:000265479700013
J	Richer, MJ; Lavallee, DJ; Shanina, I; Horwitz, MS				Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.			Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection	PLOS ONE			English	Article								Toll-like receptor 3 (TLR3) has been proposed to play a central role in the early recognition of viruses by sensing double stranded RNA, a common intermediate of viral replication. However, several reports have demonstrated that TLR3 signaling is either dispensable or even harmful following infection with certain viruses. Here, we asked whether TLR3 plays a role in the response to coxsackievirus B4 (CB4), a prevalent human pathogen that has been associated with pancreatitis, myocarditis and diabetes. We demonstrate that TLR3 signaling on macrophages is critical to establish protective immunity to CB4. TLR3 deficient mice produced reduced pro-inflammatory mediators and are unable to control viral replication at the early stages of infection resulting in severe cardiac damage. Intriguingly, the absence of TLR3 did not affect the activation of several key innate and adaptive cellular effectors. This suggests that in the absence of TLR3 signaling on macrophages, viral replication outpaces the developing adaptive immune response. We further demonstrate that the MyD88-dependent signaling pathways are not only unable to compensate for the loss of TLR3, they are also dispensable in the response to this RNA virus. Our results demonstrate that TLR3 is not simply part of a redundant system of viral recognition, but rather TLR3 plays an essential role in recognizing the molecular signatures associated with specific viruses including CB4.	[Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Richer, MJ (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@interchange.ubc.ca			Canadian Institute of Health Research; Michael Smith Foundation for Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Canadian Institute of Health Research and Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bertinchant JP, 1996, CLIN BIOCHEM, V29, P587, DOI 10.1016/S0009-9120(96)00105-1; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Carpentier PA, 2007, GLIA, V55, P239, DOI 10.1002/glia.20450; DAFFIS S, 2008, J VIROL; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; KLAVINSKIS LS, 1989, J GEN VIROL, V70, P3317, DOI 10.1099/0022-1317-70-12-3317; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2006, CLIN IMMUNOL, V121, P339, DOI 10.1016/j.clim.2006.07.009; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Rose NR, 2008, CURR TOP MICROBIOL, V323, P293; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tam PE, 2006, VIRAL IMMUNOL, V19, P133, DOI 10.1089/vim.2006.19.133; Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Ure DR, 2005, INT IMMUNOL, V17, P569, DOI 10.1093/intimm/dxh236; Wada H, 2001, CIRCULATION, V103, P743; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239; WEINZIERL AO, J VIROL; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730	52	107	109	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4127	10.1371/journal.pone.0004127	http://dx.doi.org/10.1371/journal.pone.0004127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122812	Green Submitted, Green Published, gold			2022-12-27	WOS:000265472900007
J	Laouar, A; Manocha, M; Haridas, V; Manjunath, N				Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.			Concurrent Generation of Effector and Central Memory CD8 T Cells during Vaccinia Virus Infection	PLOS ONE			English	Article								It is generally thought that during the contraction phase of an acute anti-viral T cell reponse, the effector T cells that escape activation-induced cell death eventually differentiate into central memory T cells over the next several weeks. Here we report that antigen-specific CD8T cells with the phenotype and function of central memory cells develop concomitantly with effector T cells during vaccinia virus (vv) infection. As soon as 5 days after an intraperitoneal infection with vv, we could identify a subset of CD44(hi) and CD62L(+) vv-specific CD8 T cells in the peritoneal exudate lymphocytes. This population constituted approximately 10% of all antigen-specific T cells and like central memory T cells, they also expressed high levels of CCR7 and IL-7R but expressed little granzyme B. Importantly, upon adoptive transfer into naive congenic hosts, CD62L(+), but not CD62L(-) CD8 T cells were able to expand and mediate a rapid recall response to a new vv challenge initiated 6 weeks after transfer, confirming that the CD62L(+) vv-specific CD8 T cells are bonafide memory cells. Our results are thus consistent with the branched differentiation model, where effector and memory cells develop simultaneously. These results are likely to have implications in the context of vaccine design, particularly those based on vaccinia virus recombinants.	[Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.] Harvard Univ, Sch Med, Immune Dis Inst Inc, Boston, MA 02115 USA; [Laouar, Amale; Manocha, Monika; Haridas, Viraga; Manjunath, N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Laouar, A (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst Inc, Boston, MA 02115 USA.	laouar@cbr.med.harvard.edu; manjunath.swamy@ttuhsc.edu	Laouar, Amale/AAO-2903-2020		NIH/NIAID	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Curtsinger JM, 1998, J IMMUNOL, V160, P3236; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Richards H, 2008, J IMMUNOL, V180, P198, DOI 10.4049/jimmunol.180.1.198; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schildknecht A, 2007, EUR J IMMUNOL, V37, P716, DOI 10.1002/eji.200636824; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	30	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4089	10.1371/journal.pone.0004089	http://dx.doi.org/10.1371/journal.pone.0004089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116651	Green Published, Green Submitted, gold			2022-12-27	WOS:000265466600010
J	Shawkey, MD; Firestone, MK; Brodie, EL; Beissinger, SR				Shawkey, Matthew D.; Firestone, Mary K.; Brodie, Eoin L.; Beissinger, Steven R.			Avian Incubation Inhibits Growth and Diversification of Bacterial Assemblages on Eggs	PLOS ONE			English	Article								Microbial infection is a critical source of mortality for early life stages of oviparous vertebrates, but parental defenses against infection are less well known. Avian incubation has been hypothesized to reduce the risk of trans-shell infection by limiting microbial growth of pathogenic bacteria on eggshells, while enhancing growth of commensal or beneficial bacteria that inhibit or competitively exclude pathogens. We tested this hypothesis by comparing bacterial assemblages on naturally incubated and experimentally unincubated eggs at laying and late incubation using a universal 16S rRNA microarray containing probes for over 8000 bacterial taxa. Before treatment, bacterial assemblages on individual eggs from both treatment groups were dissimilar to one another, as measured by clustering in non-metric dimensional scaling (NMDS) ordination space. After treatment, assemblages of unincubated eggs were similar to one another, but those of incubated eggs were not. Furthermore, assemblages of unincubated eggs were characterized by high abundance of six indicator species while incubated eggs had no indicator species. Bacterial taxon richness remained static on incubated eggs, but increased significantly on unincubated eggs, especially in several families of Gram-negative bacteria. The relative abundance of individual bacterial taxa did not change on incubated eggs, but that of 82 bacterial taxa, including some known to infect the interior of eggs, increased on unincubated eggs. Thus, incubation inhibits all of the relatively few bacteria that grow on eggshells, and does not appear to promote growth of any bacteria.	[Shawkey, Matthew D.; Firestone, Mary K.; Beissinger, Steven R.] Univ Calif, Dept Environm Sci Policy & Management, Div Ecosyst Sci Div, Berkeley, CA USA; [Firestone, Mary K.; Brodie, Eoin L.] Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Shawkey, MD (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	beis@nature.berkeley.edu	Brodie, Eoin L/A-7853-2008; Beissinger, Steven R/F-3809-2012	Brodie, Eoin L/0000-0002-8453-8435; Shawkey, Matthew/0000-0002-5131-8209	NSF [IOB-0517549]; U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02- 05CH11231]	NSF(National Science Foundation (NSF)); U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	This work was supported by NSF grant IOB-0517549 to S. R. Beissinger and M. K. Firestone. Additional work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under Contract DE-AC02- 05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2007, LABDSV ORDINATION MU; ARENDT WJ, 1993, PEARY EYED THRASHER; Bandyopadhyay Anuradha, 1996, Indian Journal of Experimental Biology, V34, P48; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; Board RG, 1994, MICROBIOLOGY AVIAN E; Borg I, 2010, MODERN MULTIDIMENSIO; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; BRUCE J, 1991, POULT SCI S, V22, P257; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557; Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Giacomello E, 2006, BIOL LETTERS, V2, P330, DOI 10.1098/rsbl.2006.0492; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Han XY, 2005, J ANTIMICROB CHEMOTH, V55, P853, DOI 10.1093/jac/dki139; Houston CS, 1997, J WILDLIFE DIS, V33, P328, DOI 10.7589/0090-3558-33.2.328; Knouft JH, 2003, P ROY SOC B-BIOL SCI, V270, P2405, DOI 10.1098/rspb.2003.2501; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; KOZLOWSKI S, 1989, INTECOL SLUPSK, P121; Law-Brown J, 2003, INT J SYST EVOL MICR, V53, P683, DOI 10.1099/ijs.0.02334-0; LIU WT, 2002, MANUAL ENV MICROBIOL, P114; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Mielke P. W., 2001, PERMUTATION METHODS; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Raffaele H.A., 1998, GUIDE BIRDS W INDIES; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; *TEAM TDC, 2008, R LANG ENV STAT COMP; Zar J. H., 1996, BIOSTATISTICAL ANAL	40	69	70	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4522	10.1371/journal.pone.0004522	http://dx.doi.org/10.1371/journal.pone.0004522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225566	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000004
J	Brown, AE; Baumbach, J; Cook, PE; Ligoxygakis, P				Brown, Anthony E.; Baumbach, Janina; Cook, Peter E.; Ligoxygakis, Petros			Short-Term Starvation of Immune Deficient Drosophila Improves Survival to Gram-Negative Bacterial Infections	PLOS ONE			English	Article							NITRIC-OXIDE; DIETARY RESTRICTION; MITOCHONDRIAL BIOGENESIS; PATHOGEN RECOGNITION	Background: Primary immunodeficiencies are inborn errors of immunity that lead to life threatening conditions. These predispositions describe human immunity in natura and highlight the important function of components of the Toll-IL-1-receptor-nuclear factor kappa B (TIR-NF-kappa B) pathway. Since the TIR-NF-kappa B circuit is a conserved component of the host defence in higher animals, genetically tractable models may contribute ideas for clinical interventions. Methodology/Principal Findings: We used immunodeficient fruit flies (Drosophila melanogaster) to address questions pertaining to survival following bacterial infection. We describe here that flies lacking the NF-kappa B protein Relish, indispensable for countering Gram-negative bacteria, had a greatly improved survival to such infections when subject to dietary short-term starvation (STS) prior to immune challenge. STS induced the release of Nitric Oxide (NO), a potent molecule against pathogens in flies, mice and humans. Administering the NO Synthase-inhibitory arginine analog N-Nitro-L-Arginine-Methyl-Ester (L-NAME) but not its inactive enantiomer D-NAME increased once again sensitivity to infection to levels expected for relish mutants. Surprisingly, NO signalling required the NF-kappa B protein Dif, usually needed for responses against Gram-positive bacteria. Conclusions/Significance: Our results show that NO release through STS may reflect an evolutionary conserved process. Moreover, STS could be explored to address immune phenotypes related to infection and may offer ways to boost natural immunity.	[Brown, Anthony E.; Baumbach, Janina; Ligoxygakis, Petros] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; [Brown, Anthony E.; Cook, Peter E.] Univ Oxford, Peter Medawar Building Pathogen Res, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Brown, AE (corresponding author), Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England.	petros.ligoxygakis@bioch.ox.ac.uk		Brown, Anthony/0000-0002-1271-310X	Medical Research Council UK [G0300170]; EPA Cephalosporin Trust Fund [CF 115]; Studienstiftung des Deutschen Volkes [scholarship]; EMBO [long-term fellowship]; MRC [G0300170] Funding Source: UKRI; Medical Research Council [G0300170] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPA Cephalosporin Trust Fund; Studienstiftung des Deutschen Volkes; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This investigation was supported by the Medical Research Council UK (career establishment grant G0300170 to PL) and the EPA Cephalosporin Trust Fund (pump-priming grant CF 115 to PL). JB was the recipient of a Studienstiftung des Deutschen Volkes scholarship. PEC was supported by an EMBO long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; CHER DJ, 1987, J IMMUNOL, V138, P3688; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Huang FP, 1998, EUR J IMMUNOL, V28, P4062, DOI 10.1002/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mojena M, 2001, FASEB J, V15, P583; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; van den Brink GR, 2002, CLIN DIAGN LAB IMMUN, V9, P182, DOI 10.1128/CDLI.9.1.182-183.2002; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wu JL, 2007, CELL MICROBIOL, V9, P1073, DOI 10.1111/j.1462-5822.2006.00853.x; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	25	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4490	10.1371/journal.pone.0004490	http://dx.doi.org/10.1371/journal.pone.0004490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221590	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485700015
J	Grigoryan, A; Hall, HI; Durant, T; Wei, XM				Grigoryan, Anna; Hall, H. Irene; Durant, Tonji; Wei, Xiangming			Late HIV Diagnosis and Determinants of Progression to AIDS or Death after HIV Diagnosis among Injection Drug Users, 33 US States, 1996-2004	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; DISEASE PROGRESSION; SURVIVAL; ERA; INFECTION; ADHERENCE; MORTALITY	Background: The timeliness of HIV diagnosis and the initiation of antiretroviral treatment are major determinants of survival for HIV-infected people. Injection drug users (IDUs) are less likely than persons in other transmission categories to seek early HIV counseling, testing, and treatment. Our objective was to estimate the proportion of IDUs with a late HIV diagnosis (AIDS diagnosis within 12 months of HIV diagnosis) and determine the factors associated with disease progression after HIV diagnosis. Methodology/Principal Findings: Using data from 33 states with confidential name-based HIV reporting, we determined the proportion of IDUs aged >= 13 years who received a late HIV diagnosis during 1996-2004. We used standardized Kaplan-Meier survival methods to determine differences in time of progression from HIV to AIDS and death, by race/ethnicity, sex, age group, CD4(+) T-cell count, metropolitan residence, and diagnosis year. We compared the survival of IDUs with the survival of persons in other transmission categories. During 1996-2004, 42.2% (11,635) of 27,572 IDUs were diagnosed late. For IDUs, the risk for progression from HIV to AIDS 3 years after HIV diagnosis was greater for nonwhites, males and older persons. Three-year survival after HIV diagnosis was lower for IDU males (87.3%, 95% confidence interval (CI), 87.1-87.4) compared with males exposed through male-to-male sexual contact (91.6%, 95% CI, 91.6-91.7) and males exposed through high-risk heterosexual contact (HRHC) (91.9%, 95% CI, 91.8-91.9). Survival was also lower for IDU females (89.5%, 95% CI, 89.4-89.6) compared to HRHC females (93.3%, 95% CI, 93.3-93.4). Conclusions/Significance: A substantial proportion of IDUs living with HIV received their HIV diagnosis late. To improve survival of IDUs, HIV prevention efforts must ensure early access to HIV testing and care, as well as encourage adherence to antiretroviral treatment to slow disease progression.	[Grigoryan, Anna; Hall, H. Irene; Durant, Tonji] Ctr Dis Control & Prevent, Div HIV AIDS, Atlanta, GA 30333 USA; [Wei, Xiangming] McKing Consult Corp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Grigoryan, A (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS, Atlanta, GA 30333 USA.	ffg7@cdc.gov						Amato D., 1988, COMMUN STAT-THEOR M, V17, P143; Andersen R, 2000, HEALTH SERV RES, V35, P389; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2007, HIV AIDS SURV REP 20, V17; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Couturier E, 1998, AIDS, V12, P795, DOI 10.1097/00002030-199807000-00016; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jarlais DCD, 2004, JAIDS-J ACQ IMM DEF, V35, P158, DOI 10.1097/00126334-200402010-00010; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Manfredi R, 2002, DRUG AGING, V19, P647, DOI 10.2165/00002512-200219090-00003; Mitty JA, 2002, CLIN INFECT DIS, V34, P984, DOI 10.1086/339447; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; Muga R, 2004, J EPIDEMIOL COMMUN H, V58, P286, DOI 10.1136/jech.2003.010066; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Porter D, 2003, MOL CANCER RES, V1, P362; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; *US DEP HHS, 2008, GUID US ANT AG HIV 1; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wood E, 2003, CAN MED ASSOC J, V169, P656	29	54	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4445	10.1371/journal.pone.0004445	http://dx.doi.org/10.1371/journal.pone.0004445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JR	19214229	gold, Green Published			2022-12-27	WOS:000265484300004
J	Hildebrand, PW; Scheerer, P; Park, JH; Choe, HW; Piechnick, R; Ernst, OP; Hofmann, KP; Heck, M				Hildebrand, Peter W.; Scheerer, Patrick; Park, Jung Hee; Choe, Hui-Woog; Piechnick, Ronny; Ernst, Oliver P.; Hofmann, Klaus Peter; Heck, Martin			A Ligand Channel through the G Protein Coupled Receptor Opsin	PLOS ONE			English	Article								The G protein coupled receptor rhodopsin contains a pocket within its seven-transmembrane helix (TM) structure, which bears the inactivating 11-cis-retinal bound by a protonated Schiff-base to Lys296 in TM7. Light-induced 11-cis-/all-trans-isomerization leads to the Schiff-base deprotonated active Meta II intermediate. With Meta II decay, the Schiff-base bond is hydrolyzed, all-trans-retinal is released from the pocket, and the apoprotein opsin reloaded with new 11-cis-retinal. The crystal structure of opsin in its active Ops* conformation provides the basis for computational modeling of retinal release and uptake. The ligand-free 7TM bundle of opsin opens into the hydrophobic membrane layer through openings A (between TM1 and 7), and B (between TM5 and 6), respectively. Using skeleton search and molecular docking, we find a continuous channel through the protein that connects these two openings and comprises in its central part the retinal binding pocket. The channel traverses the receptor over a distance of ca. 70 angstrom and is between 11.6 and 3.2 angstrom wide. Both openings are lined with aromatic residues, while the central part is highly polar. Four constrictions within the channel are so narrow that they must stretch to allow passage of the retinal beta-ionone-ring. Constrictions are at openings A and B, respectively, and at Trp265 and Lys296 within the retinal pocket. The lysine enforces a 90 degrees elbow-like kink in the channel which limits retinal passage. With a favorable Lys side chain conformation, 11-cis-retinal can take the turn, whereas passage of the all-trans isomer would require more global conformational changes. We discuss possible scenarios for the uptake of 11-cis- and release of all-trans-retinal. If the uptake gate of 11-cis-retinal is assigned to opening B, all-trans is likely to leave through the same gate. The unidirectional passage proposed previously requires uptake of 11-cis-retinal through A and release of photolyzed all-trans-retinal through B.	[Hildebrand, Peter W.; Scheerer, Patrick; Park, Jung Hee; Piechnick, Ronny; Ernst, Oliver P.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University	Hildebrand, PW (corresponding author), Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany.	peter.hildebrand@charite.de		Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft [SFB 449, SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 449 and SFB 740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Hildebrand PW, 2004, FEBS LETT, V559, P145, DOI 10.1016/S0014-5793(04)00061-4; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MATSUMOTO H, 1978, VISION RES, V18, P607, DOI 10.1016/0042-6989(78)90212-2; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977	22	93	93	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4382	10.1371/journal.pone.0004382	http://dx.doi.org/10.1371/journal.pone.0004382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194506	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483600011
J	Doxiadis, GGM; Heijmans, CMC; Bonhomme, M; Otting, N; Crouau-Roy, B; Bontrop, RE				Doxiadis, Gaby G. M.; Heijmans, Corrine M. C.; Bonhomme, Maxime; Otting, Nel; Crouau-Roy, Brigitte; Bontrop, Ronald E.			Compound Evolutionary History of the Rhesus Macaque Mhc Class I B Region Revealed by Microsatellite Analysis and Localization of Retroviral Sequences	PLOS ONE			English	Article								In humans, the single polymorphic B locus of the major histocompatibility complex is linked to the microsatellite MIB. In rhesus macaques, however, haplotypes are characterized by the presence of unique combinations of multiple B genes, which may display different levels of polymorphism. The aim of the study was to shed light on the evolutionary history of this highly complex region. First, the robustness of the microsatellite MIB-linked to almost half of the B genes in rhesus macaques (Mamu-B)-for accurate B haplotyping was studied. Based on the physical map of an established haplotype comprising 7 MIB loci, each located next to a certain Mamu-B gene, two MIB loci, MIB1 and MIB6, were investigated in a panel of MHC homozygous monkeys. MIB1 revealed a complex genotyping pattern, whereas MIB6 analysis resulted in the detection of one or no amplicon. Both patterns are specific for a given B haplotype, show Mendelian segregation, and even allow a more precise haplotype definition than do traditional typing methods. Second, a search was performed for retroelements that may have played a role in duplication processes as observed in the macaque B region. This resulted in the description of two types of duplicons. One basic unit comprises an expressed Mamu-B gene, adjacent to an HERV16 copy closely linked to MIB. The second type of duplicon comprises a Mamu-B (pseudo) gene, linked to a truncated HERV16 structure lacking its MIB segment. Such truncation seems to coincide with the loss of B gene transcription. Subsequent to the duplication processes, recombination between MIB and Mamu-B loci appears to have occurred, resulting in a hyperplastic B region. Thus, analysis of MIB in addition to B loci allows deciphering of the compound evolutionary history of the class I B region in Old World monkeys.	[Doxiadis, Gaby G. M.; Heijmans, Corrine M. C.; Otting, Nel; Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, Rijswijk, Netherlands; [Bonhomme, Maxime; Crouau-Roy, Brigitte] Univ Paul Sabatier, Dept Evolut & Divers Biol, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Doxiadis, GGM (corresponding author), Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, Rijswijk, Netherlands.	doxiadis@bprc.nl	Bontrop, Ronald E/J-3628-2012; Bonhomme, Maxime/AAK-3263-2020; Bonhomme, Maxime/F-2962-2014; Bontrop, Ronald E./D-4844-2011	Bontrop, Ronald E/0000-0003-0874-6467; Bonhomme, Maxime/0000-0002-1210-4777; 	NIH/NIAID [HHSN266200400088C, 5R24RR016038-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by NIH/NIAID contract number HHSN266200400088C and 5R24RR016038-05. The funding organization played no active role in the study or preparation of the manuscript.	Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Bonhomme M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-514; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Bontrop RE, 2005, TRENDS IMMUNOL, V26, P227, DOI 10.1016/j.it.2005.02.003; Bontrop RE, 1999, IMMUNOL REV, V167, P339, DOI 10.1111/j.1600-065X.1999.tb01403.x; BONTROP RE, 1995, IMMUNOL REV, V143, P33, DOI 10.1111/j.1600-065X.1995.tb00669.x; BOYSON JE, 1995, IMMUNOGENETICS, V41, P59; Boyson JE, 1996, J IMMUNOL, V157, P5428; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; Clisson I, 2000, AM J PRIMATOL, V50, P205, DOI 10.1002/(SICI)1098-2345(200003)50:3<205::AID-AJP3>3.0.CO;2-Y; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; Doxiadis GGM, 2008, J VIROL, V82, P6667, DOI 10.1128/JVI.00097-08; Doxiadis GGM, 2006, P NATL ACAD SCI USA, V103, P5864, DOI 10.1073/pnas.0600643103; Grimaldi MC, 1996, HUM IMMUNOL, V51, P89, DOI 10.1016/S0198-8859(96)00228-5; Grimaldi MC, 1997, J MOL EVOL, V44, P336, DOI 10.1007/PL00006151; Karl JA, 2008, IMMUNOGENETICS, V60, P37, DOI 10.1007/s00251-007-0267-x; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kulski JK, 1999, J MOL EVOL, V48, P675, DOI 10.1007/PL00006511; Kulski JK, 2005, CYTOGENET GENOME RES, V110, P181, DOI 10.1159/000084951; Kulski JK, 2004, MOL BIOL EVOL, V21, P2079, DOI 10.1093/molbev/msh216; Kulski JK, 1999, J MOL EVOL, V49, P84, DOI 10.1007/PL00006537; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; OTTING N, 1993, IMMUNOGENETICS, V38, P141; Otting N, 2008, IMMUNOGENETICS, V60, P507, DOI 10.1007/s00251-008-0311-5; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Shiina T, 2006, GENETICS, V173, P1555, DOI 10.1534/genetics.106.057034; SLIERENDREGT BL, 1995, INT IMMUNOL, V7, P1671, DOI 10.1093/intimm/7.10.1671; Urvater JA, 2000, J IMMUNOL, V164, P1386, DOI 10.4049/jimmunol.164.3.1386; Vierboom MPM, 2005, ARTHRITIS RES THER, V7, P145, DOI 10.1186/ar1773; Vogel TU, 1999, IMMUNOL REV, V167, P327, DOI 10.1111/j.1600-065X.1999.tb01402.x	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4287	10.1371/journal.pone.0004287	http://dx.doi.org/10.1371/journal.pone.0004287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172173	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482900007
J	Sabado, RL; Kavanagh, DG; Kaufmann, DE; Fru, K; Babcock, E; Rosenberg, E; Walker, B; Lifson, J; Bhardwaj, N; Larsson, M				Sabado, Rachel Lubong; Kavanagh, Daniel G.; Kaufmann, Daniel E.; Fru, Karlhans; Babcock, Ethan; Rosenberg, Eric; Walker, Bruce; Lifson, Jeffrey; Bhardwaj, Nina; Larsson, Marie			In Vitro Priming Recapitulates In Vivo HIV-1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4(+) T Cells in Acute HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; CROSS-PRESENTATION; CD8(+); VACCINE; LYMPHOCYTES; ACTIVATION; MATURATION; INDUCTION; ANTIGENS	Background: The requirements for priming of HIV-specific T cell responses initially seen in infected individuals remain to be defined. Activation of T cell responses in lymph nodes requires cell-cell contact between T cells and DCs, which can give concurrent activation of T cells and HIV transmission. Methodology: The study aim was to establish whether DCs pulsed with HIV-1 could prime HIV-specific T cell responses and to characterize these responses. Both infectious and aldrithiol-2 inactivated noninfectious HIV-1 were compared to establish efficiencies in priming and the type of responses elicited. Findings: Our findings show that both infectious and inactivated HIV-1 pulsed DCs can prime HIV-specific responses from naive T cells. Responses included several CD4(+) and CD8(+) T cell epitopes shown to be recognized in vivo by acutely and chronically infected individuals and some CD4(+) T cell epitopes not identified previously. Follow up studies of acute and recent HIV infected samples revealed that these latter epitopes are among the earliest recognized in vivo, but the responses are lost rapidly, presumably through activation-induced general CD4(+) T cell depletion which renders the newly activated HIV-specific CD4(+) T cells prime targets for elimination. Conclusion: Our studies highlight the ability of DCs to efficiently prime naive T cells and induce a broad repertoire of HIV-specific responses and also provide valuable insights to the pathogenesis of HIV-1 infection in vivo.	[Babcock, Ethan; Bhardwaj, Nina] NYU, Sch Med, New York, NY 10003 USA; [Kavanagh, Daniel G.; Kaufmann, Daniel E.; Rosenberg, Eric; Walker, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, PARC, Charlestown, MA USA; [Lifson, Jeffrey] NCI, NIH, SAIC Fredrick Inc, Frederick, MD USA; [Fru, Karlhans; Larsson, Marie] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden	New York University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Linkoping University	Sabado, RL (corresponding author), NYU, Sch Med, New York, NY 10003 USA.	marla@imk.liu.se		Larsson, Marie/0000-0002-4524-0177; Bhardwaj, Nina/0000-0003-1865-4187	The Swedish Research Council; The Swedish, Physicians against AIDS research Foundation; The Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University hospital research Fund; C ALF; The Swedish Society of Medicine; Emerald Foundation; Burroughs Wellcome; Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation; Center for HIV/AIDS Vaccine Initiative (CHAVI); NIH [AI52731, AI55274, AI61684, AI57127, AI44628]; National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, R01AI052731, R01AI061684, R21AI055274, R01AI044628, F32AI058457, P01AI057127, R37AI052731] Funding Source: NIH RePORTER	The Swedish Research Council(Swedish Research Council); The Swedish, Physicians against AIDS research Foundation; The Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University hospital research Fund; C ALF; The Swedish Society of Medicine; Emerald Foundation; Burroughs Wellcome(Burroughs Wellcome Fund); Elizabeth Glaser Pediatric AIDS Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center for HIV/AIDS Vaccine Initiative (CHAVI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All below funders have provided funding for performing this study. This work has been supported by grants through: ML: AI52731, The Swedish Research Council, The Swedish, Physicians against AIDS research Foundation, The Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University hospital research Fund, C ALF, and The Swedish Society of Medicine. NB: Emerald Foundation, Burroughs Wellcome, Elizabeth Glaser Pediatric AIDS Foundation, Bill and Melinda Gates Foundation and the Center for HIV/AIDS Vaccine Initiative (CHAVI) and NIH grants AI52731, AI55274, AI61684, AI57127, and AI44628. JL: with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Addo MM, 2002, AIDS, V16, P1071, DOI 10.1097/00002030-200205030-00015; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; BEBENEK K, 1993, MOL PHARMACOL, V43, P57; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BERZOFSKY JA, 1988, NATURE, V334, P706, DOI 10.1038/334706a0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Engelmayer J, 2001, J VIROL, V75, P2142, DOI 10.1128/JVI.75.5.2142-2153.2001; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang XL, 2003, J INFECT DIS, V187, P315, DOI 10.1086/346054; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Karlsson H, 2004, INFECT IMMUN, V72, P2671, DOI 10.1128/IAI.72.5.2671-2678.2004; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kent SJ, 1997, J IMMUNOL, V158, P807; Larsson M, 2003, CURR TOP MICROBIOL, V276, P261; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; LARSSON M, 2004, SPRINGER SEMIN IMMUN; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Malhotra U, 2003, J VIROL, V77, P2663, DOI 10.1128/JVI.77.4.2663-2674.2003; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; OTT DE, 1995, J VIROL, V69, P2443, DOI 10.1128/JVI.69.4.2443-2450.1995; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Palmer BE, 2004, J IMMUNOL, V172, P3337, DOI 10.4049/jimmunol.172.5.3337; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1998, AIDS RES HUM RETROV, V14, pS143; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Saito H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1621; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Walsh SR, 2003, CURR HIV RES, V1, P205, DOI 10.2174/1570162033485285; Wilson CC, 1999, J IMMUNOL, V162, P3070; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Zarling AL, 1999, J IMMUNOL, V162, P5197; Zaunders JJ, 2005, BLOOD, V106, P1660, DOI 10.1182/blood-2005-01-0206; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	63	37	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4256	10.1371/journal.pone.0004256	http://dx.doi.org/10.1371/journal.pone.0004256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165342	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482400004
J	Sowa, NA; Vadakkan, KI; Zylka, MJ				Sowa, Nathaniel A.; Vadakkan, Kunjumon I.; Zylka, Mark J.			Recombinant Mouse PAP Has pH-Dependent Ectonucleotidase Activity and Acts through A(1)-Adenosine Receptors to Mediate Antinociception	PLOS ONE			English	Article							PROSTATIC ACID-PHOSPHATASE; ADENOSINE KINASE-INHIBITOR; SITE-DIRECTED MUTAGENESIS; NEUROPATHIC PAIN; SPINAL MICROGLIA; THERMAL HYPERALGESIA; ALLODYNIA; ENZYME; SPECIFICITY; NOCICEPTION	Prostatic acid phosphatase (PAP) is expressed in nociceptive neurons and functions as an ectonucleotidase. When injected intraspinally, the secretory isoforms of human and bovine PAP protein have potent and long-lasting antinociceptive effects that are dependent on A(1)-adenosine receptor (A(1)R) activation. In this study, we purified the secretory isoform of mouse (m) PAP using the baculovirus expression system to determine if recombinant mPAP also had antinociceptive properties. We found that mPAP dephosphorylated AMP, and to a much lesser extent, ADP at neutral pH (pH 7.0). In contrast, mPAP dephosphorylated all purine nucleotides (AMP, ADP, ATP) at an acidic pH (pH 5.6). The transmembrane isoform of mPAP had similar pH-dependent ectonucleotidase activity. A single intraspinal injection of mPAP protein had long-lasting (three day) antinociceptive properties, including antihyperalgesic and antiallodynic effects in the Complete Freund's Adjuvant (CFA) inflammatory pain model. These antinociceptive effects were transiently blocked by the A1R antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX), suggesting mPAP dephosphorylates nucleotides to adenosine to mediate antinociception just like human and bovine PAP. Our studies indicate that PAP has species-conserved antinociceptive effects and has pH-dependent ectonucleotidase activity. The ability to metabolize nucleotides in a pH-dependent manner could be relevant to conditions like inflammation where tissue acidosis and nucleotide release occur. Lastly, our studies demonstrate that recombinant PAP protein can be used to treat chronic pain in animal models.	[Sowa, Nathaniel A.; Vadakkan, Kunjumon I.; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Sowa, NA (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	Vadakkan, Kunjumon/A-3254-2008	Vadakkan, Kunjumon/0000-0002-2721-6931	UNC; The Sloan Foundation; The Searle Scholars Program; The Klingenstein Foundation; The Whitehall Foundation; Rita Allen Foundation [Milton E. Cassel Scholar]; NINDS [R01NS060725, F30NS063507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, F30NS063507] Funding Source: NIH RePORTER	UNC; The Sloan Foundation(Alfred P. Sloan Foundation); The Searle Scholars Program; The Klingenstein Foundation(Klingenstein Philanthropies); The Whitehall Foundation; Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by UNC startup funds, grants to M.J.Z. from The Sloan Foundation, The Searle Scholars Program, The Klingenstein Foundation, The Whitehall Foundation, Rita Allen Foundation and NINDS (R01NS060725), a grant to N.A.S. from NINDS (F30NS063507). M.J.Z. is a Rita Allen Foundation Milton E. Cassel Scholar. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Belfrage M, 1999, ANESTH ANALG, V89, P136, DOI 10.1097/00000539-199907000-00023; Burch PA, 2004, PROSTATE, V60, P197, DOI 10.1002/pros.20040; Burch PA, 2000, CLIN CANCER RES, V6, P2175; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; DODD J, 1983, COLD SPRING HARB SYM, V48, P685, DOI 10.1101/SQB.1983.048.01.072; DORR RT, 1993, DRUGS, V45, P177, DOI 10.2165/00003495-199345020-00003; DZIEMBOR E, 1971, ACTA BIOCHIM POL, V18, P249; DZIEMBORGRYSZKIEWICZ E, 1978, B ACAD POL SCI BIOL, V26, P815; Eisenach JC, 2003, PAIN, V105, P65, DOI 10.1016/S0304-3959(03)00158-1; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashida Masakazu, 2005, J Anesth, V19, P225, DOI 10.1007/s00540-005-0310-8; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jakob CG, 2000, PROSTATE, V42, P211, DOI 10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U; Jarvis MF, 2002, PHARMACOL BIOCHEM BE, V73, P573, DOI 10.1016/S0091-3057(02)00840-7; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KEIL GJ, 1992, LIFE SCI, V51, pPL171, DOI 10.1016/0024-3205(92)90566-8; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; LAM KW, 1973, CLIN CHEM, V19, P483; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lavand'homme PM, 1999, PAIN, V80, P31, DOI 10.1016/S0304-3959(98)00193-6; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; OSTANIN K, 1994, J BIOL CHEM, V269, P8971; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; POON A, 1995, EUR J PHARMACOL, V286, P177, DOI 10.1016/0014-2999(95)00444-P; Poon A, 1998, PAIN, V74, P235, DOI 10.1016/S0304-3959(97)00186-3; PORVARI KS, 1994, J BIOL CHEM, V269, P22642; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; Rodriguez-Nunez A, 2000, BRAIN DEV-JPN, V22, P427, DOI 10.1016/S0387-7604(00)00172-8; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; Sawynok J, 2007, Handb Exp Pharmacol, P309; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; SYKOVA E, 1990, BRAIN RES, V512, P181, DOI 10.1016/0006-8993(90)90625-L; SYKOVA E, 1988, CIBA F SYMP, V139, P220; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; VIHKO P, 1978, CLIN CHEM, V24, P1783; VIHKO P, 1979, INVEST UROL, V16, P349; VIHKO P, 1993, P NATL ACAD SCI USA, V90, P799, DOI 10.1073/pnas.90.3.799; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie John A., 2008, P661, DOI 10.1007/978-0-387-77232-5_22; Wu WP, 2005, PAIN, V113, P395, DOI 10.1016/j.pain.2004.11.020; Zucchini S, 2008, CURR OPIN INVEST DR, V9, P396; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	52	34	35	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4248	10.1371/journal.pone.0004248	http://dx.doi.org/10.1371/journal.pone.0004248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158948	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482200005
J	Aabye, MG; Ravn, P; PrayGod, G; Jeremiah, K; Mugomela, A; Jepsen, M; Faurholt, D; Range, N; Friis, H; Changalucha, J; Andersen, AB				Aabye, Martine G.; Ravn, Pernille; PrayGod, George; Jeremiah, Kidola; Mugomela, Apolinary; Jepsen, Maria; Faurholt, Daniel; Range, Nyagosya; Friis, Henrik; Changalucha, John; Andersen, Aase B.			The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							WHOLE-BLOOD; LATENT TUBERCULOSIS; SKIN-TEST; T-CELLS; ACTIVE TUBERCULOSIS; INDIVIDUALS; SENSITIVITY; DIAGNOSIS; ADULTS; PREVALENCE	Background: The performance of the tuberculosis specific Interferon Gamma Release Assays (IGRAs) has not been sufficiently documented in tuberculosis-and HIV-endemic settings. This study evaluated the sensitivity of the QuantiFERON TB-Gold In-Tube (QFT-IT) in patients with culture confirmed pulmonary tuberculosis (PTB) in a TB-and HIV-endemic population and the effect of HIV-infection and CD4 cell count on test performance. Methodology/Principal Findings: 161 patients with sputum culture confirmed PTB were subjected to HIV- and QFT-IT testing and measurement of CD4 cell count. The QFT-IT was positive in 74% (119/161; 95% CI: 67-81%). Sensitivity was higher in HIV-negative (75/93) than in HIV-positive (44/68) patients (81% vs. 65%, p = 0.02) and increased with CD4 cell count in HIV-positive patients (test for trend p = 0.03). 23 patients (14%) had an indeterminate result and this proportion decreased with increasing CD4 cell count in HIV-positive patients (test for trend p = 0.03). Low CD4 cell count (<300 cells/ml) did not account for all QFT-IT indeterminate nor all negative results. Sensitivity when excluding indeterminate results was 86% (95% CI: 81-92%) and did not differ between HIV-negative and HIV-positive patients (88 vs. 83%, p = 0.39). Conclusions/Significance: Sensitivity of the QFT-IT for diagnosing active PTB infection was reasonable when excluding indeterminate results and in HIV-negative patients. However, since the test missed more than 10% of patients, its potential as a rule-out test for active TB disease is limited. Furthermore, test performance is impaired by low CD4 cell count in HIV-positive patients and possibly by other factors as well in both HIV-positive and HIV-negative patients. This might limit the potential of the test in populations where HIV-infection is prevalent.	[Andersen, Aase B.] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Ravn, Pernille] Univ Copenhagen, Herlev Hosp, Unit Infect Dis Q, DK-1168 Copenhagen, Denmark; [PrayGod, George; Jeremiah, Kidola; Changalucha, John] Mwanza Med Res Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Mugomela, Apolinary] Bugando Med Ctr, Zonal TB Reference Lab, Mwanza, Tanzania; [Jepsen, Maria; Faurholt, Daniel; Friis, Henrik] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Frederiksberg, Denmark; [Range, Nyagosya] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; National Institute of Medical Research; University of Copenhagen; National Institute of Medical Research	Aabye, MG (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	martine@aabye.com	Friis, Henrik/N-2047-2014; Faurholt-Jepsen, Daniel/D-9453-2012; Friis, Henrik/P-2891-2019; Faurholt-Jepsen, Daniel/M-6324-2019; PrayGod, George/L-7098-2018	Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Jeremiah, Kidola/0000-0001-7900-9689; Andersen, Aase Bengaard/0000-0003-4779-7603; PrayGod, George/0000-0002-0329-4839	Danish Council for Medical Research	Danish Council for Medical Research	The study was funded by the Danish Council for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; BAKIR M, 2008, ANN INTERN MED; Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; de Leon DP, 2008, J RHEUMATOL, V35, P776; DIEL R, 2008, CHEST; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Jones S, 2007, INT J TUBERC LUNG D, V11, P1190; Kanunfre KA, 2008, CLIN VACCINE IMMUNOL, V15, P1028, DOI 10.1128/CVI.00026-08; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kobashi Y, 2008, INTERNAL MED, V47, P237, DOI 10.2169/internalmedicine.47.0389; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LUETKEMEYER AF, 2007, AM J RESP CRIT CARE; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Menzies D, 2008, ANN INTERN MED, V148, P398, DOI 10.7326/0003-4819-148-5-200803040-00011; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; PAI M, 2008, ANN INTERN MED; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Ramarokoto H, 2002, INT J TUBERC LUNG D, V6, P909; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Range N, 2007, ANN TROP MED PARASIT, V101, P343, DOI 10.1179/136485907X176373; Rathman G, 2003, INT J TUBERC LUNG D, V7, P942; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; *US FDA, 2007, PREM APPR DAT QUANT; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; WHO, 2004, INT POL COLL TB HIV; *WHO, 2005, COUNTR PROF UN REP T; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	43	73	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4220	10.1371/journal.pone.0004220	http://dx.doi.org/10.1371/journal.pone.0004220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156218	gold, Green Published, Green Submitted			2022-12-27	WOS:000265481900003
J	Kelly, TK; Karsten, SL; Geschwind, DH; Kornblum, HI				Kelly, Theresa K.; Karsten, Stanislav L.; Geschwind, Daniel H.; Kornblum, Harley I.			Cell Lineage and Regional Identity of Cultured Spinal Cord Neural Stem Cells and Comparison to Brain-Derived Neural Stem Cells	PLOS ONE			English	Article								Neural stem cells (NSCs) can be isolated from different regions of the central nervous system. There has been controversy whether regional differences amongst stem and progenitor cells are cell intrinsic and whether these differences are maintained during expansion in culture. The identification of inherent regional differences has important implications for the use of these cells in neural repair. Here, we compared NSCs derived from the spinal cord and embryonic cortex. We found that while cultured cortical and spinal cord derived NSCs respond similarly to mitogens and are equally neuronogenic, they retain and maintain through multiple passages gene expression patterns indicative of the region from which they were isolated (e.g Emx2 and HoxD10). Further microarray analysis identified 229 genes that were differentially expressed between cortical and spinal cord derived neurospheres, including many Hox genes, Nuclear receptors, Irx3, Pace4, Lhx2, Emx2 and Ntrk2. NSCs in the cortex express LeX. However, in the embryonic spinal cord there are two lineally related populations of NSCs: one that expresses LeX and one that does not. The LeX negative population contains few markers of regional identity but is able to generate LeX expressing NSCs that express markers of regional identity. LeX positive cells do not give rise to LeX-negative NSCs. These results demonstrate that while both embryonic cortical and spinal cord NSCs have similar self-renewal properties and multipotency, they retain aspects of regional identity, even when passaged long-term in vitro. Furthermore, there is a population of a LeX negative NSC that is present in neurospheres derived from the embryonic spinal cord but not the cortex.	[Kelly, Theresa K.; Geschwind, Daniel H.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA; [Kelly, Theresa K.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90024 USA; [Karsten, Stanislav L.] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Dept Neurol, Div Neurosci Res, Los Angeles, CA 90024 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90024 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharm Psychiat Pediat & Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kelly, TK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA.	hkornblum@mednet.ucla.edu	kelly, theresa/E-3624-2010; Karsten, Stan/AAI-4076-2021	Karsten, Stanislav/0000-0001-7387-4874	Miriam and Sheldon Adelson Program for Neural Repair and Rehabilitation; The Ron Shapiro Foundation; NIMH [MH065756]; The Roman-Reed Research Foundation; Mental Retardation Research Fellowship [5T32HD007032-028];  [5T32NS007449-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007449] Funding Source: NIH RePORTER	Miriam and Sheldon Adelson Program for Neural Repair and Rehabilitation; The Ron Shapiro Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); The Roman-Reed Research Foundation; Mental Retardation Research Fellowship; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Miriam and Sheldon Adelson Program for Neural Repair and Rehabilitation, The Ron Shapiro Foundation and NIMH grant MH065756. TKK was supported by training grant for Neural Repair 5T32NS007449-10, The Roman-Reed Research Foundation and a Mental Retardation Research Fellowship 5T32HD007032-028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell KWS, 1997, ANAT EMBRYOL, V196, P13, DOI 10.1007/s004290050076; BARTSCH D, 1991, CELL TISSUE RES, V263, P353, DOI 10.1007/BF00318777; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Brock SC, 1998, METHODS, V16, P268, DOI 10.1006/meth.1998.0684; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Dennis C, 2003, NATURE, V421, P877, DOI 10.1038/421877a; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Herault Y, 1998, DEVELOPMENT, V125, P1669; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Horiguchi S, 2004, J NEUROSCI RES, V75, P817, DOI 10.1002/jnr.20046; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.0.CO;2-G; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Kim M, 2003, J NEUROSCI, V23, P10703; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Kornblum HI, 2001, NAT REV NEUROSCI, V2, P843, DOI 10.1038/35097597; Kukekov VG, 1997, GLIA, V21, P399, DOI 10.1002/(SICI)1098-1136(199712)21:4<399::AID-GLIA7>3.0.CO;2-Z; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Na E, 1998, CURR BIOL, V8, P987, DOI 10.1016/S0960-9822(98)70403-8; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; NORNES HO, 1972, P NATL ACAD SCI USA, V69, P1962, DOI 10.1073/pnas.69.7.1962; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Pluchino S, 2005, BRAIN RES REV, V48, P211, DOI 10.1016/j.brainresrev.2004.12.011; Qian XM, 1998, DEVELOPMENT, V125, P3143; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Santa-Olalla J, 2003, EUR J NEUROSCI, V18, P1073, DOI 10.1046/j.1460-9568.2003.02824.x; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Singh SK, 2003, CANCER RES, V63, P5821; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Verdugo RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-58; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Watanabe K, 2004, DEV NEUROSCI-BASEL, V26, P275, DOI 10.1159/000082144; Weiss S, 1996, J NEUROSCI, V16, P7599; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yang H, 2000, P NATL ACAD SCI USA, V97, P13366, DOI 10.1073/pnas.97.24.13366; Zappone MV, 2000, DEVELOPMENT, V127, P2367	61	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4213	10.1371/journal.pone.0004213	http://dx.doi.org/10.1371/journal.pone.0004213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148290	gold, Green Published, Green Submitted			2022-12-27	WOS:000265479900007
J	Martinand-Mari, C; Maury, B; Rousset, F; Sahuquet, A; Mennessier, G; Rochal, S; Lorman, V; Mangeat, P; Baghdiguian, S				Martinand-Mari, Camille; Maury, Benoit; Rousset, Francois; Sahuquet, Alain; Mennessier, Gerard; Rochal, Sergei; Lorman, Vladimir; Mangeat, Paul; Baghdiguian, Stephen			Topological Control of Life and Death in Non-Proliferative Epithelia	PLOS ONE			English	Article								Programmed cell death is one of the most fascinating demonstrations of the plasticity of biological systems. It is classically described to act upstream of and govern major developmental patterning processes (e. g. inter-digitations in vertebrates, ommatidia in Drosophila). We show here the first evidence that massive apoptosis can also be controlled and coordinated by a pre-established pattern of a specific 'master cell' population. This new concept is supported by the development and validation of an original model of cell patterning. Ciona intestinalis eggs are surrounded by a three-layered follicular organization composed of 60 elongated floating extensions made of as many outer and inner cells, and indirectly spread through an extracellular matrix over 1200 test cells. Experimental and selective ablation of outer and inner cells results in the abrogation of apoptosis in respective remaining neighbouring test cells. In addition incubation of outer/inner follicular cell-depleted eggs with a soluble extract of apoptotic outer/inner cells partially restores apoptosis to apoptotic-defective test cells. The 60 inner follicular cells were thus identified as 'apoptotic master' cells which collectively are induction sites for programmed cell death of the underlying test cells. The position of apoptotic master cells is controlled by topological constraints exhibiting a tetrahedral symmetry, and each cell spreads over and can control the destiny of 20 smaller test cells, which leads to optimized apoptosis signalling.	[Martinand-Mari, Camille; Maury, Benoit; Rousset, Francois; Baghdiguian, Stephen] Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR 5554, Montpellier, France; [Sahuquet, Alain; Mangeat, Paul] Univ Montpellier 2, CNRS 5327, CRBM, UMR, F-34095 Montpellier, France; [Mennessier, Gerard; Lorman, Vladimir] Univ Montpellier 2, CNRS 5207, LPTA, UMR, F-34095 Montpellier, France; [Rochal, Sergei] S Fed Univ, Fac Phys, Rostov Na Donu, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Southern Federal University	Martinand-Mari, C (corresponding author), Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR 5554, Montpellier, France.	stbaghdi@univ-montp2.fr	Rousset, Francois/GRJ-3980-2022; Rousset, Francois/C-7360-2008; Rochal, Sergei/AAY-3323-2020	Rousset, Francois/0000-0003-4670-0371; Rousset, Francois/0000-0003-4670-0371; Rochal, Sergei/0000-0001-6135-0440; Baghdiguian, Stephen/0000-0002-2992-9708	programme interdisciplinaire Interface Physique Chimie Biologie; CNRS; Comite Herault de la Ligue Nationale Contre le Cancer	programme interdisciplinaire Interface Physique Chimie Biologie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Comite Herault de la Ligue Nationale Contre le Cancer	Funding was from programme interdisciplinaire Interface Physique Chimie Biologie : soutien a la prise de risque du CNRS and Comite Herault de la Ligue Nationale Contre le Cancer to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULER EL, 1994, PHYS REV LETT, V72, P2671, DOI 10.1103/PhysRevLett.72.2671; Baghdiguian S, 2007, SEMIN CANCER BIOL, V17, P147, DOI 10.1016/j.semcancer.2006.11.005; Bates WR, 2004, ZOOL SCI, V21, P553, DOI 10.2108/zsj.21.553; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; Chambon JP, 2002, DEVELOPMENT, V129, P3105; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Cox DR, 1974, THEORETICAL STAT; Coxeter H. S. M., 1969, INTRO GEOMETRY; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; ERBER T, 1991, J PHYS A-MATH GEN, V24, pL1369, DOI 10.1088/0305-4470/24/23/008; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Jeffery WR, 2002, MECH DEVELOP, V118, P111, DOI 10.1016/S0925-4773(02)00236-8; Lauzon RJ, 2007, DEV BIOL, V301, P92, DOI 10.1016/j.ydbio.2006.08.055; Lorman VL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.185502; Maury B, 2006, DEV BIOL, V289, P152, DOI 10.1016/j.ydbio.2005.10.021; Morris JR, 1996, PHYS REV B, V53, pR1740, DOI 10.1103/PhysRevB.53.R1740; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Satoh N., 1994, DEV BIOL ASCIDIANS; SLOANE NJA, 2004, SPHERICAL CODES NICE; SUGINO YM, 1987, J EXP ZOOL, V242, P205, DOI 10.1002/jez.1402420212; Takada N, 2005, APOPTOSIS, V10, P1211, DOI 10.1007/s10495-005-1391-4; TAMMES PML, 1930, REC TRAV BOT NEERL, P1; Tarallo R, 2004, DEV DYNAM, V230, P251, DOI 10.1002/dvdy.20055; Tarnai T, 2002, STRUCT CHEM, V13, P289, DOI 10.1023/A:1015859822819; Terajima D, 2003, CELL DEATH DIFFER, V10, P749, DOI 10.1038/sj.cdd.4401223; Thompson D. W., 1917, GROWTH FORM; Thomson JJ, 1904, PHILOS MAG, V7, P237, DOI 10.1080/14786440409463107; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Voskoboynik A, 2004, J EXP BIOL, V207, P2409, DOI 10.1242/jeb.01045	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4202	10.1371/journal.pone.0004202	http://dx.doi.org/10.1371/journal.pone.0004202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145253	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479800008
J	Hirose, T; Satoh, D; Kurihara, H; Kusaka, C; Hirose, H; Akimoto, K; Matsusaka, T; Ichikawa, I; Noda, T; Ohno, S				Hirose, Tomonori; Satoh, Daisuke; Kurihara, Hidetake; Kusaka, Chiho; Hirose, Hiroko; Akimoto, Kazunori; Matsusaka, Taiji; Ichikawa, Iekuni; Noda, Tetsuo; Ohno, Shigeo			An Essential Role of the Universal Polarity Protein, aPKC lambda, on the Maintenance of Podocyte Slit Diaphragms	PLOS ONE			English	Article								Glomerular visceral epithelial cells (podocytes) contain interdigitated processes that form specialized intercellular junctions, termed slit diaphragms, which provide a selective filtration barrier in the renal glomerulus. Analyses of disease-causing mutations in familial nephrotic syndromes and targeted mutagenesis in mice have revealed critical roles of several proteins in the assembly of slit diaphragms. The nephrin-podocin complex is the main constituent of slit diaphragms. However, the molecular mechanisms regulating these proteins to maintain the slit diaphragms are still largely unknown. Here, we demonstrate that the PAR3-atypical protein kinase C (aPKC) -PAR6 beta cell polarity proteins co-localize to the slit diaphragms with nephrin. Furthermore, selective depletion of aPKC lambda in mouse podocytes results in the disassembly of slit diaphragms, a disturbance in apico-basal cell polarity, and focal segmental glomerulosclerosis (FSGS). The aPKC-PAR3 complex associates with the nephrin-podocin complex in podocytes through direct interaction between PAR3 and nephrin, and the kinase activity of aPKC is required for the appropriate distribution of nephrin and podocin in podocytes. These observations not only establish a critical function of the polarity proteins in the maintenance of slit diaphragms, but also imply their potential involvement in renal failure in FSGS.	[Hirose, Tomonori; Satoh, Daisuke; Kusaka, Chiho; Hirose, Hiroko; Akimoto, Kazunori; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Kanagawa, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Tokyo, Japan; [Matsusaka, Taiji] Tokai Univ, Sch Med, Inst Med Sci, Hiratsuka, Kanagawa 25912, Japan; [Ichikawa, Iekuni] Tokai Univ, Sch Med, Dept Bioeth, Hiratsuka, Kanagawa 25912, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Canc Inst, Dept Cell Biol, Tokyo, Japan; [Ohno, Shigeo] Yokohama City Univ, Advanced Med Res Ctr, Yokohama, Kanagawa, Japan	Yokohama City University; Juntendo University; Tokai University; Tokai University; Japanese Foundation for Cancer Research; Yokohama City University	Hirose, T (corresponding author), Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Kanagawa, Japan.	ohnos@med.yokohama-cu.ac.jp	Ohno, Shigeo/B-1768-2010; Noda, Tetsuo/B-1667-2016; Hirose, Tomonori/M-8872-2019; Hirose, Tomonori/F-6015-2010	Ohno, Shigeo/0000-0002-1294-5269; Hirose, Tomonori/0000-0003-2428-0919; Hirose, Tomonori/0000-0003-2428-0919	Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science; Mitsubishi Foundation	Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation	This work was supported by the Yokohama City University Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This work was also supported in part by grants from the Japan Society for the Promotion of Science, by grants from MEXT, and by the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, J AM SOC NEPHROL, V16, P2257, DOI 10.1681/ASN.2004121134; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; KURIHARA H, 1992, AM J PATHOL, V141, P805; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	38	55	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4194	10.1371/journal.pone.0004194	http://dx.doi.org/10.1371/journal.pone.0004194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142224	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700014
J	Tuvim, MJ; Evans, SE; Clement, CG; Dickey, BF; Gilbert, BE				Tuvim, Michael J.; Evans, Scott E.; Clement, Cecilia G.; Dickey, Burton F.; Gilbert, Brian E.			Augmented Lung Inflammation Protects against Influenza A Pneumonia	PLOS ONE			English	Article								Background: Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people. Influenza-related mortality has been variously ascribed to an ineffective host response that fails to limit viral replication, an excessive host inflammatory response that results in lung injury and impairment of gas exchange, or to bacterial superinfection. We sought to determine whether lung inflammation promoted or impaired host survival in influenza pneumonia. Methods and Findings: To distinguish among these possible causes of influenza-related death, we induced robust lung inflammation by exposing mice to an aerosolized bacterial lysate prior to challenge with live virus. The treatment induced expression of the inflammatory cytokines IL-6 and TNF in bronchoalveolar lavage fluid 8- and 40-fold greater, respectively, than that caused by lethal influenza infection. Yet, this augmented inflammation was associated with striking resistance to host mortality (0% vs 90% survival, p = 0.0001) and reduced viral titers (p = 0.004). Bacterial superinfection of virus infected lungs was not observed. When mice were repeatedly exposed to the bacterial lysate, as would be clinically desirable during an influenza epidemic, there was no tachyphylaxis of the induced viral resistance. When the bacterial lysate was administered after the viral challenge, there was still some mortality benefit, and when ribavirin was added to the aerosolized bacterial lysate, host survival was synergistically improved (0% vs 93.3% survival, p < 0.0001). Conclusions: Together, these data indicate that innate immune resistance to influenza can be effectively stimulated, and suggest that ineffective rather than excessive inflammation is the major cause of mortality in influenza pneumonia.	[Tuvim, Michael J.; Evans, Scott E.; Clement, Cecilia G.; Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Tuvim, Michael J.; Evans, Scott E.; Dickey, Burton F.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Lung Inflammat & Infect, Houston, TX USA; [Gilbert, Brian E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine	Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	seevans@mdanderson.org	Clement, Cecilia/AAP-1141-2020	Tuvim, Michael/0000-0001-8126-7716; Dickey, Burton/0000-0002-4780-1847; Evans, Scott/0000-0003-4503-0644	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-15437]; National Center for Research Resources, National Institutes of Health [KL2-RR-02419]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002419] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by contract N01-AI-15437 from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health to Dr. Gilbert. Dr Evans is supported by KL2-RR-02419 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Budd A, 2007, ANTIMICROB AGENTS CH, V51, P2965, DOI 10.1128/AAC.00219-07; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garcia-Sastre A, 2006, EMERG INFECT DIS, V12, P44, DOI 10.3201/eid1201.051186; GILBERT BE, 1992, ANTIVIR RES, V17, P33, DOI 10.1016/0166-3542(92)90088-M; Gilbert BE, 2008, ANTIVIR RES, V78, P223, DOI 10.1016/j.antiviral.2008.01.005; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Hillman MR, 2002, VACCINE, V20, P3055, DOI 10.1016/S0264-410X(02)00300-6; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Joos Ladina, 2005, Proc Am Thorac Soc, V2, P445, DOI 10.1513/pats.200508-097JS; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x; World Health Organization, 2004, WORLD HLTH REP 2004; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	30	82	86	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4176	10.1371/journal.pone.0004176	http://dx.doi.org/10.1371/journal.pone.0004176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137067	gold, Green Published			2022-12-27	WOS:000265479500007
J	Georgette, NT				Georgette, Nathan T.			Predicting the Herd Immunity Threshold during an Outbreak: A Recursive Approach	PLOS ONE			English	Article							MEASLES OUTBREAK; REPRODUCTION NUMBERS; REAL-TIME; IMMUNIZATION; EPIDEMIOLOGY	Background: The objective was to develop a novel algorithm that can predict, based on field survey data, the minimum vaccination coverage required to reduce the mean number of infections per infectious individual to less than one (the Outbreak Response Immunization Threshold or ORIT) from up to six days in the advance. Methodology/Principal Findings: First, the relationship between the rate of immunization and the ORIT was analyzed to establish a link. This relationship served as the basis for the development of a recursive algorithm that predicts the ORIT using survey data from two consecutive days. The algorithm was tested using data from two actual measles outbreaks. The prediction day difference (PDD) was defined as the number of days between the second day of data input and the day of the prediction. The effects of different PDDs on the prediction error were analyzed, and it was found that a PDD of 5 minimized the error in the prediction. In addition, I developed a model demonstrating the relationship between changes in the vaccination coverage and changes in the individual reproduction number. Conclusions/Significance: The predictive algorithm for the ORIT generates a viable prediction of the minimum number of vaccines required to stop an outbreak in real time. With this knowledge, the outbreak control agency may plan to expend the lowest amount of funds required stop an outbreak, allowing the diversion of the funds saved to other areas of medical need.	Allen D Nease High Sch, Dept Sci, Ponte Vedra, FL USA		Georgette, NT (corresponding author), Allen D Nease High Sch, Dept Sci, Ponte Vedra, FL USA.	ntg2009@bellsouth.net						ANDERSON R M, 1991; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; *CDCP, 2003, VACC MAN HANDL STOR; Develin M, 2007, DISCRETE APPL MATH, V155, P2257, DOI 10.1016/j.dam.2007.06.002; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Farrington CP, 2003, BIOSTATISTICS, V4, P621, DOI 10.1093/biostatistics/4.4.621; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; GEORGETTE N, 2007, INTERNET J EPIDEMIOL, V5; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; HARTNELL B, 1995, 20 C NUM MATH COMP U; Hyde TB, 2006, INT J EPIDEMIOL, V35, P299, DOI 10.1093/ije/dyi222; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Ng KL, 2008, DISCRETE APPL MATH, V156, P730, DOI 10.1016/j.dam.2007.08.011; ROBERTSON SE, 1992, PUBLIC HEALTH REP, V107, P24; Samuela S., 2006, Morbidity and Mortality Weekly Report, V55, P963; Sniadack DH, 1999, B WORLD HEALTH ORGAN, V77, P545; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WHITE CC, 1985, AM J PUBLIC HEALTH, V75, P739, DOI 10.2105/AJPH.75.7.739; *WHO, 2007, MEASL FACT SHEET	21	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4168	10.1371/journal.pone.0004168	http://dx.doi.org/10.1371/journal.pone.0004168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132101	gold, Green Published			2022-12-27	WOS:000265473700007
J	Rose, AP				Rose, Alexandra P.			Temporal and Individual Variation in Offspring Provisioning by Tree Swallows: A New Method of Automated Nest Attendance Monitoring	PLOS ONE			English	Article							INCUBATION; ATTENTIVENESS; SPARROWS; TIME; CARE	Studies of the ecology and evolution of avian nesting behavior have been limited by the difficulty and expense of sampling nest attendance behavior across entire days or throughout a substantial portion of the nestling period. Direct observation of nesting birds using human observers and most automated devices requires sub-sampling of the nestling period, which does not allow for the quantification of the duration of chick-feeding by parents within a day, and may also inadequately capture temporal variation in the rate at which chicks are fed. Here I describe an inexpensive device, the Automated Perch Recorder (APR) system, which collects accurate, long-term data on hourly rates of nest visitation, the duration of a pair's workday, and the total number of visits the pair makes to their nest across the entire period for which it is deployed. I also describe methods for verifying the accuracy of the system in the field, and several examples of how these data can be used to explore the causes of variation in and tradeoffs between the rate at which birds feed their chicks and the total length of time birds spend feeding chicks in a day.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Rose, AP (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	rose@biology.ucsc.edu			American Museum of Natural History; American Ornithologist's Union; STEPS Institute for Innovation in Environmental Research	American Museum of Natural History; American Ornithologist's Union; STEPS Institute for Innovation in Environmental Research	This project was funded by the American Museum of Natural History, the American Ornithologist's Union, and the STEPS Institute for Innovation in Environmental Research. No sponsors or funders had any role in any aspect of the design or conduct of this study or manuscript.	CARTAR RV, 1987, CONDOR, V89, P252, DOI 10.2307/1368478; Cooper CB, 2005, J FIELD ORNITHOL, V76, P352, DOI 10.1648/0273-8570-76.4.352; Gill F. B., 1990, ORNITHOLOGY; JONES G, 1987, J ANIM ECOL, V56, P229, DOI 10.2307/4812; Joyce EM, 2001, J FIELD ORNITHOL, V72, P369, DOI 10.1648/0273-8570-72.3.369; Kluijver H.N., 1950, PARUS M MAJOR L ARDE, V38, P99; Lack D., 1968, pvii; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Magrath MJL, 1997, P ROY SOC B-BIOL SCI, V264, P1731, DOI 10.1098/rspb.1997.0240; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; McCarty JP, 2002, J FIELD ORNITHOL, V73, P9, DOI 10.1648/0273-8570-73.1.9; Norment CJ, 1995, J FIELD ORNITHOL, V66, P553; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Quinn GP, 2003, EXPT DESIGN DATA ANA; SIMMONS GA, 1969, AM MIDL NAT, V81, P276, DOI 10.2307/2423675; Skutch A.F., 1976, PARENT BIRDS THEIR Y; SZEP T, 1995, J FIELD ORNITHOL, V66, P1; WEEDEN JS, 1966, AUK, V83, P368, DOI 10.2307/4083049	20	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4111	10.1371/journal.pone.0004111	http://dx.doi.org/10.1371/journal.pone.0004111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119316	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472600010
J	Ren, H; Yu, DY; Ge, BS; Cook, B; Xu, ZN; Zhang, SG				Ren, Hui; Yu, Daoyong; Ge, Baosheng; Cook, Brian; Xu, Zhinan; Zhang, Shuguang			High-Level Production, Solubilization and Purification of Synthetic Human GPCR Chemokine Receptors CCR5, CCR3, CXCR4 and CX3CR1	PLOS ONE			English	Article								Chemokine receptors belong to a class of integral membrane G-protein coupled receptors (GPCRs) and are responsible for transmitting signals from the extracellular environment. However, the structural changes in the receptor, connecting ligand binding to G-protein activation, remain elusive for most GPCRs due to the difficulty to produce them for structural and functional studies. We here report high-level production in E. coli of 4 human GPCRs, namely chemokine receptors (hCRs) CCR5, CCR3, CXCR4 and CX3CR1 that are directly involved in HIV-1 infection, asthma and cancer metastasis. The synthetic genes of CCR5, CCR3, CXCR4 and CX3CR1 were synthesized using a two-step assembly/amplification PCR method and inserted into two different kinds of expression systems. After systematic screening of growth conditions and host strains, TB medium was selected for expression of pEXP-hCRs. The low copy number pBAD-DEST49 plasmid, with a moderately strong promoter tightly regulated by L-arabinose, proved helpful for reducing toxicity of expressed membrane proteins. The synthetic Trx-hCR fusion genes in the pBAD-DEST49 vector were expressed at high levels in the Top10 strain. After a systematic screen of 96 detergents, the zwitterionic detergents of the Fos-choline series (FC9-FC16) emerged as the most effective for isolation of the hCRs. The FC14 was selected both for solubilization from bacterial lysates and for stabilization of the Trx-hCRs during purification. Thus, the FC-14 solubilized Trx-hCRs could be purified using size exclusion chromatography as monomers and dimers with the correct apparent MW and their alpha-helical content determined by circular dichroism. The identity of two of the expressed hCRs (CCR3 and CCR5) was confirmed using immunoblots using specific monoclonal antibodies. After optimization of expression systems and detergent-mediated purification procedures, we achieved large-scale, high-level production of 4 human GPCR chemokine receptor in a two-step purification, yielding milligram quantities of CCR5, CCR3, CXCR4 and CX3CR1 for biochemical, biophysical and structural analysis.	[Ren, Hui; Yu, Daoyong; Ge, Baosheng; Cook, Brian; Xu, Zhinan; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Yu, Daoyong; Ge, Baosheng] China Univ Petr, Ctr Bioengn & Biotechnol, Qingdao, Peoples R China	Massachusetts Institute of Technology (MIT); China University of Petroleum	Ren, H (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu	Ge, Baosheng/AAT-4788-2020; Yu, Daoyong/E-5269-2013	Ge, Baosheng/0000-0001-9906-2081; Yu, Daoyong/0000-0002-3380-1897; Zhang, Shuguang/0000-0002-3856-3752	John Simon Guggenheim Fellowship; NIH	John Simon Guggenheim Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SZ gratefully acknowledges a John Simon Guggenheim Fellowship to provide freedom to pursue frontiers of studying membrane protein structures. This work is supported in part by NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Baedeker M, 1999, FEBS LETT, V457, P57, DOI 10.1016/S0014-5793(99)01000-5; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bane SE, 2007, PROTEIN EXPRES PURIF, V52, P348, DOI 10.1016/j.pep.2006.10.017; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Elsner J, 2004, ALLERGY, V59, P1243, DOI 10.1111/j.1398-9995.2004.00710.x; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANNINEN AL, 1994, BIOL CHEM H-S, V375, P833; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; HJELMELAND LM, 1990, METHOD ENZYMOL, V182, P253; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; KAISER L, 2008, P NATL ACAD SCI, V105; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Lu ZJ, 1996, J BIOL CHEM, V271, P5059; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Luster AD, 2001, CURR OPIN ALLERGY CL, V1, P561, DOI 10.1097/00130832-200112000-00012; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Morokata T, 2006, J PHARMACOL EXP THER, V317, P244, DOI 10.1124/jpet.105.097048; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; NASSAL M, 1987, J BIOL CHEM, V262, P9264; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Niegowski D, 2006, INT J BIOL MACROMOL, V39, P83, DOI 10.1016/j.ijbiomac.2006.02.011; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sambrook J., 2001, MOL CLONING LAB MANU; SARDET C, 1976, J MOL BIOL, V105, P383, DOI 10.1016/0022-2836(76)90100-5; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shaw Alison Z, 2003, Methods Mol Biol, V228, P23, DOI 10.1385/1-59259-400-X:23; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Suzuki K, 2006, BIOCHEM BIOPH RES CO, V339, P1217, DOI 10.1016/j.bbrc.2005.11.141; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; VANRENSWOUDE J, 1984, METHOD ENZYMOL, V104, P329; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; [No title captured]	78	71	74	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4509	10.1371/journal.pone.0004509	http://dx.doi.org/10.1371/journal.pone.0004509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223978	Green Published, gold			2022-12-27	WOS:000265485800012
J	Azam, A; Leong, TG; Zarafshar, AM; Gracias, DH				Azam, Anum; Leong, Timothy G.; Zarafshar, Aasiyeh M.; Gracias, David H.			Compactness Determines the Success of Cube and Octahedron Self-Assembly	PLOS ONE			English	Article							SECONDARY STRUCTURE; PACKING DENSITY; POLYHEDRA; PROTEINS; ORIGINS; SCALE	Nature utilizes self-assembly to fabricate structures on length scales ranging from the atomic to the macro scale. Self-assembly has emerged as a paradigm in engineering that enables the highly parallel fabrication of complex, and often three-dimensional, structures from basic building blocks. Although there have been several demonstrations of this self-assembly fabrication process, rules that govern a priori design, yield and defect tolerance remain unknown. In this paper, we have designed the first model experimental system for systematically analyzing the influence of geometry on the self-assembly of 200 and 500 mm cubes and octahedra from tethered, multi-component, two-dimensional (2D) nets. We examined the self-assembly of all eleven 2D nets that can fold into cubes and octahedra, and we observed striking correlations between the compactness of the nets and the success of the assembly. Two measures of compactness were used for the nets: the number of vertex or topological connections and the radius of gyration. The success of the self-assembly process was determined by measuring the yield and classifying the defects. Our observation of increased self-assembly success with decreased radius of gyration and increased topological connectivity resembles theoretical models that describe the role of compactness in protein folding. Because of the differences in size and scale between our system and the protein folding system, we postulate that this hypothesis may be more universal to self-assembling systems in general. Apart from being intellectually intriguing, the findings could enable the assembly of more complicated polyhedral structures (e. g. dodecahedra) by allowing a priori selection of a net that might self-assemble with high yields.	[Zarafshar, Aasiyeh M.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Leong, Timothy G.; Gracias, David H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Gracias, David H.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Azam, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	dgracias@jhu.edu	Gracias, David/A-1942-2010	Gracias, David/0000-0003-2735-4725; Glasgow, Anum/0000-0002-0938-881X	Arnold and Mabel Beckman Foundation; Camille-Dreyfus Foundation; National Science Foundation [DMMI 044816]	Arnold and Mabel Beckman Foundation; Camille-Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF))	This material is based in part upon work supported by grants from the Arnold and Mabel Beckman Foundation, Camille-Dreyfus Foundation and the National Science Foundation (Career-DMMI 044816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any conclusions expressed in this paper are those of the authors and do not reflect the views of the funding agencies.	Bern M, 2003, COMP GEOM-THEOR APPL, V24, P51, DOI 10.1016/S0925-7721(02)00091-3; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Buekenhout F, 1998, DISCRETE MATH, V186, P69, DOI 10.1016/S0012-365X(97)00225-2; CHAN HS, 1990, P NATL ACAD SCI USA, V87, P6388, DOI 10.1073/pnas.87.16.6388; CHAN HS, 1989, MACROMOLECULES, V22, P4559, DOI 10.1021/ma00202a031; Demaine Erik., 2007, GEOMETRIC FOLDING AL; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Gracias DH, 2000, SCIENCE, V289, P1170, DOI 10.1126/science.289.5482.1170; Gracias DH, 2002, ADV MATER, V14, P235, DOI 10.1002/1521-4095(20020205)14:3<235::AID-ADMA235>3.0.CO;2-B; GREGORET LM, 1991, J MOL BIOL, V219, P109, DOI 10.1016/0022-2836(91)90861-Y; Grunbaum B, 2003, CONVEX POLYTOPES; HUNT NG, 1994, J MOL BIOL, V241, P214, DOI 10.1006/jmbi.1994.1490; Leong T, 2006, J AM CHEM SOC, V128, P11336, DOI 10.1021/ja063100z; Leong TG, 2007, LANGMUIR, V23, P8747, DOI 10.1021/la700913m; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; SHIMOYAMA I, 1998, P 11 INT WORKSH MICR, P25; SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735; Suzuki K, 2007, MICROSYST TECHNOL, V13, P1047, DOI 10.1007/s00542-006-0303-z; Turnev P. D., 1984, J RECREAT MATH, V17, P1984; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; YEE DP, 1994, J MOL BIOL, V241, P557, DOI 10.1006/jmbi.1994.1531	22	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4451	10.1371/journal.pone.0004451	http://dx.doi.org/10.1371/journal.pone.0004451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212438	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484200011
J	Tavabi, K; Elling, L; Dobel, C; Pantev, C; Zwitserlood, P				Tavabi, Kambiz; Elling, Ludger; Dobel, Christian; Pantev, Christo; Zwitserlood, Pienie			Effects of Place of Articulation Changes on Auditory Neural Activity: A Magnetoencephalography Study	PLOS ONE			English	Article							PHONOLOGICAL VARIATION; MISMATCH NEGATIVITY; LEXICAL ACCESS; ASSIMILATION; PERCEPTION; REGULARITIES; RECOGNITION; INFERENCE; LANGUAGE; GERMAN	In casual speech, phonemic segments often assimilate such that they adopt features from adjacent segments, a typical feature being their place of articulation within the vocal tract (e.g., labial, coronal, velar). Place assimilation (e.g., from coronal /n/ to labial /m/: rainbow ->*raimbow) alters the surface form of words. Listeners' ability to perceptually compensate for such changes seems to depend on the phonemic context, on whether the adjacent segment (e.g., the /b/ in "rainbow'') invites the particular change. Also, some assimilations occur frequently (e.g., /n/->/m/), others are rare (e.g., /m/->/n/). We investigated the effects of place assimilation, its contextual dependency, and its frequency on the strength of auditory evoked mismatch negativity (MMN) responses, using pseudowords. Results from magnetoencephalography (MEG) revealed that the MMN was modulated both by the frequency and contextual appropriateness of assimilations.	[Tavabi, Kambiz; Elling, Ludger; Dobel, Christian; Pantev, Christo] Inst Biomagnetism & Biosignalanal, Munster, Germany; [Tavabi, Kambiz] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA USA; [Zwitserlood, Pienie] Univ Munster, Dept Psychol, D-4400 Munster, Germany	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Munster	Tavabi, K (corresponding author), Inst Biomagnetism & Biosignalanal, Munster, Germany.	zwitser@psy.uni-muenster.de		Tavabi, Kambiz/0000-0003-1881-892X	Deutsche Forschungsgemeinschaft [ZW-65-65/5-1]; German Volkswagen Foundation [I/80709]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Volkswagen Foundation(Volkswagen)	The Deutsche Forschungsgemeinschaft as part of SPP 1234: Phonological and phonetic competence: between grammar, signal processing, and neural activity (Project ZW-65-65/5-1 Neural and psychological correlates of phonological categories). For his involvement in this project C.D. was supported by the German Volkswagen Foundation (Volkswagen Stiftung, I/80709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma Paul, 2002, GLOT INT, V5, P341; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Coenen E, 2001, LANG COGNITIVE PROC, V16, P535, DOI 10.1080/01690960143000155; DARCY I, VARIATION G IN PRESS; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Frauenfelder U., 1999, LANGUAGE COMPREHENSI, P1; Friedrich Claudia K, 2006, Behav Brain Funct, V2, P36, DOI 10.1186/1744-9081-2-36; Gaskell MG, 2008, J EXP PSYCHOL HUMAN, V34, P1632, DOI 10.1037/a0011977; Gaskell MG, 2003, J PHONETICS, V31, P447, DOI 10.1016/S0095-4470(03)00012-3; Gaskell MG, 1998, J EXP PSYCHOL HUMAN, V24, P380, DOI 10.1037/0096-1523.24.2.380; Gow DW, 2003, PERCEPT PSYCHOPHYS, V65, P575, DOI 10.3758/BF03194584; Gow DW, 2001, J MEM LANG, V45, P133, DOI 10.1006/jmla.2000.2764; Gumnior H, 2005, LANG COGNITIVE PROC, V20, P465, DOI 10.1080/01690960444002174; Jun J, 2004, PHONETICALLY BASED P, P58, DOI DOI 10.1017/CBO9780511486401.003; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; MARSLENWILSON W, 1995, LANG COGNITIVE PROC, V10, P285, DOI 10.1080/01690969508407097; Mitterer H, 2003, PERCEPT PSYCHOPHYS, V65, P956, DOI 10.3758/BF03194826; Mitterer H, 2006, Q J EXP PSYCHOL, V59, P1395, DOI 10.1080/17470210500198726; Mitterer H, 2006, COGNITIVE SCI, V30, P451, DOI 10.1207/s15516709cog0000_57; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pulvermuller F, 2006, NEUROIMAGE, V31, P1297, DOI 10.1016/j.neuroimage.2006.01.030; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Ranbom LJ, 2007, J MEM LANG, V57, P273, DOI 10.1016/j.jml.2007.04.001; Takegata R, 2001, PSYCHOPHYSIOLOGY, V38, P92, DOI 10.1017/S0048577201991243; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Wheeldon L., 2000, STUDIES COGNITION SE, P165	29	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4452	10.1371/journal.pone.0004452	http://dx.doi.org/10.1371/journal.pone.0004452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209225	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484100011
J	Boddaert, N; Zilbovicius, M; Philipe, A; Robel, L; Bourgeois, M; Barthelemy, C; Seidenwurm, D; Meresse, I; Laurier, L; Desguerre, I; Bahi-Buisson, N; Brunelle, F; Munnich, A; Samson, Y; Mouren, MC; Chabane, N				Boddaert, Nathalie; Zilbovicius, Monica; Philipe, Anne; Robel, Laurence; Bourgeois, Marie; Barthelemy, Catherine; Seidenwurm, David; Meresse, Isabelle; Laurier, Laurence; Desguerre, Isabelle; Bahi-Buisson, Nadia; Brunelle, Francis; Munnich, Arnold; Samson, Yves; Mouren, Marie-Christine; Chabane, Nadia			MRI Findings in 77 Children with Non-Syndromic Autistic Disorder	PLOS ONE			English	Article							CREATINE DEFICIENCY SYNDROMES; VIRCHOW-ROBIN SPACES; DEVELOPMENTAL DISORDERS; INCIDENTAL FINDINGS; MENTAL-RETARDATION; BRAIN; DIAGNOSIS	Background: The clinical relevance of MR scanning in children with autism is still an open question and must be considered in light of the evolution of this technology. MRI was judged to be of insufficient value to be included in the standard clinical evaluation of autism according to the guidelines of the American Academy of Neurology and Child Neurology Society in 2000 [1]. However, this statement was based on results obtained from small samples of patients and, more importantly, included mostly insufficient MRI sequences. Our main objective was to evaluate the prevalence of brain abnormalities in a large group of children with a non-syndromic autistic disorder (AD) using T1, T2 and FLAIR MRI sequences. Methodology: MRI inspection of 77 children and adolescents with non-syndromic AD (mean age 7.463.6) was performed. All met the DSM-IV and ADI -R criteria for autism. Based on recommended clinical and biological screenings, we excluded patients with infectious, metabolic or genetic diseases, seizures or any other neurological symptoms. Identical MRI inspections of 77 children (mean age 7.064.2) without AD, developmental or neurological disorders were also performed. All MRIs were acquired with a 1.5-T Signa GE (3-D T1-FSPGR, T2, FLAIR coronal and axial sequences). Two neuroradiologists independently inspected cortical and sub-cortical regions. MRIs were reported to be normal, abnormal or uninterpretable. Principal Findings: MRIs were judged as uninterpretable in 10% (8/77) of the cases. In 48% of the children (33/69 patients), abnormalities were reported. Three predominant abnormalities were observed, including white matter signal abnormalities (19/69), major dilated Virchow-Robin spaces (12/69) and temporal lobe abnormalities (20/69). In all, 52% of the MRIs were interpreted as normal (36/69 patients). Conclusions: An unexpectedly high rate of MRI abnormalities was found in the first large series of clinical MRI investigations in non-syndromic autism. These results could contribute to further etiopathogenetic research into autism.	[Boddaert, Nathalie; Zilbovicius, Monica; Meresse, Isabelle; Laurier, Laurence; Brunelle, Francis] CEA, Serv Hosp Frederic Joliot, INSERM, U797, F-91406 Orsay, France; [Boddaert, Nathalie; Zilbovicius, Monica; Seidenwurm, David; Brunelle, Francis] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Radiol Pediat, U 797, F-75270 Paris, France; [Mouren, Marie-Christine; Chabane, Nadia] AP HP, Hop Robert Debre, Serv Pedopsychiat, Paris, France; [Philipe, Anne; Munnich, Arnold] Univ Paris 05, Hop Necker Enfants Malades, Genet Clin & Res Unit, INSERM 781, F-75270 Paris, France; [Robel, Laurence] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Pedopsychiat, F-75270 Paris, France; [Bourgeois, Marie; Desguerre, Isabelle; Bahi-Buisson, Nadia] Univ Paris 05, AP HP, Hop Necker Enfants Malades, Serv Neurol Metabolisme, F-75270 Paris, France; [Barthelemy, Catherine] CHU Bretonneau, INSERM, U 916, Tours, France; [Meresse, Isabelle; Samson, Yves] AP HP, Serv Urgences Cerebro Vasculaires, Grp Hosp Pitie Salpetriere, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Boddaert, N (corresponding author), CEA, Serv Hosp Frederic Joliot, INSERM, U797, F-91406 Orsay, France.	nathalie.boddaert@nck.aphp.fr	samson, yves/C-5647-2013; boddaert, nathalie/GWV-2865-2022	samson, yves/0000-0002-8080-1427; boddaert, nathalie/0000-0003-0991-7774	France Foundation; Orange Foundation	France Foundation; Orange Foundation	France Foundation and Orange Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Dimas A, 2006, REV NEUROLOGIA, V43, P302, DOI 10.33588/rn.4305.2005519; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Cheillan A, 2005, REV NEUROL-FRANCE, V161, P284, DOI 10.1016/S0035-3787(05)85034-9; Decobert F, 2005, PEDIATR RADIOL, V35, P587, DOI 10.1007/s00247-005-1406-x; Filipek PA, 1999, J CHILD PSYCHOL PSYC, V40, P113, DOI 10.1111/1469-7610.00426; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191; HEIER LA, 1989, AM J NEURORADIOL, V10, P929; Kanner L, 1943, NERV CHILD, V2, P217; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1; PIVEN J, 1990, AM J PSYCHIAT, V147, P734; SCHIFTER T, 1994, J CHILD NEUROL, V9, P155, DOI 10.1177/088307389400900210; Soto-Ares G, 2003, PEDIATR RADIOL, V33, P334, DOI 10.1007/s00247-003-0891-z; STANFIELD AC, 2007, EUR PSYCHIAT; Steiner CE, 2004, J AUTISM DEV DISORD, V34, P723; Taber KH, 2004, J COMPUT ASSIST TOMO, V28, P263, DOI 10.1097/00004728-200403000-00017; van der Knaap MS, 2004, RADIOLOGY, V230, P529, DOI 10.1148/radiol.2302021459; VANDERKNAAP, 2005, MAGNETIC RESONANCE M; Zeegers M, 2006, BRAIN DEV-JPN, V28, P495, DOI 10.1016/j.braindev.2006.02.006; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	25	68	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4415	10.1371/journal.pone.0004415	http://dx.doi.org/10.1371/journal.pone.0004415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JO	19204795	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484000006
J	Trape, S				Trape, Sebastien			Impact of Climate Change on the Relict Tropical Fish Fauna of Central Sahara: Threat for the Survival of Adrar Mountains Fishes, Mauritania	PLOS ONE			English	Article							AFRICA	Background: Four central Sahara mountainous massifs provide habitats for relict populations of fish. In the Adrar of Mauritania all available data on the presence and distribution of fish come from pre-1960 surveys where five fish species were reported: Barbus pobeguini, Barbus macrops, Barbus mirei, Sarotherodon galilaeus, and Clarias anguillaris. Since 1970, drought has had a severe impact in the Adrar where rainfall decreased by 35%. To investigate whether the relict populations of fish have survived the continuing drought, a study was carried out from 2004 to 2008. Methodology/Principal Findings: An inventory of perennial bodies of water was drawn up using a literature review and analysis of topographical and hydrological maps. Field surveys were carried out in order to locate the bodies of water described in the literature, identify the presence of fish, determine which species were present and estimate their abundance. The thirteen sites where the presence of fish was observed in the 1950s -Ksar Torchane, Ilij, Molomhar, Agueni, Tachot, Hamdoun, Terjit, Toungad, El Berbera, Timagazine, Dayet el Mbarek, Dayet et-Tefla, Nkedei-were located and surveyed. The Ksar Torchane spring -type locality and the only known locality of B. mirei- has dried up at the height of the drought in 1984, and any fish populations have since become extinct there. The Timagazine, Dayet el Mbarek and Dayet et-Tefla pools have become ephemeral. The Hamdoun guelta appears to be highly endangered. The fish populations at the other sites remain unchanged. Four perennial pools which are home to populations of B. pobeguini are newly recorded. Conclusion/Significance: The tropical relict fish populations of the Adrar mountains of Mauritania appear to be highly endangered. Of thirteen previously recorded populations, four have become extinct since the beginning of the drought period. New fish population extinctions may occur should low levels of annual rainfall be repeated.	[Trape, Sebastien] IRD, Unite Rech 070, Dakar, Senegal; [Trape, Sebastien] Univ Montpellier 2, Lab ECOLAG, Unite Mixte Rech 5119, F-34095 Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Trape, S (corresponding author), IRD, Unite Rech 070, Dakar, Senegal.	sebastien_trape@yahoo.fr			IRD special programme Evolution Climatique et Sante	IRD special programme Evolution Climatique et Sante	This work was supported in part by the IRD special programme Evolution Climatique et Sante. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAGET J, 1959, NOTE POISSONS BORKOU, P173; Dekeyser P. L., 1955, Notes Africaines, VNo. 65, P28; DEKEYSER PL, 1956, MEMOIRE IFAN, V54; DRUYAN LM, 1989, INT J CLIMATOL, V9, P77, DOI 10.1002/joc.3370090107; Dumont H.J., 1982, Palaeoecology of Africa and the Surrounding Islands, V14, P1; DUMONT HJ, 1994, HYDROBIOLOGIA, V272, P1, DOI 10.1007/BF00006508; DUMONT HJ, 1987, AFRICAN WETLANDS SHA, P79; ESTEVE ROLANDE, 1952, BULL MUS NATL HIST NAT, V24, P176; Gasse F, 2006, CR PALEVOL, V5, P35, DOI 10.1016/j.crpv.2005.09.012; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; HULME M, 1992, INT J CLIMATOL, V12, P685, DOI 10.1002/joc.3370120703; L'Hote Y, 2002, HYDROLOG SCI J, V47, P563, DOI 10.1080/02626660209492960; LEBERRE C, 1989, FAUNE SAHARA, V1; Leveque C., 1990, Ichthyological Exploration of Freshwaters, V1, P39; Leveque C., 1989, Cybium, V13, P165; LEVEQUE C, 2003, POISSONS EAUX DOUCES, V1, P322; LHOTE H, 1942, B SOC CENTR AGR PECH, V49, P19; Monod T., 1951, Bull Inst franc Afr noire, V13, P802; Monod T., 1955, Bull Inst franY Afr noire, V17A, P590; Monod T., 1954, Bull Inst franY Afr noire, V16A, P295; PELLEGRIN J, 1921, MEM SOC SC NAT MAROC, V1; PELLEGRIN J, 1937, POISSONS SAHARA OCCI, P337; PELLEGRIN J, 1913, C R ASS FR AVANC SCI, V42, P346; RISER J, 1986, REV GEOL DYN GEOGR, V27, P205; *STAT MET AT, REL PLUV ANN 1921 20; TALBOT MR, 1980, SAHARA NILE, P37; Teugels G., 2003, POISSONS EAUX DOUCES, V40, P144; Vernet R., 1995, CLIMATS ANCIENS NORD; VILLIERS A, 1953, B IFAN, V15, P631	29	41	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4400	10.1371/journal.pone.0004400	http://dx.doi.org/10.1371/journal.pone.0004400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204792	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484000004
J	Barbour, JD; Ndhlovu, LC; Tan, QX; Ho, T; Epling, L; Bredt, BM; Levy, JA; Hecht, FM; Sinclair, E				Barbour, Jason D.; Ndhlovu, Lishomwa C.; Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Levy, Jay A.; Hecht, Frederick M.; Sinclair, Elizabeth			High CD8+T Cell Activation Marks a Less Differentiated HIV-1 Specific CD8+T Cell Response that Is Not Altered by Suppression of Viral Replication	PLOS ONE			English	Article								Background: The relationship of elevated T cell activation to altered T cell differentiation profiles, each defining features of HIV-1 infection, has not been extensively explored. We hypothesized that anti-retroviral suppression of T cell activation levels would lead to alterations in the T cell differentiation of total and HIV-1 specific CD8+ T cell responses among recently HIV-1 infected adults. Methodology/Principal Findings: We performed a longitudinal study simultaneously measuring T cell activation and maturation markers on both total and antigen-specific T cells in recently infected adults: prior to treatment; after the initiation of HAART; and after treatment was halted. Prior to treatment, HIV-1 Gag-specific CD8+ T cells were predominantly of a highly activated, intermediate memory (CD27+CD28-) phenotype, while CMV pp65-specific CD8+ T cells showed a late memory (CD27-CD28-), low activation phenotype. Participants with the highest fraction of late memory (CD27-CD28-) HIV-1-specific CD8+ T cells had higher CD4+ T cell counts (rho = +0.74, p = 0.004). In turn, those with the highest fraction of intermediate memory (CD27+CD28-) HIV-1 specific CD8+ T cells had high total CD8+ T cell activation (rho = +0.68, p = 0.01), indicating poorer long-term clinical outcomes. The HIV-1 specific T cell differentiation profile was not readily altered by suppression of T cell activation following HAART treatment. Conclusions/Significance: A more differentiated, less activated HIV-1 specific CD8+ T cell response may be clinically protective. Anti-retroviral treatment initiated two to four months after infection lowered T cell activation but had no effect on the differentiation profile of the HIV-1-specific response. Intervention during the first month of acute infection may be required to shift the differentiation phenotype of HIV-1 specific responses to a more clinically favorable profile.	[Barbour, Jason D.; Levy, Jay A.; Hecht, Frederick M.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Ndhlovu, Lishomwa C.; Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA; [Tan, Qi Xuan; Ho, Terence; Epling, Lorrie; Bredt, Barry M.; Sinclair, Elizabeth] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Core Immunol Lab, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Barbour, JD (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	jbarbour@php.ucsf.edu	n, l/AAX-3992-2020	Hecht, Frederick/0000-0002-5782-1171; Ndhlovu, Lishomwa/0000-0001-5427-4187	NIH/NIAID [AI066917, AI41531, AI47062, AI68498]; Irvington Institute Fellowship Program of the Cancer Research Institute; University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research [P30 AI27763]; NIH/NCRR UCSF-CTSI [UL1 RR024131-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068498, K01AI066917, R01AI047062, P30AI027763, U01AI041531] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Irvington Institute Fellowship Program of the Cancer Research Institute; University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research; NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.D.B. is supported by AI066917 (NIH/NIAID) and L.C.N. by the Irvington Institute Fellowship Program of the Cancer Research Institute. This project was supported by grants from the National Institutes of Health AI41531 (Levy/Hecht NIAID), AI47062 (Jacobson), AI68498 (Nixon) National Institutes of Health, and pilot awards to J.D.B. and L.C.N. from the University of California San Francisco-Gladstone Institute of Virology&Immunology Center for AIDS Research, P30 AI27763. This publication was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131-01. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Peptide pools were the generous gift of BD Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; APPAY V, 2008, CYTOMETRY A; Barbour JD, 2004, J INFECT DIS, V190, P251, DOI 10.1086/422036; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Lubaki NM, 1999, J ACQ IMMUN DEF SYND, V22, P19, DOI 10.1097/00042560-199909010-00003; Lucas M, 2004, J IMMUNOL, V172, P1744, DOI 10.4049/jimmunol.172.3.1744; Muthumani K, 2008, J VIROL; Nomura Laurel E, 2006, AIDS Res Ther, V3, P18, DOI 10.1186/1742-6405-3-18; NORTHFIELD JW, 2007, J VIROL; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8	26	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4408	10.1371/journal.pone.0004408	http://dx.doi.org/10.1371/journal.pone.0004408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198651	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483900010
J	Schulthess, FT; Katz, S; Ardestani, A; Kawahira, H; Georgia, S; Bosco, D; Bhushan, A; Maedler, K				Schulthess, Fabienne T.; Katz, Sophie; Ardestani, Amin; Kawahira, Hiroshi; Georgia, Senta; Bosco, Domenico; Bhushan, Anil; Maedler, Kathrin			Deletion of the Mitochondrial Flavoprotein Apoptosis Inducing Factor (AIF) Induces beta-Cell Apoptosis and Impairs beta-Cell Mass	PLOS ONE			English	Article								Background: Apoptosis is a hallmark of beta-cell death in both type 1 and type 2 diabetes mellitus. Understanding how apoptosis contributes to beta-cell turnover may lead to strategies to prevent progression of diabetes. A key mediator of apoptosis, mitochondrial function, and cell survival is apoptosis inducing factor (AIF). In the present study, we investigated the role of AIF on beta-cell mass and survival using the Harlequin (Hq) mutant mice, which are hypomorphic for AIF. Methodology/Principal Findings: Immunohistochemical evaluation of pancreata from Hq mutant mice displayed much smaller islets compared to wild-type mice (WT). Analysis of beta-cell mass in these mice revealed a greater than 4-fold reduction in beta-cell mass together with an 8-fold increase in beta-cell apoptosis. Analysis of cell cycle dynamics, using BrdU pulse as a marker for cells in S-phase, did not detect significant differences in the frequency of beta-cells in S-phase. In contrast, double staining for phosphorylated Histone H3 and insulin showed a 3-fold increase in beta-cells in the G2 phase in Hq mutant mice, but no differences in M-phase compared to WT mice. This suggests that the beta-cells from Hq mutant mice are arrested in the G2 phase and are unlikely to complete the cell cycle. beta-cells from Hq mutant mice display increased sensitivity to hydrogen peroxide-induced apoptosis, which was confirmed in human islets in which AIF was depleted by siRNA. AIF deficiency had no effect on glucose stimulated insulin secretion, but the impaired effect of hydrogen peroxide on beta-cell function was potentiated. Conclusions/Significance: Our results indicate that AIF is essential for maintaining beta-cell mass and for oxidative stress response. A decrease in the oxidative phosphorylation capacity may counteract the development of diabetes, despite its deleterious effects on beta-cell survival.	[Schulthess, Fabienne T.; Ardestani, Amin; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, Bremen, Germany; [Schulthess, Fabienne T.; Katz, Sophie; Kawahira, Hiroshi; Georgia, Senta; Bhushan, Anil; Maedler, Kathrin] Univ Calif Los Angeles, Dept Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA; [Bosco, Domenico] Univ Geneva, Sch Med, Dept Surg, Cell Isolat & Transplant Ctr, CH-1211 Geneva, Switzerland	University of Bremen; University of California System; University of California Los Angeles; University of Geneva	Schulthess, FT (corresponding author), Univ Bremen, Ctr Biomol Interact, Bremen, Germany.	kmaedler@uni-bremen.de	Maedler, Kathrin/ABE-3022-2021; Georgia, Senta/AAP-1971-2020	Maedler, Kathrin/0000-0002-7436-1197; Georgia, Senta/0000-0002-2016-7866; Ardestani, Amin/0000-0002-0685-8564; Bosco, Domenico/0000-0003-3453-9613	Larry Hillblom Research Foundation; German Research Foundation; European Foundation for the Study of Diabetes (EFSD); Swiss National Foundation Fellowship award; NCRR; NIDDK; JDRF [NA 31-2008-416]	Larry Hillblom Research Foundation; German Research Foundation(German Research Foundation (DFG)); European Foundation for the Study of Diabetes (EFSD); Swiss National Foundation Fellowship award; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation)	This work was supported by the Larry Hillblom Research Foundation, the German Research Foundation (DFG, Emmy Noether Program) and the European Foundation for the Study of Diabetes (EFSD). Fabienne Schulthess is recipient of the Swiss National Foundation Fellowship award. Human islets were provided through the Islet Cell Resource Consortium, administered by the ABCC and supported by NCRR, NIDDK and JDRF and through the European Consortium for Islet Transplantation (ECIT), Islets for Research Distribution Program, supported by JDRF grant NA 31-2008-416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Sakurai K, 2001, BIOL PHARM BULL, V24, P876, DOI 10.1248/bpb.24.876; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WIEDERKEHR A, 2008, CELL CALCIUM; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Zhong LW, 2007, J CLIN INVEST, V117, P2869, DOI 10.1172/JCI32198	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4394	10.1371/journal.pone.0004394	http://dx.doi.org/10.1371/journal.pone.0004394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197367	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483700009
J	Martuszewska, D; Ljungberg, B; Johansson, M; Landberg, G; Oslakovic, C; Dahlback, B; Hafizi, S				Martuszewska, Danuta; Ljungberg, Borje; Johansson, Martin; Landberg, Goran; Oslakovic, Cecilia; Dahlback, Bjorn; Hafizi, Sassan			Tensin3 Is a Negative Regulator of Cell Migration and All Four Tensin Family Members Are Downregulated in Human Kidney Cancer	PLOS ONE			English	Article								Background: The Tensin family of intracellular proteins (Tensin1, -2, -3 and -) are thought to act as links between the extracellular matrix and the cytoskeleton, and thereby mediate signaling for cell shape and motility. Dysregulation of Tensin expression has previously been implicated in human cancer. Here, we have for the first time evaluated the significance of all four Tensins in a study of human renal cell carcinoma (RCC), as well as probed the biological function of Tensin3. Principal Findings: Expression of Tensin2 and Tensin3 at mRNA and protein levels was largely absent in a panel of diverse human cancer cell lines. Quantitative RT-PCR analysis revealed mRNA expression of all four Tensin genes to be significantly downregulated in human kidney tumors (50 - 100% reduction versus normal kidney cortex; P < 0.001). Furthermore, the mRNA expressions of Tensins mostly correlated positively with each other and negatively with tumor grade, but not tumor size. Immunohistochemical analysis revealed Tensin3 to be present in the cytoplasm of tubular epithelium in normal human kidney sections, whilst expression was weaker or absent in 41% of kidney tumors. A subset of tumor sections showed a preferential plasma membrane expression of Tensin3, which in clear cell RCC patients was correlated with longer survival. Stable expression of Tensin3 in HEK 293 cells markedly inhibited both cell migration and matrix invasion, a function independent of putative phosphatase activity in Tensin3. Conversely, siRNA knockdown of endogenous Tensin3 in human cancer cells significantly increased their migration. Conclusions: Our findings indicate that the Tensins may represent a novel group of metastasis suppressors in the kidney, the loss of which leads to greater tumor cell motility and consequent metastasis. Moreover, tumorigenesis in the human kidney may be facilitated by a general downregulation of Tensins. Therefore, anti-metastatic therapies may benefit from restoring or preserving Tensin expression in primary tumors.	[Martuszewska, Danuta; Oslakovic, Cecilia; Dahlback, Bjorn; Hafizi, Sassan] Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioper Sci, S-90187 Umea, Sweden; [Johansson, Martin; Landberg, Goran] Lund Univ, Univ Hosp Malmo, Dept Lab Med, Sect Pathol, S-22100 Lund, Sweden	Lund University; Skane University Hospital; Umea University; Lund University; Skane University Hospital	Martuszewska, D (corresponding author), Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden.	Sassan.Hafizi@med.lu.se	Hafizi, Sassan/W-4424-2019	Hafizi, Sassan/0000-0002-4539-0888; Ljungberg, Borje/0000-0002-4121-3753; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council (Vetenskapsradet); Malmo University Hospital Trust; Malmo University Hospital Cancer Trust; Greta and Johan Kock Trust; Crafoord Trust; Royal Physiographic Society in Lund; Anna-Greta Crafoord Trust [fellowship]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Malmo University Hospital Trust; Malmo University Hospital Cancer Trust; Greta and Johan Kock Trust; Crafoord Trust; Royal Physiographic Society in Lund; Anna-Greta Crafoord Trust	Swedish Research Council (Vetenskapsradet), the Cancer Foundation, Alfred Osterlund Trust, Malmo University Hospital Trust, Malmo University Hospital Cancer Trust, Greta and Johan Kock Trust, Crafoord Trust, and the Royal Physiographic Society in Lund. D.M. was supported by a fellowship from the Anna-Greta Crafoord Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Chen HY, 2000, BIOCHEM J, V351, P403, DOI 10.1042/0264-6021:3510403; Chen HY, 2002, P NATL ACAD SCI USA, V99, P733, DOI 10.1073/pnas.022518699; Chiang MK, 2005, DEV BIOL, V279, P368, DOI 10.1016/j.ydbio.2004.12.027; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Cui YM, 2004, MOL CANCER RES, V2, P225; Escudier B, 2008, CANCER J, V14, P325, DOI 10.1097/PPO.0b013e3181867605; Gitlitz BJ, 2003, UROL CLIN N AM, V30, P589, DOI 10.1016/S0094-0143(03)00027-2; Glazer AA, 1996, J UROLOGY, V155, P448, DOI 10.1016/S0022-5347(01)66415-2; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hedberg Y, 2003, BRIT J CANCER, V88, P1417, DOI 10.1038/sj.bjc.6600922; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lidgren A, 2008, BJU INT, V101, P480, DOI 10.1111/j.1464-410X.2007.07238.x; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; Lo SH, 1997, J CELL BIOL, V136, P1349, DOI 10.1083/jcb.136.6.1349; Maeda I, 2006, J MOL ENDOCRINOL, V36, pR1, DOI 10.1677/jme.1.01913; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Ries L MD, 2008, SEER CANC STAT REV 1; Rodrigue CM, 2005, ONCOGENE, V24, P3274, DOI 10.1038/sj.onc.1208485; Ryschich E, 2006, CANCER RES, V66, P198, DOI 10.1158/0008-5472.CAN-05-1636; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Sasaki H, 2003, TUMOR BIOL, V24, P271, DOI 10.1159/000076141; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; SKINNER DG, 1971, CANCER-AM CANCER SOC, V28, P1165, DOI 10.1002/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850	32	49	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4350	10.1371/journal.pone.0004350	http://dx.doi.org/10.1371/journal.pone.0004350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194507	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483500006
J	Arking, DE; Khera, A; Xing, C; Kao, WHL; Post, W; Boerwinkle, E; Chakravarti, A				Arking, Dan E.; Khera, Amit; Xing, Chao; Kao, W. H. Linda; Post, Wendy; Boerwinkle, Eric; Chakravarti, Aravinda			Multiple Independent Genetic Factors at NOS1AP Modulate the QT Interval in a Multi-Ethnic Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIAC REPOLARIZATION; CARDIOVASCULAR MORTALITY; REGULATOR NOS1AP; HAPLOTYPE MAP; ELDERLY-MEN; PROLONGATION; ASSOCIATION; VARIANTS	Extremes of electrocardiographic QT interval are associated with increased risk for sudden cardiac death (SCD); thus, identification and characterization of genetic variants that modulate QT interval may elucidate the underlying etiology of SCD. Previous studies have revealed an association between a common genetic variant in NOS1AP and QT interval in populations of European ancestry, but this finding has not been extended to other ethnic populations. We sought to characterize the effects of NOS1AP genetic variants on QT interval in the multi-ethnic population-based Dallas Heart Study (DHS, n = 3,072). The SNP most strongly associated with QT interval in previous samples of European ancestry, rs16847548, was the most strongly associated in White (P = 0.005) and Black (P = 3.6 x 10(-5)) participants, with the same direction of effect in Hispanics (P = 0.17), and further showed a significant SNP x sex-interaction (P = 0.03). A second SNP, rs16856785, uncorrelated with rs16847548, was also associated with QT interval in Blacks (P = 0.01), with qualitatively similar results in Whites and Hispanics. In a previously genotyped cohort of 14,107 White individuals drawn from the combined Atherosclerotic Risk in Communities (ARIC) and Cardiovascular Health Study (CHS) cohorts, we validated both the second locus at rs16856785 (P = 7.63 x 10(-8)), as well as the sex-interaction with rs16847548 (P = 8.68 x 10(-6)). These data extend the association of genetic variants in NOS1AP with QT interval to a Black population, with similar trends, though not statistically significant at P < 0.05, in Hispanics. In addition, we identify a strong sex-interaction and the presence of a second independent site within NOS1AP associated with the QT interval. These results highlight the consistent and complex role of NOS1AP genetic variants in modulating QT interval.	[Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Khera, Amit] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; [Khera, Amit] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Div Epidemiol, Houston, TX USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Arking, DE (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	arking@jhmi.edu		Xing, Chao/0000-0002-1838-0502; Ballantyne, Christie/0000-0002-6432-1730	Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore; UT Southwestern at Dallas; NIH/NCRR-CR [M01-RR00633]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, N01-HC-85086, N01 HC-15103, N01 HC-55222, U01 HL080295]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC045133, N01HC055222, N01HC085086, N01HC055015, N01HC055021, N01HC055016, N01HC055022, N01HC085079, N01HC075150, N01HC015103, N01HC055019, N01HC055018, N01HC055020] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R41HL055019, R42HL055018, R41HL055018] Funding Source: NIH RePORTER	Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore; UT Southwestern at Dallas; NIH/NCRR-CR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Donald W. Reynolds Clinical Cardiovascular Research Centers at Johns Hopkins University at Baltimore (DEA, WHLK, WP, AC) and UT Southwestern at Dallas (AK, CX). The Dallas Heart Study was funded by the Donald W. Reynolds Foundation (Las Vegas, NE) and was partially supported by USPHS GCRC grant # M01-RR00633 from NIH/NCRR-CR. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The Cardiovascular Heart Study is supported by contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01 HC-15103, N01 HC-55222, and U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; EIJGELSHEIM M, 2008, HUM MOL GENET; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; KAO WHL, 2009, CIRCULATION IN PRESS; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; RAITAKARI OT, 2008, ANN MED         0910, P1; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sharp DS, 1998, ANN EPIDEMIOL, V8, P99, DOI 10.1016/S1047-2797(97)00121-X; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	27	26	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4333	10.1371/journal.pone.0004333	http://dx.doi.org/10.1371/journal.pone.0004333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180230	Green Submitted, Green Published, gold			2022-12-27	WOS:000274089700015
J	Wagner, MV; Smolka, MB; de Bruin, RAM; Zhou, HL; Wittenberg, C; Dowdy, SF				Wagner, Michelle V.; Smolka, Marcus B.; de Bruin, Rob A. M.; Zhou, Huilin; Wittenberg, Curt; Dowdy, Steven F.			Whi5 Regulation by Site Specific CDK-Phosphorylation in Saccharomyces cerevisiae	PLOS ONE			English	Article								The Whi5 transcriptional repressor is a negative regulator of G1 cell cycle progression in Saccharomyces cerevisiae and is functionally equivalent to the Retinoblastoma (Rb) tumor suppressor protein in mammals. In early G1, Whi5 binds to and inhibits SBF (Swi4/Swi6) transcriptional complexes. At Start, Cln:Cdc28 kinases phosphorylate and inactivate Whi5, causing its dissociation from SBF promoters and nuclear export, allowing activation of SBF transcription and entry into late G1. In an analysis of Whi5 phosphorylation, we found that 10 of the 12 putative CDK phosphorylation sites on Whi5 were occupied in vivo in asynchronously growing cells. In addition, we identified 6 non-CDK Whi5 phosphorylation sites. Whi5 CDK and non-CDK phosphorylation mutants were functional and able to rescue the small cell size of whi5 Delta cells. However, the Whi5 CDK mutant with all 12 putative CDK sites changed to alanine causes a dramatic cell cycle phenotype when expressed with a Swi6 CDK phosphorylation mutant. Mutational analysis of Whi5 determined that only four C-terminal CDK sites were necessary and sufficient for Whi5 inactivation when Swi6 CDK sites were also mutated. Although these four Whi5 CDK sites do not wholly determine Whi5 nuclear export, they do impact regulation of cell size. Taken together, these observations begin to dissect the regulatory role of specific phosphorylation sites on Whi5.	[Dowdy, Steven F.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Wagner, Michelle V.; Smolka, Marcus B.; Zhou, Huilin; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Molecular Med, La Jolla, CA 92093 USA; [Wagner, Michelle V.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smolka, Marcus B.; Zhou, Huilin] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [de Bruin, Rob A. M.; Wittenberg, Curt] Scripps Res Inst, Dept Molecular Biol, La Jolla, CA USA; [Wittenberg, Curt] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute	Wagner, MV (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu		Zhou, Huilin/0000-0002-1350-4430	NIH [CA067754, GM008666]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA067754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469, T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.V.W. was funded by the NIH Cancer Cell Biology Training grant (CA067754) and the NIH Basic Clinical Genetics Training grant (GM008666). This work was supported by the Howard Hughes Medical Institute (S.F.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Brachmann CB, 1998, YEAST, V14, P115; Breeden L, 1996, CURR TOP MICROBIOL, V208, P95; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MITTNACHT S, 1994, EMBO J, V13, P118, DOI 10.1002/j.1460-2075.1994.tb06241.x; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Wijnen H, 1999, GENETICS, V153, P1131; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4300	10.1371/journal.pone.0004300	http://dx.doi.org/10.1371/journal.pone.0004300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172996	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483000009
J	Chiori, R; Jager, M; Denker, E; Wincker, P; Da Silva, C; Le Guyader, H; Manuel, M; Queinnec, E				Chiori, Roxane; Jager, Muriel; Denker, Elsa; Wincker, Patrick; Da Silva, Corinne; Le Guyader, Herve; Manuel, Michael; Queinnec, Eric			Are Hox Genes Ancestrally Involved in Axial Patterning? Evidence from the Hydrozoan Clytia hemisphaerica (Cnidaria)	PLOS ONE			English	Article								Background: The early evolution and diversification of Hox-related genes in eumetazoans has been the subject of conflicting hypotheses concerning the evolutionary conservation of their role in axial patterning and the pre-bilaterian origin of the Hox and ParaHox clusters. The diversification of Hox/ParaHox genes clearly predates the origin of bilaterians. However, the existence of a "Hox code'' predating the cnidarian-bilaterian ancestor and supporting the deep homology of axes is more controversial. This assumption was mainly based on the interpretation of Hox expression data from the sea anemone, but growing evidence from other cnidarian taxa puts into question this hypothesis. Methodology/Principal Findings: Hox, ParaHox and Hox-related genes have been investigated here by phylogenetic analysis and in situ hybridisation in Clytia hemisphaerica, an hydrozoan species with medusa and polyp stages alternating in the life cycle. Our phylogenetic analyses do not support an origin of ParaHox and Hox genes by duplication of an ancestral ProtoHox cluster, and reveal a diversification of the cnidarian HOX9-14 genes into three groups called A, B, C. Among the 7 examined genes, only those belonging to the HOX9-14 and the CDX groups exhibit a restricted expression along the oralaboral axis during development and in the planula larva, while the others are expressed in very specialised areas at the medusa stage. Conclusions/Significance: Cross species comparison reveals a strong variability of gene expression along the oral-aboral axis and during the life cycle among cnidarian lineages. The most parsimonious interpretation is that the Hox code, collinearity and conservative role along the antero-posterior axis are bilaterian innovations.	[Chiori, Roxane; Jager, Muriel; Le Guyader, Herve; Manuel, Michael; Queinnec, Eric] Univ Paris 06, CNRS, UPMC, MNHN,IRD,UMR 7138,Case 05, Paris, France; [Denker, Elsa] Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Wincker, Patrick; Da Silva, Corinne] Genoscope, Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Chiori, R (corresponding author), Univ Paris 06, CNRS, UPMC, MNHN,IRD,UMR 7138,Case 05, Paris, France.	eric.queinnec@snv.jussieu.fr		Denker, Elsa/0000-0002-7092-1038; DA SILVA, Corinne/0000-0002-7618-7831	French Ministry of Research; Consortium National de Recherche en Genomique; Genoscope; GIS Institut de la Genomique Marine [PhD fellowship]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Consortium National de Recherche en Genomique; Genoscope; GIS Institut de la Genomique Marine	This work was supported by the French Ministry of Research (ACI jeunes chercheurs and ANR NT_NV_52), the Consortium National de Recherche en Genomique, the Genoscope and the GIS Institut de la Genomique Marine. RC was supported by a PhD fellowship from the GIS Institut de la Genomique Marine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AERNE BL, 1995, DEV BIOL, V169, P547, DOI 10.1006/dbio.1995.1168; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0; Arnone MI, 2006, DEV BIOL, V300, P63, DOI 10.1016/j.ydbio.2006.07.037; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Brooke NM, 1998, NATURE, V392, P920, DOI 10.1038/31933; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Cartwright P, 1999, P NATL ACAD SCI USA, V96, P2183, DOI 10.1073/pnas.96.5.2183; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Coutinho CC, 2003, MECH DEVELOP, V120, P429, DOI 10.1016/S0925-4773(03)00007-8; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Ferrier DEK, 2003, INT J DEV BIOL, V47, P605; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1997, BIOL BULL-US, V193, P62, DOI 10.2307/1542736; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; Finnerty JR, 2003, EVOL DEV, V5, P331, DOI 10.1046/j.1525-142X.2003.03041.x; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gauchat D, 2000, P NATL ACAD SCI USA, V97, P4493, DOI 10.1073/pnas.97.9.4493; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Hill A, 2003, MOL PHYLOGENET EVOL, V28, P529, DOI 10.1016/S1055-7903(03)00062-9; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Jakob W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000694; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kourakis MJ, 2000, J EXP ZOOL, V288, P175, DOI 10.1002/1097-010X(20000815)288:2<175::AID-JEZ8>3.0.CO;2-N; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Kuhn K, 1996, MOL PHYLOGENET EVOL, V6, P30, DOI 10.1006/mpev.1996.0055; Kulakova MA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-61; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Le Gouar M, 2003, GENE EXPR PATTERNS, V3, P35, DOI 10.1016/S1567-133X(02)00091-1; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MANUEL M, 2008, C R BIOL IN PRESS; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Masuda-Nakagawa LM, 2000, DEV GENES EVOL, V210, P151, DOI 10.1007/s004270050022; Mazza ME, 2007, J EXP ZOOL PART B, V308B, P494, DOI 10.1002/jez.b.21158; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; MILES A, 1992, P ROY SOC B-BIOL SCI, V248, P159, DOI 10.1098/rspb.1992.0057; Miljkovic-Licina M, 2007, DEVELOPMENT, V134, P1191, DOI 10.1242/dev.02804; MILLER DJ, 1993, NATURE, V365, P215, DOI 10.1038/365215b0; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; Offield MF, 1996, DEVELOPMENT, V122, P983; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; SCHUMMER M, 1992, EMBO J, V11, P1815, DOI 10.1002/j.1460-2075.1992.tb05233.x; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299	85	63	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4231	10.1371/journal.pone.0004231	http://dx.doi.org/10.1371/journal.pone.0004231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156208	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482100003
J	Ng, LFP; Chow, A; Sun, YJ; Kwek, DJC; Lim, PL; Dimatatac, F; Ng, LC; Ooi, EE; Choo, KH; Her, Z; Kourilsky, P; Leo, YS				Ng, Lisa F. P.; Chow, Angela; Sun, Yong-Jiang; Kwek, Dyan J. C.; Lim, Poh-Lian; Dimatatac, Frederico; Ng, Lee-Ching; Ooi, Eng-Eong; Choo, Khar-Heng; Her, Zhisheng; Kourilsky, Philippe; Leo, Yee-Sin			IL-1 beta, IL-6, and RANTES as Biomarkers of Chikungunya Severity	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; NATURAL-KILLER-CELLS; INDIAN-OCEAN; RHEUMATOID-ARTHRITIS; INTENSIVE-CARE; GROWTH-FACTOR; RISK-FACTORS; VIRUS; OUTBREAK; SEPSIS	Background: Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity. Methods and Findings: Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1b, IL-6 and a decrease in RANTES were associated with disease severity. Conclusions: This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.	[Ng, Lisa F. P.; Kwek, Dyan J. C.; Her, Zhisheng; Kourilsky, Philippe] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Chow, Angela; Sun, Yong-Jiang; Lim, Poh-Lian; Dimatatac, Frederico; Leo, Yee-Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Singapore, Singapore; [Ng, Lee-Ching] Environm Hlth Inst, Singapore, Singapore; [Ooi, Eng-Eong] DSO Natl Lab, Singapore, Singapore; [Choo, Khar-Heng] ASTAR, Inst Infocomm Res, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Tan Tock Seng Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.	lisa_ng@immunol.astar.edu.sg; Yee_Sin_Leo@ttsh.com.sg		Chow, Angela/0000-0002-4063-736X; Ng, Lisa/0000-0003-4071-5222; Ooi, Eng Eong/0000-0002-0520-1544	Singapore Immunology Network; Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR); Communicable Disease Centre, Tan Tock Seng Hospital	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Communicable Disease Centre, Tan Tock Seng Hospital	This work was supported by core grants provided by the Singapore Immunology Network, Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR); and the Communicable Disease Centre, Tan Tock Seng Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; Asquith DL, 2007, CURR OPIN RHEUMATOL, V19, P246, DOI 10.1097/BOR.0b013e3280eec78c; Avila-Aguero ML, 2004, CYTOKINE, V27, P173, DOI 10.1016/j.cyto.2004.05.007; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bonn D, 2006, LANCET INFECT DIS, V6, P543, DOI 10.1016/S1473-3099(06)70559-X; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Churchman SM, 2008, RHEUMATOLOGY, V47, P753, DOI 10.1093/rheumatology/ken053; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI 10.1089/vbz.2007.7272; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ECONOMOPOULOU A, 2008, EPIDEMIOL INFECT, V11, P1; Ellis M, 2005, BRIT J HAEMATOL, V128, P482, DOI 10.1111/j.1365-2141.2004.05350.x; Enserink M, 2007, SCIENCE, V317, P1485, DOI 10.1126/science.317.5844.1485a; FELDMANN M, 1990, ANN RHEUM DIS, P480; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; GIRI JG, 1995, J LEUKOCYTE BIOL, V57, P763, DOI 10.1002/jlb.57.5.763; Hansmann L, 2008, CLIN IMMUNOL, V127, P252, DOI 10.1016/j.clim.2008.01.014; Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; KENDALL DG, 1982, ENCY STAT SCI, V8, P417; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lee N, 2006, EMERG INFECT DIS, V12, P1790, DOI 10.3201/eid1211.060574; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Leelarasamee Amorn, 2004, Journal of the Medical Association of Thailand, V87, P464; Levi M, 2004, J THROMB HAEMOST, V2, P2094, DOI 10.1111/j.1538-7836.2004.01004.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; McQuitty L, 1996, EDUC PSYCHOL MEAS, V26, P825; *MIN HLTH SING, UPD CHIK FEV CAS 5; *MIN HLTH SING, CHIK FEV CAS DET CLI; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; *PROMED MAIL, CHIK 07 SING PROMED; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Wang E, 2006, J CLIN MICROBIOL, V44, P4000, DOI 10.1128/JCM.00175-06; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	57	207	215	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4261	10.1371/journal.pone.0004261	http://dx.doi.org/10.1371/journal.pone.0004261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156204	Green Submitted, gold, Green Published			2022-12-27	WOS:000265482100015
J	Jin, HJ; Tyler-Smith, C; Kim, W				Jin, Han-Jun; Tyler-Smith, Chris; Kim, Wook			The Peopling of Korea Revealed by Analyses of Mitochondrial DNA and Y-Chromosomal Markers	PLOS ONE			English	Article							CONTROL REGION SEQUENCES; POPULATION HISTORY; ETHNIC POPULATIONS; GENETIC-STRUCTURE; STRS HAPLOTYPES; EAST-ASIA; PHYLOGENETIC ANALYSIS; DUAL ORIGINS; MTDNA; DIVERSITY	Background: The Koreans are generally considered a northeast Asian group because of their geographical location. However, recent findings from Y chromosome studies showed that the Korean population contains lineages from both southern and northern parts of East Asia. To understand the genetic history and relationships of Korea more fully, additional data and analyses are necessary. Methodology and Results: We analyzed mitochondrial DNA (mtDNA) sequence variation in the hypervariable segments I and II (HVS-I and HVS-II) and haplogroup-specific mutations in coding regions in 445 individuals from seven east Asian populations (Korean, Korean-Chinese, Mongolian, Manchurian, Han (Beijing), Vietnamese and Thais). In addition, published mtDNA haplogroup data (N=3307), mtDNA HVS-I sequences (N=2313), Y chromosome haplogroup data (N=1697) and Y chromosome STR data (N=2713) were analyzed to elucidate the genetic structure of East Asian populations. All the mtDNA profiles studied here were classified into subsets of haplogroups common in East Asia, with just two exceptions. In general, the Korean mtDNA profiles revealed similarities to other northeastern Asian populations through analysis of individual haplogroup distributions, genetic distances between populations or an analysis of molecular variance, although a minor southern contribution was also suggested. Reanalysis of Y-chromosomal data confirmed both the overall similarity to other northeastern populations, and also a larger paternal contribution from southeastern populations. Conclusion: The present work provides evidence that peopling of Korea can be seen as a complex process, interpreted as an early northern Asian settlement with at least one subsequent male-biased southern-to-northern migration, possibly associated with the spread of rice agriculture.	[Kim, Wook] Dankook Univ, Dept Biol Sci, Cheonan, South Korea; [Jin, Han-Jun; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England	Dankook University; Wellcome Trust Sanger Institute	Jin, HJ (corresponding author), Dankook Univ, Dept Biol Sci, Cheonan, South Korea.	wookkim@dankook.ac.kr			Conservation Technology Research and Development; National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea; Koguryo Research Foundation, Republic of Korea; The Wellcome Trust	Conservation Technology Research and Development; National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea; Koguryo Research Foundation, Republic of Korea; The Wellcome Trust(Wellcome TrustEuropean Commission)	This study, which forms a part of the project, has been achieved with the support of Conservation Technology Research and Development project, which has been hosted by National Research Institute of Cultural Heritage of Cultural Heritage Administration, Republic of Korea. This work was supported by grant from the Koguryo Research Foundation, Republic of Korea. CTS was supported by The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Brandstatter A, 2006, INT J LEGAL MED, V120, P310, DOI 10.1007/s00414-006-0114-x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHOI ML, 2001, SEOUL J KOREAN STUD, V14, P117; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; DERENKO MV, 2004, RUSSIAN J GENET, V40, P1562; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EXCOFFIER L, 1992, GENETICS, V131, P479; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goedde H W, 1987, Gene Geogr, V1, P177; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAN YH, 1995, ALTAI KOREAN PENINSU; Hara Masaaki, 2007, Legal Medicine, V9, P161, DOI 10.1016/j.legalmed.2006.11.002; Hong S. S, 1993, MOL CELLS, V3, P457; Hong SB, 2006, KOREAN J GENETIC, V28, P1; Huang TY, 2008, FORENSIC SCI INT, V174, P249, DOI 10.1016/j.forsciint.2007.06.003; Hwang JH, 2007, FORENSIC SCI INT, V168, P73, DOI 10.1016/j.forsciint.2006.01.014; Jin Han Jun, 1999, Korean Journal of Biological Sciences, V3, P393; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; KIM K, 1970, ITS PEOPLE CULTURES; Kim W, 2000, J HUM GENET, V45, P76, DOI 10.1007/s100380050015; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Kwak KD, 2005, INT J LEGAL MED, V119, P195, DOI 10.1007/s00414-004-0518-4; Lee H, 2006, INT J LEGAL MED, V120, P5, DOI 10.1007/s00414-005-0005-6; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Maruyama S, 2003, INT J LEGAL MED, V117, P218, DOI 10.1007/s00414-003-0379-2; NEI M, 1993, MOL BIOL EVOL, V10, P927; Powell GT, 2007, FORENSIC SCI INT-GEN, V1, P115, DOI 10.1016/j.fsigen.2007.01.015; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; SAHA N, 1992, AM J PHYS ANTHROPOL, V88, P27, DOI 10.1002/ajpa.1330880104; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Sokal RR, 1998, HUM BIOL, V70, P1; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; Underhill PA, 2003, COLD SPRING HARB SYM, V68, P487, DOI 10.1101/sqb.2003.68.487; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wells Spencer, 2002, JOURNEY MAN GENETIC; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yan Jiangwei, 2007, Legal Medicine, V9, P196, DOI 10.1016/j.legalmed.2006.11.016; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yong RYY, 2006, FORENSIC SCI INT, V159, P244, DOI 10.1016/j.forsciint.2005.05.010; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020; Zhang Qingxia, 2006, Legal Medicine, V8, P300, DOI 10.1016/j.legalmed.2006.07.001; Zhang YJ, 2005, FORENSIC SCI INT, V149, P267, DOI 10.1016/j.forsciint.2004.07.012; Zhang YJ, 2007, FORENSIC SCI INT, V173, P197, DOI 10.1016/j.forsciint.2006.12.017	66	70	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4210	10.1371/journal.pone.0004210	http://dx.doi.org/10.1371/journal.pone.0004210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IH	19148289	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479900004
J	Wang, AL; Lukas, TJ; Yuan, M; Du, N; Tso, MO; Neufeld, AH				Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Tso, Mark O.; Neufeld, Arthur H.			Autophagy and Exosomes in the Aged Retinal Pigment Epithelium: Possible Relevance to Drusen Formation and Age-Related Macular Degeneration	PLOS ONE			English	Article								Age-related macular degeneration (AMD) is a major cause of loss of central vision in the elderly. The formation of drusen, an extracellular, amorphous deposit of material on Bruch's membrane in the macula of the retina, occurs early in the course of the disease. Although some of the molecular components of drusen are known, there is no understanding of the cell biology that leads to the formation of drusen. We have previously demonstrated increased mitochondrial DNA (mtDNA) damage and decreased DNA repair enzyme capabilities in the rodent RPE/choroid with age. In this study, we found that drusen in AMD donor eyes contain markers for autophagy and exosomes. Furthermore, these markers are also found in the region of Bruch's membrane in old mice. By in vitro modeling increased mtDNA damage induced by rotenone, an inhibitor of mitochondrial complex I, in the RPE, we found that the phagocytic activity was not altered but that there were: 1) increased autophagic markers, 2) decreased lysosomal activity, 3) increased exocytotic activity and 4) release of chemoattractants. Exosomes released by the stressed RPE are coated with complement and can bind complement factor H, mutations of which are associated with AMD. We speculate that increased autophagy and the release of intracellular proteins via exosomes by the aged RPE may contribute to the formation of drusen. Molecular and cellular changes in the old RPE may underlie susceptibility to genetic mutations that are found in AMD patients and may be associated with the pathogenesis of AMD in the elderly.	[Wang, Ai Ling; Lukas, Thomas J.; Yuan, Ming; Du, Nga; Tso, Mark O.; Neufeld, Arthur H.] Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA	Northwestern University	Wang, AL (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Forsythe Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-neufeld@northwestern.edu			NIH [EY12017]; Forsythe Foundation; RPB; NATIONAL EYE INSTITUTE [R01EY012017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forsythe Foundation; RPB(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY12017, a generous gift from the Forsythe Foundation and an unrestricted grant from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOK D, 1993, J CELL SCI, P189; BOULTON M, 1994, BRIT J OPHTHALMOL, V78, P125, DOI 10.1136/bjo.78.2.125; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Deretic V, 2008, SCI AM, V298, P74, DOI 10.1038/scientificamerican0508-74; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fischer R, 2006, CHEMBIOCHEM, V7, P1428, DOI 10.1002/cbic.200600209; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Ping JA, 2004, J CHROMATOGR B, V805, P297, DOI 10.1016/j.jchromb.2004.03.008; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Wang AL, 2008, MOL VIS, V14, P644	34	239	252	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4160	10.1371/journal.pone.0004160	http://dx.doi.org/10.1371/journal.pone.0004160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129916	gold, Green Submitted, Green Published			2022-12-27	WOS:000265473500007
J	Wan, QH; Zeng, CJ; Ni, XW; Pan, HJ; Fang, SG				Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo			Giant Panda Genomic Data Provide Insight into the Birth-and-Death Process of Mammalian Major Histocompatibility Complex Class II Genes	PLOS ONE			English	Article							CATTLE MHC; EVOLUTION; ORGANIZATION; SEQUENCE; FERTILIZATION; SIMILARITY; REGION; MOUSE	To gain an understanding of the genomic structure and evolutionary history of the giant panda major histocompatibility complex (MHC) genes, we determined a 636,503-bp nucleotide sequence spanning the MHC class II region. Analysis revealed that the MHC class II region from this rare species contained 26 loci (17 predicted to be expressed), of which 10 are classical class II genes (1 DRA, 2 DRB, 2 DQA, 3 DQB, 1 DYB, 1 DPA, and 2 DPB) and 4 are non-classical class II genes (1 DOA, 1 DOB, 1 DMA, and 1 DMB). The presence of DYB, a gene specific to ruminants, prompted a comparison of the giant panda class II sequence with those of humans, cats, dogs, cattle, pigs, and mice. The results indicated that birth and death events within the DQ and DRB-DY regions led to major lineage differences, with absence of these regions in the cat and in humans and mice respectively. The phylogenetic trees constructed using all expressed alpha and beta genes from marsupials and placental mammals showed that: (1) because marsupials carry loci corresponding to DR, DP, DO and DM genes, those subregions most likely developed before the divergence of marsupials and placental mammals, approximately 150 million years ago (MYA); ( 2) conversely, the DQ and DY regions must have evolved later, but before the radiation of placental mammals (100 MYA). As a result, the typical genomic structure of MHC class II genes for the giant panda is similar to that of the other placental mammals and corresponds to BTNL2 similar to DR1 similar to DQ similar to DR2 similar to DY similar to DO_box similar to DP similar to COL11A2. Over the past 100 million years, there has been birth and death of mammalian DR, DQ, DY, and DP genes, an evolutionary process that has brought about the current species-specific genomic structure of the MHC class II region. Furthermore, facing certain similar pathogens, mammals have adopted intra-subregion (DR and DQ) and inter-subregion (between DQ and DP) convergent evolutionary strategies for their alpha and beta genes, respectively.	[Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] Minist Ed, Key Lab Conserv Genet & Reproduct Biol Endanger, Hangzhou, Peoples R China; [Wan, Qiu-Hong; Zeng, Chang-Jun; Ni, Xiao-Wei; Pan, Hui-Juan; Fang, Sheng-Guo] State Conserv Ctr Gene Resources Endangered, Hangzhou, Peoples R China	Zhejiang University	Wan, QH (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	sgfang@mail.hz.zj.cn			National Basic Research Program of China (973 program) [2007CB411600]; State Forestry Administration of P. R. China	National Basic Research Program of China (973 program)(National Basic Research Program of China); State Forestry Administration of P. R. China	This work was supported by a grant from the National Basic Research Program of China (973 program) (No. 2007CB411600) and a special grant from the State Forestry Administration of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando A, 2006, ANIM SCI J, V77, P127, DOI 10.1111/j.1740-0929.2006.00331.x; Ballingall KT, 2004, IMMUNOGENETICS, V55, P748, DOI 10.1007/s00251-004-0641-x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113; BENTON MJ, 1993, PHYLOGENY MAJOR TETR; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Childers CP, 2006, ANIM GENET, V37, P121, DOI 10.1111/j.1365-2052.2005.01395.x; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Ellis SA, 1999, IMMUNOL REV, V167, P159, DOI 10.1111/j.1600-065X.1999.tb01389.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fernandez N, 1999, HUM REPROD UPDATE, V5, P234, DOI 10.1093/humupd/5.3.234; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gorer PA, 1936, BRIT J EXP PATHOL, V17, P42; Hu JC, 2001, RES GIANT PANDA; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1990, MOL BIOL EVOL, V7, P491; HUGHES AL, 1989, MOL BIOL EVOL, V6, P559; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kielan-Jaworowska Z., 1992, Historical Biology, V6, P185; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lum JK, 2000, MOL BIOL EVOL, V17, P1417, DOI 10.1093/oxfordjournals.molbev.a026242; McCluskey J, 1999, Rev Immunogenet, V1, P3; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; OBER C, 1993, J REPROD IMMUNOL, V25, P195, DOI 10.1016/0165-0378(93)90063-N; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; ROWEN L, 1998, SEQUENCE MOUSE MAJOR; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Skarstein F, 2005, BEHAV ECOL SOCIOBIOL, V57, P374, DOI 10.1007/s00265-004-0860-z; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; State Forestry Administration, 2006, 3 NAT SURV REP GIANT; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theodor JM, 2004, J PALEONTOL, V78, P39, DOI 10.1666/0022-3360(2004)078<0039:MCDEAT>2.0.CO;2; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; XIE Z, 2007, 2007 INT STUDBOOK GI; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zeng C. J., 2005, CYTOGENET GENOME RES, V109, p534H, DOI [10. 1159/000084222, DOI 10.1159/000084222]; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315; ZHAO XM, GIANT PANDAS NATURAL	57	27	33	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4147	10.1371/journal.pone.0004147	http://dx.doi.org/10.1371/journal.pone.0004147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127303	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473300012
J	Keriel, A; Mahuteau-Betzer, F; Jacquet, C; Plays, M; Grierson, D; Sitbon, M; Tazi, J				Keriel, Anne; Mahuteau-Betzer, Florence; Jacquet, Chantal; Plays, Marc; Grierson, David; Sitbon, Marc; Tazi, Jamal			Protection against Retrovirus Pathogenesis by SR Protein Inhibitors	PLOS ONE			English	Article								Indole derivatives compounds (IDC) are a new class of splicing inhibitors that have a selective action on exonic splicing enhancers (ESE)-dependent activity of individual serine-arginine-rich (SR) proteins. Some of these molecules have been shown to compromise assembly of HIV infectious particles in cell cultures by interfering with the activity of the SR protein SF2/ASF and by subsequently suppressing production of splicing-dependent retroviral accessory proteins. For all replication-competent retroviruses, a limiting requirement for infection and pathogenesis is the expression of the envelope glycoprotein which strictly depends on the host splicing machinery. Here, we have evaluated the efficiency of IDC on an animal model of retroviral pathogenesis using a fully replication-competent retrovirus. In this model, all newborn mice infected with a fully replicative murine leukemia virus (MLV) develop erythroleukemia within 6 to 8 weeks of age. We tested several IDC for their ability to interfere ex vivo with MLV splicing and virus spreading as well as for their protective effect in vivo. We show here that two of these IDC, IDC13 and IDC78, selectively altered splicing-dependent production of the retroviral envelope gene, thus inhibiting early viral replication in vivo, sufficiently to protect mice from MLV-induced pathogenesis. The apparent specificity and clinical safety observed here for both IDC13 and IDC78 strongly support further assessment of inhibitors of SR protein splicing factors as a new class of antiretroviral therapeutic agents.			Keriel, A (corresponding author), Univ Montpellier 1, Univ Montpellier 2, IFR122, CNRS,IGMM,UMR5535, Montpellier, France.	marc.sitbon@igmm.cnrs.fr; jamal.tazi@igmm.cnrs.fr	Keriel, Anne/N-3753-2017; Sitbon, Marc/A-6771-2010	Keriel, Anne/0000-0003-3340-299X; Sitbon, Marc/0000-0003-3616-2338; Mahuteau-Betzer, Florence/0000-0002-3009-252X; Tazi, Jamal/0000-0002-1949-8748				Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Anderson Jenny L, 2004, Curr HIV/AIDS Rep, V1, P47, DOI 10.1007/s11904-004-0007-x; Audit M, 1999, J VIROL, V73, P10472, DOI 10.1128/JVI.73.12.10472-10479.1999; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; CHATIS PA, 1984, J VIROL, V52, P248, DOI 10.1128/JVI.52.1.248-254.1984; CHESEBRO B, 1983, VIROLOGY, V128, P221, DOI 10.1016/0042-6822(83)90332-X; CHESEBRO B, 1981, VIROLOGY, V112, P131, DOI 10.1016/0042-6822(81)90619-X; Dejardin J, 2000, J VIROL, V74, P3709, DOI 10.1128/JVI.74.8.3709-3714.2000; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Mikkers H, 2003, ADV CANCER RES, V88, P53, DOI 10.1016/S0065-230X(03)88304-5; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Peterson KE, 2006, CURR TOP MICROBIOL, V303, P67, DOI 10.1007/978-3-540-33397-5_4; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SITBON M, 1986, CELL, V47, P851, DOI 10.1016/0092-8674(86)90800-7; SITBON M, 1991, P NATL ACAD SCI USA, V88, P5932, DOI 10.1073/pnas.88.13.5932; SITBON M, 1985, VIROLOGY, V141, P110, DOI 10.1016/0042-6822(85)90187-4; SITBON M, 1986, J VIROL, V57, P389, DOI 10.1128/JVI.57.1.389-393.1986; Sorensen AB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-46; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Soret J, 2003, Prog Mol Subcell Biol, V31, P89; Soret J, 2006, PROG MOLEC, V44, P65; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; Wolff L, 1996, CURR TOP MICROBIOL, V211, P191; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07	32	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4533	10.1371/journal.pone.0004533	http://dx.doi.org/10.1371/journal.pone.0004533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225570	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000010
J	Miracle, A; Denslow, ND; Kroll, KJ; Liu, MC; Wang, KKW				Miracle, Ann; Denslow, Nancy D.; Kroll, Kevin J.; Liu, Ming Cheng; Wang, Kevin K. W.			Spillway-Induced Salmon Head Injury Triggers the Generation of Brain alpha II-Spectrin Breakdown Product Biomarkers Similar to Mammalian Traumatic Brain Injury	PLOS ONE			English	Article								Recent advances in biomedical research have resulted in the development of specific biomarkers for diagnostic testing of disease condition or physiological risk. Of specific interest are alpha II-spectrin breakdown products (SBDPs), which are produced by proteolytic events in traumatic brain injury and have been used as biomarkers to predict the severity of injury in humans and other mammalian brain injury models. This study describes and demonstrates the successful use of antibody-based mammalian SBDP biomarkers to detect head injury in migrating juvenile Chinook salmon (Oncorhynchus tshawytscha) that have been injured during passage through high-energy hydraulic environments present in spillways under different operational configurations. Mortality and injury assessment techniques currently measure only near-term direct mortality and easily observable acute injury. Injury-based biomarkers may serve as a quantitative indicator of subacute physical injury and recovery, and aid hydropower operators in evaluation of safest passage configuration and operation actions for migrating juvenile salmonids. We describe a novel application of SBDP biomarkers for head injury for migrating salmon. To our knowledge, this is the first documented cross-over use of a human molecular biomarker in a wildlife and operational risk management scenario.	Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA; [Denslow, Nancy D.; Kroll, Kevin J.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA; [Liu, Ming Cheng; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovative Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Ctr Neuroproteom & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Banyan Biomarkers Inc.; State University System of Florida; University of Florida	Miracle, A (corresponding author), Pacific NW Natl Lab, Environm Sustainabil Div, Richland, WA 99352 USA.	ann.miracle@pnl.gov		Wang, Kevin/0000-0002-9343-6473; kroll, kevin j/0000-0002-5374-6733	Pacific Northwest National Laboratory	Pacific Northwest National Laboratory(United States Department of Energy (DOE))	This work was supported by directed funds from Pacific Northwest National Laboratory to ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Bergman PJ, 2003, CLIN TECH SMALL AN P, V18, P88, DOI 10.1053/svms.2003.36621; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Burger J, 2007, ENVIRON RES, V104, P135, DOI 10.1016/j.envres.2006.08.002; Cianci CD, 1999, BIOCHEMISTRY-US, V38, P15721, DOI 10.1021/bi991458k; de Boer JG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-422; Eason C, 2002, TOXICOLOGY, V181, P517, DOI 10.1016/S0300-483X(02)00472-9; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Gastaldi L, 2007, COMP BIOCHEM PHYS C, V146, P398, DOI 10.1016/j.cbpc.2007.04.014; Johnson GE, 2003, N AM J FISH MANAGE, V23, P441, DOI 10.1577/1548-8675(2003)023<0441:EOJEAH>2.0.CO;2; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; LIVINGSTONE DR, 1993, J CHEM TECHNOL BIOT, V57, P195; Miracle AL, 2005, REPROD TOXICOL, V19, P321, DOI 10.1016/j.reprotox.2004.06.007; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Neitzel DA, 2004, T AM FISH SOC, V133, P447, DOI 10.1577/02-021; *NOAA, 2008, ISS SUMM FED COL RIV; PERKINS EJ, 2008, TOXICOGENOMICS REGUL, P87; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Plummer PJ, 2007, VET CLIN N AM-FOOD A, V23, P481, DOI 10.1016/j.cvfa.2007.07.005; Robbens J, 2007, TRENDS BIOTECHNOL, V25, P460, DOI 10.1016/j.tibtech.2007.08.005; SKALSKI JR, 2003, SURVIVAL CONDITION C; Soutschek J, 1996, DEV BRAIN RES, V97, P279, DOI 10.1016/S0165-3806(96)00145-9; Soutschek J, 1995, NEUROSCI LETT, V202, P133, DOI 10.1016/0304-3940(95)12231-1; Stark KDC, 2006, BMC HEALTH SERV RES, V6, P1, DOI 10.1186/1472-6963-6-20; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zupanc GKH, 1999, J EXP BIOL, V202, P1435	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4491	10.1371/journal.pone.0004491	http://dx.doi.org/10.1371/journal.pone.0004491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214235	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484300016
J	Fan, ZM; Yuan, L; Chatterjee, R				Fan, Zhanmin; Yuan, Ling; Chatterjee, Ranjini			Increased Hydrogen Production by Genetic Engineering of Escherichia coli	PLOS ONE			English	Article							FORMATE HYDROGENLYASE; TRANSCRIPTIONAL ACTIVATOR; OPERON; EXPRESSION; GLUCOSE; FHLA; FNR; IMPROVEMENT; PROTEIN; NITRITE	Escherichia coli is capable of producing hydrogen under anaerobic growth conditions. Formate is converted to hydrogen in the fermenting cell by the formate hydrogenlyase enzyme system. The specific hydrogen yield from glucose was improved by the modification of transcriptional regulators and metabolic enzymes involved in the dissimilation of pyruvate and formate. The engineered E. coli strains ZF1 (Delta focA; disrupted in a formate transporter gene) and ZF3 (Delta narL; disrupted in a global transcriptional regulator gene) produced 14.9, and 14.4 mu mols of hydrogen/mg of dry cell weight, respectively, compared to 9.8 mu mols of hydrogen/mg of dry cell weight generated by wild-type E. coli strain W3110. The molar yield of hydrogen for strain ZF3 was 0.96 mols of hydrogen/mol of glucose, compared to 0.54 mols of hydrogen/mol of glucose for the wild-type E. coli strain. The expression of the global transcriptional regulator protein FNR at levels above natural abundance had a synergistic effect on increasing the hydrogen yield in the Delta focA genetic background. The modification of global transcriptional regulators to modulate the expression of multiple operons required for the biosynthesis of formate hydrogenlyase represents a practical approach to improve hydrogen production.	[Fan, Zhanmin; Yuan, Ling] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Fan, Zhanmin; Yuan, Ling] Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY 40506 USA; [Chatterjee, Ranjini] Farasis Energy Inc, Hayward, CA USA	University of Kentucky; University of Kentucky	Fan, ZM (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	rjic@novozymes.com			U.S. Department of Energy [DE-FG02-03ER83868]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Small Business Innovative Research grant DE-FG02-03ER83868 from the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2006, FEMS MICROBIOL REV, V30, P187, DOI 10.1111/j.1574-6976.2005.00009.x; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Buckley M, 2006, MICROBIAL ENERGY CON; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gokarn RR, 2000, APPL ENVIRON MICROB, V66, P1844, DOI 10.1128/AEM.66.5.1844-1850.2000; HOPPER S, 1994, J BIOL CHEM, V269, P19597; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, P262; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Khanal SK, 2004, INT J HYDROGEN ENERG, V29, P1123, DOI 10.1016/j.ijhydene.2003.11.002; Maeda T, 2007, APPL MICROBIOL BIOT, V77, P879, DOI 10.1007/s00253-007-1217-0; MAUPIN JA, 1990, J BACTERIOL, V172, P4798, DOI 10.1128/jb.172.9.4798-4806.1990; Miller J.H., 1972, EXPT MOL GENETICS CO; Nath K, 2004, APPL MICROBIOL BIOT, V65, P520, DOI 10.1007/s00253-004-1644-0; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; PAULETTE M, 2006, FEMS MICROBIOLOGY RE, V25, P455; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Petri R, 2004, CURR OPIN BIOTECH, V15, P298, DOI 10.1016/j.copbio.2004.05.005; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; SCHLENSOG V, 1994, J BIOL CHEM, V269, P19590; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; Self WT, 1999, MICROBIOL-UK, V145, P41, DOI 10.1099/13500872-145-1-41; Self WT, 2001, MICROBIOL-SGM, V147, P3093, DOI 10.1099/00221287-147-11-3093; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Yoshida A, 2006, APPL MICROBIOL BIOT, V73, P67, DOI 10.1007/s00253-006-0456-9	30	39	41	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4432	10.1371/journal.pone.0004432	http://dx.doi.org/10.1371/journal.pone.0004432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212440	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484200003
J	Kredel, S; Oswald, F; Nienhaus, K; Deuschle, K; Rocker, C; Wolff, M; Heilker, R; Nienhaus, GU; Wiedenmann, J				Kredel, Simone; Oswald, Franz; Nienhaus, Karin; Deuschle, Karen; Roecker, Carlheinz; Wolff, Michael; Heilker, Ralf; Nienhaus, G. Ulrich; Wiedenmann, Joerg			mRuby, a Bright Monomeric Red Fluorescent Protein for Labeling of Subcellular Structures	PLOS ONE			English	Article							ENTACMAEA-QUADRICOLOR; PEROXISOMES; VARIANTS; ORANGE; PHOTOCONVERSION; ISOMERIZATION; ASSOCIATION; INHERITANCE; EVOLUTION; ANTHOZOA	A monomeric variant of the red fluorescent protein eqFP611, mRuby, is described. With excitation and emission maxima at 558 nm and 605 nm, respectively, and a large Stokes shift of 47 nm, mRuby appears particularly useful for imaging applications. The protein shows an exceptional resistance to denaturation at pH extremes. Moreover, mRuby is about tenfold brighter compared to EGFP when being targeted to the endoplasmic reticulum. The engineering process of eqFP611 revealed that the C-terminal tail of the protein acts as a natural peroxisomal targeting signal (PTS). Using an mRuby variant carrying the eqFP611-PTS, we discovered that ordered inheritance of peroxisomes is widespread during mitosis of different mammalian cell types. The ordered partitioning is realized by the formation of peroxisome clusters around the poles of the mitotic spindle and ensures that equal numbers of the organelle are inherited by the daughter cells. The unique spectral properties make mRuby the marker of choice for a multitude of cell biological applications. Moreover, the use of mRuby has allowed novel insights in the biology of organelles responsible for severe human diseases.	[Kredel, Simone; Wolff, Michael; Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med I, D-89069 Ulm, Germany; [Nienhaus, Karin; Deuschle, Karen; Roecker, Carlheinz; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89069 Ulm, Germany; [Wolff, Michael; Heilker, Ralf] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL USA; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanog Ctr, Southampton SO9 5NH, Hants, England	Ulm University; Ulm University; Ulm University; Boehringer Ingelheim; University of Illinois System; University of Illinois Urbana-Champaign; NERC National Oceanography Centre; University of Southampton	Kredel, S (corresponding author), Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany.	joerg.wiedenmann@noc.soton.ac.uk	Oswald, Franz/AAO-9584-2020; Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192	Deutsche Forschungsgemeinschaft [Ni291/4, SFB 569/A4, SFB 497/D2, Wi1990/2-1, SFB 497/B9, SFB 518/A18]; Fonds der Chemischen Industrie; Landesstiftung Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Landesstiftung Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany(Boehringer Ingelheim)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, grants DFG Ni291/4, SFB 569/A4 and SFB 497/D2 to G.U.N., Wi1990/2-1 to J.W., and SFB 497/B9 and SFB 518/A18 to F.O.), Fonds der Chemischen Industrie (to G.U.N.), Landesstiftung Baden-Wurttemberg (Elite Postdoc Program to J.W.) and a collaborative grant of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany to J.W. and G.U.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Collings DA, 2003, PLANTA, V218, P204, DOI 10.1007/s00425-003-1096-2; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu M, 2006, BBA-MOL CELL RES, V1763, P1669, DOI 10.1016/j.bbamcr.2006.08.015; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Griesbeck O, 2004, CURR OPIN NEUROBIOL, V14, P636, DOI 10.1016/j.conb.2004.08.002; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hendrix J, 2008, BIOPHYS J, V94, P4103, DOI 10.1529/biophysj.107.123596; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Ivanchenko S, 2007, BIOPHYS J, V92, P4451, DOI [10.1529/biophysj.106.103408, 10.1529/biophysj. 106.103408]; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2008, CHEM BIOL, V15, P224, DOI 10.1016/j.chembiol.2008.02.008; Loos DC, 2006, J AM CHEM SOC, V128, P6270, DOI 10.1021/ja0545113; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nienhaus K, 2008, J AM CHEM SOC, V130, P12578, DOI 10.1021/ja8046443; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Wanders RJA, 2004, AM J MED GENET A, V126A, P355, DOI 10.1002/ajmg.a.20661; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Wiedenmann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854680; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J., 1997, (sulcata) Pennant, (Cnidaria, Anthozoa, Actinaria) in Gentechnologie und Molekularbiologie, Offenlegungsschrift DE, Patent No. [197 18 640 A1, 19718640]; Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	42	141	150	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4391	10.1371/journal.pone.0004391	http://dx.doi.org/10.1371/journal.pone.0004391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194514	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000265483600016
J	Guzman-Ayala, M; Lee, KL; Mavrakis, KJ; Goggolidou, P; Norris, DP; Episkopou, V				Guzman-Ayala, Marcela; Lee, Kian Leong; Mavrakis, Konstantinos J.; Goggolidou, Paraskevi; Norris, Dominic P.; Episkopou, Vasso			Graded Smad2/3 Activation Is Converted Directly into Levels of Target Gene Expression in Embryonic Stem Cells	PLOS ONE			English	Article								The Transforming Growth Factor (TGF) beta signalling family includes morphogens, such as Nodal and Activin, with important functions in vertebrate development. The concentration of the morphogen is critical for fate decisions in the responding cells. Smad2 and Smad3 are effectors of the Nodal/Activin branch of TGF beta signalling: they are activated by receptors, enter the nucleus and directly transcribe target genes. However, there have been no studies correlating levels of Smad2/3 activation with expression patterns of endogenous target genes in a developmental context over time. We used mouse Embryonic Stem (ES) cells to create a system whereby levels of activated Smad2/3 can be manipulated by an inducible constitutively active receptor (Alk4*) and an inhibitor (SB-431542) that blocks specifically Smad2/3 activation. The transcriptional responses were analysed by microarrays at different time points during activation and repression. We identified several genes that follow faithfully and reproducibly the Smad2/3 activation profile. Twenty-seven of these were novel and expressed in the early embryo downstream of Smad2/3 signalling. As they responded to Smad2/3 activation in the absence of protein synthesis, they were considered direct. These immediate responsive genes included negative intracellular feedback factors, like SnoN and I-Smad7, which inhibit the transcriptional activity of Smad2/3. However, their activation did not lead to subsequent repression of target genes over time, suggesting that this type of feedback is inefficient in ES cells or it is counteracted by mechanisms such as ubiquitin-mediated degradation by Arkadia. Here we present an ES cell system along with a database containing the expression profile of thousands of genes downstream of Smad2/3 activation patterns, in the presence or absence of protein synthesis. Furthermore, we identify primary target genes that follow proportionately and with high sensitivity changes in Smad2/3 levels over 15-30 hours. The above system and resource provide tools to study morphogen function in development.	[Guzman-Ayala, Marcela; Lee, Kian Leong; Mavrakis, Konstantinos J.; Episkopou, Vasso] Imperial Coll Sch Med, Hammersmith Hosp, Ctr Clin Sci, MRC, London, England; [Goggolidou, Paraskevi; Norris, Dominic P.] MRC, Mammalian Genet Unit, Harwell, Berks, England	Imperial College London	Guzman-Ayala, M (corresponding author), Imperial Coll Sch Med, Hammersmith Hosp, Ctr Clin Sci, MRC, London, England.	vepiskop@csc.mrc.ac.uk	LEE, Kian Leong/E-3584-2013; Episkopou, Vasso/E-2952-2010	LEE, Kian Leong/0000-0002-0443-2746; 	Medical Research Council, United Kingdom; Medical Research Council [MC_EX_G0501680, MC_U120074332] Funding Source: researchfish; MRC [MC_EX_G0501680, MC_U120074332] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, United Kingdom.	Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Ang SL, 2004, SEMIN CELL DEV BIOL, V15, P555, DOI 10.1016/j.semcdb.2004.04.009; Armes NA, 1997, DEVELOPMENT, V124, P3797; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dickmeis T, 2001, DEV DYNAM, V222, P571, DOI 10.1002/dvdy.1220; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; JONES CM, 1995, DEVELOPMENT, V121, P3651; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LEVY L, 2007, MOL CELL BIOL; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; NAGANO Y, 2007, J BIOL CHEM; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Norris DP, 2002, DEVELOPMENT, V129, P3455; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Robb L, 2004, SEMIN CELL DEV BIOL, V15, P543, DOI 10.1016/j.semcdb.2004.04.005; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Salgueiro AM, 2006, INT J DEV BIOL, V50, P705, DOI 10.1387/ijdb.062168as; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	72	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4268	10.1371/journal.pone.0004268	http://dx.doi.org/10.1371/journal.pone.0004268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172185	Green Published, gold, Green Accepted			2022-12-27	WOS:000265482900001
J	Hirrlinger, J; Scheller, A; Hirrlinger, PG; Kellert, B; Tang, WN; Wehr, MC; Goebbels, S; Reichenbach, A; Sprengel, R; Rossner, MJ; Kirchhoff, F				Hirrlinger, Johannes; Scheller, Anja; Hirrlinger, Petra G.; Kellert, Beate; Tang, Wannan; Wehr, Michael C.; Goebbels, Sandra; Reichenbach, Andreas; Sprengel, Rolf; Rossner, Moritz J.; Kirchhoff, Frank			Split-Cre Complementation Indicates Coincident Activity of Different Genes In Vivo	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; TRANSGENIC MICE; STEM-CELLS; NG2 CELLS; EXPRESSION; MOUSE; RECOMBINASE; OLIGODENDROCYTES; ASTROCYTES	Cre/LoxP recombination is the gold standard for conditional gene regulation in mice in vivo. However, promoters driving the expression of Cre recombinase are often active in a wide range of cell types and therefore unsuited to target more specific subsets of cells. To overcome this limitation, we designed inactive "split-Cre'' fragments that regain Cre activity when overlapping co-expression is controlled by two different promoters. Using transgenic mice and virus-mediated expression of split-Cre, we show that efficient reporter gene activation is achieved in vivo. In the brain of transgenic mice, we genetically defined a subgroup of glial progenitor cells in which the Plp1- and the Gfap-promoter are simultaneously active, giving rise to both astrocytes and NG2-positive glia. Similarly, a subset of interneurons was labelled after viral transfection using Gad67- and Cck1 promoters to express split-Cre. Thus, split-Cre mediated genomic recombination constitutes a powerful spatial and temporal coincidence detector for in vivo targeting.	[Hirrlinger, Johannes] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany; [Hirrlinger, Johannes; Scheller, Anja; Hirrlinger, Petra G.; Kellert, Beate; Wehr, Michael C.; Goebbels, Sandra; Rossner, Moritz J.; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Hirrlinger, Johannes; Kirchhoff, Frank] DFG, Research Ctr Molecular Physiol Brain, Gottingen, Germany; [Scheller, Anja] Free Univ Berlin, Sect Biol Chem & Pharm, D-1000 Berlin, Germany; [Hirrlinger, Petra G.; Reichenbach, Andreas] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Tang, Wannan; Sprengel, Rolf] Max Planck Inst Med Res, Dept Molecular Neurobiol, Heidelberg, Germany	Leipzig University; Max Planck Society; German Research Foundation (DFG); Free University of Berlin; Leipzig University; Max Planck Society	Hirrlinger, J (corresponding author), Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany.	johannes.hirrlinger@medizin.uni-leipzig.de; kirchhoff@em.mpg.de	Kirchhoff, Frank/B-9335-2008; Hirrlinger, Johannes/F-5984-2010; Scheller, Anja/B-8577-2018; Wehr, Michael/J-7989-2019; Reichenbach, Andreas/B-2510-2017	Kirchhoff, Frank/0000-0002-2324-2761; Scheller, Anja/0000-0001-8955-2634; Wehr, Michael/0000-0003-1770-8323; Rossner, Moritz/0000-0002-0667-3420; Tang, Wannan/0000-0002-2263-6435	Max Planck Society; Deutsche Forschungsgemeinschaft; DFG Research Center for Molecular Physiology of the Brain [SPP 1172, SFB636/A4]; INSERM/Max-Planck Society [AMIGO]; VW Stiftung [AZ-1/80 704]; Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); INSERM/Max-Planck Society(Institut National de la Sante et de la Recherche Medicale (Inserm)Max Planck Society); VW Stiftung; Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig	This work was supported by the Max Planck Society (FK), by the Deutsche Forschungsgemeinschaft through the DFG Research Center for Molecular Physiology of the Brain (FK), SPP 1172 (FK, AR, JH), SFB636/A4 (RS), a joint INSERM/Max-Planck Society AMIGO grant (FK), the VW Stiftung (AZ-1/80 704; RS) and by the Interdisciplinary Centre for Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; During Matthew J, 2003, Methods Mol Med, V76, P221; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nolte C, 2001, GLIA, V33, P72; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; Xu YW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm559; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	51	98	101	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4286	10.1371/journal.pone.0004286	http://dx.doi.org/10.1371/journal.pone.0004286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172189	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482900006
J	Zhao, Y; Lin, B; Darflinger, R; Zhang, YK; Holterman, MJ; Skidgel, RA				Zhao, Yong; Lin, Brian; Darflinger, Robert; Zhang, Yongkang; Holterman, Mark J.; Skidgel, Randal A.			Human Cord Blood Stem Cell-Modulated Regulatory T Lymphocytes Reverse the Autoimmune-Caused Type 1 Diabetes in Nonobese Diabetic (NOD) Mice	PLOS ONE			English	Article								Background: The deficit of pancreatic islet beta cells caused by autoimmune destruction is a crucial issue in type 1 diabetes (T1D). It is essential to fundamentally control the autoimmunity for treatment of T1D. Regulatory T cells (Tregs) play a pivotal role in maintaining self-tolerance through their inhibitory impact on autoreactive effector T cells. An abnormality of Tregs is associated with initiation of progression of T1D. Methodology/Principal Findings: Here, we report that treatment of established autoimmune-caused diabetes in NOD mice with purified autologous CD4(+)CD62L(+) Tregs co-cultured with human cord blood stem cells (CB-SC) can eliminate hyperglycemia, promote islet beta-cell regeneration to increase beta-cell mass and insulin production, and reconstitute islet architecture. Correspondingly, treatment with CB-SC-modulated CD4(+)CD62L(+) Tregs (mCD4CD62L Tregs) resulted in a marked reduction of insulitis, restored Th1/Th2 cytokine balance in blood, and induced apoptosis of infiltrated leukocytes in pancreatic islets. Conclusions/Significance: These data demonstrate that treatment with mCD4CD62L Tregs can reverse overt diabetes, providing a novel strategy for the treatment of type 1 diabetes as well as other autoimmune diseases.	[Zhao, Yong; Lin, Brian; Darflinger, Robert] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Zhang, Yongkang; Skidgel, Randal A.] Univ Illinois, Dept Pharm, Chicago, IL 60680 USA; [Holterman, Mark J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, Y (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	yongzhao@uic.edu			Illinois Regenerative Medicine Institute	Illinois Regenerative Medicine Institute	This work was supported by University start-up funding (Y.Zhao) and Stem cell research grant from the Illinois Regenerative Medicine Institute (M.J.H). M.J.H. contributed to the writing of manuscript and provision of reagents/materials. The funders had no role in study design, data collection and analysis, or decision to publish.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Ablamunits V, 2007, ANN NY ACAD SCI, V1103, P19, DOI 10.1196/annals.1394.006; ALLEN JS, 2008, DIABETES; Bayry J, 2008, NAT REV IMMUNOL, V8, DOI 10.1038/nri2138-c1; BLUESTONE JA, 2008, J CLIN IMMUNOL; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Bour-Jordan H, 2007, J IMMUNOL, V179, P1004, DOI 10.4049/jimmunol.179.2.1004; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Chatenoud L, 2005, EXPERT OPIN BIOL TH, V5, pS73, DOI 10.1517/14712598.5.1.S73; Chatenoud L, 2005, INT REV IMMUNOL, V24, P247, DOI 10.1080/08830180590934994; Gombert JM, 1996, CR ACAD SCI III-VIE, V319, P125; Goudy KS, 2003, J IMMUNOL, V171, P2270, DOI 10.4049/jimmunol.171.5.2270; Huang YM, 2008, DIABETES, V57, P2360, DOI 10.2337/db08-0356; JIN Y, 2008, CLIN IMMUNOL; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Marleau AM, 2008, J IMMUNOL, V180, P5235, DOI 10.4049/jimmunol.180.8.5235; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Ricordi C, 2008, LANCET, V372, P27, DOI 10.1016/S0140-6736(08)60984-8; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Roncarolo MG, 2003, J AUTOIMMUN, V20, P269, DOI 10.1016/S0896-8411(03)00047-7; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Staeva-Vieira T, 2007, CLIN EXP IMMUNOL, V148, P17, DOI 10.1111/j.1365-2249.2007.03328.x; Summers KL, 2006, CLIN IMMUNOL, V121, P81, DOI 10.1016/j.clim.2006.05.015; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2004, P NATL ACAD SCI USA, V101, P14580, DOI 10.1073/pnas.0404870101; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; Zhao Y, 2007, IMMUNOL LETT, V108, P78, DOI 10.1016/j.imlet.2006.10.007; Zhao Y, 2006, EXP CELL RES, V312, P2454, DOI 10.1016/j.yexcr.2006.04.008; ZHOU Q, 2008, NATURE	43	61	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4226	10.1371/journal.pone.0004226	http://dx.doi.org/10.1371/journal.pone.0004226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156219	Green Published, Green Submitted, gold			2022-12-27	WOS:000265481900008
J	Mostowy, S; Tham, TN; Danckaert, A; Guadagnini, S; Boisson-Dupuis, S; Pizarro-Cerda, J; Cossart, P				Mostowy, Serge; Tham, To Nam; Danckaert, Anne; Guadagnini, Stephanie; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale			Septins Regulate Bacterial Entry into Host Cells	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; PROTEIN; INVASION; INTERNALIN; INIB; SUFFICIENT; ACTIVATION; PATTERNS; RECEPTOR; 3-KINASE	Background: Septins are conserved GTPases that form filaments and are required in many organisms for several processes including cytokinesis. We previously identified SEPT9 associated with phagosomes containing latex beads coated with the Listeria surface protein InIB. Methodology/Principal Findings: Here, we investigated septin function during entry of invasive bacteria in non-phagocytic mammalian cells. We found that SEPT9, and its interacting partners SEPT2 and SEPT11, are recruited as collars next to actin at the site of entry of Listeria and Shigella. SEPT2-depletion by siRNA decreased bacterial invasion, suggesting that septins have roles during particle entry. Incubating cells with InIB-coated beads confirmed an essential role for SEPT2. Moreover, SEPT2-depletion impaired InIB-mediated stimulation of Met-dependent signaling as shown by FRET. Conclusions/Significance: Together these findings highlight novel roles for SEPT2, and distinguish the roles of septin and actin in bacterial entry.	[Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] Inserm, U604, Paris, France; [Mostowy, Serge; Tham, To Nam; Boisson-Dupuis, Stephanie; Pizarro-Cerda, Javier; Cossart, Pascale] INRA, USC2020, Paris, France; [Danckaert, Anne] Inst Pasteur, Plate forme Imagerie Dynamique, Paris, France; [Guadagnini, Stephanie] Inst Pasteur, Plateforme Microscop Electron, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mostowy, S (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France.	pcossart@pasteur.fr	Boisson-Dupuis, Stephanie/AAF-5066-2021; Boisson-Dupuis, Stéphanie/I-2040-2017	Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Mostowy, Serge/0000-0002-7286-6503	Canadian Institutes of Health Research [fellowship]; Canadian Foundation Louis Pasteur; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute; ANR [ANR-05-MIME-O13-01]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation Louis Pasteur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ANR(French National Research Agency (ANR))	S.M. is supported by a long-term fellowship from the Canadian Institutes of Health Research, the Canadian Foundation Louis Pasteur, and the Fondation pour la Recherche Medicale. P.C. is an international research scholar from the Howard Hughes Medical Institute. This study received financial support from an ANR grant (ANR-05-MIME-O13-01).	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	55	70	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4196	10.1371/journal.pone.0004196	http://dx.doi.org/10.1371/journal.pone.0004196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145258	gold, Green Published, Green Submitted			2022-12-27	WOS:000265479800004
J	Homsy, J; Bunnell, R; Moore, D; King, R; Malamba, S; Nakityo, R; Glidden, D; Tappero, J; Mermin, J				Homsy, Jaco; Bunnell, Rebecca; Moore, David; King, Rachel; Malamba, Samuel; Nakityo, Rose; Glidden, David; Tappero, Jordan; Mermin, Jonathan			Reproductive Intentions and Outcomes among Women on Antiretroviral Therapy in Rural Uganda: A Prospective Cohort Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-POSITIVE WOMEN; PREGNANCY RATES; SOUTH-AFRICA; NORTHERN TANZANIA; SEXUAL-BEHAVIOR; RISK BEHAVIOR; MEN; FERTILITY; ABORTION	Background: Antiretroviral therapy (ART) may influence the biological, social and behavioral determinants of pregnancy in HIV-infected women. However, there are limited longitudinal data on the reproductive intentions and outcomes among women on ART in Africa. Methodology /Principal Findings: Using a prospective cohort design, we analyzed trends in desire for children and predictors of pregnancy among a cohort of 733 HIV-infected women in rural Uganda who initiated ART between May 2003 and May 2004 and were followed up in their homes until June 2006. Women answered in-depth social and behavioral questionnaires administered every quarter in year 1 after initiating ART, and every 6 to 12 months thereafter. Use of family planning methods was assessed at 18 and 24 months after starting ART. We tested for non-constant pregnancy incidence by using a shape parameter test from the Weibull distribution. We modeled repeated measurements of all variables related to the women's desire for children over time using a generalized estimating equation (GEE) extension to the logistic regression model. Risk factors for pregnancy were examined using Cox proportional hazards model. 711 women eligible for the study were followed-up for a median time of 2.4 years after starting ART. During this time, less than 7% of women reported wanting more children at any time point yet 120 (16.9%) women experienced 140 pregnancies and pregnancy incidence increased from 3.46 per 100 women-years (WY) in the first quarter to 9.5 per 100 WY at 24 months (p< 0.0001). This was paralleled by an increase in the proportion of women reporting sexual activity in the past 3 months, from 24.4% at baseline to 32.5% over 24 months of follow-up (p = 0.001). Only 14% of women used permanent or semi-permanent family planning methods by their second year on ART. In the multivariate model, younger age (HR = 2.71 per 10-year decrease, 95% CI: 2.953.78), having a BMI > 18.5 (HR = 1.09, CI: 1.01-1.18) and not having used condoms consistently in the last 3 months (HR = 1.79, CI: 1.02-3.13) were independently associated with pregnancy. Conclusion/Significance: Women on ART and their partners should be consistently counseled on the effects of ART in restoring fertility, and offered regularly free and comprehensive family planning services as part of their standard package of care.	[Homsy, Jaco; Bunnell, Rebecca; Moore, David; King, Rachel; Malamba, Samuel; Nakityo, Rose; Tappero, Jordan; Mermin, Jonathan] Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Entebbe, Uganda; [Homsy, Jaco; King, Rachel; Glidden, David] Univ Calif San Francisco, Prevent & Publ Hlth Grp, San Francisco, CA 94143 USA; [Moore, David] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V5Z 1M9, Canada	University of California System; University of California San Francisco; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Homsy, J (corresponding author), Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Entebbe, Uganda.	jhomsy@psg.ucsf.edu	Glidden, David/AAD-4730-2020; Mermin, Jonathan/J-9847-2012	Glidden, David/0000-0001-5888-1419	U.S. Government LIFE Initiative and the President Emergency Plan for AIDS Relief (PEPFAR)	U.S. Government LIFE Initiative and the President Emergency Plan for AIDS Relief (PEPFAR)	Funding for this study was provided by the U.S. Government LIFE Initiative and the President Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ANDIA I, 2008, AM J PUBLIC HLT 1204; Apondi R, 2007, JAIDS-J ACQ IMM DEF, V44, P71, DOI 10.1097/01.qai.0000243113.29412.dd; Baylies C, 2000, REPROD HEALTH MATTER, V8, P77, DOI 10.1016/S0968-8080(00)90008-9; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bussmann H, 2007, JAIDS-J ACQ IMM DEF, V45, P269; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V187, P220; Delvaux T, 2007, REPROD HEALTH MATTER, V15, P46, DOI 10.1016/S0968-8080(07)29031-7; FARLANE L, 2008, REPROD ASPIRATIONS I; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Hollos M, 2004, SOC SCI MED, V58, P1733, DOI 10.1016/S0277-9536(03)00365-4; Hollos M, 2008, CULT HEALTH SEX, V10, P159, DOI 10.1080/13691050701656789; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kaida Angela, 2006, Curr HIV/AIDS Rep, V3, P187, DOI 10.1007/s11904-006-0015-0; Kaleeba N, 1997, AIDS CARE, V9, P13, DOI 10.1080/09540129750125307; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; KING R, 2008, HIV IMPL M JUN 4 7 2; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; MacPhail C, 2007, CONTRACEPTION, V75, P383, DOI 10.1016/j.contraception.2006.12.020; MAIER M, 2008, AIDS BEHAV      0404; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Massad LS, 2004, AIDS, V18, P281, DOI 10.1097/00002030-200401230-00018; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Moyo W, 2004, AIDS BEHAV, V8, P9, DOI 10.1023/B:AIBE.0000017521.26426.9d; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; NAMALE L, 2007, 14 C RETR OPP INF LO; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nzioka C, 2001, Afr J Reprod Health, V5, P132, DOI 10.2307/3583331; Oladapo Olufemi T, 2005, J Natl Med Assoc, V97, P1672; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Smith Meredith Y, 2007, J Pain Palliat Care Pharmacother, V21, P5, DOI 10.1300/J354v21n03_03; Smits AK, 1999, AIDS PATIENT CARE ST, V13, P739, DOI 10.1089/apc.1999.13.739; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UG MIN HLTH, 2003, POL RED MOTH TO CHIL; *UG MIN HLTH AOM, 2006, UG HIV AIDS SER SURV; *UG MIN HLTH NACP, 2006, NAT STRAT FRAM HIV A; *UG MIN HLTH NCAP, 2007, UG DEM HLTH SURV 200; *UN GEN ASS, 2006, UN GEN ASS 60 SESS A; *US BUR CENS IPC G, 2008, INT DAT BAS AG SPEC; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	48	150	151	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4149	10.1371/journal.pone.0004149	http://dx.doi.org/10.1371/journal.pone.0004149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FZ	19129911	Green Published, Green Submitted, gold			2022-12-27	WOS:000265473500004
J	Brookfield, KF; Cheung, MC; Yang, R; Byrne, MM; Koniaris, LG				Brookfield, Kathleen F.; Cheung, Michael C.; Yang, Relin; Byrne, Margaret M.; Koniaris, Leonidas G.			Will Patients Benefit from Regionalization of Gynecologic Cancer Care?	PLOS ONE			English	Article								Objective: Patient chances for cure and palliation for a variety of malignancies may be greatly affected by the care provided by a treating hospital. We sought to determine the effect of volume and teaching status on patient outcomes for five gynecologic malignancies: endometrial, cervical, ovarian and vulvar carcinoma and uterine sarcoma. Methods: The Florida Cancer Data System dataset was queried for all patients undergoing treatment for gynecologic cancers from 1990-2000. Results: Overall, 48,981 patients with gynecologic malignancies were identified. Endometrial tumors were the most common, representing 43.2% of the entire cohort, followed by ovarian cancer (30.9%), cervical cancer (20.8%), vulvar cancer (4.6%), and uterine sarcoma (0.5%). By univariate analysis, although patients treated at high volume centers (HVC) were significantly younger, they benefited from an improved short-term (30-day and/or 90-day) survival for cervical, ovarian and endometrial cancers. Multivariate analysis (MVA), however, failed to demonstrate significant survival benefit for gynecologic cancer patients treated at teaching facilities (TF) or HVC. Significant prognostic factors at presentation by MVA were age over 65 (HR = 2.6, p < 0.01), African-American race (HR = 1.36, p < 0.01), and advanced stage (regional HR = 2.08, p < 0.01; advanced HR = 3.82, p < 0.01, respectively). Surgery and use of chemotherapy were each significantly associated with improved survival. Conclusion: No difference in patient survival was observed for any gynecologic malignancy based upon treating hospital teaching or volume status. Although instances of improved outcomes may occur, overall further regionalization would not appear to significantly improve patient survival.	Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA; [Cheung, Michael C.; Yang, Relin; Koniaris, Leonidas G.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL USA; [Byrne, Margaret M.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL USA	University of Miami; University of Miami; University of Miami	Brookfield, KF (corresponding author), Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA.	lkoniaris@med.miami.edu						Bristow RE, 2004, GYNECOL ONCOL, V93, P353, DOI 10.1016/j.ygyno.2004.02.010; Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; Casson AG, 2005, J SURG ONCOL, V92, P262, DOI 10.1002/jso.20368; CHEUNG MC, 2008, ANN SURG ONCOL; Cheung MC, 2008, J GASTROINTEST SURG, V12, P731, DOI 10.1007/s11605-007-0417-3; Diaz-Montes TP, 2007, GYNECOL ONCOL, V107, P436, DOI 10.1016/j.ygyno.2007.07.060; Diaz-Montes TP, 2006, GYNECOL ONCOL, V103, P1043, DOI 10.1016/j.ygyno.2006.06.018; Earle CC, 2006, J NATL CANCER I, V98, P172, DOI 10.1093/jnci/djj019; EISENKOP SM, 1992, GYNECOL ONCOL, V47, P203, DOI 10.1016/0090-8258(92)90107-T; Gutierrez JC, 2007, J GASTROINTEST SURG, V11, P1441, DOI 10.1007/s11605-007-0308-7; Gutierrez JC, 2007, ANN SURG, V245, P952, DOI 10.1097/01.sla.0000250438.04393.a8; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hodgson N, 2005, SURG ENDOSC, V19, P1610, DOI 10.1007/s00464-005-0232-4; Hoekstra A, 2006, GYNECOL ONCOL, V103, P897, DOI 10.1016/j.ygyno.2006.05.019; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; Macdonald OK, 2005, GYNECOL ONCOL, V99, P730, DOI 10.1016/j.ygyno.2005.07.111; MAYER AR, 1992, GYNECOL ONCOL, V47, P223, DOI 10.1016/0090-8258(92)90110-5; Meguid RA, 2008, ANN THORAC SURG, V85, P1015, DOI 10.1016/j.athoracsur.2007.09.046; MOLINA MA, 2008, CANCER IN PRESS; NGUYEN HN, 1993, CANCER, V72, P3663, DOI 10.1002/1097-0142(19931215)72:12<3663::AID-CNCR2820721218>3.0.CO;2-S; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Perez EA, 2006, J AM COLL SURGEONS, V202, P623, DOI 10.1016/j.jamcollsurg.2006.01.002; Perez EA, 2007, WORLD J SURG, V31, P1022, DOI 10.1007/s00268-005-0774-6; PETRELLI NJ, 2008, J CLIN ONCOL; Puls LE, 1997, SOUTHERN MED J, V90, P1097; Riall TS, 2007, J GASTROINTEST SURG, V11, P1242, DOI 10.1007/s11605-007-0245-5; Schrag D, 2006, JNCI-J NATL CANCER I, V98, P163, DOI 10.1093/jnci/djj018; Silber JH, 2007, J CLIN ONCOL, V25, P1169, DOI 10.1200/JCO.2006.08.2933; Vernooij F, 2007, GYNECOL ONCOL, V105, P801, DOI 10.1016/j.ygyno.2007.02.030; Woodman C, 1997, BRIT J OBSTET GYNAEC, V104, P135, DOI 10.1111/j.1471-0528.1997.tb11032.x	30	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4049	10.1371/journal.pone.0004049	http://dx.doi.org/10.1371/journal.pone.0004049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125205	gold, Green Published, Green Submitted			2022-12-27	WOS:000265473100001
J	Mairal, T; Nieto, J; Pinto, M; Almeida, MR; Gales, L; Ballesteros, A; Barluenga, J; Perez, JJ; Vazquez, JT; Centeno, NB; Saraiva, MJ; Damas, AM; Planas, A; Arsequell, G; Valencia, G				Mairal, Teresa; Nieto, Joan; Pinto, Marta; Almeida, Maria Rosario; Gales, Luis; Ballesteros, Alfredo; Barluenga, Jose; Perez, Juan J.; Vazquez, Jesus T.; Centeno, Nuria B.; Saraiva, Maria Joao; Damas, Ana M.; Planas, Antoni; Arsequell, Gemma; Valencia, Gregorio			Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors	PLOS ONE			English	Article								The thyroid hormone and retinol transporter protein known as transthyretin ( TTR) is in the origin of one of the 20 or so known amyloid diseases. TTR self assembles as a homotetramer leaving a central hydrophobic channel with two symmetrical binding sites. The aggregation pathway of TTR into amiloid fibrils is not yet well characterized but in vitro binding of thyroid hormones and other small organic molecules to TTR binding channel results in tetramer stabilization which prevents amyloid formation in an extent which is proportional to the binding constant. Up to now, TTR aggregation inhibitors have been designed looking at various structural features of this binding channel others than its ability to host iodine atoms. In the present work, greatly improved inhibitors have been designed and tested by taking into account that thyroid hormones are unique in human biochemistry owing to the presence of multiple iodine atoms in their molecules which are probed to interact with specific halogen binding domains sitting at the TTR binding channel. The new TTR fibrillogenesis inhibitors are based on the diflunisal core structure because diflunisal is a registered salicylate drug with NSAID activity now undergoing clinical trials for TTR amyloid diseases. Biochemical and biophysical evidence confirms that iodine atoms can be an important design feature in the search for candidate drugs for TTR related amyloidosis.	[Arsequell, Gemma; Valencia, Gregorio] CSIC, IQAC, Unit Glycoconjugate Chem, Barcelona, Spain; [Nieto, Joan; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Lab Biochem, Barcelona, Spain; [Pinto, Marta; Perez, Juan J.] Univ Politecn Barcelona, ETSEIB, Dept Ingenieria Quim, Barcelona, Spain; [Almeida, Maria Rosario; Gales, Luis; Saraiva, Maria Joao; Damas, Ana M.] Univ Porto, IBMC, Oporto, Portugal; [Ballesteros, Alfredo; Barluenga, Jose] Univ Porto, ICBAS, Oporto, Portugal; [Vazquez, Jesus T.] Univ Oviedo, Unidad Asociada CSIC, Instituto Univ Quim Organometal Enrique Moles, Oviedo, Spain; [Centeno, Nuria B.] Univ la Laguna, Inst Univ Bio Organ Antonio Gonzalez, San Cristobal de la Laguna, Spain; Univ Pompeu Fabra, IMIM, GRIB, Comp Assisted Drug Design Lab, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Universitat Ramon Llull; Institut Quimic de Sarria; Universitat Politecnica de Catalunya; Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Mairal, T (corresponding author), CSIC, IQAC, Unit Glycoconjugate Chem, Barcelona, Spain.	gvpqbp@iiqab.csic.es	Centeno, Nuria B/G-9548-2014; PLANAS, ANTONI/I-4803-2015; Ballesteros, Alfredo/P-5834-2014; Gasull, Martina/J-4076-2019; Arsequell, Gemma/ABG-7934-2020; Saraiva, Maria João/K-3907-2013; Perez, Juan J/E-3710-2010; Almeida, Maria Rosario/K-3938-2013; Vázquez, Jesús T/K-6549-2014; Gales, Luis/J-8716-2013	Centeno, Nuria B/0000-0001-7905-2329; PLANAS, ANTONI/0000-0001-7073-3320; Ballesteros, Alfredo/0000-0003-2093-4444; Saraiva, Maria João/0000-0002-3360-6899; Perez, Juan J/0000-0002-0748-8147; Almeida, Maria Rosario/0000-0001-9289-3835; Gales, Luis/0000-0002-8352-6539; Trujillo Vazquez, Jesus/0000-0002-3622-3148; ARSEQUELL, GEMMA/0000-0002-7009-3738	MCYT (Spain) [EET2002 05157 CO5]; MEC (Spain) [CTQ2004 08077 CO2, BIO2007 67904]; CEC Principado de Asturias [IB05 136]; Generalitat de Catalunya [2005SGR00883]; red Heracles ISCIII (Spain) [DR06/0009]; Fundacao Ciencia e Tecnologia (FCT) (Portugal); FEDER [POCI/SAU-MMO/57321/ 2004, POCTI/SAU NEU/58735/2004, PTDC/SAU NEU/69123/2006]	MCYT (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEC (Spain)(Spanish Government); CEC Principado de Asturias; Generalitat de Catalunya(Generalitat de Catalunya); red Heracles ISCIII (Spain); Fundacao Ciencia e Tecnologia (FCT) (Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission)	This work was supported by grants: EET2002 05157 CO5 (to G.V., J.B., A.P.) from MCYT (Spain), CTQ2004 08077 CO2 (to J.B.) and BIO2007 67904 (to A.P.) from MEC (Spain), IB05 136 (to J.B.) from CEC Principado de Asturias, 2005SGR00883 (to A.P.) from Generalitat de Catalunya, DR06/0009 (to N.B.C.) from red Heracles ISCIII (Spain). Funding from Fundacao Ciencia e Tecnologia (FCT) (Portugal) through POCTI and POCI programmes (Programa Operacional Ciencia e Inovacao 2010) (to M.J.S.) and FEDER (Project POCI/SAU-MMO/57321/ 2004 to M.R.A.). POCTI/SAU NEU/58735/2004 (to A.M.D.), PTDC/SAU NEU/69123/2006 (to A.M.D.) and FEDER funds (to A.M.D.) are acknowledged. Diffraction data were collected at ESRF beam line ID14 1.	Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; BARLUENGA J, 1992, J CHEM SOC CHEM COMM, P1016, DOI 10.1039/c39920001016; Barluenga J, 1999, PURE APPL CHEM, V71, P431, DOI 10.1351/pac199971030431; Barluenga J., 1999, CURRENT TRENDS ORGAN, P145; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; Baures PW, 1999, BIOORGAN MED CHEM, V7, P1339, DOI 10.1016/S0968-0896(99)00066-8; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; *BOST U FDA NINDS, NCT00294671 BOST U F; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; CASE DA, 1999, AMBER VERSION 6; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; De la Paz P., 1992, DESIGN DRUGS MACROMO, P119; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dolado I, 2005, J COMB CHEM, V7, P246, DOI 10.1021/cc049849s; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; HAGEN GA, 1973, J CLIN ENDOCR METAB, V37, P415, DOI 10.1210/jcem-37-3-415; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2008, J MED CHEM, V51, P6348, DOI 10.1021/jm800435s; Johnson SM, 2008, J MED CHEM, V51, P260, DOI 10.1021/jm0708735; Julius RL, 2007, P NATL ACAD SCI USA, V104, P4808, DOI 10.1073/pnas.0700316104; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P238; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Liu F, 2008, P NATL ACAD SCI USA, V105, P2369, DOI 10.1073/pnas.0711908105; McCarthy RE, 1998, CLIN CARDIOL, V21, P547; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NILSSON SF, 1975, J BIOL CHEM, V250, P8554; Oravcova J, 1996, J CHROMATOGR B, V677, P1, DOI 10.1016/0378-4347(95)00425-4; Oza VB, 1999, BIOORG MED CHEM LETT, V9, P1, DOI 10.1016/S0960-894X(98)00696-9; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Petrassi HM, 2005, J AM CHEM SOC, V127, P6662, DOI 10.1021/ja044351f; Purkey HE, 2004, CHEM BIOL, V11, P1719, DOI 10.1016/j.chembiol.2004.10.009; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Razavi H, 2003, ANGEW CHEM INT EDIT, V42, P2758, DOI 10.1002/anie.200351179; Razavi H, 2005, BIOORG MED CHEM LETT, V15, P1075, DOI 10.1016/j.bmcl.2004.12.022; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; ROUSSEL A, 1991, TURBOFRODO SILICON G; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; *SIM IM, 2000, INS 2 VERS 2000; STEELMAN SL, 1978, CURR MED RES OPIN, V5, P506, DOI 10.1185/03007997809108993; Tagoe CE, 2007, AMYLOID, V14, P227, DOI 10.1080/13506120701464396; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P9265, DOI 10.1021/bi050352o; Wiseman RL, 2005, J AM CHEM SOC, V127, P5540, DOI 10.1021/ja042929f; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	79	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4124	10.1371/journal.pone.0004124	http://dx.doi.org/10.1371/journal.pone.0004124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125186	Green Published, gold			2022-12-27	WOS:000265473100003
J	Wang, S; Ziman, B; Bodi, I; Rubio, M; Zhou, YY; D'Souza, K; Bishopric, NH; Schwartz, A; Lakatta, EG				Wang, Su; Ziman, Bruce; Bodi, Ilona; Rubio, Marta; Zhou, Ying-Ying; D'Souza, Karen; Bishopric, Nanette H.; Schwartz, Arnold; Lakatta, Edward G.			Dilated Cardiomyopathy with Increased SR Ca2+ Loading Preceded by a Hypercontractile State and Diastolic Failure in the alpha(1C)TG Mouse	PLOS ONE			English	Article								Mice over-expressing the alpha(1)-subunit (pore) of the L-type Ca2+ channel (alpha(1C)TG) by 4months (mo) of age exhibit an enlarged heart, hypertrophied myocytes, increased Ca2+ current and Ca2+ transient amplitude, but a normal SR Ca2+ load. With advancing age (8-11 mo), some mice demonstrate advanced hypertrophy but are not in congestive heart failure (NFTG), while others evolve to frank dilated congestive heart failure (FTG). We demonstrate that older NFTG myocytes exhibit a hypercontractile state over a wide range of stimulation frequencies, but maintain a normal SR Ca2+ load compared to age matched non-transgenic (NTG) myocytes. However, at high stimulation rates (2-4 Hz) signs of diastolic contractile failure appear in NFTG cells. The evolution of frank congestive failure in FTG is accompanied by a further increase in heart mass and myocyte size, and phospholamban and ryanodine receptor protein levels and phosphorylation become reduced. In FTG, the SR Ca2+ load increases and Ca2+ release following excitation, increases further. An enhanced NCX function in FTG, as reflected by an accelerated relaxation of the caffeine-induced Ca2+ transient, is insufficient to maintain a normal diastolic Ca2+ during high rates of stimulation. Although a high SR Ca2+ release following excitation is maintained, the hypercontractile state is not maintained at high rates of stimulation, and signs of both systolic and diastolic contractile failure appear. Thus, the dilated cardiomyopathy that evolves in this mouse model exhibits signs of both systolic and diastolic failure, but not a deficient SR Ca2+ loading or release, as occurs in some other cardiomyopathic models.	[Wang, Su; Ziman, Bruce; Zhou, Ying-Ying; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD USA; [Bodi, Ilona; Rubio, Marta; D'Souza, Karen; Schwartz, Arnold] Univ Cincinnati, Coll Med, Dept Surg, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45221 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol Med & Pediat, Miami, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Ohio; University of Cincinnati; University of Miami	Wang, S (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Baltimore, MD USA.	schwara@email.uc.edu; LakattaE@grc.nia.nih.gov	Lakatta, Edward G/AAL-1447-2020	Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the National Institutes of Health, National Institute on Aging [R01 HL079599, T-32 HL07382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079599, T32HL007382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000235] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging, and in part by R01 HL079599 (AS), and T-32 HL07382 (AS).	Antoons G, 2006, J MOL CELL CARDIOL, V40, P350, DOI 10.1016/j.yjmcc.2005.12.002; Balke CW, 1998, CARDIOVASC RES, V37, P290, DOI 10.1016/S0008-6363(97)00272-1; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; Bito V, 2004, CIRC RES, V94, P794, DOI 10.1161/01.RES.0000124934.84048.DF; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Boluyt MO, 1995, EUR HEART J, V16, P19, DOI 10.1093/eurheartj/16.suppl_N.19; Bridge JHB, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.176172; BROOKSBY P, 1993, CARDIOVASC RES, V27, P1268, DOI 10.1093/cvr/27.7.1268; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; DELMONTE F, 1995, CARDIOVASC RES, V30, P281, DOI 10.1016/S0008-6363(95)00040-2; Eisner DA, 2002, CIRC RES, V91, P979, DOI 10.1161/01.RES.0000045654.34731.FF; GWATHMEY JK, 1991, J CLIN INVEST, V87, P1023, DOI 10.1172/JCI115061; HARIGAYA S, 1969, CIRC RES, V25, P781, DOI 10.1161/01.RES.25.6.781; Harris DM, 2005, CIRC RES, V96, P543, DOI 10.1161/01.RES.0000158966.58380.37; Houser SR, 1999, CIRCULATION, V99, P600, DOI 10.1161/01.CIR.99.5.600; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Lakatta EG, 2004, J MOL CELL CARDIOL, V36, P1, DOI 10.1016/j.yjmcc.2003.10.014; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; MacDonnell SM, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.174722; MELZER W, 1987, BIOPHYS J, V51, P849, DOI 10.1016/S0006-3495(87)83413-6; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Palomeque J, 2007, J CARD FAIL, V13, P143, DOI 10.1016/j.cardfail.2006.11.002; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; SCHWARTZ A, 1973, AM J CARDIOL, V32, P407, DOI 10.1016/S0002-9149(73)80031-1; Sen LY, 2000, AM J PHYSIOL-HEART C, V279, pH709, DOI 10.1152/ajpheart.2000.279.2.H709; Sipido KR, 2005, CARDIOVASC RES, V68, P167, DOI 10.1016/j.cardiores.2005.08.011; SIRI FM, 1991, AM J PHYSIOL, V261, pH514, DOI 10.1152/ajpheart.1991.261.2.H514; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Song LS, 2005, CIRC RES, V97, P457, DOI 10.1161/01.RES.0000179722.79295.d4; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; STERN MD, 1989, AM J PHYSIOL, V257, pH665, DOI 10.1152/ajpheart.1989.257.2.H665; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159	36	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4133	10.1371/journal.pone.0004133	http://dx.doi.org/10.1371/journal.pone.0004133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125184	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473100007
J	Field, KL; Bachmanov, AA; Mennella, JA; Beauchamp, GK; Kimball, BA				Field, Kristin L.; Bachmanov, Alexander A.; Mennella, Julie A.; Beauchamp, Gary K.; Kimball, Bruce A.			Protein Hydrolysates Are Avoided by Herbivores but Not by Omnivores in Two-Choice Preference Tests	PLOS ONE			English	Article								Background: The negative sensory properties of casein hydrolysates (HC) often limit their usage in products intended for human consumption, despite HC being nutritious and having many functional benefits. Recent, but taxonomically limited, evidence suggests that other animals also avoid consuming HC when alternatives exist. Methodology/Principal Findings: We evaluated ingestive responses of five herbivorous species (guinea pig, mountain beaver, gopher, vole, and rabbit) and five omnivorous species (rat, coyote, house mouse, white-footed mouse, and deer mouse; N = 16-18/species) using solid foods containing 20% HC in a series of two-choice preference tests that used a nonprotein, cellulose-based alternative. Individuals were also tested with collagen hydrolysate (gelatin; GE) to determine whether it would induce similar ingestive responses to those induced by HC. Despite HC and GE having very different nutritional and sensory qualities, both hydrolysates produced similar preference score patterns. We found that the herbivores generally avoided the hydrolysates while the omnivores consumed them at similar levels to the cellulose diet or, more rarely, preferred them (HC by the white-footed mouse; GE by the rat). Follow-up preference tests pairing HC and the nutritionally equivalent intact casein (C) were performed on the three mouse species and the guinea pigs. For the mice, mean HC preference scores were lower in the HC v C compared to the HC v Cel tests, indicating that HC's sensory qualities negatively affected its consumption. However, responses were species-specific. For the guinea pigs, repeated exposure to HC or C (4.7-h sessions; N = 10) were found to increase subsequent HC preference scores in an HC v C preference test, which was interpreted in the light of conservative foraging strategies thought to typify herbivores. Conclusions/Significance: This is the first empirical study of dietary niche-related taxonomic differences in ingestive responses to protein hydrolysates using multiple species under comparable conditions. Our results provide a basis for future work in sensory, physiological, and behavioral mechanisms of hydrolysate avoidance and on the potential use of hydrolysates for pest management.	[Field, Kristin L.; Bachmanov, Alexander A.; Mennella, Julie A.; Beauchamp, Gary K.; Kimball, Bruce A.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Kimball, Bruce A.] USDA, APHIS, Natl Wildlife Res Ctr, Ft Collins, CO USA	Monell Chemical Senses Center; United States Department of Agriculture (USDA)	Field, KL (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	bkimball@monell.org	Bachmanov, Alexander A./AAH-8857-2020	Bachmanov, Alexander A./0000-0002-2861-3322; Mennella, Julie/0000-0002-8855-0204	USDA-NWRC Monell Cooperative agreement [07-7442-0585-CA]; California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee [2 T32 DC 00014]; KLF: Ruth L. Kirschstein National Research Service Award; National Institutes of Health [DC00882, HD37119]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000882, T32DC000014] Funding Source: NIH RePORTER	USDA-NWRC Monell Cooperative agreement; California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee; KLF: Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	USDA-NWRC Monell Cooperative agreement (07-7442-0585-CA) California Dept. of Food and Agriculture Vertebrate Pest Control Research Advisory Committee. Author funding sources: KLF: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (2 T32 DC 00014) from the National Institutes of Health. AAB and GKB: National Institutes of Health R01 grant (DC00882). JAM: National Institutes of Health R01 grant (HD37119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker L. M., 1977, LEARNING MECH FOOD S; BEAUCHAMP GK, 1977, J COMP PHYSIOL PSYCH, V91, P1118, DOI 10.1037/h0077380; BLUNDELL JE, 1983, NUTR BRAIN, P163; CASTLE KT, 1995, J COMP PHYSIOL B, V164, P609, DOI 10.1007/BF00389801; Day JEL, 1998, NUTR RES REV, V11, P25, DOI 10.1079/NRR19980004; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Dominy NJ, 2001, EVOL ANTHROPOL, V10, P171, DOI 10.1002/evan.1031; Domjan M., 1977, LEARNING MECH FOOD S, P151; Feurte S, 2002, NUTR NEUROSCI, V5, P269, DOI 10.1080/10284150290032003; Feurte S, 2000, PHYSIOL BEHAV, V68, P423, DOI 10.1016/S0031-9384(99)00202-4; Field KL, 2008, PHYSIOL BEHAV, V93, P189, DOI 10.1016/j.physbeh.2007.08.010; Figueroa JA, 2008, CROP PROT, V27, P851, DOI 10.1016/j.cropro.2007.07.004; FitzGerald RJ, 2006, BIOTECHNOL ADV, V24, P234, DOI 10.1016/j.biotechadv.2005.11.002; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Haq AU, 1996, J NUTR, V126, P3083, DOI 10.1093/jn/126.12.3083; Harris JA, 2004, J EXP PSYCHOL-ANIM B, V30, P177, DOI 10.1037/0097-7403.30.3.177; Host A, 2004, ALLERGY, V59, P45, DOI 10.1111/j.1398-9995.2004.00574.x; HUME ID, 1994, DIGESTIVE SYSTEM IN MAMMALS: FOOD, FORM, AND FUNCTION, P315, DOI 10.1017/CBO9780511661716.020; Kilara A, 2003, CRIT REV FOOD SCI, V43, P607, DOI 10.1080/10408690390251138; Kimball B., 2006, ADV VERTEBRATE PEST, P59; Kimball BA, 2006, WEST J APPL FOR, V21, P108, DOI 10.1093/wjaf/21.2.108; Kimball BA, 2005, HORTSCIENCE, V40, P1810, DOI 10.21273/HORTSCI.40.6.1810; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; LANDRY SO, 1970, Q REV BIOL, V45, P351, DOI 10.1086/406647; Lax P, 1998, PHYSIOL BEHAV, V65, P69, DOI 10.1016/S0031-9384(98)00123-1; Linden M. C., 1985, NUTR BIOCH METABOLIS, P51; Linhart SB, 2002, J WILDLIFE DIS, V38, P363, DOI 10.7589/0090-3558-38.2.363; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; MATOBA T, 1969, AGR BIOL CHEM TOKYO, V33, P1662, DOI 10.1080/00021369.1969.10859521; Meisel H, 1998, INT DAIRY J, V8, P363, DOI 10.1016/S0958-6946(98)00059-4; Mennella JA, 2002, EARLY HUM DEV, V68, P71, DOI 10.1016/S0378-3782(02)00008-7; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; Mennella JA, 2005, CHEM SENSES, V30, pI242, DOI 10.1093/chemse/bjh204; MURRAY TK, 1952, J SCI FOOD AGR, V3, P470, DOI 10.1002/jsfa.2740031006; NCNAB BK, 2002, DIET NUTR PHYSL ECOL, P390; Ohsumi M, 2007, AMINO ACIDS, V32, P247, DOI 10.1007/s00726-006-0362-6; PEDERSEN B, 1994, FOOD TECHNOL-CHICAGO, V48, P96; Pedrosa M, 2006, J INVEST ALLERG CLIN, V16, P351; PIQUARD F, 1978, PHYSIOL BEHAV, V20, P771, DOI 10.1016/0031-9384(78)90304-9; Ribeiro RPP, 1998, PHYSIOL BEHAV, V63, P185, DOI 10.1016/S0031-9384(97)00419-8; RoudotAlgaron F, 1996, LAIT, V76, P313, DOI 10.1051/lait:1996425; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saha BC, 2001, BIOTECHNOL ADV, V19, P355, DOI 10.1016/S0734-9750(01)00070-2; SAKAGUCHI E, 1987, BRIT J NUTR, V58, P149, DOI 10.1079/BJN19870078; SHINODA I, 1986, AGR BIOL CHEM TOKYO, V50, P1247, DOI 10.1080/00021369.1986.10867553; SLADE LM, 1969, J ANIM SCI, V28, P842, DOI 10.2527/jas1969.286842x; Sokal R.R., 2012, BIOMETRY; *STATSOFT INC, 2002, STATISTICA 6 1; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; White T. C. R., 1993, INADEQUATE ENV NITRO; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001	53	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4126	10.1371/journal.pone.0004126	http://dx.doi.org/10.1371/journal.pone.0004126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122811	Green Submitted, gold, Green Published			2022-12-27	WOS:000265472900006
J	Grandison, RC; Wong, R; Bass, TM; Partridge, L; Piper, MDW				Grandison, Richard C.; Wong, Richard; Bass, Timothy M.; Partridge, Linda; Piper, Matthew D. W.			Effect of a Standardised Dietary Restriction Protocol on Multiple Laboratory Strains of Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; CALORIC RESTRICTION; HISTORY; SENESCENCE; LONGEVITY; SELECTION; REPRODUCTION; WOLBACHIA; EVOLUTION; GENOTYPE	Background: Outcomes of lifespan studies in model organisms are particularly susceptible to variations in technical procedures. This is especially true of dietary restriction, which is implemented in many different ways among laboratories. Principal Findings: In this study, we have examined the effect of laboratory stock maintenance, genotype differences and microbial infection on the ability of dietary restriction (DR) to extend life in the fruit fly Drosophila melanogaster. None of these factors block the DR effect. Conclusions: These data lend support to the idea that nutrient restriction genuinely extends lifespan in flies, and that any mechanistic discoveries made with this model are of potential relevance to the determinants of lifespan in other organisms.	[Grandison, Richard C.; Wong, Richard; Bass, Timothy M.; Partridge, Linda; Piper, Matthew D. W.] UCL, UCL Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England	University of London; University College London	Grandison, RC (corresponding author), UCL, UCL Inst Hlth Ageing, Dept Genet Evolut & Environm, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Wong, Richard/H-5189-2015; Piper, Matthew/C-1714-2008	Wong, Richard/0000-0002-4382-1568; Piper, Matthew/0000-0003-3245-7219; Partridge, Linda/0000-0001-9615-0094; Grandison, Richard/0000-0002-4552-0494	Wellcome Trust Strategic Award; Medical Research Council; Research into Ageing; Biotechnology and Biological Science Research Council	Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research into Ageing; Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Strategic Award (MP and LP); Medical Research Council (RW); Research into Ageing (RG); and the Biotechnology and Biological Science Research Council (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Carey JR, 2002, AGING CELL, V1, P140, DOI 10.1046/j.1474-9728.2002.00019.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy David J., 2001, Drosophila Information Service, V84, P168; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5; Jiang JC, 2000, FASEB J, V14, P2135; Kirk KL, 2001, J GERONTOL A-BIOL, V56, pB123, DOI 10.1093/gerona/56.3.B123; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kopec S, 1928, BR J EXP BIOL, V5, P204; Le Bourg E, 2005, AGEING RES REV, V4, P409, DOI 10.1016/j.arr.2004.12.001; Le Bourg E., 1991, AGE NUTR, V2, P90; Linnen C, 2001, EVOL ECOL RES, V3, P877; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; MIN KJ, 2008, AGING CELL IN PRESS; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Oishi K, 2004, NEUROREPORT, V15, P739, DOI 10.1097/00001756-200403220-00034; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1992, EVOLUTION, V46, P76, DOI [10.2307/2409806, 10.1111/j.1558-5646.1992.tb01986.x]; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; R Development Core Team, 2005, R LANG ENV STAT COMP; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weindruch R., 1988, RETARDATION AGING DI; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	46	71	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4067	10.1371/journal.pone.0004067	http://dx.doi.org/10.1371/journal.pone.0004067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119322	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472600001
J	Bossi, P; Gay, F; Fouzai, I; Combadiere, B; Brousse, G; Lebrun-Vignes, B; Crance, JM; Autran, B; Garin, D				Bossi, Philippe; Gay, Frederick; Fouzai, Imene; Combadiere, Behazine; Brousse, Genevieve; Lebrun-Vignes, Benedicte; Crance, Jean-Marc; Autran, Brigitte; Garin, Daniel		IMMUVAR Grp	Demographic and Clinical Factors Associated with Response to Smallpox Vaccine in Preimmunized Volunteers	PLOS ONE			English	Article								Context: In March 2003, the French Ministry of Health implemented a program on preparedness and response to a biological attack using smallpox as weapon. This program included the establishment of a preoutbreak national team that could be revaccinated against smallpox. Objective: To identify demographic and clinical factors associated with vaccination success defined as the presence of a pustule at the inoculation site at day 8 (days 7-9), with an undiluted vaccinia virus derived from a Lister strain among preimmunized volunteers. Volunteers and Methods: From March 2003 to November 2006, we have studied prospectively 226 eligible volunteers. Demographic data were recorded for each volunteer (age, sex, number of previously smallpox vaccinations and date of the last vaccination). Smallpox vaccine adverse reactions were diagnosed on the basis of clinical examination performed at days 0, 7, 14, 21 and 28 after revaccination. Results: A total of 226 volunteers (sex ratio H/F = 2.7) were revaccinated. Median age was 45 years (range: 27-63 yrs). All volunteers completed follow-up. Median number of vaccinations before revaccination was 2 (range: 1-8). The median delay between time of the study and the last vaccination was 29 years (range; 18-60 yrs). Sixty-one volunteers (27%) experienced one (n = 40) or more (n = 21) minor side effects during the 2-14 days after revaccination. Successful vaccination was noted in 216/226 volunteers (95.6%) at day 8 and the median of the pustule diameter was 5 mm (range: 1-20 mm). Size of the pustule at day 8 was correlated with age (p = 0.03) and with the presence of axillary adenopathy after revaccination (p = 0.007). Sex, number of prior vaccinations, delay between the last vaccination and revaccination, and local or systemic side effects with the exception of axillary adenopathy, were not correlated with the size of the pustule at day 8. Conclusions: Previously vaccinated volunteers can be successfully revaccinated with the Lister strain.	[Bossi, Philippe; Gay, Frederick; Fouzai, Imene; Combadiere, Behazine] Univ Paris 06, Dept Infect Dis, Paris, France; [Brousse, Genevieve; Autran, Brigitte] Univ Paris 06, Dept Immunol, INSERM U543, F-75252 Paris, France; [Lebrun-Vignes, Benedicte] Univ Paris 06, Dept Pharmacol, Paris, France; [Bossi, Philippe; Gay, Frederick; Combadiere, Behazine; Brousse, Genevieve; Lebrun-Vignes, Benedicte; Autran, Brigitte; Garin, Daniel] Univ Paris 06, Pitie Salpetriere Hosp, Paris, France; [Crance, Jean-Marc; Garin, Daniel] CRSSA Emile Parde, Dept Virol, Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bossi, P (corresponding author), Univ Paris 06, Dept Infect Dis, Paris, France.	philippe.bossi@psl.aphp.fr	Combadiere, Behazine/G-3881-2013; Combadiere, Behazine/S-8054-2019	Combadiere, Behazine/0000-0002-2353-4406	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The financial contribution of INSERM (Institut National de la Sante et de la Recherche Medicale) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artenstein AW, 2005, VACCINE, V23, P3301, DOI 10.1016/j.vaccine.2005.01.079; Bartlett J, 2003, CLIN INFECT DIS, V36, P883, DOI 10.1086/374792; Bossi P, 2006, CELL MOL LIFE SCI, V63, P2196, DOI 10.1007/s00018-006-6308-z; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Casey Christine, 2006, Morbidity and Mortality Weekly Report, V55, P1; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Ennis FA, 2002, J INFECT DIS, V185, P1657, DOI 10.1086/340517; Ferrier-Rembert A, 2007, VACCINE, V25, P8290, DOI 10.1016/j.vaccine.2007.09.050; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431; Frey SE, 2003, JAMA-J AM MED ASSOC, V289, P3295, DOI 10.1001/jama.289.24.3295; Graham PL, 2007, VACCINE, V25, P5763, DOI 10.1016/j.vaccine.2007.04.063; Greenberg RN, 2005, LANCET, V365, P398, DOI 10.1016/S0140-6736(05)70234-8; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hsieh SM, 2006, VACCINE, V24, P510, DOI 10.1016/j.vaccine.2005.07.082; Kim SH, 2007, CLIN MICROBIOL INFEC, V13, P91, DOI 10.1111/j.1469-0691.2006.01576.x; Kim SH, 2005, J INFECT DIS, V192, P1066, DOI 10.1086/432765; Levy-Bruhl D, 2001, Euro Surveill, V6, P171; Metzger W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004913.pub2; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; Talbot TR, 2004, JAMA-J AM MED ASSOC, V292, P1205, DOI 10.1001/jama.292.10.1205; Vellozzi C, 2005, CLIN INFECT DIS, V41, P689, DOI 10.1086/432584; World Health Organization, 1980, GLOB ER SMALLP FIN R; 2006, PLAN NATL REPONSE ME	30	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4087	10.1371/journal.pone.0004087	http://dx.doi.org/10.1371/journal.pone.0004087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116649	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466600008
J	Cauda, F; Sacco, K; Duca, S; Cocito, D; D'Agata, F; Geminiani, GC; Canavero, S				Cauda, Franco; Sacco, Katiuscia; Duca, Sergio; Cocito, Dario; D'Agata, Federico; Geminiani, Giuliano C.; Canavero, Sergio			Altered Resting State in Diabetic Neuropathic Pain	PLOS ONE			English	Article							MODE NETWORK ACTIVITY; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; BRAIN-FUNCTION; CORTEX; FLUCTUATIONS; MECHANISMS; SYNCHRONY; FREQUENCY; RESONANCE	Background: The spontaneous component of neuropathic pain (NP) has not been explored sufficiently with neuroimaging techniques, given the difficulty to coax out the brain components that sustain background ongoing pain. Here, we address for the first time the correlates of this component in an fMRI study of a group of eight patients suffering from diabetic neuropathic pain and eight healthy control subjects. Specifically, we studied the functional connectivity that is associated with spontaneous neuropathic pain with spatial independent component analysis (sICA). Principal Findings: Functional connectivity analyses revealed a cortical network consisting of two anti-correlated patterns: one includes the left fusiform gyrus, the left lingual gyrus, the left inferior temporal gyrus, the right inferior occipital gyrus, the dorsal anterior cingulate cortex bilaterally, the pre and postcentral gyrus bilaterally, in which its activity is correlated negatively with pain and positively with the controls; the other includes the left precuneus, dorsolateral prefrontal, frontopolar cortex (both bilaterally), right superior frontal gyrus, left inferior frontal gyrus, thalami, both insulae, inferior parietal lobuli, right mammillary body, and a small area in the left brainstem, in which its activity is correlated positively with pain and negatively with the controls. Furthermore, a power spectra analyses revealed group differences in the frequency bands wherein the sICA signal was decomposed: patients' spectra are shifted towards higher frequencies. Conclusion: In conclusion, we have characterized here for the first time a functional network of brain areas that mark the spontaneous component of NP. Pain is the result of aberrant default mode functional connectivity.	[Cauda, Franco; Sacco, Katiuscia; Duca, Sergio; D'Agata, Federico; Geminiani, Giuliano C.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Cauda, Franco; Sacco, Katiuscia; D'Agata, Federico; Geminiani, Giuliano C.] Univ Turin, Dept Psychol, I-10124 Turin, Italy; [Cocito, Dario; D'Agata, Federico] AOU San Giovanni Battista, Dept Neurosci, Turin, Italy; [Canavero, Sergio] Turin Advanced Neuromodulat Grp, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Cauda, F (corresponding author), Koelliker Hosp, CCS fMRI, Turin, Italy.	franco.cauda@unito.it; sercan@inwind.it	Sacco, Katiuscia/J-2133-2012; Cocito, Dario/O-4820-2019; Cauda, Franco/G-5021-2010; D'Agata, Federico/ABG-8839-2021	Sacco, Katiuscia/0000-0002-9660-5236; Cauda, Franco/0000-0003-1526-8475; D'Agata, Federico/0000-0001-9432-0248	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita(Regione Piemonte)	Regione Piemonte, Ricerca Scientifica Applicata, Settore Scienze della Vita, 2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Brambilla M, 2004, ARCH ITAL BIOL, V142, P275; Buzsaki G., 2006, RHYTHMS BRAIN; CANAVERO S, 1993, NEUROSURGERY, V32, P185, DOI 10.1227/00006123-199302000-00006; Canavero S, 2007, CENTRAL PAIN SYNDROME: PATHOPHYSIOLOGY, DIAGNOSIS AND MANAGEMENT, P1, DOI 10.1017/CBO9780511585692; CAUDA F, 2009, J NEUROL NE IN PRESS; COLE LJ, 2008, NEUROBIOL AGING; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Foss JM, 2006, J NEUROPHYSIOL, V95, P730, DOI 10.1152/jn.00768.2005; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gusnard DA, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1267; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Koenig T, 2005, PHILOS T R SOC B, V360, P1015, DOI 10.1098/rstb.2005.1649; KRAUTHAMER GM, 1974, BRAIN RES, V80, P141, DOI 10.1016/0006-8993(74)90732-X; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Meyer-Base Anke, 2004, Int J Neural Syst, V14, P217, DOI 10.1142/S0129065704002017; Ohara S, 2006, PAIN, V123, P244, DOI 10.1016/j.pain.2006.02.012; PETRIDES M, 2004, HUMAN NERVOUS SYSTEM, P951; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Quiton RL, 2007, PAIN, V132, pS134, DOI 10.1016/j.pain.2007.09.001; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Vercelli A, 2006, NEUROINFORMATICS, V4, P319, DOI 10.1385/NI:4:4:319; Wang JY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-34; Ward LM, 2006, CAN J EXP PSYCHOL, V60, P319, DOI 10.1037/cjep2006029; WILLIS WD, 2004, HUMAN NERVOUS SYSTEM, P1125, DOI DOI 10.1016/B978-012547626-3/50031-4; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006	53	161	170	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4542	10.1371/journal.pone.0004542	http://dx.doi.org/10.1371/journal.pone.0004542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229326	Green Submitted, Green Published, gold			2022-12-27	WOS:000265486200013
J	Perera, F; Tang, WY; Herbstman, J; Tang, DL; Levin, L; Miller, R; Ho, SM				Perera, Frederica; Tang, Wan-yee; Herbstman, Julie; Tang, Deliang; Levin, Linda; Miller, Rachel; Ho, Shuk-mei			Relation of DNA Methylation of 5 '-CpG Island of ACSL3 to Transplacental Exposure to Airborne Polycyclic Aromatic Hydrocarbons and Childhood Asthma	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; PROSTATE CARCINOGENESIS; RESPIRATORY SYMPTOMS; BREAST-MILK; FATTY-ACIDS; HIGH-RISK; GENE; BIRTH; IDENTIFICATION; TRANSCRIPTION	In a longitudinal cohort of similar to 700 children in New York City, the prevalence of asthma (>25%) is among the highest in the US. This high risk may in part be caused by transplacental exposure to traffic-related polycyclic aromatic hydrocarbons (PAHs) but biomarkers informative of PAH-asthma relationships is lacking. We here hypothesized that epigenetic marks associated with transplacental PAH exposure and/or childhood asthma risk could be identified in fetal tissues. Mothers completed personal prenatal air monitoring for PAH exposure determination. Methylation sensitive restriction fingerprinting was used to analyze umbilical cord white blood cell (UCWBC) DNA of 20 cohort children. Over 30 DNA sequences were identified whose methylation status was dependent on the level of maternal PAH exposure. Six sequences were found to be homologous to known genes having one or more 5'-CpG island(s) (5'-CGI). Of these, acyl-CoA synthetase long-chain family member 3 (ACSL3) exhibited the highest concordance between the extent of methylation of its 5'-CGI in UCWBCs and the level of gene expression in matched fetal placental tissues in the initial 20 cohort children. ACSL3 was therefore chosen for further investigation in a larger sample of 56 cohort children. Methylation of the ACSL3 5'-CGI was found to be significantly associated with maternal airborne PAH exposure exceeding 2.41 ng/m(3) (OR = 13.8; p<0.001; sensitivity = 75%; specificity = 82%) and with a parental report of asthma symptoms in children prior to age 5 (OR = 3.9; p<0.05). Thus, if validated, methylated ACSL3 5'CGI in UCWBC DNA may be a surrogate endpoint for transplacental PAH exposure and/or a potential biomarker for environmentally-related asthma. This exploratory report provides a new blueprint for the discovery of epigenetic biomarkers relevant to other exposure assessments and/or investigations of exposure-disease relationships in birth cohorts. The results support the emerging theory of early origins of later life disease development.	[Perera, Frederica; Herbstman, Julie; Tang, Deliang; Miller, Rachel] Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10027 USA; [Tang, Wan-yee; Levin, Linda; Ho, Shuk-mei] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ho, Shuk-mei] Univ Cincinnati, Ctr Environm Genet, Cincinnati, OH 45221 USA; [Ho, Shuk-mei] Univ Cincinnati, Coll Med, Canc Ctr, Cincinnati, OH 45221 USA; [Miller, Rachel] Columbia Univ, Coll Phys & Surgeons, Div Pulmonary Allergy & Critical Care Med, New York, NY 10027 USA	Columbia University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Columbia University	Perera, F (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10027 USA.	shuk-mei.ho@uc.edu		Tang, Wan-Yee/0000-0002-0663-9820	National Institutes of Health [ES009600, ES008977, ES015905, ES013071, ES015584, ES006096, ES016817]; Department of Defense [DAMD W81XWH-06-1-0373]; U.S. Environmental Protection Agency [RD-832141]; New York Community Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015905, K99ES016817, R21ES013071, P30ES006096, R01ES015584, R01ES013163, P50ES009600, P01ES009600, R01ES008977, R00ES016817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); U.S. Environmental Protection Agency(United States Environmental Protection Agency); New York Community Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is in part supported by National Institutes of Health grants: ES009600 (FP), ES008977 (FP), ES015905 (FP, SMH, RM, DT), ES013071 (SMH), ES015584 (SMH), and ES006096 (SMH), ES016817 (WYT), the Department of Defense award DAMD W81XWH-06-1-0373 (WYT), the U.S. Environmental Protection Agency award RD-832141(FP), and the New York Community Trust (FP,RM, DT, JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Beck M, 2000, ACTA PAEDIATR, V89, P279, DOI 10.1080/080352500750028401; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAS DK, 1982, LUNG, V160, P207, DOI 10.1007/BF02719294; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Gyorffy E, 2008, MUTAGENESIS, V23, P1, DOI 10.1093/mutage/gem043; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilakivi-Clarke L, 2006, TRENDS ENDOCRIN MET, V17, P340, DOI 10.1016/j.tem.2006.09.002; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Huang THM, 1997, CANCER RES, V57, P1030; Jedrychowski W, 2005, EUR J EPIDEMIOL, V20, P775, DOI 10.1007/s10654-005-1048-1; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Kuzmin A, 2008, GENE EXPR PATTERNS, V8, P107, DOI 10.1016/j.modgep.2007.09.005; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Li SF, 2003, ANN NY ACAD SCI, V983, P161, DOI 10.1111/j.1749-6632.2003.tb05971.x; Liu J, 2008, TOXICOL SCI, V102, P76, DOI 10.1093/toxsci/kfm290; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Miller RL, 2008, AM J RESP CRIT CARE, V177, P567, DOI 10.1164/rccm.200710-1511PP; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Minekura H, 2001, GENE, V278, P185, DOI 10.1016/S0378-1119(01)00714-4; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Nicholas SW, 2005, AM J PUBLIC HEALTH, V95, P245, DOI 10.2105/AJPH.2004.042705; Oddy WH, 2006, PEDIAT ALLERG IMM-UK, V17, P4, DOI 10.1111/j.1399-3038.2005.00340.x; Padmanabhan V, 2007, REV ENDOCR METAB DIS, V8, P67, DOI 10.1007/s11154-007-9051-3; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Selgrade MK, 2006, ENVIRON HEALTH PERSP, V114, P615, DOI 10.1289/ehp.8376; Stock W, 2000, LANCET, V355, P1351, DOI 10.1016/S0140-6736(00)02125-5; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; TANG WY, 2008, ENDOCRINOLOGY   0731; Tomita Michiyo, 2004, Lipids Health Dis, V3, P1, DOI 10.1186/1476-511X-3-1; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Weber P, 2001, BRIT J NUTR, V86, pS93, DOI 10.1079/BJN2001344; Wijga A, 2003, PEDIAT ALLERG IMM-UK, V14, P156, DOI 10.1034/j.1399-3038.2003.00022.x; Woods RK, 2004, THORAX, V59, P105, DOI 10.1136/thorax.2003.009498; Wu MC, 2004, ONCOGENE, V23, P250, DOI 10.1038/sj.onc.1207076	51	308	320	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4488	10.1371/journal.pone.0004488	http://dx.doi.org/10.1371/journal.pone.0004488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221603	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485700013
J	Vidarsson, H; Westergren, R; Heglind, M; Blomqvist, SR; Breton, S; Enerback, S				Vidarsson, Hilmar; Westergren, Rickard; Heglind, Mikael; Blomqvist, Sandra Rodrigo; Breton, Sylvie; Enerback, Sven			The Forkhead Transcription Factor Foxi1 Is a Master Regulator of Vacuolar H+-ATPase Proton Pump Subunits in the Inner Ear, Kidney and Epididymis	PLOS ONE			English	Article								The vacuolar H+-ATPase dependent transport of protons across cytoplasmic membranes in FORE (forkhead related) cells ofendolymphatic epithelium in the inner ear, intercalated cells of collecting ducts in the kidney and in narrow and clear cells of epididymis require expression of several subunits that assemble into a functional multimeric proton pump. We demonstrate that expression of four such subunits A1, B1, E2 and a4 all co-localize with the forkhead transcription factor Foxi1 in a subset of epithelial cells at these three locations. In cells, of such epithelia, that lack Foxi1 we fail to identify any expression of A1, B1, E2 and a4 demonstrating an important role for the transcription factor Foxi1 in regulating subunit availability. Promoter reporter experiments, electrophoretic mobility shift assays (EMSA) and site directed mutagenesis demonstrate that a Foxi1 expression vector can trans-activate an a4-promoter reporter construct in a dose dependent manner. Furthermore, we demonstrate using chromatin immunoprecipitation (ChIP) assays that Foxi1-dependent activation to a large extent depends on cis-elements at position -561/-547 in the a4 promoter. Thus, we provide evidence that Foxi1 is necessary for expression of at least four subunits in three different epithelia and most likely is a major determinant for proper assembly of a functional vacuolar H+-ATPase complex at these locations.	[Vidarsson, Hilmar; Westergren, Rickard; Heglind, Mikael; Blomqvist, Sandra Rodrigo; Enerback, Sven] Univ Gothenburg, Ctr Med Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Breton, Sylvie] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nephrol Div, Ctr Syst Biol, Program Membrane Biol, Boston, MA USA	University of Gothenburg; Harvard University; Harvard Medical School; Massachusetts General Hospital	Vidarsson, H (corresponding author), Univ Gothenburg, Ctr Med Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	sven.enerback@medgen.gu.se			Swedish Research Council [K2005-32BI-15324-01A]; EU [QLK3-CT-2002-02149, LSHM-CT-2003-503041]; The Arne and IngaBritt Foundation; The Soderberg Foundation; NIH [HD040793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); The Arne and IngaBritt Foundation; The Soderberg Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SE's laboratory is supported from the Swedish Research Council (grant K2005-32BI-15324-01A), EU grants (QLK3-CT-2002-02149) and (LSHM-CT-2003-503041), The Arne and IngaBritt Foundation and The Soderberg Foundation. SB's laboratory is supported by NIH grant HD040793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314	20	91	93	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4471	10.1371/journal.pone.0004471	http://dx.doi.org/10.1371/journal.pone.0004471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214237	Green Submitted, gold, Green Published			2022-12-27	WOS:000265484300010
J	Komarova, NL; Katouli, AA; Wodarz, D				Komarova, Natalia L.; Katouli, Allen A.; Wodarz, Dominik			Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia	PLOS ONE			English	Article								Chronic myeloid leukemia (CML) is a cancer of the hematopoietic system and has been treated with the drug Imatinib relatively successfully. Drug resistance, acquired by mutations, is an obstacle to success. Two additional drugs are now considered and could be combined with Imatinib to prevent resistance, Dasatinib and Nilotinib. While most mutations conferring resistance to one drug do not confer resistance to the other drugs, there is one mutation (T315I) that induces resistance against all three drugs. Using computational methods, the combination of two drugs is found to increase the probability of treatment success despite this cross-resistance. Combining more than two drugs, however, does not provide further advantages. We also explore possible combination therapies using drugs currently under development. We conclude that among the targeted drugs currently available for the treamtent of CML, only the two most effective ones should be used in combination for the prevention of drug resistance.	[Komarova, Natalia L.; Katouli, Allen A.; Wodarz, Dominik] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [R01 CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded in part by NIH grant R01 CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Burley SK, 2005, BLOOD, V106, p206A, DOI 10.1182/blood.V106.11.698.698; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; COLDMAN AJ, 1983, MATH BIOSCI, V65, P291, DOI 10.1016/0025-5564(83)90066-4; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Daley GQ, 2003, SEMIN HEMATOL, V40, P11, DOI 10.1053/shem.2003.50035; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Duncan EA, 2008, MOL CANCER THER, V7, P391, DOI 10.1158/1535-7163.MCT-07-0305; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; GOLDIE JH, 1998, DRUG RESISTANCE CANC; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Melo JV, 2007, CANCER LETT, V249, P121, DOI 10.1016/j.canlet.2006.07.010; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; O'Dwyer ME, 2002, ANNU REV MED, V53, P369, DOI 10.1146/annurev.med.53.082901.103853; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788	34	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4423	10.1371/journal.pone.0004423	http://dx.doi.org/10.1371/journal.pone.0004423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204794	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484000012
J	Morse, AM; Peterson, DG; Islam-Faridi, MN; Smith, KE; Magbanua, Z; Garcia, SA; Kubisiak, TL; Amerson, HV; Carlson, JE; Nelson, CD; Davis, JM				Morse, Alison M.; Peterson, Daniel G.; Islam-Faridi, M. Nurul; Smith, Katherine E.; Magbanua, Zenaida; Garcia, Saul A.; Kubisiak, Thomas L.; Amerson, Henry V.; Carlson, John E.; Nelson, C. Dana; Davis, John M.			Evolution of Genome Size and Complexity in Pinus	PLOS ONE			English	Article							GYPSY-LIKE RETROTRANSPOSON; LOBLOLLY-PINE; CENTROMERIC REGION; DNA CONTENT; GENE; MAIZE; ARABIDOPSIS; SEQUENCES; ORGANIZATION; POPULATIONS	Background: Genome evolution in the gymnosperm lineage of seed plants has given rise to many of the most complex and largest plant genomes, however the elements involved are poorly understood. Methodology/Principal Findings: Gymny is a previously undescribed retrotransposon family in Pinus that is related to Athila elements in Arabidopsis. Gymny elements are dispersed throughout the modern Pinus genome and occupy a physical space at least the size of the Arabidopsis thaliana genome. In contrast to previously described retroelements in Pinus, the Gymny family was amplified or introduced after the divergence of pine and spruce ( Picea). If retrotransposon expansions are responsible for genome size differences within the Pinaceae, as they are in angiosperms, then they have yet to be identified. In contrast, molecular divergence of Gymny retrotransposons together with other families of retrotransposons can account for the large genome complexity of pines along with protein-coding genic DNA, as revealed by massively parallel DNA sequence analysis of Cot fractionated genomic DNA. Conclusions/Significance: Most of the enormous genome complexity of pines can be explained by divergence of retrotransposons, however the elements responsible for genome size variation are yet to be identified. Genomic resources for Pinus including those reported here should assist in further defining whether and how the roles of retrotransposons differ in the evolution of angiosperm and gymnosperm genomes.	[Morse, Alison M.; Davis, John M.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Peterson, Daniel G.; Magbanua, Zenaida] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS USA; [Islam-Faridi, M. Nurul; Smith, Katherine E.; Kubisiak, Thomas L.; Nelson, C. Dana] USDA Forest Serv So Res Stn, Saucier, MS USA; [Garcia, Saul A.; Amerson, Henry V.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA; [Carlson, John E.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA	State University System of Florida; University of Florida; Mississippi State University; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Morse, AM (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	jmdavis@ufl.edu		Davis, John/0000-0002-8522-5406; Peterson, Daniel/0000-0002-0274-5968	USDA Forest Service-Southern Research Station [SRS 00-CA-11330126-016]; NSF [DBI-0421717]; USDA-CSREES [2006-34506-17290]	USDA Forest Service-Southern Research Station(United States Department of Agriculture (USDA)United States Forest Service); NSF(National Science Foundation (NSF)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the USDA Forest Service-Southern Research Station (Agreement SRS 00-CA-11330126-016 to JMD and AMM), NSF DBI-0421717 (to DGP, CDN and MNI-F) and USDA-CSREES 2006-34506-17290 (to DGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1998, GENES GENET SYST, V73, P243, DOI 10.1266/ggs.73.243; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Auckland LD, 2001, CAN J BOT, V79, P1375, DOI 10.1139/cjb-79-11-1375; Belyayev A, 2005, CYTOGENET GENOME RES, V109, P43, DOI 10.1159/000082380; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bennett MD, 2004, PLANT DNA C VALUES D; Bennetzen JL, 1998, CURR OPIN PLANT BIOL, V1, P103, DOI 10.1016/S1369-5266(98)80010-1; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Cai Q, 2006, ANN BOT-LONDON, V97, P715, DOI 10.1093/aob/mcl030; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dvorak WS, 2000, NEW FOREST, V20, P163, DOI 10.1023/A:1006763120982; Elsik CG, 2000, MOL GEN GENET, V264, P47, DOI 10.1007/s004380000279; Friesen N, 2001, MOL BIOL EVOL, V18, P1176, DOI 10.1093/oxfordjournals.molbev.a003905; Fuchs J, 2008, CHROMOSOME RES, V16, P891, DOI 10.1007/s10577-008-1252-4; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2008, PLANT SCI, V174, P557, DOI 10.1016/j.plantsci.2008.03.015; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Hill P, 2005, MOL GENET GENOMICS, V273, P371, DOI 10.1007/s00438-005-1141-x; Islam-Faridi MN, 2007, GENOME, V50, P241, DOI 10.1139/G06-153; Jewell David C., 1994, P484; Joyner KL, 2001, CAN J BOT, V79, P192, DOI 10.1139/cjb-79-2-192; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kamm A, 1996, P NATL ACAD SCI USA, V93, P2708, DOI 10.1073/pnas.93.7.2708; Kinlaw CS, 1997, TRENDS PLANT SCI, V2, P356, DOI 10.1016/S1360-1385(97)84624-9; Kossack DS, 1999, PLANT MOL BIOL, V39, P417, DOI 10.1023/A:1006115732620; Kumekawa N, 2000, DNA RES, V7, P315, DOI 10.1093/dnares/7.6.315; Liu RY, 2007, P NATL ACAD SCI USA, V104, P11844, DOI 10.1073/pnas.0704258104; Lorenz WW, 2002, TREE PHYSIOL, V22, P301, DOI 10.1093/treephys/22.5.301; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McKeand S, 2003, J FOREST, V101, P32; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Millar Constance L., 1998, P69; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; MURRAY MG, 1981, J MOL EVOL, V17, P31, DOI 10.1007/BF01792422; OHRI D, 1986, PLANT SYST EVOL, V153, P119, DOI 10.1007/BF00989421; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Paterson AH, 2006, NAT REV GENET, V7, P174, DOI 10.1038/nrg1806; Pereira V, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r79; Peterson DG, 2002, TRENDS GENET, V18, P547, DOI 10.1016/S0168-9525(02)02764-6; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; PRICE RA, 1989, ECOLOGY BIOGEOGRAPHY, P49; RAKE AV, 1980, CAN J GENET CYTOL, V22, P69, DOI 10.1139/g80-010; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Santini S, 2002, CHROMOSOMA, V111, P192, DOI 10.1007/s00412-002-0196-2; Schmidt A, 2000, THEOR APPL GENET, V101, P7, DOI 10.1007/s001220051442; Shibata F, 2004, J CELL SCI, V117, P2963, DOI 10.1242/jcs.01144; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VARMUS H, 1989, MOBILE DNA, P53; VOYTAS DF, 1988, NATURE, V336, P242, DOI 10.1038/336242a0; Voytas DF, 1996, SCIENCE, V274, P737, DOI 10.1126/science.274.5288.737; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Walbot V, 2001, P NATL ACAD SCI USA, V98, P8163, DOI 10.1073/pnas.161278798; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Wilcox PL, 1996, P NATL ACAD SCI USA, V93, P3859, DOI 10.1073/pnas.93.9.3859; Williams CG, 2002, BIOL J LINN SOC, V75, P503, DOI 10.1046/j.1095-8312.2002.00038.x; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yuan YN, 2003, PLANT J, V34, P249, DOI 10.1046/j.1365-313X.2003.01716.x; YUE X, 1988, MOL BIOL EVOL, V5, P675; ZIMMER EA, 1988, GENETICS, V120, P1125; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	74	118	122	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4332	10.1371/journal.pone.0004332	http://dx.doi.org/10.1371/journal.pone.0004332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194510	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483600001
J	Touma, C; Fenzl, T; Ruschel, J; Palme, R; Holsboer, F; Kimura, M; Landgraf, R				Touma, Chadi; Fenzl, Thomas; Ruschel, Joerg; Palme, Rupert; Holsboer, Florian; Kimura, Mayumi; Landgraf, Rainer			Rhythmicity in Mice Selected for Extremes in Stress Reactivity: Behavioural, Endocrine and Sleep Changes Resembling Endophenotypes of Major Depression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL SYSTEM; SLOW-WAVE ACTIVITY; ATYPICAL DEPRESSION; GROWTH-HORMONE; HPA AXIS; CORTICOSTERONE; CORTISOL; BRAIN; CRH	Background: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, including hyper- or hypo-activity of the stress hormone system, plays a critical role in the pathophysiology of mood disorders such as major depression (MD). Further biological hallmarks of MD are disturbances in circadian rhythms and sleep architecture. Applying a translational approach, an animal model has recently been developed, focusing on the deviation in sensitivity to stressful encounters. This so-called 'stress reactivity' (SR) mouse model consists of three separate breeding lines selected for either high (HR), intermediate (IR), or low (LR) corticosterone increase in response to stressors. Methodology/Principle Findings: In order to contribute to the validation of the SR mouse model, our study combined the analysis of behavioural and HPA axis rhythmicity with sleep-EEG recordings in the HR/IR/LR mouse lines. We found that hyper-responsiveness to stressors was associated with psychomotor alterations (increased locomotor activity and exploration towards the end of the resting period), resembling symptoms like restlessness, sleep continuity disturbances and early awakenings that are commonly observed in melancholic depression. Additionally, HR mice also showed neuroendocrine abnormalities similar to symptoms of MD patients such as reduced amplitude of the circadian glucocorticoid rhythm and elevated trough levels. The sleep-EEG analyses, furthermore, revealed changes in rapid eye movement (REM) and non-REM sleep as well as slow wave activity, indicative of reduced sleep efficacy and REM sleep disinhibition in HR mice. Conclusion/Significance: Thus, we could show that by selectively breeding mice for extremes in stress reactivity, clinically relevant endophenotypes of MD can be modelled. Given the importance of rhythmicity and sleep disturbances as biomarkers of MD, both animal and clinical studies on the interaction of behavioural, neuroendocrine and sleep parameters may reveal molecular pathways that ultimately lead to the discovery of new targets for antidepressant drugs tailored to match specific pathologies within MD.	[Touma, Chadi; Fenzl, Thomas; Ruschel, Joerg; Holsboer, Florian; Kimura, Mayumi; Landgraf, Rainer] Max Planck Inst Psychiat, Munich, Germany; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria	Max Planck Society; University of Veterinary Medicine Vienna	Touma, C (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	touma@mpipsykl.mpg.de	Touma, Chadi/G-4677-2011; Yan, Shuo/B-8381-2009; Palme, Rupert/A-3499-2008	Palme, Rupert/0000-0001-9466-3662	Max Planck Society (MPS)	Max Planck Society (MPS)(Max Planck Society)	Funding for this study was provided by the Max Planck Society (MPS). The MPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2002, J AFFECT DISORDERS, V72, P125, DOI 10.1016/S0165-0327(02)00169-6; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Antonijevic I, 2008, STRESS, V11, P15, DOI 10.1080/10253890701378967; Armitage R, 2000, PSYCHIAT RES, V95, P201, DOI 10.1016/S0165-1781(00)00178-5; Armitage R., 1997, CURRENT REV MOOD ANX, V1, P139; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Buysse DJ, 1997, BIOL PSYCHIAT, V41, P406, DOI 10.1016/S0006-3223(96)00041-8; Chang FC, 1998, AM J PHYSIOL-REG I, V275, pR793, DOI 10.1152/ajpregu.1998.275.3.R793; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0; Deuschle M, 1997, J CLIN ENDOCR METAB, V82, P234, DOI 10.1210/jc.82.1.234; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Fenzl T, 2007, J NEUROSCI METH, V166, P229, DOI 10.1016/j.jneumeth.2007.07.007; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Gonzalez MMD, 1998, BEHAV PHARMACOL, V9, P655, DOI 10.1097/00008877-199812000-00001; Gonzalez MMD, 1997, J SLEEP RES, V6, P164; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hartmann A, 1997, NEUROBIOL AGING, V18, P285, DOI 10.1016/S0197-4580(97)80309-0; Hasler G, 2004, PSYCHOL MED, V34, P1047, DOI 10.1017/S0033291703001697; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 2008, NAT REV NEUROSCI, V9, P638, DOI 10.1038/nrn2453; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kimura M, 2006, J SLEEP RES, V15, P101; Kleitman N., 1963, SLEEP WAKEFULNESS; Kriegsfeld LJ, 2006, HORM BEHAV, V49, P557, DOI 10.1016/j.yhbeh.2005.12.011; KUPFER DJ, 1995, BIOL PSYCHIAT, V38, P391, DOI 10.1016/0006-3223(94)00295-E; KUPFER DJ, 1976, BIOL PSYCHIAT, V11, P159; Lepschy M, 2007, LAB ANIM-UK, V41, P372, DOI 10.1258/002367707781282730; Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Modell Sieglinde, 2007, Curr Psychiatry Rep, V9, P480, DOI 10.1007/s11920-007-0065-z; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; QUITKIN FM, 1985, J AFFECT DISORDERS, V8, P61, DOI 10.1016/0165-0327(85)90073-4; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; REYNOLDS CF, 1987, SLEEP, V10, P199, DOI 10.1093/sleep/10.3.199; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V16, P461; SACHAR EJ, 1973, ARCH GEN PSYCHIAT, V28, P19; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V17, P554; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shaffery J, 2003, NEUROSCIENTIST, V9, P82, DOI 10.1177/1073858402239594; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Steiger A, 2002, SLEEP MED REV, V6, P125, DOI 10.1053/smrv.2001.0159; STEIGER A, 1994, J PSYCHIAT RES, V28, P225, DOI 10.1016/0022-3956(94)90008-6; Steiger A, 2007, J PSYCHIATR RES, V41, P537, DOI 10.1016/j.jpsychires.2006.04.007; Stone EA, 2008, NEUROSCI BIOBEHAV R, V32, P508, DOI 10.1016/j.neubiorev.2007.08.007; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Thomson F, 2008, NEUROCHEM RES, V33, P691, DOI 10.1007/s11064-007-9518-3; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Voigtlander T, 2006, EUR J NEUROSCI, V23, P2723, DOI 10.1111/j.1460-9568.2006.04801.x; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Yassouridis A, 1999, J SLEEP RES, V8, P25, DOI 10.1046/j.1365-2869.1999.00133.x; [No title captured]; [No title captured]; [No title captured]	78	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4325	10.1371/journal.pone.0004325	http://dx.doi.org/10.1371/journal.pone.0004325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JH	19177162	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483100008
J	Allemand, MC; Irving, BA; Asmann, YW; Klaus, KA; Tatpati, L; Coddington, CC; Nair, KS				Allemand, Michael C.; Irving, Brian A.; Asmann, Yan W.; Klaus, Katherine A.; Tatpati, Laura; Coddington, Charles C.; Nair, K. Sreekumaran			Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes-A Potential Model for PCOS-Related Insulin Resistance	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; SKELETAL-MUSCLE CELLS; RECEPTOR SUBSTRATE-1; GLUCOSE-TRANSPORT; FEMALE RATS; PATHWAY; KINASE; SENSITIVITY; WOMEN; RISK	Background: Polycystic ovary syndrome (PCOS) is characterized by a hyperandrogenic state and frequently develops skeletal muscle insulin resistance. We determined whether testosterone adversely affects insulin action by increasing serine phosphorylation of IRS-1(636/639) in differentiated rat skeletal muscle myotubes. The phosphorylation of Akt, mTOR, and S6K, downstream targets of the PI3-kinase-IRS-1 complex were also studied. Methods: Primary differentiated rat skeletal muscle myotubes were subjected to insulin for 30 min after 16-hour pre-exposure to either low (20 ng/ml) or high (200 ng/ml) doses of testosterone. Protein phosphorylation of IRS-1 Ser(636/639), Akt Ser(473), mTOR-Ser(2448), and S6K-Thr(389) were measured by Western blot with signal intensity measured by immunofluorescence. Results: Cells exposed to 100 nM of insulin had increased IRS-1 Ser(636/639) and Akt Ser(473) phosphorylation. Cells pre-exposed to low-dose testosterone had significantly increased insulin-induced mTOR-Ser(2448) and S6K-Thr(389) phosphorylation (p < 0.05), and further increased insulin-induced IRS-1 Ser(636/639) phosphorylation (p = 0.042) compared to control cells. High-dose testosterone pre-exposure attenuated the insulin-induced mTOR-Ser(2448) and S6K-Thr(389) phosphorylation. Conclusions: The data demonstrated an interaction between testosterone and insulin on phosphorylation of intracellular signaling proteins, and suggests a link between a hyperandrogenic, hyperinsulinemic environment and the development of insulin resistance involving serine phosphorylation of IRS-1 Ser(636/639). These results may guide further investigations of potential mechanisms of PCOS-related insulin resistance.	[Allemand, Michael C.; Tatpati, Laura; Coddington, Charles C.] Mayo Clin, Grad Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Irving, Brian A.; Asmann, Yan W.; Klaus, Katherine A.; Nair, K. Sreekumaran] Mayo Clin, Grad Sch Med, Dept Internal Med, Endocrine Res Unit, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Allemand, MC (corresponding author), Mayo Clin, Grad Sch Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Rochester, MN 55905 USA.	nair.sree@mayo.edu	Irving, Brian/B-9683-2016	Irving, Brian/0000-0002-4131-9523	NIH [RO1 DK 41973]; David Murdock Dole Professorship [KL2 RR024151]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Murdock Dole Professorship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH RO1 DK 41973 and David Murdock Dole Professorship (KSN), KL2 RR024151 (BAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Bertacca A, 2005, METABOLISM, V54, P1687, DOI 10.1016/j.metabol.2005.06.019; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Diamond MP, 1998, J CLIN ENDOCR METAB, V83, P4420, DOI 10.1210/jc.83.12.4420; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Dunaif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE392, DOI 10.1152/ajpendo.2001.281.2.E392; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152; HOLMANG A, 1990, AM J PHYSIOL, V259, pE555, DOI 10.1152/ajpendo.1990.259.4.E555; Holmang A, 2001, ACTA PHYSIOL SCAND, V171, P427, DOI 10.1046/j.1365-201X.2001.00801.x; HOLMANG A, 1992, AM J PHYSIOL, V262, pE851, DOI 10.1152/ajpendo.1992.262.6.E851; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Li M, 2002, J CLIN ENDOCR METAB, V87, P4088, DOI 10.1210/jc.2002-020363; Moghetti P, 1996, J CLIN ENDOCR METAB, V81, P952, DOI 10.1210/jc.81.3.952; Mussig K, 2005, BIOCHEM BIOPH RES CO, V335, P819, DOI 10.1016/j.bbrc.2005.07.154; O'Connor JC, 2003, METABOLISM, V52, P666, DOI 10.1016/S0026-0495(03)00026-X; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Partridge T A, 1997, Methods Mol Biol, V75, P131; Rincon J, 1996, DIABETES, V45, P615, DOI 10.2337/diabetes.45.5.615; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tremblay F, 2001, J BIOL CHEM, V276, P38052; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001	31	45	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4274	10.1371/journal.pone.0004274	http://dx.doi.org/10.1371/journal.pone.0004274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169352	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482800004
J	Beaslas, O; Cueille, C; Delers, F; Chateau, D; Chambaz, J; Rousset, M; Carriere, V				Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique			Sensing of Dietary Lipids by Enterocytes: A New Role for SR-BI/CLA-1	PLOS ONE			English	Article								Background: The intestine is responsible for absorbing dietary lipids and delivering them to the organism as triglyceride-rich lipoproteins (TRL). It is important to determine how this process is regulated in enterocytes, the absorptive cells of the intestine, as prolonged postprandial hypertriglyceridemia is a known risk factor for atherosclerosis. During the postprandial period, dietary lipids, mostly triglycerides (TG) hydrolyzed by pancreatic enzymes, are combined with bile products and reach the apical membrane of enterocytes as postprandial micelles (PPM). Our aim was to determine whether these micelles induce, in enterocytes, specific early cell signaling events that could control the processes leading to TRL secretion. Methodology/Principal Findings: The effects of supplying PPM to the apex of Caco-2/TC7 enterocytes were analyzed. Micelles devoid of TG hydrolysis products, like those present in the intestinal lumen in the interprandial period, were used as controls. The apical delivery of PPM specifically induced a number of cellular events that are not induced by interprandial micelles. These early events included the trafficking of apolipoprotein B, a structural component of TRL, from apical towards secretory domains, and the rapid, dose-dependent activation of ERK and p38MAPK. PPM supply induced the scavenger receptor SR-BI/CLA-1 to cluster at the apical brush border membrane and to move from non-raft to raft domains. Competition, inhibition or knockdown of SR-BI/CLA-1 impaired the PPM-dependent apoB trafficking and ERK activation. Conclusions/Significance: These results are the first evidence that enterocytes specifically sense postprandial dietary lipid-containing micelles. SR-BI/CLA-1 is involved in this process and could be a target for further study with a view to modifying intestinal TRL secretion early in the control pathway.	[Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] Univ Paris 06, UMR S 872, Paris, France; [Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] INSERM, U 872, Paris, France; [Beaslas, Olivier; Cueille, Carine; Delers, Francois; Chateau, Danielle; Chambaz, Jean; Rousset, Monique; Carriere, Veronique] Univ Paris 05, UMR S 872, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Beaslas, O (corresponding author), Univ Paris 06, UMR S 872, Paris, France.	veronique.carriere@crc.jussieu.fr	Carrière, Véronique/AAQ-5027-2021	Carrière, Véronique/0000-0002-6263-0847	Ministere de l'Enseignement Superieur et de la Recherche [fellowship]; Fondation pour la Recherche Medicale; Le Conseil Regional d'Ile de France [fellowship]	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Le Conseil Regional d'Ile de France	O.B. is recipient of a fellowship from Ministere de l'Enseignement Superieur et de la Recherche and from Fondation pour la Recherche Medicale. C.C. is recipient of a fellowship from Le Conseil Regional d'Ile de France. This work was supported in part by a grant from Groupe Lipides Nutrition.	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Alqub M, 2008, CHEM PHYS LIPIDS, V154, pS57, DOI 10.1016/j.chemphyslip.2008.05.155; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Beaslas O, 2008, AM J PHYSIOL-GASTR L, V295, pG942, DOI 10.1152/ajpgi.90237.2008; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Boisfer E, 1999, J BIOL CHEM, V274, P11564, DOI 10.1074/jbc.274.17.11564; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Cai SF, 2001, J LIPID RES, V42, P902; Carriere V, 2005, J BIOL CHEM, V280, P5406, DOI 10.1074/jbc.M408002200; CHANTRET I, 1994, J CELL SCI, V107, P213; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davidson NO, 2000, ANNU REV NUTR, V20, P169, DOI 10.1146/annurev.nutr.20.1.169; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Hansen GH, 2003, GUT, V52, P1424, DOI 10.1136/gut.52.10.1424; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hui DY, 2005, SEMIN CELL DEV BIOL, V16, P183, DOI 10.1016/j.semcdb.2005.01.003; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Labonte ED, 2007, BBA-MOL CELL BIOL L, V1771, P1132, DOI 10.1016/j.bbalip.2007.03.002; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Leng SY, 2007, AM J PHYSIOL-GASTR L, V293, pG475, DOI 10.1152/ajpgi.00072.2007; Levy E, 2004, J CELL SCI, V117, P327, DOI 10.1242/jcs.00856; Levy E, 2007, CURR OPIN LIPIDOL, V18, P310, DOI 10.1097/MOL.0b013e32813fa2e2; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Mardones P, 2001, J LIPID RES, V42, P170; McLaughlin J, 2007, BIOCHEM SOC T, V35, P1199, DOI 10.1042/BST0351199; Mineo C, 2003, TRENDS CARDIOVAS MED, V13, P226, DOI 10.1016/S1050-1738(03)00098-7; Morel E, 2004, MOL BIOL CELL, V15, P132, DOI 10.1091/mbc.E03-04-0215; Mu HL, 2004, PROG LIPID RES, V43, P105, DOI 10.1016/S0163-7827(03)00050-X; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; Nieland TJF, 2008, BIOCHEMISTRY-US, V47, P460, DOI 10.1021/bi701277x; Nordskog BK, 2001, ADV DRUG DELIVER REV, V50, P21, DOI 10.1016/S0169-409X(01)00147-8; Orlowski S, 2007, EUR BIOPHYS J BIOPHY, V36, P869, DOI 10.1007/s00249-007-0193-8; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; POTTER BJ, 1989, ANNU REV NUTR, V9, P253, DOI 10.1146/annurev.nu.09.070189.001345; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Qin XF, 2005, CURR DRUG TARGETS, V6, P145, DOI 10.2174/1389450053174541; Raybould HE, 1999, AM J PHYSIOL-GASTR L, V277, pG751, DOI 10.1152/ajpgi.1999.277.4.G751; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Sanderson IR, 2000, ANNU REV NUTR, V20, P311, DOI 10.1146/annurev.nutr.20.1.311; Schulthess G, 2000, BIOCHEMISTRY-US, V39, P12623, DOI 10.1021/bi0011633; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shikany JM, 2000, SOUTH MED J, V93, P1138, DOI 10.1097/00007611-200093120-00001; Tomkin GH, 2001, DIABETES-METAB RES, V17, P27, DOI 10.1002/dmrr.179; Tondu AL, 2005, J BIOL CHEM, V280, P33536, DOI 10.1074/jbc.M502392200; Van Eck M, 2005, CURR OPIN LIPIDOL, V16, P307; Voshol PJ, 2001, BIOCHEM J, V356, P317, DOI 10.1042/0264-6021:3560317; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1340, DOI 10.1161/ATVBAHA.106.136382; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	62	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4278	10.1371/journal.pone.0004278	http://dx.doi.org/10.1371/journal.pone.0004278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169357	Green Submitted, gold, Green Published			2022-12-27	WOS:000265482800008
J	Mabilleau, G; Sabokbar, A				Mabilleau, Guillaume; Sabokbar, Afsie			Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation	PLOS ONE			English	Article								Background: Interleukin-32 (IL-32) is a newly described cytokine produced after stimulation by IL-2 or IL-18 and IFN-gamma. IL-32 has the typical properties of a pro-inflammatory mediator and although its role in rheumatoid arthritis has been recently reported its effect on the osteoclastogenesis process remains unclear. Methodology/Principal Findings: In the present study, we have shown that IL-32 was a potent modulator of osteoclastogenesis in vitro, whereby it promoted the differentiation of osteoclast precursors into TRAcP+ VNR+ multinucleated cells expressing specific osteoclast markers (up-regulation of NFATc1, OSCAR, Cathepsin K), but it was incapable of inducing the maturation of these multinucleated cells into bone-resorbing cells. The lack of bone resorption in IL-32-treated cultures could in part be explain by the lack of F-actin ring formation by the multinucleated cells generated. Moreover, when IL-32 was added to PBMC cultures maintained with soluble RANKL, although the number of newly generated osteoclast was increased, a significant decrease of the percentage of lacunar resorption was evident suggesting a possible inhibitory effect of this cytokine on osteoclast activation. To determine the mechanism by which IL-32 induces such response, we sought to determine the intracellular pathways activated and the release of soluble mediators in response to IL-32. Our results indicated that compared to RANKL, IL-32 induced a massive activation of ERK1/2 and Akt. Moreover, IL-32 was also capable of stimulating the release of IL-4 and IFN-gamma, two known inhibitors of osteoclast formation and activation. Conclusions/Significance: This is the first in vitro report on the complex role of IL-32 on osteoclast precursors. Further clarification on the exact role of IL-32 in vivo is required prior to the development of any potential therapeutic approach.	[Mabilleau, Guillaume; Sabokbar, Afsie] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England	University of Oxford	Mabilleau, G (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England.	guillaume.mabilleau@ndos.ox.ac.uk	Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X	Musculoskeletal Biomedical Research Unit; Nuffield Department of Orthopaedic Surgery; Nuffield Orthopaedic Centre	Musculoskeletal Biomedical Research Unit; Nuffield Department of Orthopaedic Surgery; Nuffield Orthopaedic Centre	The authors are also grateful for the support provided by Musculoskeletal Biomedical Research Unit in partnership with Nuffield Department of Orthopaedic Surgery and Nuffield Orthopaedic Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2006, BIOCHEM BIOPH RES CO, V350, P478, DOI 10.1016/j.bbrc.2006.09.076; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; BEGG SK, 1993, EXP HEMATOL, V21, P493; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Csernok E, 2008, CLIN EXP RHEUMATOL, V26, pS112; DAHL CA, 1992, J IMMUNOL, V148, P597; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Edwards JR, 2006, ARTHRITIS RHEUM-US, V54, P1451, DOI 10.1002/art.21821; FELIX R, 1990, ENDOCRINOLOGY, V127, P2592, DOI 10.1210/endo-127-5-2592; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; HORTON MA, 1985, CANCER RES, V45, P5663; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Itonaga I, 2004, BONE, V34, P57, DOI 10.1016/j.bone.2003.08.008; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707; Mabilleau G, 2008, DIABETOLOGIA, V51, P1035, DOI 10.1007/s00125-008-0992-1; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; O'Gradaigh D, 2004, RHEUMATOLOGY, V43, P122, DOI 10.1093/rheumatology/keh447; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Udagawa N, 2003, J BONE MINER METAB, V21, P337, DOI 10.1007/s00774-003-0439-1; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777	60	68	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4173	10.1371/journal.pone.0004173	http://dx.doi.org/10.1371/journal.pone.0004173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137064	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479500004
J	Hashimoto, S; Qu, W; Ahsan, B; Ogoshi, K; Sasaki, A; Nakatani, Y; Lee, Y; Ogawa, M; Ametani, A; Suzuki, Y; Sugano, S; Lee, CC; Nutter, RC; Morishita, S; Matsushima, K				Hashimoto, Shin-ichi; Qu, Wei; Ahsan, Budrul; Ogoshi, Katsumi; Sasaki, Atsushi; Nakatani, Yoichiro; Lee, Yongjun; Ogawa, Masako; Ametani, Akio; Suzuki, Yutaka; Sugano, Sumio; Lee, Clarence C.; Nutter, Robert C.; Morishita, Shinichi; Matsushima, Kouji			High-Resolution Analysis of the 5 '-End Transcriptome Using a Next Generation DNA Sequencer	PLOS ONE			English	Article								Massively parallel, tag-based sequencing systems, such as the SOLiD system, hold the promise of revolutionizing the study of whole genome gene expression due to the number of data points that can be generated in a simple and cost-effective manner. We describe the development of a 5'-end transcriptome workflow for the SOLiD system and demonstrate the advantages in sensitivity and dynamic range offered by this tag-based application over traditional approaches for the study of whole genome gene expression. 5'-end transcriptome analysis was used to study whole genome gene expression within a colon cancer cell line, HT-29, treated with the DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5Aza). More than 20 million 25-base 5'-end tags were obtained from untreated and 5Aza-treated cells and matched to sequences within the human genome. Seventy three percent of the mapped unique tags were associated with RefSeq cDNA sequences, corresponding to approximately 14,000 different protein-coding genes in this single cell type. The level of expression of these genes ranged from 0.02 to 4,704 transcripts per cell. The sensitivity of a single sequence run of the SOLiD platform was 100-1,000 fold greater than that observed from 5' end SAGE data generated from the analysis of 70,000 tags obtained by Sanger sequencing. The high-resolution 5' end gene expression profiling presented in this study will not only provide novel insight into the transcriptional machinery but should also serve as a basis for a better understanding of cell biology.	[Hashimoto, Shin-ichi; Ogoshi, Katsumi; Lee, Yongjun; Ogawa, Masako; Ametani, Akio; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Qu, Wei; Ahsan, Budrul; Sasaki, Atsushi; Nakatani, Yoichiro; Morishita, Shinichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Lee, Clarence C.; Nutter, Robert C.] Appl Biosyst Inc, Foster City, CA USA	University of Tokyo; University of Tokyo; University of Tokyo; Thermo Fisher Scientific; Applied Biosystems	Hashimoto, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan.	koujim@m.u-tokyo.ac.jp		Nakatani, Yoichiro/0000-0001-7604-0242; Morishita, Shinichi/0000-0002-6201-8885	KAKENHI; Ministry of Education, Culture, Sports, Science and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was in part supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas of "Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Hashimoto SI, 2003, BLOOD, V101, P3509, DOI 10.1182/blood-2002-06-1866; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Lu J, 2004, GENOMICS, V84, P631, DOI 10.1016/j.ygeno.2004.06.014; MARUYAMA K, 1994, GENE, V138, P171; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Porter D, 2006, DRUG DISCOV TODAY, V11, P110, DOI 10.1016/S1359-6446(05)03694-9; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487	21	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4108	10.1371/journal.pone.0004108	http://dx.doi.org/10.1371/journal.pone.0004108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119315	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472600008
J	Teissedre, B; Pinderhughes, A; Incassati, A; Hatsell, SJ; Hiremath, M; Cowin, P				Teissedre, Brigitte; Pinderhughes, Alicia; Incassati, Angela; Hatsell, Sarah J.; Hiremath, Minoti; Cowin, Pamela			MMTV-Wnt1 and -Delta N89 beta-Catenin Induce Canonical Signaling in Distinct Progenitors and Differentially Activate Hedgehog Signaling within Mammary Tumors	PLOS ONE			English	Article								Canonical Wnt/beta-catenin signaling regulates stem/progenitor cells and, when perturbed, induces many human cancers. A significant proportion of human breast cancer is associated with loss of secreted Wnt antagonists and mice expressing MMTV-Wnt1 and MMTV-Delta N89 beta-catenin develop mammary adenocarcinomas. Many studies have assumed these mouse models of breast cancer to be equivalent. Here we show that MMTV-Wnt1 and MMTV-Delta N89 beta-catenin transgenes induce tumors with different phenotypes. Using axin2/conductin reporter genes we show that MMTV-Wnt1 and MMTV-Delta N89 beta-catenin activate canonical Wnt signaling within distinct cell-types. Delta N89 beta-catenin activated signaling within a luminal subpopulation scattered along ducts that exhibited a K18(+)ER(-)PR(-)CD24(high)CD49(flow) profile and progenitor properties. In contrast, MMTV-Wnt1 induced canonical signaling in K14(+) basal cells with CD24/CD49f profiles characteristic of two distinct stem/progenitor cell-types. MMTV-Wnt1 produced additional profound effects on multiple cell-types that correlated with focal activation of the Hedgehog pathway. We document that large melanocytic nevi are a hitherto unreported hallmark of early hyperplastic Wnt1 glands. These nevi formed along the primary mammary ducts and were associated with Hedgehog pathway activity within a subset of melanocytes and surrounding stroma. Hh pathway activity also occurred within tumor-associated stromal and K14(+)/p63(+) subpopulations in a manner correlated with Wnt1 tumor onset. These data show MMTV-Wnt1 and MMTV-Delta N89 beta-catenin induce canonical signaling in distinct progenitors and that Hedgehog pathway activation is linked to melanocytic nevi and mammary tumor onset arising from excess Wnt1 ligand. They further suggest that Hedgehog pathway activation maybe a critical component and useful indicator of breast tumors arising from unopposed Wnt1 ligand.	[Teissedre, Brigitte; Pinderhughes, Alicia; Incassati, Angela; Hatsell, Sarah J.; Hiremath, Minoti; Cowin, Pamela] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Teissedre, B (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	cowinp01@nyumc.org		Hatsell, Sarah/0000-0003-1103-6087; Cowin, Pamela/0000-0002-1827-1154	NIH [R01-GM47429]; Susan G. Komen Foundation [BCTR0504557, PDF0707333]; Philip Morris International; Kimmel Foundation; NIH-NRSA [F31CA119940-02, F31CA130137];  [DOD-BC074763]; NATIONAL CANCER INSTITUTE [R21CA129905, F31CA130137, F31CA119940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Philip Morris International; Kimmel Foundation; NIH-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH-R01-GM47429, Susan G. Komen Foundation BCTR0504557 and by training awards from Philip Morris International, Kimmel Foundation, and DOD-BC074763, Susan G Komen PDF0707333, NIH-NRSA F31CA119940-02 and F31CA130137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BRADBURY JM, 1995, DEV BIOL, V170, P553, DOI 10.1006/dbio.1995.1236; Brisken C, 2000, GENE DEV, V14, P650; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; COWIN P, 2005, CURRENT OPI IN PRESS; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; FIASCHI M, 2007, J BIOL CHEM; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hatsell S, 2007, J MAMMARY GLAND BIOL, V12, P163, DOI 10.1007/s10911-007-9048-2; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Hiremath M, 2007, DEVELOPMENT, V134, P3703, DOI 10.1242/dev.006585; Howe LR, 2003, CANCER RES, V63, P1906; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KAMINO H, 1991, J CUTAN PATHOL, V18, P436, DOI 10.1111/j.1600-0560.1991.tb01381.x; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; MORAES RC, 2007, DEVELOPMENT; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Rowlands TM, 2003, P NATL ACAD SCI USA, V100, P11400, DOI 10.1073/pnas.1534601100; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wang YF, 2003, BIOESSAYS, V25, P317, DOI 10.1002/bies.10255; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	52	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4537	10.1371/journal.pone.0004537	http://dx.doi.org/10.1371/journal.pone.0004537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225568	gold, Green Published, Green Submitted			2022-12-27	WOS:000265486000012
J	Campos, SK; Ozbun, MA				Campos, Samuel K.; Ozbun, Michelle A.			Two Highly Conserved Cysteine Residues in HPV16 L2 Form an Intramolecular Disulfide Bond and Are Critical for Infectivity in Human Keratinocytes	PLOS ONE			English	Article								Background: Minor capsid protein L2 performs an indispensable but uncharacterized role in human papillomavirus infections. A neutralizing B cell epitope has recently been mapped to the N-terminus of HPV16 L2, residues 17-36, and exposure of this region of L2 has been implicated in translocation of incoming virions from the endo/lysosomal compartment to the cellular cytoplasm. Here we examine the redox state of Cys22 and Cys28 two highly conserved cysteines located within this epitope. We also investigate the infectivity of virions containing L2 single and double cysteine point mutants. Methodology and Principal Findings: Denaturing/non-reducing gel analysis and thiol labeling experiments of wild type and cysteine mutant HPV16 virion particles strongly support the existence of a buried intramolecular C22-C28 disulfide bond. The disulfide was confirmed by tandem mass spectrometry of L2 protein from non-reduced virions. Single C22S and C28S and the double C22/28S mutants were non-infectious but had no apparent defects in cell binding, endocytosis, or trafficking to lysosomes by 8 h post infection. During infection with L2 mutant particles, there was a marked decrease in L2 levels compared to wild type L2-containing virions, suggesting a failure of mutant L2/genome complexes to exit the endo/lysosomal compartment. Conclusions and Significance: L2 residues C22 and C28 are bound as an intramolecular disulfide bond in HPV16 virions and are necessary for infectivity. Previous work has suggested that the furin-dependent exposure of the 17-36 epitope and subsequent interaction of this region with an unknown receptor is necessary for egress from the endo/lysosomal compartment and infection. Identification of the C22-C28 disulfide suggests that reduction of this disufide bond may be necessary for exposure of 17-36 and HPV16 infection.	Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Campos, Samuel K.; Ozbun, Michelle A.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Arizona; University of New Mexico	Campos, SK (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.	mozbun@salud.unm.edu	Campos, Samuel K/H-8998-2019; Ozbun, Michelle Adair/Q-4158-2017; Ozbun, Michelle/AAN-2922-2021	Campos, Samuel K/0000-0003-1540-9821; Ozbun, Michelle Adair/0000-0001-8551-4606; Ozbun, Michelle/0000-0001-8551-4606	NIH [CA085747, CA132136, T32 AI07538]; NRSA postdoctoral fellowship [F32 CA123842];  [1 CO6 RR012511]; NATIONAL CANCER INSTITUTE [R01CA132136, R01CA085747, F32CA123842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants CA085747 and CA132136 (MAO), NIH Training Grant T32 AI07538 (SKC) and NRSA postdoctoral fellowship F32 CA123842 (SKC). We acknowledge 1 CO6 RR012511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Culp TD, 2006, J VIROL, V80, P11381, DOI 10.1128/JVI.01328-06; Culp TD, 2006, J VIROL, V80, P8940, DOI 10.1128/JVI.00724-06; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2007, J VIROL, V81, P8784, DOI 10.1128/JVI.00552-07; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 1998, J VIROL, V72, P142, DOI 10.1128/JVI.72.1.142-150.1998; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DUNKER AK, 1969, J BIOL CHEM, V244, P5074; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fenouillet E, 2008, J BIOL CHEM, V283, P26340, DOI 10.1074/jbc.M805221200; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Florin L, 2006, J VIROL, V80, P6691, DOI 10.1128/JVI.00057-06; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Heino P, 2000, VIROLOGY, V276, P304, DOI 10.1006/viro.2000.0342; Holmgren SC, 2005, J VIROL, V79, P3938, DOI 10.1128/JVI.79.7.3938-3948.2005; INOCENCIO NM, 1994, J BIOL CHEM, V269, P31831; Ishii Y, 2005, VIRUS GENES, V31, P321, DOI 10.1007/s11262-005-3250-3; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Kawana Y, 2001, J VIROL, V75, P2331, DOI 10.1128/JVI.75.5.2331-2336.2001; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Langenbach KJ, 1999, J BIOL CHEM, V274, P7032, DOI 10.1074/jbc.274.11.7032; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; McKee ML, 1999, BIOCHEMISTRY-US, V38, P16507, DOI 10.1021/bi991308+; Mere J, 2005, J BIOL CHEM, V280, P21194, DOI 10.1074/jbc.M412656200; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Okoye A, 2005, VIRUS RES, V108, P1, DOI 10.1016/j.virusres.2004.07.004; Okun MM, 2001, J VIROL, V75, P4332, DOI 10.1128/JVI.75.9.4332-4342.2001; Ozbun MA, 2002, J GEN VIROL, V83, P2753, DOI 10.1099/0022-1317-83-11-2753; Patterson NA, 2005, J VIROL, V79, P6838, DOI 10.1128/JVI.79.11.6838-6847.2005; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Schelhaas M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000148; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Sen J, 2007, PROTEIN SCI, V16, P1236, DOI 10.1110/ps.072771407; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Smith S, 2008, ECONTENT, V31, P21; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015; Yang RC, 2003, J BIOL CHEM, V278, P12546, DOI 10.1074/jbc.M208691200; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	63	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4463	10.1371/journal.pone.0004463	http://dx.doi.org/10.1371/journal.pone.0004463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214230	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484300007
J	Alghisi, GC; Ponsonnet, L; Ruegg, C				Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio			The Integrin Antagonist Cilengitide Activates alpha V beta 3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells	PLOS ONE			English	Article								Cilengitide is a high-affinity cyclic pentapeptdic alpha V integrin antagonist previously reported to suppress angiogenesis by inducing anoikis of endothelial cells adhering through alpha V beta 3/alpha V beta 5 integrins. Angiogenic endothelial cells express multiple integrins, in particular those of the beta 1 family, and little is known on the effect of cilengitide on endothelial cells expressing alpha V beta 3 but adhering through beta 1 integrins. Through morphological, biochemical, pharmacological and functional approaches we investigated the effect of cilengitide on alpha V beta 3-expressing human umbilical vein endothelial cells (HUVEC) cultured on the beta 1 ligands fibronectin and collagen I. We show that cilengitide activated cell surface alpha V beta 3, stimulated phosphorylation of FAK (Y(397) and Y(576/577)), Src (S(418)) and VE-cadherin (Y(658) and Y(731)), redistributed alpha V beta 3 at the cell periphery, caused disappearance of VE-cadherin from cellular junctions, increased the permeability of HUVEC monolayers and detached HUVEC adhering on low-density beta 1 integrin ligands. Pharmacological inhibition of Src kinase activity fully prevented cilengitide-induced phosphorylation of Src, FAK and VE-cadherin, and redistribution of aV beta 3 and VE-cadherin and partially prevented increased permeability, but did not prevent HUVEC detachment from low-density matrices. Taken together, these observations reveal a previously unreported effect of cilengitide on endothelial cells namely its ability to elicit signaling events disrupting VE-cadherin localization at cellular contacts and to increase endothelial monolayer permeability. These effects are potentially relevant to the clinical use of cilengitide as anticancer agent.	[Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio] Univ Lausanne, Div Expt Oncol, CePO, Fac Biol & Med, CH-1066 Epalinges, Switzerland; [Alghisi, Gian Carlo; Ponsonnet, Lionel; Rueegg, Curzio] NCCR Mol Oncol, ISREC, Epalinges, Switzerland	University of Lausanne; Swiss Institute Experimental Cancer Research	Alghisi, GC (corresponding author), Univ Lausanne, Div Expt Oncol, CePO, Fac Biol & Med, CH-1066 Epalinges, Switzerland.	curzio.ruegg@unil.ch			Oncosuisse [0181212-12-2005, 02020.02.2007]; National Center for Competence in Research; Medic Foundation	Oncosuisse; National Center for Competence in Research; Medic Foundation	This work was supported by grants from Oncosuisse (OCS 0181212-12-2005 and 02020.02.2007), the National Center for Competence in Research (NCCR, molecular Oncology, a research instrument of the SNF), and the Medic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, INT J RADIAT ONCOL, V65, P1536, DOI 10.1016/j.ijrobp.2006.04.036; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bezzi M, 2003, J BIOL CHEM, V278, P43603, DOI 10.1074/jbc.M308114200; Bieler G, 2007, ONCOGENE, V26, P5722, DOI 10.1038/sj.onc.1210354; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Buerkle MA, 2002, BRIT J CANCER, V86, P788, DOI 10.1038/sj.bjc.6600141; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Dormond O, 2004, THROMB HAEMOSTASIS, V92, P151, DOI 10.1160/th03-11-0728; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Esser S, 1998, J CELL SCI, V111, P1853; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Friess H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-285; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Khaspekova S G, 1996, Biokhimiia, V61, P412; Kumar CC, 2003, CURR DRUG TARGETS, V4, P123, DOI 10.2174/1389450033346830; Loges S, 2007, BIOCHEM BIOPH RES CO, V357, P1016, DOI 10.1016/j.bbrc.2007.04.060; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; MITJANS F, 1995, J CELL SCI, V108, P2825; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; QIAO RL, 1995, AM J PHYSIOL-CELL PH, V269, pC110, DOI 10.1152/ajpcell.1995.269.1.C110; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Smith Jeffrey W, 2003, Curr Opin Investig Drugs, V4, P741; Stupp R, 2007, J CLIN ONCOL, V25, P1637, DOI 10.1200/JCO.2006.09.8376; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tatone C, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-48; Tentori L, 2008, ONCOL REP, V19, P1039; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Watson PMD, 2007, MOL CELL NEUROSCI, V34, P147, DOI 10.1016/j.mcn.2006.10.007; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Xiong JP, 2007, METHOD ENZYMOL, V426, P307, DOI 10.1016/S0076-6879(07)26014-8; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamada S, 2006, NEUROSURGERY, V59, P1304, DOI 10.1227/01.NEU.0000245622.70344.BE; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200	53	112	117	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4449	10.1371/journal.pone.0004449	http://dx.doi.org/10.1371/journal.pone.0004449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212436	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484200010
J	Dupierrix, E; Gresty, M; Ohlmann, T; Chokron, S				Dupierrix, Eve; Gresty, Michael; Ohlmann, Theophile; Chokron, Sylvie			Long Lasting Egocentric Disorientation Induced by Normal Sensori-Motor Spatial Interaction	PLOS ONE			English	Article							PRISM ADAPTATION; UNILATERAL NEGLECT; PERCEIVING DISTANCE; BODY ORIENTATION; PERCEPTION; REPRESENTATION; STIMULATION; SLEEP; SPACE; REHABILITATION	Background: Perception of the cardinal directions of the body, right-left, up-down, ahead-behind, which appears so absolute and fundamental to the organisation of behaviour can in fact, be modified. Perhaps unsurprisingly, it has been shown that prolonged distorted perception of the orientation of body axes can be a consequence of disordered sensorimotor signals, including long-term prismatic adaptation and lesions of the central nervous system. We report the novel and surprising finding that a long-lasting distortion of perception of personal space can also be induced by an ecological pointing task without the artifice of distorting normal sensori-motor relationships. Methodology/Principal Findings: Twelve right-handed healthy adults performed the task of pointing with their arms, without vision, to indicate their subjective 'straight ahead', a task often used to assess the Egocentric Reference. This was performed before, immediately, and one day after a second task intended to 'modulate' perception of spatial direction. The 'modulating' task lasted 5 minutes and consisted of asking participants to point with the right finger to targets that appeared only in one (right or left) half of a computer screen. Estimates of the 'straight-ahead' during pre-test were accurate (inferior to 0.3 degrees deviation). Significantly, up to one day after performing the modulating task, the subjective 'straight-ahead' was deviated (by approximately 3.2 degrees) to the same side to which subjects had pointed to targets. Conclusion/Significance: These results reveal that the perception of directional axes for behaviour is readily influenced by interactions with the environment that involve no artificial distortion of normal sensori-motor-spatial relationships and does not necessarily conform to the cardinal directions as defined by the anatomy of orthostatic posture. We thus suggest that perceived space is a dynamic construction directly dependent upon our past experience about the direction and/or the localisation of our sensori-motor spatial interaction with environment.	Coll France, LPPA, CNRS, UMR 7152, F-75231 Paris, France; [Dupierrix, Eve; Ohlmann, Theophile; Chokron, Sylvie] CNRS, LPNC, UMR 5105, Grenoble, France; [Dupierrix, Eve; Ohlmann, Theophile; Chokron, Sylvie] Fdn Adolphe De Rothschild, Serv Neurol, ERT TREAT Vision, Paris, France; [Gresty, Michael] Imperial Coll London, MRC, Div Neurosci & Mental Hlth, Sect Neuro Otol, London, England	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Imperial College London	Dupierrix, E (corresponding author), Coll France, LPPA, CNRS, UMR 7152, F-75231 Paris, France.	eve.dupierrix@college-de-france.fr			University Pierre Mendes France of Grenoble; Centre National de la Recherche Scientifique; Edmond and Benjamin de Rothschild Foundations (New York, Geneva); Medical Research Council [MC_U950770497, G0600183] Funding Source: researchfish; MRC [MC_U950770497, G0600183] Funding Source: UKRI	University Pierre Mendes France of Grenoble; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Edmond and Benjamin de Rothschild Foundations (New York, Geneva); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the University Pierre Mendes France of Grenoble and the Centre National de la Recherche Scientifique. We thank also the Edmond and Benjamin de Rothschild Foundations (New York, Geneva) for supporting the research of the TREAT vision team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 2006, EXP BRAIN RES, V170, P30, DOI 10.1007/s00221-005-0174-z; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; BIGUER B, 1988, BRAIN, V111, P1405, DOI 10.1093/brain/111.6.1405; CHAIN F, 1979, REV NEUROL, V135, P105; Chokron S, 1997, CORTEX, V33, P47, DOI 10.1016/S0010-9452(97)80004-4; Chokron S, 1997, NEUROPSYCHOLOGIA, V35, P1503, DOI 10.1016/S0028-3932(97)00079-1; Chokron S, 2003, NEUROIMAGE, V20, pS75, DOI 10.1016/j.neuroimage.2003.09.002; CHOKRON S, 1995, NEUROPSYCHOLOGIA, V33, P703, DOI 10.1016/0028-3932(95)00007-P; Chokron S, 2007, NEUROPSYCHOLOGIA, V45, P3127, DOI 10.1016/j.neuropsychologia.2007.08.001; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; Coello Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002862; Colent C, 2000, NEUROREPORT, V11, P1899, DOI 10.1097/00001756-200006260-00019; DELLATOLAS G, 1988, REV PSYCHOL APPL, V38, P117; Duclos C, 2004, EXP BRAIN RES, V158, P58, DOI 10.1007/s00221-004-1871-8; Dupierrix E, 2008, BRAIN RES, V1214, P127, DOI 10.1016/j.brainres.2008.01.021; Fadiga L, 2000, INT J PSYCHOPHYSIOL, V35, P165, DOI 10.1016/S0167-8760(99)00051-3; Frank MG, 2006, NEUROSCIENTIST, V12, P477, DOI 10.1177/1073858406293552; Gibson J.J., 1986, ECOLOGICAL APPROACH; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Humphreys GW, 2006, COGN NEUROPSYCHOL, V23, P463, DOI 10.1080/02643290500202755; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karnath HO, 1996, J NEUROL NEUROSUR PS, V60, P217, DOI 10.1136/jnnp.60.2.217; Karnath HO, 2002, EXP BRAIN RES, V143, P350, DOI 10.1007/s00221-001-0996-2; KAZANDJIAN S, 2008, BRAIN RES; Kazandjian S, 2008, NAT REV NEUROSCI, V9, P965, DOI 10.1038/nrn2456-c1; Kerkhoff G, 2006, RESTOR NEUROL NEUROS, V24, P201; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Laureys S, 2001, NEUROSCIENCE, V105, P521, DOI 10.1016/S0306-4522(01)00269-X; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Michel C, 2006, RESTOR NEUROL NEUROS, V24, P419; OXBURY JM, 1974, BRAIN, V97, P551, DOI 10.1093/brain/97.1.551; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 2001, PSYCHOL SCI, V12, P418, DOI 10.1111/1467-9280.00377; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Redding GA, 2006, NEUROPSYCHOLOGIA, V44, P1, DOI 10.1016/j.neuropsychologia.2005.04.009; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1990, REV NEUROL, V146, P626; ROBERTSON IH, 1992, NEUROPSYCHOLOGIA, V30, P553, DOI 10.1016/0028-3932(92)90058-T; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; SEAMAN MA, 1991, PSYCHOL BULL, V110, P577, DOI 10.1037/0033-2909.110.3.577; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Witt JK, 2004, PERCEPTION, V33, P577, DOI 10.1068/p5090; ZUCKERMAN M, 1993, PSYCHOL SCI, V4, P49, DOI 10.1111/j.1467-9280.1993.tb00556.x	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4465	10.1371/journal.pone.0004465	http://dx.doi.org/10.1371/journal.pone.0004465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JQ	19212433	Green Published, gold			2022-12-27	WOS:000265484200015
J	Mani, P; Yadav, VK; Das, SK; Chowdhury, S				Mani, Prithvi; Yadav, Vinod Kumar; Das, Swapan Kumar; Chowdhury, Shantanu			Genome-Wide Analyses of Recombination Prone Regions Predict Role of DNA Structural Motif in Recombination	PLOS ONE			English	Article								HapMap findings reveal surprisingly asymmetric distribution of recombinogenic regions. Short recombinogenic regions (hotspots) are interspersed between large relatively non-recombinogenic regions. This raises the interesting possibility of DNA sequence and/or other cis-elements as determinants of recombination. We hypothesized the involvement of non-canonical sequences that can result in local non-B DNA structures and tested this using the G-quadruplex DNA as a model. G-quadruplex or G4 DNA is a unique form of four-stranded non-B DNA structure that engages certain G-rich sequences, presence of such motifs has been noted within telomeres. In support of this hypothesis, genome-wide computational analyses presented here reveal enrichment of potential G4 (PG4) DNA forming sequences within 25618 human hotspots relative to 9290 coldspots (p < 0.0001). Furthermore, co- occurrence of PG4 DNA within several short sequence elements that are associated with recombinogenic regions was found to be significantly more than randomly expected. Interestingly, analyses of more than 50 DNA binding factors revealed that co- occurrence of PG4 DNA with target DNA binding sites of transcription factors c-Rel, NF-kappa B (p50 and p65) and Evi-1 was significantly enriched in recombination-prone regions. These observations support involvement of G4 DNA in recombination, predicting a functional model that is consistent with duplex-strand separation induced by formation of G4 motifs in supercoiled DNA and/or when assisted by other cellular factors.	[Mani, Prithvi; Yadav, Vinod Kumar; Chowdhury, Shantanu] CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, Delhi, India; [Chowdhury, Shantanu] CSIR, Inst Genom & Integrat Biol, Proteom & Struct Biol Unit, Delhi, India; [Das, Swapan Kumar] CSIR, Inst Genom & Integrat Biol, Funct Genom Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Mani, P (corresponding author), CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, Delhi, India.	shantanuc@igib.res.in	Yadav, Vinod k/J-9279-2014	Yadav, Vinod k/0000-0001-6450-7036; Das, Swapan/0000-0002-2197-8855	CSIR Task Force Project [CMM 0017]	CSIR Task Force Project(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR Task Force Project (CMM 0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha S, 2004, NUCLEIC ACIDS RES, V32, P2378, DOI 10.1093/nar/gkh559; Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Du Z, 2007, BIOCHEM BIOPH RES CO, V354, P1067, DOI 10.1016/j.bbrc.2007.01.093; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Fojtik P, 2004, NUCLEIC ACIDS RES, V32, P298, DOI 10.1093/nar/gkh179; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; Ghosal G, 2007, J MOL BIOL, V372, P864, DOI 10.1016/j.jmb.2007.07.013; Gilbert DE, 1999, CURR OPIN STRUC BIOL, V9, P305, DOI 10.1016/S0959-440X(99)80041-4; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kirkpatrick DT, 1999, GENETICS, V152, P101; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; LEITH IR, 1993, BIOCHEM BIOPH RES CO, V196, P601, DOI 10.1006/bbrc.1993.2292; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; McManus SA, 2008, J MOL BIOL, V375, P960, DOI 10.1016/j.jmb.2007.10.080; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Muniyappa K, 2000, MOL CELL BIOL, V20, P1361, DOI 10.1128/MCB.20.4.1361-1369.2000; Myers S, 2006, BIOCHEM SOC T, V34, P526, DOI 10.1042/BST0340526; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qiu P, 2002, MAMM GENOME, V13, P327, DOI 10.1007/s00335-001-2141-8; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sandovici I, 2006, PLOS GENET, V2, P944, DOI 10.1371/journal.pgen.0020101; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Sinden RR, 2005, NATURE, V437, P1097, DOI 10.1038/4371097a; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Weitzmann MN, 1997, J BIOL CHEM, V272, P9517; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wyman C, 2008, MOL CELL, V30, P5, DOI 10.1016/j.molcel.2008.03.007; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhang J, 2004, HUM MOL GENET, V13, P2823, DOI 10.1093/hmg/ddh310; Zhao YQ, 2007, FEBS LETT, V581, P1951, DOI 10.1016/j.febslet.2007.04.017	63	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4399	10.1371/journal.pone.0004399	http://dx.doi.org/10.1371/journal.pone.0004399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198658	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483900008
J	Piganeau, G; Eyre-Walker, A				Piganeau, Gwenael; Eyre-Walker, Adam			Evidence for Variation in the Effective Population Size of Animal Mitochondrial DNA	PLOS ONE			English	Article							GENETIC DIVERSITY; CODON USAGE; POLYMORPHISM; EVOLUTION; MUTATION; RATES	Background: It has recently been shown that levels of diversity in mitochondrial DNA are remarkably constant across animals of diverse census population sizes and ecologies, which has led to the suggestion that the effective population of mitochondrial DNA may be relatively constant. Results: Here we present several lines of evidence that suggest, to the contrary, that the effective population size of mtDNA does vary, and that the variation can be substantial. First, we show that levels of mitochondrial and nuclear diversity are correlated within all groups of animals we surveyed. Second, we show that the effectiveness of selection on non-synonymous mutations, as measured by the ratio of the numbers of non-synonymous and synonymous polymorphisms, is negatively correlated to levels of mitochondrial diversity. Finally, we estimate the effective population size of mitochondrial DNA in selected mammalian groups and show that it varies by at least an order of magnitude. Conclusions: We conclude that there is variation in the effective population size of mitochondria. Furthermore we suggest that the relative constancy of DNA diversity may be due to a negative correlation between the effective population size and the mutation rate per generation.	[Piganeau, Gwenael] Univ Paris 06, MBCE, Observ Oceanol, UMR 7628, Banyuls Sur Mer, France; [Piganeau, Gwenael] CNRS, MBCE, Observ Oceanol, UMR 7628, Banyuls sur Mer, France; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton BN1 9RH, E Sussex, England	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Sussex	Piganeau, G (corresponding author), Univ Paris 06, MBCE, Observ Oceanol, UMR 7628, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr; a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011; Piganeau, Gwenael V/C-7600-2011	Eyre-Walker, Adam/0000-0001-5527-8729; Piganeau, Gwenael V/0000-0002-9992-4187	CNRS; GAP Marine Genomics fellowship; BBSRC	CNRS(Centre National de la Recherche Scientifique (CNRS)); GAP Marine Genomics fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	G.P. was funded by the CNRS and a GAP Marine Genomics fellowship. AEW was funded by the BBSRC. The funding agencies took no part in the design and conduct of the analysis.	Albu M, 2008, MOL BIOL EVOL, V25, P2521, DOI 10.1093/molbev/msn224; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bazin E, 2005, NUCLEIC ACIDS RES, V33, pD481, DOI 10.1093/nar/gki076; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bierne N, 2003, GENETICS, V165, P1587; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; CHAO L, 1993, EVOLUTION, V47, P688, DOI 10.1111/j.1558-5646.1993.tb02124.x; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; EyreWalker A, 1997, MOL BIOL EVOL, V14, P455, DOI 10.1093/oxfordjournals.molbev.a025781; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Gillespie JH, 2000, GENETICS, V155, P909; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Mulligan CJ, 2006, SCIENCE, V314, DOI 10.1126/science.1132585; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; NEVO E, 1984, EVOLUTIONARY DYNAMIC, P13; Popadin K, 2007, P NATL ACAD SCI USA, V104, P13390, DOI 10.1073/pnas.0701256104; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Welch JJ, 2008, J MOL EVOL, V67, P418, DOI 10.1007/s00239-008-9146-9; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	26	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4396	10.1371/journal.pone.0004396	http://dx.doi.org/10.1371/journal.pone.0004396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198657	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265483900006
J	Kroner, A; Schwab, N; Ip, CW; Leder, C; Nave, KA; Maurer, M; Wiendl, H; Martini, R				Kroner, Antje; Schwab, Nicholas; Ip, Chi Wang; Leder, Christoph; Nave, Klaus-Armin; Maeurer, Mathias; Wiendl, Heinz; Martini, Rudolf			PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; MYELIN DEGENERATION; PROTEOLIPID PROTEIN; AXONOPATHIC CHANGES; CLONAL EXPANSIONS; IMMUNE-DEFICIENCY; MICE; CELLS; CNS; AUTOIMMUNITY	We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T- lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype of the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T- lymphocytes in PLPtg/PD-1-/- double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T- cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.	[Kroner, Antje; Schwab, Nicholas; Ip, Chi Wang; Leder, Christoph; Maeurer, Mathias; Wiendl, Heinz; Martini, Rudolf] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Kroner, Antje; Ip, Chi Wang; Maeurer, Mathias; Martini, Rudolf] Univ Wurzburg, Sect Dev Neurobiol, D-97070 Wurzburg, Germany; [Schwab, Nicholas; Leder, Christoph; Wiendl, Heinz] Univ Wurzburg, Clin Res Grp MS & Neuroimmunol, D-97070 Wurzburg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Max Planck Society	Kroner, A (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	heinz.wiendl@klinik.uni-wuerzburg.de; rudolf.martini@mail.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021; Nave, Klaus-Armin/C-8883-2011; Ip, Chi Wang/HCH-3822-2022; Schwab, Nicholas/H-4516-2019	Ip, Chi Wang/0000-0003-0484-385X; Martini, Rudolf/0000-0002-5463-5592; Schwab, Nicholas/0000-0001-5494-9885; Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [SFB 581]; Gemeinnutzige Hertie-Stiftung [1.01.1/05/10]; Thyssen foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; Thyssen foundation	The project was funded by the Deutsche Forschungsgemeinschaft (SFB 581; to RM and HW), by the Gemeinnutzige Hertie-Stiftung (1.01.1/05/10 to RM) and the Thyssen foundation (to R. M. and H. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Gorman MP, 2007, NEUROLOGY, V68, P1305, DOI 10.1212/01.wnl.0000259522.49388.53; Grundtner R, 2007, NEUROBIOL DIS, V28, P261, DOI 10.1016/j.nbd.2007.05.006; Hafler DA, 2005, NAT REV IMMUNOL, V5, P83, DOI 10.1038/nri1532; Ip CW, 2008, MOL CELL NEUROSCI, V38, P489, DOI 10.1016/j.mcn.2008.04.009; Ip CW, 2007, NEUROBIOL DIS, V25, P105, DOI 10.1016/j.nbd.2006.08.023; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Ip CW, 2006, NEUROMOL MED, V8, P175, DOI 10.1385/NMM:8:1-2:175; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kobsar I, 2003, BRAIN, V126, P804, DOI 10.1093/brain/awg072; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; KRONER A, 2008, NEUROBIOL D IN PRESS; Leder C, 2007, MOL CELL NEUROSCI, V36, P416, DOI 10.1016/j.mcn.2007.08.002; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Martin-Orozco N, 2006, J EXP MED, V203, P817, DOI 10.1084/jem.20060219; Maurer M, 2001, MOL CELL NEUROSCI, V17, P1094, DOI 10.1006/mcne.2001.0990; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Schmid CD, 2000, J NEUROSCI, V20, P729, DOI 10.1523/JNEUROSCI.20-02-00729.2000; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Warshawsky I, 2005, ANN NEUROL, V58, P470, DOI 10.1002/ana.20601	35	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4405	10.1371/journal.pone.0004405	http://dx.doi.org/10.1371/journal.pone.0004405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197390	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483700012
J	Ilin, Y; Richter-Levin, G				Ilin, Yana; Richter-Levin, Gal			Enriched Environment Experience Overcomes Learning Deficits and Depressive-Like Behavior Induced by Juvenile Stress	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; CORTICOTROPIN-RELEASING HORMONE; NEURAL RECOGNITION MOLECULES; MESSENGER-RNA EXPRESSION; OPEN-FIELD ACTIVITY; EARLY-LIFE STRESS; MEMORY CONSOLIDATION; MAJOR DEPRESSION; ANIMAL-MODEL; HIPPOCAMPAL PLASTICITY	Mood disorders affect the lives and functioning of millions each year. Epidemiological studies indicate that childhood trauma is predominantly associated with higher rates of both mood and anxiety disorders. Exposure of rats to stress during juvenility (JS) (27-29 days of age) has comparable effects and was suggested as a model of induced predisposition for these disorders. The importance of the environment in the regulation of brain, behavior and physiology has long been recognized in biological, social and medical sciences. Here, we studied the effects of JS on emotional and cognitive aspects of depressive-like behavior in adulthood, on Hypothalamic-Pituitary-Adrenal (HPA) axis reactivity and on the expression of cell adhesion molecule L1 (L1-CAM). Furthermore, we combined it with the examination of potential reversibility by enriched environment (EE) of JS - induced disturbances of emotional and cognitive aspects of behavior in adulthood. Three groups were tested: Juvenile Stress -subjected to Juvenile stress; Enriched Environment -subjected to Juvenile stress and then, from day 30 on to EE; and Naives. In adulthood, coping and stress responses were examined using the elevated plus-maze, open field, novel setting exploration and two way shuttle avoidance learning. We found that, JS rats showed anxiety-and depressive-like behaviors in adulthood, altered HPA axis activity and altered L1-CAM expression. Increased expression of L1-CAM was evident among JS rats in the basolateral amygdala (BLA) and Thalamus (TL). Furthermore, we found that EE could reverse most of the effects of Juvenile stress, both at the behavioral, endocrine and at the biochemical levels. The interaction between JS and EE resulted in an increased expression of L1-CAM in dorsal cornu ammonis (CA) area 1 (dCA1).	[Ilin, Yana; Richter-Levin, Gal] Univ Haifa, Dept Psychol, ISAN, IL-31999 Haifa, Israel	University of Haifa	Ilin, Y (corresponding author), Univ Haifa, Dept Psychol, ISAN, IL-31999 Haifa, Israel.	galrichterlevin@gmail.com	Richter Levin, Gal/GVT-4050-2022	Richter Levin, Gal/0000-0001-7980-5212	EU [512012]; Institute for the Study of Affective Neuroscience (ISAN)	EU(European Commission); Institute for the Study of Affective Neuroscience (ISAN)	This study was supported by the EU's PROMEMORIA grant # 512012 to GRL, and by a grant from The Institute for the Study of Affective Neuroscience (ISAN) (2007) to GRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 1999, J NEUROSCI, V19, P10530; Armstrong KR, 1998, CONTEMP TOP LAB ANIM, V37, P64; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Avital A, 2001, NEUROPSYCHOPHARMACOL, V25, P669, DOI 10.1016/S0893-133X(01)00286-X; Bardo MT, 2004, NEBR SYM MOTIV, V50, P127; Becker K, 2007, DEV NEUROBIOL, V67, P617, DOI 10.1002/dneu.20372; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bevins RA, 1999, BEHAV BRAIN RES, V99, P53, DOI 10.1016/S0166-4328(98)00069-2; Brook GA, 2000, EUR J NEUROSCI, V12, P3224, DOI 10.1046/j.1460-9568.2000.00228.x; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; CHAMOVE AS, 1989, LAB ANIM, V23, P215, DOI 10.1258/002367789780810608; Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; ENGELLENNER WJ, 1982, PHYSIOL BEHAV, V29, P885, DOI 10.1016/0031-9384(82)90339-0; ESCORIHUELA RM, 1994, BEHAV BRAIN RES, V61, P169, DOI 10.1016/0166-4328(94)90157-0; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; Gutman David A, 2002, Semin Clin Neuropsychiatry, V7, P89, DOI 10.1053/scnp.2002.31781; Hansen LT, 2000, APPL ANIM BEHAV SCI, V68, P163, DOI 10.1016/S0168-1591(00)00093-9; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Huang-Brown KM, 2002, LAB ANIMAL, V31, P34; Ichise M, 2006, J NEUROSCI, V26, P4638, DOI 10.1523/JNEUROSCI.5199-05.2006; Jaferi A, 2006, ENDOCRINOLOGY, V147, P4917, DOI 10.1210/en.2005-1393; Jucker M, 1996, NEUROSCIENCE, V75, P703, DOI 10.1016/0306-4522(96)00276-X; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Knafo S, 2005, EUR J NEUROSCI, V21, P581, DOI 10.1111/j.1460-9568.2005.03862.x; Laifenfeld D, 2005, NEUROBIOL DIS, V20, P432, DOI 10.1016/j.nbd.2005.03.023; Laifenfeld D, 2005, BIOL PSYCHIAT, V57, P716, DOI 10.1016/j.biopsych.2004.12.016; Laifenfeld D, 2002, J NEUROCHEM, V83, P1054, DOI 10.1046/j.1471-4159.2002.01215.x; Law JWS, 2003, J NEUROSCI, V23, P10419; Leventopoulos M, 2007, BRAIN RES, V1142, P119, DOI 10.1016/j.brainres.2007.01.039; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maroun M, 2003, J NEUROSCI, V23, P4406; Matsumoto M, 2008, PHARMACOL BIOCHEM BE, V89, P247, DOI 10.1016/j.pbb.2007.12.017; Mattson MP, 2001, J MOL NEUROSCI, V17, P205, DOI 10.1385/JMN:17:2:205; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2002, METABOLISM, V51, P2, DOI 10.1053/meta.2002.33183; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mello DMD, 2007, BEHAV BRAIN RES, V181, P232, DOI 10.1016/j.bbr.2007.04.010; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; MOHAMMED AH, 1993, BEHAV BRAIN RES, V57, P183, DOI 10.1016/0166-4328(93)90134-C; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Patterson-Kane E G, 1999, J Appl Anim Welf Sci, V2, P97, DOI 10.1207/s15327604jaws0202_2; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Price JL, 1996, PROG BRAIN RES, V107, P523; Pryce C, 2002, PHARMACOL BIOCHEM BE, V73, P1, DOI 10.1016/S0091-3057(02)00861-4; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; RICE CJ, 2008, ENDOCRINOLOGY; Roozendaal B, 2002, P NATL ACAD SCI USA, V99, P13908, DOI 10.1073/pnas.212504599; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Sandi C, 2001, NEUROSCIENCE, V102, P329, DOI 10.1016/S0306-4522(00)00484-X; Sandi C, 2007, NEUROENDOCRINOLOGY, V85, P158, DOI 10.1159/000101535; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P9; SHARP PE, 1987, BEHAV NEUROSCI, V101, P170, DOI 10.1037/0735-7044.101.2.170; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; STYREN SD, 1995, EXP NEUROL, V131, P165, DOI 10.1016/0014-4886(95)90038-1; Tsoory M, 2007, EUR NEUROPSYCHOPHARM, V17, P245, DOI 10.1016/j.euroneuro.2006.06.007; Tsoory M, 2006, INT J NEUROPSYCHOPH, V9, P713, DOI 10.1017/S1461145705006255; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Venero C, 2004, J NEUROSCI RES, V75, P172, DOI 10.1002/jnr.10857; Venero C, 2002, NEUROSCIENCE, V115, P1211, DOI 10.1016/S0306-4522(02)00543-2; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wilner Warren, 2005, Psychoanal Rev, V92, P759, DOI 10.1521/prev.2005.92.5.759; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; WOOD PM, 1990, J NEUROSCI, V10, P3635	92	79	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4329	10.1371/journal.pone.0004329	http://dx.doi.org/10.1371/journal.pone.0004329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549YF	19180243	Green Submitted, Green Published, gold			2022-12-27	WOS:000274089700012
J	Farke, AA; Wolff, EDS; Tanke, DH				Farke, Andrew A.; Wolff, Ewan D. S.; Tanke, Darren H.			Evidence of Combat in Triceratops	PLOS ONE			English	Article								Background: The horns and frill of Triceratops and other ceratopsids (horned dinosaurs) are interpreted variously as display structures or as weapons against conspecifics and predators. Lesions (in the form of periosteal reactive bone, healing fractures, and alleged punctures) on Triceratops skulls have been used as anecdotal support of intraspecific combat similar to that in modern horned and antlered animals. If ceratopsids with different cranial morphologies used their horns in such combat, this should be reflected in the rates of lesion occurrence across the skull. Methodology/Principal Findings: We used a G-test of independence to compare incidence rates of lesions in Triceratops (which possesses two large brow horns and a smaller nasal horn) and the related ceratopsid Centrosaurus (with a large nasal horn and small brow horns), for the nasal, jugal, squamosal, and parietal bones of the skull. The two taxa differ significantly in the occurrence of lesions on the squamosal bone of the frill (P = 0.002), but not in other cranial bones (P>0.20). Conclusions/Significance: This pattern is consistent with Triceratops using its horns in combat and the frill being adapted as a protective structure for this taxon. Lower pathology rates in Centrosaurus may indicate visual rather than physical use of cranial ornamentation in this genus, or a form of combat focused on the body rather than the head.	Raymond M Alf Museum Paleontol, Claremont, CA USA; [Wolff, Ewan D. S.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Tanke, Darren H.] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada	University of Wisconsin System; University of Wisconsin Madison	Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA USA.	afarke@webb.org		Wolff, Ewan/0000-0002-5726-4766; Farke, Andrew/0000-0002-6930-2002	National Science Foundation [Graduate Research Fellowship, EAR-0819953]; Division Of Earth Sciences [0819953] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded in part by a National Science Foundation Graduate Research Fellowship and a National Science Foundation grant (EAR-0819953) to AAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro TM, 2003, BEHAV ECOL SOCIOBIOL, V55, P32, DOI 10.1007/s00265-003-0672-6; FARK AA, 2004, PALAEONTOL ELECT, V7; Farke AA, 2007, J VERTEBR PALEONTOL, V27, P724, DOI 10.1671/0272-4634(2007)27[724:ROPIPA]2.0.CO;2; FARLOW JO, 1975, EVOLUTION, V29, P353, DOI 10.1111/j.1558-5646.1975.tb00214.x; FROSTER CA, 1996, J VERTEBRATE PALEONT, V16, P246; Happ John, 2008, P354; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Kumar V., 2004, ROBBINS COTRAN PATHO; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Lull RS, 1908, AM J SCI, V25, P387; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; McGavin M.D., 2006, PATHOLOGIC BASIS VET; MOLNAR R E, 1977, Evolutionary Theory, V3, P165; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Sokal RR, 1995, BIOMETRY; Tanke D.H., 2006, HORNS BEAKS CERATOPS, P319; TANKE DH, NEW PERSPEC IN PRESS	17	45	46	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4252	10.1371/journal.pone.0004252	http://dx.doi.org/10.1371/journal.pone.0004252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19172995	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483000001
J	Murphy, TM; Belmonte, M; Shu, S; Britt, AB; Hatteroth, J				Murphy, Terence M.; Belmonte, Mark; Shu, Stephanie; Britt, Anne B.; Hatteroth, James			Requirement for Abasic Endonuclease Gene Homologues in Arabidopsis Seed Development	PLOS ONE			English	Article							DNA GLYCOSYLASE DOMAIN; REPAIR; METHYLATION; DEMETER; ENDOSPERM; PROTEIN; APN1	Arabidopsis thaliana has three genes, Ape1L, Ape2, and Arp, that show homology to abasic (apurinic/apyrimidinic) endonuclease genes of bacterial, yeast, or animal cells. In bacteria, yeast, and animals, abasic endonucleases function in base excision repair of oxidized and other modified DNA bases. Here we report that plants with knock-out mutations in any one of Ape1L, Ape2, or Arp show no apparent differences from wild type in growth rate, growth habit, and fertility. However, coincident knock-out mutations in Ape1L and Ape2 are lethal and lead to abortion of developing embryos. Mutations of Arp are not deleterious, even in combination with one of the other two mutations. The results are consistent with the interpretation that the process of base excision repair, involving at least one intact copy of Ape1L or Ape2, is required in the process of embryogenesis.	[Murphy, Terence M.; Belmonte, Mark; Shu, Stephanie; Britt, Anne B.; Hatteroth, James] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Murphy, TM (corresponding author), Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA.	tmmurphy@ucdavis.edu			Natural Sciences and Engineering Research Council of Canada postdoctoral [fellowship]	Natural Sciences and Engineering Research Council of Canada postdoctoral(Natural Sciences and Engineering Research Council of Canada (NSERC))	MB was supported by a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2000, DEVELOPMENT, V127, P2493; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Britt A. B., 2002, ARABIDOPSIS BOOK; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Choi Y, 2004, P NATL ACAD SCI USA, V101, P7481, DOI 10.1073/pnas.0402328101; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Kimura S, 2006, CHEM REV, V106, P753, DOI 10.1021/cr040482n; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; KUNZ BA, 1994, P NATL ACAD SCI USA, V91, P8165, DOI 10.1073/pnas.91.17.8165; Liedl B. E., 1993, Plant Molecular Biology Reporter, V11, P194, DOI 10.1007/BF02669844; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murphy TM, 2005, PHYSIOL PLANTARUM, V123, P227, DOI 10.1111/j.1399-3054.2005.00453.x; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; Ramotar D, 1997, BIOCHEM CELL BIOL, V75, P327, DOI 10.1139/bcb-75-4-327; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sorensen MB, 1996, MOL GEN GENET, V250, P750, DOI 10.1007/BF02172987; SORENSEN MB, 1992, P NATL ACAD SCI USA, V89, P4119, DOI 10.1073/pnas.89.9.4119; Wang D, 2004, MOL CANCER THER, V3, P679; Wang Y, 2006, MOL CELL BIOL, V26, P9083, DOI 10.1128/MCB.01216-06; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836	23	20	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4297	10.1371/journal.pone.0004297	http://dx.doi.org/10.1371/journal.pone.0004297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172180	Green Published, gold			2022-12-27	WOS:000265482900012
J	Henry, M; Guetard, D; Suspene, R; Rusniok, C; Wain-Hobson, S; Vartanian, JP				Henry, Michel; Guetard, Denise; Suspene, Rodolphe; Rusniok, Christophe; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; DOMAIN ORGANIZATION; CYTOSINE DEAMINASE; ADAPTIVE EVOLUTION; HUMAN HEPATOCYTES; PROVIDES INSIGHT; HIV-1 INFECTION; IN-VITRO	Hepatitis B virus (HBV) DNA is vulnerable to editing by human cytidine deaminases of the APOBEC3 (A3A-H) family albeit to much lower levels than HIV cDNA. We have analyzed and compared HBV editing by all seven enzymes in a quail cell line that does not produce any endogenous DNA cytidine deaminase activity. Using 3DPCR it was possible to show that all but A3DE were able to deaminate HBV DNA at levels from 10(-2) to 10(-5) in vitro, with A3A proving to be the most efficient editor. The amino terminal domain of A3G alone was completely devoid of deaminase activity to within the sensitivity of 3DPCR (similar to 10(-4) to 10(-5)). Detailed analysis of the dinucleotide editing context showed that only A3G and A3H have strong preferences, notably CpC and TpC. A phylogenic analysis of A3 exons revealed that A3G is in fact a chimera with the first two exons being derived from the A3F gene. This might allow co-expression of the two genes that are able to restrict HIV-1 Delta vif efficiently.	[Henry, Michel; Guetard, Denise; Suspene, Rodolphe; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, CNRS, URA 3015, Mol Retrovirol Unit, Paris, France; [Rusniok, Christophe] Inst Pasteur, Biol Intracellular Bacteria Unit, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Henry, M (corresponding author), Inst Pasteur, CNRS, URA 3015, Mol Retrovirol Unit, Paris, France.	jean-pierre.vartanian@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS)	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS)(ANRS)	Institut Pasteur and Agence Nationale de Recherche sur le SIDA (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gooch BD, 2008, VIROLOGY, V379, P118, DOI 10.1016/j.virol.2008.06.013; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Jonsson SR, 2006, NUCLEIC ACIDS RES, V34, P5683, DOI 10.1093/nar/gkl721; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; LARUE RS, 2008, J VIROL IN PRESS; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lei YC, 2006, WORLD J GASTROENTERO, V12, P7488, DOI 10.3748/wjg.v12.i46.7488; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r48; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; PETIT V, 2008, J MOL BIOL IN PRESS; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stunkel W, 1999, J VIROL, V73, P1918; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2003, TRENDS MOL MED, V9, P409, DOI 10.1016/j.molmed.2003.08.008; Vartanian JP, 1997, J MOL BIOL, V270, P139, DOI 10.1006/jmbi.1997.1104; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	75	64	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4277	10.1371/journal.pone.0004277	http://dx.doi.org/10.1371/journal.pone.0004277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169351	Green Published, gold			2022-12-27	WOS:000265482800007
J	Meani, N; Pezzimenti, F; Deflorian, G; Mione, M; Alcalay, M				Meani, Natalia; Pezzimenti, Federica; Deflorian, Gianluca; Mione, Marina; Alcalay, Myriam			The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development	PLOS ONE			English	Article								PRDM genes are a family of transcriptional regulators that modulate cellular processes such as differentiation, cell growth and apoptosis. Some family members are involved in tissue or organ maturation, and are differentially expressed in specific phases of embryonic development. PRDM5 is a recently identified family member that functions as a transcriptional repressor and behaves as a putative tumor suppressor in different types of cancer. Using gene expression profiling, we found that transcriptional targets of PRDM5 in human U2OS cells include critical genes involved in developmental processes, and specifically in regulating wnt signaling. We therefore assessed PRDM5 function in vivo by performing loss-of-function and gain-of-function experiments in zebrafish embryos. Depletion of prdm5 resulted in impairment of morphogenetic movements during gastrulation and increased the occurrence of the masterblind phenotype in axin+/- embryos, characterized by the loss of eyes and telencephalon. Overexpression of PRDM5 mRNA had opposite effects on the development of anterior neural structures, and resulted in embryos with a shorter body axis due to posterior truncation, a bigger head and abnormal somites. In situ hybridization experiments aimed at analyzing the integrity of wnt pathways during gastrulation at the level of the prechordal plate revealed inhibition of non canonical PCP wnt signaling in embryos overexpressing PRDM5, and over-activation of wnt/beta-catenin signaling in embryos lacking Prdm5. Our data demonstrate that PRDM5 regulates the expression of components of both canonical and non canonical wnt pathways and negatively modulates wnt signaling in vivo.	[Alcalay, Myriam] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Pezzimenti, Federica; Deflorian, Gianluca; Alcalay, Myriam] Cogentech, Milan, Italy; [Deflorian, Gianluca; Mione, Marina] Inst Molecular Oncol Fdn, IFOM, FIRC, Milan, Italy; [Alcalay, Myriam] Univ Studi Milano, Dipartimento Med, Chirurg Odontoiat, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Milan	Meani, N (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	marina.mione@ifom-ieo-campus.it; myriam.alcalay@ifom-ieo-campus.it	Alcalay, Myriam/AAB-4300-2019; Alcalay, Myriam/B-3182-2016; Mione, Maria Caterina/ABG-9926-2021; Mione, Maria Caterina/I-3073-2013	Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272; Mione, Maria Caterina/0000-0002-9040-3705	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Cariplo	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) and from Fondazione Cariplo to M.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Costagli A, 2002, J COMP NEUROL, V450, P73, DOI 10.1002/cne.10292; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Finocchiaro G, 2004, BIOINFORMATICS, V20, P3670, DOI 10.1093/bioinformatics/bth416; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; He LS, 1998, CANCER RES, V58, P4238; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jiang GL, 1999, INT J CANCER, V83, P541, DOI 10.1002/(SICI)1097-0215(19991112)83:4<541::AID-IJC17>3.0.CO;2-F; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Peeters P, 1997, CANCER RES, V57, P564; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sakurada K, 2001, GENE CHROMOSOME CANC, V30, P207, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1080>3.0.CO;2-V; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Song HH, 2005, J BIOL CHEM, V280, P2116, DOI 10.1074/jbc.M410090200; Tada M, 2000, DEVELOPMENT, V127, P2227; Tam W, 2006, BLOOD, V107, P4090, DOI 10.1182/blood-2005-09-3778; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Wilm TP, 2005, DEVELOPMENT, V132, P393, DOI 10.1242/dev.01572; WU Y, 2007, J MOL CELL CARDIOL; Yang XH, 1999, GENOMICS, V61, P319, DOI 10.1006/geno.1999.5967	38	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4273	10.1371/journal.pone.0004273	http://dx.doi.org/10.1371/journal.pone.0004273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169355	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482800003
J	Mruk, K; Kobertz, WR				Mruk, Karen; Kobertz, William R.			Discovery of a Novel Activator of KCNQ1-KCNE1 K+ Channel Complexes	PLOS ONE			English	Article								KCNQ1 voltage-gated K+ channels (Kv7.1) associate with the family of five KCNE peptides to form complexes with diverse gating properties and pharmacological sensitivities. The varied gating properties of the different KCNQ1-KCNE complexes enables the same K+ channel to function in both excitable and non excitable tissues. Small molecule activators would be valuable tools for dissecting the gating mechanisms of KCNQ1-KCNE complexes; however, there are very few known activators of KCNQ1 channels and most are ineffective on the physiologically relevant KCNQ1-KCNE complexes. Here we show that a simple boronic acid, phenylboronic acid (PBA), activates KCNQ1/KCNE1 complexes co-expressed in Xenopus oocytes at millimolar concentrations. PBA shifts the voltage sensitivity of KCNQ1 channel complexes to favor the open state at negative potentials. Analysis of different- sized charge carriers revealed that PBA also targets the permeation pathway of KCNQ1 channels. Activation by the boronic acid moiety has some specificity for the Kv7 family members (KCNQ1, KCNQ2/3, and KCNQ4) since PBA does not activate Shaker or hERG channels. Furthermore, the commercial availability of numerous PBA derivatives provides a large class of compounds to investigate the gating mechanisms of KCNQ1-KCNE complexes.	[Mruk, Karen; Kobertz, William R.] Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mruk, K (corresponding author), Univ Massachusetts, Sch Med, Program Neurosci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	william.kobertz@umassmed.edu	Mruk, Karen/J-7135-2019	Mruk, Karen/0000-0003-4560-4951	NIH (NIDCD) [DC007669]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007669] Funding Source: NIH RePORTER	NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the NIH (NIDCD) DC007669. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol I, 1999, EMBO J, V18, P4137, DOI 10.1093/emboj/18.15.4137; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bunn PA, 2004, CLIN CANCER RES, V10, p4263S, DOI 10.1158/1078-0432.CCR-040011; Busch AE, 1997, BRIT J PHARMACOL, V122, P187, DOI 10.1038/sj.bjp.0701434; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Gage SD, 2004, J GEN PHYSIOL, V124, P759, DOI 10.1085/jgp.200409114; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, BRIT J PHARMACOL, V131, P1503, DOI 10.1038/sj.bjp.0703734; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; PATTHY L, 1975, J BIOL CHEM, V250, P557; Pusch M, 2000, BIOPHYS J, V78, P211, DOI 10.1016/S0006-3495(00)76586-6; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Seebohm G, 2003, J PHYSIOL-LONDON, V552, P369, DOI 10.1113/jphysiol.2003.046490; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	44	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4236	10.1371/journal.pone.0004236	http://dx.doi.org/10.1371/journal.pone.0004236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156197	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482100008
J	Holmes, EA; James, EL; Coode-Bate, T; Deeprose, C				Holmes, Emily A.; James, Ella L.; Coode-Bate, Thomas; Deeprose, Catherine			Can Playing the Computer Game "Tetris'' Reduce the Build-Up of Flashbacks for Trauma? A Proposal from Cognitive Science	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ELABORATED INTRUSION THEORY; WORKING-MEMORY; EMOTIONAL MEMORIES; EYE-MOVEMENTS; IMAGERY; RECONSOLIDATION; PROPRANOLOL; FILM; CONSOLIDATION	Background: Flashbacks are the hallmark symptom of Posttraumatic Stress Disorder (PTSD). Although we have successful treatments for full-blown PTSD, early interventions are lacking. We propose the utility of developing a 'cognitive vaccine' to prevent PTSD flashback development following exposure to trauma. Our theory is based on two key findings: 1) Cognitive science suggests that the brain has selective resources with limited capacity; 2) The neurobiology of memory suggests a 6-hr window to disrupt memory consolidation. The rationale for a 'cognitive vaccine' approach is as follows: Trauma flashbacks are sensory-perceptual, visuospatial mental images. Visuospatial cognitive tasks selectively compete for resources required to generate mental images. Thus, a visuospatial computer game (e.g. "Tetris'') will interfere with flashbacks. Visuospatial tasks post-trauma, performed within the time window for memory consolidation, will reduce subsequent flashbacks. We predicted that playing "Tetris'' half an hour after viewing trauma would reduce flashback frequency over 1-week. Methodology/Principal Findings: The Trauma Film paradigm was used as a well-established experimental analog for Posttraumatic Stress. All participants viewed a traumatic film consisting of scenes of real injury and death followed by a 30-min structured break. Participants were then randomly allocated to either a no-task or visuospatial ("Tetris'') condition which they undertook for 10-min. Flashbacks were monitored for 1-week. Results indicated that compared to the no-task condition, the "Tetris'' condition produced a significant reduction in flashback frequency over 1-week. Convergent results were found on a clinical measure of PTSD symptomatology at 1-week. Recognition memory between groups did not differ significantly. Conclusions/Significance: Playing "Tetris'' after viewing traumatic material reduces unwanted, involuntary memory flashbacks to that traumatic film, leaving deliberate memory recall of the event intact. Pathological aspects of human memory in the aftermath of trauma may be malleable using non-invasive, cognitive interventions. This has implications for a novel avenue of preventative treatment development, much-needed as a crisis intervention for the aftermath of traumatic events.	[Holmes, Emily A.; James, Ella L.; Coode-Bate, Thomas; Deeprose, Catherine] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Holmes, EA (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	emily.holmes@psych.ox.ac.uk	Holmes, Emily/D-8075-2011; Deeprose, Catherine/G-3459-2012; Holmes, Emily/ABD-4367-2020; James, Ella/D-8795-2011	Holmes, Emily/0000-0001-7319-3112; 	Royal Society Dorothy Hodgkin Fellowship	Royal Society Dorothy Hodgkin Fellowship(Royal Society of London)	This research was supported by a Royal Society Dorothy Hodgkin Fellowship awarded to Emily A. Holmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson C.A., 2007, VIOLENT VIDEO GAME E, DOI DOI 10.1111/j.1469-8986.2009.00925.x; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; BRYANT RA, 2000, BEHAV RES THER, V33, P631; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Gunter RW, 2008, BEHAV RES THER, V46, P913, DOI 10.1016/j.brat.2008.04.006; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Hartshorne JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002716; Henry M, 2007, AM J BIOETHICS, V7, P12, DOI 10.1080/15265160701518474; Hertel PT, 2005, PSYCHON B REV, V12, P484, DOI 10.3758/BF03193792; Holmes EA, 2005, J BEHAV THER EXP PSY, V36, P3, DOI 10.1016/j.jbtep.2004.11.002; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; HOLMES EA, 2007, MEMORY SUPPRESSION P; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HOROWITZ MJ, 1969, ARCH GEN PSYCHIAT, V20, P552; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Kavanagh DJ, 2001, BRIT J CLIN PSYCHOL, V40, P267, DOI 10.1348/014466501163689; Kemps E, 2004, INT J EAT DISORDER, V36, P31, DOI 10.1002/eat.20005; Kemps E, 2007, J EXP PSYCHOL-APPL, V13, P95, DOI 10.1037/1076-898X.13.2.95; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; LILLEY SA, BRIT J CLIN IN PRESS; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; *NIH CLIN EXC, 2005, POST TRAUM STRESS DI; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Rudy JW, 2008, NAT NEUROSCI, V11, P1241, DOI 10.1038/nn1108-1241; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Sims VK, 2002, APPL COGNITIVE PSYCH, V16, P97, DOI 10.1002/acp.759; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stuart ADP, 2006, BEHAV RES THER, V44, P611, DOI 10.1016/j.brat.2005.04.004; *TETR HOLD LLC, PC VERS TETR; VANDENHOUT M, 2001, BRIT J CLIN PSYCHOL, V36, P209; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WESCHSLER D, 1981, WAIS R MANUAL; Wllper AP, 2008, HEALTH AFFAIR, V27, pW84, DOI 10.1377/hlthaff.27.2.w84	48	221	225	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4153	10.1371/journal.pone.0004153	http://dx.doi.org/10.1371/journal.pone.0004153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437FX	19127289	gold, Green Published, Green Submitted			2022-12-27	WOS:000265473300016
J	El-Hage, N; Bruce-Keller, AJ; Yakovleva, T; Bazov, I; Bakalkin, G; Knapp, PE; Hauser, KF				El-Hage, Nazira; Bruce-Keller, Annadora J.; Yakovleva, Tatiana; Bazov, Igor; Bakalkin, Georgy; Knapp, Pamela E.; Hauser, Kurt F.			Morphine Exacerbates HIV-1 Tat-Induced Cytokine Production in Astrocytes through Convergent Effects on [Ca2+](i), NF-kappa B Trafficking and Transcription	PLOS ONE			English	Article								Astroglia are key cellular sites where opiate drug signals converge with the proinflammatory effects of HIV-1 Tat signals to exacerbate HIV encephalitis. Despite this understanding, the molecular sites of convergence driving opiate-accelerated neuropathogenesis have not been deciphered. We therefore explored potential points of interaction between the signaling pathways initiated by HIV-1 Tat and opioids in striatal astrocytes. Profiling studies screening 152 transcription factors indicated that the nuclear factor-kappa B (NF-kappa B) subunit, c-Rel, was a likely candidate for Tat or Tat plus opiate-induced increases in cytokine and chemokine production by astrocytes. Pretreatment with the NF-kappa B inhibitor parthenolide provided evidence that Tat +/- morphine-induced release of MCP-1, IL-6 and TNF-alpha by astrocytes is NF-kappa B dependent. The nuclear export inhibitor, leptomycin B, blocked the nucleocytoplasmic shuttling of NF-kappa B; causing p65 (RelA) accumulation in the nucleus, and significantly attenuated cytokine production in Tat +/- morphine exposed astrocytes. Similarly, chelating intracellular calcium ([Ca2+](i)) blocked Tat +/- morphine-evoked MCP-1 and IL-6 release, while artificially increasing the concentration of extracellular Ca2+ reversed this effect. Taken together, these results demonstrate that: 1) exposure to Tat +/- morphine is sufficient to activate NF-kappa B and cytokine production, 2) the release of MCP-1 and IL-6 by Tat +/- morphine are highly Ca2+ -dependent, while TNF-alpha appears to be less affected by the changes in [Ca2+](i), and 3) in the presence of Tat, exposure to opiates augments Tat-induced NF-kappa B activation and cytokine release through a Ca2+ -dependent pathway.	[El-Hage, Nazira; Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Bruce-Keller, Annadora J.] Louisiana State Univ, Pennington Biomed Res Ctr, Div Basic Res, Baton Rouge, LA 70803 USA; [Yakovleva, Tatiana; Bazov, Igor; Bakalkin, Georgy] Uppsala Univ, Dept Pharm Biosci, Div Biol Res Drug Dependence, Uppsala, Sweden; [Knapp, Pamela E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Inst Drug & Alcohol Stud, Richmond, VA 23284 USA	Virginia Commonwealth University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Uppsala University; Virginia Commonwealth University; Virginia Commonwealth University	El-Hage, N (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	nelhage@vcu.edu	Hauser, Kurt/AAX-8361-2020; Bruce-Keller, Annadora/N-1954-2017	Bakalkin, Georgy/0000-0002-8074-9833; Bazov, Igor/0000-0003-4388-1656; Hauser, Kurt/0000-0001-7886-0332	NIH [P01 DA19398, P20 RR012292]; AFA Forsakring; Swedish Alcohol Retail Monopoly; Swedish Research Council; Torsten och Ragnar Soderbergs stiftelser; Swedish National Drug Policy Coordinator; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018633, K02DA027374, P01DA019398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFA Forsakring; Swedish Alcohol Retail Monopoly; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten och Ragnar Soderbergs stiftelser; Swedish National Drug Policy Coordinator; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants P01 DA19398 to KH, PK, and AB-K, and P20 RR012292 to AB-K. This work was also funded by grants from AFA Forsakring, the Swedish Alcohol Retail Monopoly, the Swedish Research Council, Torsten och Ragnar Soderbergs stiftelser, and the Swedish National Drug Policy Coordinator to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bell JE, 1998, BRAIN, V121, P2043, DOI 10.1093/brain/121.11.2043; Bell JE, 2006, CURR HIV RES, V4, P249, DOI 10.2174/157016206777709401; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Choi S, 2006, J BIOL CHEM, V281, P12722, DOI 10.1074/jbc.M601018200; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; El-Hage N, 2006, GLIA, V53, P132, DOI 10.1002/glia.20262; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2008, J NEUROIMMUNE PHARM, V3, P275, DOI 10.1007/s11481-008-9127-1; El-Hage N, 2006, J NEUROIMMUNOL, V178, P9, DOI 10.1016/j.jneuroim.2006.05.027; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Fiala M, 1996, J NEUROVIROL, V2, P158, DOI 10.3109/13550289609146878; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; Hauser KF, 2005, NEUROTOX RES, V8, P63, DOI 10.1007/BF03033820; Hauser KF, 1996, BRAIN RES, V720, P191, DOI 10.1016/0006-8993(96)00103-5; Hauser KF, 2007, J NEUROCHEM, V100, P567, DOI 10.1111/j.1471-4159.2006.04227.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hua LWL, 2002, J NEUROIMMUNOL, V126, P180, DOI 10.1016/S0165-5728(02)00055-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kim JM, 2005, CLIN EXP IMMUNOL, V140, P450, DOI 10.1111/j.1365-2249.2005.02804.x; KURIYAN J, 1995, STRUCTURE, V3, P135, DOI 10.1016/S0969-2126(01)00143-5; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Luo Y, 2003, GLIA, V43, P119, DOI 10.1002/glia.10231; Luo Y, 2002, GLIA, V39, P19, DOI 10.1002/glia.10079; Mahajan SD, 2005, CLIN IMMUNOL, V115, P323, DOI 10.1016/j.clim.2005.02.004; Mahajan SD, 2002, J IMMUNOL, V169, P3589, DOI 10.4049/jimmunol.169.7.3589; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 1998, INT REV NEUROBIOL, V42, P103, DOI 10.1016/S0074-7742(08)60609-1; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nath A, 2001, J NEUROVIROL, V7, P66; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Prat A, 2001, GLIA, V36, P145, DOI 10.1002/glia.1104; Quinones MP, 2008, MOL CELL NEUROSCI, V37, P96, DOI 10.1016/j.mcn.2007.08.017; Roy S, 1998, BIOCHEM BIOPH RES CO, V245, P392, DOI 10.1006/bbrc.1998.8415; Sen CK, 1996, FEBS LETT, V385, P58, DOI 10.1016/0014-5793(96)00346-8; Sevigny JJ, 2004, NEUROLOGY, V63, P2084, DOI 10.1212/01.WNL.0000145763.68284.15; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; Stylianou E, 1999, KIDNEY INT, V56, P873, DOI 10.1046/j.1523-1755.1999.00640.x; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wolff R, 1997, GENOME ANAL, V1, P1; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zhai QW, 2004, GLIA, V48, P327, DOI 10.1002/glia.20087	60	92	93	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4093	10.1371/journal.pone.0004093	http://dx.doi.org/10.1371/journal.pone.0004093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116667	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600014
J	Varghese, RM; Sreenivas, V; Puliyel, JM; Varughese, S				Varghese, Raji Mathew; Sreenivas, Vishnubhatla; Puliyel, Jacob Mammen; Varughese, Sara			Refractive Status at Birth: Its Relation to Newborn Physical Parameters at Birth and Gestational Age	PLOS ONE			English	Article								Background: Refractive status at birth is related to gestational age. Preterm babies have myopia which decreases as gestational age increases and term babies are known to be hypermetropic. This study looked at the correlation of refractive status with birth weight in term and preterm babies, and with physical indicators of intra-uterine growth such as the head circumference and length of the baby at birth. Methods: All babies delivered at St. Stephens Hospital and admitted in the nursery were eligible for the study. Refraction was performed within the first week of life. 0.8% tropicamide with 0.5% phenylephrine was used to achieve cycloplegia and paralysis of accommodation. 599 newborn babies participated in the study. Data pertaining to the right eye is utilized for all the analyses except that for anisometropia where the two eyes were compared. Growth parameters were measured soon after birth. Simple linear regression analysis was performed to see the association of refractive status, ( mean spherical equivalent (MSE), astigmatism and anisometropia) with each of the study variables, namely gestation, length, weight and head circumference. Subsequently, multiple linear regression was carried out to identify the independent predictors for each of the outcome parameters. Results: Simple linear regression showed a significant relation between all 4 study variables and refractive error but in multiple regression only gestational age and weight were related to refractive error. The partial correlation of weight with MSE adjusted for gestation was 0.28 and that of gestation with MSE adjusted for weight was 0.10. Birth weight had a higher correlation to MSE than gestational age. Conclusion: This is the first study to look at refractive error against all these growth parameters, in preterm and term babies at birth. It would appear from this study that birth weight rather than gestation should be used as criteria for screening for refractive error, especially in developing countries where the incidence of intrauterine malnutrition is higher.	[Varghese, Raji Mathew; Puliyel, Jacob Mammen] St Stephens Hosp, Dept Neonatol, Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India; [Varughese, Sara] Christoffel Blindenmiss S Asia Region Office, Delhi, India	St. Stephen's Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Varghese, RM (corresponding author), St Stephens Hosp, Dept Neonatol, Delhi, India.	sara.varughese@gmail.com						BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Choi MY, 2000, BRIT J OPHTHALMOL, V84, P138, DOI 10.1136/bjo.84.2.138; Cook A, 2003, INVEST OPHTH VIS SCI, V44, P953, DOI 10.1167/iovs.02-0124; GRAHAM MV, 1963, BRIT MED J, V343, P1452; Holmstrom G, 1998, BRIT J OPHTHALMOL, V82, P1265, DOI 10.1136/bjo.82.11.1265; Khanna Rajesh, 2002, Indian Journal of Pediatrics, V69, P957, DOI 10.1007/BF02726013; Kuo A, 2003, J AAPOS, V7, P174, DOI 10.1016/S1091-8531(03)00017-X; MEHRA KS, 1965, BR J OPHTHALMOL, V49, P76; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; NISSENKORN I, 1983, BRIT J OPHTHALMOL, V67, P170, DOI 10.1136/bjo.67.3.170; Patel A R, 1970, J All India Ophthalmol Soc, V18, P59; Quinn GE, 1998, OPHTHALMOLOGY, V105, P1292, DOI 10.1016/S0161-6420(98)97036-1; Saunders KJ, 2002, BRIT J OPHTHALMOL, V86, P1035, DOI 10.1136/bjo.86.9.1035; SCHARF J, 1978, J PEDIAT OPHTH STRAB, V15, P48; SCHARF J, 1975, Journal of Pediatric Ophthalmology, V12, P193; Snir M, 2004, BRIT J OPHTHALMOL, V88, P900, DOI 10.1136/bjo.2003.037499; Ton Y, 2004, J AAPOS, V8, P534, DOI 10.1016/j.jaapos.2004.09.002; Varughese S, 2005, CURR EYE RES, V30, P423, DOI 10.1080/02713680590959295; Verma M, 1994, Indian Pediatr, V31, P1183	19	24	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4469	10.1371/journal.pone.0004469	http://dx.doi.org/10.1371/journal.pone.0004469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214228	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484300008
J	Rahmioglu, N; Andrew, T; Cherkas, L; Surdulescu, G; Swaminathan, R; Spector, T; Ahmadi, KR				Rahmioglu, Nilufer; Andrew, Toby; Cherkas, Lynn; Surdulescu, Gabriela; Swaminathan, Ramasamyiyer; Spector, Tim; Ahmadi, Kourosh R.			Epidemiology and Genetic Epidemiology of the Liver Function Test Proteins	PLOS ONE			English	Article								Background: The liver function test (LFT) is among the most commonly used clinical investigations to assess hepatic function, severity of liver diseases and the effect of therapies, as well as to detect drug-induced liver injury (DILI). Aims: To determine the relative contribution of genetic and environmental factors as well as test and quantify the effects of sex, age, BMI and alcohol consumption to variation in liver function test proteins-including alanine amino transaminase (ALT), Albumin, gamma glutamyl transpeptidase (GGT),total bilirubin, total protein, total globulin, aspartate transaminase (AST), and alkaline phosphotase (ALP)-using the classical twin model. Methods: Blood samples were collected from a total of 5380 twin pairs from the TwinsUK registry. We measured the expression levels of major proteins associated with the LFT, calculated BMI from measured weight and height and questionnaires were completed for alcohol consumption by the twins. The relative contribution of genetic and environmental factors to variation in the LFT proteins was assessed and quantified using a variance components model fitting approach. Results: Our results show that (1) variation in all the LFTs has a significant heritable basis (h(2) ranging from 20% to 77%); (2) other than GGT, the LFTs are all affected to some extent by common environmental factors (c(2) ranging from 24% to 54%); and (3) a small but significant proportion of the variation in the LFTs was due to confounding effects of age, sex, BMI, and alcohol use. Conclusions: Variation in the LFT proteins is under significant genetic and common environmental control although sex, alcohol use, age and BMI also contribute significantly to inter-individual variation in the LFT proteins. Understanding the underlying genetic contribution of liver function tests may help the interpretation of their results and explain wide variation among individuals.	[Rahmioglu, Nilufer; Andrew, Toby; Cherkas, Lynn; Surdulescu, Gabriela; Spector, Tim; Ahmadi, Kourosh R.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Swaminathan, Ramasamyiyer] Guys & St Thomas Hosp Trust, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Rahmioglu, N (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	kourosh.ahmadi@kcl.ac.uk	rahmioglu, nilufer/AAO-5653-2020; Ahmadi, Kourosh R/B-6379-2012; Andrew, Toby/O-8868-2017	Andrew, Toby/0000-0001-8838-4384; RAHMIOGLU, NILUFER/0000-0002-5169-8571	Wellcome Trust; Department of Health via the National Institute for Health Research (NIHR); NHS Foundation Trust in partnership with King's College London; Arthritis Research Campaign/ EC FP6 Programme [512066]; EC Framework 7 programme [200800]; Treat OA/EC Framework 7 Health; 2007-A ENGAGE/EC Framework 7 Healh; MyEuropia Research Training Network [MRTN-CT-2006-034021]; Chronic Disease Research Foundation (CDRF) [studentship, fellowship]; National Health and Medical Research Council (NHMRC); National Institute of Aging (NIA); Guide Dogs for the blind Association(GDBA); Biotechnology and biological Sciences Research Council (BBSRC)	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NHS Foundation Trust in partnership with King's College London; Arthritis Research Campaign/ EC FP6 Programme(Versus Arthritis); EC Framework 7 programme(European Commission); Treat OA/EC Framework 7 Health; 2007-A ENGAGE/EC Framework 7 Healh; MyEuropia Research Training Network; Chronic Disease Research Foundation (CDRF); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Guide Dogs for the blind Association(GDBA); Biotechnology and biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the Wellcome Trust, the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London,/ Arthritis Research Campaign/ EC FP6 Programme Grant-512066 (LSHG-CT-2004)MOLPAGE/EC Framework 7 programme grant 200800 Treat OA/EC Framework 7 Health-2007-A ENGAGE/EC Framework 7 Healh-2007-2.4.5-4 GEFOS/EC FP6 MRTN-CT-2006-034021 MyEuropia Research Training Network/Chronic Disease Research Foundation (CDRF)/National Health and Medical Research Council (NHMRC)/National Institute of Aging (NIA)/Guide Dogs for the blind Association(GDBA)/Biotechnology and biological Sciences Research Council (BBSRC). NR is supported by a CDRF prize studentship. KRA is in part supported by a CDRF career development fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Bathum L, 2001, CLIN CHEM, V47, P81; Drivdal M, 2006, SCAND J GASTROENTERO, V41, P469, DOI 10.1080/0036552050033518; HOPPER JL, 1992, ACTA GENET MED GEMEL, V41, P261, DOI 10.1017/S0001566000002129; Khedmat H, 2007, WORLD J GASTROENTERO, V13, P889, DOI 10.3748/wjg.v13.i6.889; Kyvic K., 2000, ADV TWIN SIB PAIR AN, P67; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Leclercq I, 1999, ACTA GASTRO-ENT BELG, V62, P16; Middelberg RPS, 2007, TWIN RES HUM GENET, V10, P757, DOI 10.1375/twin.10.5.757; Montagnese C, 2007, INT J EAT DISORDER, V40, P746, DOI 10.1002/eat.20432; Moranska Izabella, 2004, Wiad Lek, V57, P427; NEAL MC, 1998, MX STAT MODELING; Neale MC, 1992, METHODOLOGY GENETIC, P1; REED T, 1994, ALCOHOL CLIN EXP RES, V18, P702, DOI 10.1111/j.1530-0277.1994.tb00934.x; ROTHSCHILD MA, 1972, NEW ENGL J MED, V286, P748, DOI 10.1056/NEJM197204062861404; Scheig R, 1996, PRIMARY CARE, V23, P551, DOI 10.1016/S0095-4543(05)70347-X; Shankar S, 2006, J BONE MINER RES, V21, pP22, DOI 10.1359/JBMR.06S204; SHEEHAN M, 1979, CLIN BIOCHEM, V12, P262, DOI 10.1016/S0009-9120(79)80122-8; SPECTOR TD, 1999, ADV TWIN SIB PAIR AN, P153; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; *STATACORP LP, 2007, STAT 10 WIND; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; Stranges S, 2004, ALCOHOL CLIN EXP RES, V28, P949, DOI 10.1097/01.ALC.0000128229.23396.42; Tromm A, 2005, HEPATO-GASTROENTEROL, V52, P753; Whitfield JB, 2002, CLIN CHEM, V48, P1426; Williams FMK, 2005, ANN RHEUM DIS, V64, P309, DOI 10.1136/ard.2004.022269	27	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4435	10.1371/journal.pone.0004435	http://dx.doi.org/10.1371/journal.pone.0004435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209234	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484100007
J	Sone, M; Uchida, A; Komatsu, A; Suzuki, E; Ibuki, I; Asada, M; Shiwaku, H; Tamura, T; Hoshino, M; Okazawa, H; Nabeshima, Y				Sone, Masaki; Uchida, Atsuko; Komatsu, Ayumi; Suzuki, Emiko; Ibuki, Ikue; Asada, Megumi; Shiwaku, Hiroki; Tamura, Takuya; Hoshino, Mikio; Okazawa, Hitoshi; Nabeshima, Yo-ichi			Loss of yata, a Novel Gene Regulating the Subcellular Localization of APPL, Induces Deterioration of Neural Tissues and Lifespan Shortening	PLOS ONE			English	Article								Background: The subcellular localization of membrane and secreted proteins is finely and dynamically regulated through intracellular vesicular trafficking for permitting various biological processes. Drosophila Amyloid precursor protein like (APPL) and Hikaru genki (HIG) are examples of proteins that show differential subcellular localization among several developmental stages. Methodology/Principal Findings: During the study of the localization mechanisms of APPL and HIG, we isolated a novel mutant of the gene, CG1973, which we named yata. This molecule interacted genetically with Appl and is structurally similar to mouse NTKL/SCYL1, whose mutation was reported to cause neurodegeneration. yata null mutants showed phenotypes that included developmental abnormalities, progressive eye vacuolization, brain volume reduction, and lifespan shortening. Exogenous expression of Appl or hig in neurons partially rescued the mutant phenotypes of yata. Conversely, the phenotypes were exacerbated in double null mutants for yata and Appl. We also examined the subcellular localization of endogenous APPL and exogenously pulse-induced APPL tagged with FLAG by immunostaining the pupal brain and larval motor neurons in yata mutants. Our data revealed that yata mutants showed impaired subcellular localization of APPL. Finally, yata mutant pupal brains occasionally showed aberrant accumulation of Sec23p, a component of the COPII coat of secretory vesicles traveling from the endoplasmic reticulum (ER) to the Golgi. Conclusion/Significance: We identified a novel gene, yata, which is essential for the normal development and survival of tissues. Loss of yata resulted in the progressive deterioration of the nervous system and premature lethality. Our genetic data showed a functional relationship between yata and Appl. As a candidate mechanism of the abnormalities, we found that yata regulates the subcellular localization of APPL and possibly other proteins.	[Sone, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan; [Sone, Masaki; Shiwaku, Hiroki; Tamura, Takuya; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Sone, Masaki; Uchida, Atsuko; Komatsu, Ayumi; Ibuki, Ikue; Asada, Megumi; Hoshino, Mikio; Nabeshima, Yo-ichi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Sone, Masaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Japan; [Suzuki, Emiko] Natl Inst Genet, Mishima, Shizuoka, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sone, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan.	sone.mtt@mri.tmd.ac.jp	Uchida, Atsuko/E-3081-2010; Sone, Masaki/Q-9058-2019; Ibuki, Yuko/AAY-8199-2020	Uchida, Atsuko/0000-0002-4658-1504; Ibuki, Yuko/0000-0001-6702-526X; Suzuki, Emiko/0000-0002-4005-0542; Shiwaku, Hiroki/0000-0001-7503-8044	center-of-excellence grant; Ministry of Education, Culture, Sports, Science and Technology of Japan [grants-in-aid for scientific research]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders	center-of-excellence grant; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders	This work was supported by center-of-excellence grant, program for improvement of research environment for young researchers from special coordination funds for promoting science and technology and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Mochida Memorial Foundation for Medical and Pharmaceutical Research and Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hoshino M, 1999, DEV GENES EVOL, V209, P1, DOI 10.1007/s004270050221; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kato M, 2002, GENOMICS, V79, P760, DOI 10.1006/geno.2002.6774; Knust E, 2007, CURR OPIN NEUROBIOL, V17, P541, DOI 10.1016/j.conb.2007.08.001; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Y, 2004, J NEUROBIOL, V61, P343, DOI 10.1002/neu.20048; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; McGuire AT, 2007, EMBO J, V26, P288, DOI 10.1038/sj.emboj.7601493; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Sone M, 2000, DEVELOPMENT, V127, P4157; Torroja L, 1996, J NEUROSCI, V16, P4638; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Torroja L, 1999, J NEUROSCI, V19, P7793; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; XU T, 1993, DEVELOPMENT, V117, P1223	38	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4466	10.1371/journal.pone.0004466	http://dx.doi.org/10.1371/journal.pone.0004466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209226	gold, Green Submitted, Green Published			2022-12-27	WOS:000265484100016
J	Wang, D; Lu, M; Miao, J; Li, TT; Wang, E; Cui, QH				Wang, Dong; Lu, Ming; Miao, Jing; Li, Tingting; Wang, Edwin; Cui, Qinghua			Cepred: Predicting the Co-Expression Patterns of the Human Intronic microRNAs with Their Host Genes	PLOS ONE			English	Article							IDENTIFICATION; GENOMICS; ATLAS	Identifying the tissues in which a microRNA is expressed could enhance the understanding of the functions, the biological processes, and the diseases associated with that microRNA. However, the mechanisms of microRNA biogenesis and expression remain largely unclear and the identification of the tissues in which a microRNA is expressed is limited. Here, we present a machine learning based approach to predict whether an intronic microRNA show high co-expression with its host gene, by doing so, we could infer the tissues in which a microRNA is high expressed through the expression profile of its host gene. Our approach is able to achieve an accuracy of 79% in the leave-one-out cross validation and 95% on an independent testing dataset. We further estimated our method through comparing the predicted tissue specific microRNAs and the tissue specific microRNAs identified by biological experiments. This study presented a valuable tool to predict the co-expression patterns between human intronic microRNAs and their host genes, which would also help to understand the microRNA expression and regulation mechanisms. Finally, this framework can be easily extended to other species.	[Wang, Dong; Lu, Ming; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China; [Wang, Dong; Lu, Ming; Cui, Qinghua] Peking Univ, MOE Key Lab Mol Cardiol, Beijing, Peoples R China; [Miao, Jing] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Li, Tingting] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Wang, Edwin] Natl Res Council Canada, Biotechnol Res Inst, Comp Chem & Biol Grp, Montreal, PQ, Canada	Peking University; Peking University; Peking University; Tsinghua University; National Research Council Canada	Wang, D (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China.	cuiqinghua@bjmu.edu.cn	Wang, Edwin/Y-1553-2019	Miao, Jing/0000-0003-0642-9740	National Basic Research program of China [2007CB512100]; 985 project of Peking University [985-2-108-121]	National Basic Research program of China(National Basic Research Program of China); 985 project of Peking University(Peking University)	This research was supported by the National Basic Research program of China (2007CB512100) and the 985 project of Peking University (No. 985-2-108-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vapnik V. N., 1998, NATURE STAT LEARNING; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou HJ, 2008, BIOCHEM BIOPH RES CO, V368, P709, DOI 10.1016/j.bbrc.2008.01.117	29	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4421	10.1371/journal.pone.0004421	http://dx.doi.org/10.1371/journal.pone.0004421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204784	Green Published, gold			2022-12-27	WOS:000265484000010
J	Foley, JE; Yeh, JRJ; Maeder, ML; Reyon, D; Sander, JD; Peterson, RT; Joung, JK				Foley, Jonathan E.; yeh, Jing-Ruey J.; Maeder, Morgan L.; Reyon, Deepak; Sander, Jeffry D.; Peterson, Randall T.; Joung, J. Keith			Rapid Mutation of Endogenous Zebrafish Genes Using Zinc Finger Nucleases Made by Oligomerized Pool ENgineering (OPEN)	PLOS ONE			English	Article								Background: Customized zinc finger nucleases (ZFNs) form the basis of a broadly applicable tool for highly efficient genome modification. ZFNs are artificial restriction endonucleases consisting of a non-specific nuclease domain fused to a zinc finger array which can be engineered to recognize specific DNA sequences of interest. Recent proof-of-principle experiments have shown that targeted knockout mutations can be efficiently generated in endogenous zebrafish genes via non-homologous end-joining-mediated repair of ZFN-induced DNA double-stranded breaks. The Zinc Finger Consortium, a group of academic laboratories committed to the development of engineered zinc finger technology, recently described the first rapid, highly effective, and publicly available method for engineering zinc finger arrays. The Consortium has previously used this new method (known as OPEN for Oligomerized Pool ENgineering) to generate high quality ZFN pairs that function in human and plant cells. Methodology/Principal Findings: Here we show that OPEN can also be used to generate ZFNs that function efficiently in zebrafish. Using OPEN, we successfully engineered ZFN pairs for five endogenous zebrafish genes: tfr2, dopamine transporter, telomerase, hif1aa, and gridlock. Each of these ZFN pairs induces targeted insertions and deletions with high efficiency at its endogenous gene target in somatic zebrafish cells. In addition, these mutations are transmitted through the germline with sufficiently high frequency such that only a small number of fish need to be screened to identify founders. Finally, in silico analysis demonstrates that one or more potential OPEN ZFN sites can be found within the first three coding exons of more than 25,000 different endogenous zebrafish gene transcripts. Conclusions and Significance: In summary, our study nearly triples the total number of endogenous zebrafish genes successfully modified using ZFNs (from three to eight) and suggests that OPEN provides a reliable method for introducing targeted mutations in nearly any zebrafish gene of interest.	[Foley, Jonathan E.; Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA; [Foley, Jonathan E.; Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Comput & Integrat Biol, Charlestown, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] MIT, Broad Inst, Cambridge, MA USA; [yeh, Jing-Ruey J.; Peterson, Randall T.] Harvard Univ, Cambridge, MA USA; [Reyon, Deepak; Sander, Jeffry D.] Iowa State Univ, Dept Genet Dev & Cell Biol, Interdept Grad Program Bioinformat & Comp Biol, Ames, IA 50011 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Iowa State University; Harvard University; Harvard Medical School	Foley, JE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA USA.	jjoung@partners.org	Reyon, Deepak/HCH-3183-2022	Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Peterson, Randall/0000-0003-0727-3469	NIH [R01 GM069906, R21 HL091808, R01 HL79267, R33-GM066387]; MGH Department of Pathology; National Institute of Aging [K01 AG031300]; Claflin Distinguished Scholar Award; Pioneer-Hi-Bred International, Inc [2008 Graduate Fellowship]; ISU CIAG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091808, R01HL079267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387, R01GM069906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Department of Pathology; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Claflin Distinguished Scholar Award; Pioneer-Hi-Bred International, Inc; ISU CIAG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.E.F., M.L.M., and J.K.J. are supported by the NIH (R01 GM069906 and R21 HL091808) and the MGH Department of Pathology. J.-R.J.Y. is supported by the National Institute of Aging (K01 AG031300) and by a Claflin Distinguished Scholar Award. J.-R.J.Y. and R.T.P. are supported by the NIH (R01 HL79267). J.D.S is supported by Pioneer-Hi-Bred International, Inc 2008 Graduate Fellowship, NIH R33-GM066387, and ISU CIAG. D.R is supported by ISU CIAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Camenisch TD, 2008, MINI-REV MED CHEM, V8, P669, DOI 10.2174/138955708784567458; CARROLL D, 2008, GENE THER; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Choo Y, 2000, CURR OPIN STRUC BIOL, V10, P411, DOI 10.1016/S0959-440X(00)00107-X; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Isalan M, 1998, BIOCHEMISTRY-US, V37, P12026, DOI 10.1021/bi981358z; Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Kiermer V, 2008, NAT METHODS, V5, P579, DOI 10.1038/nmeth0708-579; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kim YG, 1997, GENE, V203, P43, DOI 10.1016/S0378-1119(97)00489-7; Lee DK, 2003, CURR TOP MED CHEM, V3, P645, DOI 10.2174/1568026033452384; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pearson H, 2008, NATURE, V455, P160, DOI [10.1038/455160a, 10.1038/453150a]; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Segal DJ, 2001, CURR OPIN BIOTECH, V12, P632, DOI 10.1016/S0958-1669(01)00272-5; Thibodeau-Beganny Stacey, 2007, V408, P317; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Woods IG, 2008, NAT BIOTECHNOL, V26, P650, DOI 10.1038/nbt0608-650; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8	47	185	215	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4348	10.1371/journal.pone.0004348	http://dx.doi.org/10.1371/journal.pone.0004348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198653	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900001
J	Belin, S; Kaya, F; Duisit, G; Giacometti, S; Ciccolini, J; Fontes, M				Belin, Sophie; Kaya, Ferdinand; Duisit, Ghislaine; Giacometti, Sarah; Ciccolini, Joseph; Fontes, Michel			Antiproliferative Effect of Ascorbic Acid Is Associated with the Inhibition of Genes Necessary to Cell Cycle Progression	PLOS ONE			English	Article								Background: Ascorbic acid (AA), or Vitamin C, is most well known as a nutritional supplement with antioxidant properties. Recently, we demonstrated that high concentrations of AA act on PMP22 gene expression and partially correct the Charcot-Marie-Tooth disease phenotype in a mouse model. This is due to the capacity of AA, but not other antioxidants, to down-modulate cAMP intracellular concentration by a competitive inhibition of the adenylate cyclase enzymatic activity. Because of the critical role of cAMP in intracellular signalling, we decided to explore the possibility that ascorbic acid could modulate the expression of other genes. Methods and Findings: Using human pangenomic microarrays, we found that AA inhibited the expression of two categories of genes necessary for cell cycle progression, tRNA synthetases and translation initiation factor subunits. In in vitro assays, we demonstrated that AA induced the S-phase arrest of proliferative normal and tumor cells. Highest concentrations of AA leaded to necrotic cell death. However, quiescent cells were not susceptible to AA toxicity, suggesting the blockage of protein synthesis was mainly detrimental in metabolically-active cells. Using animal models, we found that high concentrations of AA inhibited tumor progression in nude mice grafted with HT29 cells (derived from human colon carcinoma). Consistently, expression of tRNA synthetases and ieF2 appeared to be specifically decreased in tumors upon AA treatment. Conclusions: AA has an antiproliferative activity, at elevated concentration that could be obtained using IV injection. This activity has been observed in vitro as well in vivo and likely results from the inhibition of expression of genes involved in protein synthesis. Implications for a clinical use in anticancer therapies will be discussed.	[Belin, Sophie; Kaya, Ferdinand; Duisit, Ghislaine; Fontes, Michel] Fac Med Timone, EA 4263, Marseille, France; [Giacometti, Sarah; Ciccolini, Joseph] Fac Pharm Marseille, Lab Pharmacokinet & Toxicokinet, UPRES, EA 3286, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Belin, S (corresponding author), Fac Med Timone, EA 4263, Marseille, France.	michel.fontes@univmed.fr	Ciccolini, Joseph/AAP-7193-2021; Belin, Sophie/AAJ-7962-2020	Ciccolini, Joseph/0000-0003-1733-3410	French ANR maladies rares program; INSERM; PACA	French ANR maladies rares program(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PACA(Region Provence-Alpes-Cote d'Azur)	This work has been funded by French ANR maladies rares program. S.Belin is supported by INSERM and PACA region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline S, 2006, CAN MED ASSOC J, V174, P956, DOI 10.1503/cmaj.060228; CAMERON E, 1974, CHEM-BIOL INTERACT, V9, P285, DOI 10.1016/0009-2797(74)90019-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; ENGER MD, 1978, BIOCHEMISTRY-US, V17, P2435, DOI 10.1021/bi00605a029; Heckelen A, 2004, ACTA OPHTHALMOL SCAN, V82, P564, DOI 10.1111/j.1600-0420.2004.00317.x; HOFFER L, 2008, ANN ONCOL; HOHMANN S, 1992, GENE, V120, P43, DOI 10.1016/0378-1119(92)90007-C; KAYA F, 2008, FEBS LETT; Kaya F, 2008, MUSCLE NERVE, V38, P1052, DOI 10.1002/mus.21071; Kaya F, 2007, NEUROMUSCULAR DISORD, V17, P248, DOI 10.1016/j.nmd.2006.12.008; Kuwai T, 2008, CLIN EXP METASTAS, V25, P477, DOI 10.1007/s10585-008-9153-7; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Motomura S, 1996, GENES CELLS, V1, P1101, DOI 10.1046/j.1365-2443.1996.d01-227.x; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; PAULING L, 1985, P NATL ACAD SCI USA, V82, P5185, DOI 10.1073/pnas.82.15.5185; PAULING L, 1986, NUTR REV, V44, P28; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SUSS J, 1972, Z ALLG MIKROBIOL, V12, P161, DOI 10.1002/jobm.3630120211; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; ZIRVI KA, 1989, CLIN EXP METASTAS, V7, P591, DOI 10.1007/BF01753670	25	56	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4409	10.1371/journal.pone.0004409	http://dx.doi.org/10.1371/journal.pone.0004409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197388	gold, Green Published			2022-12-27	WOS:000265483700015
J	Li, Y; Agarwal, P				Li, Yong; Agarwal, Pankaj			A Pathway-Based View of Human Diseases and Disease Relationships	PLOS ONE			English	Article								It is increasingly evident that human diseases are not isolated from each other. Understanding how different diseases are related to each other based on the underlying biology could provide new insights into disease etiology, classification, and shared biological mechanisms. We have taken a computational approach to studying disease relationships through 1) systematic identification of disease associated genes by literature mining, 2) associating diseases to biological pathways where disease genes are enriched, and 3) linking diseases together based on shared pathways. We identified 4,195 candidate disease associated genes for 1028 diseases. On average, about 50% of disease associated genes of a disease are statistically mapped to pathways. We generated a disease network which consists of 591 diseases and 6,931 disease relationships. We examined properties of this network and provided examples of novel disease relationships which cannot be readily captured through simple literature search or gene overlap analysis. Our results could potentially provide insights into the design of novel, pathway-guided therapeutic interventions for diseases.	[Li, Yong; Agarwal, Pankaj] GlaxoSmithKline R&D, Computat Biol, King Of Prussia, PA USA	GlaxoSmithKline	Li, Y (corresponding author), GlaxoSmithKline R&D, Computat Biol, King Of Prussia, PA USA.	yong.2.li@gsk.com	Agarwal, Pankaj/N-2147-2019; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Agarwal, Pankaj/0000-0002-4165-9990				Agarwal P, 2008, BRIEF BIOINFORM, V9, P479, DOI 10.1093/bib/bbn035; Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Childs B, 2000, ANNU REV GENOM HUM G, V1, P1, DOI 10.1146/annurev.genom.1.1.1; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Moseley FL, 2007, J PHARM PHARMACOL, V59, P609, DOI 10.1211/jpp.59.5.0001; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047	19	138	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4346	10.1371/journal.pone.0004346	http://dx.doi.org/10.1371/journal.pone.0004346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194489	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483500004
J	Oberto, J; Nabti, S; Jooste, V; Mignot, H; Rouviere-Yaniv, J				Oberto, Jacques; Nabti, Sabrina; Jooste, Valerie; Mignot, Herve; Rouviere-Yaniv, Josette			The HU Regulon Is Composed of Genes Responding to Anaerobiosis, Acid Stress, High Osmolarity and SOS Induction	PLOS ONE			English	Article								Background: The Escherichia coli heterodimeric HU protein is a small DNA-bending protein associated with the bacterial nucleoid. It can introduce negative supercoils into closed circular DNA in the presence of topoisomerase I. Cells lacking HU grow very poorly and display many phenotypes. Methodology/Principal Findings: We analyzed the transcription profile of every Escherichia coli gene in the absence of one or both HU subunits. This genome-wide in silico transcriptomic approach, performed in parallel with in vivo genetic experimentation, defined the HU regulon. This large regulon, which comprises 8% of the genome, is composed of four biologically relevant gene classes whose regulation responds to anaerobiosis, acid stress, high osmolarity, and SOS induction. Conclusions/Significance: The regulation a large number of genes encoding enzymes involved in energy metabolism and catabolism pathways by HU explains the highly pleiotropic phenotype of HU-deficient cells. The uniform chromosomal distribution of the many operons regulated by HU strongly suggests that the transcriptional and nucleoid architectural functions of HU constitute two aspects of a unique protein-DNA interaction mechanism.	[Oberto, Jacques; Nabti, Sabrina; Rouviere-Yaniv, Josette] CNRS, Inst Biolo Physico chim, Lab Physiol Bacterienne, UPR 9073, Paris, France; [Jooste, Valerie] Univ Dijon, INSERM, Epidemiol & Biostat Grp, UMR 866, Dijon, France; [Mignot, Herve] SPSS, Courbevoie, France	Centre National de la Recherche Scientifique (CNRS); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; International Business Machines (IBM)	Oberto, J (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France.	jacques.oberto@igmors.u-psud.fr; josette.rouviere-yaniv@ibpc.fr	Jooste, Valerie/AFW-1362-2022	Jooste, Valerie/0000-0002-9902-0700	French "Ministere de la Recherche"; Centre National pour la Recherche Scientifique	French "Ministere de la Recherche"(Ministry of Research, France); Centre National pour la Recherche Scientifique	The French "Ministere de la Recherche" for microarray financing and the "Centre National pour la Recherche Scientifique" for general financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Bensaid A, 1996, J MOL BIOL, V256, P292, DOI 10.1006/jmbi.1996.0086; BLISKA JB, 1987, J MOL BIOL, V194, P205, DOI 10.1016/0022-2836(87)90369-X; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Conter A, 1997, J MOL BIOL, V273, P75, DOI 10.1006/jmbi.1997.1308; CORTASSA S, 1993, MOL CELL BIOCHEM, V126, P115, DOI 10.1007/BF00925689; Davison A. C., 1997, BOOSTRAP METHODS THE; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DORMAN CJ, 2008, REGULATION TRANSCRIP, P151; DRI AM, 1991, J BACTERIOL, V173, P2852, DOI 10.1128/JB.173.9.2852-2863.1991; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; ELLEDGE SJ, 1983, J MOL BIOL, V164, P175, DOI 10.1016/0022-2836(83)90074-8; Fernandez S, 1997, MOL MICROBIOL, V23, P1169, DOI 10.1046/j.1365-2958.1997.3061670.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Giangrossi M, 2002, MOL MICROBIOL, V44, P205, DOI 10.1046/j.1365-2958.2002.02868.x; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Green J, 1997, MICROBIOL-SGM, V143, P2865, DOI 10.1099/00221287-143-9-2865; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Hartigan J., 1975, CLUSTERING ALGORITHM; HASELKORN R, 1976, P NATL ACAD SCI USA, V73, P1917, DOI 10.1073/pnas.73.6.1917; Hobman JL, 2007, J BACTERIOL, V189, P8786, DOI 10.1128/JB.00977-07; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; HSIEH LS, 1991, J MOL BIOL, V219, P443, DOI 10.1016/0022-2836(91)90185-9; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; Kovacs AT, 2005, BIOCHEM SOC T, V33, P36, DOI 10.1042/BST0330061; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Li C., 2003, ANAL GENE EXPRESSION, P120; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luke K, 2002, VIROLOGY, V299, P182, DOI 10.1006/viro.2002.1409; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; LUTKENHAUS JF, 1983, J BACTERIOL, V154, P1339, DOI 10.1128/JB.154.3.1339-1346.1983; Malik M, 1996, J MOL BIOL, V256, P66, DOI 10.1006/jmbi.1996.0068; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; MANNA D, 1994, J BACTERIOL, V176, P5378, DOI 10.1128/JB.176.17.5378-5384.1994; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Miller J.H., 1972, EXPT MOL GENETICS; Miyabe I, 2000, INT J RADIAT BIOL, V76, P43; Morales P, 2002, J BACTERIOL, V184, P1565, DOI 10.1128/JB.184.6.1565-1570.2002; Oberto J, 1996, J BACTERIOL, V178, P293, DOI 10.1128/jb.178.1.293-297.1996; OBERTO J, 1994, BIOCHIMIE, V76, P901, DOI 10.1016/0300-9084(94)90014-0; Oberto J, 2008, BIOINFORMATICS, V24, P424, DOI 10.1093/bioinformatics/btm600; PAINBENI E, 1993, J MOL BIOL, V234, P1021, DOI 10.1006/jmbi.1993.1656; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PREOBRAJENSKAYA O, 1994, MOL MICROBIOL, V13, P459, DOI 10.1111/j.1365-2958.1994.tb00440.x; Ramstein J, 2003, J MOL BIOL, V331, P101, DOI 10.1016/S0022-2836(03)00725-3; Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07; Rouviere-Yaniv J, 1978, Cold Spring Harb Symp Quant Biol, V42 Pt 1, P439; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sagi D, 2004, J MOL BIOL, V341, P419, DOI 10.1016/j.jmb.2004.06.023; Saint-Ruf C, 2004, GENETICS, V168, P541, DOI 10.1534/genetics.104.028704; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Semsey S, 2006, J MOL BIOL, V358, P355, DOI 10.1016/j.jmb.2006.02.022; Shanado Y, 1998, GENES CELLS, V3, P511, DOI 10.1046/j.1365-2443.1998.00208.x; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P111; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SINDEN RR, 1981, P NATL ACAD SCI-BIOL, V78, P224, DOI 10.1073/pnas.78.1.224; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; StataCorp, 2005, STAT STAT SOFTW REL; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Tucker DL, 2003, J BACTERIOL, V185, P3190, DOI 10.1128/JB.185.10.3190-3201.2003; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	92	124	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4367	10.1371/journal.pone.0004367	http://dx.doi.org/10.1371/journal.pone.0004367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194530	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483500011
J	Zhao, M; Li, X; Xu, P; Shen, X; Gui, XH; Wang, LL; DeRiemer, K; Mei, J; Gao, Q				Zhao, Ming; Li, Xia; Xu, Peng; Shen, Xin; Gui, Xiaohong; Wang, Lili; DeRiemer, Kathryn; Mei, Jian; Gao, Qian			Transmission of MDR and XDR Tuberculosis in Shanghai, China	PLOS ONE			English	Article								Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) are global health problems. We sought to determine the characteristics, prevalence, and relative frequency of transmission of MDR and XDR TB in Shanghai, one of the largest cities in Asia. Methods: TB is diagnosed in district TB hospitals in Shanghai, China. Drug susceptibility testing for first-line drugs was performed for all culture positive TB cases, and tests for second-line drugs were performed for MDR cases. VNTR-7 and VNTR-16 were used to genotype the strains, and prior treatment history and treatment outcomes were determined for each patient. Results: There were 4,379 culture positive TB cases diagnosed with drug susceptibility test results available during March 2004 through November 2007. 247 (5.6%) were infected with a MDR strain of M. tuberculosis and 11 (6.3%) of the 175 MDR patients whose isolate was tested for susceptibility to second-line drugs, were XDR. More than half of the patients with MDR and XDR were newly diagnosed and had no prior history of TB treatment. Nearly 57% of the patients with MDR were successfully treated. Discussion: Transmission of MDR and XDR strains is a serious problem in Shanghai. While a history of prior anti-TB treatment indicates which individuals may have acquired MDR or XDR TB, it does not accurately predict which TB patients have disease caused by transmission of MDR and XDR strains. Therefore, universal drug susceptibility testing is recommended for new and retreatment TB cases.	[Zhao, Ming; Xu, Peng; Shen, Xin; Gui, Xiaohong; Wang, Lili; Mei, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China; [Zhao, Ming; Li, Xia; Xu, Peng; Gao, Qian] Fudan Univ, Inst Biomed Sci, Key Lab Med Molecular Virol, Shanghai, Peoples R China; [Zhao, Ming; Li, Xia; Xu, Peng; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China; [DeRiemer, Kathryn] Univ Calif Davis, Sch Med, Davis, CA USA	Shanghai Center for Disease Control & Prevention; Fudan University; Fudan University; University of California System; University of California Davis	Zhao, M (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China.	meijiansh@yahoo.com.cn; qgao99@yahoo.com	Xu, Pengcheng/J-1429-2012	Xu, Pengcheng/0000-0001-8651-208X	Key Project of Chinese National Programs [2008ZX100/03-010, 2005CB523102, 2006AA02Z423]; NIH [D43 TW007887]; FOGARTY INTERNATIONAL CENTER [D43TW007887] Funding Source: NIH RePORTER	Key Project of Chinese National Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Key Project of Chinese National Programs (2008ZX100/03-010), the Key Project of Chinese National Programs for Fundamental Research and Development (973 program 2005CB523102), the Chinese National Programs 863 (2006AA02Z423), and NIH grant D43 TW007887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582; CANETTI GFW, 1969, B WORLD HEALTH ORGAN, P21; Chen J, 2007, TUBERCULOSIS, V87, P446, DOI 10.1016/j.tube.2007.05.014; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; WHO, 2001, COMM DIS CLUST GUID; *WHO, 2007, XDR TB FACTS NOV 200; *WHO, 2008, WHOHTMTB2008394; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 2007, MMWR MORB MORTAL WKL, V56, P250; 2006, MMWR MORB MORTAL WKL, V55, P301; 1998, INT J TUBERC LUNG DI, V2, P72	27	86	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4370	10.1371/journal.pone.0004370	http://dx.doi.org/10.1371/journal.pone.0004370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190774	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483300009
J	Lapidus, N; Minetti, A; Djibo, A; Guerin, PJ; Hustache, S; Gaboulaud, V; Grais, RF				Lapidus, Nael; Minetti, Andrea; Djibo, Ali; Guerin, Philippe J.; Hustache, Sarah; Gaboulaud, Valerie; Grais, Rebecca F.			Mortality Risk among Children Admitted in a Large-Scale Nutritional Program in Niger, 2006	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; ORGANIZATION GROWTH STANDARDS; MALNUTRITION	Background: In 2006, the Medecins sans Frontieres nutritional program in the region of Maradi (Niger) included 68,001 children 6-59 months of age with either moderate or severe malnutrition, according to the NCHS reference (weight-for-height, 80% of the NCHS median, and/or mid-upper arm circumference, 110 mm for children taller than 65 cm and/or presence of bipedal edema). Our objective was to identify baseline risk factors for death among children diagnosed with severe malnutrition using the newly introduced WHO growth standards. As the release of WHO growth standards changed the definition of severe malnutrition, which now includes many children formerly identified as moderately malnourished with the NCHS reference, studying this new category of children is crucial. Methodology: Program monitoring data were collected from the medical records of all children admitted in the program. Data included age, sex, height, weight, MUAC, clinical signs on admission including edema, and type of discharge (recovery, death, and default/loss to follow up). Additional data included results of a malaria rapid diagnostic test due to Plasmodium falciparum (Paracheck (R)) and whether the child was a resident of the region of Maradi or came from bordering Nigeria to seek treatment. Multivariate logistic regression was performed on a subset of 27,687 children meeting the new WHO growth standards criteria for severe malnutrition (weight-for-height< -3 Z score, mid-upper arm circumference< 110 mm for children taller than 65 cm or presence of bipedal edema). We explored two different models: one with only basic anthropometric data and a second model that included perfunctory clinical signs. Principal Findings: In the first model including only weight, height, sex and presence of edema, the risk factors retained were the weight/height(1.84) ratio (OR: 5,774; 95% CI: [2,284; 14,594]) and presence of edema (7.51 [5.12; 11.0]). A second model, taking into account supplementary data from perfunctory clinical examination, identified other risk factors for death: apathy (9.71 [6.92; 13.6]), pallor (2.25 [1.25; 4.05]), anorexia (1.89 [1.35; 2.66]), fever>38.5 degrees C (1.83 [1.25; 2.69]), and age below 1 year (1.42 [1.01; 1.99]). Conclusions: Although clinicians will continue to perform screening using clinical signs and anthropometry, these risk indicators may provide additional criteria for the assessment of absolute and relative risk of death. Better appraisal of the child's risk of death may help orientate the child towards either hospitalization or ambulatory care. As the transition from the NCHS growth reference to the WHO standards will increase the number of children classified as severely malnourished, further studies should explore means to identify children at highest risk of death within this group using simple and standardized indicators.	[Lapidus, Nael; Minetti, Andrea; Guerin, Philippe J.; Hustache, Sarah; Gaboulaud, Valerie; Grais, Rebecca F.] Epictr, Paris, France; [Djibo, Ali] Minist Hlth, Niamey, Niger		Lapidus, N (corresponding author), Epictr, Paris, France.	rebecca.grais@epicentre.msf.org	Lapidus, N./AAT-4479-2020; Guerin, Philippe/AAH-8873-2021	Lapidus, N./0000-0002-4837-1068; Freeman Grais, Rebecca/0000-0002-5037-8218; Guerin, Philippe/0000-0002-6008-2963	Medecins sans Frontieres-France; UN Standing Committee on Nutrition	Medecins sans Frontieres-France; UN Standing Committee on Nutrition	This research was funded entirely by Medecins sans Frontieres-France and the UN Standing Committee on Nutrition. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The MSF-France nutrition representative and Niger program officer provided their comments on the manuscript and are appropriately acknowledged.	Aguayo V., 2006, Morbidity and Mortality Weekly Report, V55, P1172; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 2003, LANCET, V362, P249, DOI 10.1016/S0140-6736(03)13926-8; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; ERINOSO HO, 1993, TROP GEOGR MED, V45, P290; Fawzi WW, 1997, AM J CLIN NUTR, V65, P1062, DOI 10.1093/ajcn/65.4.1062; Gernaat HBPE, 1998, J TROP PEDIATRICS, V44, P211, DOI 10.1093/tropej/44.4.211; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; *INS, 2007, SURV MORT NUTR CHILD; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Manary MJ, 1998, J PEDIATR-US, V133, P789, DOI 10.1016/S0022-3476(98)70153-2; Manary MJ, 1997, J PEDIATR GASTR NUTR, V24, P194, DOI 10.1097/00005176-199702000-00014; *NIS NIG MACR INC, 2007, DEM HLTH SURV MULT I; Prudhon C, 1997, EUR J CLIN NUTR, V51, P771, DOI 10.1038/sj.ejcn.1600483; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 1999, MAN SEV MALN MAN PHY; YIP R, 1994, J NUTR, V124, pS2043	20	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4313	10.1371/journal.pone.0004313	http://dx.doi.org/10.1371/journal.pone.0004313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177169	gold, Green Submitted, Green Published			2022-12-27	WOS:000265483100004
J	Sakamoto, H; Matsuda, KI; Zuloaga, DG; Nishiura, N; Takanami, K; Jordan, CL; Breedlove, SM; Kawata, M				Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Zuloaga, Damian G.; Nishiura, Nobuko; Takanami, Keiko; Jordan, Cynthia L.; Breedlove, S. Marc; Kawata, Mitsuhiro			Stress Affects a Gastrin-Releasing Peptide System in the Spinal Cord That Mediates Sexual Function: Implications for Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							SINGLE-PROLONGED STRESS; PLASMA TESTOSTERONE LEVELS; COMBAT VETERANS; MALE RATS; DISORDER; RECEPTOR; BOMBESIN; NEURONS; EXPRESSION; PTSD	Background: Many men suffering from stress, including post-traumatic stress disorder (PTSD), report sexual dysfunction, which is traditionally treated via psychological counseling. Recently, we identified a gastrin-releasing peptide (GRP) system in the lumbar spinal cord that is a primary mediator for male reproductive functions. Methodology/Principal Findings: To ask whether an acute severe stress could alter the male specific GRP system, we used a single-prolonged stress (SPS), a putative rat model for PTSD in the present study. Exposure of SPS to male rats decreases both the local content and axonal distribution of GRP in the lower lumbar spinal cord and results in an attenuation of penile reflexes in vivo. Remarkably, pharmacological stimulation of GRP receptors restores penile reflexes in SPS-exposed males, and induces spontaneous ejaculation in a dose-dependent manner. Furthermore, although the level of plasma testosterone is normal 7 days after SPS exposure, we found a significant decrease in the expression of androgen receptor protein in this spinal center. Conclusions/Significance: We conclude that the spinal GRP system appears to be a stress-vulnerable center for male reproductive functions, which may provide new insight into a clinical target for the treatment of erectile dysfunction triggered by stress and psychiatric disorders.	[Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Nishiura, Nobuko; Takanami, Keiko; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto, Japan; [Zuloaga, Damian G.; Jordan, Cynthia L.; Breedlove, S. Marc] Michigan State Univ, Dept Psychol & Zool, Program Neurosci, E Lansing, MI 48824 USA	Kyoto Prefectural University of Medicine; Michigan State University	Sakamoto, H (corresponding author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto, Japan.	hsakamo@koto.kpu-m.ac.jp	Sakamoto, Hirotaka/AAE-3720-2021; SAKAMOTO, Hirotaka/C-3009-2015; Waldvogel, Henry/D-6691-2012	Sakamoto, Hirotaka/0000-0002-6224-4591; Waldvogel, Henry/0000-0003-2165-8568; Breedlove, S. Marc/0000-0003-4359-4315	Ministry of Education, Science, Sports, Culture and Technology, Japan [Grants-in-Aid for Scientific Research]; NIH [NS28421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028421] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan (to HS K-IM MK) and NIH Grant NS28421 (to SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BAUER M, 1994, PSYCHIAT RES, V51, P75, DOI 10.1016/0165-1781(94)90048-5; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Cui H, 2008, NEUROSCIENCE, V152, P703, DOI 10.1016/j.neuroscience.2007.12.028; HOLSBOER F, 1994, ANN NY ACAD SCI, V746, P345; Iwamoto Y, 2007, PROG NEURO-PSYCHOPH, V31, P642, DOI 10.1016/j.pnpbp.2006.12.010; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; KAPLAN HS, 1988, J CLIN PSYCHIAT, V49, P21; KAPLAN PM, 1989, J SEX MARITAL THER, V15, P74; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; KREUZ LE, 1972, ARCH GEN PSYCHIAT, V26, P479; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; Letourneau EJ, 1997, J TRAUMA STRESS, V10, P125, DOI 10.1023/A:1024868632543; Levine L, 2003, CANCER RES, V63, P3495; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; MASON JW, 1988, BIOL PSYCHIAT, V23, P357, DOI 10.1016/0006-3223(88)90286-7; Matsumoto A, 2005, STRESS, V8, P133, DOI 10.1080/10253890500140642; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; MONAGHAN EP, 1992, BRAIN RES, V587, P178, DOI 10.1016/0006-8993(92)91443-I; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; PANULA P, 1988, ANN NY ACAD SCI, V547, P54, DOI 10.1111/j.1749-6632.1988.tb23875.x; Pitman RK, 1997, ANN NY ACAD SCI, V821, P1, DOI 10.1111/j.1749-6632.1997.tb48264.x; Rajfer J, 2000, Rev Urol, V2, P122; Retana-Marquez S, 2003, HORM BEHAV, V44, P327, DOI 10.1016/j.yhbeh.2003.04.001; SACHS BD, 1982, J REPROD FERTIL, V66, P433, DOI 10.1530/jrf.0.0660433; Sakamoto H, 2008, NAT NEUROSCI, V11, P634, DOI 10.1038/nn.2126; Sakamoto H, 2007, ENDOCRINOLOGY, V148, P5842, DOI 10.1210/en.2007-0436; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 1997, ANN NY ACAD SCI, V821, P57, DOI 10.1111/j.1749-6632.1997.tb48269.x; YESAVAGE JA, 1985, BIOL PSYCHIAT, V20, P222, DOI 10.1016/0006-3223(85)90088-5; Yoshii T, 2008, NEUROSCIENCE, V156, P466, DOI 10.1016/j.neuroscience.2008.07.049	39	25	27	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4276	10.1371/journal.pone.0004276	http://dx.doi.org/10.1371/journal.pone.0004276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JE	19169356	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482800006
J	Bezuidenhout, J; Roberts, T; Muller, L; van Helden, P; Walzl, G				Bezuidenhout, Juanita; Roberts, Teri; Muller, Liesel; van Helden, Paul; Walzl, Gerhard			Pleural Tuberculosis in Patients with Early HIV Infection Is Associated with Increased TNF-Alpha Expression and Necrosis in Granulomas	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA-RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; MACROPHAGE APOPTOSIS; MESSENGER-RNA; IFN-GAMMA; IN-VITRO; CYTOKINE; IMMUNODEFICIENCY	Although granulomas may be an essential host response against persistent antigens, they are also associated with immunopathology. We investigated whether HIV co-infection affects histopathological appearance and cytokine profiles of pleural granulomas in patients with active pleural tuberculosis (TB). Granulomas were investigated in pleural biopsies from HIV positive and negative TB pleuritis patients. Granulomas were characterised as necrotic or non-necrotic, graded histologically and investigated for the mRNA expression of IL-12, IFN-gamma, TNF-alpha and IL-4 by in situ hybridisation. In all TB patients a mixed Th1/Th2 profile was noted. Necrotic granulomas were more evident in HIV positive patients with a clear association between TNF- alpha and necrosis. This study demonstrates immune dysregulation which may include TNF-alpha-mediated immunopathology at the site of disease in HIV infected pleural TB patients.	[Bezuidenhout, Juanita] Tygerberg Hosp, Dept Histopathol, Cape Town, Western Cape, South Africa; [Roberts, Teri; Muller, Liesel; van Helden, Paul; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, DST, Ctr Excellence Biomed TB Res, NRF, ZA-7600 Stellenbosch, South Africa	Tygerberg Hospital; National Research Foundation - South Africa; Stellenbosch University	Bezuidenhout, J (corresponding author), Tygerberg Hosp, Dept Histopathol, Cape Town, Western Cape, South Africa.	teri.roberts@uct.ac.za	Walzl, Gerhard/N-6371-2016	Walzl, Gerhard/0000-0003-2487-125X	GlaxoSmithKline Action TB; South African MRC; South African National Research Foundation; University of Stellenbosch	GlaxoSmithKline Action TB; South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Research Foundation(National Research Foundation - South Africa); University of Stellenbosch	GlaxoSmithKline Action TB, South African MRC, South African National Research Foundation, University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; BARNES PF, 1989, J IMMUNOL, V142, P1114; BARNES PF, 1990, J IMMUNOL, V145, P149; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; BRAUN MM, 1991, AM REV RESPIR DIS, V143, P501, DOI 10.1164/ajrccm/143.3.501; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Das SD, 2004, FEMS IMMUNOL MED MIC, V41, P85, DOI 10.1016/j.femsim.2004.01.006; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Dheda K, 2005, AIDS, V19, P1601, DOI 10.1097/01.aids.0000183520.52760.ef; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Ehlers S, 2000, J IMMUNOL, V165, P483, DOI 10.4049/jimmunol.165.1.483; Ellner J J, 1988, Semin Respir Infect, V3, P335; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Fayyazi A, 2000, J PATHOL, V191, P417, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH664&gt;3.0.CO;2-R; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Fenhalls G, 2002, IMMUNOLOGY, V105, P325, DOI 10.1046/j.1365-2567.2002.01378.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garrait V, 1997, J IMMUNOL, V159, P2824; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; HASLETON PS, 1996, SPENCERS PATHOLOGY L, pCH7; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; HOEFAKKER S, 1995, J IMMUNOL METHODS, V185, P149, DOI 10.1016/0022-1759(95)00122-Q; Imperiali FG, 2001, CLIN EXP IMMUNOL, V123, P435, DOI 10.1046/j.1365-2249.2001.01481.x; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; LYNCH ML, 1969, MED LAB TECHNOLOGY C, pCH26; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; MULLER KM, 1993, J IMMUNOL, V150, P5576; MYATT N, 1994, J CLIN PATHOL, V47, P423, DOI 10.1136/jcp.47.5.423; OYAIZU N, 1990, P NATL ACAD SCI USA, V87, P2379, DOI 10.1073/pnas.87.6.2379; Polyak S, 1997, J IMMUNOL, V159, P2177; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rhodes SG, 2000, INFECT IMMUN, V68, P5393, DOI 10.1128/IAI.68.9.5393-5400.2000; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; ROPER WH, 1955, AM REV TUBERC PULM, V71, P616; Rydell-Tormanen K, 2006, EUR RESPIR J, V28, P268, DOI 10.1183/09031936.06.00126905; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Schluger NW, 2001, RESP RES, V2, P157, DOI 10.1186/rr53; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; Tan JS, 1997, J IMMUNOL, V159, P290; THURLBECK W, 1995, PATHOLOGY LUNG, pCH13; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Uhal BD, 2002, CHEST, V122, p293S, DOI 10.1378/chest.122.6_suppl.293S; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; VYAKARNAM A, 1995, IMMUNOLOGY, V86, P85; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Zhang M, 1999, J IMMUNOL, V162, P2441	62	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4228	10.1371/journal.pone.0004228	http://dx.doi.org/10.1371/journal.pone.0004228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156215	Green Published, Green Submitted, gold			2022-12-27	WOS:000265481900010
J	Fukushima, F; Nakao, K; Shinoe, T; Fukaya, M; Muramatsu, S; Sakimura, K; Kataoka, H; Mori, H; Watanabe, M; Manabe, T; Mishina, M				Fukushima, Fumiaki; Nakao, Kazuhito; Shinoe, Toru; Fukaya, Masahiro; Muramatsu, Shin-ichi; Sakimura, Kenji; Kataoka, Hirotaka; Mori, Hisashi; Watanabe, Masahiko; Manabe, Toshiya; Mishina, Masayoshi			Ablation of NMDA Receptors Enhances the Excitability of Hippocampal CA3 Neurons	PLOS ONE			English	Article								Synchronized discharges in the hippocampal CA3 recurrent network are supposed to underlie network oscillations, memory formation and seizure generation. In the hippocampal CA3 network, NMDA receptors are abundant at the recurrent synapses but scarce at the mossy fiber synapses. We generated mutant mice in which NMDA receptors were abolished in hippocampal CA3 pyramidal neurons by postnatal day 14. The histological and cytological organizations of the hippocampal CA3 region were indistinguishable between control and mutant mice. We found that mutant mice lacking NMDA receptors selectively in CA3 pyramidal neurons became more susceptible to kainate-induced seizures. Consistently, mutant mice showed characteristic large EEG spikes associated with multiple unit activities (MUA), suggesting enhanced synchronous firing of CA3 neurons. The electrophysiological balance between fast excitatory and inhibitory synaptic transmission was comparable between control and mutant pyramidal neurons in the hippocampal CA3 region, while the NMDA receptor-slow AHP coupling was diminished in the mutant neurons. In the adult brain, inducible ablation of NMDA receptors in the hippocampal CA3 region by the viral expression vector for Cre recombinase also induced similar large EEG spikes. Furthermore, pharmacological blockade of CA3 NMDA receptors enhanced the susceptibility to kainate-induced seizures. These results raise an intriguing possibility that hippocampal CA3 NMDA receptors may suppress the excitability of the recurrent network as a whole in vivo by restricting synchronous firing of CA3 neurons.	[Fukushima, Fumiaki; Nakao, Kazuhito; Kataoka, Hirotaka; Mori, Hisashi; Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan; [Shinoe, Toru; Manabe, Toshiya] Univ Tokyo, Inst Med Sci, Div Neuronal Network, Tokyo, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Tochigi, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 95021, Japan; [Manabe, Toshiya] JST, CREST, Kawaguchi, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Jichi Medical University; Niigata University; Japan Science & Technology Agency (JST)	Fukushima, F (corresponding author), Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo, Japan.	mishina@m.u-tokyo.ac.jp	Watanabe, Masahiko/S-3614-2019; Muramatsu, Shinichi/ABC-6093-2021; WATANABE, Masahiko/A-4055-2012; Muramatsu, Shin-ichi/K-9420-2013; nakao, kazuhito/J-9419-2019	Watanabe, Masahiko/0000-0001-5037-7138; Muramatsu, Shinichi/0000-0002-3185-7790; WATANABE, Masahiko/0000-0001-5037-7138; Muramatsu, Shin-ichi/0000-0002-3185-7790; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. F.F. was supported by Japan Society for the Promotion of Science, and S.T. by the 21st Century COE Program, the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Fukaya M, 2000, J COMP NEUROL, V426, P572; Galvan CD, 2000, J NEUROSCI, V20, P2904; Galvan CD, 2003, EUR J NEUROSCI, V18, P1861, DOI 10.1046/j.1460-9568.2003.02920.x; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jefferys JGR, 1993, TXB EPILEPSY, P241; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; NICOLL RA, 1981, SCIENCE, V212, P957, DOI 10.1126/science.6262912; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Scammell TE, 2003, J NEUROSCI, V23, P5762; SCHWARTZKROIN PA, 1980, SCIENCE, V210, P1125, DOI 10.1126/science.6777871; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TRAUB RD, 1991, NEURONAL NETWORKS HI, P119; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Westbrook G. L., 2000, PRINCIPLES NEURAL SC, P910; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada K, 2001, EUR J NEUROSCI, V13, P2025, DOI 10.1046/j.0953-816x.2001.01580.x; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I; YLINEN A, 1995, J NEUROSCI, V15, P30	61	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e3993	10.1371/journal.pone.0003993	http://dx.doi.org/10.1371/journal.pone.0003993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142228	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479700001
J	Boo, JH; Song, HD; Kim, JE; Kang, DE; Mook-Jung, I				Boo, Jung H.; Song, Hyundong; Kim, Ji E.; Kang, David E.; Mook-Jung, Inhee			Accumulation of Phosphorylated beta-Catenin Enhances ROS-Induced Cell Death in Presenilin-Deficient Cells	PLOS ONE			English	Article								Presenilin (PS) is involved in many cellular events under physiological and pathological conditions. Previous reports have revealed that PS deficiency results in hyperproliferation and resistance to apoptotic cell death. In the present study, we investigated the effects of PS on beta-catenin and cell mortality during serum deprivation. Under these conditions, PS1/PS2 double-knockout MEFs showed aberrant accumulation of phospho-beta-catenin, higher ROS generation, and notable cell death. Inhibition of beta-catenin phosphorylation by LiCl reversed ROS generation and cell death in PS deficient cells. In addition, the K19/49R mutant form of beta-catenin, which undergoes normal phosphorylation but not ubiquitination, induced cytotoxicity, while the phosphorylation deficient S37A beta-catenin mutant failed to induce cytotoxicity. These results indicate that aberrant accumulation of phospho-beta-catenin underlies ROS-mediated cell death in the absence of PS. We propose that the regulation of beta-catenin is useful for identifying therapeutic targets of hyperproliferative diseases and other degenerative conditions.	[Boo, Jung H.; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Sch Biol Sci, Interdisciplinary Program Brain Sci, Seoul, South Korea; [Boo, Jung H.; Song, Hyundong; Kim, Ji E.; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul 151, South Korea; [Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California San Diego	Boo, JH (corresponding author), Seoul Natl Univ, Coll Med, Sch Biol Sci, Interdisciplinary Program Brain Sci, Seoul, South Korea.	inhee@snu.ac.kr	Kang, David E./E-5234-2012; Mook, Inhee/J-2754-2012		21 C Frontier Functional Proteomics Project [FPR08K1301-02210]; New Drug Target Discovery project [08N4800-09610]; AARC [R11-2002-097-08001]	21 C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); New Drug Target Discovery project; AARC	This work was supported by grants from the 21 C Frontier Functional Proteomics Project (FPR08K1301-02210), the New Drug Target Discovery project (08N4800-09610), and the AARC program project (R11-2002-097-08001) for IMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Usami N, 2003, ONCOGENE, V22, P7922, DOI 10.1038/sj.onc.1206533; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	33	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4172	10.1371/journal.pone.0004172	http://dx.doi.org/10.1371/journal.pone.0004172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137062	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479500003
J	Jeong, PY; Kwon, MS; Joo, HJ; Paik, YK				Jeong, Pan-Young; Kwon, Min-Seok; Joo, Hyoe-Jin; Paik, Young-Ki			Molecular Time-Course and the Metabolic Basis of Entry into Dauer in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN; LARVAL DEVELOPMENT; GENE-EXPRESSION; INTERMEDIARY METABOLISM; DEVELOPMENTAL ARREST; AUTOPHAGY GENES; LONGEVITY; DAF-2; LONG; TOR	When Caenorhabditis elegans senses dauer pheromone (daumone), signaling inadequate growth conditions, it enters the dauer state, which is capable of long-term survival. However, the molecular pathway of dauer entry in C. elegans has remained elusive. To systematically monitor changes in gene expression in dauer paths, we used a DNA microarray containing 22,625 gene probes corresponding to 22,150 unique genes from C. elegans. We employed two different paths: direct exposure to daumone (Path 1) and normal growth media plus liquid culture (Path 2). Our data reveal that entry into dauer is accomplished through the multi-step process, which appears to be compartmentalized in time and according to metabolic flux. That is, a time-course of dauer entry in Path 1 shows that dauer larvae formation begins at post-embryonic stage S4 (48 h) and is complete at S6 (72 h). Our results also suggest the presence of a unique adaptive metabolic control mechanism that requires both stage-specific expression of specific genes and tight regulation of different modes of fuel metabolite utilization to sustain the energy balance in the context of prolonged survival under adverse growth conditions. It is apparent that worms entering dauer stage may rely heavily on carbohydrate-based energy reserves, whereas dauer larvae utilize fat or glyoxylate cycle-based energy sources. We created a comprehensive web-based dauer metabolic database for C. elegans (www.DauerDB.org) that makes it possible to search any gene and compare its relative expression at a specific stage, or evaluate overall patterns of gene expression in both paths. This database can be accessed by the research community and could be widely applicable to other related nematodes as a molecular atlas.	[Jeong, Pan-Young; Kwon, Min-Seok; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Coll Life Sci & Biotechnol, Yonsei Proteome Res Ctr, Dept Biochem, Seoul 120749, South Korea; [Jeong, Pan-Young; Kwon, Min-Seok; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Biomed Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University	Jeong, PY (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	paikyk@yonsei.ac.kr			Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea [A030003]; Forest Science & Technology Project, Korea Forest Service [S110707L0501501]	Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea; Forest Science & Technology Project, Korea Forest Service	This study was supported by a grant from the Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A030003 to YKP) and a Forest Science & Technology Project (No. S110707L0501501) through the Korea Forest Service (to YKP).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BAIGA TJ, 2008, ACS CHEM BIOL; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holt SJ, 2003, MECH AGEING DEV, V124, P779, DOI 10.1016/S0047-6374(03)00132-5; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Liu Tao, 2004, BMC Developmental Biology, V4; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Riddle D.L., 1997, GENETIC ENV REGULATI, VII, P739; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Ruzanov P, 2007, EXP GERONTOL, V42, P825, DOI 10.1016/j.exger.2007.04.002; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Toth ML, 2007, J CELL SCI, V120, P1134, DOI 10.1242/jcs.03401; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Zwaal RR, 1997, GENETICS, V145, P715	51	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4162	10.1371/journal.pone.0004162	http://dx.doi.org/10.1371/journal.pone.0004162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129915	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473500009
J	Foygel, K; Choi, B; Jun, S; Leong, DE; Lee, A; Wong, CC; Zuo, E; Eckart, M; Pera, RAR; Wong, WH; Yao, MWM				Foygel, Kira; Choi, Bokyung; Jun, Sunny; Leong, Denise E.; Lee, Alan; Wong, Connie C.; Zuo, Elizabeth; Eckart, Michael; Pera, Renee A. Reijo; Wong, Wing H.; Yao, Mylene W. M.			A Novel and Critical Role for Oct4 as a Regulator of the Maternal-Embryonic Transition	PLOS ONE			English	Article								Background: Compared to the emerging embryonic stem cell (ESC) gene network, little is known about the dynamic gene network that directs reprogramming in the early embryo. We hypothesized that Oct4, an ESC pluripotency regulator that is also highly expressed at the 1- to 2-cell stages in embryos, may be a critical regulator of the earliest gene network in the embryo. Methodology/Principal Findings: Using antisense morpholino oligonucleotide (MO)-mediated gene knockdown, we show that Oct4 is required for development prior to the blastocyst stage. Specifically, Oct4 has a novel and critical role in regulating genes that encode transcriptional and post-transcriptional regulators as early as the 2-cell stage. Our data suggest that the key function of Oct4 may be to switch the developmental program from one that is predominantly regulated by post-transcriptional control to one that depends on the transcriptional network. Further, we propose to rank candidate genes quantitatively based on the inter-embryo variation in their differential expression in response to Oct4 knockdown. Of over 30 genes analyzed according to this proposed paradigm, Rest and Mta2, both of which have established pluripotency functions in ESCs, were found to be the most tightly regulated by Oct4 at the 2-cell stage. Conclusions/Significance: We show that the Oct4-regulated gene set at the 1-to 2-cell stages of early embryo development is large and distinct from its established network in ESCs. Further, our experimental approach can be applied to dissect the gene regulatory network of Oct4 and other pluripotency regulators to deconstruct the dynamic developmental program in the early embryo.	[Foygel, Kira; Jun, Sunny; Leong, Denise E.; Lee, Alan; Wong, Connie C.; Pera, Renee A. Reijo; Yao, Mylene W. M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Choi, Bokyung] Stanford Univ, Sch Humanities & Sci, Dept Appl Phys, Stanford, CA 94305 USA; [Wong, Connie C.; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regen Med, Ctr Human Embryo and Embryon Stem Cell Res & Ed, Palo Alto, CA USA; [Zuo, Elizabeth; Eckart, Michael] Stanford Univ, Beckman Ctr, Protein & Nucleic Acid Facil, Stanford, CA 94305 USA; [Wong, Wing H.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Foygel, K (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	mylene.yao@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	NIH [HD057970, HD00849, HD01249, GM067250]; American Society for Reproductive Medicine; March of Dimes; William R. Hewlett Stanford Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057970, K12HD000849] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Reproductive Medicine; March of Dimes(March of Dimes); William R. Hewlett Stanford Graduate Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.Y. and this project are supported by NIH (HD057970, HD00849, HD01249), and the American Society for Reproductive Medicine; W.H.W. is supported by NIH GM067250; R.A.R.P. is supported by the March of Dimes; B.C. is supported by the William R. Hewlett Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hara KT, 2005, DEV BIOL, V286, P102, DOI 10.1016/j.ydbio.2005.07.012; Haraguchi S, 2004, MOL REPROD DEV, V68, P17, DOI 10.1002/mrd.20047; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; Kim SK, 2005, STEM CELLS, V23, P458, DOI 10.1634/stemcells.2004-0245; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Stefanovic S, 2007, CELL CYCLE, V6, P8, DOI 10.4161/cc.6.1.3633; Sumanas Saulius, 2002, Briefings in Functional Genomics & Proteomics, V1, P239; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	37	83	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4109	10.1371/journal.pone.0004109	http://dx.doi.org/10.1371/journal.pone.0004109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19129941	Green Submitted, gold, Green Published			2022-12-27	WOS:000265466600024
J	Pfister, JA; Ma, C; Morrison, BE; D'Mello, SR				Pfister, Jason A.; Ma, Chi; Morrison, Brad E.; D'Mello, Santosh R.			Opposing Effects of Sirtuins on Neuronal Survival: SIRT1-Mediated Neuroprotection Is Independent of Its Deacetylase Activity	PLOS ONE			English	Article							CEREBELLAR GRANULE NEURONS; NF-KAPPA-B; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; NEGATIVE REGULATOR; THERAPEUTIC ROLE; YEAST SIR2; RESVERATROL; INHIBITION; PROTEIN	Background: Growing evidence suggests that sirtuins, a family of seven distinct NAD-dependent enzymes, are involved in the regulation of neuronal survival. Indeed, SIRT1 has been reported to protect against neuronal death, while SIRT2 promotes neurodegeneration. The effect of SIRTs 3-7 on the regulation of neuronal survival, if any, has yet to be reported. Methodology and Principal Findings: We examined the effect of expressing each of the seven SIRT proteins in healthy cerebellar granule neurons (CGNs) or in neurons induced to die by low potassium (LK) treatment. We report that SIRT1 protects neurons from LK-induced apoptosis, while SIRT2, SIRT3 and SIRT6 induce apoptosis in otherwise healthy neurons. SIRT5 is generally localized to both the nucleus and cytoplasm of CGNs and exerts a protective effect. In a subset of neurons, however, SIRT5 localizes to the mitochondria and in this case it promotes neuronal death. Interestingly, the protective effect of SIRT1 in neurons is not reduced by treatments with nicotinamide or sirtinol, two pharmacological inhibitors of SIRT1. Neuroprotection was also observed with two separate mutant forms of SIRT1, H363Y and H355A, both of which lack deacetylase activity. Furthermore, LK-induced neuronal death was not prevented by resveratrol, a pharmacological activator of SIRT1, at concentrations at which it activates SIRT1. We extended our analysis to HT-22 neuroblastoma cells which can be induced to die by homocysteic acid treatment. While the effects of most of the SIRT proteins were similar to that observed in CGNs, SIRT6 was modestly protective against homocysteic acid toxicity in HT-22 cells. SIRT5 was generally localized in the mitochondria of HT-22 cells and was apoptotic. Conclusions/Significance: Overall, our study makes three contributions -(a) it represents the first analysis of SIRT3-7 in the regulation of neuronal survival, (b) it shows that neuroprotection by SIRT1 can be mediated by a novel, non-catalytic mechanism, and (c) that subcellular localization may be an important determinant in the effect of SIRT5 on neuronal viability.	[Pfister, Jason A.; Ma, Chi; Morrison, Brad E.; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Pfister, JA (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020; Waldvogel, Henry/D-6691-2012	D'Mello, Santosh/0000-0002-7652-1334; , Chi/0000-0002-4171-0813; Morrison, Brad/0000-0002-6356-7149; Waldvogel, Henry/0000-0003-2165-8568	NIH [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066404, R21NS058462, R01NS040408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS40408 and NS058462 to SRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alvira D, 2007, NEUROSCIENCE, V147, P746, DOI 10.1016/j.neuroscience.2007.04.029; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Biacsi R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000017; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cao C, 2019, J CELL MOL MED, V23, P7342, DOI 10.1111/jcmm.14593; CHEN HMW, EUR J NEURO IN PRESS; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dey S, 2008, CARCINOGENESIS, V29, P1920, DOI 10.1093/carcin/bgn175; Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Morozova N, 2007, GENES CELLS, V12, P561, DOI 10.1111/j.1365-2443.2007.01074.x; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okawara M, 2007, BIOCHEM PHARMACOL, V73, P550, DOI 10.1016/j.bcp.2006.11.003; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Outeiro TF, 2008, BBA-MOL BASIS DIS, V1782, P363, DOI 10.1016/j.bbadis.2008.02.010; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shindler KS, 2007, INVEST OPHTH VIS SCI, V48, P3602, DOI 10.1167/iovs.07-0131; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Venkatesan B, 2008, FASEB J, V22, P3469, DOI 10.1096/fj.08-109488; Verdin E, 2007, MOL CELL, V28, P354, DOI 10.1016/j.molcel.2007.10.013; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	68	150	164	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4090	10.1371/journal.pone.0004090	http://dx.doi.org/10.1371/journal.pone.0004090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116652	gold, Green Submitted, Green Published			2022-12-27	WOS:000265466600011
J	Klimentidis, YC; Shriver, MD				Klimentidis, Yann C.; Shriver, Mark D.			Estimating Genetic Ancestry Proportions from Faces	PLOS ONE			English	Article							FACIAL RESEMBLANCE; UNITED-STATES; BIOGEOGRAPHICAL ANCESTRY; INFORMATIVE MARKERS; BIOMEDICAL-RESEARCH; ANTHROPOMETRIC DATA; GENOMIC ANCESTRY; KIN RECOGNITION; SKIN COLOR; OWN-RACE	Ethnicity can be a means by which people identify themselves and others. This type of identification mediates many kinds of social interactions and may reflect adaptations to a long history of group living in humans. Recent admixture in the US between groups from different continents, and the historically strong emphasis on phenotypic differences between members of these groups, presents an opportunity to examine the degree of concordance between estimates of group membership based on genetic markers and on visually-based estimates of facial features. We first measured the degree of Native American, European, African and East Asian genetic admixture in a sample of 14 self-identified Hispanic individuals, chosen to cover a broad range of Native American and European genetic admixture proportions. We showed frontal and side-view photographs of the 14 individuals to 241 subjects living in New Mexico, and asked them to estimate the degree of NA admixture for each individual. We assess the overall concordance for each observer based on an aggregated measure of the difference between the observer and the genetic estimates. We find that observers reach a significantly higher degree of concordance than expected by chance, and that the degree of concordance as well as the direction of the discrepancy in estimates differs based on the ethnicity of the observer, but not on the observers' age or sex. This study highlights the potentially high degree of discordance between physical appearance and genetic measures of ethnicity, as well as how perceptions of ethnic affiliation are context-specific. We compare our findings to those of previous studies and discuss their implications.	Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Klimentidis, YC (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	yann@unm.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044; Shriver, Mark/0000-0003-0006-0479	NIH NHGRI;  [HG02154]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER	NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	NIH NHGRI HG02154 to MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Boehmer U, 2002, AM J PUBLIC HEALTH, V92, P1471, DOI 10.2105/AJPH.92.9.1471; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Condit CM, 2004, PUBLIC UNDERST SCI, V13, P249, DOI 10.1177/0963662504045573; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Gil-White F. J., 2002, FIELD METHOD, V14, P161, DOI [10.1177/1525822X02014002003, DOI 10.1177/1525822X02014002003]; Gil-White FJ, 2001, CURR ANTHROPOL, V42, P515, DOI 10.1086/321802; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Goldstein DG, 2002, PSYCHOL REV, V109, P75, DOI 10.1037//0033-295X.109.1.75; Gomez SL, 2005, ANN EPIDEMIOL, V15, P71, DOI 10.1016/j.annepidem.2004.03.002; HABYARIMANA J, 2004, ETHNIC IDENTIFIABILI; HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P259, DOI 10.1001/jama.267.2.259; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Harris David R., 2000, 00452 POP STUD CTR; Harris David R., 2002, 02522 POP STUD CTR; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HOLGUIN S, 2000, W PSYCH ASS ANN M PO; Johnson Gary R., 1987, SOCIOBIOLOGY ETHNOCE; Jones D, 2000, CURR ANTHROPOL, V41, P779, DOI 10.1086/317406; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KLIMENTIDIS YC, AM J PHYS ANTH UNPUB; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Luizon MR, 2008, AM J HUM BIOL, V20, P86, DOI 10.1002/ajhb.20681; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Montalvo FrankF., 2001, ETHNICITIES, V1, P321, DOI DOI 10.1177/146879680100100303; NESSE RM, 1990, ETHOL SOCIOBIOL, V11, P11, DOI 10.1016/0162-3095(90)90003-O; Ohman A, 2005, SCIENCE, V309, P711, DOI 10.1126/science.1116710; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Palmer C. T., 1997, J SOC EVOL SYST, V20, P39, DOI [DOI 10.1016/S1061-7361(97)90028-X, 10.1016/S1061-7361(97)90028-X]; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PFENNIG DW, 1995, SCI AM, V272, P98, DOI 10.1038/scientificamerican0695-98; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sinha M, 2006, NEW ENGL J MED, V354, P421, DOI 10.1056/NEJMc052515; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WEST CN, 2005, J NATL CANC I MONOGR, V35, P72, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI041; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809	53	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4460	10.1371/journal.pone.0004460	http://dx.doi.org/10.1371/journal.pone.0004460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KG	19223962	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485800001
J	Lutgendorff, F; Nijmeijer, RM; Sandstrom, PA; Trulsson, LM; Magnusson, KE; Timmerman, HM; van Minnen, LP; Rijkers, GT; Gooszen, HG; Akkermans, LMA; Soderholm, JD				Lutgendorff, Femke; Nijmeijer, Rian M.; Sandstrom, Per A.; Trulsson, Lena M.; Magnusson, Karl-Eric; Timmerman, Harro M.; van Minnen, L. Paul; Rijkers, Ger T.; Gooszen, Hein G.; Akkermans, Louis M. A.; Soderholm, Johan D.			Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis	PLOS ONE			English	Article							DOUBLE-BLIND; INFECTIOUS COMPLICATIONS; LACTOBACILLUS-FERMENTUM; ULCERATIVE-COLITIS; TIGHT JUNCTIONS; NITRIC-OXIDE; APOPTOSIS; MODEL; DISRUPTION; CYSTEINE	Background: During acute pancreatitis (AP), oxidative stress contributes to intestinal barrier failure. We studied actions of multispecies probiotics on barrier dysfunction and oxidative stress in experimental AP. Methodology/Principal Findings: Fifty-three male Spraque-Dawley rats were randomly allocated into five groups: 1) controls, non-operated, 2) sham-operated, 3) AP, 4) AP and probiotics and 5) AP and placebo. AP was induced by intraductal glycodeoxycholate infusion and intravenous cerulein (6 h). Daily probiotics or placebo were administered intragastrically, starting five days prior to AP. After cerulein infusion, ileal mucosa was collected for measurements of E. coli K12 and Cr-51-EDTA passage in Ussing chambers. Tight junction proteins were investigated by confocal immunofluorescence imaging. Ileal mucosal apoptosis, lipid peroxidation, and glutathione levels were determined and glutamate-cysteine-ligase activity and expression were quantified. AP-induced barrier dysfunction was characterized by epithelial cell apoptosis and alterations of tight junction proteins (i.e. disruption of occludin and claudin-1 and up-regulation of claudin-2) and correlated with lipid peroxidation (r>0.8). Probiotic pre-treatment diminished the AP-induced increase in E. coli passage (probiotics 57.4 +/- 33.5 vs. placebo 223.7 +/- 93.7 a.u.; P<0.001), Cr-51-EDTA flux (16.7 +/- 10.1 vs. 32.1 +/- 10.0 cm/s10(-6); P<0.005), apoptosis, lipid peroxidation (0.42 +/- 0.13 vs. 1.62 +/- 0.53 pmol MDA/mg protein; P<0.001), and prevented tight junction protein disruption. AP-induced decline in glutathione was not only prevented (14.33 +/- 1.47 vs. 8.82 +/- 1.30 nmol/mg protein, P<0.001), but probiotics even increased mucosal glutathione compared with sham rats (14.33 +/- 1.47 vs. 10.70 +/- 1.74 nmol/ mg protein, P<0.001). Glutamate-cysteine-ligase activity, which is rate- limiting in glutathione biosynthesis, was enhanced in probiotic pre-treated animals (probiotics 2.88 +/- 1.21 vs. placebo 1.94 +/- 0.55 nmol/min/mg protein; P<0.05) coinciding with an increase in mRNA expression of glutamate-cysteine-ligase catalytic (GCLc) and modifier (GCLm) subunits. Conclusions: Probiotic pre-treatment diminished AP-induced intestinal barrier dysfunction and prevented oxidative stress via mechanisms mainly involving mucosal glutathione biosynthesis.	[Lutgendorff, Femke; Sandstrom, Per A.; Trulsson, Lena M.; Soderholm, Johan D.] Linkoping Univ, Div Surg, Dept Clin & Expt Med, Linkoping, Sweden; [Lutgendorff, Femke; Nijmeijer, Rian M.; Timmerman, Harro M.; van Minnen, L. Paul; Rijkers, Ger T.; Gooszen, Hein G.; Akkermans, Louis M. A.] Univ Med Ctr, Dept Surg, Gastrointestinal Res Unit, Utrecht, Netherlands; [Magnusson, Karl-Eric] Linkoping Univ, Dept Clin & Expt Med, Div Med Microbiol, S-58183 Linkoping, Sweden	Linkoping University; Utrecht University; Utrecht University Medical Center; Linkoping University	Lutgendorff, F (corresponding author), Linkoping Univ, Div Surg, Dept Clin & Expt Med, Linkoping, Sweden.	johan.d.soderholm@liu.se	SandstrÃm, Per/AAF-1841-2019; Rijkers, Ger/AAW-6143-2020; Rijkers, Ger/R-7236-2019; Gooszen, H.G./H-8036-2014	Rijkers, Ger/0000-0001-6948-6123; Magnusson, Karl-Eric/0000-0002-7809-8437	Swedish Research Council: Medicine; Senter, an agency of the Dutch Ministry of Economic Affairs [TSGE3109]	Swedish Research Council: Medicine(Swedish Research Council); Senter, an agency of the Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	Johan D. Soderholm and Karl-Eric Magnusson received financial support from the Swedish Research Council: Medicine. Part of this study was supported by Senter, an agency of the Dutch Ministry of Economic Affairs (grant number: TSGE3109). Funding sources were not involved in study design; collection, analysis and interpretation of data; writing of the paper; and the decision to submit it for publication.	Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Deitch EA, 2006, CRIT CARE MED, V34, P2294, DOI 10.1097/01.CCM.0000233857.94604.73; Ding Y, 2008, AM J PATHOL, V172, P1529, DOI 10.2353/ajpath.2008.070429; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; GRASS GM, 1988, PHARMACEUT RES, V5, P372, DOI 10.1023/A:1015911712079; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HAGEN TM, 1990, AM J PHYSIOL, V259, pG530, DOI 10.1152/ajpgi.1990.259.4.G530; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Katsube T, 2007, BBA-MOL CELL RES, V1773, P794, DOI 10.1016/j.bbamcr.2007.03.002; Kohler JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1048, DOI 10.1152/ajpgi.00241.2004; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; LU SC, 2008, MOL ASPECTS MED; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Musenga A, 2007, ANAL BIOANAL CHEM, V387, P917, DOI 10.1007/s00216-006-0980-6; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Peran L, 2006, INT J COLORECTAL DIS, V21, P737, DOI 10.1007/s00384-005-0773-y; Rau B, 2000, ANN SURG, V231, P352, DOI 10.1097/00000658-200003000-00008; Resta-Lenert S, 2002, GASTROENTEROLOGY, V122, P1070, DOI 10.1053/gast.2002.32372; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Siriwardena AK, 2007, GUT, V56, P1439, DOI 10.1136/gut.2006.115873; Solis WA, 2002, BIOCHEM PHARMACOL, V63, P1739, DOI 10.1016/S0006-2952(02)00897-3; SPORMANN H, 1989, PATHOL RES PRACT, V184, P507, DOI 10.1016/S0344-0338(89)80143-8; Sugawara G, 2006, ANN SURG, V244, P706, DOI 10.1097/01.sla.0000219039.20924.88; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; Tomson FL, 2004, GASTROENTEROLOGY, V127, P859, DOI 10.1053/j.gastro.2004.06.014; Trulsson LM, 2002, REGUL PEPTIDES, V106, P97, DOI 10.1016/S0167-0115(02)00056-3; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007; Velin AK, 2004, GUT, V53, P494, DOI 10.1136/gut.2003.028506; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; YASUDA T, 2007, J SURG RES; Yasuda T, 2006, J SURG RES, V135, P18, DOI 10.1016/j.jss.2006.02.050; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	47	90	103	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4512	10.1371/journal.pone.0004512	http://dx.doi.org/10.1371/journal.pone.0004512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223985	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485800013
J	Caffrey, CR; Rohwer, A; Oellien, F; Marhofer, RJ; Braschi, S; Oliveira, G; McKerrow, JH; Selzer, PM				Caffrey, Conor R.; Rohwer, Andreas; Oellien, Frank; Marhoefer, Richard J.; Braschi, Simon; Oliveira, Guilherme; McKerrow, James H.; Selzer, Paul M.			A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni	PLOS ONE			English	Article								Schistosomiasis is a prevalent and chronic helmintic disease in tropical regions. Treatment and control relies on chemotherapy with just one drug, praziquantel and this reliance is of concern should clinically relevant drug resistance emerge and spread. Therefore, to identify potential target proteins for new avenues of drug discovery we have taken a comparative chemogenomics approach utilizing the putative proteome of Schistosoma mansoni compared to the proteomes of two model organisms, the nematode, Caenorhabditis elegans and the fruitfly, Drosophila melanogaster. Using the genome comparison software Genlight, two separate in silico workflows were implemented to derive a set of parasite proteins for which gene disruption of the orthologs in both the model organisms yielded deleterious phenotypes ( e. g., lethal, impairment of motility), i.e., are essential genes/proteins. Of the 67 and 68 sequences generated for each workflow, 63 were identical in both sets, leading to a final set of 72 parasite proteins. All but one of these were expressed in the relevant developmental stages of the parasite infecting humans. Subsequent in depth manual curation of the combined workflow output revealed 57 candidate proteins. Scrutiny of these for 'druggable' protein homologs in the literature identified 35 S. mansoni sequences, 18 of which were homologous to proteins with 3D structures including co-crystallized ligands that will allow further structure-based drug design studies. The comparative chemogenomics strategy presented generates a tractable set of S. mansoni proteins for experimental validation as drug targets against this insidious human pathogen.	[Caffrey, Conor R.; Braschi, Simon; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Rohwer, Andreas; Oellien, Frank; Marhoefer, Richard J.; Selzer, Paul M.] BioChemInformat, Intervet Innovat GmbH, Schwabenheim, Germany; [Oliveira, Guilherme] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Cellular & Mol Parasitol, Belo Horizonte, MG, Brazil	University of California System; University of California San Francisco; Merck & Company; Intervet International B.V.; Fundacao Oswaldo Cruz	Caffrey, CR (corresponding author), Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA.	Paul.Selzer@sp.intervet.com	DoenÃas Tropicais, Inct/K-2308-2013; Oliveira, Guilherme/E-2624-2014	Oliveira, Guilherme/0000-0003-0054-3438	Sandler Foundation; United States NIH [TW007012]; FAPEMG [5323-4.01/07]; FOGARTY INTERNATIONAL CENTER [D43TW007012] Funding Source: NIH RePORTER	Sandler Foundation; United States NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPEMG; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported by the Sandler Foundation. GO receives funding from the United States NIH (TW007012) and FAPEMG (5323-4.01/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; [Anonymous], OMIM ONLINE MENDELIA; [Anonymous], PDB PROTEIN DATA BAN; BECKSTETTE M, 2004, J INTEGRATIVE BIOINF, V1; Botros SS, 2007, EXPERT OPIN DRUG DIS, V2, pS35, DOI 10.1517/17460441.2.S1.S35; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Chen XC, 2006, P NATL ACAD SCI USA, V103, P14548, DOI 10.1073/pnas.0604101103; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Delcroix M, 2006, J BIOL CHEM, V281, P39316, DOI 10.1074/jbc.M607128200; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; *FLYB, FLYB DAT DROS GEN GE; Gelb MH, 2003, MOL BIOCHEM PARASIT, V126, P155, DOI 10.1016/S0166-6851(02)00282-7; Greenberg RM, 2005, PARASITOLOGY, V131, pS97, DOI 10.1017/S0031182005008346; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Haas BJ, 2007, EXP PARASITOL, V117, P225, DOI 10.1016/j.exppara.2007.06.005; Herrera LA, 2005, ENVIRON MOL MUTAGEN, V45, P284, DOI 10.1002/em.20122; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; KEIL M, 2008, FRONTIERS B IN PRESS; KEISER J, 2007, EXPERT OPINION DRUG, V23, P2; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Krasky A, 2007, GENOMICS, V89, P36, DOI 10.1016/j.ygeno.2006.09.008; Lodge JK, 1998, J BIOL CHEM, V273, P12482, DOI 10.1074/jbc.273.20.12482; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Odds Frank C., 2005, Revista Iberoamericana de Micologia, V22, P229; Oellien F, 2006, J CHEM INF MODEL, V46, P2342, DOI 10.1021/ci060109b; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Robinson MW, 2004, J MOL GRAPH MODEL, V23, P275, DOI 10.1016/j.jmgm.2004.08.001; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Selzer PM, 1997, EXP PARASITOL, V87, P212, DOI 10.1006/expr.1997.4220; Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; Wheeler DL, 2007, NUCL ACIDS RES; Wilson RA, 2006, MEM I OSWALDO CRUZ, V101, P13, DOI 10.1590/S0074-02762006000900004; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274; Zhong HZ, 2006, CURR MED CHEM, V13, P849, DOI 10.2174/092986706776361085	57	81	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4413	10.1371/journal.pone.0004413	http://dx.doi.org/10.1371/journal.pone.0004413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198654	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483900013
J	Mi, J; Dziegielewski, J; Bolesta, E; Brautigan, DL; Larner, JM				Mi, Jun; Dziegielewski, Jaroslaw; Bolesta, Elzbieta; Brautigan, David L.; Larner, James M.			Activation of DNA-PK by Ionizing Radiation Is Mediated by Protein Phosphatase 6	PLOS ONE			English	Article								DNA-dependent protein kinase (DNA-PK) plays a critical role in DNA damage repair, especially in non-homologous end-joining repair of double-strand breaks such as those formed by ionizing radiation (IR) in the course of radiation therapy. Regulation of DNA-PK involves multisite phosphorylation but this is incompletely understood and little is known about protein phosphatases relative to DNA-PK. Mass spectrometry analysis revealed that DNA-PK interacts with the protein phosphatase-6 (PP6) SAPS subunit PP6R1. PP6 is a heterotrimeric enzyme that consists of a catalytic subunit, plus one of three PP6 SAPS regulatory subunits and one of three ankyrin repeat subunits. Endogenous PP6R1 co-immunoprecipitated DNA-PK, and IR enhanced the amount of complex and promoted its import into the nucleus. In addition, siRNA knockdown of either PP6R1 or PP6 significantly decreased IR activation of DNA-PK, suggesting that PP6 activates DNA-PK by association and dephosphorylation. Knockdown of other phosphatases PP5 or PP1c1 and subunits PP6R3 or ARS-A did not reduce IR activation of DNA-PK, demonstrating specificity for PP6R1. Finally, siRNA knockdown of PP6R1 or PP6 but not other phosphatases increased the sensitivity of glioblastoma cells to radiation-induced cell death to a level similar to DNA-PK deficient cells. Our data demonstrate that PP6 associates with and activates DNA-PK in response to ionizing radiation. Therefore, the PP6/PP6R1 phosphatase is a potential molecular target for radiation sensitization by chemical inhibition.	[Mi, Jun; Dziegielewski, Jaroslaw; Bolesta, Elzbieta; Larner, James M.] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA USA; [Brautigan, David L.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Mi, J (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA USA.	jml2p@virginia.edu			NIH [ES011975, GM-56362]; Charles R. Burnett, Jr. and W. Griffin Burnett Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles R. Burnett, Jr. and W. Griffin Burnett Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants ES011975 (to J. M. L) and GM-56362 (to D. L. B.), as well as the Charles R. Burnett, Jr. and W. Griffin Burnett Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Block WD, 2004, NUCLEIC ACIDS RES, V32, P1967, DOI 10.1093/nar/gkh508; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Douglas P, 2005, DNA REPAIR, V4, P1006, DOI 10.1016/j.dnarep.2005.05.003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Povirk LF, 2007, NUCLEIC ACIDS RES, V35, P3869, DOI 10.1093/nar/gkm339; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106	35	76	80	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4395	10.1371/journal.pone.0004395	http://dx.doi.org/10.1371/journal.pone.0004395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198648	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483900005
J	Salvi, R; Arsenijevic, Y; Giacomini, M; Rey, JP; Voirol, MJ; Gaillard, RC; Risold, PY; Pralong, F				Salvi, Roberto; Arsenijevic, Yvan; Giacomini, Marco; Rey, Jean-Pierre; Voirol, Marie-Jeanne; Gaillard, Rolf Christian; Risold, Pierre-Yves; Pralong, Francois			The Fetal Hypothalamus Has the Potential to Generate Cells with a Gonadotropin Releasing Hormone (GnRH) Phenotype	PLOS ONE			English	Article							NEURAL STEM-CELL; FIBROBLAST GROWTH FACTOR-2; ADULT; NEURONS; BRAIN; NEUROGENESIS; PROGENITORS; POPULATIONS; LINEAGES; REGIONS	Background: Neurospheres (NS) are colonies of neural stem and precursor cells capable of differentiating into the central nervous system (CNS) cell lineages upon appropriate culture conditions: neurons, and glial cells. NS were originally derived from the embryonic and adult mouse striatum subventricular zone. More recently, experimental evidence substantiated the isolation of NS from almost any region of the CNS, including the hypothalamus. Methodology/Findings: Here we report a protocol that enables to generate large quantities of NS from both fetal and adult rat hypothalami. We found that either FGF-2 or EGF were capable of inducing NS formation from fetal hypothalamic cultures, but that only FGF-2 is effective in the adult cultures. The hypothalamic-derived NS are capable of differentiating into neurons and glial cells and most notably, as demonstrated by immunocytochemical detection with a specific anti-GnRH antibody, the fetal cultures contain cells that exhibit a GnRH phenotype upon differentiation. Conclusions/Significance: This in vitro model should be useful to study the molecular mechanisms involved in GnRH neuronal differentiation.	[Salvi, Roberto; Giacomini, Marco; Rey, Jean-Pierre; Voirol, Marie-Jeanne; Gaillard, Rolf Christian; Pralong, Francois] Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland; [Arsenijevic, Yvan] Univ Lausanne Hosp, Jules Gonin Eye Hosp, Lausanne, Switzerland; [Pralong, Francois] Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metabol, Geneva, Switzerland; [Risold, Pierre-Yves] Fac Med Pharm, EA 3922, Lab Histol, Besancon, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Salvi, R (corresponding author), Univ Lausanne Hosp, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland.	Francois.Pralong@chuv.ch	Messier, Claude/A-2322-2008; Risold, Pierre-Yves/AAJ-9535-2021; Risold, Pierre-Yves/M-7730-2018	Messier, Claude/0000-0002-4791-1763; Risold, Pierre-Yves/0000-0001-6801-591X; Arsenijevic, Yvan/0000-0001-6960-1291	Swiss National Science Foundation [320000-112075]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation grant #320000-112075 to FPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Arsenijevic Y, 2003, MOL NEUROBIOL, V27, P73, DOI 10.1385/MN:27:1:73; Chipperfield H, 2005, BRAIN RES PROTOC, V14, P146, DOI 10.1016/j.brainresprot.2004.12.003; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Ciofi P, 2000, NEUROSCIENCE, V99, P133, DOI 10.1016/S0306-4522(00)00186-X; Craig CG, 1996, J NEUROSCI, V16, P2649; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kruger GM, 2002, CELL, V110, P399, DOI 10.1016/S0092-8674(02)00899-1; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lillien L, 1998, CURR BIOL, V8, pR872, DOI 10.1016/S0960-9822(07)00548-9; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mastronardi C, 2006, J NEUROSCI, V26, P13167, DOI 10.1523/JNEUROSCI.4238-06.2006; Morshead CM, 2001, CURR OPIN NEUROBIOL, V11, P59, DOI 10.1016/S0959-4388(00)00174-4; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Salvi R, 2006, ENDOCRINOLOGY, V147, P816, DOI 10.1210/en.2005-0728; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Tobet SA, 2002, EUR J NEUROSCI, V16, P373, DOI 10.1046/j.1460-9568.2002.02105.x; Treier M, 1996, CURR OPIN CELL BIOL, V8, P833, DOI 10.1016/S0955-0674(96)80085-8; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Whitlock KE, 2006, MOL CELL ENDOCRINOL, V254, P39, DOI 10.1016/j.mce.2006.04.038; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2009	4	2							e4392	10.1371/journal.pone.0004392	http://dx.doi.org/10.1371/journal.pone.0004392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JM	19197372	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483700007
J	Qin, JY; Zhao, B; Wang, XW; Wang, LM; Yu, B; Ma, YH; Ma, CQ; Tang, HZ; Sun, JB; Xu, P				Qin, Jiayang; Zhao, Bo; Wang, Xiuwen; Wang, Limin; Yu, Bo; Ma, Yanhe; Ma, Cuiqing; Tang, Hongzhi; Sun, Jibin; Xu, Ping			Non-Sterilized Fermentative Production of Polymer-Grade L-Lactic Acid by a Newly Isolated Thermophilic Strain Bacillus sp 2-6	PLOS ONE			English	Article							LACTOBACILLUS-CASEI FERMENTATION; D-LACTATE DEHYDROGENASE; L(+)-LACTIC ACID; STATISTICAL OPTIMIZATION; RHIZOPUS-ORYZAE; COAGULANS; BATCH; HYDROLYSATE; GLUCOSE; BIOMASS	Background: The demand for lactic acid has been increasing considerably because of its use as a monomer for the synthesis of polylactic acid (PLA), which is a promising and environment-friendly alternative to plastics derived from petrochemicals. Optically pure L-lactic acid is essential for polymerization of PLA. The high fermentation cost of L-lactic acid is another limitation for PLA polymers to compete with conventional plastics. Methodology/Principal Findings: A Bacillus sp. strain 2-6 for production of L-lactic acid was isolated at 55 degrees C from soil samples. Its thermophilic characteristic made it a good lactic acid producer because optically pure L-lactic acid could be produced by this strain under open condition without sterilization. In 5-liter batch fermentation of Bacillus sp. 2-6, 118.0 g/liter of L-lactic acid with an optical purity of 99.4% was obtained from 121.3 g/liter of glucose. The yield was 97.3% and the average productivity was 4.37 g/liter/ h. The maximum L-lactic acid concentration of 182.0 g/liter was obtained from 30-liter fed-batch fermentation with an average productivity of 3.03 g/liter/ h and product optical purity of 99.4%. Conclusions/Significance: With the newly isolated Bacillus sp. strain 2-6, high concentration of optically pure L-lactic acid could be produced efficiently in open fermentation without sterilization, which would lead to a new cost-effective method for polymer-grade L-lactic acid production from renewable resources.	[Qin, Jiayang; Wang, Xiuwen; Wang, Limin; Ma, Yanhe; Sun, Jibin; Xu, Ping] Chinese Acad Sci, Tianjin Ind Biotechnol R&D Ctr, Tianjin, Peoples R China; [Zhao, Bo; Wang, Limin; Yu, Bo; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Beijing 100864, Peoples R China; [Qin, Jiayang; Wang, Xiuwen; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microb Technol, Jinan, Peoples R China; [Tang, Hongzhi; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Minist Educat, Key Lab Microb Metabolism, Shanghai, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong University; Shanghai Jiao Tong University	Qin, JY (corresponding author), Chinese Acad Sci, Tianjin Ind Biotechnol R&D Ctr, Tianjin, Peoples R China.	pingxu@sjtu.edu.cn	MA, YAN/HHN-2912-2022; yu, bo/A-9467-2008	yu, bo/0000-0003-3148-0986; Ma, Cuiqing/0000-0002-7468-1027; Sun, Jibin/0000-0002-0208-504X	National Basic Research Program of China [2007CB707803]; Chinese National Program for High Technology Research and Development [2006AA020102, 2007AA10Z360]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2007CB707803) and Chinese National Program for High Technology Research and Development (2006AA020102 and 2007AA10Z360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DM, 2003, BIOTECHNOL LETT, V25, P1833, DOI 10.1023/A:1026276925649; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SF, 2003, FORTUNE, V148, P92; CAMPBELL LL, 1959, J BACTERIOL, V78, P267, DOI 10.1128/JB.78.2.267-271.1959; CLEVERDON RC, 1949, J BACTERIOL, V58, P113, DOI 10.1128/JB.58.1.113-114.1949; CLEVERDON RC, 1949, J BACTERIOL, V58, P523, DOI 10.1128/JB.58.4.523-526.1949; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Datta R, 2006, J CHEM TECHNOL BIOT, V81, P1119, DOI 10.1002/jctb.1486; Ding SF, 2006, PROCESS BIOCHEM, V41, P1451, DOI 10.1016/j.procbio.2006.01.014; EINARSSON H, 1983, J AGR FOOD CHEM, V31, P1043, DOI 10.1021/jf00119a031; FERAIN T, 1994, J BACTERIOL, V176, P596, DOI 10.1128/jb.176.3.596-601.1994; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Hofvendahl K, 2000, ENZYME MICROB TECH, V26, P87, DOI 10.1016/S0141-0229(99)00155-6; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; Kyla-Nikkila K, 2000, APPL ENVIRON MICROB, V66, P3835, DOI 10.1128/AEM.66.9.3835-3841.2000; Li Zheng, 2006, Biotechnology Journal, V1, P1453, DOI 10.1002/biot.200600099; Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; Manome A, 1998, J GEN APPL MICROBIOL, V44, P371, DOI 10.2323/jgam.44.371; Michelson T, 2006, ENZYME MICROB TECH, V39, P861, DOI 10.1016/j.enzmictec.2006.01.015; Pan CM, 2008, BIORESOURCE TECHNOL, V99, P3146, DOI 10.1016/j.biortech.2007.05.055; Park EY, 1998, BIOTECHNOL PROGR, V14, P699, DOI 10.1021/bp9800642; Patel M, 2004, BIOTECHNOL LETT, V26, P865, DOI 10.1023/B:bile.0000025893.27700.5c; Payot T, 1999, ENZYME MICROB TECH, V24, P191, DOI 10.1016/S0141-0229(98)00098-2; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Rosenberg M, 2005, BIOTECHNOL LETT, V27, P1943, DOI 10.1007/s10529-005-3907-y; Sakai K, 2006, J BIOSCI BIOENG, V101, P457, DOI 10.1263/jbb.101.457; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/s0079-6700(02)00012-6; TAGUCHI H, 1991, J BIOL CHEM, V266, P12588; Tay A, 2002, BIOTECHNOL BIOENG, V80, P1, DOI 10.1002/bit.10340; Tsuji F, 2002, POLYMER, V43, P1789; Viana R, 2005, RES MICROBIOL, V156, P641, DOI 10.1016/j.resmic.2005.02.011; Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5	35	78	89	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4359	10.1371/journal.pone.0004359	http://dx.doi.org/10.1371/journal.pone.0004359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194504	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483500009
J	Louie, SH; Yang, XY; Conrad, WH; Muster, J; Angers, S; Moon, RT; Cheyette, BNR				Louie, Sarah H.; Yang, Xiao Yong; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.; Cheyette, Benjamin N. R.			Modulation of the beta-Catenin Signaling Pathway by the Dishevelled-Associated Protein Hipk1	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; PLANAR CELL-POLARITY; NEURAL-TUBE CLOSURE; N-TERMINAL KINASE; XENOPUS-EMBRYOS; WNT/BETA-CATENIN; C-JUN; DIX DOMAIN; VERTEBRATE EMBRYOS; AXIS FORMATION	Background: Wnts are evolutionarily conserved ligands that signal through beta-catenin-dependent and beta-catenin-independent pathways to regulate cell fate, proliferation, polarity, and movements during vertebrate development. Dishevelled (Dsh/Dvl) is a multi-domain scaffold protein required for virtually all known Wnt signaling activities, raising interest in the identification and functions of Dsh-associated proteins. Methodology: We conducted a yeast-2-hybrid screen using an N-terminal fragment of Dsh, resulting in isolation of the Xenopus laevis ortholog of Hipk1. Interaction between the Dsh and Hipk1 proteins was confirmed by co-immunoprecipitation assays and mass spectrometry, and further experiments suggest that Hipk1 also complexes with the transcription factor Tcf3. Supporting a nuclear function during X. laevis development, Myc-tagged Hipk1 localizes primarily to the nucleus in animal cap explants, and the endogenous transcript is strongly expressed during gastrula and neurula stages. Experimental manipulations of Hipk1 levels indicate that Hipk1 can repress Wnt/beta-catenin target gene activation, as demonstrated by beta-catenin reporter assays in human embryonic kidney cells and by indicators of dorsal specification in X. laevis embryos at the late blastula stage. In addition, a subset of Wnt-responsive genes subsequently requires Hipk1 for activation in the involuting mesoderm during gastrulation. Moreover, either over-expression or knock-down of Hipk1 leads to perturbed convergent extension cell movements involved in both gastrulation and neural tube closure. Conclusions: These results suggest that Hipk1 contributes in a complex fashion to Dsh-dependent signaling activities during early vertebrate development. This includes regulating the transcription of Wnt/beta-catenin target genes in the nucleus, possibly in both repressive and activating ways under changing developmental contexts. This regulation is required to modulate gene expression and cell movements that are essential for gastrulation.	[Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Louie, Sarah H.; Conrad, William H.; Muster, Jeanot; Angers, Stephane; Moon, Randall T.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yang, Xiao Yong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Program Biol Sci, Grad Program Dev Biol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Louie, SH (corresponding author), Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA.	benjamin.cheyette@ucsf.edu	Moon, Randall T/B-1743-2014; Cheyette, Benjamin/K-5535-2014; Angers, Stephane/E-1432-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Cheyette, Benjamin/0000-0001-9934-7941; Angers, Stephane/0000-0001-7241-9044; Moon, Randall/0000-0002-9352-1408; Muster, Jeanot/0000-0002-1972-6851	NIH [R01, MH01750 K08]; HHMI [fellow]; NARSAD/Browning Foundation Young Investigator Award;  [1R01HD055300]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NARSAD/Browning Foundation Young Investigator Award(NARSAD); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by an NIH R01. RTM is an investigator, and SA was a fellow of the HHMI. BNRC was supported by NIH MH01750 K08 and a NARSAD/Browning Foundation Young Investigator Award, and he and XYY are currently supported by 1R01HD055300 to BNRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHEYETTE BN, 2004, SCI STKE, pPE54; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1; CUI YZ, 1995, DEVELOPMENT, V121, P2177; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Djiane A, 2000, DEVELOPMENT, V127, P3091; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; HUANG HHEX, 2008, CURR OPIN CELL BIOL; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; KELLER R, 1988, DEVELOPMENT, V103, P193; KELLER R, 1991, METHOD CELL BIOL, V36, P61; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Makita R, 1998, MECH DEVELOP, V71, P165, DOI 10.1016/S0925-4773(98)00013-6; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; MCGREW LL, 1992, DEVELOPMENT, V115, P463; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; ROTHBACHER U, 1995, DEV BIOL, V170, P717, DOI 10.1006/dbio.1995.1249; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; RUI Y, 2004, EMBO J; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SOKOL SY, 1995, DEVELOPMENT, V121, P3487; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Sumanas S, 2001, GENESIS, V30, P119, DOI 10.1002/gene.1044; Tada M, 2000, DEVELOPMENT, V127, P2227; Tahinci E, 2007, DEVELOPMENT, V134, P4095, DOI 10.1242/dev.010272; THEISEN H, 1994, DEVELOPMENT, V120, P347; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yokota C, 2003, DEVELOPMENT, V130, P2199, DOI 10.1242/dev.00434; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	116	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4310	10.1371/journal.pone.0004310	http://dx.doi.org/10.1371/journal.pone.0004310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183803	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483200002
J	Nikolaev, A; Zheng, L; Wardill, TJ; O'Kane, CJ; de Polavieja, GG; Juusola, M				Nikolaev, Anton; Zheng, Lei; Wardill, Trevor J.; O'Kane, Cahir J.; de Polavieja, Gonzalo G.; Juusola, Mikko			Network Adaptation Improves Temporal Representation of Naturalistic Stimuli in Drosophila Eye: II Mechanisms	PLOS ONE			English	Article							LIGHT ADAPTATION; VISUAL-SYSTEM; HISTAMINE; PHOTORECEPTORS; CHANNEL; LAMINA; TRANSMISSION; PREFERENCE; TERMINALS; RESPONSES	Retinal networks must adapt constantly to best present the ever changing visual world to the brain. Here we test the hypothesis that adaptation is a result of different mechanisms at several synaptic connections within the network. In a companion paper (Part I), we showed that adaptation in the photoreceptors (R1-R6) and large monopolar cells (LMC) of the Drosophila eye improves sensitivity to under-represented signals in seconds by enhancing both the amplitude and frequency distribution of LMCs' voltage responses to repeated naturalistic contrast series. In this paper, we show that such adaptation needs both the light-mediated conductance and feedback-mediated synaptic conductance. A faulty feedforward pathway in histamine receptor mutant flies speeds up the LMC output, mimicking extreme light adaptation. A faulty feedback pathway from L2 LMCs to photoreceptors slows down the LMC output, mimicking dark adaptation. These results underline the importance of network adaptation for efficient coding, and as a mechanism for selectively regulating the size and speed of signals in neurons. We suggest that concert action of many different mechanisms and neural connections are responsible for adaptation to visual stimuli. Further, our results demonstrate the need for detailed circuit reconstructions like that of the Drosophila lamina, to understand how networks process information.	[Nikolaev, Anton; Zheng, Lei; Wardill, Trevor J.; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain; [Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci, Beijing 100875, Peoples R China	University of Sheffield; University of Cambridge; Autonomous University of Madrid; Autonomous University of Madrid; Beijing Normal University	Nikolaev, A (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Juusola, Mikko/E-6948-2011	O'Kane, Cahir/0000-0002-3488-2078; de Polavieja, Gonzalo/0000-0001-5359-3426; Wardill, Trevor/0000-0002-2049-113X; Juusola, Mikko/0000-0002-4428-5330	Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Royal Society; MEC; Biociencia program; CAM-UAM; BBSRC [BB/F012071/1, BB/D001900/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001900/1, BB/F012071/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Royal Society(Royal Society of London); MEC(European Commission); Biociencia program; CAM-UAM; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Biotechnology and Biological Sciences Research Council (MJ, CJO'K), the Gatsby Charitable Foundation (MJ), the Royal Society (MJ, GGdP), MEC (GGdP), Biociencia program (GGdP) and CAM-UAM (GGdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 1990, J COMP PHYSIOL A, V167, P723, DOI 10.1007/BF00189763; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Pak W.L., 1979, P67; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; SHAW SR, 1984, J EXP BIOL, V112, P225; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; STRAUSFE.NJ, 1970, Z VERGL PHYSIOL, V70, P95, DOI 10.1007/BF00297712; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; UUSITALO RO, 1995, J NEUROPHYSIOL, V73, P1782, DOI 10.1152/jn.1995.73.5.1782; UUSITALO RO, 1995, J NEUROPHYSIOL, V74, P470, DOI 10.1152/jn.1995.74.1.470; Vahasoyrinki M, 2006, J NEUROSCI, V26, P2652, DOI 10.1523/JNEUROSCI.3316-05.2006; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Wolfram V, 2004, J NEUROPHYSIOL, V92, P1918, DOI 10.1152/jn.00201.2004; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4306	10.1371/journal.pone.0004306	http://dx.doi.org/10.1371/journal.pone.0004306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180195	Green Published, gold, Green Accepted			2022-12-27	WOS:000274089700005
J	Yonehara, K; Ishikane, H; Sakuta, H; Shintani, T; Nakamura-Yonehara, K; Kamiji, NL; Usui, S; Noda, M				Yonehara, Keisuke; Ishikane, Hiroshi; Sakuta, Hiraki; Shintani, Takafumi; Nakamura-Yonehara, Kayo; Kamiji, Nilton L.; Usui, Shiro; Noda, Masaharu			Identification of Retinal Ganglion Cells and Their Projections Involved in Central Transmission of Information about Upward and Downward Image Motion	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; MEDIAL TERMINAL NUCLEUS; VERTICAL OPTOKINETIC NYSTAGMUS; STARBURST AMACRINE CELLS; EYE-MOVEMENTS; DIRECTION SELECTIVITY; VISUAL EXPERIENCE; RABBIT RETINA; DYNAMIC CHARACTERISTICS; SPATIAL-ORGANIZATION	The direction of image motion is coded by direction-selective (DS) ganglion cells in the retina. Particularly, the ON DS ganglion cells project their axons specifically to terminal nuclei of the accessory optic system (AOS) responsible for optokinetic reflex (OKR). We recently generated a knock-in mouse in which SPIG1 (SPARC-related protein containing immunoglobulin domains 1)-expressing cells are visualized with GFP, and found that retinal ganglion cells projecting to the medial terminal nucleus (MTN), the principal nucleus of the AOS, are comprised of SPIG1(+) and SPIG1(-) ganglion cells distributed in distinct mosaic patterns in the retina. Here we examined light responses of these two subtypes of MTN-projecting cells by targeted electrophysiological recordings. SPIG1(+) and SPIG1(-) ganglion cells respond preferentially to upward motion and downward motion, respectively, in the visual field. The direction selectivity of SPIG1(+) ganglion cells develops normally in dark-reared mice. The MTN neurons are activated by optokinetic stimuli only of the vertical motion as shown by Fos expression analysis. Combination of genetic labeling and conventional retrograde labeling revealed that axons of SPIG1(+) and SPIG1(-) ganglion cells project to the MTN via different pathways. The axon terminals of the two subtypes are organized into discrete clusters in the MTN. These results suggest that information about upward and downward image motion transmitted by distinct ON DS cells is separately processed in the MTN, if not independently. Our findings provide insights into the neural mechanisms of OKR, how information about the direction of image motion is deciphered by the AOS.	[Yonehara, Keisuke; Sakuta, Hiraki; Shintani, Takafumi; Nakamura-Yonehara, Kayo; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Yonehara, Keisuke; Sakuta, Hiraki; Shintani, Takafumi; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Ishikane, Hiroshi; Kamiji, Nilton L.; Usui, Shiro] RIKEN, Brain Sci Inst, Lab Neuroinformat, Wako, Saitama, Japan; [Ishikane, Hiroshi] Senshu Univ, Grad Sch Humanities, Dept Psychol, Kawasaki, Kanagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; RIKEN	Yonehara, K (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Kamiji, Nilton/N-8420-2015; Noda, Masaharu/D-7146-2016; Kamiji, Nilton Liuji/AAF-3860-2020	Noda, Masaharu/0000-0002-3796-524X; Kamiji, Nilton Liuji/0000-0001-5006-6612; Shintani, Takafumi/0000-0002-6165-2307; Sakuta, Hiraki/0000-0003-2375-0528; Ishikane, Hiroshi/0000-0003-1316-2255; Yonehara, Keisuke/0000-0001-9541-6671	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. N. and H. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BENASSI C, 1989, VISUAL NEUROSCI, V2, P377, DOI 10.1017/S0952523800002182; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; COLLEWIJN H, 1977, EXP BRAIN RES, V27, P287; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; DAW NW, 1974, J PHYSIOL-LONDON, V240, P309, DOI 10.1113/jphysiol.1974.sp010612; De Zeeuw CI, 1998, OTOLARYNG HEAD NECK, V119, P193, DOI 10.1016/S0194-5998(98)70054-3; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; ERICKSON RG, 1980, EXP BRAIN RES, V40, P448; EVINGER C, 1978, J PHYSIOL-LONDON, V285, P209, DOI 10.1113/jphysiol.1978.sp012568; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; GIOLLI RA, 1984, J COMP NEUROL, V227, P228, DOI 10.1002/cne.902270208; GIOLLI RA, 1968, J COMP NEUROL, V133, P309, DOI 10.1002/cne.901330303; GRASSE KL, 1982, J NEUROPHYSIOL, V48, P490, DOI 10.1152/jn.1982.48.2.490; HAYHOW WR, 1960, J COMP NEUROL, V115, P187, DOI 10.1002/cne.901150207; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; HOFFMANN KP, 1995, J NEUROPHYSIOL, V73, P727, DOI 10.1152/jn.1995.73.2.727; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; IWAHORI N, 1981, NEUROSCI LETT, V23, P229, DOI 10.1016/0304-3940(81)90002-1; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Kao YH, 2003, J NEUROCYTOL, V32, P245, DOI 10.1023/B:NEUR.0000010083.03446.78; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LUI F, 1990, EXP BRAIN RES, V81, P77; MANGINI NJ, 1985, J COMP NEUROL, V241, P191, DOI 10.1002/cne.902410207; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MATSUO V, 1984, EXP BRAIN RES, V53, P197; MITCHINER JC, 1976, VISION RES, V16, P1169, DOI 10.1016/0042-6989(76)90258-3; MURASUGI CM, 1989, EXP BRAIN RES, V77, P183; NAKAYAMA K, 1981, VISION RES, V21, P1475, DOI 10.1016/0042-6989(81)90218-2; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; PAK MW, 1987, J COMP NEUROL, V258, P435, DOI 10.1002/cne.902580311; Peters MA, 2002, CURR OPIN NEUROBIOL, V12, P43, DOI 10.1016/S0959-4388(02)00288-X; Rodieck R.W., 1998, 1 STEPS SEEING; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sakatani T, 2007, NEUROSCI RES, V58, P324, DOI 10.1016/j.neures.2007.04.003; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sakuta H, 2006, J NEUROSCI, V26, P10868, DOI 10.1523/JNEUROSCI.3027-06.2006; SATAKANI T, 2004, NEUROSCI RES, V49, P123; Schmidt M, 1998, EUR J NEUROSCI, V10, P1533, DOI 10.1046/j.1460-9568.1998.00161.x; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Simpson J I, 1979, Prog Brain Res, V50, P715; SIMPSON JI, 1988, J NEUROPHYSIOL, V60, P2055, DOI 10.1152/jn.1988.60.6.2055; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; SINEX DG, 1979, VISION RES, V19, P853, DOI 10.1016/0042-6989(79)90018-X; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; STEWART DL, 1971, J NEUROPHYSIOL, V34, P139, DOI 10.1152/jn.1971.34.1.139; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; TERUBAYASHI H, 1984, J COMP NEUROL, V227, P285, DOI 10.1002/cne.902270211; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; VANDERTOGT C, 1993, J COMP NEUROL, V338, P175, DOI 10.1002/cne.903380204; VANEY DI, 1981, BRAIN RES, V212, P447, DOI 10.1016/0006-8993(81)90476-5; Vaney DI, 2001, MOTION VISION, P13; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANEY DI, 1994, J NEUROSCI, V14, P6301; WALLMAN J, 1985, J NEUROSCI, V5, P317; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847; Yamada H, 1974, Z Mikrosk Anat Forsch, V88, P997; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	81	119	124	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2009	4	1							e4320	10.1371/journal.pone.0004320	http://dx.doi.org/10.1371/journal.pone.0004320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JH	19177171	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483100007
J	Liang, YJ; Zhang, SC; Wang, ZP				Liang, Yujun; Zhang, Shicui; Wang, Zhiping			Alternative Complement Activity in the Egg Cytosol of Amphioxus Branchiostoma belcheri: Evidence for the Defense Role of Maternal Complement Components	PLOS ONE			English	Article								Background: The eggs in most invertebrates are fertilized externally, and therefore their resulting embryos are exposed to an environment full of microbes, many of which are pathogens capable of killing other organisms. How the developing embryos of invertebrates defend themselves against pathogenic attacks is an intriguing question to biologists, and remains largely unknown. Methodology/Principal Findings: Here we clearly demonstrated that the egg cytosol prepared from the newly fertilized eggs of amphioxus Branchiostoma belcheri, an invertebrate chordate, was able to inhibit the growth of both the Gramnegative bacterium Vibrio anguillarum and the Gram-positive bacterium Staphylococcus aureus. All findings point to that it is the complement system operating via the alternative pathway that is attributable to the bacteriostatic activity. Conclusions/Significance: This appears to be the first report providing the evidence for the functional role of the maternal complement components in the eggs of invertebrate species, paving the way for the study of maternal immunity in other invertebrate organisms whose eggs are fertilized in vitro. It also supports the notion that the early developing embryos share some defense mechanisms common with the adult species.	[Liang, Yujun; Zhang, Shicui; Wang, Zhiping] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China; [Wang, Zhiping] Hebei Agr Univ, Ocean Coll, Qingdao, Peoples R China	Ocean University of China; Hebei Agricultural University	Liang, YJ (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn		Liang, Yujun/0000-0002-1253-8364	Ministry of Science and Technology (MOST) [2006CB101805]; Natural Science Foundation of China (NSFC) [30730072]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants (2006CB101805; 30730072) of Ministry of Science and Technology (MOST) and Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; GROOMBRIDGE B, 1992, GLOBAL DIVERSITY STA, P17; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; Hemmrich G, 2007, TRENDS IMMUNOL, V28, P449, DOI 10.1016/j.it.2007.08.003; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang CC, 1999, DEV COMP IMMUNOL, V23, P545, DOI 10.1016/S0145-305X(99)00038-5; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kuo MM, 2000, J PARASITOL, V86, P1223, DOI 10.1645/0022-3395(2000)086[1223:ACSOMA]2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZM, 2008, FISH SHELLFISH IMMUN, V24, P215, DOI 10.1016/j.fsi.2007.10.016; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; Robertson M, 1998, CURR BIOL, V8, pR595, DOI 10.1016/S0960-9822(98)70384-7; Rubio-Godoy M, 2004, FISH SHELLFISH IMMUN, V17, P95, DOI 10.1016/j.fsi.2003.11.005; RUDDY S, 1974, TRANSPLANT P, V6, P1; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Suzuki MM, 2002, J MOL EVOL, V54, P671, DOI 10.1007/s00239-001-0068-z; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Yano Tomoki, 1996, Fish Physiology, V15, P105; ZHANG S, 2008, PROG NAT SC IN PRESS; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207; Zhang SC, 2001, OPHELIA, V54, P115, DOI 10.1080/00785236.2001.10409459; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	32	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4234	10.1371/journal.pone.0004234	http://dx.doi.org/10.1371/journal.pone.0004234			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156196	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482100006
J	Xu, P; Shi, M; Chen, XX				Xu, Peng; Shi, Min; Chen, Xue-xin			Antimicrobial Peptide Evolution in the Asiatic Honey Bee Apis cerana	PLOS ONE			English	Article							NOSEMA-CERANAE; MICROSPORIDIAN PARASITE; APIDAECIN; ANTIBIOTICS; BIODIVERSITY; INFECTION; MELLIFERA; GENETICS; MAMMALS; VIRUS	The Asiatic honeybee, Apis cerana Fabricius, is an important honeybee species in Asian countries. It is still found in the wild, but is also one of the few bee species that can be domesticated. It has acquired some genetic advantages and significantly different biological characteristics compared with other Apis species. However, it has been less studied, and over the past two decades, has become a threatened species in China. We designed primers for the sequences of the four antimicrobial peptide cDNA gene families (abaecin, defensin, apidaecin, and hymenoptaecin) of the Western honeybee, Apis mellifera L. and identified all the antimicrobial peptide cDNA genes in the Asiatic honeybee for the first time. All the sequences were amplified by reverse transcriptase-polymerase chain reaction (RT-PCR). In all, 29 different defensin cDNA genes coding 7 different defensin peptides, 11 different abaecin cDNA genes coding 2 different abaecin peptides, 13 different apidaecin cDNA genes coding 4 apidaecin peptides and 34 different hymenoptaecin cDNA genes coding 13 different hymenoptaecin peptides were cloned and identified from the Asiatic honeybee adult workers. Detailed comparison of these four antimicrobial peptide gene families with those of the Western honeybee revealed that there are many similarities in the quantity and amino acid components of peptides in the abaecin, defensin and apidaecin families, while many more hymenoptaecin peptides are found in the Asiatic honeybee than those in the Western honeybee (13 versus 1). The results indicated that the Asiatic honeybee adult generated more variable antimicrobial peptides, especially hymenoptaecin peptides than the Western honeybee when stimulated by pathogens or injury. This suggests that, compared to the Western honeybee that has a longer history of domestication, selection on the Asiatic honeybee has favored the generation of more variable antimicrobial peptides as protection against pathogens.	[Xu, Peng; Shi, Min; Chen, Xue-xin] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, P (corresponding author), Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xxchen@zju.edu.cn	Chen, Xue-xin/D-1592-2010	Chen, Xue-xin/0000-0002-9109-8853	973 Program [2006CB102005, 2007CB109202]; National Science Fund for Distinguished Young Scholars [30625006]; Innovation Research Team Program of the Ministry of Education of China [IRT0355]; National S&T Infrastructure Project [2005DKA21402, 2005DKA21105]	973 Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Research Team Program of the Ministry of Education of China(Ministry of Education, China); National S&T Infrastructure Project	Funding for this study was provided jointly by 973 Program (2006CB102005, 2007CB109202), the National Science Fund for Distinguished Young Scholars (30625006), Innovation Research Team Program of the Ministry of Education of China (IRT0355), and the National S&T Infrastructure Project (2005DKA21402, 2005DKA21105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SIGNALP 3 0 SERVER; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; CASTEELS P, 1994, J BIOL CHEM, V269, P26107; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2007, AM BEE J, V147, P1027; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Kasprzak Sylwia, 2007, Wiadomosci Parazytologiczne, V53, P281; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Mueller Uwe, 2008, V15, P21, DOI 10.1159/000135684; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; Santillan-Galicia MT, 2008, J GEN VIROL, V89, P1685, DOI 10.1099/vir.0.83223-0; Souza RM, 2007, Z NATURFORSCH C, V62, P801; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Zhou XX, 2008, APPL MICROBIOL BIOT, V78, P947, DOI 10.1007/s00253-008-1380-y	36	76	88	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4239	10.1371/journal.pone.0004239	http://dx.doi.org/10.1371/journal.pone.0004239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156201	Green Published, gold			2022-12-27	WOS:000265482100011
J	Maas, S; Gommans, WM				Maas, Stefan; Gommans, Willemijn M.			Novel Exon of Mammalian ADAR2 Extends Open Reading Frame	PLOS ONE			English	Article								Background: The post-transcriptional processing of pre-mRNAs by RNA editing contributes significantly to the complexity of the mammalian transcriptome. RNA editing by site-selective A-to-I modification also regulates protein function through recoding of genomically specified sequences. The adenosine deaminase ADAR2 is the main enzyme responsible for recoding editing and loss of ADAR2 function in mice leads to a phenotype of epilepsy and premature death. Although A-to-I RNA editing is known to be subject to developmental and cell-type specific regulation, there is little knowledge regarding the mechanisms that regulate RNA editing in vivo. Therefore, the characterization of ADAR expression and identification of alternative ADAR variants is an important prerequisite for understanding the mechanisms for regulation of RNA editing and the causes for deregulation in disease. Methodology/Principal Findings: Here we present evidence for a new ADAR2 splice variant that extends the open reading frame of ADAR2 by 49 amino acids through the utilization of an exon located 18 kilobases upstream of the previously annotated first coding exon and driven by a candidate alternative promoter. Interestingly, the 49 amino acid extension harbors a sequence motif that is closely related to the R-domain of ADAR3 where it has been shown to function as a basic, single-stranded RNA binding domain. Quantitative expression analysis shows that expression of the novel ADAR2 splice variant is tissue specific being highest in the cerebellum. Conclusions/Significance: The strong sequence conservation of the ADAR2 R-domain between human, mouse and rat ADAR2 genes suggests a conserved function for this isoform of the RNA editing enzyme.	[Maas, Stefan; Gommans, Willemijn M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Maas, S (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	smaas@lehigh.edu			National Institutes of Health [NS057739]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS057739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funds to S.M. from the National Institutes of Health (NS057739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Gerber A, 1997, RNA, V3, P453; Gommans W.M., 2008, DNA RNA EDITING, P3; HAUSSLER DAS, 2004, P 8 ANN INT C RES CO, P177; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Maydanovych O, 2006, CHEM REV, V106, P3397, DOI 10.1021/cr050314a; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Villard L, 1997, SOMAT CELL MOLEC GEN, V23, P135, DOI 10.1007/BF02679972; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang WD, 2004, MOL BRAIN RES, V124, P70, DOI 10.1016/j.molbrainres.2004.02.010	30	38	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4225	10.1371/journal.pone.0004225	http://dx.doi.org/10.1371/journal.pone.0004225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156214	Green Published, gold, Green Submitted			2022-12-27	WOS:000265481900007
J	Young, JW; Light, GA; Marston, HM; Sharp, R; Geyer, MA				Young, Jared W.; Light, Gregory A.; Marston, Hugh M.; Sharp, Richard; Geyer, Mark A.			The 5-Choice Continuous Performance Test: Evidence for a Translational Test of Vigilance for Mice	PLOS ONE			English	Article							REACTION-TIME-TASK; DEFICIT HYPERACTIVITY DISORDER; POSTERIOR PARIETAL CORTEX; SIGNAL-DETECTION-THEORY; SUSTAINED ATTENTION; VISUAL-ATTENTION; BEHAVIORAL VIGILANCE; COGNITIVE DEFICITS; IMPAIRED ATTENTION; SCHIZOPHRENIA	Background: Attentional dysfunction is related to functional disability in patients with neuropsychiatric disorders such as schizophrenia, bipolar disorder, and Alzheimer's disease. Indeed, sustained attention/vigilance is among the leading targets for new medications designed to improve cognition in schizophrenia. Although vigilance is assessed frequently using the continuous performance test (CPT) in humans, few tests specifically assess vigilance in rodents. Methods: We describe the 5-choice CPT (5C-CPT), an elaboration of the 5-choice serial reaction (5CSR) task that includes non-signal trials, thus mimicking task parameters of human CPTs that use signal and non-signal events to assess vigilance. The performances of C57BL/6J and DBA/2J mice were assessed in the 5C-CPT to determine whether this task could differentiate between strains. C57BL/6J mice were also trained in the 5CSR task and a simple reaction-time (RT) task involving only one choice (1CRT task). We hypothesized that: 1) C57BL/6J performance would be superior to DBA/2J mice in the 5C-CPT as measured by the sensitivity index measure from signal detection theory; 2) a vigilance decrement would be observed in both strains; and 3) RTs would increase across tasks with increased attentional load (1CRT task<5CSR task<5C-CPT). Conclusions: C57BL/6J mice exhibited superior SI levels compared to DBA/2J mice, but with no difference in accuracy. A vigilance decrement was observed in both strains, which was more pronounced in DBA/2J mice and unaffected by response bias. Finally, we observed increased RTs with increased attentional load, such that 1CRT task<5CSR task<5C-CPT, consistent with human performance in simple RT, choice RT, and CPT tasks. Thus we have demonstrated construct validity for the 5CCPT as a measure of vigilance that is analogous to human CPT studies.	[Young, Jared W.; Light, Gregory A.; Sharp, Richard; Geyer, Mark A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Marston, Hugh M.] Schering Plough Corp, Lanarkshire, England	University of California System; University of California San Diego; Merck & Company	Young, JW (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	jaredyoung@ucsd.edu	Young, Jared W/G-9601-2012; Light, Gregory/AAA-5696-2020; Marston, Hugh M/G-8555-2011	Marston, Hugh M/0000-0002-7460-0581; Light, Gregory/0000-0003-4730-8646	National Institute of Mental Health [R01 MH071916, R01 MH42228]; Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center; Stein Institute for Research in Aging Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071916, R01MH042228] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center(US Department of Veterans Affairs); Stein Institute for Research in Aging Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (R01 MH071916; R01 MH42228), the Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center, as well as current support from a Stein Institute for Research in Aging Fellowship (JWY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari-Teule M, 1998, BEHAV BRAIN RES, V95, P85, DOI 10.1016/S0166-4328(97)00213-1; Baron SP, 2001, BEHAV BRAIN RES, V118, P143, DOI 10.1016/S0166-4328(00)00322-3; Birkett P, 2007, SCHIZOPHR RES, V95, P76, DOI 10.1016/j.schres.2007.05.030; Broussard J, 2006, NEUROSCIENCE, V143, P407, DOI 10.1016/j.neuroscience.2006.08.030; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Caine SB, 1999, PSYCHOPHARMACOLOGY, V147, P22, DOI 10.1007/s002130051134; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Carter CS, 2007, SCHIZOPHRENIA BULL, V33, P1131, DOI 10.1093/schbul/sbm081; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Chudasama Y, 2004, PSYCHOPHARMACOLOGY, V174, P86, DOI 10.1007/s00213-004-1805-y; CONNERS CK, 1985, PSYCHOPHARMACOL BULL, V21, P891; Cordova CA, 2006, SLEEP, V29, P69; CORNBLATT BA, 1988, PSYCHIAT RES, V26, P223, DOI 10.1016/0165-1781(88)90076-5; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; D'Este L, 2007, J CHEM NEUROANAT, V33, P67, DOI 10.1016/j.jchemneu.2006.12.005; Day M, 2008, CURR OPIN INVEST DR, V9, P696; DUDCHENKO P, 1992, PSYCHOPHARMACOLOGY, V109, P203, DOI 10.1007/BF02245501; DUPAUL GJ, 1992, BEHAV MODIF, V16, P204, DOI 10.1177/01454455920162004; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Evenden J, 1999, J PSYCHOPHARMACOL, V13, P180, DOI 10.1177/026988119901300211; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fletcher PJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1122, DOI 10.1038/sj.npp.1301221; Floresco SB, 2005, SCHIZOPHRENIA BULL, V31, P888, DOI 10.1093/schbul/sbi041; FREY P W, 1973, Learning and Motivation, V4, P327, DOI 10.1016/0023-9690(73)90023-4; Grafton ST, 1998, J NEUROSCI, V18, P9420; Greco B, 2005, PSYCHOPHARMACOLOGY, V179, P68, DOI 10.1007/s00213-004-2127-9; Green DM, 1966, SIGNAL DETECTION THE; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hagan JJ, 2005, SCHIZOPHRENIA BULL, V31, P830, DOI 10.1093/schbul/sbi058; Hayward MD, 2007, NEUROSCIENCE, V144, P17, DOI 10.1016/j.neuroscience.2006.08.067; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Humby T, 1999, EUR J NEUROSCI, V11, P2813, DOI 10.1046/j.1460-9568.1999.00701.x; Inglis WL, 2001, BEHAV BRAIN RES, V123, P117, DOI 10.1016/S0166-4328(01)00181-4; JONES DNC, 1995, PSYCHOPHARMACOLOGY, V120, P142, DOI 10.1007/BF02246186; KLORMAN R, 1988, J ABNORM PSYCHOL, V97, P413, DOI 10.1037/0021-843X.97.4.413; Levin ED, 1998, PSYCHOPHARMACOLOGY, V140, P135, DOI 10.1007/s002130050750; Mackworth N.H., 1950, RES MEASUREMENT HUMA; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; MARKOU A, 2008, NEUROPSYCHOPHARMACOL; Marston HM, 1996, COGNITIVE BRAIN RES, V3, P269, DOI 10.1016/0926-6410(96)00012-2; Martin LA, 2006, BEHAV NEUROSCI, V120, P477, DOI 10.1037/0735-7044.120.2.477; Maruff P, 1996, NEUROPSYCHOLOGIA, V34, P1079, DOI 10.1016/0028-3932(96)00035-8; MCGAUGHY J, 1995, PSYCHOPHARMACOLOGY, V117, P340, DOI 10.1007/BF02246109; McNicol D., 1972, PRIMER SIGNAL DETECT; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; NESTOR PG, 1990, SCHIZOPHR RES, V3, P329, DOI 10.1016/0920-9964(90)90018-3; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2006, DEV PSYCHOPATHOL, V18, P831; Parasuraman, 1998, ATTENTIVE BRAIN; Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Riccio CA, 2001, J NEUROPSYCH CLIN N, V13, P326, DOI 10.1176/appi.neuropsych.13.3.326; Risbrough V, 2002, PSYCHOPHARMACOLOGY, V164, P71, DOI 10.1007/s00213-002-1170-7; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robbins TW, 1998, ATTENTIVE BRAIN, P189; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; ROBINSON ES, 2007, NEUROPSYCHOPHARMACOL; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; SAHAKIAN BJ, 1993, PSYCHOPHARMACOLOGY, V110, P395, DOI 10.1007/BF02244644; SAHGAL A, 1987, PSYCHOPHARMACOLOGY, V91, P517, DOI 10.1007/BF00216022; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Sarter M, 2004, NEUROSCI BIOBEHAV R, V28, P645, DOI 10.1016/j.neubiorev.2004.09.005; Sarter M, 2006, TRENDS PHARMACOL SCI, V27, P602, DOI 10.1016/j.tips.2006.09.004; See JE, 1997, HUM FACTORS, V39, P14, DOI 10.1518/001872097778940704; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; SOSTEK AJ, 1980, J ABNORM CHILD PSYCH, V8, P491, DOI 10.1007/BF00916502; Spratt C., 2000, BNA, V17; STECKLER T, 1995, NEUROSCIENCE, V66, P101, DOI 10.1016/0306-4522(94)00603-3; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; STRAUSS J, 1984, PSYCHOPHYSIOLOGY, V21, P609, DOI 10.1111/j.1469-8986.1984.tb00247.x; ThinusBlanc C, 1996, BEHAV BRAIN RES, V80, P33, DOI 10.1016/0166-4328(96)00016-2; WARBURTON DM, 1972, PSYCHOPHARMACOLOGIA, V27, P275, DOI 10.1007/BF00422808; WEINGARTNER H, 1980, J ABNORM PSYCHOL, V89, P25, DOI 10.1037/0021-843X.89.1.25; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Young JW, 2004, NEUROPSYCHOPHARMACOL, V29, P891, DOI 10.1038/sj.npp.1300393	80	104	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4227	10.1371/journal.pone.0004227	http://dx.doi.org/10.1371/journal.pone.0004227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IZ	19156216	Green Published, gold, Green Submitted			2022-12-27	WOS:000265481900009
J	Wang, SZ; Liu, BH; Tao, HW; Xia, K; Zhang, LI				Wang, Sheng-zhi; Liu, Bao-hua; Tao, Huizhong W.; Xia, Kun; Zhang, Li I.			A Genetic Strategy for Stochastic Gene Activation with Regulated Sparseness (STARS)	PLOS ONE			English	Article								It remains a challenge to establish a straightforward genetic approach for controlling the probability of gene activation or knockout at a desired level. Here, we developed a method termed STARS: stochastic gene activation with genetically regulated sparseness. The stochastic expression was achieved by two cross-linked, mutually-exclusive Cre-mediated recombinations. The stochastic level was further controlled by regulating Cre/lox reaction kinetics through varying the intrachromosomal distance between the lox sites mediating one of the recombinations. In mammalian cell lines stably transfected with a single copy of different STARS transgenes, the activation/knockout of reporter genes was specifically controlled to occur in from 5% to 50% of the cell population. STARS can potentially provide a convenient way for genetic labeling as well as gene expression/knockout in a population of cells with a desired sparseness level.	[Wang, Sheng-zhi; Liu, Bao-hua; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Wang, Sheng-zhi; Liu, Bao-hua; Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA USA; [Xia, Kun] Cent S Univ, State Key Lab Med Genet, Changsha, Peoples R China	University of Southern California; University of Southern California; University of Southern California; Central South University	Wang, SZ (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	liizhang@usc.edu	XIA, KUN/AAO-3525-2020; Tao, Huizhong W/HDM-9767-2022		Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation [Packard Fellowships for Science and Engineering]; NATIONAL EYE INSTITUTE [R01EY019049, R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008588, R01DC008983] Funding Source: NIH RePORTER	Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to L.I.Z. from the Searle Scholar Program, the Klingenstein Foundation, and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luo L, 2007, BRAIN RES REV, V55, P220, DOI 10.1016/j.brainresrev.2007.01.012; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wang W, 2007, P NATL ACAD SCI USA, V104, P4501, DOI 10.1073/pnas.0607953104; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	25	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4200	10.1371/journal.pone.0004200	http://dx.doi.org/10.1371/journal.pone.0004200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145242	Green Published, Green Submitted, gold			2022-12-27	WOS:000265479800006
J	Watson, KK; Ghodasra, JH; Platt, ML				Watson, Karli K.; Ghodasra, Jason H.; Platt, Michael L.			Serotonin Transporter Genotype Modulates Social Reward and Punishment in Rhesus Macaques	PLOS ONE			English	Article							GENE VARIATION; HUMAN AMYGDALA; EYE-MOVEMENTS; LIFE STRESS; MONKEYS; FACES; RISK; POLYMORPHISM; AUTISM; GAZE	Background: Serotonin signaling influences social behavior in both human and nonhuman primates. In humans, variation upstream of the promoter region of the serotonin transporter gene (5-HTTLPR) has recently been shown to influence both behavioral measures of social anxiety and amygdala response to social threats. Here we show that length polymorphisms in 5-HTTLPR predict social reward and punishment in rhesus macaques, a species in which 5-HTTLPR variation is analogous to that of humans. Methodology/Principal Findings: In contrast to monkeys with two copies of the long allele (L/L), monkeys with one copy of the short allele of this gene (S/L) spent less time gazing at face than non-face images, less time looking in the eye region of faces, and had larger pupil diameters when gazing at photos of a high versus low status male macaques. Moreover, in a novel primed gambling task, presentation of photos of high status male macaques promoted risk-aversion in S/L monkeys but promoted risk-seeking in L/L monkeys. Finally, as measured by a "pay-per-view" task, S/L monkeys required juice payment to view photos of high status males, whereas L/L monkeys sacrificed fluid to see the same photos. Conclusions/Significance: These data indicate that genetic variation in serotonin function contributes to social reward and punishment in rhesus macaques, and thus shapes social behavior in humans and rhesus macaques alike.	[Watson, Karli K.; Platt, Michael L.] Duke Univ, Dept Neurobiol, Durham, NC 27706 USA; [Ghodasra, Jason H.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA	Duke University; Northwestern University; Feinberg School of Medicine	Watson, KK (corresponding author), Duke Univ, Dept Neurobiol, LSRC Room, Durham, NC 27706 USA.	karlikiiko@gmail.com		WATSON, KARLI/0000-0002-5513-1492	Cure Autism Now Foundation; National Institutes of Health [R01 5R01-EY-013496-07]; Howard Hughes Medical Institute;  [Training Grant in Fundamental and Translational Neuroscience]; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086712] Funding Source: NIH RePORTER	Cure Autism Now Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We gratefully acknowledge financial support from the Cure Autism Now Foundation (KKW), National Institutes of Health (R01 5R01-EY-013496-07 to MLP and Training Grant in Fundamental and Translational Neuroscience to KKW), and Howard Hughes Medical Institute (JHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr CS, 2004, BIOL PSYCHIAT, V55, P733, DOI 10.1016/j.biopsych.2003.12.008; Barr CS, 2003, ALCOHOL CLIN EXP RES, V27, P812, DOI 10.1097/01.ALC.0000067976.62827.ED; BELLAMY RJ, 1991, HUM GENET, V87, P341; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEANER RO, 2005, J VISION, V5, P394; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hauser, 1996, EVOL COMMUN; Hayden BY, 2007, CURR BIOL, V17, P49, DOI 10.1016/j.cub.2006.10.055; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; KLEIN JT, 2008, CURR BIOL IN PRESS; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Spezio ML, 2007, NEUROPSYCHOLOGIA, V45, P144, DOI 10.1016/j.neuropsychologia.2006.04.027; Suomi SJ, 2006, ANN NY ACAD SCI, V1094, P52, DOI 10.1196/annals.1376.006; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; VAN HOOF J. A. R. A. M., 1967, P7; Wendland JR, 2006, BEHAV GENET, V36, P163, DOI 10.1007/s10519-005-9017-8; WRIGHT S, 1922, COEFFICIENTS INBREED, P330; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	43	78	79	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4156	10.1371/journal.pone.0004156	http://dx.doi.org/10.1371/journal.pone.0004156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437IF	19142220	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700003
J	Merad, H; Porumb, H; Zargarian, L; Rene, B; Hobaika, Z; Maroun, RG; Mauffret, O; Fermandjian, S				Merad, Hayate; Porumb, Horea; Zargarian, Loussine; Rene, Brigitte; Hobaika, Zeina; Maroun, Richard G.; Mauffret, Olivier; Fermandjian, Serge			An Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF	PLOS ONE			English	Article								Background: Integrase (IN) of the type 1 human immunodeficiency virus (HIV-1) catalyzes the integration of viral DNA into host cellular DNA. We identified a bi-helix motif (residues 149-186) in the crystal structure of the catalytic core (CC) of the IN-Phe185Lys variant that consists of the alpha(4) and alpha(5) helices connected by a 3 to 5-residue turn. The motif is embedded in a large array of interactions that stabilize the monomer and the dimer. Principal Findings: We describe the conformational and binding properties of the corresponding synthetic peptide. This displays features of the protein motif structure thanks to the mutual intramolecular interactions of the alpha(4) and alpha(5) helices that maintain the fold. The main properties are the binding to: 1- the processing-attachment site at the LTR (long terminal repeat) ends of virus DNA with a K(d) (dissociation constant) in the sub-micromolar range; 2- the whole IN enzyme; and 3- the IN binding domain (IBD) but not the IBD-Asp366Asn variant of LEDGF (lens epidermal derived growth factor) lacking the essential Asp366 residue. In our motif, in contrast to the conventional HTH (helix-turn-helix), it is the N terminal helix (alpha(4)) which has the role of DNA recognition helix, while the C terminal helix (alpha(5)) would rather contribute to the motif stabilization by interactions with the alpha(4) helix. Conclusion: The motif, termed HTHi (i, for inverted) emerges as a central piece of the IN structure and function. It could therefore represent an attractive target in the search for inhibitors working at the DNA-IN, IN-IN and IN-LEDGF interfaces.	[Merad, Hayate; Porumb, Horea; Zargarian, Loussine; Rene, Brigitte; Hobaika, Zeina; Mauffret, Olivier; Fermandjian, Serge] Ecole Normale Super, CNRS, UMR 8113, LBPA, Cachan, France; [Maroun, Richard G.] Univ St Joseph, Fac Sci, Dept Sci Vie Terre, Beirut, Lebanon	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Saint Joseph University Beirut	Merad, H (corresponding author), Ecole Normale Super, CNRS, UMR 8113, LBPA, Cachan, France.	serge.fermandjian@lbpa.ens-cachan.fr	Maroun, Richard/ABG-6613-2020	Maroun, Richard/0000-0002-0697-2535	Centre National de la Recherche Scientifique (CNRS); French-Libanese program CEDRE [05 SF21/L14]; SIDACTION; National Agency for Research against AIDS (ANRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French-Libanese program CEDRE; SIDACTION; National Agency for Research against AIDS (ANRS)(ANRS)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the French-Libanese program CEDRE (05 SF21/L14) and in part by grants from SIDACTION and the National Agency for Research against AIDS (ANRS) (to H. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brown P. O., 1997, P161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Craigie R, 2002, MOBILE DNA, P613; Debyser Zeger, 2002, Antiviral Chemistry & Chemotherapy, V13, P1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dvorin JD, 2002, J VIROL, V76, P12087, DOI 10.1128/JVI.76.23.12087-12096.2002; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; GOODARZI G, 1995, J VIROL, V69, P6090, DOI 10.1128/JVI.69.10.6090-6097.1995; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill JJ, 1997, METHOD ENZYMOL, V278, P390; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Krebs D, 1996, EUR J BIOCHEM, V235, P699, DOI 10.1111/j.1432-1033.1996.t01-1-00699.x; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; Llano M, 2006, SCIENCE; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Maroun RG, 1999, EUR J BIOCHEM, V260, P145, DOI 10.1046/j.1432-1327.1999.00130.x; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Maroun RG, 1999, J BIOL CHEM, V274, P34174, DOI 10.1074/jbc.274.48.34174; Melek M, 2002, P NATL ACAD SCI USA, V99, P134, DOI 10.1073/pnas.012610699; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Morant-Lhomel A, 2006, BIOCHIMIE, V88, P253, DOI 10.1016/j.biochi.2005.08.003; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Porumb H, 2004, BBA-PROTEINS PROTEOM, V1699, P77, DOI 10.1016/j.bbapap.2004.01.005; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VANGENT DC, 1993, NUCLEIC ACIDS RES, V21, P3373, DOI 10.1093/nar/21.15.3373; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2; Zargarian L, 2003, J BIOL CHEM, V278, P19966, DOI 10.1074/jbc.M211711200; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	75	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4081	10.1371/journal.pone.0004081	http://dx.doi.org/10.1371/journal.pone.0004081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119323	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472600002
J	Queipo-Ortuno, MI; Colmenero, JD; Bermudez, P; Bravo, MJ; Morata, P				Isabel Queipo-Ortuno, Maria; Colmenero, Juan D.; Bermudez, Pilar; Bravo, Maria Jose; Morata, Pilar			Rapid Differential Diagnosis between Extrapulmonary Tuberculosis and Focal Complications of Brucellosis Using a Multiplex Real-Time PCR Assay	PLOS ONE			English	Article								Background: Arduous to differ clinically, extrapulmonary tuberculosis and focal complications of brucellosis remain important causes of morbidity and mortality in many countries. We developed and applied a multiplex real-time PCR assay (M RT-PCR) for the simultaneous detection of Mycobacterium tuberculosis complex and Brucella spp. Methodology: Conventional microbiological techniques and M RT-PCR for M. tuberculosis complex and Brucella spp were performed on 45 clinical specimens from patients with focal complications of brucellosis or extrapulmonary tuberculosis and 26 control samples. Fragments of 207 bp and 164 bp from the conserved region of the genes coding for an immunogenic membrane protein of 31 kDa of B. abortus (BCSP31) and the intergenic region SenX3-RegX3 were used for the identification of Brucella and M. tuberculosis complex, respectively. Conclusions: The detection limit of the M RT-PCR was 2 genomes per reaction for both pathogens and the intra- and inter-assay coefficients of variation were 0.44% and 0.93% for Brucella and 0.58% and 1.12% for Mycobacterium. M RT-PCR correctly identified 42 of the 45 samples from patients with tuberculosis or brucellosis and was negative in all the controls. Thus, the overall sensitivity, specificity, PPV and NPV values of the M RT PCR assay were 93.3%, 100%, 100% and 89.7%, respectively, with an accuracy of 95.8% (95% CI, 91.1%-100%). Since M RT-PCR is highly reproducible and more rapid and sensitive than conventional microbiological tests, this technique could be a promising and practical approach for the differential diagnosis between extrapulmonary tuberculosis and focal complications of brucellosis.			Queipo-Ortuno, MI (corresponding author), Univ Malaga, Fac Med, Dept Biochem & Mol Biol, E-29071 Malaga, Spain.	iqueipo@uma.es	Bravo Romero, Maria Jose/L-1464-2017; Ortuño, María Isabel Queipo/AAC-1238-2021	Bravo Romero, Maria Jose/0000-0001-5884-348X; QUEIPO ORTUNO, MARIA ISABEL/0000-0002-2867-0845; Morata Losa, Maria Pilar/0000-0002-2423-6347				Alton G.G., 1975, LAB TECHNIQUES BRUCE; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Cheng VCC, 2004, J CLIN PATHOL, V57, P281, DOI 10.1136/jcp.2003.012658; Colmenero JD, 2004, EUR J CLIN MICROBIOL, V23, P477, DOI 10.1007/s10096-004-1148-y; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; DAY C, 2006, LANCET, V367, P938; Debeaumont C, 2005, EUR J CLIN MICROBIOL, V24, P842, DOI 10.1007/s10096-005-0064-0; Denis-Delpierre N, 1998, PRESSE MED, V27, P341; DOLBERG OT, 1991, REV INFECT DIS, V13, P177; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gillespie SH, 1997, J CLIN MICROBIOL, V35, P799, DOI 10.1128/JCM.35.3.799-801.1997; Hasaneen NA, 2003, CHEST, V124, P2105, DOI 10.1378/chest.124.6.2105; Hofman V, 2003, ANN PATHOL, V23, P206; Kami M, 2001, CLIN INFECT DIS, V33, P1504, DOI 10.1086/323337; Kattar MM, 2007, DIAGN MICR INFEC DIS, V59, P23, DOI 10.1016/j.diagmicrobio.2007.04.002; Laifer G, 2004, CHEST, V125, P981, DOI 10.1378/chest.125.3.981; Markoulatos P, 2000, J CLIN LAB ANAL, V14, P214, DOI 10.1002/1098-2825(2000)14:5<214::AID-JCLA3>3.3.CO;2-W; MCLEAN DR, 1992, CLIN INFECT DIS, V15, P582, DOI 10.1093/clind/15.4.582; Morata P, 2001, J CLIN MICROBIOL, V39, P3743, DOI 10.1128/JCM.39.10.3743-3746.2001; MOYER N, 1995, MANUAL CLIN MICROBIO, P382; Navarro E, 2002, FEMS IMMUNOL MED MIC, V34, P147, DOI 10.1111/j.1574-695X.2002.tb00616.x; Orduna A, 2000, J CLIN MICROBIOL, V38, P4000; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Park DY, 2003, ARCH PATHOL LAB MED, V127, P326; Queipo-Ortuno MI, 2005, CLIN INFECT DIS, V40, P260, DOI 10.1086/426818; Rimek D, 2002, J CLIN MICROBIOL, V40, P3089, DOI 10.1128/JCM.40.8.3089-3092.2002; Smith K, 2004, J MED MICROBIOL, V53, P115, DOI 10.1099/jmm.0.05416-0; Stralin K, 2006, J CLIN MICROBIOL, V44, P643, DOI 10.1128/JCM.44.2.643-645.2006; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x	30	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4526	10.1371/journal.pone.0004526	http://dx.doi.org/10.1371/journal.pone.0004526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225565	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000006
J	Koslowski, MJ; Kubler, I; Chamaillard, M; Schaeffeler, E; Reinisch, W; Wang, GX; Beisner, J; Teml, A; Peyrin-Biroulet, L; Winter, S; Herrlinger, KR; Rutgeerts, P; Vermeire, S; Cooney, R; Fellermann, K; Jewell, D; Bevins, CL; Schwab, M; Stange, EF; Wehkamp, J				Koslowski, Maureen J.; Kuebler, Irmgard; Chamaillard, Mathias; Schaeffeler, Elke; Reinisch, Walter; Wang, Guoxing; Beisner, Julia; Teml, Alexander; Peyrin-Biroulet, Laurent; Winter, Stefan; Herrlinger, Klaus R.; Rutgeerts, Paul; Vermeire, Severine; Cooney, Rachel; Fellermann, Klaus; Jewell, Derek; Bevins, Charles L.; Schwab, Matthias; Stange, Eduard F.; Wehkamp, Jan			Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease	PLOS ONE			English	Article								Reduced expression of Paneth cell antimicrobial alpha-defensins, human defensin (HD)-5 and -6, characterizes Crohn's disease (CD) of the ileum. TCF-4 (also named TCF7L2), a Wnt signalling pathway transcription factor, orchestrates Paneth cell differentiation, directly regulates the expression of HD-5 and -6, and was previously associated with the decrease of these antimicrobial peptides in a subset of ileal CD. To investigate a potential genetic association of TCF-4 with ileal CD, we sequenced 2.1 kb of the 5' flanking region of TCF-4 in a small group of ileal CD patients and controls (n = 10 each). We identified eight single nucleotide polymorphisms (SNPs), of which three (rs3814570, rs10885394, rs10885395) were in linkage disequilibrium and found more frequently in patients; one (rs3814570) was thereby located in a predicted regulatory region. We carried out high-throughput analysis of this SNP in three cohorts of inflammatory bowel disease (IBD) patients and controls. Overall 1399 healthy individuals, 785 ulcerative colitis (UC) patients, 225 CD patients with colonic disease only and 784 CD patients with ileal involvement were used to determine frequency distributions. We found an association of rs3814570 with ileal CD but neither with colonic CD or UC, in a combined analysis (allele positivity: OR 1.27, 95% CI 1.07 to 1.52, p = 0.00737), which was the strongest in ileal CD patients with stricturing behaviour (allele frequency: OR 1.32, 95% CI 1.08 to 1.62, p = 0.00686) or an additional involvement of the upper GIT (allele frequency: OR 1.38, 95% CI 1.03 to1.84, p = 0.02882). The newly identified genetic association of TCF-4 with ileal CD provides evidence that the decrease in Paneth cell alpha-defensins is a primary factor in disease pathogenesis.			Koslowski, MJ (corresponding author), Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.	jan.wehkamp@ikp-stuttgart.de	Wang, Guoxing/G-6586-2013; Chamaillard, Mathias/L-6542-2013; Schwab, Matthias/ABH-7449-2020; Bevins, Charles L/P-4438-2015; Wehkamp, Jan/B-7319-2011	Chamaillard, Mathias/0000-0002-0243-9717; Bevins, Charles L/0000-0003-2725-2622; Cooney, Rachel/0000-0003-3710-157X; peyrin-biroulet, laurent/0000-0003-2536-6618; Wehkamp, Jan/0000-0001-6788-841X; Vermeire, Severine/0000-0001-9942-3019	NIAID NIH HHS [R01 AI050843-01, R01 AI050843, AI32738, AI50843, R01 AI032738, R01 AI032738-11, R37 AI032738] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI050843, R01AI032738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Duval A, 1999, CANCER RES, V59, P4213; Elphick D, 2008, AM J PATHOL, V172, P702, DOI 10.2353/ajpath.2008.070755; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Gasche C, 2005, GUT, V54, P162, DOI 10.1136/gut.2003.035600; George MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-209; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kiehne K, 2006, WORLD J GASTROENTERO, V12, P1056, DOI 10.3748/wjg.v12.i7.1056; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Medici V, 2006, EUR J HUM GENET, V14, P459, DOI 10.1038/sj.ejhg.5201576; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Strober W, 2006, SCIENCE, V313, P1052, DOI 10.1126/science.1131997; Tenesa A, 2006, EUR J HUM GENET, V14, P259, DOI 10.1038/sj.ejhg.5201516; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083	32	94	99	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4496	10.1371/journal.pone.0004496	http://dx.doi.org/10.1371/journal.pone.0004496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221600	gold, Green Submitted, Green Published			2022-12-27	WOS:000265485700017
J	Martinez, RN; Alcober, OA				Martinez, Ricardo N.; Alcober, Oscar A.			A Basal Sauropodomorph (Dinosauria: Saurischia) from the Ischigualasto Formation (Triassic, Carnian) and the Early Evolution of Sauropodomorpha	PLOS ONE			English	Article							ARGENTINA; NOMENCLATURE; ASSEMBLAGE	Background: The earliest dinosaurs are from the early Late Triassic (Carnian) of South America. By the Carnian the main clades Saurischia and Ornithischia were already established, and the presence of the most primitive known sauropodomorph Saturnalia suggests also that Saurischia had already diverged into Theropoda and Sauropodomorpha. Knowledge of Carnian sauropodomorphs has been restricted to this single species. Methodology/Principal Findings: We describe a new small sauropodomorph dinosaur from the Ischigualsto Formation (Carnian) in northwest Argentina, Panphagia protos gen. et sp. nov., on the basis of a partial skeleton. The genus and species are characterized by an anteroposteriorly elongated fossa on the base of the anteroventral process of the nasal; wide lateral flange on the quadrate with a large foramen; deep groove on the lateral surface of the lower jaw surrounded by prominent dorsal and ventral ridges; bifurcated posteroventral process of the dentary; long retroarticular process transversally wider than the articular area for the quadrate; oval scars on the lateral surface of the posterior border of the centra of cervical vertebrae; distinct prominences on the neural arc of the anterior cervical vertebra; distal end of the scapular blade nearly three times wider than the neck; scapular blade with an expanded posterodistal corner; and medial lamina of brevis fossa twice as wide as the iliac spine. Conclusions/Significance: We regard Panphagia as the most basal sauropodomorph, which shares the following apomorphies with Saturnalia and more derived sauropodomorphs: basally constricted crowns; lanceolate crowns; teeth of the anterior quarter of the dentary higher than the others; and short posterolateral flange of distal tibia. The presence of Panphagia at the base of the early Carnian Ischigualasto Formation suggests an earlier origin of Sauropodomorpha during the Middle Triassic.	[Martinez, Ricardo N.; Alcober, Oscar A.] Museo Ciencias Nat, San Juan, Argentina		Martinez, RN (corresponding author), Museo Ciencias Nat, San Juan, Argentina.	martinez@unsj.edu.ar			Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; TV Tokio	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan; TV Tokio	Instituto y Museo de Ciencias Naturales of the Universidad Nacional de San Juan, research funders. TV Tokio, Fieldwork funders. The funders didn't have any role in the study or in the decision to publish or preperation of the manuscript.	ARCUCCI A, 1987, Ameghiniana, V24, P89; Barberena M.C., 1977, PESQUISAS, V7, P111; BARBERENA MC, 1985, NATL GEOGR RES, V1, P5; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P806, DOI 10.1671/0272-4634(2005)025[0806:COOLHY]2.0.CO;2; Benton MJ, 2000, J VERTEBR PALEONTOL, V20, P77, DOI 10.1671/0272-4634(2000)020[0077:AASOTP]2.0.CO;2; Bonaparte J.F., 2007, Historical Biology, V19, P73, DOI 10.1080/08912960600866862; BONAPARTE JF, 1999, BRAZIL NATL SCI MUS, V15, P89; CASAMIQUELA RM, 1967, AMEGHINIANA, V4, P47; CHATTERJEE S, 1994, J VERTEBR PALEONTOL, V14, P142, DOI 10.1080/02724634.1994.10011546; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Colbert E. H., 1970, Am. Mus. Novit., VNo. 2405, P1; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; EZCURRA MD, 2008, LIBR RES 3 C LAT PAL; Galton P.M., 1985, Geologica et Palaeontologica, V19, P119; Galton P.M., 1984, Geologica et Palaeontologica, V18, P139; GALTON P M, 1973, Palaeontologische Zeitschrift, V47, P229; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Galton Peter M., 2007, Revue de Paleobiologie, V26, P505; Galton PM, 1985, STUTTGARTER BEITRAGE, V118, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; MARTINEZ RN, 2008, LIBR RES 3 C LAT PAL; MARTINEZ RN, 2007, AMEGHINIANA S4, V44, pR28; Moser Markus, 2003, Zitteliana Reihe B, V24, P5; Novaco R., 1986, ADV STUDY AGGRESSION, VII, P1; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; RAATH MA, 1977, THESIS RHODES U SALI; Reig O. A., 1963, Ameghiniana, V3, P3; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A. S., 1971, Breviora, VNo. 378, P1; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; Tykoski RS, 2005, THESIS U TEXAS AUSTI; von Huene F., 1926, GEOL PALAEONTOL ABHA, V15, P139; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P591, DOI 10.1080/02724634.1999.10011168; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x	54	122	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4397	10.1371/journal.pone.0004397	http://dx.doi.org/10.1371/journal.pone.0004397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19209223	Green Published, gold			2022-12-27	WOS:000265485700001
J	Tsuruta, H; Paddon, CJ; Eng, D; Lenihan, JR; Horning, T; Anthony, LC; Regentin, R; Keasling, JD; Renninger, NS; Newman, JD				Tsuruta, Hiroko; Paddon, Christopher J.; Eng, Diana; Lenihan, Jacob R.; Horning, Tizita; Anthony, Larry C.; Regentin, Rika; Keasling, Jay D.; Renninger, Neil S.; Newman, Jack D.			High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli	PLOS ONE			English	Article							CELL-DENSITY CULTIVATION; MEVALONATE PATHWAY; BIOSYNTHESIS; EXPRESSION; REDUCTASE; SYNTHASE; PROTEIN; ACID	Background: Artemisinin derivatives are the key active ingredients in Artemisinin combination therapies (ACTs), the most effective therapies available for treatment of malaria. Because the raw material is extracted from plants with long growing seasons, artemisinin is often in short supply, and fermentation would be an attractive alternative production method to supplement the plant source. Previous work showed that high levels of amorpha-4,11-diene, an artemisinin precursor, can be made in Escherichia coli using a heterologous mevalonate pathway derived from yeast (Saccharomyces cerevisiae), though the reconstructed mevalonate pathway was limited at a particular enzymatic step. Methodology/Principal Findings: By combining improvements in the heterologous mevalonate pathway with a superior fermentation process, commercially relevant titers were achieved in fed-batch fermentations. Yeast genes for HMG-CoA synthase and HMG-CoA reductase (the second and third enzymes in the pathway) were replaced with equivalent genes from Staphylococcus aureus, more than doubling production. Amorpha-4,11-diene titers were further increased by optimizing nitrogen delivery in the fermentation process. Successful cultivation of the improved strain under carbon and nitrogen restriction consistently yielded 90 g/L dry cell weight and an average titer of 27.4 g/L amorpha-4,11-diene. Conclusions/Significance: Production of >25 g/L amorpha-4,11-diene by fermentation followed by chemical conversion to artemisinin may allow for development of a process to provide an alternative source of artemisinin to be incorporated into ACTs.	[Tsuruta, Hiroko; Paddon, Christopher J.; Eng, Diana; Lenihan, Jacob R.; Horning, Tizita; Anthony, Larry C.; Regentin, Rika; Renninger, Neil S.; Newman, Jack D.] Amyris Biotechnol, Emeryville, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn & Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Lawrence Berkeley Natl Lab, Div Phys Biosci, Berkeley, CA USA; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Tsuruta, H (corresponding author), Amyris Biotechnol, Emeryville, CA USA.	Paddon@amyris.com	Williams, Katherine/I-7881-2012; Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Paddon, Christopher/0000-0003-4182-2855	Institute for OneWorld Health; Bill & Melinda Gates Foundation	Institute for OneWorld Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was conducted under the sponsorship of the Institute for OneWorld Health through generous support of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Bloland PB., 2001, DRUG RESISTANCE MALA; Campobasso N, 2004, J BIOL CHEM, V279, P44883, DOI 10.1074/jbc.M407882200; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hedl M, 2004, J BACTERIOL, V186, P1927, DOI 10.1128/JB.186.7.1927-1932.2004; Hedl M, 2002, J BACTERIOL, V184, P2116, DOI 10.1128/JB.184.8.2116-2122.2002; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Korenromp E, 2005, WORLD MALARIA REPORT; KORZ DJ, 1995, J BIOTECHNOL, V39, P59, DOI 10.1016/0168-1656(94)00143-Z; Lau J, 2004, J BIOTECHNOL, V110, P95, DOI 10.1016/j.jbiotec.2004.02.001; Lenihan JR, 2008, BIOTECHNOL PROGR, V24, P1026, DOI 10.1002/btpr.27; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Olumese P, 2006, GUIDELINES TREATMENT; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Regentin R, 2003, APPL MICROBIOL BIOT, V61, P451, DOI 10.1007/s00253-003-1263-1; RIESENBERG D, 1991, CURR OPIN BIOTECH, V2, P380, DOI 10.1016/S0958-1669(05)80142-9; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rozkov A, 2004, BIOTECHNOL BIOENG, V88, P909, DOI 10.1002/bit.20327; Shang F, 2006, J BIOTECHNOL, V122, P285, DOI 10.1016/j.jbiotec.2005.11.020; Shapiro H.S., 1989, REG SEC MET ACT, P149; Sutherlin A, 2002, J BACTERIOL, V184, P4065, DOI 10.1128/JB.184.15.4065-4070.2002; Tabata K, 2004, BIOTECHNOL LETT, V26, P1487, DOI 10.1023/B:BILE.0000044449.08268.7d; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000; Wong A., 2006, [No title captured], Patent No. [WO2006128126 A1 (74), 2006128126]; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550	34	252	293	9	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4489	10.1371/journal.pone.0004489	http://dx.doi.org/10.1371/journal.pone.0004489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221601	Green Published, Green Submitted, gold			2022-12-27	WOS:000265485700014
J	Krstic, D; Boll, W; Noll, M				Krstic, Dimitrije; Boll, Werner; Noll, Markus			Sensory Integration Regulating Male Courtship Behavior in Drosophila	PLOS ONE			English	Article								The courtship behavior of Drosophila melanogaster serves as an excellent model system to study how complex innate behaviors are controlled by the nervous system. To understand how the underlying neural network controls this behavior, it is not sufficient to unravel its architecture, but also crucial to decipher its logic. By systematic analysis of how variations in sensory inputs alter the courtship behavior of a naive male in the single-choice courtship paradigm, we derive a model describing the logic of the network that integrates the various sensory stimuli and elicits this complex innate behavior. This approach and the model derived from it distinguish (i) between initiation and maintenance of courtship, (ii) between courtship in daylight and in the dark, where the male uses a scanning strategy to retrieve the decamping female, and (iii) between courtship towards receptive virgin females and mature males. The last distinction demonstrates that sexual orientation of the courting male, in the absence of discriminatory visual cues, depends on the integration of gustatory and behavioral feedback inputs, but not on olfactory signals from the courted animal. The model will complement studies on the connectivity and intrinsic properties of the neurons forming the circuitry that regulates male courtship behavior.	[Krstic, Dimitrije; Boll, Werner; Noll, Markus] Univ Zurich, Inst Mol Biol, Zurich, Switzerland; [Krstic, Dimitrije] PhD Program Mol Life Sci, Zurich, Switzerland	University of Zurich	Krstic, D (corresponding author), Univ Zurich, Inst Mol Biol, Zurich, Switzerland.	markus.noll@molbio.uzh.ch			Swiss National Science Foundation [3100A0-105823]; Kanton Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Zurich	This work was supported by grant 3100A0-105823 from the Swiss National Science Foundation (to M.N.) and the Kanton Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Benzer S., 1968, ENG SCI, V32, P50; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; BURNET B, 1973, EXPERIENTIA, V29, P488, DOI 10.1007/BF01926800; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; CONNOLLY K, 1969, EVOLUTION, V23, P548, DOI 10.1111/j.1558-5646.1969.tb03540.x; CROSSLEY S, 1970, NATURE, V225, P1064, DOI 10.1038/2251064a0; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Egan ES, 1999, J NEUROSCI, V19, P3665; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hall JC, 2002, J NEUROGENET, V16, P135, DOI 10.1080/01677060215307; HARDELAND R, 1971, AM NAT, V105, P198, DOI 10.1086/282717; Heisenberg M, 1997, BIOESSAYS, V19, P1065, DOI 10.1002/bies.950191205; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VENARD R, 1980, EXPERIENTIA, V36, P211, DOI 10.1007/BF01953737; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Villella A, 1997, GENETICS, V147, P1107; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; WELBERGEN P, 1987, BEHAVIOUR, V101, P253, DOI 10.1163/156853987X00017; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551	68	86	85	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4457	10.1371/journal.pone.0004457	http://dx.doi.org/10.1371/journal.pone.0004457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214231	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484300006
J	Cheng, X; Eisenbraun, M; Xu, Q; Zhou, HL; Kulkarni, D; Subbarao, K; Kemble, G; Jin, H				Cheng, Xing; Eisenbraun, Michael; Xu, Qi; Zhou, Helen; Kulkarni, Deepali; Subbarao, Kanta; Kemble, George; Jin, Hong			H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; VIRUS-INFECTION; A VIRUS; TEMPERATURE SENSITIVITY; AVIAN INFLUENZA; MICE; ORIGIN; IMMUNIZATION; TRIVALENT; ANTIBODY	Background: Live attenuated influenza H5N1 vaccines have been produced and evaluated in mice and ferrets that were never exposed to influenza A virus infection (Suguitan et al., Plos Medicine, e360: 1541, 2006). However, the preexisting influenza heterosubtypic immunity on live attenuated H5N1 vaccine induced immune response has not been evaluated. Methodology and Principal Findings: Primary and recall B cell responses to live attenuated H5N1 vaccine viruses were examined using a sensitive antigen-specific B cell ELISpot assay to investigate the effect of preexisting heterosubtypic influenza immunity on the development of H5N1-specific B cell immune responses in ferrets. Live attenuated H5N1 A/Hong Kong/213/03 and A/Vietnam/1203/04 vaccine viruses induced measurable H5-specific IgM and IgG secreting B cells after intranasal vaccination. However, H5-specific IgG secreting cells were detected significantly earlier and at a greater frequency after H5N1 inoculation in ferrets previously primed with trivalent live attenuated influenza (H1N1, H3N2 and B) vaccine. Priming studies further revealed that the more rapid B cell responses to H5 resulted from cross-reactive B cell immunity to the hemagglutinin H1 protein. Moreover, vaccination with the H1N1 vaccine virus was able to induce protective responses capable of limiting replication of the H5N1 vaccine virus to a level comparable with prior vaccination with the H5N1 vaccine virus without affecting H5N1 vaccine virus induced antibody response. Conclusion: The findings indicate that previous vaccination with seasonal influenza vaccine may accelerate onset of immunity by an H5N1 ca vaccine and the heterosubtypic immunity may be beneficial for pandemic preparedness.	[Cheng, Xing; Eisenbraun, Michael; Xu, Qi; Zhou, Helen; Kulkarni, Deepali; Kemble, George; Jin, Hong] MedImmune, Mountain View, CA USA; [Subbarao, Kanta] NIAID, NIH, Lab Infect Dis, Bethesda, MD USA	AstraZeneca; Medimmune; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cheng, X (corresponding author), MedImmune, Mountain View, CA USA.	jinh@medimmune.com		Subbarao, Kanta/0000-0003-1713-3056	Intramural Research Program of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000933, ZIAAI000933] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding was provided by MedImmune. This research was supported in part by the Intramural Research Program of NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Brokstad KA, 2001, SCAND J IMMUNOL, V54, P243, DOI 10.1046/j.1365-3083.2001.00947.x; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Cox RJ, 2006, VACCINE, V24, P6577, DOI 10.1016/j.vaccine.2006.05.041; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; HAYNES JR, 2008, VACCINE IN PRESS; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hoffmann E, 2005, J VIROL, V79, P11014, DOI 10.1128/JVI.79.17.11014-11021.2005; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lindemann M, 2006, CLIN IMMUNOL, V120, P342, DOI 10.1016/j.clim.2006.03.002; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Smirnov YA, 1999, ACTA VIROL, V43, P237; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Takahashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2358, DOI 10.1271/bbb.70142; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	36	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4436	10.1371/journal.pone.0004436	http://dx.doi.org/10.1371/journal.pone.0004436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209231	gold, Green Submitted, Green Published			2022-12-27	WOS:000265484100008
J	Rizzoli, A; Hauffe, HC; Tagliapietra, V; Neteler, M; Rosa, R				Rizzoli, Annapaola; Hauffe, Heidi C.; Tagliapietra, Valentina; Neteler, Markus; Rosa, Roberto			Forest Structure and Roe Deer Abundance Predict Tick-Borne Encephalitis Risk in Italy	PLOS ONE			English	Article								Background: The Western Tick-borne encephalitis (TBE) virus often causes devastating or lethal disease. In Europe, the number of human TBE cases has increased dramatically over the last decade, risk areas are expanding and new foci are being discovered every year. The early localisation of new TBE foci and the identification of the main risk factors associated with disease emergence represent a priority for the public health community. Although a number of socio-economic parameters have been suggested to explain TBE upsurges in eastern Europe, the principal driving factors in relatively stable western European countries have not been identified. Methodology/Principal Findings: In this paper, we analyse the correlation between the upsurge of TBE in 17 alpine provinces in northern Italy from 1992 to 2006 with climatic variables, forest structure (as a proxy for small mammal reservoir host abundance), and abundance of the principal large vertebrate tick host (roe deer), using datasets available for the last 40 years. No significant differences between the pattern of changes in climatic variables in provinces where TBE has emerged compared to provinces were no clinical TBE cases have been observed to date. Instead, the best model for explaining the increase in TBE incidence in humans in this area include changes in forest structure, in particular the ratio of coppice to high stand forest, and the density of roe deer. Conclusion/Significance: Substantial changes in vegetation structure that improve habitat suitability for the main TBE reservoir hosts (small mammals), as well as an increase in roe deer abundance due to changes in land and wildlife management practices, are likely to be among the most crucial factors affecting the circulation potential of Western TBE virus and, consequently, the risk of TBE emergence in humans in western Europe. We believe our approach will be useful in predicting TBE risk on a wider scale.	[Rizzoli, Annapaola; Hauffe, Heidi C.; Tagliapietra, Valentina; Neteler, Markus; Rosa, Roberto] Fdn Edmund Mach, Ctr Ric & Innovaz, Michele Alladige, Italy	Fondazione Edmund Mach	Rizzoli, A (corresponding author), Fdn Edmund Mach, Ctr Ric & Innovaz, Michele Alladige, Italy.	rizzoli@cealp.it	Tagliapietra, Valentina/P-8733-2015; Rizzoli, Annapaola/J-2439-2012; Hauffe, Heidi Christine/AAU-1684-2021; Rosa, Roberto/B-8562-2011; Hauffe, Heidi Christine C/B-9105-2011; Neteler, Markus/C-6328-2008; Rizzoli, Annapaola/B-8583-2011; Rosà, Roberto/AAB-4479-2021	Tagliapietra, Valentina/0000-0001-9535-2823; Rizzoli, Annapaola/0000-0003-3997-6783; Hauffe, Heidi Christine/0000-0003-3098-8964; Rosa, Roberto/0000-0002-8655-2230; Hauffe, Heidi Christine C/0000-0003-3098-8964; Neteler, Markus/0000-0003-1916-1966; Rosà, Roberto/0000-0002-8655-2230	EU [GOCE-2003-010284]	EU(European Commission)	This publication was partially funded by EU grant GOCE-2003-010284 EDEN and is catalogued by the EDEN Steering Committee as EDEN0130 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.	Amaducci L, 1976, Riv Patol Nerv Ment, V97, P77; [Anonymous], 2005, EC HUM WELL BEING SY; *APAT, 2006, GLI IND CLIM IT NEL; *APAT, 2007, GLI IND CLIM IT NEL; Auer I, 2007, INT J CLIMATOL, V27, P17, DOI 10.1002/joc.1377; Carpi G, 2008, EPIDEMIOL INFECT, V136, P1416, DOI 10.1017/S0950268807000039; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2006, INT J MED MICROBIOL, V296, P41, DOI 10.1016/j.ijmm.2006.02.008; Danielova V, 2006, INT J MED MICROBIOL, V296, P48, DOI 10.1016/j.ijmm.2006.02.007; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Floris R, 2006, NEW MICROBIOL, V29, P147; GASHWILER JS, 1979, AM MIDL NAT, V102, P95, DOI 10.2307/2425070; Gern L, 2008, INT J MED MICROBIOL, V298, P55, DOI 10.1016/j.ijmm.2008.01.005; Gilot B., 1975, Acta Tropica, V32, P340; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Gurnell J., 1985, Symposia of the Zoological Society of London, P377; Hansmann Y, 2006, SCAND J INFECT DIS, V38, P520, DOI 10.1080/00365540600585073; Hubalek Z, 2006, MED VET ENTOMOL, V20, P166, DOI 10.1111/j.1365-2915.2006.00615.x; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; Huss A, 2007, TICK BORNE DIS SWITZ; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; Kaiser R, 2000, INFECTION, V28, P78, DOI 10.1007/s150100050051; KAISER R, 2007, MONOGRAPH TICK BORNE, P21; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kriz B, 2004, INT J MED MICROBIOL, V293, P63, DOI 10.1016/S1433-1128(04)80010-X; KUNZ C, 2007, MONOGRAPH TICK BORNE, P4; Kunz Christian, 2002, IJMM International Journal of Medical Microbiology, V291, P56; KUNZE M, 2006, ISW TBE RESUME ISW T; Kunze U, 2007, WIEN MED WOCHENSCHR, V157, P228, DOI 10.1007/s10354-007-0424-8; Kunze Ursula, 2004, Wien Med Wochenschr, V154, P242, DOI 10.1007/s10354-004-0061-4; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lesnicar G, 2003, PEDIATR INFECT DIS J, V22, P612, DOI 10.1097/00006454-200307000-00009; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Materna J., 2005, Central European Journal of Public Health, V13, P24; MAZURKIEWICZ M, 1986, ACTA THERIOL, V31, P55, DOI 10.4098/AT.arch.86-4; MAZURKIEWICZ M, 1991, ACTA THERIOL, V36, P207, DOI 10.4098/AT.arch.91-21; Michalik J, 2003, J MED ENTOMOL, V40, P690, DOI 10.1603/0022-2585-40.5.690; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Niethammer J., 1978, HDB SAUGETIERE EUROP, P325; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Pedrotti L., 2001, BANCA DATI UNGULATI; Perkins SE, 2006, ECOLOGY, V87, P1981, DOI 10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2; Piccolin G, 2006, VECTOR-BORNE ZOONOT, V6, P24, DOI 10.1089/vbz.2006.6.24; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; Pugliese A, 2008, PARASITOLOGY, V135, P1531, DOI 10.1017/S003118200800036X; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; RANDOLPH SE, 2007, OIE SCI TEC IN PRESS, V27; RATCLIFFE PR, 1992, ECOLOGY MANAGEMENT C, P213; Rosa R, 2007, VECTOR-BORNE ZOONOT, V7, P285, DOI 10.1089/vbz.2006.0607; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stefanoff Pawel, 2006, Przegl Epidemiol, V60 Suppl 1, P151; Suess J, 2006, INT J MED MICROBIOL, V296, P63, DOI 10.1016/j.ijmm.2005.12.005; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Sumilo D, 2006, INT J MED MICROBIOL, V296, P76, DOI 10.1016/j.ijmm.2005.12.006; SUSS, 2007, MONOGRAPH TICK BORNE, P16; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Talleklint L, 1998, J MED ENTOMOL, V35, P521, DOI 10.1093/jmedent/35.4.521; Verani P., 1995, Parassitologia (Rome), V37, P105; WATTS CHS, 1969, J ANIM ECOL, V38, P285, DOI 10.2307/2772; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zeman P, 1999, COMP IMMUNOL MICROB, V22, P247, DOI 10.1016/S0147-9571(99)00015-6	72	101	102	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4336	10.1371/journal.pone.0004336	http://dx.doi.org/10.1371/journal.pone.0004336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183811	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483200010
J	Lai, SK; Wang, YY; Cone, R; Wirtz, D; Hanes, J				Lai, Samuel K.; Wang, Ying-Ying; Cone, Richard; Wirtz, Denis; Hanes, Justin			Altering Mucus Rheology to "Solidify'' Human Mucus at the Nanoscale	PLOS ONE			English	Article								The ability of mucus to function as a protective barrier at mucosal surfaces rests on its viscous and elastic properties, which are not well understood at length scales relevant to pathogens and ultrafine environmental particles. Here we report that fresh, undiluted human cervicovaginal mucus (CVM) transitions from an impermeable elastic barrier to non-adhesive objects sized 1 mu m and larger to a highly permeable viscoelastic liquid to non-adhesive objects smaller than 500 nm in diameter. Addition of a nonionic detergent, present in vaginal gels, lubricants and condoms, caused CVM to behave as an impermeable elastic barrier to 200 and 500 nm particles, suggesting that the dissociation of hydrophobically-bundled mucin fibers created a finer elastic mucin mesh. Surprisingly, the macroscopic viscoelasticity, which is critical to proper mucus function, was unchanged. These findings provide important insight into the nanoscale structural and barrier properties of mucus, and how the penetration of foreign particles across mucus might be inhibited.	[Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Wang, Ying-Ying; Hanes, Justin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Dept Biomed Engn, Baltimore, MD 21218 USA; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Cone, Richard; Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Dept Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Wirtz, Denis; Hanes, Justin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Dept Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lai, SK (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	hanes@jhu.edu	wang, yingying/GRS-3058-2022; Wirtz, Denis/A-3257-2010	Lai, Samuel/0000-0003-4721-528X	NIH [5U01AI066726, R01GM075305, R21HL089816]; NSF [graduate research fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the NIH 5U01AI066726 (R.C.), NIH R01GM075305 (D.W.), NIH R21HL089816 (J.H.), and NSF graduate research fellowship (Y-Y.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Carlstedt I, 1989, Symp Soc Exp Biol, V43, P289; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; GALABERT C, 1987, CLIN CHIM ACTA, V164, P139, DOI 10.1016/0009-8981(87)90065-9; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GIROD S, 1992, EUR RESPIR J, V5, P477; Gittes F, 1997, PHYS REV LETT, V79, P3286, DOI 10.1103/PhysRevLett.79.3286; Goodman A, 2002, J MOL BIOL, V323, P199, DOI 10.1016/S0022-2836(02)00893-8; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; King M, 2006, PAEDIATR RESPIR REV, V7, pS212, DOI 10.1016/j.prrv.2006.04.199; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lech MM, 2002, EUR J CONTRACEP REPR, V7, P173, DOI 10.1080/713604342; Liu J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.118104; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; PARKHURST MR, 1994, CELL IMMUNOL, V156, P77, DOI 10.1006/cimm.1994.1154; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; SAROSIEK J, 1984, ANN NY ACAD SCI, V435, P575, DOI 10.1111/j.1749-6632.1984.tb13888.x; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; SLOMIANY BL, 1986, BIOCHEM BIOPH RES CO, V141, P387, DOI 10.1016/S0006-291X(86)80381-3; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; WIRTZ D, 2008, ANN REV BIO IN PRESS	39	100	102	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4294	10.1371/journal.pone.0004294	http://dx.doi.org/10.1371/journal.pone.0004294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173002	gold, Green Published, Green Submitted			2022-12-27	WOS:000265483000007
J	Parker, SK; Barkley, RM; Rino, JG; Vasil, ML				Parker, Sarah K.; Barkley, Robert M.; Rino, John G.; Vasil, Michael L.			Mycobacterium tuberculosis Rv3802c Encodes a Phospholipase/Thioesterase and Is Inhibited by the Antimycobacterial Agent Tetrahydrolipstatin	PLOS ONE			English	Article								The cell wall of M. tuberculosis is central to its success as a pathogen. Mycolic acids are key components of this cell wall. The genes involved in joining the a and mero mycolates are located in a cluster, beginning with Rv3799c and extending at least until Rv3804c. The role of each enzyme encoded by these five genes is fairly well understood, except for Rv3802c. Rv3802 is one of seven putative cutinases encoded by the genome of M. tuberculosis. In phytopathogens, cutinases hydrolyze the waxy layer of plants, cutin. In a strictly mammalian pathogen, such as M. tuberculosis, it is likely that these proteins perform a different function. Of the seven, we chose to focus on Rv3802c because of its location in a mycolic acid synthesis gene cluster, its putative essentiality, its ubiquitous presence in actinomycetes, and its conservation in the minimal genome of Mycobacterium leprae. We expressed Rv3802 in Escherichia coli and purified the enzymatically active form. We probed its activities and inhibitors characterizing those relevant to its possible role in mycolic acid biosynthesis. In addition to its reported phospholipase A activity, Rv3802 has significant thioesterase activity, and it is inhibited by tetrahydrolipstatin (THL). THL is a described anti-tuberculous compound with an unknown mechanism, but it reportedly targets cell wall synthesis. Taken together, these data circumstantially support a role for Rv3802 in mycolic acid synthesis and, as the cell wall is integral to M. tuberculosis pathogenesis, identification of a novel cell wall enzyme and its inhibition has therapeutic and diagnostic implications.	[Rino, John G.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Vasil, Michael L.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [Barkley, Robert M.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Parker, SK (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	sarah.parker@ucdenver.edu			National Institute of Allergy and Infectious Diseases [K08 AI050646]; Potts Foundation; The Children's Hospital Research Institute; American Lung Foundation; National Heart, Lung and Blood Institute [HL062608]; LIPID MAPS; National Institutes of Health [GM-069338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Potts Foundation; The Children's Hospital Research Institute; American Lung Foundation; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); LIPID MAPS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (K08 AI050646) from National Institute of Allergy and Infectious Diseases, a grant from the Potts Foundation, a grant from The Children's Hospital Research Institute and a grant from the American Lung Foundation to Sarah K. Parker, and by a grant (HL062608) from the National Heart, Lung and Blood Institute to Michael L. Vasil. The contribution of Robert M. Barkley was supported by LIPID MAPS, a Large-Scale Collabrative Grant from the National Institutes of Health (Grant GM-069338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Deems RA, 2000, ANAL BIOCHEM, V287, P1, DOI 10.1006/abio.2000.4766; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gilleron M, 2006, ANAL CHEM, V78, P8543, DOI 10.1021/ac061574a; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; KURIOKA S, 1976, ANAL BIOCHEM, V75, P281, DOI 10.1016/0003-2697(76)90078-6; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; MARTINEZ C, 1994, BIOCHEMISTRY-US, V33, P83, DOI 10.1021/bi00167a011; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Richardson RD, 2008, J MED CHEM, V51, P5285, DOI 10.1021/jm800321h; Richardson RD, 2007, MOL CANCER THER, V6, P2120, DOI 10.1158/1535-7163.MCT-07-0187; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; VISSA VD, 2001, GENOME BIOL, V2; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; WHEELER PR, 1988, J GEN MICROBIOL, V134, P2111; WHEELER PR, 1993, BIOCHIM BIOPHYS ACTA, V1167, P182, DOI 10.1016/0005-2760(93)90160-B; *WHO, 2006, 104 WHO; Zhang W, 2008, BIOORG MED CHEM LETT, V18, P2491, DOI 10.1016/j.bmcl.2008.02.043	45	51	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4281	10.1371/journal.pone.0004281	http://dx.doi.org/10.1371/journal.pone.0004281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19169353	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482800011
J	Bjorklund, P; Svedlund, J; Olsson, AK; Akerstrom, G; Westin, G				Bjoerklund, Peyman; Svedlund, Jessica; Olsson, Anna-Karin; Akerstroem, Goeran; Westin, Gunnar			The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer	PLOS ONE			English	Article								Background: Breast cancer is a common malignant disease, which may be caused by a number of genes deregulated by genomic or epigenomic events. Deregulated WNT/beta-catenin signaling with accumulation of beta-catenin is common in breast tumors, but mutations in WNT signaling pathway components have been rare. An aberrantly spliced internally truncated LRP5 receptor (LRP5 Delta 666-809, LRP5 Delta) was shown recently to be resistant to DKK1 inhibition, and was required for beta-catenin accumulation in hyperparathyroid tumors and parathyroid tumor growth. Methodology/Principal Findings: Here we show, by reverse transcription PCR and Western blot analysis, that LRP5D is frequently expressed in breast tumors of different cancer stage (58-100%), including carcinoma in situ and metastatic carcinoma. LRP5 Delta was required in MCF7 breast cancer cells for the non-phosphorylated active beta-catenin level, transcription activity of beta-catenin, cell growth in vitro, and breast tumor growth in a xenograft SCID mouse model. WNT3 ligand, but not WNT1 and WNT3A augmented the endogenous beta-catenin activity of MCF7 cells in a DKK1-insensitive manner. Furthermore, an anti-LRP5 antibody attenuated beta-catenin activity, inhibited cell growth, and induced apoptosis in LRP5 Delta-positive MCF7 and T-47D breast cancer cells, but not in control cells. Conclusions/Significance: Our results suggest that the LRP5 Delta receptor is strongly implicated in mammary gland tumorigenesis and that its aberrant expression present an early event during disease progression. LRP5 antibody therapy may have a significant role in the treatment of breast cancer.	[Bjoerklund, Peyman; Svedlund, Jessica; Akerstroem, Goeran; Westin, Gunnar] Uppsala Univ, Univ Uppsala Hosp, Endocrine Unit, Dept Surg Sci, Uppsala, Sweden; [Olsson, Anna-Karin] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University	Bjorklund, P (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Endocrine Unit, Dept Surg Sci, Uppsala, Sweden.	gunnar.westin@surgsci.uu.se	Björklund, Peyman/A-1509-2014	Björklund, Peyman/0000-0002-9398-4496	Swedish Research Council; Swedish Cancer Society; Lions Fund for Cancer Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lions Fund for Cancer Research	This work was supported by the Swedish Research Council, Swedish Cancer Society, and Lions Fund for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 1988, LAB ANIM-UK, V22, P195; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Benhaj K, 2006, ONCOL REP, V15, P701; Bjorklund P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-53; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Candidus S, 1996, CANCER RES, V56, P49; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chung GG, 2004, CANCER, V100, P2084, DOI 10.1002/cncr.20232; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Pfeiffer P, 2007, ONCOGENE, V26, P3661, DOI 10.1038/sj.onc.1210377; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; ROELINK H, 1992, ONCOGENE, V7, P487; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Segersten U, 2005, BREAST CANCER RES, V7, pR980, DOI 10.1186/bcr1332; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2006, MOL CANCER RES, V4, P729, DOI 10.1158/1541-7786.MCR-06-0136; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van de Wetering M, 2001, CANCER RES, V61, P278; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Zafir-Lavie I, 2007, ONCOGENE, V26, P3714, DOI 10.1038/sj.onc.1210372; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	43	52	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4243	10.1371/journal.pone.0004243	http://dx.doi.org/10.1371/journal.pone.0004243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158955	gold, Green Published			2022-12-27	WOS:000265482200001
J	Willemse, J; van Wezel, GP				Willemse, Joost; van Wezel, Gilles P.			Imaging of Streptomyces coelicolor A3(2) with Reduced Autofluorescence Reveals a Novel Stage of FtsZ Localization	PLOS ONE			English	Article								Imaging of low abundance proteins in time and space by fluorescence microscopy is typically hampered by host-cell autofluorescence. Streptomycetes are an important model system for the study of bacterial development, and undergo multiple synchronous cell division during the sporulation stage. To analyse this phenomenon in detail, fluorescence microscopy, and in particular also the recently published novel live imaging techniques, require optimal signal to noise ratios. Here we describe the development of a novel derivative of Streptomyces coelicolor A3(2) with strongly reduced autofluorescence, allowing the imaging of fluorescently labelled proteins at significantly higher resolution. The enhanced image detail provided novel localization information for the cell division protein FtsZ, demonstrating a new developmental stage where multiple FtsZ foci accumulate at the septal plane. This suggests that multiple foci are sequentially produced, ultimately connecting to form the complete Z ring. The enhanced imaging properties are an important step forward for the confocal and live imaging of less abundant proteins and for the use of lower intensity fluorophores in streptomycetes.	[Willemse, Joost; van Wezel, Gilles P.] Leiden Univ, Leiden Inst Chem, Dept Mol Genet, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Willemse, J (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Mol Genet, NL-2300 RA Leiden, Netherlands.	g.wezel@chem.leidenuniv.nl	Willemse, Joost/B-1861-2008; van Wezel, Gilles/ABC-7854-2021	Willemse, Joost/0000-0001-9312-6021; van Wezel, Gilles/0000-0003-0341-1561	Dutch government (Netherlands Organization for scientific research NWO) [ECHO]	Dutch government (Netherlands Organization for scientific research NWO)(Netherlands Organization for Scientific Research (NWO))	Joost Willemse is supported by an ECHO grant from the Dutch government (Netherlands Organization for scientific research NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; CHATER KF, 1997, MYCELIAL LIFE STYLE, P149; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grantcharova N, 2003, MOL MICROBIOL, V47, P645, DOI 10.1046/j.1365-2958.2003.03334.x; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jyothikumar V, 2008, APPL ENVIRON MICROB, V74, P6774, DOI 10.1128/AEM.01233-08; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Manteca A, 2007, FEMS MICROBIOL LETT, V274, P118, DOI 10.1111/j.1574-6968.2007.00825.x; Manteca A, 2006, PROTEOMICS, V6, P6008, DOI 10.1002/pmic.200600147; MCCORMICK JR, 1994, MOL MICROBIOL, V14, P243, DOI 10.1111/j.1365-2958.1994.tb01285.x; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rigali S, 2006, MOL MICROBIOL, V61, P1237, DOI 10.1111/j.1365-2958.2006.05319.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902	30	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2009	4	1							e4242	10.1371/journal.pone.0004242	http://dx.doi.org/10.1371/journal.pone.0004242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JB	19156202	Green Submitted, Green Published, gold			2022-12-27	WOS:000265482100014
J	Becker, M; Korn, C; Sienerth, AR; Voswinckel, R; Luetkenhaus, K; Ceteci, F; Rapp, UR				Becker, Matthias; Korn, Christian; Sienerth, Arnold R.; Voswinckel, Robert; Luetkenhaus, Katharina; Ceteci, Fatih; Rapp, Ulf R.			Polycomb Group Protein Bmi1 Is Required for Growth of RAF Driven Non-Small-Cell Lung Cancer	PLOS ONE			English	Article								Background: We have previously described a RAF oncogene driven transgenic mouse model for non small cell lung cancer (NSCLC). Here we examine whether tumor initiation and growth requires the stem cell self-renewal factor Bmi1. Principal Findings: In order to evaluate Bmi1 function in NSCLC two founder lines that differ in incidence and latency of tumor formation were compared. Ablation of Bmi1 expression in both lines had a dramatically decreased tumor growth. As the line with shorter latency matched the life span of Bmi1 knock out mice, these mice were chosen for further study. The absence of Bmi1 did not decrease the number of tumor initiation in these mice as only the size and not the number of tumors decreased. Reduction in tumor growth resulted from an increase in cell death and decrease in cell cycle progression that corresponded with up-regulation of the p16(INK4a) and p19(ARF). Significance: The data identifies Bmi1 as an important factor for expansion but not initiation of RAF driven NSCLC.	[Becker, Matthias; Korn, Christian; Sienerth, Arnold R.; Luetkenhaus, Katharina; Ceteci, Fatih; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum MSZ, Wurzburg, Germany; [Voswinckel, Robert] Univ Hosp Giessen, Lung Ctr, Dept Internal Med, D-35390 Giessen, Germany	University of Wurzburg; University Hospital of Giessen & Marburg	Becker, M (corresponding author), Univ Wurzburg, Bayer Krebsforschungszentrum MSZ, Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de		Sienerth, Arnold/0000-0003-1497-5020	DFG	DFG(German Research Foundation (DFG))	MB and CK were supported by SFB TR 17 of the DFG, ARS and KL were supported by the DFG graduate college 1141 Wuerzburg-Nice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Breuer RHJ, 2004, NEOPLASIA, V6, P736, DOI 10.1593/neo.04160; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fedorov LM, 2003, CANCER RES, V63, P2268; Fedorov LM, 2002, CANCER RES, V62, P6297; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gotz R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-85; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kramer BW, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-24; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Roper JM, 2003, AM J PHYSIOL-LUNG C, V285, pL691, DOI 10.1152/ajplung.00034.2003; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; Vrzalikova K, 2008, J CANC RES CLIN ONCO; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yu Q, 2007, OLIGONUCLEOTIDES, V17, P327, DOI 10.1089/oli.2007.0070; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	38	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4230	10.1371/journal.pone.0004230	http://dx.doi.org/10.1371/journal.pone.0004230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156217	gold, Green Published, Green Submitted			2022-12-27	WOS:000265481900011
J	Creary, LE; Ulug, P; Menzel, S; McKenzie, CA; Hanchard, NA; Taylor, V; Farrall, M; Forrester, TE; Thein, SL				Creary, Lisa E.; Ulug, Pinar; Menzel, Stephan; McKenzie, Colin A.; Hanchard, Neil A.; Taylor, Veronica; Farrall, Martin; Forrester, Terrence E.; Thein, Swee Lay			Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients	PLOS ONE			English	Article								Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a quantitative trait locus on chromosome 6q23 was significantly associated with HbF and F cell levels in individuals of African descent. Single nucleotide polymorphisms (SNPs) in a 24-kb intergenic region, 33-kb upstream of the HBS1L gene and 80-kb upstream of the MYB gene, were typed in 177 healthy Afro-Caribbean subjects (AC) of approximately 7% European admixture, 631 healthy Afro-Germans (AG, a group of African and German descendents located in rural Jamaica with about 20% European admixture), 87 West African and Afro-Caribbean individuals with sickle cell anaemia (HbSS), as well as 75 Northern Europeans, which served as a contrasting population. Association with a tag SNP for the locus was detected in all four groups (AC, P=0.005, AG, P=0.002, HbSS patients, P=0.019, Europeans, P=1.5x10(-7)). The association signal varied across the interval in the African-descended groups, while it is more uniform in Europeans. The 6q QTL for HbF traits is present in populations of African origin and is also acting in sickle cell anaemia patients. We have started to distinguish effects originating from European and African ancestral populations in our admixed study populations.	[Creary, Lisa E.; Ulug, Pinar; Menzel, Stephan; Thein, Swee Lay] Kings Coll London, Sch Med, Div Gene & Cell, James Black Ctr, London WC2R 2LS, England; [McKenzie, Colin A.; Hanchard, Neil A.; Forrester, Terrence E.] Univ W Indies, Trop Med Res Inst, Trop Metabolism Res Unit, Kingston, Jamaica; [Taylor, Veronica] Natl Blood Transfusion Ctr, Kingston, Jamaica; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX1 2JD, England; [Thein, Swee Lay] Kings Coll Hosp, Dept Haematol Med, London, England	University of London; King's College London; University West Indies Mona Jamaica; University of Oxford; Wellcome Centre for Human Genetics; King's College Hospital NHS Foundation Trust; King's College Hospital	Creary, LE (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell, James Black Ctr, Denmark Hill Campus, London WC2R 2LS, England.	sl.thein@kcl.ac.uk	Hanchard, Neil/AAY-9075-2021; Menzel, Stephan/U-6906-2019	Hanchard, Neil/0000-0003-1925-2665; ULUG, PINAR/0000-0001-9719-1090; Menzel, Stephan/0000-0002-1590-9108	Medical Research Council [G0000111, ID51640]; MRC [G0000111] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council (MRC G0000111, ID51640) to S L Thein and T Forrester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; CREARY LE, 2008, BRIT J HAEM IN PRESS; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; THORPE SJ, 1994, BRIT J HAEMATOL, V87, P125, DOI 10.1111/j.1365-2141.1994.tb04881.x; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	16	60	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4218	10.1371/journal.pone.0004218	http://dx.doi.org/10.1371/journal.pone.0004218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148297	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265479900010
J	Kakiuchi, C; Ishigaki, S; Oslowski, CM; Fonseca, SG; Kato, T; Urano, F				Kakiuchi, Chihiro; Ishigaki, Shinsuke; Oslowski, Christine M.; Fonseca, Sonya G.; Kato, Tadafumi; Urano, Fumihiko			Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates Its Interaction with ER Stress Protein GRP94	PLOS ONE			English	Article								Background: Valproate is a standard treatment for bipolar disorder and a first-line mood stabilizer. The molecular mechanisms underlying its actions in bipolar disorder are unclear. It has been suggested that the action of valproate is linked to changes in gene expression and induction of endoplasmic reticulum (ER) stress-response proteins. Principal Findings: Here we show that valproate modulates the ER stress response through the regulation of WFS1, an important component for mitigating ER stress. Therapeutic concentrations of valproate induce expression of WFS1 mRNA and activate the WFS1 promoter. In addition, WFS1 forms a complex with GRP94, an ER stress-response protein, in which valproate dose-dependently enhances its dissociation from GRP94. Conclusions: These results suggest that the therapeutic effects of valproate in bipolar disorder may be mediated by WFS1 expression and its dissociation from GRP94.	[Kakiuchi, Chihiro; Ishigaki, Shinsuke; Oslowski, Christine M.; Fonseca, Sonya G.; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Kakiuchi, Chihiro; Kato, Tadafumi] RIKEN Brain Sci Inst, Wako, Saitama, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; RIKEN	Kakiuchi, C (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	Fumihiko.Urano@umassmed.edu	ISHIGAKI, Shinsuke/I-7305-2014; Kakiuchi, Chihiro/AAO-1103-2020; Urano, Fumihiko/AAF-4492-2020; Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952; Ishigaki, Shinsuke/0000-0002-9555-0659	NIH [R01DK067493]; Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation; Iacocca Foundation; Worcester Foundation for Biomedical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Iacocca Foundation; Worcester Foundation for Biomedical Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the laboratory of F. Urano is supported by an NIH R01DK067493 grant, a grant from the Diabetes and Endocrinology Research Center at the University of Massachusetts Medical School, a Juvenile Diabetes Research Foundation Regular Research Grant, an Iacocca Foundation Grant, and an Worcester Foundation for Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bown CD, 2000, NEUROPHARMACOLOGY, V39, P2162, DOI 10.1016/S0028-3908(00)00029-0; Chen G, 1997, NEUROPSYCHOPHARMACOL, V16, P238; Chen S., 1999, HALLYM INT J AGING, V1, P58, DOI DOI 10.2190/HA1.2.F; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Hardy C, 1999, AM J HUM GENET, V65, P1279, DOI 10.1086/302609; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Johannessen CU, 2003, CNS DRUG REV, V9, P199; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Kakiuchi C., 2007, J HUM GENET; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lawson B, 1998, J CELL PHYSIOL, V174, P170, DOI 10.1002/(SICI)1097-4652(199802)174:2<170::AID-JCP4>3.3.CO;2-A; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	24	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4134	10.1371/journal.pone.0004134	http://dx.doi.org/10.1371/journal.pone.0004134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125190	Green Published, gold			2022-12-27	WOS:000265473100008
J	Moorthy, A; Gupta, A; Bhosale, R; Tripathy, S; Sastry, J; Kulkarni, S; Thakar, M; Bharadwaj, R; Kagal, A; Bhore, AV; Patil, S; Kulkarni, V; Venkataramani, V; Balasubramaniam, U; Suryavanshi, N; Ziemniak, C; Gupte, N; Bollinger, R; Persaud, D				Moorthy, Anitha; Gupta, Amita; Bhosale, Ramesh; Tripathy, Srikanth; Sastry, Jayagowri; Kulkarni, Smita; Thakar, Madhuri; Bharadwaj, Renu; Kagal, Anju; Bhore, Arvind V.; Patil, Sandesh; Kulkarni, Vandana; Venkataramani, Varadharajan; Balasubramaniam, Usha; Suryavanshi, Nishi; Ziemniak, Carrie; Gupte, Nikhil; Bollinger, Robert; Persaud, Deborah		India SWEN Study Team	Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants	PLOS ONE			English	Article								Background: Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV transmission. We assessed NVP-resistance in Indian infants enrolled in the "six-week extended-dose nevirapine'' (SWEN) trial who received single-dose NVP (SD-NVP) or SWEN for prevention of breast-milk HIV transmission but who also acquired subtype C HIV infection during the first year of life. Methods/Findings: Standard population sequencing and cloning for viral subpopulations present at >= 5% frequency were used to determine HIV genotypes from 94% of the 79 infected Indian infants studied. Timing of infection was defined based on when an infant's blood sample first tested positive for HIV DNA. SWEN-exposed infants diagnosed with HIV by six weeks of age had a significantly higher prevalence of NVP-resistance than those who received SD-NVP, by both standard population sequencing (92% of 12 vs. 38% of 29; p = 0.002) and low frequency clonal analysis (92% of 12 vs. 59% of 29; p = 0.06). Likelihood of infection with NVP-resistant HIV through breast-milk among infants infected after age six weeks was substantial, but prevalence of NVP-resistance did not differ among SWEN or SD-NVP exposed infants by standard population sequencing (15% of 13 vs. 15% of 20; p = 1.00) and clonal analysis (31% of 13 vs. 40% of 20; p = 0.72). Types of NVP-resistance mutations and patterns of persistence at one year of age were similar between the two groups. NVP-resistance mutations did differ by timing of HIV infection; the Y181C variant was predominant among infants diagnosed in the first six weeks of life, compared to Y188C/H during late breast-milk transmission. Conclusions/Significance: Use of SWEN to prevent breast-milk HIV transmission carries a high likelihood of resistance if infection occurs in the first six weeks of life. Moreover, there was a continued risk of transmission of NVP-resistant HIV through breastfeeding during the first year of life, but did not differ between SD-NVP and SWEN groups. As with SD-NVP, the value of preventing HIV infection in a large number of infants should be considered alongside the high risk of resistance associated with extended NVP prophylaxis. Trial Registration: ClinicalTrials.gov NCT 00061321	[Moorthy, Anitha] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Gupta, Amita; Bollinger, Robert] Johns Hopkins Univ, Sch Med, Dept Adult Infect Dis, Baltimore, MD 21218 USA; [Bhosale, Ramesh; Bharadwaj, Renu; Kagal, Anju; Bhore, Arvind V.; Venkataramani, Varadharajan] Byramjee Jeejeebhoy Med Coll, Pune, Maharashtra, India; [Tripathy, Srikanth; Kulkarni, Smita; Thakar, Madhuri] Natl AIDS Res Inst, Pune, Maharashtra, India; [Sastry, Jayagowri; Patil, Sandesh; Kulkarni, Vandana; Balasubramaniam, Usha; Suryavanshi, Nishi; Gupte, Nikhil] India SWEN Study Team, Pune, Maharashtra, India; [Ziemniak, Carrie; Persaud, Deborah] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University	Moorthy, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	dpers@jhmi.edu	Bharadwaj, Renu/I-1979-2019	Bharadwaj, Renu/0000-0002-4286-7337; Bollinger, Robert/0000-0002-6798-6834; Gupta, Amita/0000-0001-7036-2718; Sastry, Jayagowri/0000-0002-2510-1727; Tripathy, Srikanth/0000-0002-8363-2606	Elizabeth Glaser Pediatric AIDS Foundation [14-05]; National Institute of Allergy and Infectious Diseases [R01-AI-055312, R01-AI-45462]; Fogarty International Center/USNIH [2 D 43 TW000010-20-AITRP]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057784] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055312, R01AI045462] Funding Source: NIH RePORTER	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center/USNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for the drug resistance study was provided by the Elizabeth Glaser Pediatric AIDS Foundation (grant 14-05) and the National Institute of Allergy and Infectious Diseases (R01-AI-055312) to Deborah Persaud. Support for the parent trial was provided by the National Institute of Allergy and Infectious Diseases (grant R01-AI-45462) to Robert Bollinger and by the Fogarty International Center/USNIH (2 D 43 TW000010-20-AITRP). The financial supporters had no role in study design, data analysis, data interpretation, or writing, reviewing, or approving of this report.	Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Church JD, 2008, J INFECT DIS, V198, P1075, DOI 10.1086/591503; Church JD, 2006, J MOL DIAGN, V8, P430, DOI 10.2353/jmoldx.2006.050148; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Gupta A, 2007, INDIAN J MED RES, V126, P131; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kassaye S, 2007, AIDS RES HUM RETROV, V23, P1055, DOI 10.1089/aid.2007.0045; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lee EJ, 2005, J INFECT DIS, V192, P1260, DOI 10.1086/444424; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V44, P148, DOI 10.1097/QAI.0b013e31802b920e; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Mofenson LM, 2008, JAIDS-J ACQ IMM DEF, V48, P237, DOI 10.1097/QAI.0b013e31817dc89e; *NAT AIDS CONTR OR, 2008, GUID HIV CAR TREATM; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Stanford University, 2008, HIV DRUG RES DAT; *UNAIDS WHO, 2007, AIDS EP UPD; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; *WHO UNICEF, 2006, WHO HIV INF FEED TEC; World Health Organization (WHO), 2008, REP WHO TECHN REF GR; ZEH C, 15 C RETR OPP INF 3, P8; Ziemniak C, 2006, J VIROL METHODS, V136, P238, DOI 10.1016/j.jviromet.2006.05.030	42	56	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2009	4	1							e4096	10.1371/journal.pone.0004096	http://dx.doi.org/10.1371/journal.pone.0004096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FR	19119321	Green Published, Green Submitted, gold			2022-12-27	WOS:000265472600004
J	Gillespie, JJ; Williams, K; Shukla, M; Snyder, EE; Nordberg, EK; Ceraul, SM; Dharmanolla, C; Rainey, D; Soneja, J; Shallom, JM; Vishnubhat, ND; Wattam, R; Purkayastha, A; Czar, M; Crasta, O; Setubal, JC; Azad, AF; Sobral, BS				Gillespie, Joseph J.; Williams, Kelly; Shukla, Maulik; Snyder, Eric E.; Nordberg, Eric K.; Ceraul, Shane M.; Dharmanolla, Chitti; Rainey, Daphne; Soneja, Jeetendra; Shallom, Joshua M.; Vishnubhat, Nataraj Dongre; Wattam, Rebecca; Purkayastha, Anjan; Czar, Michael; Crasta, Oswald; Setubal, Joao C.; Azad, Abdu F.; Sobral, Bruno S.			Rickettsia Phylogenomics: Unwinding the Intricacies of Obligate Intracellular Life	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; PROGRAMMED CELL-DEATH; OPEN READING FRAMES; MEMBRANE PROTEIN-A; MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE EXCHANGE FACTOR; APHID ACYRTHOSIPHON-PISUM; COMPLETE GENOME SEQUENCE; SPOTTED-FEVER; PHYLOGENETIC ANALYSIS	Background: Completed genome sequences are rapidly increasing for Rickettsia, obligate intracellular alpha-proteobacteria responsible for various human diseases, including epidemic typhus and Rocky Mountain spotted fever. In light of phylogeny, the establishment of orthologous groups (OGs) of open reading frames (ORFs) will distinguish the core rickettsial genes and other group specific genes (class 1 OGs or C1OGs) from those distributed indiscriminately throughout the rickettsial tree (class 2 OG or C2OGs). Methodology/Principal Findings: We present 1823 representative (no gene duplications) and 259 non-representative (at least one gene duplication) rickettsial OGs. While the highly reductive (similar to 1.2 MB) Rickettsia genomes range in predicted ORFs from 872 to 1512, a core of 752 OGs was identified, depicting the essential Rickettsia genes. Unsurprisingly, this core lacks many metabolic genes, reflecting the dependence on host resources for growth and survival. Additionally, we bolster our recent reclassification of Rickettsia by identifying OGs that define the AG (ancestral group), TG (typhus group), TRG (transitional group), and SFG (spotted fever group) rickettsiae. OGs for insect-associated species, tick-associated species and species that harbor plasmids were also predicted. Through superimposition of all OGs over robust phylogeny estimation, we discern between C1OGs and C2OGs, the latter depicting genes either decaying from the conserved C1OGs or acquired laterally. Finally, scrutiny of non-representative OGs revealed high levels of split genes versus gene duplications, with both phenomena confounding gene orthology assignment. Interestingly, non-representative OGs, as well as OGs comprised of several gene families typically involved in microbial pathogenicity and/or the acquisition of virulence factors, fall predominantly within C2OG distributions. Conclusion/Significance: Collectively, we determined the relative conservation and distribution of 14354 predicted ORFs from 10 rickettsial genomes across robust phylogeny estimation. The data, available at PATRIC (PathoSystems Resource Integration Center), provide novel information for unwinding the intricacies associated with Rickettsia pathogenesis, expanding the range of potential diagnostic, vaccine and therapeutic targets.	[Gillespie, Joseph J.; Williams, Kelly; Shukla, Maulik; Snyder, Eric E.; Nordberg, Eric K.; Dharmanolla, Chitti; Rainey, Daphne; Soneja, Jeetendra; Shallom, Joshua M.; Vishnubhat, Nataraj Dongre; Wattam, Rebecca; Purkayastha, Anjan; Czar, Michael; Crasta, Oswald; Setubal, Joao C.; Sobral, Bruno S.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Gillespie, Joseph J.; Ceraul, Shane M.; Azad, Abdu F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA	Virginia Polytechnic Institute & State University; University System of Maryland; University of Maryland Baltimore	Gillespie, JJ (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	pvittata@hotmail.com	Setubal, Joao Carlos/C-7305-2012; Sobral, Bruno/GVU-7637-2022	Setubal, Joao Carlos/0000-0001-9174-2816; Sobral, Bruno/0000-0003-3908-577X; Gillespie, Joseph/0000-0002-5447-7264	NIAID [HHSN266200400035C]; NIH [AI59118, AI17828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059118, R01AI017828, R37AI017828] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded through NIAID contract HHSN266200400035C to BSS and NIH grants AI59118 and AI17828 to AFA.	ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; ALLIGNET J, 1993, GENE, V130, P91, DOI 10.1016/0378-1119(93)90350-C; Allignet J, 1998, ANTIMICROB AGENTS CH, V42, P1794, DOI 10.1128/AAC.42.7.1794; ALLIGNET J, 1995, ANTIMICROB AGENTS CH, V39, P2027, DOI 10.1128/AAC.39.9.2027; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amor JC, 2005, J BIOL CHEM, V280, P1392, DOI 10.1074/jbc.M410820200; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson S G, 1996, Microb Comp Genomics, V1, P293; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bergey DH., 2001, BERGEYS MANUAL SYSTE; BININDAEMONDS O, 2006, SEQCONVERTER PL VERS; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; BRINTON LP, 1971, J BACTERIOL, V105, P1149, DOI 10.1128/JB.105.3.1149-1159.1971; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; BURGDORFER W, 1968, J HYG EPID MICROB IM, V12, P26; Campbell CL, 2004, J MED ENTOMOL, V41, P340, DOI 10.1603/0022-2585-41.3.340; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen M, 1998, ACTA VIROL, V42, P91; Chen M, 1998, ACTA VIROL, V42, P196; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHING WM, 1990, ANN NY ACAD SCI, V590, P334, DOI 10.1111/j.1749-6632.1990.tb42241.x; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cooper TF, 2000, P NATL ACAD SCI USA, V97, P12643, DOI 10.1073/pnas.220077897; Cooper TF, 2005, P ROY SOC B-BIOL SCI, V272, P403, DOI 10.1098/rspb.2004.2921; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DASCH GA, 1981, RICKETTSIAE RICKETTS, P61; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Deng Z, 2005, J VIROL, V79, P4640, DOI 10.1128/JVI.79.8.4640-4650.2005; Diaz-Montero CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/ajtmh.2001.65.371; Donigian JR, 2007, J BIOL CHEM, V282, P22662, DOI 10.1074/jbc.M702620200; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; EREMEEVA M, 1995, J CLIN MICROBIOL, V33, P3022, DOI 10.1128/JCM.33.11.3022-3024.1995; Eremeeva ME, 2005, ANN NY ACAD SCI, V1063, P47, DOI 10.1196/annals.1355.006; EREMEEVA ME, 2006, 20 M AM SOC RICK CON; EREMEEVA ME, 2007, 21 M AM SOC RICK SEP; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIETZ MJ, 1993, J CELL BIOL, V121, P855, DOI 10.1083/jcb.121.4.855; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Fukatsu T, 1999, APPL ENTOMOL ZOOL, V34, P391, DOI 10.1303/aez.34.391; Fuxelius HH, 2007, RES MICROBIOL, V158, P745, DOI 10.1016/j.resmic.2007.09.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; GILMORE RD, 1993, GENE, V125, P97, DOI 10.1016/0378-1119(93)90752-O; GILMORE RD, 1991, MOL MICROBIOL, V5, P3089; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Grimaldi David, 2005, pi; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; HAMILTON EH, 1991, J INVEST DERMATOL, V96, P666, DOI 10.1111/1523-1747.ep12470590; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Houhamdi L, 2006, AM J TROP MED HYG, V74, P521, DOI 10.4269/ajtmh.2006.74.521; Houhamdi L, 2002, J INFECT DIS, V186, P1639, DOI 10.1086/345373; HUEBNER RJ, 1946, PUBLIC HEALTH REP, V61, P1677, DOI 10.2307/4585913; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jado I, 2007, EMERG INFECT DIS, V13, P1405, DOI 10.3201/eid1309.060186; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jiggins FM, 2006, J MOL EVOL, V62, P99, DOI 10.1007/s00239-005-0080-9; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kamen B, 1997, SEMIN ONCOL, V24, P30; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lawson ET, 2001, HEREDITY, V86, P497, DOI 10.1046/j.1365-2540.2001.00848.x; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1273, DOI 10.1128/AAC.35.7.1273; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindow JC, 2002, J BACTERIOL, V184, P5317, DOI 10.1128/JB.184.19.5317-5322.2002; LUSHER M, 1989, J GEN MICROBIOL, V135, P1145; Malek JA, 2004, NUCLEIC ACIDS RES, V32, P1059, DOI 10.1093/nar/gkh254; MCCLENAGHAN M, 1988, J GEN MICROBIOL, V134, P559; MCKIEL JA, 1967, CAN J MICROBIOL, V13, P503, DOI 10.1139/m67-065; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Medina-Sancheza A, 2005, ANN NY ACAD SCI, V1063, P327, DOI 10.1196/annals.1355.052; METZGER S, 1989, J BIOL CHEM, V264, P9122; METZGER S, 1988, J BIOL CHEM, V263, P15699; Moron CG, 2000, AM J TROP MED HYG, V62, P598, DOI 10.4269/ajtmh.2000.62.598; Myers W. F., 1981, RICKETTSIAE RICKETTS, P313; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ngwamidiba M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-12; Ngwamidiba M, 2005, ANN NY ACAD SCI, V1063, P94, DOI 10.1196/annals.1355.015; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Ogata H, 2005, ANN NY ACAD SCI, V1063, P26, DOI 10.1196/annals.1355.004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2002, GENOME RES, V12, P808, DOI 10.1101/gr.227602; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2000, SCIENCE, V290, P347, DOI 10.1126/science.290.5490.347; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; OGUIN WM, 1991, ANN NY ACAD SCI, V642, P51; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARENT R, 1992, J BACTERIOL, V174, P2891, DOI 10.1128/JB.174.9.2891-2897.1992; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Reeves WK, 2007, EXP APPL ACAROL, V41, P101, DOI 10.1007/s10493-006-9040-3; REISSGUTFREUND RJ, 1966, AM J TROP MED HYG, V15, P943, DOI 10.4269/ajtmh.1966.15.943; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Renesto P, 2005, FEMS MICROBIOL REV, V29, P99, DOI 10.1016/j.femsre.2004.09.002; ROTHNAGEL JA, 1986, J CELL BIOL, V102, P1419, DOI 10.1083/jcb.102.4.1419; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; ROUX V, 1993, J BACTERIOL, V175, P4895, DOI 10.1128/JB.175.15.4895-4904.1993; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; SAVINELLI EA, 1990, ANN NY ACAD SCI, V590, P523, DOI 10.1111/j.1749-6632.1990.tb42262.x; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; Sekeyova Z, 2001, INT J SYST EVOL MICR, V51, P1353, DOI 10.1099/00207713-51-4-1353; Seoane A, 2000, ANTIMICROB AGENTS CH, V44, P905, DOI 10.1128/AAC.44.4.905-909.2000; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Sopko R, 2006, GENOME RES, V16, P314, DOI 10.1101/gr.4976706; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; SORVILLO FJ, 1993, AM J TROP MED HYG, V48, P269, DOI 10.4269/ajtmh.1993.48.269; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; Stenos J, 2000, INT J SYST EVOL MICR, V50, P1775, DOI 10.1099/00207713-50-5-1775; STOTHARD DR, 1995, SYST APPL MICROBIOL, V18, P52, DOI 10.1016/S0723-2020(11)80448-0; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Uchiyama T., 1999, RICKETTSIAE RICKETTS, P182; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; Van Dongen SM, 2000, THESIS U UTRECHT NET; van Passel MWJ, 2006, INFECT IMMUN, V74, P4892, DOI 10.1128/IAI.02087-05; VERBIST L, 1992, J ANTIMICROB CHEMOTH, V30, P39, DOI 10.1093/jac/30.suppl_A.39; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Weiss E., 1984, Bergey's Manual of systematic bacteriology. Volume 1, P687; WEISS E, 1975, APPL MICROBIOL, V30, P456, DOI 10.1128/AEM.30.3.456-463.1975; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Willems H, 1997, J BACTERIOL, V179, P3293, DOI 10.1128/jb.179.10.3293-3297.1997; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Xu WB, 1997, CLIN DIAGN LAB IMMUN, V4, P753, DOI 10.1128/CDLI.4.6.753-763.1997; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Yusuf M, 2004, J STORED PROD RES, V40, P207, DOI 10.1016/S0022-474X(02)00098-X; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869; Zchori-Fein E, 2006, PHYSIOL ENTOMOL, V31, P164, DOI 10.1111/j.1365-3032.2006.00504.x; Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221	190	137	142	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2018	10.1371/journal.pone.0002018	http://dx.doi.org/10.1371/journal.pone.0002018			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	19194535	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300027
J	Martin, DN; Boersma, BJ; Yi, M; Reimers, M; Howe, TM; Yfantis, HG; Tsai, YC; Williams, EH; Lee, DH; Stephens, RM; Weissman, AM; Ambs, S				Martin, Damali N.; Boersma, Brenda J.; Yi, Ming; Reimers, Mark; Howe, Tiffany M.; Yfantis, Harry G.; Tsai, Yien Che; Williams, Erica H.; Lee, Dong H.; Stephens, Robert M.; Weissman, Allan M.; Ambs, Stefan			Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; GENE-EXPRESSION; IN-VIVO; SURVIVAL; WOMEN; WHITE; CARCINOMA; ANGIOGENESIS; METASTASIS; ETHNICITY	Background: African-American breast cancer patients experience higher mortality rates than European-American patients despite having a lower incidence of the disease. We tested the hypothesis that intrinsic differences in the tumor biology may contribute to this cancer health disparity. Methods and Results: Using laser capture microdissection, we examined genome-wide mRNA expression specific to tumor epithelium and tumor stroma in 18 African-American and 17 European-American patients. Numerous genes were differentially expressed between these two patient groups and a two-gene signature in the tumor epithelium distinguished between them. To identify the biological processes in tumors that are different by race/ethnicity, Gene Ontology and disease association analyses were performed. Several biological processes were identified which may contribute to enhanced disease aggressiveness in African-American patients, including angiogenesis and chemotaxis. African-American tumors also contained a prominent interferon signature. The role of angiogenesis in the tumor biology of African-Americans was further investigated by examining the extent of vascularization and macrophage infiltration in an expanded set of 248 breast tumors. Immunohistochemistry revealed that microvessel density and macrophage infiltration is higher in tumors of African-Americans than in tumors of European-Americans. Lastly, using an in silico approach, we explored the potential of tailored treatment options for African-American patients based on their gene expression profile. This exploratory approach generated lists of therapeutics that may have specific antagonistic activity against tumors of African-American patients, e. g., sirolimus, resveratrol, and chlorpromazine in estrogen receptor-negative tumors. Conclusions: The gene expression profiles of breast tumors indicate that differences in tumor biology may exist between African-American and European-American patients beyond the knowledge of current markers. Notably, pathways related to tumor angiogenesis and chemotaxis could be functionally different in these two patient groups.	[Martin, Damali N.; Boersma, Brenda J.; Howe, Tiffany M.; Williams, Erica H.; Ambs, Stefan] NCI, Human Carcinogenesis Lab, CCR, NIH, Bethesda, MD 20892 USA; [Martin, Damali N.] NCI, NIH, Office Prevent Oncol, Canc Prevent Fellowship Program, Bethesda, MD USA; [Yi, Ming; Stephens, Robert M.] NCI Frederick, SAIC Frederick Inc, NIH, Advanced Biomed Comput Ctr, Frederick, MD USA; [Reimers, Mark] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; [Yfantis, Harry G.; Lee, Dong H.] Baltimore VA Med Ctr, Baltimore, MD USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, CCR, NIH, Lab Protein Dynam & Signaling, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Martin, DN (corresponding author), NCI, Human Carcinogenesis Lab, CCR, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambss@mail.nih.gov	Boersma, Brenda/A-9270-2009	Boersma, Brenda/0000-0002-8992-2735; Tsai, Yien Che/0000-0001-9624-1092; Ambs, Stefan/0000-0001-7651-9309; Yi, Ming/0000-0001-9098-1364	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Cancer Prevention Fellowship Program, Office for Preventive Oncology, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009392, Z01BC009392, ZIABC010624, Z01BC010624, ZIABC010887, Z01BC010292, ZIABC010292] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Fellowship Program, Office for Preventive Oncology, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Damali N. Martin is supported by the Cancer Prevention Fellowship Program, Office for Preventive Oncology, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2004, BREAST CANCER RES, V6, P188, DOI 10.1186/bcr905; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; Burke L, 2005, CLIN CANCER RES, V11, P232; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Curran EM, 2006, CLIN CANCER RES, V12, P5641, DOI 10.1158/1078-0432.CCR-05-1117; Degols G, 2007, BIOCHIMIE, V89, P831, DOI 10.1016/j.biochi.2007.03.006; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil-Ad I, 2006, ONCOL REP, V15, P107; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; GUINEE DG, 1995, CARCINOGENESIS, V16, P993, DOI 10.1093/carcin/16.5.993; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hayanga AJ, 2007, SURG CLIN N AM, V87, P551, DOI 10.1016/j.suc.2007.01.003; Hurgin V, 2007, P NATL ACAD SCI USA, V104, P5044, DOI 10.1073/pnas.0611608104; Ihemelandu CU, 2007, J SURG RES, V143, P109, DOI 10.1016/j.jss.2007.03.085; Jackson FLC, 2008, AM J HUM BIOL, V20, P165, DOI 10.1002/ajhb.20709; Jatoi I, 2003, CANCER-AM CANCER SOC, V98, P894, DOI 10.1002/cncr.11604; Jones BA, 2004, CANCER, V101, P1293, DOI 10.1002/cncr.20500; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Lee MS, 2007, CANCER RES, V67, P11359, DOI 10.1158/0008-5472.CAN-07-2235; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Porter PL, 2004, CANCER-AM CANCER SOC, V100, P2533, DOI 10.1002/cncr.20279; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vakkala M, 2000, CLIN CANCER RES, V6, P2408; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	55	145	147	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4531	10.1371/journal.pone.0004531	http://dx.doi.org/10.1371/journal.pone.0004531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225562	Green Submitted, Green Published, gold			2022-12-27	WOS:000265486000008
J	Daehler, CC				Daehler, Curtis C.			Short Lag Times for Invasive Tropical Plants: Evidence from Experimental Plantings in Hawai'i	PLOS ONE			English	Article								Background: The lag time of an invasion is the delay between arrival of an introduced species and its successful spread in a new area. To date, most estimates of lag times for plants have been indirect or anecdotal, and these estimates suggest that plant invasions are often characterized by lag times of 50 years or more. No general estimates are available of lag times for tropical plant invasions. Historical plantings and documentation were used to directly estimate lag times for tropical plant invasions in Hawai'i. Methodology/Principal Findings: Historical planting records for the Lyon Arboretum dating back to 1920 were examined to identify plants that have since become invasive pests in the Hawaiian Islands. Annual reports describing escape from plantings were then used to determine the lag times between initial plantings and earliest recorded spread of the successful invaders. Among 23 species that eventually became invasive pests, the average lag time between introduction and first evidence of spread was 14 years for woody plants and 5 years for herbaceous plants. onclusions/Significance: These direct estimates of lag times are as much as an order of magnitude shorter than previous, indirect estimates, which were mainly based on temperate plants. Tropical invaders may have much shorter lag times than temperate species. A lack of direct and deliberate observations may have also inflated many previous lag time estimates. Although there have been documented cases of long lag times due to delayed arrival of a mutualist or environmental changes over time, this study suggests that most successful invasions are likely to begin shortly after arrival of the plant in a suitable habitat, at least in tropical environments. Short lag times suggest that controlled field trials may be a practical element of risk assessment for plant introductions.	Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Daehler, CC (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	daehler@hawaii.edu						Barney JN, 2006, BIOL INVASIONS, V8, P703, DOI 10.1007/s10530-005-3174-9; Beauchamp VB, 2007, WETLANDS, V27, P381, DOI 10.1672/0277-5212(2007)27[381:FROTVR]2.0.CO;2; Broncano MJ, 2005, FOREST ECOL MANAG, V211, P257, DOI 10.1016/j.foreco.2005.02.055; BURDON JJ, 1977, OECOLOGIA, V31, P1, DOI 10.1007/BF00348703; Caley P, 2008, DIVERS DISTRIB, V14, P196, DOI 10.1111/j.1472-4642.2007.00440.x; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; DAEHLER CC, 2006, BISHOP MUSEUM OCCASI, V86, P3; Dawson W, 2008, BIODIVERS CONSERV, V17, P1979, DOI 10.1007/s10531-008-9345-0; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; HARTT CE, HAWAIIAN SUGAR BOT; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Huang H, 2007, ECOL ENG, V29, P164, DOI 10.1016/j.ecoleng.2006.06.005; Jefferson L, 2004, WEED TECHNOL, V18, P1434, DOI 10.1614/0890-037X(2004)018[1434:IISPTC]2.0.CO;2; KOWARIK I, 1995, PLANT INVASIONS, P15; Lockwood J, 2006, INVASION ECOLOGY; Mack RN, 1996, BIOL CONSERV, V78, P107, DOI 10.1016/0006-3207(96)00021-3; MCKEY D, 1989, EXPERIENTIA, V45, P661, DOI 10.1007/BF01975683; Memmott J, 2005, J ANIM ECOL, V74, P50, DOI 10.1111/j.1365-2656.2004.00896.x; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; PIERSON EA, 1990, OECOLOGIA, V84, P519, DOI 10.1007/BF00328169; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Smith CW, 1998, PEST PLANTS HAWAIIAN; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Virtue J. G., 2008, Plant Protection Quarterly, V23, P166; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wangen SR, 2006, J APPL ECOL, V43, P258, DOI 10.1111/j.1365-2664.2006.01138.x	31	66	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4462	10.1371/journal.pone.0004462	http://dx.doi.org/10.1371/journal.pone.0004462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223966	gold, Green Published, Green Submitted			2022-12-27	WOS:000265485800002
J	Huang, SK; Darfler, MM; Nicholl, MB; You, JS; Bemis, KG; Tegeler, TJ; Wang, M; Wery, JP; Chong, KK; Nguyen, L; Scolyer, RA; Hoon, DSB				Huang, Sharon K.; Darfler, Marlene M.; Nicholl, Michael B.; You, Jinsam; Bemis, Kerry G.; Tegeler, Tony J.; Wang, Mu; Wery, Jean-Pierre; Chong, Kelly K.; Nguyen, Linhda; Scolyer, Richard A.; Hoon, Dave S. B.			LC/MS-Based Quantitative Proteomic Analysis of Paraffin-Embedded Archival Melanomas Reveals Potential Proteomic Biomarkers Associated with Metastasis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PYRUVATE-KINASE; PLASTIN GENE; CANCER; QUANTIFICATION; IDENTIFICATION; PROTEINS; HSP90; DJ-1; OVEREXPRESSION	Background: Melanoma metastasis status is highly associated with the overall survival of patients; yet, little is known about proteomic changes during melanoma tumor progression. To better understand the changes in protein expression involved in melanoma progression and metastasis, and to identify potential biomarkers, we conducted a global quantitative proteomic analysis on archival metastatic and primary melanomas. Methodology and Findings: A total of 16 metastatic and 8 primary cutaneous melanomas were assessed. Proteins were extracted from laser captured microdissected formalin fixed paraffin-embedded archival tissues by liquefying tissue cells. These preparations were analyzed by a LC/MS-based label-free protein quantification method. More than 1500 proteins were identified in the tissue lysates with a peptide ID confidence level of >75%. This approach identified 120 significant changes in protein levels. These proteins were identified from multiple peptides with high confidence identification and were expressed at significantly different levels in metastases as compared with primary melanomas (q-Value<0.05). Conclusions and Significance: The differentially expressed proteins were classified by biological process or mapped into biological system networks, and several proteins were implicated by these analyses as cancer-or metastasis-related. These proteins represent potential biomarkers for tumor progression. The study successfully identified proteins that are differentially expressed in formalin fixed paraffin-embedded specimens of metastatic and primary melanoma.	[Huang, Sharon K.; Nicholl, Michael B.; Chong, Kelly K.; Nguyen, Linhda; Hoon, Dave S. B.] St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Darfler, Marlene M.] Expression Pathol Inc, Gaithersburg, MD USA; [You, Jinsam; Bemis, Kerry G.; Tegeler, Tony J.; Wang, Mu; Wery, Jean-Pierre] Monarch LifeSci LLC, Indianapolis, IN USA; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney Melanoma Unit, Camperdown, NSW, Australia	John Wayne Cancer Institute; Melanoma Institute Australia; University of Sydney	Huang, SK (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA.	hoon@jwci.org	Hoon, Dave SB/C-7146-2018; Scolyer, Richard/AAE-8511-2019	Hoon, Dave SB/0000-0003-1915-3683; Scolyer, Richard/0000-0002-8991-0013; Nicholl, Michael/0000-0002-8513-845X	NIH, National Cancer Institute [CA029605, CA012582]; Leslie and Susan Gonda (Goldschmied) Foundation; Martin H. Weil Research Foundation; NATIONAL CANCER INSTITUTE [P01CA012582, P01CA029605] Funding Source: NIH RePORTER	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leslie and Susan Gonda (Goldschmied) Foundation; Martin H. Weil Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH, National Cancer Institute P0 grants CA029605 and CA012582, the Leslie and Susan Gonda (Goldschmied) Foundation, and the Martin H. Weil Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Deichmann M, 1999, J CLIN ONCOL, V17, P1891, DOI 10.1200/JCO.1999.17.6.1891; Ekins S, 2007, METH MOL B, V356, P319; Ekins S, 2005, PHARM DEV, P123, DOI 10.1002/0471728780.ch4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fitzpatrick DPG, 2007, PROTEOM CLIN APPL, V1, P246, DOI 10.1002/prca.200600768; Goto Y, 2008, CLIN CANCER RES, V14, P3401, DOI 10.1158/1078-0432.CCR-07-1842; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Higgs RE, 2005, J PROTEOME RES, V4, P1442, DOI 10.1021/pr050109b; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Hood BL, 2006, PROTEOMICS, V6, P4106, DOI 10.1002/pmic.200600016; Huang SKS, 1998, J INVEST DERMATOL, V111, P662, DOI 10.1046/j.1523-1747.1998.00354.x; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Koyanagi K, 2006, CLIN CANCER RES, V12, P1137, DOI 10.1158/1078-0432.CCR-05-1847; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LIN CS, 1993, J BIOL CHEM, V268, P2781; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Martinez SR, 2006, FROM MELANOCYTES TO MELANOMA: THE PROGRESSION TO MALIGNANCY, P551, DOI 10.1007/978-1-59259-994-3_31; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; MEYERS ML, 1998, CUTANEOUS MELANOMA, P325; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Okamoto T, 1998, J INVEST DERMATOL, V111, P1034, DOI 10.1046/j.1523-1747.1998.00411.x; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Otsuka M, 2001, BIOCHEM BIOPH RES CO, V289, P876, DOI 10.1006/bbrc.2001.6047; Pardo M, 2007, J PROTEOME RES, V6, P2802, DOI 10.1021/pr070021t; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; PARK TS, 1994, CANCER RES, V54, P1775; Picard D, 2004, NAT CELL BIOL, V6, P479, DOI 10.1038/ncb0604-479; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takeuchi H, 2003, CANCER RES, V63, P441; Troke PJF, 2006, BIOCHEM SOC SYMP, V73, P23; Wachsberger PR, 2002, MELANOMA RES, V12, P35, DOI 10.1097/00008390-200202000-00006; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	54	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4430	10.1371/journal.pone.0004430	http://dx.doi.org/10.1371/journal.pone.0004430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221597	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485700002
J	Kerneis, S; Guerin, PJ; von Seidlein, L; Legros, D; Grais, RF				Kerneis, Solen; Guerin, Philippe J.; von Seidlein, Lorenz; Legros, Dominique; Grais, Rebecca F.			A Look Back at an Ongoing Problem: Shigella dysenteriae Type 1 Epidemics in Refugee Settings in Central Africa (1993-1995)	PLOS ONE			English	Article								Background: Shigella dysenteriae type 1 (Sd1) is a cause of major dysentery outbreaks, particularly among children and displaced populations in tropical countries. Although outbreaks continue, the characteristics of such outbreaks have rarely been documented. Here, we describe the Sd1 outbreaks occurring between 1993 and 1995 in 11 refugee settlements in Rwanda, Tanzania and Democratic Republic of the Congo (DRC). We also explored the links between the different types of the camps and the magnitude of the outbreaks. Methodology/Principal Findings: Number of cases of bloody diarrhea and deaths were collected on a weekly basis in 11 refugee camps, and analyzed retrospectively. Between November 1993 and February 1995, 181,921 cases of bloody diarrhea were reported. Attack rates ranged from 6.3% to 39.1% and case fatality ratios (CFRs) from 1.5% to 9.0% (available for 5 camps). The CFRs were higher in children under age 5. In Tanzania where the response was rapidly deployed, the mean attack rate was lower than in camps in the region of Goma without an immediate response (13.3% versus 32.1% respectively). Conclusions/Significance: This description, and the areas where data is missing, highlight both the importance of collecting data in future epidemics, difficulties in documenting outbreaks occurring in complex emergencies and most importantly, the need to assure that minimal requirements are met.	[Kerneis, Solen; Guerin, Philippe J.; Grais, Rebecca F.] Epictr, Paris, France; [von Seidlein, Lorenz] Joint Malaria Programme, Tanga, Tanzania; [von Seidlein, Lorenz] London Sch Hyg & Trop Med, Wellcome Trust Unit, Bangkok, Thailand; [Legros, Dominique] WHO, Geneva, Switzerland	World Health Organization	Kerneis, S (corresponding author), Epictr, Paris, France.	philippe.guerin@ndm.ox.ac.uk	Guerin, Philippe/AAH-8873-2021	Freeman Grais, Rebecca/0000-0002-5037-8218; Guerin, Philippe/0000-0002-6008-2963	international humanitarian aid organisation Medecins sans Frontieres	international humanitarian aid organisation Medecins sans Frontieres	This research was funded by the international humanitarian aid organisation Medecins sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P94; BOGAERTS J, 1985, ANN SOC BELG MED TR, V65, P281; Brown V, 2008, PLOS MED, V5, P553, DOI 10.1371/journal.pmed.0050089; Cavallo J D, 1995, Med Trop (Mars), V55, P351; Checchi F, 2007, 61 HPN; GANGAROSA EJ, 1970, J INFECT DIS, V122, P181, DOI 10.1093/infdis/122.3.170; Guerin PJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-8; Guerin PJ, 2004, T ROY SOC TROP MED H, V98, P635, DOI 10.1016/j.trstmh.2004.01.005; Guerin PJ, 2003, LANCET, V362, P705, DOI 10.1016/S0140-6736(03)14227-4; Heyman SN, 1997, J CLIN GASTROENTEROL, V25, P595, DOI 10.1097/00004836-199712000-00009; Klugman KP, 1997, S AFR MED J, V87, P1145; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laureillard D, 1998, Sante, V8, P303; Legros D, 1999, TROP MED INT HEALTH, V4, P428, DOI 10.1046/j.1365-3156.1999.00413.x; LEVINE MM, 1970, LANCET, V2, P607; LOW S, 1994, IMPACT MASSIVE POPUL; Milleliri JM, 1995, ANN SOC BELG MED TR, V75, P201; MOORE PS, 1993, LANCET, V341, P935, DOI 10.1016/0140-6736(93)91223-9; MURRAY JCS, 1994, EP INT SERV 43 ANN C; Paquet C, 1995, Sante, V5, P181; RAHAMAN MM, 1975, J INFECT DIS, V131, P700, DOI 10.1093/infdis/132.1.15; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; ROGERIE F, 1986, ANTIMICROB AGENTS CH, V29, P883, DOI 10.1128/AAC.29.5.883; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Soares J L, 1994, Med Trop (Mars), V54, P319; TAYLOR DN, 1989, AM J TROP MED HYG, V40, P77, DOI 10.4269/ajtmh.1989.40.77; The Sphere Project, 2004, HUM CHART MIN STAND; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; TUTTLE J, 1995, J INFECT DIS, V171, P371, DOI 10.1093/infdis/171.2.371; United Nations High Commissioner for Refugees, 2000, STAT WORLDS REF 2000; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; *WHO, 1993, WHOCDD9445; *WHO, 2004, WHOCDD9345; YIP R, 1993, JAMA-J AM MED ASSOC, V270, P587, DOI 10.1001/jama.270.5.587; 1994, REFUGEES MAGAZIN SEP, V97	35	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4494	10.1371/journal.pone.0004494	http://dx.doi.org/10.1371/journal.pone.0004494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214226	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484300017
J	Ermakova, EA; Shnol, EE; Panteleev, MA; Butylin, AA; Volpert, V; Ataullakhanov, FI				Ermakova, Elena A.; Shnol, Emmanuil E.; Panteleev, Mikhail A.; Butylin, Andrey A.; Volpert, Vitaly; Ataullakhanov, Fazoil I.			On Propagation of Excitation Waves in Moving Media: The FitzHugh-Nagumo Model	PLOS ONE			English	Article							BLOOD-COAGULATION; FLOW; DYNAMICS; SYSTEM; LYSIS	Background: Existence of flows and convection is an essential and integral feature of many excitable media with wave propagation modes, such as blood coagulation or bioreactors. Methods/Results: Here, propagation of two-dimensional waves is studied in parabolic channel flow of excitable medium of the FitzHugh-Nagumo type. Even if the stream velocity is hundreds of times higher that the wave velocity in motionless medium (w), steady propagation of an excitation wave is eventually established. At high stream velocities, the wave does not span the channel from wall to wall, forming isolated excited regions, which we called "restrictons''. They are especially easy to observe when the model parameters are close to critical ones, at which waves disappear in still medium. In the subcritical region of parameters, a sufficiently fast stream can result in the survival of excitation moving, as a rule, in the form of "restrictons''. For downstream excitation waves, the axial portion of the channel is the most important one in determining their behavior. For upstream waves, the most important region of the channel is the near-wall boundary layers. The roles of transversal diffusion, and of approximate similarity with respect to stream velocity are discussed. Conclusions: These findings clarify mechanisms of wave propagation and survival in flow.	Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia; [Shnol, Emmanuil E.] Russian Acad Sci, Inst Math Problems Biol, Moscow 117901, Russia; [Shnol, Emmanuil E.] Pushchino State Univ, Pushchino, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Russian Acad Med Sci, Natl Res Ctr Hematol, Moscow 109801, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Russian Acad Sci, Ctr Theoret Problems Physico Chem Pharmacol, Moscow 117901, Russia; [Butylin, Andrey A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Volpert, Vitaly] Univ Lyon 1, Inst Math, CNRS, UMR 5208, F-69622 Villeurbanne, France	Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Russian Academy of Sciences; Lomonosov Moscow State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet	Ermakova, EA (corresponding author), Russian Acad Sci, NN Semenov Chem Phys Inst, Moscow, Russia.	fazly@hc.comcor.ru	Volpert, Vitaly/E-2969-2019; Panteleev, Mikhail A/H-5491-2012; Shnol, Emmanuil/N-9189-2013; Ataullakhanov, Fazoil/O-3458-2019; Ataullakhanov, Fazoil/J-8076-2012	Panteleev, Mikhail A/0000-0002-8128-7757; Shnol, Emmanuil/0000-0002-2703-6324; 	PICS (France); RFBR (Russia) [05-01-22001, 07-04-00146]; Federal Agency of Science and Innovations [MK-340.2008.4]; Russian Academy of Science Presidium Basic Research Program "Molecular and Cellular Biology" (MCB RAS Russia)	PICS (France); RFBR (Russia)(Russian Foundation for Basic Research (RFBR)); Federal Agency of Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Academy of Science Presidium Basic Research Program "Molecular and Cellular Biology" (MCB RAS Russia)	This study was supported in part by grant "Modelling of structures and processes in biology" from the PICS (France), by grants 05-01-22001 and 07-04-00146 from the RFBR (Russia) and by grant MK-340.2008.4 from the Federal Agency of Science and Innovations, and by the Russian Academy of Science Presidium Basic Research Program "Molecular and Cellular Biology" (MCB RAS Russia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 1996, PHYS REV E, V54, P2140, DOI 10.1103/PhysRevE.54.2140; Anand M, 2008, J THEOR BIOL, V253, P725, DOI 10.1016/j.jtbi.2008.04.015; Anand M, 2005, PATHOPHYSIOL HAEMO T, V34, P109, DOI 10.1159/000089931; ANAND M, 2005, J THEOR MED, V5, P183; Ataullakhanov FI, 2002, PHYS-USP+, V45, P619, DOI 10.1070/PU2002v045n06ABEH001090; Beltrami E, 2001, MATH BIOSCI, V172, P1, DOI 10.1016/S0025-5564(01)00064-5; Beyer T, 2008, INT IMMUNOL, V20, P615, DOI 10.1093/intimm/dxn020; Biktashev VN, 1998, PHYS REV LETT, V81, P2815, DOI 10.1103/PhysRevLett.81.2815; Chorvat D, 2008, BIOSYSTEMS, V92, P49, DOI 10.1016/j.biosystems.2007.11.003; Edwards BF, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.104501; Epstein IR, 2006, CHAOS, V16, DOI 10.1063/1.2354477; Ermakova EA, 2005, PATHOPHYSIOL HAEMO T, V34, P135, DOI 10.1159/000089933; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Fujita H, 2006, J THEOR BIOL, V241, P541, DOI 10.1016/j.jtbi.2005.12.016; Ivanov P, 1999, GEN PHYSIOL BIOPHYS, V18, P357; Kumar S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016208; Kuptsov PV, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036216; Leconte M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.128302; McGraw PN, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026210; Mikhailov A. S., 1994, FDN SYNERGETICS, VI; NEWITT DM, 1937, J CHEM SOC, V57, P1657; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Shayeganrad G, 2008, APPL OPTICS, V47, P619, DOI 10.1364/AO.47.000619; Thomas DG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.054501; Vavilin VA, 2002, WATER RES, V36, P2405, DOI 10.1016/S0043-1354(01)00454-7; Viranyi Z, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088301; Yang LF, 2006, PHYS CHEM CHEM PHYS, V8, P4647, DOI 10.1039/b609214d; Zarnitsina VI, 2001, CHAOS, V11, P57, DOI 10.1063/1.1345728	29	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4454	10.1371/journal.pone.0004454	http://dx.doi.org/10.1371/journal.pone.0004454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212435	Green Submitted, Green Published, gold			2022-12-27	WOS:000265484200012
J	Lorincz, ML; Geall, F; Bao, Y; Crunelli, V; Hughes, SW				Lorincz, Magor L.; Geall, Freya; Bao, Ying; Crunelli, Vincenzo; Hughes, Stuart W.			ATP-Dependent Infra-Slow (< 0.1 Hz) Oscillations in Thalamic Networks	PLOS ONE			English	Article								An increasing number of EEG and resting state fMRI studies in both humans and animals indicate that spontaneous low frequency fluctuations in cerebral activity at <0.1 Hz (infra-slow oscillations, ISOs) represent a fundamental component of brain functioning, being known to correlate with faster neuronal ensemble oscillations, regulate behavioural performance and influence seizure susceptibility. Although these oscillations have been commonly indicated to involve the thalamus their basic cellular mechanisms remain poorly understood. Here we show that various nuclei in the dorsal thalamus in vitro can express a robust ISO at similar to 0.005-0.1 Hz that is greatly facilitated by activating metabotropic glutamate receptors (mGluRs) and/or Ach receptors (AchRs). This ISO is a neuronal population phenomenon which modulates faster gap junction (GJ)-dependent network oscillations, and can underlie epileptic activity when AchRs or mGluRs are stimulated excessively. In individual thalamocortical neurons the ISO is primarily shaped by rhythmic, long-lasting hyperpolarizing potentials which reflect the activation of A1 receptors, by ATP-derived adenosine, and subsequent opening of Ba2+-sensitive K+ channels. We argue that this ISO has a likely non-neuronal origin and may contribute to shaping ISOs in the intact brain.	[Lorincz, Magor L.; Geall, Freya; Bao, Ying; Crunelli, Vincenzo; Hughes, Stuart W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Lorincz, ML (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	HughesSW@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010; Lőrincz, Magor L/C-7746-2012	Lőrincz, Magor L/0000-0001-5240-1904; Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X	Wellcome Trust [71436, 78403, 78311]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grants 71436, 78403 awarded to VC and 78311 awarded to SWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Albrecht D, 1998, NEUROSCI RES, V32, P209, DOI 10.1016/S0168-0102(98)00087-X; ALBRECHT D, 1994, NEUROREPORT, V5, P1909, DOI 10.1097/00001756-199410000-00017; CHATILA M, 1992, ELECTROEN CLIN NEURO, V83, P217, DOI 10.1016/0013-4694(92)90147-A; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Eisensehr I, 2001, EPILEPSY RES, V46, P241, DOI 10.1016/S0920-1211(01)00280-7; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Filippov IV, 2007, BRAIN RES, V1133, P78, DOI 10.1016/j.brainres.2006.11.038; Filippov IV, 2005, BRAIN RES, V1066, P179, DOI 10.1016/j.brainres.2005.10.061; Filippov IV, 2005, NEUROSCI LETT, V373, P51, DOI 10.1016/j.neulet.2004.09.056; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; He JF, 2003, J NEUROSCI, V23, P8281; Hughes SW, 2007, INT J PSYCHOPHYSIOL, V64, P3, DOI 10.1016/j.ijpsycho.2006.08.004; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hughes SW, 2002, NEUROSCIENCE, V110, P395, DOI 10.1016/S0306-4522(01)00577-2; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LOPESDAS.FH, 1973, ELECTROEN CLIN NEURO, V35, P641, DOI 10.1016/0013-4694(73)90217-4; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Lorincz ML, 2008, J NEUROSCI, V28, P660, DOI 10.1523/JNEUROSCI.4468-07.2008; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Parrino L, 2000, CLIN NEUROPHYSIOL, V111, pS39, DOI 10.1016/S1388-2457(00)00400-4; Pirchio M, 1997, J NEUROSCI, V17, P5428; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Tennigkeit F, 1998, NEUROSCIENCE, V83, P1063, DOI 10.1016/S0306-4522(97)00458-2; Terzano MG, 2000, SLEEP MED REV, V4, P101, DOI 10.1053/smrv.1999.0083; Timofeev I, 1998, J NEUROPHYSIOL, V80, P1495, DOI 10.1152/jn.1998.80.3.1495; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Vanhatalo S, 2005, CLIN NEUROPHYSIOL, V116, P1, DOI 10.1016/j.clinph.2004.09.015; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Yamada M, 1998, PHARMACOL REV, V50, P723; ZHANG D, 2008, J NEUROPHYSIOL  0813; Zhu L, 2006, NEUROSCIENCE, V141, P621, DOI 10.1016/j.neuroscience.2006.04.069	57	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4447	10.1371/journal.pone.0004447	http://dx.doi.org/10.1371/journal.pone.0004447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212445	gold, Green Published, Green Accepted			2022-12-27	WOS:000265484200008
J	Raevuori, A; Hoek, HW; Susser, E; Kaprio, J; Rissanen, A; Keski-Rahkonen, A				Raevuori, Anu; Hoek, Hans W.; Susser, Ezra; Kaprio, Jaakko; Rissanen, Aila; Keski-Rahkonen, Anna			Epidemiology of Anorexia Nervosa in Men: A Nationwide Study of Finnish Twins	PLOS ONE			English	Article							EATING-DISORDERS; HERITABILITY; BMI	Background: To examine the epidemiology of anorexia nervosa in men, we screened Finnish male twins born in 1975-79. Methods and Findings: Men (N = 2122) from FinnTwin16 birth cohorts were screened for lifetime eating disorders by a questionnaire. The screen positives (N = 18), their male co-twins (N = 10) and those with lifetime minimum BMI <= 17.5 (N = 21) were administered the Structured Clinical Interview for DSM-IV anorexia nervosa. The incidence rate of anorexia nervosa for the presumed peak age of risk (10-24y) was 15.7 per 100 000 person-years; its lifetime prevalence was 0.24%. All probands had recovered from eating disorders, but suffered from substantial psychiatric comorbidity, which also manifested in their co-twins. Additionally, male co-twins displayed significant dissatisfaction with body musculature, a male-specific feature of body dysmorphic disorder. Conclusions: Anorexia nervosa in males in the community is more common, transient and accompanied by more substantial comorbidity than previously thought.	[Raevuori, Anu; Kaprio, Jaakko; Keski-Rahkonen, Anna] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Raevuori, Anu; Susser, Ezra] NY State Psychiat Inst, New York, NY USA; [Hoek, Hans W.] Parnassia Bavo Psychiat Inst, The Hague, Netherlands; [Hoek, Hans W.] Univ Groningen, Med Ctr, Dept Psychiat, NL-9700 AB Groningen, Netherlands; [Hoek, Hans W.; Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth, Helsinki, Finland; [Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland	University of Helsinki; New York State Psychiatry Institute; Parnassia Psychiatric Institute; University of Groningen; Columbia University; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Raevuori, A (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.	anu.raevuori@helsinki.fi	Keski-Rahkonen, Anna/C-7073-2013; Kaprio, Jaakko/A-1820-2008	Keski-Rahkonen, Anna/0000-0002-6713-7488; Kaprio, Jaakko/0000-0002-3716-2455; Raevuori, Anu/0000-0001-7704-9441; Huicho, Luis/0000-0002-5272-5885; Hoek, Hans/0000-0001-6353-5465	National Graduate School for Clinical Investigation; National Institute on Alcohol Abuse and Alcoholism [AA-12502]; Academy of Finland [100499, 201461]; Academy of Finland Centre of Excellence in Complex Disease Genetics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012502, R01AA012502] Funding Source: NIH RePORTER	National Graduate School for Clinical Investigation; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland(Academy of Finland); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	AR was funded by National Graduate School for Clinical Investigation. Data collection was supported by the National Institute on Alcohol Abuse and Alcoholism (grant AA-12502), the Academy of Finland (Grants 100499 and 201461), the Academy of Finland Centre of Excellence in Complex Disease Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Bulik CM, 2006, ARCH GEN PSYCHIAT, V63, P305, DOI 10.1001/archpsyc.63.3.305; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; First MB, 2002, STRUCTURED CLIN INTE; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/136905202320906101; Keel PK, 2005, INT J EAT DISORDER, V38, P99, DOI 10.1002/eat.20168; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; Pietilainen KH, 1999, INT J OBESITY, V23, P107, DOI 10.1038/sj.ijo.0800767; Raevuori Anu, 2006, Clin Pract Epidemiol Ment Health, V2, P6, DOI 10.1186/1745-0179-2-6; Ruffolo JS, 2006, INT J EAT DISORDER, V39, P11, DOI 10.1002/eat.20219; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Strober M, 2001, INT J EAT DISORDER, V29, P263, DOI 10.1002/eat.1017; Wade TD, 2000, AM J PSYCHIAT, V157, P469, DOI 10.1176/appi.ajp.157.3.469; Woodside DB, 2001, AM J PSYCHIAT, V158, P570, DOI 10.1176/appi.ajp.158.4.570	16	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4402	10.1371/journal.pone.0004402	http://dx.doi.org/10.1371/journal.pone.0004402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JO	19204790	gold, Green Published, Green Submitted			2022-12-27	WOS:000265484000005
J	Mainardi, M; Landi, S; Berardi, N; Maffei, L; Pizzorusso, T				Mainardi, Marco; Landi, Silvia; Berardi, Nicoletta; Maffei, Lamberto; Pizzorusso, Tommaso			Reduced Responsiveness to Long-Term Monocular Deprivation of Parvalbumin Neurons Assessed by c-Fos Staining in Rat Visual Cortex	PLOS ONE			English	Article								Background: It is generally assumed that visual cortical cells homogeneously shift their ocular dominance (OD) in response to monocular deprivation (MD), however little experimental evidence directly supports this notion. By using immunohistochemistry for the activity-dependent markers c-Fos and Arc, coupled with staining for markers of inhibitory cortical sub-populations, we studied whether long-term MD initiated at P21 differentially affects visual response of inhibitory neurons in rat binocular primary visual cortex. Methodology/Principal Findings: The inhibitory markers GAD67, parvalbumin (PV), calbindin (CB) and calretinin (CR) were used. Visually activated Arc did not colocalize with PV and was discarded from further studies. MD decreased visually induced c-Fos activation in GAD67 and CR positive neurons. The CB population responded to MD with a decrease of CB expression, while PV cells did not show any effect of MD on c-Fos expression. The persistence of c-Fos expression induced by deprived eye stimulation in PV cells is not likely to be due to a particularly low threshold for activity-dependent c-Fos induction. Indeed, c-Fos induction by increasing concentrations of the GABAA antagonist picrotoxin in visual cortical slices was similar between PV cells and the other cortical neurons. Conclusion: These data indicate that PV cells are particularly refractory to MD, suggesting that different cortical subpopulation may show different response to MD.	[Mainardi, Marco; Landi, Silvia; Maffei, Lamberto] Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy; [Berardi, Nicoletta; Pizzorusso, Tommaso] Univ Florence, Dept Psychol, I-50121 Florence, Italy; [Berardi, Nicoletta; Maffei, Lamberto; Pizzorusso, Tommaso] CNR, Inst Neurosci, Pisa, Italy	Scuola Normale Superiore di Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Mainardi, M (corresponding author), Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy.	tommaso@in.cnr.it	Mainardi, Marco/AAY-4025-2020; Landi, Silvia/P-9418-2018; Pizzorusso, Tommaso/D-1399-2013	Landi, Silvia/0000-0001-7999-3452; Pizzorusso, Tommaso/0000-0001-5614-0668	Italian Ministry for University and research; Telethon [GGP05236]	Italian Ministry for University and research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon)	Funded by Italian Ministry for University and research and Telethon grant GGP05236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chow A, 1999, J NEUROSCI, V19, P9332; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fields RD, 1997, J NEUROSCI, V17, P7252; GANDHI SP, 2008, DELAYED PLASTICITY I; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hada Y, 1999, INVEST OPHTH VIS SCI, V40, P2535; HARTIG W, 1992, NEUROREPORT, V3, P869; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Landi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000346; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MOWER GD, 1989, DEV BRAIN RES, V45, P211, DOI 10.1016/0165-3806(89)90040-0; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Sekirnjak C, 1997, BRAIN RES, V766, P173, DOI 10.1016/S0006-8993(97)00527-1; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; WEISER M, 1995, J NEUROSCI, V15, P4298; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	42	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4342	10.1371/journal.pone.0004342	http://dx.doi.org/10.1371/journal.pone.0004342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194492	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483500003
J	Youngsteadt, E; Baca, JA; Osborne, J; Schal, C				Youngsteadt, Elsa; Alvarez Baca, Jeniffer; Osborne, Jason; Schal, Coby			Species-Specific Seed Dispersal in an Obligate Ant-Plant Mutualism	PLOS ONE			English	Article							RAIN-FOREST; EVOLUTION; EPIPHYTES; SELECTION; CONFLICT; SURVIVAL; BEHAVIOR; REMOVAL; SIZE	Throughout lowland Amazonia, arboreal ants collect seeds of specific plants and cultivate them in nutrient-rich nests, forming diverse yet obligate and species-specific symbioses called Neotropical ant-gardens (AGs). The ants depend on their symbiotic plants for nest stability, and the plants depend on AGs for substrate and nutrients. Although the AGs are limited to specific participants, it is unknown at what stage specificity arises, and seed fate pathways in AG epiphytes are undocumented. Here we examine the specificity of the ant-seed interaction by comparing the ant community observed at general food baits to ants attracted to and removing seeds of the AG plant Peperomia macrostachya. We also compare seed removal rates under treatments that excluded vertebrates, arthropods, or both. In the bait study, only three of 70 ant species collected P. macrostachya seeds, and 84% of observed seed removal by ants was attributed to the AG ant Camponotus femoratus. In the exclusion experiment, arthropod exclusion significantly reduced seed removal rates, but vertebrate exclusion did not. We provide the most extensive empirical evidence of species specificity in the AG mutualism and begin to quantify factors that affect seed fate in order to understand conditions that favor its departure from the typical diffuse model of plant-animal mutualism.	[Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Youngsteadt, Elsa; Schal, Coby] N Carolina State Univ, WM Keck Ctr Behavior Biol, Raleigh, NC USA; [Alvarez Baca, Jeniffer] Univ Nacl San Antonio Abad Cusco, Fac Cienc Biol, Cuzco, Peru; [Osborne, Jason] N Carolina State Univ, Dept Stat, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Universidad Nacional de San Antonio Abad del Cusco; University of North Carolina; North Carolina State University	Youngsteadt, E (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Alvarez-Baca, Jeniffer Katherine/0000-0003-1373-089X; Youngsteadt, Elsa/0000-0003-2032-9674	NSF [Predoctoral Fellowship]; United States Department of Education [GAANN Fellowship]; NCSU [Internationalization seed]; Blanton J. Whitmire endowment	NSF(National Science Foundation (NSF)); United States Department of Education(US Department of Education); NCSU; Blanton J. Whitmire endowment	This work was supported by an NSF Predoctoral Fellowship and a United States Department of Education GAANN Fellowship (E.Y.), by an NCSU Internationalization seed grant (C.S.), and the Blanton J. Whitmire endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VM, 2008, ECOL ENTOMOL, V33, P59, DOI 10.1111/j.1365-2311.2007.00938.x; Auld TD, 1999, PLANT ECOL, V144, P201, DOI 10.1023/A:1009817132378; Beattie Andrew J., 2002, P211; Bebawi FF, 2004, AUST J EXP AGR, V44, P1157, DOI 10.1071/EA03194; Benzing D.H., 1990, VASCULAR EPIPHYTES; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; BESTELMEYER BT, ANTS STANDARD METHOD; Bluthgen N, 2001, J TROP ECOL, V17, P887, DOI 10.1017/S0266467401001651; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Chapman Colin A., 2002, P275, DOI 10.1079/9780851995250.0275; Corbara B, 1996, NATURWISSENSCHAFTEN, V83, P227; Cox DR., 1970, ANAL BINARY DATA; Croat T.B., 1978, FLORA BARRO COLORADO; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; Dejean A, 2000, SOCIOBIOLOGY, V35, P425; FEINSINGER P, 1978, BIOTROPICA, V10, P238, DOI 10.2307/2387911; Fornara DA, 2005, J TROP ECOL, V21, P79, DOI 10.1017/S026646740400197X; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; Holldobler B., 1990, pi; HORVITZ CC, 1980, AM J BOT, V67, P321, DOI 10.2307/2442342; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; Junker RR, 2008, EVOL ECOL RES, V10, P295; Kaspari M, 1996, OECOLOGIA, V105, P397, DOI 10.1007/BF00328743; KASPARI M, 1993, OECOLOGIA, V95, P81, DOI 10.1007/BF00649510; KJELLSSON G, 1991, OECOLOGIA, V88, P435, DOI 10.1007/BF00317590; Kleinfeldt S.E., 1986, P283; Leal IR, 1998, BIOTROPICA, V30, P170, DOI 10.1111/j.1744-7429.1998.tb00052.x; LEMAIRE M, 1990, J CHEM ECOL, V16, P2067, DOI 10.1007/BF01020517; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; Madison M., 1979, SELBYANA, V5, P107; Nicklen EF, 2006, OECOLOGIA, V148, P81, DOI 10.1007/s00442-006-0359-6; Nieder J, 2000, BIOTROPICA, V32, P385, DOI 10.1111/j.1744-7429.2000.tb00485.x; Orivel J, 1999, ECOSCIENCE, V6, P51, DOI 10.1080/11956860.1999.11952205; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Passos L, 2002, J ECOL, V90, P517, DOI 10.1046/j.1365-2745.2002.00687.x; Pizo MA, 2001, PLANT ECOL, V157, P37, DOI 10.1023/A:1013735305100; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; ROBERTS JT, 1986, ECOLOGY, V67, P1046, DOI 10.2307/1939827; Satterthwaite FE, 1941, PSYCHOMETRIKA, V6, P309, DOI 10.1007/BF02288586; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; VANDUNNE HJF, 2001, EPIPHYTES SECONDARY; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1987, BIOTROPICA, V19, P245, DOI 10.2307/2388342; Winkler M, 2005, ANN BOT-LONDON, V95, P1039, DOI 10.1093/aob/mci115; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105; YU DW, 1994, BIOTROPICA, V26, P222, DOI 10.2307/2388813; Zotz G, 1998, J TROP ECOL, V14, P725, DOI 10.1017/S0266467498000534	52	28	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2009	4	2							e4335	10.1371/journal.pone.0004335	http://dx.doi.org/10.1371/journal.pone.0004335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JK	19194502	Green Submitted, Green Published, gold			2022-12-27	WOS:000265483500002
J	Castle, JC; Hara, Y; Raymond, CK; Garrett-Engele, P; Ohwaki, K; Kan, ZY; Kusunoki, J; Johnson, JM				Castle, John C.; Hara, Yoshikazu; Raymond, Christopher K.; Garrett-Engele, Philip; Ohwaki, Kenji; Kan, Zhengyan; Kusunoki, Jun; Johnson, Jason M.			ACC2 Is Expressed at High Levels Human White Adipose and Has an Isoform with a Novel N-Terminus	PLOS ONE			English	Article								Acetyl-CoA carboxylases ACC1 and ACC2 catalyze the carboxylation of acetyl-CoA to malonyl-CoA, regulating fatty-acid synthesis and oxidation, and are potential targets for treatment of metabolic syndrome. Expression of ACC1 in rodent lipogenic tissues and ACC2 in rodent oxidative tissues, coupled with the predicted localization of ACC2 to the mitochondrial membrane, have suggested separate functional roles for ACC1 in lipogenesis and ACC2 in fatty acid oxidation. We find, however, that human adipose tissue, unlike rodent adipose, expresses more ACC2 mRNA relative to the oxidative tissues muscle and heart. Human adipose, along with human liver, expresses more ACC2 than ACC1. Using RT-PCR, real-time PCR, and immunoprecipitation we report a novel isoform of ACC2 (ACC2.v2) that is expressed at significant levels in human adipose. The protein generated by this isoform has enzymatic activity, is endogenously expressed in adipose, and lacks the N-terminal sequence. Both ACC2 isoforms are capable of de novo lipogenesis, suggesting that ACC2, in addition to ACC1, may play a role in lipogenesis. The results demonstrate a significant difference in ACC expression between human and rodents, which may introduce difficulties for the use of rodent models for development of ACC inhibitors.	[Castle, John C.; Raymond, Christopher K.; Garrett-Engele, Philip; Kan, Zhengyan; Johnson, Jason M.] Rosetta Inpharmat LLC, Seattle, WA USA; [Hara, Yoshikazu; Ohwaki, Kenji; Kusunoki, Jun] Banyu Pharm Co Ltd, Tsukuba Res Inst, Metabol Disorder Res, Ibaraki, Osaka, Japan	Merck & Company	Castle, JC (corresponding author), Rosetta Inpharmat LLC, Seattle, WA USA.	john_castle@merck.com; jason_johnson@merck.com						Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Applied Biosystems, ESS REAL TIM PCR ESS; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; COOK GA, 1984, BIOCHEM J, V219, P337, DOI 10.1042/bj2190337; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Dean D, 2000, DIABETES, V49, P1295, DOI 10.2337/diabetes.49.8.1295; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Harwood H James Jr, 2004, Curr Opin Investig Drugs, V5, P283; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; THAMPY KG, 1988, J BIOL CHEM, V263, P6454; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; WAKIL SJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P225, DOI 10.1016/0006-3002(58)90177-X; Widmer J, 1996, BIOCHEM J, V316, P915, DOI 10.1042/bj3160915; WINZ R, 1994, J BIOL CHEM, V269, P14438; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	37	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4369	10.1371/journal.pone.0004369	http://dx.doi.org/10.1371/journal.pone.0004369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190759	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483300008
J	Nunes, JPL; Silva, JC				Nunes, Jose Pedro L.; Silva, Joao Carlos			Systemic Correlates of Angiographic Coronary Artery Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HEART-DISEASE; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; RISK; PROGRESSION; CHOLESTEROL; OBESITY; EXTENT	Coronary angiography allows a direct evaluation of coronary anatomy. The aim of the present investigation was to search for correlations between the magnitude of coronary artery disease, as assessed by angiography, and a number of systemic parameters. A group of 116 patients (80 male, 36 female) with coronary heart disease diagnosed by angiography, aged 62.0+/-10.5 years, was the subject of an observational study. Correlation and linear regression analysis using coronary artery disease burden (CADB - sum of the percentage of the luminal stenosis encountered in all the lesions of the coronary arterial trees) as dependent variable, and age, sex, plasma calcium, phosphorus, magnesium, glucose, HDL cholesterol, LDL cholesterol, triglycerides, uric acid, estimated glomerular filtration rate and body mass index as independent variables, were carried out. Significant correlation values versus CADB were seen with age (r 0.19, p 0.04), uric acid (r 0.18, p 0.048) and fasting plasma glucose (r 0.33, p < 0.001). Linear regression analysis, yielding a global significance level of 0.002, showed a significant value for glucose (p 0.018) and for sex (0.008). In conclusion, among several systemic parameters studied, plasma glucose was found to be correlated to coronary artery atherosclerosis lesions.	[Nunes, Jose Pedro L.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Silva, Joao Carlos] Hosp Sao Joao, Oporto, Portugal	Universidade do Porto; Sao Joao Hospital	Nunes, JPL (corresponding author), Univ Porto, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jplnunes@med.up.pt	Nunes, José Pedro L/D-9546-2013	Nunes, José Pedro L/0000-0001-6739-0304				[Anonymous], 2002, AM J KIDNEY DIS, V39, pS76, DOI DOI 10.1053/ajkd.2002.30944; Bo S, 2008, CURR OPIN LIPIDOL, V19, P50, DOI 10.1097/MOL.0b013e3282f33ccc; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Drexel H, 2005, DIABETES CARE, V28, P101, DOI 10.2337/diacare.28.1.101; DREXEL H, 1992, AM J CARDIOL, V70, P436, DOI 10.1016/0002-9149(92)91186-8; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HOOPER J, 1975, Annals of Clinical Biochemistry, V12, P255; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVEY AS, 2000, J AM SOC NEPHROL, V11, P828; Lomashvili K, 2006, KIDNEY INT, V69, P1464, DOI 10.1038/sj.ki.5000297; MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Niraj A, 2007, CLIN CARDIOL, V30, P391, DOI 10.1002/clc.20113; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nunes JPL, 2007, CLIN CARDIOL, V30, P464, DOI 10.1002/clc.20145; Nunes JPL, 2007, MED HYPOTHESES, V68, P541, DOI 10.1016/j.mehy.2006.08.021; Saely CH, 2008, ATHEROSCLEROSIS, V199, P317, DOI 10.1016/j.atherosclerosis.2007.11.020; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Taubert G, 2003, AM HEART J, V145, P285, DOI 10.1067/mhj.2003.134; Wenger NK, 2003, PROG CARDIOVASC DIS, V46, P199, DOI 10.1016/j.pcad.2003.08.003; Xi XP, 1997, FEBS LETT, V417, P283, DOI 10.1016/S0014-5793(97)01303-3	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4322	10.1371/journal.pone.0004322	http://dx.doi.org/10.1371/journal.pone.0004322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180194	Green Submitted, Green Published, gold			2022-12-27	WOS:000274089700009
J	Sidell, N; Hao, LJ; Pasquali, M; McDonald, JD				Sidell, Neil; Hao, Lijuan; Pasquali, Marzia; McDonald, J. David			Carcinogenic Effects in a Phenylketonuria Mouse Model	PLOS ONE			English	Article								Phenylketonuria (PKU) is a metabolic disorder caused by impaired phenylalanine hydroxylase (PAH). This condition results in hyperphenylalaninemia and elevated levels of abnormal phenylalanine metabolites, among which is phenylacetic acid/phenylacetate (PA). In recent years, PA and its analogs were found to have anticancer activity against a variety of malignancies suggesting the possibility that PKU may offer protection against cancer through chronically elevated levels of PA. We tested this hypothesis in a genetic mouse model of PKU (PAH(enu2)) which has a biochemical profile that closely resembles that of human PKU. Plasma levels of phenylalanine in homozygous (HMZ) PAH(enu2) mice were >12-fold those of heterozygous (HTZ) littermates while tyrosine levels were reduced. Phenylketones, including PA, were also markedly elevated to the range seen in the human disease. Mice were subjected to 7,12 dimethylbenz[a] anthracene (DMBA) carcinogenesis, a model which is sensitive to the anticancer effects of the PA derivative 4-chlorophenylacetate (4-CPA). Tumor induction by DMBA was not significantly different between the HTZ and HMZ mice, either in total tumor development or in the type of cancers that arose. HMZ mice were then treated with 4-CPA as positive controls for the anticancer effects of PA and to evaluate its possible effects on phenylalanine metabolism in PKU mice. 4-CPA had no effect on the plasma concentrations of phenylalanine, phenylketones, or tyrosine. Surprisingly, the HMZ mice treated with 4-CPA developed an unexplained neuromuscular syndrome which precluded its use in these animals as an anticancer agent. Together, these studies support the use of PAH(enu2) mice as a model for studying human PKU. Chronically elevated levels of PA in the PAH(enu2) mice were not protective against cancer.	[Hao, Lijuan] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Pasquali, Marzia] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [McDonald, J. David] Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA	Emory University; Utah System of Higher Education; University of Utah; Wichita State University	Sidell, N (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.	nsidell@emory.edu		Huicho, Luis/0000-0002-5272-5885	National Institutes of Health [HD040932]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD040932] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA129424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Study funded by a grant from the National Institutes of Health (HD040932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; BATSHAW ML, 1987, ENZYME, V38, P242, DOI 10.1159/000469211; BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; FELLMAN JH, 1972, BIOCHIM BIOPHYS ACTA, V284, P90, DOI 10.1016/0005-2744(72)90048-4; FISHER SM, 1992, CANCER RES, V52, P662; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI DOI 10.1515/BCHM2.1934.227.1-4.169; GULDBERG P, 1993, GENOMICS, V17, P141, DOI 10.1006/geno.1993.1295; GUTHRIE R, 1963, PEDIATRICS, V32, P338; HANIGAN MH, 1990, CARCINOGENESIS, V11, P589, DOI 10.1093/carcin/11.4.589; Horlings H, 2005, EXP LUNG RES, V31, P513, DOI 10.1080/01902140590918740; Huang MT, 1998, CARCINOGENESIS, V19, P1697, DOI 10.1093/carcin/19.9.1697; HUDGINS WR, 1995, BIOCHEM PHARMACOL, V50, P1273, DOI 10.1016/0006-2952(95)02013-3; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; KAUR H, 1994, ANAL BIOCHEM, V220, P11, DOI 10.1006/abio.1994.1291; Keshava N, 2001, CANCER LETT, V167, P125, DOI 10.1016/S0304-3835(01)00478-5; LINBLAD B, 1977, J BIOL CHEM, V252, P5073; Liu JB, 2007, CANCER CHEMOTH PHARM, V59, P217, DOI 10.1007/s00280-006-0260-3; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; MICHALS K, 1988, BIOCHEM MED METAB B, V39, P18, DOI 10.1016/0885-4505(88)90053-9; Qing WG, 1997, CARCINOGENESIS, V18, P553, DOI 10.1093/carcin/18.3.553; SAMID D, 1992, CANCER RES, V52, P1988; Sarkissian CN, 2000, MOL GENET METAB, V69, P188, DOI 10.1006/mgme.2000.2974; Sawatsri S, 2001, INT J CANCER, V93, P687, DOI 10.1002/ijc.1399; Scaglia F, 2004, MOL GENET METAB, V81, pS79, DOI 10.1016/j.ymgme.2003.11.017; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SIDELL N, 1995, INT J CANCER, V60, P507, DOI 10.1002/ijc.2910600414; Sidell N, 2005, J STEROID BIOCHEM, V96, P335, DOI 10.1016/j.jsbmb.2005.04.040; Sidell N, 2003, BRIT J CANCER, V89, P412, DOI 10.1038/sj.bjc.6601108; Sidell N, 2007, CANCER LETT, V251, P302, DOI 10.1016/j.canlet.2006.11.031; TUCHMAN M, 1985, BIOCHEM MED METAB B, V34, P203, DOI 10.1016/0006-2944(85)90112-7; Wurz GT, 2005, J STEROID BIOCHEM, V97, P230, DOI 10.1016/j.jsbmb.2005.06.027	33	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2009	4	1							e4292	10.1371/journal.pone.0004292	http://dx.doi.org/10.1371/journal.pone.0004292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JF	19172175	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482900009
J	Budd, ME; Campbell, JL				Budd, Martin E.; Campbell, Judith L.			Interplay of Mre11 Nuclease with Dna2 plus Sgs1 in Rad51-Dependent Recombinational Repair	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE MRE11; YEAST DNA2; ENDONUCLEASE ACTIVITY; REPLICATION; HELICASE; RAD50; MUTANTS; PROTEIN; EXO1	The Mre11/Rad50/Xrs2 complex initiates IR repair by binding to the end of a double-strand break, resulting in 5' to 3' exonuclease degradation creating a single-stranded 3' overhang competent for strand invasion into the unbroken chromosome. The nuclease(s) involved are not well understood. Mre11 encodes a nuclease, but it has 3' to 5', rather than 5' to 3' activity. Furthermore, mutations that inactivate only the nuclease activity of Mre11 but not its other repair functions, mre11-D56N and mre11-H125N, are resistant to IR. This suggests that another nuclease can catalyze 5' to 3' degradation. One candidate nuclease that has not been tested to date because it is encoded by an essential gene is the Dna2 helicase/nuclease. We recently reported the ability to suppress the lethality of a dna2 Delta with a pif1 Delta. The dna2 Delta pif1 Delta mutant is IR-resistant. We have determined that dna2 Delta pif1 Delta mre11-D56N and dna2 Delta pif1 Delta mre11-H125N strains are equally as sensitive to IR as mre11 Delta strains, suggesting that in the absence of Dna2, Mre11 nuclease carries out repair. The dna2 Delta pif1 Delta mre11-D56N triple mutant is complemented by plasmids expressing Mre11, Dna2 or dna2K1080E, a mutant with defective helicase and functional nuclease, demonstrating that the nuclease of Dna2 compensates for the absence of Mre11 nuclease in IR repair, presumably in 5' to 3' degradation at DSB ends. We further show that sgs1 Delta mre11-H125N, but not sgs1 Delta, is very sensitive to IR, implicating the Sgs1 helicase in the Dna2-mediated pathway.	[Budd, Martin E.; Campbell, Judith L.] CALTECH, Div Biol, Braun Labs, Pasadena, CA 91125 USA	California Institute of Technology	Budd, ME (corresponding author), CALTECH, Div Biol, Braun Labs, Pasadena, CA 91125 USA.	jcampbel@caltech.edu			NIH [GM087666]; Philip Morris External Research Program; Ellison Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program; Ellison Foundation(Lawrence Ellison Foundation)	This work was supported by NIH GM087666, the Philip Morris External Research Program, and the Ellison Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1989, GENETICS, V122, P47; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lewis LK, 2002, GENETICS, V160, P49; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; Weitao T, 2003, MUTAT RES-FUND MOL M, V532, P157, DOI 10.1016/j.mrfmmm.2003.08.015; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	51	57	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4267	10.1371/journal.pone.0004267	http://dx.doi.org/10.1371/journal.pone.0004267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165339	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000265482400011
J	Bondar, NP; Boyarskikh, UA; Kovalenko, IL; Filipenko, ML; Kudryavtseva, NN				Bondar, Natalia P.; Boyarskikh, Ul'yana A.; Kovalenko, Irina L.; Filipenko, Maxim L.; Kudryavtseva, Natalia N.			Molecular Implications of Repeated Aggression: Th, Dat1, Snca and Bdnf Gene Expression in the VTA of Victorious Male Mice	PLOS ONE			English	Article								Background: It is generally recognized that recurrent aggression can be the result of various psychiatric disorders. The aim of our study was to analyze the mRNA levels, in the ventral tegmental area (VTA) of the midbrain, of the genes that may possibly be associated with aggression consistently shown by male mice in special experimental settings. Methodology/Principal Findings: The genes were Th, Dat1, Snca and Bdnf; the male mice were a group of animals that had each won 20 daily encounters in succession and a group of animals that had the same winning track record followed by a no-fight period for 14 days. Increased Th, Dat1 and Snca mRNA levels were in the fresh-from-the-fight group as compared to the controls. Increased Th and Dat1 mRNA levels were in the no-fight winners as compared to the controls. Significant positive correlations were found between the level of aggression and Th and Snca mRNA levels. Conclusions: Repeated positive fighting experience enhances the expression of the Th, Dat1 and Snca genes, which are associated with brain dopaminergic systems. The expression of the Th and Dat1 genes stays enhanced for a long time.	[Bondar, Natalia P.; Kovalenko, Irina L.; Kudryavtseva, Natalia N.] RAS, SD, Inst Cytol & Genet, Novosibirsk, Russia; [Boyarskikh, Ul'yana A.; Filipenko, Maxim L.] RAS, SD, Inst Chem Biol & Basic Med, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences	Bondar, NP (corresponding author), RAS, SD, Inst Cytol & Genet, Novosibirsk, Russia.	natnik@bionet.nsc.ru	Boyarskikh, Ulyana/AAU-9540-2020; Kudryavtseva, Natalia/AAI-1127-2019; Bondar, Natalya/Q-7908-2016	Bondar, Natalya/0000-0002-5602-5149	Russian Academy of Sciences (Molecular and Cellular Biology Program) [10.13]; Russian Foundation for Basic Research [07-04-00014]	Russian Academy of Sciences (Molecular and Cellular Biology Program)(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by research grant 10.13 from the Russian Academy of Sciences (Molecular and Cellular Biology Program) and grant 07-04-00014 from the Russian Foundation for Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Abumaria N, 2007, EUR NEUROPSYCHOPHARM, V17, P417, DOI 10.1016/j.euroneuro.2006.08.009; Andrade M. L., 1987, HOUSE MOUSE AGGRESSI, P223; APA, 1994, DIAGN STAT MAN MENT; Azaryan AV, 1998, CAN J PHYSIOL PHARM, V76, P278, DOI 10.1139/cjpp-76-3-278; Baron R., 1994, HUMAN AGGRESSION, DOI 10.1002/1098-2337(1994)20:63.0.CO;2-O; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Caramaschi D, 2008, BEHAV BRAIN RES, V189, P263, DOI 10.1016/j.bbr.2008.01.003; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER SJ, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P331; Crespo JA, 2001, NEUROPSYCHOPHARMACOL, V25, P185, DOI 10.1016/S0893-133X(01)00221-4; Devoino L V, 1998, Vestn Ross Akad Med Nauk, P19; Filipenko ML, 2002, STRESS: NEURAL, ENDOCRINE AND MOLECULAR STUDIES, P157; Filipenko ML, 2001, MOL BRAIN RES, V96, P77, DOI 10.1016/S0169-328X(01)00270-4; Filipenko ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P451, DOI 10.1023/A:1015238124000; Fish EW, 2002, PSYCHOPHARMACOLOGY, V163, P459, DOI 10.1007/s00213-002-1211-2; GOLDSMITH JF, 1976, AGGRESSIVE BEHAV, V2, P307, DOI 10.1002/1098-2337(1976)2:4<307::AID-AB2480020407>3.0.CO;2-I; Goloshchapov AV, 2005, MOL BRAIN RES, V135, P290, DOI 10.1016/j.molbrainres.2004.11.009; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kollack-Walker S, 1999, J NEUROENDOCRINOL, V11, P547; Kudryavtseva N.N., 2006, PERSPECTIVES PSYCHOL, P35; Kudryavtseva NN, 1998, AGGRESSIVE BEHAV, V24, P271, DOI 10.1002/(SICI)1098-2337(1998)24:4<271::AID-AB3>3.0.CO;2-M; KUDRYAVTSEVA NN, 1991, ZH VYSSH NERV DEYAT+, V41, P459; Kudryavtseva NN, 2004, RUSS J GENET+, V40, P590, DOI 10.1023/B:RUGE.0000033307.59669.d6; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; Lagerspetz K.M.J., 1964, ANN ACAD SCI FENN B, V131, P1; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Meyer U, 2001, HIPPOCAMPUS, V11, P329, DOI 10.1002/hipo.1047; Miczek K.A., 2007, HDB NEUROCHEMISTRY M, P285, DOI DOI 10.1007/978-0-387-30405-2_7; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; MOYER KE, 1987, VIOLENCE AGGRESSION; Nichols CD, 2003, MOL BRAIN RES, V111, P182, DOI 10.1016/S0169-328X(03)00029-9; Nikulina EM, 1999, NEUROREPORT, V10, P3015, DOI 10.1097/00001756-199909290-00026; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Rosen GD, 2000, INT MOUSE GENOME C, V14, P166; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Scott J.P., 1971, PHYSL AGGRESSION DEF, P11; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Spangler R, 1996, MOL BRAIN RES, V38, P71, DOI 10.1016/0169-328X(95)00319-N; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Van Ree JM, 1999, PHARMACOL REV, V51, P341; VANDEPOLL NE, 1982, BEHAV PROCESS, V7, P143, DOI 10.1016/0376-6357(82)90023-7; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041	52	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4190	10.1371/journal.pone.0004190	http://dx.doi.org/10.1371/journal.pone.0004190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142237	Green Published, gold, Green Submitted			2022-12-27	WOS:000265479700011
J	Oyama, S; Yamakawa, H; Sasagawa, N; Hosoi, Y; Futai, E; Ishiura, S				Oyama, Satoko; Yamakawa, Hidekuni; Sasagawa, Noboru; Hosoi, Yoshio; Futai, Eugene; Ishiura, Shoichi			Dysbindin-1, a Schizophrenia-Related Protein, Functionally Interacts with the DNA- Dependent Protein Kinase Complex in an Isoform-Dependent Manner	PLOS ONE			English	Article								DTNBP1 has been recognized as a schizophrenia susceptible gene, and its protein product, dysbindin-1, is down-regulated in the brains of schizophrenic patients. However, little is known about the physiological role of dysbindin-1 in the central nervous system. We hypothesized that disruption of dysbindin-1 with unidentified proteins could contribute to pathogenesis and the symptoms of schizophrenia. GST pull-down from human neuroblastoma lysates showed an association of dysbindin-1 with the DNA-dependent protein kinase (DNA-PK) complex. The DNA-PK complex interacts only with splice isoforms A and B, but not with C. We found that isoforms A and B localized in nucleus, where the kinase complex exist, whereas the isoform C was found exclusively in cytosol. Furthermore, results of phosphorylation assay suggest that the DNA-PK complex phosphorylated dysbindin-1 isoforms A and B in cells. These observations suggest that DNA-PK regulates the dysbindin-1 isoforms A and B by phosphorylation in nucleus. Isoform C does not contain exons from 1 to 6. Since schizophrenia-related single nucleotide polymorphisms (SNPs) occur in these introns between exon 1 and exon 6, we suggest that these SNPs might affect splicing of DTNBP1, which leads to impairment of the functional interaction between dysbindin-1 and DNA-PK in schizophrenic patients.	[Oyama, Satoko; Yamakawa, Hidekuni; Sasagawa, Noboru; Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Hosoi, Yoshio] Niigata Univ, Sch Hlth Sci, Dept Radiol Technol, Niigata 95021, Japan	University of Tokyo; Niigata University	Oyama, S (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Ministry of Health, Labor, and Welfare, Japan (to S.I.), and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to E.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; CAO QP, 1994, BIOCHEMISTRY-US, V33, P8548, DOI 10.1021/bi00194a021; Chu G, 1996, CURR TOP MICROBIOL, V217, P113; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Duan JB, 2007, HUM HERED, V64, P97, DOI 10.1159/000101961; Endoh D, 2001, RADIAT RES, V155, P320, DOI 10.1667/0033-7587(2001)155[0320:HTIRIN]2.0.CO;2; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; FELDMANN H, 1993, J BIOL CHEM, V268, P12895; Feng LJ, 2000, GENOMICS, V69, P370, DOI 10.1006/geno.2000.6350; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Fewell JW, 1996, J CELL SCI, V109, P1937; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; Koike M, 1998, BIOCHEM BIOPH RES CO, V252, P679, DOI 10.1006/bbrc.1998.9368; Koike M, 1999, J CELL SCI, V112, P4031; Koike M, 1996, GENOMICS, V38, P38, DOI 10.1006/geno.1996.0589; Kretzschmar D, 2000, GENETICS, V155, P213; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Matsumoto Y, 1997, BIOCHEM BIOPH RES CO, V234, P568, DOI 10.1006/bbrc.1997.6689; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Setaluri V, 2000, PIGM CELL RES, V13, P128, DOI 10.1034/j.1600-0749.2000.130302.x; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tochigi M, 2006, NEUROSCI RES, V56, P154, DOI 10.1016/j.neures.2006.06.009; Tosato S, 2007, AM J MED GENET B, V144B, P647, DOI 10.1002/ajmg.b.30484; Turunen JA, 2007, SCHIZOPHR RES, V91, P27, DOI 10.1016/j.schres.2006.11.028; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vilella E, 2008, J PSYCHIATR RES, V42, P278, DOI 10.1016/j.jpsychires.2007.02.005; Weaver DT, 1996, CRIT REV EUKAR GENE, V6, P345, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.20; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	75	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2009	4	1							e4199	10.1371/journal.pone.0004199	http://dx.doi.org/10.1371/journal.pone.0004199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IF	19142223	gold, Green Published, Green Submitted			2022-12-27	WOS:000265479700017
J	Lin, JH; Li, H; Zhang, YH; Ron, D; Walter, P				Lin, Jonathan H.; Li, Han; Zhang, Yuhong; Ron, David; Walter, Peter			Divergent Effects of PERK and IRE1 Signaling on Cell Viability	PLOS ONE			English	Article								Protein misfolding in the endoplasmic reticulum ( ER) activates a set of intracellular signaling pathways, collectively termed the Unfolded Protein Response (UPR). UPR signaling promotes cell survival by reducing misfolded protein levels. If homeostasis cannot be restored, UPR signaling promotes cell death. The molecular basis for the switch between prosurvival and proapoptotic UPR function is poorly understood. The ER-resident proteins, PERK and IRE1, control two key UPR signaling pathways. Protein misfolding concomitantly activates PERK and IRE1 and has clouded insight into their contributions toward life or death cell fates. Here, we employed chemical-genetic strategies to activate individually PERK or IRE1 uncoupled from protein misfolding. We found that sustained PERK signaling impaired cell proliferation and promoted apoptosis. By contrast, equivalent durations of IRE1 signaling enhanced cell proliferation without promoting cell death. These results demonstrate that extended PERK and IRE1 signaling have opposite effects on cell viability. Differential activation of PERK and IRE1 may determine life or death decisions after ER protein misfolding.	[Lin, Jonathan H.; Li, Han; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Lin, Jonathan H.; Li, Han; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Zhang, Yuhong; Ron, David] NYU, Sch Med, Dept Cell Biol & Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University	Lin, JH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	JLin@ucsd.edu	Longo, Kenneth A/A-5631-2010	Ron, David/0000-0002-3014-5636; Lin, Jonathan/0000-0002-7438-6941	NIH [DK047119, ES08681, EY018313, GM032384]; Cystic Fibrosis Foundation; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [K08EY018313, R01EY020846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047119, R29DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032384, R01GM032384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants DK047119, ES08681, EY018313, and GM032384, and the Cystic Fibrosis Foundation. Peter Walter is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	37	235	250	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2009	4	1							e4170	10.1371/journal.pone.0004170	http://dx.doi.org/10.1371/journal.pone.0004170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437ID	19137072	Green Submitted, Green Published, gold			2022-12-27	WOS:000265479500001
J	Heidelberg, JF; Nelson, WC; Schoenfeld, T; Bhaya, D				Heidelberg, John F.; Nelson, William C.; Schoenfeld, Thomas; Bhaya, Devaki			Germ Warfare in a Microbial Mat Community: CRISPRs Provide Insights into the Co-Evolution of Host and Viral Genomes	PLOS ONE			English	Article								CRISPR arrays and associated cas genes are widespread in bacteria and archaea and confer acquired resistance to viruses. To examine viral immunity in the context of naturally evolving microbial populations we analyzed genomic data from two thermophilic Synechococcus isolates (Syn OS-A and Syn OS-B9) as well as a prokaryotic metagenome and viral metagenome derived from microbial mats in hotsprings at Yellowstone National Park. Two distinct CRISPR types, distinguished by the repeat sequence, are found in both the Syn OS-A and Syn OS-B9 genomes. The genome of Syn OS-A contains a third CRISPR type with a distinct repeat sequence, which is not found in Syn OS-B9, but appears to be shared with other microorganisms that inhabit the mat. The CRISPR repeats identified in the microbial metagenome are highly conserved, while the spacer sequences (hereafter referred to as "viritopes'' to emphasize their critical role in viral immunity) were mostly unique and had no high identity matches when searched against GenBank. Searching the viritopes against the viral metagenome, however, yielded several matches with high similarity some of which were within a gene identified as a likely viral lysozyme/lysin protein. Analysis of viral metagenome sequences corresponding to this lysozyme/lysin protein revealed several mutations all of which translate into silent or conservative mutations which are unlikely to affect protein function, but may help the virus evade the host CRISPR resistance mechanism. These results demonstrate the varied challenges presented by a natural virus population, and support the notion that the CRISPR/viritope system must be able to adapt quickly to provide host immunity. The ability of metagenomics to track population-level variation in viritope sequences allows for a culture-independent method for evaluating the fast co-evolution of host and viral genomes and its consequence on the structuring of complex microbial communities.	[Nelson, William C.] Univ So Calif, Dept Biol Sci, Marine Environm Biol Div, Wrigley Inst Environm Studies, Avalon, CA USA; [Schoenfeld, Thomas] Lucigen Corp, Middleton, WI USA; [Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	University of Southern California; Carnegie Institution for Science	Heidelberg, JF (corresponding author), Univ So Calif, Dept Biol Sci, Marine Environm Biol Div, Wrigley Inst Environm Studies, Avalon, CA USA.	jheidelb@usc.edu	Nelson, William C/E-9263-2016	Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224	Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award [EF-0328698]	Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award	This research was supported by the Nation Science Foundation Frontiers in Integrative Biological Research (FIBR) award (EF-0328698).	Ackermann HW, 2007, RES MICROBIOL, V158, P555, DOI 10.1016/j.resmic.2007.07.006; Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BELOGLAZOVA N, 2008, J BIOL CHEM; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brock T.D., 1978, THERMOPHILIC MICROOR; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Nubel U, 2002, APPL ENVIRON MICROB, V68, P4593, DOI 10.1128/AEM.68.9.4593-4603.2002; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ramsing NB, 2000, APPL ENVIRON MICROB, V66, P1038, DOI 10.1128/AEM.66.3.1038-1049.2000; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; SCHOENFELD T, 2008, APPL ENV MICROBIOL; Snyder JC, 2004, MICROB ECOL, V48, P561, DOI 10.1007/s00248-004-0246-9; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Ward DM, 2006, ANTON LEEUW INT J G, V90, P309, DOI 10.1007/s10482-006-9090-x; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	40	107	126	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4169	10.1371/journal.pone.0004169	http://dx.doi.org/10.1371/journal.pone.0004169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132092	gold, Green Published, Green Submitted			2022-12-27	WOS:000265473700008
J	Cudney-Bueno, R; Lavin, MF; Marinone, SG; Raimondi, PT; Shaw, WW				Cudney-Bueno, Richard; Lavin, Miguel F.; Marinone, Silvio G.; Raimondi, Peter T.; Shaw, William W.			Rapid Effects of Marine Reserves via Larval Dispersal	PLOS ONE			English	Article								Marine reserves have been advocated worldwide as conservation and fishery management tools. It is argued that they can protect ecosystems and also benefit fisheries via density-dependent spillover of adults and enhanced larval dispersal into fishing areas. However, while evidence has shown that marine reserves can meet conservation targets, their effects on fisheries are less understood. In particular, the basic question of if and over what temporal and spatial scales reserves can benefit fished populations via larval dispersal remains unanswered. We tested predictions of a larval transport model for a marine reserve network in the Gulf of California, Mexico, via field oceanography and repeated density counts of recently settled juvenile commercial mollusks before and after reserve establishment. We show that local retention of larvae within a reserve network can take place with enhanced, but spatially-explicit, recruitment to local fisheries. Enhancement occurred rapidly ( 2 yrs), with up to a three-fold increase in density of juveniles found in fished areas at the downstream edge of the reserve network, but other fishing areas within the network were unaffected. These findings were consistent with our model predictions. Our findings underscore the potential benefits of protecting larval sources and show that enhancement in recruitment can be manifested rapidly. However, benefits can be markedly variable within a local seascape. Hence, effects of marine reserve networks, positive or negative, may be overlooked when only focusing on overall responses and not considering finer spatially-explicit responses within a reserve network and its adjacent fishing grounds. Our results therefore call for future research on marine reserves that addresses this variability in order to help frame appropriate scenarios for the spatial management scales of interest.	[Shaw, William W.] Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA; [Cudney-Bueno, Richard; Raimondi, Peter T.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Cudney-Bueno, Richard] CEDO, Puerto Penasco, Mexico; [Lavin, Miguel F.; Marinone, Silvio G.] CICESE, Dept Oceanografia Fisica, Ensenada, Baja California, Mexico	University of Arizona; University of California System; University of California Santa Cruz; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Cudney-Bueno, R (corresponding author), Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA.	cud@ag.arizona.edu			David and Lucile Packard Foundation; PADI-Project AWARE; Sandler Family Foundation; Tinker Foundation; Wallace Research Foundation; World Wildlife Fund	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); PADI-Project AWARE; Sandler Family Foundation; Tinker Foundation; Wallace Research Foundation; World Wildlife Fund	Research was funded by the David and Lucile Packard Foundation, PADI-Project AWARE, Sandler Family Foundation, Tinker Foundation, Wallace Research Foundation, and World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; BAQUEIRO E, 1988, I NACL PESCA MEXIC D, V11, P1; Botsford LW, 2001, ECOL LETT, V4, P144; Botsford LW, 2003, ECOL APPL, V13, pS25; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cudney-Bueno R, 2008, B MAR SCI, V83, P285; DASARO CN, 1991, OPHELIA, V35, P1; Gaines SD, 2003, ECOL APPL, V13, pS32; Gaylord B, 2005, ECOL APPL, V15, P2180, DOI 10.1890/04-1810; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hastings A, 2003, ECOL APPL, V13, pS65; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Lavin MF, 1997, J PHYS OCEANOGR, V27, P2298, DOI 10.1175/1520-0485(1997)027<2298:LOOTCI>2.0.CO;2; Marinone SG, 2005, ESTUAR COAST SHELF S, V64, P519, DOI 10.1016/j.ecss.2005.03.009; Marinone SG, 2004, ESTUAR COAST SHELF S, V60, P611, DOI 10.1016/j.ecss.2004.03.002; Marinone SG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001720; Mateos E, 2006, DEEP-SEA RES PT II, V53, P60, DOI 10.1016/j.dsr2.2005.07.010; National Research Council, 2001, MAR PROT AR TOOLS SU; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Ostrom E., 1990, GOVERNING COMMONS EV; Parnell PE, 2002, VELIGER, V45, P58; Roberts C., 2000, WWF ENDANGERED SEAS; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Villalejo-Fuerte M, 2002, J SHELLFISH RES, V21, P103	29	87	87	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4140	10.1371/journal.pone.0004140	http://dx.doi.org/10.1371/journal.pone.0004140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129910	Green Published, gold			2022-12-27	WOS:000265473500001
J	Stolze-Rybczynski, JL; Cui, YL; Stevens, MHH; Davis, DJ; Fischer, MWF; Money, NP				Stolze-Rybczynski, Jessica L.; Cui, Yunluan; Stevens, M. Henry H.; Davis, Diana J.; Fischer, Mark W. F.; Money, Nicholas P.			Adaptation of the Spore Discharge Mechanism in the Basidiomycota	PLOS ONE			English	Article								Spore discharge in the majority of the 30,000 described species of Basidiomycota is powered by the rapid motion of a fluid droplet, called Buller's drop, over the spore surface. In basidiomycete yeasts, and phytopathogenic rusts and smuts, spores are discharged directly into the airflow around the fungal colony. Maximum discharge distances of 12 mm have been reported for these fungi. In mushroom-forming species, however, spores are propelled over much shorter ranges. In gilled mushrooms, for example, discharge distances of <0.1 mm ensure that spores do not collide with opposing gill surfaces. The way in which the range of the mechanism is controlled has not been studied previously. Methodology/Principal Findings: In this study, we report high-speed video analysis of spore discharge in selected basidiomycetes ranging from yeasts to wood-decay fungi with poroid fruiting bodies. Analysis of these video data and mathematical modeling show that discharge distance is determined by both spore size and the size of the Buller's drop. Furthermore, because the size of Buller's drop is controlled by spore shape, these experiments suggest that seemingly minor changes in spore morphology exert major effects upon discharge distance. Conclusions/Significance: This biomechanical analysis of spore discharge mechanisms in mushroom-forming fungi and their relatives is the first of its kind and provides a novel view of the incredible variety of spore morphology that has been catalogued by traditional taxonomists for more than 200 years. Rather than representing non-selected variations in micromorphology, the new experiments show that changes in spore architecture have adaptive significance because they control the distance that the spores are shot through air. For this reason, evolutionary modifications to fruiting body architecture, including changes in gill separation and tube diameter in mushrooms, must be tightly linked to alterations in spore morphology.	[Stolze-Rybczynski, Jessica L.; Cui, Yunluan; Stevens, M. Henry H.; Davis, Diana J.; Money, Nicholas P.] Miami Univ, Dept Bot, Oxford, OH 45056 USA; [Davis, Diana J.; Fischer, Mark W. F.] Coll Mt St Joseph, Dept Chem & Phys Sci, Cincinnati, OH USA	University System of Ohio; Miami University; Mount St. Joseph University	Stolze-Rybczynski, JL (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.	moneynp@muohio.edu			National Science Foundation [0743074]; National Institutes of Health [1R15 ES016425]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES016425] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by grants from the National Science Foundation (0743074) to N.P.M. and D.J.D., and the National Institutes of Health (1R15 ES016425) to N.P.M. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buller A.H.R., 1922, RES FUNGI, V2; Buller AHR, 1909, RES FUNGI, VI; Gilbertson R. L., 1987, N AM POLYPORES, V2; Ingold C. T., 1992, Mycologist, V6, P111; Ingold C. Terence, 2001, Mycologist, V15, P165; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; PEGLER DN, 1971, NOVA HEDWIGIA, V35; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; Ryvarden L., 1986, N AM POLYPORES, VI; TURNER JCR, 1991, CHEM ENG SCI, V46, P1145, DOI 10.1016/0009-2509(91)85107-9; TURNER JCR, 1995, CHEM ENG SCI, V50, P2359, DOI 10.1016/0009-2509(95)00097-O; WEBSTER J, 1995, MYCOL RES, V99, P833, DOI 10.1016/S0953-7562(09)80737-5; WEBSTER J, 1984, T BRIT MYCOL SOC, V83, P524, DOI 10.1016/S0007-1536(84)80055-8; Webster J., 2007, INTRO FUNGI, V3rd; Yafetto L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003237; ZOBERI MH, 1969, T BRIT MYCOL SOC, V52, P170, DOI 10.1016/S0007-1536(69)80172-5	16	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4163	10.1371/journal.pone.0004163	http://dx.doi.org/10.1371/journal.pone.0004163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129912	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473500010
J	Stein, CM; Zalwango, S; Malone, LL; Won, SH; Mayanja-Kizza, H; Mugerwa, RD; Leontiev, DV; Thompson, CL; Cartier, KC; Elston, RC; Iyengar, SK; Boom, WH; Whalen, CC				Stein, Catherine M.; Zalwango, Sarah; Malone, LaShaunda L.; Won, Sungho; Mayanja-Kizza, Harriet; Mugerwa, Roy D.; Leontiev, Dmitry V.; Thompson, Cheryl L.; Cartier, Kevin C.; Elston, Robert C.; Iyengar, Sudha K.; Boom, W. Henry; Whalen, Christopher C.			Genome Scan of M-tuberculosis Infection and Disease in Ugandans	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA RECEPTOR; QUANTITATIVE-TRAIT; ASSOCIATION ANALYSIS; LINKAGE ANALYSIS; IMMUNE-RESPONSE; IFN-GAMMA; SUSCEPTIBILITY; POLYMORPHISM; GENES	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is an enduring public health problem globally, particularly in sub-Saharan Africa. Several studies have suggested a role for host genetic susceptibility in increased risk for TB but results across studies have been equivocal. As part of a household contact study of Mtb infection and disease in Kampala, Uganda, we have taken a unique approach to the study of genetic susceptibility to TB, by studying three phenotypes. First, we analyzed culture confirmed TB disease compared to latent Mtb infection (LTBI) or lack of Mtb infection. Second, we analyzed resistance to Mtb infection in the face of continuous exposure, defined by a persistently negative tuberculin skin test (PTST-); this outcome was contrasted to LTBI. Third, we analyzed an intermediate phenotype, tumor necrosis factor-alpha (TNF alpha) expression in response to soluble Mtb ligands enriched with molecules secreted from Mtb (culture filtrate). We conducted a full microsatellite genome scan, using genotypes generated by the Center for Medical Genetics at Marshfield. Multipoint model-free linkage analysis was conducted using an extension of the Haseman-Elston regression model that includes half sibling pairs, and HIV status was included as a covariate in the model. The analysis included 803 individuals from 193 pedigrees, comprising 258 full sibling pairs and 175 half sibling pairs. Suggestive linkage (p, 10 23) was observed on chromosomes 2q21-2q24 and 5p13-5q22 for PTST-, and on chromosome 7p22-7p21 for TB; these findings for PTST-are novel and the chromosome 7 region contains the IL6 gene. In addition, we replicated recent linkage findings on chromosome 20q13 for TB (p = 0.002). We also observed linkage at the nominal a = 0.05 threshold to a number of promising candidate genes, SLC11A1 (PTST-p = 0.02), IL-1 complex (TB p = 0.01), IL12BR2 (TNF alpha p = 0.006), IL12A (TB p = 0.02) and IFNGR2 (TNF alpha p = 0.002). These results confirm not only that genetic factors influence the interaction between humans and Mtb but more importantly that they differ according to the outcome of that interaction: exposure but no infection, infection without progression to disease, or progression of infection to disease. Many of the genetic factors for each of these stages are part of the innate immune system.	[Stein, Catherine M.; Won, Sungho; Leontiev, Dmitry V.; Cartier, Kevin C.; Elston, Robert C.; Iyengar, Sudha K.; Whalen, Christopher C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.; Malone, LaShaunda L.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Dept Med, TB Res Unit, Cleveland, OH 44106 USA; [Thompson, Cheryl L.] Case Western Reserve Univ, Dept Family Med, Cleveland, OH 44106 USA; [Stein, Catherine M.; Zalwango, Sarah; Mayanja-Kizza, Harriet; Mugerwa, Roy D.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Uganda Res Collaborat, Kampala, Uganda; [Mayanja-Kizza, Harriet; Mugerwa, Roy D.] Makerere Univ, Sch Med, Mulago Hosp, Kampala, Uganda	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Mulago National Referral Hospital	Stein, CM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	kasia@darwin.cwru.edu	Mayanja-Kizza, Harriet/AAM-5372-2020; /S-1190-2019; Stein, Catherine/P-9498-2019	Mayanja-Kizza, Harriet/0000-0002-9297-6208; /0000-0001-7488-250X; Stein, Catherine/0000-0002-9763-5023	National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development [KL2RR024990]; Tuberculosis Research Unit [N01-AI95383, HHSN266200700022C]; NIAID [N01-AI70022]; STERIS Corporation; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NHLBI Mammalian Genotyping Service [HV48141]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990, P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Tuberculosis Research Unit; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); STERIS Corporation; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NHLBI Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by the National Institutes of Health, National Center for Research Resources (NCRR) Multidisciplinary Clinical Research Career Development Programs Grant (KL2RR024990), Tuberculosis Research Unit (grant N01-AI95383 and HHSN266200700022C/ N01-AI70022 from the NIAID), a developmental grant from the STERIS Corporation, the Gene Expression and Genotyping Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703), and the NHLBI Mammalian Genotyping Service (Contract Number HV48141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Awomoyi AA, 2005, J ENDOTOXIN RES, V11, P281, DOI 10.1179/096805105X58706; BARNES PF, 1990, J IMMUNOL, V145, P149; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Cordell HJ, 2001, ANN HUM GENET, V65, P491, DOI 10.1017/S0003480001008831; CROWLE AJ, 1990, INFECT IMMUN, V58, P632, DOI 10.1128/IAI.58.3.632-638.1990; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fisher R., 1950, STAT METHODS RES WOR; Gomez LM, 2006, TISSUE ANTIGENS, V67, P290, DOI 10.1111/j.1399-0039.2006.00566.x; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hall MA, 2002, AM J HUM GENET, V70, P1172, DOI 10.1086/340090; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jorgenson E, 2005, AM J HUM GENET, V76, P276, DOI 10.1086/427926; Kaufmann SHE, 2006, INT J TUBERC LUNG D, V10, P1068; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; McKinney JD, 1998, BIOMED RES REP, P51; Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031; Montoya-Delgado LE, 2001, GENETICS, V158, P875; Ohyama H, 2005, J CLIN PATHOL, V58, P740, DOI 10.1136/jcp.2004.023903; Olson JM, 2004, HUM HERED, V58, P49, DOI 10.1159/000081456; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Pritchard JK, 2000, GENETICS, V155, P945; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RICE J, 1978, AM J HUM GENET, V30, P618; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Schaid DJ, 2000, GENET EPIDEMIOL, V19, P30, DOI 10.1002/1098-2272(200007)19:1<30::AID-GEPI3>3.3.CO;2-O; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Sinha R, 2008, HUM HERED, V65, P66, DOI 10.1159/000108938; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Stein CM, 2007, HUM GENET, V121, P663, DOI 10.1007/s00439-007-0357-8; Stein CM, 2005, HUM HERED, V60, P109, DOI 10.1159/000088913; Stein CM, 2003, J INFECT DIS, V187, P1679, DOI 10.1086/375249; Thompson CL, 2006, AM J HUM GENET, V79, P606, DOI 10.1086/507847; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Wheeler E, 2006, ANN HUM GENET, V70, P78, DOI 10.1111/j.1529-8817.2005.00223.x; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	59	89	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4094	10.1371/journal.pone.0004094	http://dx.doi.org/10.1371/journal.pone.0004094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116662	gold, Green Published, Green Submitted			2022-12-27	WOS:000265466600015
J	Zhou, YC; Zheng, M; Shi, QX; Zhang, L; Zhen, W; Chen, WY; Zhang, YL				Zhou, Yuchuan; Zheng, Min; Shi, Qixian; Zhang, Li; Zhen, Wei; Chen, Wenying; Zhang, Yonglian			An Epididymis-Specific Secretory Protein HongrES1 Critically Regulates Sperm Capacitation and Male Fertility	PLOS ONE			English	Article								Mammalian sperm capacitation is an essential prerequisite to fertilizion. Although progress had been made in understanding the physiology and biochemistry of capacitation, little is known about the potential roles of epididymal proteins during this process. Here we report that HongrES1, a new member of the SERPIN ( serine proteinase inhibitor) family exclusively expressed in the rat cauda epididymis and up-regulated by androgen, is secreted into the lumen and covers the sperm head. Co-culture of caudal sperms with HongrES1 antibody in vitro resulted in a significant increase in the percentage of capacitated spermatozoa. Furthermore, the percentage of capacitated spermatozoa clearly increased in rats when HongrES1 was down-regulated by RNAi in vivo. Remarkably, knockdown of HongrES1 in vivo led to reduced fertility accompanied with deformed appearance of fetuses and pups. These results identify HongrES1 as a novel and critical molecule in the regulation of sperm capacitation and male fertility.	[Zhou, Yuchuan; Zheng, Min; Zhang, Li; Zhen, Wei; Zhang, Yonglian] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Shi, Qixian; Chen, Wenying] Zhejiang Acad Med Sci, Unit Reproduct Physiol, Hangzhou, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Academy of Medical Sciences	Zhou, YC (corresponding author), Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	ylzhang@sibs.ac.cn	zhou, yuchuan/AAF-6202-2019		973 program [2006CB504002, 2006CB944002]; National Natural Science Foundation of China [30400072]; Chinese Post Doctoral Science Foundation [2005037519]; Shanghai Science and Technology [06JC14075]; Chinese Academy of Sciences (CAS) Knowledge Creative Program [KSCX1-YW-R-54]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Post Doctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Science and Technology(Shanghai Science & Technology Committee); Chinese Academy of Sciences (CAS) Knowledge Creative Program(Chinese Academy of Sciences)	This research was supported by following grants: The 973 program (2006CB504002 and 2006CB944002), the National Natural Science Foundation of China (30400072), Chinese Post Doctoral Science Foundation (2005037519), Shanghai Science and Technology funding (06JC14075), the Chinese Academy of Sciences (CAS) Knowledge Creative Program (KSCX1-YW-R-54).	Ajduk A, 2006, BIOL REPROD, V75, P442, DOI 10.1095/biolreprod.106.053223; Araki Y, 2002, J ANDROL, V23, P854; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Brewis Ian A, 2005, Hum Fertil (Camb), V8, P253, DOI 10.1080/14647270500420178; CHANG MC, 1955, NATURE, V175, P1036, DOI 10.1038/1751036a0; CHANG MC, 1951, NATURE, V168, P997; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; DAVIS BK, 1980, P NATL ACAD SCI-BIOL, V77, P1546, DOI 10.1073/pnas.77.3.1546; DAVIS BK, 1981, P NATL ACAD SCI-BIOL, V78, P7560, DOI 10.1073/pnas.78.12.7560; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; DOW MPD, 1989, GAMETE RES, V23, P171, DOI 10.1002/mrd.1120230204; FRASER LR, 1993, J REPROD FERTIL, V97, P539, DOI 10.1530/jrf.0.0970539; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hinton BT, 1995, REPROD FERT DEVELOP, V7, P731, DOI 10.1071/RD9950731; Hu YX, 2002, CELL RES, V12, P157, DOI 10.1038/sj.cr.7290122; Hu ZH, 2002, CELL RES, V12, P407, DOI 10.1038/sj.cr.7290143; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kirby JL, 2004, BIOL REPROD, V71, P613, DOI 10.1095/biolreprod.103.025635; KOHANE AC, 1980, BIOL REPROD, V23, P737, DOI 10.1095/biolreprod23.4.737; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Luconi M, 1998, BIOL REPROD, V58, P1476, DOI 10.1095/biolreprod58.6.1476; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Oberlander G, 1996, J REPROD FERTIL, V106, P231, DOI 10.1530/jrf.0.1060231; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; ROCHWERGER L, 1992, MOL REPROD DEV, V31, P34, DOI 10.1002/mrd.1080310107; ROYERE D, 1991, MOL REPROD DEV, V28, P177, DOI 10.1002/mrd.1080280211; Saxena DK, 2004, BIOL REPROD, V70, P993, DOI 10.1095/biolreprod.103.021667; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Shoji M, 2005, DEV BIOL, V282, P524, DOI 10.1016/j.ydbio.2005.03.030; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Syntin P, 1996, BIOL REPROD, V55, P956, DOI 10.1095/biolreprod55.5.956; TAFT R, 1992, Journal of Animal Science, V70, P256; TOYODA Y, 1974, J REPROD FERTIL, V36, P125, DOI 10.1530/jrf.0.0360125; Tulsiani DRP, 2004, BIOESSAYS, V26, P281, DOI 10.1002/bies.20003; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; WATSON PF, 1995, REPROD FERT DEVELOP, V7, P891; Yanagimachi R., 1994, P189; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	52	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4106	10.1371/journal.pone.0004106	http://dx.doi.org/10.1371/journal.pone.0004106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116669	Green Published, gold, Green Submitted			2022-12-27	WOS:000265466600023
J	Pesendorfer, MB; Gunhold, T; Schiel, N; Souto, A; Huber, L; Range, F				Pesendorfer, Mario B.; Gunhold, Tina; Schiel, Nicola; Souto, Antonio; Huber, Ludwig; Range, Friederike			The Maintenance of Traditions in Marmosets: Individual Habit, Not Social Conformity? A Field Experiment	PLOS ONE			English	Article							ANIMAL CULTURES DEBATE; COMMON MARMOSETS; CALLITHRIX-JACCHUS; IMITATION; EVOLUTION; TRANSMISSION; CHIMPANZEES; FOOD; PRIMATE; MONKEYS	Background: Social conformity is a cornerstone of human culture because it accelerates and maintains the spread of behaviour within a group. Few empirical studies have investigated the role of social conformity in the maintenance of traditions despite an increasing body of literature on the formation of behavioural patterns in non-human animals. The current report presents a field experiment with free-ranging marmosets (Callithrix jacchus) which investigated whether social conformity is necessary for the maintenance of behavioural patterns within groups or whether individual effects such as habit formation would suffice. Methods: Using a two-action apparatus, we established alternative behavioural patterns in six family groups composed of 36 individuals. These groups experienced only one technique during a training phase and were thereafter tested with two techniques available. The monkeys reliably maintained the trained method over a period of three weeks, despite discovering the alternative technique. Three additional groups were given the same number of sessions, but those 21 individuals could freely choose the method to obtain a reward. In these control groups, an overall bias towards one of the two methods was observed, but animals with a different preference did not adjust towards the group norm. Thirteen of the fifteen animals that discovered both techniques remained with the action with which they were initially successful, independent of the group preference and the type of action (Binomial test: exp. proportion: 0.5, p < 0.01). Conclusions: The results indicate that the maintenance of behavioural patterns within groups 1) could be explained by the first rewarded manipulation and subsequent habit formation and 2) do not require social conformity as a mechanism. After an initial spread of a behaviour throughout a group, this mechanism may lead to a superficial appearance of conformity without the involvement of such a socially and cognitively complex mechanism. This is the first time that such an experiment has been conducted with free-ranging primates.	[Pesendorfer, Mario B.; Gunhold, Tina; Huber, Ludwig; Range, Friederike] Univ Vienna, Dept Neurobiol & Cognit Res, A-1010 Vienna, Austria; [Schiel, Nicola] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil; [Souto, Antonio] Univ Fed Pernambuco, Ctr Cienc Biol, Dept Zool, Recife, PE, Brazil	University of Vienna; Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco	Pesendorfer, MB (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA.	mario.pesendorfer@yahoo.com	Pesendorfer, Mario/H-6636-2019; Souto, Antonio S/G-1799-2010; Schiel, Nicola/H-9047-2012; Pesendorfer, Mario/ABD-7365-2021	Pesendorfer, Mario/0000-0002-7994-7090; Souto, Antonio S/0000-0003-1692-1958; Schiel, Nicola/0000-0002-2454-0912; Range, Friederike/0000-0003-3127-5536; Huber, Ludwig/0000-0002-0217-136X	"Hochschuljubileumsfonds der Stadt Wien"; EDICI project of the European Commission [12929]	"Hochschuljubileumsfonds der Stadt Wien"; EDICI project of the European Commission	This study was financed by the "Hochschuljubileumsfonds der Stadt Wien" and the EDICI project (NEST, No 12929) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezerra BM, 2007, AM J PRIMATOL, V69, P945, DOI 10.1002/ajp.20394; Boesch C, 2007, J COMP PSYCHOL, V121, P227, DOI 10.1037/0735-7036.121.3.227; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 2005, EVOLUTION CULTURE, P105, DOI [10.7551/mitpress/2870.003.0009, DOI 10.7551/MITPRESS/2870.003.0009]; Bugnyar T, 1997, ANIM BEHAV, V54, P817, DOI 10.1006/anbe.1996.0497; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Caldwell CA, 2004, ANIM COGN, V7, P77, DOI 10.1007/s10071-003-0192-9; Caldwell CA, 2003, ANIM BEHAV, V65, P1085, DOI 10.1006/anbe.2003.2145; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Dawkins Richard, 1976, SELFISH GENE; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Fragaszy D, 2003, EVOL ANTHROPOL, V12, P61, DOI 10.1002/evan.10104; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; GALEF BG, 1995, J COMP PSYCHOL, V109, P99, DOI 10.1037/0735-7036.109.1.99; Galef BG, 2004, LEARN BEHAV, V32, P53; Halsey LG, 2006, ANIM COGN, V9, P229, DOI 10.1007/s10071-006-0016-9; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Leca JB, 2007, BEHAVIOUR, V144, P251, DOI 10.1163/156853907780425712; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; Lessells CM, 2006, ANIM BEHAV, V72, P1249, DOI 10.1016/j.anbehav.2006.02.024; Marshall-Pescini S, 2008, ANIM COGN, V11, P449, DOI 10.1007/s10071-007-0135-y; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Nicolakakis N, 2003, ANIM BEHAV, V65, P445, DOI 10.1006/anbe.2003.2085; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Schiel N, 2006, AM J PRIMATOL, V68, P1150, DOI 10.1002/ajp.20284; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Souto A, 2007, INT J PRIMATOL, V28, P881, DOI 10.1007/s10764-007-9165-1; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	45	39	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4472	10.1371/journal.pone.0004472	http://dx.doi.org/10.1371/journal.pone.0004472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437KG	19223965	Green Published			2022-12-27	WOS:000265485800003
J	Secchiero, P; Corallini, F; Ceconi, C; Parrinello, G; Volpato, S; Ferrari, R; Zauli, G				Secchiero, Paola; Corallini, Federica; Ceconi, Claudio; Parrinello, Giovanni; Volpato, Stefano; Ferrari, Roberto; Zauli, Giorgio			Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; ENDOTHELIAL-CELLS; PROLIFERATION; EXPRESSION; INVOLVEMENT; ACTIVATION; SURVIVAL; OSTEOPROTEGERIN; NEUTROPHILS; PROMOTES	Background: Since soluble TRAIL exhibits anti-inflammatory and anti-atherosclerotic activities both in vitro and in animal models, this study was designed to assess the relationship between the serum levels of TRAIL and clinical outcomes in patients with acute myocardial infarction (AMI). Methodology/Principal Findings: Levels of TRAIL were measured by ELISA in serial serum samples obtained from 60 patients admitted for AMI, both during hospitalization and in a follow-up of 12 months, as well as in 60 healthy control subjects. Serum levels of TRAIL were significantly decreased in patients with AMI at baseline (within 24 hours from admission), compared with healthy controls, and showed a significant inverse correlation with a series of negative prognostic markers, such as CK, CK-MB and BNP. TRAIL serum levels progressively increased at discharge, but normalized only at 6-12 months after AMI. Of note, low TRAIL levels at the patient discharge were associated with increased incidence of cardiac death and heart failure in the 12-month follow-up, even after adjustment for demographic and clinical risk parameters (hazard ratio [HR] of 0.93 [95% CI, 0.89 to 0.97]; p = 0.001). Conclusions/Significance: Although the number of patients studied was limited, our findings indicate for the first time that circulating TRAIL might represent an important predictor of cardiovascular events, independent of conventional risk markers.	[Secchiero, Paola; Corallini, Federica; Zauli, Giorgio] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Ceconi, Claudio; Ferrari, Roberto] Azienda Ospedaliera Univ S Anna, Cardiovasc Inst, Ferrara, Italy; [Parrinello, Giovanni] Univ Brescia, Med Stat Unit, I-25121 Brescia, Italy; [Volpato, Stefano] Univ Ferrara, Dept Expt & Clin Med, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Brescia; University of Ferrara	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Zauli, Giorgio/ABE-8001-2020; VOLPATO, STEFANO/H-2977-2014; secchiero, paola/G-9689-2015; FERRARI, ROBERTO/ABD-5169-2020	VOLPATO, STEFANO/0000-0003-4335-6034; secchiero, paola/0000-0003-4101-7987; Ferrari, Roberto/0000-0003-2046-9175; Zauli, Giorgio/0000-0002-3750-8698; Ceconi, Claudio/0000-0002-6381-1404	Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna)	Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna)	This work was supported by a grant from "Programma di Ricerca Regione - University 2007/2009" (Regione Emilia Romagna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005; Cassatella MA, 2006, J LEUKOCYTE BIOL, V79, P123, DOI 10.1189/jlb.0805431; Chen PL, 2008, J VASC RES, V45, P111, DOI 10.1159/000109880; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Jeremias I, 2000, CIRCULATION, V102, P915; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Ladenson JH, 2007, CLIN CHIM ACTA, V381, P3, DOI 10.1016/j.cca.2007.02.039; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Liao XD, 2005, LIFE SCI, V77, P160, DOI 10.1016/j.lfs.2004.11.029; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Nakajima H, 2003, JPN HEART J, V44, P833, DOI 10.1536/jhj.44.833; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; Nyormoi O, 2003, CELL DEATH DIFFER, V10, P558, DOI 10.1038/sj.cdd.4401209; Pritzker LB, 2004, MOL BIOL CELL, V15, P2834, DOI 10.1091/mbc.E04-01-0059; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Takahashi T, 2007, AM J CARDIOL, V100, P35, DOI 10.1016/j.amjcard.2007.02.049; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Zauli G, 2003, CIRC RES, V92, P732, DOI 10.1161/01.RES.0000067928.83455.9C; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zhang XD, 2000, FEBS LETT, V482, P193, DOI 10.1016/S0014-5793(00)02042-1	32	75	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4442	10.1371/journal.pone.0004442	http://dx.doi.org/10.1371/journal.pone.0004442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221598	Green Published, gold, Green Submitted			2022-12-27	WOS:000265485700004
J	Bryant, PA; Smyth, GK; Robins-Browne, R; Curtis, N				Bryant, Penelope A.; Smyth, Gordon K.; Robins-Browne, Roy; Curtis, Nigel			Detection of Gene Expression in an Individual Cell Type within a Cell Mixture Using Microarray Analysis	PLOS ONE			English	Article								Background: A central issue in the design of microarray-based analysis of global gene expression is the choice between using cells of single type and a mixture of cells. This study quantified the proportion of lipopolysaccharide (LPS) induced differentially expressed monocyte genes that could be measured in peripheral blood mononuclear cells (PBMC), and determined the extent to which gene expression in the non-monocyte cell fraction diluted or obscured fold changes that could be detected in the cell mixture. Methodology/Principal Findings: Human PBMC were stimulated with LPS, and monocytes were then isolated by positive (Mono+) or negative (Mono-) selection. The non-monocyte cell fraction (MonoD) remaining after positive selection of monocytes was used to determine the effect of non-monocyte cells on overall expression. RNA from LPS-stimulated PBMC, Mono+, Mono- and MonoD samples was co-hybridised with unstimulated RNA for each cell type on oligonucleotide microarrays. There was a positive correlation in gene expression between PBMC and both Mono+ (0.77) and Mono- (0.61-0.67) samples. Analysis of individual genes that were differentially expressed in Mono+ and Mono- samples showed that the ability to detect expression of some genes was similar when analysing PBMC, but for others, differential expression was either not detected or changed in the opposite direction. As a result of the dilutional or obscuring effect of gene expression in non-monocyte cells, overall about half of the statistically significant LPS-induced changes in gene expression in monocytes were not detected in PBMC. However, 97% of genes with a four fold or greater change in expression in monocytes after LPS stimulation, and almost all (96-100%) of the top 100 most differentially expressed monocyte genes were detected in PBMC. Conclusions/Significance: The effect of non-responding cells in a mixture dilutes or obscures the detection of subtle changes in gene expression in an individual cell type. However, for studies in which only the most highly differentially expressed genes are of interest, separating and analysing individual cell types may be unnecessary.	[Bryant, Penelope A.; Curtis, Nigel] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia; [Bryant, Penelope A.; Robins-Browne, Roy; Curtis, Nigel] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Microbiol & Infect Dis Res Grp, Parkville, Vic, Australia; [Bryant, Penelope A.; Curtis, Nigel] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia; [Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Bryant, PA (corresponding author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Smyth, Gordon/B-5276-2008; Robinsbrowne, Roy/ABF-8434-2020; Curtis, Nigel/B-3491-2012	Smyth, Gordon/0000-0001-9221-2892; Robinsbrowne, Roy/0000-0001-9179-7884; Curtis, Nigel/0000-0003-3446-4594	National Health and Medical Research Council; National Heart Foundation of Australia; European Society of Paediatric Infectious Diseases [Fellowship Award]; University of Melbourne [Research Scholarship]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); European Society of Paediatric Infectious Diseases; University of Melbourne(University of Melbourne)	This study was supported by a grant from the National Health and Medical Research Council and National Heart Foundation of Australia. Dr. Bryant was the recipient of a European Society of Paediatric Infectious Diseases Fellowship Award and a University of Melbourne Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANO T, 1994, J PHARMACOL EXP THER, V268, P1032; Baqui AAMA, 2000, IMMUNOPHARM IMMUNOT, V22, P401, DOI 10.3109/08923970009026002; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolt G, 2002, J GEN VIROL, V83, P1157, DOI 10.1099/0022-1317-83-5-1157; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEFORGE LE, 1991, BIOCHEM BIOPH RES CO, V174, P18, DOI 10.1016/0006-291X(91)90478-P; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fessele S, 2001, FASEB J, V15, P577; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Holloway AJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-511; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Rus V, 2002, CLIN IMMUNOL, V102, P283, DOI 10.1006/clim.2001.5182; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; Viemann D, 2005, BBA-MOL CELL RES, V1746, P73, DOI 10.1016/j.bbamcr.2005.09.005; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640	25	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2009	4	2							e4427	10.1371/journal.pone.0004427	http://dx.doi.org/10.1371/journal.pone.0004427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JQ	19212463	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484200002
J	Perez-Berna, AJ; Pabst, G; Laggner, P; Villalain, J				Perez-Berna, Ana J.; Pabst, George; Laggner, Peter; Villalain, Jose			Screening a Peptide Library by DSC and SAXD: Comparison with the Biological Function of the Parent Proteins	PLOS ONE			English	Article								We have recently identified the membranotropic regions of the hepatitis C virus proteins E1, E2, core and p7 proteins by observing the effect of protein-derived peptide libraries on model membrane integrity. We have studied in this work the ability of selected sequences of these proteins to modulate the L-beta-L-alpha and L alpha-H-II phospholipid phase transitions as well as check the viability of using both DSC and SAXD to screen a protein-derived peptide library. We demonstrate that it is feasible to screen a library of peptides corresponding to one or several proteins by both SAXD and DSC. This methodological combination should allow the identification of essential regions of membrane-interacting proteins which might be implicated in the molecular mechanism of membrane fusion and/or budding.	[Villalain, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante, Spain; [Pabst, George; Laggner, Peter] Austrian Acad Sci, Inst Biophys & Nanosyst Res, Graz, Austria	Universidad Miguel Hernandez de Elche; Austrian Academy of Sciences	Perez-Berna, AJ (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante, Spain.	jvillalain@umh.es	Perez-Berna, Ana/G-2789-2016; Pabst, Georg/O-1452-2019; Pabst, Georg/I-6919-2015	Pabst, Georg/0000-0003-1967-1536; Pabst, Georg/0000-0003-1967-1536; Perez-Berna, Ana/0000-0003-4145-532X; Villalain, Jose/0000-0002-5148-141X	Ministerio de Ciencia y Tecnologia, Spain [BFU2005-00186-BMC]	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grant BFU2005-00186-BMC (Ministerio de Ciencia y Tecnologia, Spain) to J.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bottcher C. S. F., 1961, ANAL CHIM ACTA, V1061, P203; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; CHA TA, 1992, P NATL ACAD SCI USA, V89, P7144, DOI 10.1073/pnas.89.15.7144; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Garry RF, 2003, VIROLOGY, V307, P255, DOI 10.1016/S0042-6822(02)00065-X; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KILLIAN JA, 1985, BIOCHEMISTRY-US, V24, P7890, DOI 10.1021/bi00348a007; Kunkel M, 2004, FEBS LETT, V557, P174, DOI 10.1016/S0014-5793(03)01486-8; Laggner P, 1994, Subcell Biochem, V23, P451; Lee SK, 2007, BIOCHEM BIOPH RES CO, V352, P756, DOI 10.1016/j.bbrc.2006.11.098; LUZZATI V, 1968, NATURE, V217, P1028, DOI 10.1038/2171028a0; Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Peisajovich SG, 2003, BBA-BIOMEMBRANES, V1614, P122, DOI 10.1016/S0005-2736(03)00170-6; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Perez-Berna AJ, 2008, J VIRAL HEPATITIS, V15, P346, DOI 10.1111/j.1365-2893.2007.00948.x; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Perez-Berna AJ, 2008, J BIOL CHEM, V283, P8089, DOI 10.1074/jbc.M709413200; Perez-Fons L, 2006, ARCH BIOCHEM BIOPHYS, V453, P224, DOI 10.1016/j.abb.2006.07.004; Pozzetto B, 1996, NEPHROL DIAL TRANSPL, V11, P2; Qureshi SA, 2007, MED RES REV, V27, P353, DOI 10.1002/med.20063; RAPPOLT M, 2008, CHEM PHYS LIPIDS; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200	42	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2009	4	2							e4356	10.1371/journal.pone.0004356	http://dx.doi.org/10.1371/journal.pone.0004356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JL	19194494	Green Published, gold, Green Submitted			2022-12-27	WOS:000265483600005
J	Milstein, J; Mormann, F; Fried, I; Koch, C				Milstein, Joshua; Mormann, Florian; Fried, Itzhak; Koch, Christof			Neuronal Shot Noise and Brownian 1/f(2) Behavior in the Local Field Potential	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; BRAIN; EEG; AWAKE	We demonstrate that human electrophysiological recordings of the local field potential (LFP) from intracranial electrodes, acquired from a variety of cerebral regions, show a ubiquitous 1/f(2) scaling within the power spectrum. We develop a quantitative model that treats the generation of these fields in an analogous way to that of electronic shot noise, and use this model to specifically address the cause of this 1/f(2) Brownian noise. The model gives way to two analytically tractable solutions, both displaying Brownian noise: 1) uncorrelated cells that display sharp initial activity, whose extracellular fields slowly decay in time and 2) rapidly firing, temporally correlated cells that generate UP-DOWN states.	[Milstein, Joshua; Mormann, Florian; Koch, Christof] CALTECH, Pasadena, CA 91125 USA; [Mormann, Florian; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90024 USA; [Mormann, Florian; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behavior, Los Angeles, CA 90024 USA; [Fried, Itzhak] Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Milstein, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.	milstein@caltech.edu	Mormann, Florian/K-1582-2014	Mormann, Florian/0000-0003-1305-8028	Sloan-Swartz Foundation; European Commission; NINDS; DARPA; NSF; Mathers Foundation	Sloan-Swartz Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Mathers Foundation	Funding was provided by a fellowship from the Sloan-Swartz Foundation to J.N. Milstein, by a Marie Curie fellowship from the European Commission to F. Mormann, and by NINDS, DARPA, NSF and the Mathers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HDB STOCHASTIC METHO; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bragin A, 2002, ANN NEUROL, V52, P407, DOI 10.1002/ana.10291; BROWN J, 2000, SCALING BIOL SANTA I; Buzsaki G., 2006, RHYTHMS BRAIN; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gutenberg B., 1942, B SEISMOL SOC AM, V32, P163; Gutenberg B., 1954, SEISMICITY EARTH ASS; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kandel E., 2000, PRINCIPLES NEURAL SC; Koch Christof, 1999, P1; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Milstein JN, 2008, NEURAL COMPUT, V20, P2070, DOI 10.1162/neco.2008.06-07-537; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; PARETO V, 1897, COURS EC POLITQUE, V2; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Schottky W, 1918, ANN PHYS-BERLIN, V57, P541; STERIADE M, 1993, J NEUROSCI, V13, P3266; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006	30	95	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2009	4	2							e4338	10.1371/journal.pone.0004338	http://dx.doi.org/10.1371/journal.pone.0004338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JJ	19190760	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000265483300002
J	Meur, AML; Mohebiany, AN; O'Connor, TP				Meur, Ana Mingorance-Le; Mohebiany, Alma N.; O'Connor, Timothy P.			Varicones and Growth Cones: Two Neurite Terminals in PC12 Cells	PLOS ONE			English	Article								The rat adrenal pheochromocytoma PC12 cell line is one of the traditional models for the study of neurite outgrowth and growth cone behavior. To clarify to what extent PC12 neurite terminals can be compared to neuronal growth cones, we have analyzed their morphology and protein distribution in fixed PC12 cells by immunocytochemistry. Our results show that that PC12 cells display a special kind of neurite terminal that includes a varicosity in close association with a growth cone. This hybrid terminal, or "varicone'', is characterized by the expression of specific markers not typically present in neuronal growth cones. For example, we show that calpain-2 is a specific marker of varicones and can be detected even before the neurite develops. Our data also shows that a fraction of PC12 neurites end in regular growth cones, which we have compared to hippocampal neurites as a control. We also report the extraordinary incidence of varicones in the literature referred to as "growth cones''. In summary, we provide evidence of two different kinds of neurite terminals in PC12 cells, including a PC12-specific terminal, which implies that care must be taken when using them as a model for neuronal growth cones or neurite outgrowth.	[Meur, Ana Mingorance-Le; Mohebiany, Alma N.; O'Connor, Timothy P.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Meur, AML (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	alemeur@interchange.ubc.ca		Mingorance, Ana/0000-0002-6213-6160; Mohebiany, Alma/0000-0001-9818-6867	CIHR [MOP-13246]; EMBO [Long-Term Fellowship]; MSFHR [Postdoctoral Fellowship]	CIHR(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); MSFHR(Michael Smith Foundation for Health Research)	This work was supported by CIHR grant (MOP-13246) to TPO and by an EMBO Long-Term Fellowship and a MSFHR Postdoctoral Fellowship to AMLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 2006, SCI STKE, pTR9; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; Evans JS, 2007, J NEUROCHEM, V103, P849, DOI 10.1111/j.1471-4159.2007.04815.x; GISPEN WH, 1991, MOL NEUROBIOL, V5, P61, DOI 10.1007/BF02935540; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1977, BRAIN RES, V129, P247, DOI 10.1016/0006-8993(77)90005-1; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Lamoureux P, 1997, J CELL SCI, V110, P635; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Lochner JE, 1998, MOL BIOL CELL, V9, P2463, DOI 10.1091/mbc.9.9.2463; LUCKENBILLEDDS L, 1979, J NEUROCYTOL, V8, P493, DOI 10.1007/BF01214805; MANIVANNAN S, 1994, J NEUROSCI, V14, P5917; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; MINGORANCELEMEU.A, 2009, EMBO J          1218, DOI DOI 10.1038/EMBOJ.2008.1265; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; Nakanishi S, 1998, ARCH HISTOL CYTOL, V61, P221, DOI 10.1679/aohc.61.221; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Park SJ, 2005, EMBO J, V24, P1557, DOI 10.1038/sj.emboj.7600586; PINTER M, 1994, NEUROSCI LETT, V170, P91, DOI 10.1016/0304-3940(94)90246-1; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Smith CL, 2004, J NEUROBIOL, V61, P222, DOI 10.1002/neu.20038; TAOCHENG JH, 1995, J NEUROSCI RES, V42, P323, DOI 10.1002/jnr.490420306; To KCW, 2008, NEUROSCIENCE, V153, P645, DOI 10.1016/j.neuroscience.2008.02.043; To KCW, 2007, MOL CELL NEUROSCI, V36, P425, DOI 10.1016/j.mcn.2007.08.001; VARNUMFINNEY B, 1994, J CELL BIOL, V127, P1071, DOI 10.1083/jcb.127.4.1071; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Zhou T, 2006, ACTA NEUROBIOL EXP, V66, P105	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2009	4	2							e4334	10.1371/journal.pone.0004334	http://dx.doi.org/10.1371/journal.pone.0004334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JI	19183810	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483200009
J	Tamura, T; Sone, M; Yamashita, M; Wanker, EE; Okazawa, H				Tamura, Takuya; Sone, Masaki; Yamashita, Mayumi; Wanker, Erich E.; Okazawa, Hitoshi			Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models	PLOS ONE			English	Article								Background: In several neurodegenerative disorders, toxic effects of glial cells on neurons are implicated. However the generality of the non-cell autonomous pathologies derived from glial cells has not been established, and the specificity among different neurodegenerative disorders remains unknown. Methodology/Principal Findings: We newly generated Drosophila models expressing human mutant huntingtin (hHtt103Q) or ataxin-1 (hAtx1-82Q) in the glial cell lineage at different stages of differentiation, and analyzed their morphological and behavioral phenotypes. To express hHtt103Q and hAtx1-82Q, we used 2 different Gal4 drivers, gcm-Gal4 and repo-Gal4. Gcm-Gal4 is known to be a neuroglioblast/glioblast-specific driver whose effect is limited to development. Repo-Gal4 is known to be a pan-glial driver and the expression starts at glioblasts and continues after terminal differentiation. Gcm-Gal4-induced hHtt103Q was more toxic than repo-Gal4-induced hHtt103Q from the aspects of development, locomotive activity and survival of flies. When hAtx1-82Q was expressed by gcm-or repo-Gal4 driver, no fly became adult. Interestingly, the head and brain sizes were markedly reduced in a part of pupae expressing hAtx1-82Q under the control of gcm-Gal4, and these pupae showed extreme destruction of the brain structure. The other pupae expressing hAtx1-82Q also showed brain shrinkage and abnormal connections of neurons. These results suggested that expression of polyQ proteins in neuroglioblasts provided a remarkable effect on the developmental and adult brains, and that glial cell lineage expression of hAtx1-82Q was more toxic than that of hHtt103Q in our assays. Conclusion/Significance: All these studies suggested that the non-cell autonomous effect of glial cells might be a common pathology shared by multiple neurodegenerative disorders. In addition, the fly models would be available for analyzing molecular pathologies and developing novel therapeutics against the non-cell autonomous polyQ pathology. In conclusion, our novel fly models have extended the non-cell autonomous pathology hypothesis as well as the developmental effect hypothesis to multiple polyQ diseases. The two pathologies might be generally shared in neurodegeneration.	[Tamura, Takuya; Yamashita, Mayumi; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan; [Sone, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo, Japan; [Wanker, Erich E.] Max Delbruck Ctr Molecular Med, Dept Neurogenet, Berlin, Germany	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Tamura, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Sone, Masaki/Q-9058-2019	Wanker, Erich/0000-0001-8072-1630	Japan Science Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [16390249, 16650076, 18390254, 18650097, 17025017, 18023014, 20023011]	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to H.O. from Japan Science Technology Agency (PRESTO, JST, Japan) and from Ministry of Education, Culture, Sports, Science and Technology of Japan (16390249, 16650076, 18390254, 18650097, Research on Pathomechanisms of Brain Disorders: 17025017, 18023014, 20023011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama-Oda Y, 2000, DEVELOPMENT, V127, P3513; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hoshino M, 2006, J CELL BIOL, V172, P589, DOI 10.1083/jcb.200509132; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Soustelle L, 2007, DEV DYNAM, V236, P2101, DOI 10.1002/dvdy.21232; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wegner M, 2001, TRENDS GENET, V17, P286, DOI 10.1016/S0168-9525(01)02275-2; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	25	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4262	10.1371/journal.pone.0004262	http://dx.doi.org/10.1371/journal.pone.0004262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JD	19165334	Green Published, Green Accepted, gold			2022-12-27	WOS:000265482400009
J	Tu, CT; Yang, TC; Tsai, HJ				Tu, Chi-Tang; Yang, Tzu-Ching; Tsai, Huai-Jen			Nkx2.7 and Nkx2.5 Function Redundantly and Are Required for Cardiac Morphogenesis of Zebrafish Embryos	PLOS ONE			English	Article							HEART PROGENITOR CELLS; HOMEOBOX GENE; TINMAN; EXPRESSION; SPECIFICATION; FAMILY; MYOGENESIS; XNKX-2.3; HOMOLOGS; DEFECTS	Background: Nkx2.7 is the tinman-related gene, as well as orthologs of Nkx2.5 and Nkx-2.3. Nkx2.7 and Nkx2.5 express in zebrafish heart fields of lateral plate mesoderm. The temporal and spatial expression patterns of Nkx2.7 are similar to those of Nkx2.5, but their functions during cardiogenesis remain unclear. Methodology/Principal Findings: Here, Nkx2.7 is demonstrated to compensate for Nkx2.5 loss of function and play a predominant role in the lateral development of the heart, including normal cardiac looping and chamber formation. Knocking down Nkx2.5 showed that heart development was normal from 24 to 72 hpf. However, when knocking down either Nkx2.7 or Nkx2.5 together with Nkx2.7, it appeared that the heart failed to undergo looping and showed defective chambers, although embryos developed normally before the early heart tube stage. Decreased ventricular myocardium proliferation and defective myocardial differentiation appeared to result from late-stage up-regulation of bmp4, versican, tbx5 and tbx20, which were all expressed normally in hearts at an early stage. We also found that tbx5 and tbx20 were modulated by Nkx2.7 through the heart maturation stage because an inducible overexpression of Nkx2.7 in the heart caused down-regulation of tbx5 and tbx20. Although heart defects were induced by overexpression of an injection of 150-pg Nkx2.5 or 5-pg Nkx2.7 mRNA, either Nkx2.5 or Nkx2.7 mRNA rescued the defects induced by Nkx2.7-morpholino(MO) and Nkx2.5-MO with Nkx2.7-MO. Conclusions and Significance: Therefore, we conclude that redundant activities of Nkx2.5 and Nkx2.7 are required for cardiac morphogenesis, but that Nkx2.7 plays a more critical function, specifically indicated by the gain-of-function and loss-of-function experiments where Nkx2.7 is observed to regulate the expressions of tbx5 and tbx20 through the maturation stage.	Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Taiwan University	Tu, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, ROC	National Science Council, ROC(Ministry of Science and Technology, Taiwan)	This paper was partially supported by the grant from National Science Council, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biben C, 1998, MECH DEVELOP, V73, P125, DOI 10.1016/S0925-4773(98)00037-9; BODMER R, 1993, DEVELOPMENT, V118, P719; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brand T, 1997, MECH DEVELOP, V64, P53, DOI 10.1016/S0925-4773(97)00044-0; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Buchberger A, 1996, MECH DEVELOP, V56, P151, DOI 10.1016/0925-4773(96)00521-7; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen L M, 2001, Matern Child Health J, V5, P35, DOI 10.1023/A:1011345801673; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; EVANS SM, 1995, DEVELOPMENT, V121, P3889; Fu YC, 1998, DEVELOPMENT, V125, P4439; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang HG, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-7; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lee KH, 1996, DEV BIOL, V180, P722, DOI 10.1006/dbio.1996.0341; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Moore JL, 2002, BIOTECHNIQUES, V32, P296, DOI 10.2144/02322st03; Newman CS, 1998, DEV GENET, V22, P230; Pabst O, 1997, DEV DYNAM, V209, P29; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Reecy JM, 1997, DEV BIOL, V188, P295, DOI 10.1006/dbio.1997.8641; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Tanaka M, 2000, MOL CELL BIOL, V20, P2874, DOI 10.1128/MCB.20.8.2874-2879.2000; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Targoff KL, 2008, DEV BIOL, V322, P314, DOI 10.1016/j.ydbio.2008.07.037; Vaughan CJ, 2000, AM J MED GENET, V97, P304, DOI 10.1002/1096-8628(200024)97:4<304::AID-AJMG1281>3.0.CO;2-#; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	41	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4249	10.1371/journal.pone.0004249	http://dx.doi.org/10.1371/journal.pone.0004249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158954	Green Published, Green Submitted, gold			2022-12-27	WOS:000265482200006
J	Lindorff-Larsen, K; Ferkinghoff-Borg, J				Lindorff-Larsen, Kresten; Ferkinghoff-Borg, Jesper			Similarity Measures for Protein Ensembles	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NMR STRUCTURES; DISTANCE; ENERGY; PROBABILITY; BACKBONE; CONVERGENCE; INFORMATION; VALIDATION; RELAXATION	Analyses of similarities and changes in protein conformation can provide important information regarding protein function and evolution. Many scores, including the commonly used root mean square deviation, have therefore been developed to quantify the similarities of different protein conformations. However, instead of examining individual conformations it is in many cases more relevant to analyse ensembles of conformations that have been obtained either through experiments or from methods such as molecular dynamics simulations. We here present three approaches that can be used to compare conformational ensembles in the same way as the root mean square deviation is used to compare individual pairs of structures. The methods are based on the estimation of the probability distributions underlying the ensembles and subsequent comparison of these distributions. We first validate the methods using a synthetic example from molecular dynamics simulations. We then apply the algorithms to revisit the problem of ensemble averaging during structure determination of proteins, and find that an ensemble refinement method is able to recover the correct distribution of conformations better than standard single-molecule refinement.	Univ Copenhagen, Dept Mol Biol, Copenhagen O, Denmark; [Ferkinghoff-Borg, Jesper] Tech Univ Denmark, Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Lindorff-Larsen, K (corresponding author), Univ Copenhagen, Dept Mol Biol, Copenhagen O, Denmark.	Lindorff@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039				Agrafiotis DK, 2002, P NATL ACAD SCI USA, V99, P15869, DOI 10.1073/pnas.242424399; Allen LR, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285211; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andricioaei I, 2001, J CHEM PHYS, V115, P6289, DOI 10.1063/1.1401821; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; BEGLOV D, 1995, BIOPOLYMERS, V35, P171, DOI 10.1002/bip.360350205; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bonvin AMJJ, 1996, J BIOMOL NMR, V7, P72; BONVIN AMJJ, 1995, J MOL BIOL, V250, P80, DOI 10.1006/jmbi.1995.0360; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS BR, 1995, J COMPUT CHEM, V16, P1522, DOI 10.1002/jcc.540161209; Bruschweiler R, 2003, PROTEINS, V50, P26, DOI 10.1002/prot.10250; BRUSCHWEILER R, 1992, J AM CHEM SOC, V114, P2289, DOI 10.1021/ja00033a002; Burling FT, 1996, SCIENCE, V271, P72, DOI 10.1126/science.271.5245.72; Carugo O, 2007, PROTEIN ENG DES SEL, V20, P33, DOI 10.1093/protein/gzl051; Chalaoux FR, 1999, PROTEINS, V34, P453, DOI 10.1002/(SICI)1097-0134(19990301)34:4<453::AID-PROT5>3.0.CO;2-7; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; Cover T. M., 1991, ELEMENTS INFORM THEO; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; DING C, 2004, P 21 INT C ICML 2004; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Furnham N, 2006, NAT STRUCT MOL BIOL, V13, P184, DOI 10.1038/nsmb0306-184; Goldsmith-Fischman S, 2003, PROTEIN SCI, V12, P1813, DOI 10.1110/ps.0242903; GRAY AG, 2003, VERY FAST MULTIVARIA; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; GUHA R, 2007, C IMPLEMENTATION STO; HALL P, 1991, BIOMETRIKA, V78, P263; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Ihler A., 2003, KERNEL DENSITY ESTIM; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; Krzanowski WJ, 2003, J APPL STAT, V30, P743, DOI 10.1080/0266476032000076029; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; Latzer J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2375121; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Ming DM, 2005, PROTEINS, V59, P697, DOI 10.1002/prot.20440; Murdock SE, 2006, J CHEM THEORY COMPUT, V2, P1477, DOI 10.1021/ct6001708; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Osterreicher F, 2003, ANN I STAT MATH, V55, P639, DOI 10.1007/BF02517812; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; POST CB, 1992, J MOL BIOL, V224, P1087, DOI 10.1016/0022-2836(92)90471-U; Qian H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.042103; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; ROTHER D, 2007, IEEE ACM T IN PRESS; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; SCHEEK RM, 1991, STRUCTURE DETERMINAT, P209; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Schneider TR, 1999, J MOL BIOL, V285, P727, DOI 10.1006/jmbi.1998.2323; SIBSON R, 1969, Z WAHRSCHEINLICHKEIT, V14, P149, DOI 10.1007/BF00537520; Sierk ML, 2004, PROTEIN SCI, V13, P773, DOI 10.1110/ps.03328504; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Wall ME, 2006, LIGAND BINDING PROTE, P16; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zagrovic B, 2006, PROTEINS, V63, P210, DOI 10.1002/prot.20872; Zhou SK, 2006, IEEE T PATTERN ANAL, V28, P917, DOI 10.1109/TPAMI.2006.120; Zidek L, 1999, NAT STRUCT BIOL, V6, P1118	84	49	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2009	4	1							e4203	10.1371/journal.pone.0004203	http://dx.doi.org/10.1371/journal.pone.0004203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IG	19145244	gold, Green Published, Green Submitted			2022-12-27	WOS:000265479800009
J	Meunier, MC; Baron, C; Perreault, C				Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude			Two Host Factors Regulate Persistence of H7(a)-Specific T Cells Injected in Tumor-Bearing Mice	PLOS ONE			English	Article								Background: Injection of CD8 T cells primed against immunodominant minor histocompatibility antigens (MiHA) such as H7(a) can eradicate leukemia and solid tumors. To understand why MiHA-targeted T cells have such a potent antitumor effect it is essential to evaluate their in vivo behavior. In the present work, we therefore addressed two specific questions: what is the proliferative dynamics of H7(a)-specifc T cells in tumors, and do H7(a)-specific T cells persist long-term after adoptive transfer? Methodology/Principal Findings: By day 3 after adoptive transfer, we observed a selective infiltration of melanomas by anti-H7(a) T cells. Over the next five days, anti-H7(a) T cells expanded massively in the tumor but not in the spleen. Thus, by day 8 after injection, anti-H7(a) T cells in the tumor had undergone more cell divisions than those in the spleen. These data strongly suggest that anti-H7(a) T cells proliferate preferentially and extensively in the tumors. We also found that two host factors regulated long-term persistence of anti-H7(a) memory T cells: thymic function and expression of H7(a) by host cells. On day 100, anti-H7(a) memory T cells were abundant in euthymic H7(a)-negative (B10.H7(b)) mice, present in low numbers in thymectomized H7(a)-positive (B10) hosts, and undetectable in euthymic H7(a)-positive recipients. Conclusions/Significance: Although in general the tumor environment is not propitious to T-cell invasion and expansion, the present work shows that this limitation may be overcome by adoptive transfer of primed CD8 T cells targeted to an immunodominant MiHA (here H7(a)). At least in some cases, prolonged persistence of adoptively transferred T cells may be valuable for prevention of late cancer relapse in adoptive hosts. Our findings therefore suggest that it may be advantageous to target MiHAs with a restricted tissue distribution in order to promote persistence of memory T cells and thereby minimize the risk of cancer recurrence.	[Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Meunier, Marie-Christine; Baron, Chantal; Perreault, Claude] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Meunier, MC (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	c.perreault@videotron.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383	Canadian Cancer Society; National Cancer Institute of Canada; Canada Research Chair in Immunobiology	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair in Immunobiology(Canada Research Chairs)	This work was supported by the Canadian Cancer Society. MCM was supported by a training grant from the National Cancer Institute of Canada. CP holds a Canada Research Chair in Immunobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Baron C, 2006, J IMMUNOL, V177, P8466, DOI 10.4049/jimmunol.177.12.8466; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blais ME, 2004, BLOOD, V103, P3102, DOI 10.1182/blood-2003-09-3311; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brickner AG, 2006, BLOOD, V107, P3779, DOI 10.1182/blood-2005-08-3501; Choi EY, 2002, BLOOD, V100, P4259, DOI 10.1182/blood-2002-05-1299; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Dulude G, 1999, J EXP MED, V189, P1329, DOI 10.1084/jem.189.8.1329; Eden PA, 1999, J IMMUNOL, V162, P4502; Fontaine P, 2001, NAT MED, V7, P789, DOI 10.1038/89907; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Klein CA, 2002, J EXP MED, V196, P359, DOI 10.1084/jem.20011838; Korngold R, 1997, Biol Blood Marrow Transplant, V3, P57; Lane C, 2004, CANCER RES, V64, P1509, DOI 10.1158/0008-5472.CAN-03-3227; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McBride K, 2002, IMMUNOGENETICS, V54, P562, DOI 10.1007/s00251-002-0502-4; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Meunier MC, 2003, BLOOD, V101, P766, DOI 10.1182/blood-2002-04-1032; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Nijmeijer BA, 2005, EXP HEMATOL, V33, P1172, DOI 10.1016/j.exphem.2005.06.034; Obhrai JS, 2006, J IMMUNOL, V176, P4051, DOI 10.4049/jimmunol.176.7.4051; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Oosten LEM, 2004, BLOOD, V104, P224, DOI 10.1182/blood-2003-07-2461; Perreault C, 2002, J MOL MED, V80, P212, DOI 10.1007/s00109-001-0315-1; Pion S, 1997, EUR J IMMUNOL, V27, P421, DOI 10.1002/eji.1830270212; Rice J, 2006, CANCER RES, V66, P5436, DOI 10.1158/0008-5472.CAN-05-3130; Riddell SR, 2006, BIOL BLOOD MARROW TR, V12, P9, DOI 10.1016/j.bbmt.2005.10.025; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Roy-Proulx G, 2005, BIOL BLOOD MARROW TR, V11, P260, DOI 10.1016/j.bbmt.2004.12.334; Roy-Proulx G, 2001, EUR J IMMUNOL, V31, P2284, DOI 10.1002/1521-4141(200108)31:8<2284::AID-IMMU2284>3.0.CO;2-E; Spierings E, 2004, TRENDS IMMUNOL, V25, P56, DOI 10.1016/j.it.2003.12.002; STORB R, 1983, ANN INTERN MED, V98, P461, DOI 10.7326/0003-4819-98-4-461; Truitt RL, 2004, BIOL BLOOD MARROW TR, V10, P505, DOI 10.1016/j.bbmt.2004.05.005; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Yu P, 2006, CURR OPIN IMMUNOL, V18, P226, DOI 10.1016/j.coi.2006.01.004; Zecca M, 2002, BLOOD, V100, P1192, DOI 10.1182/blood-2001-11-0059; Zinkernagel RM, 1999, IMMUNOL REV, V168, P305, DOI 10.1111/j.1600-065X.1999.tb01300.x; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	53	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4116	10.1371/journal.pone.0004116	http://dx.doi.org/10.1371/journal.pone.0004116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127288	Green Submitted, gold, Green Published			2022-12-27	WOS:000265473300002
J	Fulton, A; Peters, ST; Perkins, GA; Jarosinski, KW; Damiani, A; Brosnahan, M; Buckles, EL; Osterrieder, N; Van de Walle, GR				Fulton, Amy; Peters, Sarah T.; Perkins, Gillian A.; Jarosinski, Keith W.; Damiani, Armando; Brosnahan, Margaret; Buckles, Elizabeth L.; Osterrieder, Nikolaus; Van de Walle, Gerlinde R.			Effective Treatment of Respiratory Alphaherpesvirus Infection Using RNA Interference	PLOS ONE			English	Article								Background: Equine herpesvirus type 1 (EHV-1), a member of the Alphaherpesvirinae, is spread via nasal secretions and causes respiratory disease, neurological disorders and abortions. The virus is a significant equine pathogen, but current EHV-1 vaccines are only partially protective and effective metaphylactic and therapeutic agents are not available. Small interfering RNAs (siRNA's), delivered intranasally, could prove a valuable alternative for infection control. siRNA's against two essential EHV-1 genes, encoding the viral helicase (Ori) and glycoprotein B, were evaluated for their potential to decrease EHV-1 infection in a mouse model. Methodology/Principal Fndings: siRNA therapy in vitro significantly reduced virus production and plaque size. Viral titers were reduced 80-fold with 37.5 pmol of a single siRNA or with as little as 6.25 pmol of each siRNA when used in combination. siRNA therapy in vivo significantly reduced viral replication and clinical signs. Intranasal treatment did not require a transport vehicle and proved effective when given up to 12 h before or after infection. Conclusions/Significance: siRNA treatment has potential for both prevention and early treatment of EHV-1 infections.	[Fulton, Amy; Peters, Sarah T.; Jarosinski, Keith W.; Damiani, Armando; Brosnahan, Margaret; Osterrieder, Nikolaus; Van de Walle, Gerlinde R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Perkins, Gillian A.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Buckles, Elizabeth L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany	Cornell University; Cornell University; Cornell University; Free University of Berlin	Fulton, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	no34@cornell.edu		Van de Walle, Gerlinde/0000-0002-2064-8029; Jarosinski, Keith/0000-0002-0391-9018; Osterrieder, Nikolaus/0000-0002-5313-2176	Harry M. Zweig Fund for Equine Research at Cornell University	Harry M. Zweig Fund for Equine Research at Cornell University	This work was supported by the Harry M. Zweig Fund for Equine Research at Cornell University to G.A.P and N.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN FH, 1987, J CHEM SOC P2, V11, P1; Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78; AWAN AR, 1990, J GEN VIROL, V71, P1131, DOI 10.1099/0022-1317-71-5-1131; Barik S, 2006, EXPERT OPIN BIOL TH, V6, P1151, DOI 10.1517/14712598.6.11.1151; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bitko V, 2007, CURR OPIN MOL THER, V9, P119; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; COLLINS LF, 1996, OT PRACTICE, V1, P43; Dallas A, 2006, MED SCI MONITOR, V12, pRA67; Dykxhoorn DM, 2006, PLOS MED, V3, P1000, DOI 10.1371/journal.pmed.0030242; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Frampton AR, 2002, VIRUS RES, V90, P287, DOI 10.1016/S0168-1702(02)00245-9; Galosi CM, 2004, VET MICROBIOL, V103, P1, DOI 10.1016/j.vetmic.2004.07.015; Garre B, 2007, ANTIMICROB AGENTS CH, V51, P4308, DOI 10.1128/AAC.00116-07; Garre B, 2007, VET MICROBIOL, V122, P43, DOI 10.1016/j.vetmic.2007.01.004; GARRE B, 2008, VET MICROBIOL, DOI DOI 10.1016/J.TVJL.2008.03.027; GIBSON JS, 1992, ARCH VIROL, V123, P351, DOI 10.1007/BF01317269; Goodman LB, 2007, PLOS PATHOG, V3, P1583, DOI 10.1371/journal.ppat.0030160; Goodman LB, 2006, VACCINE, V24, P3636, DOI 10.1016/j.vaccine.2006.01.062; Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038; Henninger RW, 2007, J VET INTERN MED, V21, P157, DOI 10.1892/0891-6640(2007)21[157:OONDCB]2.0.CO;2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jarosinski KW, 2007, VIRUS GENES, V34, P9, DOI 10.1007/s11262-006-0004-9; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kydd JH, 2006, VET IMMUNOL IMMUNOP, V111, P15, DOI 10.1016/j.vetimm.2006.01.005; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; MARTIN DW, 1994, J VIROL, V68, P3674, DOI 10.1128/JVI.68.6.3674-3681.1994; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1066, DOI 10.1152/ajplung.00067.2004; Neubauer A, 1997, VIROLOGY, V227, P281, DOI 10.1006/viro.1996.8336; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; PELLETT PE, 2007, HERPESVIRIDAE, P2479; Ruitenberg KM, 1999, VET MICROBIOL, V68, P35, DOI 10.1016/S0378-1135(99)00059-0; Ruitenberg KM, 1999, VACCINE, V17, P237, DOI 10.1016/S0264-410X(98)00192-3; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Tsujimura K, 2006, J VET MED SCI, V68, P1029, DOI 10.1292/jvms.68.1029; *USDA APHIS, 2007, EQ HERP MYEL POT EM; Van de Walle GR, 2008, J VIROL, V82, P1714, DOI 10.1128/JVI.02137-07; Van de Walle GR, 2007, J IMMUNOL, V179, P4161, DOI 10.4049/jimmunol.179.6.4161; VANWOENSEL PAM, 1995, J VIROL METHODS, V54, P39, DOI 10.1016/0166-0934(95)00024-O; von Einem J, 2007, VIROLOGY, V362, P151, DOI 10.1016/j.virol.2006.12.008; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; Zhang J, 2007, MOL BIOTECHNOL, V37, P225, DOI 10.1007/s12033-007-9000-0; Zheng BJ, 2004, ANTIVIR THER, V9, P365	46	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2009	4	1							e4118	10.1371/journal.pone.0004118	http://dx.doi.org/10.1371/journal.pone.0004118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FT	19122813	Green Published, gold, Green Submitted			2022-12-27	WOS:000265472900003
J	Hirata, M; Kugimiya, F; Fukai, A; Ohba, S; Kawamura, N; Ogasawara, T; Kawasaki, Y; Saito, T; Yano, F; Ikeda, T; Nakamura, K; Chung, UI; Kawaguchi, H				Hirata, Makoto; Kugimiya, Fumitaka; Fukai, Atsushi; Ohba, Shinsuke; Kawamura, Naohiro; Ogasawara, Toru; Kawasaki, Yosuke; Saito, Taku; Yano, Fumiko; Ikeda, Toshiyuki; Nakamura, Kozo; Chung, Ung-Il; Kawaguchi, Hiroshi			C/EBP beta Promotes Transition from Proliferation to Hypertrophic Differentiation of Chondrocytes through Transactivation of p57(Kip2)	PLOS ONE			English	Article								Background: Although transition from proliferation to hypertrophic differentiation of chondrocytes is a crucial step for endochondral ossification in physiological skeletal growth and pathological disorders like osteoarthritis, the underlying mechanism remains an enigma. This study investigated the role of the transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta) in chondrocytes during endochondral ossification. Methodology/Principal Findings: Mouse embryos with homozygous deficiency in C/EBP beta (C/EBP beta-/-) exhibited dwarfism with elongated proliferative zone and delayed chondrocyte hypertrophy in the growth plate cartilage. In the cultures of primary C/EBP beta-/- chondrocytes, cell proliferation was enhanced while hypertrophic differentiation was suppressed. Contrarily, retroviral overexpression of C/EBP beta in chondrocytes suppressed the proliferation and enhanced the hypertrophy, suggesting the cell cycle arrest by C/EBP beta. In fact, a DNA cell cycle histogram revealed that the C/EBP beta overexpression caused accumulation of cells in the G0/G1 fraction. Among cell cycle factors, microarray and real-time RT-PCR analyses have identified the cyclin-dependent kinase inhibitor p57(Kip2) as the transcriptional target of C/EBP beta. p57(Kip2) was co-localized with C/EBP beta in late proliferative and pre-hypertrophic chondrocytes of the mouse growth plate, which was decreased by the C/EBP beta deficiency. Luciferase-reporter and electrophoretic mobility shift assays identified the core responsive element of C/EBP beta in the p57(Kip2) promoter between -150 and -130 bp region containing a putative C/EBP motif. The knockdown of p57(Kip2) by the siRNA inhibited the C/EBP beta-induced chondrocyte hypertrophy. Finally, when we created the experimental osteoarthritis model by inducing instability in the knee joints of adult mice of wild-type and C/EBP beta+/- littermates, the C/EBP beta insufficiency caused resistance to joint cartilage destruction. Conclusions/Significance: C/EBPb transactivates p57(Kip2) to promote transition from proliferation to hypertrophic differentiation of chondrocytes during endochondral ossification, suggesting that the C/EBP beta-p57(Kip2) signal would be a therapeutic target of skeletal disorders like growth retardation and osteoarthritis.	[Hirata, Makoto; Kugimiya, Fumitaka; Fukai, Atsushi; Kawamura, Naohiro; Ogasawara, Toru; Kawasaki, Yosuke; Saito, Taku; Ikeda, Toshiyuki; Nakamura, Kozo; Chung, Ung-Il; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory Motor Syst Med, Tokyo 113, Japan; [Ohba, Shinsuke; Yano, Fumiko] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Hirata, M (corresponding author), Univ Tokyo, Fac Med, Dept Sensory Motor Syst Med, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Kawamura, Naohiro/J-8372-2019; Ikeda, Toshiyuki/GVS-5588-2022; Ogasawara, Toru/I-1629-2014	Ohba, Shinsuke/0000-0002-6874-8539; Ogasawara, Toru/0000-0002-2996-081X	Japanese Ministry of Education, Culture, Sports, Science, and Technology [19109007]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#19109007). The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Imamura T, 2005, J BIOL CHEM, V280, P16625, DOI 10.1074/jbc.M411469200; Imamura T, 2008, ARTHRITIS RHEUM-US, V58, P1366, DOI 10.1002/art.23438; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kawasaki H, 2003, NUCLEIC ACIDS RES, V31, P700, DOI 10.1093/nar/gkg158; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn K, 2004, OSTEOARTHR CARTILAGE, V12, P1, DOI 10.1016/j.joca.2003.09.015; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li H, 2007, CELL MOL IMMUNOL, V4, P407; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; LuValle P, 2000, FRONT BIOSCI-LANDMRK, V5, pD493, DOI 10.2741/LuValle; MacLean HE, 2004, J CLIN INVEST, V113, P1334, DOI 10.1172/JCI200421252; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Meergans T, 1998, EUR J BIOCHEM, V256, P436, DOI 10.1046/j.1432-1327.1998.2560436.x; Mizui Y, 2000, MOL BIOL REP, V27, P167, DOI 10.1023/A:1007253930568; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moro T, 2005, J CELL PHYSIOL, V204, P927, DOI 10.1002/jcp.20350; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Raymond L, 2006, J CELL PHYSIOL, V207, P683, DOI 10.1002/jcp.20608; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Schlossmann J, 2005, DRUG DISCOV TODAY, V10, P627, DOI 10.1016/S1359-6446(05)03406-9; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Thomas B, 2000, EUR J BIOCHEM, V267, P6798, DOI 10.1046/j.1432-1327.2000.01778.x; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhao Qi-jin, 2005, Journal of Shanghai Jiaotong University (English Edition), VE-10, P280	59	73	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2009	4	2							e4543	10.1371/journal.pone.0004543	http://dx.doi.org/10.1371/journal.pone.0004543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KK	19229324	gold, Green Submitted, Green Published			2022-12-27	WOS:000265486200014
J	Zhang, D; Shooshtarizadeh, P; Laventie, BJ; Colin, DA; Chich, JF; Vidic, J; de Barry, J; Chasserot-Golaz, S; Delalande, F; Van Dorsselaer, A; Schneider, F; Helle, K; Aunis, D; Prevost, G; Metz-Boutigue, MH				Zhang, Dan; Shooshtarizadeh, Peiman; Laventie, Benoit-Joseph; Colin, Didier Andre; Chich, Jean-Francois; Vidic, Jasmina; de Barry, Jean; Chasserot-Golaz, Sylvette; Delalande, Francois; Van Dorsselaer, Alain; Schneider, Francis; Helle, Karen; Aunis, Dominique; Prevost, Gilles; Metz-Boutigue, Marie-Helene			Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A(2)	PLOS ONE			English	Article								Background: Antimicrobial peptides derived from the natural processing of chromogranin A (CgA) are co-secreted with catecholamines upon stimulation of chromaffin cells. Since PMNs play a central role in innate immunity, we examine responses by PMNs following stimulation by two antimicrobial CgA-derived peptides. Methodology/Principal Findings: PMNs were treated with different concentrations of CgA-derived peptides in presence of several drugs. Calcium mobilization was observed by using flow cytometry and calcium imaging experiments. Immunocytochemistry and confocal microscopy have shown the intracellular localization of the peptides. The calmodulin-binding and iPLA2 activating properties of the peptides were shown by Surface Plasmon Resonance and iPLA2 activity assays. Finally, a proteomic analysis of the material released after PMNs treatment with CgA-derived peptides was performed by using HPLC and Nano-LC MS-MS. By using flow cytometry we first observed that after 15 s, in presence of extracellular calcium, Chromofungin (CHR) or Catestatin (CAT) induce a concentration-dependent transient increase of intracellular calcium. In contrast, in absence of extra cellular calcium the peptides are unable to induce calcium depletion from the stores after 10 minutes exposure. Treatment with 2-APB (2-aminoethoxydiphenyl borate), a store operated channels (SOCs) blocker, inhibits completely the calcium entry, as shown by calcium imaging. We also showed that they activate iPLA2 as the two CaM-binding factors (W7 and CMZ) and that the two sequences can be aligned with the two CaM-binding domains reported for iPLA2. We finally analyzed by HPLC and Nano-LC MS-MS the material released by PMNs following stimulation by CHR and CAT. We characterized several factors important for inflammation and innate immunity. Conclusions/Significance: For the first time, we demonstrate that CHR and CAT, penetrate into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 pathway. Our study highlights the role of two CgA-derived peptides in the active communication between neuroendocrine and immune systems.	[Zhang, Dan; Shooshtarizadeh, Peiman; Chich, Jean-Francois; Delalande, Francois; Aunis, Dominique; Metz-Boutigue, Marie-Helene] INSERM, U575, Strasbourg, France; [Laventie, Benoit-Joseph; Colin, Didier Andre; Prevost, Gilles] Univ Louis Pasteur, Hop Univ Strasbourg, Inst Bacteriol,UPRES, Fac Med,EA 3432, F-67070 Strasbourg, France; [Chich, Jean-Francois; Vidic, Jasmina] INRA, Virol & Immunol Mol, Jouy En Josas, France; [de Barry, Jean; Chasserot-Golaz, Sylvette] Univ Louis Pasteur, CNRS, Inst Neurosci Cellulaires Integrat, UMR 7168, F-67070 Strasbourg, France; [Zhang, Dan; Schneider, Francis] Hop Hautepierre, Dept Reanimat Med, Strasbourg, France; [Van Dorsselaer, Alain] ULP, CNRS, IPHC DSA, Lab spectromet BioOrgan,UMR7178, Strasbourg, France; [Helle, Karen] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Zhang, Dan] Chongqing Univ Med Sci, Hosp 1, Chongqing, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Bergen; Chongqing Medical University	Zhang, D (corresponding author), INSERM, U575, Strasbourg, France.	metz@neurochem.u-strasbg.fr	Chasserot-Golaz, Sylvette/K-7625-2017; Dominique, Aunis/W-1419-2019; LAVENTIE, Benoît-Joseph/H-5260-2011; Vidic, Jasmina/AFP-6747-2022	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Vidic, Jasmina/0000-0002-8549-8199; Delalande, Francois/0000-0003-3590-9874; Chasserot-Golaz, Sylvette/0000-0002-7437-2558	Inserm; CNRS; Universite Louis Pasteur Strasbourg; The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg [3150]; Fondation Transplantation; French ministery de la recherche et de l'enseignement superieur; BRAHMS	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur Strasbourg; The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg; Fondation Transplantation; French ministery de la recherche et de l'enseignement superieur; BRAHMS	Inserm, CNRS, Universite Louis Pasteur Strasbourg, The Delegation a la Recherche clinique des Hopitaux universitaires de Strasbourg (Grant 3150), Fondation Transplantation, French ministery de la recherche et de l'enseignement superieur, BRAHMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDAL S, 1992, REGUL PEPTIDES, V41, P9, DOI 10.1016/0167-0115(92)90509-S; Amato A, 2005, REGUL PEPTIDES, V130, P42, DOI 10.1016/j.regpep.2005.03.004; ANDERSSON KB, 1988, NATURE, V332, P688, DOI 10.1038/332688a0; ANGELETTI RH, 1994, ACTA PHYSIOL SCAND, V152, P11, DOI 10.1111/j.1748-1716.1994.tb09780.x; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Blois A, 2006, REGUL PEPTIDES, V135, P78, DOI 10.1016/j.regpep.2006.04.007; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; BOLOTINA VM, 2004, SCI STKE, pPE34; Brekke JF, 2002, REGUL PEPTIDES, V105, P93, DOI 10.1016/S0167-0115(02)00004-6; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cerra MC, 2008, FASEB J, V22, P3992, DOI 10.1096/fj.08-110239; CHEUNG NS, 1994, J NEUROCHEM, V62, P2246; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Corti A, 2004, GEN COMP ENDOCR, V136, P217, DOI 10.1016/j.ygcen.2003.12.012; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; EIDEN LE, 1987, NATURE, V325, P301, DOI 10.1038/325301a0; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Gasparri A, 1997, J BIOL CHEM, V272, P20835, DOI 10.1074/jbc.272.33.20835; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Goumon Y, 1996, EUR J BIOCHEM, V235, P516, DOI 10.1111/j.1432-1033.1996.t01-1-00516.x; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Jean-Eric G, 2005, REGUL PEPTIDES, V124, P27, DOI 10.1016/j.regpep.2004.06.022; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2007, EUR BIOPHYS J BIOPHY, V36, P1019, DOI 10.1007/s00249-007-0169-8; JEANFRANCOIS F, 2008, BIOPHYS J; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Joubert O, 2006, BIOCHEM J, V396, P381, DOI 10.1042/BJ20051878; Kang YL, 2008, BIOORG MED CHEM LETT, V18, P3749, DOI 10.1016/j.bmcl.2008.05.046; Kieffer AE, 2003, FASEB J, V17, P776, DOI 10.1096/fj.02-0699fje; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Koeslag JH, 1999, J PHYSIOL-LONDON, V517, P643, DOI 10.1111/j.1469-7793.1999.0643s.x; Koike T, 1998, J BIOCHEM-TOKYO, V123, P1079; LAIBLE NJ, 1985, INFECT IMMUN, V48, P720, DOI 10.1128/IAI.48.3.720-728.1985; Lasunskaia EB, 1997, APOPTOSIS, V2, P156, DOI 10.1023/A:1026460330596; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lohr C, 2006, GLIA, V54, P642, DOI 10.1002/glia.20368; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Metz-Boutigue MH, 1998, CELL MOL NEUROBIOL, V18, P249, DOI 10.1023/A:1022573004910; METZBOUTIGUE MH, 1993, EUR J BIOCHEM, V217, P247, DOI 10.1111/j.1432-1033.1993.tb18240.x; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Morita K, 2002, J PHARMACOL EXP THER, V302, P972, DOI 10.1124/jpet.102.033456; Moussa LB, 1999, FEBS LETT, V461, P280, DOI 10.1016/S0014-5793(99)01453-2; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; OSEAS R, 1981, BLOOD, V57, P939; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; RUSSELL J, 1994, ENDOCRINOLOGY, V135, P337, DOI 10.1210/en.135.1.337; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; STRUB JM, 1995, EUR J BIOCHEM, V229, P356, DOI 10.1111/j.1432-1033.1995.0356k.x; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tota B, 2003, REGUL PEPTIDES, V114, P123, DOI 10.1016/S0167-0115(03)00112-5; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wong SH, 2009, RHEUMATOLOGY, V48, P39, DOI 10.1093/rheumatology/ken412; YOO SH, 1992, BIOCHEMISTRY-US, V31, P6134, DOI 10.1021/bi00141a025; Zhang KX, 2006, DIABETES OBES METAB, V8, P621, DOI 10.1111/j.1463-1326.2006.00575.x	80	88	96	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2009	4	2							e4501	10.1371/journal.pone.0004501	http://dx.doi.org/10.1371/journal.pone.0004501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KI	19225567	Green Published, gold, Green Submitted			2022-12-27	WOS:000265486000001
J	Mishra, BS; Singh, M; Aggrawal, P; Laxmi, A				Mishra, Bhuwaneshwar S.; Singh, Manjul; Aggrawal, Priyanka; Laxmi, Ashverya			Glucose and Auxin Signaling Interaction in Controlling Arabidopsis thaliana Seedlings Root Growth and Development	PLOS ONE			English	Article								Background: Plant root growth and development is highly plastic and can adapt to many environmental conditions. Sugar signaling has been shown to affect root growth and development by interacting with phytohormones such as gibberellins, cytokinin and abscisic acid. Auxin signaling and transport has been earlier shown to be controlling plant root length, number of lateral roots, root hair and root growth direction. Principal Findings: Increasing concentration of glucose not only controls root length, root hair and number of lateral roots but can also modulate root growth direction. Since root growth and development is also controlled by auxin, whole genome transcript profiling was done to find out the extent of interaction between glucose and auxin response pathways. Glucose alone could transcriptionally regulate 376 (62%) genes out of 604 genes affected by IAA. Presence of glucose could also modulate the extent of regulation 2 fold or more of almost 63% genes induced or repressed by IAA. Interestingly, glucose could affect induction or repression of IAA affected genes (35%) even if glucose alone had no significant effect on the transcription of these genes itself. Glucose could affect auxin biosynthetic YUCCA genes family members, auxin transporter PIN proteins, receptor TIR1 and members of a number of gene families including AUX/IAA, GH3 and SAUR involved in auxin signaling. Arabidopsis auxin receptor tir1 and response mutants, axr2, axr3 and slr1 not only display a defect in glucose induced change in root length, root hair elongation and lateral root production but also accentuate glucose induced increase in root growth randomization from vertical suggesting glucose effects on plant root growth and development are mediated by auxin signaling components. Conclusion: Our findings implicate an important role of the glucose interacting with auxin signaling and transport machinery to control seedling root growth and development in changing nutrient conditions.	[Mishra, Bhuwaneshwar S.; Singh, Manjul; Aggrawal, Priyanka; Laxmi, Ashverya] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Mishra, BS (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	ashverya_laxmi@nipgr.res.in	singh, manjul/L-3521-2019	singh, manjul/0000-0001-9547-269X	Department of Biotechnology, Government of India; University Grant Commission, India [Junior Research Fellowship]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grant Commission, India(University Grants Commission, India)	Project support from Department of Biotechnology, Government of India. Junior Research Fellowship to BSM from University Grant Commission, India	Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Dekkers BJW, 2008, PLANT MOL BIOL, V67, P151, DOI 10.1007/s11103-008-9308-6; FEIFEI S, 2007, PLANT PHYSIOL, V146, P178; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gonzali S, 2005, PLANT J, V44, P633, DOI 10.1111/j.1365-313X.2005.02555.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; JASON WR, 2001, TRENDS PLANT SCI, V6, P425; KARZ W, 1990, PHYSIOL PLANTARUM, V80, P257; Laxmi A, 2004, PLANT MOL BIOL, V56, P185, DOI 10.1007/s11103-004-2799-x; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Laxmi A, 2006, PLANT MOL BIOL, V62, P409, DOI 10.1007/s11103-006-9032-z; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Ohto MA, 2006, PLANT CELL PHYSIOL, V47, P1603, DOI 10.1093/pcp/pcl027; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; RADERMACHER E, 1993, J PLANT PHYSIOL, V141, P698, DOI 10.1016/S0176-1617(11)81577-4; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Shin H, 2005, PLANT J, V42, P188, DOI 10.1111/j.1365-313X.2005.02369.x; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yuan K, 2006, J EXP BOT, V57, P3359, DOI 10.1093/jxb/erl096	22	236	245	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2009	4	2							e4502	10.1371/journal.pone.0004502	http://dx.doi.org/10.1371/journal.pone.0004502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KG	19223973	Green Submitted, gold, Green Published			2022-12-27	WOS:000265485800008
J	Saxe, JP; Tomilin, A; Scholer, HR; Plath, K; Huang, J				Saxe, Jonathan P.; Tomilin, Alexey; Schoeler, Hans R.; Plath, Kathrin; Huang, Jing			Post-Translational Regulation of Oct4 Transcriptional Activity	PLOS ONE			English	Article								Oct4 is a key component of the molecular circuitry which regulates embryonic stem cell proliferation and differentiation. It is essential for maintenance of undifferentiated, pluripotent cell populations, and accomplishes these tasks by binding DNA in multiple heterodimer and homodimer configurations. Very little is known about how formation of these complexes is regulated, or the mechanisms through which Oct4 proteins respond to complex extracellular stimuli which regulate pluripotency. Here, we provide evidence for a phosphorylation-based mechanism which regulates specific Oct4 homodimer conformations. Point mutations of a putative phosphorylation site can specifically abrogate transcriptional activity of a specific homodimer assembly, with little effect on other configurations. Moreover, we performed bioinformatic predictions to identify a subset of Oct4 target genes which may be regulated by this specific assembly, and show that altering Oct4 protein levels affects transcription of Oct4 target genes which are regulated by this assembly but not others. Finally, we identified several signaling pathways which may mediate this phosphorylation and act in combination to regulate Oct4 transcriptional activity and protein stability. These results provide a mechanism for rapid and reversible alteration of Oct4 transactivation potential in response to extracellular signals.			Saxe, JP (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.	jonathan.saxe@yale.edu; jinghuang@mednet.ucla.edu	Tomilin, Alexey/AAK-3068-2021; Tomilin, Alexey N/C-3361-2014; Tomilin, Alexey/AAA-8774-2022; , HS/AAB-4434-2019	Tomilin, Alexey N/0000-0002-1137-7167; Tomilin, Alexey/0000-0002-1137-7167; , HS/0000-0003-2643-5136; Saxe, Jonathan/0000-0001-7301-6423; Plath, Kathrin/0000-0001-7796-3372	NCI NIH HHS [R01 CA124974-02, R01 CA124974-03, R01 CA124974, R01 CA124974-01] Funding Source: Medline; NHGRI NIH HHS [R21 HG003729, R21 HG003729-01A1, R21 HG003729-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA124974] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003729] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUITT SC, 1994, DEVELOPMENT, V120, P37; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Remenyi A, 2001, MOL CELL, V8, P569, DOI 10.1016/S1097-2765(01)00336-7; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	43	95	98	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2009	4	2							e4467	10.1371/journal.pone.0004467	http://dx.doi.org/10.1371/journal.pone.0004467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437KF	19221599	gold, Green Published			2022-12-27	WOS:000265485700005
J	Croteau, NJ; Furgason, MLM; Devos, D; Munson, M				Croteau, Nicole J.; Furgason, Melonnie L. M.; Devos, Damien; Munson, Mary			Conservation of Helical Bundle Structure between the Exocyst Subunits	PLOS ONE			English	Article								Background: The exocyst is a large hetero-octomeric protein complex required for regulating the targeting and fusion of secretory vesicles to the plasma membrane in eukaryotic cells. Although the sequence identity between the eight different exocyst subunits is less than 10%, structures of domains of four of the subunits revealed a similar helical bundle topology. Characterization of several of these subunits has been hindered by lack of soluble protein for biochemical and structural studies. Methodology/Principal Findings: Using advanced hidden Markov models combined with secondary structure predictions, we detect significant sequence similarity between each of the exocyst subunits, indicating that they all contain helical bundle structures. We corroborate these remote homology predictions by identifying and purifying a predicted domain of yeast Sec10p, a previously insoluble exocyst subunit. This domain is soluble and folded with approximately 60% alpha-helicity, in agreement with our predictions, and capable of interacting with several known Sec10p binding partners. Conclusions/Significance: Although all eight of the exocyst subunits had been suggested to be composed of similar helical bundles, this has now been validated by our hidden Markov model structure predictions. In addition, these predictions identified protein domains within the exocyst subunits, resulting in creation and characterization of a soluble, folded domain of Sec10p.	[Croteau, Nicole J.; Furgason, Melonnie L. M.; Munson, Mary] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Devos, Damien] EMBL, Heidelberg, Germany	University of Massachusetts System; University of Massachusetts Worcester; European Molecular Biology Laboratory (EMBL)	Croteau, NJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	mary.munson@umassmed.edu	devos, damien/ABH-5348-2020; Munson, Mary/A-9777-2009	Munson, Mary/0000-0003-2297-8053; Devos, Damien/0000-0002-9453-4753	EU [LSHG-CT-2005-5120828]; US National Institutes of Health [GM068803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068803] Funding Source: NIH RePORTER	EU(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the EU grant 3D-Repertoire (LSHG-CT-2005-5120828) to D.D., and by the US National Institutes of Health grant GM068803 to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cavanaugh LF, 2007, J BIOL CHEM, V282, P23418, DOI 10.1074/jbc.M703716200; Chen Y, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-45; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kuemmel D, 2008, CURR PROTEIN PEPT SC, V9, P197, DOI 10.2174/138920308783955252; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHOLTZ JM, 1995, P NATL ACAD SCI USA, V92, P185, DOI 10.1073/pnas.92.1.185; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoon J, 2005, PROTEIN EXPRES PURIF, V44, P1, DOI 10.1016/j.pep.2005.04.020	45	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4443	10.1371/journal.pone.0004443	http://dx.doi.org/10.1371/journal.pone.0004443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214222	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484300002
J	Kumar, KA; Baxter, P; Tarun, AS; Kappe, SHI; Nussenzweig, V				Kumar, Kota Arun; Baxter, Peter; Tarun, Alice S.; Kappe, Stefan H. I.; Nussenzweig, Victor			Conserved Protective Mechanisms in Radiation and Genetically Attenuated uis3(-) and uis4(-) Plasmodium Sporozoites	PLOS ONE			English	Article								Immunization with radiation attenuated Plasmodium sporozoites (RAS) elicits sterile protective immunity against sporozoite challenge in murine models and in humans. Similarly to RAS, the genetically attenuated sporozoites (GAPs) named uis3(-), uis4(-) and P36p(-) have arrested growth during the liver stage development, and generate a powerful protective immune response in mice. We compared the protective mechanisms in P. yoelii RAS, uis3(-) and uis4(-) in BALB/c mice. In RAS and GAPs, sterile immunity is only achieved after one or more booster injections. There were no differences in the immune responses to the circumsporozoite protein (CSP) generated by RAS and GAPs. To evaluate the role of non-CSP T-cell antigens we immunized antibody deficient, CSP-transgenic BALB/c mice, that are T cell tolerant to CSP, with P. yoelii RAS or with uis3(-) or uis4(-) GAPs, and challenged them with wild type sporozoites. In every instance the parasite liver stage burden was approximately 3 logs higher in antibody deficient CSP transgenic mice as compared to antibody deficient mice alone. We conclude that CSP is a powerful protective antigen in both RAS and GAPs viz., uis3(-) and uis4(-) and that the protective mechanisms are similar independently of the method of sporozoite attenuation.	[Kumar, Kota Arun; Baxter, Peter; Nussenzweig, Victor] NYU, Sch Med, Dept Pathol, Micheal Hidelberg Div Immunol, New York, NY 10003 USA; [Kumar, Kota Arun] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Tarun, Alice S.; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA USA	New York University; University of Hyderabad; Center for Infectious Disease Research	Kumar, KA (corresponding author), NYU, Sch Med, Dept Pathol, Micheal Hidelberg Div Immunol, New York, NY 10003 USA.	kaksl@uohyd.ernet.in		Tarun, Alice/0000-0002-0300-6657	Dana Foundation; Bill and Melinda Gates Foundation	Dana Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by Dana Foundation (to Victor Nussenzweig) and the Bill and Melinda Gates Foundation (to Stefan H.I. Kappe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; KLOTZ FW, 1995, J IMMUNOL, V154, P3391; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; RODRIGUES M, 1993, IMMUNOLOGY, V80, P1; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Tarun AS, 2006, INT J PARASITOL, V36, P1283, DOI 10.1016/j.ijpara.2006.06.009; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; VANDERBERG JP, 2005, PLOS BIOL, V34, P991; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	35	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2009	4	2							e4480	10.1371/journal.pone.0004480	http://dx.doi.org/10.1371/journal.pone.0004480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JR	19214236	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484300013
J	Johansson, A; Jonasson, I; Gyllensten, U				Johansson, Asa; Jonasson, Inger; Gyllensten, Ulf			Extended Haplotypes in the Growth Hormone Releasing Hormone Receptor Gene (GHRHR) Are Associated with Normal Variation in Height	PLOS ONE			English	Article								Mutations in the gene for growth hormone releasing hormone receptor (GHRHR) cause isolated growth hormone deficiency (IGHD) but this gene has not been found to affect normal variation in height. We performed a whole genome linkage analysis for height in a population from northern Sweden and identified a region on chromosome 7 with a lod-score of 4.7. The GHRHR gene is located in this region and typing of tagSNPs identified a haplotype that is associated with height (p=0.00077) in the original study population. Analysis of a sample from an independent population from the most northern part of Sweden also showed an association with height (p=0.0039) but with another haplotype in the GHRHR gene. Both haplotypes span the 39 part of the GHRHR gene, including the region in which most of the mutations in IGHD have been located. The effect size of these haplotypes are larger than that of any gene previously associated with height, which indicates that GHRHR might be one of the most important genes so far identified affecting normal variation in human height.	[Johansson, Asa; Jonasson, Inger; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden	Uppsala University	Johansson, A (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden.	ulf.gyllensten@genpat.uu.se	Johansson, Åsa/G-5270-2011; Johansson, Åsa/AAG-6799-2021	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498	Swedish Natural Sciences Research Council; European Commission /EUROSPAN; Foundation for Strategic Research; The Linneaus Centre for Bioinformatics	Swedish Natural Sciences Research Council; European Commission /EUROSPAN(European CommissionEuropean Commission Joint Research Centre); Foundation for Strategic Research; The Linneaus Centre for Bioinformatics	The study was supported by grants from The Swedish Natural Sciences Research Council, The European Commission /EUROSPAN, The Foundation for Strategic Research (SSF) and The Linneaus Centre for Bioinformatics (LCB). None of the sponsors or funders had any involvement in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aguiar-Oliveira MH, 1999, J CLIN ENDOCR METAB, V84, P4118, DOI 10.1210/jc.84.11.4118; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Cann HM, 2002, SCIENCE, V296, P261; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; HASSLER S, 2004, BEFOLKNING BOSATTNIN, P107; Johansson A, 2005, HUM GENET, V116, P105, DOI 10.1007/s00439-004-1213-8; JOHANSSON A, 2003, HUM GENET; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lettre G, 2007, HUM GENET, V122, P129, DOI 10.1007/s00439-007-0385-4; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Liu YZ, 2004, ANN HUM GENET, V68, P472, DOI 10.1046/j.1529-8817.2003.00117.x; Norio R, 2003, HUM GENET, V112, P470, DOI 10.1007/s00439-002-0877-1; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salvatori R, 1999, J CLIN ENDOCR METAB, V84, P917, DOI 10.1210/jc.84.3.917; Salvatori R, 2002, MOL ENDOCRINOL, V16, P450, DOI 10.1210/me.16.3.450; Salvatori R, 2001, J CLIN ENDOCR METAB, V86, P273, DOI 10.1210/jc.86.1.273; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; Wajnrajch MP, 1996, NAT GENET, V12, P88, DOI 10.1038/ng0196-88; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2009	4	2							e4464	10.1371/journal.pone.0004464	http://dx.doi.org/10.1371/journal.pone.0004464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JP	19209235	Green Published, Green Submitted, gold			2022-12-27	WOS:000265484100015
J	Pan, J; Wang, J; Zhou, ZF; Yan, YL; Zhang, W; Lu, W; Ping, S; Dai, QL; Yuan, ML; Feng, B; Hou, XG; Zhang, Y; Ma, R; Liu, T; Feng, L; Wang, L; Chen, M; Lin, M				Pan, Jie; Wang, Jin; Zhou, Zhengfu; Yan, Yongliang; Zhang, Wei; Lu, Wei; Ping, Shuzhen; Dai, Qilin; Yuan, Menglong; Feng, Bin; Hou, Xiaoguang; Zhang, Ying; Ma, Ruiqiang; Liu, Tingting; Feng, Lu; Wang, Lei; Chen, Ming; Lin, Min			IrrE, a Global Regulator of Extreme Radiation Resistance in Deinococcus radiodurans, Enhances Salt Tolerance in Escherichia coli and Brassica napus	PLOS ONE			English	Article								Background: Globally, about 20% of cultivated land is now affected by salinity. Salt tolerance is a trait of importance to all crops in saline soils. Previous efforts to improve salt tolerance in crop plants have met with only limited success. Bacteria of the genus Deinococcus are known for their ability to survive highly stressful conditions, and therefore possess a unique pool of genes conferring extreme resistance. In Deinococcus radiodurans, the irrE gene encodes a global regulator responsible for extreme radioresistance. Methodology/Principal Findings: Using plate assays, we showed that IrrE protected E. coli cells against salt shock and other abiotic stresses such as oxidative, osmotic and thermal shocks. Comparative proteomic analysis revealed that IrrE functions as a switch to regulate different sets of proteins such as stress responsive proteins, protein kinases, glycerol-degrading enzymes, detoxification proteins, and growth-related proteins in E. coli. We also used quantitative RT-PCR to investigate expression of nine selected stress-responsive genes in transgenic and wild-type Brassica napus plants. Transgenic B. napus plants expressing the IrrE protein can tolerate 350 mM NaCl, a concentration that inhibits the growth of almost all crop plants. Conclusions: Expression of IrrE, a global regulator for extreme radiation resistance in D. radiodurans, confers significantly enhanced salt tolerance in both E. coli and B. napus. We thus propose that the irrE gene might be used as a potentially promising transgene to improve abiotic stress tolerances in crop plants.	[Pan, Jie; Zhou, Zhengfu; Yan, Yongliang; Zhang, Wei; Lu, Wei; Yuan, Menglong; Hou, Xiaoguang; Zhang, Ying; Ma, Ruiqiang; Chen, Ming; Lin, Min] Chinese Acad Agr Sci, Key Lab Crop Biotechnol, Minist Agr, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Jin; Dai, Qilin; Feng, Bin; Liu, Tingting] SW Univ Sci & Technol, Commission Sci Technol & Industry Natl Defence, Key Lab Nuclear Waste Treatment & Environm Safety, Mianyang, Peoples R China; [Yan, Yongliang; Zhang, Wei; Ping, Shuzhen; Lin, Min] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Feng, Lu; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin Key Lab Microb Funct Genom, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Southwest University of Science & Technology - China; Chinese Academy of Sciences; Nankai University	Pan, J (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Biotechnol, Minist Agr, Biotechnol Res Inst, Beijing, Peoples R China.	chenmingbio@hotmail.com; linmin57@vip.163.com	feng, lu/M-5113-2015; Wang, Lei/C-5176-2009; min, lin/AAJ-7325-2020; Dai, Qilin/AAX-4057-2020	Wang, Lei/0000-0003-4427-0881; Dai, Qilin/0000-0001-8680-4306; yan, yongliang/0000-0002-4297-6648	National Basic Research (973) Program of China [2007CB707805]; National Natural Science Foundation of China [30670050]; National High-Tech (863) Program of China [2007AA021305]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Basic Research (973) Program of China (No.2007CB707805), the National Natural Science Foundation of China (No.30670050), and the National High-Tech (863) Program of China Grant 2007AA021305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; ANDRE L, 1988, J GEN MICROBIOL, V134, P669; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubunenko M, 2007, J BACTERIOL, V189, P2844, DOI 10.1128/JB.01713-06; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holmstrom KO, 2000, J EXP BOT, V51, P177, DOI 10.1093/jexbot/51.343.177; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; Ohba H, 2005, GENE, V363, P133, DOI 10.1016/j.gene.2005.07.035; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; RANDALL SK, 1986, J BIOL CHEM, V261, P1364; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Rus AM, 2001, PLANT CELL ENVIRON, V24, P875, DOI 10.1046/j.1365-3040.2001.00719.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; TRUNIGER V, 1994, J BACTERIOL, V176, P1796, DOI 10.1128/jb.176.6.1796-1800.1994; Vijayakumar SRV, 2004, J BACTERIOL, V186, P8499, DOI 10.1128/JB.186.24.8499-8507.2004; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	55	61	78	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2009	4	2							e4422	10.1371/journal.pone.0004422	http://dx.doi.org/10.1371/journal.pone.0004422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JO	19204796	Green Published, gold, Green Submitted			2022-12-27	WOS:000265484000011
J	Hunter, RG; Bellani, R; Bloss, E; Costa, A; McCarthy, K; McEwen, BS				Hunter, Richard G.; Bellani, Rudy; Bloss, Erik; Costa, Ana; McCarthy, Katharine; McEwen, Bruce S.			Regulation of Kainate Receptor Subunit mRNA by Stress and Corticosteroids in the Rat Hippocampus	PLOS ONE			English	Article							MOSSY FIBER SYNAPSES; GLUCOCORTICOID-RECEPTOR; KAINIC ACID; MINERALOCORTICOID RECEPTOR; PYRAMIDAL NEURONS; ADULT-RAT; EXPRESSION; ADRENALECTOMY; BRAIN; CELLS	Kainate receptors are a class of ionotropic glutamate receptors that have a role in the modulation of glutamate release and synaptic plasticity in the hippocampal formation. Previous studies have implicated corticosteroids in the regulation of these receptors and recent clinical work has shown that polymorphisms in kainate receptor subunit genes are associated with susceptibility to major depression and response to anti-depressant treatment. In the present study we sought to examine the effects of chronic stress and corticosteroid treatments upon the expression of the mRNA of kainate receptor subunits GluR5-7 and KA1-2. Our results show that, after 7 days, adrenalectomy results in increased expression of hippocampal KA1, GluR6 and GluR7 mRNAs, an effect which is reversed by treatment with corticosterone in the case of KA1 and GluR7 and by aldosterone treatment in the case of GluR6. 21 days of chronic restraint stress (CRS) elevated the expression of the KA1 subunit, but had no effect on the expression of the other subunits. Similarly, 21 days of treatment with a moderate dose of corticosterone also increased KA1 mRNA in the dentate gyrus, whereas a high corticosterone dose has no effect. Our results suggest an interaction between hippocampal kainate receptor composition and the hypothalamic-pituitary-adrenal (HPA) axis and show a selective chronic stress induced modulation of the KA1 subunit in the dentate gyrus and CA3 that has implications for stress-induced adaptive structural plasticity.	[Hunter, Richard G.; Bellani, Rudy; Bloss, Erik; Costa, Ana; McCarthy, Katharine; McEwen, Bruce S.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Rockefeller University	Hunter, RG (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave, New York, NY 10021 USA.	rhunter@rockefeller.edu	Hunter, Richard/A-8043-2009; McEwen, Bruce/Z-1630-2019; Hunter, Richard G./F-1314-2014	Hunter, Richard G./0000-0002-3130-0941; Bloss, Erik/0000-0001-5031-4591	NIH [MH 15125, MH41256, MH065749]; Gary R. Helman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015125, R01MH041256, R37MH041256, F32MH065749] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gary R. Helman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH MH 15125, MH41256 and MH065749. RGH was supported by the Gary R. Helman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2006, NEUROENDOCRINOLOGY, V83, P371, DOI 10.1159/000096092; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Blackwood DHR, 2007, NEUROTOX RES, V11, P73, DOI 10.1007/BF03033484; Bortolotto ZA, 2005, NEUROTOXICOLOGY, V26, P769, DOI 10.1016/j.neuro.2005.02.004; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P249, DOI 10.1080/10408440801981957; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CLARK AS, 1992, BRAIN RES, V585, P161, DOI 10.1016/0006-8993(92)91202-P; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Darstein M, 2003, J NEUROSCI, V23, P8013; DEMONTIGNY C, 1987, EXP BRAIN RES, V65, P605, DOI 10.1007/BF00235983; Frye C A, 2000, Stress, V3, P185, DOI 10.3109/10253890009001122; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Han F, 2005, NEUROSCI RES, V51, P371, DOI 10.1016/j.neures.2004.12.013; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUNTER RG, 2006, NEUROPHARMACOLOGY; Hunter RG, 2007, BRAIN RES, V1152, P234, DOI 10.1016/j.brainres.2007.03.042; Joels M, 1996, MOL BRAIN RES, V37, P15, DOI 10.1016/0169-328X(95)00267-V; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Laje G, 2007, AM J PSYCHIAT, V164, P1530, DOI 10.1176/appi.ajp.2007.06122018; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; LUINE VN, 1993, BRAIN RES, V616, P65, DOI 10.1016/0006-8993(93)90193-Q; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Magarinos AM, 1998, BRAIN RES, V809, P314, DOI 10.1016/S0006-8993(98)00882-8; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; MUNCK A, 1994, ANN NY ACAD SCI, V746, P115, DOI 10.1111/j.1749-6632.1994.tb39221.x; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1980, BRAIN RES, V195, P47; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Raudensky J, 2007, BRAIN RES, V1135, P129, DOI 10.1016/j.brainres.2006.12.002; Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798; Schiffer HH, 2007, AM J MED GENET B, V144B, P20, DOI 10.1002/ajmg.b.30374; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P391, DOI 10.1113/jphysiol.2004.079624; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1995, BRAIN RES, V680, P217, DOI 10.1016/0006-8993(95)00235-I; WISDEN W, 1993, J NEUROSCI, V13, P3582; WOOLLEY CS, 1991, BRAIN RES, V554, P312, DOI 10.1016/0006-8993(91)90207-C; Wullner U, 1997, BRAIN RES, V768, P215, DOI 10.1016/S0006-8993(97)00645-8	44	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4328	10.1371/journal.pone.0004328	http://dx.doi.org/10.1371/journal.pone.0004328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180187	Green Published, gold, Green Submitted			2022-12-27	WOS:000274089700011
J	Wodarz, D; Komarova, N				Wodarz, Dominik; Komarova, Natalia			Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection	PLOS ONE			English	Article							VIRAL REPLICATION; TRANSMISSION; VIROTHERAPY; PATHOGEN; GROWTH	Oncolytic viruses are viruses that specifically infect cancer cells and kill them, while leaving healthy cells largely intact. Their ability to spread through the tumor makes them an attractive therapy approach. While promising results have been observed in clinical trials, solid success remains elusive since we lack understanding of the basic principles that govern the dynamical interactions between the virus and the cancer. In this respect, computational models can help experimental research at optimizing treatment regimes. Although preliminary mathematical work has been performed, this suffers from the fact that individual models are largely arbitrary and based on biologically uncertain assumptions. Here, we present a general framework to study the dynamics of oncolytic viruses that is independent of uncertain and arbitrary mathematical formulations. We find two categories of dynamics, depending on the assumptions about spatial constraints that govern that spread of the virus from cell to cell. If infected cells are mixed among uninfected cells, there exists a viral replication rate threshold beyond which tumor control is the only outcome. On the other hand, if infected cells are clustered together ( e. g. in a solid tumor), then we observe more complicated dynamics in which the outcome of therapy might go either way, depending on the initial number of cells and viruses. We fit our models to previously published experimental data and discuss aspects of model validation, selection, and experimental design. This framework can be used as a basis for model selection and validation in the context of future, more detailed experimental studies. It can further serve as the basis for future, more complex models that take into account other clinically relevant factors such as immune responses.	[Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA; [Komarova, Natalia] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA.	dwodarz@uci.edu			NIH [1R01AI058153-04]; Dr. Wodarz's university; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Wodarz's university; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant: 1R01AI058153-04 and Institutional funding from Dr. Wodarz's university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JA, 1997, SURVEY MODELS TUMOR; Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; ANDERSON R M, 1991; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; BARBOUR A, 1990, STOCHASTIC PROCESSES; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bell JC, 2007, CURR CANCER DRUG TAR, V7, P127, DOI 10.2174/156800907780058844; Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3; Chahlavi Ali, 1999, Neoplasia (New York), V1, P162, DOI 10.1038/sj.neo.7900016; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Davis JJ, 2005, J GENE MED, V7, P1380, DOI 10.1002/jgm.800; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Goodrum FD, 1997, J VIROL, V71, P548, DOI 10.1128/JVI.71.1.548-561.1997; Harrison D, 2001, HUM GENE THER, V12, P1323, DOI 10.1089/104303401750270977; Kaplan JM, 2005, CURR GENE THER, V5, P595, DOI 10.2174/156652305774964677; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Kirn DH, 1996, MOL MED TODAY, V2, P519, DOI 10.1016/S1357-4310(97)81456-6; Korn WM, 2006, CANCER GENE THER, V13, P792, DOI 10.1038/sj.cgt.7700947; Lorence RM, 2003, CURR OPIN MOL THER, V5, P618; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCormick F, 2005, ONCOGENE, V24, P7817, DOI 10.1038/sj.onc.1209064; McCormick F, 2003, CANCER BIOL THER, V2, pS157; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Novozhilov AS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-6; Nowak MA., 2000, VIRUS DYNAMICS MATH; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Post Dawn E, 2005, Future Oncol, V1, P247, DOI 10.1517/14796694.1.2.247; Roberts MS, 2006, CURR OPIN MOL THER, V8, P314; SHIRLEY MD, 2005, ECOL COMPLEX, V2; Vaha-Koskela M. J., 2007, CANC LETT; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodarz D, 2003, HUM GENE THER, V14, P153, DOI 10.1089/104303403321070847; Wodarz D, 2001, CANCER RES, V61, P3501; Wodarz D., 2004, GENES THER MOL BIOL, V8, P137	38	55	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4271	10.1371/journal.pone.0004271	http://dx.doi.org/10.1371/journal.pone.0004271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19180240	Green Submitted, Green Published, gold			2022-12-27	WOS:000274089700004
J	Storchi, R; Biella, GEM; Liberati, D; Baselli, G				Storchi, Riccardo; Biella, Gabriele E. M.; Liberati, Diego; Baselli, Giuseppe			Extraction and Characterization of Essential Discharge Patterns from Multisite Recordings of Spiking Ongoing Activity	PLOS ONE			English	Article								Background: Neural activation patterns proceed often by schemes or motifs distributed across the involved cortical networks. As neurons are correlated, the estimate of all possible dependencies quickly goes out of control. The complex nesting of different oscillation frequencies and their high non-stationariety further hamper any quantitative evaluation of spiking network activities. The problem is exacerbated by the intrinsic variability of neural patterns. Methodology/Principal Findings: Our technique introduces two important novelties and enables to insulate essential patterns on larger sets of spiking neurons and brain activity regimes. First, the sampling procedure over N units is based on a fixed spike number k in order to detect N-dimensional arrays (k-sequences), whose sum over all dimension is k. Then k-sequences variability is greatly reduced by a hierarchical separative clustering, that assigns large amounts of distinct k-sequences to few classes. Iterative separations are stopped when the dimension of each cluster comes to be smaller than a certain threshold. As threshold tuning critically impacts on the number of classes extracted, we developed an effective cost criterion to select the shortest possible description of our dataset. Finally we described three indexes (C, S, R) to evaluate the average pattern complexity, the structure of essential classes and their stability in time. Conclusions/Significance: We validated this algorithm with four kinds of surrogated activity, ranging from random to very regular patterned. Then we characterized a selection of ongoing activity recordings. By the S index we identified unstable, moderatly and strongly stable patterns while by the C and the R indices we evidenced their non-random structure. Our algorithm seems able to extract interesting and non-trivial spatial dynamics from multisource neuronal recordings of ongoing and potentially stimulated activity. Combined with time-frequency analysis of LFPs could provide a powerful multiscale approach linking population oscillations with multisite discharge patterns.	Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; [Storchi, Riccardo] Inst Molecular Bioimaging & Physiol, Milan, Italy; [Biella, Gabriele E. M.] Inst Molecular Bioimaging & Physiol, Natl Res Council, Milan, Italy; [Liberati, Diego] Politech Sch Milan, Natl Res Council, Dept Electron & Informat, Milan, Italy; [Baselli, Giuseppe] Politech Sch Milan, Dept Biomed Engn, Milan, Italy	Universita di Modena e Reggio Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Storchi, R (corresponding author), Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy.	riccardo.storchi@gmail.com	Liberati, Diego Ettore/AAE-2900-2020	Biella, Gabriele/0000-0001-8451-249X; Storchi, Riccardo/0000-0002-3656-7514	University of Modena; San Raffaele Hospital	University of Modena; San Raffaele Hospital	Support was provided by the University of Modena and by San Raffaele Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Boley D, 1998, DATA MIN KNOWL DISC, V2, P325, DOI 10.1023/A:1009740529316; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; HEKSTRA AP, 1989, IEEE T INFORM THEORY, V35, P44, DOI 10.1109/18.42175; HOCHBAUM DS, 1985, MATH OPER RES, V10, P180, DOI 10.1287/moor.10.2.180; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Johnson DH, 2001, J COMPUT NEUROSCI, V10, P47, DOI 10.1023/A:1008968010214; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; McKay DJC., 2003, INFORM THEORY INFERE; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; RIEKE F, BIALEK W SPIKES EXPL; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Savaresi S. M., 2004, Intelligent Data Analysis, V8, P345; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Smith AC, 2006, NEURAL COMPUT, V18, P1197, DOI 10.1162/neco.2006.18.5.1197; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steriade M, 1998, Sleep Res Online, V1, P1; Steriade M., 1990, THALAMIC OSCILLATION; Tetko IV, 2001, J NEUROSCI METH, V105, P15, DOI 10.1016/S0165-0270(00)00337-X; Tetko IV, 2001, J NEUROSCI METH, V105, P1, DOI 10.1016/S0165-0270(00)00336-8; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	43	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2009	4	1							e4299	10.1371/journal.pone.0004299	http://dx.doi.org/10.1371/journal.pone.0004299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JG	19173006	Green Submitted, gold, Green Published			2022-12-27	WOS:000265483000008
J	Fernandez, E; Fu, M; Pascual, JA; Lopez, MJ; Perez-Rios, M; Schiaffino, A; Martinez-Sanchez, JM; Ariza, C; Salto, E; Nebot, M				Fernandez, Esteve; Fu, Marcela; Pascual, Jose A.; Lopez, Maria J.; Perez-Rios, Monica; Schiaffino, Anna; Martinez-Sanchez, Jose M.; Ariza, Carles; Salto, Esteve; Nebot, Manel		Spanish Smoking Law Evaluation Grp	Impact of the Spanish Smoking Law on Exposure to Second-Hand Smoke and Respiratory Health in Hospitality Workers: A Cohort Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; BAR WORKERS; PASSIVE SMOKING; CIGARETTE-SMOKE; SALIVA COTININE; FREE WORKPLACES; PUBLIC PLACES; AIR NICOTINE; PREVALENCE	Background: A smoke-free law came into effect in Spain on 1st January 2006, affecting all enclosed workplaces except hospitality venues, whose proprietors can choose among totally a smoke-free policy, a partial restriction with designated smoking areas, or no restriction on smoking on the premises. We aimed to evaluate the impact of the law among hospitality workers by assessing second-hand smoke (SHS) exposure and the frequency of respiratory symptoms before and one year after the ban. Methods and Finding: We formed a baseline cohort of 431 hospitality workers in Spain and 45 workers in Portugal and Andorra. Of them, 318 (66.8%) were successfully followed up 12 months after the ban, and 137 nonsmokers were included in this analysis. We obtained self-reported exposure to SHS and the presence of respiratory symptoms, and collected saliva samples for cotinine measurement. Salivary cotinine decreased by 55.6% after the ban among nonsmoker workers in venues where smoking was totally prohibited (from median of 1.6 ng/ml before to 0.5 ng/ml, p < 0.01). Cotinine concentration decreased by 27.6% (p = 0.068) among workers in venues with designated smoking areas, and by 10.7% (p = 0.475) among workers in venues where smoking was allowed. In Portugal and Andorra, no differences between cotinine concentration were found before (1.2 ng/ml) and after the ban (1.2 ng/ml). In Spain, reported respiratory symptom declined significantly (by 71.9%; p < 0.05) among workers in venues that became smoke-free. After adjustment for potential confounders, salivary cotinine and respiratory symptoms decreased significantly among workers in Spanish hospitality venues where smoking was totally banned. Conclusions: Among nonsmoker hospitality workers in bars and restaurants where smoking was allowed, exposure to SHS after the ban remained similar to pre-law levels. The partial restrictions on smoking in Spanish hospitality venues do not sufficiently protect hospitality workers against SHS or its consequences for respiratory health.	[Fu, Marcela; Martinez-Sanchez, Jose M.] ICO, Tobacco Res & Control Unit, Barcelona, Spain; [Fernandez, Esteve; Fu, Marcela; Martinez-Sanchez, Jose M.] Univ Barcelona, Hosp, Dept Clin Sci, E-08007 Barcelona, Spain; [Fernandez, Esteve; Fu, Marcela; Martinez-Sanchez, Jose M.] Hosp Llobregat, IDIBELL, Barcelona, Spain; [Pascual, Jose A.; Schiaffino, Anna; Nebot, Manel] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Pascual, Jose A.] Hosp Mar, IMIM, Bioanalysis Res Grp, Neuropsychopharmacol Programme, Barcelona, Spain; [Lopez, Maria J.; Ariza, Carles; Nebot, Manel] ASPB, Evaluat & Intervent Methods Unit, Barcelona, Spain; [Lopez, Maria J.; Perez-Rios, Monica; Ariza, Carles; Nebot, Manel] CIBERESP, Barcelona, Spain; [Lopez, Maria J.] Univ Autonoma Barcelona, Programme Publ Hlth & Biomed Res, Bellaterra, Spain; [Perez-Rios, Monica] Consejeria Salud, Xunta Galicia, Santiago De Compostela, Spain; [Perez-Rios, Monica] Univ Santiago Compostela, Dept Publ Hlth, Santiago De Compostela, Spain; [Schiaffino, Anna] IMSABS, Terrassa, Spain; [Salto, Esteve] Univ Barcelona, Dept Publ Hlth, E-08007 Barcelona, Spain; [Salto, Esteve] Generalitat Catalunya, Dept Hlth, Barcelona, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Universidade de Santiago de Compostela; University of Barcelona	Fernandez, E (corresponding author), ICO, Tobacco Res & Control Unit, Barcelona, Spain.	efernandez@ico.scs.es	Fernandez, Esteve/A-9750-2008; Pérez-Ríos, Mónica/AAA-5941-2019; Pascual, José Antonio/F-3884-2015; Martínez-Sánchez, Jose M/ABH-3093-2020; Lopez, Maria/HHC-3659-2022; Martínez-Sánchez, Jose/AAA-6343-2019; Pérez-Ortuño, Raúl/AAB-6105-2019	Fernandez, Esteve/0000-0003-4239-723X; Pascual, José Antonio/0000-0003-0837-4026; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Pérez-Ortuño, Raúl/0000-0002-1837-5447; Borras, Josep M/0000-0001-7330-6308; Salto, Esteve/0000-0002-6739-8936; ARIZA, Carles/0000-0002-0101-1911; Fu, Marcela/0000-0002-4962-0927; Lopez Medina, Maria Jose/0000-0003-4402-2239; Precioso, Jose/0000-0002-7889-8290; Perez-Rios, Monica/0000-0003-4456-6631	Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community; Spanish Ministry of Health [FIS PI052072, CIBERESP CB06/02/0032, RTICC RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [SGR200500646]	Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Ministry of Universities and Research, Government of Catalonia	This project was funded by the Public Health Directorates of the Departments of Health of the Regional Governments of Balearic Islands, Cantabria, Catalonia, Galicia and Valencian Community, the Spanish Ministry of Health (FIS PI052072, CIBERESP CB06/02/0032, and RTICC RD06/0020/0089), and the Ministry of Universities and Research, Government of Catalonia (SGR200500646). We thank Chupa Chups Spain for providing the Smint candies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SM, 2006, AM J PUBLIC HEALTH, V96, P296, DOI 10.2105/AJPH.2004.055012; Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Barker LE, 2002, AM J EPIDEMIOL, V156, P1056, DOI 10.1093/aje/kwf149; Bates MN, 2002, TOB CONTROL, V11, P125, DOI 10.1136/tc.11.2.125; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Blackford AL, 2006, CANCER EPIDEM BIOMAR, V15, P1799, DOI 10.1158/1055-9965.EPI-06-0427; Chen R, 2002, J Cancer Epidemiol Prev, V7, P85, DOI 10.1080/147666502321082746; Coll M, 2000, REV EPIDEMIOL SANTE, V48, P305; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Dimich-Ward H, 2005, SCAND J WORK ENV HEA, V31, P75, DOI 10.5271/sjweh.851; DWYER J, 1992, STAT MODELS LONGITUD, P3; EISNER MD, 1988, JAMA-J AM MED ASSOC, V280, P1909; Ellingsen DG, 2006, J ENVIRON MONITOR, V8, P362, DOI 10.1039/b600050a; *ENC POBL ACT, 2008, AS SEX RAM ACT VAL A; ETZEL RA, 1990, PREV MED, V19, P190, DOI 10.1016/0091-7435(90)90020-K; *EUR PUBL HLTH ALL, 2007, EUR SMOK BANS EV LEG; Farrelly MC, 2005, TOB CONTROL, V14, P236, DOI 10.1136/tc.2004.008839; Fernandez E, 2006, TOB CONTROL, V15, P79; Fernandez E, 2007, GAC SANIT, V21, P5, DOI 10.1016/S0213-9111(07)71962-3; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; GALAN I, 2008, GAC SANIT IN PRESS, V23; Garcia-Algar O, 2003, JAMA-J AM MED ASSOC, V290, P196, DOI 10.1001/jama.290.2.196; Goodman P, 2007, AM J RESP CRIT CARE, V175, P840, DOI 10.1164/rccm.200608-1085OC; Gorini G, 2008, TUMORI, V94, P798; Hahn EJ, 2006, J OCCUP ENVIRON MED, V48, P906, DOI 10.1097/01.jom.0000215709.09305.01; *HLTH CONS PROT, 2007, DIR GEN GREEN PAP EU; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; JARVIS MJ, 1992, BRIT J ADDICT, V87, P111; Johnsson T, 2006, ANN OCCUP HYG, V50, P331, DOI 10.1093/annhyg/mel011; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Koh HK, 2007, NEW ENGL J MED, V356, P1496, DOI 10.1056/NEJMp068279; Lui KJ, 1997, STAT MED, V16, P1777, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1777::AID-SIM608>3.0.CO;2-3; Lushchenkova O, 2008, REV ESP CARDIOL, V61, P687, DOI 10.1016/S1885-5857(08)60205-4; MARTIN A, 2007, GAC SANIT S, V1, P13; Martin-Luengo IA, 2007, OCU SALUD, P13; MARTINEZSANCHEZ JM, 2009, ARCH PREV R IN PRESS; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Nebot M, 2007, GAC SANIT, V21, P95, DOI 10.1157/13101033; Pascual JA, 2003, RAPID COMMUN MASS SP, V17, P2853, DOI 10.1002/rcm.1279; Pichini S, 2003, J EXPO ANAL ENV EPID, V13, P144, DOI 10.1038/sj.jea.7500264; Poetschke-Langer M, 2001, TOB CONTROL, V10, P300, DOI 10.1136/tc.10.4.300; Precioso J, 2007, REV SAUDE PUBL, V41, P808, DOI 10.1590/S0034-89102007000500015; Repace J L, 1987, IARC Sci Publ, P25; Repace JL, 1998, RISK ANAL, V18, P71, DOI 10.1111/j.1539-6924.1998.tb00917.x; RUTTER CM, 1994, STAT MED, V13, P1211, DOI 10.1002/sim.4780131204; Sanchez-Martinez F, 2007, MED CLIN-BARCELONA, V129, P100, DOI 10.1157/13107374; Santos AC, 2004, PREV MED, V38, P114, DOI 10.1016/j.ypmed.2003.09.040; Sebrie EM, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.018275; Semple S, 2007, ANN OCCUP HYG, V51, P571, DOI 10.1093/annhyg/mem044; Shiell A, 2000, SOC SCI MED, V51, P1111, DOI 10.1016/S0277-9536(00)00018-6; Siegel Michael, 2006, Clin Occup Environ Med, V5, P31; Spinney L, 2007, LANCET, V369, P1507, DOI 10.1016/S0140-6736(07)60691-6; Stark MJ, 2007, AM J PUBLIC HEALTH, V97, P1457, DOI 10.2105/AJPH.2006.094086; Sunyer J, 2000, AM J RESP CRIT CARE, V162, P930, DOI 10.1164/ajrccm.162.3.9911062; Toledo J, 2006, TOB CONTROL, V15, P147; TRAVIS CC, 1987, ENVIRON SCI TECHNOL, V21, P415, DOI 10.1021/es00159a001; Twose J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-194; Valente P, 2007, TOB CONTROL, V16, P312, DOI 10.1136/tc.2006.019646; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Villalbí Joan R., 2006, Gac Sanit, V20, P1, DOI 10.1157/13084119; *WHO, 2003, EUR COUNTR PROF TOB; *WHO, 2007, PROT EXP 2 HAND TOB; World Health Organization Regional Office for Europe, 2007, EUR TOB CONTR REP 20; WYNDER EL, 1990, J CLIN EPIDEMIOL, V43, P619, DOI 10.1016/0895-4356(90)90167-N; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220; 2007, EUR NEWS B, V208, P6	68	99	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2009	4	1							e4244	10.1371/journal.pone.0004244	http://dx.doi.org/10.1371/journal.pone.0004244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	437JD	19165321	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482400002
J	Wang, Z; Johnston, PR; Yang, ZL; Townsend, JP				Wang, Zheng; Johnston, Peter R.; Yang, Zhu L.; Townsend, Jeffrey P.			Evolution of Reproductive Morphology in Leaf Endophytes	PLOS ONE			English	Article								The endophytic lifestyle has played an important role in the evolution of the morphology of reproductive structures (body) in one of the most problematic groups in fungal classification, the Leotiomycetes (Ascomycota). Mapping fungal morphologies to two groups in the Leiotiomycetes, the Rhytismatales and Hemiphacidiaceae reveals significant divergence in body size, shape and complexity. Mapping ecological roles to these taxa reveals that the groups include endophytic fungi living on leaves and saprobic fungi living on duff or dead wood. Finally, mapping of the morphologies to ecological roles reveals that leaf endophytes produce small, highly reduced fruiting bodies covered with fungal tissue or dead host tissue, while saprobic species produce large and intricate fruiting bodies. Intriguingly, resemblance between asexual conidiomata and sexual ascomata in some leotiomycetes implicates some common developmental pathways for sexual and asexual development in these fungi.	[Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Johnston, Peter R.] Landcare Res, Herbarium PDD, Auckland, New Zealand; [Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeography, Kunming, Peoples R China	Yale University; Landcare Research - New Zealand; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Wang, Z (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	wang.zheng@yale.edu	Townsend, Jeffrey/H-2747-2019; Johnston, Peter/AAP-6300-2021; Johnston, Peter/GZL-2513-2022; Wang, Zheng/A-2318-2011	Townsend, Jeffrey/0000-0002-9890-3907; Johnston, Peter/0000-0003-0761-9116; Wang, Zheng/0000-0002-8849-8549	Yale University [Postdoctoral Fellowship]	Yale University	This research was supported by Yale University Anonymous Postdoctoral Fellowship (ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Gamundi IJ, 1995, NEW ZEAL J BOT, V33, P513; HAWKSWORTH DL, 2004, STUD MYCOL, V50, P9; Hendrikse JL, 2007, EVOL DEV, V9, P393, DOI 10.1111/j.1525-142X.2007.00176.x; Hibbett DS, 2007, MYCOL RES, V111, P1001, DOI 10.1016/j.mycres.2007.01.012; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JOHNSTON PR, 1989, NEW ZEAL J BOT, V27, P243, DOI 10.1080/0028825X.1989.10410377; Landvik Sara, 1996, Mycoscience, V37, P237, DOI 10.1007/BF02461292; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Roy K, 2008, SCIENCE, V321, P1451, DOI 10.1126/science.1163097; SAENZ GS, 1994, MYCOLOGIA, V86, P212, DOI 10.2307/3760639; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang Z, 2002, MYCOLOGIA, V94, P641, DOI 10.2307/3761715; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031	22	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2009	4	1							e4246	10.1371/journal.pone.0004246	http://dx.doi.org/10.1371/journal.pone.0004246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JC	19158947	gold, Green Published, Green Submitted			2022-12-27	WOS:000265482200003
J	Nath, AK; Krauthammer, M; Li, PY; Davidov, E; Butler, LC; Copel, J; Katajamaa, M; Oresic, M; Buhimschi, I; Buhimschi, C; Snyder, M; Madri, JA				Nath, Anjali K.; Krauthammer, Michael; Li, Puyao; Davidov, Eugene; Butler, Lucas C.; Copel, Joshua; Katajamaa, Mikko; Oresic, Matej; Buhimschi, Irina; Buhimschi, Catalin; Snyder, Michael; Madri, Joseph A.			Proteomic-Based Detection of a Protein Cluster Dysregulated during Cardiovascular Development Identifies Biomarkers of Congenital Heart Defects	PLOS ONE			English	Article								Background: Cardiovascular development is vital for embryonic survival and growth. Early gestation embryo loss or malformation has been linked to yolk sac vasculopathy and congenital heart defects (CHDs). However, the molecular pathways that underlie these structural defects in humans remain largely unknown hindering the development of molecular-based diagnostic tools and novel therapies. Methodology/Principal Findings: Murine embryos were exposed to high glucose, a condition known to induce cardiovascular defects in both animal models and humans. We further employed a mass spectrometry-based proteomics approach to identify proteins differentially expressed in embryos with defects from those with normal cardiovascular development. The proteins detected by mass spectrometry (WNT16, ST14, Pcsk1, Jumonji, Morca2a, TRPC5, and others) were validated by Western blotting and immunoflorescent staining of the yolk sac and heart. The proteins within the proteomic dataset clustered to adhesion/migration, differentiation, transport, and insulin signaling pathways. A functional role for several proteins (WNT16, ADAM15 and NOGO-A/B) was demonstrated in an ex vivo model of heart development. Additionally, a successful application of a cluster of protein biomarkers (WNT16, ST14 and Pcsk1) as a prenatal screen for CHDs was confirmed in a study of human amniotic fluid (AF) samples from women carrying normal fetuses and those with CHDs. Conclusions/Significance: The novel finding that WNT16, ST14 and Pcsk1 protein levels increase in fetuses with CHDs suggests that these proteins may play a role in the etiology of human CHDs. The information gained through this bed-side to bench translational approach contributes to a more complete understanding of the protein pathways dysregulated during cardiovascular development and provides novel avenues for diagnostic and therapeutic interventions, beneficial to fetuses at risk for CHDs.	[Davidov, Eugene; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Nath, Anjali K.; Krauthammer, Michael; Li, Puyao; Butler, Lucas C.; Madri, Joseph A.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Copel, Joshua; Buhimschi, Irina; Buhimschi, Catalin] Yale Univ, Dept Obstet & Gynecol, New Haven, CT 06520 USA; [Katajamaa, Mikko; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland	Yale University; Yale University; Yale University; VTT Technical Research Center Finland	Nath, AK (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	anjali.nath@aya.yale.edu	Oresic, Matej/K-7673-2016; Buhimschi, Irina/AAY-6619-2021; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Buhimschi, Irina/0000-0002-1701-1326; Snyder, Michael/0000-0003-0784-7987; Krauthammer, Michael/0000-0002-4808-1845	NIHR [37HL28373];  [HG02357];  [5 T32 GM07499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028373, R01HL028373] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	NIHR(National Institute for Health Research (NIHR)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported by NIHR37HL28373 to JAM, HG02357 to MS and 5 T32 GM07499 to AKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Ahmed S, 2006, FEBS J, V273, P615, DOI 10.1111/j.1742-4658.2005.05094.x; Akazawa Shoichi, 2005, Congenital Anomalies, V45, P73, DOI 10.1111/j.1741-4520.2005.00070.x; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Carvalho JS, 1998, LANCET, V351, P1023, DOI 10.1016/S0140-6736(97)08406-7; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen L, 2005, AM J NEPHROL, V25, P459, DOI 10.1159/000087853; Cheyssac C, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-44; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DELACRUZ MV, 1977, J ANAT, V123, P661; DELACRUZ MV, 1983, AM J ANAT, V166, P63, DOI 10.1002/aja.1001660105; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; EISENBERG CA, 1995, DEV BIOL, V167, P469, DOI 10.1006/dbio.1995.1042; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; ERIKSSON UJ, 1991, DIABETOLOGIA, V34, P325, DOI 10.1007/BF00405004; Finney GL, 2008, ANAL CHEM, V80, P961, DOI 10.1021/ac701649e; Flanagan TC, 2006, CELLS TISSUES ORGANS, V183, P12, DOI 10.1159/000094902; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003; HUNTER ES, 1992, TERATOLOGY, V45, P195, DOI 10.1002/tera.1420450213; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Joshua IG, 2005, J CELL BIOCHEM, V96, P1149, DOI 10.1002/jcb.20620; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Laigaard J, 2005, PRENATAL DIAG, V25, P45, DOI 10.1002/pd.1029; LAMERS WH, 1995, CIRCULATION, V91, P111, DOI 10.1161/01.CIR.91.1.111; Li X, 2001, J LEUKOCYTE BIOL, V69, P565; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; LINASK KK, 1993, DEV DYNAM, V196, P62, DOI 10.1002/aja.1001960108; Loffredo CA, 2001, TERATOLOGY, V64, P98, DOI 10.1002/tera.1051; Masmiquel L, 2000, AM J OPHTHALMOL, V129, P347, DOI 10.1016/S0002-9394(99)00361-X; MCBRIDE RE, 1981, AM J ANAT, V160, P309, DOI 10.1002/aja.1001600308; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Moat SJ, 2004, J NUTR BIOCHEM, V15, P64, DOI 10.1016/j.jnutbio.2003.08.010; Moens AL, 2008, AM J PHYSIOL-HEART C, V294, pH1971, DOI 10.1152/ajpheart.91503.2007; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; NEW DAT, 1991, HUM REPROD, V6, P58, DOI 10.1093/oxfordjournals.humrep.a137259; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; Nyberg DA, 2006, RADIOL CLIN N AM, V44, P837, DOI 10.1016/j.rcl.2006.10.017; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Pinter E, 1999, AM J PATHOL, V154, P1367, DOI 10.1016/S0002-9440(10)65391-6; PINTER E, 1986, TERATOLOGY, V33, P73, DOI 10.1002/tera.1420330110; Pinter E, 2001, AM J PATHOL, V158, P1199, DOI 10.1016/S0002-9440(10)64069-2; Root-Bernstein R, 2002, J THEOR BIOL, V216, P345, DOI 10.1006/jtbi.2002.2535; Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; SADLER TW, 1988, AM J PERINAT, V5, P319, DOI 10.1055/s-2007-999717; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Small M, 2004, PEDIATR CARDIOL, V25, P210, DOI 10.1007/s00246-003-0587-z; Smrcek JM, 2006, J ULTRAS MED, V25, P173, DOI 10.7863/jum.2006.25.2.173; Smrcek JM, 2006, J ULTRAS MED, V25, P187, DOI 10.7863/jum.2006.25.2.187; Spencer-Jones NJ, 2005, DIABETES, V54, P3296, DOI 10.2337/diabetes.54.11.3296; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Wren C, 2003, HEART, V89, P1217, DOI 10.1136/heart.89.10.1217; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yutzey KEE, 2002, DEV DYNAM, V223, P307, DOI 10.1002/dvdy.10068	82	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2009	4	1							e4221	10.1371/journal.pone.0004221	http://dx.doi.org/10.1371/journal.pone.0004221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IZ	19156209	Green Published, gold, Green Submitted			2022-12-27	WOS:000265481900004
J	Arce, F; Novick, I; Shahar, M; Link, Y; Ghez, C; Vaadia, E				Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Ghez, Claude; Vaadia, Eilon			Differences in Context and Feedback Result in Different Trajectories and Adaptation Strategies in Reaching	PLOS ONE			English	Article								Computational models of motor control have often explained the straightness of horizontal planar reaching movements as a consequence of optimal control. Departure from rectilinearity is thus regarded as sub-optimal. Here we examine if subjects may instead select to make curved trajectories following adaptation to force fields and visuomotor rotations. Separate subjects adapted to force fields with or without visual feedback of their hand trajectory and were retested after 24 hours. Following adaptation, comparable accuracies were achieved in two ways: with visual feedback, adapted trajectories in force fields were straight whereas without it, they remained curved. The results suggest that trajectory shape is not always straight, but is also influenced by the calibration of available feedback signals for the state estimation required by the task. In a follow-up experiment, where additional subjects learned a visuomotor rotation immediately after force field, the trajectories learned in force fields (straight or curved) were transferred when directions of the perturbations were similar but not when directions were opposing. This demonstrates a strong bias by prior experience to keep using a recently acquired control policy that continues to produce successful performance inspite of differences in tasks and feedback conditions. On relearning of force fields on the second day, facilitation by intervening visuomotor rotations occurred only when required motor adjustments and calibration of feedback signals were similar in both tasks. These results suggest that both the available feedback signals and prior history of learning influence the choice and maintenance of control policy during adaptations.	[Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Vaadia, Eilon] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Vaadia, Eilon] Interdisciplinary Ctr Neural Computat, Jerusalem, Israel; [Arce, Fritzie; Novick, Itai; Shahar, Maayan; Link, Yuval; Vaadia, Eilon] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Ghez, Claude] Columbia Univ, Coll Physicians & Surgeons, Ctr Neurobiol & Behavior, New York, NY 10027 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Columbia University	Arce, F (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	fritziea@ekmd.huji.ac.il	Vaadia, Eilon/E-9347-2011	Arce-McShane, Fritzie/0000-0001-6616-3564	Binational Science Foundation (BSF); Israel Science Foundation (ISF); Johnson&Johnson Fund for Innovative Science; Rosetrees Trust; Ida Baruch fund; Jack H. Skirball Chair of Brain Research	Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); Johnson&Johnson Fund for Innovative Science; Rosetrees Trust(Rosetrees Trust); Ida Baruch fund; Jack H. Skirball Chair of Brain Research	This work was supported in part by the Binational Science Foundation (BSF), the Israel Science Foundation (ISF), the Johnson&Johnson Fund for Innovative Science and special contributions from the Rosetrees Trust and the Ida Baruch fund. EV is the Jack H. Skirball Chair of Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Chib VS, 2006, J NEUROPHYSIOL, V95, P1068, DOI 10.1152/jn.00610.2005; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001336; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GHEZ C, 2007, J NEUROPHYSIOL; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; Jordan Michael I., 1995, P597; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Liu XL, 2008, J NEUROPHYSIOL, V99, P2546, DOI 10.1152/jn.01044.2007; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paillard J, 1996, CAN J PHYSIOL PHARM, V74, P401, DOI 10.1139/cjpp-74-4-401; Paz R, 2005, J NEUROSCI, V25, P10941, DOI 10.1523/JNEUROSCI.0164-05.2005; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Scheidt R. A., 2007, J NEUROPHYSIOL; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; [No title captured]	44	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2009	4	1							e4214	10.1371/journal.pone.0004214	http://dx.doi.org/10.1371/journal.pone.0004214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437IH	19148302	Green Submitted, gold, Green Published			2022-12-27	WOS:000265479900008
J	Kishioka, A; Fukushima, F; Ito, T; Kataoka, H; Mori, H; Ikeda, T; Itohara, S; Sakimura, K; Mishina, M				Kishioka, Ayumi; Fukushima, Fumiaki; Ito, Tamae; Kataoka, Hirotaka; Mori, Hisashi; Ikeda, Toshio; Itohara, Shigeyoshi; Sakimura, Kenji; Mishina, Masayoshi			A Novel Form of Memory for Auditory Fear Conditioning at a Low-Intensity Unconditioned Stimulus	PLOS ONE			English	Article								Fear is one of the most potent emotional experiences and is an adaptive component of response to potentially threatening stimuli. On the other hand, too much or inappropriate fear accounts for many common psychiatric problems. Cumulative evidence suggests that the amygdala plays a central role in the acquisition, storage and expression of fear memory. Here, we developed an inducible striatal neuron ablation system in transgenic mice. The ablation of striatal neurons in the adult brain hardly affected the auditory fear learning under the standard condition in agreement with previous studies. When conditioned with a low-intensity unconditioned stimulus, however, the formation of long-term fear memory but not short-tem memory was impaired in striatal neuron-ablated mice. Consistently, the ablation of striatal neurons 24 h after conditioning with the low-intensity unconditioned stimulus, when the long-term fear memory was formed, diminished the retention of the long-term memory. Our results reveal a novel form of the auditory fear memory depending on striatal neurons at the low-intensity unconditioned stimulus.	[Kishioka, Ayumi; Fukushima, Fumiaki; Ito, Tamae; Kataoka, Hirotaka; Mori, Hisashi; Mishina, Masayoshi] Univ Tokyo, Grad Sch Sci, Dept Mol Neurobiol & Pharmacol, Tokyo 113, Japan; [Ikeda, Toshio; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Lab Behav Genet, Saitama, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 95021, Japan	University of Tokyo; RIKEN; Niigata University	Kishioka, A (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Mol Neurobiol & Pharmacol, Tokyo 113, Japan.	mishina@m.u-tokyo.ac.jp	Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (Molecular Brain Science) and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. F.F. was supported by Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Armony JL, 1998, J NEUROSCI, V18, P2592; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Drago J, 1998, J NEUROSCI, V18, P9845; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1984, BEHAV NEUROSCI, V98, P269, DOI 10.1037/0735-7044.98.2.269; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Ferreira TL, 2003, BRAIN RES, V987, P17, DOI 10.1016/S0006-8993(03)03217-7; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GRAVELAND GA, 1985, BRAIN RES, V327, P307, DOI 10.1016/0006-8993(85)91524-0; Haralambous T, 1999, BEHAV NEUROSCI, V113, P925, DOI 10.1037/0735-7044.113.5.925; Jongen-Relo AL, 2003, BEHAV NEUROSCI, V117, P150, DOI 10.1037/0735-7044.117.1.150; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; Kent Justine M, 2003, Curr Psychiatry Rep, V5, P266, DOI 10.1007/s11920-003-0055-8; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Koresawa Y, 2000, J BIOCHEM, V127, P367, DOI 10.1093/oxfordjournals.jbchem.a022617; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LEDOUX JE, 1984, J NEUROSCI, V4, P683; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Riedel G, 1997, NEUROREPORT, V8, P2477, DOI 10.1097/00001756-199707280-00013; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROTHWELL JC, 1987, ANATOMICAL PHYSL BAS; SCHOENFELD TA, 1977, PHYSIOL BEHAV, V18, P951, DOI 10.1016/0031-9384(77)90206-2; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Tsujita M, 1999, J NEUROSCI, V19, P10318; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Uys Joachim D K, 2003, Curr Psychiatry Rep, V5, P274; WATERS CH, 1993, MOVEMENT DISORD, V8, P387, DOI 10.1002/mds.870080328; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	54	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2009	4	1							e4157	10.1371/journal.pone.0004157	http://dx.doi.org/10.1371/journal.pone.0004157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GB	19132103	Green Published, gold, Green Submitted			2022-12-27	WOS:000265473700001
J	Chakraborty, A; Uechi, T; Higa, S; Torihara, H; Kenmochi, N				Chakraborty, Anirban; Uechi, Tamayo; Higa, Sayomi; Torihara, Hidetsugu; Kenmochi, Naoya			Loss of Ribosomal Protein L11 Affects Zebrafish Embryonic Development through a p53-Dependent Apoptotic Response	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; P53; GENE; RNA; ACTIVATION; CHECKPOINT; SUBUNIT; IDENTIFICATION; NUCLEOLUS; MINUTE	Ribosome is responsible for protein synthesis in all organisms and ribosomal proteins (RPs) play important roles in the formation of a functional ribosome. L11 was recently shown to regulate p53 activity through a direct binding with MDM2 and abrogating the MDM2-induced p53 degradation in response to ribosomal stress. However, the studies were performed in cell lines and the significance of this tumor suppressor function of L11 has yet to be explored in animal models. To investigate the effects of the deletion of L11 and its physiological relevance to p53 activity, we knocked down the rp/11 gene in zebrafish and analyzed the p53 response. Contrary to the cell line-based results, our data indicate that an L11 deficiency in a model organism activates the p53 pathway. The L11-deficient embryos (morphants) displayed developmental abnormalities primarily in the brain, leading to embryonic lethality within 6-7 days post fertilization. Extensive apoptosis was observed in the head region of the morphants, thus correlating the morphological defects with apparent cell death. A decrease in total abundance of genes involved in neural patterning of the brain was observed in the morphants, suggesting a reduction in neural progenitor cells. Upregulation of the genes involved in the p53 pathway were observed in the morphants. Simultaneous knockdown of the p53 gene rescued the developmental defects and apoptosis in the morphants. These results suggest that ribosomal dysfunction due to the loss of L11 activates a p53-dependent checkpoint response to prevent improper embryonic development.	[Chakraborty, Anirban; Uechi, Tamayo; Higa, Sayomi; Torihara, Hidetsugu; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan	University of Miyazaki	Chakraborty, A (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	kenmochi@med.miyazaki-u.ac.jp	Chakraborty, Anirban/AAP-5348-2020; Kenmochi, Naoya/ABF-3564-2021	/0000-0003-3476-6576	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [Grants-in-Aid]; Japan Society for the Promotion of Science (JSPS) [P06457]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by 'Grants-in-Aid' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS). AC is a research fellow of JSPS (P06457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; CMEJLA R, 2007, HUM MUTAT, P1; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DANILOVA N, 2008, BLOOD IN PRESS; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Heisenberg CP, 1999, DEVELOPMENT, V126, P2129; KENMOCHI N, 2003, NATURE ENCY HUMAN GE, V5, P77; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; MCGOWAN KA, 2008, NATURE GENE IN PRESS; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Opferman JT, 2006, CELL DEATH DIFFER, V13, P898, DOI 10.1038/sj.cdd.4401923; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SKARIE JM, 2008, HUM MOL GEN IN PRESS; Soulet F, 2001, BIOCHEM BIOPH RES CO, V289, P591, DOI 10.1006/bbrc.2001.5960; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Thisse B, 2004, ZFIN DIRECT DATA SUB; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; ZFIN, ZEBR MOD ORG DAT; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	50	101	105	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2009	4	1							e4152	10.1371/journal.pone.0004152	http://dx.doi.org/10.1371/journal.pone.0004152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FZ	19129914	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473500005
J	Martin, B; Pearson, M; Brenneman, R; Golden, E; Wood, W; Prabhu, V; Becker, KG; Mattson, MP; Maudsley, S				Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Wood, William, III; Prabhu, Vinayakumar; Becker, Kevin G.; Mattson, Mark P.; Maudsley, Stuart			Gonadal Transcriptome Alterations in Response to Dietary Energy Intake: Sensing the Reproductive Environment	PLOS ONE			English	Article								Reproductive capacity and nutritional input are tightly linked and animals' specific responses to alterations in their physical environment and food availability are crucial to ensuring sustainability of that species. We have assessed how alterations in dietary energy intake (both reductions and excess), as well as in food availability, via intermittent fasting (IF), affect the gonadal transcriptome of both male and female rats. Starting at four months of age, male and female rats were subjected to a 20% or 40% caloric restriction (CR) dietary regime, every other day feeding (IF) or a high fat-high glucose (HFG) diet for six months. The transcriptional activity of the gonadal response to these variations in dietary energy intake was assessed at the individual gene level as well as at the parametric functional level. At the individual gene level, the females showed a higher degree of coherency in gonadal gene alterations to CR than the males. The gonadal transcriptional and hormonal response to IF was also significantly different between the male and female rats. The number of genes significantly regulated by IF in male animals was almost 5 times greater than in the females. These IF males also showed the highest testosterone to estrogen ratio in their plasma. Our data show that at the level of gonadal gene responses, the male rats on the IF regime adapt to their environment in a manner that is expected to increase the probability of eventual fertilization of females that the males predict are likely to be sub-fertile due to their perception of a food deficient environment.	[Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Mattson, Mark P.] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Wood, William, III; Prabhu, Vinayakumar; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Baltimore, MD USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Neurosci Lab, Baltimore, MD 21224 USA.	maudsleyst@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Mattson, Mark P/F-6038-2012	Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Martin, Bronwen/0000-0002-9185-6925	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZICAG000616, ZIAAG000318, ZIAAG000916, Z01AG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1477, DOI 10.1093/jnci/djn329; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Ewertz M, 2001, ACTA ONCOL, V40, P467, DOI 10.1080/028418601750288181; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; GREWAL T, 1971, P SOC EXP BIOL MED, V138, P723, DOI 10.3181/00379727-138-35976; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Holekamp KE, 1999, J REPROD FERTIL, V116, P87; HOWLAND BE, 1975, J REPROD FERTIL, V44, P429, DOI 10.1530/jrf.0.0440429; Huyghe S, 2001, BIOCHEM J, V353, P673, DOI 10.1042/0264-6021:3530673; Jabbour HN, 1999, J CLIN ENDOCR METAB, V84, P4260, DOI 10.1210/jc.84.11.4260; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; KAMAT BR, 1995, AM J PATHOL, V146, P157; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kimura M, 2001, CYTOGENET CELL GENET, V94, P33, DOI 10.1159/000048779; Kitaya K, 2007, INT J MOL MED, V20, P689; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; LENFANTPEJOVIC MH, 1990, INT J CANCER, V45, P661, DOI 10.1002/ijc.2910450415; Liang JH, 2001, J MED PRIMATOL, V30, P107, DOI 10.1034/j.1600-0684.2001.300206.x; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; McNatty KP, 2005, REPRODUCTION, V129, P481, DOI 10.1530/rep.1.00517; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Muniz LC, 2006, BIOL REPROD, V75, P279, DOI 10.1095/biolreprod.105.049486; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Silva FP, 2006, ONCOGENE, V25, P5063, DOI 10.1038/sj.onc.1209517; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Sorensen HT, 1998, AM J GASTROENTEROL, V93, P231, DOI 10.1016/S0002-9270(97)00050-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabibzadeh S, 1996, HUM REPROD, V11, P633, DOI 10.1093/HUMREP/11.3.633; THOMAS DB, 1992, AM J EPIDEMIOL, V135, P734, DOI 10.1093/oxfordjournals.aje.a116360; Whitney LW, 1999, ANN NEUROL, V46, P425; Williams JG, 2005, TRENDS GENET, V21, P392, DOI 10.1016/j.tig.2005.05.002; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	54	30	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2009	4	1							e4146	10.1371/journal.pone.0004146	http://dx.doi.org/10.1371/journal.pone.0004146			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FX	19127293	Green Submitted, Green Published, gold			2022-12-27	WOS:000265473300011
J	Kucera, T; Strilic, B; Regener, K; Schubert, M; Laudet, V; Lammert, E				Kucera, Tomas; Strilic, Boris; Regener, Kathrin; Schubert, Michael; Laudet, Vincent; Lammert, Eckhard			Ancestral Vascular Lumen Formation via Basal Cell Surfaces	PLOS ONE			English	Article								The cardiovascular system of bilaterians developed from a common ancestor. However, no endothelial cells exist in invertebrates demonstrating that primitive cardiovascular tubes do not require this vertebrate-specific cell type in order to form. This raises the question of how cardiovascular tubes form in invertebrates? Here we discovered that in the invertebrate cephalochordate amphioxus, the basement membranes of endoderm and mesoderm line the lumen of the major vessels, namely aorta and heart. During amphioxus development a laminin-containing extracellular matrix (ECM) was found to fill the space between the basal cell surfaces of endoderm and mesoderm along their anterior-posterior (A-P) axes. Blood cells appear in this ECM-filled tubular space, coincident with the development of a vascular lumen. To get insight into the underlying cellular mechanism, we induced vessels in vitro with a cell polarity similar to the vessels of amphioxus. We show that basal cell surfaces can form a vascular lumen filled with ECM, and that phagocytotic blood cells can clear this luminal ECM to generate a patent vascular lumen. Therefore, our experiments suggest a mechanism of blood vessel formation via basal cell surfaces in amphioxus and possibly in other invertebrates that do not have any endothelial cells. In addition, a comparison between amphioxus and mouse shows that endothelial cells physically separate the basement membranes from the vascular lumen, suggesting that endothelial cells create cardiovascular tubes with a cell polarity of epithelial tubes in vertebrates and mammals.	[Kucera, Tomas; Strilic, Boris; Regener, Kathrin; Lammert, Eckhard] Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany; [Kucera, Tomas] Charles Univ Prague, First Fac Med, Inst Histol & Embryol, Prague, Czech Republic; [Schubert, Michael; Laudet, Vincent] Univ Lyon, Inst Genom Fonct Lyon, Ecole Normale Superieure Lyon, CNRS, Lyon, France; [Lammert, Eckhard] Univ Dusseldorf, Inst Animal Physiol, Dusseldorf, Germany	Max Planck Society; Charles University Prague; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Heinrich Heine University Dusseldorf	Kucera, T (corresponding author), Max Planck Inst Mol Cell Biol & Genet MPI CBG, Dresden, Germany.	lammert@uni-duesseldorf.de	Kučera, Tomáš/C-7532-2017; Schubert, Michael/C-1875-2008	Kučera, Tomáš/0000-0003-2134-4657; Schubert, Michael/0000-0002-2341-712X	Deutsche Forschungsgemeinschaft; Behrens Weise Foundation; Ministry of Education, Youth and Sports of Czech Republic [MSM0021620807]; ANR; CNRS; MENRT; CRESCENDO	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Behrens Weise Foundation; Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); MENRT; CRESCENDO(European Commission)	The Sonderforschungsbereich SFB 655 "Cells into tissues" (Deutsche Forschungsgemeinschaft) and the Behrens Weise Foundation funded this work. Tomas Kucera was also supported by the Research Project MSM0021620807 from the Ministry of Education, Youth and Sports of Czech Republic. Michael Schubert was supported by the ANR, the CNRS, the MENRT and CRESCENDO, a European Union Integrated Project of FP6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishopric NH, 2005, ANN NY ACAD SCI, V1047, P13, DOI 10.1196/annals.1341.002; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Durbeej M, 1996, MATRIX BIOL, V15, P397, DOI 10.1016/S0945-053X(96)90159-6; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Hartenstein V, 2006, BIOESSAYS, V28, P1203, DOI 10.1002/bies.20497; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Holland ND, 2003, DEV BIOL, V255, P128, DOI 10.1016/S0012-1606(02)00050-7; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; MOLLER PC, 1973, J MORPHOL, V139, P389, DOI 10.1002/jmor.1051390403; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; RHODES CP, 1982, SCIENCE, V217, P263, DOI 10.1126/science.7089565; RUPPERT E, 1997, MICROSCOPIC ANATOMY, P394; RUPPERT EE, 1983, ZOOMORPHOLOGY, V103, P193, DOI 10.1007/BF00310477; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Stach T, 1998, BIOL BULL, V195, P260, DOI 10.2307/1543137; STACH T, 2000, MICROSCOPIC ANATOMY, P1; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; VERNON RB, 1992, LAB INVEST, V66, P536; WANG AZ, 1990, J CELL SCI, V95, P137; Yano K, 2007, BLOOD, V109, P613, DOI 10.1182/blood-2006-05-026401	36	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2009	4	1							e4132	10.1371/journal.pone.0004132	http://dx.doi.org/10.1371/journal.pone.0004132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437FV	19125185	Green Published, gold			2022-12-27	WOS:000265473100006
J	Ohazama, A; Johnson, EB; Ota, MS; Choi, HJ; Porntaveetus, T; Oommen, S; Itoh, N; Eto, K; Gritli-Linde, A; Herz, J; Sharpe, PT				Ohazama, Atsushi; Johnson, Eric B.; Ota, Masato S.; Choi, Hong J.; Porntaveetus, Thantrira; Oommen, Shelly; Itoh, Nobuyuki; Eto, Kazuhiro; Gritli-Linde, Amel; Herz, Joachim; Sharpe, Paul T.			Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development	PLOS ONE			English	Article							TOOTH DEVELOPMENT; LIPOPROTEIN RECEPTORS; SYNAPTIC PLASTICITY; BMP ANTAGONIST; VASCULAR WALL; MOUSE; BONE; PROTEINS; REELIN; USAG-1	The extent to which cell signaling is integrated outside the cell is not currently appreciated. We show that a member of the low-density receptor-related protein family, Lrp4 modulates and integrates Bmp and canonical Wnt signalling during tooth morphogenesis by binding the secreted Bmp antagonist protein Wise. Mouse mutants of Lrp4 and Wise exhibit identical tooth phenotypes that include supernumerary incisors and molars, and fused molars. We propose that the Lrp4/Wise interaction acts as an extracellular integrator of epithelial-mesenchymal cell signaling. Wise, secreted from mesenchyme cells binds to BMP's and also to Lrp4 that is expressed on epithelial cells. This binding then results in the modulation of Wnt activity in the epithelial cells. Thus in this context Wise acts as an extracellular signaling molecule linking two signaling pathways. We further show that a downstream mediator of this integration is the Shh signaling pathway.	[Ohazama, Atsushi; Porntaveetus, Thantrira; Oommen, Shelly; Sharpe, Paul T.] Kings Coll London, Guys Hosp, Inst Dent, Dept Craniofacial Dev, London, England; [Johnson, Eric B.; Choi, Hong J.; Herz, Joachim] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX USA; [Ota, Masato S.; Eto, Kazuhiro] Tokyo Med & Dent Univ, Grad Sch, Sect Mol Craniofacial Embryol, Tokyo, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharm Sci, Dept Genet Biochem, Kyoto, Japan; [Gritli-Linde, Amel] Gothenburg Univ, Sahlgrenska Acad, Dept Oral Biochem, Gothenburg, Sweden	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU); Kyoto University; University of Gothenburg	Ohazama, A (corresponding author), Kings Coll London, Guys Hosp, Inst Dent, Dept Craniofacial Dev, London, England.	paul.sharpe@kcl.ac.uk	Porntaveetus, Thantrira/ABF-6854-2020	porntaveetus, thantrira/0000-0003-0145-9801; Sharpe, Paul/0000-0003-2116-9561	Wellcome Trust; MRC; RCUK [fellow]; NIH; Wolfgang Paul Award from the Alexander-von-Humboldt Foundation [HL20948, HL63762]; Swedish Research Council-Medicine [2789, 14100, 15181]; Faculty of Odontology; Biotechnology and Biological Sciences Research Council [BB/E01335X/1] Funding Source: researchfish; Medical Research Council [G0200709] Funding Source: researchfish; BBSRC [BB/E01335X/1] Funding Source: UKRI; MRC [G0200709] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R37HL063762, R01HL063762] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK(UK Research & Innovation (UKRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wolfgang Paul Award from the Alexander-von-Humboldt Foundation; Swedish Research Council-Medicine(Swedish Research Council); Faculty of Odontology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust and MRC. A.O. is an RCUK Fellow. J.H. is supported by grants from the NIH and is the recipient of a Wolfgang Paul Award from the Alexander-von-Humboldt Foundation (HL20948 and HL63762). A.G.L. is supported by the Swedish Research Council-Medicine (grants 2789, 14100 and 15181) and Faculty of Odontology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Herz J, 2004, CURR OPIN LIPIDOL, V15, P175, DOI 10.1097/00041433-200404000-00010; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Ohazama A, 2004, CURR OPIN GENET DEV, V14, P513, DOI 10.1016/j.gde.2004.07.008; Peterkova R, 2002, CONNECT TISSUE RES, V43, P120, DOI 10.1080/03008200290000745; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Simon-Chazottes D, 2006, GENOMICS, V87, P673, DOI 10.1016/j.ygeno.2006.01.007; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TENCATE AR, 2003, TENCATES ORAL HISTOL, P79; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wilkinson D.G, 1995, SITU HYBRIDISATION P; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075	45	143	147	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2008	3	12							e4092	10.1371/journal.pone.0004092	http://dx.doi.org/10.1371/journal.pone.0004092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437DO	19116665	Green Submitted, Green Published, gold			2022-12-27	WOS:000265466600013
J	Ghani, AC; Sutherland, CJ; Riley, EM; Drakeley, CJ; Griffin, JT; Gosling, RD; Filipe, JAN				Ghani, Azra C.; Sutherland, Colin J.; Riley, Eleanor M.; Drakeley, Chris J.; Griffin, Jamie T.; Gosling, Roly D.; Filipe, Joao A. N.			Loss of Population Levels of Immunity to Malaria as a Result of Exposure-Reducing Interventions: Consequences for Interpretation of Disease Trends	PLOS ONE			English	Article								Background: The persistence of malaria as an endemic infection and one of the major causes of childhood death in most parts of Africa has lead to a radical new call for a global effort towards eradication. With the deployment of a highly effective vaccine still some years away, there has been an increased focus on interventions which reduce exposure to infection in the individual and -by reducing onward transmission-at the population level. The development of appropriate monitoring of these interventions requires an understanding of the timescales of their effect. Methods & Findings: Using a mathematical model for malaria transmission which incorporates the acquisition and loss of both clinical and parasite immunity, we explore the impact of the trade-off between reduction in exposure and decreased development of immunity on the dynamics of disease following a transmission-reducing intervention such as insecticide-treated nets. Our model predicts that initially rapid reductions in clinical disease incidence will be observed as transmission is reduced in a highly immune population. However, these benefits in the first 5-10 years after the intervention may be offset by a greater burden of disease decades later as immunity at the population level is gradually lost. The negative impact of having fewer immune individuals in the population can be counterbalanced either by the implementation of highly-effective transmission-reducing interventions (such as the combined use of insecticide-treated nets and insecticide residual sprays) for an indefinite period or the concurrent use of a pre-erythrocytic stage vaccine or prophylactic therapy in children to protect those at risk from disease as immunity is lost in the population. Conclusions: Effective interventions will result in rapid decreases in clinical disease across all transmission settings while population-level immunity is maintained but may subsequently result in increases in clinical disease many years later as population-level immunity is lost. A dynamic, evolving intervention programme will therefore be necessary to secure substantial, stable reductions in malaria transmission.	[Ghani, Azra C.; Griffin, Jamie T.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Ghani, Azra C.; Filipe, Joao A. N.] London Sch Hygiene & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Sutherland, Colin J.; Riley, Eleanor M.; Drakeley, Chris J.; Gosling, Roly D.] London Sch Hygiene & Trop Med, Dept Infect & Trop Dis, London, England; [Filipe, Joao A. N.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 1TN, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Ghani, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England.	a.ghani@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Riley, Eleanor/AAL-1382-2020; Ghani, Azra/B-8560-2009; Sutherland, Colin/AAN-3939-2020; Riley, Eleanor M/C-8960-2013; Ferguson, Neil/B-8578-2008	Fraser, Christophe/0000-0003-2399-9657; Riley, Eleanor/0000-0003-3447-3570; Sutherland, Colin/0000-0003-1592-6407; Riley, Eleanor M/0000-0003-3447-3570; Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; White, Michael/0000-0002-7472-4138; Ghani, Azra/0000-0002-0007-4910; Filipe, Joao/0000-0002-2353-7981; Flasche, Stefan/0000-0002-5808-2606	The Gates Foundation; MRC;  [38773];  [G9901439]; Medical Research Council [G0600719B] Funding Source: researchfish	The Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was in part funded by a grant from The Gates Foundation (Grant ID# 38773). Data used in the study were collected in an MRC-funded study (grant number: G9901439). The funders played no role in the design, analysis or drafting of the results.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; ANDERSON RM, 1985, NATURE, V315, P493, DOI 10.1038/315493a0; [Anonymous], 2004, COCHRANE DB SYST REV; Aron J.L., 1982, P139; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; DELORON P, 1992, PARASITOL TODAY, V8, P375, DOI 10.1016/0169-4758(92)90174-Z; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; GOSLING R, 2008, MALARIA J, V3, P7; GRAMICCIA G, 1988, PRINCIPLE PRACTICE M; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vega JC, 2007, TROP MED INT HEALTH, V12, P1524, DOI 10.1111/j.1365-3156.2007.01961.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Wipasa J, 2007, EXPERT OPIN BIOL TH, V7, P1841, DOI 10.1517/14712598.7.12.1841; World Health Organization, 2008, INS TREAT MOSQ NETS	32	112	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2009	4	2							e4383	10.1371/journal.pone.0004383	http://dx.doi.org/10.1371/journal.pone.0004383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JN	19198649	Green Published, Green Submitted, gold			2022-12-27	WOS:000265483900004
J	Kang, Y; Choi, M; Lee, J; Koh, GY; Kwon, K; Choi, C				Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Koh, Gou Young; Kwon, Kihwan; Choi, Chulhee			Quantitative Analysis of Peripheral Tissue Perfusion Using Spatiotemporal Molecular Dynamics	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; INDOCYANINE GREEN; IN-VIVO; PHOTODYNAMIC THERAPY; CONTRAST; PATHOPHYSIOLOGY; ARTERIOGENESIS; ANGIOGENESIS; INJECTION	Background: Accurate measurement of peripheral tissue perfusion is challenging but necessary to diagnose peripheral vascular insufficiency. Because near infrared (NIR) radiation can penetrate relatively deep into tissue, significant attention has been given to intravital NIR fluorescence imaging. Methodology/Principal Findings: We developed a new optical imaging-based strategy for quantitative measurement of peripheral tissue perfusion by time-series analysis of local pharmacokinetics of the NIR fluorophore, indocyanine green (ICG). Time-series NIR fluorescence images were obtained after injecting ICG intravenously in a murine hindlimb ischemia model. Mathematical modeling and computational simulations were used for translating time-series ICG images into quantitative pixel perfusion rates and a perfusion map. We could successfully predict the prognosis of ischemic hindlimbs based on the perfusion profiles obtained immediately after surgery, which were dependent on the preexisting collaterals. This method also reflected increases in perfusion and improvements in prognosis of ischemic hindlimbs induced by treatment with vascular endothelial growth factor and COMP-angiopoietin-1. Conclusions/Significance: We propose that this novel NIR-imaging-based strategy is a powerful tool for biomedical studies related to the evaluation of therapeutic interventions directed at stimulating angiogenesis.	[Kang, Yujung; Choi, Myunghwan; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon, South Korea; [Koh, Gou Young; Choi, Chulhee] Korea Adv Inst Sci & Technol, Taejon, South Korea; [Kwon, Kihwan] Ewha Womans Univ, Sch Med, Dept Cardiol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University	Kang, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Koh, Gou Young/C-1615-2011; Choi, Chulhee/C-1642-2011; Lee, Jungsul/A-7851-2013; Maunsell, John/G-5702-2010	Choi, Chulhee/0000-0001-5542-9136; Lee, Jungsul/0000-0002-8600-5851; Lauwereyns, Jan/0000-0003-0551-2550; Lee, Joonyeol/0000-0001-9929-6080; Maunsell, John/0000-0003-0018-4439; Choi, Myunghwan (Mark)/0000-0002-4235-7003	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	Chung Moon Soul Center for BioInformation and BioElectronics, KAIST	This work was supported by the Chung Moon Soul Center for BioInformation and BioElectronics, KAIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels C, 2004, PHOTOCH PHOTOBIO SCI, V3, P765, DOI 10.1039/b314241h; Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7; Cai QY, 2007, INVEST RADIOL, V42, P797, DOI 10.1097/RLI.0b013e31811ecdcd; CARSON ER, 1979, NEW ENGL J MED, V300, P1078, DOI 10.1056/NEJM197905103001904; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Crescenzi E, 2004, MOL CANCER THER, V3, P537; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gora F, 2002, J NEUROSURG ANESTH, V14, P218, DOI 10.1097/00008506-200207000-00008; Henneman MM, 2006, BRIT MED BULL, V79-80, P187, DOI 10.1093/bmb/ldl014; Keller E, 2001, J NEUROSURG ANESTH, V13, P43, DOI 10.1097/00008506-200101000-00008; LEITGEB RA, 2007, C P IEEE ENG MED BIO, V1, P530; Leung TS, 2007, APPL OPTICS, V46, P1604, DOI 10.1364/AO.46.001604; Leung TS, 2004, PEDIATR RES, V55, P134, DOI 10.1203/01.PDR.0000099775.87684.FB; Liddell RP, 2005, J VASC INTERV RADIOL, V16, P991, DOI 10.1097/01.RVI.0000161381.48445.48; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; PORTER TR, 1995, J AM COLL CARDIOL, V25, P509, DOI 10.1016/0735-1097(94)00376-2; Ryu JK, 2006, MOL THER, V13, P705, DOI 10.1016/j.ymthe.2005.10.016; Schmidt-Erfurth U, 2005, OPHTHALMOLOGY, V112, P2061, DOI 10.1016/j.ophtha.2005.09.007; Scholz D, 2006, CELL TISSUE RES, V324, P395, DOI 10.1007/s00441-005-0072-5; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; WHEELER HO, 1958, P SOC EXP BIOL MED, V99, P11; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Ziv K, 2004, MAGN RESON MED, V51, P304, DOI 10.1002/mrm.10687	30	70	74	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2009	4	1							e4275	10.1371/journal.pone.0004275	http://dx.doi.org/10.1371/journal.pone.0004275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437JE	19247494	Green Published, gold, Green Submitted			2022-12-27	WOS:000265482800005
J	Nickerson, EK; Wuthiekanun, V; Wongsuvan, G; Limmathurosakul, D; Srisamang, P; Mahavanakul, W; Thaipadungpanit, J; Shah, KR; Arayawichanont, A; Amornchai, P; Thanwisai, A; Day, NP; Peacock, SJ				Nickerson, Emma K.; Wuthiekanun, Vanaporn; Wongsuvan, Gumphol; Limmathurosakul, Direk; Srisamang, Pramot; Mahavanakul, Weera; Thaipadungpanit, Janjira; Shah, Krupal R.; Arayawichanont, Arkhom; Amornchai, Premjit; Thanwisai, Aunchalee; Day, Nicholas P.; Peacock, Sharon J.			Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; BACTEREMIA; GENES; COMMUNITY; IDENTIFICATION; DETERMINANTS; ASSOCIATION; INFECTIONS; EXPERIENCE	Background: Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world. The factors determining mortality in developing countries have not been identified. Methods: A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period. All-cause and S. aureus-attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL). Principal Findings: A total of 270 patients with invasive S. aureus infection were recruited. The range of clinical manifestations was broad and comparable to that described in developed countries. All-cause and S. aureus-attributable mortality rates were 26% and 20%, respectively. Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p < 0.001) on univariate analysis. Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p < 0.001). Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus-attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival. Conclusions: Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world. Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.			Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Afroz S, 2008, JPN J INFECT DIS, V61, P393; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Korownyk C, 2007, CAN FAM PHYSICIAN, V53, P1680; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAUTENSCHLAGER S, 1993, CLIN INFECT DIS, V16, P567, DOI 10.1093/clind/16.4.567; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; *NCCLS, 2004, M100S14  S, V24, P40; NEELA V, 2008, INT J INFECT DIS; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; Renwick L, 2008, EUR J CLIN MICROBIOL, V27, P791, DOI 10.1007/s10096-008-0503-9; Tang YW, 2007, J CLIN MICROBIOL, V45, P1867, DOI 10.1128/JCM.02100-06; Topeli A, 2000, INT J ANTIMICROB AG, V14, P57, DOI 10.1016/S0924-8579(99)00147-8; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; WILSON R, 1957, AM J MED, V22, P437, DOI 10.1016/0002-9343(57)90099-2; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004	32	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6512	10.1371/journal.pone.0006512	http://dx.doi.org/10.1371/journal.pone.0006512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19652705	Green Submitted, Green Published, gold			2022-12-27	WOS:000268637800018
J	Nickerson, EK; Hongsuwan, M; Limmathurotsakul, D; Wuthiekanun, V; Shah, KR; Srisomang, P; Mahavanakul, W; Wacharaprechasgul, T; Fowler, VG; West, TE; Teerawatanasuk, N; Becher, H; White, NJ; Chierakul, W; Day, NP; Peacock, SJ				Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; Shah, Krupal R.; Srisomang, Pramot; Mahavanakul, Weera; Wacharaprechasgul, Therapon; Fowler, Vance G., Jr.; West, T. Eoin; Teerawatanasuk, Nitaya; Becher, Harald; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.			Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; MEDICAL PROGRESS; EPIDEMIOLOGY; POPULATION; MORTALITY; CHILDREN	Background: Most information on invasive Staphylococcus aureus infections comes from temperate countries. There considerable knowledge gaps in epidemiology, treatment, drug resistance and outcome of invasive S. aureus infection in the tropics. Methods: A prospective, observational study of S. aureus bacteraemia was conducted in a 1000-bed regional hospital in northeast Thailand over 1 year. Detailed clinical data were collected and final outcomes determined at 12 weeks, and correlated with antimicrobial susceptibility profiles of infecting isolates. Principal Findings: Ninety-eight patients with S. aureus bacteraemia were recruited. The range of clinical manifestations was similar to that reported from temperate countries. The prevalence of endocarditis was 14%. The disease burden was highest at both extremes of age, whilst mortality increased with age. The all-cause mortality rate was 52%, with a mortality attributable to S. aureus of 44%. Methicillin-resistant S. aureus (MRSA) was responsible for 28% of infections, all of which were healthcare-associated. Mortality rates for MRSA and methicillin-susceptible S. aureus (MSSA) were 67% (18/27) and 46% (33/71), respectively (p = 0.11). MRSA isolates were multidrug resistant. Only vancomycin or fusidic acid would be suitable as empirical treatment options for suspected MRSA infection. Conclusions: S. aureus is a significant pathogen in northeast Thailand, with comparable clinical manifestations and a similar endocarditis prevalence but higher mortality than industrialised countries. S. aureus bacteraemia is frequently associated with exposure to healthcare settings with MRSA causing a considerable burden of disease. Further studies are required to define setting-specific strategies to reduce mortality from S. aureus bacteraemia, prevent MRSA transmission, and to define the burden of S. aureus disease and emergence of drug resistance throughout the developing world.	[Nickerson, Emma K.; Hongsuwan, Maliwan; Limmathurotsakul, Direk; Wuthiekanun, Vanaporn; White, Nicholas J.; Chierakul, Wirongrong; Day, Nicholas P.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nickerson, Emma K.; White, Nicholas J.; Day, Nicholas P.; Peacock, Sharon J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Shah, Krupal R.; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Durham, NC USA; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Wacharaprechasgul, Therapon] Sappasithiprasong Hosp, Dept Radiol, Ubon Ratchathani, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [Teerawatanasuk, Nitaya] Sappasithiprasong Hosp, Dept Microbiol, Ubon Ratchathani, Thailand; [Becher, Harald] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Duke University; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford	Nickerson, EK (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	emma@tropmedres.ac	Peacock, Sharon J/ABE-6331-2020; Thaipadungpanit, Janjira/ABF-9857-2021; Chierakul, Wirongrong/AAC-3226-2020; Fowler, Vance/AAW-2017-2021; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	Thaipadungpanit, Janjira/0000-0002-6184-3381; Chierakul, Wirongrong/0000-0003-2103-9425; White, Nick/0000-0002-1897-1978; West, T Eoin/0000-0001-5503-7204; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; National Institutes of Health [R01-AI068804, U54 AI057141]; Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS [U54 AI057141, R01 AI068804, R01-AI068804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust. EKN, MH, DL, VW, NJW, WC, NPD and SJP are funded by the Wellcome Trust. VGF is funded by National Institutes of Health award R01-AI068804. TEW is funded by National Institutes of Health award U54 AI057141 and by a Parker B. Francis Fellowship in Pulmonary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Das I, 2007, J HOSP INFECT, V65, P117, DOI 10.1016/j.jhin.2006.09.022; DHAWAN A, 1993, ANN TROP PAEDIATR, V13, P189, DOI 10.1080/02724936.1993.11747644; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Karunakaran Rina, 2007, Journal of Microbiology Immunology and Infection, V40, P432; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; *NCCLS, 2004, M100S14  S, V24, P40; Nkomo VT, 2007, HEART, V93, P1510, DOI 10.1136/hrt.2007.118810; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Powell JP, 2008, EXPERT REV ANTI-INFE, V6, P299, DOI 10.1586/14787210.6.3.299; Singhi S, 2008, INDIAN J PEDIATR, V75, P25, DOI 10.1007/s12098-008-0002-0; Wallin TR, 2008, EMERG MED CLIN N AM, V26, P431, DOI 10.1016/j.emc.2008.01.010; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wyllie DH, 2007, J HOSP INFECT, V67, P301, DOI 10.1016/j.jhin.2007.08.018	25	88	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2009	4	1							e4308	10.1371/journal.pone.0004308	http://dx.doi.org/10.1371/journal.pone.0004308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549YF	19652705	Green Published, gold			2022-12-27	WOS:000274089700007
